Citrus Sinensis ID: 013745

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------
Protein Sequence
MLRHLSHILRHPILDDQNHQHHHNHNHNLSVDEMNLKHFISNLFPCLKTSLRGGRAAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFTLPKPGKPGIQGRGGRWTTSTISAFTNTNTNTTNTNTNASSSTNTGVTKISGGNSFVEEYSRNSISYSSLDEGR
Secondary Structure (PSIPRED)
ccccccEEEEccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccHHHHHHHHccccccccccccccccccEEccccccEEEEEEcccccccHHHHHHHHHHHHHcccccccccEEcccccccEEEEEEEccccccccEEcccccccccccHHHHHHHHHHHHHHHHHHcccccccEEcccccccccccccccccccccccccccccccccccccccEEEEcccccHHHHccccccccccccccccEEEEEEccccccccccccccccHHHHHHHHccccccccccccccccccHHHHHHHHHHcEEcccccccccccHHHHHHHHccccccccccccccEEEccccccccccccccccccccccccccccccccEEEEEEEccccccccccccEEEEEcccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccccccHHHEEEEHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccEEcHHHHHHHHccccHHccccccccccEEccEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHHccEEccccEEEEEEEcccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHccccccccccccHHHEEEcccccEEEcccccccHcccccccccccEEEEEcccccHHHHHcccccEcccHEHEEEEEEEEEcccccccccccccHHHHHHHHHHHHHcccccHHccccHccccHHHHHHHHHHHHHHHcccHcccccHHHEEEEcccccEEcccccccEEEEEcccccccccccccccccccccccccccccccEEEEEEcccccccccccccccccccccccc
Coil and Loop (DISEMBL)
MLRHLSHIlrhpilddqnhqhhhnhnhnlsvdEMNLKHFISNLfpclktslrggraagesaedadgsgadswnLFFDLRTLQVATNFFSdlnqlghggfgpvyrglmpngqEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLfgccaegpekMLVYeylpnksldyfifdktksssldwttRYRIVMGVARGLlylheeaparIIHRDIKASNilldeqlnpkisdfglarlfpgedthvntfrisgthgymapeyalhGYLSVKTDVFSYGVLVLEIVSgrknhdgrlgkEKADLLSYTWTLFQGekalelvdpslakcNRDEAAMCIQLGLLCCqqsvaerpdmnsvhlmlsgdsftlpkpgkpgiqgrggrwttSTISAFTNtntnttntntnassstntgvtkisggnsfveeysrnsisyssldegr
Flexible Loop (DISEMBL)
MLRHLSHILRHPILDDQNHQHHHNHNHNLSVDEMNLKHFISNLFPCLKTSLRGGRAAGEsaedadgsgaDSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDktksssldwttrYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVsgrknhdgrlgkEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFTLPKPGKPGIQGRGGRWTTSTISAFTntntnttntntnassstntgvTKISggnsfveeysrnsisyssldegr
Low Complexity Region (SEG)
MLRHLSHILRHPILDDqnhqhhhnhnhnLSVDEMNLKHFISNLFPCLKTSLRGGRAAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFTLPKPGKPGIQGRGGRWttstisaftntntnttntntnassstntGVTKISGGNSFVEEYSRNSISYSSLDEGR
Disordered region (IsUnstruct)
****************************LSVDEMNLKHFISNLFPCLKTSL******************DSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVA*******************************************************************************************
Disordered Region (DISOPRED)
***HLSH**********************SVDEMNLKHFISNLFPCLKTS***********************LFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFTLPKPGKPGIQG*******************************NTGVTKISGGNSFVEEYSRNSIS********
Disordered Region (DISEMBL)
MLRHLSHILRHPILDDQNHQHHHNHNHNLSVDEMNLKHFISNLFPCLKTSL****************GADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFTLPKPGKPGIQGRGGRWTTSTISAFTNTNTNTTNTNTNASSSTNTGVTKISGGNSFVEEYSRN***********
Disordered Region (DISPRO)
*******ILRH***********HNHNHNLSVDEMNLKHFISNLFPCLKTSLRGG***************DSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFTLPKPGKPGIQGRGG**************************STNTG*TKISG**********************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MLRHLSHILRHPILDDQNHQHHHNHNHNLSVDEMNLKHFISNLFPCLKTSLRGGRAAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFTLPKPGKPGIQGRGGRWTTSTISAFTNTNTNTTNTNTNASSSTNTGVTKISGGNSFVEEYSRNSISYSSLDEGR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	437	2.2.26 [Sep-21-2011]
Q8GYA4	669	Cysteine-rich receptor-li	yes	no	0.716	0.467	0.540	1e-98
O81906	849	G-type lectin S-receptor-	no	no	0.718	0.369	0.519	8e-98
O65468	676	Cysteine-rich receptor-li	no	no	0.773	0.5	0.511	5e-97
Q9C5S9	674	Cysteine-rich receptor-li	no	no	0.711	0.461	0.541	1e-96
Q8S9L6	679	Cysteine-rich receptor-li	no	no	0.718	0.462	0.545	6e-96
O65405	683	Cysteine-rich receptor-li	no	no	0.688	0.440	0.550	6e-94
Q8W4G6	627	Cysteine-rich receptor-li	no	no	0.727	0.507	0.510	1e-93
Q9SY89	842	Putative G-type lectin S-	no	no	0.675	0.350	0.548	4e-92
Q9SXB8	842	G-type lectin S-receptor-	no	no	0.695	0.361	0.518	4e-92
Q9ZT07	833	G-type lectin S-receptor-	no	no	0.691	0.362	0.530	1e-91

>sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3

 Score =  360 bits (923), Expect = 1e-98,   Method: Compositional matrix adjust.
 Identities = 172/318 (54%), Positives = 232/318 (72%), Gaps = 5/318 (1%)

Query: 65  DGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQ 124
           D + ADS  L  D RT+Q AT+ F + N++G GGFG VY+G + +G E+AVK+LS  S Q
Sbjct: 327 DITTADSLQL--DYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQ 384

Query: 125 GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDW 184
           G  EF NEV L+ K+QH+NLV L G C +G E++LVYEY+PNKSLDYF+FD  K   LDW
Sbjct: 385 GEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDW 444

Query: 185 TTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244
           T RY+I+ GVARG+LYLH+++   IIHRD+KASNILLD  +NPKI+DFG+AR+F  + T 
Sbjct: 445 TRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTE 504

Query: 245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSY 304
            NT RI GT+GYM+PEYA+HG  S+K+DV+S+GVLVLEI+SG+KN          DL+SY
Sbjct: 505 ENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDLVSY 564

Query: 305 TWTLFQGEKALELVDPSLAK-CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSF 363
            W L+   + LELVDP++ + C R+E   C+ +GLLC Q+  AERP ++++ LML+ ++ 
Sbjct: 565 AWGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLTSNTV 624

Query: 364 TLPKPGKPGI--QGRGGR 379
           TLP P +PG+  Q R G+
Sbjct: 625 TLPVPRQPGLFFQSRIGK 642

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1

 Score =  357 bits (917), Expect = 8e-98,   Method: Compositional matrix adjust.
 Identities = 172/331 (51%), Positives = 228/331 (68%), Gaps = 17/331 (5%)

Query: 76  FDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKL 135
           F L  + +ATN F   N+LG GGFGPVY+G++ +G+EIAVK+LS  S QG+ EF NE+ L
Sbjct: 517 FSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIIL 576

Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVA 195
           + K+QH+NLV L GCC EG EKMLVYEY+PNKSLD+F+FD+TK + +DW  R+ I+ G+A
Sbjct: 577 IAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIA 636

Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG 255
           RGLLYLH ++  RIIHRD+K SN+LLD ++NPKISDFG+AR+F G     NT R+ GT+G
Sbjct: 637 RGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYG 696

Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKAL 315
           YM+PEYA+ G  SVK+DV+S+GVL+LEIVSG++N   R   E   L+ Y W L+   ++ 
Sbjct: 697 YMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLR-SSEHGSLIGYAWYLYTHGRSE 755

Query: 316 ELVDPSL-AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFTLPKPGKPGIQ 374
           ELVDP +   C++ EA  CI + +LC Q S AERP+M SV LML  D+ TL  P +P   
Sbjct: 756 ELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDTATLAAPRQP--- 812

Query: 375 GRGGRWTTSTISAFTNTNTNTTNTNTNASSS 405
                        FT+T  N+ + N    SS
Sbjct: 813 ------------TFTSTRRNSIDVNFALDSS 831

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O65468|CRK8_ARATH Cysteine-rich receptor-like protein kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=2 SV=2

 Score =  355 bits (910), Expect = 5e-97,   Method: Compositional matrix adjust.
 Identities = 179/350 (51%), Positives = 242/350 (69%), Gaps = 12/350 (3%)

Query: 57  AGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVK 116
           A  S    D + ADS  L  D RT+Q ATN F++ N++G GGFG VY+G   NG+E+AVK
Sbjct: 324 ASASEVGDDMATADSLQL--DYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVK 381

Query: 117 KLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDK 176
           +LS +SRQG  EF  EV ++ K+QH+NLV L G   +G E++LVYEY+PNKSLD  +FD 
Sbjct: 382 RLSKNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDP 441

Query: 177 TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
           TK + LDW  RY I+ G+ARG+LYLH+++   IIHRD+KASNILLD  +NPKI+DFG+AR
Sbjct: 442 TKQTQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMAR 501

Query: 237 LFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGK 296
           +F  + T  NT RI GT+GYMAPEYA+HG  S+K+DV+S+GVLVLEI+SGRKN       
Sbjct: 502 IFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESD 561

Query: 297 EKADLLSYTWTLFQGEKALELVDPSLA-KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVH 355
              DLL++TW L+    AL+LVDP +A  C   E   CI +GLLC Q+  A+RP +++V 
Sbjct: 562 GAQDLLTHTWRLWTNRTALDLVDPLIANNCQNSEVVRCIHIGLLCVQEDPAKRPTISTVF 621

Query: 356 LMLSGDSFTLPKPGKPG--IQGRGGRWTTSTISAFTNTNTNTTNTNTNAS 403
           +ML+ ++ TLP P +PG  IQ       +S +   T+++ +TT  +T AS
Sbjct: 622 MMLTSNTVTLPVPRQPGFFIQ-------SSPVKDPTDSDQSTTTKSTPAS 664

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9C5S9|CRK6_ARATH Cysteine-rich receptor-like protein kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1

 Score =  353 bits (907), Expect = 1e-96,   Method: Compositional matrix adjust.
 Identities = 171/316 (54%), Positives = 228/316 (72%), Gaps = 5/316 (1%)

Query: 65  DGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQ 124
           D + ADS  L  D RT+Q ATN F++ N++G GGFG VY+G   NG+E+AVK+LS +SRQ
Sbjct: 330 DMATADSLQL--DYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVKRLSKNSRQ 387

Query: 125 GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDW 184
           G  EF  EV ++ K+QH+NLV L G   +G E++LVYEY+PNKSLD  +FD TK   LDW
Sbjct: 388 GEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDPTKQIQLDW 447

Query: 185 TTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244
             RY I+ G+ARG+LYLH+++   IIHRD+KASNILLD  +NPKI+DFG+AR+F  + T 
Sbjct: 448 MQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMARIFGLDQTQ 507

Query: 245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSY 304
            NT RI GT+GYMAPEYA+HG  S+K+DV+S+GVLVLEI+SGRKN          DLL++
Sbjct: 508 DNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFGESDGAQDLLTH 567

Query: 305 TWTLFQGEKALELVDPSLAK-CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSF 363
            W L+  +KAL+LVDP +A+ C   E   CI +GLLC Q+  A+RP +++V +ML+ ++ 
Sbjct: 568 AWRLWTNKKALDLVDPLIAENCQNSEVVRCIHIGLLCVQEDPAKRPAISTVFMMLTSNTV 627

Query: 364 TLPKPGKPG--IQGRG 377
           TLP P +PG  IQ R 
Sbjct: 628 TLPVPRQPGFFIQCRA 643

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8S9L6|CRK29_ARATH Cysteine-rich receptor-like protein kinase 29 OS=Arabidopsis thaliana GN=CRK29 PE=2 SV=1

 Score =  351 bits (900), Expect = 6e-96,   Method: Compositional matrix adjust.
 Identities = 175/321 (54%), Positives = 232/321 (72%), Gaps = 7/321 (2%)

Query: 57  AGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVK 116
           +G  AED     +++ +L     TL+ AT+ FS  N+LG GGFG VY+G+ P GQEIAVK
Sbjct: 329 SGSIAED---EFSNTESLLVHFETLKTATDNFSSENELGRGGFGSVYKGVFPQGQEIAVK 385

Query: 117 KLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDK 176
           +LS +S QG  EF NE+ LL K+QH+NLV L G C +G E++LVYE++ N SLD FIFD 
Sbjct: 386 RLSGNSGQGDNEFKNEILLLAKLQHRNLVRLIGFCIQGEERLLVYEFIKNASLDQFIFDT 445

Query: 177 TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
            K   LDW  RY+++ G+ARGLLYLHE++  RIIHRD+KASNILLD+++NPKI+DFGLA+
Sbjct: 446 EKRQLLDWVVRYKMIGGIARGLLYLHEDSRFRIIHRDLKASNILLDQEMNPKIADFGLAK 505

Query: 237 LFPGEDTHVNTF--RISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHD-GR 293
           LF    T  + F  RI+GT+GYMAPEYA+HG  SVKTDVFS+GVLV+EI++G++N++ G 
Sbjct: 506 LFDSGQTMTHRFTSRIAGTYGYMAPEYAMHGQFSVKTDVFSFGVLVIEIITGKRNNNGGS 565

Query: 294 LGKEKA-DLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMN 352
            G E A DLLS+ W  ++ +  L ++DPSL   +R+E   CI +GLLC Q+S A RP M 
Sbjct: 566 NGDEDAEDLLSWVWRSWREDTILSVIDPSLTAGSRNEILRCIHIGLLCVQESAATRPTMA 625

Query: 353 SVHLMLSGDSFTLPKPGKPGI 373
           +V LML+  SFTLP P +P  
Sbjct: 626 TVSLMLNSYSFTLPTPLRPAF 646

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65405|CRK28_ARATH Cysteine-rich receptor-like protein kinase 28 OS=Arabidopsis thaliana GN=CRK28 PE=3 SV=2

 Score =  345 bits (884), Expect = 6e-94,   Method: Compositional matrix adjust.
 Identities = 168/305 (55%), Positives = 223/305 (73%), Gaps = 4/305 (1%)

Query: 73  NLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNE 132
           +L  D  TL+ AT+ FS  N+LG GGFG VY+G+   GQEIAVK+LS  S QG  EF NE
Sbjct: 346 SLVVDFETLKAATDNFSPENELGRGGFGSVYKGVFSGGQEIAVKRLSCTSGQGDSEFKNE 405

Query: 133 VKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVM 192
           + LL K+QH+NLV L G C EG E++LVYE++ N SLD FIFD  K   LDW  RY+++ 
Sbjct: 406 ILLLAKLQHRNLVRLLGFCIEGQERILVYEFIKNASLDNFIFDLKKRQLLDWGVRYKMIG 465

Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF--RI 250
           GVARGLLYLHE++  RIIHRD+KASNILLD+++NPKI+DFGLA+L+  + T  + F  +I
Sbjct: 466 GVARGLLYLHEDSRYRIIHRDLKASNILLDQEMNPKIADFGLAKLYDTDQTSTHRFTSKI 525

Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLG--KEKADLLSYTWTL 308
           +GT+GYMAPEYA++G  SVKTDVFS+GVLV+EI++G+ N++GR    +E  +LLS+ W  
Sbjct: 526 AGTYGYMAPEYAIYGQFSVKTDVFSFGVLVIEIITGKGNNNGRSNDDEEAENLLSWVWRC 585

Query: 309 FQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFTLPKP 368
           ++ +  L ++DPSL   +R E   CI +GLLC Q+S A RP M+SV LML+  S+TLP P
Sbjct: 586 WREDIILSVIDPSLTTGSRSEILRCIHIGLLCVQESPASRPTMDSVALMLNSYSYTLPTP 645

Query: 369 GKPGI 373
            +P  
Sbjct: 646 SRPAF 650

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8W4G6|CRK15_ARATH Cysteine-rich receptor-like protein kinase 15 OS=Arabidopsis thaliana GN=CRK15 PE=2 SV=2

 Score =  343 bits (880), Expect = 1e-93,   Method: Compositional matrix adjust.
 Identities = 163/319 (51%), Positives = 225/319 (70%), Gaps = 1/319 (0%)

Query: 55  RAAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIA 114
           + + ++A   DG    + +L  D R ++ ATN FS+ N++G GGFG VY+G   NG E+A
Sbjct: 304 KNSSDNAPAFDGDDITTESLQLDYRMIRAATNKFSENNKIGQGGFGEVYKGTFSNGTEVA 363

Query: 115 VKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIF 174
           VK+LS  S QG  EF NEV ++ K+QH+NLV L G    G E++LVYEY+PNKSLDYF+F
Sbjct: 364 VKRLSKSSGQGDTEFKNEVVVVAKLQHRNLVRLLGFSIGGGERILVYEYMPNKSLDYFLF 423

Query: 175 DKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL 234
           D  K + LDWT RY+++ G+ARG+LYLH+++   IIHRD+KASNILLD  +NPK++DFGL
Sbjct: 424 DPAKQNQLDWTRRYKVIGGIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKLADFGL 483

Query: 235 ARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRL 294
           AR+F  + T  NT RI GT GYMAPEYA+HG  SVK+DV+S+GVLVLEI+SG+KN+    
Sbjct: 484 ARIFGMDQTQENTSRIVGTFGYMAPEYAIHGQFSVKSDVYSFGVLVLEIISGKKNNSFYE 543

Query: 295 GKEKADLLSYTWTLFQGEKALELVDPSLA-KCNRDEAAMCIQLGLLCCQQSVAERPDMNS 353
                DL+++ W L+    AL+LVDP +   C + E   CI + LLC Q+  AERP +++
Sbjct: 544 TDGAHDLVTHAWRLWSNGTALDLVDPIIIDNCQKSEVVRCIHICLLCVQEDPAERPILST 603

Query: 354 VHLMLSGDSFTLPKPGKPG 372
           + +ML+ ++ TLP P +PG
Sbjct: 604 IFMMLTSNTVTLPVPLQPG 622

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1

 Score =  338 bits (868), Expect = 4e-92,   Method: Compositional matrix adjust.
 Identities = 164/299 (54%), Positives = 212/299 (70%), Gaps = 4/299 (1%)

Query: 75  FFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVK 134
            F   ++  AT  F++ N+LG GGFG VY+G    G+EIAVK+LS  S+QGL EF NE+ 
Sbjct: 512 IFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNEIL 571

Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGV 194
           L+ K+QH+NLV L GCC E  EKML+YEY+PNKSLD F+FD++K  SLDW  R+ ++ G+
Sbjct: 572 LIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDWRKRWEVIGGI 631

Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH 254
           ARGLLYLH ++  +IIHRD+KASNILLD ++NPKISDFG+AR+F     H NT R+ GT+
Sbjct: 632 ARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDHANTIRVVGTY 691

Query: 255 GYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKA 314
           GYMAPEYA+ G  S K+DV+S+GVL+LEIVSGRKN   R G +   L+ Y W L+   K 
Sbjct: 692 GYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFR-GTDHGSLIGYAWHLWSQGKT 750

Query: 315 LELVDPSLAKCNRD--EAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFTLPKPGKP 371
            E++DP + K  RD  EA  CI +G+LC Q SV  RP+M SV LML   +  LP P +P
Sbjct: 751 KEMIDP-IVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLESQTSQLPPPRQP 808

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3

 Score =  338 bits (867), Expect = 4e-92,   Method: Compositional matrix adjust.
 Identities = 158/305 (51%), Positives = 212/305 (69%), Gaps = 1/305 (0%)

Query: 75  FFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVK 134
            F+ + L  +T+ FS  N+LG GGFGPVY+G +P GQEIAVK+LS  S QGL E  NEV 
Sbjct: 511 LFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKLPEGQEIAVKRLSRKSGQGLEELMNEVV 570

Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGV 194
           ++ K+QH+NLV L GCC EG E+MLVYEY+P KSLD ++FD  K   LDW TR+ I+ G+
Sbjct: 571 VISKLQHRNLVKLLGCCIEGEERMLVYEYMPKKSLDAYLFDPMKQKILDWKTRFNIMEGI 630

Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH 254
            RGLLYLH ++  +IIHRD+KASNILLDE LNPKISDFGLAR+F   +   NT R+ GT+
Sbjct: 631 CRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFRANEDEANTRRVVGTY 690

Query: 255 GYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKA 314
           GYM+PEYA+ G+ S K+DVFS GV+ LEI+SGR+N      +   +LL+Y W L+   +A
Sbjct: 691 GYMSPEYAMEGFFSEKSDVFSLGVIFLEIISGRRNSSSHKEENNLNLLAYAWKLWNDGEA 750

Query: 315 LELVDPSL-AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFTLPKPGKPGI 373
             L DP++  KC   E   C+ +GLLC Q+   +RP++++V  ML+ ++ +L  P +P  
Sbjct: 751 ASLADPAVFDKCFEKEIEKCVHIGLLCVQEVANDRPNVSNVIWMLTTENMSLADPKQPAF 810

Query: 374 QGRGG 378
             R G
Sbjct: 811 IVRRG 815

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3

 Score =  337 bits (863), Expect = 1e-91,   Method: Compositional matrix adjust.
 Identities = 164/309 (53%), Positives = 222/309 (71%), Gaps = 7/309 (2%)

Query: 75  FFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVK 134
            FDL T+  ATN FS  N+LG GGFGPVY+G++ N  EIAVK+LS +S QG+ EF NEVK
Sbjct: 502 LFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRLSRNSGQGMEEFKNEVK 561

Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGV 194
           L+ K+QH+NLV + GCC E  EKMLVYEYLPNKSLDYFIF + + + LDW  R  IV G+
Sbjct: 562 LISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEEQRAELDWPKRMEIVRGI 621

Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH 254
           ARG+LYLH+++  RIIHRD+KASNILLD ++ PKISDFG+AR+F G      T R+ GT 
Sbjct: 622 ARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARIFGGNQMEGCTSRVVGTF 681

Query: 255 GYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKA 314
           GYMAPEYA+ G  S+K+DV+S+GVL+LEI++G+KN      +E ++L+ + W L++  +A
Sbjct: 682 GYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKN--SAFHEESSNLVGHIWDLWENGEA 739

Query: 315 LELVDPSLAKCNRDEAAM--CIQLGLLCCQQSVAERPDMNSVHLMLSGDSFTLPKPGKPG 372
            E++D  + +   DE  +  CIQ+GLLC Q++ ++R DM+SV +ML  ++  LP P  P 
Sbjct: 740 TEIIDNLMDQETYDEREVMKCIQIGLLCVQENASDRVDMSSVVIMLGHNATNLPNPKHPA 799

Query: 373 I---QGRGG 378
               + RGG
Sbjct: 800 FTSARRRGG 808

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	437
224118794	393	predicted protein [Populus trichocarpa]	0.894	0.994	0.774	1e-177
255586073	395	serine-threonine protein kinase, plant-t	0.899	0.994	0.769	1e-176
225455972	389	PREDICTED: G-type lectin S-receptor-like	0.885	0.994	0.769	1e-174
356522771	387	PREDICTED: G-type lectin S-receptor-like	0.874	0.987	0.731	1e-169
357500311	384	Cysteine-rich receptor-like protein kina	0.876	0.997	0.716	1e-164
449439411	391	PREDICTED: G-type lectin S-receptor-like	0.860	0.961	0.700	1e-162
388494528	384	unknown [Medicago truncatula]	0.876	0.997	0.709	1e-162
326506568	400	predicted protein [Hordeum vulgare subsp	0.844	0.922	0.626	1e-133
212275640	410	uncharacterized protein LOC100191927 [Ze	0.842	0.897	0.632	1e-131
357132628	408	PREDICTED: cysteine-rich receptor-like p	0.828	0.887	0.626	1e-128

>gi|224118794|ref|XP_002317908.1| predicted protein [Populus trichocarpa] gi|222858581|gb|EEE96128.1| predicted protein [Populus trichocarpa]

 Score =  628 bits (1619), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 309/399 (77%), Positives = 351/399 (87%), Gaps = 8/399 (2%)

Query: 39  FISNLFPCLKTSLRGGRAAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGG 98
             SNL  CL+T LR  R    +AE A     ++ +LFF+LRTL++ATNFFS+LNQLGHGG
Sbjct: 3   LFSNLCACLQTKLRIRRH--NAAEGAPDEVVETNDLFFELRTLELATNFFSELNQLGHGG 60

Query: 99  FGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158
           FGPVY+GL+PNGQE+AVKKLS+ SRQG+REFTNEVKLLLKIQHKNLV+L GCCA+GPEKM
Sbjct: 61  FGPVYKGLIPNGQEVAVKKLSLTSRQGIREFTNEVKLLLKIQHKNLVSLLGCCAQGPEKM 120

Query: 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASN 218
           LVYEYLPN+SLDYF+FDK KS+ LDWTTR++IV GVARGLLYLHEEAP RIIHRDIKASN
Sbjct: 121 LVYEYLPNRSLDYFLFDKVKSTRLDWTTRFQIVTGVARGLLYLHEEAPERIIHRDIKASN 180

Query: 219 ILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGV 278
           ILLDE LNPKISDFGLARLFPG+DTH+NTFRISGT+GYMAPEYA+HGYLSVKTDVFSYGV
Sbjct: 181 ILLDENLNPKISDFGLARLFPGDDTHMNTFRISGTYGYMAPEYAMHGYLSVKTDVFSYGV 240

Query: 279 LVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGL 338
           LVLEIVSGRKNHD +LG EKADLL+YTW L+QG K LELVDPSLA+CN DEAAMCIQLGL
Sbjct: 241 LVLEIVSGRKNHDRQLGAEKADLLNYTWMLYQGGKTLELVDPSLARCNWDEAAMCIQLGL 300

Query: 339 LCCQQSVAERPDMNSVHLMLSGDSFTLPKPGKPGIQGRGGRWTTSTISAFTNTNTNTTNT 398
           LCCQQS+A+RPDMNSVHLMLS DSFTLPKPGKPGIQGRGGRWTT+T SA       T + 
Sbjct: 301 LCCQQSIADRPDMNSVHLMLSSDSFTLPKPGKPGIQGRGGRWTTTTTSAL------TNSA 354

Query: 399 NTNASSSTNTGVTKISGGNSFVEEYSRNSISYSSLDEGR 437
               +S+TNTG T++SGGNSF++EYSRNS+S SS++EGR
Sbjct: 355 TATNASTTNTGATRVSGGNSFIDEYSRNSMSVSSIEEGR 393

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255586073|ref|XP_002533701.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526396|gb|EEF28684.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  624 bits (1610), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 307/399 (76%), Positives = 349/399 (87%), Gaps = 6/399 (1%)

Query: 39  FISNLFPCLKTSLRGGRAAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGG 98
            +S+L  CL+  L+ GR  G + +       +S +LFFDLRTLQ+ATNFFS+LNQLGHGG
Sbjct: 3   LLSSLCACLEKRLKSGRGGGGADDAD--DEVESHDLFFDLRTLQIATNFFSELNQLGHGG 60

Query: 99  FGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158
           FGPV++GL+PNG+E+AVKKLS+ SRQGLREF+NEVKLLLKIQHKNLVTL GCC EGPEKM
Sbjct: 61  FGPVFKGLIPNGEEVAVKKLSLSSRQGLREFSNEVKLLLKIQHKNLVTLLGCCVEGPEKM 120

Query: 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASN 218
           LVYEYLPNKSLDYF+FDK KS+SLDWTTR++IV GVARGLLYLHEEAP RIIHRDIKASN
Sbjct: 121 LVYEYLPNKSLDYFLFDKQKSASLDWTTRFKIVTGVARGLLYLHEEAPVRIIHRDIKASN 180

Query: 219 ILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGV 278
           ILLDE+LNPKISDFGLARLFPGEDTH+NTF+ISGTHGYMAPEYA+HGYLSVK+DVFSYGV
Sbjct: 181 ILLDERLNPKISDFGLARLFPGEDTHMNTFKISGTHGYMAPEYAMHGYLSVKSDVFSYGV 240

Query: 279 LVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGL 338
           LVLEIVSGRKN+D RLG +KAD+LSYTW L+Q  K LELVDPSLAKCNRDEAAMCIQLGL
Sbjct: 241 LVLEIVSGRKNYDIRLGGDKADILSYTWMLYQQGKTLELVDPSLAKCNRDEAAMCIQLGL 300

Query: 339 LCCQQSVAERPDMNSVHLMLSGDSFTLPKPGKPGIQGRGGRWTTSTISAFTNTNTNTTNT 398
           LCCQQ VAERPDMNSVHLML  DSFTLP+PG+PG+QGR G  TT++ SAF    TN+   
Sbjct: 301 LCCQQIVAERPDMNSVHLMLLSDSFTLPRPGRPGLQGRRGHLTTTSTSAF----TNSNTN 356

Query: 399 NTNASSSTNTGVTKISGGNSFVEEYSRNSISYSSLDEGR 437
               +SSTNTG++K SGGNSFVE+YSRNS+S SS+DEGR
Sbjct: 357 TNTNASSTNTGISKASGGNSFVEDYSRNSMSVSSIDEGR 395

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225455972|ref|XP_002278538.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase B120 [Vitis vinifera] gi|297734222|emb|CBI15469.3| unnamed protein product [Vitis vinifera]

 Score =  616 bits (1588), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 307/399 (76%), Positives = 336/399 (84%), Gaps = 12/399 (3%)

Query: 39  FISNLFPCLKTSLRGGRAAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGG 98
           F+S L  CL+  L+G   AG+   DA   G DS++LFFDLR LQVATNFFS+ N+LGHGG
Sbjct: 3   FLSLLCSCLERRLKGRGGAGDDEADAASDG-DSFDLFFDLRALQVATNFFSEFNELGHGG 61

Query: 99  FGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158
           FGPVY+GLMPNG +IAVKKLS+DSRQG+REFTNEVKLLLKIQHKNLVTL GCC EGPEKM
Sbjct: 62  FGPVYKGLMPNGTQIAVKKLSLDSRQGVREFTNEVKLLLKIQHKNLVTLLGCCVEGPEKM 121

Query: 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASN 218
           LVYEYLPNKSLD F+FDKTKS+SLDW TR+RIVMGV RGLLYLHEEAP RIIHRDIKASN
Sbjct: 122 LVYEYLPNKSLDCFLFDKTKSASLDWATRFRIVMGVVRGLLYLHEEAPERIIHRDIKASN 181

Query: 219 ILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGV 278
           ILLDE+LNPKISDFGLARLFPG++THVNTFRISGTHGYMAPEYALHGYLSVKTDVFS+GV
Sbjct: 182 ILLDEKLNPKISDFGLARLFPGDETHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSFGV 241

Query: 279 LVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGL 338
           LVLEIVSGRKNH+  L  EK DLLSYTW L+QG KALELVDPSLAKCN DEAAMCIQLGL
Sbjct: 242 LVLEIVSGRKNHNSHLSAEKTDLLSYTWKLYQGGKALELVDPSLAKCNPDEAAMCIQLGL 301

Query: 339 LCCQQSVAERPDMNSVHLMLSGDSFTLPKPGKPGIQGRGGRWTTSTISAFTNTNTNTTNT 398
           LCCQ SVA+RPDMNSVHLMLS DSF LP+PGKPGIQ                  T T+  
Sbjct: 302 LCCQASVADRPDMNSVHLMLSSDSFNLPRPGKPGIQ-----------GRTGRWTTTTSAF 350

Query: 399 NTNASSSTNTGVTKISGGNSFVEEYSRNSISYSSLDEGR 437
               ++ST+TG+TK S G+SFVEEYSRNSIS SSLDEGR
Sbjct: 351 TNTNATSTSTGITKASAGSSFVEEYSRNSISISSLDEGR 389

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356522771|ref|XP_003530019.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase B120-like [Glycine max]

 Score =  602 bits (1551), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 294/402 (73%), Positives = 337/402 (83%), Gaps = 20/402 (4%)

Query: 39  FISNLFPCLKTSLRGGRA--AGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGH 96
           F+  L PCL    +GG A   G+  +       DS++L F L TLQ+ATNFFSD+N+LGH
Sbjct: 3   FLRRLCPCLH---KGGAAFHDGDDDDIDRNHPGDSFDLIFGLHTLQLATNFFSDINRLGH 59

Query: 97  GGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE 156
           GGFGPV+RGLMPNGQE+AVKKLS++SRQG REFTNEV+LLL+IQHKNLVTL GCCAEGPE
Sbjct: 60  GGFGPVFRGLMPNGQEVAVKKLSLESRQGDREFTNEVRLLLRIQHKNLVTLLGCCAEGPE 119

Query: 157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKA 216
           KMLVYEYLPNKSLD F+FDK +SSSLDW TR+RIV GVARGLLYLHEEAP RIIHRDIKA
Sbjct: 120 KMLVYEYLPNKSLDRFLFDKRRSSSLDWATRFRIVTGVARGLLYLHEEAPERIIHRDIKA 179

Query: 217 SNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSY 276
           SNILLDE+LNPKISDFGLARLFPGED+++ TFRISGTHGYMAPEYALHGYLSVKTDVFSY
Sbjct: 180 SNILLDEKLNPKISDFGLARLFPGEDSYMQTFRISGTHGYMAPEYALHGYLSVKTDVFSY 239

Query: 277 GVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQL 336
           GVL+LEIVSGRKNHD +LG EKADLLSY W+L+QG K ++L+DP+L + N DEAAMCIQL
Sbjct: 240 GVLLLEIVSGRKNHDMQLGSEKADLLSYAWSLYQGRKIMDLIDPTLGRYNGDEAAMCIQL 299

Query: 337 GLLCCQQSVAERPDMNSVHLMLSGDSFTLPKPGKPGIQGRGGRWTTSTISAFTNTNTNTT 396
           GLLCCQ S+ ERPDMN+V+LMLS DSFTLP+PGKPGIQGR GRW T++ SA TNTN ++ 
Sbjct: 300 GLLCCQASIIERPDMNNVNLMLSSDSFTLPRPGKPGIQGRAGRWNTTSTSALTNTNASS- 358

Query: 397 NTNTNASSSTNTGVTKISGGN-SFVEEYSRNSISYSSLDEGR 437
                         T++SGG+ SFVE+YSRNSIS SS DEGR
Sbjct: 359 -------------ATRVSGGSGSFVEDYSRNSISTSSFDEGR 387

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357500311|ref|XP_003620444.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355495459|gb|AES76662.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula]

 Score =  585 bits (1509), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 286/399 (71%), Positives = 327/399 (81%), Gaps = 16/399 (4%)

Query: 39  FISNLFPCLKTSLRGGRAAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGG 98
           F S L  CL+     G   G   ++      DS NL F+L TLQ+ATNFFS+LNQLG GG
Sbjct: 2   FFSRLCFCLQKKHGTGSEDGGDDDEDTVDPGDSGNLLFELNTLQLATNFFSELNQLGRGG 61

Query: 99  FGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158
           FGPV++GLMPNG+E+A+KKLS++SRQG+REFTNEV+LLL+IQHKNLVTL GCCAEGPEKM
Sbjct: 62  FGPVFKGLMPNGEEVAIKKLSMESRQGIREFTNEVRLLLRIQHKNLVTLLGCCAEGPEKM 121

Query: 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASN 218
           LVYEYLPNKSLD+F+FDK +S  LDW TR+RIV G+ARGLLYLHEEAP RIIHRDIKASN
Sbjct: 122 LVYEYLPNKSLDHFLFDKKRS--LDWMTRFRIVTGIARGLLYLHEEAPERIIHRDIKASN 179

Query: 219 ILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGV 278
           ILLDE+LNPKISDFGLARLFPGEDTHV TFRISGTHGYMAPEYAL GYLSVKTDVFSYGV
Sbjct: 180 ILLDEKLNPKISDFGLARLFPGEDTHVQTFRISGTHGYMAPEYALRGYLSVKTDVFSYGV 239

Query: 279 LVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGL 338
           LVLEIVSGRKNHD +L  EKADLLSY W L+QG K ++L+D ++ K N DEAAMCIQLGL
Sbjct: 240 LVLEIVSGRKNHDLKLDAEKADLLSYAWKLYQGGKIMDLIDQNIGKYNGDEAAMCIQLGL 299

Query: 339 LCCQQSVAERPDMNSVHLMLSGDSFTLPKPGKPGIQGRGGRWTTSTISAFTNTNTNTTNT 398
           LCCQ S+ ERPDMNSV+LMLS DSFTLP+P +PG+QGR G+W T+T SA +NTN +T   
Sbjct: 300 LCCQASLVERPDMNSVNLMLSSDSFTLPRPSRPGVQGRVGKWNTTTTSALSNTNGST--- 356

Query: 399 NTNASSSTNTGVTKISGGNSFVEEYSRNSISYSSLDEGR 437
                       T+ SGG+SFVE+YSRNSIS SS DEGR
Sbjct: 357 -----------ATRASGGSSFVEDYSRNSISTSSFDEGR 384

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449439411|ref|XP_004137479.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase B120-like [Cucumis sativus] gi|449516693|ref|XP_004165381.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase B120-like [Cucumis sativus]

 Score =  577 bits (1488), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 274/391 (70%), Positives = 327/391 (83%), Gaps = 15/391 (3%)

Query: 48  KTSLRGGRAAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLM 107
           +  L+   +AG  A++AD     S ++FF+L TLQ+ATNFFS++N+LG+GGFGPVY+GLM
Sbjct: 15  QKKLKPANSAG--ADEADDEDV-STDIFFELNTLQIATNFFSEVNKLGNGGFGPVYKGLM 71

Query: 108 PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNK 167
           PNGQ++AVKKLS+DSRQG+++F+NEVKLLL+IQH+NLV L GCC EGPEKMLVYEYLPN+
Sbjct: 72  PNGQQVAVKKLSIDSRQGVKQFSNEVKLLLRIQHRNLVILLGCCVEGPEKMLVYEYLPNR 131

Query: 168 SLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP 227
           SLDYFIFDK KS SLDWTTR+ I+ G+ RGLLYLHEEAP+RIIHRDIKASNILLDE+LNP
Sbjct: 132 SLDYFIFDKKKSPSLDWTTRFHIITGIVRGLLYLHEEAPSRIIHRDIKASNILLDEKLNP 191

Query: 228 KISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
           KISDFGLARLFPGEDTH+NTF+I+GTHGYMAPEYA+HGYLSVK+D+FS+G+LVLEIVSGR
Sbjct: 192 KISDFGLARLFPGEDTHLNTFKIAGTHGYMAPEYAIHGYLSVKSDIFSFGILVLEIVSGR 251

Query: 288 KNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAE 347
           KNHD RLG ++ DLL Y W L+Q  + LELVD SL K N DEAAMCIQLGLLCCQ  V++
Sbjct: 252 KNHDIRLGAQQVDLLGYAWLLYQEGRVLELVDQSLTKYNVDEAAMCIQLGLLCCQAKVSD 311

Query: 348 RPDMNSVHLMLSGDSFTLPKPGKPGIQGRGGR-WTTSTISAFTNTNTNTTNTNTNASSST 406
           RPDM++ HLMLS DSFTLP+PGKPGI GR  R  TT++  AFT TNT           ST
Sbjct: 312 RPDMSTTHLMLSSDSFTLPRPGKPGIHGRAPRHRTTTSTLAFTKTNT-----------ST 360

Query: 407 NTGVTKISGGNSFVEEYSRNSISYSSLDEGR 437
           ++GVTK S  NS +E+YSRNS+S SS DEGR
Sbjct: 361 HSGVTKASTSNSLMEDYSRNSMSVSSFDEGR 391

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|388494528|gb|AFK35330.1| unknown [Medicago truncatula]

 Score =  576 bits (1485), Expect = e-162,   Method: Compositional matrix adjust.
 Identities = 283/399 (70%), Positives = 324/399 (81%), Gaps = 16/399 (4%)

Query: 39  FISNLFPCLKTSLRGGRAAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGG 98
           F S L  CL+     G   G   ++      DS NL F+L  LQ+ATNFFS+LNQLG GG
Sbjct: 2   FFSRLCFCLQKKHGTGSEDGGDDDEDTVDPGDSGNLLFELNALQLATNFFSELNQLGRGG 61

Query: 99  FGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158
           FGPV++GLMPNG+E+A+KKLS++SRQG+REFTNEV+LLL+IQHKNLVTL GCCAEGPEKM
Sbjct: 62  FGPVFKGLMPNGEEVAIKKLSMESRQGIREFTNEVRLLLRIQHKNLVTLLGCCAEGPEKM 121

Query: 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASN 218
           LVYEYLPNKSLD+F+FDK +S  LDW TR+RIV G+ARGLLYLHEEAP RIIH DIKASN
Sbjct: 122 LVYEYLPNKSLDHFLFDKKRS--LDWMTRFRIVTGIARGLLYLHEEAPERIIHGDIKASN 179

Query: 219 ILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGV 278
           ILLDE+LNPKISDFGLARLFPGEDTHV TFRISGTHGYMAPEYAL GYLSVKTDVFSYGV
Sbjct: 180 ILLDEKLNPKISDFGLARLFPGEDTHVQTFRISGTHGYMAPEYALRGYLSVKTDVFSYGV 239

Query: 279 LVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGL 338
           LVLEIVSGRKNHD +L  EKADLLSY   L+QG K ++L+D ++ K N DEAAMCIQLGL
Sbjct: 240 LVLEIVSGRKNHDLKLDAEKADLLSYARKLYQGGKIMDLIDQNIGKYNGDEAAMCIQLGL 299

Query: 339 LCCQQSVAERPDMNSVHLMLSGDSFTLPKPGKPGIQGRGGRWTTSTISAFTNTNTNTTNT 398
           LCCQ S+ ERPDMNSV+LMLS DSFTLP+P +PG+QGR G+W T+T SA +NTN +T   
Sbjct: 300 LCCQASLVERPDMNSVNLMLSSDSFTLPRPSRPGVQGRVGKWNTTTTSALSNTNGST--- 356

Query: 399 NTNASSSTNTGVTKISGGNSFVEEYSRNSISYSSLDEGR 437
                       T+ SGG+SFVE+YSRNSIS SS DEGR
Sbjct: 357 -----------ATRASGGSSFVEDYSRNSISTSSFDEGR 384

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|326506568|dbj|BAJ91325.1| predicted protein [Hordeum vulgare subsp. vulgare]

 Score =  482 bits (1241), Expect = e-133,   Method: Compositional matrix adjust.
 Identities = 238/380 (62%), Positives = 291/380 (76%), Gaps = 11/380 (2%)

Query: 63  DADGSGAD-----SWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKK 117
           D DG+GA       W LF DL  L+ AT  FSD N LG GGFGPVY+G+M  GQE+AVK+
Sbjct: 27  DEDGAGASGREGGQWTLFIDLPVLEAATAGFSDRNLLGRGGFGPVYKGVMDGGQEVAVKR 86

Query: 118 LSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKT 177
           LS++SRQG+REF NEV+LLLK+QH+NLV+L GCCA   +KMLVY Y PN SLD+ +FD+ 
Sbjct: 87  LSLESRQGVREFLNEVRLLLKVQHRNLVSLLGCCAAAGQKMLVYPYFPNGSLDHILFDRE 146

Query: 178 KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237
           K   LDW  R++I++G+ARGLLYLHEE+P +IIHRDIKASN+LLDE+LNPKISDFG+ARL
Sbjct: 147 KRVQLDWPKRHQIILGLARGLLYLHEESPVKIIHRDIKASNVLLDEKLNPKISDFGMARL 206

Query: 238 FPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKE 297
           F  + THVNTFRISGT+GYMAPEYA++GYLS KTDVFS+G+LVLEIVSGRKN D  LG E
Sbjct: 207 FLEDATHVNTFRISGTYGYMAPEYAMNGYLSTKTDVFSFGMLVLEIVSGRKNIDRHLGDE 266

Query: 298 KADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLM 357
           K DLL+YTW L +  ++LE+VDP L+  +  E  MC+QLGLLCCQ  V+ERPDM SVHLM
Sbjct: 267 KVDLLNYTWKLSEEGRSLEIVDPGLSGWDAGEVGMCVQLGLLCCQAVVSERPDMYSVHLM 326

Query: 358 LSGDSFTLPKPGKPGIQGRGGRWTTSTISAFTNTNTNTTNTNTNASSSTNTGVTKISGGN 417
           LS DSFTLPKPGKP I GR GRW    +S   + ++  +  NTN++ +T+T  TK S   
Sbjct: 327 LSSDSFTLPKPGKPAIHGRIGRW----MSTTGSASSAASGGNTNSTFATDT--TKASTLG 380

Query: 418 SFVEEYSRNSISYSSLDEGR 437
           +  E+ SRNSIS S   EGR
Sbjct: 381 NIAEDESRNSISISFTTEGR 400

Source: Hordeum vulgare subsp. vulgare

Species: Hordeum vulgare

Genus: Hordeum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|212275640|ref|NP_001130823.1| uncharacterized protein LOC100191927 [Zea mays] gi|194689254|gb|ACF78711.1| unknown [Zea mays] gi|194690208|gb|ACF79188.1| unknown [Zea mays] gi|195607356|gb|ACG25508.1| hypothetical protein [Zea mays] gi|414876530|tpg|DAA53661.1| TPA: putative protein kinase superfamily protein isoform 1 [Zea mays] gi|414876531|tpg|DAA53662.1| TPA: putative protein kinase superfamily protein isoform 2 [Zea mays] gi|414876532|tpg|DAA53663.1| TPA: putative protein kinase superfamily protein isoform 3 [Zea mays]

 Score =  473 bits (1218), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 234/370 (63%), Positives = 289/370 (78%), Gaps = 2/370 (0%)

Query: 70  DSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREF 129
           D W+LF DL  L+ AT  FSD N LG GGFGPVY+G+M NGQ+IAVK+LS+ SRQG+REF
Sbjct: 41  DEWSLFIDLPVLEAATGGFSDDNLLGRGGFGPVYKGVMENGQQIAVKRLSLGSRQGVREF 100

Query: 130 TNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYR 189
            NEV+LLLK+QH+NLV+L GCCA    KMLVY Y PN SLD+ +FD+ K ++LDW  RY 
Sbjct: 101 LNEVRLLLKVQHRNLVSLLGCCASSGHKMLVYPYFPNSSLDHTLFDRNKCAALDWPKRYH 160

Query: 190 IVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR 249
           I++G+ARGLLYLHEE+P +IIHRDIKASN+LLD+QLNPKISDFG+ARLF  + THVNTFR
Sbjct: 161 IIVGLARGLLYLHEESPVKIIHRDIKASNVLLDDQLNPKISDFGMARLFLEDATHVNTFR 220

Query: 250 ISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLF 309
           ISGT+GYMAPEYA++GYLS KTDVFS+G+LVLEIVSGRKN    L  EK DLLSYTW LF
Sbjct: 221 ISGTYGYMAPEYAMNGYLSAKTDVFSFGILVLEIVSGRKNIVRHLDDEKVDLLSYTWKLF 280

Query: 310 QGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFTLPKPG 369
              ++LE+VDPSL+  + D+A +CIQLGLLCCQ +V++RPDM+SVHLMLS DSFTLP+PG
Sbjct: 281 GEGRSLEIVDPSLSSPDSDQALLCIQLGLLCCQAAVSDRPDMHSVHLMLSSDSFTLPRPG 340

Query: 370 KPGIQGRGGRWTTSTISAFTNTNTNTTNTNTNA-SSSTNTGVTKISG-GNSFVEEYSRNS 427
           KP + GR GRWT +T +A  + + ++    T+     T+T  T+ S    S  E+ SRNS
Sbjct: 341 KPAVHGRTGRWTAATTTASGSASASSATNTTSTFGFGTDTNTTRASALLASVAEDESRNS 400

Query: 428 ISYSSLDEGR 437
           IS S   +GR
Sbjct: 401 ISISFTTDGR 410

Source: Zea mays

Species: Zea mays

Genus: Zea

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357132628|ref|XP_003567931.1| PREDICTED: cysteine-rich receptor-like protein kinase 41-like [Brachypodium distachyon]

 Score =  464 bits (1193), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 230/367 (62%), Positives = 286/367 (77%), Gaps = 5/367 (1%)

Query: 74  LFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEV 133
           +F DL  L+ AT  FSDLN LG GGFGPVY+G++ +G+EIAVKKLS++SRQG+REF NEV
Sbjct: 44  IFIDLPVLEAATAGFSDLNLLGRGGFGPVYKGVLGSGEEIAVKKLSLESRQGVREFLNEV 103

Query: 134 KLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG 193
           +LLLK+QH+NLV+L GCCA   +KMLVY + PN SLD+ +FD+ K + LDW  RY+I++G
Sbjct: 104 RLLLKVQHRNLVSLLGCCAASGQKMLVYPFFPNGSLDHILFDRDKRAQLDWPKRYQIILG 163

Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           +ARGLLYLHEE+P +IIHRDIKASN+LLDE+LNPKISDFG+ARLF  + +HVNTFRISGT
Sbjct: 164 LARGLLYLHEESPVKIIHRDIKASNVLLDEKLNPKISDFGMARLFLEDASHVNTFRISGT 223

Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEK 313
           +GYMAPEYA++GYLS KTDVFS+G+LVLEIVSGRKN D RL  EK DLL+YTW L++  +
Sbjct: 224 YGYMAPEYAMNGYLSTKTDVFSFGMLVLEIVSGRKNIDRRLDDEKVDLLNYTWKLWEEGR 283

Query: 314 ALELVDPSLA-KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFTLPKPGKPG 372
           +LE +DP L+   + DEAA+C+QLGLLCCQ  V+ERPDM SVHLMLS  SFTLP+PGKP 
Sbjct: 284 SLETLDPGLSGGWDEDEAALCVQLGLLCCQAVVSERPDMYSVHLMLSSGSFTLPRPGKPA 343

Query: 373 IQGRGGRW--TTSTISAFTNTNTNTTNTNTNASSSTNTGVTKISGGNSFVEEYSRNSISY 430
           I GR GRW  TT+T SA  + +  T    +N + +T      +  G    E+ SRNSIS 
Sbjct: 344 IHGRVGRWISTTTTPSASGSGSGTTNTNTSNTTDTTRASAGLVLEG--IAEDESRNSISV 401

Query: 431 SSLDEGR 437
           S   EGR
Sbjct: 402 SFTTEGR 408

Source: Brachypodium distachyon

Species: Brachypodium distachyon

Genus: Brachypodium

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	437
TAIR|locus:2121676	669	CRK10 "cysteine-rich RLK (RECE	0.716	0.467	0.540	8.3e-90
TAIR|locus:2141201	679	CRK29 "cysteine-rich RLK (RECE	0.713	0.459	0.561	2.2e-89
TAIR|locus:2141176	849	B120 [Arabidopsis thaliana (ta	0.700	0.360	0.540	3.6e-89
TAIR|locus:2121651	676	CRK8 "cysteine-rich RLK (RECEP	0.718	0.464	0.536	4.1e-88
TAIR|locus:2200908	842	AT1G61610 [Arabidopsis thalian	0.695	0.361	0.540	8.9e-86
TAIR|locus:2134603	665	CRK41 "cysteine-rich RLK (RECE	0.736	0.484	0.512	3.4e-84
TAIR|locus:2131684	783	AT4G27290 [Arabidopsis thalian	0.679	0.379	0.543	9.1e-84
TAIR|locus:2131694	815	AT4G27300 [Arabidopsis thalian	0.745	0.4	0.498	9.1e-84
TAIR|locus:2077147	676	CRK4 "cysteine-rich RLK (RECEP	0.725	0.468	0.5	1.5e-83
TAIR|locus:2123111	669	CRK34 "cysteine-rich RLK (RECE	0.695	0.454	0.516	1.5e-83

TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 896 (320.5 bits), Expect = 8.3e-90, P = 8.3e-90
 Identities = 172/318 (54%), Positives = 232/318 (72%)

Query:    65 DGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQ 124
             D + ADS  L  D RT+Q AT+ F + N++G GGFG VY+G + +G E+AVK+LS  S Q
Sbjct:   327 DITTADSLQL--DYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQ 384

Query:   125 GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDW 184
             G  EF NEV L+ K+QH+NLV L G C +G E++LVYEY+PNKSLDYF+FD  K   LDW
Sbjct:   385 GEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDW 444

Query:   185 TTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244
             T RY+I+ GVARG+LYLH+++   IIHRD+KASNILLD  +NPKI+DFG+AR+F  + T 
Sbjct:   445 TRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTE 504

Query:   245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSY 304
              NT RI GT+GYM+PEYA+HG  S+K+DV+S+GVLVLEI+SG+KN          DL+SY
Sbjct:   505 ENTSRIVGTYGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDLVSY 564

Query:   305 TWTLFQGEKALELVDPSLAK-CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSF 363
              W L+   + LELVDP++ + C R+E   C+ +GLLC Q+  AERP ++++ LML+ ++ 
Sbjct:   565 AWGLWSNGRPLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLTSNTV 624

Query:   364 TLPKPGKPGI--QGRGGR 379
             TLP P +PG+  Q R G+
Sbjct:   625 TLPVPRQPGLFFQSRIGK 642

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

TAIR|locus:2141201 CRK29 "cysteine-rich RLK (RECEPTOR-like protein kinase) 29" [Arabidopsis thaliana (taxid:3702)]

 Score = 892 (319.1 bits), Expect = 2.2e-89, P = 2.2e-89
 Identities = 179/319 (56%), Positives = 236/319 (73%)

Query:    57 AGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVK 116
             +G  AED + S  +S  + F+  TL+ AT+ FS  N+LG GGFG VY+G+ P GQEIAVK
Sbjct:   329 SGSIAED-EFSNTESLLVHFE--TLKTATDNFSSENELGRGGFGSVYKGVFPQGQEIAVK 385

Query:   117 KLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDK 176
             +LS +S QG  EF NE+ LL K+QH+NLV L G C +G E++LVYE++ N SLD FIFD 
Sbjct:   386 RLSGNSGQGDNEFKNEILLLAKLQHRNLVRLIGFCIQGEERLLVYEFIKNASLDQFIFDT 445

Query:   177 TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
              K   LDW  RY+++ G+ARGLLYLHE++  RIIHRD+KASNILLD+++NPKI+DFGLA+
Sbjct:   446 EKRQLLDWVVRYKMIGGIARGLLYLHEDSRFRIIHRDLKASNILLDQEMNPKIADFGLAK 505

Query:   237 LFP-GED-THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRL 294
             LF  G+  TH  T RI+GT+GYMAPEYA+HG  SVKTDVFS+GVLV+EI++G++N++G  
Sbjct:   506 LFDSGQTMTHRFTSRIAGTYGYMAPEYAMHGQFSVKTDVFSFGVLVIEIITGKRNNNGGS 565

Query:   295 -GKEKA-DLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMN 352
              G E A DLLS+ W  ++ +  L ++DPSL   +R+E   CI +GLLC Q+S A RP M 
Sbjct:   566 NGDEDAEDLLSWVWRSWREDTILSVIDPSLTAGSRNEILRCIHIGLLCVQESAATRPTMA 625

Query:   353 SVHLMLSGDSFTLPKPGKP 371
             +V LML+  SFTLP P +P
Sbjct:   626 TVSLMLNSYSFTLPTPLRP 644

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005773 "vacuole" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)]

 Score = 890 (318.4 bits), Expect = 3.6e-89, P = 3.6e-89
 Identities = 167/309 (54%), Positives = 223/309 (72%)

Query:    65 DGSGADSWNL-FFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR 123
             +G   ++  L  F L  + +ATN F   N+LG GGFGPVY+G++ +G+EIAVK+LS  S 
Sbjct:   505 EGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSG 564

Query:   124 QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLD 183
             QG+ EF NE+ L+ K+QH+NLV L GCC EG EKMLVYEY+PNKSLD+F+FD+TK + +D
Sbjct:   565 QGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALID 624

Query:   184 WTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243
             W  R+ I+ G+ARGLLYLH ++  RIIHRD+K SN+LLD ++NPKISDFG+AR+F G   
Sbjct:   625 WKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQN 684

Query:   244 HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS 303
               NT R+ GT+GYM+PEYA+ G  SVK+DV+S+GVL+LEIVSG++N   R   E   L+ 
Sbjct:   685 EANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLR-SSEHGSLIG 743

Query:   304 YTWTLFQGEKALELVDPSL-AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDS 362
             Y W L+   ++ ELVDP +   C++ EA  CI + +LC Q S AERP+M SV LML  D+
Sbjct:   744 YAWYLYTHGRSEELVDPKIRVTCSKREALRCIHVAMLCVQDSAAERPNMASVLLMLESDT 803

Query:   363 FTLPKPGKP 371
              TL  P +P
Sbjct:   804 ATLAAPRQP 812

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006979 "response to oxidative stress" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2121651 CRK8 "cysteine-rich RLK (RECEPTOR-like protein kinase) 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 880 (314.8 bits), Expect = 4.1e-88, P = 4.1e-88
 Identities = 170/317 (53%), Positives = 226/317 (71%)

Query:    57 AGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVK 116
             A  S    D + ADS  L  D RT+Q ATN F++ N++G GGFG VY+G   NG+E+AVK
Sbjct:   324 ASASEVGDDMATADSLQL--DYRTIQTATNDFAESNKIGRGGFGEVYKGTFSNGKEVAVK 381

Query:   117 KLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDK 176
             +LS +SRQG  EF  EV ++ K+QH+NLV L G   +G E++LVYEY+PNKSLD  +FD 
Sbjct:   382 RLSKNSRQGEAEFKTEVVVVAKLQHRNLVRLLGFSLQGEERILVYEYMPNKSLDCLLFDP 441

Query:   177 TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
             TK + LDW  RY I+ G+ARG+LYLH+++   IIHRD+KASNILLD  +NPKI+DFG+AR
Sbjct:   442 TKQTQLDWMQRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDADINPKIADFGMAR 501

Query:   237 LFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGK 296
             +F  + T  NT RI GT+GYMAPEYA+HG  S+K+DV+S+GVLVLEI+SGRKN       
Sbjct:   502 IFGLDQTQDNTSRIVGTYGYMAPEYAMHGQFSMKSDVYSFGVLVLEIISGRKNSSFDESD 561

Query:   297 EKADLLSYTWTLFQGEKALELVDPSLAK-CNRDEAAMCIQLGLLCCQQSVAERPDMNSVH 355
                DLL++TW L+    AL+LVDP +A  C   E   CI +GLLC Q+  A+RP +++V 
Sbjct:   562 GAQDLLTHTWRLWTNRTALDLVDPLIANNCQNSEVVRCIHIGLLCVQEDPAKRPTISTVF 621

Query:   356 LMLSGDSFTLPKPGKPG 372
             +ML+ ++ TLP P +PG
Sbjct:   622 MMLTSNTVTLPVPRQPG 638

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)]

 Score = 858 (307.1 bits), Expect = 8.9e-86, P = 8.9e-86
 Identities = 167/309 (54%), Positives = 217/309 (70%)

Query:    66 GSGADSWNL-FFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQ 124
             G   D+ +L  F   ++  AT  F++ N+LG GGFG VY+G    G+EIAVK+LS  S+Q
Sbjct:   502 GDQVDTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQ 561

Query:   125 GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDW 184
             GL EF NE+ L+ K+QH+NLV L GCC E  EKML+YEY+PNKSLD F+FD++K  SLDW
Sbjct:   562 GLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDW 621

Query:   185 TTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244
               R+ ++ G+ARGLLYLH ++  +IIHRD+KASNILLD ++NPKISDFG+AR+F     H
Sbjct:   622 RKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDH 681

Query:   245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSY 304
              NT R+ GT+GYMAPEYA+ G  S K+DV+S+GVL+LEIVSGRKN   R G +   L+ Y
Sbjct:   682 ANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFR-GTDHGSLIGY 740

Query:   305 TWTLFQGEKALELVDPSLAKCNRD--EAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDS 362
              W L+   K  E++DP + K  RD  EA  CI +G+LC Q SV  RP+M SV LML   +
Sbjct:   741 AWHLWSQGKTKEMIDP-IVKDTRDVTEAMRCIHVGMLCTQDSVIHRPNMGSVLLMLESQT 799

Query:   363 FTLPKPGKP 371
               LP P +P
Sbjct:   800 SQLPPPRQP 808

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

TAIR|locus:2134603 CRK41 "cysteine-rich RLK (RECEPTOR-like protein kinase) 41" [Arabidopsis thaliana (taxid:3702)]

 Score = 843 (301.8 bits), Expect = 3.4e-84, P = 3.4e-84
 Identities = 168/328 (51%), Positives = 225/328 (68%)

Query:    55 RAAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIA 114
             R  G+  E+     A    L FD  T+++ATN FS  NQLG GGFG VY+G++  G+EIA
Sbjct:   313 RHEGKDLEELMIKDAQLLQLDFD--TIRLATNDFSRDNQLGEGGFGAVYKGVLDYGEEIA 370

Query:   115 VKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIF 174
             VK+LS+ S QG  EF NEV L+ K+QH+NLV L G C +G E++L+YE+  N SLD++IF
Sbjct:   371 VKRLSMKSGQGDNEFINEVSLVAKLQHRNLVRLLGFCLQGEERILIYEFFKNTSLDHYIF 430

Query:   175 DKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL 234
             D  +   LDW TRYRI+ GVARGLLYLHE++  +I+HRD+KASN+LLD+ +NPKI+DFG+
Sbjct:   431 DSNRRMILDWETRYRIISGVARGLLYLHEDSRFKIVHRDMKASNVLLDDAMNPKIADFGM 490

Query:   235 ARLFPGEDTHVNTF--RISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
             A+LF  + T    F  +++GT+GYMAPEYA+ G  SVKTDVFS+GVLVLEI+ G+KN+  
Sbjct:   491 AKLFDTDQTSQTRFTSKVAGTYGYMAPEYAMSGEFSVKTDVFSFGVLVLEIIKGKKNNWS 550

Query:   293 RLGKEKADLLSYTWTLFQGEKALELVDPSLAKCN--RDEAAMCIQLGLLCCQQSVAERPD 350
                     LLSY W  ++  + L +VDPSL +     DE   CI +GLLC Q++   RP 
Sbjct:   551 PEEDSSLFLLSYVWKSWREGEVLNIVDPSLVETIGVSDEIMKCIHIGLLCVQENAESRPT 610

Query:   351 MNSVHLMLSGDSFTLPKPGKPGIQGRGG 378
             M SV +ML+ +SFTLP+P +P      G
Sbjct:   611 MASVVVMLNANSFTLPRPSQPAFYSGDG 638

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)]

 Score = 839 (300.4 bits), Expect = 9.1e-84, P = 9.1e-84
 Identities = 163/300 (54%), Positives = 213/300 (71%)

Query:    75 FFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVK 134
             F DL T+  AT+ FS  N+LG GGFGPVY+G +  GQE+AVK+LS  SRQG+ EF NE+K
Sbjct:   452 FLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRLSRTSRQGVEEFKNEIK 511

Query:   135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGV 194
             L+ K+QH+NLV + G C +  E+ML+YEY PNKSLD FIFDK +   LDW  R  I+ G+
Sbjct:   512 LIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRELDWPKRVEIIKGI 571

Query:   195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH 254
             ARG+LYLHE++  RIIHRD+KASN+LLD  +N KISDFGLAR   G++T  NT R+ GT+
Sbjct:   572 ARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGDETEANTTRVVGTY 631

Query:   255 GYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKA 314
             GYM+PEY + GY S+K+DVFS+GVLVLEIVSGR+N   R  + K +LL + W  F  +KA
Sbjct:   632 GYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEEHKLNLLGHAWRQFLEDKA 691

Query:   315 LELVDPSLAKCNRD--EAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFTLPKPGKPG 372
              E++D ++ +   D  E    I +GLLC QQ   +RP+M+ V LMLS +   L  P +PG
Sbjct:   692 YEIIDEAVNESCTDISEVLRVIHIGLLCVQQDPKDRPNMSVVVLMLSSEMLLLD-PRQPG 750

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)]

 Score = 839 (300.4 bits), Expect = 9.1e-84, P = 9.1e-84
 Identities = 166/333 (49%), Positives = 229/333 (68%)

Query:    43 LFPCLKTSLRGGRAAGESAEDADGSGADSWNL-FFDLRTLQVATNFFSDLNQLGHGGFGP 101
             +F C +  +   R  GE+     G   +  +L  FD +T+ +AT+ FS +N LG GGFGP
Sbjct:   457 VFACFRKKIMK-RYRGENFRK--GIEEEDLDLPIFDRKTISIATDDFSYVNFLGRGGFGP 513

Query:   102 VYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY 161
             VY+G + +GQEIAVK+LS +S QG+ EF NEVKL+ K+QH+NLV L GCC +G E ML+Y
Sbjct:   514 VYKGKLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIY 573

Query:   162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL 221
             EY+PNKSLD+FIFD+ +S+ LDW  R  I+ GVARG+LYLH+++  RIIHRD+KA N+LL
Sbjct:   574 EYMPNKSLDFFIFDERRSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLL 633

Query:   222 DEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVL 281
             D  +NPKISDFGLA+ F G+ +  +T R+ GT+GYM PEYA+ G+ SVK+DVFS+GVLVL
Sbjct:   634 DNDMNPKISDFGLAKSFGGDQSESSTNRVVGTYGYMPPEYAIDGHFSVKSDVFSFGVLVL 693

Query:   282 EIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS-LAKCNR-DEAAMCIQLGLL 339
             EI++G+ N   R      +LL + W ++  ++ +E+ +   L + +   E   CI + LL
Sbjct:   694 EIITGKTNRGFRHADHDLNLLGHVWKMWVEDREIEVPEEEWLEETSVIPEVLRCIHVALL 753

Query:   340 CCQQSVAERPDMNSVHLMLSGDSFTLPKPGKPG 372
             C QQ   +RP M SV LM   DS +LP P +PG
Sbjct:   754 CVQQKPEDRPTMASVVLMFGSDS-SLPHPTQPG 785

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2077147 CRK4 "cysteine-rich RLK (RECEPTOR-like protein kinase) 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 837 (299.7 bits), Expect = 1.5e-83, P = 1.5e-83
 Identities = 162/324 (50%), Positives = 225/324 (69%)

Query:    59 ESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKL 118
             E ++D   +G+    L FD + ++ ATN F + N+LG GGFG VY+G+ P+G ++AVK+L
Sbjct:   326 EESDDITTAGS----LQFDFKAIEAATNKFCETNKLGQGGFGEVYKGIFPSGVQVAVKRL 381

Query:   119 SVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTK 178
             S  S QG REF NEV ++ K+QH+NLV L G C E  E++LVYE++PNKSLDYFIFD T 
Sbjct:   382 SKTSGQGEREFANEVIVVAKLQHRNLVRLLGFCLERDERILVYEFVPNKSLDYFIFDSTM 441

Query:   179 SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238
              S LDWT RY+I+ G+ARG+LYLH+++   IIHRD+KA NILL + +N KI+DFG+AR+F
Sbjct:   442 QSLLDWTRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLGDDMNAKIADFGMARIF 501

Query:   239 PGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRL--GK 296
               + T  NT RI GT+GYM+PEYA++G  S+K+DV+S+GVLVLEI+SG+KN +     G 
Sbjct:   502 GMDQTEANTRRIVGTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGKKNSNVYQMDGT 561

Query:   297 EKADLLSYTWTLFQGEKALELVDPSLAKCNR-DEAAMCIQLGLLCCQQSVAERPDMNSVH 355
                +L++YTW L+     LELVDPS     R +E + CI + LLC Q+   +RP M+++ 
Sbjct:   562 SAGNLVTYTWRLWSNGSPLELVDPSFRDNYRINEVSRCIHIALLCVQEEAEDRPTMSAIV 621

Query:   356 LMLSGDSFTLPKPGKPGIQGRGGR 379
              ML+  S  L  P +PG   R  +
Sbjct:   622 QMLTTSSIALAVPQRPGFFFRSSK 645

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006952 "defense response" evidence=TAS

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0012501 "programmed cell death" evidence=IMP

GO:0042742 "defense response to bacterium" evidence=IEP

TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)]

 Score = 837 (299.7 bits), Expect = 1.5e-83, P = 1.5e-83
 Identities = 159/308 (51%), Positives = 220/308 (71%)

Query:    73 NLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNE 132
             +L F  +T++ AT+ FSD N +G GGFG VYRG + +G E+AVK+LS  S QG  EF NE
Sbjct:   330 SLQFSFKTIEAATDKFSDSNMIGRGGFGEVYRGKLSSGPEVAVKRLSKTSGQGAEEFKNE 389

Query:   133 VKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVM 192
               L+ K+QHKNLV L G C EG EK+LVYE++PNKSLDYF+FD  K   LDWT RY I+ 
Sbjct:   390 AVLVSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLFDPAKQGELDWTRRYNIIG 449

Query:   193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISG 252
             G+ARG+LYLH+++   IIHRD+KASNILLD  +NPKI+DFG+AR+F  + +  NT RI+G
Sbjct:   450 GIARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGVDQSQANTRRIAG 509

Query:   253 THGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDG-RLGKEKADLLSYTWTLFQG 311
             T GYM+PEYA+ G+ S+K+DV+S+GVLVLEI+SG+KN     +    ++L+++ W L++ 
Sbjct:   510 TFGYMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKKNSSFYNIDDSGSNLVTHAWRLWRN 569

Query:   312 EKALELVDPSLAKCNRD-EAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFTLPKPGK 370
                LELVDP++ +  +  EA  CI + LLC Q+  A+RP + ++ +ML+  + TL  P  
Sbjct:   570 GSPLELVDPTIGESYQSSEATRCIHIALLCVQEDPADRPLLPAIIMMLTSSTTTLHVPRA 629

Query:   371 PG--IQGR 376
             PG  + GR
Sbjct:   630 PGFCLSGR 637

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.824
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00017705001 SubName- Full=Chromosome chr17 scaffold_16, whole genome shotgun sequence; (389 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	437
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-52
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-51
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	7e-50
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-49
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-47
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-45
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-44
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-38
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-37
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-34
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-33
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	5e-32
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-31
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-30
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-30
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-30
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	9e-30
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-29
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-29
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	5e-29
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	6e-29
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-29
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-27
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-27
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-27
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-27
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-26
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-26
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-26
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	4e-26
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-26
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-26
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-26
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	8e-26
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-25
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-25
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-25
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-25
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	6e-25
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-24
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-24
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-24
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-24
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-24
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	7e-24
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	9e-24
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-23
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-23
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-23
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-23
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	5e-23
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	7e-23
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-23
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	8e-23
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-23
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-22
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-22
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-22
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-22
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-22
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-22
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-22
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-22
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-22
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-22
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-22
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-21
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-21
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-21
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-21
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-21
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-21
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-21
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-21
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-21
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-21
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-21
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-20
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-20
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-20
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-20
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-20
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-20
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	3e-20
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-20
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-20
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	4e-20
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-20
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	6e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	7e-20
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-19
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-19
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-19
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-19
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-19
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-19
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	8e-19
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-18
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-18
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-18
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-18
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-18
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-18
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-18
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-18
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-18
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-18
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-18
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-18
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-18
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-18
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	6e-18
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-18
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-18
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	8e-18
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	9e-18
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-17
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-17
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-17
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-17
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-17
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-17
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	5e-17
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	5e-17
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	6e-17
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	8e-17
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-16
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-16
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-16
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-16
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-16
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-16
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-16
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-16
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-16
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-16
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-16
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-16
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-16
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-16
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-16
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	7e-16
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-16
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-15
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-15
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-15
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-15
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-15
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-15
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-15
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-15
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-15
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-15
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-15
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-15
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-15
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-15
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	9e-15
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	9e-15
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-14
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-14
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-14
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-14
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-14
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-14
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-14
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-14
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-14
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	5e-14
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-14
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	9e-14
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-13
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-13
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-13
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-13
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-13
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-13
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-13
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-13
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-13
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-13
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	6e-13
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	7e-13
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	7e-13
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	8e-13
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	8e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	9e-13
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-12
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-12
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-12
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-12
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	1e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-12
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-12
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	6e-12
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	8e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	9e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-11
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-11
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-11
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-11
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	4e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-11
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	5e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	5e-11
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	6e-11
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	7e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	9e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	9e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-10
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-10
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-10
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	4e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	7e-10
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-09
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-09
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-09
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-09
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-09
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	4e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	7e-09
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	9e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	9e-09
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	9e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-08
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	4e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	4e-08
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-08
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	6e-08
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	7e-08
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-07
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	3e-07
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-07
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	5e-07
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	6e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	7e-07
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	9e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-06
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-06
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-06
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	4e-06
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	5e-05
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	5e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	2e-04
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-04
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.001
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	0.002
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	0.003
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  174 bits (443), Expect = 3e-52
 Identities = 71/194 (36%), Positives = 102/194 (52%), Gaps = 11/194 (5%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLVTLFGCC 151
           LG GGFG VY       G+++A+K +  +    L E    E+++L K+ H N+V L+G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 152 AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIH 211
            +     LV EY    SL   +  K     L      RI++ +  GL YLH      IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLL--KENEGKLSEDEILRILLQILEGLEYLHSN---GIIH 115

Query: 212 RDIKASNILLDE-QLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH-GYLSV 269
           RD+K  NILLD      K++DFGL++L   + + + T    GT  YMAPE  L  GY S 
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV--GTPAYMAPEVLLGKGYYSE 173

Query: 270 KTDVFSYGVLVLEI 283
           K+D++S GV++ E+
Sbjct: 174 KSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  171 bits (437), Expect = 7e-51
 Identities = 84/283 (29%), Positives = 125/283 (44%), Gaps = 44/283 (15%)

Query: 91  LNQLGHGGFGPVYRG-----LMPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNL 144
             +LG G FG VY+G           E+AVK L  D S Q + EF  E +++ K+ H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L G C E     +V EY+    L  ++  +     L  +      + +ARG+ YL  +
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLESK 121

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG---YMAPEY 261
                IHRD+ A N L+ E L  KISDFGL+R    +D +    R  G      +MAPE 
Sbjct: 122 ---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY----RKRGGKLPIRWMAPES 174

Query: 262 ALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD- 319
              G  + K+DV+S+GVL+ EI + G + + G   +E                 LE +  
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE----------------VLEYLKN 218

Query: 320 ----PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML 358
               P    C  +       L L C  +   +RP  + +  +L
Sbjct: 219 GYRLPQPPNCPPE----LYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  169 bits (431), Expect = 7e-50
 Identities = 83/284 (29%), Positives = 128/284 (45%), Gaps = 40/284 (14%)

Query: 92  NQLGHGGFGPVYRG--LMPNGQEI--AVKKL-SVDSRQGLREFTNEVKLLLKIQHKNLVT 146
            +LG G FG VY+G     +G+    AVK L    S +  ++F  E +++ K+ H N+V 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFI------FDKTKSSSLDWTTRYRIVMGVARGLLY 200
           L G C E     LV EY+    L  ++      F   + S+L         + +A+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG----- 255
           L  +   + +HRD+ A N L+ E L  KISDFGL+R     D + + +    T G     
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSR-----DVYDDDYYRKKTGGKLPIR 172

Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKA 314
           +MAPE    G  + K+DV+S+GVL+ EI + G   + G   +E  + L          K 
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL---------RKG 223

Query: 315 LELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML 358
             L  P    C  +   +     L C Q    +RP  + +   L
Sbjct: 224 YRLPKPEY--CPDELYELM----LSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  168 bits (429), Expect = 1e-49
 Identities = 87/282 (30%), Positives = 131/282 (46%), Gaps = 41/282 (14%)

Query: 91  LNQLGHGGFGPVYRG-----LMPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNL 144
             +LG G FG VY+G           E+AVK L  D S Q + EF  E +++ K+ H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L G C E    M+V EY+P   L  ++  K +   L  +      + +ARG+ YL  +
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLESK 122

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG---YMAPEY 261
                IHRD+ A N L+ E L  KISDFGL+R    +D +    ++ G      +MAPE 
Sbjct: 123 ---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY----KVKGGKLPIRWMAPES 175

Query: 262 ALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD-- 319
              G  + K+DV+S+GVL+ EI +        LG+E    +S         + LE +   
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFT--------LGEEPYPGMS-------NAEVLEYLKKG 220

Query: 320 ---PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML 358
              P    C  +      +L L C  +   +RP  + +  +L
Sbjct: 221 YRLPKPPNCPPE----LYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  163 bits (416), Expect = 1e-47
 Identities = 69/204 (33%), Positives = 100/204 (49%), Gaps = 12/204 (5%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSR--QGLREFTNEVKLLLKIQHKNL 144
           +  L +LG G FG VY+      G+ +AVK L   S   +  +    E+++L ++ H N+
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L     +     LV EY     L  ++        L      +I + + RGL YLH  
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP---LSEDEAKKIALQILRGLEYLHSN 117

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE-YAL 263
               IIHRD+K  NILLDE    KI+DFGLA+      + + TF   GT  YMAPE    
Sbjct: 118 ---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV--GTPWYMAPEVLLG 172

Query: 264 HGYLSVKTDVFSYGVLVLEIVSGR 287
                 K DV+S GV++ E+++G+
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  157 bits (399), Expect = 3e-45
 Identities = 67/205 (32%), Positives = 101/205 (49%), Gaps = 21/205 (10%)

Query: 93  QLGHGGFGPVYRGLM-----PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVT 146
           +LG G FG VY+G +         ++AVK L    S +   EF  E  ++ K+ H N+V 
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           L G C +G    +V EY+P   L  F+  +     L      ++ + +A+G+ YL  +  
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLESK-- 121

Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGY-----MAPEY 261
              +HRD+ A N L+ E L  KISDFGL+R    +D +          G      MAPE 
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYR-----KRGGGKLPIKWMAPES 175

Query: 262 ALHGYLSVKTDVFSYGVLVLEIVSG 286
              G  + K+DV+S+GVL+ EI + 
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  154 bits (392), Expect = 3e-44
 Identities = 68/202 (33%), Positives = 100/202 (49%), Gaps = 11/202 (5%)

Query: 88  FSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLV 145
           +  L +LG G FG VY       G+ +A+K +     +  RE    E+K+L K++H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
            L+    +  +  LV EY     L   +  K    S D    Y +   +   L YLH   
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLL-KKRGRLSEDEARFY-LRQ-ILSALEYLHS-- 115

Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHG 265
              I+HRD+K  NILLDE  + K++DFGLAR        + TF   GT  YMAPE  L  
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQL-DPGEKLTTF--VGTPEYMAPEVLLGK 171

Query: 266 YLSVKTDVFSYGVLVLEIVSGR 287
                 D++S GV++ E+++G+
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  138 bits (351), Expect = 3e-38
 Identities = 63/201 (31%), Positives = 97/201 (48%), Gaps = 11/201 (5%)

Query: 92  NQLGHGGFGPVYRGLMP-NGQEIAVKKLSV--DSRQGLREFTNEVKLLLKIQHKNLVTLF 148
             LG G FG VY  L    G+ +AVK + +  DS + L     E+++L  +QH N+V  +
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 149 GCCAEGPEKML-VY-EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           G   +  +  L ++ EY+   SL   +    K   L      +    +  GL YLH    
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLL---KKFGKLPEPVIRKYTRQILEGLAYLHS--- 119

Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGY 266
             I+HRDIK +NIL+D     K++DFG A+     +T   T  + GT  +MAPE      
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179

Query: 267 LSVKTDVFSYGVLVLEIVSGR 287
                D++S G  V+E+ +G+
Sbjct: 180 YGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  136 bits (345), Expect = 2e-37
 Identities = 82/278 (29%), Positives = 132/278 (47%), Gaps = 32/278 (11%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
           F+   +LG G FG V+ GL  N   +A+K L  D     ++F  EV+ L +++HK+L++L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           F  C+ G    ++ E +   SL  F+    +   L   +   +   VA G+ YL E+   
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRS-PEGQVLPVASLIDMACQVAEGMAYLEEQ--- 123

Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARL-----FPGEDTHVNTFRISGTHGYMAPEYA 262
             IHRD+ A NIL+ E L  K++DFGLARL     +   D  +        + + APE A
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI-------PYKWTAPEAA 176

Query: 263 LHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS 321
            HG  S K+DV+S+G+L+ E+ + G+  + G    E  D ++  + +           P 
Sbjct: 177 SHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM-----------PC 225

Query: 322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS 359
            AKC         ++ L C      +RP   ++   L 
Sbjct: 226 PAKC----PQEIYKIMLECWAAEPEDRPSFKALREELD 259

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  129 bits (326), Expect = 1e-34
 Identities = 64/202 (31%), Positives = 107/202 (52%), Gaps = 11/202 (5%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           F  L ++G GGFG VY+      G+E+A+K + ++S++   +  NE+++L K +H N+V 
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
            +G   +  E  +V E+    SL   +  K+ + +L  +    +   + +GL YLH    
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHSN-- 117

Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLA-RLFPGEDTHVNTFRISGTHGYMAPEYALHG 265
             IIHRDIKA+NILL      K+ DFGL+ +L   +  +     + GT  +MAPE     
Sbjct: 118 -GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN----TMVGTPYWMAPEVINGK 172

Query: 266 YLSVKTDVFSYGVLVLEIVSGR 287
               K D++S G+  +E+  G+
Sbjct: 173 PYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  126 bits (318), Expect = 1e-33
 Identities = 86/285 (30%), Positives = 128/285 (44%), Gaps = 45/285 (15%)

Query: 92  NQLGHGGFGPVYRG--LMPNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVT 146
            +LGHG FG V +G  LM +G+E+  AVK L  +    G +EF  E  ++ ++ H  +V 
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLD---WTTRYRIVMGVARGLLYLHE 203
           L G C +G   MLV E  P   L  ++  + +    D      +      VA G+ YL  
Sbjct: 61  LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLES 113

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLAR-LFPGEDTHVNTFRISGTHG-----YM 257
           +     +HRD+ A N+LL  +   KISDFG++R L  G D +  T     T G     + 
Sbjct: 114 K---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT-----TAGRWPLKWY 165

Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALE 316
           APE   +G  S K+DV+SYGV + E  S G K +    G E   +L         E    
Sbjct: 166 APECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML---------ESGER 216

Query: 317 LVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD 361
           L  P   +C ++       + L C +    +RP  + +      D
Sbjct: 217 LPRPE--ECPQE----IYSIMLSCWKYRPEDRPTFSELESTFRRD 255

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  122 bits (307), Expect = 5e-32
 Identities = 74/213 (34%), Positives = 105/213 (49%), Gaps = 23/213 (10%)

Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQG---LREFTNEVKLLLKIQHKNLVTLFGC 150
           LG G FG V+ G      ++AVK L    + G      F  E +++ K++H  LV L+  
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69

Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
           C+E     +V EY+   SL  F+        L       +   +A G+ YL        I
Sbjct: 70  CSEEEPIYIVTEYMSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESR---NYI 125

Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT-----FRISGTHGYMAPEYALHG 265
           HRD+ A NIL+ E L  KI+DFGLARL   ED          F I  T    APE A +G
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLI--EDDEYTAREGAKFPIKWT----APEAANYG 179

Query: 266 YLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKE 297
             ++K+DV+S+G+L+ EIV+ GR  + G   +E
Sbjct: 180 RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE 212

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  120 bits (304), Expect = 2e-31
 Identities = 71/225 (31%), Positives = 117/225 (52%), Gaps = 31/225 (13%)

Query: 94  LGHGGFGPVYRGL-MPNGQ----EIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTL 147
           LG G FG VY+G+ +P G+     +A+K L  ++  +  +E  +E  ++  + H ++V L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 148 FGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARGLLYLHE 203
            G C    +  L+ + +P   L DY    K    S   L+W  +      +A+G+ YL E
Sbjct: 75  LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLEE 127

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMA 258
           +   R++HRD+ A N+L+    + KI+DFGLA+L   ++   +        G     +MA
Sbjct: 128 K---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHA-----EGGKVPIKWMA 179

Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
            E  LH   + K+DV+SYGV V E+++ G K ++G    E  DLL
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  117 bits (295), Expect = 4e-30
 Identities = 76/223 (34%), Positives = 111/223 (49%), Gaps = 39/223 (17%)

Query: 91  LNQLGHGGFGPVYRG--LMPNGQE----IAVKKL----SVDSRQGLREFTNEVKLLLKIQ 140
           L +LG G FG VY+G    PN +     +A+K L        +Q   EF  E +L+  +Q
Sbjct: 10  LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ---EFRQEAELMSDLQ 66

Query: 141 HKNLVTLFGCCA-EGPEKMLVYEYLPNKSLDYFIF-------------DKTKSSSLDWTT 186
           H N+V L G C  E P  ML +EYL +  L  F+              D+T  SSLD + 
Sbjct: 67  HPNIVCLLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125

Query: 187 RYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246
              I + +A G+ YL   +    +HRD+ A N L+ E L  KISDFGL+R     D    
Sbjct: 126 FLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSAD---- 178

Query: 247 TFRISGTH----GYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
            +R+         +M PE  L+G  + ++D++S+GV++ EI S
Sbjct: 179 YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  117 bits (295), Expect = 4e-30
 Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 17/210 (8%)

Query: 91  LNQLGHGGFGPVYRG-LMPN----GQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNL 144
           + QLG G FG V      P     G+++AVK L+     Q   +F  E+++L  + H+N+
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68

Query: 145 VTLFGCC--AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
           V   G C    G    L+ EYLP+ SL  ++  +     ++          + +G+ YL 
Sbjct: 69  VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLG 126

Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH--VNTFRISGTHGYMAPE 260
            +   R IHRD+ A NIL++ +   KISDFGLA++ P +  +  V     S    Y APE
Sbjct: 127 SQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182

Query: 261 YALHGYLSVKTDVFSYGVLVLEIVS-GRKN 289
                  S  +DV+S+GV + E+ + G  +
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDPS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  119 bits (298), Expect = 7e-30
 Identities = 66/212 (31%), Positives = 102/212 (48%), Gaps = 17/212 (8%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQH-KN 143
           +  L +LG G FG VY     + + +A+K L+       + +  F  E+++L  + H  N
Sbjct: 2   YRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           +V L+    +     LV EY+   SL+  +    +   L  +    I+  +   L YLH 
Sbjct: 60  IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119

Query: 204 EAPARIIHRDIKASNILLDEQLN-PKISDFGLARLFPGEDTHVNTFR----ISGTHGYMA 258
           +    IIHRDIK  NILLD      K+ DFGLA+L P   +  +         GT GYMA
Sbjct: 120 K---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 259 PEYALH---GYLSVKTDVFSYGVLVLEIVSGR 287
           PE  L     Y S  +D++S G+ + E+++G 
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208

Length = 384

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  115 bits (291), Expect = 9e-30
 Identities = 66/202 (32%), Positives = 99/202 (49%), Gaps = 24/202 (11%)

Query: 93  QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCA 152
            +G G FG V  G    GQ++AVK L  DS    + F  E  ++  ++H NLV L G   
Sbjct: 13  TIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVL 70

Query: 153 EGPEKMLVYEYLPNKSL-DYFIFDKTKSSS-LDWTTRYRIVMGVARGLLYLHEEAPARII 210
           +G    +V EY+   SL DY    +++  + +    +    + V  G+ YL E+     +
Sbjct: 71  QGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFV 124

Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN----TFRISGTHGYMAPEYALHGY 266
           HRD+ A N+L+ E L  K+SDFGLA+     +           +  T    APE      
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWT----APEALREKK 175

Query: 267 LSVKTDVFSYGVLVLEIVS-GR 287
            S K+DV+S+G+L+ EI S GR
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  115 bits (290), Expect = 1e-29
 Identities = 71/213 (33%), Positives = 106/213 (49%), Gaps = 17/213 (7%)

Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           L +LG G FG V+ GL  N   +AVK L   +    ++F  E +++ K++H  L+ L+  
Sbjct: 11  LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAV 69

Query: 151 CAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
           C       +V E +   SL +Y         +L       +   VA G+ YL  +     
Sbjct: 70  CTLEEPIYIVTELMKYGSLLEYL--QGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NY 124

Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGED----THVNTFRISGTHGYMAPEYALHG 265
           IHRD+ A N+L+ E    K++DFGLAR+   ED         F I  T    APE AL+ 
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVI-KEDIYEAREGAKFPIKWT----APEAALYN 179

Query: 266 YLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKE 297
             S+K+DV+S+G+L+ EIV+ GR  + G    E
Sbjct: 180 RFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE 212

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  114 bits (287), Expect = 4e-29
 Identities = 64/206 (31%), Positives = 97/206 (47%), Gaps = 17/206 (8%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLV 145
              +  LG G  G VY+    P G+  A+KK+ VD  +  R +   E+K L   +   +V
Sbjct: 3   LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVV 62

Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR----GLLYL 201
             +G   +  E  +V EY+   SL   +    K           ++  +AR    GL YL
Sbjct: 63  KCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPE-------PVLAYIARQILKGLDYL 115

Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEY 261
           H      IIHRDIK SN+L++ +   KI+DFG++++        NTF   GT  YM+PE 
Sbjct: 116 H--TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF--VGTVTYMSPER 171

Query: 262 ALHGYLSVKTDVFSYGVLVLEIVSGR 287
                 S   D++S G+ +LE   G+
Sbjct: 172 IQGESYSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  113 bits (286), Expect = 5e-29
 Identities = 65/197 (32%), Positives = 99/197 (50%), Gaps = 11/197 (5%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSV--DSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           +G G FG VY+GL +  G  +A+K++S+     + L+    E+ LL  ++H N+V   G 
Sbjct: 8   IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67

Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
                   ++ EY  N SL   I  K           Y  V  V +GL YLHE+    +I
Sbjct: 68  IETSDSLYIILEYAENGSL-RQIIKKFGPFPESLVAVY--VYQVLQGLAYLHEQG---VI 121

Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVK 270
           HRDIKA+NIL  +    K++DFG+A      D   +   + GT  +MAPE       S  
Sbjct: 122 HRDIKAANILTTKDGVVKLADFGVATKLN--DVSKDDASVVGTPYWMAPEVIEMSGASTA 179

Query: 271 TDVFSYGVLVLEIVSGR 287
           +D++S G  V+E+++G 
Sbjct: 180 SDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  113 bits (285), Expect = 6e-29
 Identities = 82/277 (29%), Positives = 118/277 (42%), Gaps = 32/277 (11%)

Query: 93  QLGHGGFGPVYRG--LMPNGQEI--AVKKLSVDSRQG-LREFTNEVKLLLKIQHKNLVTL 147
           +LG G FG V RG      G+ I  AVK L  D     + +F  E  ++  + H+NL+ L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           +G     P  M+V E  P  SL      K        +T     + +A G+ YL  +   
Sbjct: 62  YGVVLTHP-LMMVTELAPLGSL-LDRLRKDALGHFLISTLCDYAVQIANGMRYLESK--- 116

Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFP-GEDTHVNTFRISGTHGYMAPEYALHGY 266
           R IHRD+ A NILL      KI DFGL R  P  ED +V    +     + APE      
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT 176

Query: 267 LSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCN 326
            S  +DV+ +GV + E+ +         G+E        W    G + L+ +D    +  
Sbjct: 177 FSHASDVWMFGVTLWEMFT--------YGEEP-------WAGLSGSQILKKIDKEGERLE 221

Query: 327 RDEAAMCIQ----LGLLCCQQSVAERPDMNSVHLMLS 359
           R EA  C Q    + L C   + A+RP   ++   L 
Sbjct: 222 RPEA--CPQDIYNVMLQCWAHNPADRPTFAALREFLP 256

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  113 bits (285), Expect = 7e-29
 Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 16/206 (7%)

Query: 86  NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL 144
             F  L +LG G +G VY+ +    GQ +A+K + V+    L+E   E+ +L +     +
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYI 60

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD--KTKSSSLDWTTRYRIVMGVARGLLYLH 202
           V  +G   +  +  +V EY    S    + D  K  + +L       I+    +GL YLH
Sbjct: 61  VKYYGSYFKNTDLWIVMEYCGAGS----VSDIMKITNKTLTEEEIAAILYQTLKGLEYLH 116

Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
                + IHRDIKA NILL+E+   K++DFG++          NT  + GT  +MAPE  
Sbjct: 117 SN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGTPFWMAPEVI 171

Query: 263 LH-GYLSVKTDVFSYGVLVLEIVSGR 287
              GY + K D++S G+  +E+  G+
Sbjct: 172 QEIGYNN-KADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  109 bits (274), Expect = 2e-27
 Identities = 75/216 (34%), Positives = 111/216 (51%), Gaps = 28/216 (12%)

Query: 93  QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLRE---FTNEVKLLLKIQHKNLVTLFG 149
           +LG G FG V+ G      ++A+K L    +QG      F  E  L+ ++QH  LV L+ 
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLYA 68

Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG--VARGLLYLHEEAPA 207
              + P   ++ EY+ N SL  F+  KT    +  T    I M   +A G+ ++  +   
Sbjct: 69  VVTQEP-IYIITEYMENGSLVDFL--KT-PEGIKLTINKLIDMAAQIAEGMAFIERK--- 121

Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT-----FRISGTHGYMAPEYA 262
             IHRD++A+NIL+ E L  KI+DFGLARL   ED          F I  T    APE  
Sbjct: 122 NYIHRDLRAANILVSETLCCKIADFGLARLI--EDNEYTAREGAKFPIKWT----APEAI 175

Query: 263 LHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKE 297
            +G  ++K+DV+S+G+L+ EIV+ GR  + G    E
Sbjct: 176 NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE 211

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  109 bits (274), Expect = 2e-27
 Identities = 68/219 (31%), Positives = 97/219 (44%), Gaps = 13/219 (5%)

Query: 88  FSDLNQLGHGGFGPVYR-GLMPNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQHKN 143
           F  L  +G G FG V         +  A+K   K     +  +R   NE ++L ++ H  
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           LV L+    +     LV + L    L Y +  K K S  +   ++ I   +   L YLH 
Sbjct: 62  LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFS--EEQVKFWICE-IVLALEYLHS 118

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
           +    IIHRDIK  NILLDEQ +  I+DF +A     +     T   SGT GYMAPE   
Sbjct: 119 K---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD---TLTTSTSGTPGYMAPEVLC 172

Query: 264 HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLL 302
               SV  D +S GV   E + G++ + G     +  + 
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR 211

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  108 bits (271), Expect = 5e-27
 Identities = 61/222 (27%), Positives = 114/222 (51%), Gaps = 14/222 (6%)

Query: 93  QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGL---REFTNEVKLLLKIQHKNLVTLFG 149
           ++G G FG V+ G     +++A+K +    R+G     +F  E ++++K+ H  LV L+G
Sbjct: 11  EIGSGQFGLVWLGYWLEKRKVAIKTI----REGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66

Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
            C E     LV+E++ +  L  ++  + +       T   + + V  G+ YL     + +
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLES---SNV 121

Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           IHRD+ A N L+ E    K+SDFG+ R F  +D + ++        + +PE       S 
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSS 180

Query: 270 KTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQ 310
           K+DV+S+GVL+ E+ S G+  ++ R   E  + ++  + L++
Sbjct: 181 KSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK 222

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  108 bits (272), Expect = 6e-27
 Identities = 67/203 (33%), Positives = 102/203 (50%), Gaps = 10/203 (4%)

Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQ-GLREFTNEVKLLLKIQHKNLVTLF 148
           +  +G G    VY  + +PN +++A+K++ ++  Q  + E   EV+ + +  H N+V  +
Sbjct: 6   IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65

Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
                G E  LV  YL   SL   +        LD      ++  V +GL YLH      
Sbjct: 66  TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---G 122

Query: 209 IIHRDIKASNILLDEQLNPKISDFGL-ARLF-PGEDTHVNTFRISGTHGYMAPE--YALH 264
            IHRDIKA NILL E  + KI+DFG+ A L   G+ T        GT  +MAPE    +H
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182

Query: 265 GYLSVKTDVFSYGVLVLEIVSGR 287
           GY   K D++S+G+  +E+ +G 
Sbjct: 183 GY-DFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 1e-26
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 16/200 (8%)

Query: 93  QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLVTLFGCC 151
           ++G G FG VY+G++    E+AVK         L+  F  E ++L +  H N+V L G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 152 AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIH 211
            +     +V E +P  SL  F+  + K + L      ++ +  A G+ YL  +     IH
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIH 116

Query: 212 RDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAPEYALHGY 266
           RD+ A N L+ E    KISDFG++R     +     + +S         + APE   +G 
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR-----EEEGGIYTVSDGLKQIPIKWTAPEALNYGR 171

Query: 267 LSVKTDVFSYGVLVLEIVSG 286
            + ++DV+SYG+L+ E  S 
Sbjct: 172 YTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  106 bits (268), Expect = 2e-26
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 33/214 (15%)

Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKK---LSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
           + Q+G G FG VY     +  ++ V K   LS  S +   +  NEVK+L K+ H N++  
Sbjct: 5   IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64

Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSS-------LDWTTRYRIVMGVARGLLY 200
           +    E  +  +V EY     L   I  + K          LDW  +  + +     L Y
Sbjct: 65  YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ--LCLA----LKY 118

Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE 260
           LH     +I+HRDIK  NI L      K+ DFG++++         T    GT  Y++PE
Sbjct: 119 LHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV--VGTPYYLSPE 173

Query: 261 ------YALHGYLSVKTDVFSYGVLVLEIVSGRK 288
                 Y      + K+D++S G ++ E+ + + 
Sbjct: 174 LCQNKPY------NYKSDIWSLGCVLYELCTLKH 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  107 bits (268), Expect = 2e-26
 Identities = 65/207 (31%), Positives = 106/207 (51%), Gaps = 20/207 (9%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLV 145
              L +LG G  G V + L  P G+ +AVK + ++  + ++ +   E+ +L K     +V
Sbjct: 3   LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIV 62

Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWT-TRY--RIVMGVARGLLYLH 202
             +G      +  +  EY+   SLD     K           R   +I + V +GL YLH
Sbjct: 63  GFYGAFYNNGDISICMEYMDGGSLD-----KILKEVQGRIPERILGKIAVAVLKGLTYLH 117

Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE--DTHVNTFRISGTHGYMAPE 260
           E+   +IIHRD+K SNIL++ +   K+ DFG++    G+  ++   TF   GT  YMAPE
Sbjct: 118 EKH--KIIHRDVKPSNILVNSRGQIKLCDFGVS----GQLVNSLAKTF--VGTSSYMAPE 169

Query: 261 YALHGYLSVKTDVFSYGVLVLEIVSGR 287
                  SVK+D++S G+ ++E+ +GR
Sbjct: 170 RIQGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  106 bits (267), Expect = 4e-26
 Identities = 71/205 (34%), Positives = 104/205 (50%), Gaps = 17/205 (8%)

Query: 91  LNQLGHGGFGPV----YRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV 145
           + QLG G FG V    Y  L  N G+ +AVKKL   + + LR+F  E+++L  +QH N+V
Sbjct: 9   IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIV 68

Query: 146 TLFGCC--AEGPEKMLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
              G C  A      LV EYLP  SL DY    + +   LD          + +G+ YL 
Sbjct: 69  KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER---LDHRKLLLYASQICKGMEYLG 125

Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG--YMAPE 260
            +   R +HRD+   NIL++ +   KI DFGL ++ P +D      R  G     + APE
Sbjct: 126 SK---RYVHRDLATRNILVESENRVKIGDFGLTKVLP-QDKEYYKVREPGESPIFWYAPE 181

Query: 261 YALHGYLSVKTDVFSYGVLVLEIVS 285
                  SV +DV+S+GV++ E+ +
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  106 bits (266), Expect = 4e-26
 Identities = 63/218 (28%), Positives = 105/218 (48%), Gaps = 31/218 (14%)

Query: 91  LNQLGHGGFGPVYRG----LMPNGQE--IAVKKLS-VDSRQGLREFTNEVKLLLKIQHKN 143
             +LG G FG V+ G    L P   +  +AVK L    S    ++F  E +LL   QH+N
Sbjct: 10  KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYF-----------IFDKTKSSSLDWTTRYRIVM 192
           +V  +G C EG   ++V+EY+ +  L+ F               +    L  +   +I +
Sbjct: 70  IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129

Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT-FRIS 251
            +A G++YL   A    +HRD+   N L+   L  KI DFG++R     D +    +R+ 
Sbjct: 130 QIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR-----DVYTTDYYRVG 181

Query: 252 GTH----GYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           G       +M PE  ++   + ++DV+S+GV++ EI +
Sbjct: 182 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  106 bits (266), Expect = 5e-26
 Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 26/212 (12%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLSVDS-----RQGLREFTNEVKLLLKIQH 141
             +L++LG G  G V +  + N   I A+K ++ D      +Q LRE    +++    + 
Sbjct: 3   IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRE----LEINKSCKS 58

Query: 142 KNLVTLFGCCAEGPEKML--VYEYLPNKSLDYFIFDKTKSSSLDWTTRY--RIVMGVARG 197
             +V  +G   +     +    EY    SLD  I+ K K        +   +I   V +G
Sbjct: 59  PYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKG 117

Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE--DTHVNTFRISGTHG 255
           L YLH     +IIHRDIK SNILL  +   K+ DFG++    GE  ++   TF  +GT  
Sbjct: 118 LSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS----GELVNSLAGTF--TGTSF 168

Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
           YMAPE       S+ +DV+S G+ +LE+   R
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  106 bits (266), Expect = 6e-26
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 25/211 (11%)

Query: 85  TNFFSDLNQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN 143
              + +L ++G G  G VY+      G+E+A+KK+ +   Q      NE+ ++   +H N
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSL----DYFIFDKTKSSSLDWTTRYRI--VMG-VAR 196
           +V  +     G E  +V EY+   SL            +          +I  V   V +
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEP---------QIAYVCREVLQ 127

Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGY 256
           GL YLH      +IHRDIK+ NILL +  + K++DFG A     E +  N+  + GT  +
Sbjct: 128 GLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYW 182

Query: 257 MAPEYAL-HGYLSVKTDVFSYGVLVLEIVSG 286
           MAPE      Y   K D++S G++ +E+  G
Sbjct: 183 MAPEVIKRKDY-GPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  105 bits (264), Expect = 8e-26
 Identities = 77/241 (31%), Positives = 108/241 (44%), Gaps = 26/241 (10%)

Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKL-SVDSRQGLREFTNEVK 134
           +V  +  + L  LGHG FG VY GL           ++AVK L    S Q   +F  E  
Sbjct: 2   EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61

Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRI 190
           ++ K  H+N+V L G   E   + ++ E +    L  F+ +      + SSL        
Sbjct: 62  IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121

Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLD---EQLNPKISDFGLARLFPGEDTHVNT 247
              VA+G  YL E      IHRDI A N LL         KI+DFG+AR           
Sbjct: 122 ARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASY---- 174

Query: 248 FRISGTH----GYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
           +R  G       +M PE  L G  + KTDV+S+GVL+ EI S G   + GR  +E  + +
Sbjct: 175 YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV 234

Query: 303 S 303
           +
Sbjct: 235 T 235

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  104 bits (262), Expect = 1e-25
 Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 14/199 (7%)

Query: 94  LGHGGFGPVYRGLM--PNGQEI--AVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLVTLF 148
           +G G FG V RG +  P  +EI  A+K L   S    R +F  E  ++ +  H N++ L 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71

Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G   +    M++ EY+ N SLD F+  +             ++ G+A G+ YL E     
Sbjct: 72  GVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYLSEMN--- 126

Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF--RISGTHGYMAPEYALHGY 266
            +HRD+ A NIL++  L  K+SDFGL+R     +    T   +I     + APE   +  
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR--WTAPEAIAYRK 184

Query: 267 LSVKTDVFSYGVLVLEIVS 285
            +  +DV+S+G+++ E++S
Sbjct: 185 FTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  103 bits (259), Expect = 3e-25
 Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 13/201 (6%)

Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGL---REFTNEVKLLLKIQHKNLVTL 147
           L +LG G FG V+ G      ++A+K +    R+G     +F  E K+++K+ H NLV L
Sbjct: 9   LKELGSGQFGVVHLGKWRGKIDVAIKMI----REGAMSEDDFIEEAKVMMKLSHPNLVQL 64

Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           +G C +     +V EY+ N  L  ++ ++      +W     +   V   + YL      
Sbjct: 65  YGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWL--LDMCSDVCEAMEYLES---N 119

Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
             IHRD+ A N L+ E    K+SDFGLAR +  +D + ++        +  PE   +   
Sbjct: 120 GFIHRDLAARNCLVGEDNVVKVSDFGLAR-YVLDDQYTSSQGTKFPVKWAPPEVFDYSRF 178

Query: 268 SVKTDVFSYGVLVLEIVSGRK 288
           S K+DV+S+GVL+ E+ S  K
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score =  103 bits (259), Expect = 3e-25
 Identities = 81/290 (27%), Positives = 131/290 (45%), Gaps = 41/290 (14%)

Query: 91  LNQLGHGGFGPVYRGL-----MPNGQEIAVKKLS-VDSRQGLREFTNEVKLLLKIQHKNL 144
           + +LG   FG +Y+G      M + Q +A+K L  +++ Q   EF  E  L+ ++ H N+
Sbjct: 10  MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNI 69

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIF--------------DKTKSSSLDWTTRYRI 190
           V L G   +     +++EYL    L  F+               D T  SSLD      I
Sbjct: 70  VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129

Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
            + +A G+ YL   +    +H+D+ A NIL+ EQL+ KISD GL+R     D +    + 
Sbjct: 130 AIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186

Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLF 309
                +M PE  ++G  S  +D++S+GV++ EI S G + + G                F
Sbjct: 187 LLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG----------------F 230

Query: 310 QGEKALELVDP-SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML 358
             ++ +E+V    L  C+ D       L   C Q+  + RP    +H  L
Sbjct: 231 SNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  103 bits (258), Expect = 3e-25
 Identities = 82/278 (29%), Positives = 129/278 (46%), Gaps = 34/278 (12%)

Query: 93  QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCA 152
           +LG G FG V+ G       +A+K L   +      F  E +++ K++H+ LV L+   +
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 153 EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHR 212
           E P   +V EY+   SL  F+  +     L       +   +A G+ Y+        +HR
Sbjct: 72  EEP-IYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 126

Query: 213 DIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT-----FRISGTHGYMAPEYALHGYL 267
           D++A+NIL+ E L  K++DFGLARL   ED          F I  T    APE AL+G  
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWT----APEAALYGRF 180

Query: 268 SVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCN 326
           ++K+DV+S+G+L+ E+ + GR  + G + +E  D         Q E+   +  P   +C 
Sbjct: 181 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD---------QVERGYRMPCPP--EC- 228

Query: 327 RDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFT 364
                    L   C ++   ERP    +   L  D FT
Sbjct: 229 ---PESLHDLMCQCWRKEPEERPTFEYLQAFLE-DYFT 262

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  102 bits (256), Expect = 6e-25
 Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 32/209 (15%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSV-----DSRQGLREFTNEVKLLLKIQHKNLVTL 147
           LG G FG VY GL + +G   AVK++S+       ++ +++   E+ LL K+QH N+V  
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 148 FGCCAEGPEKMLVY-EYLPNKSLD--YFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
            G   E  + + ++ E +P  SL      +       +   TR +I++G+     YLH+ 
Sbjct: 68  LGTEREE-DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILLGLE----YLHDR 121

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR----ISGTHGYMAPE 260
                +HRDIK +NIL+D     K++DFG+A+        V  F       G+  +MAPE
Sbjct: 122 ---NTVHRDIKGANILVDTNGVVKLADFGMAK-------QVVEFSFAKSFKGSPYWMAPE 171

Query: 261 YAL--HGYLSVKTDVFSYGVLVLEIVSGR 287
                 GY  +  D++S G  VLE+ +G+
Sbjct: 172 VIAQQGGY-GLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  101 bits (254), Expect = 1e-24
 Identities = 63/200 (31%), Positives = 103/200 (51%), Gaps = 17/200 (8%)

Query: 92  NQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           ++LG G +G VY G+       +AVK L  D+ + + EF  E  ++ +I+H NLV L G 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 151 CAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
           C   P   ++ E++   +L DY    +     ++      +   ++  + YL ++     
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 125

Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV----NTFRISGTHGYMAPEYALHG 265
           IHRD+ A N L+ E    K++DFGL+RL  G DT+       F I  T    APE   + 
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWT----APESLAYN 180

Query: 266 YLSVKTDVFSYGVLVLEIVS 285
             S+K+DV+++GVL+ EI +
Sbjct: 181 KFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  101 bits (252), Expect = 2e-24
 Identities = 83/265 (31%), Positives = 130/265 (49%), Gaps = 33/265 (12%)

Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           + +LG+G FG V+ G      ++AVK L   +      F  E +++ K++H  LV L+  
Sbjct: 11  IKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAV 69

Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
            +E P   +V EY+   SL  F+ D  +  +L       +   VA G+ Y+        I
Sbjct: 70  VSEEP-IYIVTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIER---MNYI 124

Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT-----FRISGTHGYMAPEYALHG 265
           HRD++++NIL+ + L  KI+DFGLARL   ED          F I  T    APE AL+G
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWT----APEAALYG 178

Query: 266 YLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK 324
             ++K+DV+S+G+L+ E+V+ GR  + G   +E          L Q E+   +       
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---------VLEQVERGYRM------P 223

Query: 325 CNRDEAAMCIQLGLLCCQQSVAERP 349
           C +D      +L L C ++   ERP
Sbjct: 224 CPQDCPISLHELMLQCWKKDPEERP 248

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  100 bits (251), Expect = 3e-24
 Identities = 69/202 (34%), Positives = 96/202 (47%), Gaps = 20/202 (9%)

Query: 94  LGHGGFGPVY--RGLMPNGQEIAVKKLS---VDSRQGLREFTNEVKLLLKIQHKNLVTLF 148
           LG G FG V   R     G+  A+K L    +  R+ +     E  +L +I H  +V L 
Sbjct: 1   LGKGSFGKVLLVRKKD-TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59

Query: 149 GCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRY--RIVMGVARGLLYLHEEA 205
               +  EK+ LV EY P   L   +  K    S +    Y   IV+     L YLH   
Sbjct: 60  -YAFQTEEKLYLVLEYAPGGELFSHL-SKEGRFSEERARFYAAEIVLA----LEYLHSL- 112

Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHG 265
              II+RD+K  NILLD   + K++DFGLA+    E +  NTF   GT  Y+APE  L  
Sbjct: 113 --GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTF--CGTPEYLAPEVLLGK 168

Query: 266 YLSVKTDVFSYGVLVLEIVSGR 287
                 D +S GVL+ E+++G+
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  100 bits (252), Expect = 3e-24
 Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 19/207 (9%)

Query: 86  NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKN 143
             F+ L  +G G FG VY+ +     Q +A+K + ++ +   + +   E++ L + +   
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPY 60

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           +   +G   +G +  ++ EY    S      D  K   LD T    I+  V  GL YLHE
Sbjct: 61  ITKYYGSFLKGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHE 116

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV----NTFRISGTHGYMAP 259
           E     IHRDIKA+NILL E+ + K++DFG++    G+ T      NTF   GT  +MAP
Sbjct: 117 E---GKIHRDIKAANILLSEEGDVKLADFGVS----GQLTSTMSKRNTF--VGTPFWMAP 167

Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVSG 286
           E         K D++S G+  +E+  G
Sbjct: 168 EVIKQSGYDEKADIWSLGITAIELAKG 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  100 bits (250), Expect = 6e-24
 Identities = 71/254 (27%), Positives = 119/254 (46%), Gaps = 22/254 (8%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQG-LREFTNEVKLLLKIQH---K 142
           +  L  +G G +G VYRG  +P G+ +A+K +++D+    + +   EV LL +++     
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
           N+   +G   +GP   ++ EY    S+   +    K+  +       I+  V   L Y+H
Sbjct: 63  NITKYYGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIH 118

Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
           +     +IHRDIKA+NIL+    N K+ DFG+A L     +  +TF   GT  +MAPE  
Sbjct: 119 K---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF--VGTPYWMAPEVI 173

Query: 263 LHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS 321
             G Y   K D++S G+ + E+ +G   +          L+  +       K   L D  
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS-------KPPRLEDNG 226

Query: 322 LAKCNRDEAAMCIQ 335
            +K  R+  A C+ 
Sbjct: 227 YSKLLREFVAACLD 240

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score =  100 bits (250), Expect = 7e-24
 Identities = 70/220 (31%), Positives = 117/220 (53%), Gaps = 21/220 (9%)

Query: 94  LGHGGFGPVYRGL-MPNGQEI----AVKKLS-VDSRQGLREFTNEVKLLLKIQHKNLVTL 147
           LG G FG VY+G+ +P G+ +    A+K L+     +   EF +E  ++  + H +LV L
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSS----LDWTTRYRIVMGVARGLLYLHE 203
            G C   P   LV + +P+  L  ++ +   +      L+W  +      +A+G++YL E
Sbjct: 75  LGVCLS-PTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
               R++HRD+ A N+L+    + KI+DFGLARL  G++   N         +MA E   
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184

Query: 264 HGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
           +   + ++DV+SYGV + E+++ G K +DG   +E  DLL
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 224

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  100 bits (250), Expect = 9e-24
 Identities = 67/218 (30%), Positives = 106/218 (48%), Gaps = 34/218 (15%)

Query: 94  LGHGGFGPVYRG------LMPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLV 145
           LG G FG V +              +AVK L  D + + L +  +E++++  I +HKN++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDK----TKSSSLDWT------TRYRIV---M 192
            L G C +     +V EY  + +L  F+  +      +S  D        T+  +V    
Sbjct: 80  NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139

Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISG 252
            VARG+ +L   A  + IHRD+ A N+L+ E    KI+DFGLAR     D H   +    
Sbjct: 140 QVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR-----DIHHIDYYRKT 191

Query: 253 THG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           T+G     +MAPE       + ++DV+S+GVL+ EI +
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 99.5 bits (248), Expect = 1e-23
 Identities = 58/215 (26%), Positives = 92/215 (42%), Gaps = 27/215 (12%)

Query: 89  SDLNQLGHGGFGPVYRGLMPNGQE------IAVKKL-SVDSRQGLREFTNEVKLLLKIQH 141
            ++  LG G FG V+       +E      + VK L          EF  E+ +  K+ H
Sbjct: 8   QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSH 67

Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFI------FDKTKSSSLDWTTRYRIVMGVA 195
           KN+V L G C E     ++ EY     L  F+       +K K   L    +  +   +A
Sbjct: 68  KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127

Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED--THVNTF---RI 250
            G+ +L   + AR +HRD+ A N L+  Q   K+S   L++     +     N     R 
Sbjct: 128 LGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR- 183

Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
                ++APE       S K+DV+S+GVL+ E+ +
Sbjct: 184 -----WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 98.7 bits (246), Expect = 2e-23
 Identities = 69/218 (31%), Positives = 112/218 (51%), Gaps = 39/218 (17%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSV--------DSRQG--LREFTNEVKLLLKIQHK 142
           +G G +G VY  L +  G+ +AVK++ +        DSRQ   ++   +E++ L  + H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 143 NLVTLFGCCAEGPEKMLVY-EYLPNKSL-----DYFIFDKTKSSSLDWTTRYRIVMGVAR 196
           N+V   G      E + ++ EY+P  S+      Y  F++        T +      V  
Sbjct: 69  NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFF--TEQ------VLE 119

Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN--TFRISGTH 254
           GL YLH +    I+HRD+KA N+L+D     KISDFG+++    +D + N     + G+ 
Sbjct: 120 GLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK--KSDDIYDNDQNMSMQGSV 174

Query: 255 GYMAPEYALH----GYLSVKTDVFSYGVLVLEIVSGRK 288
            +MAPE  +H    GY S K D++S G +VLE+ +GR+
Sbjct: 175 FWMAPE-VIHSYSQGY-SAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 98.2 bits (244), Expect = 3e-23
 Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 11/202 (5%)

Query: 87  FFSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLSVDSRQG-LREFTNEVKLLLKIQHKNL 144
            F+ L ++G G FG VY+G+    +E+ A+K + ++  +  + +   E+ +L +     +
Sbjct: 5   LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 64

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
              +G   +G +  ++ EYL   S      D  K   L+ T    I+  + +GL YLH E
Sbjct: 65  TRYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSE 120

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              R IHRDIKA+N+LL EQ + K++DFG+A          NTF   GT  +MAPE    
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF--VGTPFWMAPEVIKQ 175

Query: 265 GYLSVKTDVFSYGVLVLEIVSG 286
                K D++S G+  +E+  G
Sbjct: 176 SAYDFKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 97.4 bits (242), Expect = 4e-23
 Identities = 67/218 (30%), Positives = 106/218 (48%), Gaps = 33/218 (15%)

Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           + +LG G FG V+ G   N  ++AVK L   +   ++ F  E  L+  +QH  LV L+  
Sbjct: 11  VKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAV 69

Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKS-----SSLDWTTRYRIVMGVARGLLYLHEEA 205
             +     ++ EY+   SL  F+             +D++ +      +A G+ Y+  + 
Sbjct: 70  VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAYIERK- 122

Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT-----FRISGTHGYMAPE 260
               IHRD++A+N+L+ E L  KI+DFGLAR+   ED          F I  T    APE
Sbjct: 123 --NYIHRDLRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWT----APE 174

Query: 261 YALHGYLSVKTDVFSYGVLVLEIVS-------GRKNHD 291
               G  ++K+DV+S+G+L+ EIV+       G  N D
Sbjct: 175 AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD 212

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 97.6 bits (244), Expect = 5e-23
 Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 43/230 (18%)

Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLRE-----FTNEVKLLLKI-Q 140
           F     +G G F  V         +E A+K L  D RQ ++E        E ++L ++  
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKIL--DKRQLIKEKKVKYVKIEKEVLTRLNG 60

Query: 141 HKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDW-TTRY---RIVMGVA 195
           H  ++ L+    +  E +  V EY PN  L  +I    K  SLD   TR+    I++ + 
Sbjct: 61  HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALE 116

Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS---- 251
               YLH      IIHRD+K  NILLD+ ++ KI+DFG A++     +  +    +    
Sbjct: 117 ----YLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169

Query: 252 --------------GTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
                         GT  Y++PE          +D+++ G ++ ++++G+
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 96.8 bits (241), Expect = 7e-23
 Identities = 57/203 (28%), Positives = 103/203 (50%), Gaps = 9/203 (4%)

Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNL 144
           F  LN++G G FG V++ +   + +  A+K++ +   +R+   E  +E ++L K+    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           +  +    +  +  +V EY  N  L   +    +   L     +R  + +  GL +LH +
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLL-KMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              +I+HRDIK+ N+ LD   N KI D G+A+L        NT  I GT  Y++PE    
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPELCED 175

Query: 265 GYLSVKTDVFSYGVLVLEIVSGR 287
              + K+DV++ GV++ E  +G+
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 97.0 bits (241), Expect = 7e-23
 Identities = 64/201 (31%), Positives = 107/201 (53%), Gaps = 17/201 (8%)

Query: 94  LGHGGFGPVYRGL--MPNGQE--IAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLVTLF 148
           +G G FG V+RG+  MP  +E  +A+K L     +  R +F +E  ++ +  H N++ L 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKS-SSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           G   +    M++ EY+ N +LD ++ D     SS       R   G+A G+ YL +    
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYLSD---M 126

Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH---GYMAPEYALH 264
             +HRD+ A NIL++  L  K+SDFGL+R+   ED    T+  SG      + APE   +
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVL--EDDPEGTYTTSGGKIPIRWTAPEAIAY 184

Query: 265 GYLSVKTDVFSYGVLVLEIVS 285
              +  +DV+S+G+++ E++S
Sbjct: 185 RKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 98.2 bits (244), Expect = 8e-23
 Identities = 70/204 (34%), Positives = 98/204 (48%), Gaps = 19/204 (9%)

Query: 87  FFSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLSVDSRQGLREFTN---EVKLLLKIQHK 142
            F+DL ++GHG FG VY        E+ A+KK+S   +Q   ++ +   EVK L +I+H 
Sbjct: 26  LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHP 85

Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
           N +   GC        LV EY    + D     K     ++      I  G  +GL YLH
Sbjct: 86  NSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---ITHGALQGLAYLH 142

Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
                 +IHRDIKA NILL E    K++DFG A +    ++ V      GT  +MAPE  
Sbjct: 143 SHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV------GTPYWMAPEVI 193

Query: 263 L---HGYLSVKTDVFSYGVLVLEI 283
           L    G    K DV+S G+  +E+
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 97.2 bits (243), Expect = 8e-23
 Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 43/218 (19%)

Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-RQG-----LREFTNEVKLLLKIQHKN 143
           + Q+G G +G VY+      G+ +A+KK+ +++ ++G     +RE    +KLL K++H N
Sbjct: 4   IAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIRE----IKLLQKLRHPN 59

Query: 144 LVTLFGCCAEGPEK--MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-------- 193
           +V L        +    +V+EY+ +   D         + L  +   +            
Sbjct: 60  IVRLKEIVTSKGKGSIYMVFEYMDH---DL--------TGLLDSPEVKFTESQIKCYMKQ 108

Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           +  GL YLH      I+HRDIK SNIL++     K++DFGLAR +   ++   T R+  T
Sbjct: 109 LLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-T 164

Query: 254 HGYMAPEYALH----GYLSVKTDVFSYGVLVLEIVSGR 287
             Y  PE  L     G    + D++S G ++ E+  G+
Sbjct: 165 LWYRPPELLLGATRYGP---EVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 96.2 bits (239), Expect = 1e-22
 Identities = 71/222 (31%), Positives = 106/222 (47%), Gaps = 22/222 (9%)

Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLVTLFGCCA 152
           LG G FG V++G + +   +AVK    D  Q L+ +F +E ++L +  H N+V L G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 153 EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHR 212
           +     +V E +P    D+  F + K   L      +  +  A G+ YL  +     IHR
Sbjct: 63  QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHR 117

Query: 213 DIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH----GYMAPEYALHGYLS 268
           D+ A N L+ E    KISDFG++R    ED  +  +  SG       + APE   +G  S
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR---QEDDGI--YSSSGLKQIPIKWTAPEALNYGRYS 172

Query: 269 VKTDVFSYGVLVLEIVS-------GRKNHDGRLGKEKADLLS 303
            ++DV+SYG+L+ E  S       G  N   R   EK   +S
Sbjct: 173 SESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMS 214

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 96.3 bits (239), Expect = 1e-22
 Identities = 69/211 (32%), Positives = 110/211 (52%), Gaps = 18/211 (8%)

Query: 93  QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCA 152
           +LG G FG V+ G      ++A+K L   +      F  E +++ K++H  LV L+   +
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 153 EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHR 212
           E P   +V E++   SL  F+  +     L       +   +A G+ Y+        IHR
Sbjct: 72  EEP-IYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHR 126

Query: 213 DIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT-----FRISGTHGYMAPEYALHGYL 267
           D++A+NIL+ + L  KI+DFGLARL   ED          F I  T    APE AL+G  
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWT----APEAALYGRF 180

Query: 268 SVKTDVFSYGVLVLEIVS-GRKNHDGRLGKE 297
           ++K+DV+S+G+L+ E+V+ GR  + G + +E
Sbjct: 181 TIKSDVWSFGILLTELVTKGRVPYPGMVNRE 211

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 97.0 bits (241), Expect = 1e-22
 Identities = 68/204 (33%), Positives = 97/204 (47%), Gaps = 19/204 (9%)

Query: 87  FFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQG---LREFTNEVKLLLKIQHK 142
            FSDL ++GHG FG VY    + N + +A+KK+S   +Q     ++   EV+ L K++H 
Sbjct: 16  LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75

Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
           N +   GC        LV EY    + D     K     ++      +  G  +GL YLH
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---VTHGALQGLAYLH 132

Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
                 +IHRD+KA NILL E    K+ DFG A +    +  V      GT  +MAPE  
Sbjct: 133 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEVI 183

Query: 263 L---HGYLSVKTDVFSYGVLVLEI 283
           L    G    K DV+S G+  +E+
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 96.3 bits (239), Expect = 2e-22
 Identities = 75/294 (25%), Positives = 133/294 (45%), Gaps = 49/294 (16%)

Query: 91  LNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKN 143
           + +LG   FG VY+G +         Q +A+K L   +   LRE F +E  +  ++QH N
Sbjct: 10  MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPN 69

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIF-------------DKTKSSSLDWTTRYRI 190
           +V L G   +     +++ Y  +  L  F+              DKT  S+L+      I
Sbjct: 70  IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129

Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
           V  +A G+ +L       ++H+D+   N+L+ ++LN KISD GL R    E    + +++
Sbjct: 130 VTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFR----EVYAADYYKL 182

Query: 251 SGTH----GYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYT 305
            G       +M+PE  ++G  S+ +D++SYGV++ E+ S G + + G             
Sbjct: 183 MGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG------------- 229

Query: 306 WTLFQGEKALELV-DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML 358
              +  +  +E++ +  +  C  D  A    L L C  +  + RP    +H  L
Sbjct: 230 ---YSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 95.4 bits (237), Expect = 2e-22
 Identities = 68/198 (34%), Positives = 102/198 (51%), Gaps = 18/198 (9%)

Query: 93  QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCA 152
            +G G FG V +G    GQ++AVK +  D     + F  E  ++ K+ HKNLV L G   
Sbjct: 13  IIGEGEFGAVLQGEY-TGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 153 EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY-RIVMGVARGLLYLHEEAPARIIH 211
                 +V E +   +L  F+  +T+  +L    +  +  + VA G+ YL  +   +++H
Sbjct: 70  HN-GLYIVMELMSKGNLVNFL--RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVH 123

Query: 212 RDIKASNILLDEQLNPKISDFGLARLFP-GEDTHVNTFRISGTHGYMAPEYALHGYLSVK 270
           RD+ A NIL+ E    K+SDFGLAR+   G D      +      + APE   H   S K
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSSK 177

Query: 271 TDVFSYGVLVLEIVS-GR 287
           +DV+SYGVL+ E+ S GR
Sbjct: 178 SDVWSYGVLLWEVFSYGR 195

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 94.9 bits (236), Expect = 3e-22
 Identities = 70/233 (30%), Positives = 116/233 (49%), Gaps = 15/233 (6%)

Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           L +LG G FG V  G      ++A+K +   S     EF  E K+++K+ H+ LV L+G 
Sbjct: 9   LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGV 67

Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
           C +     +V EY+ N  L  ++ +  K      +    +   V  G+ YL  +   + I
Sbjct: 68  CTKQRPIYIVTEYMSNGCLLNYLREHGKR--FQPSQLLEMCKDVCEGMAYLESK---QFI 122

Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVK 270
           HRD+ A N L+D+Q   K+SDFGL+R +  +D + ++        +  PE  L+   S K
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSK 181

Query: 271 TDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA 323
           +DV+++GVL+ E+ S        LGK   +  + + T+ +  + L L  P LA
Sbjct: 182 SDVWAFGVLMWEVYS--------LGKMPYERFNNSETVEKVSQGLRLYRPHLA 226

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 96.0 bits (239), Expect = 3e-22
 Identities = 68/203 (33%), Positives = 98/203 (48%), Gaps = 19/203 (9%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN---EVKLLLKIQHKN 143
           F+DL ++GHG FG VY    +   + +A+KK+S   +Q   ++ +   EV+ L +++H N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
            +   GC        LV EY    + D     K     ++      I  G  +GL YLH 
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAA---ICHGALQGLAYLHS 133

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
                 IHRDIKA NILL E    K++DFG A L    ++ V      GT  +MAPE  L
Sbjct: 134 H---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV------GTPYWMAPEVIL 184

Query: 264 ---HGYLSVKTDVFSYGVLVLEI 283
               G    K DV+S G+  +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 94.9 bits (236), Expect = 4e-22
 Identities = 67/208 (32%), Positives = 105/208 (50%), Gaps = 20/208 (9%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---------RQGLREFTNEVKLLLKIQHKN 143
           +G G FG VY G+   +G+ +AVK++ + S         R  L     E+ LL ++QH+N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           +V   G   +     +  EY+P  S+   +       + + T     V  + +GL YLH 
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVRNFVRQILKGLNYLHN 124

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE--DTHVNTFRIS--GTHGYMAP 259
                IIHRDIK +NIL+D +   KISDFG+++        T  N  R S  G+  +MAP
Sbjct: 125 R---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVSGR 287
           E       + K D++S G LV+E+++G+
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 94.6 bits (235), Expect = 5e-22
 Identities = 66/208 (31%), Positives = 99/208 (47%), Gaps = 20/208 (9%)

Query: 92  NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGL------REFTNEVKLLLKIQHKNLV 145
             LG G +G VY GL   GQ IAVK++ +D+   L       +   EV LL  ++H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFI--FDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
              G C +     +  E++P  S+   +  F           T+ +I+ GVA    YLH 
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QILDGVA----YLHN 120

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLAR---LFPGEDTHVNTFR-ISGTHGYMAP 259
                ++HRDIK +N++L      K+ DFG AR         TH N  + + GT  +MAP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177

Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVSGR 287
           E         K+D++S G  V E+ +G+
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 95.4 bits (237), Expect = 5e-22
 Identities = 67/220 (30%), Positives = 107/220 (48%), Gaps = 31/220 (14%)

Query: 94  LGHGGFGPVYRGL------MPNGQEIAVKKLSVDSRQG-LREFTNEVKLLLKIQHKNLVT 146
           LG G FG V +              +AVK L  ++    LR+  +E  LL ++ H +++ 
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTK-------------SSSLDWTTRYRIVMG 193
           L+G C++    +L+ EY    SL  F+ +  K             SS LD      + MG
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 194 --------VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV 245
                   ++RG+ YL E    +++HRD+ A N+L+ E    KISDFGL+R    ED++V
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 246 NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
              +      +MA E       + ++DV+S+GVL+ EIV+
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 95.5 bits (237), Expect = 5e-22
 Identities = 69/203 (33%), Positives = 97/203 (47%), Gaps = 19/203 (9%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLSVDSRQ---GLREFTNEVKLLLKIQHKN 143
           F  L+++GHG FG VY     +  E+ AVKK+S   +Q     ++   EVK L +++H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
            +   GC  +     LV EY    + D     K     ++      I  G  +GL YLH 
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---ITHGALQGLAYLHS 139

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
                +IHRDIKA NILL E    K++DFG A      ++ V      GT  +MAPE  L
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV------GTPYWMAPEVIL 190

Query: 264 ---HGYLSVKTDVFSYGVLVLEI 283
               G    K DV+S G+  +E+
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 94.3 bits (234), Expect = 1e-21
 Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 29/215 (13%)

Query: 93  QLGHGGFGPVY----RGLMPNGQE--IAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           +LG G FG V+      L+P   +  +AVK L   S    ++F  E +LL  +QH+++V 
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYF---------IFDKTKSSSLDWTT---RYRIVMGV 194
            +G C EG   ++V+EY+ +  L+ F         I    +  +    T      I   +
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH 254
           A G++YL   A    +HRD+   N L+ + L  KI DFG++R     D     +R+ G  
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD----YYRVGGRT 184

Query: 255 ----GYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
                +M PE  L+   + ++D++S+GV++ EI +
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 94.1 bits (235), Expect = 1e-21
 Identities = 66/217 (30%), Positives = 104/217 (47%), Gaps = 38/217 (17%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD------SRQGLREFTNEVKLLLKIQ 140
           +  L +LG G +G VY+      G+ +A+KK+ +D          LRE    + LL +++
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALRE----ISLLKELK 56

Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
           H N+V L        +  LV+EY  +  L  ++    +   L       I+  + RGL Y
Sbjct: 57  HPNIVKLLDVIHTERKLYLVFEYC-DMDLKKYL--DKRPGPLSPNLIKSIMYQLLRGLAY 113

Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF--PGEDTHVNTFRISGTHG--- 255
            H     RI+HRD+K  NIL++     K++DFGLAR F  P     + T+    TH    
Sbjct: 114 CHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIP-----LRTY----THEVVT 161

Query: 256 --YMAPEYAL--HGY-LSVKTDVFSYGVLVLEIVSGR 287
             Y APE  L    Y  +V  D++S G +  E+++G+
Sbjct: 162 LWYRAPEILLGSKHYSTAV--DIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 94.1 bits (234), Expect = 1e-21
 Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 39/223 (17%)

Query: 94  LGHGGFGPVYR----GLMPNGQE---IAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLV 145
           +G G FG V++    GL+P  +    +AVK L  + S     +F  E  L+ +  H N+V
Sbjct: 13  IGQGAFGRVFQARAPGLLP-YEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIV 71

Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFD---KTKSSSLDWTTRYR------------- 189
            L G CA G    L++EY+    L+ F+     + + S    T+  R             
Sbjct: 72  KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131

Query: 190 ---IVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246
              I   VA G+ YL E    + +HRD+   N L+ E +  KI+DFGL+R     D    
Sbjct: 132 QLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD---- 184

Query: 247 TFRISGTHG----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
            ++ S        +M PE   +   + ++DV++YGV++ EI S
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 92.9 bits (231), Expect = 2e-21
 Identities = 63/204 (30%), Positives = 106/204 (51%), Gaps = 23/204 (11%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKK-----LSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
           LG G FG VY    +  G+E+AVK+      S ++++ +     E++LL  +QH+ +V  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 148 FGCCAEGPEKMLVY-EYLPNKSLDYFIFDKTKSSSLDWTTR---YRIVMGVARGLLYLHE 203
           +GC  +  E + ++ EY+P  S+   +  K   +  +  TR    +I+     G+ YLH 
Sbjct: 70  YGCLRD-DETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQIL----EGVEYLHS 122

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR-ISGTHGYMAPEYA 262
                I+HRDIK +NIL D   N K+ DFG ++      +     + ++GT  +M+PE  
Sbjct: 123 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179

Query: 263 L-HGYLSVKTDVFSYGVLVLEIVS 285
              GY   K DV+S G  V+E+++
Sbjct: 180 SGEGY-GRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 94.3 bits (234), Expect = 2e-21
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 21/226 (9%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEI----AVKKL-SVDSRQGLREFTNEVKLLLKIQH 141
           F  +  LG G FG VY+GL +P G+++    A+K+L    S +  +E  +E  ++  + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARG 197
            ++  L G C     + L+ + +P   L DY    K    S   L+W  +      +A+G
Sbjct: 69  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 121

Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           + YL E    R++HRD+ A N+L+    + KI+DFGLA+L   ++   +         +M
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178

Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
           A E  LH   + ++DV+SYGV V E+++ G K +DG    E + +L
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 224

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 93.6 bits (232), Expect = 2e-21
 Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 29/214 (13%)

Query: 93  QLGHGGFGPVYRG----LMPNGQEI--AVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           +LG G FG V+      L P   +I  AVK L   S    ++F  E +LL  +QH+++V 
Sbjct: 12  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFI----------FDKTKSSSLDWTTRYRIVMGVAR 196
            +G C EG   ++V+EY+ +  L+ F+           +  + + L  +    I   +A 
Sbjct: 72  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131

Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG- 255
           G++YL   A    +HRD+   N L+ E L  KI DFG++R     D +   +   G H  
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR-----DVYSTDYYRVGGHTM 183

Query: 256 ----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
               +M PE  ++   + ++DV+S GV++ EI +
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 93.1 bits (231), Expect = 2e-21
 Identities = 71/220 (32%), Positives = 107/220 (48%), Gaps = 21/220 (9%)

Query: 94  LGHGGFGPVYRGL-MPNGQEI----AVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTL 147
           LG G FG V++G+ +P G  I    A+K +   S RQ  +E T+ +  +  + H  +V L
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSS----LDWTTRYRIVMGVARGLLYLHE 203
            G C  G    LV +  P  SL   +     S      L+W  +      +A+G+ YL E
Sbjct: 75  LGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLEE 127

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
               R++HR++ A NILL      +I+DFG+A L   +D             +MA E  L
Sbjct: 128 H---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184

Query: 264 HGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
            G  + ++DV+SYGV V E++S G + + G    E  DLL
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL 224

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 92.6 bits (230), Expect = 3e-21
 Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 21/204 (10%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCA 152
           LG G +G VY    +     IA+K++     + ++    E+ L   ++H+N+V   G  +
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 153 EGPEKMLVYEYLPNKSLDYFIFDK-----TKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           E     +  E +P  SL   +  K         ++ + T+      +  GL YLH+    
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQ-----ILEGLKYLHDN--- 127

Query: 208 RIIHRDIKASNILLDEQLNP-KISDFGLARLFPGEDTHVNTFRISGTHGYMAPE---YAL 263
           +I+HRDIK  N+L++      KISDFG ++   G +    TF  +GT  YMAPE      
Sbjct: 128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF--TGTLQYMAPEVIDKGP 185

Query: 264 HGYLSVKTDVFSYGVLVLEIVSGR 287
            GY     D++S G  ++E+ +G+
Sbjct: 186 RGY-GAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 92.4 bits (230), Expect = 4e-21
 Identities = 57/211 (27%), Positives = 98/211 (46%), Gaps = 25/211 (11%)

Query: 93  QLGHGGFGPVYRGLMPN------GQEIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLV 145
           +LG G FG VY GL            +A+K ++ ++    R EF NE  ++ +    ++V
Sbjct: 13  ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72

Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIF----DKTKSSSLDWTTR---YRIVMGVARGL 198
            L G  + G   ++V E +    L  ++     +   +  L   T     ++   +A G+
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH---- 254
            YL  +   + +HRD+ A N ++ E L  KI DFG+ R     D     +R  G      
Sbjct: 133 AYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETD----YYRKGGKGLLPV 185

Query: 255 GYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
            +MAPE    G  + K+DV+S+GV++ E+ +
Sbjct: 186 RWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 92.0 bits (228), Expect = 5e-21
 Identities = 73/222 (32%), Positives = 120/222 (54%), Gaps = 25/222 (11%)

Query: 94  LGHGGFGPVYRGL-MPNGQEI----AVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTL 147
           LG G FG VY+G+ +P+G+ +    A+K L  + S +  +E  +E  ++  +    +  L
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 148 FGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARGLLYLHE 203
            G C     + LV + +P   L DY   +K +  S   L+W  +      +A+G+ YL E
Sbjct: 75  LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT--HVNTFRISGTHGYMAPEY 261
               R++HRD+ A N+L+    + KI+DFGLARL   ++T  H +  ++     +MA E 
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK--WMALES 182

Query: 262 ALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
            LH   + ++DV+SYGV V E+++ G K +DG   +E  DLL
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL 224

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 92.2 bits (229), Expect = 5e-21
 Identities = 62/199 (31%), Positives = 95/199 (47%), Gaps = 13/199 (6%)

Query: 94  LGHGGFGPVYRGLMPN-GQEIAVKKLS---VDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
           LG GGFG V    +   G+  A KKL    +  R+G +   NE K+L K+  + +V+L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59

Query: 150 CCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
              E  + + LV   +    L Y I++  +    +    +     +  GL +LH+    R
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLHQR---R 115

Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLS 268
           I++RD+K  N+LLD+  N +ISD GLA    G          +GT GYMAPE        
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVLQGEVYD 172

Query: 269 VKTDVFSYGVLVLEIVSGR 287
              D F+ G  + E+++GR
Sbjct: 173 FSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 90.9 bits (226), Expect = 1e-20
 Identities = 65/208 (31%), Positives = 105/208 (50%), Gaps = 18/208 (8%)

Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVKKLS-VDSRQG-LREFTNEVKLLLKIQHKNLVTL 147
            N++G G FG VY  + +  G+ +AVK++   D+    ++E  +E+K+L  ++H NLV  
Sbjct: 5   GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY 64

Query: 148 FGCCAEGPEKMLVY-EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           +G      EK+ ++ EY    +L+  +        LD        + +  GL YLH    
Sbjct: 65  YGVEVH-REKVYIFMEYCSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHS--- 117

Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLA-RLFPGEDTHVNTFR-ISGTHGYMAPEY--- 261
             I+HRDIK +NI LD     K+ DFG A +L     T     + ++GT  YMAPE    
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177

Query: 262 -ALHGYLSVKTDVFSYGVLVLEIVSGRK 288
               G+     D++S G +VLE+ +G++
Sbjct: 178 GKGKGHGRA-ADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 89.8 bits (223), Expect = 2e-20
 Identities = 65/210 (30%), Positives = 105/210 (50%), Gaps = 11/210 (5%)

Query: 88  FSDLNQLGHGGFGPVYR-GLMPNGQEIAVKKLSVDS-RQGLREFT-NEVKLLLKIQHKNL 144
           F  L +LG G +G VY+   + + Q  A+K++ + S  Q  RE   NE+++L  + H N+
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWT-TRYRIVMGVARGLLYLHE 203
           ++      +G +  +V EY P   L   I  + K   L      +RI + + RGL  LHE
Sbjct: 62  ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE 121

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
           +   +I+HRD+K++NILL      KI D G++++              GT  YMAPE   
Sbjct: 122 Q---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI----GTPHYMAPEVWK 174

Query: 264 HGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
               S K+D++S G L+ E+ +     + R
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFEAR 204

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 56/218 (25%), Positives = 98/218 (44%), Gaps = 23/218 (10%)

Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-----RQGLREFTNEVKLLLKIQHKNL 144
           L  +G G FG V +     +G+ +  K++   +     +Q L    +EV +L +++H N+
Sbjct: 5   LETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQL---VSEVNILRELKHPNI 61

Query: 145 VTLFGCCAEGPEKMLVY---EYLPNKSLDYFIFDKTKS-SSLDWTTRYRIVMGVARGLLY 200
           V  +    +      +Y   EY     L   I    K    ++    +RI+  +   L  
Sbjct: 62  VRYYDRIID-RSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120

Query: 201 LHEEAPA--RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMA 258
            H  +     ++HRD+K +NI LD   N K+ DFGLA++   + +   T+   GT  YM+
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY--VGTPYYMS 178

Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVSGR-----KNHD 291
           PE   H     K+D++S G L+ E+ +       +N  
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL 216

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 90.3 bits (224), Expect = 2e-20
 Identities = 66/213 (30%), Positives = 98/213 (46%), Gaps = 26/213 (12%)

Query: 87  FFSDLNQLGHGGFGPV--YRGLMPN---GQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQ 140
           +   +  LG G FG V  Y     N   G+ +AVK L  +  Q     +  E+ +L  + 
Sbjct: 5   YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY 64

Query: 141 HKNLVTLFGCCAEGPEK--MLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARG 197
           H+N+V   GCC+E   K   L+ EY+P  SL DY    K   + L           +  G
Sbjct: 65  HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQL-----LLFAQQICEG 119

Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP-GEDTHVNTFRISGTHG- 255
           + YLH +     IHRD+ A N+LLD     KI DFGLA+  P G +     +R+      
Sbjct: 120 MAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE----YYRVREDGDS 172

Query: 256 ---YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
              + A E       S  +DV+S+GV + E+++
Sbjct: 173 PVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 90.5 bits (224), Expect = 3e-20
 Identities = 69/216 (31%), Positives = 106/216 (49%), Gaps = 26/216 (12%)

Query: 88  FSDLNQLGHGGFGPVYRGLMP---NGQEIAVKKL-SVDSRQGLREFTNEVKLLLKI-QHK 142
           F D+  +G G FG V R ++         A+K L    S    R+F  E+++L K+  H 
Sbjct: 6   FEDV--IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHP 63

Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFI-----------FDKTKSSSLDWTTR--YR 189
           N++ L G C       +  EY P  +L  F+           F K   ++   T++   +
Sbjct: 64  NIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123

Query: 190 IVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR 249
               VA G+ YL E+   + IHRD+ A N+L+ E L  KI+DFGL+R   GE+ +V    
Sbjct: 124 FASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYVKKTM 177

Query: 250 ISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
                 +MA E   +   + K+DV+S+GVL+ EIVS
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 89.8 bits (222), Expect = 3e-20
 Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 11/206 (5%)

Query: 87  FFSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLSVDSRQG-LREFTNEVKLLLKIQHKNL 144
            F+ L ++G G FG V++G+    Q++ A+K + ++  +  + +   E+ +L +     +
Sbjct: 5   LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
              +G   +  +  ++ EYL   S      D  +   LD T    I+  + +GL YLH E
Sbjct: 65  TKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSE 120

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              + IHRDIKA+N+LL E    K++DFG+A      DT +      GT  +MAPE    
Sbjct: 121 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVIKQ 175

Query: 265 GYLSVKTDVFSYGVLVLEIVSGRKNH 290
                K D++S G+  +E+  G   H
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPH 201

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 89.7 bits (222), Expect = 3e-20
 Identities = 59/202 (29%), Positives = 102/202 (50%), Gaps = 11/202 (5%)

Query: 87  FFSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLSVDSRQG-LREFTNEVKLLLKIQHKNL 144
            F+ L ++G G FG V++G+    Q++ A+K + ++  +  + +   E+ +L +     +
Sbjct: 5   LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
              +G   +G +  ++ EYL   S      D  ++   D      ++  + +GL YLH E
Sbjct: 65  TKYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHSE 120

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              + IHRDIKA+N+LL EQ + K++DFG+A          NTF   GT  +MAPE    
Sbjct: 121 ---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF--VGTPFWMAPEVIQQ 175

Query: 265 GYLSVKTDVFSYGVLVLEIVSG 286
                K D++S G+  +E+  G
Sbjct: 176 SAYDSKADIWSLGITAIELAKG 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 89.5 bits (222), Expect = 4e-20
 Identities = 68/218 (31%), Positives = 100/218 (45%), Gaps = 34/218 (15%)

Query: 92  NQLGHGGFGPVYRG-----LMPNGQEIAV-----KKLSVDSRQGLREFTNEVKLLLKIQH 141
           N LG G FG VY G     L P    I V     +K + D  +  +EF  E  L+    H
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNH 58

Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARG 197
            N+V L G C     + ++ E +    L  ++ D    +     L       I + VA+G
Sbjct: 59  PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118

Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNP-----KISDFGLARLFPGEDTHVNTF-RIS 251
            +YL +      IHRD+ A N L+ E+        KI DFGLAR     D + + + R  
Sbjct: 119 CVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-----DIYKSDYYRKE 170

Query: 252 GTH----GYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           G       +MAPE  L G  + ++DV+S+GVL+ EI++
Sbjct: 171 GEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 89.2 bits (221), Expect = 4e-20
 Identities = 61/200 (30%), Positives = 102/200 (51%), Gaps = 15/200 (7%)

Query: 94  LGHGGFGPVYRGLM--PNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLF 148
           +G G FG V  G +  P  +EI  A+K L    + +  R+F +E  ++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G   +    M+V EY+ N SLD F+  +             ++ G+A G+ YL +     
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFL--RKHDGQFTVIQLVGMLRGIASGMKYLSDMG--- 126

Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH---GYMAPEYALHG 265
            +HRD+ A NIL++  L  K+SDFGL+R+   ED     +   G      + APE   + 
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKIPIRWTAPEAIAYR 184

Query: 266 YLSVKTDVFSYGVLVLEIVS 285
             +  +DV+SYG+++ E++S
Sbjct: 185 KFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 89.2 bits (221), Expect = 4e-20
 Identities = 63/202 (31%), Positives = 106/202 (52%), Gaps = 17/202 (8%)

Query: 94  LGHGGFGPVYRGLM--PNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLF 148
           +G G FG V RG +  P  +EI  A+K L    + +  R+F +E  ++ +  H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G   +    M++ E++ N +LD F+  +             ++ G+A G+ YL E     
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYLSE---MN 126

Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAPEYAL 263
            +HRD+ A NIL++  L  K+SDFGL+R F  +DT   T+  S   G     + APE   
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSR-FLEDDTSDPTY-TSSLGGKIPIRWTAPEAIA 184

Query: 264 HGYLSVKTDVFSYGVLVLEIVS 285
           +   +  +DV+SYG+++ E++S
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 89.7 bits (222), Expect = 5e-20
 Identities = 59/217 (27%), Positives = 103/217 (47%), Gaps = 32/217 (14%)

Query: 93  QLGHGGFGPVYRG----LMPNGQE--IAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           +LG G FG V+      L P   +  +AVK L   +    ++F  E +LL  +QH+++V 
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIF-------------DKTKSSSLDWTTRYRIVMG 193
            +G C +G   ++V+EY+ +  L+ F+               +     L  +    I   
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131

Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           +A G++YL   A    +HRD+   N L+   L  KI DFG++R     D +   +   G 
Sbjct: 132 IASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-----DVYSTDYYRVGG 183

Query: 254 HG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           H      +M PE  ++   + ++DV+S+GV++ EI +
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 89.1 bits (221), Expect = 6e-20
 Identities = 62/215 (28%), Positives = 109/215 (50%), Gaps = 25/215 (11%)

Query: 77  DLRTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLR-EFTNEVK 134
           DL T+            LG G  G V +   +P G  +A K + + ++  +R +   E++
Sbjct: 6   DLETIS----------DLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQ 55

Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGV 194
           ++ + +   +V+ +G         +  E++   SLD  I+ K     ++   +  I + V
Sbjct: 56  IMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDR-IYKKGGPIPVEILGK--IAVAV 112

Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE--DTHVNTFRISG 252
             GL YL+     RI+HRDIK SNIL++ +   K+ DFG++    GE  ++  +TF   G
Sbjct: 113 VEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTF--VG 164

Query: 253 THGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
           T  YM+PE    G  +VK+DV+S G+ ++E+  G+
Sbjct: 165 TSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 88.9 bits (221), Expect = 7e-20
 Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 12/204 (5%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN--EVKLLLKIQHKNL 144
           +  L ++G G +G VY+      G+ +A+KK+ +         T   E+KLL ++ H N+
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L        +  LV+E++ +  L   I D+ +         Y   +   +GL + H  
Sbjct: 61  IKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQL--LQGLAFCHS- 116

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
               I+HRD+K  N+L++ +   K++DFGLAR F G      T  +  T  Y APE  L 
Sbjct: 117 --HGILHRDLKPENLLINTEGVLKLADFGLARSF-GSPVRPYTHYVV-TRWYRAPELLLG 172

Query: 265 -GYLSVKTDVFSYGVLVLEIVSGR 287
               S   D++S G +  E++S R
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 88.4 bits (219), Expect = 1e-19
 Identities = 68/278 (24%), Positives = 120/278 (43%), Gaps = 47/278 (16%)

Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGL-REFTNEVKLLLKIQHKNLVTLF 148
              LGHG  G VY+   +   + +AVK + +D    L ++  +E+++L K     ++  +
Sbjct: 6   QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65

Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G         +  E++   SLD  ++ K     L      RI + V +GL YL      +
Sbjct: 66  GAFFVENRISICTEFMDGGSLD--VYRKIPEHVLG-----RIAVAVVKGLTYLWS---LK 115

Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS--GTHGYMAPEYALHGY 266
           I+HRD+K SN+L++ +   K+ DFG++         VN+   +  GT+ YMAPE      
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQL------VNSIAKTYVGTNAYMAPERISGEQ 169

Query: 267 LSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCN 326
             + +DV+S G+  +E+  GR                + +   Q  +   L+   L +C 
Sbjct: 170 YGIHSDVWSLGISFMELALGR----------------FPYPQIQKNQG-SLMPLQLLQCI 212

Query: 327 RDEAAMCIQLGLL----------CCQQSVAERPDMNSV 354
            DE    + +G            C ++   ERP   ++
Sbjct: 213 VDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENL 250

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 87.4 bits (216), Expect = 2e-19
 Identities = 75/270 (27%), Positives = 124/270 (45%), Gaps = 32/270 (11%)

Query: 94  LGHGGFGPVYRGLMPNG---QEIAVKKL-SVDSRQGLREFTNEVKLLLKI-QHKNLVTLF 148
           +G G FG V +  +       + A+K++    S+   R+F  E+++L K+  H N++ L 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 149 GCCAEGPEKMLVYEYLPNKSL-DY------------FIFDKTKSSSLDWTTRYRIVMGVA 195
           G C       L  EY P+ +L D+            F    + +S+L           VA
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG 255
           RG+ YL ++   + IHRD+ A NIL+ E    KI+DFGL+R   G++ +V          
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLPVR 176

Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKA 314
           +MA E   +   +  +DV+SYGVL+ EIVS G   + G    E  + L   + L +    
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNC 236

Query: 315 LELVDPSLAKCNRDE-------AAMCIQLG 337
            + V   + +C R++       A + + L 
Sbjct: 237 DDEVYDLMRQCWREKPYERPSFAQILVSLN 266

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 86.1 bits (213), Expect = 4e-19
 Identities = 63/236 (26%), Positives = 109/236 (46%), Gaps = 21/236 (8%)

Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGL---REFTNEVKLLLKIQHKNLVTL 147
           + +LG G FG V+ G      ++A+K +     +G     +F  E K+++K+ H  LV L
Sbjct: 9   MKELGSGQFGVVHLGKWRAQIKVAIKAI----NEGAMSEEDFIEEAKVMMKLSHPKLVQL 64

Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           +G C +     +V E++ N  L  ++  +    S D      +   V  G+ YL   +  
Sbjct: 65  YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKD--MLLSMCQDVCEGMEYLERNS-- 120

Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
             IHRD+ A N L+      K+SDFG+ R +  +D + ++        +  PE       
Sbjct: 121 -FIHRDLAARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKY 178

Query: 268 SVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA 323
           S K+DV+S+GVL+ E+ +     +G++  EK         + +G +   L  P LA
Sbjct: 179 SSKSDVWSFGVLMWEVFT-----EGKMPFEKKSNYEVVEMISRGFR---LYRPKLA 226

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 86.8 bits (215), Expect = 5e-19
 Identities = 63/204 (30%), Positives = 110/204 (53%), Gaps = 11/204 (5%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFT-NEVKLLLKIQHKNLV 145
           F  L +LG G +  VY+G     G+ +A+K++ +D+ +G       E+ L+ +++H+N+V
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61

Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
            L        + MLV+EY+ +K L  ++       +LD  T       + +G+ + HE  
Sbjct: 62  RLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN- 119

Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS-GTHGYMAPEYALH 264
             R++HRD+K  N+L++++   K++DFGLAR F      VNTF     T  Y AP+  L 
Sbjct: 120 --RVLHRDLKPQNLLINKRGELKLADFGLARAF---GIPVNTFSNEVVTLWYRAPDVLLG 174

Query: 265 GYL-SVKTDVFSYGVLVLEIVSGR 287
               S   D++S G ++ E+++GR
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 86.3 bits (214), Expect = 5e-19
 Identities = 63/207 (30%), Positives = 106/207 (51%), Gaps = 16/207 (7%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFT--NEVKLLLKIQHKNL 144
           ++ + ++G G +G VY+G     GQ +A+KK+ ++S +     T   E+ LL ++QH N+
Sbjct: 2   YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61

Query: 145 VTLFGCCAEGPEKMLVYEYLP---NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
           V L     +     L++E+L     K LD     +   + L  +  Y+I+ G+    L+ 
Sbjct: 62  VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGI----LFC 117

Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEY 261
           H     R++HRD+K  N+L+D +   K++DFGLAR F G    V T  +  T  Y APE 
Sbjct: 118 HSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAF-GIPVRVYTHEVV-TLWYRAPEV 172

Query: 262 ALHGYL-SVKTDVFSYGVLVLEIVSGR 287
            L     S   D++S G +  E+ + +
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 86.8 bits (215), Expect = 6e-19
 Identities = 65/204 (31%), Positives = 99/204 (48%), Gaps = 20/204 (9%)

Query: 94  LGHGGFGPVYR----GLMPNGQ--EIAVKKLSVDSRQGLRE-FTNEVKLLLKI-QHKNLV 145
           LG G FG V      GL  +    ++AVK L   +    RE   +E+K++  +  H+N+V
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
            L G C  G   +++ EY     L  F+  K + S L           VA+G+ +L   A
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFL---A 158

Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH----GYMAPEY 261
               IHRD+ A N+LL      KI DFGLAR    +  + + + + G       +MAPE 
Sbjct: 159 SKNCIHRDLAARNVLLTHGKIVKICDFGLAR----DIMNDSNYVVKGNARLPVKWMAPES 214

Query: 262 ALHGYLSVKTDVFSYGVLVLEIVS 285
             +   + ++DV+SYG+L+ EI S
Sbjct: 215 IFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 85.8 bits (213), Expect = 8e-19
 Identities = 56/179 (31%), Positives = 89/179 (49%), Gaps = 22/179 (12%)

Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQG------LREFTNEVKLLLKIQHKN 143
           L ++G G  G V++      G+ +A+KK+++   +G      LRE    +K L   QH  
Sbjct: 5   LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALRE----IKALQACQHPY 60

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY--RIVMGVARGLLYL 201
           +V L      G   +LV EY+P+  L   + D+ +         Y   ++ GVA    Y+
Sbjct: 61  VVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVA----YM 115

Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE 260
           H      I+HRD+K +N+L+      KI+DFGLARLF  E+  + + ++  T  Y APE
Sbjct: 116 HAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 85.8 bits (212), Expect = 1e-18
 Identities = 71/221 (32%), Positives = 108/221 (48%), Gaps = 38/221 (17%)

Query: 94  LGHGGFGPVYR----GLMPNGQE----IAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKN 143
           LG G FG V R    G+  +  +    +AVK L  + + + L +  +E++L+  I +HKN
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 144 LVTLFGCCA-EGPEKMLVYEYLPNKSLDYFI-----------FDKTKSSS--LDWTTRYR 189
           ++ L G C  EGP  ++V EY    +L  F+           FD TK     L +     
Sbjct: 80  IINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138

Query: 190 IVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR 249
               VARG+ YL      R IHRD+ A N+L+ E    KI+DFGLAR       H   + 
Sbjct: 139 CAYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLAR-----GVHDIDYY 190

Query: 250 ISGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
              ++G     +MAPE       + ++DV+S+G+L+ EI +
Sbjct: 191 KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 85.4 bits (211), Expect = 1e-18
 Identities = 68/216 (31%), Positives = 108/216 (50%), Gaps = 26/216 (12%)

Query: 88  FSDLNQLGHGGFGPVYRG-LMPNG--QEIAVKKLS-VDSRQGLREFTNEVKLLLKI-QHK 142
           F D+  +G G FG V +  +  +G   + A+K++    S+   R+F  E+++L K+  H 
Sbjct: 11  FQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 68

Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSL-DY------------FIFDKTKSSSLDWTTRYR 189
           N++ L G C       L  EY P+ +L D+            F    + +S+L       
Sbjct: 69  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 128

Query: 190 IVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR 249
               VARG+ YL ++   + IHRD+ A NIL+ E    KI+DFGL+R   G++ +V    
Sbjct: 129 FAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTM 182

Query: 250 ISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
                 +MA E   +   +  +DV+SYGVL+ EIVS
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 84.9 bits (210), Expect = 1e-18
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 21/249 (8%)

Query: 94  LGHGGFGPVYRGLM--PNG--QEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTL 147
           LG G FG V  G +   +G   ++AVK + +D  +   + EF +E   +    H N++ L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 148 FGCCAEG------PEKMLVYEYLPNKSLDYFIFD---KTKSSSLDWTTRYRIVMGVARGL 198
            G C E       P+ M++  ++ +  L  F+           L   T  + ++ +A G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH-GYM 257
            YL        IHRD+ A N +L E +   ++DFGL++     D +    RI+     ++
Sbjct: 127 EYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQG-RIAKMPVKWI 182

Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALE 316
           A E       + K+DV+++GV + EI + G+  + G    E  D L +   L Q E  L+
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLD 242

Query: 317 LVDPSLAKC 325
            +   +  C
Sbjct: 243 ELYDLMYSC 251

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 84.6 bits (209), Expect = 2e-18
 Identities = 74/272 (27%), Positives = 121/272 (44%), Gaps = 35/272 (12%)

Query: 93  QLGHGGFGPVYRGL--MPNGQ-EIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLVTLF 148
           +LG G FG V +G+  M   Q ++A+K L  ++ + +R E   E +++ ++ +  +V + 
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVM---GVARGLLYLHEEA 205
           G C E    MLV E      L+ F+     S   D  T   +V     V+ G+ YL  + 
Sbjct: 62  GVC-EAEALMLVMEMASGGPLNKFL-----SGKKDEITVSNVVELMHQVSMGMKYLEGK- 114

Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH--GYMAPEYAL 263
               +HRD+ A N+LL  Q   KISDFGL++    +D++    R +G     + APE   
Sbjct: 115 --NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY-KARSAGKWPLKWYAPECIN 171

Query: 264 HGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL 322
               S ++DV+SYG+ + E  S G+K +    G E         +  +  K L+      
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-------VMSFIEQGKRLD------ 218

Query: 323 AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSV 354
             C  +       L   C      +RP+   V
Sbjct: 219 --CPAECPPEMYALMKDCWIYKWEDRPNFAKV 248

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 27/207 (13%)

Query: 97  GGFGPVYRGLM----PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           G FG ++ G++    P  +E    K   D  S   +     E  LL  + H+N++ +   
Sbjct: 17  GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHV 76

Query: 151 CAEGPEKMLVYEYLPNKS-LDYF-----IFDKTKSSSLDWTTRYRIVMG--VARGLLYLH 202
           C E  E   V     N   L  F     + +     +L  +T+  + M   +A G+ YLH
Sbjct: 77  CIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL--STQQLVHMAIQIACGMSYLH 134

Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLAR-LFPGEDTHV---NTFRISGTHGYMA 258
           +     +IH+DI A N ++DE+L  KI+D  L+R LFP  D H    N  R      +MA
Sbjct: 135 KR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPM-DYHCLGDNENR---PVKWMA 187

Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVS 285
            E  ++   S  +DV+S+GVL+ E+++
Sbjct: 188 LESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 15/205 (7%)

Query: 93  QLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCC 151
           +LG G FG VY+      G   A K + ++S + L +F  E+ +L + +H N+V L+   
Sbjct: 12  ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY 71

Query: 152 AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIH 211
               +  ++ E+    +LD  I  + +    +   RY +   +   L +LH     ++IH
Sbjct: 72  FYENKLWILIEFCDGGALDS-IMLELERGLTEPQIRY-VCRQMLEALNFLHSH---KVIH 126

Query: 212 RDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE------YALHG 265
           RD+KA NILL    + K++DFG++          +TF   GT  +MAPE      +  + 
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF--IGTPYWMAPEVVACETFKDNP 184

Query: 266 YLSVKTDVFSYGVLVLEIVSGRKNH 290
           Y   K D++S G+ ++E+      H
Sbjct: 185 YDY-KADIWSLGITLIELAQMEPPH 208

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 84.3 bits (208), Expect = 2e-18
 Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 28/216 (12%)

Query: 93  QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCA 152
           +LG G FG V+        ++AVK +   S   +  F  E  ++  +QH  LV L     
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT 71

Query: 153 EGPEKMLVYEYLPNKSL-DYFIFDKTKSSSL----DWTTRYRIVMGVARGLLYLHEEAPA 207
           + P   ++ E++   SL D+   D+     L    D++ +      +A G+ ++ +    
Sbjct: 72  KEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQR--- 121

Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT-----FRISGTHGYMAPEYA 262
             IHRD++A+NIL+   L  KI+DFGLAR+   ED          F I  T    APE  
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWT----APEAI 175

Query: 263 LHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKE 297
             G  ++K+DV+S+G+L++EIV+ GR  + G    E
Sbjct: 176 NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE 211

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 72/282 (25%), Positives = 126/282 (44%), Gaps = 34/282 (12%)

Query: 85  TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSV------DSRQGLREFTNEVKLLL 137
              F    ++G G F  VY+ + + +G+ +A+KK+ +       +RQ   +   E+ LL 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLK 57

Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFI--FDKTKSSSLDWTTRYRIVMGVA 195
           ++ H N++       E  E  +V E      L   I  F K K   +   T ++  + + 
Sbjct: 58  QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRL-IPERTIWKYFVQLC 116

Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG 255
             L ++H +   RI+HRDIK +N+ +      K+ D GL R F  + T      + GT  
Sbjct: 117 SALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPY 171

Query: 256 YMAPEYALH--GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEK 313
           YM+PE  +H  GY + K+D++S G L+ E+ + +    G    +K +L S    + + + 
Sbjct: 172 YMSPE-RIHENGY-NFKSDIWSLGCLLYEMAALQSPFYG----DKMNLYSLCKKIEKCDY 225

Query: 314 ALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVH 355
                D    +  RD  + CI            +RPD++ V 
Sbjct: 226 PPLPADHYSEEL-RDLVSRCINP-------DPEKRPDISYVL 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 84.2 bits (208), Expect = 2e-18
 Identities = 85/280 (30%), Positives = 130/280 (46%), Gaps = 26/280 (9%)

Query: 93  QLGHGGFGPVYRGLMPNG---QEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLF 148
           ++G+G FG V  G + +G    ++ VK+L V  S Q   +F  E +    +QH NL+   
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSL--DWTTRYRIVMGVARGLLYLHEEAP 206
           G C E    +LV E+ P   L  ++    K+  +  D TT  R+   +A GLL+LH+   
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN-- 119

Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA--LH 264
              IH D+   N LL   L  KI D+GL+     ED +V   ++     ++APE    +H
Sbjct: 120 -NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178

Query: 265 GYLSV-----KTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD 319
           G L V     +++V+S GV + E+          L  E+  +L+YT      E+ L+L  
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--VLTYTVR----EQQLKLPK 232

Query: 320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS 359
           P L     D     +Q     C     +RP    VHL+LS
Sbjct: 233 PRLKLPLSDRWYEVMQF----CWLQPEQRPSAEEVHLLLS 268

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 84.8 bits (209), Expect = 2e-18
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 10/200 (5%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           ++   ++G G  G VY  + +  GQE+A+K++++  +       NE+ ++ + ++ N+V 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
                  G E  +V EYL   SL     D    + +D      +     + L +LH    
Sbjct: 81  YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALDFLHSN-- 134

Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGY 266
            ++IHRDIK+ NILL    + K++DFG       E +  +T  + GT  +MAPE      
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 191

Query: 267 LSVKTDVFSYGVLVLEIVSG 286
              K D++S G++ +E+V G
Sbjct: 192 YGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 84.6 bits (209), Expect = 2e-18
 Identities = 72/304 (23%), Positives = 134/304 (44%), Gaps = 60/304 (19%)

Query: 93  QLGHGGFGPV----------YRGLMPNGQE-----IAVKKLSVDSRQGLR-EFTNEVKLL 136
           +LG G FG V          + G      +     +AVK L  D  +  R +F  E+K++
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 137 LKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDK------TKSSSLDWTTRYRI 190
            ++++ N++ L G C       ++ EY+ N  L+ F+  +      T ++++   +   +
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131

Query: 191 V---MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR-LFPGEDTHVN 246
           +   + +A G+ YL   A    +HRD+   N L+      KI+DFG++R L+ G+     
Sbjct: 132 LYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD----- 183

Query: 247 TFRISGTH----GYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLL 302
            +RI G       +MA E  L G  +  +DV+++GV + E+ +        L KE+    
Sbjct: 184 YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT--------LCKEQP--- 232

Query: 303 SYTWTLFQGEKALELVDPSLAKCNR----DEAAMC----IQLGLLCCQQSVAERPDMNSV 354
              ++L   E+ +E          R     +  +C     +L + C  + + +RP  N +
Sbjct: 233 ---YSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKI 289

Query: 355 HLML 358
           H  L
Sbjct: 290 HHFL 293

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 84.9 bits (211), Expect = 3e-18
 Identities = 64/236 (27%), Positives = 105/236 (44%), Gaps = 69/236 (29%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQ 140
           +  L  +G G +G V   +    G+++A+KK+S      +D+++ LRE    +KLL  ++
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILRE----IKLLRHLR 57

Query: 141 HKNLVTL---FGCCAEGPEKM----LVYEYLP---------NKSLD-----YFIFDKTKS 179
           H+N++ L          PE      +V E +           + L      YF+      
Sbjct: 58  HENIIGLLDILR--PPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFL------ 109

Query: 180 SSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239
                   Y+I+    RGL YLH    A +IHRD+K SNIL++   + KI DFGLAR   
Sbjct: 110 --------YQIL----RGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154

Query: 240 GEDTHVNTFRISGTHG-----YMAPEYAL--HGY-LSVKTDVFSYGVLVLEIVSGR 287
            ++          T       Y APE  L    Y  ++  D++S G +  E+++ +
Sbjct: 155 PDEDEKGFL----TEYVVTRWYRAPELLLSSSRYTKAI--DIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 85.0 bits (211), Expect = 3e-18
 Identities = 64/225 (28%), Positives = 108/225 (48%), Gaps = 49/225 (21%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFT-NEVKLLLKIQHKNLV 145
           + +L+ +G G +G V      P G ++A+KK+S    Q   + T  E+K+L + +H+N++
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENII 66

Query: 146 TLFGC-CAEGPEKM----LVYEYLP-------------NKSLDYFIFDKTKSSSLDWTTR 187
            +         E      +V E +              N  + YF+              
Sbjct: 67  GILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFL-------------- 112

Query: 188 YRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
           Y+I+    RGL Y+H    A ++HRD+K SN+LL+   + KI DFGLAR+   +  H +T
Sbjct: 113 YQIL----RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHT 163

Query: 248 FRIS---GTHGYMAPEYALH--GYLSVKTDVFSYGVLVLEIVSGR 287
             ++    T  Y APE  L+  GY +   D++S G ++ E++S R
Sbjct: 164 GFLTEYVATRWYRAPEIMLNSKGY-TKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 84.2 bits (208), Expect = 3e-18
 Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 10/200 (5%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           ++   ++G G  G VY  + +  GQE+A+K++++  +       NE+ ++ + +H N+V 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
                  G E  +V EYL   SL     D    + +D      +     + L +LH    
Sbjct: 81  YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 134

Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGY 266
            ++IHRDIK+ NILL    + K++DFG       E +  +T  + GT  +MAPE      
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 191

Query: 267 LSVKTDVFSYGVLVLEIVSG 286
              K D++S G++ +E+V G
Sbjct: 192 YGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 84.9 bits (210), Expect = 4e-18
 Identities = 68/221 (30%), Positives = 108/221 (48%), Gaps = 33/221 (14%)

Query: 85  TNFFSDLNQLGHGGFGPV--YRGLMPNGQEIAVKKL------SVDSRQGLREFTNEVKLL 136
           TN + DL  +G G FG V   R  +  GQ +A+KK+       V +++  RE    +KLL
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQL-TGQNVAIKKIMKPFSTPVLAKRTYRE----LKLL 63

Query: 137 LKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR 196
             ++H+N+++L        E +     L    L   +  +           Y+I+    R
Sbjct: 64  KHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQIL----R 119

Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGY 256
           GL Y+H    A ++HRD+K SNIL++E  + KI DFGLAR+   +D  +  +    T  Y
Sbjct: 120 GLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARI---QDPQMTGY--VSTRYY 171

Query: 257 MAPEYAL--HGYLSVKTDVFSYGVLVLEIVSGR-----KNH 290
            APE  L    Y  V+ D++S G +  E++ G+     K+H
Sbjct: 172 RAPEIMLTWQKY-DVEVDIWSAGCIFAEMLEGKPLFPGKDH 211

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 82.9 bits (205), Expect = 6e-18
 Identities = 67/207 (32%), Positives = 110/207 (53%), Gaps = 27/207 (13%)

Query: 94  LGHGGFGPVYRG--LMPNGQEI--AVKKLS-VDSRQGLREFTNEVKLLLKIQHKNLVTLF 148
           +G G FG VY G  +  +GQ+I  AVK L+ +   + + +F  E  ++    H N+++L 
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 149 GCC--AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG--VARGLLYLHEE 204
           G C  +EG   ++V  Y+ +  L  FI  +T +     T +  I  G  VA+G+ YL   
Sbjct: 63  GICLPSEG-SPLVVLPYMKHGDLRNFIRSETHNP----TVKDLIGFGLQVAKGMEYL--- 114

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLAR-LFPGEDTHVNTFRISGTHG-----YMA 258
           A  + +HRD+ A N +LDE    K++DFGLAR ++  E   V+    + T       +MA
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH----NHTGAKLPVKWMA 170

Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVS 285
            E       + K+DV+S+GVL+ E+++
Sbjct: 171 LESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 83.1 bits (206), Expect = 6e-18
 Identities = 63/213 (29%), Positives = 107/213 (50%), Gaps = 31/213 (14%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSV-DSRQGLREFT-NEVKLLLKIQ---H 141
           + +L ++G G +G VY+   +  G+ +A+KK+ V  S +G+   T  E+ LL +++   H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 142 KNLVTLFGCCAEGPEK------MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVA 195
            N+V L   C  GP         LV+E++ ++ L  ++  K     L   T   ++  + 
Sbjct: 61  PNIVRLLDVCH-GPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLL 117

Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH- 254
           RG+ +LH     RI+HRD+K  NIL+      KI+DFGLAR++        +F ++ T  
Sbjct: 118 RGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIY--------SFEMALTSV 166

Query: 255 ----GYMAPEYALHGYLSVKTDVFSYGVLVLEI 283
                Y APE  L    +   D++S G +  E+
Sbjct: 167 VVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 83.4 bits (207), Expect = 7e-18
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 33/205 (16%)

Query: 94  LGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTN-----EVKLLLKIQHKNLVTL 147
           LG G +  VY+      G+ +A+KK+ +  R+  ++  N     E+KLL +++H N++ L
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67

Query: 148 FGCCAEGPEKMLVYEYLP--------NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL 199
                      LV+E++         +KS+     D  KS           ++   RGL 
Sbjct: 68  LDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPAD-IKS----------YMLMTLRGLE 116

Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           YLH      I+HRD+K +N+L+      K++DFGLAR F   +  +    +  T  Y AP
Sbjct: 117 YLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV--TRWYRAP 171

Query: 260 EYALHG--YLSVKTDVFSYGVLVLE 282
           E  L G  +  V  D++S G +  E
Sbjct: 172 EL-LFGARHYGVGVDMWSVGCIFAE 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 83.2 bits (205), Expect = 8e-18
 Identities = 54/200 (27%), Positives = 99/200 (49%), Gaps = 10/200 (5%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           ++   ++G G  G V+  + +  GQE+A+K++++  +       NE+ ++ ++++ N+V 
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
                  G E  +V EYL   SL     D    + +D      +     + L +LH    
Sbjct: 81  FLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQALEFLHAN-- 134

Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGY 266
            ++IHRDIK+ N+LL    + K++DFG       E +  +T  + GT  +MAPE      
Sbjct: 135 -QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 191

Query: 267 LSVKTDVFSYGVLVLEIVSG 286
              K D++S G++ +E+V G
Sbjct: 192 YGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 82.3 bits (203), Expect = 9e-18
 Identities = 82/277 (29%), Positives = 126/277 (45%), Gaps = 37/277 (13%)

Query: 93  QLGHGGFGPVYRGL--MPNGQE-IAVKKLSVDSR-QGLR-EFTNEVKLLLKIQHKNLVTL 147
           +LG G FG V +G+  M   ++ +AVK L  D+    L+ E   E  ++ ++ +  +V +
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
            G C E    MLV E      L+ F+    K+  +       +V  V+ G+ YL E    
Sbjct: 62  IGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEE---T 114

Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAPEYA 262
             +HRD+ A N+LL  Q   KISDFGL++    ++ +      + THG     + APE  
Sbjct: 115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK----AKTHGKWPVKWYAPECM 170

Query: 263 LHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS 321
            +   S K+DV+S+GVL+ E  S G+K + G  G E   ++         E    +  P 
Sbjct: 171 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI---------ESGERMECP- 220

Query: 322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML 358
             +C  +       L  LC    V ERP    V L L
Sbjct: 221 -QRCPPE----MYDLMKLCWTYGVDERPGFAVVELRL 252

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 82.4 bits (203), Expect = 1e-17
 Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 19/205 (9%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVD-----SRQGLREFTNEVKLLLKIQHKNLVTL 147
           LG G FG VY       G+E+AVK++  D     + + +     E++LL  + H+ +V  
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 148 FGCCAEGPEKML--VYEYLPNKSLDYFIFDKTKS-SSLDWTTRYRIVMGVARGLLYLHEE 204
           +GC  +  E+ L    E++P  S    I D+ KS  +L      +    +  G+ YLH  
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVTRKYTRQILEGVSYLHSN 125

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLA-RLFPGEDTHVNTFRISGTHGYMAPEY-A 262
               I+HRDIK +NIL D   N K+ DFG + RL     +      ++GT  +M+PE  +
Sbjct: 126 M---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182

Query: 263 LHGYLSVKTDVFSYGVLVLEIVSGR 287
             GY   K D++S G  V+E+++ +
Sbjct: 183 GEGY-GRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 82.0 bits (203), Expect = 1e-17
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 29/208 (13%)

Query: 88  FSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           +  + ++G G +G VY+      G+ +A+K + ++          E+ +L + +H N+V 
Sbjct: 5   YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKT----KSSSLDWTTRYRIVMGVARGLLYLH 202
            FG      +  +V EY    SL   I+  T        + +  R        +GL YLH
Sbjct: 65  YFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRE-----TLKGLAYLH 118

Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV----NTFRISGTHGYMA 258
           E      IHRDIK +NILL E  + K++DFG++     + T       +F   GT  +MA
Sbjct: 119 ET---GKIHRDIKGANILLTEDGDVKLADFGVS----AQLTATIAKRKSF--IGTPYWMA 169

Query: 259 PEYAL----HGYLSVKTDVFSYGVLVLE 282
           PE A      GY   K D+++ G+  +E
Sbjct: 170 PEVAAVERKGGYDG-KCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 61/215 (28%), Positives = 105/215 (48%), Gaps = 33/215 (15%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQ------GLREFTNEVKLLLKIQ 140
           +  + ++G G +G VY+      G+ +A+KK+ +++         +RE    + LL ++ 
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIRE----ISLLKELN 56

Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
           H N+V L        +  LV+E+L +  L  ++ D +  + LD       +  + +G+ Y
Sbjct: 57  HPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAY 114

Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF--PGEDTHVNTFRISGTHG--- 255
            H     R++HRD+K  N+L+D +   K++DFGLAR F  P     V T+    TH    
Sbjct: 115 CHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVP-----VRTY----THEVVT 162

Query: 256 --YMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
             Y APE  L     S   D++S G +  E+V+ R
Sbjct: 163 LWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 81.9 bits (202), Expect = 1e-17
 Identities = 65/212 (30%), Positives = 99/212 (46%), Gaps = 14/212 (6%)

Query: 94  LGHGGFGPVYRGLMPN-GQEIAVKKLS---VDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
           LG GGFG V    + N G+  A KKL    +  + G +    E ++L K+    +V L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
                    LV   +    L Y I++      L+          +  G+L+LH      I
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLHS---MDI 116

Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           ++RD+K  N+LLD+Q N ++SD GLA       T     + +GT+GYMAPE       S 
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEPYSY 173

Query: 270 KTDVFSYGVLVLEIVSGR---KNHDGRLGKEK 298
             D F+ G  + E+V+GR   K+H  ++ KE+
Sbjct: 174 PVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEE 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 38/218 (17%)

Query: 90  DLNQLGHGGFGPVYRGLMPN-GQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQH-KNLV 145
           DL ++G G FG V + L    G  +AVK++   VD ++  +    ++ ++++      +V
Sbjct: 8   DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKE-QKRLLMDLDVVMRSSDCPYIV 66

Query: 146 TLFG-------C--CAEGPEKMLVYEYLPNKSLDYF---IFDKTKSSSLDWTTRYRIVMG 193
             +G       C  C E          L + SLD F   +++  KS  +      +I + 
Sbjct: 67  KFYGALFREGDCWICME----------LMDISLDKFYKYVYEVLKSV-IPEEILGKIAVA 115

Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
             + L YL EE   +IIHRD+K SNILLD   N K+ DFG++      D+   T R +G 
Sbjct: 116 TVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKT-RDAGC 170

Query: 254 HGYMAPE----YALHGYLSVKTDVFSYGVLVLEIVSGR 287
             YMAPE     A  GY  V++DV+S G+ + E+ +G+
Sbjct: 171 RPYMAPERIDPSARDGY-DVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 80.8 bits (199), Expect = 3e-17
 Identities = 79/275 (28%), Positives = 123/275 (44%), Gaps = 35/275 (12%)

Query: 93  QLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLVTLFGC 150
           ++G G FG V+ G L  +   +AVK         L+ +F  E ++L +  H N+V L G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
           C +     +V E +  +  D+  F +T+   L      ++V   A G+ YL  +     I
Sbjct: 62  CTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCI 116

Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-------YMAPEYAL 263
           HRD+ A N L+ E+   KISDFG++R    E+  V     + T G       + APE   
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR---EEEDGV----YASTGGMKQIPVKWTAPEALN 169

Query: 264 HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA 323
           +G  S ++DV+S+G+L+ E  S        LG      LS   T    E+ + L  P L 
Sbjct: 170 YGRYSSESDVWSFGILLWEAFS--------LGAVPYANLSNQQTREAIEQGVRLPCPEL- 220

Query: 324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML 358
            C         +L   C +    +RP  ++VH  L
Sbjct: 221 -CPDA----VYRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 81.4 bits (202), Expect = 3e-17
 Identities = 65/201 (32%), Positives = 96/201 (47%), Gaps = 23/201 (11%)

Query: 94  LGHGGFGPVYRG-LMPNGQEIAVKKLSVDS--RQGLREFT-NEVKLLLKIQHKNLVTLFG 149
           LG G FG V       +G+  A+K LS     +    E   NE ++L  I+H  LV L+G
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY--RIVMGVARGLLYLHEEAPA 207
              +     LV EY+P   L      K+          Y  ++V+     L YLH     
Sbjct: 69  SFQDDSNLYLVMEYVPGGELFSH-LRKSGRFPEPVARFYAAQVVLA----LEYLHSLD-- 121

Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH-GY 266
            I++RD+K  N+LLD     KI+DFG A+   G      T+ + GT  Y+APE  L  GY
Sbjct: 122 -IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTLCGTPEYLAPEIILSKGY 175

Query: 267 -LSVKTDVFSYGVLVLEIVSG 286
             +V  D ++ G+L+ E+++G
Sbjct: 176 GKAV--DWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 80.9 bits (199), Expect = 5e-17
 Identities = 54/201 (26%), Positives = 99/201 (49%), Gaps = 12/201 (5%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           ++   ++G G  G VY  + +  GQE+A++++++  +       NE+ ++ + ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
                  G E  +V EYL   SL     D    + +D      +     + L +LH    
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 135

Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGL-ARLFPGEDTHVNTFRISGTHGYMAPEYALHG 265
            ++IHRDIK+ NILL    + K++DFG  A++ P +        + GT  +MAPE     
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS---TMVGTPYWMAPEVVTRK 191

Query: 266 YLSVKTDVFSYGVLVLEIVSG 286
               K D++S G++ +E++ G
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 80.1 bits (197), Expect = 5e-17
 Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 17/204 (8%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTN---EVKLLLKIQHKNLVTL 147
           LG G FG VY    +  G+E+A K++  D  S +  +E +    E++LL  +QH+ +V  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 148 FGCCAEGPEKMLV--YEYLPNKSLDYFIFDKTKS-SSLDWTTRYRIVMGVARGLLYLHEE 204
           +GC  +  EK L    EY+P  S+     D+ K+  +L  +   +    +  G+ YLH  
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEGMSYLHSN 125

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR-ISGTHGYMAPEYAL 263
               I+HRDIK +NIL D   N K+ DFG ++            R ++GT  +M+PE   
Sbjct: 126 M---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182

Query: 264 HGYLSVKTDVFSYGVLVLEIVSGR 287
                 K DV+S G  V+E+++ +
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 80.5 bits (199), Expect = 6e-17
 Identities = 77/303 (25%), Positives = 129/303 (42%), Gaps = 57/303 (18%)

Query: 93  QLGHGGFGPVYRGLMPNGQEI-----------------AVKKLSVDSRQGLR-EFTNEVK 134
           +LG G FG V+       Q+                  AVK L  D+    R +F  EVK
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71

Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFI--------FDKTKSSSLDWTT 186
           +L ++   N+  L G C   P   ++ EY+ N  L+ F+             S SL ++T
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131

Query: 187 RYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR-LFPGEDTHV 245
              +   +A G+ YL        +HRD+   N L+ +    KI+DFG++R L+       
Sbjct: 132 LLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSS----- 183

Query: 246 NTFRISGTH----GYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKA-D 300
           + +R+ G       +MA E  L G  + K+DV+++GV + EI++        L +E+  +
Sbjct: 184 DYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT--------LCREQPYE 235

Query: 301 LLSYTW-----TLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVH 355
            L+          F  +   ++  P    C +D      +L L C ++   +RP    +H
Sbjct: 236 HLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKD----IYELMLECWRRDEEDRPTFREIH 291

Query: 356 LML 358
           L L
Sbjct: 292 LFL 294

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 79.5 bits (196), Expect = 8e-17
 Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 17/206 (8%)

Query: 94  LGHGGFGPVYRGLMPNGQ------EIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
           +G G FG V+       Q      +I V++++ D R   +   NE ++L  + H N++  
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEY 64

Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           +    E    M+V EY P  +L  +I  K  +S LD  T   I+    + LL LH     
Sbjct: 65  YENFLEDKALMIVMEYAPGGTLAEYI-QKRCNSLLDEDT---ILHFFVQILLALHHVHTK 120

Query: 208 RIIHRDIKASNILLDE-QLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGY 266
            I+HRD+K  NILLD+ ++  KI DFG++++     +    + + GT  Y++PE      
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKIL---SSKSKAYTVVGTPCYISPELCEGKP 177

Query: 267 LSVKTDVFSYGVLVLEIVSGRKNHDG 292
            + K+D+++ G ++ E+ S ++  + 
Sbjct: 178 YNQKSDIWALGCVLYELASLKRAFEA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 13/202 (6%)

Query: 91  LNQLGHGGFGPVYRGLMPN-GQEIAVKK-LSVDSRQGLREFT-NEVKLLLKIQHKNLVTL 147
           L  +G G +G V +      G+ +A+KK    +  + +++    EVK+L +++H+N+V L
Sbjct: 6   LGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNL 65

Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
                      LV+EY+    L+     +     L        +  + + + Y H     
Sbjct: 66  KEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAYCHSH--- 119

Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
            IIHRDIK  NIL+ E    K+ DFG AR          T  ++ T  Y APE  L G  
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPEL-LVGDT 177

Query: 268 SV--KTDVFSYGVLVLEIVSGR 287
           +     DV++ G ++ E++ G 
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 57/188 (30%), Positives = 85/188 (45%), Gaps = 39/188 (20%)

Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSV-DSRQG-----LREFTNEVKLLLKIQHKN 143
           L +LG G FG VY+   +  G+ +A+KK+ + + + G     LRE    +K+L K++H N
Sbjct: 13  LGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALRE----IKILKKLKHPN 68

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLD----YFIF---DKTKSSSLDWTTRYRIVMGVAR 196
           +V L           +  E            Y +    D   S  L+     ++     +
Sbjct: 69  VVPLID---------MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLE-NPSVKLTESQIK 118

Query: 197 --------GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
                   G+ YLHE     I+HRDIKA+NIL+D Q   KI+DFGLAR + G   +    
Sbjct: 119 CYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175

Query: 249 RISGTHGY 256
              GT  Y
Sbjct: 176 GGGGTRKY 183

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 14/202 (6%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
             +  ++G G  G V        G+++AVKK+ +  +Q      NEV ++   QH N+V 
Sbjct: 21  LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVE 80

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           ++     G E  +V E+L   +L     D    + ++      + + V + L +LH +  
Sbjct: 81  MYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQG- 135

Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS--GTHGYMAPEYALH 264
             +IHRDIK+ +ILL      K+SDFG    F  + +     R S  GT  +MAPE    
Sbjct: 136 --VIHRDIKSDSILLTSDGRVKLSDFG----FCAQVSKEVPRRKSLVGTPYWMAPEVISR 189

Query: 265 GYLSVKTDVFSYGVLVLEIVSG 286
                + D++S G++V+E+V G
Sbjct: 190 LPYGTEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 62/213 (29%), Positives = 96/213 (45%), Gaps = 25/213 (11%)

Query: 94  LGHGGFGPVYRGLM--PNGQEI--AVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLVTLF 148
           +G G FG VY+G+   P  ++I  AVK     +   +RE F  E  ++ +  H ++V L 
Sbjct: 14  IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73

Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G   E P   +V E  P   L  ++  +    SLD  +       ++  L YL  +   R
Sbjct: 74  GVITENP-VWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLESK---R 127

Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH---VNTFRISGTHGYMAPEYALHG 265
            +HRDI A N+L+      K+ DFGL+R    E  +        I     +MAPE     
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIK----WMAPESINFR 183

Query: 266 YLSVKTDVFSYGVLVLEIVS-------GRKNHD 291
             +  +DV+ +GV + EI+        G KN+D
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVKPFQGVKNND 216

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 79.1 bits (195), Expect = 2e-16
 Identities = 69/215 (32%), Positives = 105/215 (48%), Gaps = 32/215 (14%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQE-IAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           +  + ++G G +G VY+       E IA+KK+ ++   +G+      E+ LL ++QH N+
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG----VARGLLY 200
           V L           LV+EYL    LD     K   SS D+    R++      + RG+ Y
Sbjct: 64  VRLQDVVHSEKRLYLVFEYL---DLD---LKKHMDSSPDFAKNPRLIKTYLYQILRGIAY 117

Query: 201 LHEEAPARIIHRDIKASNILLDEQLNP-KISDFGLARLFPGEDTHVNTFRISGTHG---- 255
            H     R++HRD+K  N+L+D + N  K++DFGLAR F      V TF    TH     
Sbjct: 118 CHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAF---GIPVRTF----THEVVTL 167

Query: 256 -YMAPEYAL--HGYLSVKTDVFSYGVLVLEIVSGR 287
            Y APE  L    Y S   D++S G +  E+V+ +
Sbjct: 168 WYRAPEILLGSRHY-STPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 44/220 (20%)

Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVKKL--SVDSRQGLREFTNEVKLLLKIQH-KNLVT 146
           + +LG G +G V +   +P G  +AVK++  +V+S++  R    ++ + ++       VT
Sbjct: 6   IEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKR-LLMDLDISMRSVDCPYTVT 64

Query: 147 LFGC---------CAEGPEKMLVYEYLPNKSLDYF---IFDKTKSSSLDWTTRYRIVMGV 194
            +G          C E          + + SLD F   ++DK  +   D   +  I + +
Sbjct: 65  FYGALFREGDVWICME----------VMDTSLDKFYKKVYDKGLTIPEDILGK--IAVSI 112

Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE--DTHVNTFRISG 252
            + L YLH +    +IHRD+K SN+L++     K+ DFG++    G   D+   T    G
Sbjct: 113 VKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGIS----GYLVDSVAKTIDA-G 165

Query: 253 THGYMAPE-----YALHGYLSVKTDVFSYGVLVLEIVSGR 287
              YMAPE         GY  VK+DV+S G+ ++E+ +GR
Sbjct: 166 CKPYMAPERINPELNQKGY-DVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 78.7 bits (194), Expect = 2e-16
 Identities = 62/209 (29%), Positives = 106/209 (50%), Gaps = 21/209 (10%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+L ++ L  F+ D +  S +        +  + +GL + H  
Sbjct: 62  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAP 259
              R++HRD+K  N+L++ +   K++DFGLAR F      V T+    TH      Y AP
Sbjct: 120 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF---GVPVRTY----THEVVTLWYRAP 169

Query: 260 EYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           E  L   Y S   D++S G +  E+V+ R
Sbjct: 170 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 67/205 (32%), Positives = 105/205 (51%), Gaps = 23/205 (11%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTN---EVKLLLKIQHKNLVTL 147
           LG G FG VY       G+E+AVK++  D  S++  +E      E++LL  ++H  +V  
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 148 FGCCAEGPEKML--VYEYLPNKSLDYFIFDKTKS-SSLDWTTRYRIVMGVARGLLYLHEE 204
           +GC  +  EK L    EY+P  S    I D+ K+  +L      R    + +G+ YLH  
Sbjct: 70  YGCLRDPEEKKLSIFVEYMPGGS----IKDQLKAYGALTENVTRRYTRQILQGVSYLHSN 125

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPG---EDTHVNTFRISGTHGYMAPEY 261
               I+HRDIK +NIL D   N K+ DFG ++         T + +  ++GT  +M+PE 
Sbjct: 126 M---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS--VTGTPYWMSPEV 180

Query: 262 -ALHGYLSVKTDVFSYGVLVLEIVS 285
            +  GY   K DV+S    V+E+++
Sbjct: 181 ISGEGY-GRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 16/200 (8%)

Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           L  +G G FG V  G    G ++AVK +  D+    + F  E  ++ +++H NLV L G 
Sbjct: 11  LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 67

Query: 151 CAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
             E    + +V EY+   SL  ++  + +S  L      +  + V   + YL        
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEAN---NF 123

Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPG-EDTHVNTFRISGTHGYMAPEYALHGYLS 268
           +HRD+ A N+L+ E    K+SDFGL +     +DT     +      + APE       S
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFS 177

Query: 269 VKTDVFSYGVLVLEIVS-GR 287
            K+DV+S+G+L+ EI S GR
Sbjct: 178 TKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 52/178 (29%), Positives = 88/178 (49%), Gaps = 9/178 (5%)

Query: 109 NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKS 168
            G+++AVKK+ +  +Q      NEV ++    H+N+V ++     G E  +V E+L   +
Sbjct: 46  TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105

Query: 169 LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPK 228
           L     D    + ++      + + V R L YLH +    +IHRDIK+ +ILL      K
Sbjct: 106 LT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIK 158

Query: 229 ISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
           +SDFG       E     +  + GT  +MAPE         + D++S G++V+E++ G
Sbjct: 159 LSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDG 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 62/204 (30%), Positives = 109/204 (53%), Gaps = 15/204 (7%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLV 145
           F  L +LG G  G V + L  P+G  +A K + ++ +  +R +   E+K+L +     +V
Sbjct: 3   FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIV 62

Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
             +G      E  +  E++   SLD  +    K+  +      +I + V RGL YL E+ 
Sbjct: 63  GFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPENILGKISIAVLRGLTYLREKH 119

Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE--DTHVNTFRISGTHGYMAPEYAL 263
             +I+HRD+K SNIL++ +   K+ DFG++    G+  D+  N+F   GT  YM+PE   
Sbjct: 120 --KIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSF--VGTRSYMSPERLQ 171

Query: 264 HGYLSVKTDVFSYGVLVLEIVSGR 287
             + +V++D++S G+ ++E+  GR
Sbjct: 172 GTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 78.9 bits (194), Expect = 3e-16
 Identities = 68/220 (30%), Positives = 103/220 (46%), Gaps = 36/220 (16%)

Query: 94  LGHGGFGPVYRGLM-------PNGQ-EIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKN 143
           LG G FG V            PN    +AVK L  D + + L +  +E++++  I +HKN
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFI-----------FDKTK--SSSLDWTTRYRI 190
           ++ L G C +     ++ EY    +L  ++           FD  K     L +      
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
              VARG+ YL   A  + IHRD+ A N+L+ E    KI+DFGLAR     D H   +  
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DVHNIDYYK 191

Query: 251 SGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
             T+G     +MAPE       + ++DV+S+GVL+ EI +
Sbjct: 192 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 78.9 bits (194), Expect = 4e-16
 Identities = 58/204 (28%), Positives = 110/204 (53%), Gaps = 15/204 (7%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLV 145
           F  +++LG G  G V++    P+G  +A K + ++ +  +R +   E+++L +     +V
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
             +G      E  +  E++   SLD  +    K+  +      ++ + V +GL YL E+ 
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLREKH 123

Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE--DTHVNTFRISGTHGYMAPEYAL 263
             +I+HRD+K SNIL++ +   K+ DFG++    G+  D+  N+F   GT  YM+PE   
Sbjct: 124 --KIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSF--VGTRSYMSPERLQ 175

Query: 264 HGYLSVKTDVFSYGVLVLEIVSGR 287
             + SV++D++S G+ ++E+  GR
Sbjct: 176 GTHYSVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 78.1 bits (192), Expect = 5e-16
 Identities = 79/312 (25%), Positives = 140/312 (44%), Gaps = 65/312 (20%)

Query: 93  QLGHGGFGPVYRGLMPNGQE-----------------IAVKKLSVDSRQGLR-EFTNEVK 134
           +LG G FG V+   + N Q+                 +AVK L  D+ +  R +F  EVK
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFI-----FDKTKSSS-------- 181
           +L +++  N++ L G C +     ++ EY+ N  L+ F+      DK ++ +        
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131

Query: 182 ---LDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR-L 237
              + +++   + + +A G+ YL   +    +HRD+   N L+ E L  KI+DFG++R L
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188

Query: 238 FPGEDTHVNTFRISGTH----GYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDG 292
           + G+      +RI G       +MA E  L G  +  +DV+++GV + EI+   ++   G
Sbjct: 189 YAGD-----YYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG 243

Query: 293 RLGKEKADLLSYTWTLFQGE-KALELVDPSLAKCNRDEAAMCIQ----LGLLCCQQSVAE 347
            L  E   ++      F+ + + + L  P            C Q    L L C  +   E
Sbjct: 244 ELTDE--QVIENAGEFFRDQGRQVYLFRP----------PPCPQGLYELMLQCWSRDCRE 291

Query: 348 RPDMNSVHLMLS 359
           RP  + +H  L+
Sbjct: 292 RPSFSDIHAFLT 303

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 77.3 bits (191), Expect = 5e-16
 Identities = 63/213 (29%), Positives = 94/213 (44%), Gaps = 43/213 (20%)

Query: 94  LGHGGFGPVYR-GLMPNGQEIAVKKLS----VDSRQGLREFTNEVKLLLKIQHKNLVTLF 148
           LG GGFG V    +    +  A+K +     V++ Q      +E ++L +  H  +V L 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQ-EHIFSEKEILEECNHPFIVKL- 58

Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSL-----------DWTTRYRIVMGVARG 197
                       Y    +K   Y + +      L           ++T R+  +  V   
Sbjct: 59  ------------YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARF-YIACVVLA 105

Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR-LFPGEDTHVNTFRISGTHGY 256
             YLH      II+RD+K  N+LLD     K+ DFG A+ L  G+ T   TF   GT  Y
Sbjct: 106 FEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TF--CGTPEY 158

Query: 257 MAPEYAL-HGY-LSVKTDVFSYGVLVLEIVSGR 287
           +APE  L  GY  SV  D +S G+L+ E+++GR
Sbjct: 159 VAPEIILNKGYDFSV--DYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 76.7 bits (189), Expect = 7e-16
 Identities = 64/267 (23%), Positives = 117/267 (43%), Gaps = 40/267 (14%)

Query: 94  LGHGGFGP--VYRGLMPNGQ----EIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
           LG G FG   +YR    +      E+ + +LS   R   R+  NE+ +L  +QH N++  
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKER---RDALNEIVILSLLQHPNIIAY 64

Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLD-----WTTRYRIVMGVARGLLYLH 202
           +    +    ++  EY    +L Y    + K    +     W   ++IV  V+    Y+H
Sbjct: 65  YNHFMDDNTLLIEMEYANGGTL-YDKIVRQKGQLFEEEMVLWYL-FQIVSAVS----YIH 118

Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
           +     I+HRDIK  NI L +    K+ DFG++++   E +   T  + GT  YM+PE  
Sbjct: 119 KAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELC 173

Query: 263 LHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL 322
                + K+D+++ G ++ E+++ ++  D        + L+    + QG     +     
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLTLKRTFDA------TNPLNLVVKIVQGNYTPVV----- 222

Query: 323 AKCNRDEAAMCIQLGLLCCQQSVAERP 349
              +   + + I L     QQ   +RP
Sbjct: 223 ---SVYSSEL-ISLVHSLLQQDPEKRP 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 77.4 bits (190), Expect = 7e-16
 Identities = 69/228 (30%), Positives = 108/228 (47%), Gaps = 30/228 (13%)

Query: 77  DLRTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKL 135
           DL  L+     F  +  +G+G +G VY+G  +  GQ  A+K + V   +   E   E+ +
Sbjct: 7   DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINM 65

Query: 136 LLKI-QHKNLVTLFGC-CAEGP-----EKMLVYEYLPNKSLDYFIFDKTKSSSL--DWTT 186
           L K   H+N+ T +G    + P     +  LV E+    S+   +   TK ++L  DW  
Sbjct: 66  LKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV-KNTKGNALKEDWIA 124

Query: 187 RYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246
              I   + RGL +LH     ++IHRDIK  N+LL E    K+ DFG++          N
Sbjct: 125 Y--ICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN 179

Query: 247 TFRISGTHGYMAPEY--------ALHGYLSVKTDVFSYGVLVLEIVSG 286
           TF   GT  +MAPE         A + Y   ++D++S G+  +E+  G
Sbjct: 180 TF--IGTPYWMAPEVIACDENPDATYDY---RSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 77.4 bits (190), Expect = 8e-16
 Identities = 71/220 (32%), Positives = 109/220 (49%), Gaps = 36/220 (16%)

Query: 94  LGHGGFGPVYR----GL---MPNG-QEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKN 143
           LG G FG V      GL    PN   ++AVK L  D + + L +  +E++++  I +HKN
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 144 LVTLFGCCAE-GPEKMLV--------YEYLPNK---SLDY-FIFDKTKSSSLDWTTRYRI 190
           ++ L G C + GP  ++V         EYL  +    ++Y +   +     L +      
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
              VARG+ YL   A  + IHRD+ A N+L+ E    KI+DFGLAR     D H   +  
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 197

Query: 251 SGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
             T+G     +MAPE       + ++DV+S+GVL+ EI +
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 79.1 bits (195), Expect = 1e-15
 Identities = 74/304 (24%), Positives = 137/304 (45%), Gaps = 34/304 (11%)

Query: 62  EDADGSGADSWNL-FFDLR-----TLQVATNFFSDLNQLGHGGFGPVYRG-LMPNGQEIA 114
           E+ DG+    W L FFD +     T+    +   + N +  G  G  Y+G  + NG +  
Sbjct: 664 ENEDGT----WELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFV 719

Query: 115 VKKLS-VDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFI 173
           VK+++ V+S       ++E+  + K+QH N+V L G C       L++EY+  K+L   +
Sbjct: 720 VKEINDVNSIP-----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL 774

Query: 174 FDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG 233
                  +L W  R +I +G+A+ L +LH      ++  ++    I++D +  P      
Sbjct: 775 ------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPH----- 823

Query: 234 LARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           L    PG         IS    Y+APE      ++ K+D++ +G++++E+++G+   D  
Sbjct: 824 LRLSLPGLLCTDTKCFISS--AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE 881

Query: 294 LGKEKADLLSYTWTLFQGEKALELVDPSL---AKCNRDEAAMCIQLGLLCCQQSVAERPD 350
            G   + ++ +    +        +DPS+      N++E    + L L C       RP 
Sbjct: 882 FGVHGS-IVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPC 940

Query: 351 MNSV 354
            N V
Sbjct: 941 ANDV 944

Length = 968

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 77.6 bits (191), Expect = 1e-15
 Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 30/222 (13%)

Query: 80  TLQVATNFFSDL---NQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLR-EFTNEVK 134
           +   A    S+L   N++G G  G VY+ +  P G+  A+K +  +    +R +   E++
Sbjct: 65  SAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIE 124

Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLD-YFIFDKTKSSSLDWTTRYRIVMG 193
           +L  + H N+V          E  ++ E++   SL+   I D+   + +      +I+ G
Sbjct: 125 ILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADV----ARQILSG 180

Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           +A    YLH      I+HRDIK SN+L++   N KI+DFG++R+        N+    GT
Sbjct: 181 IA----YLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNS--SVGT 231

Query: 254 HGYMAPEY--------ALHGYLSVKTDVFSYGVLVLEIVSGR 287
             YM+PE         A  GY     D++S GV +LE   GR
Sbjct: 232 IAYMSPERINTDLNHGAYDGYAG---DIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 76.5 bits (188), Expect = 1e-15
 Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 18/210 (8%)

Query: 87  FFSDLNQLGHGGFGPV----YRGLMPN-GQEIAVKKLSVDSRQG-LREFTNEVKLLLKIQ 140
           F   +  LG G FG V    Y     N G+++AVK L  +S    + +   E+++L  + 
Sbjct: 5   FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 64

Query: 141 HKNLVTLFGCCAEGPEK--MLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARG 197
           H+N+V   G C E       L+ E+LP+ SL +Y   +K K   ++   + +  + + +G
Sbjct: 65  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK---INLKQQLKYAVQICKG 121

Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH--VNTFRISGTHG 255
           + YL      + +HRD+ A N+L++ +   KI DFGL +    +  +  V     S    
Sbjct: 122 MDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFW 178

Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           Y APE  +     + +DV+S+GV + E+++
Sbjct: 179 Y-APECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 56/188 (29%), Positives = 93/188 (49%), Gaps = 18/188 (9%)

Query: 113 IAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYEYLPNKSLD 170
           +AVK L  D + + L +  +E++++  I +HKN++ L G C +     ++ EY    +L 
Sbjct: 50  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109

Query: 171 YFI-----------FDKTKSSSLDWTTRYRI--VMGVARGLLYLHEEAPARIIHRDIKAS 217
            ++           +D  +      T +  +     VARG+ YL   A  + IHRD+ A 
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAAR 166

Query: 218 NILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYG 277
           N+L+ E    KI+DFGLAR     D +  T        +MAPE       + ++DV+S+G
Sbjct: 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 226

Query: 278 VLVLEIVS 285
           VL+ EI +
Sbjct: 227 VLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 58/204 (28%), Positives = 109/204 (53%), Gaps = 15/204 (7%)

Query: 88  FSDLNQLGHGGFGPVYR-GLMPNGQEIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLV 145
           F  +++LG G  G V +    P+G  +A K + ++ +  +R +   E+++L +     +V
Sbjct: 7   FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
             +G      E  +  E++   SLD  +    ++  +      ++ + V RGL YL E+ 
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVL---KEAKRIPEEILGKVSIAVLRGLAYLREKH 123

Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE--DTHVNTFRISGTHGYMAPEYAL 263
             +I+HRD+K SNIL++ +   K+ DFG++    G+  D+  N+F   GT  YM+PE   
Sbjct: 124 --QIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSF--VGTRSYMSPERLQ 175

Query: 264 HGYLSVKTDVFSYGVLVLEIVSGR 287
             + SV++D++S G+ ++E+  GR
Sbjct: 176 GTHYSVQSDIWSMGLSLVELAIGR 199

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 63/211 (29%), Positives = 102/211 (48%), Gaps = 28/211 (13%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPN-GQEIAVKKL--SVDSRQGLREFTNEVKLLLKIQHKNL 144
           + +L  +G G +G V +      GQ +A+KK   S D +   +    E+++L +++H+NL
Sbjct: 3   YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENL 62

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L           LV+E++ +  LD     +   + LD +   + +  + RG+ + H  
Sbjct: 63  VNLIEVFRRKKRLYLVFEFVDHTVLDDL---EKYPNGLDESRVRKYLFQILRGIEFCHSH 119

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLF--PGEDTHVNTFRISGTHGYMAPEYA 262
               IIHRDIK  NIL+ +    K+ DFG AR    PGE   V T  ++ T  Y APE  
Sbjct: 120 ---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYTDYVA-TRWYRAPE-- 170

Query: 263 LHGYLSVK-------TDVFSYGVLVLEIVSG 286
               L V         D+++ G LV E+++G
Sbjct: 171 ----LLVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 76.0 bits (188), Expect = 2e-15
 Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 30/210 (14%)

Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVKKL-----SVDSRQGLREFTNEVKLLLKIQ-HKN 143
           + QLG G FG VY       G+ +A+KK+     S +    LRE    VK L K+  H N
Sbjct: 4   IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLRE----VKSLRKLNEHPN 59

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           +V L     E  E   V+EY+   +L Y +    K      +    I+  + +GL ++H+
Sbjct: 60  IVKLKEVFRENDELYFVFEYM-EGNL-YQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN-----TFRISGTHGYMA 258
                  HRD+K  N+L+      KI+DFGLAR        +      T  +S T  Y A
Sbjct: 118 ---HGFFHRDLKPENLLVSGPEVVKIADFGLAR-------EIRSRPPYTDYVS-TRWYRA 166

Query: 259 PEYALH-GYLSVKTDVFSYGVLVLEIVSGR 287
           PE  L     S   D+++ G ++ E+ + R
Sbjct: 167 PEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 67/193 (34%), Positives = 96/193 (49%), Gaps = 43/193 (22%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD-SRQG-----LREFTNEVKLLLKIQ 140
           F  LN++G G +G VYR     +G+ +A+KK+ +D  R G     LRE T    LLL ++
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREIT----LLLNLR 64

Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIF------DKTKSSSLDWTTR------- 187
           H N+V L              E +  K LD  IF      ++  +S LD           
Sbjct: 65  HPNIVEL-------------KEVVVGKHLDS-IFLVMEYCEQDLASLLDNMPTPFSESQV 110

Query: 188 YRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
             +++ + RGL YLHE     IIHRD+K SN+LL ++   KI+DFGLAR +      + T
Sbjct: 111 KCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM-T 166

Query: 248 FRISGTHGYMAPE 260
            ++  T  Y APE
Sbjct: 167 PKVV-TLWYRAPE 178

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 75.5 bits (185), Expect = 2e-15
 Identities = 62/249 (24%), Positives = 118/249 (47%), Gaps = 22/249 (8%)

Query: 94  LGHGGFGPVYRGLMPNGQEI---AVK--KLSVDSRQGLREFTNEVKLLLKIQHKNLVTLF 148
           LG G FG V  G +     I   AVK  K+++ +R  + +F +E   + +  H N++ L 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 149 GCCAEG------PEKMLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRY--RIVMGVARGLL 199
           G C +       P  +++  ++ +  L  + ++ +         T+   + +  +A G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA-RLFPGEDTHVNTFRISGTH-GYM 257
           YL  +     IHRD+ A N +L+E +N  ++DFGL+ +++ G+  +    RI+     ++
Sbjct: 127 YLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD--YYRQGRIAKMPVKWI 181

Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALE 316
           A E       + K+DV+S+GV + EI + G+  + G    E  D L     L Q    L+
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLD 241

Query: 317 LVDPSLAKC 325
            +   ++ C
Sbjct: 242 GLYSLMSSC 250

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 3e-15
 Identities = 66/221 (29%), Positives = 97/221 (43%), Gaps = 28/221 (12%)

Query: 84  ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSV--DSRQGLREFTNEVKLLLKI- 139
            T  F  +  +G G +G VY+      GQ +A+K + +  D  + ++E   E  +L K  
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKE---EYNILRKYS 60

Query: 140 QHKNLVTLFGC------CAEGPEKMLVYEYLPNKS---LDYFIFDKTKSSSLDWTTRYRI 190
            H N+ T +G            +  LV E     S   L   +  K K    +W   Y I
Sbjct: 61  NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA-Y-I 118

Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
           +    RGL YLHE    ++IHRDIK  NILL +    K+ DFG++          NTF  
Sbjct: 119 LRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTF-- 173

Query: 251 SGTHGYMAPE-----YALHGYLSVKTDVFSYGVLVLEIVSG 286
            GT  +MAPE              ++DV+S G+  +E+  G
Sbjct: 174 IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 75.8 bits (186), Expect = 3e-15
 Identities = 53/182 (29%), Positives = 91/182 (50%), Gaps = 17/182 (9%)

Query: 109 NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKS 168
           +G+++AVK + +  +Q      NEV ++   QH+N+V ++     G E  ++ E+L   +
Sbjct: 45  SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104

Query: 169 LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPK 228
           L     D    + L+      +   V + L YLH +    +IHRDIK+ +ILL      K
Sbjct: 105 LT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVK 157

Query: 229 ISDFG----LARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIV 284
           +SDFG    +++  P   + V      GT  +MAPE         + D++S G++V+E+V
Sbjct: 158 LSDFGFCAQISKDVPKRKSLV------GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMV 211

Query: 285 SG 286
            G
Sbjct: 212 DG 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 75.3 bits (185), Expect = 3e-15
 Identities = 73/283 (25%), Positives = 124/283 (43%), Gaps = 49/283 (17%)

Query: 94  LGHGGFGPVYRGLM--PNGQE--IAVKKL---SVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           LG G FG + RG +  P+ +E  +A+  L     D ++  R F  E   L +  H N+V 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR--RGFLAEALTLGQFDHSNIVR 70

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           L G    G   M+V EY+ N +LD F+  +     L       ++ G+A G+ YL E   
Sbjct: 71  LEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYLSEMG- 127

Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE----DTHVNTFRISGTHGYMAPEYA 262
              +H+ + A  +L++  L  KIS F        +    +    T        + APE  
Sbjct: 128 --YVHKGLAAHKVLVNSDLVCKISGFR-----RLQEDKSEAIYTTMSGKSPVLWAAPEAI 180

Query: 263 LHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD-- 319
            + + S  +DV+S+G+++ E++S G + +               W +  G+  ++ V+  
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMSYGERPY---------------WDM-SGQDVIKAVEDG 224

Query: 320 ---PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS 359
              P+   C      +  QL L C Q+   ERP  + +H +LS
Sbjct: 225 FRLPAPRNCPN----LLHQLMLDCWQKERGERPRFSQIHSILS 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 75.3 bits (185), Expect = 3e-15
 Identities = 61/199 (30%), Positives = 92/199 (46%), Gaps = 10/199 (5%)

Query: 94  LGHGGFGPVYRGLM-PNGQEIAVKKLS---VDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
           LG GGFG V    M   G+  A KKL+   +  R+G      E ++L K+  + +V+L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFD-KTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
                 +  LV   +    L Y I++   ++              +  GL +LH+    R
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117

Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLS 268
           II+RD+K  N+LLD   N +ISD GLA     +D    T   +GT G+MAPE        
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGTPGFMAPELLQGEEYD 175

Query: 269 VKTDVFSYGVLVLEIVSGR 287
              D F+ GV + E+++ R
Sbjct: 176 FSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 75.3 bits (185), Expect = 3e-15
 Identities = 63/207 (30%), Positives = 99/207 (47%), Gaps = 18/207 (8%)

Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVK--KLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
           L++LG G +G VY+ L  P G  +A+K  +L +D  +   +   E+ +L K     +V  
Sbjct: 6   LDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDF 64

Query: 148 FGC-CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           +G    EG   M + EY+   SLD        +  +      RI   V +GL +L EE  
Sbjct: 65  YGAFFIEGAVYMCM-EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH- 122

Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEY----- 261
             IIHRD+K +N+L++     K+ DFG++          N     G   YMAPE      
Sbjct: 123 -NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI----GCQSYMAPERIKSGG 177

Query: 262 -ALHGYLSVKTDVFSYGVLVLEIVSGR 287
              +   +V++DV+S G+ +LE+  GR
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 10/202 (4%)

Query: 86  NFFSDLNQLGHGGFGPV-YRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL 144
            +  +  ++G G  G V    +  +G+ +AVKK+ +  +Q      NEV ++   QH+N+
Sbjct: 20  TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V ++     G E  +V E+L   +L     D    + ++      + + V + L  LH +
Sbjct: 80  VEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQ 135

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
               +IHRDIK+ +ILL      K+SDFG       E     +  + GT  +MAPE    
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISR 190

Query: 265 GYLSVKTDVFSYGVLVLEIVSG 286
                + D++S G++V+E+V G
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 74.7 bits (183), Expect = 4e-15
 Identities = 66/219 (30%), Positives = 102/219 (46%), Gaps = 20/219 (9%)

Query: 81  LQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI 139
           L+     F  +  +G+G +G VY+G  +  GQ  A+K + V   +   E   E+ +L K 
Sbjct: 1   LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKY 59

Query: 140 -QHKNLVTLFGC-CAEGPEKM-----LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVM 192
             H+N+ T +G    + P  M     LV E+    S+   I   TK ++L       I  
Sbjct: 60  SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNTKGNTLKEEWIAYICR 118

Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISG 252
            + RGL +LH+    ++IHRDIK  N+LL E    K+ DFG++          NTF   G
Sbjct: 119 EILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF--IG 173

Query: 253 THGYMAPEYAL-----HGYLSVKTDVFSYGVLVLEIVSG 286
           T  +MAPE              K+D++S G+  +E+  G
Sbjct: 174 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 74.2 bits (182), Expect = 6e-15
 Identities = 71/281 (25%), Positives = 112/281 (39%), Gaps = 26/281 (9%)

Query: 92  NQLGHGGFGPVYRGLMPNGQEIA---VKKLSVDSR-QGLREFTNEVKLLLKIQHKNLVTL 147
           +++G+G FG V  G    G   A   VK+L   +       F  EV+   ++ H N++  
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY--RIVMGVARGLLYLHEEA 205
            G C E    +LV E+ P   L  ++       +         R+   VA GLL+LH+  
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-- 118

Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEY--AL 263
            A  IH D+   N  L   L+ KI D+GLA     ED ++     +    ++APE     
Sbjct: 119 -ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 264 HGYLSV-----KTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV 318
              L       K++++S GV + E+ +        L  E   +L         E+ ++L 
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE--QVLKQVVR----EQDIKLP 231

Query: 319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS 359
            P L     D     +Q     C      RP    VH +L+
Sbjct: 232 KPQLDLKYSDRWYEVMQF----CWLDPETRPTAEEVHELLT 268

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 73.9 bits (181), Expect = 9e-15
 Identities = 66/271 (24%), Positives = 122/271 (45%), Gaps = 28/271 (10%)

Query: 93  QLGHGGFGPVYRGL-MPNGQEIAVKKLSV------DSRQGLREFTNEVKLLLKIQHKNLV 145
           ++G G F  VYR   + + + +A+KK+ +       +RQ   +   E+ LL ++ H N++
Sbjct: 9   KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ---DCVKEIDLLKQLNHPNVI 65

Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFI-FDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
                  E  E  +V E      L   I + K +   +   T ++  + +   + ++H  
Sbjct: 66  KYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR 125

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              R++HRDIK +N+ +      K+ D GL R F  + T  ++  + GT  YM+PE    
Sbjct: 126 ---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHE 180

Query: 265 GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK 324
              + K+D++S G L+ E+ + +    G    +K +L S    + Q +    L     ++
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAALQSPFYG----DKMNLFSLCQKIEQCDYP-PLPTEHYSE 235

Query: 325 CNRDEAAMCIQLGLLCCQQSVAERPDMNSVH 355
             R+  +MCI            +RPD+  VH
Sbjct: 236 KLRELVSMCI-------YPDPDQRPDIGYVH 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 73.8 bits (181), Expect = 9e-15
 Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 29/206 (14%)

Query: 93  QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREF--------TNEVKLLLKIQHKNL 144
           +LG G FG VY  L+ + + +A ++L V     + E           E +LL K+ H  +
Sbjct: 7   RLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSS-------LDWTTRYRIVMGVARG 197
           V       E     ++ EY   + LD  + +   +          +W  +  +++GV   
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQ--LLLGVH-- 120

Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
             Y+H+    RI+HRD+KA NI L   L  KI DFG++RL  G      TF  +GT  YM
Sbjct: 121 --YMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTF--TGTPYYM 172

Query: 258 APEYALHGYLSVKTDVFSYGVLVLEI 283
           +PE   H     K+D++S G ++ E+
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 52/212 (24%), Positives = 99/212 (46%), Gaps = 27/212 (12%)

Query: 93  QLGHGGFGPVY----RGLMPNGQEIAVKKLSVDSRQGLRE---FTNEVKLLLKIQHKNLV 145
           +LG G FG VY    +G++ +  E  V   +V+    +RE   F NE  ++ +    ++V
Sbjct: 13  ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIF----DKTKSSSLDWTTRYRIVM---GVARGL 198
            L G  ++G   +++ E +    L  ++     +   +      +  +++     +A G+
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG--- 255
            YL+     + +HRD+ A N ++ E    KI DFG+ R     D +   +   G  G   
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDYYRKGGKGLLP 184

Query: 256 --YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
             +M+PE    G  +  +DV+S+GV++ EI +
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 57/210 (27%), Positives = 101/210 (48%), Gaps = 26/210 (12%)

Query: 88  FSDLNQLGHGGFGPVY--RGLMPNGQ----EIAVKKLSVDSRQGLREFTNEVKLLLKIQH 141
           +  + ++G G FG +Y  +    +      EI + K+ V  ++  +    EV LL K++H
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK---KEVILLAKMKH 58

Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDK-----TKSSSLDWTTRYRIVMGVAR 196
            N+VT F    E     +V EY     L   I  +     ++   L W  +      ++ 
Sbjct: 59  PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ------ISL 112

Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQ-LNPKISDFGLARLFPGEDTHVNTFRISGTHG 255
           GL ++H+    +I+HRDIK+ NI L +  +  K+ DFG+AR     D+    +   GT  
Sbjct: 113 GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL--NDSMELAYTCVGTPY 167

Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           Y++PE   +   + KTD++S G ++ E+ +
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 61/202 (30%), Positives = 96/202 (47%), Gaps = 19/202 (9%)

Query: 93  QLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQ-GLREFT-NEVKLLLKIQ---HKNLVT 146
           ++G G +G VY+   P+ G  +A+K + V + + GL   T  EV LL +++   H N+V 
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 147 LFGCCA-----EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
           L   CA        +  LV+E++      Y   DK     L   T   ++    RGL +L
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHVDQDLRTYL--DKVPPPGLPAETIKDLMRQFLRGLDFL 124

Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEY 261
           H      I+HRD+K  NIL+      K++DFGLAR++      +    +  T  Y APE 
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEV 178

Query: 262 ALHGYLSVKTDVFSYGVLVLEI 283
            L    +   D++S G +  E+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 73.0 bits (179), Expect = 2e-14
 Identities = 54/206 (26%), Positives = 97/206 (47%), Gaps = 18/206 (8%)

Query: 93  QLGHGGFGPVY--RGLMPNGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQHKNL 144
           QLG G F   Y  R +   G  +AVK+++       +  + +     E++L+ ++ H ++
Sbjct: 7   QLGTGAFSSCYQARDVK-TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + + G   E     L  E++   S+ + +   +K  +            + RGL YLHE 
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLL---SKYGAFKEAVIINYTEQLLRGLSYLHEN 122

Query: 205 APARIIHRDIKASNILLDEQ-LNPKISDFGLARLFPGEDTHVNTFR--ISGTHGYMAPEY 261
              +IIHRD+K +N+L+D      +I+DFG A     + T    F+  + GT  +MAPE 
Sbjct: 123 ---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEV 179

Query: 262 ALHGYLSVKTDVFSYGVLVLEIVSGR 287
                     DV+S G +++E+ + +
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 17/206 (8%)

Query: 94  LGHGGFGPVYRGLMPNGQEI----AVKKLSVDSRQGLREFTNEVKLL-LKIQHKNLVTLF 148
           LG G FG V    +    E+     +KK  +     +     E ++L L  +H  L  L 
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62

Query: 149 GCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARGLLYLHEEAP 206
             C +  +++  V EY+    L + I    +        R R     +  GL +LHE   
Sbjct: 63  -SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDE----PRARFYAAEIVLGLQFLHERG- 116

Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGY 266
             II+RD+K  N+LLD + + KI+DFG+ +         +TF   GT  Y+APE   +  
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF--CGTPDYIAPEILSYQP 172

Query: 267 LSVKTDVFSYGVLVLEIVSGRKNHDG 292
                D ++ GVL+ E+++G+   +G
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQSPFEG 198

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 20/207 (9%)

Query: 93  QLGHGGFGPVY--RGLMPNGQEIAVKKLSVD-SRQGLREFT-NEVKLLLKIQ---HKNLV 145
           ++G G +G V+  R L   G+ +A+K++ V    +G+   T  EV +L  ++   H N+V
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 146 TLFGCCA-----EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
            LF  C         +  LV+E++      Y   DK     +   T   ++  + RGL +
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL--DKVPEPGVPTETIKDMMFQLLRGLDF 125

Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE 260
           LH     R++HRD+K  NIL+      K++DFGLAR++      +    +  T  Y APE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPE 179

Query: 261 YALHGYLSVKTDVFSYGVLVLEIVSGR 287
             L    +   D++S G +  E+   +
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 73.4 bits (180), Expect = 3e-14
 Identities = 58/231 (25%), Positives = 98/231 (42%), Gaps = 22/231 (9%)

Query: 57  AGESAEDADGSGADSWNLFFDLRTLQVATNF-FSDLNQLGHGGFGPVYRGLMPNGQEIAV 115
           A ES +D D     +       +  +V  +  ++ +  L  G  G V+    P   +  V
Sbjct: 41  ASESDDDDDDGLIPTKQ-----KAREVVASLGYTVIKTLTPGSEGRVFVATKPGQPDPVV 95

Query: 116 KKLSVDSRQGLREFT-NEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIF 174
            K+      G +  T  E  LL  + H +++ +      G    +V   LP+ S D + +
Sbjct: 96  LKI------GQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTY 146

Query: 175 DKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL 234
              +S  L       I   +  GL YLH +   RIIHRD+K  NI +++     I D G 
Sbjct: 147 LTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGA 203

Query: 235 ARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           A+ FP          ++GT    APE       + K D++S G+++ E+++
Sbjct: 204 AQ-FPVVAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 72.6 bits (178), Expect = 3e-14
 Identities = 64/261 (24%), Positives = 125/261 (47%), Gaps = 30/261 (11%)

Query: 113 IAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDY 171
           +AVK L  D+ +  R +F  E+K++ +++  N++ L   C       ++ EY+ N  L+ 
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108

Query: 172 FI--------FDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE 223
           F+         +K    ++ ++T   +   +A G+ YL   +    +HRD+   N L+ +
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGK 165

Query: 224 QLNPKISDFGLAR-LFPGEDTHVNTFRISGTH----GYMAPEYALHGYLSVKTDVFSYGV 278
               KI+DFG++R L+ G+      +RI G       +M+ E  L G  +  +DV+++GV
Sbjct: 166 NYTIKIADFGMSRNLYSGD-----YYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGV 220

Query: 279 LVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLG 337
            + EI++  ++    +L  E+  ++  T   F+ +   ++  P  A C         +L 
Sbjct: 221 TLWEILTLCKEQPYSQLSDEQ--VIENTGEFFRDQGR-QVYLPKPALCPD----SLYKLM 273

Query: 338 LLCCQQSVAERPDMNSVHLML 358
           L C +++  ERP    +H  L
Sbjct: 274 LSCWRRNAKERPSFQEIHATL 294

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 72.2 bits (177), Expect = 3e-14
 Identities = 53/209 (25%), Positives = 101/209 (48%), Gaps = 19/209 (9%)

Query: 91  LNQLGHGGFGPVYRGLMPNGQE--IAVKKLSV----------DSRQGLREFTNEVKLLLK 138
           L  LG G FG VY+    N  +  +A+K+++V          +  + + +  +EV ++ +
Sbjct: 5   LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64

Query: 139 -IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVAR 196
            ++H N+V  +    E     +V + +    L ++F   K K         + I + +  
Sbjct: 65  QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124

Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGY 256
            L YLH+E   RI+HRD+  +NI+L E     I+DFGLA+     ++ + +  + GT  Y
Sbjct: 125 ALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAKQ-KQPESKLTS--VVGTILY 179

Query: 257 MAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
             PE   +     K DV+++G ++ ++ +
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMCT 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 72.3 bits (177), Expect = 4e-14
 Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 31/216 (14%)

Query: 91  LNQLGHGGFGPVYRGLMPN---GQ---EIAVKKLSVDSRQGLRE---FTNEVKLLLKIQH 141
           L +LG G FG VY G   +   G+    +AVK  +V+    LRE   F NE  ++     
Sbjct: 11  LRELGQGSFGMVYEGNARDIIKGEAETRVAVK--TVNESASLRERIEFLNEASVMKGFTC 68

Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD-----KTKSSSLDWTTRYRIVMG--V 194
            ++V L G  ++G   ++V E + +  L  ++       +        T +  I M   +
Sbjct: 69  HHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEI 128

Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH 254
           A G+ YL+ +   + +HRD+ A N ++      KI DFG+ R     D +   +   G  
Sbjct: 129 ADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR-----DIYETDYYRKGGK 180

Query: 255 G-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           G     +MAPE    G  +  +D++S+GV++ EI S
Sbjct: 181 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 72.3 bits (178), Expect = 4e-14
 Identities = 66/215 (30%), Positives = 111/215 (51%), Gaps = 32/215 (14%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-RQG-----LREFTNEVKLLLKIQ 140
           +  LN++  G +G VYR      G+ +A+KKL ++  ++G     LRE    + +LLK+Q
Sbjct: 7   YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLRE----INILLKLQ 62

Query: 141 HKNLVTL----FGCCAEGPEKM-LVYEYLPN--KSLDYFIFDKTKSSSLDWTTRYRIVMG 193
           H N+VT+     G      +K+ +V EY+ +  KSL      +T       +    +++ 
Sbjct: 63  HPNIVTVKEVVVG---SNLDKIYMVMEYVEHDLKSLM-----ETMKQPFLQSEVKCLMLQ 114

Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           +  G+ +LH+     I+HRD+K SN+LL+ +   KI DFGLAR + G      T ++  T
Sbjct: 115 LLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREY-GSPLKPYT-QLVVT 169

Query: 254 HGYMAPEYAL-HGYLSVKTDVFSYGVLVLEIVSGR 287
             Y APE  L     S   D++S G +  E+++ +
Sbjct: 170 LWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 71.9 bits (176), Expect = 5e-14
 Identities = 64/214 (29%), Positives = 100/214 (46%), Gaps = 14/214 (6%)

Query: 94  LGHGGFGPVYR-GLMPNGQEIAVKKLS---VDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
           LG GGFG V    +   G+  A KKL    +  R+G     NE ++L K+  + +V+L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67

Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
                    LV   +    L + I++   +   D          +  GL  L  E   RI
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFDEQRAIFYAAELCCGLEDLQRE---RI 123

Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           ++RD+K  NILLD++ + +ISD GLA   P  +T     R+ GT GYMAPE   +   + 
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG--RV-GTVGYMAPEVINNEKYTF 180

Query: 270 KTDVFSYGVLVLEIVSGR---KNHDGRLGKEKAD 300
             D +  G L+ E++ G+   +    R+ +E+ D
Sbjct: 181 SPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD 214

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 72.1 bits (177), Expect = 5e-14
 Identities = 60/216 (27%), Positives = 110/216 (50%), Gaps = 25/216 (11%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-RQGLR-EFTNEVKLLLKIQHKNL 144
           F  + Q+G G +G VY+      G+ +A+KK+ +D+ ++G       E+K+L ++ H+N+
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68

Query: 145 VTLFGCCAEGPEKM----------LVYEYLPNKSLDYFIFDKTKSSSLDWTTRY--RIVM 192
           V L     +  + +          LV+EY+     D+ +    +S  + ++  +    + 
Sbjct: 69  VNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDHIKSFMK 123

Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISG 252
            +  GL Y H++     +HRDIK SNILL+ +   K++DFGLARL+  E++   T ++  
Sbjct: 124 QLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI- 179

Query: 253 THGYMAPEYAL-HGYLSVKTDVFSYGVLVLEIVSGR 287
           T  Y  PE  L         DV+S G ++ E+ + +
Sbjct: 180 TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 71.6 bits (175), Expect = 6e-14
 Identities = 68/218 (31%), Positives = 101/218 (46%), Gaps = 17/218 (7%)

Query: 88  FSDLNQLGHGGFGPVYR-GLMPNGQEIAVKKLS---VDSRQGLREFTNEVKLLLKIQHKN 143
           F     LG GGFG V    +   G+  A KKL    +  R+G     NE ++L K+  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR---GLLY 200
           +V+L           LV   +    L + I+   ++         R V   A    GL  
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG----FEEGRAVFYAAEICCGLED 117

Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE 260
           LH+E   RI++RD+K  NILLD+  + +ISD GLA   P E   +   R+ GT GYMAPE
Sbjct: 118 LHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVP-EGQTIKG-RV-GTVGYMAPE 171

Query: 261 YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK 298
              +   +   D ++ G L+ E+++G+     R  K K
Sbjct: 172 VVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK 209

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 71.6 bits (176), Expect = 9e-14
 Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 44/218 (20%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQHKNLVT 146
           +G G +G V   +   +G+++A+KK+         +++ LRE    +K+L   +H N++ 
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRE----LKILRHFKHDNIIA 68

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLD---YFIFDKTKS-------SSLDWTTRY-RIVMG-V 194
           +          +L     P  +     Y + D  +S       S    T  + R  +  +
Sbjct: 69  I--------RDIL----RPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQL 116

Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS--G 252
            RGL Y+H    A +IHRD+K SN+L++E    +I DFG+AR      T    F      
Sbjct: 117 LRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173

Query: 253 THGYMAPE--YALHGYLSVKTDVFSYGVLVLEIVSGRK 288
           T  Y APE   +L  Y +   D++S G +  E++ GR+
Sbjct: 174 TRWYRAPELLLSLPEY-TTAIDMWSVGCIFAEML-GRR 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 60/208 (28%), Positives = 87/208 (41%), Gaps = 32/208 (15%)

Query: 97  GGFGPVY---RGLMPNGQEIAVKKLSVDSRQGLREFTN---EVKLLLKIQHKNLVTLFGC 150
           G +G V+   +     G   A+K +         +      E  +L + Q   +V L+  
Sbjct: 4   GAYGRVFLAKKKS--TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-Y 60

Query: 151 CAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRY--RIVMGVARGLLYLHEEAPA 207
             +G + + LV EYLP   L   + +   S   D    Y   IV+     L YLH     
Sbjct: 61  SFQGKKNLYLVMEYLPGGDL-ASLLENVGSLDEDVARIYIAEIVLA----LEYLHSNG-- 113

Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLA------RLFPGEDTHVNTFRISGTHGYMAPEY 261
            IIHRD+K  NIL+D   + K++DFGL+      R     D      RI GT  Y+APE 
Sbjct: 114 -IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172

Query: 262 AL---HGYLSVKTDVFSYGVLVLEIVSG 286
            L   H       D +S G ++ E + G
Sbjct: 173 ILGQGHSK---TVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 71.3 bits (175), Expect = 1e-13
 Identities = 59/249 (23%), Positives = 104/249 (41%), Gaps = 45/249 (18%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           + DL  LG G  G V+  +  +  + +AVKK+ +   Q ++    E+K++ ++ H N+V 
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 147 LFGCCAEGPEKM--------------LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVM 192
           ++         +              +V EY+    L   +     S        Y+++ 
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSEEHARLFMYQLL- 124

Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRIS 251
              RGL Y+H    A ++HRD+K +N+ ++ E L  KI DFGLAR+     +H       
Sbjct: 125 ---RGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178

Query: 252 -GTHGYMAPEYALHGYLSVKT-DVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLF 309
             T  Y +P   L      K  D+++ G +  E+++G+                    LF
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-------------------PLF 219

Query: 310 QGEKALELV 318
            G   LE +
Sbjct: 220 AGAHELEQM 228

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 31/210 (14%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQHKNLVT 146
           +G G +G V         +++A+KK++      +D+++ LRE    +KLL  + H+N++ 
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLRE----IKLLRHLDHENVIA 68

Query: 147 LFGCCAEGPEKM------LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
           +       P +       +VYE L +  L   I  ++  +  D   +Y  +  + RGL Y
Sbjct: 69  IKD-IMPPPHREAFNDVYIVYE-LMDTDLHQII--RSSQTLSDDHCQY-FLYQLLRGLKY 123

Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE 260
           +H    A ++HRD+K SN+LL+   + KI DFGLAR     +          T  Y APE
Sbjct: 124 IHS---ANVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYRAPE 178

Query: 261 YALH--GYLSVKTDVFSYGVLVLEIVSGRK 288
             L+   Y +   DV+S G +  E++ GRK
Sbjct: 179 LLLNCSEYTTA-IDVWSVGCIFAELL-GRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 66/235 (28%), Positives = 111/235 (47%), Gaps = 55/235 (23%)

Query: 79  RTLQVATNFFSDLNQLGHGGFGPVY----RGLMPNGQEIAVKKLS------VDSRQGLRE 128
           +T+    + + +L+ +G G +G V           G+++A+KKLS      + +++  RE
Sbjct: 8   KTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKT---GRKVAIKKLSRPFQSAIHAKRTYRE 64

Query: 129 FTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFD 175
               ++LL  + H+N++ L               + P  SL+ F             + +
Sbjct: 65  ----LRLLKHMDHENVIGLLDV------------FTPASSLEDFQDVYLVTHLMGADLNN 108

Query: 176 KTKSSSL-DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL 234
             K   L D   ++ +V  + RGL Y+H    A IIHRD+K SNI ++E    KI DFGL
Sbjct: 109 IVKCQKLSDDHIQF-LVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGL 164

Query: 235 ARLFPGEDT-HVNTFRISGTHGYMAPEYALHGYLSVKT-DVFSYGVLVLEIVSGR 287
           AR    E T +V       T  Y APE  L+     +T D++S G ++ E+++G+
Sbjct: 165 ARHTDDEMTGYV------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 43/154 (27%), Positives = 79/154 (51%), Gaps = 9/154 (5%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           +  L ++G G +G V++       EI A+K++ +D   +G+      E+ LL +++HKN+
Sbjct: 2   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 61

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L+       +  LV+EY       YF    + +  +D       +  + +GL + H  
Sbjct: 62  VRLYDVLHSDKKLTLVFEYCDQDLKKYF---DSCNGDIDPEIVKSFMFQLLKGLAFCHSH 118

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLF 238
               ++HRD+K  N+L+++    K++DFGLAR F
Sbjct: 119 ---NVLHRDLKPQNLLINKNGELKLADFGLARAF 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 58/202 (28%), Positives = 82/202 (40%), Gaps = 19/202 (9%)

Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQH-----KNL 144
           L  +  G FG VY       G   A+K L         + TN VK    I         +
Sbjct: 1   LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTN-VKAERAIMMIQGESPYV 59

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
             L+          LV EYL        I         DW  +Y  +  V  G+  LH+ 
Sbjct: 60  AKLYYSFQSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWAKQY--IAEVVLGVEDLHQR 116

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
               IIHRDIK  N+L+D+  + K++DFGL+R   G +      +  GT  Y+APE  L 
Sbjct: 117 G---IIHRDIKPENLLIDQTGHLKLTDFGLSRN--GLENK----KFVGTPDYLAPETILG 167

Query: 265 GYLSVKTDVFSYGVLVLEIVSG 286
                 +D +S G ++ E + G
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 68/212 (32%), Positives = 97/212 (45%), Gaps = 19/212 (8%)

Query: 94  LGHGGFGPVYR-GLMPNGQEIAVKKLS---VDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
           LG GGFG V    +   G+  A KKL    +  R+G     NE ++L K+  + +V+L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67

Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR---GLLYLHEEAP 206
                    LV   +    L + I++             R V   A    GL  LH E  
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYNMGNPG----FDEERAVFYAAEITCGLEDLHRE-- 121

Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGY 266
            RI++RD+K  NILLD+  + +ISD GLA   P  +T     R+ GT GYMAPE   +  
Sbjct: 122 -RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG--RV-GTVGYMAPEVVKNER 177

Query: 267 LSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK 298
            +   D +  G L+ E++ G+     R  KEK
Sbjct: 178 YTFSPDWWGLGCLIYEMIEGKSPFRQR--KEK 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 67/224 (29%), Positives = 107/224 (47%), Gaps = 40/224 (17%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGL--REFTNEVKLLLKIQHKNL 144
           + DL Q+G G +G V   L    G ++A+KKL    +  L  +    E++LL  ++H+N+
Sbjct: 17  YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFI----------FDKTKSSSLDWTTRYRI---V 191
           + L               + P+ SLD F            D  K    +  +  RI   V
Sbjct: 77  IGLLDV------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLV 124

Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS 251
             + +GL Y+H    A IIHRD+K  N+ ++E    KI DFGLAR     D+ +  + + 
Sbjct: 125 YQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVV- 177

Query: 252 GTHGYMAPEYALHGYLSVKT-DVFSYGVLVLEIVSGR---KNHD 291
            T  Y APE  L+     +T D++S G ++ E+++G+   K HD
Sbjct: 178 -TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 65/214 (30%), Positives = 102/214 (47%), Gaps = 21/214 (9%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLSVDS--RQGLREFTNEVKLLLKIQHK-N 143
           F+ L  LG G FG V         E+ A+K L  D   +    E T   K +L +  K  
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61

Query: 144 LVTLFGCCAEGPEKM-LVYEYLPNKSLDYFI--FDKTKSSSLDWTTRYRIVMGVARGLLY 200
            +T    C +  +++  V EY+    L Y I    K K     +         +A GL +
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVF-----YAAEIAIGLFF 116

Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR--LFPGEDTHVNTFRISGTHGYMA 258
           LH +    II+RD+K  N++LD + + KI+DFG+ +  +F G+ T   TF   GT  Y+A
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTT--RTF--CGTPDYIA 169

Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
           PE   +       D +++GVL+ E+++G+   DG
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 203

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 72/278 (25%), Positives = 125/278 (44%), Gaps = 28/278 (10%)

Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSV----DSRQGLREFTNEVKLLLKIQHK 142
           F    ++G G F  VYR   + +G  +A+KK+ +    D++    +   E+ LL ++ H 
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAK-ARADCIKEIDLLKQLNHP 62

Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFI--FDKTKSSSLDWTTRYRIVMGVARGLLY 200
           N++  +    E  E  +V E      L   I  F K K   +   T ++  + +   L +
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL-IPEKTVWKYFVQLCSALEH 121

Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE 260
           +H     R++HRDIK +N+ +      K+ D GL R F  + T  ++  + GT  YM+PE
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 176

Query: 261 YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD- 319
                  + K+D++S G L+ E+ + +    G    +K +L S         K +E  D 
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYG----DKMNLYSLC-------KKIEQCDY 225

Query: 320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLM 357
           P L   +  E     QL  +C      +RPD+  V+ +
Sbjct: 226 PPLPSDHYSEELR--QLVNMCINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 70.0 bits (171), Expect = 3e-13
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 17/203 (8%)

Query: 91  LNQLGHGGFGPVYRG---LMPNGQEIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLVT 146
           L +LG G +  V++G   L  N   +A+K++ ++  +G       EV LL  ++H N+VT
Sbjct: 11  LEKLGEGTYATVFKGRSKLTEN--LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 68

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           L           LV+EYL +K L  ++ D     S+     +  +  + RGL Y H    
Sbjct: 69  LHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCHRR-- 123

Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGY 266
            +++HRD+K  N+L++E+   K++DFGLAR    +     T+       +  P   L G 
Sbjct: 124 -KVLHRDLKPQNLLINERGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLLGS 179

Query: 267 --LSVKTDVFSYGVLVLEIVSGR 287
              S + D++  G +  E+ SGR
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 69.3 bits (170), Expect = 4e-13
 Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 53/223 (23%)

Query: 91  LNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHK-----NL 144
           L ++G G  G VY+      G  +AVK++    R G +E    + + L +  K      +
Sbjct: 20  LGEIGSGTCGQVYKMRFKKTGHVMAVKQMR---RTGNKEENKRILMDLDVVLKSHDCPYI 76

Query: 145 VTLFGC---------CAE----GPEKML--VYEYLPNKSLDYFIFDKTKSSSLDWTTRYR 189
           V  +G          C E      +K+L  +   +P       I  K             
Sbjct: 77  VKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPE-----DILGK------------- 118

Query: 190 IVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA-RLFPGEDTHVNTF 248
           + + + + L YL E+    +IHRD+K SNILLD   N K+ DFG++ RL    D+   T 
Sbjct: 119 MTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKT- 172

Query: 249 RISGTHGYMAPEY----ALHGYLSVKTDVFSYGVLVLEIVSGR 287
           R +G   YMAPE       +    ++ DV+S G+ ++E+ +G+
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 68.9 bits (168), Expect = 4e-13
 Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 15/217 (6%)

Query: 91  LNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLVTLF 148
           L++LG G +  V++G        +A+K++ ++  +G       EV LL  ++H N+VTL 
Sbjct: 10  LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLH 69

Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVM-GVARGLLYLHEEAPA 207
                     LV+EYL +    Y         +L      +I M  + RGL Y H+    
Sbjct: 70  DIIHTERCLTLVFEYLDSDLKQYL----DNCGNLMSMHNVKIFMFQLLRGLSYCHKR--- 122

Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
           +I+HRD+K  N+L++E+   K++DFGLAR    +     T+       +  P   L G  
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLAR---AKSVPTKTYSNEVVTLWYRPPDVLLGST 179

Query: 268 SVKT--DVFSYGVLVLEIVSGRKNHDGRLGKEKADLL 302
              T  D++  G ++ E+ +GR    G   KE+  L+
Sbjct: 180 EYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 68.8 bits (168), Expect = 5e-13
 Identities = 65/218 (29%), Positives = 97/218 (44%), Gaps = 19/218 (8%)

Query: 88  FSDLNQLGHGGFGPVYR-GLMPNGQEIAVKKLS---VDSRQGLREFTNEVKLLLKIQHKN 143
           F     LG GGFG V    +   G+  A K+L    +  R+G     NE ++L K+  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR---GLLY 200
           +V L           LV   +    L + I++             R +   A    GL  
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG----FEEERALFYAAEILCGLED 117

Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE 260
           LH E     ++RD+K  NILLD+  + +ISD GLA   P  ++     R+ GT GYMAPE
Sbjct: 118 LHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG--RV-GTVGYMAPE 171

Query: 261 YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK 298
              +   ++  D +  G L+ E++ G+    GR  KEK
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR--KEK 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 69.4 bits (170), Expect = 6e-13
 Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 53/222 (23%)

Query: 93  QLGHGGFGPVYRGLMP-NGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQHKNLV 145
            +G+G FG V+    P +G+ +A+KK+       V  ++  RE    +K+L   +H N++
Sbjct: 7   PIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRE----LKMLCFFKHDNVL 62

Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYF--IFDKTKSSSLDWTTRYRIVMG---------- 193
           +               + L    +D F  I+  T+   L  +  ++I++           
Sbjct: 63  SAL-------------DILQPPHIDPFEEIYVVTE---LMQSDLHKIIVSPQPLSSDHVK 106

Query: 194 -----VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF-PGEDTHVNT 247
                + RGL YLH    A I+HRDIK  N+L++     KI DFGLAR+  P E  H+  
Sbjct: 107 VFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQ 163

Query: 248 FRISGTHGYMAPEYALHG--YLSVKTDVFSYGVLVLEIVSGR 287
             +  T  Y APE  L G  + +   D++S G +  E++  R
Sbjct: 164 EVV--TQYYRAPEI-LMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 68.8 bits (168), Expect = 7e-13
 Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 23/203 (11%)

Query: 94  LGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLRE------FTNEVKLLLKIQHKNLVT 146
           LG G FG V    +  +G+  AVK L  D    L++       T +  L L   H  L  
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVI--LQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 147 LFGCCAEGPEKML-VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
           L+ CC + P+++  V E++    L   +F   KS   D          +   L++LH++ 
Sbjct: 61  LY-CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDKG 116

Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLAR--LFPGEDTHVNTFRISGTHGYMAPEYAL 263
              II+RD+K  N+LLD + + K++DFG+ +  +F G+ T  +TF   GT  Y+APE   
Sbjct: 117 ---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT--STF--CGTPDYIAPEILQ 169

Query: 264 HGYLSVKTDVFSYGVLVLEIVSG 286
                   D ++ GVL+ E++ G
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 68.7 bits (168), Expect = 7e-13
 Identities = 68/227 (29%), Positives = 102/227 (44%), Gaps = 32/227 (14%)

Query: 91  LNQLGHGGFGPVY--RGLMP--NGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQHKN 143
           L  LG G FG V+  R +     GQ  A+K   K ++  R  +R    E  +L ++ H  
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPF 59

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL-LYLH 202
           +V L             Y +     L Y I D  +   L +T   + VM     +  YL 
Sbjct: 60  IVKLH------------YAFQTEGKL-YLILDFLRGGDL-FTRLSKEVMFTEEDVKFYLA 105

Query: 203 EEAPAR-------IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG 255
           E A A        II+RD+K  NILLDE+ + K++DFGL++     D     +   GT  
Sbjct: 106 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVE 163

Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLL 302
           YMAPE       +   D +S+GVL+ E+++G     G+  KE   ++
Sbjct: 164 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 68.0 bits (166), Expect = 8e-13
 Identities = 59/235 (25%), Positives = 108/235 (45%), Gaps = 23/235 (9%)

Query: 94  LGHGGFGPVYRGLMP----NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTL 147
           LG G FG V    +     + Q++AVK L  D  S   + EF  E   + +  H N++ L
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 148 FGCC----AEG--PEKMLVYEYLPNKSLDYFIFDK---TKSSSLDWTTRYRIVMGVARGL 198
            G      A+G  P  M++  ++ +  L  F+       +  +L   T  R ++ +A G+
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126

Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMA 258
            YL  +     IHRD+ A N +L+E +   ++DFGL++     D +           ++A
Sbjct: 127 EYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183

Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEK 313
            E       +  +DV+++GV + EI++  +      G E +++ +Y   L +G +
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIMT--RGQTPYAGVENSEIYNY---LIKGNR 233

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 68.9 bits (168), Expect = 8e-13
 Identities = 61/221 (27%), Positives = 104/221 (47%), Gaps = 45/221 (20%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQ 140
           + +L+ +G G +G V        G  +AVKKLS      + +++  RE    ++LL  ++
Sbjct: 19  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE----LRLLKHMK 74

Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSL----DYFIFDKTKSSSLDWTTRYR------- 189
           H+N++ L               + P +SL    D ++      + L+   + +       
Sbjct: 75  HENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV 122

Query: 190 --IVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
             ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E T    
Sbjct: 123 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY-- 177

Query: 248 FRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
                T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 178 ---VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 68.5 bits (167), Expect = 9e-13
 Identities = 62/204 (30%), Positives = 104/204 (50%), Gaps = 19/204 (9%)

Query: 91  LNQLGHGGFGPVYRG---LMPNGQEIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLVT 146
           L++LG G +  VY+G   L  N   +A+K++ ++  +G       EV LL  ++H N+VT
Sbjct: 11  LDKLGEGTYATVYKGRSKLTDN--LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 68

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           L           LV+EYL +K L  ++ D   S ++     +  +  + RGL Y H    
Sbjct: 69  LHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCHRR-- 123

Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARL--FPGEDTHVNTFRISGTHGYMAPEYALH 264
            +++HRD+K  N+L++E+   K++DFGLAR    P + T+ N      T  Y  P+  L 
Sbjct: 124 -KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-TYSNEVV---TLWYRPPDILLG 178

Query: 265 GY-LSVKTDVFSYGVLVLEIVSGR 287
               S + D++  G +  E+ +GR
Sbjct: 179 STDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 50/156 (32%), Positives = 78/156 (50%), Gaps = 24/156 (15%)

Query: 91  LNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFT--NEVKLLLKIQHKNLVTL 147
           L++LG G +  VY+G     GQ +A+K++ ++  +G   FT   E  LL  ++H N+VTL
Sbjct: 10  LDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGA-PFTAIREASLLKDLKHANIVTL 68

Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTR------YRIVM-GVARGLLY 200
                      LV+EYL          D      +D           R+ +  + RGL Y
Sbjct: 69  HDIIHTKKTLTLVFEYL----------DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAY 118

Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
            H+    R++HRD+K  N+L+ E+   K++DFGLAR
Sbjct: 119 CHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 53/196 (27%), Positives = 90/196 (45%), Gaps = 33/196 (16%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQ------GLREFTNEVKLLLKIQ 140
           +  L ++G G FG V++       Q +A+KK+ +++ +       LRE    +K+L  ++
Sbjct: 14  YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALRE----IKILQLLK 69

Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD----------KTKSSSLDWTTRYRI 190
           H+N+V L   C           Y   K   Y +F+            K+     +   ++
Sbjct: 70  HENVVNLIEICRTKATP-----YNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKV 124

Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP---GEDTHVNT 247
           +  +  GL Y+H     +I+HRD+KA+NIL+ +    K++DFGLAR F        +  T
Sbjct: 125 MKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181

Query: 248 FRISGTHGYMAPEYAL 263
            R+  T  Y  PE  L
Sbjct: 182 NRVV-TLWYRPPELLL 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 57/192 (29%), Positives = 86/192 (44%), Gaps = 37/192 (19%)

Query: 93  QLGHGGFGPVYRGLMPN---GQEIAVKKLSVDSRQG-------LREFTNEVKLLLKIQHK 142
            +G G +G VY+    N   G+E A+KK   D  Q         RE      LL +++H+
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIA----LLRELKHE 62

Query: 143 NLVTLFGCCAEGPEKM--LVYEYLPNKSLDYFIFDKT-KSSSLDWTTRYRIVMGVARGLL 199
           N+V+L     E  +K   L+++Y  +       F +  K  S+  +    ++  +  G+ 
Sbjct: 63  NVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVH 122

Query: 200 YLHEEAPARIIHRDIKASNILL----DEQLNPKISDFGLARLF--P-----GEDTHVNTF 248
           YLH      ++HRD+K +NIL+     E+   KI D GLARLF  P       D  V T 
Sbjct: 123 YLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI 179

Query: 249 RISGTHGYMAPE 260
                  Y APE
Sbjct: 180 ------WYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 15/209 (7%)

Query: 84  ATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFT--NEVKLLLKIQ 140
           A   + +L +LG G +  VY+G+   NGQ +A+K +S+ + +G+  FT   E  LL  ++
Sbjct: 3   AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLK 61

Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
           H N+V L            V+EY+      Y I        L        +  + RGL Y
Sbjct: 62  HANIVLLHDIIHTKETLTFVFEYMHTDLAQYMI---QHPGGLHPYNVRLFMFQLLRGLAY 118

Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE 260
           +H +    I+HRD+K  N+L+      K++DFGLAR    +     T+       +  P 
Sbjct: 119 IHGQ---HILHRDLKPQNLLISYLGELKLADFGLAR---AKSIPSQTYSSEVVTLWYRPP 172

Query: 261 YALHGY--LSVKTDVFSYGVLVLEIVSGR 287
             L G    S   D++  G + +E++ G+
Sbjct: 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 59/203 (29%), Positives = 89/203 (43%), Gaps = 54/203 (26%)

Query: 110 GQEIAVKKLSVDSRQGLREFTN---------EVKLLLKIQHKNLVTLFGCCAEGPEKMLV 160
           GQ +A+KKLS       R F N         E+ L+  + HKN++ L             
Sbjct: 41  GQNVAIKKLS-------RPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV---------- 83

Query: 161 YEYLPNKSLD-----YFIFDKTKSS-------SLDWTTRYRIVMGVARGLLYLHEEAPAR 208
             + P KSL+     Y + +   ++        LD      ++  +  G+ +LH    A 
Sbjct: 84  --FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHS---AG 138

Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISG---THGYMAPEYAL-H 264
           IIHRD+K SNI++      KI DFGLAR      T   +F ++    T  Y APE  L  
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFMMTPYVVTRYYRAPEVILGM 192

Query: 265 GYLSVKTDVFSYGVLVLEIVSGR 287
           GY     D++S G ++ E++ G 
Sbjct: 193 GY-KENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 67.1 bits (164), Expect = 1e-12
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 33/213 (15%)

Query: 94  LGHGGFGPVYRGLMPN---------GQEIAV--KKLSVDSRQGLREFTNEVKLLLKIQHK 142
           LG G F  +Y+G++           GQE++V  K L  D R  L  F     L+ ++ HK
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSL-AFFETASLMSQLSHK 61

Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
           +LV L+G C    E ++V EY+    LD F+  +  + SL W  +  +   +A  L YL 
Sbjct: 62  HLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE 118

Query: 203 EEAPARIIHRDIKASNILL-----DEQLNP--KISDFGLARLFPGEDTHVNTFRISGTHG 255
           ++   +++H ++   NIL+     +E   P  K+SD G+       +  V   RI     
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE--RIP---- 169

Query: 256 YMAPEY--ALHGYLSVKTDVFSYGVLVLEIVSG 286
           ++APE        L++  D +S+G  +LEI S 
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 62/210 (29%), Positives = 92/210 (43%), Gaps = 13/210 (6%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLSVDS--RQGLREFTNEVKLLLKIQHKN- 143
           F+ L  LG G FG V         E+ A+K L  D   +    E T   K +L +Q K  
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61

Query: 144 -LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
            L  L  C         V EY+    L Y I    +               ++ GL +LH
Sbjct: 62  FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI---QQVGKFKEPQAVFYAAEISVGLFFLH 118

Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
                 II+RD+K  N++LD + + KI+DFG+ +    +     TF   GT  Y+APE  
Sbjct: 119 RRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTF--CGTPDYIAPEII 173

Query: 263 LHGYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
            +       D ++YGVL+ E+++G+   DG
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 203

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 68.7 bits (168), Expect = 2e-12
 Identities = 51/190 (26%), Positives = 91/190 (47%), Gaps = 18/190 (9%)

Query: 110 GQEIAVKKLSVDSRQGLRE---FTNEVKLLLKIQHKNLVTLFGCCAEGPEKML-VYEYLP 165
           G E+A+K L  D+ +   +   F  E  L  ++ H N+V L       P  +  V+EY+P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL---D 222
            ++L   +       +L      R+++ V   L   H +    I+HRD+K  NI++    
Sbjct: 63  GRTLREVL---AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTG 116

Query: 223 EQLNPKISDFGLARLFPG-----EDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYG 277
            + + K+ DFG+  L PG       T   T  + GT  Y APE      ++  +D++++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176

Query: 278 VLVLEIVSGR 287
           ++ LE ++G+
Sbjct: 177 LIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 25/205 (12%)

Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
           + +LG G FG VY+      G   A K +   S + L ++  E+++L    H  +V L G
Sbjct: 17  IGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLG 76

Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL----YLHEEA 205
                 +  ++ E+ P  ++D  + +      LD       +  + R +L    YLH   
Sbjct: 77  AFYWDGKLWIMIEFCPGGAVDAIMLE------LDRGLTEPQIQVICRQMLEALQYLHSM- 129

Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS--GTHGYMAPEYAL 263
             +IIHRD+KA N+LL    + K++DFG++     ++      R S  GT  +MAPE  +
Sbjct: 130 --KIIHRDLKAGNVLLTLDGDIKLADFGVS----AKNVKTLQRRDSFIGTPYWMAPEVVM 183

Query: 264 HGYLS-----VKTDVFSYGVLVLEI 283
              +       K D++S G+ ++E+
Sbjct: 184 CETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 66.5 bits (162), Expect = 4e-12
 Identities = 67/210 (31%), Positives = 96/210 (45%), Gaps = 25/210 (11%)

Query: 94  LGHGGFGPVYRG-LMPNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKI--QHKNLVTLF 148
           LG G FG V+   L    Q  A+K L  D        E T   K +L +  +H  L  L+
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 149 GCCAEGPEKML-VYEYLPNKSLDYFI-----FDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
            C  +  E +  V EYL    L + I     FD  ++      T Y     +  GL +LH
Sbjct: 63  -CTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRA------TFY--AAEIICGLQFLH 113

Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
            +    I++RD+K  NILLD   + KI+DFG+ +     D    TF   GT  Y+APE  
Sbjct: 114 SKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTF--CGTPDYIAPEIL 168

Query: 263 LHGYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
           L    +   D +S+GVL+ E++ G+    G
Sbjct: 169 LGQKYNTSVDWWSFGVLLYEMLIGQSPFHG 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 66.5 bits (162), Expect = 6e-12
 Identities = 65/217 (29%), Positives = 104/217 (47%), Gaps = 26/217 (11%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQ 140
           ++ L Q+G G +G V   +    G+++A+KKLS      + +++  RE T    LL  +Q
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELT----LLKHMQ 72

Query: 141 HKNLVTL---FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
           H+N++ L   F     G E    Y  +P    D     K     L       +V  +  G
Sbjct: 73  HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD---LQKIMGHPLSEDKVQYLVYQMLCG 129

Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L Y+H    A IIHRD+K  N+ ++E    KI DFGLAR     D  +  + +  T  Y 
Sbjct: 130 LKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVV--TRWYR 181

Query: 258 APEYALHGYLSVKT-DVFSYGVLVLEIVSGRKNHDGR 293
           APE  L+     +T D++S G ++ E+++G+    G+
Sbjct: 182 APEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 218

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 66.0 bits (161), Expect = 8e-12
 Identities = 38/92 (41%), Positives = 51/92 (55%), Gaps = 3/92 (3%)

Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           VARG+ +L   A  + IHRD+ A NILL E    KI DFGLAR    +  +V        
Sbjct: 182 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
             +MAPE       + ++DV+S+GVL+ EI S
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 65.4 bits (159), Expect = 8e-12
 Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 21/215 (9%)

Query: 86  NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKK-LSVDSRQGLREFTNEVKLLLKIQHKNL 144
            F+  + +LG G FG VY+        +A  K +   S + L ++  E+ +L    H N+
Sbjct: 5   EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 64

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIV-MGVARGLLYLHE 203
           V L           ++ E+    ++D  + +  +  +     + R+V       L YLHE
Sbjct: 65  VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT---EPQIRVVCKQTLEALNYLHE 121

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS--GTHGYMAPEY 261
               +IIHRD+KA NIL     + K++DFG++     ++T     R S  GT  +MAPE 
Sbjct: 122 N---KIIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRTIQRRDSFIGTPYWMAPEV 174

Query: 262 AL------HGYLSVKTDVFSYGVLVLEIVSGRKNH 290
            +        Y   K DV+S G+ ++E+      H
Sbjct: 175 VMCETSKDRPY-DYKADVWSLGITLIEMAQIEPPH 208

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 64.7 bits (157), Expect = 9e-12
 Identities = 52/202 (25%), Positives = 95/202 (47%), Gaps = 16/202 (7%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           F  + ++G G +G VY+    N G+  A+K + ++  +       E+ ++   +H N+V 
Sbjct: 11  FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLD--YFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
            FG      +  +  E+    SL   Y +      S + + +R  +     +GL YLH +
Sbjct: 71  YFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSK 125

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL- 263
                +HRDIK +NILL +  + K++DFG++           +F   GT  +MAPE A  
Sbjct: 126 GK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF--IGTPYWMAPEVAAV 180

Query: 264 --HGYLSVKTDVFSYGVLVLEI 283
              G  +   D+++ G+  +E+
Sbjct: 181 ERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 63/210 (30%), Positives = 87/210 (41%), Gaps = 24/210 (11%)

Query: 88  FSDLNQLGHGGFGPV----YRGLMPNGQEIAVKKLSVD---SRQGLREFTNEVKLLL--- 137
           F  L  LG G FG V    Y+     G+  A+K L      +R  +     E ++     
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRIFETAN 57

Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VAR 196
             +H  LV LF C         V EY     L   I     S       R       V  
Sbjct: 58  SERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP-----RAVFYAACVVL 112

Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGY 256
           GL YLHE    +I++RD+K  N+LLD +   KI+DFGL +   G     +TF   GT  +
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTF--CGTPEF 167

Query: 257 MAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
           +APE       +   D +  GVL+ E++ G
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 49/156 (31%), Positives = 76/156 (48%), Gaps = 14/156 (8%)

Query: 135 LLLKIQHKNLVTLFGCCAEGPEKML-VYEYLPNKSLDYFIFDKTKSSSLDWTTRY--RIV 191
           L L  +H  L  LF C  +  E +  V EYL    L + I    +         Y   I+
Sbjct: 49  LALAWEHPFLTHLF-CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFD-EARARFYAAEII 106

Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS 251
            G    L +LH++    II+RD+K  N+LLD+  + KI+DFG+ +     +   +TF   
Sbjct: 107 CG----LQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTF--C 157

Query: 252 GTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
           GT  Y+APE       +   D +S+GVL+ E++ G+
Sbjct: 158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 67/272 (24%), Positives = 122/272 (44%), Gaps = 33/272 (12%)

Query: 91  LNQLGHGGFGPV----YRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNL 144
           +  +G G +G V    +R     G++  +KKL++   SR+  +    E +LL +++H N+
Sbjct: 5   VRVVGKGSYGEVSLVRHRTD---GKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61

Query: 145 VTLFGCCAEGPEKML--VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
           V  +    EG + +L  V  +     L Y    + K   L         + +A  L YLH
Sbjct: 62  VA-YRESWEGEDGLLYIVMGFCEGGDL-YHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119

Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
           E+    I+HRD+K  N+ L      K+ D G+AR+   +    +T  + GT  YM+PE  
Sbjct: 120 EK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELF 174

Query: 263 LHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL 322
            +   + K+DV++ G  V E+ + +   + +      D+ S  + + +G+       P +
Sbjct: 175 SNKPYNYKSDVWALGCCVYEMATLKHAFNAK------DMNSLVYRIIEGKL------PPM 222

Query: 323 AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSV 354
            K    E    I   +L  +    +RP + S+
Sbjct: 223 PKDYSPELGELIA-TMLSKRPE--KRPSVKSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 25/211 (11%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQ 140
           + +L  +G G +G V         Q++AVKKLS      + +R+  RE    ++LL  ++
Sbjct: 17  YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRE----LRLLKHMK 72

Query: 141 HKNLVTL---FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
           H+N++ L   F           VY  L    +   + +  K   L       ++  + RG
Sbjct: 73  HENVIGLLDVFTPATSIENFNEVY--LVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRG 130

Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L Y+H    A IIHRD+K SN+ ++E    +I DFGLAR    E T         T  Y 
Sbjct: 131 LKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGY-----VATRWYR 182

Query: 258 APEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           APE  L+  + +   D++S G ++ E++ G+
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 64.1 bits (156), Expect = 3e-11
 Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 21/203 (10%)

Query: 94  LGHGGFGPVYRGLMPNGQEI-AVKKLSVDSRQGLRE------FTNEVKLLLKIQHKNLVT 146
           LG G FG V    +    E+ A+K L  D    L++       T +  L L  +H  L  
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVI--LQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 147 LFGCCAEGPEKML-VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARGLLYLHEE 204
           L  CC +  +++  V EY+    L   +F   +S   D   R R     V   L++LH  
Sbjct: 61  LH-CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFD-EPRSRFYAAEVTLALMFLHRH 115

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
               +I+RD+K  NILLD + + K++DFG+ +          TF   GT  Y+APE    
Sbjct: 116 G---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTF--CGTPDYIAPEILQE 170

Query: 265 GYLSVKTDVFSYGVLVLEIVSGR 287
                  D ++ GVL+ E+++G+
Sbjct: 171 LEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 52/202 (25%), Positives = 94/202 (46%), Gaps = 16/202 (7%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           +  + ++G G +G VY+   +  G+  AVK + ++          E+ ++ + +H N+V 
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVA 70

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLD--YFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
            FG      +  +  EY    SL   Y +        + +  R  +     +GL YLH +
Sbjct: 71  YFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSK 125

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL- 263
                +HRDIK +NILL +  + K++DFG+A           +F   GT  +MAPE A  
Sbjct: 126 GK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF--IGTPYWMAPEVAAV 180

Query: 264 --HGYLSVKTDVFSYGVLVLEI 283
             +G  +   D+++ G+  +E+
Sbjct: 181 EKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 63.8 bits (155), Expect = 3e-11
 Identities = 65/207 (31%), Positives = 94/207 (45%), Gaps = 19/207 (9%)

Query: 94  LGHGGFGPVYRG-LMPNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKN-LVTLFG 149
           LG G FG V    L   G+  AVK L  D        E T   K +L +  +N  +T   
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 150 CCAEGPEKML-VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR---GLLYLHEEA 205
           C  +  E +  V E+L    L + I DK +         YR     A    GL +LH + 
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFD------LYRATFYAAEIVCGLQFLHSKG 116

Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHG 265
              II+RD+K  N++LD   + KI+DFG+ +     D   +TF   GT  Y+APE     
Sbjct: 117 ---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTF--CGTPDYIAPEILQGL 171

Query: 266 YLSVKTDVFSYGVLVLEIVSGRKNHDG 292
             +   D +S+GVL+ E++ G+    G
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQSPFHG 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 63.4 bits (154), Expect = 3e-11
 Identities = 45/137 (32%), Positives = 66/137 (48%), Gaps = 13/137 (9%)

Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGY 256
           GL ++H      +++RD+K +NILLDE  + +ISD GLA  F  +  H +     GTHGY
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGY 161

Query: 257 MAPEYALHG--YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTL---FQG 311
           MAPE    G  Y S   D FS G ++ +++ G         K+K ++   T T+      
Sbjct: 162 MAPEVLQKGVAYDS-SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 220

Query: 312 EKALELVDPSLAKCNRD 328
             + EL         RD
Sbjct: 221 SFSPELRSLLEGLLQRD 237

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 63.3 bits (154), Expect = 4e-11
 Identities = 55/215 (25%), Positives = 92/215 (42%), Gaps = 25/215 (11%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-RQGLREFT-NEVKLLLKIQHKNL 144
           +  L ++G G +G VY+      G+ +A+KK  ++   +G+      E+ LL  +     
Sbjct: 3   YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIY 62

Query: 145 VTLFGCCAEGPEKM------LVYEYLPNKSLDYFIFDKTKSSS--LDWTTRYRIVMGVAR 196
           +          EK       LV+EYL +  L  F+    +     L   T    +  + +
Sbjct: 63  IVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121

Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNP-KISDFGLARLFP---GEDTHVNTFRISG 252
           G+ + H+     ++HRD+K  N+L+D+Q    KI+D GL R F       TH        
Sbjct: 122 GVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV----- 173

Query: 253 THGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSG 286
           T  Y APE  L   + S   D++S G +  E+   
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 63.2 bits (153), Expect = 5e-11
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 15/204 (7%)

Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFT--NEVKLLLKIQHKNL 144
           +  L +LG G +  VY+G    NG+ +A+K + +   +G   FT   E  LL  ++H N+
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANI 65

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L           LV+EY+      Y   DK     L        +  + RGL Y+H+ 
Sbjct: 66  VLLHDIIHTKETLTLVFEYVHTDLCQYM--DK-HPGGLHPENVKLFLFQLLRGLSYIHQR 122

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
               I+HRD+K  N+L+ +    K++DFGLAR    +    +T+       +  P   L 
Sbjct: 123 ---YILHRDLKPQNLLISDTGELKLADFGLAR---AKSVPSHTYSNEVVTLWYRPPDVLL 176

Query: 265 GYLSVKT--DVFSYGVLVLEIVSG 286
           G     T  D++  G + +E++ G
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 62.8 bits (153), Expect = 5e-11
 Identities = 57/206 (27%), Positives = 97/206 (47%), Gaps = 24/206 (11%)

Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-------RQGLREFTNEVKLLLKIQHK 142
           L+++G G +G V++      GQ +A+KK  V+S       +  LRE    +++L +++H 
Sbjct: 6   LSKIGEGSYGVVFKCRNRETGQIVAIKKF-VESEDDPVIKKIALRE----IRMLKQLKHP 60

Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
           NLV L        +  LV+EY  +  L+    +K     +      +I+    + + + H
Sbjct: 61  NLVNLIEVFRRKRKLHLVFEYCDHTVLNEL--EK-NPRGVPEHLIKKIIWQTLQAVNFCH 117

Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
           +      IHRD+K  NIL+ +Q   K+ DFG AR+  G       +    T  Y APE  
Sbjct: 118 KH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY--VATRWYRAPEL- 171

Query: 263 LHGYLSVKT--DVFSYGVLVLEIVSG 286
           L G        DV++ G +  E+++G
Sbjct: 172 LVGDTQYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 63.5 bits (154), Expect = 5e-11
 Identities = 38/92 (41%), Positives = 51/92 (55%), Gaps = 3/92 (3%)

Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           VARG+ +L   A  + IHRD+ A NILL E    KI DFGLAR    +  +V        
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
             +MAPE       + ++DV+S+GVL+ EI S
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 63.3 bits (154), Expect = 6e-11
 Identities = 42/115 (36%), Positives = 58/115 (50%), Gaps = 3/115 (2%)

Query: 175 DKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL 234
           D   S  LD     R    VA+G+ +L   A    IHRD+ A N+LL +    KI DFGL
Sbjct: 202 DTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGL 258

Query: 235 ARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKN 289
           AR    +  +V          +MAPE       +V++DV+SYG+L+ EI S  K+
Sbjct: 259 ARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 62.6 bits (152), Expect = 7e-11
 Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 16/199 (8%)

Query: 94  LGHGGFGPVYRGLMPNGQEI----AVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
           +G G FG V +    + Q I     ++K  + SR  +     E  +L ++    +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59

Query: 150 CCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
              + PEK+ LV  ++    L + +    +    D  +R R     A  L  L       
Sbjct: 60  FSFQSPEKLYLVLAFINGGELFHHL---QREGRFD-LSRARFY--TAELLCALENLHKFN 113

Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL-HGYL 267
           +I+RD+K  NILLD Q +  + DFGL +L   +D   NTF   GT  Y+APE  L HGY 
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTF--CGTPEYLAPELLLGHGYT 171

Query: 268 SVKTDVFSYGVLVLEIVSG 286
               D ++ GVL+ E+++G
Sbjct: 172 KA-VDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 61.9 bits (150), Expect = 9e-11
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 26/206 (12%)

Query: 91  LNQLGHGGFGPVYRGLM----PNGQEIAVKKLSV-DSRQGLREFTNEVKLLLKIQHKNLV 145
           L  +G G FG   R L+     + Q+ A+K++ +  S   + +   E  LL K++H N+V
Sbjct: 5   LRVVGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61

Query: 146 TLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDK-----TKSSSLDWTTRYRIVMGVARGLL 199
             F    E    + +V EY     L   I  +      + + L W  +  + +GV     
Sbjct: 62  A-FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ--MCLGVQ---- 114

Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           ++HE+   R++HRDIK+ NI L +    K+ DFG ARL      +  T+   GT  Y+ P
Sbjct: 115 HIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY--VGTPYYVPP 169

Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVS 285
           E   +   + K+D++S G ++ E+ +
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCT 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 62.9 bits (153), Expect = 9e-11
 Identities = 53/173 (30%), Positives = 80/173 (46%), Gaps = 17/173 (9%)

Query: 116 KKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD 175
           KK+ V +  G +    E+ +L  I H+ ++ L           +V   +P    D F + 
Sbjct: 120 KKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTYV 176

Query: 176 KTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235
             +S  L       I   +   L YLH      IIHRD+K  NI LDE  N  + DFG A
Sbjct: 177 D-RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA 232

Query: 236 -RLFPGEDTHVNTFRISGTHGYM---APEY-ALHGYLSVKTDVFSYGVLVLEI 283
            +L    D H +T +  G  G +   +PE  AL  Y + KTD++S G+++ E+
Sbjct: 233 CKL----DAHPDTPQCYGWSGTLETNSPELLALDPYCA-KTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 27/209 (12%)

Query: 88  FSDLNQLGHGGFGPVY--RGLMPNGQEIAVKKLSVDSRQGLRE---FTNEVKLLLKIQHK 142
              +  +G G FG V+  R  + +    A+K +++     L++     NE ++L ++ H 
Sbjct: 3   LERIKTVGTGTFGRVHLVRDRI-SEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61

Query: 143 NLVTLFGCCAEGPEKML--VYEYLPNKSLDYFIFDKTKSSSLDWTTRY---RIVMGVARG 197
            ++ LF    E  ++ L  + EY+P   L  F + +      + T  +    IV      
Sbjct: 62  FIIRLF--WTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYASEIVCA---- 113

Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L YLH +    I++RD+K  NILLD++ + K++DFG A+          T+ + GT  Y+
Sbjct: 114 LEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAK-----KLRDRTWTLCGTPEYL 165

Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSG 286
           APE       +   D ++ G+L+ E++ G
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 62/224 (27%), Positives = 101/224 (45%), Gaps = 20/224 (8%)

Query: 94  LGHGGFGPVYRGLMPN-GQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
           +G GGFG VY     + G+  A+K   K  +  +QG     NE +++L +          
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RIMLSLVSTGDCPFIV 60

Query: 150 CCA---EGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
           C       P+K+  + + +    L Y +      S  +   R+     +  GL ++H   
Sbjct: 61  CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKE--MRF-YATEIILGLEHMHNRF 117

Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHG 265
              +++RD+K +NILLDE  + +ISD GLA  F  +  H +     GTHGYMAPE    G
Sbjct: 118 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYMAPEVLQKG 170

Query: 266 Y-LSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTL 308
                  D FS G ++ +++ G         K+K ++   T T+
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTV 214

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 62.0 bits (150), Expect = 2e-10
 Identities = 37/92 (40%), Positives = 52/92 (56%), Gaps = 3/92 (3%)

Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           VA+G+ +L   A  + IHRD+ A NILL E    KI DFGLAR    +  +V        
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
             +MAPE       ++++DV+S+GVL+ EI S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 24/213 (11%)

Query: 88  FSDLNQLGHGGFGPVY----RGLMPNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQ 140
           F  L  LG G +G V+     G    G+  A+K   K ++  +    E T   + +L+  
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61

Query: 141 HKN--LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARG 197
            +   LVTL        +  L+ +Y+    L    F           +  R+ +  +   
Sbjct: 62  RRCPFLVTLHYAFQTDTKLHLILDYVNGGEL----FTHLYQREHFTESEVRVYIAEIVLA 117

Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF-PGEDTHVNTFRISGTHGY 256
           L +LH+     II+RDIK  NILLD + +  ++DFGL++ F   E+    +F   GT  Y
Sbjct: 118 LDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSF--CGTIEY 172

Query: 257 MAPEY---ALHGYLSVKTDVFSYGVLVLEIVSG 286
           MAPE       G+     D +S GVL  E+++G
Sbjct: 173 MAPEVIRGGSGGHDKA-VDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 60.6 bits (147), Expect = 2e-10
 Identities = 55/211 (26%), Positives = 100/211 (47%), Gaps = 30/211 (14%)

Query: 94  LGHGGFGPVYRG----LMPNGQ----EIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV 145
           LG G F  +++G    +   G+    E+ +K L    R     F     ++ ++ HK+LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
             +G C  G E ++V EY+   SLD ++  K   + ++ + +  +   +A  L +L ++ 
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFLEDKG 120

Query: 206 PARIIHRDIKASNILL-----DEQLNP---KISDFGLA-RLFPGEDTHVNTFRISGTHGY 256
              + H ++ A N+LL      +  NP   K+SD G++  + P E   +   RI     +
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE---ILLERIP----W 170

Query: 257 MAPEYALHG-YLSVKTDVFSYGVLVLEIVSG 286
           + PE   +   LS+  D +S+G  + EI SG
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 26/209 (12%)

Query: 91  LNQLGHGGFGPVYRGLMPNGQE----IAVKKLS----VDSRQGLREFTNEVKLLLKIQHK 142
           L  LG GG+G V++     G +     A+K L     V +++       E  +L  ++H 
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY---RIVMGVARGLL 199
            +V L      G +  L+ EYL    L  F+  + +   ++ T  +    I +     L 
Sbjct: 61  FIVDLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISLA----LE 114

Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR--LFPGEDTHVNTFRISGTHGYM 257
           +LH++    II+RD+K  NILLD Q + K++DFGL +  +  G  TH  TF   GT  YM
Sbjct: 115 HLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH--TF--CGTIEYM 167

Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSG 286
           APE  +        D +S G L+ ++++G
Sbjct: 168 APEILMRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 37/97 (38%), Positives = 54/97 (55%), Gaps = 4/97 (4%)

Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG--EDTHVNTFRISGTHG 255
           LL +H      +IHRDIK++NILL      K+ DFG ++++     D    TF   GT  
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF--CGTPY 210

Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
           Y+APE       S K D+FS GVL+ E+++ ++  DG
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG 247

Length = 496

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 60.7 bits (147), Expect = 4e-10
 Identities = 36/92 (39%), Positives = 50/92 (54%), Gaps = 3/92 (3%)

Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           VA+G+ +L   A    IHRD+ A NILL      KI DFGLAR    +  +V        
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279

Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
             +MAPE   +   + ++DV+SYG+L+ EI S
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 60.9 bits (148), Expect = 7e-10
 Identities = 64/234 (27%), Positives = 101/234 (43%), Gaps = 40/234 (17%)

Query: 94  LGHGGFGPVYRGLMPN-GQEIAVKKLSVD-SRQGL--REFTNEVKLLLKIQHKNLVTLFG 149
           +G GG G VY    P   + +A+KK+  D S   L  + F  E K+   + H  +V ++ 
Sbjct: 10  IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69

Query: 150 CCAEGPEKMLVYEYLPN------KSLDYFIFDK-TKSSSLDWTTR----YRIVMGVARGL 198
            C++G     VY  +P       KSL   ++ K + S  L   T       I   +   +
Sbjct: 70  ICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATI 126

Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE-----DTHVNTF----- 248
            Y+H +    ++HRD+K  NILL       I D+G A     E     D  V+       
Sbjct: 127 EYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYS 183

Query: 249 ------RISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGR---KNHDGR 293
                 +I GT  YMAPE  L    S  TD+++ GV++ ++++     +   GR
Sbjct: 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR 237

Length = 932

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 59.1 bits (144), Expect = 1e-09
 Identities = 63/221 (28%), Positives = 107/221 (48%), Gaps = 46/221 (20%)

Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVKKL------SVDSRQGLRE--FTNEVKLLLKIQH 141
           L +LG G +G V++ +     + +A+KK+      + D+++  RE  F  E+       H
Sbjct: 12  LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG-----DH 66

Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD--KT------KSSSL-DWTTRYRIVM 192
            N+V L            V +   +K + Y +F+  +T      +++ L D   RY I+ 
Sbjct: 67  PNIVKLLN----------VIKAENDKDI-YLVFEYMETDLHAVIRANILEDVHKRY-IMY 114

Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF-PGEDTHVN---TF 248
            + + L Y+H      +IHRD+K SNILL+     K++DFGLAR     E+   N   T 
Sbjct: 115 QLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTD 171

Query: 249 RISGTHGYMAPEYAL--HGYLSVKTDVFSYGVLVLEIVSGR 287
            ++ T  Y APE  L    Y +   D++S G ++ E++ G+
Sbjct: 172 YVA-TRWYRAPEILLGSTRY-TKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 68/238 (28%), Positives = 100/238 (42%), Gaps = 59/238 (24%)

Query: 80  TLQVATNFFS------DLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN- 131
           ++QVA + F+       L  +G G  G V        G  +AVKKLS       R F N 
Sbjct: 9   SVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLS-------RPFQNQ 61

Query: 132 --------EVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLD-----YFIFDKTK 178
                   E+ LL  + HKN+++L               + P KSL+     Y + +   
Sbjct: 62  THAKRAYRELVLLKCVNHKNIISLLNV------------FTPQKSLEEFQDVYLVMELMD 109

Query: 179 SS-------SLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISD 231
           ++        LD      ++  +  G+ +LH    A IIHRD+K SNI++      KI D
Sbjct: 110 ANLCQVIHMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILD 166

Query: 232 FGLARLFPGEDTHVNTFRISG---THGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
           FGLAR      T    F ++    T  Y APE  L        D++S G ++ E+V G
Sbjct: 167 FGLAR------TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 34/101 (33%), Positives = 59/101 (58%), Gaps = 9/101 (8%)

Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR--LFPGEDTHVNTFRIS 251
           +A GL +LH +    II+RD+K  N++LD + + KI+DFG+ +  ++ G    V T    
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG----VTTKTFC 162

Query: 252 GTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
           GT  Y+APE   +       D +++GVL+ E+++G+   +G
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 203

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 46/153 (30%), Positives = 69/153 (45%), Gaps = 12/153 (7%)

Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
           H  LV L  C         V EY+    L   +F   +   L           ++  L Y
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 111

Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR--LFPGEDTHVNTFRISGTHGYMA 258
           LHE     II+RD+K  N+LLD + + K++D+G+ +  L PG+ T        GT  Y+A
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS----TFCGTPNYIA 164

Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHD 291
           PE           D ++ GVL+ E+++GR   D
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 53/213 (24%), Positives = 98/213 (46%), Gaps = 33/213 (15%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNG--------QEIAVKKLSVDSRQGLREFTNEVKLLLKI 139
           +  + ++G G FG     L+ +         +EI + K+S   R+  R+   EV +L  +
Sbjct: 2   YVKVKKIGEGSFGKAI--LVKSKEDGKQYVIKEINISKMSPKEREESRK---EVAVLSNM 56

Query: 140 QHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSS------LDWTTRYRIVMG 193
           +H N+V       E     +V +Y     L Y   +  +         LDW  +      
Sbjct: 57  KHPNIVQYQESFEENGNLYIVMDYCEGGDL-YKKINAQRGVLFPEDQILDWFVQ------ 109

Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS-G 252
           +   L ++H+    +I+HRDIK+ NI L +    K+ DFG+AR+    ++ V   R   G
Sbjct: 110 ICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL---NSTVELARTCIG 163

Query: 253 THGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           T  Y++PE   +   + K+D+++ G ++ E+ +
Sbjct: 164 TPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 32/87 (36%), Positives = 48/87 (55%), Gaps = 8/87 (9%)

Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           YLH +    II+RD+K  N+LLD + + K++DFG A+  P       TF + GT  Y+AP
Sbjct: 133 YLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFTLCGTPEYLAP 184

Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVSG 286
           E           D ++ GVL+ E ++G
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 47/150 (31%), Positives = 70/150 (46%), Gaps = 12/150 (8%)

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           LV L  C        LV EY+    L   +F   +   L           +   L +LHE
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHE 114

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLAR--LFPGEDTHVNTFRISGTHGYMAPEY 261
                II+RD+K  N+LLD   + K++D+G+ +  L PG+ T  +TF   GT  Y+APE 
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT--STF--CGTPNYIAPEI 167

Query: 262 ALHGYLSVKTDVFSYGVLVLEIVSGRKNHD 291
                     D ++ GVL+ E+++GR   D
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 18/205 (8%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQ--EIAVK---KLSVDSRQGLREFTNEVKLLLKIQHK 142
           F+ +  LG G FG V      N     +A+K   K  +  ++ +    +E K+L  I H 
Sbjct: 32  FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHP 91

Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIF-DKTKSSSLDWTTRYRIVMGVARGLLYL 201
             V L+G   +     LV E++     ++F F  + K    D    Y      A+ +L  
Sbjct: 92  FCVNLYGSFKDESYLYLVLEFVIGG--EFFTFLRRNKRFPNDVGCFY-----AAQIVLIF 144

Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEY 261
                  I++RD+K  N+LLD+    K++DFG A++         T+ + GT  Y+APE 
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYIAPEI 199

Query: 262 ALHGYLSVKTDVFSYGVLVLEIVSG 286
            L+       D ++ G+ + EI+ G
Sbjct: 200 LLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 56.6 bits (137), Expect = 6e-09
 Identities = 61/227 (26%), Positives = 100/227 (44%), Gaps = 42/227 (18%)

Query: 91  LNQLGHGGFGPV----YRGLMPNGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQ 140
           + +LG G +G V            + +A+KK++      + +++ LRE    +KLL   +
Sbjct: 5   IKELGQGAYGIVCSARNAETSE-EETVAIKKITNVFSKKILAKRALRE----LKLLRHFR 59

Query: 141 -HKNLVTLFGCCAEGPEK---MLVYEYLPNKSLDYFIFDKTKSSSLDWTT-RYRIVMGVA 195
            HKN+  L+      P     + +YE L    L   I      +   + +  Y+I+    
Sbjct: 60  GHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQIL---- 115

Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISG--- 252
            GL Y+H    A ++HRD+K  N+L++     KI DFGLAR F       N    +G   
Sbjct: 116 CGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGF-----SENPGENAGFMT 167

Query: 253 ----THGYMAPEYAL--HGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
               T  Y APE  L    Y +   DV+S G ++ E++  +    G+
Sbjct: 168 EYVATRWYRAPEIMLSFQSY-TKAIDVWSVGCILAELLGRKPVFKGK 213

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 57.0 bits (137), Expect = 7e-09
 Identities = 35/92 (38%), Positives = 50/92 (54%), Gaps = 3/92 (3%)

Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           VARG+ +L   A    +HRD+ A N+LL +    KI DFGLAR    +  +V+       
Sbjct: 246 VARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302

Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
             +MAPE       +  +DV+SYG+L+ EI S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 56.3 bits (136), Expect = 9e-09
 Identities = 57/203 (28%), Positives = 89/203 (43%), Gaps = 15/203 (7%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLS---VDSRQGLREFTNEVKLLLKIQHKN 143
           F  L Q+G GG+G V+     +  EI A+K++    +     +R    E  +L   + + 
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEW 62

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           LV L     +     L  EY+P       + +     S D    Y   M  A  +  LHE
Sbjct: 63  LVKLLYAFQDDEYLYLAMEYVPGGDFRTLL-NNLGVLSEDHARFYMAEMFEA--VDALHE 119

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
                 IHRD+K  N L+D   + K++DFGL++   G  T+ N+  + G+  YMAPE   
Sbjct: 120 LG---YIHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANS--VVGSPDYMAPEVLR 171

Query: 264 HGYLSVKTDVFSYGVLVLEIVSG 286
                   D +S G ++ E + G
Sbjct: 172 GKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 56.2 bits (135), Expect = 9e-09
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 10/205 (4%)

Query: 86  NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQG--LREFT-NEVKLLLKIQHK 142
           N F  L  +G G +G V +      +EI   K   DS +   ++E T  E+K+L  ++ +
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
           N+V L        +  LV+EY+    L+  + ++  +       R  I   + + + + H
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQ-LIKAIHWCH 117

Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
           +     I+HRDIK  N+L+      K+ DFG AR    E ++ N      T  Y +PE  
Sbjct: 118 KN---DIVHRDIKPENLLISHNDVLKLCDFGFARNL-SEGSNANYTEYVATRWYRSPELL 173

Query: 263 LHGYLSVKTDVFSYGVLVLEIVSGR 287
           L        D++S G ++ E+  G+
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 55.7 bits (135), Expect = 9e-09
 Identities = 54/210 (25%), Positives = 87/210 (41%), Gaps = 34/210 (16%)

Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN--EVKLLLKIQ-HKNLVT 146
           L ++G G F  V +      G+  A+K +     + L +  N  E++ L ++  H N++ 
Sbjct: 4   LGKIGEGTFSEVLKAQSRKTGKYYAIKCMK-KHFKSLEQVNNLREIQALRRLSPHPNILR 62

Query: 147 LFGCCAEGPEK----------MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR 196
           L     +              M +YE +  +        + KS        Y+++    +
Sbjct: 63  LIEVLFDRKTGRLALVFELMDMNLYELIKGRK-RPLPEKRVKS------YMYQLL----K 111

Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGY 256
            L ++H      I HRDIK  NIL+      K++DFG  R          T  IS T  Y
Sbjct: 112 SLDHMHRNG---IFHRDIKPENILIK-DDILKLADFGSCRGI--YSKPPYTEYIS-TRWY 164

Query: 257 MAPEYAL-HGYLSVKTDVFSYGVLVLEIVS 285
            APE  L  GY   K D+++ G +  EI+S
Sbjct: 165 RAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 35/96 (36%), Positives = 56/96 (58%), Gaps = 9/96 (9%)

Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR--LFPGEDTHVNTFRISGTHG 255
           L +LHE     II+RD+K  N+LLD + + K++D+G+ +  + PG+ T  +TF   GT  
Sbjct: 109 LNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT--STF--CGTPN 161

Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHD 291
           Y+APE           D ++ GVL+ E+++GR   D
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 36/91 (39%), Positives = 51/91 (56%), Gaps = 8/91 (8%)

Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L +LH+     I++RD+K  NILLD   +  + DFGL++    ++   NTF   GT  Y+
Sbjct: 109 LEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTF--CGTTEYL 163

Query: 258 APEYALH--GYLSVKTDVFSYGVLVLEIVSG 286
           APE  L   GY +   D +S GVLV E+  G
Sbjct: 164 APEVLLDEKGY-TKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 25/213 (11%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEI-------AVKKLSVDSRQGLREFTNEVKLLLKI- 139
           F  L  LG G +G V+      G +         ++K ++  +    E T   + +L+  
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61

Query: 140 -QHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARG 197
            Q   LVTL        +  L+ +Y+    +   ++ +   S        R   G +   
Sbjct: 62  RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE----DEVRFYSGEIILA 117

Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L +LH+     I++RDIK  NILLD + +  ++DFGL++ F  E+    T+   GT  YM
Sbjct: 118 LEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGTIEYM 173

Query: 258 APEY----ALHGYLSVKTDVFSYGVLVLEIVSG 286
           APE       HG      D +S G+L+ E+++G
Sbjct: 174 APEIIRGKGGHGKA---VDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 55.5 bits (133), Expect = 2e-08
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 37/223 (16%)

Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
           + +L  +G G  G V   Y  ++   + +A+KKLS    ++   +    E+ L+  + HK
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76

Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLD-----YFIFDKTKSS-------SLDWTTRYRI 190
           N+++L               + P KSL+     Y + +   ++        LD      +
Sbjct: 77  NIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 124

Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
           +  +  G+ +LH    A IIHRD+K SNI++      KI DFGLAR   G    +  + +
Sbjct: 125 LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVV 180

Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
             T  Y APE  L        D++S G ++ E+V  +    GR
Sbjct: 181 --TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 42/203 (20%), Positives = 77/203 (37%), Gaps = 16/203 (7%)

Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCC 151
                   + +   P    +AVKK+++D  S++ L+    E+    ++QH N++      
Sbjct: 10  FEDLMIVHLAKH-KPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68

Query: 152 AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIH 211
               E  +V   +   S +  +        L       I+  V   L Y+H +     IH
Sbjct: 69  IVDSELYVVSPLMAYGSCEDLL-KTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIH 124

Query: 212 RDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAPEY---AL 263
           R +KAS+ILL       +S    +                         +++PE     L
Sbjct: 125 RSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNL 184

Query: 264 HGYLSVKTDVFSYGVLVLEIVSG 286
            GY + K+D++S G+   E+ +G
Sbjct: 185 QGY-NEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 52/181 (28%), Positives = 78/181 (43%), Gaps = 16/181 (8%)

Query: 123 RQGLREFT-NEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIF--DKTKS 179
           + G R  T  E  +L  I H +++ L G         L+   LP    D + +   K   
Sbjct: 123 KAGQRGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNI 179

Query: 180 SSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239
           +  D     R V+   R + YLHE    RIIHRDIKA NI ++   +  + DFG A  FP
Sbjct: 180 AICDILAIERSVL---RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFP 232

Query: 240 GEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKA 299
            +      +  +GT    APE           D++S G+++ E+ +    HD    K+  
Sbjct: 233 VDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC---HDSLFEKDGL 289

Query: 300 D 300
           D
Sbjct: 290 D 290

Length = 391

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 3/92 (3%)

Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           VA G+ +L   A    +HRD+ A N+L+ E    KI DFGLAR    +  +++       
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
             +MAPE   +   +  +DV+S+G+L+ EI +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 54.7 bits (131), Expect = 4e-08
 Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 43/226 (19%)

Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
           + +L  +G G  G V   Y  ++   + +A+KKLS    ++   +    E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83

Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYF--------IFD----KTKSSSLDWTTRYRI 190
           N++ L               + P KSL+ F        + D    +     LD      +
Sbjct: 84  NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131

Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
           +  +  G+ +LH    A IIHRD+K SNI++      KI DFGLAR      T   +F +
Sbjct: 132 LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFMM 182

Query: 251 SG---THGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           +    T  Y APE  L        D++S G ++ E++ G     G 
Sbjct: 183 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 228

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 54.3 bits (130), Expect = 5e-08
 Identities = 62/290 (21%), Positives = 117/290 (40%), Gaps = 50/290 (17%)

Query: 13  ILDDQNHQHHHNHNHNL-----SVDEMNLKHFISNLFPCLKTSLRGGRAAGESAEDADGS 67
           I +++NH+ +   +         +DE    H           +  G     E   D D +
Sbjct: 12  IYEEKNHKANKGGSGKFEMNDKKLDEEERSH----------NNNAGEDEDEEKMIDNDIN 61

Query: 68  GADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGL 126
            + +       ++ ++        N +G+G FG VY  + +   +++A+KK+  D +   
Sbjct: 62  RSPN-------KSYKLG-------NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN 107

Query: 127 REFTNEVKLLLKIQHKNLVTL----FGCCAEGPEKML----VYEYLPNKSLDYFIFDKTK 178
           RE      ++  + H N++ L    +  C +  EK +    V E++P     Y       
Sbjct: 108 RELL----IMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARN 163

Query: 179 SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP-KISDFGLARL 237
           + +L           + R L Y+H +    I HRD+K  N+L+D   +  K+ DFG A+ 
Sbjct: 164 NHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKN 220

Query: 238 FPGEDTHVNTFRISGTHGYMAPEYALHGY-LSVKTDVFSYGVLVLEIVSG 286
                  V+      +  Y APE  L     +   D++S G ++ E++ G
Sbjct: 221 LLAGQRSVSYI---CSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 54.0 bits (130), Expect = 6e-08
 Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 22/162 (13%)

Query: 92  NQLGHGGFGPVYRGLMPN-GQEIAVKKLSV--------DSRQGLRE----FT--NEVKLL 136
             LG G +G V +      G+ +A+KK+ +          RQ +      FT   E+K++
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 137 LKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR 196
            +I+H+N++ L     EG    LV + +    L   +  K +   L  +    I++ +  
Sbjct: 75  NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIR---LTESQVKCILLQILN 130

Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238
           GL  LH+      +HRD+  +NI ++ +   KI+DFGLAR +
Sbjct: 131 GLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRY 169

Length = 335

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 53.5 bits (128), Expect = 7e-08
 Identities = 60/222 (27%), Positives = 92/222 (41%), Gaps = 19/222 (8%)

Query: 78  LRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLL 137
           L +L   T+ +  +  +G G +G VY+        +A  K+         E   E  +L 
Sbjct: 14  LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQ 73

Query: 138 KI-QHKNLVTLFGCCAE-----GPEKMLVYEYLPNKSLDYFIFDKTK-SSSLDWTTRYRI 190
            +  H N+V  +G   +     G +  LV E     S+   +         LD      I
Sbjct: 74  SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYI 133

Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
           + G   GL +LH     RIIHRD+K +NILL  +   K+ DFG++          NT   
Sbjct: 134 LYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT--S 188

Query: 251 SGTHGYMAPEYAL------HGYLSVKTDVFSYGVLVLEIVSG 286
            GT  +MAPE         + Y   + DV+S G+  +E+  G
Sbjct: 189 VGTPFWMAPEVIACEQQYDYSY-DARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 53.2 bits (127), Expect = 1e-07
 Identities = 55/198 (27%), Positives = 89/198 (44%), Gaps = 12/198 (6%)

Query: 94  LGHGGFGPVYR-GLMPNGQEIAVKKLS---VDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
           LG G FG V       +G+  A+K L    + ++  +     E ++L   +H  L +L  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
                     V EY+    L +F   + +  S D T  Y     +   L YLH     +I
Sbjct: 63  SFQTKDRLCFVMEYVNGGEL-FFHLSRERVFSEDRTRFYG--AEIVSALDYLHS---GKI 116

Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           ++RD+K  N++LD+  + KI+DFGL +    +   + TF   GT  Y+APE         
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF--CGTPEYLAPEVLEDNDYGR 174

Query: 270 KTDVFSYGVLVLEIVSGR 287
             D +  GV++ E++ GR
Sbjct: 175 AVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 51/189 (26%), Positives = 94/189 (49%), Gaps = 26/189 (13%)

Query: 108 PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE---YL 164
           P  + +  K++   SR  + +  NE+  L ++ H+N++ +        E++L  E   Y+
Sbjct: 190 PKCERLIAKRVKAGSRAAI-QLENEILALGRLNHENILKI--------EEILRSEANTYM 240

Query: 165 PNKSLDY----FIFDKT---KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKAS 217
             +  D+    F++D+    K   L   TR  I+  +   + Y+H++   ++IHRDIK  
Sbjct: 241 ITQKYDFDLYSFMYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLE 296

Query: 218 NILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE-YALHGYLSVKTDVFSY 276
           NI L+      + DFG A  F  E    + +   GT    +PE  A  GY  + TD++S 
Sbjct: 297 NIFLNCDGKIVLGDFGTAMPFEKEREAFD-YGWVGTVATNSPEILAGDGYCEI-TDIWSC 354

Query: 277 GVLVLEIVS 285
           G+++L+++S
Sbjct: 355 GLILLDMLS 363

Length = 501

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 35/103 (33%), Positives = 57/103 (55%), Gaps = 10/103 (9%)

Query: 210 IHRDIKASNILLDEQLNPKISDFG-LARLFPGEDTHVNTFRISGTHGYMAPEY--ALHGY 266
           +HRDIK  N+L+D   + K++DFG  ARL    +  VN+    GT  Y+APE    ++G 
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARL--TANKMVNSKLPVGTPDYIAPEVLTTMNGD 181

Query: 267 ----LSVKTDVFSYGVLVLEIVSGRKN-HDGRLGKEKADLLSY 304
                 V+ D +S GV+  E++ GR   H+G   K   +++++
Sbjct: 182 GKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF 224

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 61/225 (27%), Positives = 94/225 (41%), Gaps = 30/225 (13%)

Query: 77  DLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKL----SVDSRQGLREFTNE 132
            +R LQ+    +  +  +G G FG V      + Q++   KL     +  R     F  E
Sbjct: 34  KIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEE 93

Query: 133 VKLLLKIQHKNLVTLFGCCAEGPEKML--VYEYLPNKSL-----DYFIFDKTKSSSLDWT 185
             ++       +V LF  CA   +K L  V EY+P   L     +Y + +K       W 
Sbjct: 94  RDIMAFANSPWVVQLF--CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK-------WA 144

Query: 186 TRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV 245
             Y      A  +L L       +IHRD+K  N+LLD+  + K++DFG   +   E   V
Sbjct: 145 KFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGMV 198

Query: 246 NTFRISGTHGYMAPEY----ALHGYLSVKTDVFSYGVLVLEIVSG 286
                 GT  Y++PE        GY   + D +S GV + E++ G
Sbjct: 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 57/207 (27%), Positives = 89/207 (42%), Gaps = 31/207 (14%)

Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVK--------LLLKIQHKNLV 145
           +G G FG V   L  +  +     + V  ++ + +   E K        LL  ++H  LV
Sbjct: 3   IGKGSFGKVL--LAKHKADGKFYAVKVLQKKAILK-KKEQKHIMAERNVLLKNVKHPFLV 59

Query: 146 TL---FGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARGLLY 200
            L   F    +  +K+  V +Y+    L +F   + +S       R R     +A  L Y
Sbjct: 60  GLHYSF----QTADKLYFVLDYVNGGEL-FFHLQRERSFP---EPRARFYAAEIASALGY 111

Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL-FPGEDTHVNTFRISGTHGYMAP 259
           LH      II+RD+K  NILLD Q +  ++DFGL +       T  +TF   GT  Y+AP
Sbjct: 112 LHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT-TSTF--CGTPEYLAP 165

Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVSG 286
           E           D +  G ++ E++ G
Sbjct: 166 EVLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 59/225 (26%), Positives = 93/225 (41%), Gaps = 30/225 (13%)

Query: 77  DLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLSVDS---RQGLREFTNE 132
            +  L++    F  +  +G G FG V      + +++ A+K LS      R     F  E
Sbjct: 34  KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE 93

Query: 133 VKLLLKIQHKNLVTLFGCCAEGPEKML--VYEYLPNKSL-----DYFIFDKTKSSSLDWT 185
             ++     + +V L    A   +K L  V EY+P   L     +Y I +K       W 
Sbjct: 94  RDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEK-------WA 144

Query: 186 TRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV 245
             Y     V   L  +H       IHRD+K  N+LLD+  + K++DFG   +    +  V
Sbjct: 145 RFY--TAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC-MKMDANGMV 198

Query: 246 NTFRISGTHGYMAPEYAL----HGYLSVKTDVFSYGVLVLEIVSG 286
                 GT  Y++PE        GY   + D +S GV + E++ G
Sbjct: 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 51.1 bits (122), Expect = 3e-07
 Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 32/212 (15%)

Query: 93  QLGHGGFGPVYRG-LMP----------NGQEIAV--KKLSVDSRQGLREFTNEVKLLLKI 139
            LG G    +Y G L              +EI V  K L    R     F     ++ ++
Sbjct: 2   HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV 61

Query: 140 QHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL 199
            HK++V L+G C    E ++V E++    LD F+  K+   +  W  ++++   +A  L 
Sbjct: 62  SHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALS 119

Query: 200 YLHEEAPARIIHRDIKASNILL-----DEQLNP--KISDFGLARLFPGEDTHVNTFRISG 252
           YL ++    ++H ++   NILL     D +  P  K+SD G+          V   RI  
Sbjct: 120 YLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE--RIP- 173

Query: 253 THGYMAPEYALHGY-LSVKTDVFSYGVLVLEI 283
              ++APE       LS+  D +S+G  + EI
Sbjct: 174 ---WIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 20/211 (9%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEIA-------VKKLSVDSRQGLREFT-NEVKLLLKI 139
           F  L  LG G +G V+     +G +         +KK ++  +    E T  E ++L  I
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 140 -QHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARG 197
            Q   LVTL        +  L+ +Y+    L   +  + +    +      I  G +   
Sbjct: 62  RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQ----IYSGEIVLA 117

Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L +LH+     II+RDIK  NILLD   +  ++DFGL++ F  ED     +   GT  YM
Sbjct: 118 LEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFH-EDEVERAYSFCGTIEYM 173

Query: 258 APEYALHGYL--SVKTDVFSYGVLVLEIVSG 286
           AP+    G        D +S GVL+ E+++G
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 51.1 bits (123), Expect = 5e-07
 Identities = 53/238 (22%), Positives = 88/238 (36%), Gaps = 53/238 (22%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLSVDS--RQGLREFTNEVKLLLKIQHKN- 143
           F  +  +G G FG V+     +  ++ A+K L      ++         + +L     + 
Sbjct: 3   FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDIL-ADADSP 61

Query: 144 -LVTLFGCCAEGPEKML--VYEYLPNKSL-----DYFIFDKTKSSSLDWTTRYRIVMGVA 195
            +V L+   +   E+ L  V EY+P   L        +F +      +    Y     +A
Sbjct: 62  WIVKLY--YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE------ETARFY-----IA 108

Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA-------------------- 235
             +L L        IHRDIK  NIL+D   + K++DFGL                     
Sbjct: 109 ELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168

Query: 236 -------RLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
                  R    +   V      GT  Y+APE        ++ D +S GV++ E++ G
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 51.0 bits (122), Expect = 6e-07
 Identities = 45/157 (28%), Positives = 69/157 (43%), Gaps = 14/157 (8%)

Query: 130 TNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYR 189
            +E +LL ++ H  ++ L      G    LV   LP    D + +   +   L       
Sbjct: 208 VHEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQ--- 261

Query: 190 IVMGVARGLL----YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV 245
            V  VAR LL    Y+H E    IIHRDIK  N+L++   +  + DFG A    G  +  
Sbjct: 262 -VTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317

Query: 246 NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLE 282
             + I+GT    APE       +   D++S G+++ E
Sbjct: 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 50.9 bits (122), Expect = 6e-07
 Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 36/214 (16%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQHKNLVT 146
           +G G +G V   +    G+++A+KK++       D+ + LRE    +KLL  ++H ++V 
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILRE----IKLLRLLRHPDIVE 63

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSL--------DWTTRYR--IVMGVAR 196
           +         K ++      +  D ++  +   S L        D T  +    +  + R
Sbjct: 64  I---------KHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLR 114

Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL-FPGEDTHVNTFRISGTHG 255
            L Y+H    A + HRD+K  NIL +     KI DFGLAR+ F    T +       T  
Sbjct: 115 ALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171

Query: 256 YMAPEY--ALHGYLSVKTDVFSYGVLVLEIVSGR 287
           Y APE   +     +   D++S G +  E+++G+
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 31/94 (32%), Positives = 50/94 (53%), Gaps = 4/94 (4%)

Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           +   L YLH E    +++RD+K  N++LD+  + KI+DFGL +    +   + TF   GT
Sbjct: 104 IVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF--CGT 159

Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
             Y+APE           D +  GV++ E++ GR
Sbjct: 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 50.3 bits (120), Expect = 9e-07
 Identities = 54/196 (27%), Positives = 93/196 (47%), Gaps = 27/196 (13%)

Query: 108 PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLP 165
           P G  + V+   ++  + + L+   NEV L    +H N++T +     G    ++  ++ 
Sbjct: 23  PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82

Query: 166 NKSLDYFI---FDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD 222
             S +  +   F +  S +L       I+ G  RGL YLH+      IHR+IKAS+IL+ 
Sbjct: 83  YGSANSLLKTYFPEGMSEALIGN----ILFGALRGLNYLHQNG---YIHRNIKASHILIS 135

Query: 223 EQLNPKISDFGLARLFP----GEDTHV----NTFRISGTHGYMAPEYA---LHGYLSVKT 271
                 +S  GL+ L+     G+   V      F  S    +++PE     L+GY +VK+
Sbjct: 136 GDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTS-VLPWLSPELLRQDLYGY-NVKS 191

Query: 272 DVFSYGVLVLEIVSGR 287
           D++S G+   E+ +GR
Sbjct: 192 DIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 5/94 (5%)

Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           +   L YLH      +++RDIK  N++LD+  + KI+DFGL +    +   + TF   GT
Sbjct: 104 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF--CGT 158

Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
             Y+APE           D +  GV++ E++ GR
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 60/208 (28%), Positives = 89/208 (42%), Gaps = 23/208 (11%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSV--DSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           +G G +G V++ L   NG + AVK L    D  + +    N +K L    H N+V  +G 
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKAL--SDHPNVVKFYGM 83

Query: 151 -----CAEGPEKMLVYEYLPNKSLDYFI--FDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
                   G +  LV E     S+   +  F K      +    Y I+     GL +LH 
Sbjct: 84  YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY-ILHEALMGLQHLHV 142

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEY-- 261
               + IHRD+K +NILL  +   K+ DFG++          NT    GT  +MAPE   
Sbjct: 143 N---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT--SVGTPFWMAPEVIA 197

Query: 262 ---ALHGYLSVKTDVFSYGVLVLEIVSG 286
               L      + DV+S G+  +E+  G
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 66/260 (25%), Positives = 105/260 (40%), Gaps = 45/260 (17%)

Query: 109 NGQEIAV--KKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN 166
           NG+E+ V  K L    R     F     L+ ++ H +L  + G C  G E ++V E++ +
Sbjct: 41  NGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEH 100

Query: 167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNIL-----L 221
             LD  +  +     + W  +  +   +A  L YL ++    ++H ++ A NIL     L
Sbjct: 101 GPLDVCLRKEKGRVPVAW--KITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155

Query: 222 DEQLNP--KISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGV 278
            E  +P  K+SD G++      +  V   RI     ++APE    G  LS   D +S+G 
Sbjct: 156 AEGTSPFIKLSDPGVSFTALSREERVE--RIP----WIAPECVPGGNSLSTAADKWSFGT 209

Query: 279 LVLEIV-SGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLG 337
            +LEI   G      R   EK             EK   L +PS           C +L 
Sbjct: 210 TLLEICFDGEVPLKERTPSEKERFY---------EKKHRLPEPS-----------CKELA 249

Query: 338 LL---CCQQSVAERPDMNSV 354
            L   C      +RP   ++
Sbjct: 250 TLISQCLTYEPTQRPSFRTI 269

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 10/99 (10%)

Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L YLH      +++RD+K  N++LD+  + KI+DFGL +    +   + TF   GT  Y+
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF--CGTPEYL 162

Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGR-----KNHD 291
           APE           D +  GV++ E++ GR     ++H+
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 201

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 59/207 (28%), Positives = 87/207 (42%), Gaps = 31/207 (14%)

Query: 94  LGHGGFGPVY---RGLMPNGQEIAVKKLS---VDSRQGLREFTNEVKLLLK-IQHKNLVT 146
           +G G FG V    R L  +G+  AVK L    V +R+  +    E  +LLK ++H  LV 
Sbjct: 3   IGKGSFGKVLLAKRKL--DGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           L             Y +   + L YF+ D      L +  +        R   Y  E A 
Sbjct: 61  LH------------YSFQTTEKL-YFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIAS 107

Query: 207 A-------RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           A        I++RD+K  NILLD Q +  ++DFGL +    +     TF   GT  Y+AP
Sbjct: 108 ALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTF--CGTPEYLAP 165

Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVSG 286
           E           D +  G ++ E++ G
Sbjct: 166 EVIRKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 57/199 (28%), Positives = 94/199 (47%), Gaps = 15/199 (7%)

Query: 94  LGHGGFGPVYRGLMPNGQEI-AVK---KLSVDSRQGLREFTNEVKLLLK-IQHKNLVTLF 148
           +G G FG V        ++  AVK   K ++  ++  +   +E  +LLK ++H  LV L 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
                  +   V +Y+    L Y +  + +   L+   R+     +A  L YLH      
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARF-YAAEIASALGYLHS---LN 116

Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLS 268
           I++RD+K  NILLD Q +  ++DFGL +     +   +TF   GT  Y+APE  LH    
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTF--CGTPEYLAPE-VLHKQPY 173

Query: 269 VKT-DVFSYGVLVLEIVSG 286
            +T D +  G ++ E++ G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 47.8 bits (114), Expect = 4e-06
 Identities = 44/197 (22%), Positives = 88/197 (44%), Gaps = 24/197 (12%)

Query: 102 VYRGLMPNGQEIAV---KKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG----CCAEG 154
           +Y+G+  N +E+ +   KK     +  +    NE+K L +I   N++ ++G       + 
Sbjct: 36  IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 155 PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL--LYLHEEAPARIIHR 212
           P   L+ EY     L   + DK K   L + T+  + +   +GL  LY +   P    ++
Sbjct: 95  PRLSLILEYCTRGYLREVL-DKEK--DLSFKTKLDMAIDCCKGLYNLYKYTNKP----YK 147

Query: 213 DIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGY--LSVK 270
           ++ + + L+ E    KI   GL ++          F+      Y + +     +   ++K
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKILS-----SPPFKNVNFMVYFSYKMLNDIFSEYTIK 202

Query: 271 TDVFSYGVLVLEIVSGR 287
            D++S GV++ EI +G+
Sbjct: 203 DDIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 47.3 bits (112), Expect = 7e-06
 Identities = 28/67 (41%), Positives = 38/67 (56%), Gaps = 5/67 (7%)

Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           VA  + YLH      II+RD+K  NILLD Q +  ++DFGL +     +   +TF   GT
Sbjct: 105 VASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTF--CGT 159

Query: 254 HGYMAPE 260
             Y+APE
Sbjct: 160 PEYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 38/153 (24%), Positives = 64/153 (41%), Gaps = 20/153 (13%)

Query: 93  QLGHGGFGPVYRGLM---PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLF 148
           ++G+G FG V    +        + VK+L  + S +   EF  +      +QH N++   
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTR-------YRIVMGVARGLLYL 201
           G C E    +LV+EY     L      K+  S   W  R        R+   +A G+ ++
Sbjct: 62  GQCVEAIPYLLVFEYCELGDL------KSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHM 115

Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGL 234
           H+      +H D+   N  L   L  K+ D+G+
Sbjct: 116 HKH---NFLHSDLALRNCFLTSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 45.4 bits (108), Expect = 3e-05
 Identities = 35/116 (30%), Positives = 49/116 (42%), Gaps = 42/116 (36%)

Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF-RIS----------------- 251
           IHRDIK  N+LLD + + K+SDFGL      + +H   F RI                  
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGL--KKSHRTEFYRILSHALPSNFLDFISKPMS 180

Query: 252 --------------------GTHGYMAPEYAL-HGYLSVKTDVFSYGVLVLEIVSG 286
                               GT  Y+APE  L  GY + + D +S GV++ E++ G
Sbjct: 181 SKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 50/213 (23%), Positives = 95/213 (44%), Gaps = 29/213 (13%)

Query: 93  QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLVTLFGCC 151
           ++G G +G VY+    +G++     L      G+      E+ LL +++H N+++L    
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 152 AEGPEKM--LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY-----LHEE 204
               ++   L+++Y  +       F +   ++       ++  G+ + LLY     +H  
Sbjct: 68  LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYL 124

Query: 205 APARIIHRDIKASNILL----DEQLNPKISDFGLARLFPGE-------DTHVNTFRISGT 253
               ++HRD+K +NIL+     E+   KI+D G ARLF          D  V TF     
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF----- 179

Query: 254 HGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVS 285
             Y APE  L   + +   D+++ G +  E+++
Sbjct: 180 -WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 45.1 bits (106), Expect = 4e-05
 Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 37/217 (17%)

Query: 93  QLGHGGFGPVYRGLMPNGQ---EIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTL 147
           ++G G +G VY+    +G+   E A+K++     S    RE    + LL +++H N++ L
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACRE----IALLRELKHPNVIAL 63

Query: 148 FGCCAEGPEKM--LVYEYLPNKSLDYFIFDKT-----KSSSLDWTTRYRIVMGVARGLLY 200
                   ++   L+++Y  +       F +      K   L  +    ++  +  G+ Y
Sbjct: 64  QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123

Query: 201 LHEEAPARIIHRDIKASNILL----DEQLNPKISDFGLARLFPGE-------DTHVNTFR 249
           LH      ++HRD+K +NIL+     E+   KI+D G ARLF          D  V TF 
Sbjct: 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF- 179

Query: 250 ISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVS 285
                 Y APE  L   + +   D+++ G +  E+++
Sbjct: 180 -----WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 56/236 (23%), Positives = 89/236 (37%), Gaps = 43/236 (18%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPN-GQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQHKN 143
           F  L  +G G FG V      + G   A+K   K  +  ++ +     E  +L++     
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           +V +F    +     L+ E+LP   +   +  K      D  T       +A  +L +  
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK------DTLTEEETQFYIAETVLAIDS 116

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLA----------------RLFPGEDTHVN- 246
                 IHRDIK  N+LLD + + K+SDFGL                    P + T  N 
Sbjct: 117 IHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176

Query: 247 ----------------TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
                            F   GT  Y+APE  +    +   D +S GV++ E++ G
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 43.2 bits (102), Expect = 5e-05
 Identities = 33/153 (21%), Positives = 55/153 (35%), Gaps = 15/153 (9%)

Query: 89  SDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT-- 146
           S +  L  G    VY  L    ++  +K      +   RE   EV +L  +  K L    
Sbjct: 1   SSIKLLKGGLTNRVYL-LGTKDEDYVLKINPSREKGADRE--REVAILQLLARKGLPVPK 57

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           +           L+ E++  ++LD       + S  +       +   A  L  LH+   
Sbjct: 58  VLASGESDGWSYLLMEWIEGETLD-------EVSEEEKEDIAEQL---AELLAKLHQLPL 107

Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239
             + H D+   NIL+D+     I D+  A   P
Sbjct: 108 LVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 27/88 (30%), Positives = 47/88 (53%)

Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           +L L E    +++HRD+K++NI L      K+ DFG ++ +    +        GT  Y+
Sbjct: 179 VLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYL 238

Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS 285
           APE       S K D++S GV++ E+++
Sbjct: 239 APELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 46/159 (28%), Positives = 72/159 (45%), Gaps = 20/159 (12%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEI----AVKKLSVDSRQGLREFTNEVKLLLKIQHKN 143
           F  +  +  G FG VY G   N  ++     VKK  + ++  + +   E   L   +   
Sbjct: 6   FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65

Query: 144 LVTLFGCCAEGPEKMLVYEYLPN---KSL--DYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
           +V L+          LV EYL     KSL   Y  FD+      +   +Y  +  VA  L
Sbjct: 66  IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDE------EMAVKY--ISEVALAL 117

Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237
            YLH      IIHRD+K  N+L+  + + K++DFGL+++
Sbjct: 118 DYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 43.4 bits (102), Expect = 2e-04
 Identities = 63/276 (22%), Positives = 106/276 (38%), Gaps = 48/276 (17%)

Query: 81  LQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ 140
           + V+T  F  L+ LG G FG V        +E    K+  +  +  R+   E++ + K++
Sbjct: 124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVR 183

Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFI-FDKTKSSSLDWTTRY---------RI 190
             +    F         M +  Y  N++    I   K     LDW  ++         +I
Sbjct: 184 QADPADRFPL-------MKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQI 236

Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILL---DEQLNP-------------KISDFGL 234
           +      L Y H E    ++H D+K  NIL+   D  ++P             +I D G 
Sbjct: 237 IFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGG 294

Query: 235 ARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRL 294
                 ++ H  T  +S  H Y +PE  L       TD++S G ++ E+ +G+  +D   
Sbjct: 295 C----CDERHSRTAIVSTRH-YRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349

Query: 295 GKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEA 330
             E   L+  T      E A         +C  +EA
Sbjct: 350 NLEHLHLMEKTLGRLPSEWA--------GRCGTEEA 377

Length = 467

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 54/222 (24%), Positives = 91/222 (40%), Gaps = 26/222 (11%)

Query: 78  LRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKL----SVDSRQGLREFTNEV 133
           +R L++    +  +  +G G FG V      + +++   KL     +  R     F  E 
Sbjct: 35  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94

Query: 134 KLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL-----DYFIFDKTKSSSLDWTTRY 188
            ++       +V LF    +     +V EY+P   L     +Y + +K       W   Y
Sbjct: 95  DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK-------WARFY 147

Query: 189 RIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
                 A  +L L        IHRD+K  N+LLD+  + K++DFG   +   ++  V   
Sbjct: 148 -----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC-MKMNKEGMVRCD 201

Query: 249 RISGTHGYMAPEY----ALHGYLSVKTDVFSYGVLVLEIVSG 286
              GT  Y++PE        GY   + D +S GV + E++ G
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 30/102 (29%), Positives = 50/102 (49%), Gaps = 16/102 (15%)

Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR---------LFPGE-DTHVNT 247
           L YLH      I+HRD+K  N+L+    + K++DFGL++         L+ G  +     
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170

Query: 248 F---RISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
           F   ++ GT  Y+APE  L        D ++ G+++ E + G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 42.8 bits (100), Expect = 3e-04
 Identities = 62/238 (26%), Positives = 100/238 (42%), Gaps = 46/238 (19%)

Query: 86  NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLRE-----FTNEVKLLLKIQ 140
           N +  + ++G+G FG V+       QE    K    S +GL+E        EV ++ +++
Sbjct: 13  NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWK--AISYRGLKEREKSQLVIEVNVMRELK 70

Query: 141 HKNLVTLFGCCAEGPEKML--VYEYLPNKSLD------YFIFDKTKSSSLDWTTRYRIVM 192
           HKN+V           + L  + E+     L       Y +F K +  ++   TR  +  
Sbjct: 71  HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL-- 128

Query: 193 GVARGLLYLH--EEAP--ARIIHRDIKASNILLD-------------EQLN----PKISD 231
                L Y H  ++ P   R++HRD+K  NI L                LN     KI D
Sbjct: 129 ---HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185

Query: 232 FGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV--KTDVFSYGVLVLEIVSGR 287
           FGL++    E          GT  Y +PE  LH   S   K+D+++ G ++ E+ SG+
Sbjct: 186 FGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240

Length = 1021

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 41.9 bits (98), Expect = 4e-04
 Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 6/98 (6%)

Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           +A  +L +H       +HRDIK  N+LLD   + +++DFG + L   +D  V +    GT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGT 166

Query: 254 HGYMAPEY--ALH---GYLSVKTDVFSYGVLVLEIVSG 286
             Y++PE   A+    G    + D +S GV + E++ G
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 42.1 bits (99), Expect = 4e-04
 Identities = 33/123 (26%), Positives = 49/123 (39%), Gaps = 47/123 (38%)

Query: 210 IHRDIKASNILLDEQLNPKISDFGLA-------------RLFPGEDT------------- 243
           IHRDIK  NIL+D   + K+SDFGL+             +L  G+               
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182

Query: 244 ----------HVNTFRIS---------GTHGYMAPEYAL-HGYLSVKTDVFSYGVLVLEI 283
                      + T++ +         GT  Y+APE  L  GY   + D +S G ++ E 
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFEC 241

Query: 284 VSG 286
           + G
Sbjct: 242 LIG 244

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 41.8 bits (99), Expect = 4e-04
 Identities = 38/149 (25%), Positives = 62/149 (41%), Gaps = 17/149 (11%)

Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMGVARGLL 199
           + N + L+         +L+ +Y+ +  L    FD  K    L      +I+  +   L 
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAEVKKIIRQLVEALN 123

Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNP-KISDFGLARLFPGEDTHVNTFRI-SGTHGYM 257
            LH+     IIH DIK  N+L D   +   + D+GL +        + T     GT  Y 
Sbjct: 124 DLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCK-------IIGTPSCYDGTLDYF 173

Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSG 286
           +PE        V  D ++ GVL  E+++G
Sbjct: 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTG 202

Length = 267

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 41.5 bits (98), Expect = 5e-04
 Identities = 62/245 (25%), Positives = 95/245 (38%), Gaps = 63/245 (25%)

Query: 88  FSDLNQLGHGGFGPVY----RGLMPNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQ 140
           F  +  LG G  G V+    +G    G+  A+K   K  +  R  ++    E ++L  + 
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKG---TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD 59

Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR---- 196
           H  L TL+          LV +Y P    + F   + +           +   VAR    
Sbjct: 60  HPFLPTLYASFQTETYLCLVMDYCPGG--ELFRLLQRQPGK-------CLSEEVARFYAA 110

Query: 197 ----GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL-------------ARLFP 239
                L YLH      I++RD+K  NILL E  +  +SDF L             A    
Sbjct: 111 EVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKG 167

Query: 240 GEDTHVN-----------TFRIS---GTHGYMAPEY---ALHGYLSVKTDVFSYGVLVLE 282
              + VN           +FR +   GT  Y+APE      HG  +V  D ++ G+L+ E
Sbjct: 168 SRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGS-AV--DWWTLGILLYE 224

Query: 283 IVSGR 287
           ++ G 
Sbjct: 225 MLYGT 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 41.7 bits (98), Expect = 5e-04
 Identities = 44/174 (25%), Positives = 65/174 (37%), Gaps = 54/174 (31%)

Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLF----------PGEDTHVNTFRIS-------- 251
           IHRDIK  NIL+D   + K++DFGL   F           G+    ++   S        
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 252 -----------------------GTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRK 288
                                  GT  Y+APE  L    +   D +S GV++ E++ G+ 
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242

Query: 289 N-HDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCC 341
                   + +         +   E  L +  PS AK +R EA+  I    LCC
Sbjct: 243 PFLADTPAETQ-------LKVINWETTLHI--PSQAKLSR-EASDLIL--RLCC 284

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 37/151 (24%), Positives = 63/151 (41%), Gaps = 10/151 (6%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEI----AVKKLSVDSRQGLREFTNEVKLLLKIQHKN 143
           F  L  +G G FG V      +   I     ++K  +  ++ +     E  +L++     
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           +V +F    +     L+ E+LP   +   +  K      D  +       +A  +L +  
Sbjct: 63  VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK------DTLSEEATQFYIAETVLAIDA 116

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGL 234
                 IHRDIK  N+LLD + + K+SDFGL
Sbjct: 117 IHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 39.7 bits (92), Expect = 0.002
 Identities = 53/209 (25%), Positives = 85/209 (40%), Gaps = 17/209 (8%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKL----SVDSRQGLREFTNEVKLLLKIQHKN 143
           F  L  +G G FG V    + N  ++   K+     +  R     F  E  +L+   ++ 
Sbjct: 3   FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY-LH 202
           + TL     +     LV +Y     L   +         D    Y   M +A   ++ LH
Sbjct: 63  ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122

Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
                  +HRDIK  NIL+D   + +++DFG + L   ED  V +    GT  Y++PE  
Sbjct: 123 ------YVHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEIL 175

Query: 263 L-----HGYLSVKTDVFSYGVLVLEIVSG 286
                  G    + D +S GV + E++ G
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 39.0 bits (91), Expect = 0.003
 Identities = 29/85 (34%), Positives = 45/85 (52%), Gaps = 8/85 (9%)

Query: 208 RIIHRDIKASNILLDEQLNPKISDFG-LARLFPGEDTHVNTFRISGTHGYMAPEY--ALH 264
             +HRDIK  N+LLD+  + +++DFG   RL    D  V +    GT  Y++PE   A+ 
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA--DGTVQSNVAVGTPDYISPEILQAME 179

Query: 265 ---GYLSVKTDVFSYGVLVLEIVSG 286
              G    + D +S GV + E++ G
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 39.2 bits (91), Expect = 0.004
 Identities = 21/45 (46%), Positives = 27/45 (60%), Gaps = 2/45 (4%)

Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH 254
           IHRDIK  NIL+D   + K++DFGL   F    TH + +  SG H
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGF--RWTHDSKYYQSGDH 165

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	437
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.98
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.98
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.87
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.86
PRK10345	210	hypothetical protein; Provisional	99.85
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.84
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.83
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.82
smart00090	237	RIO RIO-like kinase.	99.82
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.81
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.8
PRK14879	211	serine/threonine protein kinase; Provisional	99.8
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.77
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.77
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.73
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.73
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.72
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.69
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.58
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.53
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.48
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.48
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.41
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.41
KOG1243	690	consensus Protein kinase [General function predict	99.38
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.38
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.35
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.35
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.22
KOG3087	229	consensus Serine/threonine protein kinase [General	99.18
COG4248	637	Uncharacterized protein with protein kinase and he	99.18
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.07
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.05
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.02
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.91
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.75
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.73
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.72
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.67
PRK09902	216	hypothetical protein; Provisional	98.66
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.64
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.59
PF01636	239	APH: Phosphotransferase enzyme family This family	98.54
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.47
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.45
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.44
PLN02876	822	acyl-CoA dehydrogenase	98.33
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.31
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.29
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.27
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.26
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.26
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.16
PRK10593	297	hypothetical protein; Provisional	98.16
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.11
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.91
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.83
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.83
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.74
PRK05231	319	homoserine kinase; Provisional	97.72
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.68
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.62
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.59
PLN02236	344	choline kinase	97.58
KOG2270	520	consensus Serine/threonine protein kinase involved	97.46
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.41
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.29
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.06
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.03
PLN02756	418	S-methyl-5-thioribose kinase	96.97
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.92
COG2334	331	Putative homoserine kinase type II (protein kinase	96.83
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.78
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.74
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.7
PRK11768	325	serine/threonine protein kinase; Provisional	96.6
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.47
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.43
PRK12396	409	5-methylribose kinase; Reviewed	96.41
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.35
PRK06148	1013	hypothetical protein; Provisional	95.97
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.89
PTZ00384	383	choline kinase; Provisional	95.87
PTZ00296	442	choline kinase; Provisional	95.86

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-57  Score=445.96  Aligned_cols=287  Identities=48%  Similarity=0.779  Sum_probs=253.1

Q ss_pred             CcccccHHHHHHHhcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeee
Q 013745           72 WNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCC  151 (437)
Q Consensus        72 ~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  151 (437)
                      ....|++.++..+|++|...+.||+|+||.||+|...+|+.||||++.........+|.+|+.++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            45579999999999999999999999999999999988899999988765432145699999999999999999999999


Q ss_pred             ccCC-ceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceee
Q 013745          152 AEGP-EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKIS  230 (437)
Q Consensus       152 ~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~  230 (437)
                      .+.+ +.+||||||++|+|.+.|+..... .++|..+++||.++|+||+|||+.++++||||||||+|||||+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            9998 499999999999999999765544 89999999999999999999999988889999999999999999999999


Q ss_pred             ecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhc
Q 013745          231 DFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQ  310 (437)
Q Consensus       231 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  310 (437)
                      |||+|+..+.......+.. .||.+|+|||++..+..+.|+|||||||||+||+||+.+.+.........++.|.+....
T Consensus       220 DFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~  298 (361)
T KOG1187|consen  220 DFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE  298 (361)
T ss_pred             CccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence            9999976654111111111 799999999999999999999999999999999999999886655555668999999999


Q ss_pred             ccccccccCcccc--CCCH-HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          311 GEKALELVDPSLA--KCNR-DEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       311 ~~~~~~~~d~~l~--~~~~-~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      .+...+++|+.+.  .+.. .+...+..++.+|++.+|++||+|.+|+++|+.
T Consensus       299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~  351 (361)
T KOG1187|consen  299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEG  351 (361)
T ss_pred             CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHh
Confidence            9999999999985  4443 678889999999999999999999999999964

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-51  Score=383.76  Aligned_cols=206  Identities=30%  Similarity=0.493  Sum_probs=184.3

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      ++|...+.||.|+||+||+|+. +++..||||.+...  .....+.+..|+.||+.++|||||++++++..++..|||||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            5688999999999999999984 47899999999765  55666778999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCC------CCceeeeccccc
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ------LNPKISDFGLAR  236 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~------~~~kl~DFGla~  236 (437)
                      ||.||+|..++..+   +.+++..++.++.|||.||++||+++   ||||||||+||||+..      -.+||+|||+|+
T Consensus        90 yC~gGDLs~yi~~~---~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   90 YCNGGDLSDYIRRR---GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             eCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            99999999999543   47999999999999999999999998   9999999999999764      458999999999


Q ss_pred             ccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhh
Q 013745          237 LFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKAD  300 (437)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~  300 (437)
                      .+.....   ....||++.|||||+++.+.|+.|+|+||+|+|||++++|+.||+..+..+...
T Consensus       164 ~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~  224 (429)
T KOG0595|consen  164 FLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLL  224 (429)
T ss_pred             hCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHH
Confidence            9864332   235799999999999999999999999999999999999999999877655443

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-50  Score=395.67  Aligned_cols=254  Identities=31%  Similarity=0.525  Sum_probs=208.6

Q ss_pred             ccccceeccCCCeeEEEEEcCCCcE-EEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC-ceEEEEee
Q 013745           88 FSDLNQLGHGGFGPVYRGLMPNGQE-IAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP-EKMLVYEY  163 (437)
Q Consensus        88 y~~~~~lG~G~~g~Vy~~~~~~~~~-vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~  163 (437)
                      ..+.+.||.|+||+||+|.+. |+. ||||++....  ....+.|.+|+.+|.+++|||||+|+|+|.+.. .+++||||
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~-g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy  121 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWR-GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY  121 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeC-CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence            344566999999999999994 555 9999997543  222568999999999999999999999999887 79999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCC-CceeeecccccccCCCC
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL-NPKISDFGLARLFPGED  242 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~-~~kl~DFGla~~~~~~~  242 (437)
                      +++|+|..+++.. ....+++..++.|+.+||+||.|||++++  ||||||||+||||+.++ ++||+|||+++......
T Consensus       122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~  198 (362)
T KOG0192|consen  122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK  198 (362)
T ss_pred             CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence            9999999999764 45789999999999999999999999874  99999999999999997 99999999998764322


Q ss_pred             cccceeeeecccccCChhhhc--cCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          243 THVNTFRISGTHGYMAPEYAL--HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~--~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                        .......||+.|||||++.  ...|+.|+||||||++||||+||+.||...........      ...     ...-+
T Consensus       199 --~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~------v~~-----~~~Rp  265 (362)
T KOG0192|consen  199 --TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASA------VVV-----GGLRP  265 (362)
T ss_pred             --ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHH------HHh-----cCCCC
Confidence              1122367999999999999  56999999999999999999999999987655222111      100     11112


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCC
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD  361 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~  361 (437)
                      .+   +...+..+..++.+||+.+|+.||++.+|+..|+..
T Consensus       266 ~~---p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~  303 (362)
T KOG0192|consen  266 PI---PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI  303 (362)
T ss_pred             CC---CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence            22   223566788899999999999999999999999853

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.8e-51  Score=401.54  Aligned_cols=253  Identities=25%  Similarity=0.372  Sum_probs=216.3

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      .+|...+.||+|||+.||+++. .+|+.||+|++.+.   +....+.+.+||+|.+.|+|||||+++++|++.++.|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4589999999999999999996 78999999999753   4445677899999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      |+|++++|..++.   +...+++.+++.++.||+.||.|||+.+   |||||||..|+||+++.+|||+|||||..+..+
T Consensus        98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999883   5578999999999999999999999998   999999999999999999999999999988654


Q ss_pred             CcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                      ....  ...||||.|+|||++.....+..+||||+|||+|-||+|++||+...-.+....+...          +..   
T Consensus       172 ~Erk--~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~----------~Y~---  236 (592)
T KOG0575|consen  172 GERK--KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN----------EYS---  236 (592)
T ss_pred             cccc--ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc----------Ccc---
Confidence            3333  3589999999999999999999999999999999999999999865544433322211          111   


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcCCC
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSGDS  362 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~~~  362 (437)
                         .+.....+..+|+..+|+.+|.+|||+++|+.  ++....
T Consensus       237 ---~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~  276 (592)
T KOG0575|consen  237 ---MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGF  276 (592)
T ss_pred             ---cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCC
Confidence               12244556778999999999999999999984  674433

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-51  Score=380.14  Aligned_cols=249  Identities=28%  Similarity=0.402  Sum_probs=207.9

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC-ceEEEEe
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP-EKMLVYE  162 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e  162 (437)
                      .+.+.++.||+|..|+||+++. ++++.+|+|.+... .....+++.+|+++++.++||+||.+||.|.... ..+++||
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mE  158 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICME  158 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehh
Confidence            3466688999999999999985 47899999999544 4555688999999999999999999999999988 4999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE-EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      ||++|+|+.++.   ..+.+++...-+++.++++||.|||+ ++   ||||||||+||||+..|.|||||||.++.+...
T Consensus       159 YMDgGSLd~~~k---~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  159 YMDGGSLDDILK---RVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             hcCCCCHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence            999999999983   23679999999999999999999996 55   999999999999999999999999999987544


Q ss_pred             CcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCc--hhhhhhhhhhhhhhcccccccccC
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLG--KEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                          ....++||..|||||.+.+..|+.++||||||++++|+.+|+.||.....  ....+++.+            .++
T Consensus       233 ----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~------------Iv~  296 (364)
T KOG0581|consen  233 ----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCA------------IVD  296 (364)
T ss_pred             ----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHH------------Hhc
Confidence                22357899999999999999999999999999999999999999976411  112222221            122


Q ss_pred             ccccCCCH-HHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          320 PSLAKCNR-DEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       320 ~~l~~~~~-~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ...+..+. ..+.++..++..|++.||.+||++.++++
T Consensus       297 ~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  297 EPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             CCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            12222233 36677889999999999999999999875

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-51  Score=385.00  Aligned_cols=252  Identities=23%  Similarity=0.300  Sum_probs=204.9

Q ss_pred             HhcCccccceeccCCCeeEEEEE-cCCCcEEEEEEeccCChH-------HHHHHHHHHHHHHcCCCCcceeeeeeeccCC
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQ-------GLREFTNEVKLLLKIQHKNLVTLFGCCAEGP  155 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  155 (437)
                      ..+.|.+.+.||+|+||.|-+|. .++|+.||||++.+....       ......+|++||++|+|||||+++++|...+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            45679999999999999999998 558999999999754211       1234579999999999999999999999999


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCC---CCceeeec
Q 013745          156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ---LNPKISDF  232 (437)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~---~~~kl~DF  232 (437)
                      ..||||||++||.|.+.+..   .+.+.+.....++.|++.|+.|||++|   |+||||||+|||+..+   ..+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence            99999999999999998843   455777888899999999999999999   9999999999999765   78999999


Q ss_pred             ccccccCCCCcccceeeeecccccCChhhhccCc---CCcccceehhhHHHHHHHhCCCCCCCCCchh-hhhhhhhhhhh
Q 013745          233 GLARLFPGEDTHVNTFRISGTHGYMAPEYALHGY---LSVKTDVFSYGVLVLEIVSGRKNHDGRLGKE-KADLLSYTWTL  308 (437)
Q Consensus       233 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~~~~~DvwSlG~vl~elltg~~p~~~~~~~~-~~~~~~~~~~~  308 (437)
                      |+|+.....   ......|||+.|.|||++.++.   +..++|+||+|||||-+++|.+||....... ..+.+....-.
T Consensus       324 GlAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~  400 (475)
T KOG0615|consen  324 GLAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA  400 (475)
T ss_pred             chhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccc
Confidence            999987522   2233689999999999998763   4458899999999999999999998755443 22222111111


Q ss_pred             hcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          309 FQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       309 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      +            -+..+.....+.++++.+||..||++||++.|+++
T Consensus       401 f------------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  401 F------------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             c------------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            0            01234466777889999999999999999999864

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.9e-51  Score=367.79  Aligned_cols=255  Identities=26%  Similarity=0.407  Sum_probs=211.0

Q ss_pred             cCccccceeccCCCeeEEEEE-cCCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeee-eeccCCc-eEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFG-CCAEGPE-KMLV  160 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lv  160 (437)
                      .+|.++++||.|.||+||++. ..+|..||.|.+...  .....+.+..|+.+|++|+|||||++++ .|.++.. ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            458999999999999999998 568999999999754  4555677899999999999999999999 4555555 8999


Q ss_pred             EeecCCCCcchhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCC-ceEeeccCCCCEEecCCCCceeeeccccccc
Q 013745          161 YEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAPA-RIIHRDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~-~iiHrDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                      ||||.+|+|..++... .....+++..+|+++.|++.||..+|++-+. .|+||||||.||+|+.+|.+||+||||++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            9999999999998643 3446799999999999999999999995421 3999999999999999999999999999998


Q ss_pred             CCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          239 PGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       239 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      ....+..  ...+|||.||+||.+.+..|+.|+||||+||++|||+.-++||.+.      ++.....++.+.+      
T Consensus       179 ~s~~tfA--~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~qgd------  244 (375)
T KOG0591|consen  179 SSKTTFA--HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIEQGD------  244 (375)
T ss_pred             cchhHHH--HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHHcCC------
Confidence            7654433  3578999999999999999999999999999999999999999886      2333333333321      


Q ss_pred             CccccCCC-HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013745          319 DPSLAKCN-RDEAAMCIQLGLLCCQQSVAERPDMNSVHLM  357 (437)
Q Consensus       319 d~~l~~~~-~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  357 (437)
                         .+.++ ...+..+..|+..|+..||+.||+...++.-
T Consensus       245 ---~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~d  281 (375)
T KOG0591|consen  245 ---YPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQD  281 (375)
T ss_pred             ---CCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHH
Confidence               11223 4567788899999999999999985444443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-50  Score=373.71  Aligned_cols=242  Identities=27%  Similarity=0.324  Sum_probs=204.7

Q ss_pred             hcCccccceeccCCCeeEEEEE-cCCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      .++|+++++||+|+||+||.++ .++++.||+|++++.   .....+....|..||.+++||+||+++..|++...+|||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            4679999999999999999998 457899999999754   334567789999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      +||+.||.|...|.   +.+.+++..+..++..|+.||.|||+++   ||||||||+|||||.+|+++|+||||++....
T Consensus       104 ld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            99999999999983   4467999999999999999999999998   99999999999999999999999999996544


Q ss_pred             CCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                      ....  +..+|||+.|||||++.+..|+..+|+||||+++|||++|.+||.+.......+.+....              
T Consensus       178 ~~~~--t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k--------------  241 (357)
T KOG0598|consen  178 DGDA--TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK--------------  241 (357)
T ss_pred             CCCc--cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc--------------
Confidence            3332  334799999999999999999999999999999999999999998766444333222111              


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCC
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERP  349 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RP  349 (437)
                       +...+.-...+..+++...++.+|++|.
T Consensus       242 -~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  242 -LPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             -CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence             1112222445567888899999999995

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-49  Score=384.45  Aligned_cols=252  Identities=31%  Similarity=0.487  Sum_probs=217.1

Q ss_pred             ccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCCC
Q 013745           88 FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNK  167 (437)
Q Consensus        88 y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  167 (437)
                      +..++.||+|-||.||.|.++....||+|.+....- ....|.+|+++|++|+|+|||+++++|..++.++||||||+.|
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            445788999999999999997777999999976432 2467889999999999999999999999988999999999999


Q ss_pred             CcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccce
Q 013745          168 SLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT  247 (437)
Q Consensus       168 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  247 (437)
                      +|.++|.. .....+...+.+.++.|||+|++||++++   +|||||.+.||||+++..+||+|||||+...++... ..
T Consensus       287 sLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~-~~  361 (468)
T KOG0197|consen  287 SLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT-AS  361 (468)
T ss_pred             cHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCcee-ec
Confidence            99999965 34567899999999999999999999998   999999999999999999999999999955443322 22


Q ss_pred             eeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCC
Q 013745          248 FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCN  326 (437)
Q Consensus       248 ~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  326 (437)
                      ....-...|.|||.+..+.++.|||||||||+||||+| |+.|+.+....+....++..+.+..               +
T Consensus       362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~---------------P  426 (468)
T KOG0197|consen  362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR---------------P  426 (468)
T ss_pred             CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC---------------C
Confidence            22334667999999999999999999999999999998 9999999888887777666555432               3


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          327 RDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       327 ~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ..++..+.+|+..||+.+|++|||+..+...|+.
T Consensus       427 ~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~  460 (468)
T KOG0197|consen  427 EGCPDEVYELMKSCWHEDPEDRPTFETLREVLED  460 (468)
T ss_pred             CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHH
Confidence            3466678999999999999999999999998875

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.8e-49  Score=358.22  Aligned_cols=263  Identities=22%  Similarity=0.332  Sum_probs=212.7

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      +.|+.+.++|+|+||+||+++.+ +|+.||||++..+.  ....+-.++|+++|++|+|+|+|.++.+|.....++||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            35888999999999999999955 79999999996543  3334567899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      ||+..-|+++-   .....++...+.+++.|++.|+.|+|+++   +|||||||+||||+.+|.+||||||+|+.+....
T Consensus        82 ~~dhTvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg  155 (396)
T KOG0593|consen   82 YCDHTVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG  155 (396)
T ss_pred             ecchHHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc
Confidence            99887666553   23356889999999999999999999998   9999999999999999999999999999886422


Q ss_pred             cccceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhh--------hhhhhhcccc
Q 013745          243 THVNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS--------YTWTLFQGEK  313 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~--------~~~~~~~~~~  313 (437)
                        ...+.++.|.+|.|||++.+ ..|+..+||||+|||+.||++|.+.|.+.++.+....+.        ....+|....
T Consensus       156 --d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  156 --DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             --chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence              22335678999999999988 589999999999999999999999999988766554432        2233333332


Q ss_pred             ccccc-Ccc------ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          314 ALELV-DPS------LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       314 ~~~~~-d~~------l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ....+ -|.      +..-.+....-+++++..|++.||.+|++-++++.
T Consensus       234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            22111 111      12223345557899999999999999999999863

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-48  Score=374.18  Aligned_cols=265  Identities=24%  Similarity=0.330  Sum_probs=212.6

Q ss_pred             hcCccccceeccCCCeeEEEEE-cCCCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccC--CceEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG--PEKML  159 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  159 (437)
                      .+.|+.+++||+|.||.||+|+ ..+|+.||+|++..+.  ........+||.||++|+||||++|.+...+.  ..+||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            4569999999999999999998 5689999999998664  44456678999999999999999999998776  68999


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      |+|||+. +|.-++.  .....|++.++..++.||+.||+|||+++   |+|||||.+|||||.+|.+||+|||||+++.
T Consensus       196 VFeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence            9999966 6766662  33457999999999999999999999998   9999999999999999999999999999887


Q ss_pred             CCCcccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccc---
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKAL---  315 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---  315 (437)
                      .......+ ..+-|.+|.|||++.+. .|+.++|+||.||||.||++|++.|.+....+....+...-.-..+....   
T Consensus       270 ~~~~~~~T-~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k  348 (560)
T KOG0600|consen  270 PSGSAPYT-SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK  348 (560)
T ss_pred             CCCCcccc-cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence            66655444 34559999999999986 79999999999999999999999999988766655442221111111100   


Q ss_pred             ----cccC------ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          316 ----ELVD------PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       316 ----~~~d------~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                          ..+.      ..+.+.....+...++|+..+|..||.+|.|+.++++
T Consensus       349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence                0111      1111222334556788999999999999999999863

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-47  Score=370.99  Aligned_cols=257  Identities=24%  Similarity=0.321  Sum_probs=212.7

Q ss_pred             HHHhcCccccceeccCCCeeEEEEE-cCCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCc
Q 013745           82 QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPE  156 (437)
Q Consensus        82 ~~~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  156 (437)
                      ....++|.+.+.||.|+|++|++|+ ..+++.||||++.+.   .+.....+..|-.+|.+| .||.|++|+..|.+...
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            4456789999999999999999998 558999999999654   233345567899999999 79999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                      +|+|+||+++|+|.++|.   +.+.|++..++.++.+|+.||+|||++|   ||||||||+|||||++|++||+|||.|+
T Consensus       149 LYFvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK  222 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK  222 (604)
T ss_pred             eEEEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence            999999999999999994   3477999999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCcc---------cce--eeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhh
Q 013745          237 LFPGEDTH---------VNT--FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYT  305 (437)
Q Consensus       237 ~~~~~~~~---------~~~--~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~  305 (437)
                      .+......         ...  ..++||..|.+||++..+..++.+|+|+||||||+|+.|.+||.+...-.....+.  
T Consensus       223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~--  300 (604)
T KOG0592|consen  223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ--  300 (604)
T ss_pred             cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH--
Confidence            87643222         111  34889999999999999999999999999999999999999998765432221111  


Q ss_pred             hhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          306 WTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       306 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                                 .++-   .+++..+..+.+|+.+.|..||.+|++..+|.+  ++++
T Consensus       301 -----------~l~y---~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~  343 (604)
T KOG0592|consen  301 -----------ALDY---EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG  343 (604)
T ss_pred             -----------Hhcc---cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence                       0111   222233455678888999999999999999976  4454

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.7e-47  Score=340.73  Aligned_cols=264  Identities=23%  Similarity=0.344  Sum_probs=217.0

Q ss_pred             cCccccceeccCCCeeEEEEE-cCCCcEEEEEEeccCChH--HHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQ--GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      .+|..+++||+|.||.||+|+ ..+|+.||||+++.....  -.....+|++.|+.++|+||+.++++|...+.+.||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            468889999999999999998 568999999999865322  23557899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |++ .+|..++.  .+...+....+..|+.++++||+|||+++   |+||||||.|+|++.+|.+||+|||+|+.+....
T Consensus        82 fm~-tdLe~vIk--d~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMP-TDLEVVIK--DKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             ecc-ccHHHHhc--ccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            994 58988884  34567899999999999999999999998   9999999999999999999999999999997665


Q ss_pred             cccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccc-----
Q 013745          243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE-----  316 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  316 (437)
                      .....  .+-|.+|.|||++.+. .|+..+||||.|||+.||+.|.+.|.+.++-+....+..+......+...+     
T Consensus       156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp  233 (318)
T KOG0659|consen  156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP  233 (318)
T ss_pred             ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence            44332  2569999999998876 799999999999999999999999999887766655544433222221111     


Q ss_pred             -------ccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013745          317 -------LVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLM  357 (437)
Q Consensus       317 -------~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  357 (437)
                             ...+.+....+......++++..++..||.+|.++.|.+++
T Consensus       234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence                   11122223445566677999999999999999999998764

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-47  Score=366.76  Aligned_cols=265  Identities=23%  Similarity=0.305  Sum_probs=214.8

Q ss_pred             HhcCccccceeccCCCeeEEEEE-cCCCcEEEEEEeccCChHHH-HHHHHHHHHHHcCC-CCcceeeeeeeccCC-ceEE
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGL-REFTNEVKLLLKIQ-HKNLVTLFGCCAEGP-EKML  159 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~l  159 (437)
                      ..++|.++++||.|.||.||+|+ ..+|..||||+++..-..+. ..-++|+..|++|+ |||||+++..+.+.+ .+++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            45789999999999999999998 55899999999986533332 22368999999999 999999999999888 9999


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      ||||| ..+|..++.++  +..|++..+..|+.||++||+|+|.+|   +.|||+||+|||+..+..+||+|||+||.+.
T Consensus        88 VfE~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   88 VFEFM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             eHHhh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence            99999 55888888554  678999999999999999999999998   9999999999999999999999999999886


Q ss_pred             CCCcccceeeeecccccCChhhhc-cCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccc-----
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYAL-HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEK-----  313 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----  313 (437)
                      ......   .++.|.+|.|||++. .+.|+.+.|||++|||++||.+-++.|.|....+....+-.+........     
T Consensus       162 SkpPYT---eYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~  238 (538)
T KOG0661|consen  162 SKPPYT---EYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY  238 (538)
T ss_pred             cCCCcc---hhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence            655433   467899999999775 56899999999999999999999999999876655443322211111111     


Q ss_pred             ----cccc-----cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013745          314 ----ALEL-----VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLM  357 (437)
Q Consensus       314 ----~~~~-----~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  357 (437)
                          .+.+     ..-.+....+....+.++++.+|+..||++|||+.+.++.
T Consensus       239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence                1111     1112223344577888999999999999999999999874

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.1e-46  Score=364.01  Aligned_cols=261  Identities=21%  Similarity=0.281  Sum_probs=213.5

Q ss_pred             cHHHHHHHhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeec
Q 013745           77 DLRTLQVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCA  152 (437)
Q Consensus        77 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  152 (437)
                      ..+......++|+.+.+||+|+||.||+|+. .+|..+|+|+++++   ...+.+.++.|-.+|...+.|+||+|+..|+
T Consensus       132 R~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ  211 (550)
T KOG0605|consen  132 RLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQ  211 (550)
T ss_pred             HhccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEec
Confidence            3333344568899999999999999999984 47999999999876   3455677899999999999999999999999


Q ss_pred             cCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeec
Q 013745          153 EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDF  232 (437)
Q Consensus       153 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DF  232 (437)
                      +.+.+||||||++||++..+|.   +.+.|++..+..++.+++.|+..||..|   +|||||||+|+|||..|++||+||
T Consensus       212 D~~~LYLiMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDF  285 (550)
T KOG0605|consen  212 DKEYLYLIMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDF  285 (550)
T ss_pred             CCCeeEEEEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccc
Confidence            9999999999999999999994   4467999999999999999999999998   999999999999999999999999


Q ss_pred             ccccccCCCC----------------------cc-----cc------------------eeeeecccccCChhhhccCcC
Q 013745          233 GLARLFPGED----------------------TH-----VN------------------TFRISGTHGYMAPEYALHGYL  267 (437)
Q Consensus       233 Gla~~~~~~~----------------------~~-----~~------------------~~~~~gt~~Y~aPE~~~~~~~  267 (437)
                      ||+.-+....                      ..     ..                  ....+|||.|||||++.+..|
T Consensus       286 GLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY  365 (550)
T KOG0605|consen  286 GLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY  365 (550)
T ss_pred             cccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC
Confidence            9996432100                      00     00                  123569999999999999999


Q ss_pred             CcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCC
Q 013745          268 SVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAE  347 (437)
Q Consensus       268 ~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~  347 (437)
                      +..+|+||||||+||||.|.+||.+..+.+....+..+...+.-        |.-.    ....+..+||.+|+. ||++
T Consensus       366 ~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f--------P~~~----~~s~eA~DLI~rll~-d~~~  432 (550)
T KOG0605|consen  366 GKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF--------PEEV----DLSDEAKDLITRLLC-DPEN  432 (550)
T ss_pred             CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC--------CCcC----cccHHHHHHHHHHhc-CHHH
Confidence            99999999999999999999999998888776555443332221        1111    122556788889999 9999


Q ss_pred             CCC---HHHHHH
Q 013745          348 RPD---MNSVHL  356 (437)
Q Consensus       348 RPs---~~ev~~  356 (437)
                      |.-   +.||.+
T Consensus       433 RLG~~G~~EIK~  444 (550)
T KOG0605|consen  433 RLGSKGAEEIKK  444 (550)
T ss_pred             hcCcccHHHHhc
Confidence            975   555544

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-46  Score=354.64  Aligned_cols=254  Identities=26%  Similarity=0.414  Sum_probs=202.0

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC--ceEEEEe
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP--EKMLVYE  162 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e  162 (437)
                      .++...+.||+|+||.||++... +|...|||.+........+.+.+|+.+|.+++|||||+++|......  .++++||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            34667889999999999999854 58999999997654333677899999999999999999999855444  5899999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC-CCCceeeecccccccCC-
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE-QLNPKISDFGLARLFPG-  240 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~-~~~~kl~DFGla~~~~~-  240 (437)
                      |+++|+|.+++.....  .+++..+..++.||++||+|||+++   ||||||||+||||+. ++.+||+|||+++.... 
T Consensus        97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            9999999999854332  6999999999999999999999998   999999999999999 79999999999987764 


Q ss_pred             CCcccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                      ...........||+.|||||++..+ ....++|||||||++.||+||++||...     .....+........       
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~-------  239 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGRED-------  239 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccC-------
Confidence            1111223357899999999999964 3446999999999999999999999753     11111111111111       


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLM  357 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  357 (437)
                       ..+..+...+.+..+++.+|++.+|++|||+.++++-
T Consensus       240 -~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h  276 (313)
T KOG0198|consen  240 -SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH  276 (313)
T ss_pred             -CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence             1123333455667788899999999999999999863

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-46  Score=338.89  Aligned_cols=237  Identities=27%  Similarity=0.368  Sum_probs=202.6

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      .++|+.++.||.|+||+|.+++.+ +|..+|+|++.+..   -.+.+...+|..+|+.+.||+++++++.|.+...+|||
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv  122 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV  122 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence            356899999999999999999844 78899999997653   34456788999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||++||.|..++   .+.+++++..++.++.||+.||+|||+.+   |++|||||+|||||.+|.+||+|||+|+....
T Consensus       123 meyv~GGElFS~L---rk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  123 MEYVPGGELFSYL---RKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             EeccCCccHHHHH---HhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            9999999999998   34567999999999999999999999998   99999999999999999999999999997643


Q ss_pred             CCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                      .     +...||||.|+|||+++...|+.++|+|||||++|||+.|.+||.........+.+-      ..         
T Consensus       197 r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~------~~---------  256 (355)
T KOG0616|consen  197 R-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKIL------EG---------  256 (355)
T ss_pred             c-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHH------hC---------
Confidence            3     557899999999999999999999999999999999999999998765532221111      10         


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCC
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAER  348 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~R  348 (437)
                       --..+.-....+.+|+...++.|-.+|
T Consensus       257 -~v~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  257 -KVKFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             -cccCCcccCHHHHHHHHHHHhhhhHhh
Confidence             112333445567788889999998888

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=8.8e-46  Score=363.92  Aligned_cols=260  Identities=29%  Similarity=0.409  Sum_probs=203.9

Q ss_pred             HhcCccccceeccCCCeeEEEEEc------CCCcEEEEEEeccCC-hHHHHHHHHHHHHHHcC-CCCcceeeeeeeccC-
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEG-  154 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-  154 (437)
                      ..++|++.++||+|+||.||+|..      .++..||||++.... ......+.+|+.++.++ +||||++++++|... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            356799999999999999999963      235689999987542 33456789999999999 899999999988764 


Q ss_pred             CceEEEEeecCCCCcchhhhccCC--------------------------------------------------------
Q 013745          155 PEKMLVYEYLPNKSLDYFIFDKTK--------------------------------------------------------  178 (437)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------  178 (437)
                      ...++||||+++|+|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            457899999999999988854211                                                        


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccceeeeecccc
Q 013745          179 ---SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG  255 (437)
Q Consensus       179 ---~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~  255 (437)
                         ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...............++..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence               134788899999999999999999988   99999999999999999999999999986543322222223345688


Q ss_pred             cCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHH
Q 013745          256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCI  334 (437)
Q Consensus       256 Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~  334 (437)
                      |+|||++.+..++.++|||||||+||||++ |..||.+....+..  .    .....+..     .   ..+...+..+.
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~--~----~~~~~~~~-----~---~~~~~~~~~l~  307 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF--C----QRLKDGTR-----M---RAPENATPEIY  307 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH--H----HHHhcCCC-----C---CCCCCCCHHHH
Confidence            999999999999999999999999999997 99999764332211  0    11111110     0   11123345688


Q ss_pred             HHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          335 QLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       335 ~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      +++.+||+.+|++||++.+|+++|+.
T Consensus       308 ~li~~cl~~dp~~RPs~~el~~~l~~  333 (338)
T cd05102         308 RIMLACWQGDPKERPTFSALVEILGD  333 (338)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHH
Confidence            99999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3e-46  Score=381.24  Aligned_cols=259  Identities=29%  Similarity=0.467  Sum_probs=221.3

Q ss_pred             HhcCccccceeccCCCeeEEEEEc------CCCcEEEEEEeccCChH-HHHHHHHHHHHHHcCCCCcceeeeeeeccCCc
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVDSRQ-GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE  156 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  156 (437)
                      ...+....+.||+|+||+||+|+.      ++.+.||||.++..... ...+|.+|+++|..|+|||||+|+|.|.+++.
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP  563 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence            345566778999999999999973      24567999999866444 67899999999999999999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccC-------C----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCC
Q 013745          157 KMLVYEYLPNKSLDYFIFDKT-------K----SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL  225 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~  225 (437)
                      +++|+|||..|+|.++|....       .    ..+++..+.+.||.|||.|++||-++.   +|||||...|+||.++.
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL  640 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence            999999999999999986321       1    234888999999999999999999987   99999999999999999


Q ss_pred             CceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhh
Q 013745          226 NPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSY  304 (437)
Q Consensus       226 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~  304 (437)
                      .|||+||||++.....+.......-.-..+|||||-++.++++.+||||||||||||+++ |+.||.+..+++..+.+..
T Consensus       641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~  720 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA  720 (774)
T ss_pred             EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc
Confidence            999999999998766555443322234679999999999999999999999999999998 9999999888877665442


Q ss_pred             hhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          305 TWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       305 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      .               .+-.++.+++.++..|+..||+.+|++||+++||...|+.
T Consensus       721 g---------------~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~  761 (774)
T KOG1026|consen  721 G---------------QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQA  761 (774)
T ss_pred             C---------------CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence            2               2234566778889999999999999999999999999985

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-46  Score=363.72  Aligned_cols=264  Identities=28%  Similarity=0.430  Sum_probs=212.9

Q ss_pred             HHHHHHhcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCc
Q 013745           79 RTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE  156 (437)
Q Consensus        79 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  156 (437)
                      .+.+...+.+.+...||+|.||+||+|.|.  ..||||++...  .....+.|++|+..+++-+|.||+-|.|+|.....
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~  462 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL  462 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence            344445566778899999999999999983  37999999865  45567889999999999999999999999998876


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                       .+|+.+|+|.+|+.+|+...  ..|++.+.+.|++||++|+.|||.++   |||||||..||+|.+++.|||+||||+.
T Consensus       463 -AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat  536 (678)
T KOG0193|consen  463 -AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT  536 (678)
T ss_pred             -eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence             99999999999999996543  57999999999999999999999998   9999999999999999999999999997


Q ss_pred             ccCCCCcccceeeeecccccCChhhhccC---cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccc
Q 013745          237 LFPGEDTHVNTFRISGTHGYMAPEYALHG---YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEK  313 (437)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (437)
                      .-..-..........|...|||||+++.+   +|++.+||||||||+|||+||..||..........++         ++
T Consensus       537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV---------Gr  607 (678)
T KOG0193|consen  537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV---------GR  607 (678)
T ss_pred             eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe---------cc
Confidence            54322111112234578899999999754   7999999999999999999999999843322222111         11


Q ss_pred             cccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCC
Q 013745          314 ALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD  361 (437)
Q Consensus       314 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~  361 (437)
                      -.  +.+.+.......++++.+|+..||..++++||.+.+|+..|+..
T Consensus       608 G~--l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l  653 (678)
T KOG0193|consen  608 GY--LMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL  653 (678)
T ss_pred             cc--cCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence            11  11222333446677888999999999999999999999988754

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-45  Score=361.27  Aligned_cols=249  Identities=25%  Similarity=0.318  Sum_probs=204.6

Q ss_pred             HhcCccccceeccCCCeeEEEEE-cCCCcEEEEEEeccC----Ch-HHHHHHHHHHHHHHcCC-CCcceeeeeeeccCCc
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD----SR-QGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPE  156 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  156 (437)
                      ..++|.+.+.||+|+||+|++|. ..++..||+|++...    .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            45679999999999999999997 457899999977653    12 23456778999999999 9999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCC-CCceeeecccc
Q 013745          157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ-LNPKISDFGLA  235 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~-~~~kl~DFGla  235 (437)
                      .++|||||.||+|.+++..   .+++.+..+.+++.|++.|++|||+++   |+||||||+|||++.+ +++||+|||++
T Consensus        95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            9999999999999999954   467888999999999999999999998   9999999999999999 99999999999


Q ss_pred             cccCCCCcccceeeeecccccCChhhhccCc-CC-cccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccc
Q 013745          236 RLFPGEDTHVNTFRISGTHGYMAPEYALHGY-LS-VKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEK  313 (437)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~-~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (437)
                      .........  ....+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+........      +++...  
T Consensus       169 ~~~~~~~~~--l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~------~ki~~~--  238 (370)
T KOG0583|consen  169 AISPGEDGL--LKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLY------RKIRKG--  238 (370)
T ss_pred             cccCCCCCc--ccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHH------HHHhcC--
Confidence            987422222  22578999999999999865 64 8899999999999999999999863322111      111111  


Q ss_pred             cccccCccccCCCHHH-HHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          314 ALELVDPSLAKCNRDE-AAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       314 ~~~~~d~~l~~~~~~~-~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                              .-.++... ..++..++.+|++.+|.+|+++.+|++
T Consensus       239 --------~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  239 --------EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             --------CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence                    01111122 667889999999999999999999983

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-45  Score=360.69  Aligned_cols=249  Identities=25%  Similarity=0.398  Sum_probs=212.1

Q ss_pred             cCccccceeccCCCeeEEEEE-cCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      ..|....+||+|+.|.||.|. ..+++.||||++........+-+++|+.+|+.++|+|||++++.|..++++|+|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            468888999999999999997 5578999999998776655677899999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      +||+|.+++    ....+++.++..|+++++.||+|||.++   |+|||||.+|||++.+|.+||+|||++..+......
T Consensus       353 ~ggsLTDvV----t~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K  425 (550)
T KOG0578|consen  353 EGGSLTDVV----TKTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK  425 (550)
T ss_pred             CCCchhhhh----hcccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence            999999998    3345999999999999999999999998   999999999999999999999999999988766543


Q ss_pred             cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccC
Q 013745          245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK  324 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  324 (437)
                      ..  ..+||+.|||||+.....|++|+||||||++++||+-|++||-...+-...      |-+...+.      |.+ .
T Consensus       426 R~--TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAl------yLIa~ng~------P~l-k  490 (550)
T KOG0578|consen  426 RS--TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNGT------PKL-K  490 (550)
T ss_pred             cc--cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHH------HHHhhcCC------CCc-C
Confidence            33  478999999999999999999999999999999999999999754332222      22222111      111 2


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          325 CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       325 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .....+..+.+++.+||+.|+++||++.|+++
T Consensus       491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             CccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            23345667889999999999999999999986

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.6e-44  Score=348.16  Aligned_cols=264  Identities=25%  Similarity=0.381  Sum_probs=205.0

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-----------------CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCccee
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-----------------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVT  146 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~  146 (437)
                      .++|++.++||+|+||.||+|.+.                 ++..||+|++... .......+.+|+.++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            357899999999999999999743                 2346999998754 3444567899999999999999999


Q ss_pred             eeeeeccCCceEEEEeecCCCCcchhhhccC----------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceE
Q 013745          147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKT----------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARII  210 (437)
Q Consensus       147 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ii  210 (437)
                      +++++.+.+..++||||+++++|.+++....                ....+++..++.++.||+.||.|||+.+   |+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence            9999999999999999999999998875321                1134788899999999999999999998   99


Q ss_pred             eeccCCCCEEecCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh--CCC
Q 013745          211 HRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS--GRK  288 (437)
Q Consensus       211 HrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt--g~~  288 (437)
                      ||||||+|||++.++.+||+|||+++.+.............++..|+|||++..+.++.++|||||||++|||++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            999999999999999999999999987644332222223345788999999998899999999999999999987  556


Q ss_pred             CCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          289 NHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       289 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                      ||......+..   ......+......  +..   ..++..+..+.+++.+||+.+|++||++.+|+++|+
T Consensus       241 p~~~~~~~~~~---~~~~~~~~~~~~~--~~~---~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         241 PYGELTDEQVI---ENAGEFFRDQGRQ--VYL---FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCcCCHHHHH---HHHHHHhhhcccc--ccc---cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            77654433221   1111111111000  000   011123456889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-45  Score=363.34  Aligned_cols=246  Identities=26%  Similarity=0.349  Sum_probs=210.8

Q ss_pred             HHHHhcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCC-CCcceeeeeeeccCC
Q 013745           81 LQVATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGP  155 (437)
Q Consensus        81 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  155 (437)
                      .....++|.++++||+|.||+|+++..+ +++.+|||++++.   .....+..+.|.+|+.... ||.+++++.+|++.+
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE  442 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence            4455688999999999999999999854 7889999999876   4556788899999998885 999999999999999


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccc
Q 013745          156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA  235 (437)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  235 (437)
                      ++|+||||+.||++..+.    ....+++..+..++..|+.||.|||+++   ||+||||.+|||||.+|.+||+|||++
T Consensus       443 ~l~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlc  515 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLC  515 (694)
T ss_pred             eEEEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccc
Confidence            999999999999954333    4467999999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccc
Q 013745          236 RLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKAL  315 (437)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (437)
                      +.......  .+.++|||+.|||||++.+..|+.++|+|||||+|||||.|+.||.+.+..+..+-+...          
T Consensus       516 Ke~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d----------  583 (694)
T KOG0694|consen  516 KEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND----------  583 (694)
T ss_pred             cccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC----------
Confidence            97653333  344689999999999999999999999999999999999999999987766654433211          


Q ss_pred             cccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 013745          316 ELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDM  351 (437)
Q Consensus       316 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  351 (437)
                         |   .-++...+.+.+.++.+++..+|++|.-+
T Consensus       584 ---~---~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  584 ---E---VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ---C---CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence               1   12344566778889999999999999876

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.1e-45  Score=357.29  Aligned_cols=246  Identities=26%  Similarity=0.383  Sum_probs=209.1

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      ++|.+.+.||+|+||+||||+.+ +.+.||+|.+.+.  .+.....+.+|++|++.|+|||||.++++|+...++++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            46888999999999999999844 7899999999765  34556789999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      ||.| +|..+|.   ..+.++++.+..++.+++.||.|||+.+   |+|||+||.|||++.+|.+|+||||+|+......
T Consensus        82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t  154 (808)
T KOG0597|consen   82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT  154 (808)
T ss_pred             hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence            9976 9999984   4467999999999999999999999988   9999999999999999999999999999876533


Q ss_pred             cccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccc
Q 013745          243 THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL  322 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  322 (437)
                      .  ....+.|||.|||||+..++.|+..+|+||+||||||+++|++||....-.+   ++   ..+..        |+  
T Consensus       155 ~--vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~---Lv---~~I~~--------d~--  216 (808)
T KOG0597|consen  155 S--VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQ---LV---KSILK--------DP--  216 (808)
T ss_pred             e--eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHH---HH---HHHhc--------CC--
Confidence            2  2336789999999999999999999999999999999999999997533221   11   11111        11  


Q ss_pred             cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          323 AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       323 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ...+......+..++...++.||.+|.+-.+++.
T Consensus       217 v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  217 VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            1233466777889999999999999999999864

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-44  Score=341.83  Aligned_cols=260  Identities=23%  Similarity=0.334  Sum_probs=208.4

Q ss_pred             hcCccccceeccCCCeeEEEEE-cCCCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      .+.|+..++||.|..++||+|+ .+.++.||||++..+. ....+.+.+|+..|+.++||||++++..|..+..+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            4679999999999999999998 6688999999997553 3336889999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      ||.+|++.+++...-. ..+++..+..|++++++||.|||.+|   .||||||+.||||+++|.|||+|||.+-.+....
T Consensus       105 fMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            9999999999876544 45999999999999999999999998   9999999999999999999999999876654333


Q ss_pred             cc-cce-eeeecccccCChhhhccC--cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccc--cc
Q 013745          243 TH-VNT-FRISGTHGYMAPEYALHG--YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKA--LE  316 (437)
Q Consensus       243 ~~-~~~-~~~~gt~~Y~aPE~~~~~--~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~  316 (437)
                      .. ... ..++||++|||||+++..  .|+.|+||||||+...||.+|..||....+....   ..  ++-.....  ..
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL---l~--tLqn~pp~~~t~  255 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL---LL--TLQNDPPTLLTS  255 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH---HH--HhcCCCCCcccc
Confidence            21 111 346899999999996654  7999999999999999999999999754432211   00  00000000  00


Q ss_pred             ccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          317 LVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       317 ~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .++   .+........+.+++..|++.||.+|||++++++
T Consensus       256 ~~~---~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  256 GLD---KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cCC---hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            011   0112234456888999999999999999999964

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-45  Score=354.92  Aligned_cols=240  Identities=28%  Similarity=0.434  Sum_probs=200.2

Q ss_pred             cccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCCCC
Q 013745           89 SDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKS  168 (437)
Q Consensus        89 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  168 (437)
                      ..++.||.|+.|.||+|++ .++.||||+++...+       .+|+-|++|+||||+.|.|+|.....+|||||||..|-
T Consensus       127 sELeWlGSGaQGAVF~Grl-~netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRL-HNETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhhhccCcccceeeeec-cCceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence            3468899999999999998 578999999864332       47889999999999999999999999999999999999


Q ss_pred             cchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCccccee
Q 013745          169 LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF  248 (437)
Q Consensus       169 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  248 (437)
                      |..+|.   ....+.......|..+||.|+.|||.+.   |||||||.-||||..+..|||+|||-++......   ...
T Consensus       199 L~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S---TkM  269 (904)
T KOG4721|consen  199 LYEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS---TKM  269 (904)
T ss_pred             HHHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh---hhh
Confidence            999993   3456888899999999999999999998   9999999999999999999999999998775442   233


Q ss_pred             eeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHH
Q 013745          249 RISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRD  328 (437)
Q Consensus       249 ~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  328 (437)
                      .++||..|||||++...+.+.|+|||||||||||||||..||........    -|..    +.+.+.+      ..+..
T Consensus       270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----IwGV----GsNsL~L------pvPst  335 (904)
T KOG4721|consen  270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----IWGV----GSNSLHL------PVPST  335 (904)
T ss_pred             hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee----EEec----cCCcccc------cCccc
Confidence            67899999999999999999999999999999999999999975332211    1110    0111111      12335


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          329 EAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       329 ~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                      ++..+.-|+++||+..|..||++.+|+.-|.
T Consensus       336 cP~GfklL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  336 CPDGFKLLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             CchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence            5566788999999999999999999987765

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=337.75  Aligned_cols=265  Identities=23%  Similarity=0.330  Sum_probs=209.2

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEec--cCChHHHHHHHHHHHHHHcCCCCcceeeeeeecc-----CCc
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE-----GPE  156 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~  156 (437)
                      ...|..++.||+|+||.|+.|.. .+|+.||||++.  .......++..+|+++|+.++|+||+.+++.+..     -+.
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            45577789999999999999984 489999999997  5566677889999999999999999999999865     356


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                      .|+|+|+| +.+|..++.   .++.++...+..++.||++||+|+|+-+   |+||||||+|+|++.+..+||||||+|+
T Consensus       101 vYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR  173 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR  173 (359)
T ss_pred             eEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence            79999999 779988883   3345999999999999999999999988   9999999999999999999999999999


Q ss_pred             ccCCCCcccceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccc-
Q 013745          237 LFPGEDTHVNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKA-  314 (437)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  314 (437)
                      ...........+..+.|.+|.|||++.. ..|+.+.||||+|||+.||++|++.|.|........++............ 
T Consensus       174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~  253 (359)
T KOG0660|consen  174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQ  253 (359)
T ss_pred             eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHH
Confidence            8864322222235677999999998765 48999999999999999999999999987765554443322221111110 


Q ss_pred             -------ccc---cC----ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          315 -------LEL---VD----PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       315 -------~~~---~d----~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                             ...   ..    .......+......++|+.+|+..||.+|+|++|.++
T Consensus       254 ~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  254 KIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence                   000   00    0011222344566789999999999999999999875

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.2e-43  Score=340.63  Aligned_cols=251  Identities=26%  Similarity=0.350  Sum_probs=201.7

Q ss_pred             CccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      .|+..+.||+|+||.||+|.. .+|+.||||++....   ......+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            377889999999999999985 478999999986432   2233467889999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |+++|+|...+... ....+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++.......
T Consensus        81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            99999998877533 2346899999999999999999999998   9999999999999999999999999998764322


Q ss_pred             cccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccc
Q 013745          243 THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL  322 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  322 (437)
                      ..   ....||..|+|||++.+..++.++|||||||++|||++|+.||...........+.   ....         ...
T Consensus       157 ~~---~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~~~---------~~~  221 (285)
T cd05631         157 TV---RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD---RRVK---------EDQ  221 (285)
T ss_pred             ee---cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH---HHhh---------ccc
Confidence            21   23468999999999999999999999999999999999999998654322111111   0000         000


Q ss_pred             cCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 013745          323 AKCNRDEAAMCIQLGLLCCQQSVAERPD-----MNSVHL  356 (437)
Q Consensus       323 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~  356 (437)
                      .......+..+.+|+.+||+.+|++||+     ++++++
T Consensus       222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            1122234456788999999999999997     788775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.8e-43  Score=346.47  Aligned_cols=243  Identities=21%  Similarity=0.285  Sum_probs=199.9

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ++|++.+.||+|+||.||+|+.. +++.||||++....   ......+.+|+.++++++||||+++++++.+++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56999999999999999999854 68999999986432   233466889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      ||+++++|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            99999999988843   346888999999999999999999998   999999999999999999999999999876432


Q ss_pred             CcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                      .     ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........      ... +.      ..
T Consensus       172 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~------i~~-~~------~~  233 (329)
T PTZ00263        172 T-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEK------ILA-GR------LK  233 (329)
T ss_pred             c-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHH------Hhc-CC------cC
Confidence            2     235789999999999999999999999999999999999999976443221111      111 10      00


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHH
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAERPD-----MNSVH  355 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~  355 (437)
                      +   +......+.+++.+||+.||.+||+     +.+++
T Consensus       234 ~---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll  269 (329)
T PTZ00263        234 F---PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK  269 (329)
T ss_pred             C---CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence            1   1112345778999999999999997     56665

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-44  Score=349.89  Aligned_cols=253  Identities=22%  Similarity=0.294  Sum_probs=205.4

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ++|++.+.||+|+||.||+|+.. +++.||||++....   ......+.+|+.++..++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46999999999999999999864 68999999997542   233466889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++..... 
T Consensus        81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            99999999999843   346889999999999999999999998   99999999999999999999999999986543 


Q ss_pred             CcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                          ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.......      .  .+.
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~------~--~~~  221 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL------Q--RPV  221 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccc------c--CCC
Confidence                1224568999999999999999999999999999999999999998755433322111110000      0  011


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLM  357 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  357 (437)
                      ........+.++.+++.+|++.+|.+||++.+|++.
T Consensus       222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            111012335567889999999999999999999863

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.8e-43  Score=345.43  Aligned_cols=241  Identities=22%  Similarity=0.268  Sum_probs=196.4

Q ss_pred             ceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCCC
Q 013745           92 NQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNK  167 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  167 (437)
                      +.||+|+||.||+|.. .+|+.||||++...   .......+.+|+.++++++||||+++++++...+..++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999985 47899999999753   2333456788999999999999999999999999999999999999


Q ss_pred             CcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccce
Q 013745          168 SLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT  247 (437)
Q Consensus       168 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  247 (437)
                      +|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~  152 (323)
T cd05571          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA--TM  152 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC--cc
Confidence            99888743   356899999999999999999999998   99999999999999999999999999975432221  12


Q ss_pred             eeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCH
Q 013745          248 FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNR  327 (437)
Q Consensus       248 ~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  327 (437)
                      ...+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+      .. ..      .   ..+.
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~------~~-~~------~---~~p~  216 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LM-EE------I---RFPR  216 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHH------Hc-CC------C---CCCC
Confidence            2457999999999999999999999999999999999999999764332211111      00 00      0   1112


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 013745          328 DEAAMCIQLGLLCCQQSVAERP-----DMNSVHL  356 (437)
Q Consensus       328 ~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~  356 (437)
                      .....+.+++.+||+.||++||     ++.++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            3345678899999999999999     7888864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-44  Score=343.17  Aligned_cols=244  Identities=22%  Similarity=0.283  Sum_probs=200.8

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36899999999999999999854 68999999986432   233466889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      ||+++++|.+++..   ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            99999999998843   346889999999999999999999998   999999999999999999999999999876432


Q ss_pred             CcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                      .     ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+.      . ..        
T Consensus       155 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~------~-~~--------  214 (291)
T cd05612         155 T-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKIL------A-GK--------  214 (291)
T ss_pred             c-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------h-CC--------
Confidence            1     23568999999999999899999999999999999999999997654322211110      0 00        


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAERPD-----MNSVHL  356 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~  356 (437)
                       ...+......+.+++.+||+.||.+||+     +.++++
T Consensus       215 -~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         215 -LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             -cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence             0111122446788999999999999995     777763

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.2e-43  Score=338.46  Aligned_cols=244  Identities=19%  Similarity=0.310  Sum_probs=198.3

Q ss_pred             cceeccCCCeeEEEEEcCCCcEEEEEEeccCCh---HHHHHHHHHHHHHHcCCCCcceeeeeeecc----CCceEEEEee
Q 013745           91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR---QGLREFTNEVKLLLKIQHKNLVTLFGCCAE----GPEKMLVYEY  163 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~  163 (437)
                      ...||+|+++.||+|.. +|+.||||++.....   ...+.+.+|+.+|.+++||||+++++++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            36799999999999998 789999999975432   224678899999999999999999999876    3567899999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE-APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      +++|+|.+++..   ...+++...+.++.+++.||.|||+. +   ++||||||+|||+++++.+||+|||+++......
T Consensus       104 ~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~  177 (283)
T PHA02988        104 CTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP  177 (283)
T ss_pred             CCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence            999999999843   34688999999999999999999985 5   8899999999999999999999999998654322


Q ss_pred             cccceeeeecccccCChhhhcc--CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          243 THVNTFRISGTHGYMAPEYALH--GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                      .     ...|+..|+|||++.+  ..++.++|||||||++|||++|+.||......+....+      .....     .+
T Consensus       178 ~-----~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i------~~~~~-----~~  241 (283)
T PHA02988        178 F-----KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI------INKNN-----SL  241 (283)
T ss_pred             c-----cccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH------HhcCC-----CC
Confidence            1     2457899999999976  68999999999999999999999999865433221111      00000     01


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      .+   +...+..+.+++.+||+.||++||++.+|++.|+.
T Consensus       242 ~~---~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~  278 (283)
T PHA02988        242 KL---PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL  278 (283)
T ss_pred             CC---CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence            11   11345568899999999999999999999999875

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.6e-43  Score=339.52  Aligned_cols=264  Identities=20%  Similarity=0.269  Sum_probs=203.5

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      ++|++.+.||+|+||.||+|+.+ +++.||||++....  ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46999999999999999999864 68899999987542  2334667899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |++++.+..+..   ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            999887765542   2346899999999999999999999988   9999999999999999999999999998764322


Q ss_pred             cccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhh--------hhhccc-c
Q 013745          243 THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTW--------TLFQGE-K  313 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~-~  313 (437)
                      .. ......|++.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+....        ..+... .
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         155 NA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             cc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence            21 1223568999999999998889999999999999999999999998754433221111100        000000 0


Q ss_pred             cccccCccc-------cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          314 ALELVDPSL-------AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       314 ~~~~~d~~l-------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ......+..       .......+..+.+++.+||+.||++|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000000       0111124556899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.9e-43  Score=344.28  Aligned_cols=261  Identities=25%  Similarity=0.348  Sum_probs=204.8

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      .++|++++.||+|+||.||+++.. ++..||+|++... .......+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            467999999999999999999854 6888999998754 33445678999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||+++  +|+||||||+|||++.++.+||+|||++.......
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  158 (331)
T cd06649          84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (331)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence            9999999998843   245889999999999999999999853  39999999999999999999999999998664322


Q ss_pred             cccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccc---------
Q 013745          243 THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEK---------  313 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------  313 (437)
                          .....|++.|+|||++.+..++.++|||||||++|||++|+.||......+....+..  .......         
T Consensus       159 ----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  232 (331)
T cd06649         159 ----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGR--PVVDGEEGEPHSISPR  232 (331)
T ss_pred             ----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc--cccccccCCccccCcc
Confidence                1234689999999999998999999999999999999999999976443222111100  0000000         


Q ss_pred             --------------------cccccC----cccc-CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          314 --------------------ALELVD----PSLA-KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       314 --------------------~~~~~d----~~l~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                                          ..+..+    .... ........++.+++.+||+.||++||++.+|++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~  300 (331)
T cd06649         233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMN  300 (331)
T ss_pred             cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                                000000    0000 001124567889999999999999999999975

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.5e-43  Score=334.72  Aligned_cols=255  Identities=27%  Similarity=0.372  Sum_probs=204.4

Q ss_pred             hcCccccceeccCCCeeEEEEEcC----CCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP----NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      .++|++.+.||+|+||.||+|.+.    .+..||+|.+.... ......+.+|+.++.+++||||+++++++..++..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            356899999999999999999742    46689999987653 3345678999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      ||||+++|+|.+++...  ...+++..++.++.|++.||+|||+++   ++||||||+|||++.++.+||+|||.+....
T Consensus        84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            99999999999988432  346899999999999999999999988   9999999999999999999999999876543


Q ss_pred             CCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      ..... ......++..|+|||++.+..++.++|||||||++|||++ |+.||......+....+.       ...     
T Consensus       159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-------~~~-----  225 (266)
T cd05064         159 SEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE-------DGF-----  225 (266)
T ss_pred             ccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-------CCC-----
Confidence            22111 1112335678999999999999999999999999999775 999997654432211111       000     


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ..   ..+...+..+.+++..||+.+|.+||++.+|++.|..
T Consensus       226 ~~---~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         226 RL---PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             CC---CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence            00   1122344567889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.1e-43  Score=351.93  Aligned_cols=259  Identities=27%  Similarity=0.368  Sum_probs=203.9

Q ss_pred             hcCccccceeccCCCeeEEEEEc------CCCcEEEEEEeccCC-hHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCc
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPE  156 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  156 (437)
                      .++|++.+.||+|+||.||+|.+      .++..||||++.... ....+.+.+|+.++..+ +||||++++++|.....
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            35689999999999999999962      246689999986442 33446788999999999 89999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCC----------------------------------------------------------
Q 013745          157 KMLVYEYLPNKSLDYFIFDKTK----------------------------------------------------------  178 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------  178 (437)
                      .++|||||++|+|.+++.....                                                          
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            9999999999999988854211                                                          


Q ss_pred             --------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          179 --------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       179 --------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                                    ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                          125788999999999999999999988   999999999999999999999999999876443222


Q ss_pred             cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCcccc
Q 013745          245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA  323 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  323 (437)
                      .......++..|+|||++.+..++.++|||||||++|||++ |..||........  ....    ...+..     +...
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~--~~~~----~~~~~~-----~~~~  339 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK--FYKM----IKEGYR-----MLSP  339 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH--HHHH----HHhCcc-----CCCC
Confidence            11112334667999999999999999999999999999998 8889875432211  1111    111100     0011


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       324 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                         ...+.++.+++.+||+.+|++||++.+|+++|+.
T Consensus       340 ---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         340 ---ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             ---CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence               1123468899999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.5e-43  Score=342.96  Aligned_cols=251  Identities=23%  Similarity=0.309  Sum_probs=213.7

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCc-eEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE-KMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~  161 (437)
                      ++|+.++++|+|+||.+++++.+ +++.||+|++...  .....+...+|+.++++++|||||.+++.|.+++. ++|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            56999999999999999998744 6789999999754  33344578899999999999999999999999988 89999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      +||+||+|.+.|.+.. ...+++..+++|+.|++.|+.|||++.   |+|||||+.|||++.++.|||+|||+|+.+...
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999986543 577999999999999999999999877   999999999999999999999999999998766


Q ss_pred             CcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                      ....  ..+.||+.||.||++.+.+|+.|+|||||||++|||++-+++|.+.+......      ++...         .
T Consensus       160 ~~~a--~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~------ki~~~---------~  222 (426)
T KOG0589|consen  160 DSLA--STVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELIL------KINRG---------L  222 (426)
T ss_pred             hhhh--heecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHH------HHhhc---------c
Confidence            5333  25789999999999999999999999999999999999999998755433221      11111         1


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLM  357 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  357 (437)
                      ....+.....++..++..|++.+|..||++.+++..
T Consensus       223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            123345667778899999999999999999999875

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.6e-43  Score=335.48  Aligned_cols=257  Identities=31%  Similarity=0.524  Sum_probs=208.0

Q ss_pred             cCccccceeccCCCeeEEEEEcCC------CcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMPN------GQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM  158 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  158 (437)
                      ++|++.+.||+|+||.||+|....      ...||+|.+.... ......+.+|+.++.+++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            468899999999999999997432      2579999987543 344567899999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCC
Q 013745          159 LVYEYLPNKSLDYFIFDKTK-------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL  225 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~  225 (437)
                      ++|||+++++|.+++.....             ...+++..++.++.|++.||.|||+.+   ++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999998854321             145888999999999999999999998   99999999999999999


Q ss_pred             CceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhh
Q 013745          226 NPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSY  304 (437)
Q Consensus       226 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~  304 (437)
                      .+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+. 
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~-  240 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR-  240 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence            999999999986543332222223456788999999998899999999999999999998 999998755433221111 


Q ss_pred             hhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          305 TWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       305 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                            ..        .....+...+.++.+|+.+||+.+|++||++.+|++.|+.
T Consensus       241 ------~~--------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         241 ------SR--------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             ------cC--------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                  01        1111223455678899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.1e-43  Score=351.79  Aligned_cols=259  Identities=29%  Similarity=0.420  Sum_probs=203.5

Q ss_pred             hcCccccceeccCCCeeEEEEEcC------CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCc
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPE  156 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  156 (437)
                      .++|++.+.||+|+||.||+|+..      ++..||||++... .......+.+|+.+++.+ +|+|||+++++|.....
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            457999999999999999998731      3457999999754 333456788999999999 89999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccC-----------------------------------------------------------
Q 013745          157 KMLVYEYLPNKSLDYFIFDKT-----------------------------------------------------------  177 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~-----------------------------------------------------------  177 (437)
                      .++||||+++|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999998875321                                                           


Q ss_pred             --------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccceee
Q 013745          178 --------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR  249 (437)
Q Consensus       178 --------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  249 (437)
                              ....+++..+++++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+++.............
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                    1124788899999999999999999988   99999999999999999999999999986643322211112


Q ss_pred             eecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHH
Q 013745          250 ISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRD  328 (437)
Q Consensus       250 ~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  328 (437)
                      ..++..|+|||++.+..++.++|||||||++|||++ |+.||.........      +......     ..+....   .
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~------~~~~~~~-----~~~~~~~---~  339 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF------YKMVKRG-----YQMSRPD---F  339 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH------HHHHHcc-----cCccCCC---C
Confidence            234667999999998899999999999999999997 99999764332211      0111100     0001111   1


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          329 EAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       329 ~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      .+.++.+++.+||+.+|++||++.+|+++|+.
T Consensus       340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~  371 (374)
T cd05106         340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQR  371 (374)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            24568889999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-43  Score=340.99  Aligned_cols=245  Identities=22%  Similarity=0.240  Sum_probs=197.6

Q ss_pred             eccCCCeeEEEEEcC-CCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCCCCc
Q 013745           94 LGHGGFGPVYRGLMP-NGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL  169 (437)
Q Consensus        94 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  169 (437)
                      ||+|+||.||+|... +++.||+|++...   .......+.+|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999854 6889999998643   233456788999999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccceee
Q 013745          170 DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR  249 (437)
Q Consensus       170 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  249 (437)
                      .+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......  ....
T Consensus        81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~  152 (312)
T cd05585          81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNT  152 (312)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--cccc
Confidence            988843   346899999999999999999999998   99999999999999999999999999986432222  1224


Q ss_pred             eecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHH
Q 013745          250 ISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDE  329 (437)
Q Consensus       250 ~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  329 (437)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||......+..      .......          ...+...
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~------~~~~~~~----------~~~~~~~  216 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMY------RKILQEP----------LRFPDGF  216 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHH------HHHHcCC----------CCCCCcC
Confidence            57999999999999999999999999999999999999999764332211      1111100          0111233


Q ss_pred             HHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCCC
Q 013745          330 AAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDS  362 (437)
Q Consensus       330 ~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~  362 (437)
                      ...+.+++.+||+.+|++||++..+.+.|....
T Consensus       217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~  249 (312)
T cd05585         217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPF  249 (312)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCC
Confidence            456788999999999999997666666665544

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.1e-43  Score=324.72  Aligned_cols=263  Identities=24%  Similarity=0.266  Sum_probs=203.9

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChH--HHHHHHHHHHHHHcCCCCcceeeeeeecc--CCceEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQ--GLREFTNEVKLLLKIQHKNLVTLFGCCAE--GPEKMLV  160 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  160 (437)
                      ++|+.++.|++|.||.||+|++ ++++.||+|+++.....  -.-..++||.+|.+++|||||.+..+...  -+..|||
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            4599999999999999999995 47899999999765321  12335789999999999999999888754  3568999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      ||||+. +|..++...  .++|...++..++.|+++||+|||..+   |+||||||+|+|+...|.+||+|||+|+.+..
T Consensus       156 Me~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             HHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence            999965 888887433  368999999999999999999999998   99999999999999999999999999999876


Q ss_pred             CCcccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcc--------
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQG--------  311 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------  311 (437)
                      ....  .+..+-|.+|.|||++.+. .|+.+.||||+|||+.||+++++.|.+....+..+.+........+        
T Consensus       230 p~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~  307 (419)
T KOG0663|consen  230 PLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE  307 (419)
T ss_pred             Cccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence            5322  2245669999999999876 6999999999999999999999999998776655544332221111        


Q ss_pred             ccccccc------CccccCCCHH--HHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          312 EKALELV------DPSLAKCNRD--EAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       312 ~~~~~~~------d~~l~~~~~~--~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      -.....+      -..+......  ....-.+|+...+..||.+|-|+++-++
T Consensus       308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            1111000      0011100001  2345678888999999999999998753

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=3.3e-43  Score=331.68  Aligned_cols=252  Identities=24%  Similarity=0.422  Sum_probs=203.7

Q ss_pred             cCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecC
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLP  165 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  165 (437)
                      ++|++.+.||+|+||.||+|.++++..+|+|.+..... ....+.+|+.++++++||||+++++++......++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            45888999999999999999987788999998864432 24678899999999999999999999999999999999999


Q ss_pred             CCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCccc
Q 013745          166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV  245 (437)
Q Consensus       166 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  245 (437)
                      +|+|.+++...  ...+++..++.++.|++.||+|||+++   |+||||||+||++++++.+||+|||+++.........
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            99999988532  245889999999999999999999988   9999999999999999999999999998654322211


Q ss_pred             ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccC
Q 013745          246 NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK  324 (437)
Q Consensus       246 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  324 (437)
                       .....++..|+|||++.+..++.++||||||+++|||++ |+.||......+....+..      ...   ...+    
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~------~~~---~~~~----  223 (256)
T cd05114         158 -SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR------GFR---LYRP----  223 (256)
T ss_pred             -cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC------CCC---CCCC----
Confidence             112235668999999998889999999999999999999 8999976543322221111      000   0011    


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          325 CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       325 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                        ......+.+++.+||+.+|++||++.+|++.|.
T Consensus       224 --~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         224 --KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             --CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence              112346789999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=7.7e-43  Score=348.78  Aligned_cols=252  Identities=22%  Similarity=0.319  Sum_probs=196.5

Q ss_pred             CccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      .|++++.||+|+||+||+|+. .+++.||||++...   .......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            588999999999999999984 47889999999653   23345678899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++.+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            9999999998843   345888999999999999999999988   9999999999999999999999999986432100


Q ss_pred             c---------------------------------------------ccceeeeecccccCChhhhccCcCCcccceehhh
Q 013745          243 T---------------------------------------------HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYG  277 (437)
Q Consensus       243 ~---------------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG  277 (437)
                      .                                             .......+||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            0                                             0001135699999999999988999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHH--cCCCCCCCCCCHHHHH
Q 013745          278 VLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLL--CCQQSVAERPDMNSVH  355 (437)
Q Consensus       278 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~--cl~~~p~~RPs~~ev~  355 (437)
                      |++|||++|+.||......+....+      ........  .+...    ....++.+++.+  |+..++..||++.+|+
T Consensus       236 ~il~elltG~~Pf~~~~~~~~~~~i------~~~~~~~~--~~~~~----~~s~~~~dli~~ll~~~~~~~~R~~~~~~l  303 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTETQLKV------INWENTLH--IPPQV----KLSPEAVDLITKLCCSAEERLGRNGADDIK  303 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHHHHHH------HccccccC--CCCCC----CCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence            9999999999999865433221110      00000000  01111    123345666666  5666777799999997


Q ss_pred             H
Q 013745          356 L  356 (437)
Q Consensus       356 ~  356 (437)
                      .
T Consensus       304 ~  304 (381)
T cd05626         304 A  304 (381)
T ss_pred             c
Confidence            5

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.5e-43  Score=360.08  Aligned_cols=252  Identities=19%  Similarity=0.235  Sum_probs=205.8

Q ss_pred             CccccceeccCCCeeEEEEEcC-C-CcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMP-N-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      .|.+.+.||+|+||.||+|... + ++.||+|++..........+.+|+.+++.++|||||+++++|...+..||||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4899999999999999999743 3 6788999876666555667888999999999999999999999999999999999


Q ss_pred             CCCCcchhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          165 PNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       165 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      ++|+|.+++... ....++++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999887543 23456889999999999999999999988   99999999999999999999999999987654332


Q ss_pred             ccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcccc
Q 013745          244 HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA  323 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  323 (437)
                      .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....      .... .    .++   
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~------~~~~-~----~~~---  290 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQ------VLYG-K----YDP---  290 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhC-C----CCC---
Confidence            2223346799999999999999999999999999999999999999976543221111      1000 0    011   


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       324 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                       .+......+.+++.+||+.+|++||++.+++.
T Consensus       291 -~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        291 -FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             -CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence             11123456888999999999999999999864

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-43  Score=348.77  Aligned_cols=252  Identities=22%  Similarity=0.293  Sum_probs=196.7

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ++|.+++.||+|+||.||+|.. .+++.||||++...   .......+.+|++++++++||||++++++|.+....|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4689999999999999999984 47899999998643   2334567889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            99999999998843   356889999999999999999999998   999999999999999999999999999643211


Q ss_pred             Ccc------------c---------------------------------ceeeeecccccCChhhhccCcCCcccceehh
Q 013745          242 DTH------------V---------------------------------NTFRISGTHGYMAPEYALHGYLSVKTDVFSY  276 (437)
Q Consensus       242 ~~~------------~---------------------------------~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSl  276 (437)
                      ...            .                                 .....+||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            000            0                                 0012469999999999999999999999999


Q ss_pred             hHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCC---CCHHH
Q 013745          277 GVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAER---PDMNS  353 (437)
Q Consensus       277 G~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~R---Ps~~e  353 (437)
                      ||++|||++|+.||......+....+      .........  +.    .......+.+++.+|++ +|.+|   +++.+
T Consensus       235 Gvil~elltG~~Pf~~~~~~~~~~~i------~~~~~~~~~--p~----~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~  301 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSHETYRKI------INWRETLYF--PD----DIHLSVEAEDLIRRLIT-NAENRLGRGGAHE  301 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHHHHHHHH------HccCCccCC--CC----CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence            99999999999999765543221111      000000000  11    01123456788889997 66665   58888


Q ss_pred             HHH
Q 013745          354 VHL  356 (437)
Q Consensus       354 v~~  356 (437)
                      +++
T Consensus       302 ~l~  304 (377)
T cd05629         302 IKS  304 (377)
T ss_pred             Hhc
Confidence            875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-44  Score=342.87  Aligned_cols=247  Identities=26%  Similarity=0.409  Sum_probs=208.0

Q ss_pred             cCccccceeccCCCeeEEEEE-cCCCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      ..|..++.||+|+||.||+|. ..+++.||+|++... .....+.+.+|+.+|..++++||.++|+.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            347778999999999999998 457899999999865 344567888999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      |.||++.+.+   .....+++..+.-++++++.||.|||.++   .+|||||+.|||+..+|.+||+|||.+..+.....
T Consensus        93 ~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   93 CGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             hcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            9999999988   23344588888889999999999999998   99999999999999999999999999987755443


Q ss_pred             ccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc-c
Q 013745          244 HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS-L  322 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~-l  322 (437)
                      ..  ..++||+.|||||++....|+.|+||||||++.+||++|.+|+....+...                +-+|... .
T Consensus       167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv----------------lflIpk~~P  228 (467)
T KOG0201|consen  167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV----------------LFLIPKSAP  228 (467)
T ss_pred             cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE----------------EEeccCCCC
Confidence            33  357899999999999988999999999999999999999999976544211                1111111 1


Q ss_pred             cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          323 AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       323 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      +.......+.+.+++..|++.+|+.||++.++++
T Consensus       229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             CccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            2223356667889999999999999999999964

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.7e-44  Score=353.04  Aligned_cols=249  Identities=24%  Similarity=0.297  Sum_probs=206.6

Q ss_pred             CccccceeccCCCeeEEEEE-cCCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           87 FFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      -|+..+.||.|+-|.|-+|+ ..+|+.+|||++.+.   .......+.+|+-||+.+.||||+++|+.|++..++|||.|
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE   92 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE   92 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence            37778999999999999998 458999999999754   22334567899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |+++|.|.+++..   .+++++.++.+++.||+.|+.|+|..+   |+||||||+|+|||..+++||+|||+|.+-....
T Consensus        93 yv~gGELFdylv~---kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk  166 (786)
T KOG0588|consen   93 YVPGGELFDYLVR---KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK  166 (786)
T ss_pred             ecCCchhHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence            9999999999853   467999999999999999999999998   9999999999999999999999999998654333


Q ss_pred             cccceeeeecccccCChhhhccCcC-CcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          243 THVNTFRISGTHGYMAPEYALHGYL-SVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                      ..   ...||.+.|++||++++.+| +.++||||+|||||.||||+.||++..-..   ++..+.             ..
T Consensus       167 lL---eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~---LLlKV~-------------~G  227 (786)
T KOG0588|consen  167 LL---ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV---LLLKVQ-------------RG  227 (786)
T ss_pred             cc---cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH---HHHHHH-------------cC
Confidence            22   24699999999999999854 789999999999999999999998533221   111111             11


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                      .-..+...+.+..+|+.+|+..||.+|-|+.||++  +|.+
T Consensus       228 ~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g  268 (786)
T KOG0588|consen  228 VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSG  268 (786)
T ss_pred             cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhc
Confidence            11223345566788999999999999999999987  4554

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=6.1e-43  Score=330.66  Aligned_cols=255  Identities=26%  Similarity=0.451  Sum_probs=207.8

Q ss_pred             hcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      .++|+++++||+|+||.||+|...+++.||+|.+..... ..+.+.+|+.++++++|+||+++++++......++||||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            456999999999999999999987888999999865433 3567899999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      ++++|.+++... ....+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.........
T Consensus        84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence            999999988543 3356888999999999999999999987   999999999999999999999999999876543221


Q ss_pred             cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCcccc
Q 013745          245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA  323 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  323 (437)
                      . .....++..|+|||++....++.++|||||||++|+|++ |..||...........+   ...+.        .+.. 
T Consensus       160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~---~~~~~--------~~~~-  226 (261)
T cd05072         160 A-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL---QRGYR--------MPRM-  226 (261)
T ss_pred             c-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH---HcCCC--------CCCC-
Confidence            1 112345678999999998889999999999999999998 99999765433222111   10000        0111 


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       324 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                         ...+..+.+++.+|++.+|++||++++|+++|+.
T Consensus       227 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         227 ---ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             ---CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence               1233567889999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=8e-43  Score=340.93  Aligned_cols=241  Identities=23%  Similarity=0.267  Sum_probs=195.2

Q ss_pred             ceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCCC
Q 013745           92 NQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNK  167 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  167 (437)
                      +.||+|+||.||++.. .+|+.||+|++...   .......+.+|+.++++++||||++++++|...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999985 47899999999753   2334456788999999999999999999999999999999999999


Q ss_pred             CcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccce
Q 013745          168 SLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT  247 (437)
Q Consensus       168 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  247 (437)
                      +|..++..   ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++........  .
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--~  152 (323)
T cd05595          81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--M  152 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc--c
Confidence            99887743   346899999999999999999999998   999999999999999999999999998754322211  1


Q ss_pred             eeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCH
Q 013745          248 FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNR  327 (437)
Q Consensus       248 ~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  327 (437)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.      ...       .   ..+.
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~------~~~-------~---~~p~  216 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL------MEE-------I---RFPR  216 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh------cCC-------C---CCCC
Confidence            23568999999999999999999999999999999999999997644322211110      000       0   1111


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 013745          328 DEAAMCIQLGLLCCQQSVAERP-----DMNSVHL  356 (437)
Q Consensus       328 ~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~  356 (437)
                      .....+.+++.+||+.+|++||     ++.++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            2345677899999999999998     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-43  Score=358.43  Aligned_cols=260  Identities=23%  Similarity=0.283  Sum_probs=210.4

Q ss_pred             HHHHHHhcCccccceeccCCCeeEEEEEcCCC-cEEEEEEeccCChHHHHHHHHHHHHHHcCC-CCcceeeeeee-cc--
Q 013745           79 RTLQVATNFFSDLNQLGHGGFGPVYRGLMPNG-QEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCC-AE--  153 (437)
Q Consensus        79 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~-~~--  153 (437)
                      ..+.+...++++.+.|.+|||+.||+|....+ ..||+|++-..++...+.+.+||++|++|. |+|||.+++.. ..  
T Consensus        30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~  109 (738)
T KOG1989|consen   30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS  109 (738)
T ss_pred             eEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence            44455667899999999999999999996554 999999998888888999999999999997 99999999932 11  


Q ss_pred             ----CCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCcee
Q 013745          154 ----GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKI  229 (437)
Q Consensus       154 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl  229 (437)
                          .-+++|.||||.||.|-+++..+.... |++.++++|+.++++|+++||... ++|||||||-+||||..+|..||
T Consensus       110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KL  187 (738)
T KOG1989|consen  110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKL  187 (738)
T ss_pred             CCCceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEe
Confidence                246789999999999999997665544 999999999999999999999987 56999999999999999999999


Q ss_pred             eecccccccCCCCcccce-------eeeecccccCChhhh---ccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhh
Q 013745          230 SDFGLARLFPGEDTHVNT-------FRISGTHGYMAPEYA---LHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKA  299 (437)
Q Consensus       230 ~DFGla~~~~~~~~~~~~-------~~~~gt~~Y~aPE~~---~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~  299 (437)
                      ||||.|...-........       ....-|+.|+|||++   .+..+++|+|||+|||+||-||....||+.....   
T Consensus       188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---  264 (738)
T KOG1989|consen  188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---  264 (738)
T ss_pred             CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---
Confidence            999999754222211100       012358999999987   4668999999999999999999999999854221   


Q ss_pred             hhhhhhhhhhcccccccccCcccc-CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          300 DLLSYTWTLFQGEKALELVDPSLA-KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~d~~l~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                                      .+++.... ...+.+...+.+||..||+.+|++||++.+|+..+-
T Consensus       265 ----------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~  309 (738)
T KOG1989|consen  265 ----------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF  309 (738)
T ss_pred             ----------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence                            11111110 112467888999999999999999999999987653

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.8e-43  Score=337.57  Aligned_cols=263  Identities=24%  Similarity=0.311  Sum_probs=200.4

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      ++|++.++||.|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++......++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46999999999999999999854 78999999987442 22235677899999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +++ +|..++..  ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        85 ~~~-~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          85 LDS-DLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             CCc-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            975 88777743  2345788999999999999999999998   99999999999999999999999999986543221


Q ss_pred             ccceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcc---------cc
Q 013745          244 HVNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQG---------EK  313 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------~~  313 (437)
                      .  .....|++.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+.........         ..
T Consensus       159 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         159 T--YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             c--ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchh
Confidence            1  123467999999998876 46899999999999999999999999876544333222111100000         00


Q ss_pred             cccccCcccc-----CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          314 ALELVDPSLA-----KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       314 ~~~~~d~~l~-----~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ......+...     ...+....++.+++.+|++.||.+|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            0011111100     001122345789999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.6e-42  Score=339.59  Aligned_cols=241  Identities=23%  Similarity=0.266  Sum_probs=196.0

Q ss_pred             ceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCCC
Q 013745           92 NQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNK  167 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  167 (437)
                      +.||+|+||.||++.. .+++.||||++...   .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999984 47899999999753   2334567889999999999999999999999999999999999999


Q ss_pred             CcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccce
Q 013745          168 SLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT  247 (437)
Q Consensus       168 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  247 (437)
                      +|...+..   ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.......  ..
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~  152 (328)
T cd05593          81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TM  152 (328)
T ss_pred             CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc--cc
Confidence            99888743   346899999999999999999999998   99999999999999999999999999875432211  12


Q ss_pred             eeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCH
Q 013745          248 FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNR  327 (437)
Q Consensus       248 ~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  327 (437)
                      ...+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.      ..       +.   ..+.
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~------~~-------~~---~~p~  216 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL------ME-------DI---KFPR  216 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhc------cC-------Cc---cCCC
Confidence            23579999999999999999999999999999999999999997644322211110      00       00   1112


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 013745          328 DEAAMCIQLGLLCCQQSVAERP-----DMNSVHL  356 (437)
Q Consensus       328 ~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~  356 (437)
                      .....+.+++.+||+.+|++||     ++.++++
T Consensus       217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence            2345678899999999999997     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.9e-42  Score=344.85  Aligned_cols=276  Identities=24%  Similarity=0.318  Sum_probs=214.2

Q ss_pred             ccHHHHHHHhcCccccceeccCCCeeEEEEE-cCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCC-C-----Ccceeee
Q 013745           76 FDLRTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-H-----KNLVTLF  148 (437)
Q Consensus        76 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~  148 (437)
                      |.+..-+....+|++++.||+|.||.|-+|. .++++.||||+++... ....+...|+.+|..|+ |     -|+|+++
T Consensus       176 Y~~v~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~  254 (586)
T KOG0667|consen  176 YQLVVNDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRML  254 (586)
T ss_pred             eeEEecceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEee
Confidence            3333334445589999999999999999998 4579999999997553 34577788999999997 3     4899999


Q ss_pred             eeeccCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCC--CC
Q 013745          149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ--LN  226 (437)
Q Consensus       149 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~--~~  226 (437)
                      ++|...+++|||+|.+ ..+|.++|..+ +..+++...++.++.||+.||.+||+.+   |||+||||+||||.+-  ..
T Consensus       255 d~F~fr~HlciVfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~  329 (586)
T KOG0667|consen  255 DYFYFRNHLCIVFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSR  329 (586)
T ss_pred             eccccccceeeeehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCc
Confidence            9999999999999999 66999998654 3456999999999999999999999988   9999999999999643  46


Q ss_pred             ceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhh
Q 013745          227 PKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTW  306 (437)
Q Consensus       227 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~  306 (437)
                      +||+|||.|+.....-.     ....+..|.|||++.+.+|+.+.||||||||++||++|.+.|.+....+....+....
T Consensus       330 vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~l  404 (586)
T KOG0667|consen  330 IKVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVL  404 (586)
T ss_pred             eeEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHh
Confidence            99999999997643221     4566899999999999999999999999999999999999999887655544332111


Q ss_pred             hh---------------hcc-ccc--------------------------ccccCc-cc---c-CCCHHHHHHHHHHHHH
Q 013745          307 TL---------------FQG-EKA--------------------------LELVDP-SL---A-KCNRDEAAMCIQLGLL  339 (437)
Q Consensus       307 ~~---------------~~~-~~~--------------------------~~~~d~-~l---~-~~~~~~~~~l~~l~~~  339 (437)
                      ..               +.. ...                          .+..-| ..   . .........+++++.+
T Consensus       405 G~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~  484 (586)
T KOG0667|consen  405 GLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKR  484 (586)
T ss_pred             CCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHH
Confidence            10               111 000                          000001 00   0 1112455678999999


Q ss_pred             cCCCCCCCCCCHHHHHH--HhcCCC
Q 013745          340 CCQQSVAERPDMNSVHL--MLSGDS  362 (437)
Q Consensus       340 cl~~~p~~RPs~~ev~~--~L~~~~  362 (437)
                      |+..||.+|+|..+.++  +|.+..
T Consensus       485 ~L~~dP~~R~tp~qal~Hpfl~~~~  509 (586)
T KOG0667|consen  485 CLEWDPAERITPAQALNHPFLTGTS  509 (586)
T ss_pred             HhccCchhcCCHHHHhcCccccccc
Confidence            99999999999999975  565443

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.1e-44  Score=314.88  Aligned_cols=248  Identities=25%  Similarity=0.320  Sum_probs=210.4

Q ss_pred             hcCccccceeccCCCeeEEEEE-cCCCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      .++|++.+.||+|.||.||+|+ .+++-.||+|++.+..   .....++.+|++|-..|+||||+++|++|.+....||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            4679999999999999999998 4577889999997542   33356789999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      +||.++|+|...|... ....+++...+.++.|+|.||.|+|.++   ||||||||+|+|++..+.+||+|||.+...+.
T Consensus       101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~  176 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  176 (281)
T ss_pred             EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence            9999999999988543 4567999999999999999999999998   99999999999999999999999999987542


Q ss_pred             CCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                      .    .....|||..|++||...+..++..+|+|++|++.||++.|.+||......+....+..          .+..+|
T Consensus       177 ~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k----------~~~~~p  242 (281)
T KOG0580|consen  177 N----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK----------VDLKFP  242 (281)
T ss_pred             C----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH----------ccccCC
Confidence            2    22357999999999999999999999999999999999999999987664333222211          122222


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                            ...+....+++.+|+..+|.+|.+..||++
T Consensus       243 ------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  243 ------STISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             ------cccChhHHHHHHHHhccCccccccHHHHhh
Confidence                  344556788999999999999999999976

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.7e-43  Score=344.80  Aligned_cols=245  Identities=22%  Similarity=0.292  Sum_probs=200.2

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-C-CcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-N-GQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      .++|.+.+.||+|+||.||+|..+ . +..||+|++...   .......+.+|+.+++.++||||+++++++.+....++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            356999999999999999999853 2 368999998643   23334678899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      ||||+++|+|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus       109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            9999999999998843   346889999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                      ..     .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........      .... .      
T Consensus       183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~------i~~~-~------  244 (340)
T PTZ00426        183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK------ILEG-I------  244 (340)
T ss_pred             CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHH------HhcC-C------
Confidence            32     1245799999999999998899999999999999999999999986543221111      1110 0      


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERP-----DMNSVHL  356 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~  356 (437)
                         ...+......+.+++.+|++.+|.+|+     +++++++
T Consensus       245 ---~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        245 ---IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence               001112234567899999999999995     8888865

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.7e-43  Score=330.29  Aligned_cols=273  Identities=23%  Similarity=0.299  Sum_probs=222.2

Q ss_pred             HHhcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceE
Q 013745           83 VATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM  158 (437)
Q Consensus        83 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  158 (437)
                      +..+.|+.++.||+|.-|+||++... ++..+|+|++.+..   .....+...|.+||+.++||.++.||..|+.+...|
T Consensus        74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~c  153 (459)
T KOG0610|consen   74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSC  153 (459)
T ss_pred             cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeE
Confidence            34467899999999999999999965 56899999997653   444566788999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccccc
Q 013745          159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                      ||||||+||+|..++ +++....+++..++.++.+++.||+|||-.|   ||+|||||+||||.++|++.|+||.|+...
T Consensus       154 l~meyCpGGdL~~Lr-qkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  154 LVMEYCPGGDLHSLR-QKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             EEEecCCCccHHHHH-hhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccC
Confidence            999999999998876 4556678999999999999999999999999   999999999999999999999999998643


Q ss_pred             CCCC---------------------------------c---------------------ccceeeeecccccCChhhhcc
Q 013745          239 PGED---------------------------------T---------------------HVNTFRISGTHGYMAPEYALH  264 (437)
Q Consensus       239 ~~~~---------------------------------~---------------------~~~~~~~~gt~~Y~aPE~~~~  264 (437)
                      ....                                 .                     ......++||-.|+|||++.+
T Consensus       230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G  309 (459)
T KOG0610|consen  230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG  309 (459)
T ss_pred             CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence            2100                                 0                     000123569999999999999


Q ss_pred             CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCC
Q 013745          265 GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQS  344 (437)
Q Consensus       265 ~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~  344 (437)
                      ...+.++|+|+|||+||||+.|..||.+....+....+-...             ...++. +.....+.+||++.|..|
T Consensus       310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~-------------l~Fp~~-~~vs~~akDLIr~LLvKd  375 (459)
T KOG0610|consen  310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQP-------------LKFPEE-PEVSSAAKDLIRKLLVKD  375 (459)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCC-------------CcCCCC-CcchhHHHHHHHHHhccC
Confidence            999999999999999999999999999988776544322111             111121 245567889999999999


Q ss_pred             CCCCCC----HHHHHH--HhcCCCCCCCCCCCCCC
Q 013745          345 VAERPD----MNSVHL--MLSGDSFTLPKPGKPGI  373 (437)
Q Consensus       345 p~~RPs----~~ev~~--~L~~~~~~~~~p~~p~~  373 (437)
                      |++|..    +.||.+  ++++..+.+-.-..|+.
T Consensus       376 P~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~  410 (459)
T KOG0610|consen  376 PSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPE  410 (459)
T ss_pred             hhhhhccccchHHhhcCccccCCChhheeccCCCc
Confidence            999998    888875  78887666654444443

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=8.5e-43  Score=340.88  Aligned_cols=244  Identities=27%  Similarity=0.356  Sum_probs=194.2

Q ss_pred             ccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC---hHHHHHHHHHHHHH---HcCCCCcceeeeeeeccCCceEEE
Q 013745           88 FSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLL---LKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        88 y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      |++++.||+|+||.||+|.. .+++.||||++....   ....+.+.+|++++   ..++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            67889999999999999985 478999999997432   22345566776665   566799999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||+++++|...+.    ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            99999999987772    346899999999999999999999998   99999999999999999999999999875432


Q ss_pred             CCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                      ...  ......|++.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+.      ...       .
T Consensus       154 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~------~~~-------~  218 (324)
T cd05589         154 FGD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV------NDE-------V  218 (324)
T ss_pred             CCC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hCC-------C
Confidence            221  1224578999999999999999999999999999999999999998654332211110      000       0


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERPD-----MNSVHL  356 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~  356 (437)
                         ..+...+..+.+++.+||+.+|.+||+     +.++++
T Consensus       219 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         219 ---RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence               111123455788999999999999994     555544

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=8.5e-43  Score=332.94  Aligned_cols=257  Identities=26%  Similarity=0.449  Sum_probs=206.9

Q ss_pred             hcCccccceeccCCCeeEEEEEcC------CCcEEEEEEeccCChH-HHHHHHHHHHHHHcCCCCcceeeeeeeccCCce
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVDSRQ-GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK  157 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  157 (437)
                      .++|.+.+.||+|+||.||+|...      +++.||||++...... ....+.+|++++++++|+||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            346888999999999999999753      3478999999765433 457899999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCC
Q 013745          158 MLVYEYLPNKSLDYFIFDKT-----------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN  226 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~  226 (437)
                      ++||||+++++|.+++....           ....+++..+..++.|++.||.|||+++   ++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence            99999999999999985432           2345788999999999999999999998   999999999999999999


Q ss_pred             ceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhh
Q 013745          227 PKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYT  305 (437)
Q Consensus       227 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~  305 (437)
                      +||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......+....+   
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~---  237 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI---  237 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---
Confidence            99999999986533222111122345788999999999999999999999999999998 99999765443322111   


Q ss_pred             hhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          306 WTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       306 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                      .    .+.        ....+...+..+.+++.+||+.+|++||++.||++.|+
T Consensus       238 ~----~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         238 T----QGR--------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             H----cCC--------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            1    111        01111234456889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-43  Score=350.37  Aligned_cols=257  Identities=29%  Similarity=0.405  Sum_probs=207.2

Q ss_pred             hcCccccceeccCCCeeEEEEEcC--CC---cEEEEEEecc---CChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCc
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP--NG---QEIAVKKLSV---DSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE  156 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~---~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  156 (437)
                      .++-...++||+|+||.||+|.++  ++   ..||||....   .......+|++|+++|+.++|||||++||++.....
T Consensus       156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P  235 (474)
T KOG0194|consen  156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP  235 (474)
T ss_pred             ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence            445555689999999999999854  22   2389998874   346677899999999999999999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                      +++|||+|.||+|+++|...  ...++..+.+.++.+.|.||+|||+++   +|||||-.+|+|++.++.+||+||||++
T Consensus       236 l~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~  310 (474)
T KOG0194|consen  236 LMLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSR  310 (474)
T ss_pred             cEEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcccccc
Confidence            99999999999999999433  236999999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccc
Q 013745          237 LFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKAL  315 (437)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (437)
                      .-........  ...-...|+|||.+..+.|+.++|||||||++||+++ |..||.+....+....+.      ..+.. 
T Consensus       311 ~~~~~~~~~~--~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~------~~~~r-  381 (474)
T KOG0194|consen  311 AGSQYVMKKF--LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV------KNGYR-  381 (474)
T ss_pred             CCcceeeccc--cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH------hcCcc-
Confidence            6431111110  1123578999999999999999999999999999998 889999876654332220      10100 


Q ss_pred             cccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCCC
Q 013745          316 ELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDS  362 (437)
Q Consensus       316 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~  362 (437)
                             ...+...+..+..++..||..+|++||+|.+|.+.|+...
T Consensus       382 -------~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~  421 (474)
T KOG0194|consen  382 -------MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE  421 (474)
T ss_pred             -------CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence                   0112244556777888999999999999999999998543

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-43  Score=333.43  Aligned_cols=246  Identities=24%  Similarity=0.382  Sum_probs=207.3

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      ..+|++.+.||+|.||.|-+|.. ..|+.||||.++++   ++++.-.+.+|++||..|+||||+.++.+|++.+...||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            45699999999999999999984 68999999999765   456667789999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||..+|.|.+++.+   .+.+++.++..+++||+.|+.|+|.++   ++|||||.+|||||.|+++||+||||+.++..
T Consensus       132 MEYaS~GeLYDYiSe---r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  132 MEYASGGELYDYISE---RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEecCCccHHHHHHH---hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            999999999999944   467999999999999999999999988   99999999999999999999999999998855


Q ss_pred             CCcccceeeeecccccCChhhhccCcC-CcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGYL-SVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                      ....   ..+||++-|.+||++.+..| ++.+|-|||||+||-|+.|..||++.+.......+      .. +...   .
T Consensus       206 ~kfL---qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQI------s~-GaYr---E  272 (668)
T KOG0611|consen  206 KKFL---QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQI------SR-GAYR---E  272 (668)
T ss_pred             ccHH---HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHh------hc-cccc---C
Confidence            4432   35799999999999998865 68899999999999999999999986543322111      11 1110   1


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      |       ..+....-|++||+-.+|++|.|+.+|..
T Consensus       273 P-------~~PSdA~gLIRwmLmVNP~RRATieDiAs  302 (668)
T KOG0611|consen  273 P-------ETPSDASGLIRWMLMVNPERRATIEDIAS  302 (668)
T ss_pred             C-------CCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence            1       12223445788999999999999999975

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-42  Score=329.17  Aligned_cols=255  Identities=28%  Similarity=0.431  Sum_probs=207.0

Q ss_pred             hcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      .++|++.+.||+|+||.||+|...+++.||+|.+..... ..+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            456999999999999999999977778899999875432 3467889999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      ++++|.+++.... ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++........
T Consensus        84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05068          84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE  159 (261)
T ss_pred             cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence            9999999985432 346899999999999999999999988   999999999999999999999999999877532211


Q ss_pred             cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCcccc
Q 013745          245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA  323 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  323 (437)
                       .......+..|+|||++.+..++.++||||||+++|||++ |+.||.+.........+.       ...     ..   
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~-----~~---  223 (261)
T cd05068         160 -AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-------QGY-----RM---  223 (261)
T ss_pred             -ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-------cCC-----CC---
Confidence             1111223457999999998899999999999999999999 999997654322211111       000     00   


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       324 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ......+..+.+++.+|++.+|++||++.+|++.|+.
T Consensus       224 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         224 PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            0112334568899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=9.3e-44  Score=332.03  Aligned_cols=259  Identities=25%  Similarity=0.339  Sum_probs=202.7

Q ss_pred             CccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC-----ceEEE
Q 013745           87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP-----EKMLV  160 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lv  160 (437)
                      .|...+++|.|+||.||+|+. .+++.||||+.-.+.+..    -+|+.+|++++|||||+++.+|....     ...||
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            477789999999999999984 467999999987654321    26999999999999999999885322     34589


Q ss_pred             EeecCCCCcchhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCC-CCceeeeccccccc
Q 013745          161 YEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ-LNPKISDFGLARLF  238 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~-~~~kl~DFGla~~~  238 (437)
                      |||++. +|..++... ..+..++...+.-++.||++||+|||+.+   |+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L  176 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL  176 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence            999976 777777532 23466888888899999999999999988   9999999999999966 99999999999998


Q ss_pred             CCCCcccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccc---
Q 013745          239 PGEDTHVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKA---  314 (437)
Q Consensus       239 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---  314 (437)
                      .......   ....|..|.|||.+.+. .|+.+.||||.|||+.||+-|++.|.|.+..+....+-........+.+   
T Consensus       177 ~~~epni---SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m  253 (364)
T KOG0658|consen  177 VKGEPNI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM  253 (364)
T ss_pred             ccCCCce---eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            6655443   34569999999998876 7999999999999999999999999998876665544333322221111   


Q ss_pred             ----ccccCcccc-----C-CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          315 ----LELVDPSLA-----K-CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       315 ----~~~~d~~l~-----~-~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                          .+.-.+.+.     . .......+.++++.++++.+|.+|.++.|++.
T Consensus       254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence                111222221     1 33455677899999999999999999999875

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=8.7e-43  Score=332.78  Aligned_cols=259  Identities=23%  Similarity=0.375  Sum_probs=204.8

Q ss_pred             HHhcCccccceeccCCCeeEEEEEcC------CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC
Q 013745           83 VATNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP  155 (437)
Q Consensus        83 ~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  155 (437)
                      +.+++|++.+.||+|+||.||+|...      .+..||||++... .......+.+|+.+++.++||||+++++++..+.
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            35678999999999999999998742      3567999998643 2334567889999999999999999999999999


Q ss_pred             ceEEEEeecCCCCcchhhhccCC-------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCce
Q 013745          156 EKMLVYEYLPNKSLDYFIFDKTK-------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPK  228 (437)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~k  228 (437)
                      ..++||||+++++|.+++.....       ...+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+|
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence            99999999999999998854221       234678889999999999999999987   99999999999999999999


Q ss_pred             eeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhh
Q 013745          229 ISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWT  307 (437)
Q Consensus       229 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~  307 (437)
                      |+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.+.........+     
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~-----  234 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV-----  234 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-----
Confidence            999999986543322211112345778999999999899999999999999999999 78898765433221111     


Q ss_pred             hhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          308 LFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       308 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                        ....        ....+...+..+.+++.+||+.+|++||++.|+++.|+
T Consensus       235 --~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         235 --MEGG--------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             --HcCC--------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence              0000        00111123456889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.4e-42  Score=338.87  Aligned_cols=245  Identities=22%  Similarity=0.260  Sum_probs=190.5

Q ss_pred             ceeccCCCeeEEEEEcC-CCcEEEEEEeccCC---hHHHHHHHHHHH-HHHcCCCCcceeeeeeeccCCceEEEEeecCC
Q 013745           92 NQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS---RQGLREFTNEVK-LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN  166 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  166 (437)
                      +.||+|+||.||+|+.. +++.||+|++....   ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999854 68899999986432   222344555554 67889999999999999999999999999999


Q ss_pred             CCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccc
Q 013745          167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN  246 (437)
Q Consensus       167 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  246 (437)
                      ++|...+..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~  152 (321)
T cd05603          81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--T  152 (321)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--c
Confidence            999877732   346888899999999999999999988   99999999999999999999999999875322221  1


Q ss_pred             eeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCC
Q 013745          247 TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCN  326 (437)
Q Consensus       247 ~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  326 (437)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........   .   ..... .         ...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~---~i~~~-~---------~~~~  216 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMY---D---NILHK-P---------LQLP  216 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHH---H---HHhcC-C---------CCCC
Confidence            22457899999999999889999999999999999999999999765422211   1   11110 0         0111


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHH-HHHHHhcC
Q 013745          327 RDEAAMCIQLGLLCCQQSVAERPDMN-SVHLMLSG  360 (437)
Q Consensus       327 ~~~~~~l~~l~~~cl~~~p~~RPs~~-ev~~~L~~  360 (437)
                      ......+.+++.+|++.+|.+||++. ++.+.++.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  251 (321)
T cd05603         217 GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNH  251 (321)
T ss_pred             CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCC
Confidence            23345678899999999999999764 33444443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.6e-42  Score=346.92  Aligned_cols=258  Identities=19%  Similarity=0.209  Sum_probs=195.8

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      .++|++++.||+|+||.||+|.. .+++.||+|+...      ..+.+|++++++|+|||||+++++|......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            36799999999999999999984 4789999997532      3467899999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +. ++|..++..   ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus       165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA  237 (391)
T ss_pred             CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence            95 678777633   245889999999999999999999998   99999999999999999999999999975432211


Q ss_pred             ccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhh----hhhhhhhhhhhc---c-----
Q 013745          244 HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK----ADLLSYTWTLFQ---G-----  311 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~----~~~~~~~~~~~~---~-----  311 (437)
                      . ......||+.|+|||++.+..++.++|||||||++|||++|+.||........    ...+........   .     
T Consensus       238 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        238 N-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             c-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            1 12245799999999999999999999999999999999999988754321110    000000000000   0     


Q ss_pred             --ccccc---------ccCcccc---CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          312 --EKALE---------LVDPSLA---KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       312 --~~~~~---------~~d~~l~---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                        .....         ...+...   ......+..+.+|+.+||+.||++|||+.|+++
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence              00000         0000000   001134567889999999999999999999974

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7.1e-43  Score=342.82  Aligned_cols=263  Identities=22%  Similarity=0.322  Sum_probs=196.4

Q ss_pred             CccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccC-----CceE
Q 013745           87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG-----PEKM  158 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~  158 (437)
                      +|++.+.||+|+||.||+|+. .+++.||||++...  .......+.+|+.++++++||||+++++++...     ...|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            488999999999999999984 47899999998643  223345688999999999999999999987543     3479


Q ss_pred             EEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccccc
Q 013745          159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                      +||||+. ++|..++.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIK---ANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHH---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 68887773   2346899999999999999999999998   999999999999999999999999999865


Q ss_pred             CCCCcc-cceeeeecccccCChhhhcc--CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhh--------h
Q 013745          239 PGEDTH-VNTFRISGTHGYMAPEYALH--GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTW--------T  307 (437)
Q Consensus       239 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~--------~  307 (437)
                      ...... .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||.+.........+....        .
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  233 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS  233 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            322211 11123568999999999876  578999999999999999999999997654322211110000        0


Q ss_pred             hhccccc---ccccC----ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          308 LFQGEKA---LELVD----PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       308 ~~~~~~~---~~~~d----~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .......   ...+.    ..+....+.....+.+++.+||+.+|++||++.|+++
T Consensus       234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            0000000   00000    0000111123455789999999999999999999975

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-42  Score=344.20  Aligned_cols=252  Identities=23%  Similarity=0.314  Sum_probs=198.9

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ++|++++.||+|+||.||+|+.. +++.||||++...   .......+.+|+.++..++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46999999999999999999854 7899999999753   2334456788999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            99999999998843   346899999999999999999999998   999999999999999999999999999765321


Q ss_pred             Cccc------------------------------------ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh
Q 013745          242 DTHV------------------------------------NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS  285 (437)
Q Consensus       242 ~~~~------------------------------------~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt  285 (437)
                      ....                                    .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            1100                                    0112469999999999999999999999999999999999


Q ss_pred             CCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHH
Q 013745          286 GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPD---MNSVHL  356 (437)
Q Consensus       286 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~ev~~  356 (437)
                      |..||......+....+      ........  .+...    .....+.+++.+|+. +|.+|++   +.++++
T Consensus       235 G~~Pf~~~~~~~~~~~i------~~~~~~~~--~~~~~----~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         235 GYPPFCSDNPQETYRKI------INWKETLQ--FPDEV----PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCCCHHHHHHHH------HcCCCccC--CCCCC----CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            99999865543221111      00000000  01100    123456778888886 9999998   777755

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.2e-42  Score=338.99  Aligned_cols=251  Identities=23%  Similarity=0.300  Sum_probs=197.4

Q ss_pred             CccccceeccCCCeeEEEEEc----CCCcEEEEEEeccC----ChHHHHHHHHHHHHHHcCC-CCcceeeeeeeccCCce
Q 013745           87 FFSDLNQLGHGGFGPVYRGLM----PNGQEIAVKKLSVD----SRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEK  157 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  157 (437)
                      +|++.+.||+|+||.||+++.    .+++.||+|++...    .....+.+..|+.++..++ ||||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            488999999999999999874    36889999998643    2233456788999999994 99999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                      ++||||+++|+|..++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            999999999999988843   346889999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCcccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccc
Q 013745          238 FPGEDTHVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE  316 (437)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (437)
                      +...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+.  .....      
T Consensus       155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~--~~~~~------  225 (332)
T cd05614         155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVS--RRILK------  225 (332)
T ss_pred             ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHH--HHHhc------
Confidence            5433222 12245799999999999875 48899999999999999999999997543221111110  01100      


Q ss_pred             ccCccccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 013745          317 LVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERP-----DMNSVHL  356 (437)
Q Consensus       317 ~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~  356 (437)
                       .++.+   +......+.+++.+||+.+|++||     ++.++++
T Consensus       226 -~~~~~---~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         226 -CDPPF---PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             -CCCCC---CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence             11111   112345577889999999999999     5666653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7e-43  Score=334.18  Aligned_cols=256  Identities=26%  Similarity=0.356  Sum_probs=204.0

Q ss_pred             HHHHHhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCCh--------------HHHHHHHHHHHHHHcCCCCcc
Q 013745           80 TLQVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSR--------------QGLREFTNEVKLLLKIQHKNL  144 (437)
Q Consensus        80 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~ni  144 (437)
                      +-....++|++.+.||+|.||.|-+|+. .+++.||||++.+...              ...+...+||.||++|+||||
T Consensus        91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV  170 (576)
T KOG0585|consen   91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV  170 (576)
T ss_pred             ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence            3345568899999999999999999984 4799999999965321              113568899999999999999


Q ss_pred             eeeeeeeccC--CceEEEEeecCCCCcchhhhccCCCCC-CCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEe
Q 013745          145 VTLFGCCAEG--PEKMLVYEYLPNKSLDYFIFDKTKSSS-LDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL  221 (437)
Q Consensus       145 v~l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll  221 (437)
                      |+|+.+..+.  +.+|||+|||..|.+...-    .... +++.++++++++++.||+|||.++   ||||||||+|+||
T Consensus       171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl  243 (576)
T KOG0585|consen  171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLL  243 (576)
T ss_pred             eEEEEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEE
Confidence            9999998654  5789999999999885442    2334 899999999999999999999999   9999999999999


Q ss_pred             cCCCCceeeecccccccCCCC---cccceeeeecccccCChhhhccC----cCCcccceehhhHHHHHHHhCCCCCCCCC
Q 013745          222 DEQLNPKISDFGLARLFPGED---THVNTFRISGTHGYMAPEYALHG----YLSVKTDVFSYGVLVLEIVSGRKNHDGRL  294 (437)
Q Consensus       222 ~~~~~~kl~DFGla~~~~~~~---~~~~~~~~~gt~~Y~aPE~~~~~----~~~~~~DvwSlG~vl~elltg~~p~~~~~  294 (437)
                      +++|++||+|||.+..+....   ........+|||.|+|||.+.++    ..+.+.||||+||.||.|+.|+.||-+..
T Consensus       244 ~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~  323 (576)
T KOG0585|consen  244 SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF  323 (576)
T ss_pred             cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence            999999999999998773321   11112236799999999999874    45778999999999999999999997654


Q ss_pred             chhhhhhhhhhhhhhcccccccccCccc-cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013745          295 GKEKADLLSYTWTLFQGEKALELVDPSL-AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLM  357 (437)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  357 (437)
                      ..+..+.+               +...+ ....+++...+.+|++++|+.||+.|.+..+|..-
T Consensus       324 ~~~l~~KI---------------vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H  372 (576)
T KOG0585|consen  324 ELELFDKI---------------VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH  372 (576)
T ss_pred             HHHHHHHH---------------hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence            43322211               11111 12233567778899999999999999999998653

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.5e-42  Score=345.99  Aligned_cols=251  Identities=23%  Similarity=0.313  Sum_probs=195.1

Q ss_pred             CccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      +|++++.||+|+||.||+|+. .+++.||||++....   ......+.+|+++|++++||||+++++.+.+++..++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            699999999999999999984 468999999986432   2234568899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          82 YIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            9999999999843   346888999999999999999999998   9999999999999999999999999985331100


Q ss_pred             c-----------------------------------------ccceeeeecccccCChhhhccCcCCcccceehhhHHHH
Q 013745          243 T-----------------------------------------HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVL  281 (437)
Q Consensus       243 ~-----------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~  281 (437)
                      .                                         .......+||+.|+|||++.+..++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence            0                                         00011346999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHH
Q 013745          282 EIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERP---DMNSVHL  356 (437)
Q Consensus       282 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RP---s~~ev~~  356 (437)
                      ||++|+.||.+....+....+.      ....  ....+....    ....+.+++.+|+ .+|.+|+   ++.++++
T Consensus       236 ell~G~~Pf~~~~~~~~~~~i~------~~~~--~~~~~~~~~----~s~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         236 EMLVGQPPFLADTPAETQLKVI------NWET--TLHIPSQAK----LSREASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             ehhhCCCCCCCCCHHHHHHHHh------ccCc--cccCCCCCC----CCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            9999999998755433211110      0000  000111111    2334556666765 4999999   7777764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.3e-42  Score=338.26  Aligned_cols=254  Identities=26%  Similarity=0.452  Sum_probs=201.7

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCc----EEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQ----EIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      .+|++.+.||+|+||.||+|++. +++    .||+|++... .....+.+.+|+.+++.++||||+++++++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46999999999999999999853 343    3899998654 334456788999999999999999999999765 5789


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      |+||+++|+|.+++...  ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+.
T Consensus        86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence            99999999999988533  345888999999999999999999998   9999999999999999999999999999775


Q ss_pred             CCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      ............++..|+|||++.+..++.++|||||||++|||++ |+.||.+....+....       ......  . 
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~-------~~~~~~--~-  230 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-------LEKGER--L-  230 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------HhCCCC--C-
Confidence            4333222222334678999999999999999999999999999998 9999976443221111       111100  0 


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                       +.    +......+.+++.+||+.+|.+||++.+|+..|..
T Consensus       231 -~~----~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~  267 (316)
T cd05108         231 -PQ----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK  267 (316)
T ss_pred             -CC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence             00    11223457889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=9.7e-43  Score=329.11  Aligned_cols=255  Identities=31%  Similarity=0.470  Sum_probs=210.8

Q ss_pred             hcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      ..+|++.++||.|+||.||+|...+++.+|+|++..........+.+|+.+++.++|+||+++++++......++||||+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM   84 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence            45689999999999999999998778999999998766655677899999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      ++++|.+++... ....+++..++.++.||+.||.|||+.+   |+|+||||+||++++++.+||+|||++.........
T Consensus        85 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~  160 (261)
T cd05148          85 EKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL  160 (261)
T ss_pred             ccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence            999999998543 2356899999999999999999999988   999999999999999999999999999876432211


Q ss_pred             cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCcccc
Q 013745          245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA  323 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  323 (437)
                      ..  ...++..|+|||++....++.++||||||+++|+|++ |+.||......+....+   ..    ..     ..   
T Consensus       161 ~~--~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~---~~----~~-----~~---  223 (261)
T cd05148         161 SS--DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI---TA----GY-----RM---  223 (261)
T ss_pred             cc--CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH---Hh----CC-----cC---
Confidence            11  2335678999999998899999999999999999998 89999765433222111   11    00     00   


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       324 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ......+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus       224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            1112334567899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-43  Score=344.64  Aligned_cols=252  Identities=24%  Similarity=0.304  Sum_probs=203.5

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ++|.+.+.||+|+||.||+|... +++.||||++....   ......+.+|+.++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46999999999999999999854 78999999997532   234567889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      ||+++++|.+++...   ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999998543   56899999999999999999999988   999999999999999999999999999876543


Q ss_pred             C---------------------------cccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCC
Q 013745          242 D---------------------------THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRL  294 (437)
Q Consensus       242 ~---------------------------~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~  294 (437)
                      .                           .........||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                           0011223568999999999999999999999999999999999999998655


Q ss_pred             chhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHH
Q 013745          295 GKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPD-MNSVHL  356 (437)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~ev~~  356 (437)
                      .......+.      ....  ....+...    ..+..+.+++..|++ +|.+||+ +.++++
T Consensus       235 ~~~~~~~i~------~~~~--~~~~p~~~----~~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         235 LQETYNKII------NWKE--SLRFPPDP----PVSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             HHHHHHHHh------ccCC--cccCCCCC----CCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            332211111      0000  00001111    134567788899997 9999999 999976

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.6e-42  Score=342.77  Aligned_cols=205  Identities=24%  Similarity=0.358  Sum_probs=176.6

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ++|++++.||+|+||+||+|.. .+++.||||++....   ......+.+|+.++.+++|+||+++++.+.+....|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            4689999999999999999984 468999999997532   233456788999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            99999999998843   356899999999999999999999998   999999999999999999999999999765321


Q ss_pred             Ccc---------------------------------cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCC
Q 013745          242 DTH---------------------------------VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRK  288 (437)
Q Consensus       242 ~~~---------------------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~  288 (437)
                      ...                                 ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            100                                 00123579999999999999999999999999999999999999


Q ss_pred             CCCCCCch
Q 013745          289 NHDGRLGK  296 (437)
Q Consensus       289 p~~~~~~~  296 (437)
                      ||.+....
T Consensus       235 Pf~~~~~~  242 (363)
T cd05628         235 PFCSETPQ  242 (363)
T ss_pred             CCCCCCHH
Confidence            99865543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.2e-42  Score=340.65  Aligned_cols=252  Identities=22%  Similarity=0.276  Sum_probs=201.3

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ++|.+.+.||+|+||.||+|.. .+++.||||++....   ......+.+|+.+++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            4689999999999999999985 478999999997542   234466889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      ||+++|+|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            999999999988433  246899999999999999999999998   999999999999999999999999999876543


Q ss_pred             CcccceeeeecccccCChhhhc------cCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccc
Q 013745          242 DTHVNTFRISGTHGYMAPEYAL------HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKAL  315 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~------~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (437)
                      ... ......||+.|+|||++.      ...++.++|||||||++|||++|+.||..........      .+.......
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~------~i~~~~~~~  228 (330)
T cd05601         156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN------NIMNFQRFL  228 (330)
T ss_pred             Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHH------HHHcCCCcc
Confidence            322 122346899999999987      4568899999999999999999999997654332211      111111111


Q ss_pred             cccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          316 ELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       316 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ..  +.    .......+.+++..|++ +|++||++.+++.
T Consensus       229 ~~--~~----~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         229 KF--PE----DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             CC--CC----CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            10  11    11234457788889998 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.7e-42  Score=337.20  Aligned_cols=242  Identities=27%  Similarity=0.346  Sum_probs=194.6

Q ss_pred             cceeccCCCeeEEEEEc----CCCcEEEEEEeccC----ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           91 LNQLGHGGFGPVYRGLM----PNGQEIAVKKLSVD----SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      ++.||+|+||.||++..    .+++.||||++...    .......+.+|+.+|++++||||++++++|..++..|+|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            36799999999999974    35789999998643    22334567889999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |+++++|.+.+..   ...+.+..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        81 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          81 YLSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             CCCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            9999999888843   345788889999999999999999998   9999999999999999999999999997543222


Q ss_pred             cccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccc
Q 013745          243 THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL  322 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  322 (437)
                      ..  .....||+.|+|||++.+..++.++|||||||++|||++|+.||..........      ..... .         
T Consensus       155 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~------~~~~~-~---------  216 (323)
T cd05584         155 TV--THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID------KILKG-K---------  216 (323)
T ss_pred             Cc--ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHH------HHHcC-C---------
Confidence            21  223568999999999998889999999999999999999999997644322111      11110 0         


Q ss_pred             cCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 013745          323 AKCNRDEAAMCIQLGLLCCQQSVAERP-----DMNSVHL  356 (437)
Q Consensus       323 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~  356 (437)
                      ...+......+.+++.+||+.+|++||     ++.++++
T Consensus       217 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         217 LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            011122345578899999999999999     7888765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-42  Score=327.17  Aligned_cols=256  Identities=27%  Similarity=0.415  Sum_probs=205.8

Q ss_pred             hcCccccceeccCCCeeEEEEEcC----CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP----NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      .++|++.+.||+|+||.||+|.+.    +...||||++... .......+.+|+.++++++||||+++++++......++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            356999999999999999999864    2457899998754 33345678899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      ||||+++++|.+++...  ...+++..++.++.|++.||.|||+++   |+|+||||+|||+++++.+||+|||+++.+.
T Consensus        83 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          83 ITEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            99999999999998432  346899999999999999999999988   9999999999999999999999999999875


Q ss_pred             CCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      ............++..|+|||.+.+..++.++||||||+++|||++ |..||...........+.       ...    .
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-------~~~----~  226 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-------DGY----R  226 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH-------cCC----C
Confidence            2222222212334678999999998899999999999999999998 999996544332211111       000    0


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      .+.    ....+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       227 ~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~  264 (266)
T cd05033         227 LPP----PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK  264 (266)
T ss_pred             CCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            011    11334568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.6e-42  Score=342.99  Aligned_cols=247  Identities=25%  Similarity=0.348  Sum_probs=194.3

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      ++|+.++.||+|+||.||+|+. .+++.||||++... .......+.+|+++++.++|+||+++++++...+..++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            4577789999999999999985 47899999998654 333456789999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +++++|....       ...+..+..++.||+.||.|||+++   |+||||||+|||+++++.+||+|||+++.+.....
T Consensus       154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            9999985432       3456788899999999999999998   99999999999999999999999999987643221


Q ss_pred             ccceeeeecccccCChhhhcc-----CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          244 HVNTFRISGTHGYMAPEYALH-----GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      .  .....||..|+|||++..     ...+.++|||||||++|||++|+.||......+...+...   ....       
T Consensus       224 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~---~~~~-------  291 (353)
T PLN00034        224 P--CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA---ICMS-------  291 (353)
T ss_pred             c--ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH---Hhcc-------
Confidence            1  123468999999998743     3456799999999999999999999974322211111110   0000       


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                        ............+.+++.+||+.+|++||++.||++
T Consensus       292 --~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        292 --QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             --CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              001112234556889999999999999999999976

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.7e-42  Score=338.64  Aligned_cols=266  Identities=24%  Similarity=0.333  Sum_probs=204.1

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      .++|++.+.||+|+||.||++... ++..+|+|++... .......+.+|++++++++||||++++++|.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            478999999999999999999854 6888999988754 33345678999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||+.+  +|+||||||+|||++.++.+||+|||++..+....
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~  158 (333)
T cd06650          84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (333)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence            9999999998843   345888999999999999999999852  39999999999999999999999999997653321


Q ss_pred             cccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhc------------
Q 013745          243 THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQ------------  310 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~------------  310 (437)
                      .    ....|+..|+|||++.+..++.++|||||||++|||++|+.||...........+........            
T Consensus       159 ~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (333)
T cd06650         159 A----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPP  234 (333)
T ss_pred             c----ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCc
Confidence            1    134689999999999988999999999999999999999999976443222111100000000            


Q ss_pred             --------cc-----ccccccCccc----cCC-CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--Hhc
Q 013745          311 --------GE-----KALELVDPSL----AKC-NRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLS  359 (437)
Q Consensus       311 --------~~-----~~~~~~d~~l----~~~-~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~  359 (437)
                              ..     ......+...    ... ......++.+++.+||+.||++||++.|+++  +|+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~  303 (333)
T cd06650         235 GRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIK  303 (333)
T ss_pred             cchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHh
Confidence                    00     0000000000    000 0012356789999999999999999999964  454

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.5e-42  Score=331.67  Aligned_cols=258  Identities=26%  Similarity=0.425  Sum_probs=207.3

Q ss_pred             cCccccceeccCCCeeEEEEEc------CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      ++|.+.+.||+|+||.||++..      .++..+|+|.+..........+.+|+.++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            5688999999999999999973      2345689999876666666789999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccC----------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCcee
Q 013745          160 VYEYLPNKSLDYFIFDKT----------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKI  229 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl  229 (437)
                      ||||+++++|.+++....          ....+++..++.++.|++.||+|||+++   ++||||||+|||+++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence            999999999999885322          2235899999999999999999999988   999999999999999999999


Q ss_pred             eecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhh
Q 013745          230 SDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTL  308 (437)
Q Consensus       230 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  308 (437)
                      +|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......+....+      
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i------  235 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI------  235 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------
Confidence            99999986643322221222345778999999998899999999999999999998 99999765433221111      


Q ss_pred             hcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCC
Q 013745          309 FQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD  361 (437)
Q Consensus       309 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~  361 (437)
                       ..+...     ..   ....+..+.+++.+||+.+|.+||++.+|++.|+..
T Consensus       236 -~~~~~~-----~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~  279 (288)
T cd05093         236 -TQGRVL-----QR---PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL  279 (288)
T ss_pred             -HcCCcC-----CC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence             001100     01   112334688999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.2e-42  Score=346.53  Aligned_cols=260  Identities=24%  Similarity=0.346  Sum_probs=205.6

Q ss_pred             HhcCccccceeccCCCeeEEEEEcC------CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCC-CCcceeeeeeeccCC
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGP  155 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  155 (437)
                      ..++|.+.++||+|+||.||+|...      .+..||||++... .....+.+.+|+++++++. ||||++++++|.+..
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            3567999999999999999999742      2346999999754 3334467899999999996 999999999999999


Q ss_pred             ceEEEEeecCCCCcchhhhccC----------------------------------------------------------
Q 013745          156 EKMLVYEYLPNKSLDYFIFDKT----------------------------------------------------------  177 (437)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------  177 (437)
                      ..+||||||++|+|.+++....                                                          
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            9999999999999998875421                                                          


Q ss_pred             -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEec
Q 013745          178 -----------------------------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD  222 (437)
Q Consensus       178 -----------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~  222 (437)
                                                         ....+++..++.++.||+.||.|||+.+   |+||||||+|||++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence                                               0124788889999999999999999988   99999999999999


Q ss_pred             CCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhh
Q 013745          223 EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADL  301 (437)
Q Consensus       223 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~  301 (437)
                      .++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.........  
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~--  349 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF--  349 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH--
Confidence            999999999999987643332222223346788999999999899999999999999999997 99999754322111  


Q ss_pred             hhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          302 LSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       302 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                          +.....+.     ..   ..+...+..+.+++.+||+.+|++||++.+|.++|+.
T Consensus       350 ----~~~~~~~~-----~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~  396 (400)
T cd05105         350 ----YNKIKSGY-----RM---AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVES  396 (400)
T ss_pred             ----HHHHhcCC-----CC---CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHH
Confidence                00011110     00   1112344568899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.9e-42  Score=332.57  Aligned_cols=263  Identities=24%  Similarity=0.347  Sum_probs=196.1

Q ss_pred             cCccccceeccCCCeeEEEEEc-C-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHcC---CCCcceeeeeeec-----c
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-P-NGQEIAVKKLSVDS--RQGLREFTNEVKLLLKI---QHKNLVTLFGCCA-----E  153 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~  153 (437)
                      ++|++.+.||+|+||.||+|.. . +++.||||++....  ......+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            3689999999999999999985 3 46789999886432  22234566787777766   6999999999885     3


Q ss_pred             CCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecc
Q 013745          154 GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG  233 (437)
Q Consensus       154 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG  233 (437)
                      ....++||||++ ++|..++... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            456899999996 5888877433 2345899999999999999999999998   9999999999999999999999999


Q ss_pred             cccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccc
Q 013745          234 LARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEK  313 (437)
Q Consensus       234 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (437)
                      +++......   ......||+.|+|||++.+..++.++|||||||++|||++|++||.+....+....+...........
T Consensus       156 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~  232 (290)
T cd07862         156 LARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  232 (290)
T ss_pred             ceEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhh
Confidence            998764331   12245689999999999988999999999999999999999999987654332211111000000000


Q ss_pred             cc-------cccCc----cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          314 AL-------ELVDP----SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       314 ~~-------~~~d~----~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ..       ....+    .+....+.....+.+++.+|++.+|++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            00       00000    001111233456789999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.1e-42  Score=330.05  Aligned_cols=257  Identities=29%  Similarity=0.470  Sum_probs=204.6

Q ss_pred             cCccccceeccCCCeeEEEEEc-----CCCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-----PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      +.|++.+.||+|+||.||+|.+     ..+..||+|.+... .......+.+|+.++++++||||+++++++..+...++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4588899999999999999973     25678999999743 34445678899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCC
Q 013745          160 VYEYLPNKSLDYFIFDKTK--------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL  225 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~  225 (437)
                      ||||+++++|.+++.....              ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            9999999999998853211              235788999999999999999999998   99999999999999999


Q ss_pred             CceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhh
Q 013745          226 NPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSY  304 (437)
Q Consensus       226 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~  304 (437)
                      .+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.+.........+..
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  241 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK  241 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999999987643332222223345678999999998889999999999999999998 9999976443222111110


Q ss_pred             hhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          305 TWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       305 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                             ...        ...+...+..+.+++.+||+.+|++||++.+|.+.|..
T Consensus       242 -------~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         242 -------RQL--------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             -------CCc--------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                   000        01111234567889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.3e-42  Score=324.73  Aligned_cols=266  Identities=24%  Similarity=0.296  Sum_probs=205.1

Q ss_pred             cCccccceeccCCCeeEEEEE-cCCCcEEEEEEeccCCh--HHHHHHHHHHHHHHcCCCCc-ceeeeeeeccCC------
Q 013745           86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSR--QGLREFTNEVKLLLKIQHKN-LVTLFGCCAEGP------  155 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------  155 (437)
                      ..|+.+++||+|+||+||+|+ ..+|+.||+|++.....  .......+|+.+|++|+|+| ||++++++....      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            347778899999999999998 45789999999986533  22345679999999999999 999999998877      


Q ss_pred             ceEEEEeecCCCCcchhhhccCCC-CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccc
Q 013745          156 EKMLVYEYLPNKSLDYFIFDKTKS-SSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL  234 (437)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl  234 (437)
                      .+++||||+ ..+|..++...... ..++...+..++.||+.||+|||+++   |+||||||+||||+++|.+||+|||+
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence            789999999 56888887543321 45777889999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccc
Q 013745          235 ARLFPGEDTHVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEK  313 (437)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (437)
                      |+.+.-....  ...-++|.+|.|||++.+. .|+...||||+|||++||++++..|.+....+....+........+..
T Consensus       167 Ara~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  167 ARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             HHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            9976533221  2235679999999999887 799999999999999999999999998876444333322222111111


Q ss_pred             ccc---ccC--cccc------CCC---HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013745          314 ALE---LVD--PSLA------KCN---RDEAAMCIQLGLLCCQQSVAERPDMNSVHLM  357 (437)
Q Consensus       314 ~~~---~~d--~~l~------~~~---~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  357 (437)
                      ...   +.+  ....      ...   +.......+++.+|++.+|.+|.+++..++.
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            100   000  0000      001   1111367889999999999999999998875

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9e-43  Score=339.77  Aligned_cols=246  Identities=25%  Similarity=0.301  Sum_probs=197.5

Q ss_pred             cceeccCCCeeEEEEEc----CCCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           91 LNQLGHGGFGPVYRGLM----PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      ++.||+|+||.||++..    .+|+.||+|++....  ......+.+|++++++++||||+++++++.+....|+||||+
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            36799999999999873    368899999997532  223355778999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      ++++|.+++..   ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....... 
T Consensus        81 ~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-  153 (318)
T cd05582          81 RGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-  153 (318)
T ss_pred             CCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence            99999888843   346899999999999999999999998   99999999999999999999999999986543321 


Q ss_pred             cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccC
Q 013745          245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK  324 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  324 (437)
                       ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....      .....          ..
T Consensus       154 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~------i~~~~----------~~  216 (318)
T cd05582         154 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM------ILKAK----------LG  216 (318)
T ss_pred             -ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHH------HHcCC----------CC
Confidence             12245789999999999988899999999999999999999999976543222111      11100          01


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHhcC
Q 013745          325 CNRDEAAMCIQLGLLCCQQSVAERPDMNS--VHLMLSG  360 (437)
Q Consensus       325 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~e--v~~~L~~  360 (437)
                      .+......+.+++.+||+.+|++||++.+  +.+.+..
T Consensus       217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~  254 (318)
T cd05582         217 MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH  254 (318)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence            11223455778999999999999999766  5555544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.4e-42  Score=326.21  Aligned_cols=254  Identities=26%  Similarity=0.417  Sum_probs=205.5

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      .+|.+.+.||+|+||.||+|... .++.||+|++.... .....+.+|++++++++|+||+++++++......++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45888999999999999999854 68899999987543 33567889999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      ++++|.+++... ....+++..++.++.|++.||+|||+++   ++||||||+|||+++++.+||+|||++.........
T Consensus        85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            999999988443 2356899999999999999999999988   999999999999999999999999999876433221


Q ss_pred             cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCcccc
Q 013745          245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA  323 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  323 (437)
                       ......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+.       ..     ..+   
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-------~~-----~~~---  224 (263)
T cd05052         161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------KG-----YRM---  224 (263)
T ss_pred             -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------CC-----CCC---
Confidence             1112234568999999999999999999999999999998 999997654332211111       00     001   


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       324 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ..+...+..+.+++.+||+.+|++||++.+++++|+.
T Consensus       225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence            1112234568889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.6e-42  Score=331.14  Aligned_cols=258  Identities=24%  Similarity=0.404  Sum_probs=208.4

Q ss_pred             cCccccceeccCCCeeEEEEEc------CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      .+|.+.+.||+|+||.||+|..      .++..+++|.+..........+.+|+.++++++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            4588889999999999999973      2355689999876666556778999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCC
Q 013745          160 VYEYLPNKSLDYFIFDKT-------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN  226 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~  226 (437)
                      ||||+++++|.+++....             ....+++..++.++.||+.||+|||+++   |+||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999985432             1245899999999999999999999998   999999999999999999


Q ss_pred             ceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhh
Q 013745          227 PKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYT  305 (437)
Q Consensus       227 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~  305 (437)
                      +||+|||++................++..|+|||++.+..++.++|||||||++|||++ |+.||......+...   . 
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~---~-  237 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE---C-  237 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---H-
Confidence            99999999986543322222223446788999999999999999999999999999999 999987654432211   1 


Q ss_pred             hhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCC
Q 013745          306 WTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD  361 (437)
Q Consensus       306 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~  361 (437)
                         .......        ......+..+.+++.+||+.+|++||++.+|+++|+..
T Consensus       238 ---~~~~~~~--------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~  282 (291)
T cd05094         238 ---ITQGRVL--------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL  282 (291)
T ss_pred             ---HhCCCCC--------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence               1111110        11112345688999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=365.24  Aligned_cols=259  Identities=31%  Similarity=0.447  Sum_probs=213.5

Q ss_pred             hcCccccceeccCCCeeEEEEEcC--CCc----EEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCce
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP--NGQ----EIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK  157 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  157 (437)
                      ..+.+..+.||+|+||.||.|...  +|.    .||||.+... +.+...+|.+|..+|+.++|||||+++|++.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            345667788999999999999843  343    4899999765 566678899999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccC----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecc
Q 013745          158 MLVYEYLPNKSLDYFIFDKT----KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG  233 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG  233 (437)
                      ++++|||++|+|..+|.+..    ....+.....+.++.+||+|+.||++++   +|||||..+|+||+....|||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence            99999999999999996531    1456899999999999999999999998   9999999999999999999999999


Q ss_pred             cccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhccc
Q 013745          234 LARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGE  312 (437)
Q Consensus       234 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  312 (437)
                      ||+.+...+.........-...|||||.+..+.++.|+|||||||+|||++| |..||....+.+....+.      .++
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~------~gg  921 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL------EGG  921 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH------hCC
Confidence            9995544443333222223468999999999999999999999999999998 899998877665443211      111


Q ss_pred             ccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCC
Q 013745          313 KALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD  361 (437)
Q Consensus       313 ~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~  361 (437)
                      +        | +.+..++..+++|+..||+.+|++||++..|++.+...
T Consensus       922 R--------L-~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i  961 (1025)
T KOG1095|consen  922 R--------L-DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI  961 (1025)
T ss_pred             c--------c-CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence            1        1 22445667788999999999999999999999977653

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.6e-42  Score=356.65  Aligned_cols=256  Identities=23%  Similarity=0.270  Sum_probs=205.5

Q ss_pred             HhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC-----
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP-----  155 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  155 (437)
                      ..++|.+.+.||+|+||+||+|.. .+|+.||||++...  .......+.+|+.++..++|+||++++..+....     
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            456899999999999999999984 47999999998654  3444567889999999999999999988775432     


Q ss_pred             ---ceEEEEeecCCCCcchhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeee
Q 013745          156 ---EKMLVYEYLPNKSLDYFIFDKT-KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISD  231 (437)
Q Consensus       156 ---~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~D  231 (437)
                         ..++||||+++|+|.+++..+. ....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~D  186 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGD  186 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEe
Confidence               3679999999999999886432 3356899999999999999999999998   99999999999999999999999


Q ss_pred             cccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcc
Q 013745          232 FGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQG  311 (437)
Q Consensus       232 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  311 (437)
                      ||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+...      .....
T Consensus       187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~------~~~~~  260 (496)
T PTZ00283        187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH------KTLAG  260 (496)
T ss_pred             cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH------HHhcC
Confidence            999987654322222334679999999999999999999999999999999999999997644322111      11110


Q ss_pred             cccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013745          312 EKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLM  357 (437)
Q Consensus       312 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  357 (437)
                           ..+    ..+...+..+.+++.+||+.+|.+||++.++++.
T Consensus       261 -----~~~----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        261 -----RYD----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             -----CCC----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                 011    1122344568899999999999999999999763

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3e-42  Score=330.02  Aligned_cols=256  Identities=27%  Similarity=0.438  Sum_probs=204.2

Q ss_pred             cCccccceeccCCCeeEEEEEcC------CCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM  158 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  158 (437)
                      .+|++.+.||+|+||.||+|...      .++.||||++.... ....+.+.+|+.++..++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            34778899999999999999742      35789999997543 333466889999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCC
Q 013745          159 LVYEYLPNKSLDYFIFDKT-------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL  225 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~  225 (437)
                      +++||+++++|..++....             ....+++..++.++.|++.||.|||+++   |+||||||+|||+++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence            9999999999998874221             1235888899999999999999999988   99999999999999999


Q ss_pred             CceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhh
Q 013745          226 NPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSY  304 (437)
Q Consensus       226 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~  304 (437)
                      .+||+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||.+....+....+. 
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~-  240 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR-  240 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-
Confidence            999999999987643322222223345778999999998889999999999999999998 888987654332211111 


Q ss_pred             hhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          305 TWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       305 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                           . .        .....+...+..+.+++..||+.+|++||++.+|+..|+
T Consensus       241 -----~-~--------~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         241 -----N-R--------QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             -----c-C--------CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence                 0 0        011112234556789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.3e-42  Score=339.80  Aligned_cols=241  Identities=22%  Similarity=0.263  Sum_probs=195.0

Q ss_pred             ceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCCC
Q 013745           92 NQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNK  167 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  167 (437)
                      +.||+|+||.||++.. .+|+.||+|++...   .......+.+|++++..++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999984 47899999999753   2334466788999999999999999999999999999999999999


Q ss_pred             CcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccc
Q 013745          168 SLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE-EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN  246 (437)
Q Consensus       168 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  246 (437)
                      +|..++..   ...+++..+..++.||+.||.|||+ .+   |+||||||+|||++.++.+||+|||+++........  
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~--  152 (325)
T cd05594          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--  152 (325)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc--
Confidence            99888743   3468999999999999999999997 66   999999999999999999999999998754322211  


Q ss_pred             eeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCC
Q 013745          247 TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCN  326 (437)
Q Consensus       247 ~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  326 (437)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..       ..      .   ..+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~-------~~------~---~~p  216 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-------EE------I---RFP  216 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc-------CC------C---CCC
Confidence            1235699999999999999999999999999999999999999976543322211110       00      0   111


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 013745          327 RDEAAMCIQLGLLCCQQSVAERP-----DMNSVHL  356 (437)
Q Consensus       327 ~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~  356 (437)
                      ......+.+++.+||+.||++|+     ++.++++
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence            12344578899999999999996     8898874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.9e-42  Score=336.04  Aligned_cols=237  Identities=24%  Similarity=0.294  Sum_probs=188.6

Q ss_pred             ceeccCCCeeEEEEEcC-CCcEEEEEEeccCC---hHHHHHHHHHHH-HHHcCCCCcceeeeeeeccCCceEEEEeecCC
Q 013745           92 NQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS---RQGLREFTNEVK-LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN  166 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  166 (437)
                      +.||+|+||+||+|+.. +|+.||||++....   ......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999854 78999999996432   222344555555 56789999999999999999999999999999


Q ss_pred             CCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccc
Q 013745          167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN  246 (437)
Q Consensus       167 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  246 (437)
                      |+|..++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~  152 (323)
T cd05575          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--T  152 (323)
T ss_pred             CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--c
Confidence            999888743   346889999999999999999999998   99999999999999999999999999875432221  1


Q ss_pred             eeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCC
Q 013745          247 TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCN  326 (437)
Q Consensus       247 ~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  326 (437)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+...      ......          ....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~------~i~~~~----------~~~~  216 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD------NILNKP----------LRLK  216 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHH------HHHcCC----------CCCC
Confidence            224578999999999999999999999999999999999999997654322111      111100          0111


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHH
Q 013745          327 RDEAAMCIQLGLLCCQQSVAERPDMN  352 (437)
Q Consensus       327 ~~~~~~l~~l~~~cl~~~p~~RPs~~  352 (437)
                      +..+..+.+++.+|++.+|.+||++.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         217 PNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            12345678899999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-42  Score=325.42  Aligned_cols=252  Identities=26%  Similarity=0.390  Sum_probs=202.3

Q ss_pred             cCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecC
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLP  165 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  165 (437)
                      .+|++.+.||+|+||.||+|.++++..+|+|++..... ....+.+|++++++++||||+++++++......++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            35888999999999999999987777899999864432 23568889999999999999999999999999999999999


Q ss_pred             CCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCccc
Q 013745          166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV  245 (437)
Q Consensus       166 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  245 (437)
                      +++|.+++...  ...+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.........
T Consensus        83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence            99999988533  236899999999999999999999998   9999999999999999999999999998654322111


Q ss_pred             ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccC
Q 013745          246 NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK  324 (437)
Q Consensus       246 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  324 (437)
                       .....++..|+|||++.+..++.++|||||||++|||++ |+.||......+....+.   .    .     .....  
T Consensus       158 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~---~----~-----~~~~~--  222 (256)
T cd05059         158 -SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS---A----G-----YRLYR--  222 (256)
T ss_pred             -cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH---c----C-----CcCCC--
Confidence             111123457999999999999999999999999999999 899997644332211110   0    0     00111  


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          325 CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       325 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                       +...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus       223 -~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         223 -PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             -CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence             1124556889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=8.9e-43  Score=329.90  Aligned_cols=250  Identities=33%  Similarity=0.504  Sum_probs=195.4

Q ss_pred             ccceeccCCCeeEEEEEcC-----CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           90 DLNQLGHGGFGPVYRGLMP-----NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        90 ~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      +.+.||.|.||.||+|.+.     .+..|+||.+... .....+.+.+|++++++++||||++++|++...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4678999999999999864     3678999999653 344578899999999999999999999999988889999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +++|+|.+++... ....+++..++.|+.||+.||.|||+++   ++|+||+++|||++.++.+||+|||++........
T Consensus        83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999999654 2467899999999999999999999988   99999999999999999999999999987733322


Q ss_pred             ccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCccc
Q 013745          244 HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL  322 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  322 (437)
                      ........+...|+|||.+....++.++||||||+++|||++ |+.||......+....+.      . ...        
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~------~-~~~--------  223 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLK------Q-GQR--------  223 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHH------T-TEE--------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc------c-ccc--------
Confidence            222223456788999999999999999999999999999999 788987654332211111      1 111        


Q ss_pred             cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHh
Q 013745          323 AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML  358 (437)
Q Consensus       323 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L  358 (437)
                      ...+...+..+..++..||+.+|++||++.+|++.|
T Consensus       224 ~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            011112345578899999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.4e-42  Score=345.37  Aligned_cols=251  Identities=22%  Similarity=0.317  Sum_probs=193.8

Q ss_pred             CccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      +|+++++||+|+||.||+|+. .+++.||||++....   ......+.+|+.++++++||||+++++.|.+++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            588999999999999999985 478899999986532   3345678899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      ||++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            9999999998843   246888999999999999999999998   9999999999999999999999999985431100


Q ss_pred             c---------------------------------------------ccceeeeecccccCChhhhccCcCCcccceehhh
Q 013745          243 T---------------------------------------------HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYG  277 (437)
Q Consensus       243 ~---------------------------------------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG  277 (437)
                      .                                             .......+||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence            0                                             0001134699999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCC---HHHH
Q 013745          278 VLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPD---MNSV  354 (437)
Q Consensus       278 ~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~ev  354 (437)
                      |+||||++|+.||.+....+....+      .....  ....+...    ....++.+++.+++ .+|.+|++   +.++
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~~i------~~~~~--~~~~p~~~----~~s~~~~~li~~l~-~~p~~R~~~~~~~ei  302 (382)
T cd05625         236 VILYEMLVGQPPFLAQTPLETQMKV------INWQT--SLHIPPQA----KLSPEASDLIIKLC-RGPEDRLGKNGADEI  302 (382)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHH------HccCC--CcCCCCcc----cCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence            9999999999999865443221111      00000  00011111    12334556665655 49999997   6666


Q ss_pred             HH
Q 013745          355 HL  356 (437)
Q Consensus       355 ~~  356 (437)
                      ++
T Consensus       303 ~~  304 (382)
T cd05625         303 KA  304 (382)
T ss_pred             hc
Confidence            53

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4.9e-42  Score=322.77  Aligned_cols=248  Identities=26%  Similarity=0.376  Sum_probs=197.5

Q ss_pred             ceeccCCCeeEEEEEcC-CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCCCCc
Q 013745           92 NQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL  169 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  169 (437)
                      +.||+|+||.||+|... +++.||+|.+... .......+.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46999999999999854 7899999988643 334456789999999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccceee
Q 013745          170 DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR  249 (437)
Q Consensus       170 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  249 (437)
                      .+++..  ....+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++..............
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            998843  2346889999999999999999999988   99999999999999999999999999986542211111111


Q ss_pred             eecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHH
Q 013745          250 ISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRD  328 (437)
Q Consensus       250 ~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  328 (437)
                      ..++..|+|||.+.++.++.++|||||||++|||++ |..||...........+..       .     ...   ..+..
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~-------~-----~~~---~~~~~  220 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-------G-----VRL---PCPEL  220 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc-------C-----CCC---CCccc
Confidence            123456999999999899999999999999999998 8888875443222111110       0     000   11122


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          329 EAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       329 ~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                      .+..+.+++.+|++.+|++||++.+|+++|+
T Consensus       221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            3456888999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-42  Score=329.17  Aligned_cols=251  Identities=27%  Similarity=0.348  Sum_probs=201.8

Q ss_pred             CccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      +|++.+.||+|+||.||++.. .+++.||||++....   ......+.+|+.++++++||||+++++++..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            488899999999999999985 478999999986432   2223457789999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |+++|+|..++... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            99999998887543 2356899999999999999999999998   9999999999999999999999999998764322


Q ss_pred             cccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccc
Q 013745          243 THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL  322 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  322 (437)
                      ..   ....|+..|+|||++.+..++.++|||||||++|||++|+.||.+.........+.   ..         +....
T Consensus       157 ~~---~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~---~~---------~~~~~  221 (285)
T cd05605         157 TI---RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE---RR---------VKEDQ  221 (285)
T ss_pred             cc---ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHH---HH---------hhhcc
Confidence            21   13468999999999998899999999999999999999999998644322111111   00         00111


Q ss_pred             cCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 013745          323 AKCNRDEAAMCIQLGLLCCQQSVAERP-----DMNSVHL  356 (437)
Q Consensus       323 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~  356 (437)
                      ...+...+..+.+++.+||+.||++||     ++.++++
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            112233455678899999999999999     7778754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.6e-42  Score=344.93  Aligned_cols=253  Identities=21%  Similarity=0.252  Sum_probs=200.8

Q ss_pred             HhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      ..++|++.+.||+|+||.||+|+. .+++.||+|++...   .......+.+|+.+++.++||||+++++++.+....++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            356799999999999999999985 47889999998643   22334557889999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      ||||+++|+|..++..    ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus       121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            9999999999998832    34788889999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcccceeeeecccccCChhhhccC----cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccc
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALHG----YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKAL  315 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (437)
                      ..... ......||+.|+|||++.+.    .++.++|||||||++|||++|+.||.+........      .+.......
T Consensus       194 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~------~i~~~~~~~  266 (370)
T cd05596         194 ANGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS------KIMDHKNSL  266 (370)
T ss_pred             CCCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHH------HHHcCCCcC
Confidence            33221 11235699999999998753    48899999999999999999999998654322111      111110000


Q ss_pred             cccCccccCCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHH
Q 013745          316 ELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAE--RPDMNSVHL  356 (437)
Q Consensus       316 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~  356 (437)
                      .  .+.    ....+..+.+++..|++.+|++  ||++.++++
T Consensus       267 ~--~~~----~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         267 T--FPD----DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             C--CCC----cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            0  011    1123456788999999999988  999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.5e-42  Score=332.45  Aligned_cols=262  Identities=23%  Similarity=0.328  Sum_probs=196.8

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      .++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            467999999999999999999854 789999999875432 223457789999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |+. ++|.+++..  ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++.......
T Consensus        84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            995 566666633  2356888999999999999999999998   9999999999999999999999999997643222


Q ss_pred             cccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccc---c-----
Q 013745          243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGE---K-----  313 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~-----  313 (437)
                      ..  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+......  .+..........   .     
T Consensus       158 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         158 HT--YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             cc--CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhCCCChhhccchh
Confidence            11  1234679999999998764 689999999999999999999999986533211  111111100000   0     


Q ss_pred             cccccCc---------cccCC--CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          314 ALELVDP---------SLAKC--NRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       314 ~~~~~d~---------~l~~~--~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .....++         .+...  .......+.+++.+|++.||++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            0000000         00000  0011245678999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.6e-42  Score=338.28  Aligned_cols=259  Identities=28%  Similarity=0.402  Sum_probs=203.1

Q ss_pred             hcCccccceeccCCCeeEEEEEcC------CCcEEEEEEeccCC-hHHHHHHHHHHHHHHcC-CCCcceeeeeeecc-CC
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKI-QHKNLVTLFGCCAE-GP  155 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~  155 (437)
                      .++|++.+.||+|+||.||+|...      +++.||+|++.... ......+.+|+.++.++ +|+||++++++|.. +.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            357999999999999999999632      35789999987442 33346678899999999 79999999998764 45


Q ss_pred             ceEEEEeecCCCCcchhhhccCC---------------------------------------------------------
Q 013745          156 EKMLVYEYLPNKSLDYFIFDKTK---------------------------------------------------------  178 (437)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------  178 (437)
                      ..+++|||+++++|.+++.....                                                         
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            67899999999999988753211                                                         


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccceeeeecccccC
Q 013745          179 -SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM  257 (437)
Q Consensus       179 -~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~  257 (437)
                       ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+.............++..|+
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence             136889999999999999999999988   9999999999999999999999999998764433222222344677899


Q ss_pred             ChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHH
Q 013745          258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQL  336 (437)
Q Consensus       258 aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l  336 (437)
                      |||++.+..++.++|||||||+||||++ |..||.+....+..      .........     .   ..+.....++.++
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~------~~~~~~~~~-----~---~~~~~~~~~~~~l  308 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF------CRRLKEGTR-----M---RAPEYATPEIYSI  308 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHH------HHHHhccCC-----C---CCCccCCHHHHHH
Confidence            9999999999999999999999999998 99999764322211      011111100     0   0111234568899


Q ss_pred             HHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          337 GLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       337 ~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      +.+||+.+|++||++.||++.|+.
T Consensus       309 ~~~cl~~~p~~RPs~~ell~~l~~  332 (337)
T cd05054         309 MLDCWHNNPEDRPTFSELVEILGD  332 (337)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHH
Confidence            999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.3e-42  Score=336.69  Aligned_cols=241  Identities=24%  Similarity=0.314  Sum_probs=194.6

Q ss_pred             CccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCC-cceeeeeeeccCCceEEEE
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHK-NLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~  161 (437)
                      +|++++.||+|+||.||+|+.. +++.||||++...   .....+.+..|++++..+.|+ +|+++++++...+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4888999999999999999854 6789999999753   233456678899999999764 6888999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      ||+++|+|..++..   ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            99999999888843   346889999999999999999999998   999999999999999999999999998753222


Q ss_pred             CcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+      ...       .. 
T Consensus       155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i------~~~-------~~-  218 (324)
T cd05587         155 GK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI------MEH-------NV-  218 (324)
T ss_pred             CC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------HcC-------CC-
Confidence            21  122457999999999999999999999999999999999999999865433221111      000       00 


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDM  351 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  351 (437)
                        ..+......+.+++.+||+.+|.+|++.
T Consensus       219 --~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         219 --SYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             --CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence              1111234567889999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.6e-42  Score=324.20  Aligned_cols=252  Identities=27%  Similarity=0.426  Sum_probs=203.1

Q ss_pred             cCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecC
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLP  165 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  165 (437)
                      ++|++.+.||+|+||.||+|.+.++..+|||.+..... ....+.+|+.++++++||||+++++++......++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            45888999999999999999876777899998875432 34678899999999999999999999999989999999999


Q ss_pred             CCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCccc
Q 013745          166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV  245 (437)
Q Consensus       166 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  245 (437)
                      +++|.+++...  ...+++..++.++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||+++........ 
T Consensus        83 ~~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~-  156 (256)
T cd05113          83 NGCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-  156 (256)
T ss_pred             CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee-
Confidence            99999988432  236899999999999999999999988   999999999999999999999999999865433211 


Q ss_pred             ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccC
Q 013745          246 NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK  324 (437)
Q Consensus       246 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  324 (437)
                      ......++..|+|||++.+..++.++|||||||++|||++ |..||......+....+      .....      ...  
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~------~~~~~------~~~--  222 (256)
T cd05113         157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV------SQGLR------LYR--  222 (256)
T ss_pred             ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH------hcCCC------CCC--
Confidence            1112235678999999998889999999999999999998 99999754432221111      11000      000  


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          325 CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       325 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                       .......+.+++.+||+.+|.+||++.+|++.|+
T Consensus       223 -~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         223 -PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence             1123456889999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=5e-42  Score=330.09  Aligned_cols=260  Identities=27%  Similarity=0.387  Sum_probs=207.3

Q ss_pred             HHhcCccccceeccCCCeeEEEEEcC------CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccC
Q 013745           83 VATNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEG  154 (437)
Q Consensus        83 ~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  154 (437)
                      ...++|++.+.||+|+||.||++...      ....+|+|++... .......+.+|+.++.++ +|+||+++++++..+
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            34567999999999999999999853      2367899998754 334456788999999999 799999999999999


Q ss_pred             CceEEEEeecCCCCcchhhhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEe
Q 013745          155 PEKMLVYEYLPNKSLDYFIFDK-------------TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL  221 (437)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll  221 (437)
                      +..++||||+++|+|..++...             .....+++..++.++.|++.||+|||+.+   |+||||||+|||+
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence            9999999999999999988542             22356899999999999999999999988   9999999999999


Q ss_pred             cCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhh
Q 013745          222 DEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKAD  300 (437)
Q Consensus       222 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~  300 (437)
                      +.++.+||+|||+++.+.............++..|+|||++.+..++.++|||||||++|||++ |..||......+...
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  245 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK  245 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence            9999999999999987654332222222335678999999998899999999999999999997 999987644322211


Q ss_pred             hhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          301 LLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      .+       .....        ...+......+.+++.+||+.+|++|||+.+|++.|+.
T Consensus       246 ~~-------~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~  290 (293)
T cd05053         246 LL-------KEGYR--------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR  290 (293)
T ss_pred             HH-------HcCCc--------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHH
Confidence            11       11100        01112334568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=8.3e-42  Score=332.75  Aligned_cols=240  Identities=25%  Similarity=0.351  Sum_probs=190.8

Q ss_pred             ceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCceEEEEeecCC
Q 013745           92 NQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYEYLPN  166 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  166 (437)
                      +.||+|+||.||+|.. .+++.||||++...   .....+.+..|..++..+ +||||+++++++..+...++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999985 46889999998753   222344556677777654 799999999999999999999999999


Q ss_pred             CCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccc
Q 013745          167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN  246 (437)
Q Consensus       167 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  246 (437)
                      |+|..++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--~  152 (316)
T cd05592          81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--K  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC--c
Confidence            999888743   346899999999999999999999988   99999999999999999999999999986533221  1


Q ss_pred             eeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCC
Q 013745          247 TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCN  326 (437)
Q Consensus       247 ~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  326 (437)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+      ...       .+   ..+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i------~~~-------~~---~~~  216 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI------LND-------RP---HFP  216 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH------HcC-------CC---CCC
Confidence            22457999999999999989999999999999999999999999865432221111      000       01   111


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHH-HHH
Q 013745          327 RDEAAMCIQLGLLCCQQSVAERPDMN-SVH  355 (437)
Q Consensus       327 ~~~~~~l~~l~~~cl~~~p~~RPs~~-ev~  355 (437)
                      ......+.+++.+||+.+|++||++. +++
T Consensus       217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         217 RWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            22344567889999999999999875 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.3e-42  Score=342.61  Aligned_cols=255  Identities=20%  Similarity=0.254  Sum_probs=199.0

Q ss_pred             HHHhcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCce
Q 013745           82 QVATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK  157 (437)
Q Consensus        82 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  157 (437)
                      ....++|++.+.||+|+||.||+|... +++.||+|++...   .......+.+|+.+++.++||||+++++++.++...
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            344578999999999999999999854 6889999998642   223345678999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                      ++||||+++|+|.+++..    ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus       119 ~lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~  191 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK  191 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccccee
Confidence            999999999999998832    35788999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcccceeeeecccccCChhhhccC----cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccc
Q 013745          238 FPGEDTHVNTFRISGTHGYMAPEYALHG----YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEK  313 (437)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (437)
                      ....... ......||+.|+|||++.+.    .++.++|||||||+||||++|+.||..........      .+.....
T Consensus       192 ~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~------~i~~~~~  264 (370)
T cd05621         192 MDETGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYS------KIMDHKN  264 (370)
T ss_pred             cccCCce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHH------HHHhCCc
Confidence            6432221 12245799999999998754    37899999999999999999999998654322211      1111111


Q ss_pred             cccccCccccCCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHH
Q 013745          314 ALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAE--RPDMNSVHL  356 (437)
Q Consensus       314 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~  356 (437)
                      ...     .+. .......+.+++..|++.++.+  ||++.++++
T Consensus       265 ~~~-----~p~-~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~  303 (370)
T cd05621         265 SLN-----FPE-DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ  303 (370)
T ss_pred             ccC-----CCC-cccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence            000     000 1123445677888888755543  889998876

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.2e-41  Score=327.88  Aligned_cols=264  Identities=26%  Similarity=0.412  Sum_probs=206.7

Q ss_pred             hcCccccceeccCCCeeEEEEEcCC-----------------CcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCccee
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPN-----------------GQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVT  146 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  146 (437)
                      .++|++.+.||+|+||.||+|....                 +..||+|++.... ......+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3579999999999999999987432                 2458999987553 345677899999999999999999


Q ss_pred             eeeeeccCCceEEEEeecCCCCcchhhhccC--------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCC
Q 013745          147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKT--------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASN  218 (437)
Q Consensus       147 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~N  218 (437)
                      +++++..+...++||||+++++|..++....        ....+++..++.++.|++.||+|||+.+   |+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            9999999999999999999999999885432        1126899999999999999999999988   9999999999


Q ss_pred             EEecCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh--CCCCCCCCCch
Q 013745          219 ILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS--GRKNHDGRLGK  296 (437)
Q Consensus       219 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt--g~~p~~~~~~~  296 (437)
                      |+++.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999986544332222223456788999999998899999999999999999998  67788654332


Q ss_pred             hhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          297 EKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                      +.   +......+.........     ..+...+.++.+++.+||+.+|++||++.+|+++|+
T Consensus       241 ~~---~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 QV---IENAGHFFRDDGRQIYL-----PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HH---HHHHHhccccccccccC-----CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            22   11111111111100000     111233457899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=5.9e-42  Score=327.18  Aligned_cols=257  Identities=31%  Similarity=0.442  Sum_probs=203.5

Q ss_pred             hcCccccceeccCCCeeEEEEEcC------CCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCce
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK  157 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  157 (437)
                      .++|.+.+.||+|+||.||+|.+.      .+..||+|.+.... ......+.+|+.++++++|+||+++++++.+....
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   84 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR   84 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence            567999999999999999999864      35678999886443 33446789999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccCC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCC---Cceee
Q 013745          158 MLVYEYLPNKSLDYFIFDKTK----SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL---NPKIS  230 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~---~~kl~  230 (437)
                      ++||||+++++|.+++.....    ...+++..++.++.||+.||+|||+++   ++||||||+|||++.++   .+||+
T Consensus        85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence            999999999999998854321    135899999999999999999999998   99999999999998765   58999


Q ss_pred             ecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhh
Q 013745          231 DFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLF  309 (437)
Q Consensus       231 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  309 (437)
                      |||+++................+..|+|||++.+..++.++|||||||++|||++ |..||...........+.      
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~------  235 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT------  235 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH------
Confidence            9999987633222111112223567999999999999999999999999999997 999998654433221111      


Q ss_pred             cccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          310 QGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       310 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                      ....         ...+...+..+.+++.+|++.+|++||++.+|++.|+
T Consensus       236 ~~~~---------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         236 GGGR---------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             cCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            0000         0111223456889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-41  Score=328.41  Aligned_cols=264  Identities=22%  Similarity=0.363  Sum_probs=203.5

Q ss_pred             hcCccccceeccCCCeeEEEEEcCC---------------CcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeee
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPN---------------GQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLF  148 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~  148 (437)
                      .++|++.+.||+|+||.||++....               ...||+|++... .......+.+|++++.+++|+||++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3579999999999999999987532               235899998754 334456789999999999999999999


Q ss_pred             eeeccCCceEEEEeecCCCCcchhhhccC---------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCE
Q 013745          149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKT---------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNI  219 (437)
Q Consensus       149 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NI  219 (437)
                      +++......++||||+++++|.+++....         ....+++..++.++.|++.||+|||+.+   ++||||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence            99999999999999999999999885432         1124788899999999999999999998   99999999999


Q ss_pred             EecCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh--CCCCCCCCCchh
Q 013745          220 LLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS--GRKNHDGRLGKE  297 (437)
Q Consensus       220 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt--g~~p~~~~~~~~  297 (437)
                      ++++++.+||+|||++................++..|+|||++.++.++.++|||||||++|||++  |..||......+
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            999999999999999986543322211222345678999999998899999999999999999998  567776544333


Q ss_pred             hhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          298 KADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                      .....   ...+........     .......+..+.+++.+||+.+|++||++.+|+++|+
T Consensus       241 ~~~~~---~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 VIENT---GEFFRNQGRQIY-----LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHH---HHhhhhcccccc-----CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            22111   111111000000     0011123457899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.2e-42  Score=326.02  Aligned_cols=257  Identities=24%  Similarity=0.390  Sum_probs=206.7

Q ss_pred             hcCccccceeccCCCeeEEEEEcC------CCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCce
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK  157 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  157 (437)
                      .++|.+.+.||+|+||.||+|...      .+..||+|.+.... ......+.+|+.++..++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            467999999999999999999753      24689999987543 34456788999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccC-------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceee
Q 013745          158 MLVYEYLPNKSLDYFIFDKT-------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKIS  230 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~  230 (437)
                      ++||||+++++|..++....       ....+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            99999999999999885432       1234788999999999999999999988   9999999999999999999999


Q ss_pred             ecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhh
Q 013745          231 DFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLF  309 (437)
Q Consensus       231 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  309 (437)
                      |||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||......+....+.      
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~------  235 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI------  235 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh------
Confidence            9999986643332222223346788999999998899999999999999999998 999997654433222111      


Q ss_pred             cccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          310 QGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       310 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                       .....        ..+...+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus       236 -~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         236 -DGGHL--------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             -cCCCC--------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence             11100        111122556889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=8.4e-42  Score=326.72  Aligned_cols=256  Identities=25%  Similarity=0.401  Sum_probs=205.2

Q ss_pred             cCccccceeccCCCeeEEEEEc------CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      .+|...++||+|+||.||++..      .++..+|+|.+..........+.+|++++++++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            4578889999999999999963      2456789999876666667789999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCC------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCc
Q 013745          160 VYEYLPNKSLDYFIFDKTK------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP  227 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~  227 (437)
                      ||||+++++|.+++.....            ...+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            9999999999998854321            135889999999999999999999988   9999999999999999999


Q ss_pred             eeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhh
Q 013745          228 KISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTW  306 (437)
Q Consensus       228 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~  306 (437)
                      ||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||......+....+..  
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~--  239 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ--  239 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc--
Confidence            9999999986543322111112335678999999999999999999999999999998 9999965443322111110  


Q ss_pred             hhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          307 TLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       307 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                           ...     .   ..+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus       240 -----~~~-----~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         240 -----GRE-----L---ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             -----Ccc-----C---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                 000     0   011123345788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=8.7e-42  Score=328.17  Aligned_cols=256  Identities=28%  Similarity=0.411  Sum_probs=203.6

Q ss_pred             CccccceeccCCCeeEEEEEcC------CCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      +|++.+.||+|+||.||+|...      ....+++|.+.... ......+.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4778899999999999999742      23568888886543 3445678899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccC---------------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCC
Q 013745          160 VYEYLPNKSLDYFIFDKT---------------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASN  218 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~N  218 (437)
                      ||||+.+++|.+++....                     ....+++..++.++.|++.||+|||+.+   |+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999998874321                     1235789999999999999999999988   9999999999


Q ss_pred             EEecCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchh
Q 013745          219 ILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKE  297 (437)
Q Consensus       219 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~  297 (437)
                      ||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.+.....
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999986643332222222345678999999988899999999999999999998 999997654332


Q ss_pred             hhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          298 KADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ....+.       ...     ...   .+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       238 ~~~~~~-------~~~-----~~~---~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~  285 (290)
T cd05045         238 LFNLLK-------TGY-----RME---RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEK  285 (290)
T ss_pred             HHHHHh-------CCC-----CCC---CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence            221111       000     000   111233568899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-41  Score=332.25  Aligned_cols=254  Identities=21%  Similarity=0.241  Sum_probs=195.1

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ++|++.+.||+|+||.||+++. .+++.||||++...   .......+.+|+.++..++|+||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            4699999999999999999985 46899999998642   2233456889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      ||+++|+|.+++..  ....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            99999999998843  2346889999999999999999999998   999999999999999999999999999766433


Q ss_pred             CcccceeeeecccccCChhhhcc-----CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALH-----GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE  316 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (437)
                      .... .....||+.|+|||++..     ..++.++|||||||++|||++|+.||......+....      .........
T Consensus       156 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~------i~~~~~~~~  228 (331)
T cd05597         156 GTVQ-SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK------IMNHKEHFQ  228 (331)
T ss_pred             CCcc-ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHH------HHcCCCccc
Confidence            2221 123468999999999873     4678899999999999999999999976443222111      111111011


Q ss_pred             ccCccccCCCHHHHHHHHHHHHHcCCC--CCCCCCCHHHHHH
Q 013745          317 LVDPSLAKCNRDEAAMCIQLGLLCCQQ--SVAERPDMNSVHL  356 (437)
Q Consensus       317 ~~d~~l~~~~~~~~~~l~~l~~~cl~~--~p~~RPs~~ev~~  356 (437)
                       +.+.    ....+..+.+++.+|+..  ++..||++.++++
T Consensus       229 -~~~~----~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~  265 (331)
T cd05597         229 -FPPD----VTDVSEEAKDLIRRLICSPETRLGRNGLQDFKD  265 (331)
T ss_pred             -CCCc----cCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence             1111    112334456677676654  3344788888865

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.1e-41  Score=322.85  Aligned_cols=254  Identities=28%  Similarity=0.447  Sum_probs=204.4

Q ss_pred             hcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      .++|++.++||+|+||.||+|.+.+...||+|++..... ....+.+|+.++++++||||+++++.+.+ ...++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence            356999999999999999999876667899999975332 23578899999999999999999998754 5679999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      ++++|.+++... ....+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++.+......
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            999999998533 2345789999999999999999999988   999999999999999999999999999876543321


Q ss_pred             cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCcccc
Q 013745          245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA  323 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  323 (437)
                      . .....++..|+|||+..+..++.++|||||||++|||++ |..||......+....+..       ..     .   .
T Consensus       159 ~-~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~-------~~-----~---~  222 (262)
T cd05071         159 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-------GY-----R---M  222 (262)
T ss_pred             c-ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhc-------CC-----C---C
Confidence            1 112345678999999998899999999999999999999 8889876543322111110       00     0   0


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       324 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ......+..+.+++.+|++.+|++||++.+++++|+.
T Consensus       223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence            1122445668899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=5.1e-42  Score=334.92  Aligned_cols=241  Identities=22%  Similarity=0.316  Sum_probs=193.8

Q ss_pred             ceeccCCCeeEEEEEcC-CCcEEEEEEeccC---ChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCceEEEEeecCC
Q 013745           92 NQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD---SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYEYLPN  166 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  166 (437)
                      +.||+|+||.||+|+.. +++.||||++...   .......+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999854 6889999998753   233345677899999876 799999999999999999999999999


Q ss_pred             CCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccc
Q 013745          167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN  246 (437)
Q Consensus       167 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  246 (437)
                      ++|...+..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++.........  
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~--  152 (321)
T cd05591          81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--  152 (321)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCcc--
Confidence            999888743   346889999999999999999999998   999999999999999999999999999764322221  


Q ss_pred             eeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCC
Q 013745          247 TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCN  326 (437)
Q Consensus       247 ~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  326 (437)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....      .....    ..      .+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~------i~~~~----~~------~p  216 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES------ILHDD----VL------YP  216 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHH------HHcCC----CC------CC
Confidence            2245689999999999999999999999999999999999999986543322111      11110    00      11


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCC-------CHHHHHH
Q 013745          327 RDEAAMCIQLGLLCCQQSVAERP-------DMNSVHL  356 (437)
Q Consensus       327 ~~~~~~l~~l~~~cl~~~p~~RP-------s~~ev~~  356 (437)
                      ......+.+++..||+.+|++||       ++.++++
T Consensus       217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            12235678899999999999999       7777764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.1e-41  Score=322.04  Aligned_cols=254  Identities=30%  Similarity=0.488  Sum_probs=204.3

Q ss_pred             hcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      .++|++.++||+|+||.||+|...++..||+|++..... ....+.+|+.++++++|+||+++++++.. ...++||||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEec
Confidence            457899999999999999999987888899999875433 23568899999999999999999998854 5689999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      ++++|.+++... ....+++..++.++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++..+......
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence            999999988543 2345899999999999999999999988   999999999999999999999999999876433211


Q ss_pred             cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCcccc
Q 013745          245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA  323 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  323 (437)
                      . .....++..|+|||++.+..++.++||||||+++|||++ |..||......+....+   .   ...      ..   
T Consensus       159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~---~---~~~------~~---  222 (260)
T cd05070         159 A-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV---E---RGY------RM---  222 (260)
T ss_pred             c-ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---H---cCC------CC---
Confidence            1 112235668999999988899999999999999999999 89999764432221111   0   000      00   


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       324 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ..+...+..+.+++.+|++.+|++|||+.+++++|+.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1122344568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-41  Score=322.74  Aligned_cols=255  Identities=24%  Similarity=0.398  Sum_probs=202.1

Q ss_pred             ccccceeccCCCeeEEEEEcC----CCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCc-----
Q 013745           88 FSDLNQLGHGGFGPVYRGLMP----NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE-----  156 (437)
Q Consensus        88 y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  156 (437)
                      |.+.+.||+|+||.||+|...    .+..||+|++...  .......+.+|+.+++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            567889999999999999853    2467999998754  33445678999999999999999999998866554     


Q ss_pred             -eEEEEeecCCCCcchhhhccC---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeec
Q 013745          157 -KMLVYEYLPNKSLDYFIFDKT---KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDF  232 (437)
Q Consensus       157 -~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DF  232 (437)
                       .++||||+++++|..++....   ....+++..++.++.|++.||.|||+++   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             799999999999998875432   2246899999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcc
Q 013745          233 GLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQG  311 (437)
Q Consensus       233 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  311 (437)
                      |+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.+....+..   .....    
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~---~~~~~----  230 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY---DYLRH----  230 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHc----
Confidence            99987654433222222335678999999988899999999999999999999 88999765433221   11111    


Q ss_pred             cccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          312 EKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       312 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ...        ...+......+.+++.+||+.+|++||++.+|++.|+.
T Consensus       231 ~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~  271 (273)
T cd05035         231 GNR--------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN  271 (273)
T ss_pred             CCC--------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            000        01122344568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.7e-41  Score=330.60  Aligned_cols=240  Identities=25%  Similarity=0.339  Sum_probs=191.5

Q ss_pred             ceeccCCCeeEEEEEcC-CCcEEEEEEeccCC---hHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCceEEEEeecCC
Q 013745           92 NQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS---RQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYEYLPN  166 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  166 (437)
                      +.||+|+||.||+|..+ +|+.||||++....   ......+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999854 68899999997532   22345567788888765 899999999999999999999999999


Q ss_pred             CCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccc
Q 013745          167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN  246 (437)
Q Consensus       167 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  246 (437)
                      |+|..++..   ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~  152 (316)
T cd05620          81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--R  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCC--c
Confidence            999888743   346889999999999999999999998   99999999999999999999999999875322211  1


Q ss_pred             eeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCC
Q 013745          247 TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCN  326 (437)
Q Consensus       247 ~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  326 (437)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+   ..    .      .+.+   +
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~---~~----~------~~~~---~  216 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI---RV----D------TPHY---P  216 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH---Hh----C------CCCC---C
Confidence            22457899999999999999999999999999999999999999765432221111   00    0      0111   1


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHH-HHH
Q 013745          327 RDEAAMCIQLGLLCCQQSVAERPDMN-SVH  355 (437)
Q Consensus       327 ~~~~~~l~~l~~~cl~~~p~~RPs~~-ev~  355 (437)
                      .....++.+++.+||+.||++||++. +++
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         217 RWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            12334577899999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5.3e-42  Score=335.10  Aligned_cols=241  Identities=24%  Similarity=0.308  Sum_probs=194.6

Q ss_pred             CccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC---hHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCceEEEE
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS---RQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      +|.+.+.||+|+||.||+|+.. +++.||||++....   ......+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4888999999999999999854 67899999987532   23345567788888877 5899999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      ||+++|+|...+..   ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            99999999888743   346889999999999999999999988   999999999999999999999999999754322


Q ss_pred             CcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                      ...  .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+.      .. .        
T Consensus       155 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~------~~-~--------  217 (323)
T cd05616         155 GVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM------EH-N--------  217 (323)
T ss_pred             CCc--cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH------hC-C--------
Confidence            211  224578999999999999999999999999999999999999998654332211111      00 0        


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDM  351 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  351 (437)
                       ...+.....++.+++.+|++.+|.+|++.
T Consensus       218 -~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         218 -VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             -CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence             01112334567889999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=7.4e-42  Score=334.97  Aligned_cols=243  Identities=21%  Similarity=0.305  Sum_probs=190.8

Q ss_pred             ceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCceEEEEeecCC
Q 013745           92 NQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYEYLPN  166 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  166 (437)
                      +.||+|+||.||+|.. .+++.||+|++...   .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4699999999999985 46889999999753   333445678899988877 799999999999999999999999999


Q ss_pred             CCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccc
Q 013745          167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN  246 (437)
Q Consensus       167 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  246 (437)
                      |+|..++..   ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++........  
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~--  152 (329)
T cd05618          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--  152 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc--
Confidence            999887732   346899999999999999999999998   999999999999999999999999999754322211  


Q ss_pred             eeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhh--hhhhhhhhhhhcccccccccCccccC
Q 013745          247 TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK--ADLLSYTWTLFQGEKALELVDPSLAK  324 (437)
Q Consensus       247 ~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~d~~l~~  324 (437)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||........  .....+.+.......         ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~---------~~  223 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---------IR  223 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC---------CC
Confidence            2245789999999999999999999999999999999999999964221111  111111111111111         01


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 013745          325 CNRDEAAMCIQLGLLCCQQSVAERPDM  351 (437)
Q Consensus       325 ~~~~~~~~l~~l~~~cl~~~p~~RPs~  351 (437)
                      .+......+.+++.+||+.+|++||++
T Consensus       224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         224 IPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            122334567789999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.2e-41  Score=325.63  Aligned_cols=254  Identities=29%  Similarity=0.412  Sum_probs=200.3

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCc----EEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQ----EIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      ++|++.+.||+|+||.||+|.+. +++    .+++|++.... .....++..|+.++.+++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            46888999999999999999853 444    47788875432 3334677889999999999999999998864 45789


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      ++||+++|+|.+++...  ...+++..++.|+.||+.||.|||+++   ++||||||+|||++.++.+||+|||+++...
T Consensus        86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            99999999999998532  346899999999999999999999988   9999999999999999999999999998764


Q ss_pred             CCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      ............++..|+|||++.++.++.++|||||||++|||++ |..||.+.........+.       .+..  ..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-------~~~~--~~  231 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE-------KGER--LA  231 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------CCCc--CC
Confidence            3332222223456788999999998899999999999999999998 999997654433222211       1110  00


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      .+.      .....+..++.+||+.+|++||++.|+++.|..
T Consensus       232 ~~~------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~  267 (279)
T cd05111         232 QPQ------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTR  267 (279)
T ss_pred             CCC------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            111      122356788999999999999999999998874

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=8.7e-42  Score=334.48  Aligned_cols=243  Identities=21%  Similarity=0.288  Sum_probs=191.0

Q ss_pred             ceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCceEEEEeecCC
Q 013745           92 NQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYEYLPN  166 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  166 (437)
                      +.||+|+||.||+|.. .+++.||||++...   .......+..|+.++.++ +||||++++++|.+....|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4699999999999985 47889999999753   233345678899999998 699999999999999999999999999


Q ss_pred             CCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccc
Q 013745          167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN  246 (437)
Q Consensus       167 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  246 (437)
                      |+|..++..   ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--~  152 (329)
T cd05588          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--T  152 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCC--c
Confidence            999887733   356899999999999999999999998   99999999999999999999999999975322111  1


Q ss_pred             eeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchh--hhhhhhhhhhhhcccccccccCccccC
Q 013745          247 TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKE--KADLLSYTWTLFQGEKALELVDPSLAK  324 (437)
Q Consensus       247 ~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~l~~  324 (437)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ......+.........         ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~---------~~  223 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ---------IR  223 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC---------CC
Confidence            224579999999999999999999999999999999999999996432111  1111111111111110         01


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 013745          325 CNRDEAAMCIQLGLLCCQQSVAERPDM  351 (437)
Q Consensus       325 ~~~~~~~~l~~l~~~cl~~~p~~RPs~  351 (437)
                      .+......+.+++.+||+.+|.+||++
T Consensus       224 ~p~~~~~~~~~li~~~L~~dP~~R~~~  250 (329)
T cd05588         224 IPRSLSVKASSVLKGFLNKDPKERLGC  250 (329)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            112234557889999999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=9e-42  Score=340.00  Aligned_cols=266  Identities=22%  Similarity=0.272  Sum_probs=200.9

Q ss_pred             CccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC-----ceE
Q 013745           87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP-----EKM  158 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  158 (437)
                      +|++.+.||+|+||.||+|.. .+++.||||++...  .......+.+|+.+++.++||||+++++++....     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478899999999999999985 47899999998643  2334567889999999999999999999998776     789


Q ss_pred             EEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccccc
Q 013745          159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                      +||||+. ++|...+.   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999996 56766663   3356899999999999999999999998   999999999999999999999999999865


Q ss_pred             CCCCcccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhh----------
Q 013745          239 PGEDTHVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWT----------  307 (437)
Q Consensus       239 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~----------  307 (437)
                      ........ ....+++.|+|||++.+. .++.++|||||||++|||++|+.||.+....+....+.....          
T Consensus       154 ~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~  232 (372)
T cd07853         154 EPDESKHM-TQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA  232 (372)
T ss_pred             ccCccccC-CCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            43322211 134578999999998875 589999999999999999999999987654333222111000          


Q ss_pred             ------hhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          308 ------LFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       308 ------~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                            ..............+.........++.+++.+|++.||++|||+.++++  ++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  293 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE  293 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence                  0000000000000000111223456789999999999999999999975  4544

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6.2e-42  Score=334.26  Aligned_cols=236  Identities=23%  Similarity=0.332  Sum_probs=190.7

Q ss_pred             ceeccCCCeeEEEEEcC-CCcEEEEEEeccC---ChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCceEEEEeecCC
Q 013745           92 NQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD---SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYEYLPN  166 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  166 (437)
                      +.||+|+||.||+|+.+ +++.||||++...   .....+.+..|+.++..+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999854 6889999998643   223345677898998876 699999999999999999999999999


Q ss_pred             CCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccc
Q 013745          167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN  246 (437)
Q Consensus       167 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  246 (437)
                      |+|..++..   ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++........  
T Consensus        81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~--  152 (320)
T cd05590          81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--  152 (320)
T ss_pred             chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc--
Confidence            999888743   346899999999999999999999998   999999999999999999999999998754322211  


Q ss_pred             eeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCC
Q 013745          247 TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCN  326 (437)
Q Consensus       247 ~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  326 (437)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+      ... .   .      ..+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i------~~~-~---~------~~~  216 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI------LND-E---V------VYP  216 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH------hcC-C---C------CCC
Confidence            22357899999999999999999999999999999999999999865433221111      110 0   0      011


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCH
Q 013745          327 RDEAAMCIQLGLLCCQQSVAERPDM  351 (437)
Q Consensus       327 ~~~~~~l~~l~~~cl~~~p~~RPs~  351 (437)
                      ......+.+++.+|++.||++||++
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         217 TWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCC
Confidence            1234457889999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.4e-41  Score=321.21  Aligned_cols=255  Identities=28%  Similarity=0.430  Sum_probs=205.8

Q ss_pred             HhcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      ..+.|++.++||+|+||.||+|..++++.||+|.+..... ....+.+|+.++++++|+||+++++++. .+..++||||
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            3467999999999999999999988889999999875443 2467889999999999999999999874 4568999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +++++|.+++... ....+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          82 MENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            9999999887543 3356899999999999999999999988   99999999999999999999999999987653222


Q ss_pred             ccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCccc
Q 013745          244 HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL  322 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  322 (437)
                      .. .....++..|+|||++....++.++||||||+++|||++ |+.||.+....+....+.   .    ..     ... 
T Consensus       158 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---~----~~-----~~~-  223 (260)
T cd05067         158 TA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE---R----GY-----RMP-  223 (260)
T ss_pred             cc-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH---c----CC-----CCC-
Confidence            11 112345678999999998899999999999999999999 999997654332211110   0    00     001 


Q ss_pred             cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          323 AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       323 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                        .....+..+.+++.+||+.+|++||++++++.+|+.
T Consensus       224 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         224 --RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             --CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence              111234568899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.2e-41  Score=325.34  Aligned_cols=259  Identities=24%  Similarity=0.352  Sum_probs=206.2

Q ss_pred             HhcCccccceeccCCCeeEEEEEcCC-----CcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeecc-CCc
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMPN-----GQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE-GPE  156 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  156 (437)
                      ..++|.+.+.||+|+||.||+|....     +..|++|++... .......+.+|+.++++++|+||+++++++.. ...
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            35679999999999999999998654     688999988644 34446778899999999999999999998765 567


Q ss_pred             eEEEEeecCCCCcchhhhccCCC-----CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeee
Q 013745          157 KMLVYEYLPNKSLDYFIFDKTKS-----SSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISD  231 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~D  231 (437)
                      .++++||+++++|..++......     ..+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence            89999999999999988543222     56899999999999999999999988   99999999999999999999999


Q ss_pred             cccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhc
Q 013745          232 FGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQ  310 (437)
Q Consensus       232 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  310 (437)
                      ||+++.+.............++..|+|||++.+..++.++|||||||++||+++ |+.||......+..   .+...   
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---~~~~~---  234 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA---AYLKD---  234 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHH---HHHHc---
Confidence            999986643332221122345778999999998889999999999999999999 99999764332211   11111   


Q ss_pred             ccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          311 GEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       311 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                       +.     ...   .....+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       235 -~~-----~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  275 (280)
T cd05043         235 -GY-----RLA---QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTD  275 (280)
T ss_pred             -CC-----CCC---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence             10     000   011234567899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.8e-41  Score=322.41  Aligned_cols=255  Identities=24%  Similarity=0.401  Sum_probs=198.1

Q ss_pred             ccccceeccCCCeeEEEEEcCC-Cc--EEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccC------Cc
Q 013745           88 FSDLNQLGHGGFGPVYRGLMPN-GQ--EIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG------PE  156 (437)
Q Consensus        88 y~~~~~lG~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  156 (437)
                      |.+.+.||+|+||.||+|++.. +.  .||+|.+...  .....+.+.+|+.++++++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3467889999999999998643 33  5899988653  344567789999999999999999999987432      24


Q ss_pred             eEEEEeecCCCCcchhhhcc---CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecc
Q 013745          157 KMLVYEYLPNKSLDYFIFDK---TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG  233 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG  233 (437)
                      .++||||+++|+|..++...   .....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence            68999999999998877422   12345899999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhccc
Q 013745          234 LARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGE  312 (437)
Q Consensus       234 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  312 (437)
                      +++.+.............+++.|+|||++.+..++.++|||||||++|||++ |+.||.+....+....       ...+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-------~~~~  230 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY-------LRQG  230 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------HHcC
Confidence            9987654332111112345678999999999999999999999999999999 8899976443221111       1111


Q ss_pred             ccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          313 KALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       313 ~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ...        ......+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       231 ~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         231 NRL--------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             CCC--------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            100        0111233457899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.1e-41  Score=326.14  Aligned_cols=246  Identities=26%  Similarity=0.356  Sum_probs=195.6

Q ss_pred             eccCCCeeEEEEEcC-CCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCCCCc
Q 013745           94 LGHGGFGPVYRGLMP-NGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL  169 (437)
Q Consensus        94 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  169 (437)
                      ||+|+||+||++... +++.||+|++....   ....+.+..|++++++++|+||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999854 78999999986432   22345678899999999999999999999999999999999999999


Q ss_pred             chhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCccccee
Q 013745          170 DYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF  248 (437)
Q Consensus       170 ~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  248 (437)
                      ...+... .....+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++..+......  ..
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--cc
Confidence            8877432 23456899999999999999999999998   999999999999999999999999999876443322  22


Q ss_pred             eeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHH
Q 013745          249 RISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRD  328 (437)
Q Consensus       249 ~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  328 (437)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||..........  .......         ... ...+..
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~---------~~~-~~~~~~  223 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELKQRIL---------NDS-VTYPDK  223 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--HHHHhhc---------ccC-CCCccc
Confidence            3568999999999999999999999999999999999999997543221110  0000000         000 112223


Q ss_pred             HHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 013745          329 EAAMCIQLGLLCCQQSVAERP-----DMNSVHL  356 (437)
Q Consensus       329 ~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~  356 (437)
                      .+..+.+++.+||+.+|++||     +++++++
T Consensus       224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            455678899999999999999     6677764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=9.3e-42  Score=339.58  Aligned_cols=259  Identities=22%  Similarity=0.253  Sum_probs=201.3

Q ss_pred             HHHHHHhcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccC
Q 013745           79 RTLQVATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG  154 (437)
Q Consensus        79 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  154 (437)
                      +.+....++|++.+.||+|+||.||+|... +++.||+|++...   .......+.+|+.+++.++||||+++++++.++
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            344555688999999999999999999854 6889999998642   223345678899999999999999999999999


Q ss_pred             CceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccc
Q 013745          155 PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL  234 (437)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl  234 (437)
                      ...++||||+++|+|..++..    ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~  188 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT  188 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence            999999999999999988832    34788889999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcccceeeeecccccCChhhhccC----cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhc
Q 013745          235 ARLFPGEDTHVNTFRISGTHGYMAPEYALHG----YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQ  310 (437)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  310 (437)
                      ++......... .....||+.|+|||++.+.    .++.++|||||||++|||++|+.||..........      .+..
T Consensus       189 a~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~------~i~~  261 (371)
T cd05622         189 CMKMNKEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS------KIMN  261 (371)
T ss_pred             eeEcCcCCccc-ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHH------HHHc
Confidence            98764332211 2245799999999998754    37899999999999999999999998654322211      1111


Q ss_pred             ccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHHH
Q 013745          311 GEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAE--RPDMNSVHLM  357 (437)
Q Consensus       311 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~~  357 (437)
                      ........+      .......+.+++..|++..+.+  ||++.+|++.
T Consensus       262 ~~~~~~~~~------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         262 HKNSLTFPD------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             CCCcccCCC------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            111111111      1133455678888999844433  7888888763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=307.93  Aligned_cols=261  Identities=23%  Similarity=0.248  Sum_probs=209.5

Q ss_pred             HhcCccccceeccCCCeeEEEEE-cCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC-----ce
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP-----EK  157 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~  157 (437)
                      ..++|++.+.||+|||+-||+++ ..++..||+|++...+..+.+..++|++..++++|||+++++++...+.     ..
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            35789999999999999999998 5688999999998877777889999999999999999999999875443     48


Q ss_pred             EEEEeecCCCCcchhhhccCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          158 MLVYEYLPNKSLDYFIFDKTK-SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                      ||+++|...|+|.+.+..... +..+++.++++|+.+|++||++||+.. +++.||||||.|||+.+.+.++|.|||.++
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence            999999999999998865443 347999999999999999999999987 469999999999999999999999999998


Q ss_pred             ccCCCCcccc-------eeeeecccccCChhhhcc---CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhh
Q 013745          237 LFPGEDTHVN-------TFRISGTHGYMAPEYALH---GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTW  306 (437)
Q Consensus       237 ~~~~~~~~~~-------~~~~~gt~~Y~aPE~~~~---~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~  306 (437)
                      ..+-.-....       ...-..|..|.|||++.-   ...+.++|||||||+||+|+.|..||+......         
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G---------  248 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG---------  248 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC---------
Confidence            6532111000       001236889999999864   468999999999999999999999997432211         


Q ss_pred             hhhccccc-ccccCccc--cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          307 TLFQGEKA-LELVDPSL--AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       307 ~~~~~~~~-~~~~d~~l--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                           +.+ .....+.+  +... ..+..+.+++.+|++.||.+||+..+++..+..
T Consensus       249 -----gSlaLAv~n~q~s~P~~~-~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~  299 (302)
T KOG2345|consen  249 -----GSLALAVQNAQISIPNSS-RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD  299 (302)
T ss_pred             -----CeEEEeeeccccccCCCC-CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence                 111 11111111  1212 267779999999999999999999999988764

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.6e-41  Score=320.40  Aligned_cols=246  Identities=30%  Similarity=0.449  Sum_probs=196.6

Q ss_pred             eeccCCCeeEEEEEc---CCCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCCC
Q 013745           93 QLGHGGFGPVYRGLM---PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNK  167 (437)
Q Consensus        93 ~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  167 (437)
                      +||+|+||.||+|.+   +++..+|+|++....  ....+.+.+|+.++++++||||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            599999999999964   367889999986442  334567899999999999999999999885 45678999999999


Q ss_pred             CcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccc-
Q 013745          168 SLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN-  246 (437)
Q Consensus       168 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~-  246 (437)
                      +|.+++..   ...+++..++.++.|++.||+|||+++   |+||||||.||+++.++.+||+|||+++.......... 
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            99998843   246889999999999999999999988   99999999999999999999999999987654332211 


Q ss_pred             eeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCC
Q 013745          247 TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKC  325 (437)
Q Consensus       247 ~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  325 (437)
                      .....++..|+|||.+....++.++|||||||++|||++ |..||......+....+.       ....     +   ..
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-------~~~~-----~---~~  219 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-------SGER-----M---EC  219 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------CCCC-----C---CC
Confidence            111234578999999988889999999999999999998 999997654433222211       1110     0   11


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          326 NRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       326 ~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      +...+..+.+++.+||+.+|++||++.+|++.|++
T Consensus       220 ~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         220 PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            12334567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.3e-41  Score=326.73  Aligned_cols=261  Identities=23%  Similarity=0.380  Sum_probs=205.3

Q ss_pred             HHhcCccccceeccCCCeeEEEEEcC------CCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC
Q 013745           83 VATNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP  155 (437)
Q Consensus        83 ~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  155 (437)
                      +..++|++.+.||+|+||.||+|..+      .+..||+|.+.... ......+.+|+.++++++||||+++++++.+..
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            34678999999999999999998642      24579999886443 333456789999999999999999999999999


Q ss_pred             ceEEEEeecCCCCcchhhhccCC-------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCce
Q 013745          156 EKMLVYEYLPNKSLDYFIFDKTK-------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPK  228 (437)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~k  228 (437)
                      ..++||||+++|+|.+++.....       ...+.+..+..++.|++.||.|||+++   |+||||||+|||+++++.+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence            99999999999999999854221       234567788999999999999999988   99999999999999999999


Q ss_pred             eeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhh
Q 013745          229 ISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWT  307 (437)
Q Consensus       229 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~  307 (437)
                      |+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||.+....+....      
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~------  233 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------  233 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------
Confidence            999999986543322211112235678999999999899999999999999999998 7889876443221111      


Q ss_pred             hhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCC
Q 013745          308 LFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD  361 (437)
Q Consensus       308 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~  361 (437)
                      .....         ....+...+..+.+++.+|++.+|++||++.++++.|+..
T Consensus       234 ~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         234 VMDGG---------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             HHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            11110         0011112345788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.1e-41  Score=331.12  Aligned_cols=238  Identities=24%  Similarity=0.287  Sum_probs=188.8

Q ss_pred             ceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHH-HHHcCCCCcceeeeeeeccCCceEEEEeecCC
Q 013745           92 NQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVK-LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN  166 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  166 (437)
                      +.||+|+||.||+|+. .+|+.||+|++...   .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999984 47899999998643   2223345555655 46778999999999999999999999999999


Q ss_pred             CCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccc
Q 013745          167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN  246 (437)
Q Consensus       167 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  246 (437)
                      |+|...+.   ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 ~~L~~~l~---~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~  152 (325)
T cd05604          81 GELFFHLQ---RERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--T  152 (325)
T ss_pred             CCHHHHHH---HcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--C
Confidence            99988773   3356899999999999999999999998   99999999999999999999999999875422211  1


Q ss_pred             eeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCC
Q 013745          247 TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCN  326 (437)
Q Consensus       247 ~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  326 (437)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+...      ..... .        + ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~------~~~~~-~--------~-~~~  216 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD------NILHK-P--------L-VLR  216 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHH------HHHcC-C--------c-cCC
Confidence            224579999999999999999999999999999999999999997654322111      11110 0        0 011


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 013745          327 RDEAAMCIQLGLLCCQQSVAERPDMNS  353 (437)
Q Consensus       327 ~~~~~~l~~l~~~cl~~~p~~RPs~~e  353 (437)
                      +.....+.+++.+|++.+|.+||++.+
T Consensus       217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         217 PGASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             CCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence            123445778999999999999998864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.9e-41  Score=324.73  Aligned_cols=264  Identities=23%  Similarity=0.370  Sum_probs=203.8

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-----------------CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCccee
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-----------------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVT  146 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~  146 (437)
                      .++|++.+.||+|+||.||++...                 ++..||+|++... .......+.+|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            356999999999999999998532                 2446899998754 3444567899999999999999999


Q ss_pred             eeeeeccCCceEEEEeecCCCCcchhhhccCC--------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCC
Q 013745          147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTK--------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASN  218 (437)
Q Consensus       147 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~N  218 (437)
                      +++++...+..++||||+++++|.+++.....        ...+++..++.++.|++.||+|||+.+   ++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence            99999999999999999999999998854321        124778899999999999999999998   9999999999


Q ss_pred             EEecCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh--CCCCCCCCCch
Q 013745          219 ILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS--GRKNHDGRLGK  296 (437)
Q Consensus       219 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt--g~~p~~~~~~~  296 (437)
                      ||++.++.++|+|||+++.+.............++..|++||+..++.++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            9999999999999999986643322211212334678999999888899999999999999999998  77888654433


Q ss_pred             hhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          297 EKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                      +...   .....+..... ....+.    +...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus       241 ~~~~---~~~~~~~~~~~-~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         241 QVIE---NTGEFFRDQGR-QVYLPK----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHHH---HHHHHHhhccc-cccCCC----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            2211   11111111100 001111    1123356889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1e-41  Score=332.07  Aligned_cols=241  Identities=26%  Similarity=0.366  Sum_probs=192.4

Q ss_pred             ceeccCCCeeEEEEEcC-CCcEEEEEEeccCC---hHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCceEEEEeecCC
Q 013745           92 NQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS---RQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYEYLPN  166 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  166 (437)
                      +.||+|+||.||+|... +++.||||++....   ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999854 68899999997531   22345566788888764 899999999999999999999999999


Q ss_pred             CCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccc
Q 013745          167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN  246 (437)
Q Consensus       167 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  246 (437)
                      |+|..++..   ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~  152 (316)
T cd05619          81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--K  152 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--c
Confidence            999988843   346889999999999999999999998   99999999999999999999999999975432221  1


Q ss_pred             eeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCC
Q 013745          247 TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCN  326 (437)
Q Consensus       247 ~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  326 (437)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+..       .      .+..   +
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~-------~------~~~~---~  216 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM-------D------NPCY---P  216 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-------C------CCCC---C
Confidence            2245789999999999998999999999999999999999999986543322111110       0      0111   1


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHH-HHHH
Q 013745          327 RDEAAMCIQLGLLCCQQSVAERPDMN-SVHL  356 (437)
Q Consensus       327 ~~~~~~l~~l~~~cl~~~p~~RPs~~-ev~~  356 (437)
                      ......+.+++.+||+.+|++||++. ++.+
T Consensus       217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         217 RWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             ccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            12334577899999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-42  Score=338.51  Aligned_cols=247  Identities=28%  Similarity=0.394  Sum_probs=204.4

Q ss_pred             eeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCCCCcch
Q 013745           93 QLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDY  171 (437)
Q Consensus        93 ~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  171 (437)
                      +||+|.||+||.|++. +...+|||-+........+-+.+||..-++|+|.|||+++|.+.+++..-+.||-++||+|..
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            5999999999999965 455789999876666666778999999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCC--CHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEec-CCCCceeeecccccccCCCCccccee
Q 013745          172 FIFDKTKSSSL--DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTF  248 (437)
Q Consensus       172 ~l~~~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~  248 (437)
                      ++..  +=+++  .+.+.-.+..||++||.|||++.   |||||||-+||||+ -.|.+||+|||-++.+..-  ...+.
T Consensus       662 LLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi--nP~TE  734 (1226)
T KOG4279|consen  662 LLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI--NPCTE  734 (1226)
T ss_pred             HHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC--Ccccc
Confidence            9943  34566  78888899999999999999998   99999999999995 6789999999999887533  33344


Q ss_pred             eeecccccCChhhhccC--cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCC
Q 013745          249 RISGTHGYMAPEYALHG--YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCN  326 (437)
Q Consensus       249 ~~~gt~~Y~aPE~~~~~--~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  326 (437)
                      .+.||..|||||++..+  .|+.++|||||||.+.||.||++||.........-        |+.+-     ...-+..+
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM--------FkVGm-----yKvHP~iP  801 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM--------FKVGM-----YKVHPPIP  801 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh--------hhhcc-----eecCCCCc
Confidence            57899999999999876  69999999999999999999999997544322211        11110     01113456


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--Hhc
Q 013745          327 RDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLS  359 (437)
Q Consensus       327 ~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~  359 (437)
                      .+...+...++++|+.++|.+||+++++++  +|+
T Consensus       802 eelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq  836 (1226)
T KOG4279|consen  802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQ  836 (1226)
T ss_pred             HHHHHHHHHHHHHHcCCCcccCccHHHhccCcccc
Confidence            678888999999999999999999999875  454

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2e-41  Score=325.16  Aligned_cols=257  Identities=28%  Similarity=0.457  Sum_probs=204.5

Q ss_pred             hcCccccceeccCCCeeEEEEEcC------CCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCce
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK  157 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  157 (437)
                      .++|++.+.||+|+||.||+|...      ++..||+|++.... ......+.+|+.++++++||||+++++++.++...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467999999999999999999853      46789999987543 34456788999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccC-------------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCC
Q 013745          158 MLVYEYLPNKSLDYFIFDKT-------------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASN  218 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~N  218 (437)
                      ++||||+++++|.+++....                   ....+++..++.++.|++.||+|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            99999999999999985321                   1134788899999999999999999988   9999999999


Q ss_pred             EEecCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchh
Q 013745          219 ILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKE  297 (437)
Q Consensus       219 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~  297 (437)
                      ||+++++.+||+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||.+....+
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999876543322111112234667999999998899999999999999999997 888987544322


Q ss_pred             hhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          298 KADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                      ....       ......        ...+...+..+.+++.+||+.+|.+||++.||++.|+
T Consensus       241 ~~~~-------~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         241 VIYY-------VRDGNV--------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             HHHH-------HhcCCC--------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            1111       111111        0111233456888999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.2e-41  Score=329.88  Aligned_cols=240  Identities=23%  Similarity=0.266  Sum_probs=189.1

Q ss_pred             ceeccCCCeeEEEEEcC-CCcEEEEEEeccCC---hHHHHHHHHHHH-HHHcCCCCcceeeeeeeccCCceEEEEeecCC
Q 013745           92 NQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS---RQGLREFTNEVK-LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN  166 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  166 (437)
                      +.||+|+||+||+|+.. +++.||+|++....   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999854 67889999986432   222234444544 56788999999999999999999999999999


Q ss_pred             CCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccc
Q 013745          167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN  246 (437)
Q Consensus       167 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  246 (437)
                      ++|..++..   ...+.+..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~  152 (325)
T cd05602          81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--T  152 (325)
T ss_pred             CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--C
Confidence            999988843   345788888999999999999999998   99999999999999999999999999975432221  1


Q ss_pred             eeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCC
Q 013745          247 TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCN  326 (437)
Q Consensus       247 ~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  326 (437)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+....      .... .         ....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~------i~~~-~---------~~~~  216 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN------ILNK-P---------LQLK  216 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHH------HHhC-C---------cCCC
Confidence            2245799999999999999999999999999999999999999976543322111      1110 0         0111


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 013745          327 RDEAAMCIQLGLLCCQQSVAERPDMNSVH  355 (437)
Q Consensus       327 ~~~~~~l~~l~~~cl~~~p~~RPs~~ev~  355 (437)
                      +.....+.+++.+|++.+|.+||++.+.+
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         217 PNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            23345577899999999999999987544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.2e-41  Score=319.83  Aligned_cols=259  Identities=23%  Similarity=0.343  Sum_probs=207.5

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ++|++.+.||+|+||.||+|+. .+++.||||++...   .......+.+|++++++++||||+++++++...+..++||
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            5799999999999999999985 47899999987532   3344567889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          162 EYLPNKSLDYFIFDKT-KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      ||+++++|..++.... ....+++..++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            9999999988875322 2345788999999999999999999988   99999999999999999999999999987654


Q ss_pred             CCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                      .....  ....|++.|+|||.+.+..++.++||||||+++|||++|+.||....... .   ........      ...+
T Consensus       159 ~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~---~~~~~~~~------~~~~  226 (267)
T cd08228         159 KTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-F---SLCQKIEQ------CDYP  226 (267)
T ss_pred             hhHHH--hcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-H---HHHHHHhc------CCCC
Confidence            32211  12457889999999998889999999999999999999999986432211 1   11111100      0011


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCC
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD  361 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~  361 (437)
                      ..  .....+..+.+++.+||+.+|++||++.+|++.|++.
T Consensus       227 ~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         227 PL--PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             CC--ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            11  1123446688999999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.1e-41  Score=332.20  Aligned_cols=241  Identities=25%  Similarity=0.323  Sum_probs=194.5

Q ss_pred             ceeccCCCeeEEEEEcC-CCcEEEEEEeccC---ChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCceEEEEeecCC
Q 013745           92 NQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD---SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYEYLPN  166 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  166 (437)
                      +.||+|+||.||+|... +++.||||++...   .......+..|+.++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999854 6889999999753   233345677899999888 699999999999999999999999999


Q ss_pred             CCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccc
Q 013745          167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN  246 (437)
Q Consensus       167 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  246 (437)
                      ++|...+..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++........  
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--  152 (318)
T cd05570          81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--  152 (318)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc--
Confidence            999888743   346899999999999999999999998   999999999999999999999999998753222211  


Q ss_pred             eeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCC
Q 013745          247 TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCN  326 (437)
Q Consensus       247 ~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  326 (437)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........      .... .      .   ..+
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~------i~~~-~------~---~~~  216 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQS------ILED-E------V---RYP  216 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHH------HHcC-C------C---CCC
Confidence            2235789999999999999999999999999999999999999976543222111      1100 0      0   011


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHH
Q 013745          327 RDEAAMCIQLGLLCCQQSVAERPDM-----NSVHL  356 (437)
Q Consensus       327 ~~~~~~l~~l~~~cl~~~p~~RPs~-----~ev~~  356 (437)
                      ...+..+.+++.+||+.+|++||++     .++++
T Consensus       217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            1234567889999999999999999     77754

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.9e-41  Score=331.85  Aligned_cols=243  Identities=22%  Similarity=0.301  Sum_probs=192.3

Q ss_pred             ceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCceEEEEeecCC
Q 013745           92 NQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYEYLPN  166 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  166 (437)
                      +.||+|+||.||+|.. .+++.||+|++...   .......+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999985 46889999999754   223445688999999888 599999999999999999999999999


Q ss_pred             CCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccc
Q 013745          167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN  246 (437)
Q Consensus       167 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  246 (437)
                      |+|..++..   ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.......  .
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~  152 (327)
T cd05617          81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--T  152 (327)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCC--c
Confidence            999887732   346899999999999999999999998   99999999999999999999999999975322211  1


Q ss_pred             eeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCC
Q 013745          247 TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCN  326 (437)
Q Consensus       247 ~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  326 (437)
                      ....+||+.|+|||++.+..++.++|||||||+||||++|+.||.............+.+.......         ...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------~~~p  223 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP---------IRIP  223 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC---------CCCC
Confidence            2245799999999999999999999999999999999999999975433222221122222111110         0112


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCH
Q 013745          327 RDEAAMCIQLGLLCCQQSVAERPDM  351 (437)
Q Consensus       327 ~~~~~~l~~l~~~cl~~~p~~RPs~  351 (437)
                      ...+..+.+++.+||+.||++||++
T Consensus       224 ~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         224 RFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCC
Confidence            2234557789999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=313.56  Aligned_cols=252  Identities=21%  Similarity=0.285  Sum_probs=204.3

Q ss_pred             HhcCccccceeccCCCeeEEEEE-cCCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      .++.|++-++||+|.|+.||++. .++|+.+|+|++...  ...+.+.+.+|++|-+.|+|||||++.+.+......|||
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            35678889999999999999987 458999999988643  333567889999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEec---CCCCceeeecccccc
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD---EQLNPKISDFGLARL  237 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~---~~~~~kl~DFGla~~  237 (437)
                      +|+|.|++|-.-|..+   .-+++..+-.+++||+++|.|+|.++   |||||+||.|+|+-   ...-+||+|||+|..
T Consensus        89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~  162 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE  162 (355)
T ss_pred             EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence            9999999997666444   44678888899999999999999998   99999999999994   344589999999998


Q ss_pred             cCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccc
Q 013745          238 FPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALEL  317 (437)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (437)
                      +....   .....+|||+|||||++...+|+..+|||+.|||||-|+.|.+||.+.+.....+.+...        ..+.
T Consensus       163 l~~g~---~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g--------~yd~  231 (355)
T KOG0033|consen  163 VNDGE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG--------AYDY  231 (355)
T ss_pred             eCCcc---ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc--------ccCC
Confidence            86222   223468999999999999999999999999999999999999999875443322221110        0111


Q ss_pred             cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          318 VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       318 ~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ..    ...+...++..+|+.+|+..||.+|.|+.|.+.
T Consensus       232 ~~----~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  232 PS----PEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             CC----cccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            11    123344556778999999999999999998753

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5.1e-41  Score=316.09  Aligned_cols=250  Identities=25%  Similarity=0.391  Sum_probs=205.5

Q ss_pred             CccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      +|.+.+.||+|+||.||+|... +++.|++|.+...  .......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4788899999999999999854 7899999998643  344567789999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +++++|.+++... ....+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++.+.....
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            9999999988643 2356899999999999999999999987   99999999999999999999999999987654332


Q ss_pred             ccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcccc
Q 013745          244 HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA  323 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  323 (437)
                      ..  ....|++.|+|||++.+..++.++|||||||++|||++|+.||.........   .   .... .        ...
T Consensus       157 ~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~---~~~~-~--------~~~  219 (256)
T cd08529         157 FA--NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALI---L---KIIR-G--------VFP  219 (256)
T ss_pred             hh--hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH---H---HHHc-C--------CCC
Confidence            21  2346889999999999999999999999999999999999999765422211   1   1100 0        011


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013745          324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLM  357 (437)
Q Consensus       324 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  357 (437)
                      .........+.+++.+||+.+|++||++.+|++.
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            1122345668899999999999999999999763

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=2e-41  Score=321.39  Aligned_cols=255  Identities=22%  Similarity=0.318  Sum_probs=202.3

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.++++++||||+++++++..+...++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            35699999999999999999985 47889999999765444456788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++........
T Consensus        88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06646          88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA  161 (267)
T ss_pred             CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence            999999988743   346889999999999999999999988   99999999999999999999999999987643221


Q ss_pred             ccceeeeecccccCChhhhc---cCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          244 HVNTFRISGTHGYMAPEYAL---HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                      .  .....|+..|+|||.+.   ...++.++|||||||++|||++|+.||............       ....   ...+
T Consensus       162 ~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-------~~~~---~~~~  229 (267)
T cd06646         162 K--RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-------SKSN---FQPP  229 (267)
T ss_pred             c--cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-------ecCC---CCCC
Confidence            1  12346889999999885   345788999999999999999999998644322111100       0000   0001


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHh
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML  358 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L  358 (437)
                      ... .....+..+.+++.+||+.+|++||++++|++.|
T Consensus       230 ~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         230 KLK-DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCc-cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            111 1112345688999999999999999999998643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=333.56  Aligned_cols=251  Identities=24%  Similarity=0.254  Sum_probs=211.4

Q ss_pred             HhcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCCh---HHHHHHHHHHHHHHcCC-CCcceeeeeeeccCCceE
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR---QGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKM  158 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  158 (437)
                      ....|++.+.||+|.||.||+++.+ +|+.+|+|++.+...   .....+.+|+.+|+++. |||||.+++.|.+...++
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            3567999999999999999999955 599999999976532   23467899999999998 999999999999999999


Q ss_pred             EEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC----CCCceeeeccc
Q 013745          159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE----QLNPKISDFGL  234 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~----~~~~kl~DFGl  234 (437)
                      +|||+|.||.|.+.+...    .+++..+..++.|++.++.|||+.+   |+||||||+|+|+..    ++.+|++|||+
T Consensus       113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            999999999999998655    3999999999999999999999998   999999999999953    35799999999


Q ss_pred             ccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccc
Q 013745          235 ARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKA  314 (437)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  314 (437)
                      +.....   ......++||+.|+|||++....|+..+||||+||++|.|++|.+||.+.........+.....       
T Consensus       186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~-------  255 (382)
T KOG0032|consen  186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF-------  255 (382)
T ss_pred             ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC-------
Confidence            998765   2233468999999999999999999999999999999999999999998765544332211111       


Q ss_pred             ccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          315 LELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       315 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                       ++.    ..........+.+++..|+..||.+|+++.++++
T Consensus       256 -~f~----~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  256 -DFT----SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             -CCC----CCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence             111    1234455667888999999999999999999987

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=4.2e-41  Score=318.17  Aligned_cols=253  Identities=28%  Similarity=0.450  Sum_probs=203.1

Q ss_pred             cCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecC
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLP  165 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  165 (437)
                      ++|++.+.||+|+||.||+|....+..+|+|++..... ..+.+.+|+.++++++|+|++++++++.. ...++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCC
Confidence            56889999999999999999977777899998865432 23668899999999999999999998854 56899999999


Q ss_pred             CCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCccc
Q 013745          166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV  245 (437)
Q Consensus       166 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  245 (437)
                      +++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++.+||+|||++..........
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05069          84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence            99999988543 2345889999999999999999999988   9999999999999999999999999998764332211


Q ss_pred             ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccC
Q 013745          246 NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK  324 (437)
Q Consensus       246 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  324 (437)
                       .....++..|+|||++.+..++.++|||||||++|||++ |+.||.+....+...   +....+         ..   .
T Consensus       160 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~---~~~~~~---------~~---~  223 (260)
T cd05069         160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLE---QVERGY---------RM---P  223 (260)
T ss_pred             -cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHHcCC---------CC---C
Confidence             112345678999999998899999999999999999999 899997654332211   111000         00   1


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          325 CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       325 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      .+...+..+.+++.+||+.+|++||++.+|+++|+.
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            122345668899999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.9e-41  Score=328.65  Aligned_cols=258  Identities=27%  Similarity=0.371  Sum_probs=204.1

Q ss_pred             hcCccccceeccCCCeeEEEEEcC--------CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccC
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP--------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEG  154 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  154 (437)
                      .++|.+.+.||+|+||.||+|...        +...+|+|++... .......+.+|+.+++++ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            467999999999999999999742        2356999999754 234456788999999999 799999999999999


Q ss_pred             CceEEEEeecCCCCcchhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEe
Q 013745          155 PEKMLVYEYLPNKSLDYFIFDKTK-------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL  221 (437)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll  221 (437)
                      ...++||||+++++|.+++.....             ...+++..++.++.|++.||+|||+++   ++||||||+|||+
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            999999999999999999864321             235889999999999999999999988   9999999999999


Q ss_pred             cCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhh
Q 013745          222 DEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKAD  300 (437)
Q Consensus       222 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~  300 (437)
                      +.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.+....+...
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~  253 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK  253 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence            9999999999999986643222111112234568999999998889999999999999999998 888986543322111


Q ss_pred             hhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          301 LLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      .+.       ....        ...+......+.+++.+||+.+|++||++.+|++.|+.
T Consensus       254 ~~~-------~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~  298 (307)
T cd05098         254 LLK-------EGHR--------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  298 (307)
T ss_pred             HHH-------cCCC--------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHH
Confidence            111       1110        01112334567889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.1e-41  Score=327.80  Aligned_cols=259  Identities=26%  Similarity=0.379  Sum_probs=206.1

Q ss_pred             HhcCccccceeccCCCeeEEEEEc--------CCCcEEEEEEeccC-ChHHHHHHHHHHHHHHcC-CCCcceeeeeeecc
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM--------PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAE  153 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  153 (437)
                      ..++|.+.+.||+|+||.||+|+.        .++..||+|++... .......+.+|+.+++.+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            356789999999999999999963        13457999998644 234457789999999999 79999999999999


Q ss_pred             CCceEEEEeecCCCCcchhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEE
Q 013745          154 GPEKMLVYEYLPNKSLDYFIFDKTK-------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNIL  220 (437)
Q Consensus       154 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIl  220 (437)
                      ....++||||+++++|.+++.....             ...+++..++.++.||+.||.|||+++   |+||||||+|||
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence            9999999999999999999865321             235788899999999999999999998   999999999999


Q ss_pred             ecCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhh
Q 013745          221 LDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKA  299 (437)
Q Consensus       221 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~  299 (437)
                      ++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+..
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~  249 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF  249 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH
Confidence            99999999999999987654332222222345678999999998889999999999999999998 78888765432221


Q ss_pred             hhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          300 DLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ..+       ......        ..+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       250 ~~~-------~~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~  295 (304)
T cd05101         250 KLL-------KEGHRM--------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR  295 (304)
T ss_pred             HHH-------HcCCcC--------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence            111       111100        0111334568889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.2e-41  Score=345.71  Aligned_cols=262  Identities=19%  Similarity=0.278  Sum_probs=193.6

Q ss_pred             HhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccC--------
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG--------  154 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  154 (437)
                      ..++|++.+.||+|+||.||+|+. .+++.||||++.....    ...+|+.+|+.++|||||++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ----YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            356799999999999999999985 4789999998864422    234799999999999999998876432        


Q ss_pred             CceEEEEeecCCCCcchhhhc-cCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCC-Cceeeec
Q 013745          155 PEKMLVYEYLPNKSLDYFIFD-KTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL-NPKISDF  232 (437)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~-~~kl~DF  232 (437)
                      ..+++||||+++ +|..++.. ......+++..++.++.||+.||.|||+++   |+||||||+||||+.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence            246789999975 56555532 223467899999999999999999999998   99999999999998664 6999999


Q ss_pred             ccccccCCCCcccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcc
Q 013745          233 GLARLFPGEDTHVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQG  311 (437)
Q Consensus       233 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  311 (437)
                      |+++.+......   ....||+.|+|||++.+. .++.++|||||||+||||++|.+||.+....+....+.........
T Consensus       216 Gla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        216 GSAKNLLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             ccchhccCCCCc---ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            999876433221   134689999999998764 6899999999999999999999999876543322211110000000


Q ss_pred             -------cccccccCcc-----c-cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          312 -------EKALELVDPS-----L-AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       312 -------~~~~~~~d~~-----l-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                             ....+...+.     + ...+...+.++.+|+.+||+.+|.+|||+.|+++
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence                   0000000000     0 0111123456889999999999999999999974

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=6.5e-41  Score=328.56  Aligned_cols=254  Identities=20%  Similarity=0.215  Sum_probs=196.7

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ++|++.+.||+|+||.||+++.. +++.||+|++...   .......+.+|+.++..++|+||+++++++.+.+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46999999999999999999854 6889999998642   2233455788999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      ||+++|+|..++...  ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999998532  346889999999999999999999988   999999999999999999999999999876543


Q ss_pred             CcccceeeeecccccCChhhhcc-----CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALH-----GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE  316 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (437)
                      .... .....||+.|+|||++.+     +.++.++|||||||+||||++|+.||......+...      ......... 
T Consensus       156 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~------~i~~~~~~~-  227 (331)
T cd05624         156 GTVQ-SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KIMNHEERF-  227 (331)
T ss_pred             Ccee-eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHH------HHHcCCCcc-
Confidence            3221 123569999999999876     468899999999999999999999997644322211      111111000 


Q ss_pred             ccCccccCCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHH
Q 013745          317 LVDPSLAKCNRDEAAMCIQLGLLCCQQSVAE--RPDMNSVHL  356 (437)
Q Consensus       317 ~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~  356 (437)
                          .++......+..+.+++.+|++..+++  |+++.++++
T Consensus       228 ----~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         228 ----QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             ----cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence                011111123455777888888865544  457777754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=8e-42  Score=338.87  Aligned_cols=258  Identities=23%  Similarity=0.310  Sum_probs=198.7

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ++|++++.||+|+||.||+|.. .+++.||||++...   .......+.+|+.++..++||||+++++.+.+.+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4689999999999999999985 46899999999643   2333466888999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      ||+++|+|.+++..   ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            99999999998843   356899999999999999999999998   999999999999999999999999998754321


Q ss_pred             Ccc---------------------------------cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCC
Q 013745          242 DTH---------------------------------VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRK  288 (437)
Q Consensus       242 ~~~---------------------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~  288 (437)
                      ...                                 ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            100                                 00113469999999999999999999999999999999999999


Q ss_pred             CCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCCC
Q 013745          289 NHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDS  362 (437)
Q Consensus       289 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~  362 (437)
                      ||...........+.      ....  ....+...    .....+.+++.+|+ .+|.+|++...+-+.++...
T Consensus       235 Pf~~~~~~~~~~~i~------~~~~--~~~~p~~~----~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~  295 (360)
T cd05627         235 PFCSETPQETYRKVM------NWKE--TLVFPPEV----PISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPF  295 (360)
T ss_pred             CCCCCCHHHHHHHHH------cCCC--ceecCCCC----CCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCC
Confidence            998655433221111      0000  00001100    12334566776766 49999997544444454433

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-41  Score=316.62  Aligned_cols=250  Identities=31%  Similarity=0.470  Sum_probs=204.3

Q ss_pred             ceeccCCCeeEEEEEcCC----CcEEEEEEeccCChH-HHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCC
Q 013745           92 NQLGHGGFGPVYRGLMPN----GQEIAVKKLSVDSRQ-GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN  166 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  166 (437)
                      +.||+|+||.||+|....    +..|++|++...... ..+.+.+|+++++.++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            469999999999998543    888999999765332 367889999999999999999999999999999999999999


Q ss_pred             CCcchhhhccCC------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          167 KSLDYFIFDKTK------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       167 gsL~~~l~~~~~------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      ++|.+++.....      ...+++..++.++.|++.||+|||+++   ++||||||+||+++.++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999854321      367999999999999999999999988   99999999999999999999999999988765


Q ss_pred             CCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                      ...........++..|+|||.+....++.++|||||||++|||++ |..||......+....+.      . ..      
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~------~-~~------  224 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR------K-GY------  224 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH------c-CC------
Confidence            432222223457889999999998899999999999999999999 699998764322211111      0 00      


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                        ....+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus       225 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 --RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             --CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence              01112233567889999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.6e-41  Score=320.14  Aligned_cols=255  Identities=26%  Similarity=0.406  Sum_probs=202.4

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CC---cEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NG---QEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      +.|++.+.||+|+||.||+|... ++   ..||||++... .......|..|+.++++++||||+++++++.++...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            35888999999999999999854 33   36999998754 344567899999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||+++++|.+++...  .+.+++..++.++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||++.....
T Consensus        84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  158 (269)
T cd05065          84 TEFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  158 (269)
T ss_pred             EecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence            9999999999988432  346899999999999999999999988   99999999999999999999999999986643


Q ss_pred             CCcccceeeee---cccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhccccccc
Q 013745          241 EDTHVNTFRIS---GTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALE  316 (437)
Q Consensus       241 ~~~~~~~~~~~---gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (437)
                      ...........   .+..|+|||++.+..++.++|||||||++|||++ |..||......+...   +....+   .   
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~---~i~~~~---~---  229 (269)
T cd05065         159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIN---AIEQDY---R---  229 (269)
T ss_pred             CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHH---HHHcCC---c---
Confidence            22211111111   2357999999999999999999999999999886 999997654332211   111000   0   


Q ss_pred             ccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          317 LVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       317 ~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                        .+    ...+.+..+.+++.+||+.+|++||++.+|+..|+.
T Consensus       230 --~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         230 --LP----PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             --CC----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence              00    011234567889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=3.9e-41  Score=321.75  Aligned_cols=255  Identities=27%  Similarity=0.418  Sum_probs=201.8

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCc----EEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQ----EIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM  158 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  158 (437)
                      .++|++.+.||+|+||+||+|.+ .+++    .||+|++... .......+.+|+.++..+.||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            45689999999999999999984 3454    4899998654 334456788999999999999999999998754 578


Q ss_pred             EEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccccc
Q 013745          159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                      ++|||+++|+|.+++...  ...+++..++.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++.+
T Consensus        85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence            999999999999988432  346899999999999999999999988   999999999999999999999999999877


Q ss_pred             CCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccc
Q 013745          239 PGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALEL  317 (437)
Q Consensus       239 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (437)
                      .............++..|+|||.+.+..++.++|||||||++|||++ |..||...........+.       ....   
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~~---  229 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE-------KGER---  229 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-------CCCc---
Confidence            54332211112234678999999998899999999999999999998 899987543322211111       0000   


Q ss_pred             cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          318 VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       318 ~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                       .    ......+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       230 -~----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~  267 (279)
T cd05109         230 -L----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSR  267 (279)
T ss_pred             -C----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence             0    0111234567889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.7e-41  Score=323.51  Aligned_cols=265  Identities=26%  Similarity=0.405  Sum_probs=201.0

Q ss_pred             ccccceeccCCCeeEEEEEc-----CCCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccC--CceEE
Q 013745           88 FSDLNQLGHGGFGPVYRGLM-----PNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG--PEKML  159 (437)
Q Consensus        88 y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  159 (437)
                      |.+++.||+|+||+||++..     .+++.||+|.+.... ......+.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            48899999999999988642     367889999987543 33456788999999999999999999987653  45789


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      ||||+++++|.+++..    ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  158 (283)
T cd05080          86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  158 (283)
T ss_pred             EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence            9999999999998832    35899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcccc-eeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          240 GEDTHVN-TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       240 ~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      ....... .....++..|+|||.+.+..++.++|||||||++|||++|..||....... .................+.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05080         159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRLIELL  237 (283)
T ss_pred             CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhhhhhh
Confidence            3322111 111235667999999998889999999999999999999999986533211 11111111000011111111


Q ss_pred             Cccc-cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          319 DPSL-AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       319 d~~l-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      +... ...+...+..+.+++..||+.+|++||++++|+++|+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~  280 (283)
T cd05080         238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKE  280 (283)
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence            1111 11222345678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-41  Score=319.31  Aligned_cols=256  Identities=29%  Similarity=0.448  Sum_probs=207.5

Q ss_pred             HhcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      ..++|++.+.||+|+||.||+|..++++.||||.+..... ....+.+|+.++++++|+||+++++++......++||||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            3567999999999999999999987788999999875433 346788999999999999999999999998899999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +++++|.+++... ....+++..+..++.|++.||.|||+++   ++|+||||+||++++++.+||+|||++..+.....
T Consensus        83 ~~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          83 MSKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             cCCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            9999999988543 2346899999999999999999999998   99999999999999999999999999987653221


Q ss_pred             ccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCccc
Q 013745          244 HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL  322 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  322 (437)
                      .. .....++..|+|||.+.+..++.++|||||||++|||++ |+.||.+.........+   ...+         ... 
T Consensus       159 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~---~~~~---------~~~-  224 (261)
T cd05034         159 TA-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV---ERGY---------RMP-  224 (261)
T ss_pred             hh-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---HcCC---------CCC-
Confidence            11 112234568999999998899999999999999999998 99999765433221111   1000         000 


Q ss_pred             cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          323 AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       323 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                        .+...+..+.+++.+|++.+|++||+++++++.|+.
T Consensus       225 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         225 --RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             --CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence              011224568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3e-41  Score=323.26  Aligned_cols=270  Identities=25%  Similarity=0.375  Sum_probs=201.6

Q ss_pred             cCccccceeccCCCeeEEEEEc-----CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeecc--CCceE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-----PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE--GPEKM  158 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  158 (437)
                      .+|++++.||+|+||.||+|..     .++..||+|++........+.+.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4688999999999999999873     2578999999987766667789999999999999999999998643  35689


Q ss_pred             EEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccccc
Q 013745          159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                      +||||+++++|.+++...  ...+++..++.++.|++.||.|||+++   |+||||||+||++++++.+||+|||+++..
T Consensus        84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            999999999999988432  346899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcccc-eeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccc
Q 013745          239 PGEDTHVN-TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALEL  317 (437)
Q Consensus       239 ~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (437)
                      ........ .....++..|+|||++.+..++.++|||||||++|||++|..++...........-.............+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL  238 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence            54322111 11112345699999999889999999999999999999988776432211000000000000000000000


Q ss_pred             cCcc-ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          318 VDPS-LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       318 ~d~~-l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      +... ........+..+.+++.+||+.+|++|||+.+|++.|+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05081         239 LKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA  282 (284)
T ss_pred             HhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence            0000 001112334568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.3e-41  Score=331.01  Aligned_cols=260  Identities=27%  Similarity=0.369  Sum_probs=205.2

Q ss_pred             HhcCccccceeccCCCeeEEEEEcC--------CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcC-CCCcceeeeeeecc
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMP--------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAE  153 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  153 (437)
                      ...+|.+.+.||+|+||.||+|...        .+..||+|.+... .......+.+|+.+++++ +||||++++++|..
T Consensus        10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (334)
T cd05100          10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   89 (334)
T ss_pred             CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence            3456999999999999999999732        1236899988754 334457889999999999 79999999999999


Q ss_pred             CCceEEEEeecCCCCcchhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEE
Q 013745          154 GPEKMLVYEYLPNKSLDYFIFDKT-------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNIL  220 (437)
Q Consensus       154 ~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIl  220 (437)
                      ....+++|||+++|+|.+++....             ....+++..++.++.|++.||+|||+++   |+||||||+|||
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil  166 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVL  166 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEE
Confidence            999999999999999999986432             1235788999999999999999999988   999999999999


Q ss_pred             ecCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhh
Q 013745          221 LDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKA  299 (437)
Q Consensus       221 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~  299 (437)
                      ++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.+....+..
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  246 (334)
T cd05100         167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF  246 (334)
T ss_pred             EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            99999999999999987643322221212234567999999999999999999999999999998 88998765433221


Q ss_pred             hhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCC
Q 013745          300 DLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD  361 (437)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~  361 (437)
                      ..+       ......        ..+...+..+.+++.+||+.+|++||++.+|++.|...
T Consensus       247 ~~~-------~~~~~~--------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~  293 (334)
T cd05100         247 KLL-------KEGHRM--------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV  293 (334)
T ss_pred             HHH-------HcCCCC--------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            111       111000        11112345688999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=5.8e-41  Score=314.91  Aligned_cols=247  Identities=26%  Similarity=0.397  Sum_probs=198.6

Q ss_pred             ceeccCCCeeEEEEEcCCCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCCCCcc
Q 013745           92 NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLD  170 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  170 (437)
                      +.||+|+||.||+|...+++.||+|++.... ......+.+|++++++++||||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            3699999999999997788999999987543 333456889999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccceeee
Q 013745          171 YFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI  250 (437)
Q Consensus       171 ~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  250 (437)
                      +++...  ...+++..++.++.|++.+|.|||+.+   ++||||||+||+++.++.+||+|||++.......... ....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~  154 (250)
T cd05085          81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGLK  154 (250)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccccc-CCCC
Confidence            987432  345889999999999999999999988   9999999999999999999999999997643322111 1112


Q ss_pred             ecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHH
Q 013745          251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDE  329 (437)
Q Consensus       251 ~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  329 (437)
                      .++..|+|||++.+..++.++||||||+++|||++ |..||...........+.   .    ...     .   ..+...
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~---~----~~~-----~---~~~~~~  219 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE---K----GYR-----M---SCPQKC  219 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH---c----CCC-----C---CCCCCC
Confidence            34567999999998899999999999999999998 999997654322211111   0    000     0   111123


Q ss_pred             HHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          330 AAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       330 ~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                      +..+.+++.+|++.+|++||++.+|++.|.
T Consensus       220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         220 PDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            456889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=6.2e-41  Score=325.33  Aligned_cols=260  Identities=25%  Similarity=0.355  Sum_probs=202.2

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      ++|++.+.||+|+||.||++... ++..+|+|.+... .......+.+|++++.+++||||++++++|.+++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46899999999999999999854 6888999988654 333456688999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE-APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      +++++|.+++..   ...+++..+..++.|++.||.|||+. +   ++||||||+|||++.++.+||+|||++.......
T Consensus        81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (308)
T cd06615          81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  154 (308)
T ss_pred             cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence            999999999843   25688999999999999999999984 5   9999999999999999999999999987653321


Q ss_pred             cccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccc--------
Q 013745          243 THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKA--------  314 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------  314 (437)
                      .    ....|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+............        
T Consensus       155 ~----~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         155 A----NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             c----ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence            1    2346889999999998888999999999999999999999999754432221111111000000000        


Q ss_pred             ---------cccc-------CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013745          315 ---------LELV-------DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLM  357 (437)
Q Consensus       315 ---------~~~~-------d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  357 (437)
                               .+..       .+.+.  .......+.+++.+||+.+|++||++.+|++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEPPPKLP--SGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCccchhhHHHHHHHHhcCCCccCc--CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                     0000       00000  01134568899999999999999999999753

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=8.9e-41  Score=327.72  Aligned_cols=254  Identities=20%  Similarity=0.211  Sum_probs=195.8

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ++|++.+.||+|+||.||+++.+ +++.||+|++...   .......+.+|+.++..++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46899999999999999999854 6788999998642   2223345788999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      ||+++|+|.+++...  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            999999999998532  346889999999999999999999998   999999999999999999999999999765433


Q ss_pred             CcccceeeeecccccCChhhhc-----cCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccc
Q 013745          242 DTHVNTFRISGTHGYMAPEYAL-----HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE  316 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (437)
                      ... ......||+.|+|||++.     ...++.++|||||||++|||++|+.||......+....      ........ 
T Consensus       156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~------i~~~~~~~-  227 (332)
T cd05623         156 GTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK------IMNHKERF-  227 (332)
T ss_pred             Ccc-eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHH------HhCCCccc-
Confidence            221 122356999999999986     34689999999999999999999999986543322211      11111000 


Q ss_pred             ccCccccCCCHHHHHHHHHHHHHcCCCCCC--CCCCHHHHHH
Q 013745          317 LVDPSLAKCNRDEAAMCIQLGLLCCQQSVA--ERPDMNSVHL  356 (437)
Q Consensus       317 ~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~--~RPs~~ev~~  356 (437)
                          ..+.........+.+++.+|+..+++  .|+++.++++
T Consensus       228 ----~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~  265 (332)
T cd05623         228 ----QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ  265 (332)
T ss_pred             ----cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhC
Confidence                01111112345567777787765444  3788888865

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.8e-41  Score=333.85  Aligned_cols=261  Identities=25%  Similarity=0.277  Sum_probs=196.6

Q ss_pred             HhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC-----
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP-----  155 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  155 (437)
                      ..++|++.+.||+|+||.||+|.. .+|+.||||++...  .......+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            357899999999999999999985 46899999998643  3334567889999999999999999999986543     


Q ss_pred             -ceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccc
Q 013745          156 -EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL  234 (437)
Q Consensus       156 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl  234 (437)
                       ..|+||||+++ +|...+.     ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence             46999999965 4544442     24788899999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhh-----------
Q 013745          235 ARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS-----------  303 (437)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~-----------  303 (437)
                      ++.......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+.           
T Consensus       170 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  246 (359)
T cd07876         170 ARTACTNFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFM  246 (359)
T ss_pred             ccccccCcc---CCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHH
Confidence            976533221   123468999999999999999999999999999999999999998654322111000           


Q ss_pred             -----hhhhhhccc------ccccc----cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          304 -----YTWTLFQGE------KALEL----VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       304 -----~~~~~~~~~------~~~~~----~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                           .........      ...+.    ..+............+.+++.+||+.||++|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence                 000000000      00000    000001111123456789999999999999999999976

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.2e-41  Score=327.36  Aligned_cols=259  Identities=27%  Similarity=0.374  Sum_probs=205.1

Q ss_pred             hcCccccceeccCCCeeEEEEEcC--------CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccC
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP--------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEG  154 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  154 (437)
                      .++|.+.+.||+|+||.||+|...        ....+|+|++... .......+.+|+.+++++ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            457889999999999999999631        2457899998754 334456788999999999 699999999999999


Q ss_pred             CceEEEEeecCCCCcchhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEe
Q 013745          155 PEKMLVYEYLPNKSLDYFIFDKT-------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL  221 (437)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll  221 (437)
                      ...++||||+++|+|.+++....             ....+++..+..++.|++.||.|||+++   |+||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence            99999999999999999985432             1245889999999999999999999988   9999999999999


Q ss_pred             cCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhh
Q 013745          222 DEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKAD  300 (437)
Q Consensus       222 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~  300 (437)
                      +.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.+....+...
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~  247 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK  247 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            9999999999999987643322211112234567999999998899999999999999999999 889997654332222


Q ss_pred             hhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCC
Q 013745          301 LLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD  361 (437)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~  361 (437)
                      .+.       .....        ..+...+..+.+++.+||+.+|++||++.+|++.|...
T Consensus       248 ~~~-------~~~~~--------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~  293 (314)
T cd05099         248 LLR-------EGHRM--------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV  293 (314)
T ss_pred             HHH-------cCCCC--------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            111       11100        11123344677899999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=6.8e-41  Score=317.55  Aligned_cols=258  Identities=24%  Similarity=0.358  Sum_probs=207.2

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ++|++.+.||+|+||.||+|.. .+++.+|||.+...   .......+.+|+.+++.++||||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688899999999999999984 57899999988643   2334467889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          162 EYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       162 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      ||+++++|.+++... .....+++..++.++.||+.||.|||+++   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999887532 22356899999999999999999999988   99999999999999999999999999987643


Q ss_pred             CCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                      .....  ....|+..|+|||++.+..++.++||||||+++|+|++|..||.+..... .....   ..      .....+
T Consensus       159 ~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~---~~------~~~~~~  226 (267)
T cd08229         159 KTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCK---KI------EQCDYP  226 (267)
T ss_pred             CCccc--ccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-HHHhh---hh------hcCCCC
Confidence            32211  13468899999999998889999999999999999999999996532211 11100   00      011111


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      .+.  .......+.+++.+||+.+|++||||.+|+++++.
T Consensus       227 ~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~  264 (267)
T cd08229         227 PLP--SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR  264 (267)
T ss_pred             CCC--cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence            111  12345568899999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=7.6e-41  Score=316.40  Aligned_cols=255  Identities=25%  Similarity=0.403  Sum_probs=205.5

Q ss_pred             HhcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      ..++|++.+.||+|+||.||+|....+..+|+|.+.... .....+.+|++++++++|+||+++++++.. ...+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            346799999999999999999987677889999887543 234678899999999999999999999887 778999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +++++|.+++... ....+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++..+.....
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  157 (260)
T cd05073          82 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  157 (260)
T ss_pred             CCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence            9999999998543 3356888999999999999999999987   99999999999999999999999999987643222


Q ss_pred             ccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCccc
Q 013745          244 HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL  322 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  322 (437)
                      .. .....++..|+|||++....++.++|||||||++|++++ |+.||...........+.       .....       
T Consensus       158 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-------~~~~~-------  222 (260)
T cd05073         158 TA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-------RGYRM-------  222 (260)
T ss_pred             cc-ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh-------CCCCC-------
Confidence            11 112335678999999998889999999999999999999 999997654332211111       11000       


Q ss_pred             cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          323 AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       323 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                       ......+..+.+++.+|++.+|++||++.+|+++|+.
T Consensus       223 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         223 -PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             -CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence             0112334568899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=7.6e-41  Score=316.17  Aligned_cols=247  Identities=26%  Similarity=0.419  Sum_probs=195.9

Q ss_pred             eeccCCCeeEEEEEcC---CCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCCCC
Q 013745           93 QLGHGGFGPVYRGLMP---NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKS  168 (437)
Q Consensus        93 ~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  168 (437)
                      .||+|+||.||+|.+.   .+..||+|++.... ....+.+.+|+.++++++||||+++++++.. ...++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            4899999999999753   45579999987553 3345678999999999999999999998864 57899999999999


Q ss_pred             cchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccce-
Q 013745          169 LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT-  247 (437)
Q Consensus       169 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~-  247 (437)
                      |.+++..  ....+++..++.++.|++.||.|||+++   ++||||||+|||++.++.+||+|||++............ 
T Consensus        81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            9998843  2356899999999999999999999988   999999999999999999999999999866433221111 


Q ss_pred             eeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCC
Q 013745          248 FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCN  326 (437)
Q Consensus       248 ~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  326 (437)
                      ....++..|+|||++....++.++|||||||++|||++ |..||......+....+.       ....        ...+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~~--------~~~~  220 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIE-------QGKR--------LDCP  220 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH-------CCCC--------CCCC
Confidence            11223578999999988889999999999999999996 999997654433221111       1100        1112


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          327 RDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       327 ~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ...+.++.+++.+||+.+|++||++.+|.+.|+.
T Consensus       221 ~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         221 AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence            2345667889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.3e-41  Score=327.32  Aligned_cols=263  Identities=24%  Similarity=0.335  Sum_probs=199.4

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      ++|.+.+.||+|+||.||+|..+ +++.||+|++.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56999999999999999999854 68889999987442 22234577899999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +++ +|..++..  ....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        86 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          86 LDK-DLKQYMDD--CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            975 77776633  2345788999999999999999999988   99999999999999999999999999976543222


Q ss_pred             ccceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhh--------hhhccccc
Q 013745          244 HVNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTW--------TLFQGEKA  314 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~  314 (437)
                      .  .....+++.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+....        ........
T Consensus       160 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07872         160 T--YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE  237 (309)
T ss_pred             c--cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence            1  112457899999998875 468999999999999999999999998765443322221111        10000000


Q ss_pred             cccc-Ccc-----ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          315 LELV-DPS-----LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       315 ~~~~-d~~-----l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .... .+.     +....+....++.+++.+|++.||.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         238 FKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            0000 000     00011123456788999999999999999999976

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.4e-41  Score=316.87  Aligned_cols=252  Identities=25%  Similarity=0.473  Sum_probs=202.7

Q ss_pred             cCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecC
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLP  165 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  165 (437)
                      .+|++.+.||+|+||.||+|.+.++..+|+|++..... ....+.+|++++++++||||+++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            46888999999999999999876788999999875432 23568899999999999999999999999999999999999


Q ss_pred             CCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCccc
Q 013745          166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV  245 (437)
Q Consensus       166 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  245 (437)
                      +++|.+++...  ...+++..++.++.|++.+|+|||+.+   ++|+||||+||+++.++.+||+|||+++.........
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            99999887432  346889999999999999999999988   9999999999999999999999999998654332211


Q ss_pred             ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccC
Q 013745          246 NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK  324 (437)
Q Consensus       246 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  324 (437)
                       .....++..|+|||++.++.++.++|||||||++|||++ |+.||...........+.      ..   .....+.   
T Consensus       158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~------~~---~~~~~~~---  224 (256)
T cd05112         158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN------AG---FRLYKPR---  224 (256)
T ss_pred             -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh------CC---CCCCCCC---
Confidence             112234678999999998899999999999999999998 999997544322111110      00   0111111   


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          325 CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       325 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                         ..+..+.+++.+||+.+|++||++.+|++.|.
T Consensus       225 ---~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         225 ---LASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             ---CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence               12356889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=7.5e-41  Score=319.96  Aligned_cols=251  Identities=24%  Similarity=0.340  Sum_probs=198.6

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      ++|++.+.||+|+||.||+|+. .+++.||+|++... .......+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3578899999999999999984 47899999998654 333456788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +++++|..+.       .+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.+||+|||++..+.... 
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-  149 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-  149 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence            9999986542       4678889999999999999999988   9999999999999999999999999998664322 


Q ss_pred             ccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcccc
Q 013745          244 HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA  323 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  323 (437)
                         .....|+..|+|||++.+..++.++|||||||++|+|++|+.||......................     ..+.+.
T Consensus       150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~  221 (279)
T cd06619         150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-----DPPVLP  221 (279)
T ss_pred             ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc-----CCCCCC
Confidence               113468999999999999899999999999999999999999997533222111100000000000     011111


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013745          324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLM  357 (437)
Q Consensus       324 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  357 (437)
                        .......+.+++.+|++.+|++||++.++++.
T Consensus       222 --~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         222 --VGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             --CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence              11233467889999999999999999998753

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.3e-41  Score=329.56  Aligned_cols=241  Identities=24%  Similarity=0.325  Sum_probs=193.9

Q ss_pred             CccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCC-CCcceeeeeeeccCCceEEEE
Q 013745           87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  161 (437)
                      +|++.+.||+|+||.||+|.. .+|+.||+|++...   .......+..|+.++..+. |++|+++++++.+.+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            477889999999999999985 47899999998753   2233456778999998886 577888999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      ||+++|+|..++..   ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            99999999888743   346899999999999999999999998   999999999999999999999999999864322


Q ss_pred             CcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+      ... .      . 
T Consensus       155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i------~~~-~------~-  218 (323)
T cd05615         155 GV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI------MEH-N------V-  218 (323)
T ss_pred             Cc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------HhC-C------C-
Confidence            21  122356899999999999999999999999999999999999999865432221111      000 0      0 


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDM  351 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  351 (437)
                        ..+......+.+++.+||+.+|.+|++.
T Consensus       219 --~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 --SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             --CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence              1112234567889999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-42  Score=348.15  Aligned_cols=255  Identities=26%  Similarity=0.413  Sum_probs=217.5

Q ss_pred             cCccccceeccCCCeeEEEEEcC----CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP----NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      ....+.++||.|.||.||+|+++    ....||||.++.. .+....+|+.|+.||.+++||||++|-|........++|
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi  708 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII  708 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence            34667889999999999999864    2457999999866 455678899999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      .|||++|+|+.+|..+  .+.|.+.+...++++|+.|++||-+++   +|||||...||||+.+..+|++||||++.+.+
T Consensus       709 TEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  709 TEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             hhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence            9999999999999544  466999999999999999999999998   99999999999999999999999999998754


Q ss_pred             CCcccce-eeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          241 EDTHVNT-FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       241 ~~~~~~~-~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      +.....+ ..-.=..+|.|||.+...+++.++||||||+|+||.++ |.+||....+.+....++..+.+.         
T Consensus       784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLP---------  854 (996)
T KOG0196|consen  784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLP---------  854 (996)
T ss_pred             CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCC---------
Confidence            4321111 11112468999999999999999999999999999886 999999888887776665544431         


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                            .+.+++..|.+|++.|||.|..+||.+.+|+..|..
T Consensus       855 ------pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDk  890 (996)
T KOG0196|consen  855 ------PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDK  890 (996)
T ss_pred             ------CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHH
Confidence                  133667789999999999999999999999998874

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.9e-40  Score=314.19  Aligned_cols=258  Identities=23%  Similarity=0.364  Sum_probs=207.9

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ++|++.+.||+|+||.||+|... +|+.||+|.+...   .......+.+|++++++++|+||+++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57999999999999999999965 7999999988632   2333567889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          162 EYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       162 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      ||+++++|..++... .....+++..++.++.+++.||.|||+.+   |+||||||+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999887542 22356899999999999999999999988   99999999999999999999999999987644


Q ss_pred             CCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                      ....  .....++..|+|||++.+..++.++|||||||++|+|++|+.||...... ......   .. ....     .+
T Consensus       159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~---~~-~~~~-----~~  226 (267)
T cd08224         159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCK---KI-EKCD-----YP  226 (267)
T ss_pred             CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHHHh---hh-hcCC-----CC
Confidence            3222  12346889999999999888999999999999999999999999643211 111111   00 0000     01


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ...  .......+.+++.+||+.+|++||++.+|+++|+.
T Consensus       227 ~~~--~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~  264 (267)
T cd08224         227 PLP--ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKE  264 (267)
T ss_pred             CCC--hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHH
Confidence            110  11344567899999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=6.2e-41  Score=320.39  Aligned_cols=245  Identities=26%  Similarity=0.342  Sum_probs=193.0

Q ss_pred             eccCCCeeEEEEEc-CCCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCCCCc
Q 013745           94 LGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL  169 (437)
Q Consensus        94 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  169 (437)
                      ||+|+||.||++.. .+|+.||+|++....   ......+..|++++++++||||+++++++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            79999999999985 468999999986431   12234456799999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccceee
Q 013745          170 DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR  249 (437)
Q Consensus       170 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  249 (437)
                      ..++... ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.++|+|||++........   ...
T Consensus        81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~  153 (277)
T cd05607          81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQ  153 (277)
T ss_pred             HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eec
Confidence            8887543 2345889999999999999999999988   99999999999999999999999999987643321   123


Q ss_pred             eecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHH
Q 013745          250 ISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDE  329 (437)
Q Consensus       250 ~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  329 (437)
                      ..|+..|+|||++.+..++.++|||||||++|||++|+.||..........  .........     .+..    .....
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~--~~~~~~~~~-----~~~~----~~~~~  222 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE--ELKRRTLED-----EVKF----EHQNF  222 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH--HHHHHhhcc-----cccc----ccccC
Confidence            468999999999998889999999999999999999999997543211111  111111110     0000    01123


Q ss_pred             HHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          330 AAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       330 ~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ..++.+++.+||+.+|++||++.|+++
T Consensus       223 ~~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         223 TEESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             CHHHHHHHHHHhccCHhhCCCCccchh
Confidence            456789999999999999999977653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5.5e-41  Score=323.88  Aligned_cols=254  Identities=30%  Similarity=0.403  Sum_probs=199.9

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCc--EEEEEEeccC-ChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCceEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQ--EIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  160 (437)
                      ++|++.+.||+|+||.||+|+.+ ++.  .+++|.+... .....+.+.+|+.++.++ +||||+++++++......++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            46899999999999999999854 333  4688888642 344456789999999999 799999999999999999999


Q ss_pred             EeecCCCCcchhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCc
Q 013745          161 YEYLPNKSLDYFIFDKT-------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP  227 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~  227 (437)
                      |||+++++|.+++....             ....+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999985422             1135889999999999999999999988   9999999999999999999


Q ss_pred             eeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhh
Q 013745          228 KISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTW  306 (437)
Q Consensus       228 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~  306 (437)
                      ||+|||++.......   .......+..|+|||++.+..++.++|||||||++|||++ |..||......+....     
T Consensus       159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~-----  230 (297)
T cd05089         159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK-----  230 (297)
T ss_pred             EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-----
Confidence            999999986432111   1111123457999999998899999999999999999997 9999976543322111     


Q ss_pred             hhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          307 TLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       307 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                       . ...     ....   .+...+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       231 -~-~~~-----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  274 (297)
T cd05089         231 -L-PQG-----YRME---KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSR  274 (297)
T ss_pred             -H-hcC-----CCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence             1 000     0011   111234567889999999999999999999988874

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=6.3e-41  Score=323.44  Aligned_cols=249  Identities=23%  Similarity=0.375  Sum_probs=203.6

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      .+|++.+.||+|+||.||+|+. .+++.||+|.+..........+.+|+.+++.+.|+||+++++.+..+...++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            5699999999999999999984 478999999997665545577889999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      ++++|.+++.    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.........
T Consensus       100 ~~~~L~~~~~----~~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  172 (296)
T cd06654         100 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (296)
T ss_pred             CCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence            9999999883    235788999999999999999999998   999999999999999999999999998865433221


Q ss_pred             cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccC
Q 013745          245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK  324 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  324 (437)
                      .  ....|++.|+|||.+.+..++.++|||||||++|+|++|+.||..........  .    ......      +.+ .
T Consensus       173 ~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~--~----~~~~~~------~~~-~  237 (296)
T cd06654         173 R--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY--L----IATNGT------PEL-Q  237 (296)
T ss_pred             c--CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH--H----HhcCCC------CCC-C
Confidence            1  12458899999999998889999999999999999999999997644322110  0    000000      000 1


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          325 CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       325 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .+......+.+++.+||+.+|++||++.+|++
T Consensus       238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             CccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            12234456788999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=8.1e-41  Score=317.39  Aligned_cols=256  Identities=27%  Similarity=0.446  Sum_probs=203.9

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CC---cEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NG---QEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      .++|+..+.||+|+||.||+|+.+ ++   ..+|+|++... .....+.+.+|++++.+++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            457888999999999999999854 33   36899998755 34445678999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      ||||+++++|..++..  ....+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          84 ITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence            9999999999998843  2356899999999999999999999988   9999999999999999999999999998764


Q ss_pred             CCCcccce-eeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccc
Q 013745          240 GEDTHVNT-FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALEL  317 (437)
Q Consensus       240 ~~~~~~~~-~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (437)
                      ........ .....+..|+|||++....++.++|||||||++|||++ |+.||......+....+      ....     
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i------~~~~-----  227 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI------NDGF-----  227 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH------hcCC-----
Confidence            33221111 11123457999999998889999999999999999997 99999764432211111      0000     


Q ss_pred             cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          318 VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       318 ~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ..+.    ....+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       228 ~~~~----~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~  266 (268)
T cd05063         228 RLPA----PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK  266 (268)
T ss_pred             CCCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            0011    11234567899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.2e-41  Score=314.82  Aligned_cols=250  Identities=28%  Similarity=0.395  Sum_probs=205.6

Q ss_pred             hcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      .++|++.+.||.|+||.||+|.. .|+.||+|.+..... ....+.+|+.++++++|+||+++++++.+....++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            45688999999999999999987 488999999976544 4577899999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      ++++|.+++.... ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++....... 
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            9999999885432 236899999999999999999999998   99999999999999999999999999987643222 


Q ss_pred             cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCcccc
Q 013745          245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA  323 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  323 (437)
                          ...++..|+|||++....++.++||||||+++|||++ |..||......+....+.   .    ...     .   
T Consensus       158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~---~----~~~-----~---  218 (256)
T cd05039         158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE---K----GYR-----M---  218 (256)
T ss_pred             ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh---c----CCC-----C---
Confidence                1234668999999998889999999999999999997 999997543322211111   0    000     0   


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       324 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ..+...+..+.+++.+||+.+|++||++.+|+++|+.
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            0111234568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.7e-41  Score=321.52  Aligned_cols=262  Identities=21%  Similarity=0.375  Sum_probs=201.6

Q ss_pred             cCccccceeccCCCeeEEEEEc-----CCCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccC--Cce
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-----PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG--PEK  157 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  157 (437)
                      ..|.+++.||+|+||.||++..     .++..||+|.+... .......+.+|+.++++++||||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3478999999999999999973     35788999998754 344456789999999999999999999998765  567


Q ss_pred             EEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                      ++||||+++++|.+++...  ...+++..++.++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            9999999999999988432  235899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcc-cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhh--------hhhhhhhhhh
Q 013745          238 FPGEDTH-VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK--------ADLLSYTWTL  308 (437)
Q Consensus       238 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~--------~~~~~~~~~~  308 (437)
                      +...... .......++..|+|||++.+..++.++|||||||++|||++++.|+........        ..........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            6543221 111134467789999999988899999999999999999998876532211000        0000000000


Q ss_pred             hcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          309 FQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       309 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      .....        ........+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       239 ~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         239 LEEGK--------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             HHcCc--------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence            00000        001112345678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=7.3e-41  Score=324.10  Aligned_cols=255  Identities=29%  Similarity=0.403  Sum_probs=200.3

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCc--EEEEEEeccC-ChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCceEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQ--EIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  159 (437)
                      .++|++.+.||+|+||.||+|.+. ++.  .+|+|.+... .......+.+|+.++.++ +||||+++++++..++..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            357899999999999999999854 454  3577776543 344456788999999999 89999999999999999999


Q ss_pred             EEeecCCCCcchhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCC
Q 013745          160 VYEYLPNKSLDYFIFDKT-------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN  226 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~  226 (437)
                      ||||+++++|.+++....             ....+++..++.++.|++.||+|||+++   |+||||||+|||++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence            999999999999885432             1235889999999999999999999988   999999999999999999


Q ss_pred             ceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhh
Q 013745          227 PKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYT  305 (437)
Q Consensus       227 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~  305 (437)
                      +||+|||++......   .......++..|+|||++.+..++.++|||||||++|||+| |..||......+....+   
T Consensus       163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~---  236 (303)
T cd05088         163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL---  236 (303)
T ss_pred             EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH---
Confidence            999999998643211   11111224567999999988889999999999999999998 99999755433221111   


Q ss_pred             hhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          306 WTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       306 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                          ....     ..   ..+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       237 ----~~~~-----~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~  279 (303)
T cd05088         237 ----PQGY-----RL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  279 (303)
T ss_pred             ----hcCC-----cC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                0000     00   0111233457889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=6.2e-41  Score=321.54  Aligned_cols=262  Identities=24%  Similarity=0.328  Sum_probs=194.4

Q ss_pred             CccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHcC---CCCcceeeeeeecc-----CC
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS--RQGLREFTNEVKLLLKI---QHKNLVTLFGCCAE-----GP  155 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~  155 (437)
                      +|++.+.||+|+||.||+|... +++.||+|.+....  ......+.+|+.+++++   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4889999999999999999854 78999999986432  11223455677777665   69999999998864     34


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccc
Q 013745          156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA  235 (437)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  235 (437)
                      ..++||||+++ +|..++... ....+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            57899999974 787776432 2345899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccc-
Q 013745          236 RLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKA-  314 (437)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  314 (437)
                      +.......   .....||..|+|||++.+..++.++|||||||++|||++|++||.+....+....+............ 
T Consensus       156 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         156 RIYSCQMA---LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             ccccCccc---CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCc
Confidence            87643322   12346799999999999889999999999999999999999999765443221111100000000000 


Q ss_pred             ------ccccCc----cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          315 ------LELVDP----SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       315 ------~~~~d~----~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                            .....+    .+....+.....+.+++.+|++.||++||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                  000000    011122234456789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=8.8e-41  Score=317.23  Aligned_cols=255  Identities=27%  Similarity=0.413  Sum_probs=203.4

Q ss_pred             cCccccceeccCCCeeEEEEEcC-C---CcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-N---GQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      .+|++.+.||+|+||.||+|... +   +..+|+|.+.... ......+.+|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            56889999999999999999853 2   3378999987542 33456789999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||+++++|.+++...  ...+++..++.++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.....
T Consensus        84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            9999999999998433  346899999999999999999999988   99999999999999999999999999987654


Q ss_pred             CCcccce-eeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          241 EDTHVNT-FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       241 ~~~~~~~-~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      ....... ....++..|+|||++.+..++.++|+|||||++||+++ |..||......+....+.   .    ..  .  
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~---~----~~--~--  227 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE---E----GY--R--  227 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh---C----CC--c--
Confidence            3221111 11223567999999998899999999999999999886 999997654332211111   0    00  0  


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      .+.    ....+..+.+++.+|++.+|.+||++.+|++.|+.
T Consensus       228 ~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         228 LPA----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             CCC----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence            011    11234567899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-40  Score=313.24  Aligned_cols=248  Identities=28%  Similarity=0.413  Sum_probs=199.8

Q ss_pred             ceeccCCCeeEEEEEcCCCcEEEEEEeccCCh-HHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCCCCcc
Q 013745           92 NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR-QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLD  170 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  170 (437)
                      ++||+|+||.||+|...+++.||+|++..... .....+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            46999999999999976699999999875433 34567899999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccceeee
Q 013745          171 YFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI  250 (437)
Q Consensus       171 ~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  250 (437)
                      +++...  ...+++..++.++.+++.+|.|||+++   ++||||||+|||++.++.+||+|||++...............
T Consensus        81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            988432  346789999999999999999999988   999999999999999999999999999865432211111112


Q ss_pred             ecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHH
Q 013745          251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDE  329 (437)
Q Consensus       251 ~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  329 (437)
                      .++..|+|||++.++.++.++|||||||++|||++ |..||...........+..       ..  .      ...+...
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~-------~~--~------~~~~~~~  220 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES-------GY--R------MPAPQLC  220 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc-------CC--C------CCCCccC
Confidence            33567999999998899999999999999999999 8888876543222211110       00  0      0111233


Q ss_pred             HHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          330 AAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       330 ~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                      +..+.+++.+||+.+|++||++.||++.|.
T Consensus       221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            457889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.9e-41  Score=337.62  Aligned_cols=262  Identities=21%  Similarity=0.254  Sum_probs=200.5

Q ss_pred             HhcCccccceeccCCCeeEEEEEcC---CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMP---NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      ...+|++++.||+|+||.||++...   .+..||+|.+...     ..+.+|+++|++++||||+++++++......++|
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            4567999999999999999999742   4678999988643     2345799999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      ||++. ++|..++   .....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.+..
T Consensus       165 ~e~~~-~~l~~~l---~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        165 MPKYK-CDLFTYV---DRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             ehhcC-CCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            99995 5777777   23457899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccc------
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKA------  314 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------  314 (437)
                      ...........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+............      
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence            43333333467999999999999999999999999999999999999999765432211111111111000000      


Q ss_pred             -----------ccccCcc--ccCC--CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013745          315 -----------LELVDPS--LAKC--NRDEAAMCIQLGLLCCQQSVAERPDMNSVHLM  357 (437)
Q Consensus       315 -----------~~~~d~~--l~~~--~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  357 (437)
                                 .....+.  ++..  .......+.+++.+||+.+|++||++.|++..
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                       0000000  0000  01123457788999999999999999999764

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.5e-41  Score=317.70  Aligned_cols=252  Identities=27%  Similarity=0.436  Sum_probs=200.7

Q ss_pred             ccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHH--HHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           88 FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGL--REFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        88 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      |++.+.||+|+||+||+++.. +++.||+|++........  ....+|+.++++++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            678999999999999999954 567899999987654332  23456999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      ++++|.+++.   ....+++..++.++.||++||.+||+.+   |+|+||||+||+++.++.++|+|||.+.......  
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~--  152 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSENN--  152 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTSTT--
T ss_pred             cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--
Confidence            9999999985   3456899999999999999999999998   9999999999999999999999999998642111  


Q ss_pred             cceeeeecccccCChhhhc-cCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcccc
Q 013745          245 VNTFRISGTHGYMAPEYAL-HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA  323 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~-~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  323 (437)
                      .......++..|+|||++. +..++.++||||||+++|+|++|..||...........+........        .... 
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~-  223 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPL--------PSSS-  223 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHH--------HHHT-
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccc--------cccc-
Confidence            1222456899999999998 78899999999999999999999999986532222222111111000        0000 


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       324 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .........+.+++.+||+.+|++||++.++++
T Consensus       224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000011267899999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.5e-40  Score=316.05  Aligned_cols=254  Identities=30%  Similarity=0.405  Sum_probs=193.5

Q ss_pred             ceeccCCCeeEEEEEcC---CCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCCC
Q 013745           92 NQLGHGGFGPVYRGLMP---NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNK  167 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  167 (437)
                      +.||+|+||.||+|...   .+..+|+|.+.... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            36999999999999743   34678999887543 333457889999999999999999999999999999999999999


Q ss_pred             CcchhhhccCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCccc
Q 013745          168 SLDYFIFDKTK--SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV  245 (437)
Q Consensus       168 sL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  245 (437)
                      +|.+++.....  ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999854322  234677788899999999999999988   9999999999999999999999999997654333222


Q ss_pred             ceeeeecccccCChhhhccC-------cCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccc
Q 013745          246 NTFRISGTHGYMAPEYALHG-------YLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALEL  317 (437)
Q Consensus       246 ~~~~~~gt~~Y~aPE~~~~~-------~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (437)
                      ......++..|+|||++.+.       .++.++|||||||++|||++ |+.||......+...   ....    ......
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~---~~~~----~~~~~~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT---YTVR----EQQLKL  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH---HHhh----cccCCC
Confidence            22234577889999998643       35789999999999999996 999997644332211   1100    111112


Q ss_pred             cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          318 VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       318 ~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                      .++.+..   .....+.+++..|| .+|++||++.+|+..|+
T Consensus       231 ~~~~~~~---~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRLKL---PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCccCC---CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            2222221   12334667888998 68999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.2e-40  Score=314.09  Aligned_cols=249  Identities=28%  Similarity=0.428  Sum_probs=200.6

Q ss_pred             ceeccCCCeeEEEEEcCC--C--cEEEEEEeccCCh-HHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCC
Q 013745           92 NQLGHGGFGPVYRGLMPN--G--QEIAVKKLSVDSR-QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN  166 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  166 (437)
                      +.||+|++|.||+|.+.+  +  ..||||.+..... ...+.+.+|+.++++++||||+++++.+.+ ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998532  3  3689999986654 556789999999999999999999999988 889999999999


Q ss_pred             CCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc-c
Q 013745          167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH-V  245 (437)
Q Consensus       167 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~-~  245 (437)
                      ++|.+.+..... ..+++..++.++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999865432 56899999999999999999999998   999999999999999999999999999877543221 1


Q ss_pred             ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccC
Q 013745          246 NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK  324 (437)
Q Consensus       246 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  324 (437)
                      ......++..|+|||++....++.++|||||||++|||++ |..||......+....+.   .   ...       .. .
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~---~---~~~-------~~-~  221 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID---K---EGE-------RL-E  221 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---h---cCC-------cC-C
Confidence            1112456789999999999899999999999999999998 999997554332211111   0   000       00 0


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          325 CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       325 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                      .+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus       222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            11123456889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-40  Score=315.42  Aligned_cols=252  Identities=24%  Similarity=0.350  Sum_probs=202.0

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC-----hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS-----RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      ++|.+.+.||+|+||.||+|.. .+++.||+|.+....     ......+.+|+.++++++||||+++++++.+....++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4688999999999999999985 468999999886432     2234568899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      ||||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||+++...
T Consensus        82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            9999999999988743   345888999999999999999999998   9999999999999999999999999998654


Q ss_pred             CCCcccc-eeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          240 GEDTHVN-TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       240 ~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      ....... .....|+..|+|||++.+..++.++|||||||++|||++|+.||..........      ......      
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~~~~~------  223 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF------KIATQP------  223 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH------HHhccC------
Confidence            3221111 123457889999999999889999999999999999999999997543221110      000000      


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLM  357 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  357 (437)
                        .....+......+.+++.+||+.+|++||++.++++.
T Consensus       224 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         224 --TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             --CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence              0011122344567889999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.2e-40  Score=314.10  Aligned_cols=248  Identities=26%  Similarity=0.369  Sum_probs=199.8

Q ss_pred             cCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeee-ccCCceEEEEeec
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCC-AEGPEKMLVYEYL  164 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e~~  164 (437)
                      ++|.+.+.||+|+||.||++.. .|..||+|.+.....  .+.+.+|+.++++++|+|++++++++ ..+...++||||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCch--HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            4688999999999999999986 578899999865432  35788999999999999999999975 4556789999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      ++++|.+++... ....+++..++.++.|++.||+|||+++   ++||||||+||++++++.+||+|||++........ 
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-  157 (256)
T cd05082          83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-  157 (256)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccCC-
Confidence            999999988543 2345889999999999999999999988   99999999999999999999999999986543221 


Q ss_pred             cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCcccc
Q 013745          245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA  323 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  323 (437)
                          ...++..|+|||++.+..++.++|||||||++|||++ |+.||......+..   .....    +.     .+   
T Consensus       158 ----~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~---~~~~~----~~-----~~---  218 (256)
T cd05082         158 ----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PRVEK----GY-----KM---  218 (256)
T ss_pred             ----CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHhc----CC-----CC---
Confidence                2234668999999998899999999999999999997 99998754322211   11110    00     00   


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       324 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ......+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            1112334567889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.3e-40  Score=313.56  Aligned_cols=250  Identities=22%  Similarity=0.275  Sum_probs=203.2

Q ss_pred             CccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      +|++.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++|+||+++++.+.++...++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4788999999999999999854 7899999998643 3344567889999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      ++++|.+++... ....+++..++.++.|++.||.|||+++   |+|+||||+||++++++.++|+|||++.........
T Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  156 (255)
T cd08219          81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY  156 (255)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccccc
Confidence            999998887432 3356889999999999999999999988   999999999999999999999999999876433221


Q ss_pred             cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccC
Q 013745          245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK  324 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  324 (437)
                        .....|++.|+|||++.+..++.++||||||+++|+|++|..||.........      ..... +..        ..
T Consensus       157 --~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~------~~~~~-~~~--------~~  219 (255)
T cd08219         157 --ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLI------LKVCQ-GSY--------KP  219 (255)
T ss_pred             --cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHH------HHHhc-CCC--------CC
Confidence              12356889999999999889999999999999999999999999754322211      11111 000        01


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013745          325 CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLM  357 (437)
Q Consensus       325 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  357 (437)
                      .+...+..+.+++.+||+.+|++||++.+|+..
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            112234457889999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-40  Score=319.53  Aligned_cols=252  Identities=25%  Similarity=0.376  Sum_probs=202.2

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      ++|++++.||+|+||.||+|... +++.||+|.+... .......+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36889999999999999999864 7899999988754 334456788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE-APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      +++++|..++........+++..+..++.|++.||.|||+. +   |+|+||||+||+++.++.+||+|||++..+....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            99999988885433345789999999999999999999974 5   9999999999999999999999999997664322


Q ss_pred             cccceeeeecccccCChhhhccC------cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccc
Q 013745          243 THVNTFRISGTHGYMAPEYALHG------YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE  316 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~------~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (437)
                      .    ....++..|+|||++.+.      .++.++|||||||++|+|++|+.||...........+   ..         
T Consensus       158 ~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~---~~---------  221 (286)
T cd06622         158 A----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL---SA---------  221 (286)
T ss_pred             c----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH---HH---------
Confidence            2    123578899999998554      3588999999999999999999999754322211111   00         


Q ss_pred             ccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          317 LVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       317 ~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ..+......+......+.+++.+||+.+|++||++.+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         222 IVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             HhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            0111111223345667889999999999999999999976

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=2.7e-41  Score=346.32  Aligned_cols=267  Identities=21%  Similarity=0.242  Sum_probs=195.9

Q ss_pred             HHHHHhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCC------Ccceeeeeeec
Q 013745           80 TLQVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQH------KNLVTLFGCCA  152 (437)
Q Consensus        80 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~  152 (437)
                      .+....++|+++++||+|+||+||+|.. .+++.||||++..... ....+..|+.+++.++|      .++++++++|.
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            3445568899999999999999999985 4688999999964322 23445667777777754      45888988887


Q ss_pred             cC-CceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCceEeeccCCCCEEecCCC-----
Q 013745          153 EG-PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE-APARIIHRDIKASNILLDEQL-----  225 (437)
Q Consensus       153 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~iiHrDikp~NIll~~~~-----  225 (437)
                      .. ...|+|||++ +++|.+++..   ...+++..+..|+.||+.||.|||++ +   ||||||||+|||++.++     
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~  274 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP  274 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence            54 5688999988 7788777743   35689999999999999999999984 6   99999999999998765     


Q ss_pred             -----------CceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCC
Q 013745          226 -----------NPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRL  294 (437)
Q Consensus       226 -----------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~  294 (437)
                                 .+||+|||++......     ....+||+.|+|||++.+..++.++|||||||+||||++|+.||.+..
T Consensus       275 ~~~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        275 VTNRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             ccccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                       4999999988643221     224679999999999999999999999999999999999999998765


Q ss_pred             chhhhhhhhhhhh-----------------hhcccc-cccccCcc-c-------cCCCHHHHHHHHHHHHHcCCCCCCCC
Q 013745          295 GKEKADLLSYTWT-----------------LFQGEK-ALELVDPS-L-------AKCNRDEAAMCIQLGLLCCQQSVAER  348 (437)
Q Consensus       295 ~~~~~~~~~~~~~-----------------~~~~~~-~~~~~d~~-l-------~~~~~~~~~~l~~l~~~cl~~~p~~R  348 (437)
                      ..+....+.....                 .+.... .....++. +       ..........+.+|+.+||+.||++|
T Consensus       350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R  429 (467)
T PTZ00284        350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR  429 (467)
T ss_pred             hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence            4433222211100                 000000 00000000 0       00001123457799999999999999


Q ss_pred             CCHHHHHH--Hhc
Q 013745          349 PDMNSVHL--MLS  359 (437)
Q Consensus       349 Ps~~ev~~--~L~  359 (437)
                      ||++|+++  +|.
T Consensus       430 ~ta~e~L~Hp~~~  442 (467)
T PTZ00284        430 LNARQMTTHPYVL  442 (467)
T ss_pred             CCHHHHhcCcccc
Confidence            99999986  554

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=8.6e-41  Score=334.96  Aligned_cols=260  Identities=23%  Similarity=0.358  Sum_probs=204.0

Q ss_pred             HhcCccccceeccCCCeeEEEEEcC------CCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCC-CCcceeeeeeeccCC
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGP  155 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  155 (437)
                      ..++|.+.+.||+|+||.||+|++.      .+..||||++.... ......+.+|+.+|.++. |||||+++++|....
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            3456888899999999999999842      34689999997542 333457889999999997 999999999999999


Q ss_pred             ceEEEEeecCCCCcchhhhccC----------------------------------------------------------
Q 013745          156 EKMLVYEYLPNKSLDYFIFDKT----------------------------------------------------------  177 (437)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------  177 (437)
                      ..++||||+++|+|.+++....                                                          
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            9999999999999999885421                                                          


Q ss_pred             -------------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEE
Q 013745          178 -------------------------------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNIL  220 (437)
Q Consensus       178 -------------------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIl  220 (437)
                                                           ....+++..++.++.||+.||+|||+.+   |+||||||+|||
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL  271 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL  271 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence                                                 1124677888999999999999999987   999999999999


Q ss_pred             ecCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhh
Q 013745          221 LDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKA  299 (437)
Q Consensus       221 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~  299 (437)
                      +++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||......+..
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~  351 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF  351 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence            99999999999999986543322111223356788999999998889999999999999999998 89998754322211


Q ss_pred             hhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          300 DLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                            ......+.  .   +   ..+...+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       352 ------~~~~~~~~--~---~---~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~  398 (401)
T cd05107         352 ------YNAIKRGY--R---M---AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD  398 (401)
T ss_pred             ------HHHHHcCC--C---C---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                  00000000  0   0   0111234568889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.6e-40  Score=318.89  Aligned_cols=250  Identities=25%  Similarity=0.355  Sum_probs=199.4

Q ss_pred             ccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           88 FSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        88 y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      |+..+.||+|+||+||+|.. .+++.||+|++....   ......+.+|++++++++|+||+.+++++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            77789999999999999985 478999999986432   22234578899999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +++++|..++... ....+++..+..++.|++.||.|||+++   |+||||||+||++++++.+||+|||++........
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence            9999998887543 2346999999999999999999999998   99999999999999999999999999976543221


Q ss_pred             ccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcccc
Q 013745          244 HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA  323 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  323 (437)
                         .....|+..|+|||++.+..++.++|+|||||++|||++|..||...........+.  ......          ..
T Consensus       158 ---~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~--~~~~~~----------~~  222 (285)
T cd05632         158 ---IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD--RRVLET----------EE  222 (285)
T ss_pred             ---ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--Hhhhcc----------cc
Confidence               123468999999999998899999999999999999999999997654322211111  111000          00


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 013745          324 KCNRDEAAMCIQLGLLCCQQSVAERPD-----MNSVHL  356 (437)
Q Consensus       324 ~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~  356 (437)
                      .........+.+++..|++.+|++||+     +.+++.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            111223445778999999999999999     666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-41  Score=328.40  Aligned_cols=240  Identities=23%  Similarity=0.271  Sum_probs=186.9

Q ss_pred             eccCCCeeEEEEEcC-CCcEEEEEEeccCC---hHHHHHHHHHHHHHHcC---CCCcceeeeeeeccCCceEEEEeecCC
Q 013745           94 LGHGGFGPVYRGLMP-NGQEIAVKKLSVDS---RQGLREFTNEVKLLLKI---QHKNLVTLFGCCAEGPEKMLVYEYLPN  166 (437)
Q Consensus        94 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  166 (437)
                      ||+|+||+||+|+.. +++.||||++....   ......+..|..++.++   +||||+++++++.+....++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999854 68999999986432   22234456677777765   699999999999999999999999999


Q ss_pred             CCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccc
Q 013745          167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN  246 (437)
Q Consensus       167 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  246 (437)
                      |+|..++..   ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++........  
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~--  152 (330)
T cd05586          81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--  152 (330)
T ss_pred             ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC--
Confidence            999888743   356899999999999999999999998   999999999999999999999999999764322221  


Q ss_pred             eeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCC
Q 013745          247 TFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKC  325 (437)
Q Consensus       247 ~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  325 (437)
                      ....+||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+      ... .      ..+.. 
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i------~~~-~------~~~~~-  218 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI------AFG-K------VRFPK-  218 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH------HcC-C------CCCCC-
Confidence            2245799999999998765 5899999999999999999999999765432221111      000 0      00110 


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCC----HHHHHH
Q 013745          326 NRDEAAMCIQLGLLCCQQSVAERPD----MNSVHL  356 (437)
Q Consensus       326 ~~~~~~~l~~l~~~cl~~~p~~RPs----~~ev~~  356 (437)
                       ......+.+++.+||+.+|++||+    +.++++
T Consensus       219 -~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         219 -NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             -ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence             112345678899999999999984    555544

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.3e-40  Score=322.28  Aligned_cols=259  Identities=27%  Similarity=0.373  Sum_probs=205.3

Q ss_pred             HhcCccccceeccCCCeeEEEEEc------CCCcEEEEEEeccCC-hHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCC
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGP  155 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  155 (437)
                      ..++|.+.+.||+|+||.||+|..      ..+..||||++.... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            346799999999999999999963      134579999987542 33456788999999999 7999999999999999


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccc
Q 013745          156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA  235 (437)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  235 (437)
                      ..++||||+++++|.+++.... ...+++..+..++.|++.||.|||+++   |+|+||||+|||++.++.+||+|||++
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence            9999999999999999885432 234899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhccccc
Q 013745          236 RLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKA  314 (437)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  314 (437)
                      +...............++..|+|||++.+..++.++|||||||++|||++ |..||......+..  ..    ...... 
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~--~~----~~~~~~-  261 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF--YK----LIKEGY-  261 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH--HH----HHHcCC-
Confidence            87644322211112345778999999999999999999999999999998 99998754432211  01    011010 


Q ss_pred             ccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          315 LELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       315 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                          ..   ......+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       262 ----~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         262 ----RM---AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             ----cC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence                00   0111224568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=7.3e-41  Score=331.32  Aligned_cols=261  Identities=25%  Similarity=0.274  Sum_probs=197.0

Q ss_pred             HhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccC------
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG------  154 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  154 (437)
                      ..++|++.+.||+|+||.||+|.. ..++.||||++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            457899999999999999999985 36889999998753  333456788999999999999999999988543      


Q ss_pred             CceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccc
Q 013745          155 PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL  234 (437)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl  234 (437)
                      ...++||||+++ +|...+.     ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence            346999999965 5555542     24788899999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhh----------
Q 013745          235 ARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSY----------  304 (437)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~----------  304 (437)
                      ++.......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+..          
T Consensus       166 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (355)
T cd07874         166 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_pred             cccCCCccc---cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            986543221   1234689999999999998999999999999999999999999986543222111000          


Q ss_pred             ------hhhhhcc-cccccccCc-----cc----cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          305 ------TWTLFQG-EKALELVDP-----SL----AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       305 ------~~~~~~~-~~~~~~~d~-----~l----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                            ....... ........+     .+    ..........+.+++.+|++.||++|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~  310 (355)
T cd07874         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ  310 (355)
T ss_pred             HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence                  0000000 000000000     00    0111123456789999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.6e-41  Score=329.58  Aligned_cols=260  Identities=25%  Similarity=0.336  Sum_probs=196.1

Q ss_pred             HhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccC------
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG------  154 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  154 (437)
                      ..++|.+++.||+|+||.||+|.. .+++.||||++....  ......+.+|+.++++++||||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            457899999999999999999984 478899999987542  23345677899999999999999999987543      


Q ss_pred             CceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccc
Q 013745          155 PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL  234 (437)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl  234 (437)
                      ...++++|++ +++|..++.    ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence            3468999988 788887762    346899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcccceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhh------
Q 013745          235 ARLFPGEDTHVNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWT------  307 (437)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~------  307 (437)
                      ++......     ....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+.....      
T Consensus       165 ~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07878         165 ARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV  239 (343)
T ss_pred             ceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            98764321     13468999999999877 4789999999999999999999999976443221111100000      


Q ss_pred             --hhccccc---cccc----CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          308 --LFQGEKA---LELV----DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       308 --~~~~~~~---~~~~----d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                        .......   ...+    ...+..........+.+++.+|++.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              0000000   0000    00000001112334678999999999999999999974

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-40  Score=312.73  Aligned_cols=253  Identities=24%  Similarity=0.332  Sum_probs=205.9

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      ++|++.+.||.|+||.||+|.. .+++.+++|++..........+.+|+.++++++||||+++++++......+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            5799999999999999999985 467889999998765556678899999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      ++++|.+++...  ...+++..++.++.|++.||.|||+.+   |+|+||||+||++++++.+||+|||++.........
T Consensus        83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  157 (262)
T cd06613          83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAK  157 (262)
T ss_pred             CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhhc
Confidence            999999887432  256899999999999999999999988   999999999999999999999999999876432211


Q ss_pred             cceeeeecccccCChhhhccC---cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          245 VNTFRISGTHGYMAPEYALHG---YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~---~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                        .....++..|+|||++.+.   .++.++|||||||++|||++|+.||...........+.  .     .    ...+.
T Consensus       158 --~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~--~-----~----~~~~~  224 (262)
T cd06613         158 --RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS--K-----S----NFPPP  224 (262)
T ss_pred             --cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--h-----c----cCCCc
Confidence              1134678899999999876   88999999999999999999999997654332211100  0     0    00111


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ........+..+.+++.+||+.+|.+||++.+|+.
T Consensus       225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         225 KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            11112344567889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=8.5e-41  Score=329.37  Aligned_cols=259  Identities=27%  Similarity=0.371  Sum_probs=200.3

Q ss_pred             hcCccccceeccCCCeeEEEEEc------CCCcEEEEEEeccCC-hHHHHHHHHHHHHHHcC-CCCcceeeeeeeccC-C
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEG-P  155 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  155 (437)
                      .++|++.+.||+|+||.||+|++      .+++.||||++.... ......+.+|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            46799999999999999999973      357889999997543 33456788999999999 689999999987654 4


Q ss_pred             ceEEEEeecCCCCcchhhhccCC---------------------------------------------------------
Q 013745          156 EKMLVYEYLPNKSLDYFIFDKTK---------------------------------------------------------  178 (437)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------  178 (437)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            67899999999999988854210                                                         


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccceeeee
Q 013745          179 -------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS  251 (437)
Q Consensus       179 -------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  251 (437)
                             ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++................
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                   124688889999999999999999988   9999999999999999999999999998753322221121234


Q ss_pred             cccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHHH
Q 013745          252 GTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEA  330 (437)
Q Consensus       252 gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  330 (437)
                      ++..|+|||++.+..++.++|||||||++|||++ |..||.........  ..    ....+..     ...+.   ...
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~--~~----~~~~~~~-----~~~~~---~~~  308 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CR----RLKEGTR-----MRAPD---YTT  308 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH--HH----HHhccCC-----CCCCC---CCC
Confidence            5678999999998899999999999999999997 99999754322111  00    0111100     00111   123


Q ss_pred             HHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          331 AMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       331 ~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ..+.+++..||+.+|++||++.+|++.|+.
T Consensus       309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~  338 (343)
T cd05103         309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGN  338 (343)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            457899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.6e-40  Score=315.75  Aligned_cols=254  Identities=24%  Similarity=0.366  Sum_probs=191.0

Q ss_pred             ceeccCCCeeEEEEEcC---CCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCCC
Q 013745           92 NQLGHGGFGPVYRGLMP---NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNK  167 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  167 (437)
                      +.||+|+||.||+|...   ....+|+|.+.... ......+.+|+.+++.++|+||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            36999999999999743   34578888876442 334467889999999999999999999999999999999999999


Q ss_pred             CcchhhhccCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCccc
Q 013745          168 SLDYFIFDKTK--SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV  245 (437)
Q Consensus       168 sL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  245 (437)
                      +|.+++.....  ....++..++.++.||+.||+|||+++   |+||||||+|||+++++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999855322  233567888999999999999999998   9999999999999999999999999987543322221


Q ss_pred             ceeeeecccccCChhhhcc-------CcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccc
Q 013745          246 NTFRISGTHGYMAPEYALH-------GYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALEL  317 (437)
Q Consensus       246 ~~~~~~gt~~Y~aPE~~~~-------~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (437)
                      ......++..|+|||++..       ..++.++|||||||++|||++ |..||......+...   .   ... ......
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~---~---~~~-~~~~~~  230 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLK---Q---VVR-EQDIKL  230 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHH---H---Hhh-ccCccC
Confidence            1222345678999998753       357889999999999999999 788887543322111   0   000 111112


Q ss_pred             cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          318 VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       318 ~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                      ..+.+   .......+.+++..|| .+|++||++++|+++|.
T Consensus       231 ~~~~~---~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         231 PKPQL---DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCCcc---cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            22222   2233445567778888 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.3e-40  Score=315.46  Aligned_cols=240  Identities=23%  Similarity=0.392  Sum_probs=189.6

Q ss_pred             ceeccCCCeeEEEEEcCC-------------CcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceE
Q 013745           92 NQLGHGGFGPVYRGLMPN-------------GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM  158 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  158 (437)
                      +.||+|+||.||+|....             ...|++|.+..........+.+|+.++..++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999997421             2358889887655555567889999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCC-------ceeee
Q 013745          159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN-------PKISD  231 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~-------~kl~D  231 (437)
                      +||||+++++|+.++..  ....+++..++.++.||+.||+|||+++   |+||||||+|||++.++.       +|++|
T Consensus        81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            99999999999888743  2356899999999999999999999988   999999999999987664       89999


Q ss_pred             cccccccCCCCcccceeeeecccccCChhhhc-cCcCCcccceehhhHHHHHHH-hCCCCCCCCCchhhhhhhhhhhhhh
Q 013745          232 FGLARLFPGEDTHVNTFRISGTHGYMAPEYAL-HGYLSVKTDVFSYGVLVLEIV-SGRKNHDGRLGKEKADLLSYTWTLF  309 (437)
Q Consensus       232 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-~~~~~~~~DvwSlG~vl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~  309 (437)
                      ||++.......      ...++..|+|||++. +..++.++|||||||++|||+ +|..||......+...       ..
T Consensus       156 ~g~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-------~~  222 (262)
T cd05077         156 PGIPITVLSRQ------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-------FY  222 (262)
T ss_pred             CCCCccccCcc------cccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-------HH
Confidence            99987653221      235788999999887 467899999999999999998 5888886543222111       00


Q ss_pred             cccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          310 QGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       310 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                      ...  ...        .......+.+++.+||+.+|++||++.+|++.|+
T Consensus       223 ~~~--~~~--------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         223 EGQ--CML--------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             hcC--ccC--------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            100  000        0112345788999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1e-40  Score=331.41  Aligned_cols=261  Identities=23%  Similarity=0.267  Sum_probs=197.1

Q ss_pred             HhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccC------
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG------  154 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  154 (437)
                      ..++|.+.+.||+|+||.||+|.. ..++.||||++...  .......+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            357899999999999999999984 46889999999753  233446788999999999999999999987543      


Q ss_pred             CceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccc
Q 013745          155 PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL  234 (437)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl  234 (437)
                      ...|+||||+++ +|...+.     ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence            357999999965 5655552     24788899999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhh--------h
Q 013745          235 ARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYT--------W  306 (437)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~--------~  306 (437)
                      ++.......   .....||..|+|||++.+..++.++|||||||++|||++|+.||.+....+....+...        .
T Consensus       173 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (364)
T cd07875         173 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  249 (364)
T ss_pred             ccccCCCCc---ccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            986543221   12346899999999999999999999999999999999999999865543322111000        0


Q ss_pred             hh--------hccc-cc----cc-----ccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          307 TL--------FQGE-KA----LE-----LVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       307 ~~--------~~~~-~~----~~-----~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ..        .... ..    .+     .+.+............+.+++.+|++.||++|||+.++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            00        0000 00    00     0000000111122346789999999999999999999876

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1e-40  Score=316.53  Aligned_cols=253  Identities=21%  Similarity=0.321  Sum_probs=200.8

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      .++|.+.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.+++.++||||+++++.+...+..++||||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            35688999999999999999984 46889999998766555556788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +++++|.+++..   .+.+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++........
T Consensus        88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06645          88 CGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA  161 (267)
T ss_pred             cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence            999999998743   346899999999999999999999998   99999999999999999999999999976643221


Q ss_pred             ccceeeeecccccCChhhhc---cCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          244 HVNTFRISGTHGYMAPEYAL---HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                      .  .....|+..|+|||++.   ...++.++|||||||++|+|++|..||...........      ... ..   ...+
T Consensus       162 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~------~~~-~~---~~~~  229 (267)
T cd06645         162 K--RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL------MTK-SN---FQPP  229 (267)
T ss_pred             c--cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh------hhc-cC---CCCC
Confidence            1  12346899999999874   45688999999999999999999999864332211100      000 00   0001


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ... .....+..+.+++.+|++.+|++||++.+|++
T Consensus       230 ~~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         230 KLK-DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             ccc-ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            110 00112345778999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.7e-40  Score=318.72  Aligned_cols=251  Identities=27%  Similarity=0.347  Sum_probs=199.6

Q ss_pred             CccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      .|++.+.||+|+||.||++.. .+++.||||++....   ......+.+|+.++++++|+||+.+++.+.+.+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            377889999999999999985 478999999986432   2223557789999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |+++++|.+++... ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05630          81 LMNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ  156 (285)
T ss_pred             ecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence            99999999887543 2346899999999999999999999988   9999999999999999999999999997654322


Q ss_pred             cccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccc
Q 013745          243 THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL  322 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  322 (437)
                      ..   ....|+..|+|||++.+..++.++|||||||++|||++|+.||..................         ..   
T Consensus       157 ~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~---------~~---  221 (285)
T cd05630         157 TI---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE---------VQ---  221 (285)
T ss_pred             cc---cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh---------hh---
Confidence            21   1246899999999999999999999999999999999999999764322111111100000         00   


Q ss_pred             cCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 013745          323 AKCNRDEAAMCIQLGLLCCQQSVAERPD-----MNSVHL  356 (437)
Q Consensus       323 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~  356 (437)
                      ..........+.+++..||+.+|++||+     +.|+++
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            0111223445788999999999999999     778875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.7e-42  Score=306.84  Aligned_cols=251  Identities=25%  Similarity=0.308  Sum_probs=203.9

Q ss_pred             hcCccccceeccCCCeeEEEEE-cCCCcEEEEEEeccCC--------hHHHHHHHHHHHHHHcCC-CCcceeeeeeeccC
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS--------RQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEG  154 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  154 (437)
                      -+.|+..+.||.|..++|-+++ .++|+.+|+|++....        ..-.+.-.+|+.||+++. ||+|+.+.++|+..
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            3557778899999999999987 4578999999986421        122345678999999985 99999999999999


Q ss_pred             CceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccc
Q 013745          155 PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL  234 (437)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl  234 (437)
                      ...++|+|.|+.|.|.++|.   ....++++...+|+.|+.+|++|||.++   ||||||||+|||+|+|.++||+|||+
T Consensus        96 sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGF  169 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGF  169 (411)
T ss_pred             chhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccce
Confidence            99999999999999999993   3457999999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcccceeeeecccccCChhhhcc------CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhh
Q 013745          235 ARLFPGEDTHVNTFRISGTHGYMAPEYALH------GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTL  308 (437)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~  308 (437)
                      |+.+.....   ....||||+|+|||.+..      ..|+..+|+|++|||+|.|+.|.+||......-...++....- 
T Consensus       170 a~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGky-  245 (411)
T KOG0599|consen  170 ACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKY-  245 (411)
T ss_pred             eeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccc-
Confidence            998865443   235799999999999864      2688899999999999999999999975332211111111111 


Q ss_pred             hcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          309 FQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       309 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                             ++-.    ..+.+......+|+.+|++.||.+|-|++|.++
T Consensus       246 -------qF~s----peWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  246 -------QFRS----PEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             -------ccCC----cchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence                   1111    223456667889999999999999999999874

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1e-40  Score=319.36  Aligned_cols=264  Identities=23%  Similarity=0.323  Sum_probs=199.0

Q ss_pred             CccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      +|++.+.||+|+||.||+|... +++.||||++....  ......+.+|+.++++++||||+++++++.++...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4888999999999999999854 78999999986432  22345678899999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      ++ ++|.+++........+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            97 578777754444467899999999999999999999988   99999999999999999999999999986543221


Q ss_pred             ccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhh-----hhhccccc---
Q 013745          244 HVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTW-----TLFQGEKA---  314 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~---  314 (437)
                      .  .....+++.|+|||++.+. .++.++|||||||++|||++|+.||.+.............+     ..+.....   
T Consensus       157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         157 V--YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             c--ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence            1  1123568899999988764 57899999999999999999999998654322111000000     00000000   


Q ss_pred             -----ccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          315 -----LELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       315 -----~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                           .......+.........++.+++.+||+.||++|||+.+|++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                 000000000111123456778999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-40  Score=313.14  Aligned_cols=248  Identities=30%  Similarity=0.458  Sum_probs=196.7

Q ss_pred             ceeccCCCeeEEEEEcC-C---CcEEEEEEeccCCh-HHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCC
Q 013745           92 NQLGHGGFGPVYRGLMP-N---GQEIAVKKLSVDSR-QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN  166 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  166 (437)
                      ++||+|+||.||+|++. .   +..||+|.+..... .....+.+|+.+++++.|+||+++++++. ....++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46999999999999742 2   36899999875543 34567899999999999999999999876 4568999999999


Q ss_pred             CCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccc
Q 013745          167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN  246 (437)
Q Consensus       167 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  246 (437)
                      ++|.+++...   ..+++..++.++.|++.||+|||..+   ++|+||||+|||++.++.+||+|||+++..........
T Consensus        80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            9999998433   36899999999999999999999988   99999999999999999999999999987643332111


Q ss_pred             -eeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccC
Q 013745          247 -TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK  324 (437)
Q Consensus       247 -~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  324 (437)
                       .....++..|+|||.+.+..++.++|||||||++|||++ |..||......+....+..       ....        .
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~-------~~~~--------~  218 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES-------GERL--------P  218 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc-------CCcC--------C
Confidence             111223467999999998899999999999999999998 9999976544322211111       1000        1


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCC
Q 013745          325 CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD  361 (437)
Q Consensus       325 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~  361 (437)
                      .+...+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus       219 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         219 RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            1112345678999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=2.2e-40  Score=317.00  Aligned_cols=250  Identities=24%  Similarity=0.340  Sum_probs=200.3

Q ss_pred             CccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecC
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLP  165 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  165 (437)
                      .|++.+.||+|+||.||+|... ++..+++|.+..........+.+|+++++.++||||+++++++..+...++||||++
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            3788899999999999999854 578889999876666667788999999999999999999999999999999999999


Q ss_pred             CCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCccc
Q 013745          166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV  245 (437)
Q Consensus       166 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  245 (437)
                      +++|..++..  ....+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++......... 
T Consensus        86 ~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~-  159 (282)
T cd06643          86 GGAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR-  159 (282)
T ss_pred             CCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccccc-
Confidence            9999887743  2356899999999999999999999988   999999999999999999999999999765332211 


Q ss_pred             ceeeeecccccCChhhhc-----cCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          246 NTFRISGTHGYMAPEYAL-----HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       246 ~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                       .....++..|+|||++.     +..++.++|||||||++|||++|++||......+...      ......      .+
T Consensus       160 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~------~~~~~~------~~  226 (282)
T cd06643         160 -RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLL------KIAKSE------PP  226 (282)
T ss_pred             -cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHH------HHhhcC------CC
Confidence             12346899999999984     3457889999999999999999999997543222111      010000      00


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .+ ..+...+..+.+++.+||+.+|.+||++.++++
T Consensus       227 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         227 TL-AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             CC-CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00 011123456788999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.3e-40  Score=353.39  Aligned_cols=258  Identities=23%  Similarity=0.346  Sum_probs=201.3

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ++|++.++||+|+||.||+|+.. +|+.||||++...   .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57999999999999999999854 6899999999753   2333567899999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccC--------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecc
Q 013745          162 EYLPNKSLDYFIFDKT--------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG  233 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG  233 (437)
                      ||++|++|.+++....        ....+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999885321        1234567788999999999999999998   9999999999999999999999999


Q ss_pred             cccccCCCCcc----------------cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchh
Q 013745          234 LARLFPGEDTH----------------VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKE  297 (437)
Q Consensus       234 la~~~~~~~~~----------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~  297 (437)
                      +++........                ......+||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            99876211100                00112469999999999999999999999999999999999999997633221


Q ss_pred             hhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHhc
Q 013745          298 KADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERP-DMNSVHLMLS  359 (437)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~ev~~~L~  359 (437)
                      ..    ....         ..++.........+..+.+++.+|++.+|++|| +++++++.|+
T Consensus       239 i~----~~~~---------i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le  288 (932)
T PRK13184        239 IS----YRDV---------ILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLE  288 (932)
T ss_pred             hh----hhhh---------ccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            11    0000         001100001123345678899999999999996 5666666554

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.4e-40  Score=323.84  Aligned_cols=198  Identities=25%  Similarity=0.377  Sum_probs=160.6

Q ss_pred             cceeccCCCeeEEEEEcC---CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeecc--CCceEEEEeecC
Q 013745           91 LNQLGHGGFGPVYRGLMP---NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE--GPEKMLVYEYLP  165 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  165 (437)
                      .++||+|+||+||+|+..   +++.||+|++.....  ...+.+|+.++++++||||+++++++..  ....++||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999853   567899999865432  2456789999999999999999998854  456789999985


Q ss_pred             CCCcchhhhcc------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEe----cCCCCceeeecccc
Q 013745          166 NKSLDYFIFDK------TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL----DEQLNPKISDFGLA  235 (437)
Q Consensus       166 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll----~~~~~~kl~DFGla  235 (437)
                       ++|..++...      .....+++..+..++.||+.||.|||+++   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             4776665321      12235889999999999999999999998   9999999999999    45678999999999


Q ss_pred             cccCCCCcc-cceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCC
Q 013745          236 RLFPGEDTH-VNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRL  294 (437)
Q Consensus       236 ~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~  294 (437)
                      +.+...... .......||+.|+|||++.+. .++.++|||||||++|||++|++||....
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            876533211 112245689999999999874 68999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2e-40  Score=353.37  Aligned_cols=260  Identities=22%  Similarity=0.302  Sum_probs=200.9

Q ss_pred             HHhcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeecc--CCce
Q 013745           83 VATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE--GPEK  157 (437)
Q Consensus        83 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  157 (437)
                      ...++|++++.||+|+||.||+|... +++.||+|++...  .......+..|+.++++|+|||||+++++|..  ...+
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            34568999999999999999999854 6788999988643  33445678999999999999999999998854  4568


Q ss_pred             EEEEeecCCCCcchhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCC----CceEeeccCCCCEEecC---------
Q 013745          158 MLVYEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAP----ARIIHRDIKASNILLDE---------  223 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~----~~iiHrDikp~NIll~~---------  223 (437)
                      ||||||+++++|..+|... .....+++..++.|+.||+.||.|||+.+.    .+||||||||+||||+.         
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~  169 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT  169 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence            9999999999999988542 223579999999999999999999998541    24999999999999964         


Q ss_pred             --------CCCceeeecccccccCCCCcccceeeeecccccCChhhhcc--CcCCcccceehhhHHHHHHHhCCCCCCCC
Q 013745          224 --------QLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH--GYLSVKTDVFSYGVLVLEIVSGRKNHDGR  293 (437)
Q Consensus       224 --------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DvwSlG~vl~elltg~~p~~~~  293 (437)
                              .+.+||+|||++..+.....   .....||+.|+|||++.+  ..++.++||||||||||||++|+.||...
T Consensus       170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        170 AQANNLNGRPIAKIGDFGLSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             ccccccCCCCceEEccCCcccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                    33489999999987643322   123568999999999864  45899999999999999999999999754


Q ss_pred             CchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH--HHhcC
Q 013745          294 LGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVH--LMLSG  360 (437)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~--~~L~~  360 (437)
                      .....  ++.    .....     ....+.    ..+..+.+|+..||+.+|.+||++.+++  .++..
T Consensus       247 ~~~~q--li~----~lk~~-----p~lpi~----~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~  300 (1021)
T PTZ00266        247 NNFSQ--LIS----ELKRG-----PDLPIK----GKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN  300 (1021)
T ss_pred             CcHHH--HHH----HHhcC-----CCCCcC----CCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence            32211  111    11100     011111    2245678899999999999999999998  45543

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.3e-40  Score=311.68  Aligned_cols=250  Identities=25%  Similarity=0.382  Sum_probs=204.7

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      .++|++.+.||+|+||.||+|... +++.|++|.+.....  ...+.+|++++++++||||+++++++......++++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            357999999999999999999965 488999999875433  57899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +++++|.+++..  ....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++........
T Consensus        80 ~~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (256)
T cd06612          80 CGAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA  154 (256)
T ss_pred             CCCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence            999999998843  2356899999999999999999999988   99999999999999999999999999987654322


Q ss_pred             ccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcccc
Q 013745          244 HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA  323 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  323 (437)
                      .  .....++..|+|||++.+..++.++|||||||++|+|++|+.||...........+.      .      ...+. .
T Consensus       155 ~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~------~------~~~~~-~  219 (256)
T cd06612         155 K--RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP------N------KPPPT-L  219 (256)
T ss_pred             c--cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc------c------CCCCC-C
Confidence            1  123457899999999998899999999999999999999999997543322111000      0      00000 1


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       324 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ..+......+.+++.+||+.+|++||++.+|++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            112234456888999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.3e-40  Score=310.13  Aligned_cols=250  Identities=21%  Similarity=0.314  Sum_probs=205.3

Q ss_pred             CccccceeccCCCeeEEEEE-cCCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           87 FFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      +|++++.||.|+||.||.++ ..+++.+++|.+...  .......+.+|+.++++++|+||+++++++.+....++||||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            58899999999999999988 447899999988643  344556788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +++++|.+++.... ...+++..+..++.|++.+|.|||+.+   ++|+||||+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999885432 356899999999999999999999988   99999999999999999999999999987654332


Q ss_pred             ccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcccc
Q 013745          244 HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA  323 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  323 (437)
                      .  .....|++.|+|||++.+..++.++||||||+++|||++|..||......+....      ... +.        ..
T Consensus       157 ~--~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~------~~~-~~--------~~  219 (256)
T cd08221         157 M--AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVK------IVQ-GN--------YT  219 (256)
T ss_pred             c--ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHH------HHc-CC--------CC
Confidence            1  1235689999999999888899999999999999999999999976443221111      111 00        11


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013745          324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLM  357 (437)
Q Consensus       324 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  357 (437)
                      ......+..+.+++.+||+.+|++||++.++++.
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            1112344568889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.2e-40  Score=318.01  Aligned_cols=239  Identities=23%  Similarity=0.344  Sum_probs=188.6

Q ss_pred             eeccCCCeeEEEEEcCC-------------------------CcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceee
Q 013745           93 QLGHGGFGPVYRGLMPN-------------------------GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTL  147 (437)
Q Consensus        93 ~lG~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  147 (437)
                      .||+|+||.||+|.+..                         ...||+|++..........+.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            59999999999987311                         13588998876555455678899999999999999999


Q ss_pred             eeeeccCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCC--
Q 013745          148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL--  225 (437)
Q Consensus       148 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~--  225 (437)
                      ++++.+....++||||+++|+|+.++..  ..+.+++..+..++.||++||+|||+++   |+||||||+|||++..+  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            9999999999999999999999988843  2356889999999999999999999988   99999999999997654  


Q ss_pred             -----CceeeecccccccCCCCcccceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHH-hCCCCCCCCCchhh
Q 013745          226 -----NPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIV-SGRKNHDGRLGKEK  298 (437)
Q Consensus       226 -----~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~ell-tg~~p~~~~~~~~~  298 (437)
                           .+||+|||++.......      ...++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||......+.
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~~------~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~  230 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSRE------ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK  230 (274)
T ss_pred             cCccceeeecCCcccccccccc------ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence                 37999999986542221      2346788999998876 56899999999999999995 79999976543332


Q ss_pred             hhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          299 ADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                      ......       .       ..+.   ......+.+++.+||+.+|++||++.+|++.|.
T Consensus       231 ~~~~~~-------~-------~~~~---~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 ERFYEK-------K-------HRLP---EPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHHHHh-------c-------cCCC---CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            111110       0       0000   011235788999999999999999999998773

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=3.1e-40  Score=317.67  Aligned_cols=251  Identities=23%  Similarity=0.333  Sum_probs=201.3

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      +.|++++.||+|+||.||+|... +++.||+|++..........+.+|+.+++.++||||+++++++..+...++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56999999999999999999854 68999999998776666788999999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      ++++|..++...  ...+++..++.++.|++.+|.|||+.+   ++||||||+||+++.++.+||+|||++........ 
T Consensus        92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~-  165 (292)
T cd06644          92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ-  165 (292)
T ss_pred             CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccccc-
Confidence            999998876432  346899999999999999999999988   99999999999999999999999999875432211 


Q ss_pred             cceeeeecccccCChhhhc-----cCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          245 VNTFRISGTHGYMAPEYAL-----HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                       ......++..|+|||++.     ...++.++|||||||++|||++|..||.........      .......      .
T Consensus       166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~~------~  232 (292)
T cd06644         166 -RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL------LKIAKSE------P  232 (292)
T ss_pred             -ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH------HHHhcCC------C
Confidence             112346789999999885     345788999999999999999999999754322111      0111000      0


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      +.. ..+......+.+++.+||+.+|++||++.+|++
T Consensus       233 ~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         233 PTL-SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             ccC-CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            110 011233445788999999999999999999865

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.3e-40  Score=312.54  Aligned_cols=256  Identities=24%  Similarity=0.345  Sum_probs=200.6

Q ss_pred             HHhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           83 VATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        83 ~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ..++++.....||+|+||.||+|.. .++..||+|.+........+.+.+|+.++++++|+||+++++++..++..++||
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            3455566678899999999999984 467889999988766666678999999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC-CCCceeeecccccccCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE-QLNPKISDFGLARLFPG  240 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~-~~~~kl~DFGla~~~~~  240 (437)
                      ||+++++|.+++.........++..+..++.||+.||+|||+++   |+||||||+||+++. ++.+||+|||++.....
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  161 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG  161 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence            99999999998854322112278888999999999999999988   999999999999976 67999999999976543


Q ss_pred             CCcccceeeeecccccCChhhhccC--cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHG--YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      ....  .....|+..|+|||++.+.  .++.++||||||+++|+|++|+.||.........   .+......       .
T Consensus       162 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~~~~~~-------~  229 (268)
T cd06624         162 INPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFKVGMFK-------I  229 (268)
T ss_pred             CCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhhhhhhc-------c
Confidence            2221  1123578999999998765  3789999999999999999999999653221111   01000000       0


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .   ...+.....++.+++.+||+.+|++||++.+|++
T Consensus       230 ~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         230 H---PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             C---CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            1   1122234456788999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-40  Score=316.72  Aligned_cols=252  Identities=23%  Similarity=0.354  Sum_probs=203.8

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      .++|++.+.||.|+||.||+|... +++.||+|.+..........+.+|++++++++||||+++++.+..+...++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            456999999999999999999854 6889999999877666677899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +++++|..++...  ...+++..++.++.|++.||.|||+++   |+|+||||+||+++.++.++|+|||++........
T Consensus        84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            9999999988432  346899999999999999999999998   99999999999999999999999999876543222


Q ss_pred             ccceeeeecccccCChhhhcc-----CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          244 HVNTFRISGTHGYMAPEYALH-----GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      .  .....+++.|+|||++..     ..++.++|||||||++|||++|+.||..........      ......      
T Consensus       159 ~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~~------  224 (280)
T cd06611         159 K--RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLL------KILKSE------  224 (280)
T ss_pred             c--cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHH------HHhcCC------
Confidence            1  123568999999998853     357889999999999999999999997653322111      111000      


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .+.+ ..+......+.+++..||+.+|.+||++.+|++
T Consensus       225 ~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         225 PPTL-DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             CCCc-CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence            0011 111223456788999999999999999999965

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-41  Score=329.26  Aligned_cols=267  Identities=24%  Similarity=0.393  Sum_probs=219.6

Q ss_pred             HhcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      ......+.++||+|-||.|.++....+..||||+++... ......|.+|+++|.+|+|||||+++|.|..++.+++|+|
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            345677889999999999999998777999999998764 3445889999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      ||++|+|..++..... ..+.-.....|+.||+.|++||.+.+   +|||||.+.|+|+++++++||+|||+++.+...+
T Consensus       616 YmEnGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~  691 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD  691 (807)
T ss_pred             HHhcCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence            9999999999965533 22455667789999999999999988   9999999999999999999999999999877766


Q ss_pred             cccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh--CCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          243 THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS--GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                      ........+-..+|||||.+..++++.++|||+||+.+||+++  ...||.....++..+   ..-..+..... ..+. 
T Consensus       692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vve---n~~~~~~~~~~-~~~l-  766 (807)
T KOG1094|consen  692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVE---NAGEFFRDQGR-QVVL-  766 (807)
T ss_pred             ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHH---hhhhhcCCCCc-ceec-
Confidence            6655555666789999999999999999999999999999864  788997765544332   22222222211 1111 


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCCC
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDS  362 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~  362 (437)
                         .-++.++..+++++++||..+-++||++++|...|+.+.
T Consensus       767 ---~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  767 ---SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             ---cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence               223455667889999999999999999999999998643

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.4e-40  Score=311.79  Aligned_cols=247  Identities=29%  Similarity=0.412  Sum_probs=199.7

Q ss_pred             cCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecC
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLP  165 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  165 (437)
                      ++|++.+.||+|+||.||++.. +++.||+|++.....  ...+.+|+.++++++||||+++++++... ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~--~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcch--HHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4588999999999999999875 678899999865432  35788999999999999999999998765 4799999999


Q ss_pred             CCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCccc
Q 013745          166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV  245 (437)
Q Consensus       166 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  245 (437)
                      +++|.+++... ....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........  
T Consensus        82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~--  155 (254)
T cd05083          82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD--  155 (254)
T ss_pred             CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccCC--
Confidence            99999998543 2345889999999999999999999987   99999999999999999999999999976432211  


Q ss_pred             ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccC
Q 013745          246 NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK  324 (437)
Q Consensus       246 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  324 (437)
                         ....+..|+|||++.+..++.++|||||||++|||++ |+.||......+....+.       .....   +     
T Consensus       156 ---~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~~~---~-----  217 (254)
T cd05083         156 ---NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE-------KGYRM---E-----  217 (254)
T ss_pred             ---CCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-------CCCCC---C-----
Confidence               1233567999999998899999999999999999997 999997654332211111       11000   0     


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          325 CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       325 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      .....+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            111334567889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.4e-40  Score=319.53  Aligned_cols=249  Identities=24%  Similarity=0.364  Sum_probs=203.3

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      ++|++++.||+|+||.||+|+. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..+...++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            5799999999999999999984 579999999997655445567889999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      ++++|.+++.    ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.........
T Consensus        99 ~~~~L~~~~~----~~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~  171 (297)
T cd06656          99 AGGSLTDVVT----ETCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (297)
T ss_pred             CCCCHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccC
Confidence            9999999873    245788999999999999999999988   999999999999999999999999999865433221


Q ss_pred             cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccC
Q 013745          245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK  324 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  324 (437)
                      .  ....+++.|+|||.+.+..++.++|||||||++|+|++|+.||..........   ....   ..      .+. ..
T Consensus       172 ~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~---~~~~---~~------~~~-~~  236 (297)
T cd06656         172 R--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---LIAT---NG------TPE-LQ  236 (297)
T ss_pred             c--CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee---eecc---CC------CCC-CC
Confidence            1  13457899999999999889999999999999999999999997543221110   0000   00      000 01


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          325 CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       325 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .+......+.+++.+||+.+|++||++.+|++
T Consensus       237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            12233455778999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.8e-40  Score=320.33  Aligned_cols=249  Identities=23%  Similarity=0.391  Sum_probs=203.5

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      .+|++.+.||.|+||.||+|+. .+++.||+|.+..........+.+|+.+++.++||||+++++++......++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4599999999999999999984 578999999997655445577889999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      ++++|..++.    ...+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++.........
T Consensus        99 ~~~~L~~~~~----~~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  171 (296)
T cd06655          99 AGGSLTDVVT----ETCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK  171 (296)
T ss_pred             CCCcHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence            9999998873    235899999999999999999999998   999999999999999999999999998865433221


Q ss_pred             cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccC
Q 013745          245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK  324 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  324 (437)
                        .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...........+   .   ... .     +.+ .
T Consensus       172 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~---~---~~~-~-----~~~-~  236 (296)
T cd06655         172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---A---TNG-T-----PEL-Q  236 (296)
T ss_pred             --CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---H---hcC-C-----ccc-C
Confidence              11345889999999999888999999999999999999999999765432221111   0   000 0     000 1


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          325 CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       325 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .+......+.+++.+||+.+|++||++.+|+.
T Consensus       237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            11223445778999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.2e-40  Score=316.63  Aligned_cols=252  Identities=26%  Similarity=0.382  Sum_probs=198.1

Q ss_pred             HhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccC------C
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEG------P  155 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------~  155 (437)
                      +++.|++.+.||+|+||.||+|.. .+++.||+|++..... ....+.+|+.++.++ +|+||+++++++...      .
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc-cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            456799999999999999999985 4688999999875432 235678899999998 699999999998653      4


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccc
Q 013745          156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA  235 (437)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  235 (437)
                      ..++||||+++++|.+++... ....+++..+..++.|++.||+|||+++   |+|+||||+||+++.++.+||+|||++
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence            578999999999999988542 2356889999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcccceeeeecccccCChhhhc-----cCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhc
Q 013745          236 RLFPGEDTHVNTFRISGTHGYMAPEYAL-----HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQ  310 (437)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  310 (437)
                      .........  .....|+..|+|||++.     ...++.++|||||||++|||++|+.||...........      ...
T Consensus       159 ~~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~------~~~  230 (272)
T cd06637         159 AQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL------IPR  230 (272)
T ss_pred             eeccccccc--CCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH------Hhc
Confidence            865432221  22356899999999986     33688899999999999999999999965432221111      000


Q ss_pred             ccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          311 GEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       311 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                       ..     .+.+  .....+..+.+++.+||+.+|.+||++.+|++
T Consensus       231 -~~-----~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         231 -NP-----APRL--KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             -CC-----CCCC--CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence             00     0011  11123346788999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.1e-40  Score=314.56  Aligned_cols=250  Identities=30%  Similarity=0.438  Sum_probs=198.0

Q ss_pred             ceeccCCCeeEEEEEcCC-------CcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           92 NQLGHGGFGPVYRGLMPN-------GQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      +.||+|+||.||+|...+       ++.+|+|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            369999999999998532       2578999886542 23456788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccC----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCC-----Cceeeeccc
Q 013745          164 LPNKSLDYFIFDKT----KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL-----NPKISDFGL  234 (437)
Q Consensus       164 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~-----~~kl~DFGl  234 (437)
                      +++++|.+++....    ....+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++     .+||+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999986432    2245789999999999999999999987   99999999999999877     899999999


Q ss_pred             ccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccc
Q 013745          235 ARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEK  313 (437)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (437)
                      +................++..|+|||++.++.++.++|||||||++|||++ |..||......+....+.      . ..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~------~-~~  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT------A-GG  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh------c-CC
Confidence            986543322211112345678999999999999999999999999999998 999997544322211110      0 00


Q ss_pred             cccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          314 ALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       314 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                              ........+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus       231 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         231 --------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             --------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                    00112234566789999999999999999999999986

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.1e-40  Score=314.96  Aligned_cols=254  Identities=24%  Similarity=0.350  Sum_probs=202.3

Q ss_pred             hcCccccceeccCCCeeEEEEEcCC----CcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPN----GQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      .++|.+.+.||+|+||.||+|...+    ...||||...... ....+.+.+|+.++++++||||+++++++.+ ...++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            3568889999999999999998532    2468999887654 4456789999999999999999999999876 45789


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      ||||+++++|.+++...  ...+++..++.++.|++.||+|||+.+   ++|+||||+|||++.++.+||+|||+++...
T Consensus        84 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          84 VMELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence            99999999999998432  345899999999999999999999988   9999999999999999999999999998764


Q ss_pred             CCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      ........ ...++..|+|||.+....++.++|||||||++|||++ |..||......+....+.      .....    
T Consensus       159 ~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~------~~~~~----  227 (270)
T cd05056         159 DESYYKAS-KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE------NGERL----  227 (270)
T ss_pred             cccceecC-CCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH------cCCcC----
Confidence            43222111 2234568999999988889999999999999999996 999997655433221111      10000    


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                           ..+...+..+.+++.+|+..+|++||++.++++.|+.
T Consensus       228 -----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~  264 (270)
T cd05056         228 -----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSD  264 (270)
T ss_pred             -----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                 0112234568889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.5e-40  Score=317.75  Aligned_cols=262  Identities=25%  Similarity=0.394  Sum_probs=203.8

Q ss_pred             cCccccceeccCCCeeEEEEEcC-----CCcEEEEEEeccCChH-HHHHHHHHHHHHHcCCCCcceeeeeeecc--CCce
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-----NGQEIAVKKLSVDSRQ-GLREFTNEVKLLLKIQHKNLVTLFGCCAE--GPEK  157 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  157 (437)
                      ..|.+.+.||+|+||.||+|++.     ++..||||++...... ....+.+|+++++.+.|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45778899999999999999843     4688999999765443 46789999999999999999999999877  5678


Q ss_pred             EEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                      ++||||+++++|.+++...  ...+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            9999999999999998432  235899999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCcc-cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhh--------hhhhhhhhh
Q 013745          238 FPGEDTH-VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKA--------DLLSYTWTL  308 (437)
Q Consensus       238 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~--------~~~~~~~~~  308 (437)
                      ....... .......++..|+|||.+.+..++.++|||||||++|||++|..|+.........        .........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence            7533221 1111123456799999998889999999999999999999999998653322110        000000000


Q ss_pred             hcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          309 FQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       309 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      .....       . ...+...+..+.+++.+||+.+|++||++.+|+++|+.
T Consensus       239 ~~~~~-------~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05038         239 LKEGE-------R-LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR  282 (284)
T ss_pred             HHcCC-------c-CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence            00000       0 01112334668899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.8e-40  Score=313.12  Aligned_cols=251  Identities=26%  Similarity=0.382  Sum_probs=200.6

Q ss_pred             CccccceeccCCCeeEEEEEcCCCcEEEEEEeccCC------hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS------RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      +|.+.+.||+|+||.||+|...+++.+|||++....      ......+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            477889999999999999987789999999886432      22345688999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||+++++|.+++...   ..+++..+..++.|++.||+|||+.+   |+|+||||+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            9999999999998432   45789999999999999999999988   99999999999999999999999999986532


Q ss_pred             CCc----ccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccc
Q 013745          241 EDT----HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE  316 (437)
Q Consensus       241 ~~~----~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (437)
                      ...    ........|+..|+|||++.+..++.++|||||||++|+|++|..||...........      ....    .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~------~~~~----~  224 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY------IGAH----R  224 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHH------hhhc----c
Confidence            111    1111234588999999999988899999999999999999999999975432211100      0000    0


Q ss_pred             ccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          317 LVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       317 ~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ...+.+   +......+.+++.+||+.+|++||++.+|++
T Consensus       225 ~~~~~~---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         225 GLMPRL---PDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCCCCC---CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            011111   2234456788999999999999999999864

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-40  Score=335.48  Aligned_cols=261  Identities=20%  Similarity=0.218  Sum_probs=195.0

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      ...|.+.+.||+|+||.||+|... .++.||||....      ..+.+|+++|++|+|+|||++++++..++..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            447999999999999999999854 578899996432      2356899999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +. ++|..++...  ...+++..++.|+.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.+.....
T Consensus       242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            94 6777776432  346999999999999999999999998   99999999999999999999999999987644322


Q ss_pred             ccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCC-c-------hhhhhhhhhhhhh---hcc-
Q 013745          244 HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRL-G-------KEKADLLSYTWTL---FQG-  311 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~-~-------~~~~~~~~~~~~~---~~~-  311 (437)
                      ........||+.|+|||++.+..++.++|||||||+||||++|..++.... .       ......+......   +.. 
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~  395 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH  395 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence            222224579999999999999999999999999999999999886553221 1       0111111111000   000 


Q ss_pred             --cccc--------cccCccc-cCCC---HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013745          312 --EKAL--------ELVDPSL-AKCN---RDEAAMCIQLGLLCCQQSVAERPDMNSVHLM  357 (437)
Q Consensus       312 --~~~~--------~~~d~~l-~~~~---~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  357 (437)
                        ....        ....+.. ....   ......+.+|+.+||+.||++|||+.||++.
T Consensus       396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence              0000        0000000 0000   0122357789999999999999999999863

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-40  Score=314.92  Aligned_cols=255  Identities=26%  Similarity=0.425  Sum_probs=202.5

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCc----EEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQ----EIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM  158 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  158 (437)
                      ..+|++.+.||+|+||.||+|.++ +|.    .||+|.+.... ......+.+|+.++++++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            356889999999999999999853 333    58999887553 3445678899999999999999999999987 7889


Q ss_pred             EEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccccc
Q 013745          159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                      +||||+++|+|.+++...  ...+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.+||+|||+++..
T Consensus        85 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          85 LITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             EEEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence            999999999999988432  345899999999999999999999987   999999999999999999999999999876


Q ss_pred             CCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccc
Q 013745          239 PGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALEL  317 (437)
Q Consensus       239 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (437)
                      .............++..|+|||.+....++.++|+|||||++|||++ |+.||......+....+.       ....   
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~~---  229 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-------KGER---  229 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-------CCCC---
Confidence            53322221111223568999999988899999999999999999998 999997654332211111       0000   


Q ss_pred             cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          318 VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       318 ~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                           ...+......+.+++.+||..+|++||++.++++.|..
T Consensus       230 -----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~  267 (279)
T cd05057         230 -----LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSK  267 (279)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence                 00111233457889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-40  Score=313.05  Aligned_cols=248  Identities=30%  Similarity=0.426  Sum_probs=194.1

Q ss_pred             ceeccCCCeeEEEEEcC-CCc--EEEEEEeccC-ChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCceEEEEeecCC
Q 013745           92 NQLGHGGFGPVYRGLMP-NGQ--EIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYEYLPN  166 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  166 (437)
                      +.||+|+||.||+|... ++.  .+++|.+... .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            35999999999999864 443  4688888643 344456788999999999 799999999999999999999999999


Q ss_pred             CCcchhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecc
Q 013745          167 KSLDYFIFDKT-------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG  233 (437)
Q Consensus       167 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG  233 (437)
                      ++|.+++....             ....+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999885432             1235789999999999999999999987   9999999999999999999999999


Q ss_pred             cccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhccc
Q 013745          234 LARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGE  312 (437)
Q Consensus       234 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  312 (437)
                      ++.......   .......+..|+|||++....++.++|||||||++|||++ |..||......+....+       ...
T Consensus       158 l~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~-------~~~  227 (270)
T cd05047         158 LSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-------PQG  227 (270)
T ss_pred             Cccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHH-------hCC
Confidence            986432111   1111223567999999988899999999999999999997 99999764432211111       000


Q ss_pred             ccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          313 KALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       313 ~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ...        .........+.+++.+||+.+|.+||++.+++..|+.
T Consensus       228 ~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~  267 (270)
T cd05047         228 YRL--------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  267 (270)
T ss_pred             CCC--------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence            000        0111233467899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.2e-40  Score=320.28  Aligned_cols=263  Identities=25%  Similarity=0.351  Sum_probs=199.1

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      ++|++.+.||.|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++......++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            56999999999999999999854 68899999986442 22234577899999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      ++ ++|..++...  ...+++..+..++.||+.||.|||+.+   |+|+||||+|||++.++.+||+|||++........
T Consensus        86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            96 5887777432  346889999999999999999999988   99999999999999999999999999976543221


Q ss_pred             ccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhh--------hhhhh-cccc
Q 013745          244 HVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSY--------TWTLF-QGEK  313 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~--------~~~~~-~~~~  313 (437)
                      .  .....+++.|+|||++.+. .++.++|||||||++|||++|++||......+....+..        .|... ....
T Consensus       160 ~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (301)
T cd07873         160 T--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  237 (301)
T ss_pred             c--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccc
Confidence            1  1123568899999988764 588999999999999999999999986554322211111        01100 0000


Q ss_pred             cccccCcc-----ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          314 ALELVDPS-----LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       314 ~~~~~d~~-----l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ......+.     +..........+.+++.+|++.+|.+|||+.||++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00000000     00111123446788999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=8.5e-40  Score=308.11  Aligned_cols=249  Identities=23%  Similarity=0.328  Sum_probs=201.1

Q ss_pred             CccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeecc-CCceEEEEe
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE-GPEKMLVYE  162 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  162 (437)
                      +|++.+.||.|++|.||++... +++.||+|++...  .....+.+.+|+.++++++|+|++++++.+.. ....++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4889999999999999999854 6789999998643  23445678899999999999999999998764 445789999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |+++++|.+++... ....+++..++.++.+++.||+|||+++   ++||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            99999999888543 2356899999999999999999999998   9999999999999999999999999998764332


Q ss_pred             cccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccc
Q 013745          243 THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL  322 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  322 (437)
                      ..  .....+++.|+|||++.+..++.++|||||||++|+|++|+.||........      ...... +.        +
T Consensus       157 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~------~~~~~~-~~--------~  219 (257)
T cd08223         157 DM--ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL------VYRIIE-GK--------L  219 (257)
T ss_pred             Cc--cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHHh-cC--------C
Confidence            21  1234688999999999999999999999999999999999999975432211      111111 00        1


Q ss_pred             cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          323 AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       323 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ..........+.+++.+|++.+|++||++.++++
T Consensus       220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            1122345567889999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=4.2e-40  Score=312.11  Aligned_cols=249  Identities=27%  Similarity=0.425  Sum_probs=199.6

Q ss_pred             CccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCCh---------HHHHHHHHHHHHHHcCCCCcceeeeeeeccCCc
Q 013745           87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSR---------QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE  156 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  156 (437)
                      +|.+.+.||+|+||.||+|.. .+++.||+|.+.....         ...+.+.+|+.++++++||||+++++++.+...
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            367788999999999999985 4688999998864321         123568899999999999999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                      .++||||+++++|..++..   ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence            9999999999999998843   356888999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCccc----ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccc
Q 013745          237 LFPGEDTHV----NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGE  312 (437)
Q Consensus       237 ~~~~~~~~~----~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  312 (437)
                      .........    ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||.........   .   ...   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~---~~~---  225 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI---F---KIG---  225 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH---H---HHh---
Confidence            765321111    111245788999999999888999999999999999999999999764322111   0   000   


Q ss_pred             ccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          313 KALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       313 ~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                         ....+   ..+...+..+.+++.+||+.+|++||++.+|++
T Consensus       226 ---~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         226 ---ENASP---EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             ---ccCCC---cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence               01111   112234456788999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.6e-40  Score=315.99  Aligned_cols=256  Identities=23%  Similarity=0.338  Sum_probs=204.2

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      .++|++++.||+|+||+||++... +++.||+|++.... ......+.+|+++++.++||||+++++++......++|||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            356889999999999999999854 68899999886542 3445778999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE-APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      |+++++|..++..   .+.+++..+..++.+++.+|.|||+. +   ++||||||+||++++++.++|+|||++......
T Consensus        84 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          84 FMDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             cCCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            9999999988733   34689999999999999999999974 5   999999999999999999999999998754322


Q ss_pred             CcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhh-----hhhhhhhhhhhccccccc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK-----ADLLSYTWTLFQGEKALE  316 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~  316 (437)
                      ..    ....|+..|+|||++.+..++.++|||||||++|+|++|+.||........     ..............    
T Consensus       158 ~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  229 (284)
T cd06620         158 IA----DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP----  229 (284)
T ss_pred             cc----CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc----
Confidence            11    135689999999999888999999999999999999999999986443211     11111111111100    


Q ss_pred             ccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHh
Q 013745          317 LVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML  358 (437)
Q Consensus       317 ~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L  358 (437)
                        .+.+.  ....+..+.+++.+|++.+|++||++.||++..
T Consensus       230 --~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         230 --PPRLP--SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             --CCCCC--chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence              01111  112445688999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3.9e-40  Score=315.35  Aligned_cols=263  Identities=22%  Similarity=0.351  Sum_probs=201.8

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      ++|++.+.||+|+||.||+|+.+ +++.||+|++....  ....+.+.+|+.++++++||||+++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46899999999999999999865 68999999886432  2223567899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |+++++|..++.   ....+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            999998887763   2345899999999999999999999988   9999999999999999999999999998765433


Q ss_pred             cccceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhh--------hhhhhcccc
Q 013745          243 THVNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSY--------TWTLFQGEK  313 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~~  313 (437)
                      ..  .....++..|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+..        ....+....
T Consensus       155 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         155 DD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             cc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence            21  112457889999999876 4688999999999999999999999987554332211110        000010000


Q ss_pred             cc---cccCcc----ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          314 AL---ELVDPS----LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       314 ~~---~~~d~~----l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ..   ...++.    +.......+..+.+++.+||+.+|++||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            00   000000    00111123566889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=5.5e-40  Score=312.85  Aligned_cols=256  Identities=25%  Similarity=0.369  Sum_probs=202.8

Q ss_pred             cCccccceeccCCCeeEEEEEcC------CCcEEEEEEeccCChH-HHHHHHHHHHHHHcCCCCcceeeeeeeccCCceE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVDSRQ-GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM  158 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  158 (437)
                      ++|++++.||+|+||.||+|+.+      +.+.|++|.+...... ....+.+|++++++++|+||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56889999999999999999853      3467899988654433 4567899999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhccCCC------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeec
Q 013745          159 LVYEYLPNKSLDYFIFDKTKS------SSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDF  232 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DF  232 (437)
                      +||||+++++|.+++......      ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999998544321      26899999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcc
Q 013745          233 GLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQG  311 (437)
Q Consensus       233 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  311 (437)
                      |++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||..........   ..    ..
T Consensus       162 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~---~~----~~  233 (275)
T cd05046         162 SLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLN---RL----QA  233 (275)
T ss_pred             ccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHH---HH----Hc
Confidence            998754322211 1112346778999999988889999999999999999998 788986543322111   10    00


Q ss_pred             cccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          312 EKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       312 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                      ... ..  +    .....+..+.+++.+||+.+|++||++.+++..|.
T Consensus       234 ~~~-~~--~----~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         234 GKL-EL--P----VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCc-CC--C----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            000 00  0    01123356888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.8e-40  Score=325.13  Aligned_cols=193  Identities=23%  Similarity=0.330  Sum_probs=164.5

Q ss_pred             HHhcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           83 VATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        83 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ....+|++++.||+|+||.||+|... +++.||+|+.....      ...|+.++++++||||+++++++......++||
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            34567999999999999999999854 57889999854332      246999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      |++. ++|..++..  ....+++..++.|+.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       137 e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  210 (357)
T PHA03209        137 PHYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA  210 (357)
T ss_pred             EccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence            9995 577777643  3356899999999999999999999998   999999999999999999999999999754322


Q ss_pred             CcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCC
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNH  290 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~  290 (437)
                      .   ......||+.|+|||++.+..++.++|||||||++|||+++..++
T Consensus       211 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        211 P---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             c---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            1   122356899999999999999999999999999999999866554

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.7e-40  Score=319.08  Aligned_cols=255  Identities=28%  Similarity=0.471  Sum_probs=200.2

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCc----EEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQ----EIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM  158 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  158 (437)
                      .++|+..+.||+|+||.||+|.+. +|.    .||+|.+.... ......+.+|+.++++++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            356888999999999999999853 444    47888886543 33345688999999999999999999998754 467


Q ss_pred             EEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccccc
Q 013745          159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                      +++||+++|+|.+++...  ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.+
T Consensus        85 ~v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             eeehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence            999999999999988432  346889999999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccc
Q 013745          239 PGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALEL  317 (437)
Q Consensus       239 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (437)
                      .............++..|+|||++.+..++.++|||||||++|||++ |..||.+.........+.       ....  .
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~~--~  230 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-------KGER--L  230 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------CCCC--C
Confidence            54332222222345778999999998899999999999999999997 999997644322221111       1100  0


Q ss_pred             cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          318 VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       318 ~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                        +.    .......+.+++..||..+|++||++.+|++.|..
T Consensus       231 --~~----~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~  267 (303)
T cd05110         231 --PQ----PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSR  267 (303)
T ss_pred             --CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence              00    11223457889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-40  Score=313.61  Aligned_cols=248  Identities=27%  Similarity=0.402  Sum_probs=203.0

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      ++|++.+.||.|+||.||+|+.. +++.||+|++.... ......+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            46888999999999999999854 68999999987543 34456788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +++++|.+++..    ..+++..++.++.|++.||.|||+++   ++|+||+|+||++++++.++|+|||+++.......
T Consensus        81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence            999999988832    27899999999999999999999988   99999999999999999999999999987754322


Q ss_pred             ccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcccc
Q 013745          244 HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA  323 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  323 (437)
                      .  .....++..|+|||++.+..++.++|||||||++|+|++|+.||...........+.            ....+.+.
T Consensus       154 ~--~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~------------~~~~~~~~  219 (274)
T cd06609         154 K--RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP------------KNNPPSLE  219 (274)
T ss_pred             c--cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhh------------hcCCCCCc
Confidence            1  123467889999999999889999999999999999999999997544221111000            00111111


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       324 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ..  ..+..+.+++.+||..+|++||+++++++
T Consensus       220 ~~--~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         220 GN--KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             cc--ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            11  14456788999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-41  Score=320.14  Aligned_cols=248  Identities=27%  Similarity=0.337  Sum_probs=207.2

Q ss_pred             HhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      ..+.|+..++||+||||.||-++. .+|+.||+|++.+.   ...+..-.++|-.||.+++.+.||.+-..|+..+.+||
T Consensus       183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence            346799999999999999999874 48999999998643   34445567899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      |+..|.||+|...|++... ..+++..++.++.+|+.||++||...   ||+||+||+|||||+.|+++|+|.|||..+.
T Consensus       263 VLtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~  338 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP  338 (591)
T ss_pred             EEEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence            9999999999999876543 67999999999999999999999998   9999999999999999999999999999987


Q ss_pred             CCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                      .......   .+||.+|||||++.++.|+...|+|||||+||||+.|+.||..........-++....            
T Consensus       339 ~g~~~~~---rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~------------  403 (591)
T KOG0986|consen  339 EGKPIRG---RVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTL------------  403 (591)
T ss_pred             CCCcccc---ccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHh------------
Confidence            6655432   3799999999999999999999999999999999999999976544333221111110            


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCCC
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPD  350 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs  350 (437)
                      ..-..++...+.+..+++...++.||++|.-
T Consensus       404 ~~~~ey~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  404 EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             cchhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence            0112344456667788888999999999853

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.1e-40  Score=315.06  Aligned_cols=240  Identities=23%  Similarity=0.374  Sum_probs=189.6

Q ss_pred             ceeccCCCeeEEEEEcC-CC-------cEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           92 NQLGHGGFGPVYRGLMP-NG-------QEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      +.||+|+||.||+|... .+       ..||+|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            36999999999999753 22       34888888655555567788999999999999999999999998999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCC--------ceeeecccc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN--------PKISDFGLA  235 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~--------~kl~DFGla  235 (437)
                      +++|+|..++...  ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.        ++++|||++
T Consensus        81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            9999999998533  236889999999999999999999988   999999999999987765        589999988


Q ss_pred             cccCCCCcccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCC-CCCCCCCchhhhhhhhhhhhhhcccc
Q 013745          236 RLFPGEDTHVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR-KNHDGRLGKEKADLLSYTWTLFQGEK  313 (437)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (437)
                      ......      ....++..|+|||++.+. .++.++|||||||++|||++|. .||...........       ... .
T Consensus       156 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-------~~~-~  221 (258)
T cd05078         156 ITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-------YED-R  221 (258)
T ss_pred             cccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-------HHc-c
Confidence            754322      124578899999999874 5899999999999999999995 55544332211110       000 0


Q ss_pred             cccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          314 ALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       314 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                            .   ..+......+.+++.+||+.+|++||++.+|++.|+
T Consensus       222 ------~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 ------H---QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ------c---cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                  0   111122346789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.3e-40  Score=314.94  Aligned_cols=247  Identities=25%  Similarity=0.419  Sum_probs=201.3

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      +.|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEc
Confidence            34778899999999999999854 67889999987443 34456788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +++++|.+++.    ...+++..+..++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus        84 ~~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          84 LGGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             cCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            99999988873    346889999999999999999999988   99999999999999999999999999987643322


Q ss_pred             ccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcccc
Q 013745          244 HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA  323 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  323 (437)
                      .  .....|+..|+|||++.+..++.++|||||||++|||++|+.||...........      . ...     ..+   
T Consensus       157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~------~-~~~-----~~~---  219 (277)
T cd06642         157 K--RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL------I-PKN-----SPP---  219 (277)
T ss_pred             h--hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh------h-hcC-----CCC---
Confidence            1  1124578899999999998999999999999999999999999865432211100      0 000     011   


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       324 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ......+..+.+++.+||+.+|++||++.+|++
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            112234456889999999999999999999987

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1e-39  Score=311.71  Aligned_cols=248  Identities=24%  Similarity=0.398  Sum_probs=204.4

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      ..|+..+.||.|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++.+....++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35788899999999999999854 68899999987543 44567789999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +++++|.+++.    ...+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        84 ~~~~~L~~~i~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          84 LGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            99999998873    245888999999999999999999987   99999999999999999999999999987654322


Q ss_pred             ccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcccc
Q 013745          244 HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA  323 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  323 (437)
                      .  .....++..|+|||++.+..++.++|+|||||++|||++|..||...........+       ...        ...
T Consensus       157 ~--~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-------~~~--------~~~  219 (277)
T cd06640         157 K--RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-------PKN--------NPP  219 (277)
T ss_pred             c--cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-------hcC--------CCC
Confidence            1  12345788999999999888999999999999999999999999764432211110       000        011


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013745          324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLM  357 (437)
Q Consensus       324 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  357 (437)
                      ......+..+.+++.+||+.+|++||++.+|+..
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            2233566778899999999999999999999653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=6.7e-40  Score=309.89  Aligned_cols=249  Identities=25%  Similarity=0.373  Sum_probs=191.4

Q ss_pred             ceeccCCCeeEEEEEcC----CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeec-cCCceEEEEeecC
Q 013745           92 NQLGHGGFGPVYRGLMP----NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCA-EGPEKMLVYEYLP  165 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  165 (437)
                      +.||+|+||.||+|.+.    .+..||+|++... .......+.+|+.+++.++||||+++++++. .+...++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999842    2457999998543 3444677889999999999999999999765 4556799999999


Q ss_pred             CCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc-
Q 013745          166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH-  244 (437)
Q Consensus       166 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~-  244 (437)
                      +++|..++...  ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||+++........ 
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            99999998432  234677888899999999999999988   999999999999999999999999999865432211 


Q ss_pred             -cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhC-CCCCCCCCchhhhhhhhhhhhhhcccccccccCccc
Q 013745          245 -VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG-RKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL  322 (437)
Q Consensus       245 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  322 (437)
                       .......++..|+|||++.+..++.++|||||||++|||++| .+||......+   .....   .....      +..
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~~---~~~~~------~~~  223 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVYL---LQGRR------LLQ  223 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH---hcCCC------CCC
Confidence             111123457789999999888999999999999999999995 55665433222   11111   11100      000


Q ss_pred             cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          323 AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       323 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                         +...+..+.+++..||+.+|++||++.+|++.|+.
T Consensus       224 ---~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~  258 (262)
T cd05058         224 ---PEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQ  258 (262)
T ss_pred             ---CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence               11223468899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.3e-39  Score=308.21  Aligned_cols=256  Identities=27%  Similarity=0.395  Sum_probs=206.3

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      ++|++.+.||.|+||+||+|.. .++..+|+|++.... ......+.+|+.+++.++|+||+++++.+......++|||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            4689999999999999999984 468899999986542 23567789999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +++++|.+++........+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999855433356899999999999999999999988   99999999999999999999999999987654332


Q ss_pred             cc--ceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          244 HV--NTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       244 ~~--~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                      ..  ......|+..|+|||++... .++.++|+|||||++|||++|+.||..........  .    ....      ..+
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~--~----~~~~------~~~  225 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLM--L----TLQN------DPP  225 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHH--H----HhcC------CCC
Confidence            21  12234689999999998877 78999999999999999999999997543321110  0    0010      011


Q ss_pred             cccCC--CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          321 SLAKC--NRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       321 ~l~~~--~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .+...  ....+..+.+++.+||+.+|++||++.+|++
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            11111  1234566789999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=9.9e-40  Score=307.25  Aligned_cols=251  Identities=31%  Similarity=0.499  Sum_probs=201.6

Q ss_pred             ccccceeccCCCeeEEEEEcCC-----CcEEEEEEeccCChH-HHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           88 FSDLNQLGHGGFGPVYRGLMPN-----GQEIAVKKLSVDSRQ-GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        88 y~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      |++.+.||.|+||.||+++...     +..||+|++...... ....+..|+.++..++|+||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567899999999999998543     388999999755432 5678899999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      ||+++++|.+++..... ..+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            99999999998854321 22899999999999999999999998   999999999999999999999999999876544


Q ss_pred             CcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                      ...... ...+++.|+|||.+.+..++.++|||||||++++|++ |..||...........+.   .    ...      
T Consensus       157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~---~----~~~------  222 (258)
T smart00219      157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLK---K----GYR------  222 (258)
T ss_pred             cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh---c----CCC------
Confidence            222211 1236789999999988889999999999999999998 888887643322211111   0    000      


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHh
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML  358 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L  358 (437)
                        .......+..+.+++.+|++.+|++|||+.+++++|
T Consensus       223 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 --LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             --CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence              011112455688899999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=4.3e-40  Score=317.10  Aligned_cols=248  Identities=23%  Similarity=0.351  Sum_probs=200.8

Q ss_pred             ccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCC
Q 013745           88 FSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN  166 (437)
Q Consensus        88 y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  166 (437)
                      |.....||+|+||.||++.. .++..||||++........+.+.+|+.+++.++|+||+++++.+...+..++||||+++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~  103 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG  103 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence            55567799999999999985 46889999998766555567789999999999999999999999999999999999999


Q ss_pred             CCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccc
Q 013745          167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN  246 (437)
Q Consensus       167 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  246 (437)
                      ++|.+++.    ...+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++.........  
T Consensus       104 ~~L~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~--  174 (292)
T cd06658         104 GALTDIVT----HTRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK--  174 (292)
T ss_pred             CcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccccc--
Confidence            99988873    235889999999999999999999998   999999999999999999999999999765433221  


Q ss_pred             eeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCC
Q 013745          247 TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCN  326 (437)
Q Consensus       247 ~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  326 (437)
                      .....|+..|+|||++.+..++.++||||||+++|||++|+.||...........+   ..         .+.+.+. ..
T Consensus       175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~---~~---------~~~~~~~-~~  241 (292)
T cd06658         175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI---RD---------NLPPRVK-DS  241 (292)
T ss_pred             CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hh---------cCCCccc-cc
Confidence            12356899999999998888999999999999999999999999754432211110   00         0111111 11


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013745          327 RDEAAMCIQLGLLCCQQSVAERPDMNSVHLM  357 (437)
Q Consensus       327 ~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  357 (437)
                      ......+.+++.+||+.+|++||++.+|++.
T Consensus       242 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         242 HKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            1234457788999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.2e-39  Score=314.34  Aligned_cols=266  Identities=23%  Similarity=0.308  Sum_probs=202.3

Q ss_pred             CccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCCh-----HHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-----QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      +|++.+.||+|+||.||+|... +++.||||++.....     .....+..|++++++++|+||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4788899999999999999854 689999999975432     2234567899999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||+ +++|..++....  ..+++..++.++.||++||.|||+++   |+|+||||+||+++.++.+||+|||+++....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 899999884322  36899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCcccceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhh--------hhhhcc
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYT--------WTLFQG  311 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~  311 (437)
                      .....  ....+++.|+|||.+.+ ..++.++|||||||++|||++|.++|.+....+....+...        +.....
T Consensus       155 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (298)
T cd07841         155 PNRKM--THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS  232 (298)
T ss_pred             CCccc--cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccc
Confidence            32211  12346788999998865 46789999999999999999998888765443221111000        000000


Q ss_pred             c-cc---ccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--hcC
Q 013745          312 E-KA---LELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLM--LSG  360 (437)
Q Consensus       312 ~-~~---~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~--L~~  360 (437)
                      . ..   .......+..........+.+++.+||+.+|++||++.||++.  +.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~  287 (298)
T cd07841         233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN  287 (298)
T ss_pred             ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence            0 00   0000011111222345678899999999999999999999873  544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=7.5e-40  Score=308.65  Aligned_cols=238  Identities=25%  Similarity=0.437  Sum_probs=189.2

Q ss_pred             ceeccCCCeeEEEEEcCCCc-----------EEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           92 NQLGHGGFGPVYRGLMPNGQ-----------EIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      +.||+|+||.||+|......           .+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999865322           4788877654433 5778899999999999999999999988 778999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCC-------Cceeeecc
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL-------NPKISDFG  233 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~-------~~kl~DFG  233 (437)
                      |||+++++|.+++....  ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            99999999999885432  26889999999999999999999988   99999999999999887       79999999


Q ss_pred             cccccCCCCcccceeeeecccccCChhhhccC--cCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhc
Q 013745          234 LARLFPGEDTHVNTFRISGTHGYMAPEYALHG--YLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQ  310 (437)
Q Consensus       234 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  310 (437)
                      ++.......      ...++..|+|||++...  .++.++|||||||++|||++ |..||.............       
T Consensus       154 ~a~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-------  220 (259)
T cd05037         154 IPITVLSRE------ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-------  220 (259)
T ss_pred             ccccccccc------ccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-------
Confidence            998754311      23467789999999877  78999999999999999999 577776543222111100       


Q ss_pred             ccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          311 GEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       311 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                      ...       ....   .....+.+++.+||+.+|.+||++.+|++.|+
T Consensus       221 ~~~-------~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 DQH-------RLPM---PDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             cCC-------CCCC---CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            000       0000   01156789999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=8.4e-40  Score=318.18  Aligned_cols=197  Identities=25%  Similarity=0.390  Sum_probs=159.5

Q ss_pred             ceeccCCCeeEEEEEcC---CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeec--cCCceEEEEeecCC
Q 013745           92 NQLGHGGFGPVYRGLMP---NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCA--EGPEKMLVYEYLPN  166 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv~e~~~~  166 (437)
                      .+||+|+||.||+|+..   ++..||+|.+.....  ...+.+|+.++++++||||+++++++.  .+...++||||+++
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            67999999999999854   457899999865432  245778999999999999999999884  35677999999965


Q ss_pred             CCcchhhhcc------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEe----cCCCCceeeeccccc
Q 013745          167 KSLDYFIFDK------TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL----DEQLNPKISDFGLAR  236 (437)
Q Consensus       167 gsL~~~l~~~------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll----~~~~~~kl~DFGla~  236 (437)
                       +|..++...      .....+++..++.++.||+.||.|||+++   |+||||||+|||+    +.++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             665555321      12235889999999999999999999998   9999999999999    566789999999998


Q ss_pred             ccCCCCcc-cceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCC
Q 013745          237 LFPGEDTH-VNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRL  294 (437)
Q Consensus       237 ~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~  294 (437)
                      ........ .......||+.|+|||++.+. .++.++|||||||++|||+||++||....
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            76543221 112235689999999998764 68999999999999999999999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=324.26  Aligned_cols=244  Identities=31%  Similarity=0.445  Sum_probs=198.6

Q ss_pred             CccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      .|..++.||.|+||.||.|++ .+.+.||||++..+.   ...+..++.|+++|++++|||+|.+.|||..+...|||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            477889999999999999984 578899999997553   3445789999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      || -|+-.+++.-  -..++.+..+..|+.+.+.||+|||+.+   .||||||..|||+++.|.|||+|||.|.......
T Consensus       107 YC-lGSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn  180 (948)
T KOG0577|consen  107 YC-LGSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN  180 (948)
T ss_pred             HH-hccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCchh
Confidence            99 5577777632  2357889999999999999999999998   9999999999999999999999999998764432


Q ss_pred             cccceeeeecccccCChhhhc---cCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          243 THVNTFRISGTHGYMAPEYAL---HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                            .++|||.|||||++.   .+.|+-|+||||||+...||...++|+..+....      ..+.+...      -.
T Consensus       181 ------sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS------ALYHIAQN------es  242 (948)
T KOG0577|consen  181 ------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQN------ES  242 (948)
T ss_pred             ------cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH------HHHHHHhc------CC
Confidence                  468999999999885   4689999999999999999999999976543221      11111111      11


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      |.+.  .++-+..+..++..|++.-|.+|||..+++.
T Consensus       243 PtLq--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  243 PTLQ--SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             CCCC--CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            2222  2233455678888999999999999988753

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=9.9e-40  Score=319.57  Aligned_cols=263  Identities=19%  Similarity=0.236  Sum_probs=194.5

Q ss_pred             ccceeccC--CCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           90 DLNQLGHG--GFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        90 ~~~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      ++++||+|  +|++||++.. .+|+.||+|++...  .....+.+.+|+.+++.++||||++++++|..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            46789999  7899999984 57899999999754  2334456788999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      ++|+|.+++.... ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++.++++||+.+.........
T Consensus        82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            9999999885432 245899999999999999999999988   999999999999999999999999875443211110


Q ss_pred             c-----ceeeeecccccCChhhhcc--CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhh-hhhhhh-hhc-----
Q 013745          245 V-----NTFRISGTHGYMAPEYALH--GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADL-LSYTWT-LFQ-----  310 (437)
Q Consensus       245 ~-----~~~~~~gt~~Y~aPE~~~~--~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~-~~~~~~-~~~-----  310 (437)
                      .     ......++..|+|||++.+  ..++.++|||||||++|||++|+.||........... ...... ...     
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP  237 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence            0     0112346778999999976  3689999999999999999999999975432211000 000000 000     


Q ss_pred             ccc-------------ccc--c---cCc-----cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          311 GEK-------------ALE--L---VDP-----SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       311 ~~~-------------~~~--~---~d~-----~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ...             ..+  .   ..+     ............+.+++.+||+.||++|||+.+|++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            000             000  0   000     000112234557889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.4e-39  Score=306.60  Aligned_cols=249  Identities=21%  Similarity=0.320  Sum_probs=202.4

Q ss_pred             CccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      +|++.+.||+|+||.||++.. .+|+.||+|.+...  .......+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            488899999999999999984 47899999998643  233456789999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +++++|.+.+... ....+++..++.++.|++.||.|||+++   ++|+||+|+|||++.++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            9999998887432 2345789999999999999999999988   99999999999999999999999999987644322


Q ss_pred             ccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcccc
Q 013745          244 HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA  323 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  323 (437)
                      .  .....|++.|+|||++.+..++.++|||||||++++|++|+.||......+..      ......         ...
T Consensus       157 ~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~------~~~~~~---------~~~  219 (256)
T cd08218         157 L--ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV------LKIIRG---------SYP  219 (256)
T ss_pred             h--hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHH------HHHhcC---------CCC
Confidence            1  11345788999999999889999999999999999999999999754322111      111110         011


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       324 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ..+......+.+++.+||+.+|++||++.+|++
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            112234556889999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.2e-39  Score=312.25  Aligned_cols=258  Identities=22%  Similarity=0.295  Sum_probs=199.8

Q ss_pred             HHHHhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcC-CCCcceeeeeeec-----c
Q 013745           81 LQVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCA-----E  153 (437)
Q Consensus        81 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-----~  153 (437)
                      +....++|++.+.||+|+||.||+|.. .+++.+|+|++..... ....+.+|+.+++++ +||||+++++++.     .
T Consensus        13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   91 (286)
T cd06638          13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN   91 (286)
T ss_pred             CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence            344578899999999999999999985 4688999998864322 235677899999999 6999999999873     4


Q ss_pred             CCceEEEEeecCCCCcchhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeec
Q 013745          154 GPEKMLVYEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDF  232 (437)
Q Consensus       154 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DF  232 (437)
                      +...++||||+++++|.+++... .....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+||
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~df  168 (286)
T cd06638          92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDF  168 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccC
Confidence            45689999999999999887532 23356889999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCcccceeeeecccccCChhhhcc-----CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhh
Q 013745          233 GLARLFPGEDTHVNTFRISGTHGYMAPEYALH-----GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWT  307 (437)
Q Consensus       233 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~  307 (437)
                      |+++........  .....|++.|+|||++..     ..++.++|||||||++|||++|+.||..........  .    
T Consensus       169 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~--~----  240 (286)
T cd06638         169 GVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF--K----  240 (286)
T ss_pred             CceeecccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh--h----
Confidence            999876433221  123468999999998853     457899999999999999999999997543221110  0    


Q ss_pred             hhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013745          308 LFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLM  357 (437)
Q Consensus       308 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  357 (437)
                       ..........++      ......+.+++.+||+.+|++||++.||++-
T Consensus       241 -~~~~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         241 -IPRNPPPTLHQP------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             -ccccCCCcccCC------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence             000000011111      1123457889999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.2e-39  Score=309.92  Aligned_cols=255  Identities=25%  Similarity=0.384  Sum_probs=198.8

Q ss_pred             ccccceeccCCCeeEEEEEcC----CCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC------
Q 013745           88 FSDLNQLGHGGFGPVYRGLMP----NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP------  155 (437)
Q Consensus        88 y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  155 (437)
                      |.+.+.||+|+||.||+|.+.    +++.||||++...  .....+++.+|+.++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567889999999999999743    4688999998654  3445677889999999999999999999886432      


Q ss_pred             ceEEEEeecCCCCcchhhhccC---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeec
Q 013745          156 EKMLVYEYLPNKSLDYFIFDKT---KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDF  232 (437)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DF  232 (437)
                      ..++++||+++|+|..++....   ....+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            2478999999999988764321   2235788999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcc
Q 013745          233 GLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQG  311 (437)
Q Consensus       233 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  311 (437)
                      |+++...............++..|++||.+....++.++|||||||++|||++ |+.||......+..   .+...   .
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~---~~~~~---~  231 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIY---NYLIK---G  231 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHH---HHHHc---C
Confidence            99987643322211222345678999999998889999999999999999999 88998754432211   11111   0


Q ss_pred             cccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          312 EKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       312 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ..      .   .........+.+++.+||+.+|++||++.+|++.|++
T Consensus       232 ~~------~---~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~  271 (273)
T cd05074         232 NR------L---KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL  271 (273)
T ss_pred             Cc------C---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            00      0   0111234568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.7e-39  Score=308.74  Aligned_cols=254  Identities=20%  Similarity=0.333  Sum_probs=190.0

Q ss_pred             ceeccCCCeeEEEEEcCCC---cEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCCC
Q 013745           92 NQLGHGGFGPVYRGLMPNG---QEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNK  167 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  167 (437)
                      +.||+|+||.||+|...++   ..+++|.+.... ....+.+.+|+.+++.++||||+++++.|......++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3699999999999974333   346677766443 344578999999999999999999999999999999999999999


Q ss_pred             CcchhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccc
Q 013745          168 SLDYFIFDKT-KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN  246 (437)
Q Consensus       168 sL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  246 (437)
                      +|.+++.... ....+++..++.++.||+.||+|||+.+   ++||||||+|||++.++.+||+|||++...........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            9999885432 2245677788899999999999999988   99999999999999999999999999864322211111


Q ss_pred             eeeeecccccCChhhhcc-------CcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          247 TFRISGTHGYMAPEYALH-------GYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       247 ~~~~~gt~~Y~aPE~~~~-------~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      .....++..|+|||++..       ..++.++|||||||++|||++ |..||......+...   .   ... +......
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~---~---~~~-~~~~~~~  230 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLN---H---VIK-DQQVKLF  230 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHH---H---HHh-hcccccC
Confidence            223467889999998753       245789999999999999997 567886543322111   1   111 1112233


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                      ++.+..   .....+.+++..|| .+|++||++.+|++.|.
T Consensus       231 ~~~~~~---~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         231 KPQLEL---PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCccCC---CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            333322   13345667888899 67999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=9.6e-40  Score=312.47  Aligned_cols=257  Identities=25%  Similarity=0.371  Sum_probs=200.7

Q ss_pred             HHHHHHhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcC-CCCcceeeeeeecc---
Q 013745           79 RTLQVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAE---  153 (437)
Q Consensus        79 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---  153 (437)
                      .++....+.|++.+.||.|+||.||+|.. .+++.+|+|++..... ....+..|+.++.++ +|+||+++++++..   
T Consensus         9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~   87 (282)
T cd06636           9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP   87 (282)
T ss_pred             hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence            34444567899999999999999999985 4688999999865433 345688899999998 69999999999853   


Q ss_pred             ---CCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceee
Q 013745          154 ---GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKIS  230 (437)
Q Consensus       154 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~  230 (437)
                         ....+++|||+++|+|.+++... ....+++..++.++.||+.||.|||+.+   |+|+||||+||++++++.++|+
T Consensus        88 ~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~  163 (282)
T cd06636          88 PGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLV  163 (282)
T ss_pred             cCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEe
Confidence               45789999999999999988543 2345888889999999999999999998   9999999999999999999999


Q ss_pred             ecccccccCCCCcccceeeeecccccCChhhhc-----cCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhh
Q 013745          231 DFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL-----HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYT  305 (437)
Q Consensus       231 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~  305 (437)
                      |||++.........  .....|+..|+|||.+.     ...++.++|||||||++|||++|..||...........+.  
T Consensus       164 dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~--  239 (282)
T cd06636         164 DFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP--  239 (282)
T ss_pred             eCcchhhhhccccC--CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh--
Confidence            99998865432211  12356899999999876     3468889999999999999999999997543222111000  


Q ss_pred             hhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          306 WTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       306 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                                ....+.+  .....+..+.+++.+||+.+|.+||++.||++
T Consensus       240 ----------~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         240 ----------RNPPPKL--KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             ----------hCCCCCC--cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                      0000111  11123456889999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.9e-39  Score=307.69  Aligned_cols=253  Identities=22%  Similarity=0.370  Sum_probs=201.7

Q ss_pred             CccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC------hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS------RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      +|+..+.||+|+||.||+|.. .+++.||+|++....      ......+.+|+.++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999984 578999999986432      2234678999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCC-Cceeeeccccccc
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL-NPKISDFGLARLF  238 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~-~~kl~DFGla~~~  238 (437)
                      ||||+++++|.+++..   ...+++..++.++.|++.||.|||+++   ++|+||||+||+++.++ .+||+|||++...
T Consensus        81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            9999999999998843   346889999999999999999999998   99999999999998776 5999999999876


Q ss_pred             CCCCccc--ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccc
Q 013745          239 PGEDTHV--NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE  316 (437)
Q Consensus       239 ~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (437)
                      .......  ......|+..|+|||++.+..++.++|||||||++|+|++|..||...........   .......     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~-----  226 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---IFKIASA-----  226 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH---HHHHhcc-----
Confidence            5432111  11234678999999999888899999999999999999999999964332211111   1111000     


Q ss_pred             ccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          317 LVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       317 ~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .   .....+......+.+++.+|++.+|.+||++.++++
T Consensus       227 ~---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         227 T---TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             C---CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            0   011223345567889999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.7e-40  Score=315.69  Aligned_cols=263  Identities=24%  Similarity=0.376  Sum_probs=200.9

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      ++|++.+.||+|+||.||+|..+ +++.||+|++....  ....+.+.+|+++++.++||||+++++++..+...++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46889999999999999999965 68999999886432  2234568899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |+++++|..+...   ...+++..++.++.||+.||+|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            9999999877632   235899999999999999999999988   9999999999999999999999999998764432


Q ss_pred             cccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhh--------hhhcccc
Q 013745          243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTW--------TLFQGEK  313 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~  313 (437)
                      ..  .....++..|+|||++.+. .++.++|||||||++|||++|++||......+....+....        ..+....
T Consensus       155 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07846         155 EV--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP  232 (286)
T ss_pred             cc--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence            21  1134578999999998764 57889999999999999999999997654322111111100        0000000


Q ss_pred             cc-cccCccc------cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          314 AL-ELVDPSL------AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       314 ~~-~~~d~~l------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .. ....+..      ....+..+..+.+++.+||+.+|++||++.+|++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            00 0000000      0111234566889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.3e-39  Score=306.57  Aligned_cols=247  Identities=27%  Similarity=0.404  Sum_probs=200.7

Q ss_pred             CccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC-----hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS-----RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      +|+..+.||+|+||.||+|... +++.|++|.+....     ....+.+.+|+.++++++|+||+++++++......++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4777899999999999999965 78999999886543     23456789999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||+++++|.+++..   ...+++..+..++.|++.||+|||+.+   |+|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999998843   245889999999999999999999988   99999999999999999999999999987643


Q ss_pred             CCcccceeeeecccccCChhhhccCc-CCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGY-LSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                      ..   ......|+..|++||.+.... ++.++|+|||||++|+|++|+.||.........      +......       
T Consensus       155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~------~~~~~~~-------  218 (258)
T cd06632         155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV------FKIGRSK-------  218 (258)
T ss_pred             cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH------HHHHhcc-------
Confidence            33   112346889999999988776 899999999999999999999999754321111      1110000       


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                       .....+......+.+++.+||+.+|++||++.+++.
T Consensus       219 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         219 -ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             -cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence             011112233456788999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.1e-39  Score=316.05  Aligned_cols=259  Identities=21%  Similarity=0.277  Sum_probs=204.4

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ++|++.+.||+|+||.||++... .++.||+|.+....   ......+.+|+.+++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46899999999999999999854 67899999987543   233457889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      ||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            99999999999843   246899999999999999999999988   999999999999999999999999998742111


Q ss_pred             Cc-------------ccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhh
Q 013745          242 DT-------------HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTL  308 (437)
Q Consensus       242 ~~-------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~  308 (437)
                      ..             ........|+..|+|||++.+..++.++|+|||||++|||++|..||.+....+...      ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~------~~  228 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG------QV  228 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HH
Confidence            00             000112357889999999988889999999999999999999999997654322111      00


Q ss_pred             hcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCCCC
Q 013745          309 FQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSF  363 (437)
Q Consensus       309 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~  363 (437)
                      ...    ....+.   .....+..+.+++.+||+.+|++||++.++.+.|+...+
T Consensus       229 ~~~----~~~~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~  276 (305)
T cd05609         229 ISD----DIEWPE---GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF  276 (305)
T ss_pred             Hhc----ccCCCC---ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccc
Confidence            000    000111   111234567899999999999999998888888886543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-41  Score=327.28  Aligned_cols=257  Identities=26%  Similarity=0.421  Sum_probs=215.6

Q ss_pred             HHHhcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           82 QVATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        82 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      +....+.....+||-|-||.||.|+|+ -.-.||||.++.+ .-..++|+.|..+|+.++|||+|+|+|+|..+..+|||
T Consensus       263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIi  341 (1157)
T KOG4278|consen  263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYII  341 (1157)
T ss_pred             hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEE
Confidence            333344556789999999999999976 4678999999754 44568999999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      +|||..|+|.++|.+- ....++....+.++.||..|++||..++   +|||||...|+|+.++..|||+||||++++..
T Consensus       342 TEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtg  417 (1157)
T KOG4278|consen  342 TEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTG  417 (1157)
T ss_pred             EecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence            9999999999999543 3456788888999999999999999998   99999999999999999999999999998754


Q ss_pred             CCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                      + +........-.+-|.|||-+....++.|+|||+|||+|||+.| |..||.+..-.+...+++..+.+           
T Consensus       418 D-TYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM-----------  485 (1157)
T KOG4278|consen  418 D-TYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRM-----------  485 (1157)
T ss_pred             C-ceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccc-----------
Confidence            3 3333323344678999999999999999999999999999998 88999887655555555444333           


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                          +.+..++..+++|++.||+.+|.+||++.|+.+.++
T Consensus       486 ----~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE  521 (1157)
T KOG4278|consen  486 ----DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE  521 (1157)
T ss_pred             ----cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence                123356677899999999999999999999998876

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.2e-39  Score=307.67  Aligned_cols=253  Identities=24%  Similarity=0.375  Sum_probs=200.9

Q ss_pred             CccccceeccCCCeeEEEEEcCC--CcEEEEEEeccC----------ChHHHHHHHHHHHHHHc-CCCCcceeeeeeecc
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMPN--GQEIAVKKLSVD----------SRQGLREFTNEVKLLLK-IQHKNLVTLFGCCAE  153 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  153 (437)
                      +|++.+.||+|+||.||+|....  ++.+|+|.+...          .......+.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47889999999999999999653  688999987532          22334567789998875 789999999999999


Q ss_pred             CCceEEEEeecCCCCcchhhhc-cCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceEeeccCCCCEEecCCCCceeee
Q 013745          154 GPEKMLVYEYLPNKSLDYFIFD-KTKSSSLDWTTRYRIVMGVARGLLYLHE-EAPARIIHRDIKASNILLDEQLNPKISD  231 (437)
Q Consensus       154 ~~~~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiHrDikp~NIll~~~~~~kl~D  231 (437)
                      ++..++||||+++++|.+++.. ......+++..++.++.|++.||.|||+ .+   ++|+||||+||+++.++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence            9999999999999999888743 2234568999999999999999999996 55   99999999999999999999999


Q ss_pred             cccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcc
Q 013745          232 FGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQG  311 (437)
Q Consensus       232 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  311 (437)
                      ||++.......   ......|+..|+|||++.+..++.++||||||+++|||++|+.||..........      .... 
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~------~~~~-  227 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT------KIVE-  227 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHH------HHhh-
Confidence            99998765433   2224568899999999998889999999999999999999999996533221111      1100 


Q ss_pred             cccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          312 EKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       312 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                      ..    ..+...   ......+.+++.+||+.+|++||++.||.++++
T Consensus       228 ~~----~~~~~~---~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         228 AV----YEPLPE---GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             cc----CCcCCc---ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            00    001000   123356788999999999999999999999886

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=7.5e-40  Score=316.15  Aligned_cols=247  Identities=24%  Similarity=0.338  Sum_probs=199.6

Q ss_pred             ccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCC
Q 013745           88 FSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN  166 (437)
Q Consensus        88 y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  166 (437)
                      |+....||+|+||.||+|.. .+++.||+|++........+.+.+|+.++..++||||+++++++..++..++||||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            44566899999999999985 47899999998755444456788999999999999999999999999999999999999


Q ss_pred             CCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccc
Q 013745          167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN  246 (437)
Q Consensus       167 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  246 (437)
                      ++|..++.    ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++..+......  
T Consensus       103 ~~L~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~--  173 (297)
T cd06659         103 GALTDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--  173 (297)
T ss_pred             CCHHHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccccc--
Confidence            99988762    245889999999999999999999998   999999999999999999999999999765433221  


Q ss_pred             eeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCC
Q 013745          247 TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCN  326 (437)
Q Consensus       247 ~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  326 (437)
                      .....|+..|+|||++.+..++.++|||||||++|||++|+.||......+....+.       ...     .+. ....
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~-------~~~-----~~~-~~~~  240 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR-------DSP-----PPK-LKNA  240 (297)
T ss_pred             ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-------ccC-----CCC-cccc
Confidence            123568999999999998899999999999999999999999997544322211110       000     000 0011


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          327 RDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       327 ~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ......+.+++.+||+.+|++||++.+|++
T Consensus       241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         241 HKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             CCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            123345778999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.9e-39  Score=305.04  Aligned_cols=251  Identities=22%  Similarity=0.343  Sum_probs=202.6

Q ss_pred             CccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeecc--CCceEEEE
Q 013745           87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE--GPEKMLVY  161 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  161 (437)
                      +|++.+.||.|+||.||+|.. .+++.||+|++...  .....+.+.+|+.++++++||||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            488899999999999999984 47889999998643  34445678899999999999999999998754  45678999


Q ss_pred             eecCCCCcchhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhh-----hcCCCceEeeccCCCCEEecCCCCceeeecccc
Q 013745          162 EYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLH-----EEAPARIIHRDIKASNILLDEQLNPKISDFGLA  235 (437)
Q Consensus       162 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH-----~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  235 (437)
                      ||+++++|.+++... .....+++..++.++.||+.||.|||     +.+   ++|+||||+||+++.++.+||+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999999988543 23467899999999999999999999     655   999999999999999999999999999


Q ss_pred             cccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccc
Q 013745          236 RLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKAL  315 (437)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (437)
                      ..........  ....++..|+|||++.+..++.++||||||+++|+|++|+.||.......   +....    ..    
T Consensus       158 ~~~~~~~~~~--~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~----~~----  224 (265)
T cd08217         158 KILGHDSSFA--KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LASKI----KE----  224 (265)
T ss_pred             ccccCCcccc--cccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHHHH----hc----
Confidence            8775443211  13468999999999998889999999999999999999999998654221   11111    00    


Q ss_pred             cccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013745          316 ELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLM  357 (437)
Q Consensus       316 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  357 (437)
                          ..........+..+.+++.+|++.+|++||++.+|++.
T Consensus       225 ----~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         225 ----GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ----CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                01112223445678899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.6e-39  Score=306.92  Aligned_cols=250  Identities=24%  Similarity=0.369  Sum_probs=194.3

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC-----ChHHHHHHHHHHHHHHcCCCCcceeeeeeecc--CCce
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD-----SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE--GPEK  157 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  157 (437)
                      .+|++.+.||+|+||.||+|.. .++..||+|++...     .......+.+|+.++++++||||+++++++.+  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4688999999999999999985 46899999988643     12334568899999999999999999998865  3567


Q ss_pred             EEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                      +++|||+++++|.+++..   ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            899999999999988843   245889999999999999999999987   99999999999999999999999999986


Q ss_pred             cCCCCc-ccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccc
Q 013745          238 FPGEDT-HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE  316 (437)
Q Consensus       238 ~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (437)
                      ...... ........++..|+|||++.+..++.++|||||||++|||++|+.||..........      ....     .
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~------~~~~-----~  224 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF------KIAT-----Q  224 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH------HHhc-----C
Confidence            532211 111112457899999999998889999999999999999999999997543221110      0000     0


Q ss_pred             ccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          317 LVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       317 ~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ...+.   .+......+..++ .||..+|++||+++||++
T Consensus       225 ~~~~~---~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         225 PTNPQ---LPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CCCCC---CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            00111   1222334455555 688899999999999964

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1e-39  Score=312.73  Aligned_cols=264  Identities=23%  Similarity=0.350  Sum_probs=203.5

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      ++|++.+.||+|+||.||+|..+ +++.||||++...  .......+.+|++++++++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36899999999999999999854 6889999988643  23334678899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |++++.+..++.   ....+++..++.++.||+.||.|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            999877766552   2345899999999999999999999998   9999999999999999999999999998775443


Q ss_pred             cccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhh--------hhhcccc
Q 013745          243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTW--------TLFQGEK  313 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~~  313 (437)
                      .... ....++..|+|||++.+. .++.++||||||+++|+|++|+.||.+....+.........        ..+....
T Consensus       155 ~~~~-~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07833         155 ASPL-TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP  233 (288)
T ss_pred             cccc-cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence            2111 234678999999999888 88999999999999999999999997654332211111100        0000000


Q ss_pred             cc---cccCccc-----cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          314 AL---ELVDPSL-----AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       314 ~~---~~~d~~l-----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ..   +..+...     .......+.++.+++.+||+.+|++||++++|++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            00   0000000     0112223677899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.2e-39  Score=311.87  Aligned_cols=263  Identities=24%  Similarity=0.338  Sum_probs=202.3

Q ss_pred             CccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      +|++.+.||+|+||.||+|.. .+|+.||+|++....  ......+.+|+.++++++||||+++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            488899999999999999985 478999999987543  33356788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      + +++|.+++...  ...+++..++.++.||+.||+|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 99999887433  256899999999999999999999988   99999999999999999999999999987754332


Q ss_pred             ccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhh--------hhhhhccc-c
Q 013745          244 HVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSY--------TWTLFQGE-K  313 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~~-~  313 (437)
                      . ......|+..|+|||++.+. .++.++|||||||++|||++|.+||.+.........+..        .|..+... .
T Consensus       155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         155 R-LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             C-ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence            1 11234688999999988654 568999999999999999999888876543322111100        01000000 0


Q ss_pred             cccccCc-----cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          314 ALELVDP-----SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       314 ~~~~~d~-----~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ......+     .+....+.....+.+++.+|++.+|++||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            0000000     001111233467889999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=4.1e-39  Score=304.32  Aligned_cols=252  Identities=25%  Similarity=0.323  Sum_probs=207.8

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      ++|++.+.||+|++|.||+|+.. +++.||||++..... .....+.+|+.++.+++|+||+++++++......++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36889999999999999999865 599999999976543 4457799999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE-EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      +++++|.+++...   ..+++..++.++.|+++||.|||+ .+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            9999999998433   568999999999999999999999 88   9999999999999999999999999998765433


Q ss_pred             cccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccc
Q 013745          243 THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL  322 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  322 (437)
                      ...  ....++..|+|||.+....++.++||||||+++|+|++|+.||...........+.+...            ...
T Consensus       155 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~------------~~~  220 (264)
T cd06623         155 DQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD------------GPP  220 (264)
T ss_pred             Ccc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc------------CCC
Confidence            222  134678999999999999999999999999999999999999976543122222211110            011


Q ss_pred             cCCCHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013745          323 AKCNRD-EAAMCIQLGLLCCQQSVAERPDMNSVHLM  357 (437)
Q Consensus       323 ~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  357 (437)
                      ...... .+..+.+++.+||+.+|++||++.++++.
T Consensus       221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            111222 45678899999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.7e-39  Score=307.62  Aligned_cols=254  Identities=24%  Similarity=0.379  Sum_probs=199.0

Q ss_pred             CccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCCh----------HHHHHHHHHHHHHHcCCCCcceeeeeeeccCC
Q 013745           87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSR----------QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP  155 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  155 (437)
                      +|.+.+.||+|+||.||+|.. .+|+.||+|.+.....          ...+.+.+|+.++++++||||+++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            477789999999999999984 4689999998853211          12346788999999999999999999999999


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccc
Q 013745          156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA  235 (437)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  235 (437)
                      ..++||||+++++|.+++...   ..+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999988432   56899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCcccceeeeecccccCChhhhccCc--CCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccc
Q 013745          236 RLFPGEDTHVNTFRISGTHGYMAPEYALHGY--LSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEK  313 (437)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (437)
                      +...............|+..|+|||++....  ++.++||||||+++|||++|..||........      .........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~~  229 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA------MFKLGNKRS  229 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH------HHHhhcccc
Confidence            8654322222222346889999999987754  89999999999999999999999964322211      111111110


Q ss_pred             cccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          314 ALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       314 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .. .++.   ......+..+.+++.+||+.+|++||++.+|++
T Consensus       230 ~~-~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         230 AP-PIPP---DVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             CC-cCCc---cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            00 1111   111234567888999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-39  Score=312.64  Aligned_cols=253  Identities=23%  Similarity=0.295  Sum_probs=202.8

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCCh---HHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR---QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ++|++.+.||+|+||.||+|... +++.||+|.+.....   .....+.+|+++++.++||||+++++.+......++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36889999999999999999854 589999999975432   24567889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      ||+.+++|.+++... ....+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            999999999987432 3457899999999999999999999988   999999999999999999999999998765322


Q ss_pred             Cccc---------------------------ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCC
Q 013745          242 DTHV---------------------------NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRL  294 (437)
Q Consensus       242 ~~~~---------------------------~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~  294 (437)
                      ....                           ......|+..|+|||++.+..++.++|||||||++|+|++|+.||.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            1110                           0112357889999999998889999999999999999999999997654


Q ss_pred             chhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCC----HHHHHH
Q 013745          295 GKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPD----MNSVHL  356 (437)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs----~~ev~~  356 (437)
                      .......      .....       ..... ....+..+.+++.+||+.+|++||+    +.+++.
T Consensus       237 ~~~~~~~------~~~~~-------~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         237 RDETFSN------ILKKE-------VTFPG-SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             hHHHHHH------HhcCC-------ccCCC-ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            4322110      00000       00111 1124567889999999999999999    666665

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3.1e-39  Score=310.47  Aligned_cols=260  Identities=24%  Similarity=0.298  Sum_probs=201.2

Q ss_pred             HHHHHHHhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccC-
Q 013745           78 LRTLQVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEG-  154 (437)
Q Consensus        78 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-  154 (437)
                      ...+....++|.+.+.||+|+||.||+|.. .+++.+|+|++..... ....+.+|+.+++++ +|||++++++++... 
T Consensus        14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~   92 (291)
T cd06639          14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD   92 (291)
T ss_pred             cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence            344445578899999999999999999985 4788999999865432 235677899999999 799999999998643 


Q ss_pred             ----CceEEEEeecCCCCcchhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCcee
Q 013745          155 ----PEKMLVYEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKI  229 (437)
Q Consensus       155 ----~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl  229 (437)
                          ...++||||+++++|.+++... .....+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||
T Consensus        93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl  169 (291)
T cd06639          93 KLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKL  169 (291)
T ss_pred             ccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEE
Confidence                3579999999999999887432 23456899999999999999999999988   999999999999999999999


Q ss_pred             eecccccccCCCCcccceeeeecccccCChhhhccC-----cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhh
Q 013745          230 SDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHG-----YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSY  304 (437)
Q Consensus       230 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~  304 (437)
                      +|||++..........  ....|+..|+|||++...     .++.++|||||||++|||++|+.||..........  . 
T Consensus       170 ~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~--~-  244 (291)
T cd06639         170 VDFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLF--K-  244 (291)
T ss_pred             eecccchhcccccccc--cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHH--H-
Confidence            9999998754322211  124578999999988654     36899999999999999999999997543321111  0 


Q ss_pred             hhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          305 TWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       305 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                         ... .......+      .......+.+++.+||+.+|++||++.++++
T Consensus       245 ---~~~-~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         245 ---IPR-NPPPTLLH------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             ---Hhc-CCCCCCCc------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence               100 00000111      1123346889999999999999999999975

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=4.4e-39  Score=302.90  Aligned_cols=248  Identities=23%  Similarity=0.398  Sum_probs=201.0

Q ss_pred             CccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      +|++.+.||+|+||.||++.. .+++.+|||.+...  .......+.+|++++++++||||+++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            588899999999999999985 47889999998654  233456789999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCC-CCceeeecccccccCCCC
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ-LNPKISDFGLARLFPGED  242 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~-~~~kl~DFGla~~~~~~~  242 (437)
                      +++++|.+++.... ...+++..+..++.+++.+|.|||+++   ++|+||||+||+++.+ +.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            99999999985432 345899999999999999999999988   9999999999999855 457999999998765432


Q ss_pred             cccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccc
Q 013745          243 THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL  322 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  322 (437)
                      ..   ....|+..|+|||.+.+..++.++||||||+++|+|++|+.||.........   ..   ....         ..
T Consensus       157 ~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~---~~---~~~~---------~~  218 (256)
T cd08220         157 KA---YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALV---LK---IMSG---------TF  218 (256)
T ss_pred             cc---cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHH---HH---HHhc---------CC
Confidence            21   1346789999999999888999999999999999999999999764432211   11   0000         00


Q ss_pred             cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          323 AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       323 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ..........+.+++.+||+.+|++||++.++++
T Consensus       219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            1111123456789999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.9e-39  Score=304.75  Aligned_cols=250  Identities=23%  Similarity=0.341  Sum_probs=196.5

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC-----ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccC--Cce
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD-----SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG--PEK  157 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  157 (437)
                      .+|++.+.||+|+||.||+|.. .++..||||++...     .......+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4688999999999999999985 46899999988532     123356788999999999999999999998764  457


Q ss_pred             EEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                      ++||||+++++|.+++...   ..+++..++.++.|++.||+|||+++   ++|+||||+||+++.++.+||+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            8999999999999887432   45788889999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCcc-cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccc
Q 013745          238 FPGEDTH-VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE  316 (437)
Q Consensus       238 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (437)
                      ....... .......|+..|+|||++.+..++.++|||||||++|||++|+.||..........      ....      
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~------~~~~------  223 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF------KIAT------  223 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH------HHhc------
Confidence            5322111 11223458899999999988889999999999999999999999997542221110      0000      


Q ss_pred             ccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          317 LVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       317 ~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                        .+.....+......+.+++.+|+. +|++||++++|++
T Consensus       224 --~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         224 --QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             --CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence              001112233455567788888884 9999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-39  Score=315.01  Aligned_cols=266  Identities=24%  Similarity=0.302  Sum_probs=196.6

Q ss_pred             CccccceeccCCCeeEEEEEcC---CCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccC--CceE
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMP---NGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG--PEKM  158 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  158 (437)
                      +|++.+.||+|+||.||+|...   +++.||+|++....   ......+.+|+.++.+++||||+++++++.+.  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4888999999999999999854   47899999997632   33345678899999999999999999999888  7899


Q ss_pred             EEEeecCCCCcchhhhcc-C-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC----CCCceeeec
Q 013745          159 LVYEYLPNKSLDYFIFDK-T-KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE----QLNPKISDF  232 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~-~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~----~~~~kl~DF  232 (437)
                      +||||+++ +|..++... . ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 555554322 2 2236899999999999999999999998   999999999999999    999999999


Q ss_pred             ccccccCCCCc-ccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhh------hhhh
Q 013745          233 GLARLFPGEDT-HVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKAD------LLSY  304 (437)
Q Consensus       233 Gla~~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~------~~~~  304 (437)
                      |++........ ........++..|+|||++.+. .++.++|||||||++|+|++|+.||.+........      .+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99987643322 1112234678999999988764 58999999999999999999999997654332000      0000


Q ss_pred             hhhhhcc------------ccccc--------ccC-ccccC-CC--HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          305 TWTLFQG------------EKALE--------LVD-PSLAK-CN--RDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       305 ~~~~~~~------------~~~~~--------~~d-~~l~~-~~--~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .......            .....        ... ..+.. ..  ......+.+++.+|++.+|++|||+.|+++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0000000            00000        000 00000 00  023456889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=5.4e-39  Score=306.69  Aligned_cols=246  Identities=24%  Similarity=0.403  Sum_probs=201.0

Q ss_pred             CccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      -|++.+.||.|+||.||+|.. .+++.||||++.... ......+.+|+.++.+++||||+++++++..+...++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            378889999999999999985 478899999986442 344567889999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      ++++|..++.    ...+++..+..++.|++.+|.|||+.+   ++|+||||+||+++.++.++|+|||++..+......
T Consensus        85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~  157 (277)
T cd06641          85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK  157 (277)
T ss_pred             CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchhh
Confidence            9999998873    246889999999999999999999988   999999999999999999999999999876433211


Q ss_pred             cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccC
Q 013745          245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK  324 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  324 (437)
                        .....++..|+|||++.+..++.++|||||||++|+|++|..||...........      ....         ....
T Consensus       158 --~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~------~~~~---------~~~~  220 (277)
T cd06641         158 --RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL------IPKN---------NPPT  220 (277)
T ss_pred             --hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH------HhcC---------CCCC
Confidence              1134578899999999888899999999999999999999999975432211111      1000         0011


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          325 CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       325 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .....+..+.+++.+||+.+|.+||++.++++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             CCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            12234456788999999999999999999987

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.9e-39  Score=307.09  Aligned_cols=252  Identities=25%  Similarity=0.376  Sum_probs=202.8

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      ++|++.+.||.|+||.||+|... +++.||+|++.... ......+.+|++++++++||||+++++.+......++|+||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            36888999999999999999864 68999999987653 34456788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE-EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      +++++|.+++....  ..+++..+..++.|++.||+|||+ .+   ++|+||||+||+++.++.+||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            99999999884332  578899999999999999999999 77   9999999999999999999999999987653222


Q ss_pred             cccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccc
Q 013745          243 THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL  322 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  322 (437)
                      ..    ...++..|+|||++.+..++.++|||||||++|+|++|+.||....... .............         ..
T Consensus       156 ~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~---------~~  221 (265)
T cd06605         156 AK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNE---------PP  221 (265)
T ss_pred             hh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcC---------CC
Confidence            11    2567899999999999999999999999999999999999997542211 1111111111110         00


Q ss_pred             cCCCHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          323 AKCNRD-EAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       323 ~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ...... ....+.+++..||..+|++||++.+++.
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            111111 4556889999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.4e-39  Score=310.24  Aligned_cols=243  Identities=27%  Similarity=0.355  Sum_probs=199.4

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ++|++.+.||+|+||.||++... +++.||+|++....   ......+.+|++++++++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46899999999999999999854 68999999986432   234567889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      ||+++++|.+++...   ..+++..+..++.|++.||.|||+.+   |+|+||+|.|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            999999999988432   56899999999999999999999988   999999999999999999999999999876443


Q ss_pred             CcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                           .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...........      ... +.      ..
T Consensus       155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------~~~-~~------~~  216 (290)
T cd05580         155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEK------ILE-GK------VR  216 (290)
T ss_pred             -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------Hhc-CC------cc
Confidence                 2234689999999999888899999999999999999999999975442211110      000 00      01


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHH
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAERP-----DMNSVH  355 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~  355 (437)
                      +   +......+.+++.+||+.+|.+||     ++++++
T Consensus       217 ~---~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         217 F---PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             C---CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence            1   112345678899999999999999     666665

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.7e-39  Score=310.96  Aligned_cols=262  Identities=19%  Similarity=0.281  Sum_probs=195.1

Q ss_pred             CccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      +|++.+.||+|+||.||+|+.. +|+.||+|++....  ......+.+|++++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4888999999999999999854 78999999986432  22234577899999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +++ +|..++..  ....+++..++.++.||++||.|||+++   |+||||||+||+++.++.+||+|||+++.+.....
T Consensus        81 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          81 CDQ-DLKKYFDS--CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             CCC-CHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            964 67666532  2356899999999999999999999998   99999999999999999999999999986643221


Q ss_pred             ccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCch-hhhhhhh--------hhhhhhcc--
Q 013745          244 HVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGK-EKADLLS--------YTWTLFQG--  311 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~-~~~~~~~--------~~~~~~~~--  311 (437)
                      .  .....++..|+|||++.+. .++.++|||||||++|||++|..|+...... +....+.        ..|.....  
T Consensus       155 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07839         155 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP  232 (284)
T ss_pred             C--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence            1  1123568899999998775 4799999999999999999999886432221 1111000        00000000  


Q ss_pred             -cccccccCccc--cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          312 -EKALELVDPSL--AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       312 -~~~~~~~d~~l--~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                       ...........  ....+.....+.+++.+||+.+|.+|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence             00000000000  0111223456788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=4.5e-39  Score=310.07  Aligned_cols=250  Identities=25%  Similarity=0.390  Sum_probs=203.2

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      ++|.+.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            5799999999999999999984 468899999987554445577889999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      ++++|.+++..    ..+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.+||+|||++.........
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~  171 (293)
T cd06647          99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  171 (293)
T ss_pred             CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence            99999998832    35788999999999999999999998   999999999999999999999999998766433222


Q ss_pred             cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccC
Q 013745          245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK  324 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  324 (437)
                      .  ....|++.|+|||.+....++.++|||||||++|+|++|+.||...........+   .   ....      +.. .
T Consensus       172 ~--~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~---~---~~~~------~~~-~  236 (293)
T cd06647         172 R--STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---A---TNGT------PEL-Q  236 (293)
T ss_pred             c--ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh---h---cCCC------CCC-C
Confidence            1  1245888999999998888999999999999999999999999754332211100   0   0000      000 1


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013745          325 CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLM  357 (437)
Q Consensus       325 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  357 (437)
                      ........+.+++.+||+.+|++||++.+++..
T Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            122344567889999999999999999999853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-39  Score=316.62  Aligned_cols=254  Identities=23%  Similarity=0.330  Sum_probs=201.7

Q ss_pred             HhcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCC-CCcceeeeeeeccCCceEEE
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  160 (437)
                      ....|+++++||+||.+.||++...+.+.||+|++...  +......|.+|+..|.+|+ |.+||+|++|-..++.+|||
T Consensus       359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv  438 (677)
T KOG0596|consen  359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV  438 (677)
T ss_pred             CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence            34569999999999999999999878889999987533  5566788999999999996 99999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||- .-+|..+|..+.. ....| .+..+..|++.|+.++|..+   |||.||||.|+|+- .|.+||+|||+|..+..
T Consensus       439 mE~G-d~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~  511 (677)
T KOG0596|consen  439 MECG-DIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQP  511 (677)
T ss_pred             eecc-cccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence            9975 6689888854432 22334 67789999999999999998   99999999999986 56899999999999988


Q ss_pred             CCcccceeeeecccccCChhhhccC-----------cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhh
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHG-----------YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLF  309 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~-----------~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~  309 (437)
                      +.+.......+||+.||+||.+...           +.+.++||||||||||+|+.|++||....+     .+.....+.
T Consensus       512 DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----~~aKl~aI~  586 (677)
T KOG0596|consen  512 DTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----QIAKLHAIT  586 (677)
T ss_pred             cccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----HHHHHHhhc
Confidence            8777777778999999999988532           367899999999999999999999964211     111111111


Q ss_pred             cccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          310 QGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       310 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ..+.  +.-.|.+...     .++++++..||+.||++||+..|+++
T Consensus       587 ~P~~--~Iefp~~~~~-----~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  587 DPNH--EIEFPDIPEN-----DELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             CCCc--cccccCCCCc-----hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            1111  1111122111     22899999999999999999999976

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=4.1e-39  Score=308.16  Aligned_cols=264  Identities=24%  Similarity=0.359  Sum_probs=201.4

Q ss_pred             CccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      +|++++.||.|++|.||+|+.. +|+.||||++..... .....+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5889999999999999999964 688999999875432 22456778999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      ++ +|.+++........+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++.........
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~  156 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT  156 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc
Confidence            75 78777755444457899999999999999999999988   999999999999999999999999999865432211


Q ss_pred             cceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhh--------hhhhcc-ccc
Q 013745          245 VNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYT--------WTLFQG-EKA  314 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~-~~~  314 (437)
                        .....++..|++||++.+. .++.++|||||||++|+|++|+.||.+....+....+...        +..... ...
T Consensus       157 --~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         157 --FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             --cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence              1123568899999988764 5789999999999999999999999876543322211110        000000 000


Q ss_pred             cc----ccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          315 LE----LVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       315 ~~----~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ..    ..+.......+..+..+.+++.+|++.+|.+||++.+|++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00    0000011111233566789999999999999999999874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=313.79  Aligned_cols=252  Identities=20%  Similarity=0.304  Sum_probs=212.3

Q ss_pred             hcCccccceeccCCCeeEEEEE-cCCCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      .+-|...+.||+|.|++|-+|+ .-+|..||||++.+..  ......+++|++-|+.++|||||+||.+......+|||+
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL   96 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL   96 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence            4457788999999999999997 3389999999997653  334567899999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEe-cCCCCceeeecccccccCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL-DEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll-~~~~~~kl~DFGla~~~~~  240 (437)
                      |+-.+|+|.++|....  ..+.+..+.+++.||+.|+.|+|...   +|||||||+||.+ .+-|-|||.|||++..+..
T Consensus        97 ELGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P  171 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP  171 (864)
T ss_pred             EecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence            9999999999996543  46899999999999999999999987   9999999999876 6778999999999988754


Q ss_pred             CCcccceeeeecccccCChhhhccCcCC-cccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGYLS-VKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                      ....   ...||+..|-|||++.+..|+ +++||||||||||.|++|++||....+.+...++.-               
T Consensus       172 G~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImD---------------  233 (864)
T KOG4717|consen  172 GKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMD---------------  233 (864)
T ss_pred             cchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhc---------------
Confidence            4332   246899999999999998665 679999999999999999999987665554433221               


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                       .....+.....++.+|+..|+..||++|.+.+||+.  ||+.
T Consensus       234 -CKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~  275 (864)
T KOG4717|consen  234 -CKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQA  275 (864)
T ss_pred             -ccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccC
Confidence             112345577888999999999999999999999974  6664

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-38  Score=306.04  Aligned_cols=258  Identities=25%  Similarity=0.319  Sum_probs=201.3

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccC--CceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG--PEKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  161 (437)
                      ++|+..+.||.|++|.||+|.. .+++.+|+|.+.... ......+.+|++++++++||||++++++|.+.  ...++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            4688999999999999999996 468899999987543 34456789999999999999999999988643  4689999


Q ss_pred             eecCCCCcchhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          162 EYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       162 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      ||+++++|.+++... .....+++..+..++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999998876432 23456888999999999999999999988   99999999999999999999999999876533


Q ss_pred             CCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCc--hhhhhhhhhhhhhhccccccccc
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLG--KEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      ...    ....++..|+|||.+.+..++.++|||||||++|+|++|+.||.....  .....+..+....    .... +
T Consensus       158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~-~  228 (287)
T cd06621         158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM----PNPE-L  228 (287)
T ss_pred             ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC----Cchh-h
Confidence            221    134578899999999998999999999999999999999999986532  1111111111110    0000 0


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .... .........+.+++.+||+.+|.+|||+.||++
T Consensus       229 ~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         229 KDEP-GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             ccCC-CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            0000 101123466889999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.2e-39  Score=309.05  Aligned_cols=263  Identities=23%  Similarity=0.329  Sum_probs=197.5

Q ss_pred             CccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      +|+.++.||.|+||.||+|+.. +++.||||++....  ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4888999999999999999854 78999999886442  22335688999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +. ++|..++... ....+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            95 5787776433 3456899999999999999999999988   99999999999999999999999999986643221


Q ss_pred             ccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhh-hhh-------hhhhhcc---
Q 013745          244 HVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADL-LSY-------TWTLFQG---  311 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~-~~~-------~~~~~~~---  311 (437)
                      .  .....++..|+|||++.+. .++.++|||||||++|||+||+.||.+......... +..       .|.....   
T Consensus       156 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07860         156 T--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPD  233 (284)
T ss_pred             c--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHH
Confidence            1  1123468899999988765 468899999999999999999999976543221110 000       0000000   


Q ss_pred             --cccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          312 --EKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       312 --~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                        ..........+....+.....+.+++.+||+.||.+||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         234 YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence              000000000011111123455778999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=7.1e-39  Score=356.06  Aligned_cols=259  Identities=24%  Similarity=0.463  Sum_probs=209.4

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      ...|...+.||+|+||.||+|+. .++..||||++......    ...|++++++++|||||+++++|.+....++||||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            35677888999999999999985 57899999998644322    12468899999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +++|+|.+++.      .++|..+.+++.|+++||+|||..+..+|+||||||+||+++.++.+++. ||.+....... 
T Consensus       765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~-  836 (968)
T PLN00113        765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDT-  836 (968)
T ss_pred             CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCC-
Confidence            99999999983      38899999999999999999996644569999999999999999888875 66654432211 


Q ss_pred             ccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcccc
Q 013745          244 HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA  323 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  323 (437)
                           ...||+.|+|||++.+..++.++|||||||++|||+||+.||...... ....+.|....+........+|+.+.
T Consensus       837 -----~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  910 (968)
T PLN00113        837 -----KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSDCHLDMWIDPSIR  910 (968)
T ss_pred             -----CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCccchhheeCcccc
Confidence                 235789999999999999999999999999999999999999643322 23345555554444444445565542


Q ss_pred             ---CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCC
Q 013745          324 ---KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD  361 (437)
Q Consensus       324 ---~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~  361 (437)
                         .....+..++.+++.+||+.+|++||+|.||++.|+..
T Consensus       911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~  951 (968)
T PLN00113        911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA  951 (968)
T ss_pred             CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHh
Confidence               23456677889999999999999999999999999854

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=7e-39  Score=307.46  Aligned_cols=247  Identities=24%  Similarity=0.352  Sum_probs=200.6

Q ss_pred             ccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCC
Q 013745           88 FSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN  166 (437)
Q Consensus        88 y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  166 (437)
                      |...+.||+|++|.||++.. .+++.+|+|++........+.+.+|+.+++.++||||+++++++...+..++|+||+++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~  100 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG  100 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence            55568999999999999984 47889999998765555556788999999999999999999999999999999999999


Q ss_pred             CCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccc
Q 013745          167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN  246 (437)
Q Consensus       167 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  246 (437)
                      ++|.+++..    ..+++..+..++.|++.||+|||+++   ++||||||+||+++.++.++|+|||++.........  
T Consensus       101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~--  171 (285)
T cd06648         101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR--  171 (285)
T ss_pred             CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcc--
Confidence            999998843    45889999999999999999999998   999999999999999999999999998765432221  


Q ss_pred             eeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCC
Q 013745          247 TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCN  326 (437)
Q Consensus       247 ~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  326 (437)
                      .....|+..|+|||.+.+..++.++|||||||++|||++|+.||...........+   .   . .     ..+.+ ...
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~---~---~-~-----~~~~~-~~~  238 (285)
T cd06648         172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI---R---D-N-----LPPKL-KNL  238 (285)
T ss_pred             cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH---H---h-c-----CCCCC-ccc
Confidence            12345899999999999888999999999999999999999999754332211110   0   0 0     00111 111


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          327 RDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       327 ~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ...+..+.+++.+||+.+|++||++.++++
T Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         239 HKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            123456889999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-39  Score=306.36  Aligned_cols=247  Identities=27%  Similarity=0.464  Sum_probs=199.9

Q ss_pred             CccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCC---CCcceeeeeeeccCCceEEEE
Q 013745           87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQ---HKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  161 (437)
                      .|++.+.||+|+||.||+|.. .+++.||+|.+... .......+.+|+.++++++   |||++++++++..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            478889999999999999985 57899999998654 3344567889999999997   999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      ||+++++|.+++..    ..+++..++.++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||++......
T Consensus        82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            99999999988732    36899999999999999999999998   999999999999999999999999999877544


Q ss_pred             CcccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                      ...  .....|+..|+|||.+.++ .++.++|||||||++|+|++|..||...........+       ..     ...+
T Consensus       155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~-------~~-----~~~~  220 (277)
T cd06917         155 SSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI-------PK-----SKPP  220 (277)
T ss_pred             ccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc-------cc-----CCCC
Confidence            322  2234688999999998764 5789999999999999999999999754322111100       00     0011


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .+..  ......+.+++.+||+.+|++||++.+++.
T Consensus       221 ~~~~--~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         221 RLED--NGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CCCc--ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            1111  013456889999999999999999999975

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-39  Score=309.19  Aligned_cols=261  Identities=25%  Similarity=0.356  Sum_probs=195.5

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      ++|++.+.||+|+||.||+|..+ +++.||||.+..... .....+.+|++++++++|+||+++++++.++...++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57999999999999999999854 689999999865422 1224567899999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +.+ +|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.......
T Consensus        85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            975 888877432  246889999999999999999999988   99999999999999999999999999875432211


Q ss_pred             ccceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcc---cc------
Q 013745          244 HVNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQG---EK------  313 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~------  313 (437)
                      .  .....++..|+|||++.+ ..++.++|||||||++|||++|+.||........  .+...+.....   ..      
T Consensus       159 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07844         159 T--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEETWPGVSS  234 (291)
T ss_pred             c--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhhhhhhhh
Confidence            1  112246788999999876 4689999999999999999999999975542111  11111110000   00      


Q ss_pred             ---cc----ccc-CccccCCCHH--HHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          314 ---AL----ELV-DPSLAKCNRD--EAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       314 ---~~----~~~-d~~l~~~~~~--~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                         ..    ... ...+......  ....+.+++.+|++.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence               00    000 0000000001  1256788999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-39  Score=305.36  Aligned_cols=254  Identities=26%  Similarity=0.362  Sum_probs=200.4

Q ss_pred             HhcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCC------
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGP------  155 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~------  155 (437)
                      .+++|++.+.||+|+||.||+|... +++.+++|++...... ...+.+|+.+++++ +|+||+++++++....      
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchh-HHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4578999999999999999999864 6789999998765443 46788999999999 6999999999996544      


Q ss_pred             ceEEEEeecCCCCcchhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccc
Q 013745          156 EKMLVYEYLPNKSLDYFIFDKT-KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL  234 (437)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl  234 (437)
                      ..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||+
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence            4899999999999998875422 2457899999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCcccceeeeecccccCChhhhcc-----CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhh
Q 013745          235 ARLFPGEDTHVNTFRISGTHGYMAPEYALH-----GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLF  309 (437)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~  309 (437)
                      +.........  .....|+..|+|||++..     ..++.++|||||||++|+|++|..||..........      ...
T Consensus       160 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~~~  231 (275)
T cd06608         160 SAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF------KIP  231 (275)
T ss_pred             ceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH------Hhh
Confidence            9765432221  123468899999998854     247889999999999999999999997433221110      000


Q ss_pred             cccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          310 QGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       310 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .      ...+.+ .........+.+++.+||..||++|||+.+|++
T Consensus       232 ~------~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         232 R------NPPPTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             c------cCCCCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            0      001111 111224557889999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-41  Score=303.72  Aligned_cols=247  Identities=25%  Similarity=0.379  Sum_probs=206.3

Q ss_pred             ccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCC
Q 013745           88 FSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN  166 (437)
Q Consensus        88 y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  166 (437)
                      |.++.+||+|+||.||+|.. ..|+.+|||++....  +.+++..|+.||++++.|++|++||.+.....+++|||||..
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            88899999999999999984 489999999987654  457889999999999999999999999999999999999999


Q ss_pred             CCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccc
Q 013745          167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN  246 (437)
Q Consensus       167 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  246 (437)
                      |++.+++  +.++.++.+.++..+++..+.||+|||...   -||||||..|||++.+|.+||+|||.|..+.+.-  ..
T Consensus       113 GSiSDI~--R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--AK  185 (502)
T KOG0574|consen  113 GSISDIM--RARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--AK  185 (502)
T ss_pred             CcHHHHH--HHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH--Hh
Confidence            9999998  455678999999999999999999999987   8999999999999999999999999998764322  22


Q ss_pred             eeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCC
Q 013745          247 TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCN  326 (437)
Q Consensus       247 ~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  326 (437)
                      ...+.||+.|||||++..-.|+.++||||||+...||..|++||....+.....++.            .. .|.--.-+
T Consensus       186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP------------T~-PPPTF~KP  252 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP------------TK-PPPTFKKP  252 (502)
T ss_pred             hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc------------CC-CCCCCCCh
Confidence            335789999999999999999999999999999999999999997543322111110            00 01111223


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          327 RDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       327 ~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ..-+.++-++++.|+-.+|++|-|+.++++
T Consensus       253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  253 EEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             HhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            344566889999999999999999988764

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.1e-38  Score=301.61  Aligned_cols=252  Identities=26%  Similarity=0.416  Sum_probs=201.6

Q ss_pred             CccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCCh--HHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSR--QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      +|.+.+.||+|+||.||+|.. .+++.||+|.+.....  ...+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            488899999999999999985 4789999999876533  3567899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            999999998843   245788999999999999999999988   99999999999999999999999999987654332


Q ss_pred             ccc--eeeeecccccCChhhhccCc---CCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          244 HVN--TFRISGTHGYMAPEYALHGY---LSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       244 ~~~--~~~~~gt~~Y~aPE~~~~~~---~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      ...  .....++..|+|||++.+..   ++.++||||||+++|||++|+.||.........     ......      ..
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~-----~~~~~~------~~  223 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI-----MFHVGA------GH  223 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH-----HHHHhc------CC
Confidence            211  11245788999999998766   899999999999999999999999754321111     000000      00


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .+.++. .......+.+++.+||+.+|.+||++.+++.
T Consensus       224 ~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         224 KPPIPD-SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCCCc-ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111111 1122455778999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-40  Score=300.77  Aligned_cols=268  Identities=23%  Similarity=0.268  Sum_probs=214.3

Q ss_pred             HHhcCccccceeccCCCeeEEEEE-cCCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceE
Q 013745           83 VATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM  158 (437)
Q Consensus        83 ~~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  158 (437)
                      +.-++|+.+++||+|.||+|-+++ ..+++.||+|++++.   .......-+.|-++|+..+||.+..+...|+..+.+|
T Consensus       165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC  244 (516)
T KOG0690|consen  165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC  244 (516)
T ss_pred             eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence            345789999999999999999998 447999999999865   3444566778999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccccc
Q 013745          159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                      +||||..||.|...|.   ....+++.....+-..|+.||.|||+++   ||+||||.+|+|+|.+|++||+||||++.-
T Consensus       245 FVMeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~  318 (516)
T KOG0690|consen  245 FVMEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE  318 (516)
T ss_pred             EEEEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc
Confidence            9999999999988873   3356888999999999999999999988   999999999999999999999999999853


Q ss_pred             CCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          239 PGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       239 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      -..  ...+..+||||.|+|||++....|+.++|+|.+|||+|||++|+.||..........++....            
T Consensus       319 I~~--g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed------------  384 (516)
T KOG0690|consen  319 IKY--GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMED------------  384 (516)
T ss_pred             ccc--cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhh------------
Confidence            222  223346899999999999999999999999999999999999999998766554444433211            


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH--HhcCCCC------CCCCCCCCCCC
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERP-----DMNSVHL--MLSGDSF------TLPKPGKPGIQ  374 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~--~L~~~~~------~~~~p~~p~~~  374 (437)
                          -.++.....+...|....+..||.+|.     .++||.+  ++.+...      .+++|-+|...
T Consensus       385 ----~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVt  449 (516)
T KOG0690|consen  385 ----LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVT  449 (516)
T ss_pred             ----ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcc
Confidence                122333444556677788999999995     4566643  3333221      45566666543

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=9.3e-39  Score=310.02  Aligned_cols=269  Identities=26%  Similarity=0.347  Sum_probs=199.5

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCCh--HHHHHHHHHHHHHHcCCCCcceeeeeeeccC--CceEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSR--QGLREFTNEVKLLLKIQHKNLVTLFGCCAEG--PEKML  159 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  159 (437)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++.....  .....+.+|+.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            35699999999999999999985 4689999999864421  1223466899999999999999999998755  46899


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      ||||+.+ +|.+++...  ...+++..++.++.||+.||.|||+.+   ++||||||+||+++.++.+||+|||++....
T Consensus        86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999964 777776432  356899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcccceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhh--------hhhhc
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYT--------WTLFQ  310 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~  310 (437)
                      ......  ....++..|+|||++.+ ..++.++|||||||++|||++|+.||......+....+...        |..+.
T Consensus       160 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         160 LPAKPM--TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             CccCCC--CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence            432111  12345788999999876 46899999999999999999999999876544332222111        00000


Q ss_pred             cccccccc--C-c---cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcCC
Q 013745          311 GEKALELV--D-P---SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSGD  361 (437)
Q Consensus       311 ~~~~~~~~--d-~---~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~~  361 (437)
                      ........  . .   .+..........+.+++.+|++.||++||++.++++  ++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~  296 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEK  296 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccC
Confidence            00000000  0 0   000001113556788999999999999999999985  44433

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=338.03  Aligned_cols=265  Identities=22%  Similarity=0.255  Sum_probs=210.4

Q ss_pred             cHHHHHHHhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEecc---CChHHHHHHHHHHHHHHcCCCCcceeeeeeec
Q 013745           77 DLRTLQVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSV---DSRQGLREFTNEVKLLLKIQHKNLVTLFGCCA  152 (437)
Q Consensus        77 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  152 (437)
                      ..++++...++|+++++||+|+||.|.+++. .+++.||+|++.+   ........|..|-.+|.--+.+-|++++..|.
T Consensus        66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ  145 (1317)
T KOG0612|consen   66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ  145 (1317)
T ss_pred             HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence            4566677788999999999999999999985 4788999999976   34445678999999999999999999999999


Q ss_pred             cCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeec
Q 013745          153 EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDF  232 (437)
Q Consensus       153 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DF  232 (437)
                      +..++|+||||++||+|-.++..   ...+++..++.++..|+.||.-||+.|   +|||||||+|||||..|++||+||
T Consensus       146 D~~~LYlVMdY~pGGDlltLlSk---~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADF  219 (1317)
T KOG0612|consen  146 DERYLYLVMDYMPGGDLLTLLSK---FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADF  219 (1317)
T ss_pred             CccceEEEEecccCchHHHHHhh---cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccc
Confidence            99999999999999999999843   337999999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCcccceeeeecccccCChhhhcc-----CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhh
Q 013745          233 GLARLFPGEDTHVNTFRISGTHGYMAPEYALH-----GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWT  307 (437)
Q Consensus       233 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~  307 (437)
                      |.+-.++....... ...+|||.|++||++..     +.|+..+|+||+||++|||+.|..||....-.+...      +
T Consensus       220 GsClkm~~dG~V~s-~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~------K  292 (1317)
T KOG0612|consen  220 GSCLKMDADGTVRS-SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYG------K  292 (1317)
T ss_pred             hhHHhcCCCCcEEe-ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHH------H
Confidence            99988865544333 35689999999999962     579999999999999999999999998654333322      2


Q ss_pred             hhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHH--HhcCC
Q 013745          308 LFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPD---MNSVHL--MLSGD  361 (437)
Q Consensus       308 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs---~~ev~~--~L~~~  361 (437)
                      +........+.+      ..+.+....+||...+ -+|+.|..   +.++..  ++.+.
T Consensus       293 Im~hk~~l~FP~------~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~  344 (1317)
T KOG0612|consen  293 IMNHKESLSFPD------ETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGI  344 (1317)
T ss_pred             HhchhhhcCCCc------ccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCC
Confidence            222222222221      1123344555555544 35666766   777754  45553

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-39  Score=317.59  Aligned_cols=265  Identities=25%  Similarity=0.350  Sum_probs=198.1

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccC-----Cce
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG-----PEK  157 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  157 (437)
                      +++|++.+.||+|+||.||+|+. .+|+.||||++... .......+.+|+.++++++||||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46899999999999999999984 47899999998643 233446678899999999999999999886543     357


Q ss_pred             EEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                      ++|+||+.+ +|..++    ....+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~-~l~~~~----~~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLI----KTQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence            999999964 776665    2346899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCccc-ceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcc---c
Q 013745          238 FPGEDTHV-NTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQG---E  312 (437)
Q Consensus       238 ~~~~~~~~-~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~  312 (437)
                      ........ ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........   .......   +
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~---~~~~~~~~~~~  232 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNL---ILGVLGTPSQE  232 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcCCCCHH
Confidence            64322211 1123468899999998765 4689999999999999999999999976432221111   0000000   0


Q ss_pred             ccc-----------cccC--cc--ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH--hcC
Q 013745          313 KAL-----------ELVD--PS--LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLM--LSG  360 (437)
Q Consensus       313 ~~~-----------~~~d--~~--l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~--L~~  360 (437)
                      ...           ..+.  +.  .....+.....+.+++.+||+.+|++||++.++++.  ++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~  297 (336)
T cd07849         233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQ  297 (336)
T ss_pred             HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccc
Confidence            000           0000  00  000112235668899999999999999999999874  553

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=5.5e-39  Score=303.08  Aligned_cols=247  Identities=27%  Similarity=0.333  Sum_probs=202.0

Q ss_pred             CccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      +|++.+.||.|+||.||+|... +++.||+|++....   ....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4889999999999999999864 68999999997432   2445788999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |+++++|..++...   ..+++..+..++.|+++||.|||+.+   ++|+||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            99999999888432   57899999999999999999999988   9999999999999999999999999998764432


Q ss_pred             cccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccc
Q 013745          243 THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL  322 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  322 (437)
                      .   .....|+..|+|||++.+..++.++|+||||+++|+|++|+.||............    .....         ..
T Consensus       155 ~---~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~---------~~  218 (258)
T cd05578         155 L---TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR----AKQET---------AD  218 (258)
T ss_pred             c---ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH----HHhcc---------cc
Confidence            1   12345788999999999888999999999999999999999999865542111111    11100         00


Q ss_pred             cCCCHHHHHHHHHHHHHcCCCCCCCCCCH--HHHH
Q 013745          323 AKCNRDEAAMCIQLGLLCCQQSVAERPDM--NSVH  355 (437)
Q Consensus       323 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~--~ev~  355 (437)
                      ...+...+..+.+++.+||+.+|.+||++  +|++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            11122334678899999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1e-38  Score=305.26  Aligned_cols=251  Identities=24%  Similarity=0.361  Sum_probs=193.0

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC-hHHHHHHHHHHHH-HHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS-RQGLREFTNEVKL-LLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      ++|++.+.||+|+||.||+|+.. +|+.||+|++.... ......+..|+.+ ++.++||||+++++++..+...++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46899999999999999999854 79999999987542 2233455566665 566789999999999999999999999


Q ss_pred             ecCCCCcchhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          163 YLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEE-APARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       163 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |++ ++|..++... .....+++..++.++.||+.||.|||++ +   ++||||||+|||++.++.+||+|||++..+..
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 6787776432 2345789999999999999999999987 6   99999999999999999999999999987643


Q ss_pred             CCcccceeeeecccccCChhhhcc----CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccc
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALH----GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE  316 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~----~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (437)
                      ...   .....|+..|+|||++.+    ..++.++|+|||||++|||++|+.||......  ...+   .....      
T Consensus       157 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~---~~~~~------  222 (283)
T cd06617         157 SVA---KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--FQQL---KQVVE------  222 (283)
T ss_pred             ccc---cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--HHHH---HHHHh------
Confidence            221   112457889999998865    45689999999999999999999999642211  0000   01100      


Q ss_pred             ccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          317 LVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       317 ~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ...+.+.  ....+..+.+++.+||..+|++||++.+|++
T Consensus       223 ~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         223 EPSPQLP--AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             cCCCCCC--ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0011111  1123456889999999999999999999975

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-40  Score=324.29  Aligned_cols=247  Identities=28%  Similarity=0.405  Sum_probs=206.1

Q ss_pred             ccceeccCCCeeEEEEEcC--CCc--EEEEEEeccCChH-HHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           90 DLNQLGHGGFGPVYRGLMP--NGQ--EIAVKKLSVDSRQ-GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        90 ~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      ..++||+|.||+|++|.|.  +|+  .||||++...... ....|++|+.+|.+|+|||+++|||...+ ....||||++
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa  192 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA  192 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence            4578999999999999865  454  4799999876543 56889999999999999999999999987 6788999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      +.|+|.+.|.. .....|.......++.|||.||.||.+++   +|||||...|+||-....||||||||.+.+...+..
T Consensus       193 plGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~  268 (1039)
T KOG0199|consen  193 PLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM  268 (1039)
T ss_pred             ccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence            99999999966 45677888999999999999999999998   999999999999999999999999999988654332


Q ss_pred             -cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCccc
Q 013745          245 -VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL  322 (437)
Q Consensus       245 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  322 (437)
                       .......-...|+|||.+....++.++|||+|||.||||+| |+.||.+..+.+....++..               ..
T Consensus       269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~---------------er  333 (1039)
T KOG0199|consen  269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAG---------------ER  333 (1039)
T ss_pred             eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccc---------------cc
Confidence             22222334568999999999999999999999999999998 78899887665443333211               11


Q ss_pred             cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          323 AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       323 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      -.-+..++..++++++.||..+|++||++..|.+
T Consensus       334 LpRPk~csedIY~imk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  334 LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             CCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence            1224467788999999999999999999999973

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=8.9e-39  Score=307.61  Aligned_cols=263  Identities=24%  Similarity=0.311  Sum_probs=199.1

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHcCCCCcceeeeeeeccC--CceEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR--QGLREFTNEVKLLLKIQHKNLVTLFGCCAEG--PEKMLV  160 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  160 (437)
                      ++|++.+.||.|+||.||+|... +++.+|+|.+.....  .....+.+|+.++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46899999999999999999965 688999999975432  2234567899999999999999999998877  889999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||+. ++|.+++...  ...+++..++.++.||+.||+|||+.+   ++|+||||+|||++.++.+||+|||++..+..
T Consensus        85 ~e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            99996 4888877432  236899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCcccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhh--------hhhhhcc
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSY--------TWTLFQG  311 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~--------~~~~~~~  311 (437)
                      ....  .....+++.|+|||.+.+. .++.++||||||+++|||++|..||...........+..        .|..+..
T Consensus       159 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         159 PLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             Cccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            3221  1123578899999998765 468999999999999999999999986554332211110        0110000


Q ss_pred             ------cccccccCcccc-CCCHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          312 ------EKALELVDPSLA-KCNRD-EAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       312 ------~~~~~~~d~~l~-~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                            ..........+. ..... ....+.+++..||+.+|++||++.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                  000000011111 11111 3556788999999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.2e-39  Score=341.18  Aligned_cols=256  Identities=28%  Similarity=0.393  Sum_probs=194.0

Q ss_pred             HHHhcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeecc------
Q 013745           82 QVATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE------  153 (437)
Q Consensus        82 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------  153 (437)
                      ..-..+|+.++.||+||||.||+++++ +|+.||||++... +......+.+|+..|++|+|||||+++..|.+      
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            445678999999999999999999966 8999999999755 34445678899999999999999999865421      


Q ss_pred             --------------------------------------------------------------------------------
Q 013745          154 --------------------------------------------------------------------------------  153 (437)
Q Consensus       154 --------------------------------------------------------------------------------  153 (437)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             -------------------------C--------CceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHH
Q 013745          154 -------------------------G--------PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY  200 (437)
Q Consensus       154 -------------------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~  200 (437)
                                               +        ..+||-||||+..+|.+++.++....  .....|+++++|++||+|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHH
Confidence                                     0        23578999999988888885433211  467889999999999999


Q ss_pred             hhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC----C------------CCcccceeeeecccccCChhhhcc
Q 013745          201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP----G------------EDTHVNTFRISGTHGYMAPEYALH  264 (437)
Q Consensus       201 LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~----~------------~~~~~~~~~~~gt~~Y~aPE~~~~  264 (437)
                      +|++|   ||||||||.||++++++.|||+|||+|....    .            .......+..+||..|+|||++.+
T Consensus       713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            99998   9999999999999999999999999998721    0            001112235679999999999976


Q ss_pred             C---cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcC
Q 013745          265 G---YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCC  341 (437)
Q Consensus       265 ~---~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl  341 (437)
                      .   .|+.|+|||||||||+||+.   ||....  +....+...    +.+.+.     ..++........-..++.|++
T Consensus       790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa~iL~~L----R~g~iP-----~~~~f~~~~~~~e~slI~~Ll  855 (1351)
T KOG1035|consen  790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERASILTNL----RKGSIP-----EPADFFDPEHPEEASLIRWLL  855 (1351)
T ss_pred             cccccccchhhhHHHHHHHHHHhc---cCCchH--HHHHHHHhc----ccCCCC-----CCcccccccchHHHHHHHHHh
Confidence            5   49999999999999999984   464322  222111111    111111     002234445555678999999


Q ss_pred             CCCCCCCCCHHHHHH
Q 013745          342 QQSVAERPDMNSVHL  356 (437)
Q Consensus       342 ~~~p~~RPs~~ev~~  356 (437)
                      +.||.+|||+.|++.
T Consensus       856 ~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  856 SHDPSKRPTATELLN  870 (1351)
T ss_pred             cCCCccCCCHHHHhh
Confidence            999999999999864

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.2e-38  Score=306.32  Aligned_cols=262  Identities=24%  Similarity=0.339  Sum_probs=195.4

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCCh-HHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSR-QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      +++|.+++.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.+++.++|+||+++++++..+...++|||
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence            46799999999999999999985 4688999999865432 222456789999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |+. ++|...+...  ...+.+..+..++.|++.||.|||+.+   |+|+||||+|||++.++.+||+|||+++......
T Consensus        84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          84 YMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             ccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence            996 5666655322  245788889999999999999999998   9999999999999999999999999997643322


Q ss_pred             cccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccc---------
Q 013745          243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGE---------  312 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------  312 (437)
                      ..  .....++..|+|||++.+. .++.++|||||||++|||++|+.||.......  ..+...+......         
T Consensus       158 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07870         158 QT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF--EQLEKIWTVLGVPTEDTWPGVS  233 (291)
T ss_pred             CC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH--HHHHHHHHHcCCCChhhhhhhh
Confidence            11  1123568999999998764 57889999999999999999999997654321  1111111111000         


Q ss_pred             ---c-ccccc----CccccCC--CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          313 ---K-ALELV----DPSLAKC--NRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       313 ---~-~~~~~----d~~l~~~--~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                         . .....    ...+...  .......+.+++.+|++.+|++|||+.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence               0 00000    0000000  0012356778999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-39  Score=305.35  Aligned_cols=278  Identities=22%  Similarity=0.324  Sum_probs=211.6

Q ss_pred             CCCCCCCcccccHHHHHHHhcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHc--CCCCc
Q 013745           66 GSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLK--IQHKN  143 (437)
Q Consensus        66 ~s~~~~~~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~n  143 (437)
                      .|++++...++-.+++   ..+....+.||+|.||.||+|.| .|+.||||++...++   +.+++|.+|.+.  |+|+|
T Consensus       194 tSGSGSGlplLVQRTi---arqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHEN  266 (513)
T KOG2052|consen  194 TSGSGSGLPLLVQRTI---ARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHEN  266 (513)
T ss_pred             cCCCCCCchhHhHHhh---hheeEEEEEecCccccceeeccc-cCCceEEEEecccch---hhhhhHHHHHHHHHhccch
Confidence            3555666666666665   56678899999999999999999 789999999975433   445566666654  59999


Q ss_pred             ceeeeeeeccCC----ceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhh-----cCCCceEeecc
Q 013745          144 LVTLFGCCAEGP----EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE-----EAPARIIHRDI  214 (437)
Q Consensus       144 iv~l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-----~~~~~iiHrDi  214 (437)
                      |+.|++.-..+.    .++||++|.+.|||.++|    ....++....++++..+|.||++||.     +|++.|.||||
T Consensus       267 ILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL----~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDl  342 (513)
T KOG2052|consen  267 ILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYL----NRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDL  342 (513)
T ss_pred             hhhhhhccccCCCceEEEEEeeecccCCcHHHHH----hhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccc
Confidence            999999875543    579999999999999999    33678999999999999999999997     46788999999


Q ss_pred             CCCCEEecCCCCceeeecccccccCCCCc--ccceeeeecccccCChhhhccC------cCCcccceehhhHHHHHHHhC
Q 013745          215 KASNILLDEQLNPKISDFGLARLFPGEDT--HVNTFRISGTHGYMAPEYALHG------YLSVKTDVFSYGVLVLEIVSG  286 (437)
Q Consensus       215 kp~NIll~~~~~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~Y~aPE~~~~~------~~~~~~DvwSlG~vl~elltg  286 (437)
                      |..||||.++|.+.|+|+|||...+....  .......+||.+|||||++...      .--..+||||||.|+||+...
T Consensus       343 KSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarR  422 (513)
T KOG2052|consen  343 KSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARR  422 (513)
T ss_pred             ccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHH
Confidence            99999999999999999999987754421  1222346799999999999754      122359999999999999752


Q ss_pred             ----------CCCCCCCCchhhhhhhhhhhhhhcccccccccCcccc--CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 013745          287 ----------RKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA--KCNRDEAAMCIQLGLLCCQQSVAERPDMNSV  354 (437)
Q Consensus       287 ----------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev  354 (437)
                                +.||....+.+...  +.+.+..    ..+.+.|.++  .........+.++++.||..+|..|-|+--|
T Consensus       423 c~~ggi~eey~~Pyyd~Vp~DPs~--eeMrkVV----Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri  496 (513)
T KOG2052|consen  423 CESGGIVEEYQLPYYDVVPSDPSF--EEMRKVV----CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI  496 (513)
T ss_pred             hhcCCEehhhcCCcccCCCCCCCH--HHHhcce----eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence                      46776554433321  1122211    1222333332  2234677889999999999999999999998


Q ss_pred             HHHhcC
Q 013745          355 HLMLSG  360 (437)
Q Consensus       355 ~~~L~~  360 (437)
                      .+.|..
T Consensus       497 KKtl~~  502 (513)
T KOG2052|consen  497 KKTLAK  502 (513)
T ss_pred             HHHHHH
Confidence            888764

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.1e-38  Score=306.98  Aligned_cols=265  Identities=22%  Similarity=0.259  Sum_probs=195.9

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCC-CCcceeeeeeeccCCc-----
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPE-----  156 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----  156 (437)
                      ++|++.+.||+|+||.||+|... +++.||||++....  ......+.+|+.+++++. ||||+++++++.....     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46899999999999999999854 78999999886542  222356788999999995 6999999999877665     


Q ss_pred             eEEEEeecCCCCcchhhhccCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC-CCCceeeecc
Q 013745          157 KMLVYEYLPNKSLDYFIFDKTK--SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE-QLNPKISDFG  233 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~-~~~~kl~DFG  233 (437)
                      .|+||||+++ +|..++.....  ...+++..++.++.||+.||.|||+++   |+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999985 78777654322  346899999999999999999999998   999999999999998 8999999999


Q ss_pred             cccccCCCCcccceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccc
Q 013745          234 LARLFPGEDTHVNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGE  312 (437)
Q Consensus       234 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  312 (437)
                      +++.+......  .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+.........+..........
T Consensus       157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (295)
T cd07837         157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ  234 (295)
T ss_pred             cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            99865332111  112346889999998865 467999999999999999999999997654322111000000000000


Q ss_pred             c---cc---------cccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          313 K---AL---------ELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       313 ~---~~---------~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .   ..         ......+....+.....+.+++.+||+.+|.+||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0   00         00000001111234566889999999999999999999864

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.5e-38  Score=303.79  Aligned_cols=259  Identities=22%  Similarity=0.274  Sum_probs=194.4

Q ss_pred             ccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCC-CCcceeeeeeeccC--CceEEEEe
Q 013745           88 FSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEG--PEKMLVYE  162 (437)
Q Consensus        88 y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e  162 (437)
                      |++.+.||+|+||.||+|.. .+++.||+|++.... ........+|+.++.++. |+||+++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            67789999999999999984 478999999987532 222234457999999885 99999999999887  88999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |++ ++|.+.+...  ...+++..++.++.|++.||+|||+.+   ++||||||+||+++. +.+||+|||+++......
T Consensus        81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            996 4776666332  246899999999999999999999998   999999999999999 999999999998764332


Q ss_pred             cccceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhh--------hhhhcccc
Q 013745          243 THVNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYT--------WTLFQGEK  313 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~  313 (437)
                      ...   ...++..|+|||++.. +.++.++|||||||++|||++|..||.+....+....+...        ........
T Consensus       154 ~~~---~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         154 PYT---EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             CcC---CCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccc
Confidence            221   2357889999997654 56789999999999999999999999775543221111000        00000001


Q ss_pred             cccccCc-----cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          314 ALELVDP-----SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       314 ~~~~~d~-----~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ......+     .+.......+..+.+++.+||+.+|++||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            1111111     111112244678899999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=9.7e-39  Score=300.72  Aligned_cols=249  Identities=24%  Similarity=0.368  Sum_probs=200.2

Q ss_pred             CccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      +|.+.+.||+|+||.||+|... +|..||+|.+...  .....+.+.+|+.++++++|+||+++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4788999999999999999854 6889999998653  123346788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCC-ceeeecccccccCCCC
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN-PKISDFGLARLFPGED  242 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~-~kl~DFGla~~~~~~~  242 (437)
                      +++++|.+++... ....+++..+..++.|++.||.|||+.+   ++|+||||+||++++++. +||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            9999999988543 2345799999999999999999999988   999999999999998864 6999999998765332


Q ss_pred             cccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccc
Q 013745          243 THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL  322 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  322 (437)
                      ...  ....|++.|+|||++.+..++.++||||||+++|||++|..||........      .......         .+
T Consensus       157 ~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~---------~~  219 (257)
T cd08225         157 ELA--YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL------VLKICQG---------YF  219 (257)
T ss_pred             ccc--cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHhcc---------cC
Confidence            211  124588999999999888899999999999999999999999975432221      1111110         11


Q ss_pred             cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          323 AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       323 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ....+.....+.+++.+||+.+|++||++.+|++
T Consensus       220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            1112233456888999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=2e-38  Score=307.43  Aligned_cols=246  Identities=30%  Similarity=0.444  Sum_probs=195.8

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      +.|.+.+.||+|+||.||+|... +++.||+|++...   .......+.+|+.+++.++||||++++++|.+....++||
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45888999999999999999854 6899999998643   2334467889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      ||+. |+|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||+|+||++++++.+||+|||++......
T Consensus        95 e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          95 EYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            9996 566665532  2346899999999999999999999988   999999999999999999999999999765332


Q ss_pred             CcccceeeeecccccCChhhhc---cCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          242 DTHVNTFRISGTHGYMAPEYAL---HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      .      ...++..|+|||++.   ...++.++||||||+++|||++|+.||..........      ......      
T Consensus       169 ~------~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~------~~~~~~------  230 (307)
T cd06607         169 N------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQND------  230 (307)
T ss_pred             C------CccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH------HHhcCC------
Confidence            1      245788999999874   3568899999999999999999999997543222111      000000      


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLM  357 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  357 (437)
                      .+.+  ........+.+++.+||+.+|++||++.+|+..
T Consensus       231 ~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         231 SPTL--SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             CCCC--CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0111  111244568899999999999999999999763

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.3e-38  Score=295.07  Aligned_cols=249  Identities=28%  Similarity=0.444  Sum_probs=204.1

Q ss_pred             CccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecC
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLP  165 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  165 (437)
                      .|++.+.||+|++|.||++... +++.+++|++..........+.+|+.++++++|+||+++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            3778899999999999999964 688999999976655456788999999999999999999999999999999999999


Q ss_pred             CCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCccc
Q 013745          166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV  245 (437)
Q Consensus       166 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  245 (437)
                      +++|.+++...  ...+++..+..++.|++.+|.|||..+   ++|+||+|+||++++++.++|+|||.+........  
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            99999988432  256899999999999999999999987   99999999999999999999999999987654332  


Q ss_pred             ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCC
Q 013745          246 NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKC  325 (437)
Q Consensus       246 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  325 (437)
                       .....++..|+|||++.+..++.++||||||+++|+|++|+.||.............   .    ...     +.+ ..
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~----~~~-----~~~-~~  219 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA---T----NGP-----PGL-RN  219 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH---h----cCC-----CCc-Cc
Confidence             224568899999999998889999999999999999999999997543222111100   0    000     000 00


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          326 NRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       326 ~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .......+.+++.+||+.+|++||++.+|++
T Consensus       220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1112456888999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.6e-38  Score=312.83  Aligned_cols=261  Identities=25%  Similarity=0.269  Sum_probs=197.7

Q ss_pred             HhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccC------
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG------  154 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  154 (437)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++...  .......+.+|+.++++++||||++++++|...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            457899999999999999999984 47899999998643  333445678899999999999999999988643      


Q ss_pred             CceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccc
Q 013745          155 PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL  234 (437)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl  234 (437)
                      ...|+||||+. ++|...+..     .+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence            35699999995 477666621     2888999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhh----------
Q 013745          235 ARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSY----------  304 (437)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~----------  304 (437)
                      ++.......   .....++..|+|||.+.+..++.++|||||||++|+|++|+.||...........+..          
T Consensus       165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  241 (353)
T cd07850         165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM  241 (353)
T ss_pred             ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            987643322   1134578999999999999999999999999999999999999976543221111100          


Q ss_pred             -----hhhhhccc-------ccccccCccc-----cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          305 -----TWTLFQGE-------KALELVDPSL-----AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       305 -----~~~~~~~~-------~~~~~~d~~l-----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                           ....+...       ...+.....+     ..........+.+++.+||+.||++||++.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                 00000000       0000000000     0011234556789999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-38  Score=305.23  Aligned_cols=262  Identities=23%  Similarity=0.308  Sum_probs=199.0

Q ss_pred             ccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccC--CceEEEEe
Q 013745           88 FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG--PEKMLVYE  162 (437)
Q Consensus        88 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  162 (437)
                      |++.+.||.|+||.||+|+.. +++.+|+|++....  ......+.+|++++++++|+|++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            678899999999999999854 58899999997652  33345688999999999999999999999887  88999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |+++ +|..++...  ...+++..++.++.||+.||+|||+.+   ++|+||||+||++++++.+||+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9975 887777432  247899999999999999999999988   9999999999999999999999999998775443


Q ss_pred             cccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccc-------
Q 013745          243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKA-------  314 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------  314 (437)
                      ... .....++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+............       
T Consensus       155 ~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07840         155 SAD-YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLP  233 (287)
T ss_pred             ccc-ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccch
Confidence            211 1123568889999987654 6799999999999999999999999765543222111110000000000       


Q ss_pred             -------ccccCccccCCCHH-HHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          315 -------LELVDPSLAKCNRD-EAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       315 -------~~~~d~~l~~~~~~-~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                             .......+...... ++..+.+++.+||+.+|.+||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                   00000001011111 2667899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.6e-38  Score=303.30  Aligned_cols=251  Identities=26%  Similarity=0.406  Sum_probs=204.2

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      ++.|++.+.||+|+||.||+|... +++.|++|++..... ....+.+|++++++++|+||+++++++......++|+||
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   96 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY   96 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence            456888999999999999999865 688999999976544 456788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +++++|.+++....  ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        97 ~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  171 (286)
T cd06614          97 MDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS  171 (286)
T ss_pred             cCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence            99999999985432  37899999999999999999999987   99999999999999999999999999876543322


Q ss_pred             ccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcccc
Q 013745          244 HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA  323 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  323 (437)
                      .  .....++..|++||++.+..++.++|||||||++|+|++|+.||...........      ... ...     +.+ 
T Consensus       172 ~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~------~~~-~~~-----~~~-  236 (286)
T cd06614         172 K--RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFL------ITT-KGI-----PPL-  236 (286)
T ss_pred             h--hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHh-cCC-----CCC-
Confidence            1  1134578899999999888899999999999999999999999975433221110      000 000     000 


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       324 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ......+..+.+++.+||+.+|.+||++.+|++
T Consensus       237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         237 KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            011123456888999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-39  Score=305.73  Aligned_cols=262  Identities=23%  Similarity=0.329  Sum_probs=197.5

Q ss_pred             ccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           88 FSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        88 y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      |++.+.||.|++|.||+|.. .+|+.||+|++....  ......+.+|++++++++||||+++++++.+++..++||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            67789999999999999985 479999999987543  222356788999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      + ++|..++.... ...+++..++.++.|++.||+|||+++   ++||||+|+||+++.++.++|+|||++.........
T Consensus        81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence            5 68888874322 246899999999999999999999987   999999999999999999999999999765432211


Q ss_pred             cceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhh-hhh-------hhhhhcc-cc-
Q 013745          245 VNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADL-LSY-------TWTLFQG-EK-  313 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~-~~~-------~~~~~~~-~~-  313 (437)
                        .....++..|+|||++.+. .++.++|||||||++|+|++|+.||........... ...       .|..... .. 
T Consensus       156 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         156 --YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             --cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence              1123468899999988764 578999999999999999999999976543221110 000       0000000 00 


Q ss_pred             ---cccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          314 ---ALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       314 ---~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                         .............+.....+.+++.+|++.+|.+||++++|++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence               0000001111122233456889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.4e-39  Score=329.87  Aligned_cols=268  Identities=21%  Similarity=0.257  Sum_probs=187.3

Q ss_pred             HHhcCccccceeccCCCeeEEEEEcC--CCcEEEEE------------------EeccCChHHHHHHHHHHHHHHcCCCC
Q 013745           83 VATNFFSDLNQLGHGGFGPVYRGLMP--NGQEIAVK------------------KLSVDSRQGLREFTNEVKLLLKIQHK  142 (437)
Q Consensus        83 ~~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~  142 (437)
                      ...++|++++.||+|+||+||++..+  .+..+++|                  .+. ........+.+|+.+|++++||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCC
Confidence            34578999999999999999998643  22222222                  111 1222345688999999999999


Q ss_pred             cceeeeeeeccCCceEEEEeecCCCCcchhhhccCC--CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEE
Q 013745          143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTK--SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNIL  220 (437)
Q Consensus       143 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIl  220 (437)
                      |||++++++...+..|+|++++. ++|..++.....  ........+..|+.||+.||.|||+++   ||||||||+|||
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL  299 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF  299 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence            99999999999999999999985 566665533211  122345667889999999999999998   999999999999


Q ss_pred             ecCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCC-CCCchhhh
Q 013745          221 LDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHD-GRLGKEKA  299 (437)
Q Consensus       221 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~-~~~~~~~~  299 (437)
                      ++.++.+||+|||+++.+....... .....||..|+|||++.+..++.++|||||||++|||++|..++. ........
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKEREAF-DYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             ECCCCCEEEEeCCCceecCcccccc-cccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence            9999999999999998775433221 223579999999999999999999999999999999999886443 22221111


Q ss_pred             hhhhhhhhh------hcc--cccccccCc--------cccCC--CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          300 DLLSYTWTL------FQG--EKALELVDP--------SLAKC--NRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       300 ~~~~~~~~~------~~~--~~~~~~~d~--------~l~~~--~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .+.......      +..  ....+.++.        .+...  .......+.+++.+|++.||++||++.|++.
T Consensus       379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            111110000      000  000000000        00000  0012234667888999999999999999976

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.5e-38  Score=307.97  Aligned_cols=263  Identities=24%  Similarity=0.325  Sum_probs=194.9

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC-------
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP-------  155 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  155 (437)
                      ++|++.+.||+|+||.||+|... +++.||||++....  ......+.+|+.++++++||||+++++++....       
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            56999999999999999999854 78999999886432  222345678999999999999999999986544       


Q ss_pred             -ceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccc
Q 013745          156 -EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL  234 (437)
Q Consensus       156 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl  234 (437)
                       ..++||||+.+ +|...+..  ....+++..++.++.||+.||.|||+++   ++|+||||+||+++.++.+||+|||+
T Consensus        92 ~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~  165 (310)
T cd07865          92 GSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL  165 (310)
T ss_pred             ceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence             34999999964 77776632  2346899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcc--cceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcc
Q 013745          235 ARLFPGEDTH--VNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQG  311 (437)
Q Consensus       235 a~~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  311 (437)
                      +..+......  .......++..|+|||++.+. .++.++||||||+++|||++|+.||.+.........+.........
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T cd07865         166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP  245 (310)
T ss_pred             cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            9876432221  111124578899999988765 4789999999999999999999999875543332222221110000


Q ss_pred             ccc-----cc-------------ccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          312 EKA-----LE-------------LVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       312 ~~~-----~~-------------~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ...     .+             .+...+.  .......+.+++.+||+.+|.+||++.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~--~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         246 EVWPGVDKLELFKKMELPQGQKRKVKERLK--PYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hhcccccchhhhhhccCCCccchhhHHhcc--cccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            000     00             0000000  0012345678999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=5.5e-38  Score=294.77  Aligned_cols=251  Identities=25%  Similarity=0.371  Sum_probs=205.3

Q ss_pred             CccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccC--CceEEEE
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG--PEKMLVY  161 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  161 (437)
                      +|...+.||+|++|.||+|... +++.|++|++....  ....+.+.+|+.++++++||||+++++.+...  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999965 78999999987554  24567889999999999999999999999888  8899999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      ||+++++|.+++...   ..+++..++.++.|++.+|+|||+.+   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            999999999998433   37899999999999999999999987   999999999999999999999999999887654


Q ss_pred             CcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                      ..........++..|+|||.+....++.++||||||+++|+|++|..||.......     ...+.....        ..
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~--------~~  221 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-----AALYKIGSS--------GE  221 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----HHHHhcccc--------CC
Confidence            33111223467899999999998889999999999999999999999997654111     111111100        01


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ....+...+..+.+++.+|++.+|++||++.+++.
T Consensus       222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            11222233567889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.6e-38  Score=306.48  Aligned_cols=258  Identities=19%  Similarity=0.225  Sum_probs=185.0

Q ss_pred             HhcCccccceeccCCCeeEEEEEcCC----CcEEEEEEeccCChHHH-----------HHHHHHHHHHHcCCCCcceeee
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMPN----GQEIAVKKLSVDSRQGL-----------REFTNEVKLLLKIQHKNLVTLF  148 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~  148 (437)
                      ..++|.+.+.||+|+||.||+|...+    +..+|+|+.........           .....+...+..+.|+||++++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            34679999999999999999998543    45567775443321110           1122344456677899999999


Q ss_pred             eeeccCC----ceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCC
Q 013745          149 GCCAEGP----EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ  224 (437)
Q Consensus       149 ~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~  224 (437)
                      +++....    ..++++|++. .++.+.+..   ....++..++.++.|++.||.|||+.+   |+||||||+|||++.+
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~  162 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN  162 (294)
T ss_pred             EeeeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence            9765443    3467888774 355555422   233577888999999999999999988   9999999999999999


Q ss_pred             CCceeeecccccccCCCCcc-----cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhh
Q 013745          225 LNPKISDFGLARLFPGEDTH-----VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKA  299 (437)
Q Consensus       225 ~~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~  299 (437)
                      +.+||+|||+|+.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.......
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~  242 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL  242 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence            99999999999876432211     1112346999999999999999999999999999999999999999865322211


Q ss_pred             -hhh--hhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          300 -DLL--SYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       300 -~~~--~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                       ...  .+...... ..    +  .+.    ..+..+.+++..|++.+|++||++.+|++.|.
T Consensus       243 ~~~~~~~~~~~~~~-~~----~--~~~----~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        243 IHAAKCDFIKRLHE-GK----I--KIK----NANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHhHHHHHHHhhh-hh----h--ccC----CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence             110  01111110 00    0  011    22466889999999999999999999998763

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-39  Score=318.23  Aligned_cols=250  Identities=26%  Similarity=0.431  Sum_probs=207.9

Q ss_pred             ccccceeccCCCeeEEEEEcC---CCc--EEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           88 FSDLNQLGHGGFGPVYRGLMP---NGQ--EIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        88 y~~~~~lG~G~~g~Vy~~~~~---~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ....+.||.|-||.||+|+..   .|+  .||||..+.+ .....+.|+.|..+|+.++|||||+++|+|.+. ..++||
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wivm  469 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVM  469 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEE
Confidence            444578999999999999842   333  4788988764 344567899999999999999999999999765 689999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      |.++-|.|..+|..  +...++......++.||+.||+|||+..   +|||||...|||+....-|||+|||+++.+...
T Consensus       470 EL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  470 ELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             ecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            99999999999954  4467899999999999999999999998   999999999999999999999999999998776


Q ss_pred             CcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                      ...... ...-..-|||||-+.-..++.++|||-|||.+||++. |..||.+..+.+..-.++..               
T Consensus       545 ~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnG---------------  608 (974)
T KOG4257|consen  545 AYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENG---------------  608 (974)
T ss_pred             chhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCC---------------
Confidence            555443 3334667999999999999999999999999999986 99999986665443222211               


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                      ....+++.++..+..|+.+||.++|.+||++.++...|.
T Consensus       609 eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~ls  647 (974)
T KOG4257|consen  609 ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILS  647 (974)
T ss_pred             CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence            112345567778999999999999999999999977664

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.5e-38  Score=312.47  Aligned_cols=266  Identities=22%  Similarity=0.301  Sum_probs=199.4

Q ss_pred             HhcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccC--Cce
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEG--PEK  157 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~  157 (437)
                      ..++|++.+.||+|+||.||+|... +++.||||++...  .......+.+|+.+++++ +||||++++++|...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3567999999999999999999854 6889999988542  233345677899999999 999999999998643  467


Q ss_pred             EEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                      ++||||++ ++|..++..    ..+++..++.++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99999996 588777732    26888999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCcc---cceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhc---
Q 013745          238 FPGEDTH---VNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQ---  310 (437)
Q Consensus       238 ~~~~~~~---~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~---  310 (437)
                      .......   .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+........   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED  236 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence            6543221   12223568999999998765 4688999999999999999999999976544332211111100000   


Q ss_pred             --------ccccccccC----ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013745          311 --------GEKALELVD----PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLM  357 (437)
Q Consensus       311 --------~~~~~~~~d----~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  357 (437)
                              .....+.+.    ..+....+..+..+.+++.+||+.+|++||++.++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                    000000000    00111111245678899999999999999999999863

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.1e-38  Score=296.07  Aligned_cols=248  Identities=26%  Similarity=0.351  Sum_probs=204.0

Q ss_pred             CccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      +|++.+.||.|+||.||++.. .+++.+|+|++...  .......+.+|++++++++|+||+++++++.+....++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            488899999999999999974 47889999998753  233456778899999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          164 LPNKSLDYFIFDKT-KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       164 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      +++++|..++.... ....+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~  157 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM  157 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence            99999999875422 2356899999999999999999999998   9999999999999999999999999998775441


Q ss_pred             cccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccc
Q 013745          243 THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL  322 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  322 (437)
                          .....++..|++||.+.+..++.++|+||||+++|||++|+.||...........+       ..        ...
T Consensus       158 ----~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~-------~~--------~~~  218 (256)
T cd08530         158 ----AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV-------QR--------GKY  218 (256)
T ss_pred             ----cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------hc--------CCC
Confidence                11245789999999999989999999999999999999999999765432211110       00        011


Q ss_pred             cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          323 AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       323 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ..........+.+++.+|++.+|++||++.++++
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            1222345567899999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.1e-38  Score=302.96  Aligned_cols=253  Identities=26%  Similarity=0.401  Sum_probs=194.8

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCC-CCcceeeeeeeccCCceEEEEe
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      ++|+..+.||+|+||.||++.. .+++.||+|++.... ......+.+|+.++.++. |+||+++++++..+...+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            3566788999999999999985 468999999987542 334567889999999996 9999999999999999999999


Q ss_pred             ecCCCCcchhhhc--cCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          163 YLPNKSLDYFIFD--KTKSSSLDWTTRYRIVMGVARGLLYLHEE-APARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       163 ~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      |+.. +|..+...  ......+++..+..++.|++.||+|||+. +   ++||||||+||+++.++.+||+|||+++.+.
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            9854 55443211  12235789999999999999999999975 5   9999999999999999999999999998654


Q ss_pred             CCCcccceeeeecccccCChhhhccC---cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccc
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALHG---YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE  316 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~~---~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (437)
                      .....   ....|+..|+|||++.+.   .++.++|||||||++|||++|+.||.....     ...........     
T Consensus       160 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~-----  226 (288)
T cd06616         160 DSIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVKG-----  226 (288)
T ss_pred             cCCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcCC-----
Confidence            32221   123578999999998876   689999999999999999999999975331     11111111100     


Q ss_pred             ccCcccc-CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          317 LVDPSLA-KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       317 ~~d~~l~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                       ..+.+. ......+..+.+++.+||+.+|++||++.+|++
T Consensus       227 -~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         227 -DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             -CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             011111 111234567889999999999999999999976

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.1e-38  Score=313.03  Aligned_cols=265  Identities=21%  Similarity=0.316  Sum_probs=199.1

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeecc----CCce
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAE----GPEK  157 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  157 (437)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++....  ......+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            46799999999999999999984 479999999987542  2334667889999999999999999998753    3467


Q ss_pred             EEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                      ++||||+. ++|..++.   ....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence            99999995 58888773   2345899999999999999999999988   99999999999999999999999999986


Q ss_pred             cCCCCcccc--eeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhh-------
Q 013745          238 FPGEDTHVN--TFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWT-------  307 (437)
Q Consensus       238 ~~~~~~~~~--~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~-------  307 (437)
                      .........  .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...........+.....       
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            543222111  113468899999998866 4689999999999999999999999976543222111110000       


Q ss_pred             -hhccccccccc---C----ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          308 -LFQGEKALELV---D----PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       308 -~~~~~~~~~~~---d----~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                       ........+.+   .    .......+..+..+.+++.+||+.+|++||++.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence             00000000000   0    0001111234667899999999999999999999876

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.9e-38  Score=304.22  Aligned_cols=264  Identities=23%  Similarity=0.285  Sum_probs=195.6

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      ++|++.+.||+|++|.||+|... +|+.||+|++....  ......+.+|++++++++||||+++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46899999999999999999854 78999999986542  2234568899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC-CCCceeeecccccccCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE-QLNPKISDFGLARLFPGE  241 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~-~~~~kl~DFGla~~~~~~  241 (437)
                      |++ ++|...+... ....+++..++.++.||+.||+|||+++   ++|+||||+||+++. ++.+||+|||++......
T Consensus        82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            996 4776665332 2234678888999999999999999988   999999999999985 557999999999865432


Q ss_pred             CcccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhh-----hhcccc--
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWT-----LFQGEK--  313 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~-----~~~~~~--  313 (437)
                      ...  .....+++.|+|||++.+. .++.++|||||||++|+|++|+.||......+....+.....     .+....  
T Consensus       157 ~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (294)
T PLN00009        157 VRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSL  234 (294)
T ss_pred             ccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccc
Confidence            111  1123568899999988764 678999999999999999999999976543322111100000     000000  


Q ss_pred             --cccc----cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          314 --ALEL----VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       314 --~~~~----~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                        ....    ....+....+.....+.+++.+|++.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence              0000    000001111233455788999999999999999999985

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-38  Score=301.90  Aligned_cols=261  Identities=24%  Similarity=0.349  Sum_probs=201.2

Q ss_pred             ccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           88 FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR--QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        88 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      |++.+.||+|++|.||+|... +++.+++|++.....  .....+.+|+.++++++|+||+++++++..+...++||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567889999999999999854 788999999875432  24567888999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      ++ +|..++...  ...+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+||+|||.+........ 
T Consensus        81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-  153 (283)
T cd05118          81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-  153 (283)
T ss_pred             CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence            75 777776432  257899999999999999999999998   99999999999999999999999999987754331 


Q ss_pred             cceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhh--------hhhhcc----
Q 013745          245 VNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYT--------WTLFQG----  311 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~----  311 (437)
                       ......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+....+...        +.....    
T Consensus       154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd05118         154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN  232 (283)
T ss_pred             -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence             11123578899999998877 7899999999999999999999999765543221111100        000000    


Q ss_pred             --cccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          312 --EKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       312 --~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                        ....+..+.......+..+..+.+++..||+.+|.+||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence              000000011111222345677899999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=2.8e-38  Score=304.50  Aligned_cols=246  Identities=24%  Similarity=0.338  Sum_probs=198.7

Q ss_pred             cccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCCC
Q 013745           89 SDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNK  167 (437)
Q Consensus        89 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  167 (437)
                      ....+||+|+||.||++.. .+++.||||++..........+.+|+.+++.++|+||+++++++...+..++||||++++
T Consensus        23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  102 (292)
T cd06657          23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG  102 (292)
T ss_pred             hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence            3347799999999999985 478999999987655555677899999999999999999999999999999999999999


Q ss_pred             CcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccce
Q 013745          168 SLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT  247 (437)
Q Consensus       168 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  247 (437)
                      +|.+++.    ...+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++.........  .
T Consensus       103 ~L~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--~  173 (292)
T cd06657         103 ALTDIVT----HTRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--R  173 (292)
T ss_pred             cHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccccc--c
Confidence            9988773    235789999999999999999999998   999999999999999999999999998765433211  1


Q ss_pred             eeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCH
Q 013745          248 FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNR  327 (437)
Q Consensus       248 ~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  327 (437)
                      ....|+..|+|||++.+..++.++|+||||+++|+|++|..||.+.........+..   .         ..+.+.. ..
T Consensus       174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~---~---------~~~~~~~-~~  240 (292)
T cd06657         174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---N---------LPPKLKN-LH  240 (292)
T ss_pred             cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---h---------CCcccCC-cc
Confidence            234688999999999888899999999999999999999999976433222111110   0         0111111 11


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          328 DEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       328 ~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .....+.+++.+||+.+|.+||++.+|++
T Consensus       241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         241 KVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             cCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            23445778899999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.6e-38  Score=312.33  Aligned_cols=264  Identities=24%  Similarity=0.341  Sum_probs=198.8

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccC-----Cc
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG-----PE  156 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  156 (437)
                      .++|.+.+.||+|+||+||+|+. .+++.||||++...  .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45799999999999999999984 47899999998643  233345677899999999999999999988644     34


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                      .++||||+. ++|..++.   ....+++..++.++.|++.||.|||+++   ++||||||+||+++.++.+||+|||++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999995 67877763   3356899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCcccceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhh--------
Q 013745          237 LFPGEDTHVNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWT--------  307 (437)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~--------  307 (437)
                      ........  .....++..|+|||.+.. ..++.++|||||||++|+|++|+.||.+.........+.....        
T Consensus       157 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07858         157 TTSEKGDF--MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG  234 (337)
T ss_pred             ccCCCccc--ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence            76433211  123457889999998875 4689999999999999999999999976543222111110000        


Q ss_pred             hhcccccc-------cccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013745          308 LFQGEKAL-------ELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLM  357 (437)
Q Consensus       308 ~~~~~~~~-------~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  357 (437)
                      ........       ...++......+..+..+.+++.+||+.+|++||++.++++-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            00000000       000111111122345668899999999999999999999864

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-39  Score=320.59  Aligned_cols=251  Identities=22%  Similarity=0.325  Sum_probs=203.7

Q ss_pred             cCccccceeccCCCeeEEEEEcCC-CcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      +.|+++..||.|+||.||+|+.+. +-..|.|++...+....+.|+-||+||..++||+||+|++.|...+.++++.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            458889999999999999999654 4445788888888888899999999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      .||-++.++..-  ...+.+.++.-++.|++.||.|||+++   |||||||..|||++-+|.++|+|||.+.....  +.
T Consensus       112 ~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~  184 (1187)
T KOG0579|consen  112 GGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TR  184 (1187)
T ss_pred             CCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--HH
Confidence            999999988543  356899999999999999999999998   99999999999999999999999999865322  22


Q ss_pred             cceeeeecccccCChhhhcc-----CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          245 VNTFRISGTHGYMAPEYALH-----GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~-----~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                      .....+.|||.|||||+.+.     .+|+.++||||||+.|.||..+.+|-....+...  +    .++-.      --.
T Consensus       185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV--l----lKiaK------SeP  252 (1187)
T KOG0579|consen  185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--L----LKIAK------SEP  252 (1187)
T ss_pred             hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH--H----HHHhh------cCC
Confidence            22345789999999998764     4799999999999999999999999765433211  1    11100      001


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      |.+. -+..-...+.+++.+|+..||..||++.++++
T Consensus       253 PTLl-qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  253 PTLL-QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             Cccc-CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            1111 12233455778899999999999999999864

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.1e-38  Score=304.93  Aligned_cols=267  Identities=23%  Similarity=0.284  Sum_probs=198.2

Q ss_pred             HHhcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC----
Q 013745           83 VATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP----  155 (437)
Q Consensus        83 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  155 (437)
                      ...++|++.+.||+|+||.||+|..+ +|+.||+|++....  ......+.+|++++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999964 68899999997542  222356778999999999999999999987654    


Q ss_pred             ------ceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCcee
Q 013745          156 ------EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKI  229 (437)
Q Consensus       156 ------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl  229 (437)
                            ..++|+||+++ ++...+..  ....+++..++.++.|++.||+|||+.+   |+|+||||+||++++++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence                  78999999976 66565532  2346899999999999999999999998   999999999999999999999


Q ss_pred             eecccccccCCCCcccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhh
Q 013745          230 SDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTL  308 (437)
Q Consensus       230 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~  308 (437)
                      +|||++........... ....++..|+|||.+.+. .++.++|||||||++|||++|++||......+....+......
T Consensus       158 ~dfg~~~~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~  236 (302)
T cd07864         158 ADFGLARLYNSEESRPY-TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS  236 (302)
T ss_pred             CcccccccccCCccccc-ccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            99999987654332111 123457889999988654 5789999999999999999999999764433222111111000


Q ss_pred             hccccc--------ccccC------ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          309 FQGEKA--------LELVD------PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       309 ~~~~~~--------~~~~d------~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ......        ....+      ..+.......+..+.+++.+||+.+|.+||++.+|++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            000000        00000      0000011123456889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.2e-38  Score=299.10  Aligned_cols=250  Identities=25%  Similarity=0.334  Sum_probs=200.3

Q ss_pred             eccCCCeeEEEEEcC-CCcEEEEEEeccCCh---HHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCCCCc
Q 013745           94 LGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR---QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL  169 (437)
Q Consensus        94 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  169 (437)
                      ||.|+||.||+++.. +|+.||+|++.....   .....+.+|++++++++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999965 599999999875432   4456788999999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc------
Q 013745          170 DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT------  243 (437)
Q Consensus       170 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~------  243 (437)
                      .+++...   ..+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........      
T Consensus        81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            9988432   36899999999999999999999988   99999999999999999999999999876543211      


Q ss_pred             ccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcccc
Q 013745          244 HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA  323 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  323 (437)
                      ........++..|++||.+....++.++||||||+++|+|++|..||......+....+.      . ..    ..  ..
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~------~-~~----~~--~~  221 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNIL------N-GK----IE--WP  221 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh------c-CC----cC--CC
Confidence            111223457889999999988889999999999999999999999997654332211110      0 00    00  00


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCCCC
Q 013745          324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSF  363 (437)
Q Consensus       324 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~  363 (437)
                      .. ...+..+.+++.+||+.+|++||++.+|.+.|+...+
T Consensus       222 ~~-~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~  260 (265)
T cd05579         222 ED-VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF  260 (265)
T ss_pred             cc-ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccc
Confidence            00 0124667899999999999999999888888876543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=9.2e-38  Score=304.35  Aligned_cols=246  Identities=30%  Similarity=0.439  Sum_probs=195.4

Q ss_pred             CccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      .|...+.||+|+||.||+|+. .++..||+|++...   .......+.+|+.++++++|||++++++++.++...++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            378889999999999999985 46889999998643   23334578899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |+++ +|.+++..  ....+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.+||+|||++.......
T Consensus       106 ~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (317)
T cd06635         106 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPAN  179 (317)
T ss_pred             CCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCcc
Confidence            9975 66666532  2356899999999999999999999988   9999999999999999999999999987653321


Q ss_pred             cccceeeeecccccCChhhhc---cCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          243 THVNTFRISGTHGYMAPEYAL---HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                            ...|+..|+|||++.   .+.++.++|||||||++|||++|+.||...........      ......      
T Consensus       180 ------~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~------~~~~~~------  241 (317)
T cd06635         180 ------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH------IAQNES------  241 (317)
T ss_pred             ------cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH------HHhccC------
Confidence                  245788999999874   45689999999999999999999999875432221110      000000      


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHh
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML  358 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L  358 (437)
                      +.  .........+.+++.+||+.+|.+||++.+|++.+
T Consensus       242 ~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         242 PT--LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             CC--CCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence            00  01113345678899999999999999999998743

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.5e-38  Score=300.95  Aligned_cols=242  Identities=25%  Similarity=0.310  Sum_probs=186.9

Q ss_pred             eeccCCCeeEEEEEc-CCCcEEEEEEeccCC---hHHHHHHHHHHHHHHc---CCCCcceeeeeeeccCCceEEEEeecC
Q 013745           93 QLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLK---IQHKNLVTLFGCCAEGPEKMLVYEYLP  165 (437)
Q Consensus        93 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~---l~h~niv~l~~~~~~~~~~~lv~e~~~  165 (437)
                      .||+|+||.||++.. .+++.||+|.+....   ......+.+|..+++.   .+||||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999985 468999999886432   1222334455544443   479999999999999999999999999


Q ss_pred             CCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCccc
Q 013745          166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV  245 (437)
Q Consensus       166 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  245 (437)
                      +++|..++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++........  
T Consensus        81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~--  152 (279)
T cd05633          81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--  152 (279)
T ss_pred             CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCc--
Confidence            9999988743   346899999999999999999999998   99999999999999999999999999976543221  


Q ss_pred             ceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccC
Q 013745          246 NTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK  324 (437)
Q Consensus       246 ~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  324 (437)
                        ....|+..|+|||.+.. ..++.++|||||||++|||++|..||........... .   ....      ....   .
T Consensus       153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-~---~~~~------~~~~---~  217 (279)
T cd05633         153 --HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-D---RMTL------TVNV---E  217 (279)
T ss_pred             --cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH-H---HHhh------cCCc---C
Confidence              12468999999998874 5689999999999999999999999975433221111 0   0000      0011   1


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 013745          325 CNRDEAAMCIQLGLLCCQQSVAERP-----DMNSVHLM  357 (437)
Q Consensus       325 ~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~  357 (437)
                      .+...+..+.+++.+||+.+|++||     +++++++.
T Consensus       218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            1223445678899999999999999     59988763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=8e-38  Score=293.83  Aligned_cols=250  Identities=23%  Similarity=0.355  Sum_probs=205.0

Q ss_pred             CccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      +|.+.+.||.|+||.||++... +++.||+|++....  ......+.+|+++++.++|||++++++.+......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4888999999999999999854 68999999997543  24556788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          164 LPNKSLDYFIFDKT-KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       164 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      +++++|.+.+.... ....+++..+..++.+++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999885432 2367899999999999999999999998   9999999999999999999999999998765443


Q ss_pred             cccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccc
Q 013745          243 THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL  322 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  322 (437)
                      .  ......|++.|+|||.+.+..++.++||||||+++++|++|..||..........      .... .        ..
T Consensus       158 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~------~~~~-~--------~~  220 (258)
T cd08215         158 D--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELAL------KILK-G--------QY  220 (258)
T ss_pred             c--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHH------HHhc-C--------CC
Confidence            1  1223468899999999998889999999999999999999999997544221111      1100 0        01


Q ss_pred             cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          323 AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       323 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ...+......+.+++.+||..+|++||++.++++
T Consensus       221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1112234456788999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-38  Score=314.64  Aligned_cols=248  Identities=24%  Similarity=0.352  Sum_probs=205.8

Q ss_pred             HhcCccccceeccCCCeeEEEEE-cCCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      -.+.|.+...||+|.|+.|.+|+ ..++..||||.+.+.  +....+.+.+|+++|..|+|||||+++.+......+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            34679999999999999999998 447999999999865  333345588999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||+.+|.+.+++..   .+.+.+..+..++.|+.+|++|||+++   |+|||||++||||+.+.++||+|||++..+..
T Consensus       134 ~eya~~ge~~~yl~~---~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  134 MEYASGGELFDYLVK---HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EEeccCchhHHHHHh---cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence            999999999999954   345666888999999999999999998   99999999999999999999999999998864


Q ss_pred             CCcccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                      ...   ....+|++.|.|||++.+. ..++.+|+||+|+|||-|+.|..||++..-.+....+-               .
T Consensus       208 ~~~---lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl---------------~  269 (596)
T KOG0586|consen  208 GLM---LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVL---------------R  269 (596)
T ss_pred             ccc---ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhe---------------e
Confidence            332   3357999999999999987 45789999999999999999999999765433221100               0


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .. -..+.-...++.+++.+++-.+|.+|+++++|.+
T Consensus       270 gk-~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  270 GK-YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             ee-ecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence            00 0112233445678888999999999999999964

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=5.9e-38  Score=299.55  Aligned_cols=244  Identities=27%  Similarity=0.355  Sum_probs=192.5

Q ss_pred             eccCCCeeEEEEEc-CCCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCCCCc
Q 013745           94 LGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL  169 (437)
Q Consensus        94 lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  169 (437)
                      ||+|+||+||+|.. .+|+.||+|++....   ......+.+|++++++++||||+++++.+...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            69999999999984 478999999986432   22344567899999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccceee
Q 013745          170 DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR  249 (437)
Q Consensus       170 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  249 (437)
                      .+++..... ..+++..++.++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||++........   ...
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~  153 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKG  153 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---ccc
Confidence            988854332 46899999999999999999999998   99999999999999999999999999986543211   112


Q ss_pred             eecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHH
Q 013745          250 ISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDE  329 (437)
Q Consensus       250 ~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  329 (437)
                      ..++..|+|||++.+..++.++|||||||++|+|++|+.||...........+..  .          +.......+...
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~----------~~~~~~~~~~~~  221 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKR--R----------TLEMAVEYPDKF  221 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHh--c----------cccccccCCccC
Confidence            4578899999999888899999999999999999999999976443111111000  0          000011122233


Q ss_pred             HHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 013745          330 AAMCIQLGLLCCQQSVAERP-----DMNSVHL  356 (437)
Q Consensus       330 ~~~l~~l~~~cl~~~p~~RP-----s~~ev~~  356 (437)
                      ...+.+++.+||+.+|.+||     ++.+++.
T Consensus       222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            55678999999999999999     6666653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=5.3e-38  Score=297.03  Aligned_cols=242  Identities=24%  Similarity=0.319  Sum_probs=195.1

Q ss_pred             eccCCCeeEEEEEcC-CCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCCCCc
Q 013745           94 LGHGGFGPVYRGLMP-NGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL  169 (437)
Q Consensus        94 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  169 (437)
                      ||.|+||.||+|+.. +++.||+|++....   ......+.+|+.++++++||||+++++.+.++...++||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            799999999999954 58999999986542   23446789999999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccceee
Q 013745          170 DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR  249 (437)
Q Consensus       170 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  249 (437)
                      .+++..   ...+++..+..++.||+.||.|||+.+   ++|+||||+||+++.++.+||+|||++.......   ....
T Consensus        81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~  151 (262)
T cd05572          81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT  151 (262)
T ss_pred             HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence            998843   245889999999999999999999988   9999999999999999999999999998765432   1223


Q ss_pred             eecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHH
Q 013745          250 ISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDE  329 (437)
Q Consensus       250 ~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  329 (437)
                      ..|+..|++||.+....++.++|+||||+++|+|++|..||....... ....   ......        ......+...
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~---~~~~~~--------~~~~~~~~~~  219 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-MEIY---NDILKG--------NGKLEFPNYI  219 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-HHHH---HHHhcc--------CCCCCCCccc
Confidence            468899999999988889999999999999999999999997654211 1111   111100        0001112222


Q ss_pred             HHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 013745          330 AAMCIQLGLLCCQQSVAERPD-----MNSVHL  356 (437)
Q Consensus       330 ~~~l~~l~~~cl~~~p~~RPs-----~~ev~~  356 (437)
                      ...+.+++.+||+.+|++||+     ++|+++
T Consensus       220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            567889999999999999999     677665

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-39  Score=289.59  Aligned_cols=251  Identities=24%  Similarity=0.386  Sum_probs=198.5

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCC-CCcceeeeeeeccCCceEEEEe
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      ++.+++..||.|..|.||++..+ +|...|||.+... +.....+++..+.++...+ +|.||+++|+|..+...++.||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            44566788999999999999854 6889999999765 4555677888888887775 9999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      .| ...++.++.  .-.+++++..+-++...++.||.||-++.  +|||||+||+|||+|+.|++||||||++..+-+..
T Consensus       172 lM-s~C~ekLlk--rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk  246 (391)
T KOG0983|consen  172 LM-STCAEKLLK--RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK  246 (391)
T ss_pred             HH-HHHHHHHHH--HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc
Confidence            98 445666653  23467899999999999999999999875  69999999999999999999999999998775443


Q ss_pred             cccceeeeecccccCChhhhccC---cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          243 THVNTFRISGTHGYMAPEYALHG---YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~---~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                      ...   ...|-+.|||||.+.-.   .|+.++||||||+.|+||.||+.||.+....  .+   ...++.+.      ..
T Consensus       247 Aht---rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe---~ltkvln~------eP  312 (391)
T KOG0983|consen  247 AHT---RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FE---VLTKVLNE------EP  312 (391)
T ss_pred             ccc---cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HH---HHHHHHhc------CC
Confidence            332   34689999999998643   7999999999999999999999999874321  11   11111111      11


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      |.+... ...+..+.+++..|++.|+.+||.+.++++
T Consensus       313 P~L~~~-~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  313 PLLPGH-MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             CCCCcc-cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            333211 125566889999999999999999999865

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=297.53  Aligned_cols=261  Identities=25%  Similarity=0.321  Sum_probs=196.4

Q ss_pred             ccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHcC---CCCcceeeeeeeccCCc-----
Q 013745           88 FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS--RQGLREFTNEVKLLLKI---QHKNLVTLFGCCAEGPE-----  156 (437)
Q Consensus        88 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----  156 (437)
                      |++.+.||+|+||.||+|+.+ +++.||+|++....  ......+.+|+.++.++   +|+||+++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            677899999999999999965 58999999997432  22234566788777666   59999999999988776     


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                      .+++|||+.+ +|.+++... ....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhccc-CHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            8999999964 787776432 2246899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccc---
Q 013745          237 LFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEK---  313 (437)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---  313 (437)
                      .+......   ....++..|+|||++.+..++.++|||||||++|||++|.+||......+....+...........   
T Consensus       156 ~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         156 IYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             eccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence            76543221   123478899999999999999999999999999999999999986554332211110000000000   


Q ss_pred             --------cccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          314 --------ALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       314 --------~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                              .............+.....+.+++.+||+.+|++||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                    0000001111222344567789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.1e-38  Score=308.05  Aligned_cols=266  Identities=24%  Similarity=0.333  Sum_probs=199.0

Q ss_pred             HHHHHHHhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccC
Q 013745           78 LRTLQVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG  154 (437)
Q Consensus        78 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  154 (437)
                      ..++....++|.+.+.||+|+||.||+|.. .+++.||+|++...  .....+.+.+|+.++++++||||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            345556778999999999999999999984 57899999998753  222345678899999999999999999987543


Q ss_pred             ------CceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCce
Q 013745          155 ------PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPK  228 (437)
Q Consensus       155 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~k  228 (437)
                            ...+++++++ +++|..++.    ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+|
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence                  3467888887 788887763    235899999999999999999999998   99999999999999999999


Q ss_pred             eeecccccccCCCCcccceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhh
Q 013745          229 ISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWT  307 (437)
Q Consensus       229 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~  307 (437)
                      |+|||+++......     ....++..|+|||++.+ ..++.++|||||||++|||++|+.||...........+.....
T Consensus       161 l~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (345)
T cd07877         161 ILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG  235 (345)
T ss_pred             Eecccccccccccc-----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            99999998653221     13457899999998876 4688999999999999999999999976443222111100000


Q ss_pred             --------hhcccc---cccccC----ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          308 --------LFQGEK---ALELVD----PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       308 --------~~~~~~---~~~~~d----~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                              ......   ....+.    .............+.+++.+|++.+|.+||++.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence                    000000   000000    0000111123456789999999999999999999875

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-38  Score=296.57  Aligned_cols=247  Identities=23%  Similarity=0.265  Sum_probs=192.9

Q ss_pred             ceeccCCCeeEEEEEc-CCCcEEEEEEeccCC---hHHHHHHHHHHHHH-HcCCCCcceeeeeeeccCCceEEEEeecCC
Q 013745           92 NQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLL-LKIQHKNLVTLFGCCAEGPEKMLVYEYLPN  166 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  166 (437)
                      +.||+|+||.||+|.. .+++.||||.+....   ......+..|..++ ...+|+||+++++++..++..++||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5699999999999985 468999999986542   22223345555544 445899999999999999999999999999


Q ss_pred             CCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccc
Q 013745          167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN  246 (437)
Q Consensus       167 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  246 (437)
                      ++|..++..   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++......     
T Consensus        82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-----  150 (260)
T cd05611          82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-----  150 (260)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecccc-----
Confidence            999998843   246889999999999999999999988   999999999999999999999999998765331     


Q ss_pred             eeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCC
Q 013745          247 TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCN  326 (437)
Q Consensus       247 ~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  326 (437)
                       ....|+..|+|||.+.+..++.++||||||+++|||++|..||...........+.       .... . ...   ...
T Consensus       151 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------~~~~-~-~~~---~~~  217 (260)
T cd05611         151 -KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNIL-------SRRI-N-WPE---EVK  217 (260)
T ss_pred             -ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-------hccc-C-CCC---ccc
Confidence             13457889999999988889999999999999999999999997654332211110       0000 0 000   111


Q ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCCC
Q 013745          327 RDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDS  362 (437)
Q Consensus       327 ~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~  362 (437)
                      ...+..+.+++.+||+.+|++||++.++.+.|....
T Consensus       218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~  253 (260)
T cd05611         218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPF  253 (260)
T ss_pred             ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChH
Confidence            134466889999999999999998887777776543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3.4e-38  Score=305.62  Aligned_cols=266  Identities=26%  Similarity=0.330  Sum_probs=195.6

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC------
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP------  155 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  155 (437)
                      .++|++.+.||+|+||.||+|... +++.||||++....  ......+.+|++++++++||||+++++++.+..      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999854 68999999886432  112245678999999999999999999875433      


Q ss_pred             --ceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecc
Q 013745          156 --EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG  233 (437)
Q Consensus       156 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG  233 (437)
                        ..++||||+.+ +|...+..  ....+++..+..++.|+++||.|||+++   |+|+||||+||++++++.+||+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              46999999965 56555532  2356999999999999999999999998   9999999999999999999999999


Q ss_pred             cccccCCCCccc---------ceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhh
Q 013745          234 LARLFPGEDTHV---------NTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS  303 (437)
Q Consensus       234 la~~~~~~~~~~---------~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~  303 (437)
                      +++.........         ......+++.|+|||++.+. .++.++|||||||++|||++|++||.+.........+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~  240 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF  240 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            998654322111         11234578899999988654 58999999999999999999999998655433222211


Q ss_pred             hhhhhhccc--------------ccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          304 YTWTLFQGE--------------KALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       304 ~~~~~~~~~--------------~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .........              .......+.+..........+.+++.+|++.+|.+|||+.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            111000000              00000011111111122356889999999999999999998864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=3.8e-38  Score=310.38  Aligned_cols=267  Identities=21%  Similarity=0.328  Sum_probs=196.8

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccC---------
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG---------  154 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------  154 (437)
                      ..+|.+.+.||.|+||.||+|.. .+|+.||+|++........+.+.+|++++++++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            36799999999999999999985 47899999998766555567788999999999999999999876543         


Q ss_pred             -----CceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEec-CCCCce
Q 013745          155 -----PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD-EQLNPK  228 (437)
Q Consensus       155 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~-~~~~~k  228 (437)
                           ...++||||++ ++|..++.    ...+++..++.++.||+.||.|||+.+   |+||||||+||+++ .++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence                 35789999996 58877762    245889999999999999999999988   99999999999997 456789


Q ss_pred             eeecccccccCCCCcccc-eeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhh
Q 013745          229 ISDFGLARLFPGEDTHVN-TFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTW  306 (437)
Q Consensus       229 l~DFGla~~~~~~~~~~~-~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~  306 (437)
                      |+|||+++.......... .....++..|+|||++.. ..++.++|||||||++|||++|+.||......+.........
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~  235 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV  235 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            999999986543211111 112357889999998755 468899999999999999999999997654332221111100


Q ss_pred             hhhcc---ccc-----------ccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--Hhc
Q 013745          307 TLFQG---EKA-----------LELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLS  359 (437)
Q Consensus       307 ~~~~~---~~~-----------~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~  359 (437)
                      .....   ...           .......+....+....++.+++.+||+.+|++||++.+|+.  +++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~  304 (342)
T cd07854         236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS  304 (342)
T ss_pred             CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccc
Confidence            00000   000           000000000111123456789999999999999999999974  454

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=292.61  Aligned_cols=247  Identities=28%  Similarity=0.412  Sum_probs=202.6

Q ss_pred             CccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCCh--HHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR--QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      +|++.+.||+|++|.||+|+.. +++.|++|.+.....  .....+.+|++++++++|+|++++++++.+....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4788999999999999999854 688999999976543  4567899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +++++|.+++...   ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            9999999988432   57899999999999999999999988   99999999999999999999999999987754433


Q ss_pred             ccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcccc
Q 013745          244 HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA  323 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  323 (437)
                      .  .....++..|+|||.+.+..++.++||||||+++|+|++|+.||........      .+..... .     .+   
T Consensus       155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~-~-----~~---  217 (254)
T cd06627         155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA------LFRIVQD-D-----HP---  217 (254)
T ss_pred             c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHhcc-C-----CC---
Confidence            2  1234678999999999888889999999999999999999999975432111      1111100 0     01   


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       324 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ..+......+.+++.+||+.+|++||++.+++.
T Consensus       218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            111123456788999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-37  Score=307.09  Aligned_cols=264  Identities=23%  Similarity=0.330  Sum_probs=198.4

Q ss_pred             HhcCccccceeccCCCeeEEEEE-cCCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC-----
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP-----  155 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  155 (437)
                      ..++|.+++.||+|+||.||+|. ..++..||||++...  .......+.+|+.++++++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            46789999999999999999998 447899999998643  2333456889999999999999999999987653     


Q ss_pred             -ceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccc
Q 013745          156 -EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL  234 (437)
Q Consensus       156 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl  234 (437)
                       ..++||||+ +++|..++.    ...+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccc
Confidence             358999999 778887773    346899999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCcccceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhh--------h
Q 013745          235 ARLFPGEDTHVNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSY--------T  305 (437)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~--------~  305 (437)
                      +.......     ....+++.|+|||++.+ ..++.++|+|||||++|+|++|+.||...........+..        .
T Consensus       165 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07880         165 ARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF  239 (343)
T ss_pred             ccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            98654321     12457889999999876 4688999999999999999999999976543211110000        0


Q ss_pred             hhhhccccc---cc----ccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          306 WTLFQGEKA---LE----LVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       306 ~~~~~~~~~---~~----~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                      .........   ..    .....+..........+.+++.+|++.+|++||++.+++.  +++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~  303 (343)
T cd07880         240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE  303 (343)
T ss_pred             HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhh
Confidence            000000000   00    0000011111233446789999999999999999999983  4543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-38  Score=300.81  Aligned_cols=263  Identities=28%  Similarity=0.413  Sum_probs=198.2

Q ss_pred             CccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHc--CCCCcceeeeeeeccCC----ceEEE
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLK--IQHKNLVTLFGCCAEGP----EKMLV  160 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~lv  160 (437)
                      ....++.||+|.||.||+|++ +++.||||++...   ..+.|.+|-+|.+.  ++|+||++|++.-....    +++||
T Consensus       211 pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             chhhHHHhhcCccceeehhhc-cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            344578899999999999998 5699999999643   34567777777665  57999999999876555    88999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcC------CCceEeeccCCCCEEecCCCCceeeeccc
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA------PARIIHRDIKASNILLDEQLNPKISDFGL  234 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------~~~iiHrDikp~NIll~~~~~~kl~DFGl  234 (437)
                      ++|.+.|+|.++|    ....++|....+++..+++||+|||+.-      +++|+|||||.+||||..++++.|+||||
T Consensus       287 t~fh~kGsL~dyL----~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  287 TEFHPKGSLCDYL----KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             eeeccCCcHHHHH----HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            9999999999999    4456999999999999999999999853      46799999999999999999999999999


Q ss_pred             ccccCCCCcccceeeeecccccCChhhhccCc-C-----CcccceehhhHHHHHHHhCCCCCCC-CCch-------hhh-
Q 013745          235 ARLFPGEDTHVNTFRISGTHGYMAPEYALHGY-L-----SVKTDVFSYGVLVLEIVSGRKNHDG-RLGK-------EKA-  299 (437)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~-----~~~~DvwSlG~vl~elltg~~p~~~-~~~~-------~~~-  299 (437)
                      |..+........+...+||.+|||||++.+.. +     -.+.||||+|.|||||++.-.-+.. ..+.       +.. 
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~  442 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN  442 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence            99987655555555578999999999997652 2     2358999999999999986544431 1110       000 


Q ss_pred             -hhhhhhhhhhcccccccccCccccCCCH--HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCC
Q 013745          300 -DLLSYTWTLFQGEKALELVDPSLAKCNR--DEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD  361 (437)
Q Consensus       300 -~~~~~~~~~~~~~~~~~~~d~~l~~~~~--~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~  361 (437)
                       --++.++....    .+...|.+++...  .....+.+.+..||+.||+.|.|+.=|-+.+...
T Consensus       443 hPt~e~mq~~VV----~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l  503 (534)
T KOG3653|consen  443 HPTLEEMQELVV----RKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL  503 (534)
T ss_pred             CCCHHHHHHHHH----hhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence             00111111111    1112223321111  3455678889999999999999999998887754

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.3e-37  Score=298.73  Aligned_cols=257  Identities=23%  Similarity=0.298  Sum_probs=201.4

Q ss_pred             CccccceeccCCCeeEEEEEc----CCCcEEEEEEeccCC----hHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCce
Q 013745           87 FFSDLNQLGHGGFGPVYRGLM----PNGQEIAVKKLSVDS----RQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEK  157 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  157 (437)
                      +|++.+.||+|+||.||+++.    .+++.||||++....    ......+.+|+.++.++ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            478899999999999999873    257889999986431    22345678999999999 599999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                      ++||||+++++|...+..   ...+++..+..++.|++++|.|||+.+   ++||||||.||+++.++.++|+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            999999999999888743   346889999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCCcccceeeeecccccCChhhhccCc--CCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccc
Q 013745          238 FPGEDTHVNTFRISGTHGYMAPEYALHGY--LSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKAL  315 (437)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~--~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (437)
                      +....... .....|+..|+|||.+.+..  .+.++||||||+++|||++|..||..........  .........    
T Consensus       155 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~--~~~~~~~~~----  227 (288)
T cd05583         155 FLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS--EISRRILKS----  227 (288)
T ss_pred             cccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHH--HHHHHHHcc----
Confidence            64332211 12345889999999987764  7889999999999999999999996432211110  111111100    


Q ss_pred             cccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCCC
Q 013745          316 ELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDS  362 (437)
Q Consensus       316 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~  362 (437)
                         .+   ..+......+.+++.+||+.+|++|||+.++.+.|+...
T Consensus       228 ---~~---~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~  268 (288)
T cd05583         228 ---KP---PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF  268 (288)
T ss_pred             ---CC---CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence               01   112223456788999999999999999999999888654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=7.5e-38  Score=298.25  Aligned_cols=249  Identities=22%  Similarity=0.317  Sum_probs=202.2

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCC-CCcceeeeeeeccCCceEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  160 (437)
                      ++|.+.+.||+|+||.||+|... +++.||+|++...   .......+.+|+.++++++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46889999999999999999854 7999999998653   2333467889999999998 99999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||+++++|.+++..   ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            999999999998843   346999999999999999999999988   99999999999999999999999999987654


Q ss_pred             CCcc------------------cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhh
Q 013745          241 EDTH------------------VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLL  302 (437)
Q Consensus       241 ~~~~------------------~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~  302 (437)
                      ....                  .......++..|+|||++....++.++||||||+++++|++|+.||..........  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~--  232 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQ--  232 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHH--
Confidence            3321                  11223457889999999998889999999999999999999999998654221111  


Q ss_pred             hhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHH
Q 013745          303 SYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDM----NSVHL  356 (437)
Q Consensus       303 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~----~ev~~  356 (437)
                       ...   .       ..   ...+...+..+.+++.+||+.+|.+||++    .+++.
T Consensus       233 -~~~---~-------~~---~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         233 -KIL---K-------LE---YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             -HHH---h-------cC---CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence             000   0       00   01112235567899999999999999999    76653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-37  Score=293.38  Aligned_cols=250  Identities=24%  Similarity=0.350  Sum_probs=196.6

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC-----ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccC--Cce
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD-----SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG--PEK  157 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  157 (437)
                      .+|++.+.||+|+||.||+|.. .+++.||+|++...     .......+.+|++++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4689999999999999999985 46899999987532     223456788999999999999999999998664  457


Q ss_pred             EEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                      ++||||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            899999999999988843   245888999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCc-ccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccc
Q 013745          238 FPGEDT-HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE  316 (437)
Q Consensus       238 ~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (437)
                      ...... ........|+..|+|||++.+..++.++|||||||++|||++|+.||.........   .   .....     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~---~~~~~-----  224 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI---F---KIATQ-----  224 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH---H---HHHcC-----
Confidence            532111 11112345889999999999888999999999999999999999999754222111   0   01000     


Q ss_pred             ccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          317 LVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       317 ~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                         +.....+......+.+++.+||+ +|..||+..+++.
T Consensus       225 ---~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         225 ---PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             ---CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence               00111233445668889999999 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.1e-38  Score=306.55  Aligned_cols=267  Identities=25%  Similarity=0.324  Sum_probs=204.2

Q ss_pred             CccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC-----ceE
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP-----EKM  158 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  158 (437)
                      +|++.+.||.|+||.||+|+.. +++.||||++....  ....+.+.+|+.+++.++|+||+++++++....     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5888999999999999999954 58999999987543  334567889999999999999999999988775     789


Q ss_pred             EEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccccc
Q 013745          159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                      +||||++ ++|..++..   ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.++|+|||++...
T Consensus        81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            9999997 578777732   237899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcc-cceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhc------
Q 013745          239 PGEDTH-VNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQ------  310 (437)
Q Consensus       239 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~------  310 (437)
                      ...... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+....+........      
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  233 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF  233 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence            543210 111234578899999999888 899999999999999999999999987654332221111110000      


Q ss_pred             --ccccccccC-------ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          311 --GEKALELVD-------PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       311 --~~~~~~~~d-------~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                        .....+.+.       ..+....+..+..+.+++.+||+.+|++||++.+++.  ++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~  294 (330)
T cd07834         234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQ  294 (330)
T ss_pred             ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHh
Confidence              000000000       0001112234567889999999999999999999986  4553

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-37  Score=296.65  Aligned_cols=261  Identities=25%  Similarity=0.304  Sum_probs=196.7

Q ss_pred             ccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCCh-HHHHHHHHHHHHHHcCC-CCcceeeeeeeccCCceEEEEeec
Q 013745           88 FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        88 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      |.+.+.||+|+||.||+|+.. +++.||||++..... .......+|+..+++++ |+||+++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            677899999999999999964 578899999865422 22234567999999999 999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                       +++|.+.+.... ...+++..++.++.|++.+|.|||+++   ++|+||+|+||+++.++.++|+|||++.........
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY  155 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCCc
Confidence             788888774432 346899999999999999999999988   999999999999999999999999999876433221


Q ss_pred             cceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhh----------hhhhhhcccc
Q 013745          245 VNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS----------YTWTLFQGEK  313 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~----------~~~~~~~~~~  313 (437)
                         ....++..|+|||++.. ..++.++|+||||+++|||++|+.||......+......          |.........
T Consensus       156 ---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         156 ---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             ---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence               12457889999998754 468999999999999999999999997654432211100          0000000000


Q ss_pred             cccccC----ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          314 ALELVD----PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       314 ~~~~~d----~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ....+.    ..+..........+.+++.+||+.+|++||+++||+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            000000    0011111122466889999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.2e-37  Score=300.44  Aligned_cols=246  Identities=30%  Similarity=0.439  Sum_probs=194.7

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      +.|...+.||+|+||.||+|+. .+++.+|+|.+...   .......+.+|+++++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            3477889999999999999985 46889999998642   2334467889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      ||+. |+|.+.+..  ....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++......
T Consensus        95 e~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          95 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             EccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            9996 577666532  2345889999999999999999999988   999999999999999999999999999765432


Q ss_pred             CcccceeeeecccccCChhhhc---cCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          242 DTHVNTFRISGTHGYMAPEYAL---HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      .      ...|+..|+|||++.   ...++.++|||||||++|+|++|..||......+...      .... ..     
T Consensus       169 ~------~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~~~-~~-----  230 (308)
T cd06634         169 N------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQ-NE-----  230 (308)
T ss_pred             c------cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH------HHhh-cC-----
Confidence            1      245788999999875   3468899999999999999999999986543221111      0000 00     


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLM  357 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  357 (437)
                      .+..  ........+.+++.+||+.+|++||++.+|++.
T Consensus       231 ~~~~--~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         231 SPAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             CCCc--CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence            0110  112344567889999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.7e-38  Score=307.81  Aligned_cols=262  Identities=24%  Similarity=0.335  Sum_probs=195.0

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC------
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP------  155 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  155 (437)
                      .++|.+.+.||+|+||.||+|+. .+|+.||||++...  .......+.+|+.++++++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            47899999999999999999985 47899999998643  2223356789999999999999999999986543      


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccc
Q 013745          156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA  235 (437)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  235 (437)
                      ..++|+||+.. +|..++     ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            46899999954 665543     235889999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcccceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhh-------
Q 013745          236 RLFPGEDTHVNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWT-------  307 (437)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~-------  307 (437)
                      +......     ....++..|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+.....       
T Consensus       165 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07879         165 RHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV  239 (342)
T ss_pred             cCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            8653321     13457889999999876 4689999999999999999999999986543221111110000       


Q ss_pred             -hhccc---ccccc----cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          308 -LFQGE---KALEL----VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       308 -~~~~~---~~~~~----~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                       .....   .....    ....+....+.....+.+++.+||+.+|++||++.+++.  +++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~  302 (342)
T cd07879         240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS  302 (342)
T ss_pred             HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhh
Confidence             00000   00000    000001111123456789999999999999999999984  4554

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2e-37  Score=296.29  Aligned_cols=241  Identities=25%  Similarity=0.315  Sum_probs=186.8

Q ss_pred             eeccCCCeeEEEEEc-CCCcEEEEEEeccCC---hHHHHHHHHHHH---HHHcCCCCcceeeeeeeccCCceEEEEeecC
Q 013745           93 QLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVK---LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLP  165 (437)
Q Consensus        93 ~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  165 (437)
                      .||+|+||.||+|.. .+++.||+|++....   ......+..|..   .++...||||+.+++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999985 468899999986532   111222334443   4444579999999999999999999999999


Q ss_pred             CCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCccc
Q 013745          166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV  245 (437)
Q Consensus       166 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  245 (437)
                      |++|..++.   ....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++..+.....  
T Consensus        81 g~~L~~~l~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~--  152 (278)
T cd05606          81 GGDLHYHLS---QHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP--  152 (278)
T ss_pred             CCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC--
Confidence            999988873   2356999999999999999999999988   99999999999999999999999999976543221  


Q ss_pred             ceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccC
Q 013745          246 NTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK  324 (437)
Q Consensus       246 ~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  324 (437)
                        ....|+..|+|||++.++ .++.++|||||||++|||++|+.||........... ..  ..       ....+.+  
T Consensus       153 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~-~~--~~-------~~~~~~~--  218 (278)
T cd05606         153 --HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DR--MT-------LTMAVEL--  218 (278)
T ss_pred             --cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH-HH--Hh-------hccCCCC--
Confidence              134689999999998755 689999999999999999999999976533221111 00  00       0011111  


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 013745          325 CNRDEAAMCIQLGLLCCQQSVAERP-----DMNSVHL  356 (437)
Q Consensus       325 ~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~  356 (437)
                       +...+..+.+++.+|++.+|.+||     ++.++++
T Consensus       219 -~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         219 -PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             -CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence             112345688899999999999999     8989875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.2e-37  Score=299.25  Aligned_cols=251  Identities=24%  Similarity=0.311  Sum_probs=195.4

Q ss_pred             CccccceeccCCCeeEEEEEc----CCCcEEEEEEeccCC----hHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCce
Q 013745           87 FFSDLNQLGHGGFGPVYRGLM----PNGQEIAVKKLSVDS----RQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEK  157 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  157 (437)
                      +|++.+.||.|+||.||+|..    .+|+.||+|++....    ....+.+.+|+.+++++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            478899999999999999974    368999999986432    22345678899999999 599999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                      ++||||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            999999999999998843   346888999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCcccceeeeecccccCChhhhccC--cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccc
Q 013745          238 FPGEDTHVNTFRISGTHGYMAPEYALHG--YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKAL  315 (437)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (437)
                      ........ .....|+..|+|||.+...  .++.++||||||+++|+|++|..||.........  ..........    
T Consensus       155 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~----  227 (290)
T cd05613         155 FHEDEVER-AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKS----  227 (290)
T ss_pred             cccccccc-cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH--HHHHHHhhcc----
Confidence            64332221 2235689999999998753  4788999999999999999999999643221111  1111111110    


Q ss_pred             cccCccccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 013745          316 ELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERP-----DMNSVHL  356 (437)
Q Consensus       316 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~  356 (437)
                         .+   ..+......+.+++.+||+.+|++||     ++.+++.
T Consensus       228 ---~~---~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         228 ---EP---PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ---CC---CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence               01   11223445678899999999999997     5666644

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=299.83  Aligned_cols=243  Identities=25%  Similarity=0.318  Sum_probs=200.7

Q ss_pred             HHhcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC---ChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCce
Q 013745           83 VATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD---SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEK  157 (437)
Q Consensus        83 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  157 (437)
                      +-..+|.++.+||+|+||.|.+|..+ +.+.||||+++++   ...+.+--+.|-++|... +-|.++++..+|+.-+.+
T Consensus       346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL  425 (683)
T KOG0696|consen  346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL  425 (683)
T ss_pred             eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence            33456889999999999999999744 6778999999865   233345556788888776 478999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                      |+||||+.||+|-..+.   .-+.+.+..+..+|..||-||-+||+++   ||+||||.+|||||.+|++||+|||+++.
T Consensus       426 yFVMEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKE  499 (683)
T KOG0696|consen  426 YFVMEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE  499 (683)
T ss_pred             eeEEEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccc
Confidence            99999999999988774   3456888899999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccc
Q 013745          238 FPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALEL  317 (437)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (437)
                      --...  ..+..++||+.|+|||++..++|+..+|+|||||+||||+.|++||++....+....+....           
T Consensus       500 ni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn-----------  566 (683)
T KOG0696|consen  500 NIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN-----------  566 (683)
T ss_pred             cccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc-----------
Confidence            43322  23446899999999999999999999999999999999999999999877655443322111           


Q ss_pred             cCccccCCCHHHHHHHHHHHHHcCCCCCCCCC
Q 013745          318 VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERP  349 (437)
Q Consensus       318 ~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RP  349 (437)
                           ..++...+.+...++...+...|.+|.
T Consensus       567 -----vsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  567 -----VSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             -----CcCcccccHHHHHHHHHHhhcCCcccc
Confidence                 133445667778888899999999984

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4e-37  Score=299.04  Aligned_cols=261  Identities=19%  Similarity=0.193  Sum_probs=194.2

Q ss_pred             cccceeccCCCeeEEEEEcCCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCC
Q 013745           89 SDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN  166 (437)
Q Consensus        89 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  166 (437)
                      .+.+.+|.|+++.||++.. +++.||||++...  .......+.+|+.++++++|+||+++++++.+....+++|||+++
T Consensus         5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            3445556666666666555 7899999998754  344567899999999999999999999999999999999999999


Q ss_pred             CCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc--
Q 013745          167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH--  244 (437)
Q Consensus       167 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~--  244 (437)
                      ++|.+++.... ...+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||.+.........  
T Consensus        84 ~~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          84 GSCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             CCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence            99999885432 345889999999999999999999998   999999999999999999999999998765322111  


Q ss_pred             ---cceeeeecccccCChhhhccC--cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhh----hhcc----
Q 013745          245 ---VNTFRISGTHGYMAPEYALHG--YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWT----LFQG----  311 (437)
Q Consensus       245 ---~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~----~~~~----  311 (437)
                         .......++..|+|||++...  .++.++|||||||++|||++|+.||........  .+.....    ....    
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~  237 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYP  237 (314)
T ss_pred             ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchh
Confidence               111123467889999998763  588999999999999999999999976432211  1110000    0000    


Q ss_pred             ---ccccc----ccCcc-----ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          312 ---EKALE----LVDPS-----LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       312 ---~~~~~----~~d~~-----l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                         .....    ..++.     ...........+.+++.+||+.+|++||+++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence               00000    00000     01223344567889999999999999999999976

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=4e-38  Score=315.03  Aligned_cols=202  Identities=29%  Similarity=0.425  Sum_probs=175.0

Q ss_pred             ccccceeccCCCeeEEEEE-cCCCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC------ceEE
Q 013745           88 FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP------EKML  159 (437)
Q Consensus        88 y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~l  159 (437)
                      +...+.||+||||.||+|+ ..+|+.||||.+... .....+...+|+++|++|+|+|||++++.-.+..      ...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            4456789999999999999 558999999999754 3344567789999999999999999999865543      5689


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEec--CCC--Cceeeecccc
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD--EQL--NPKISDFGLA  235 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~--~~~--~~kl~DFGla  235 (437)
                      |||||.+|+|...+.+..+...+++.+.+.++..++.||.|||+++   |+||||||.||++-  .+|  .-||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            9999999999999988888889999999999999999999999988   99999999999983  323  4699999999


Q ss_pred             cccCCCCcccceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCc
Q 013745          236 RLFPGEDTHVNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLG  295 (437)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~  295 (437)
                      +.+++..   ....++||..|++||+... +.|+..+|.|||||++|+++||..||....+
T Consensus       172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~  229 (732)
T KOG4250|consen  172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG  229 (732)
T ss_pred             ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence            9887654   3346789999999999984 8999999999999999999999999975443

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.5e-37  Score=305.01  Aligned_cols=265  Identities=21%  Similarity=0.246  Sum_probs=196.0

Q ss_pred             hcCccc-cceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHH--------------HHHHHHHHHHHHcCCCCcceeee
Q 013745           85 TNFFSD-LNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQG--------------LREFTNEVKLLLKIQHKNLVTLF  148 (437)
Q Consensus        85 ~~~y~~-~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~  148 (437)
                      .++|.. .+.||.|+||+||+|... +++.||||++.......              ...+.+|++++++++|+||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            355654 467999999999999854 78999999986432111              12467899999999999999999


Q ss_pred             eeeccCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCce
Q 013745          149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPK  228 (437)
Q Consensus       149 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~k  228 (437)
                      +++..+...++||||+. ++|.+++..   ...+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.+|
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k  159 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK  159 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence            99999999999999996 588887732   345889999999999999999999988   99999999999999999999


Q ss_pred             eeecccccccCCCCc------------ccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCc
Q 013745          229 ISDFGLARLFPGEDT------------HVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLG  295 (437)
Q Consensus       229 l~DFGla~~~~~~~~------------~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~  295 (437)
                      |+|||++........            ........++..|+|||++.+. .++.++|||||||++|||++|..||.+...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~  239 (335)
T PTZ00024        160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE  239 (335)
T ss_pred             ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999987641110            0011123467889999998765 479999999999999999999999986654


Q ss_pred             hhhhhhhhhhhhh-----hcccc-------cccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          296 KEKADLLSYTWTL-----FQGEK-------ALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       296 ~~~~~~~~~~~~~-----~~~~~-------~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .+....+......     +....       ......+............+.+++.+||+.+|++||++.+++.
T Consensus       240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            3322111110000     00000       0000001111111223456789999999999999999999985

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.3e-38  Score=290.36  Aligned_cols=206  Identities=26%  Similarity=0.390  Sum_probs=170.8

Q ss_pred             hcCccccceeccCCCeeEEEEEcC---C--CcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeecc-CCc
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP---N--GQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAE-GPE  156 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~---~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  156 (437)
                      ...|+.+..||+|.||.||+|+-.   +  ...+|||+++..+  ..-.....+|+.+++.++||||+.+..+|.. +..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            356999999999999999999622   2  3368999997542  1222456789999999999999999999987 788


Q ss_pred             eEEEEeecCCCCcchhhhc--cCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCC----CCceee
Q 013745          157 KMLVYEYLPNKSLDYFIFD--KTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ----LNPKIS  230 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~----~~~kl~  230 (437)
                      ++|++||.+. +|..+|.-  ......++...+..|+.||+.|+.|||++.   |+||||||.||||..+    |.|||+
T Consensus       103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa  178 (438)
T KOG0666|consen  103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA  178 (438)
T ss_pred             EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence            9999999976 66666642  223357889999999999999999999998   9999999999999877    999999


Q ss_pred             ecccccccCCCCccc-ceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCC
Q 013745          231 DFGLARLFPGEDTHV-NTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRL  294 (437)
Q Consensus       231 DFGla~~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~  294 (437)
                      |||+++.+...-... ....++-|.+|.|||++.+. .|+.+.|||+.|||+.||+|-++.|.+..
T Consensus       179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E  244 (438)
T KOG0666|consen  179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE  244 (438)
T ss_pred             cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence            999999986543222 33456779999999999886 69999999999999999999999997654

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.2e-37  Score=305.00  Aligned_cols=262  Identities=26%  Similarity=0.355  Sum_probs=197.5

Q ss_pred             HHhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeecc-CCceE
Q 013745           83 VATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE-GPEKM  158 (437)
Q Consensus        83 ~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~  158 (437)
                      ..+++|++.+.||.|+||.||+|.. .+++.||||++...  .......+.+|+.++++++||||++++++|.. ....+
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            4578899999999999999999984 47899999988643  22334667899999999999999999999865 56789


Q ss_pred             EEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccccc
Q 013745          159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                      +||||+ +++|..++.    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        87 lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~  158 (328)
T cd07856          87 FVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ  158 (328)
T ss_pred             EEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence            999998 568877762    345788888999999999999999998   999999999999999999999999999765


Q ss_pred             CCCCcccceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhh--------hhhh
Q 013745          239 PGEDTHVNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYT--------WTLF  309 (437)
Q Consensus       239 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~  309 (437)
                      ....     ....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+...        ....
T Consensus       159 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd07856         159 DPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI  233 (328)
T ss_pred             CCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            3221     12356889999998766 57899999999999999999999999765432221111100        0000


Q ss_pred             cccccccccCc-------cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013745          310 QGEKALELVDP-------SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLM  357 (437)
Q Consensus       310 ~~~~~~~~~d~-------~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  357 (437)
                      ......+.+..       ......+.....+.+++.+|++.+|++||++.+++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000000000       0000111234678899999999999999999998653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.6e-38  Score=312.73  Aligned_cols=249  Identities=24%  Similarity=0.362  Sum_probs=195.1

Q ss_pred             ccceeccCCCeeEEEEEcC-CCcEEEE---EEecc-CChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCc--eEEEEe
Q 013745           90 DLNQLGHGGFGPVYRGLMP-NGQEIAV---KKLSV-DSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE--KMLVYE  162 (437)
Q Consensus        90 ~~~~lG~G~~g~Vy~~~~~-~~~~vav---K~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e  162 (437)
                      +..+||+|+|-+||+|.+. +|-.||-   |.-.. ......+.|..|+.+|+.|+|||||++|++|.+...  ..+|+|
T Consensus        44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence            3567999999999999864 5777763   32221 244556889999999999999999999999987655  778999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC-CCCceeeecccccccCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE-QLNPKISDFGLARLFPGE  241 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~-~~~~kl~DFGla~~~~~~  241 (437)
                      .+..|+|..++.+   ...++...+..|++||++||.|||++. ++|||||||-+||+|+. -|.|||+|.|||......
T Consensus       124 L~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  124 LFTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             cccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            9999999999843   356888999999999999999999998 56999999999999975 589999999999987543


Q ss_pred             CcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                      ..    ..+.|||.|||||+.. ..|+..+||||||+.++||+|+..||..-.+...      .++....+....    .
T Consensus       200 ~a----ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ------IYKKV~SGiKP~----s  264 (632)
T KOG0584|consen  200 HA----KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ------IYKKVTSGIKPA----A  264 (632)
T ss_pred             cc----ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH------HHHHHHcCCCHH----H
Confidence            32    2478999999999776 7899999999999999999999999976443322      122111111111    1


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcCC
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSGD  361 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~~  361 (437)
                      +...   ...++.++|.+|+.. .++||++.|++.  +|..+
T Consensus       265 l~kV---~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  265 LSKV---KDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             hhcc---CCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            1111   124567888899999 999999999985  66654

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=4.8e-37  Score=291.96  Aligned_cols=243  Identities=20%  Similarity=0.246  Sum_probs=189.2

Q ss_pred             hcCcccccee--ccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCceEEE
Q 013745           85 TNFFSDLNQL--GHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        85 ~~~y~~~~~l--G~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  160 (437)
                      .++|++.+.+  |+|+||.||++.. .++..+|+|.+.......     .|+.....+ +||||++++++|...+..++|
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv   87 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLI   87 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEE
Confidence            4667777777  9999999999984 478889999986542211     122222222 699999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCC-CceeeecccccccC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL-NPKISDFGLARLFP  239 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~-~~kl~DFGla~~~~  239 (437)
                      |||+++++|.+++...   ..+++..++.++.|++.||.|||+.+   ++||||||+||+++.++ .++|+|||++....
T Consensus        88 ~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~  161 (267)
T PHA03390         88 MDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG  161 (267)
T ss_pred             EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence            9999999999988432   37899999999999999999999998   99999999999999988 99999999998764


Q ss_pred             CCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                      ...      ...|+..|+|||++.+..++.++|||||||++|||++|+.||....... .....+.... .         
T Consensus       162 ~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~---------  224 (267)
T PHA03390        162 TPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ-Q---------  224 (267)
T ss_pred             CCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh-c---------
Confidence            332      2357899999999998899999999999999999999999997543322 1111111111 0         


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHH
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPD-MNSVHL  356 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~ev~~  356 (437)
                      .. ..........+.+++.+||+.+|.+||+ ++++++
T Consensus       225 ~~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        225 KK-LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             cc-CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            00 0111234556888999999999999996 688863

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=5.3e-37  Score=300.42  Aligned_cols=261  Identities=22%  Similarity=0.311  Sum_probs=192.3

Q ss_pred             ceeccC--CCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCC
Q 013745           92 NQLGHG--GFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN  166 (437)
Q Consensus        92 ~~lG~G--~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  166 (437)
                      ..||+|  +||+||+|.. .+|+.||+|++...  .....+.+.+|+.+++.++||||++++++|..++..++||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456666  9999999985 47999999998743  233456788999999999999999999999999999999999999


Q ss_pred             CCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccc
Q 013745          167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN  246 (437)
Q Consensus       167 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  246 (437)
                      ++|.+++.... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+|++||+.+...........
T Consensus        84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            99998875432 245889999999999999999999988   99999999999999999999999986543322111100


Q ss_pred             -----eeeeecccccCChhhhccC--cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhh-hhhhh------hhhhcc-
Q 013745          247 -----TFRISGTHGYMAPEYALHG--YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKAD-LLSYT------WTLFQG-  311 (437)
Q Consensus       247 -----~~~~~gt~~Y~aPE~~~~~--~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~-~~~~~------~~~~~~-  311 (437)
                           .....++..|+|||++.+.  .++.++|||||||++|||++|+.||.......... .+...      ...+.. 
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence                 0012346679999999764  47899999999999999999999997654322110 00000      000000 


Q ss_pred             --------ccc----c----------cccCccc-cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          312 --------EKA----L----------ELVDPSL-AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       312 --------~~~----~----------~~~d~~l-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                              ...    .          ...+..+ ..........+.+++.+||+.+|++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                    000    0          0000011 1112345677899999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.8e-37  Score=290.82  Aligned_cols=249  Identities=23%  Similarity=0.299  Sum_probs=195.2

Q ss_pred             CccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC-----ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD-----SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      +|.+.+.||+|+||.||++... .+..+++|+++..     .......+..|+.++++++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            4888999999999999999853 3455566655421     122334567899999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          161 YEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      |||+++++|..++... .....+++..++.++.|++.||.|||+.+   ++|+||||+||+++. +.+||+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999887542 23457899999999999999999999988   999999999999975 569999999998764


Q ss_pred             CCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                      .....  .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||........      ......         
T Consensus       157 ~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~------~~~~~~---------  219 (260)
T cd08222         157 GSCDL--ATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV------VLRIVE---------  219 (260)
T ss_pred             CCccc--ccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH------HHHHHc---------
Confidence            33221  1134578899999999888889999999999999999999999964332111      111110         


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ......+...+..+.+++.+||+.+|++||++.++++
T Consensus       220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         220 GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            1111223345567889999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=4.4e-37  Score=296.48  Aligned_cols=252  Identities=25%  Similarity=0.416  Sum_probs=193.3

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCC-CCcceeeeeeeccCCceEEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  161 (437)
                      -++|++.+.||+|+||.||+|... +++.||||++.... ......+..|+.++.++. ||||+++++++.+....++||
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            356889999999999999999965 48999999997542 233455677887777775 999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE-APARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      ||+. ++|..++...  ...+++..+..++.|++.||.|||+. +   |+||||+|+||++++++.+||+|||++..+..
T Consensus        94 e~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          94 ELMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             eccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            9985 4676665332  24789999999999999999999974 5   99999999999999999999999999987643


Q ss_pred             CCcccceeeeecccccCChhhhccCc----CCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccc
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGY----LSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE  316 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~----~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (437)
                      ....   ....++..|+|||.+.+..    ++.++||||||+++|||++|+.||......  ...+.   .......   
T Consensus       168 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~---~~~~~~~---  236 (296)
T cd06618         168 SKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLT---KILQEEP---  236 (296)
T ss_pred             CCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHHHH---HHhcCCC---
Confidence            3222   1234788999999987553    889999999999999999999999653221  11111   1111100   


Q ss_pred             ccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013745          317 LVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLM  357 (437)
Q Consensus       317 ~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  357 (437)
                         +.... ......++.+++.+||+.+|++||++.++++.
T Consensus       237 ---~~~~~-~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         237 ---PSLPP-NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             ---CCCCC-CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence               01110 01234567889999999999999999999753

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=8.9e-37  Score=296.89  Aligned_cols=243  Identities=30%  Similarity=0.425  Sum_probs=192.1

Q ss_pred             ccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           88 FSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        88 y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      |...+.||+|+||+||+|+. .+++.||+|++...   .......+.+|+.++++++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            66678899999999999985 46889999998643   233446788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +. ++|.+++..  ....+++..++.++.||+.+|.|||+.+   ++|+||||+||+++.++.+||+|||++......  
T Consensus       103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~--  174 (313)
T cd06633         103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPA--  174 (313)
T ss_pred             CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCCC--
Confidence            96 566666532  2346899999999999999999999998   999999999999999999999999998643221  


Q ss_pred             ccceeeeecccccCChhhhc---cCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          244 HVNTFRISGTHGYMAPEYAL---HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                          ....|+..|+|||++.   ...++.++|||||||++|||++|..||..........      ......      .+
T Consensus       175 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~------~~~~~~------~~  238 (313)
T cd06633         175 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQND------SP  238 (313)
T ss_pred             ----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHHhcC------CC
Confidence                1346889999999984   4568899999999999999999999987643322111      110000      01


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ...  .......+.+++.+||+.+|.+||++.+++.
T Consensus       239 ~~~--~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         239 TLQ--SNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             CCC--ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            110  1122345788999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.9e-37  Score=302.74  Aligned_cols=263  Identities=21%  Similarity=0.283  Sum_probs=192.1

Q ss_pred             CccccceeccCCCeeEEEEEcC-C--CcEEEEEEeccC--ChHHHHHHHHHHHHHHcC-CCCcceeeeeeecc----CCc
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMP-N--GQEIAVKKLSVD--SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAE----GPE  156 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~  156 (437)
                      +|++.+.||+|+||.||++... .  +..||+|++...  .......+.+|+.+++++ +||||+++++.+..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4788999999999999999853 4  788999998643  222345678899999999 59999999987532    245


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                      .++++||+. ++|...+.   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            688999885 68887773   3356899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcc--cceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhh-------
Q 013745          237 LFPGEDTH--VNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTW-------  306 (437)
Q Consensus       237 ~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~-------  306 (437)
                      .+......  .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....       
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            76432211  11123468999999998766 468999999999999999999999997644221111000000       


Q ss_pred             -hhhcccc---ccc----ccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          307 -TLFQGEK---ALE----LVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       307 -~~~~~~~---~~~----~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                       .......   ...    .....+....+.....+.+++.+|++.+|++||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence             0000000   000    0000011111123456889999999999999999999863

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-37  Score=306.25  Aligned_cols=260  Identities=25%  Similarity=0.348  Sum_probs=197.7

Q ss_pred             HhcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCc----
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE----  156 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  156 (437)
                      ..++|++.+.||+|+||.||+|+.. +++.||||++...  .......+.+|+.++++++||||+++++++.....    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            3577999999999999999999854 6889999998643  23334567789999999999999999998876654    


Q ss_pred             --eEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccc
Q 013745          157 --KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL  234 (437)
Q Consensus       157 --~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl  234 (437)
                        .++|+||+ +++|.+++.    ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVK----CQKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence              89999998 678888873    246899999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCcccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhh-------
Q 013745          235 ARLFPGEDTHVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTW-------  306 (437)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~-------  306 (437)
                      +.......     ....++..|+|||.+.+. .++.++|||||||++|||++|+.||...........+....       
T Consensus       165 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  239 (343)
T cd07851         165 ARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL  239 (343)
T ss_pred             cccccccc-----cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence            98764321     124578899999988654 68899999999999999999999997654332211110000       


Q ss_pred             -hhhccccc---ccccC----ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          307 -TLFQGEKA---LELVD----PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       307 -~~~~~~~~---~~~~d----~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                       ..+.....   ...+.    +............+.+++.+|++.+|++|||+.+|++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence             00000000   00000    0000111123567889999999999999999999865

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-39  Score=308.54  Aligned_cols=254  Identities=23%  Similarity=0.311  Sum_probs=212.2

Q ss_pred             HhcCccccceeccCCCeeEEEEEcCCC-cEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMPNG-QEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      ...+++.+..||-||||.|-++..... ..+|+|++++.   ...+.+.+..|-.||..++.|.||++|..|.+.+..|+
T Consensus       418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm  497 (732)
T KOG0614|consen  418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM  497 (732)
T ss_pred             chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence            345677788999999999999886432 24788888643   45556788999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      +||-|-||.|..++.   .++.++..++..++..+++|++|||+++   ||+|||||+|+||+.+|.+||.|||+|+.+.
T Consensus       498 LmEaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~  571 (732)
T KOG0614|consen  498 LMEACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG  571 (732)
T ss_pred             hHHhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhc
Confidence            999999999999994   4467999999999999999999999998   9999999999999999999999999999885


Q ss_pred             CCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                      ..   ..+..+|||+.|.|||++.+...+.++|.||||+++|||++|.+||.+.++....+++-.....           
T Consensus       572 ~g---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~-----------  637 (732)
T KOG0614|consen  572 SG---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK-----------  637 (732)
T ss_pred             cC---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh-----------
Confidence            43   3456789999999999999999999999999999999999999999988776655544322211           


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHH--HHhcC
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPD-----MNSVH--LMLSG  360 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~--~~L~~  360 (437)
                         ...+....+...+|+++.+..+|.+|.-     ..+|.  .++++
T Consensus       638 ---i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g  682 (732)
T KOG0614|consen  638 ---IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEG  682 (732)
T ss_pred             ---hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence               1233455566788999999999999976     45554  35554

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-37  Score=292.97  Aligned_cols=261  Identities=26%  Similarity=0.347  Sum_probs=199.4

Q ss_pred             ccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           88 FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        88 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      |++.+.||+|+||.||+|+.. +++.||+|++....  ......+..|+.++++++|+||+++++++.+....++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            567788999999999999854 58999999997642  333466788999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      + ++|.+++....  ..+++..++.++.|++.||.|||+.+   |+||||+|+||++++++.+||+|||++.........
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~  154 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT  154 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence            7 58988884332  46899999999999999999999998   999999999999999999999999999876543221


Q ss_pred             cceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhh--------hhhhhhcccccc
Q 013745          245 VNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS--------YTWTLFQGEKAL  315 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~--------~~~~~~~~~~~~  315 (437)
                      .  ....++..|+|||.+.+. .++.++|||||||++|||++|+.||......+....+.        ..|.....-...
T Consensus       155 ~--~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07829         155 Y--THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY  232 (282)
T ss_pred             c--CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence            1  123457789999998776 88999999999999999999999997654322211110        001100000000


Q ss_pred             cccCcc-----ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          316 ELVDPS-----LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       316 ~~~d~~-----l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      +..-+.     .....+.....+.+++..||+.+|++||++.+|+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         233 KPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            000000     00111123567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=295.74  Aligned_cols=254  Identities=26%  Similarity=0.394  Sum_probs=197.4

Q ss_pred             HhcCccccceeccCCCeeEEEEE-cCCCcEEEEEEeccCCh-------HHHHHHHHHHHHHHcCCCCcceeeeeeec-cC
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSR-------QGLREFTNEVKLLLKIQHKNLVTLFGCCA-EG  154 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~  154 (437)
                      ..++|-.+.+||+|||+.||+|. +...+.||||+-..+..       ...+...+|.+|-+.|+||.||++|++|. +.
T Consensus       461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt  540 (775)
T KOG1151|consen  461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT  540 (775)
T ss_pred             hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence            34678899999999999999998 44577889998764422       22345788999999999999999999996 45


Q ss_pred             CceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEec---CCCCceeee
Q 013745          155 PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD---EQLNPKISD  231 (437)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~---~~~~~kl~D  231 (437)
                      +.+|-|+|||+|.+|+.+|.   ....+++.++..|+.||+.||.||.+.. ++|||-||||.||||-   .-|.+||+|
T Consensus       541 dsFCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITD  616 (775)
T KOG1151|consen  541 DSFCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITD  616 (775)
T ss_pred             ccceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeee
Confidence            67789999999999999984   3356899999999999999999999987 5699999999999994   457899999


Q ss_pred             cccccccCCCCcc-----cceeeeecccccCChhhhccC----cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhh
Q 013745          232 FGLARLFPGEDTH-----VNTFRISGTHGYMAPEYALHG----YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLL  302 (437)
Q Consensus       232 FGla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~----~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~  302 (437)
                      |||++.++.+...     ..+....||.+|++||.+.-+    +++.|+||||+|||+|..+.|+.||........    
T Consensus       617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd----  692 (775)
T KOG1151|consen  617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD----  692 (775)
T ss_pred             cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH----
Confidence            9999998654332     123346799999999977533    688999999999999999999999975443222    


Q ss_pred             hhhhhhhcccccc---cccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 013745          303 SYTWTLFQGEKAL---ELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSV  354 (437)
Q Consensus       303 ~~~~~~~~~~~~~---~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev  354 (437)
                           +.....++   ++-.|..    +....+...++++|+++.-++|-...++
T Consensus       693 -----ILqeNTIlkAtEVqFP~K----PvVsseAkaFIRRCLaYRKeDR~DV~qL  738 (775)
T KOG1151|consen  693 -----ILQENTILKATEVQFPPK----PVVSSEAKAFIRRCLAYRKEDRIDVQQL  738 (775)
T ss_pred             -----HHhhhchhcceeccCCCC----CccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence                 11122222   2222222    2334456788999999999999765554

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=284.91  Aligned_cols=255  Identities=24%  Similarity=0.305  Sum_probs=198.9

Q ss_pred             ceeccCCCeeEEEEE-cCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCC-CCcceeeeeeeccCCceEEEEeecCCCCc
Q 013745           92 NQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLVYEYLPNKSL  169 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL  169 (437)
                      +.||+|+|+.|--++ +.+|..||||++.+.......++.+|++++..++ |+||++|+.+|+++...|||||-|.||+|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl  163 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL  163 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence            679999999999887 6789999999998877667788999999999996 99999999999999999999999999999


Q ss_pred             chhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCC---ceeeecccccccCCC--Cc-
Q 013745          170 DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN---PKISDFGLARLFPGE--DT-  243 (437)
Q Consensus       170 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~---~kl~DFGla~~~~~~--~~-  243 (437)
                      ...|.+   ...+++.++.++...|+.||.|||.+|   |.||||||+|||..+-..   +|||||.|..-....  -+ 
T Consensus       164 LshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp  237 (463)
T KOG0607|consen  164 LSHIQK---RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP  237 (463)
T ss_pred             HHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence            988854   356899999999999999999999998   999999999999965443   799999887543211  11 


Q ss_pred             --ccceeeeecccccCChhhhc-----cCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhh-----hhhhhhhcc
Q 013745          244 --HVNTFRISGTHGYMAPEYAL-----HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLL-----SYTWTLFQG  311 (437)
Q Consensus       244 --~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~-----~~~~~~~~~  311 (437)
                        .......+|+..|||||+..     ...|+.++|.||||||||-||+|.+||.+.-+.+-..--     .....+|..
T Consensus       238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFes  317 (463)
T KOG0607|consen  238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFES  317 (463)
T ss_pred             CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHH
Confidence              11122467899999999763     237999999999999999999999999887654321100     000111110


Q ss_pred             --cccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          312 --EKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       312 --~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                        +...++.|    +.+...+.+..+++...+-.++.+|.++.+++.
T Consensus       318 IQEGkYeFPd----kdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  318 IQEGKYEFPD----KDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HhccCCcCCh----hhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence              11111222    223345566678888888999999999998876

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=335.58  Aligned_cols=254  Identities=25%  Similarity=0.321  Sum_probs=200.2

Q ss_pred             HhcCccccceeccCCCeeEEEEE-cCCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      .+-++.-...||.|.||.||-|+ ..+|.-.|+|-+...  .........+|..++..|+|||+|+.+|+-...+..+|.
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            34456667789999999999999 457888999977543  334455678999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      ||||.+|+|.+++..   ....++.....+..|++.|++|||++|   ||||||||+||+|+.+|.+|++|||.|..+..
T Consensus      1313 MEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence            999999999999833   234566666778899999999999998   99999999999999999999999999998754


Q ss_pred             CC--cccceeeeecccccCChhhhccC---cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccc
Q 013745          241 ED--THVNTFRISGTHGYMAPEYALHG---YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKAL  315 (437)
Q Consensus       241 ~~--~~~~~~~~~gt~~Y~aPE~~~~~---~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (437)
                      ..  ........+||+.|||||++.+.   ...-++||||+|||+.||+||++||...+..       |+.....+.   
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aIMy~V~~--- 1456 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAIMYHVAA--- 1456 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHHHhHHhc---
Confidence            32  11111246799999999999764   4677899999999999999999999764432       111111100   


Q ss_pred             cccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013745          316 ELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLM  357 (437)
Q Consensus       316 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  357 (437)
                          ...+..+.....+-.+++..|++.||++|-++.|+++-
T Consensus      1457 ----gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1457 ----GHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             ----cCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                11123333466667788999999999999888877664

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.6e-36  Score=322.46  Aligned_cols=145  Identities=28%  Similarity=0.403  Sum_probs=130.6

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ++|.++++||+|+||.||+|... +++.||||++...   .......+..|+.++..++||||+++++++......||||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57999999999999999999864 6899999998643   2334467889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                      ||+.+++|..++..   ...+++..++.|+.||+.||.|||..+   |+||||||+||||+.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999998843   345888999999999999999999987   9999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=290.35  Aligned_cols=270  Identities=20%  Similarity=0.227  Sum_probs=209.6

Q ss_pred             ccHHHHHHHhcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCC--CC----cceeee
Q 013745           76 FDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ--HK----NLVTLF  148 (437)
Q Consensus        76 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~----niv~l~  148 (437)
                      +-+......+++|.++..||+|.||.|-.+... .+..||||+++.-.. ..+..+-|+++|+++.  -|    -+|.+.
T Consensus        79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~  157 (415)
T KOG0671|consen   79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMR  157 (415)
T ss_pred             EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence            444555566899999999999999999998743 578999999974433 3355667999999994  22    378888


Q ss_pred             eeeccCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC-----
Q 013745          149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE-----  223 (437)
Q Consensus       149 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~-----  223 (437)
                      +||.-.++.|+|+|.+ |-|+.+++..+ ...+++...+..++.|++++++|||+.+   ++|.||||+|||+.+     
T Consensus       158 ~wFdyrghiCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~  232 (415)
T KOG0671|consen  158 DWFDYRGHICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFK  232 (415)
T ss_pred             hhhhccCceEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEE
Confidence            9999999999999998 77999998443 4467999999999999999999999998   999999999999832     


Q ss_pred             ---------------CCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCC
Q 013745          224 ---------------QLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRK  288 (437)
Q Consensus       224 ---------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~  288 (437)
                                     +..+||+|||.|+.......     .++.|..|.|||++.+-.++..+||||+||||+||+||..
T Consensus       233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs-----~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~  307 (415)
T KOG0671|consen  233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHS-----TIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGET  307 (415)
T ss_pred             EeccCCccceeccCCCcceEEEecCCcceeccCcc-----eeeeccccCCchheeccCcCCccCceeeeeEEEEeeccce
Confidence                           34589999999987655442     4678999999999999999999999999999999999999


Q ss_pred             CCCCCCchhhhhhhhhhh--------------hhhcccccc-----------cccCcc--c---cCCCHHHHHHHHHHHH
Q 013745          289 NHDGRLGKEKADLLSYTW--------------TLFQGEKAL-----------ELVDPS--L---AKCNRDEAAMCIQLGL  338 (437)
Q Consensus       289 p~~~~~~~~~~~~~~~~~--------------~~~~~~~~~-----------~~~d~~--l---~~~~~~~~~~l~~l~~  338 (437)
                      .|....+.+...+.+...              +.+..+++.           ...++.  +   ......+...|++|+.
T Consensus       308 LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~  387 (415)
T KOG0671|consen  308 LFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR  387 (415)
T ss_pred             ecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence            999877655433222111              111111100           000110  1   1223457778999999


Q ss_pred             HcCCCCCCCCCCHHHHHH
Q 013745          339 LCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       339 ~cl~~~p~~RPs~~ev~~  356 (437)
                      +|+..||.+|+|+.|++.
T Consensus       388 ~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  388 RMLEFDPARRITLREALS  405 (415)
T ss_pred             HHHccCccccccHHHHhc
Confidence            999999999999999874

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-36  Score=281.79  Aligned_cols=236  Identities=27%  Similarity=0.324  Sum_probs=192.1

Q ss_pred             eccCCCeeEEEEEcC-CCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCCCCc
Q 013745           94 LGHGGFGPVYRGLMP-NGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL  169 (437)
Q Consensus        94 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  169 (437)
                      ||+|+||.||++... +++.+|+|++....   ......+..|+.++++++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999854 58999999987542   23456788999999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccceee
Q 013745          170 DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR  249 (437)
Q Consensus       170 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  249 (437)
                      .+++...   ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........  ....
T Consensus        81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~  152 (250)
T cd05123          81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS--RTNT  152 (250)
T ss_pred             HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC--cccC
Confidence            9988432   36899999999999999999999987   99999999999999999999999999987644321  1223


Q ss_pred             eecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHH
Q 013745          250 ISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDE  329 (437)
Q Consensus       250 ~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  329 (437)
                      ..++..|++||.+.+..++.++|+||||+++|+|++|+.||.........   ..   ... .      ..   ..+...
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~---~~---~~~-~------~~---~~~~~~  216 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIY---EK---ILK-D------PL---RFPEFL  216 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH---HH---Hhc-C------CC---CCCCCC
Confidence            56788999999999888999999999999999999999999754432111   11   100 0      00   111122


Q ss_pred             HHHHHHHHHHcCCCCCCCCCCHHH
Q 013745          330 AAMCIQLGLLCCQQSVAERPDMNS  353 (437)
Q Consensus       330 ~~~l~~l~~~cl~~~p~~RPs~~e  353 (437)
                      +..+.+++.+||..+|++||++.+
T Consensus       217 ~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         217 SPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CHHHHHHHHHHhcCCHhhCCCccc
Confidence            456788999999999999999955

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-37  Score=259.15  Aligned_cols=262  Identities=21%  Similarity=0.288  Sum_probs=199.9

Q ss_pred             CccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      +|...++||+|.||+||+|+. .+++.||+|+++.+.  +.......+|+.+|+.++|.|||++++....++.+-||+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            466788999999999999994 478899999987542  23345678999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      | ..+|..+..  .-++.++.+.+..++.|+++||.++|+++   ++|||+||.|+||+.||.+||+|||+++.++-.-.
T Consensus        83 c-dqdlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   83 C-DQDLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             h-hHHHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            9 457766642  34577999999999999999999999998   99999999999999999999999999998754321


Q ss_pred             ccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhccccc---cccc
Q 013745          244 HVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKA---LELV  318 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~  318 (437)
                      -  ...-+-|.+|.+|.++.+. -|+...|+||.|||+.||.. |++.|.+..-.+....+.|......++..   ..+.
T Consensus       157 c--ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lp  234 (292)
T KOG0662|consen  157 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLP  234 (292)
T ss_pred             e--eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCC
Confidence            1  1123458999999999876 58999999999999999986 88888887665555545444433333221   1122


Q ss_pred             Cccc-c---------CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          319 DPSL-A---------KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       319 d~~l-~---------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      |-.. +         ...+.....=.++....+.-+|..|.++++.++
T Consensus       235 dyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  235 DYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            2111 1         111122222245666777889999999988654

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=276.70  Aligned_cols=253  Identities=21%  Similarity=0.194  Sum_probs=197.1

Q ss_pred             HhcCcccc-ceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcC-CCCcceeeeeeecc----CCc
Q 013745           84 ATNFFSDL-NQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAE----GPE  156 (437)
Q Consensus        84 ~~~~y~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~  156 (437)
                      .+++|.+. ++||-|-.|.|..+.. .+++.+|+|++...     ....+|++.--+. .|||||.++++|.+    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            35666655 6799999999999874 48999999998643     2334788876655 49999999999854    456


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEec---CCCCceeeecc
Q 013745          157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD---EQLNPKISDFG  233 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~---~~~~~kl~DFG  233 (437)
                      +.+|||.|+||.|...+.++ ..+.+++.++..|+.||+.|+.|||+.+   |.||||||+|+|..   .|..+||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence            78999999999999888655 4467999999999999999999999998   99999999999995   45679999999


Q ss_pred             cccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccc
Q 013745          234 LARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEK  313 (437)
Q Consensus       234 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (437)
                      +|+.....   ......+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||....+....   ..++.....+ 
T Consensus       210 FAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais---pgMk~rI~~g-  282 (400)
T KOG0604|consen  210 FAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKRRIRTG-  282 (400)
T ss_pred             cccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC---hhHHhHhhcc-
Confidence            99975432   2223467899999999999999999999999999999999999999865542211   0000000000 


Q ss_pred             cccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          314 ALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       314 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ..++.+    ..+...++...++++.+|..+|.+|.|+.+++.
T Consensus       283 qy~FP~----pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  283 QYEFPE----PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             CccCCC----hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence            011111    223456677889999999999999999999875

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.4e-38  Score=278.90  Aligned_cols=265  Identities=22%  Similarity=0.351  Sum_probs=200.4

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeecc--------C
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE--------G  154 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~  154 (437)
                      ..|+-+.+||+|.||.||+|+. ++|+.||+|++...  .........+|+++|..|+|+|++.++..|..        .
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            3477788999999999999984 46888999877542  22223456789999999999999999988853        2


Q ss_pred             CceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccc
Q 013745          155 PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL  234 (437)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl  234 (437)
                      ..+||||++|+. +|.-++.+  ....++..++.+++.++..||.|+|+..   |+|||+||.|+||+.+|.+||+|||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence            347999999965 77777632  3367899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcc--cceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcc
Q 013745          235 ARLFPGEDTH--VNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQG  311 (437)
Q Consensus       235 a~~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  311 (437)
                      ++.+...+..  ......+-|.+|++||.+.+. .|+++.|||..|||+.||+|+.+.+.+........++...-.-+..
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK  250 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence            9877543322  122234559999999998876 7999999999999999999999999998877666655433222111


Q ss_pred             --------cccccccCcc-ccC----CCHHHH------HHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          312 --------EKALELVDPS-LAK----CNRDEA------AMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       312 --------~~~~~~~d~~-l~~----~~~~~~------~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                              -.+.+.+... +++    ...+..      .+.++|+..++..||.+|+.+.+++.
T Consensus       251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence                    1111112100 110    011111      25678888999999999999999864

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-36  Score=298.16  Aligned_cols=209  Identities=23%  Similarity=0.354  Sum_probs=179.4

Q ss_pred             hcCccccceeccCCCeeEEEEE-cCCCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      ..-|..++.||-|+||+|.+++ .++...||+|.+++.+   .......+.|..||...+.+-||+||..|.+++.+|+|
T Consensus       628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV  707 (1034)
T KOG0608|consen  628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV  707 (1034)
T ss_pred             ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence            3458889999999999999997 5567789999997653   44566788999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||++||++-.+|.   +.+.|++..++.++..+..|+++.|.+|   +|||||||+|||||.+|++||+||||+.-+..
T Consensus       708 MdYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW  781 (1034)
T KOG0608|consen  708 MDYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  781 (1034)
T ss_pred             EeccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccccee
Confidence            99999999988884   4467899999999999999999999999   99999999999999999999999999975421


Q ss_pred             CCc--------cc--------------------------------ceeeeecccccCChhhhccCcCCcccceehhhHHH
Q 013745          241 EDT--------HV--------------------------------NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLV  280 (437)
Q Consensus       241 ~~~--------~~--------------------------------~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl  280 (437)
                      ...        ..                                ..-..+||+.|+|||++....|+..+|+||.||||
T Consensus       782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil  861 (1034)
T KOG0608|consen  782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL  861 (1034)
T ss_pred             ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence            100        00                                00125699999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCCCchhhh
Q 013745          281 LEIVSGRKNHDGRLGKEKA  299 (437)
Q Consensus       281 ~elltg~~p~~~~~~~~~~  299 (437)
                      |||+.|+.||......+..
T Consensus       862 ~em~~g~~pf~~~tp~~tq  880 (1034)
T KOG0608|consen  862 YEMLVGQPPFLADTPGETQ  880 (1034)
T ss_pred             HHHhhCCCCccCCCCCcce
Confidence            9999999999877665543

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-37  Score=294.65  Aligned_cols=243  Identities=24%  Similarity=0.322  Sum_probs=195.8

Q ss_pred             cceeccCCCeeEEEEE-cCCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCCC
Q 013745           91 LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNK  167 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  167 (437)
                      .++||+|-||+||-|+ .++|+.||||++.+.  ......++.+|+.||+.++||.||.+-..|+..+..++|||-+.| 
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence            3789999999999998 458999999999754  334457889999999999999999999999999999999999954 


Q ss_pred             CcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCC---CCceeeecccccccCCCCcc
Q 013745          168 SLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ---LNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       168 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~---~~~kl~DFGla~~~~~~~~~  244 (437)
                      +..++|... ..+.+++.....++.||+.||.|||-++   |+|+||||+|||+.+.   -.+||||||+|+.+++....
T Consensus       648 DMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR  723 (888)
T KOG4236|consen  648 DMLEMILSS-EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR  723 (888)
T ss_pred             hHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence            555555443 3467999888899999999999999998   9999999999999643   46899999999998765432


Q ss_pred             cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccC
Q 013745          245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK  324 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  324 (437)
                         ..++||+.|+|||+++.+.|...-||||.|||+|.-+.|-.||....+  ..+.+..+.-++.            +.
T Consensus       724 ---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd--IndQIQNAaFMyP------------p~  786 (888)
T KOG4236|consen  724 ---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED--INDQIQNAAFMYP------------PN  786 (888)
T ss_pred             ---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc--hhHHhhccccccC------------CC
Confidence               357899999999999999999999999999999999999999964322  2222221111111            12


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 013745          325 CNRDEAAMCIQLGLLCCQQSVAERPDMNSVH  355 (437)
Q Consensus       325 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~  355 (437)
                      -+.+.....++++...+|..-.+|=+...-+
T Consensus       787 PW~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  787 PWSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             chhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence            2345666778889899999999998776653

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7e-36  Score=313.33  Aligned_cols=263  Identities=25%  Similarity=0.410  Sum_probs=207.3

Q ss_pred             HHHHHhcCccccceeccCCCeeEEEEEcC----C----CcEEEEEEeccC-ChHHHHHHHHHHHHHHcC-CCCcceeeee
Q 013745           80 TLQVATNFFSDLNQLGHGGFGPVYRGLMP----N----GQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFG  149 (437)
Q Consensus        80 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~----~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~  149 (437)
                      ..+...++..+.+.||+|+||.||+|...    .    ...||||.++.. .....+.+..|+++|+.+ +|+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            34444555566779999999999999732    1    457899998754 335567899999999999 5999999999


Q ss_pred             eeccCCceEEEEeecCCCCcchhhhccC-----CC--------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCC
Q 013745          150 CCAEGPEKMLVYEYLPNKSLDYFIFDKT-----KS--------SSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKA  216 (437)
Q Consensus       150 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~--------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp  216 (437)
                      +|...+..++|+||+..|+|..++....     ..        ..+.....+.++.|||.|++||++..   +|||||-.
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence            9999999999999999999999996544     00        23889999999999999999999987   99999999


Q ss_pred             CCEEecCCCCceeeecccccccCCCCcccceeeeec--ccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCC
Q 013745          217 SNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISG--THGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGR  293 (437)
Q Consensus       217 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g--t~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~  293 (437)
                      .|||+.++..+||+|||+|+............ -.|  ...|||||.+....|+.++|||||||+||||++ |..||.+.
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~-~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~  525 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKS-SAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI  525 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecC-CCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence            99999999999999999999665444332111 111  345999999999999999999999999999998 88899763


Q ss_pred             CchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          294 LGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ....  +++.+    ...+..+        .-+..+..++.++++.||+.+|++||++.++++.|+.
T Consensus       526 ~~~~--~l~~~----l~~G~r~--------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  526 PPTE--ELLEF----LKEGNRM--------EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             CcHH--HHHHH----HhcCCCC--------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence            3111  11121    1112111        1222446678899999999999999999999999986

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=305.92  Aligned_cols=251  Identities=27%  Similarity=0.407  Sum_probs=208.7

Q ss_pred             ccccceeccCCCeeEEEEEc-CCCc----EEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           88 FSDLNQLGHGGFGPVYRGLM-PNGQ----EIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        88 y~~~~~lG~G~~g~Vy~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ....++||+|+||+||+|.+ +.|+    +||+|++... ......++++|+.+|.+|+|||+++|+++|.... +.||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            44568999999999999984 4554    5799988644 4445678999999999999999999999998765 78999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      +|++.|+|.+++..  .+..+.....+.|..|||+||.|||.+.   ++||||-..||||..-..+||.|||+++.+...
T Consensus       777 q~mP~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HhcccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            99999999999854  4467888999999999999999999987   999999999999999999999999999988755


Q ss_pred             CcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                      ..........-.+-|||=|.+....|+.++|||||||.+|||+| |..|+.+....+..++++...++            
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRL------------  919 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERL------------  919 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccC------------
Confidence            54433333334567999999999999999999999999999998 99999987776665554432221            


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                         ..++.....+..++.+||..|++.||+++++...+.
T Consensus       920 ---sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs  955 (1177)
T KOG1025|consen  920 ---SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFS  955 (1177)
T ss_pred             ---CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHH
Confidence               234456667889999999999999999999987654

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=8.7e-38  Score=279.55  Aligned_cols=255  Identities=25%  Similarity=0.389  Sum_probs=195.6

Q ss_pred             cCccccceeccCCCeeEEEEE-cCCCcEEEEEEeccCC-hHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCceEEEEe
Q 013745           86 NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      ++.+.+..||.|+||+|++-. .+.|+..|||+++... .....+++.|.+...+- ++||||++||.+..++..|+.||
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            445567889999999999987 5589999999998553 35557788888876655 69999999999999999999999


Q ss_pred             ecCCCCcchhhhc--cCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          163 YLPNKSLDYFIFD--KTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       163 ~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      +| ..||+.+-..  ......+++..+-+|+...+.||.||-..-  .||||||||+||||+..|.+||||||++..+..
T Consensus       144 LM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  144 LM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             HH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence            99 5677655321  123356888888899999999999998864  699999999999999999999999999986643


Q ss_pred             CCcccceeeeecccccCChhhhccC--cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHG--YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      .-.   ...-.|-..|||||.+...  .|+.++||||||+.|+|+.||+.|+.....     ..+.......+.      
T Consensus       221 SiA---kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~gd------  286 (361)
T KOG1006|consen  221 SIA---KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVIGD------  286 (361)
T ss_pred             HHH---hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHcCC------
Confidence            221   1234688899999988643  599999999999999999999999975322     111111111111      


Q ss_pred             Ccccc--CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013745          319 DPSLA--KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLM  357 (437)
Q Consensus       319 d~~l~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  357 (437)
                      .|.+.  .........+..++..|+..|-+.||.+.+++++
T Consensus       287 pp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  287 PPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             CCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            11111  1123456678899999999999999999998764

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-37  Score=276.43  Aligned_cols=261  Identities=25%  Similarity=0.336  Sum_probs=199.4

Q ss_pred             cccceeccCCCeeEEEEEcC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccC-----CceEEE
Q 013745           89 SDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG-----PEKMLV  160 (437)
Q Consensus        89 ~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv  160 (437)
                      +-.+.||.|+||+||.+.++ +|+.||+|++..-  +-...+.+.+|+++|..++|.|++..+++..-.     .++|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            34578999999999999854 7999999998632  333457789999999999999999998876543     346788


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      +|.| ..+|..+|.   ..+.++...+.-++.||++||+|||+.+   |+||||||.|+|++.|..+||||||+|+..+.
T Consensus       136 TELm-QSDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  136 TELM-QSDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHH-Hhhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence            9988 678888874   3456888888889999999999999988   99999999999999999999999999998766


Q ss_pred             CCcccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhh---------hhc
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWT---------LFQ  310 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~---------~~~  310 (437)
                      .+....+. -+-|..|.|||++++. .|+.+.||||.|||+.||+..+..|....+.+..+++.....         ...
T Consensus       209 d~~~hMTq-EVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  209 RDRLNMTH-EVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hhhhhhHH-HHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            55554443 3458999999999986 799999999999999999999999988777665555422211         111


Q ss_pred             ccccccccC-----cc---ccC--CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHh
Q 013745          311 GEKALELVD-----PS---LAK--CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML  358 (437)
Q Consensus       311 ~~~~~~~~d-----~~---l~~--~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L  358 (437)
                      +.+. ..+.     |.   +..  .......+.+.+..+++..+|++|.+..+.+..+
T Consensus       288 GAk~-H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  288 GAKN-HVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hhHH-HhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            1110 0110     11   111  1113334456677789999999999988887654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-36  Score=299.12  Aligned_cols=239  Identities=25%  Similarity=0.274  Sum_probs=192.2

Q ss_pred             hcCccccceeccCCCeeEEEEE-cCCCcEEEEEEeccCChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCceEEEEe
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      ++.|++...+|.|+|+.|-.+. ..+++..+||++....    .+..+|+.++.+. +||||+++.+.+.++.+.|+|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            5678888999999999999887 4578999999997652    2233677777666 59999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEe-cCCCCceeeecccccccCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL-DEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll-~~~~~~kl~DFGla~~~~~~  241 (437)
                      .+.|+-|.+.+...    +.....+..|+.+|+.|+.|||++|   ||||||||+|||+ ++.++++|+|||.++.....
T Consensus       397 ~l~g~ell~ri~~~----~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSK----PEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             hccccHHHHHHHhc----chhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            99999887766322    2222777889999999999999998   9999999999999 68999999999999977544


Q ss_pred             CcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                           ....+-|..|.|||++....|++++||||||++||+||+|+.||.......  ++..    ...        .  
T Consensus       470 -----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~--ei~~----~i~--------~--  528 (612)
T KOG0603|consen  470 -----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI--EIHT----RIQ--------M--  528 (612)
T ss_pred             -----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH--HHHH----hhc--------C--
Confidence                 112355889999999999999999999999999999999999998655441  1111    000        0  


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                       +......+....+|+.+||+.+|.+||+|.++..
T Consensus       529 -~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  529 -PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             -CccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence             1112344555678888999999999999999864

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.1e-35  Score=275.60  Aligned_cols=220  Identities=19%  Similarity=0.128  Sum_probs=175.5

Q ss_pred             CCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCCCCcchhhhc
Q 013745           97 GGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD  175 (437)
Q Consensus        97 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  175 (437)
                      |.||.||+++. .+++.||+|++.....     +.+|...+....||||+++++++.+....++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            89999999985 4789999999975432     23455555566799999999999999999999999999999988843


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccceeeeecccc
Q 013745          176 KTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG  255 (437)
Q Consensus       176 ~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~  255 (437)
                      .   ..+++..+..++.|++.||.|||+++   |+||||||+||+++.++.++|+|||++........     ...++..
T Consensus        79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~-----~~~~~~~  147 (237)
T cd05576          79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCD-----GEAVENM  147 (237)
T ss_pred             h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccccc-----cCCcCcc
Confidence            2   35899999999999999999999988   99999999999999999999999998876543211     2345778


Q ss_pred             cCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHH
Q 013745          256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQ  335 (437)
Q Consensus       256 Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~  335 (437)
                      |+|||.+.+..++.++||||+||++|||++|+.|+.......            ...     ...   ..+......+.+
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~-----~~~---~~~~~~~~~~~~  207 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTH-----TTL---NIPEWVSEEARS  207 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------ccc-----ccc---CCcccCCHHHHH
Confidence            999999988889999999999999999999998875321100            000     000   111223456788


Q ss_pred             HHHHcCCCCCCCCCCHH
Q 013745          336 LGLLCCQQSVAERPDMN  352 (437)
Q Consensus       336 l~~~cl~~~p~~RPs~~  352 (437)
                      ++.+|++.||++||++.
T Consensus       208 li~~~l~~dp~~R~~~~  224 (237)
T cd05576         208 LLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHccCCHHHhcCCC
Confidence            99999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-35  Score=296.12  Aligned_cols=254  Identities=25%  Similarity=0.376  Sum_probs=205.8

Q ss_pred             HHhcCccccceeccCCCeeEEEEE-cCCCcEEEEEEeccCChHHHHHHHHHHHHHHcC-CCCcceeeeeeec-----cCC
Q 013745           83 VATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCA-----EGP  155 (437)
Q Consensus        83 ~~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-----~~~  155 (437)
                      .-++.|++.++||.|.+|.||+++ .++++.+|||++......+ +++..|.+||+.+ +|||++.++|+|.     .++
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d-eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D   94 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE-EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD   94 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc-HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence            345679999999999999999998 5578999999987664433 6677899999988 5999999999985     357


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccc
Q 013745          156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA  235 (437)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  235 (437)
                      .+|||||||.+|+..+++..-. ...+.|..+..|+..++.||.+||...   ++|||||-.|||++.++.|||+|||.+
T Consensus        95 qLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvS  170 (953)
T KOG0587|consen   95 QLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVS  170 (953)
T ss_pred             eEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeee
Confidence            8999999999999999985544 678999999999999999999999987   999999999999999999999999999


Q ss_pred             cccCCCCcccceeeeecccccCChhhhccC-----cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhc
Q 013745          236 RLFPGEDTHVNTFRISGTHGYMAPEYALHG-----YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQ  310 (437)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  310 (437)
                      ..++..-..  .....||+.|||||++...     .|+.++|+||||++..||.-|.+|+..+.+...         +|.
T Consensus       171 aQldsT~gr--RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra---------LF~  239 (953)
T KOG0587|consen  171 AQLDSTVGR--RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA---------LFL  239 (953)
T ss_pred             eeeeccccc--ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh---------hcc
Confidence            877543332  2246799999999999653     578899999999999999999999976544221         111


Q ss_pred             ccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          311 GEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       311 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ..   ....|.+ .-+..-.+++.++|..|+..|..+||++.++++
T Consensus       240 Ip---RNPPPkL-krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  240 IP---RNPPPKL-KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             CC---CCCCccc-cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            00   1111111 123345677899999999999999999998865

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3e-35  Score=270.77  Aligned_cols=249  Identities=22%  Similarity=0.293  Sum_probs=194.7

Q ss_pred             HhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCceE
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKM  158 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  158 (437)
                      ..++|..+++||+|+|++|.++.. ++.+.||+|++++.   ...++.-...|-.+..+. +||.+|.+..+|..+..++
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            346899999999999999999984 47889999998753   344445566777777665 6999999999999999999


Q ss_pred             EEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccccc
Q 013745          159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                      +|.||++||+|--.+   ++...++++.+..+...|+.||.|||++|   ||+||||.+|||+|..|++||+|+|+++.-
T Consensus       328 fvieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             EEEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence            999999999997665   33456999999999999999999999998   999999999999999999999999999864


Q ss_pred             CCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchh-hhhhhhhhhhhhcccccccc
Q 013745          239 PGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKE-KADLLSYTWTLFQGEKALEL  317 (437)
Q Consensus       239 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  317 (437)
                      -...  ..+..++||+.|+|||++.+..|+..+|+|+|||+++||+.|+.||+...... ..+--.+.+...-+      
T Consensus       402 l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile------  473 (593)
T KOG0695|consen  402 LGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE------  473 (593)
T ss_pred             CCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh------
Confidence            3222  22346899999999999999999999999999999999999999997422111 11111222222111      


Q ss_pred             cCccccCCCHHHHHHHHHHHHHcCCCCCCCCC
Q 013745          318 VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERP  349 (437)
Q Consensus       318 ~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RP  349 (437)
                         .....+...+.....+...-+..||.+|.
T Consensus       474 ---kqiriprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  474 ---KQIRIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ---hcccccceeehhhHHHHHHhhcCCcHHhc
Confidence               11122333444455677788899999884

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.9e-34  Score=266.36  Aligned_cols=238  Identities=27%  Similarity=0.350  Sum_probs=191.9

Q ss_pred             CCeeEEEEEcC-CCcEEEEEEeccCChHH-HHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCCCCcchhhhc
Q 013745           98 GFGPVYRGLMP-NGQEIAVKKLSVDSRQG-LREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD  175 (437)
Q Consensus        98 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  175 (437)
                      +||.||+|+.. +++.+|+|++....... ...+.+|++.+++++|+||+++++++......+++|||+++++|..++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999965 58999999997654433 57899999999999999999999999999999999999999999998843


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccceeeeecccc
Q 013745          176 KTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG  255 (437)
Q Consensus       176 ~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~  255 (437)
                      .   ..+++..++.++.+++.+|.|||+.+   ++|+||+|.||+++.++.++|+|||.+.......   ......++..
T Consensus        81 ~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~  151 (244)
T smart00220       81 R---GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE  151 (244)
T ss_pred             c---cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence            2   23889999999999999999999987   9999999999999999999999999998775432   1223457889


Q ss_pred             cCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHH
Q 013745          256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQ  335 (437)
Q Consensus       256 Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~  335 (437)
                      |++||.+....++.++||||||+++++|++|..||........  ........    .      ..........+..+.+
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~--~~~~~~~~----~------~~~~~~~~~~~~~~~~  219 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE--LFKKIGKP----K------PPFPPPEWKISPEAKD  219 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHhcc----C------CCCccccccCCHHHHH
Confidence            9999999988899999999999999999999999976322111  11111100    0      0000000014456889


Q ss_pred             HHHHcCCCCCCCCCCHHHHHH
Q 013745          336 LGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       336 l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ++.+|+..+|++||++.++++
T Consensus       220 ~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      220 LIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHccCCchhccCHHHHhh
Confidence            999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2.8e-34  Score=298.51  Aligned_cols=262  Identities=19%  Similarity=0.184  Sum_probs=168.4

Q ss_pred             HhcCccccceeccCCCeeEEEEEcC-C----CcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeee------ec
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMP-N----GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC------CA  152 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~  152 (437)
                      ..++|++.+.||+|+||.||+|+.. +    +..||||++......  +....|  .+....+.+++.++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            4578999999999999999999854 4    789999998643221  111111  1222223333332222      24


Q ss_pred             cCCceEEEEeecCCCCcchhhhccCCC-----------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccC
Q 013745          153 EGPEKMLVYEYLPNKSLDYFIFDKTKS-----------------SSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIK  215 (437)
Q Consensus       153 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDik  215 (437)
                      .+...++||||+++++|.+++......                 .......+..++.||+.||.|||+++   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            566789999999999998887533210                 01123446679999999999999988   9999999


Q ss_pred             CCCEEecC-CCCceeeecccccccCCCCcccceeeeecccccCChhhhccC----------------------cCCcccc
Q 013745          216 ASNILLDE-QLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHG----------------------YLSVKTD  272 (437)
Q Consensus       216 p~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----------------------~~~~~~D  272 (437)
                      |+|||++. ++.+||+|||+|+.+....... .....+++.|+|||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~-~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYI-PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccC-CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999985 6899999999998664332222 1245789999999966422                      2345679


Q ss_pred             eehhhHHHHHHHhCCCCCCCCCchhh-------hhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCC
Q 013745          273 VFSYGVLVLEIVSGRKNHDGRLGKEK-------ADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSV  345 (437)
Q Consensus       273 vwSlG~vl~elltg~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p  345 (437)
                      ||||||+||||+++..++......-.       ..+..|.....  .....-+.... ...........+|+.+|++.||
T Consensus       362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~-~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVE--PRASPDLRRGF-EVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhc--cccchhhhhhh-hhccccchHHHHHHHHHccCCc
Confidence            99999999999997766542110000       00011110000  00000000000 0000112234579999999999


Q ss_pred             CCCCCHHHHHH
Q 013745          346 AERPDMNSVHL  356 (437)
Q Consensus       346 ~~RPs~~ev~~  356 (437)
                      ++|||+.++++
T Consensus       439 ~kR~ta~e~L~  449 (566)
T PLN03225        439 RQRISAKAALA  449 (566)
T ss_pred             ccCCCHHHHhC
Confidence            99999999976

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=4.1e-35  Score=283.08  Aligned_cols=275  Identities=21%  Similarity=0.217  Sum_probs=221.8

Q ss_pred             cccccHHHHHHHhcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCC------CCcce
Q 013745           73 NLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ------HKNLV  145 (437)
Q Consensus        73 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv  145 (437)
                      ..||.+...++..++|.+....|+|-|++|.+|... .|+.||||++..+..- ...=+.|++||++|+      --+++
T Consensus       419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hcl  497 (752)
T KOG0670|consen  419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCL  497 (752)
T ss_pred             cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHH
Confidence            468999999999999999999999999999999843 5889999999866432 344567999999995      34899


Q ss_pred             eeeeeeccCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCC-
Q 013745          146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ-  224 (437)
Q Consensus       146 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~-  224 (437)
                      +|+..|...+++|||||-+ ..+|.++|.....+..|....+..++.|+..||..|-..+   |+|.||||+||||++. 
T Consensus       498 rl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k  573 (752)
T KOG0670|consen  498 RLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESK  573 (752)
T ss_pred             HHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCc
Confidence            9999999999999999988 6689999988888888999999999999999999999887   9999999999999865 


Q ss_pred             CCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhh
Q 013745          225 LNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSY  304 (437)
Q Consensus       225 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~  304 (437)
                      ..+||||||.|..........    +.-+..|.|||++.+..|+...|+||.||.||||.||+..|.+.++.....+...
T Consensus       574 ~iLKLCDfGSA~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me  649 (752)
T KOG0670|consen  574 NILKLCDFGSASFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME  649 (752)
T ss_pred             ceeeeccCccccccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence            458999999998876544322    2336789999999999999999999999999999999999999887655444322


Q ss_pred             hhhhhcc--------------------------------cccccccCc------------cccCCCHHHHHHHHHHHHHc
Q 013745          305 TWTLFQG--------------------------------EKALELVDP------------SLAKCNRDEAAMCIQLGLLC  340 (437)
Q Consensus       305 ~~~~~~~--------------------------------~~~~~~~d~------------~l~~~~~~~~~~l~~l~~~c  340 (437)
                      ....+..                                ..++..+.|            .+++........+.+|+..|
T Consensus       650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm  729 (752)
T KOG0670|consen  650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM  729 (752)
T ss_pred             hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence            2211110                                001111222            12233445667788899999


Q ss_pred             CCCCCCCCCCHHHHHH
Q 013745          341 CQQSVAERPDMNSVHL  356 (437)
Q Consensus       341 l~~~p~~RPs~~ev~~  356 (437)
                      +..||++|.|..+.+.
T Consensus       730 l~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  730 LILDPEKRITVNQALK  745 (752)
T ss_pred             hccChhhcCCHHHHhc
Confidence            9999999999988764

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.8e-33  Score=283.73  Aligned_cols=262  Identities=21%  Similarity=0.243  Sum_probs=180.0

Q ss_pred             HhcCccccceeccCCCeeEEEEEc-----------------CCCcEEEEEEeccCChHHHHH--------------HHHH
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM-----------------PNGQEIAVKKLSVDSRQGLRE--------------FTNE  132 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E  132 (437)
                      ..++|++.++||+|+||.||+|..                 ..++.||||++........++              ...|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            356899999999999999999963                 245679999987543322223              3347


Q ss_pred             HHHHHcCCCCcc-----eeeeeeecc--------CCceEEEEeecCCCCcchhhhccCC---------------------
Q 013745          133 VKLLLKIQHKNL-----VTLFGCCAE--------GPEKMLVYEYLPNKSLDYFIFDKTK---------------------  178 (437)
Q Consensus       133 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~---------------------  178 (437)
                      +.++.+++|.++     ++++++|..        ....+|||||+++++|.+++.....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777876654     667777643        3568999999999999998853211                     


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccceeeeecccccCC
Q 013745          179 SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMA  258 (437)
Q Consensus       179 ~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~a  258 (437)
                      ...+++..++.++.|++.+|.|||+.+   |+||||||+|||++.++.+||+|||++......... ......+|+.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence            123467788999999999999999988   999999999999999999999999999765432211 1112235789999


Q ss_pred             hhhhccCc--------------------C--CcccceehhhHHHHHHHhCCC-CCCCCCchhh----hhhhhhhhhhhcc
Q 013745          259 PEYALHGY--------------------L--SVKTDVFSYGVLVLEIVSGRK-NHDGRLGKEK----ADLLSYTWTLFQG  311 (437)
Q Consensus       259 PE~~~~~~--------------------~--~~~~DvwSlG~vl~elltg~~-p~~~~~~~~~----~~~~~~~~~~~~~  311 (437)
                      ||.+....                    +  ..+.||||+|||+++|++|.. ||........    .......|..+..
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~  458 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG  458 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence            99875432                    1  234799999999999999985 6653211110    0011111221111


Q ss_pred             cccccccCccccCCCHHHHHHHHHHHHHcCCCCC---CCCCCHHHHHH
Q 013745          312 EKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSV---AERPDMNSVHL  356 (437)
Q Consensus       312 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p---~~RPs~~ev~~  356 (437)
                      ..    .+...   .........+++.+++..+|   .+|+|+.|+++
T Consensus       459 ~~----~~~~~---~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        459 QK----YDFSL---LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             cC----CCccc---ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            11    11111   11233456778888888765   68999999864

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-34  Score=248.60  Aligned_cols=209  Identities=26%  Similarity=0.410  Sum_probs=173.4

Q ss_pred             HHHHHHHhcCccccceeccCCCeeEEEEE-cCCCcEEEEEEeccC-ChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccC
Q 013745           78 LRTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEG  154 (437)
Q Consensus        78 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  154 (437)
                      .+.+++..+....+..||+|++|.|-+-+ ..+|+..|+|.+... ..+...++++|+.+..+. .+|.+|.|||.+...
T Consensus        38 ~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~re  117 (282)
T KOG0984|consen   38 DRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFRE  117 (282)
T ss_pred             cCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcc
Confidence            33466667777778999999999998876 458999999999754 344456788899987776 699999999999999


Q ss_pred             CceEEEEeecCCCCcchhhhc-cCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecc
Q 013745          155 PEKMLVYEYLPNKSLDYFIFD-KTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG  233 (437)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG  233 (437)
                      ...++.||.| ..||+.+-.+ ...++.+++..+-+|+..++.||.|||++-  .+||||+||+||||+..|++||||||
T Consensus       118 gdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFG  194 (282)
T KOG0984|consen  118 GDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFG  194 (282)
T ss_pred             ccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccc
Confidence            9999999999 5688766432 234567899999999999999999999974  69999999999999999999999999


Q ss_pred             cccccCCCCcccceeeeecccccCChhhhccC----cCCcccceehhhHHHHHHHhCCCCCCC
Q 013745          234 LARLFPGEDTHVNTFRISGTHGYMAPEYALHG----YLSVKTDVFSYGVLVLEIVSGRKNHDG  292 (437)
Q Consensus       234 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~~~DvwSlG~vl~elltg~~p~~~  292 (437)
                      ++..+.+.-...   .-.|-..|||||.+..+    .|+.|+||||||+.+.||.+++.||+.
T Consensus       195 IsG~L~dSiAkt---~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  195 ISGYLVDSIAKT---MDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             cceeehhhhHHH---HhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            998775432221   23477889999988643    799999999999999999999999974

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-33  Score=267.29  Aligned_cols=268  Identities=25%  Similarity=0.302  Sum_probs=196.5

Q ss_pred             HHHHHHh-cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCC--------CCcceeee
Q 013745           79 RTLQVAT-NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ--------HKNLVTLF  148 (437)
Q Consensus        79 ~~~~~~~-~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~  148 (437)
                      +..+... ++|.+.++||.|-|++||++.+ .+.+.||+|+.+.. ....+..+.||++|++++        ...||+|+
T Consensus        70 ~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~Ll  148 (590)
T KOG1290|consen   70 RIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLL  148 (590)
T ss_pred             eccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeee
Confidence            3334444 7899999999999999999984 46788999998643 333466788999999984        24799999


Q ss_pred             eeec----cCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCC
Q 013745          149 GCCA----EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ  224 (437)
Q Consensus       149 ~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~  224 (437)
                      +.|.    .+.++|||+|++ |-+|..+|... ....++...+.+|++||+.||.|||.++  +|||.||||+|||+..+
T Consensus       149 D~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  149 DHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST  224 (590)
T ss_pred             ccceecCCCCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence            9995    467899999999 66777777443 4567999999999999999999999997  79999999999998320


Q ss_pred             --------------------------------------------------------------------------------
Q 013745          225 --------------------------------------------------------------------------------  224 (437)
Q Consensus       225 --------------------------------------------------------------------------------  224 (437)
                                                                                                      
T Consensus       225 e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n  304 (590)
T KOG1290|consen  225 EIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYN  304 (590)
T ss_pred             ccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------------------------------------------------------------
Q 013745          225 --------------------------------------------------------------------------------  224 (437)
Q Consensus       225 --------------------------------------------------------------------------------  224 (437)
                                                                                                      
T Consensus       305 ~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~  384 (590)
T KOG1290|consen  305 NEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDI  384 (590)
T ss_pred             cccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCC
Confidence                                                                                            


Q ss_pred             ------CCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhh
Q 013745          225 ------LNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK  298 (437)
Q Consensus       225 ------~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~  298 (437)
                            ..|||+|||-|+.+...-+     .-..|..|.|||++.+..|+..+||||++|++|||+||-..|+...+...
T Consensus       385 ~~~~~di~vKIaDlGNACW~~khFT-----~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y  459 (590)
T KOG1290|consen  385 PLPECDIRVKIADLGNACWVHKHFT-----EDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENY  459 (590)
T ss_pred             CCCccceeEEEeeccchhhhhhhhc-----hhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCC
Confidence                  0034445554444322111     11247889999999999999999999999999999999999976554321


Q ss_pred             ----hh--hh-----hhhhhhhcccc----------cccccCc--------cc---cCCCHHHHHHHHHHHHHcCCCCCC
Q 013745          299 ----AD--LL-----SYTWTLFQGEK----------ALELVDP--------SL---AKCNRDEAAMCIQLGLLCCQQSVA  346 (437)
Q Consensus       299 ----~~--~~-----~~~~~~~~~~~----------~~~~~d~--------~l---~~~~~~~~~~l~~l~~~cl~~~p~  346 (437)
                          ..  ++     ..-+.+...++          .+..|..        .|   ..++.++..++.+++.=||+.+|+
T Consensus       460 ~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~Pe  539 (590)
T KOG1290|consen  460 SRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPE  539 (590)
T ss_pred             CccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCcc
Confidence                11  11     11111111111          1111110        01   256778899999999999999999


Q ss_pred             CCCCHHHHHH
Q 013745          347 ERPDMNSVHL  356 (437)
Q Consensus       347 ~RPs~~ev~~  356 (437)
                      +|||+.+.++
T Consensus       540 KR~tA~~cl~  549 (590)
T KOG1290|consen  540 KRPTAAQCLK  549 (590)
T ss_pred             ccccHHHHhc
Confidence            9999999764

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.98  E-value=5.2e-33  Score=260.62  Aligned_cols=265  Identities=25%  Similarity=0.311  Sum_probs=212.3

Q ss_pred             HHHHHHHhcCccccceeccCCCeeEEEEEcC------CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeee
Q 013745           78 LRTLQVATNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGC  150 (437)
Q Consensus        78 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~  150 (437)
                      ..++.+...+++....+-+|.||.||.|.|.      +.+.|.+|.++.. +.-+...++.|.-.+..+.|||+..+.+.
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            3555666778999999999999999999754      3445677877644 55566788999999999999999999998


Q ss_pred             eccC-CceEEEEeecCCCCcchhhh-----ccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCC
Q 013745          151 CAEG-PEKMLVYEYLPNKSLDYFIF-----DKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ  224 (437)
Q Consensus       151 ~~~~-~~~~lv~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~  224 (437)
                      +.+. ...+.+|.++.-|+|..++.     +....+.+...+...++.|++.|++|||..+   |||.||...|++||+.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence            8654 56788999999999999986     3344456777888899999999999999998   9999999999999999


Q ss_pred             CCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhh
Q 013745          225 LNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLS  303 (437)
Q Consensus       225 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~  303 (437)
                      .++||+|=.+++-+-..+.+.-...--....||+||.+....|+.++|||||||+||||+| |+.|+...++.+....+.
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk  512 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK  512 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh
Confidence            9999999999986544433322222223667999999999999999999999999999998 999998766655443332


Q ss_pred             hhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          304 YTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       304 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      -.+.+               .-+.+++.++..++.-||...|++||++++++..|..
T Consensus       513 dGyRl---------------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  513 DGYRL---------------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             cccee---------------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence            22221               1123566678999999999999999999999998864

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.98  E-value=7.8e-33  Score=280.85  Aligned_cols=245  Identities=27%  Similarity=0.387  Sum_probs=186.8

Q ss_pred             ccccceeccCCCee-EEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCC-CCcceeeeeeeccCCceEEEEeecC
Q 013745           88 FSDLNQLGHGGFGP-VYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLVYEYLP  165 (437)
Q Consensus        88 y~~~~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  165 (437)
                      |...+.+|.|+-|+ ||+|.. .|+.||||++-...   .....+|+..|+.-+ |||||++++.-.+....|+..|.| 
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence            44456799999976 599998 78999999986432   244568999999985 999999999999999999999999 


Q ss_pred             CCCcchhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC-----CCCceeeecccccccC
Q 013745          166 NKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE-----QLNPKISDFGLARLFP  239 (437)
Q Consensus       166 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~-----~~~~kl~DFGla~~~~  239 (437)
                      ..+|++++... ...........+.++.|++.||++||+.+   ||||||||.||||+.     ...++|+|||+++.+.
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            56999998552 11111121445778999999999999987   999999999999975     2568999999999987


Q ss_pred             CCCcccc-eeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhC-CCCCCCCCchhhhhhhhhhhhhhcccccccc
Q 013745          240 GEDTHVN-TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG-RKNHDGRLGKEKADLLSYTWTLFQGEKALEL  317 (437)
Q Consensus       240 ~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (437)
                      ....... .....||-+|+|||++....-+.++||||||||+|+.++| ..||......+.        .+.........
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--------NIl~~~~~L~~  734 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--------NILTGNYTLVH  734 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--------hhhcCccceee
Confidence            5543322 2346799999999999998888899999999999999986 889975432221        11111111111


Q ss_pred             cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 013745          318 VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVH  355 (437)
Q Consensus       318 ~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~  355 (437)
                      +.+     ..+.  +..+|+.+|+.++|..||++.+|+
T Consensus       735 L~~-----~~d~--eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  735 LEP-----LPDC--EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             ecc-----CchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence            111     1111  567889999999999999999994

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=1.2e-32  Score=241.65  Aligned_cols=256  Identities=17%  Similarity=0.306  Sum_probs=192.2

Q ss_pred             hcCccccceeccCCCeeEEEEE-cCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCC-CCcceeeeeeeccC--CceEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEG--PEKMLV  160 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv  160 (437)
                      .++|++++++|+|.|+.||.|. ..+++.++||+++.-..   +.+.+|+.||+.|. +|||+++++...+.  ....||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk---kKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK---KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH---HHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            3679999999999999999998 45788999999975433   55779999999998 99999999998765  446799


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC-CCCceeeecccccccC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE-QLNPKISDFGLARLFP  239 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~-~~~~kl~DFGla~~~~  239 (437)
                      +||+.+.+...+-      +.++...+..++.+++.||.|+|++|   |+|||+||.|++||. .-.++|+|+|+|.++-
T Consensus       114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence            9999887765443      45777888999999999999999999   999999999999984 5669999999999875


Q ss_pred             CCCcccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCC-CCCchhhhhhhhhhhhh-----hccc
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHD-GRLGKEKADLLSYTWTL-----FQGE  312 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~-~~~~~~~~~~~~~~~~~-----~~~~  312 (437)
                      ......   ..+.+..|--||++..- .|+..-|+|||||+|..|+..+.||- +.++.+....+..+...     +-..
T Consensus       185 p~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K  261 (338)
T KOG0668|consen  185 PGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK  261 (338)
T ss_pred             CCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence            443322   23567889999988754 68999999999999999999998885 44443332221111000     0000


Q ss_pred             ccccccCccccC----------------CCH-HHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          313 KALELVDPSLAK----------------CNR-DEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       313 ~~~~~~d~~l~~----------------~~~-~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ..+ .+||...+                ... -...+.++++...+..|-.+|||++|.+.
T Consensus       262 Y~i-~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  262 YQI-DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             Hcc-CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            000 01221110                011 12366788999999999999999999754

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=9.3e-31  Score=236.73  Aligned_cols=210  Identities=35%  Similarity=0.560  Sum_probs=182.2

Q ss_pred             eccCCCeeEEEEEcC-CCcEEEEEEeccCChH-HHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCCCCcch
Q 013745           94 LGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQ-GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDY  171 (437)
Q Consensus        94 lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  171 (437)
                      ||+|++|.||++... +++.+++|++...... ....+.+|+..++.+.|++|+++++++......+++||++++++|..
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999864 4899999999765432 34678899999999999999999999999899999999999999999


Q ss_pred             hhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC-CCCceeeecccccccCCCCcccceeee
Q 013745          172 FIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE-QLNPKISDFGLARLFPGEDTHVNTFRI  250 (437)
Q Consensus       172 ~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~  250 (437)
                      ++....  ..+++..++.++.+++.+|.+||+.+   ++|+||+|.||+++. ++.++|+|||.+........  .....
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~  153 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI  153 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence            884321  46889999999999999999999998   999999999999999 89999999999987654321  11134


Q ss_pred             ecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHH
Q 013745          251 SGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDE  329 (437)
Q Consensus       251 ~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  329 (437)
                      .+...|++||.+... .++.++|+|++|+++++|                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            578899999999887 889999999999999999                                              


Q ss_pred             HHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013745          330 AAMCIQLGLLCCQQSVAERPDMNSVHLM  357 (437)
Q Consensus       330 ~~~l~~l~~~cl~~~p~~RPs~~ev~~~  357 (437)
                       ..+.+++..|++.+|++||++.++++.
T Consensus       188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 -PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence             346788999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.5e-32  Score=243.55  Aligned_cols=254  Identities=18%  Similarity=0.303  Sum_probs=194.2

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcC-CCCcceeeeee-eccCCceEEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGC-CAEGPEKMLVY  161 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~  161 (437)
                      .+.|.+.+.||+|.||.+-++..+ +.+.+|+|.+...... .++|.+|...--.| .|.||+.-|+. |+..+.+++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt-~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT-QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh-HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            466999999999999999999854 6788999998765443 57899998876666 49999987765 67778889999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEec--CCCCceeeecccccccC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD--EQLNPKISDFGLARLFP  239 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~--~~~~~kl~DFGla~~~~  239 (437)
                      ||++.|+|..-+    ....+.+....+++.|++.|+.|+|+++   +||||||.+||||-  +.-.+||||||+.+..+
T Consensus       102 E~aP~gdL~snv----~~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  102 EFAPRGDLRSNV----EAAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             ccCccchhhhhc----CcccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence            999999998776    3356888999999999999999999998   99999999999992  34479999999998654


Q ss_pred             CCCcccceeeeecccccCChhhhccC-----cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccc
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALHG-----YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKA  314 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  314 (437)
                      ..-.     ...-+..|.+||+....     ...+.+|||.||+|+|.++||..||......+   ...|.|..|.....
T Consensus       175 ~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d---~~Y~~~~~w~~rk~  246 (378)
T KOG1345|consen  175 TTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMD---KPYWEWEQWLKRKN  246 (378)
T ss_pred             ceeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccC---chHHHHHHHhcccC
Confidence            3211     22346789999977532     46788999999999999999999997433222   22344444544433


Q ss_pred             ccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          315 LELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       315 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                      .     .+++........++.+.++-+..++++|=...++.++..
T Consensus       247 ~-----~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk  286 (378)
T KOG1345|consen  247 P-----ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK  286 (378)
T ss_pred             c-----cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence            2     333333344556778888999999999966666655544

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=6.3e-32  Score=264.07  Aligned_cols=196  Identities=26%  Similarity=0.353  Sum_probs=167.0

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC---hHHHH-----HHHHHHHHHHcCC---CCcceeeeeeecc
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS---RQGLR-----EFTNEVKLLLKIQ---HKNLVTLFGCCAE  153 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~-----~~~~E~~~l~~l~---h~niv~l~~~~~~  153 (437)
                      ..|..++.||.|+||.|++|+.+ +...|+||.+.+..   ..+.+     .+-.|+.||..|+   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            35899999999999999999854 56788999886541   11211     2456999999997   9999999999999


Q ss_pred             CCceEEEEeec-CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeec
Q 013745          154 GPEKMLVYEYL-PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDF  232 (437)
Q Consensus       154 ~~~~~lv~e~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DF  232 (437)
                      ++.+||+||-. ++-+|.++|   .....+++..+..|+.|++.|+++||+++   |||||||-+||.++.+|-+||+||
T Consensus       641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence            99999999976 456777887   34467999999999999999999999999   999999999999999999999999


Q ss_pred             ccccccCCCCcccceeeeecccccCChhhhccCcC-CcccceehhhHHHHHHHhCCCCCC
Q 013745          233 GLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL-SVKTDVFSYGVLVLEIVSGRKNHD  291 (437)
Q Consensus       233 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DvwSlG~vl~elltg~~p~~  291 (437)
                      |.|.......    ...++||..|.|||++.+.+| +..-|||++|++||.++....||.
T Consensus       715 gsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  715 GSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             cchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9998764432    235789999999999998854 667999999999999999988885

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-31  Score=244.18  Aligned_cols=259  Identities=25%  Similarity=0.302  Sum_probs=193.7

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccC------C
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG------P  155 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  155 (437)
                      ..+|..++.+|.|+- .|..|.+. .++.||+|++...  .....++..+|...+..++|+||++++.+|.-.      .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            456888899999998 66666532 6899999988643  233346678999999999999999999998643      3


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccc
Q 013745          156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA  235 (437)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  235 (437)
                      ..|+|||+| ..+|..++.     -.++..++..++.|++.|++|||+.+   |+||||||+||++..++.+||.|||+|
T Consensus        95 e~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a  165 (369)
T KOG0665|consen   95 EVYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA  165 (369)
T ss_pred             hHHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence            569999999 568877774     34677899999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhh----------
Q 013745          236 RLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYT----------  305 (437)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~----------  305 (437)
                      +..+..   -....++.|..|.|||++.+..+.+.+||||+||++.||++|...|.+...-+....+...          
T Consensus       166 r~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~  242 (369)
T KOG0665|consen  166 RTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK  242 (369)
T ss_pred             cccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence            865433   2223567799999999999988999999999999999999999999875533222211000          


Q ss_pred             ------h------hhhcccccccccCcc----ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          306 ------W------TLFQGEKALELVDPS----LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       306 ------~------~~~~~~~~~~~~d~~----l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                            .      ..+..-...+.+...    ..+..+-.....-+++.+||-.+|++|-++.++++
T Consensus       243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                  0      000010011111111    11122233444667888999999999999999875

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=6.2e-30  Score=235.12  Aligned_cols=199  Identities=31%  Similarity=0.455  Sum_probs=172.1

Q ss_pred             ccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChH-HHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecC
Q 013745           88 FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQ-GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLP  165 (437)
Q Consensus        88 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  165 (437)
                      |.+.+.||.|++|.||++... +++.+|+|.+...... ....+.+|++.+++++|+|++++++++......++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            566789999999999999865 4899999999866544 56788999999999999999999999999899999999999


Q ss_pred             CCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCccc
Q 013745          166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV  245 (437)
Q Consensus       166 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  245 (437)
                      +++|.+++....  ..+++..++.++.+++.+|.+||+.+   ++|+||+|.||+++.++.++|+|||++......... 
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-  154 (225)
T smart00221       81 GGDLFDYLRKKG--GKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-  154 (225)
T ss_pred             CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence            999999884322  11789999999999999999999987   999999999999999999999999999887544211 


Q ss_pred             ceeeeecccccCChhhh-ccCcCCcccceehhhHHHHHHHhCCCCCCC
Q 013745          246 NTFRISGTHGYMAPEYA-LHGYLSVKTDVFSYGVLVLEIVSGRKNHDG  292 (437)
Q Consensus       246 ~~~~~~gt~~Y~aPE~~-~~~~~~~~~DvwSlG~vl~elltg~~p~~~  292 (437)
                      ......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            11234678899999998 666788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=3.7e-31  Score=262.52  Aligned_cols=252  Identities=24%  Similarity=0.329  Sum_probs=201.5

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      .++|+.+..+|.|.||.||++++ .+++..|+|+++........-+.+|+-+++..+|||||.+++.+...+.++++|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            45799999999999999999994 47899999999877666667778999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      |.+|+|++.-   ...+++++.++..+.+..++||+|||+++   =+|||||-.|||+++.|.+|++|||.+..+...- 
T Consensus        94 cgggslQdiy---~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati-  166 (829)
T KOG0576|consen   94 CGGGSLQDIY---HVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI-  166 (829)
T ss_pred             cCCCccccee---eecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh-
Confidence            9999998875   34578999999999999999999999998   7999999999999999999999999987654221 


Q ss_pred             ccceeeeecccccCChhhh---ccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          244 HVNTFRISGTHGYMAPEYA---LHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~---~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                       .....+.||+.|||||+.   ..+.|...+|||++|+...||---++|.....+..  .+.......++         |
T Consensus       167 -~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr--~l~LmTkS~~q---------p  234 (829)
T KOG0576|consen  167 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR--ALFLMTKSGFQ---------P  234 (829)
T ss_pred             -hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH--HHHHhhccCCC---------C
Confidence             222357899999999976   35679999999999999999988777754322211  11111222222         1


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVH  355 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~  355 (437)
                      .-.+....-...+.++++.|+..+|++||+++.++
T Consensus       235 p~lkDk~kws~~fh~fvK~altknpKkRptaeklL  269 (829)
T KOG0576|consen  235 PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLL  269 (829)
T ss_pred             CcccCCccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence            11111222334577889999999999999998764

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=1.2e-29  Score=240.87  Aligned_cols=201  Identities=26%  Similarity=0.449  Sum_probs=166.6

Q ss_pred             HHHHhcCccccceeccCCCeeEEEEEcC----CCcEEEEEEeccCChHHHHHHHHHHHHHHcCC-CCcceeeeeeeccCC
Q 013745           81 LQVATNFFSDLNQLGHGGFGPVYRGLMP----NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGP  155 (437)
Q Consensus        81 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  155 (437)
                      +....+.|.++++||.|.|++||++.+.    ..+.||+|.+...+..  ..+.+|+++|.++. +.||+++.+++..++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            4455678999999999999999999842    4678999998755433  55779999999996 999999999999999


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC-CCCceeeeccc
Q 013745          156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE-QLNPKISDFGL  234 (437)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~-~~~~kl~DFGl  234 (437)
                      ...+|+||++.-...++.      ..++...+..+++.++.||+++|.+|   ||||||||+|+|.+. -+.-.|.||||
T Consensus       109 ~v~ivlp~~~H~~f~~l~------~~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLY------RSLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             eeEEEecccCccCHHHHH------hcCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence            999999999998888877      23667899999999999999999998   999999999999974 46689999999


Q ss_pred             ccccCCCC-------------cc-----------------------------cceeeeecccccCChhhhcc-CcCCccc
Q 013745          235 ARLFPGED-------------TH-----------------------------VNTFRISGTHGYMAPEYALH-GYLSVKT  271 (437)
Q Consensus       235 a~~~~~~~-------------~~-----------------------------~~~~~~~gt~~Y~aPE~~~~-~~~~~~~  271 (437)
                      |...+...             ..                             .......||++|.|||++.. ...++++
T Consensus       180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai  259 (418)
T KOG1167|consen  180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI  259 (418)
T ss_pred             HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence            98321000             00                             00112459999999998865 4689999


Q ss_pred             ceehhhHHHHHHHhCCCCCCC
Q 013745          272 DVFSYGVLVLEIVSGRKNHDG  292 (437)
Q Consensus       272 DvwSlG~vl~elltg~~p~~~  292 (437)
                      ||||.|||++-+++++.||-.
T Consensus       260 Diws~GVI~Lslls~~~PFf~  280 (418)
T KOG1167|consen  260 DIWSAGVILLSLLSRRYPFFK  280 (418)
T ss_pred             ceeeccceeehhhcccccccc
Confidence            999999999999999999954

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=2.2e-29  Score=273.77  Aligned_cols=195  Identities=15%  Similarity=0.195  Sum_probs=139.4

Q ss_pred             CCC-Ccceeeeeee-------ccCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceE
Q 013745          139 IQH-KNLVTLFGCC-------AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII  210 (437)
Q Consensus       139 l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ii  210 (437)
                      ++| +||++++++|       ......++++||+ +++|.++|..  ....+++..++.++.||++||.|||+++   |+
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---Iv  102 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---IV  102 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---ee
Confidence            345 5888888887       2334567888987 6699999843  2356999999999999999999999998   99


Q ss_pred             eeccCCCCEEecC-------------------CCCceeeecccccccCCCCc--------------ccceeeeecccccC
Q 013745          211 HRDIKASNILLDE-------------------QLNPKISDFGLARLFPGEDT--------------HVNTFRISGTHGYM  257 (437)
Q Consensus       211 HrDikp~NIll~~-------------------~~~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~Y~  257 (437)
                      ||||||+||||+.                   ++.+||+|||+++.......              .......+||+.||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            9999999999954                   45567777777764321000              00011245889999


Q ss_pred             ChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHH
Q 013745          258 APEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLG  337 (437)
Q Consensus       258 aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~  337 (437)
                      |||++.+..++.++|||||||+||||++|..|+.....  ..  ......         .+.+..    .........++
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~--~~~~~~---------~~~~~~----~~~~~~~~~~~  245 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--TM--SSLRHR---------VLPPQI----LLNWPKEASFC  245 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--HH--HHHHHh---------hcChhh----hhcCHHHHHHH
Confidence            99999999999999999999999999999888753211  00  000000         011111    11123456788


Q ss_pred             HHcCCCCCCCCCCHHHHHH
Q 013745          338 LLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       338 ~~cl~~~p~~RPs~~ev~~  356 (437)
                      .+||+.+|.+||+|.||++
T Consensus       246 ~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        246 LWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHhCCCChhhCcChHHHhh
Confidence            8999999999999999975

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=2.5e-26  Score=224.16  Aligned_cols=259  Identities=20%  Similarity=0.222  Sum_probs=194.1

Q ss_pred             CccccceeccCCCeeEEEEEcCCC--cEEEEEEeccCChHHHHHHHHHHHHHHcCCC----Ccceeeeeee-ccCCceEE
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMPNG--QEIAVKKLSVDSRQGLREFTNEVKLLLKIQH----KNLVTLFGCC-AEGPEKML  159 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l  159 (437)
                      +|.+.+.||+|+||.||+|.....  ..+|+|............+..|+.++..+..    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999985443  4788888765433222367789999988863    6899999998 57778899


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCC-----CCceeeeccc
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ-----LNPKISDFGL  234 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~-----~~~kl~DFGl  234 (437)
                      ||+.+ |.+|.++..... ...++..+++.++.|++.+|++||+.|   ++||||||+|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99988 889998764433 578999999999999999999999998   9999999999999754     4689999999


Q ss_pred             cc--ccCCCCcc----c-c-eeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhh
Q 013745          235 AR--LFPGEDTH----V-N-TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTW  306 (437)
Q Consensus       235 a~--~~~~~~~~----~-~-~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~  306 (437)
                      ++  .+......    . . .....||..|+++....+...+.+.|+||++.++.|++.|..||...........+....
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~  253 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP  253 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence            99  43222211    1 1 123559999999999999999999999999999999999999997654332211111110


Q ss_pred             hhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCC
Q 013745          307 TLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD  361 (437)
Q Consensus       307 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~  361 (437)
                      ..       ..... .....   +..+.++...+-..+...+|....+...|...
T Consensus       254 ~~-------~~~~~-~~~~~---~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  254 RK-------LLTDR-FGDLK---PEEFAKILEYIDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             hh-------hcccc-ccCCC---hHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence            00       00000 11222   33455555566669999999999999887653

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=6.7e-27  Score=207.84  Aligned_cols=165  Identities=19%  Similarity=0.157  Sum_probs=123.6

Q ss_pred             CCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccc
Q 013745          167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN  246 (437)
Q Consensus       167 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  246 (437)
                      |+|.+++..+  ...+++..++.|+.||+.||.|||+++         ||+|||++.++.+|+  ||+++......    
T Consensus         1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence            6888888432  356999999999999999999999975         999999999999999  99998764322    


Q ss_pred             eeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCC
Q 013745          247 TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCN  326 (437)
Q Consensus       247 ~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  326 (437)
                         ..||+.|+|||++.+..++.++|||||||++|||++|+.||........  .+........      ..++......
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~------~~~~~~~~~~  132 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA--ILEILLNGMP------ADDPRDRSNL  132 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH--HHHHHHHHhc------cCCccccccH
Confidence               2579999999999999999999999999999999999999965332111  1111100000      0000000111


Q ss_pred             HHHHH--HHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          327 RDEAA--MCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       327 ~~~~~--~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                      .....  .+.+++.+||+.+|++||++.++++.+.
T Consensus       133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~  167 (176)
T smart00750      133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCR  167 (176)
T ss_pred             HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHH
Confidence            12222  5899999999999999999999998764

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=1.4e-26  Score=226.47  Aligned_cols=178  Identities=19%  Similarity=0.204  Sum_probs=135.2

Q ss_pred             HHHHhcCccccceeccCCCeeEEEEEcC--CCcEEEEEEeccC-----ChHHHHHHHHHHHHHHcCCCCcceeeeeeecc
Q 013745           81 LQVATNFFSDLNQLGHGGFGPVYRGLMP--NGQEIAVKKLSVD-----SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE  153 (437)
Q Consensus        81 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  153 (437)
                      +....++|.+.+.||+|+||+||+|..+  +++.||||++...     .......+.+|+++|++++|+|++..+..+  
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--   90 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--   90 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence            3445678999999999999999999854  5777899987532     223356689999999999999998533322  


Q ss_pred             CCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeecc-CCCCEEecCCCCceeeec
Q 013745          154 GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDI-KASNILLDEQLNPKISDF  232 (437)
Q Consensus       154 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDi-kp~NIll~~~~~~kl~DF  232 (437)
                       +..+|||||++|++|....    .   ..   ...++.|++++|.|||+++   |+|||| ||+|||++.++.+||+||
T Consensus        91 -~~~~LVmE~~~G~~L~~~~----~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDF  156 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHLAR----P---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDF  156 (365)
T ss_pred             -CCcEEEEEccCCCCHHHhC----c---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEEC
Confidence             4579999999999996221    1   11   1467899999999999998   999999 999999999999999999


Q ss_pred             ccccccCCCCcccc------eeeeecccccCChhhhccCc------CCccccee
Q 013745          233 GLARLFPGEDTHVN------TFRISGTHGYMAPEYALHGY------LSVKTDVF  274 (437)
Q Consensus       233 Gla~~~~~~~~~~~------~~~~~gt~~Y~aPE~~~~~~------~~~~~Dvw  274 (437)
                      |+|+.+........      .....+++.|+|||++....      .+..+|-|
T Consensus       157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            99997754332111      12456888999999986542      23346666

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=3.6e-26  Score=202.49  Aligned_cols=260  Identities=21%  Similarity=0.260  Sum_probs=199.4

Q ss_pred             HhcCccccceeccCCCeeEEEEE-cCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCC-CCcceeeeeeeccCCceEEEE
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ..+.|.++++||.|+||.+|.|. ..+|..||||.-.....  ..++..|.++.+.|+ ...|..+..+..++..-.|||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            35679999999999999999998 67899999999865433  256778999999997 567888888888888999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC---CCCceeeeccccccc
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE---QLNPKISDFGLARLF  238 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~---~~~~kl~DFGla~~~  238 (437)
                      |.+ |.+|.++..  -....++..+++-++-|++.-++|+|.++   +|||||||+|+|+.-   ...+.|+|||+|+.+
T Consensus        91 dLL-GPsLEdLfn--fC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   91 DLL-GPSLEDLFN--FCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             ecc-CccHHHHHH--HHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence            998 889988862  33456899999999999999999999998   999999999999953   345899999999987


Q ss_pred             CCCCcc-----cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccc
Q 013745          239 PGEDTH-----VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEK  313 (437)
Q Consensus       239 ~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (437)
                      .+..+.     .......||.+|.+-....+...+.+.|+-|+|.||..+.-|..||.+..........+....    . 
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~E----k-  239 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISE----K-  239 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHH----h-
Confidence            543322     122346799999999888888889999999999999999999999998654333222111110    0 


Q ss_pred             cccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          314 ALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       314 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                         ...-.+.......+.++.-.+.-|-..--++-|...-+.+++.
T Consensus       240 ---K~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr  282 (341)
T KOG1163|consen  240 ---KMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR  282 (341)
T ss_pred             ---hcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence               1111111112233445566677888999999999888877654

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=2.4e-25  Score=205.58  Aligned_cols=259  Identities=20%  Similarity=0.260  Sum_probs=194.8

Q ss_pred             hcCccccceeccCCCeeEEEEE-cCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCC-CCcceeeeeeeccCCceEEEEe
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      .-.|++.++||+|.||+.+.|. +-+++.||||.-...++  ..++..|.+..+.|. .++|..++.+-.++.+-.||+|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            3469999999999999999998 44899999998765443  256778998888885 8999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCC-----CCceeeecccccc
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ-----LNPKISDFGLARL  237 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~-----~~~kl~DFGla~~  237 (437)
                      ++ |-+|.++. + -....|+.+++.-+|.|++.-++|+|++.   +|.|||||+|+||..-     ..+.|+|||+|+.
T Consensus       105 LL-GPSLEDLF-D-~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  105 LL-GPSLEDLF-D-LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hh-CcCHHHHH-H-HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            98 88998876 2 23456999999999999999999999998   9999999999999643     3589999999998


Q ss_pred             cCCCCcccc-----eeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccc
Q 013745          238 FPGEDTHVN-----TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGE  312 (437)
Q Consensus       238 ~~~~~~~~~-----~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  312 (437)
                      +.+..+..-     .....||.+||+=....+...+.+.|+-|||-|++..|-|..||.+..........+.    ..+.
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK----IGe~  254 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK----IGET  254 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH----hccc
Confidence            866554322     2245699999999999999999999999999999999999999987543221111110    1110


Q ss_pred             ccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          313 KALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       313 ~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                      +..--    +.......+.++...+.-.-..+-.+-|..+-+...+.
T Consensus       255 Kr~T~----i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~  297 (449)
T KOG1165|consen  255 KRSTP----IEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFD  297 (449)
T ss_pred             cccCC----HHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence            00000    11111123334444444555677778888877665543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=3.7e-24  Score=205.82  Aligned_cols=260  Identities=28%  Similarity=0.401  Sum_probs=197.0

Q ss_pred             ccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChH---HHHHHHHHHHHHHcCCCC-cceeeeeeeccCCceEEEEee
Q 013745           88 FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQ---GLREFTNEVKLLLKIQHK-NLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        88 y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  163 (437)
                      |.+.+.||.|+||.||++...  ..+++|.+......   ....+.+|+.+++.+.|+ +|+++++.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            677889999999999999875  78899998755322   467899999999999988 799999999777778999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCC-CceeeecccccccCCCC
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL-NPKISDFGLARLFPGED  242 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~-~~kl~DFGla~~~~~~~  242 (437)
                      +.++++..++........+.......++.|++.++.|+|+.+   ++||||||+||+++..+ .++++|||+++.+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999866632211136888999999999999999999998   99999999999999988 69999999998665443


Q ss_pred             ccc----ceeeeecccccCChhhhcc---CcCCcccceehhhHHHHHHHhCCCCCCCCCch-hhhhhhhhhhhhhccccc
Q 013745          243 THV----NTFRISGTHGYMAPEYALH---GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGK-EKADLLSYTWTLFQGEKA  314 (437)
Q Consensus       243 ~~~----~~~~~~gt~~Y~aPE~~~~---~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~  314 (437)
                      ...    ......|+..|++||.+.+   ..+....|+||+|++++++++|..||...... .........+.....   
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---  233 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP---  233 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc---
Confidence            221    2235679999999999987   58899999999999999999999997655431 011111111111100   


Q ss_pred             ccccCccc-cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Q 013745          315 LELVDPSL-AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLM  357 (437)
Q Consensus       315 ~~~~d~~l-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~  357 (437)
                        ...... ..........+.+++..|+..+|..|.++.+....
T Consensus       234 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 --SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             --ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence              000000 00002223567788889999999999999887653

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=9.3e-26  Score=234.41  Aligned_cols=254  Identities=20%  Similarity=0.200  Sum_probs=189.6

Q ss_pred             cccceeccCCCeeEEEEEc-CCCcEEEEEEec----c-CChH-HHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           89 SDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLS----V-DSRQ-GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        89 ~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~----~-~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ...+.+|.|++|.|+.+.. .....++.|.+.    . .... ....+..|+.+-..+.|+|++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            3467899999998887763 244445555443    1 1111 1222667888888899999999888888877777779


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      |||++ +|..++...   ..+....+-.++.|++.|++|||+.|   |.|||||++|+++..+|.+||+|||.+..+...
T Consensus       401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 998888432   45777888899999999999999999   999999999999999999999999999877544


Q ss_pred             Ccc--cceeeeecccccCChhhhccCcCCcc-cceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          242 DTH--VNTFRISGTHGYMAPEYALHGYLSVK-TDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       242 ~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      ...  .....++|+..|+|||++.+..|.+. .||||.|+|+..|++|+.||......+...       ..........+
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-------~~~~~~~~~~~  546 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-------KTNNYSDQRNI  546 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-------hhhcccccccc
Confidence            332  34446789999999999999887765 899999999999999999997654433211       00000001111


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ...........+.+...++.++++.+|.+|-|+++|++
T Consensus       547 ~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  547 FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            11122333455666788999999999999999999975

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=6.9e-25  Score=197.46  Aligned_cols=244  Identities=23%  Similarity=0.375  Sum_probs=187.9

Q ss_pred             ccceeccCCCeeEEEEEcCCCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCCC
Q 013745           90 DLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNK  167 (437)
Q Consensus        90 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  167 (437)
                      ++.+|.+...|..|+|++ .|..+++|++....  ....+.|..|.-.|+.+.||||+.+++.|....++.++..||+.|
T Consensus       194 l~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence            356788999999999999 56677778886542  233467889999999999999999999999999999999999999


Q ss_pred             CcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceee--ecccccccCCCCccc
Q 013745          168 SLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKIS--DFGLARLFPGEDTHV  245 (437)
Q Consensus       168 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~--DFGla~~~~~~~~~~  245 (437)
                      +|..++++.. .--++..++.+++.++++|++|||+..+ -|.---|....|+||++.+.+|.  |--++-  .  ..  
T Consensus       273 slynvlhe~t-~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfsf--q--e~--  344 (448)
T KOG0195|consen  273 SLYNVLHEQT-SVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFSF--Q--EV--  344 (448)
T ss_pred             HHHHHHhcCc-cEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceeee--e--cc--
Confidence            9999997543 3457788999999999999999999863 24444688999999999988874  321111  0  00  


Q ss_pred             ceeeeecccccCChhhhccCcC---CcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccc
Q 013745          246 NTFRISGTHGYMAPEYALHGYL---SVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL  322 (437)
Q Consensus       246 ~~~~~~gt~~Y~aPE~~~~~~~---~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  322 (437)
                         ...-.+.||+||.++..+-   -.++|+|||+++||||.|...||....+.+..-.      +     ..+.+   .
T Consensus       345 ---gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk------i-----alegl---r  407 (448)
T KOG0195|consen  345 ---GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK------I-----ALEGL---R  407 (448)
T ss_pred             ---ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh------h-----hhccc---c
Confidence               1123688999999987743   3569999999999999999999986655432211      1     01111   1


Q ss_pred             cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          323 AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       323 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                      ...++..+..+.+|+.-|+..||.+||.+..|+-.|+
T Consensus       408 v~ippgis~hm~klm~icmnedpgkrpkfdmivpile  444 (448)
T KOG0195|consen  408 VHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILE  444 (448)
T ss_pred             ccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHH
Confidence            2345566777889999999999999999999988776

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=4.5e-24  Score=194.81  Aligned_cols=173  Identities=12%  Similarity=0.132  Sum_probs=135.2

Q ss_pred             HHHhcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCCh---HHHHH------HHHHHHHHHcCCCCcceeeeeeec
Q 013745           82 QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR---QGLRE------FTNEVKLLLKIQHKNLVTLFGCCA  152 (437)
Q Consensus        82 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~------~~~E~~~l~~l~h~niv~l~~~~~  152 (437)
                      ....++|+.+++||.|+||.||++.. ++..+|||.+.....   .....      +.+|+..+.++.|++|..+.+++.
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            35678999999999999999999655 677899999974422   11122      678999999999999999988865


Q ss_pred             cC--------CceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCC
Q 013745          153 EG--------PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ  224 (437)
Q Consensus       153 ~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~  224 (437)
                      ..        ...+|||||++|.+|.++.       .++.    ....+++.+|..||+.+   ++||||||+||+++.+
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~  171 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMP-------EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKN  171 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhh-------hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCC
Confidence            33        3578999999999997763       1222    24568999999999998   9999999999999998


Q ss_pred             CCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHH
Q 013745          225 LNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIV  284 (437)
Q Consensus       225 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ell  284 (437)
                      | ++|+|||...........              ..++....+..++|+|+||+.+..+.
T Consensus       172 g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        172 G-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             C-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence            8 999999988765322111              11455556778999999999987664

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=2e-23  Score=187.84  Aligned_cols=140  Identities=16%  Similarity=0.157  Sum_probs=108.7

Q ss_pred             cceeccCCCeeEEEEEcCCCcEEEEEEeccCChH--H------------------------HHHHHHHHHHHHcCCCCcc
Q 013745           91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQ--G------------------------LREFTNEVKLLLKIQHKNL  144 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~ni  144 (437)
                      ...||+|+||.||+|...+|+.||||+++.....  .                        ......|++++.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999999778999999999754210  0                        0122459999999987776


Q ss_pred             eeeeeeeccCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCceEeeccCCCCEEecC
Q 013745          145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL-HEEAPARIIHRDIKASNILLDE  223 (437)
Q Consensus       145 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~~~iiHrDikp~NIll~~  223 (437)
                      .....+..  ...+|||||++++++...+.   ....+++..+..++.|++.+|.|| |+.+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence            43222221  22389999999887765432   234688999999999999999999 6877   99999999999998 


Q ss_pred             CCCceeeecccccccC
Q 013745          224 QLNPKISDFGLARLFP  239 (437)
Q Consensus       224 ~~~~kl~DFGla~~~~  239 (437)
                      ++.++|+|||+|....
T Consensus       153 ~~~v~LiDFG~a~~~~  168 (190)
T cd05147         153 DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             CCcEEEEEccccccCC
Confidence            4789999999998653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.89  E-value=1e-23  Score=219.89  Aligned_cols=252  Identities=23%  Similarity=0.247  Sum_probs=183.0

Q ss_pred             CccccceeccCCCeeEEEEEcCCCcEEEEEEeccCC-hHHHHH---HHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS-RQGLRE---FTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~---~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      +|...+.||.+.|=+|.+|+.+.|. |+||++-+.. ....+.   ...|++ ...+++||++++..+....+..|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5777899999999999999987776 8999986543 223333   344555 555689999999998888888999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccccc--CC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF--PG  240 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~--~~  240 (437)
                      |+.+ +|.+.+   ..++-+...+...|+.|++.||..+|..|   |+|+|||.+||||+.-.-+.|+||..-+-.  +.
T Consensus       102 yvkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  102 YVKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             HHhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            9955 776666   34566788888999999999999999998   999999999999999999999999766532  22


Q ss_pred             CCcccceee---eecccccCChhhhccC-----------cCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhh
Q 013745          241 EDTHVNTFR---ISGTHGYMAPEYALHG-----------YLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYT  305 (437)
Q Consensus       241 ~~~~~~~~~---~~gt~~Y~aPE~~~~~-----------~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~  305 (437)
                      ++....++.   -..-.+|+|||.+...           ..+++-||||+|||++||++ |++||.-      ..+..+.
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~aYr  248 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLAYR  248 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHhHh
Confidence            222211111   1223479999988541           25788999999999999998 6888852      1122211


Q ss_pred             hh-hhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCCCC
Q 013745          306 WT-LFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSF  363 (437)
Q Consensus       306 ~~-~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~  363 (437)
                      .. .+..+..++.+          +...+..+++.|++.||.+|.++++.++.-.|..+
T Consensus       249 ~~~~~~~e~~Le~I----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~F  297 (1431)
T KOG1240|consen  249 SGNADDPEQLLEKI----------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVF  297 (1431)
T ss_pred             ccCccCHHHHHHhC----------cCccHHHHHHHHHccCchhccCHHHHHHhhhcccc
Confidence            11 01111111111          11246678999999999999999999998777554

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=3.3e-22  Score=180.25  Aligned_cols=141  Identities=18%  Similarity=0.188  Sum_probs=111.4

Q ss_pred             cceeccCCCeeEEEEEcCCCcEEEEEEeccCChH--------------------------HHHHHHHHHHHHHcCCCCcc
Q 013745           91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQ--------------------------GLREFTNEVKLLLKIQHKNL  144 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni  144 (437)
                      .+.||+|+||.||+|...+|+.||||++......                          ....+..|.+.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            5789999999999999778999999998754210                          01224678999999999987


Q ss_pred             eeeeeeeccCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceEeeccCCCCEEecC
Q 013745          145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE-EAPARIIHRDIKASNILLDE  223 (437)
Q Consensus       145 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiHrDikp~NIll~~  223 (437)
                      .....+...  ..+|||||++|+++.....   ....++...+..++.|++.+|.+||+ .+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence            543333322  2489999999886544321   22457788899999999999999999 87   99999999999999 


Q ss_pred             CCCceeeecccccccCC
Q 013745          224 QLNPKISDFGLARLFPG  240 (437)
Q Consensus       224 ~~~~kl~DFGla~~~~~  240 (437)
                      ++.++|+|||++.....
T Consensus       153 ~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCCEEEEEcccceecCC
Confidence            88999999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=7.8e-22  Score=176.52  Aligned_cols=187  Identities=18%  Similarity=0.111  Sum_probs=141.6

Q ss_pred             cccceeccCCCeeEEEEEcCCCcEEEEEEeccCChH----HHHHHHHHHHHHHcCC-CCcceeeeeeeccCCceEEEEee
Q 013745           89 SDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQ----GLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        89 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      .+...|++|+||+||.+.. .+..++.+.+......    ....+.+|+++|++|. +++|++++++    ...+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            3568899999999997765 6788887777644321    1125789999999995 5889999886    346999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeecc-CCCCEEecCCCCceeeecccccccCCCC
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDI-KASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDi-kp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      +.|.+|...+.    .      ....++.|++.+|.++|+.|   |+|||| ||+|||++.++.++|+|||+|.......
T Consensus        80 I~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         80 LAGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             ecCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            99998864431    0      11357889999999999998   999999 7999999999999999999998654332


Q ss_pred             cc----cc-------eeeeecccccCChhhhccC-cCC-cccceehhhHHHHHHHhCCCCCCCC
Q 013745          243 TH----VN-------TFRISGTHGYMAPEYALHG-YLS-VKTDVFSYGVLVLEIVSGRKNHDGR  293 (437)
Q Consensus       243 ~~----~~-------~~~~~gt~~Y~aPE~~~~~-~~~-~~~DvwSlG~vl~elltg~~p~~~~  293 (437)
                      ..    ..       ......++.|++|+...-. ..+ .+.++++-|+-+|.++|++.++.+.
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            11    00       1112368889999854432 223 6789999999999999999887543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.87  E-value=8.1e-22  Score=185.28  Aligned_cols=231  Identities=19%  Similarity=0.263  Sum_probs=151.0

Q ss_pred             ccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCC-----------Ccceeeeee--
Q 013745           88 FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQH-----------KNLVTLFGC--  150 (437)
Q Consensus        88 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-----------~niv~l~~~--  150 (437)
                      +...+.||.|+|+.||.+... +|+.+|||++....   ....+.+.+|.-....+.+           ..++. ++.  
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P-~d~~~   92 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP-LDLLR   92 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B----SEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee-eEEEE
Confidence            456788999999999999854 69999999986442   2345667666655544322           11111 111  


Q ss_pred             -------eccC---C-----ceEEEEeecCCCCcchhhh---ccCC-CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEe
Q 013745          151 -------CAEG---P-----EKMLVYEYLPNKSLDYFIF---DKTK-SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIH  211 (437)
Q Consensus       151 -------~~~~---~-----~~~lv~e~~~~gsL~~~l~---~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH  211 (437)
                             +...   .     ..+++|+-+ .++|..++.   .... ...+....++.+..|+++.+++||+.|   ++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence                   1111   1     236788877 668877643   2221 123455666778899999999999998   999


Q ss_pred             eccCCCCEEecCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccC--------cCCcccceehhhHHHHHH
Q 013745          212 RDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHG--------YLSVKTDVFSYGVLVLEI  283 (437)
Q Consensus       212 rDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--------~~~~~~DvwSlG~vl~el  283 (437)
                      +||||+|++++.+|.++|+||+.....+.....     ...+..|.+||.....        .++.+.|.|+||+++|.|
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            999999999999999999999988765432111     1245789999977442        578899999999999999


Q ss_pred             HhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCC
Q 013745          284 VSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAER  348 (437)
Q Consensus       284 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~R  348 (437)
                      ++|+.||...........                   .+..|. +.+..+..|+..+++.+|.+|
T Consensus       244 WC~~lPf~~~~~~~~~~~-------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  244 WCGRLPFGLSSPEADPEW-------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHSS-STCCCGGGSTSGG-------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHccCCCCCCCccccccc-------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            999999986543222110                   234566 788889999999999999988

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.86  E-value=3.2e-23  Score=206.64  Aligned_cols=225  Identities=24%  Similarity=0.244  Sum_probs=177.7

Q ss_pred             eeccCCCeeEEEEE----cCCCcEEEEEEeccCCh--HHHHHHHHHHHHHHcCC-CCcceeeeeeeccCCceEEEEeecC
Q 013745           93 QLGHGGFGPVYRGL----MPNGQEIAVKKLSVDSR--QGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLVYEYLP  165 (437)
Q Consensus        93 ~lG~G~~g~Vy~~~----~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  165 (437)
                      .+|+|+||.|+++.    .+.|.-+|+|.+.+...  ........|..++..++ ||.+|++...+..+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            47999999999875    23577889988864321  11124566888888887 9999999999999999999999999


Q ss_pred             CCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCccc
Q 013745          166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV  245 (437)
Q Consensus       166 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  245 (437)
                      ||.|...+.   ....+++.....+...++.+++++|..+   |+|||+|++||+++.+|++++.|||+++..-..+.. 
T Consensus        81 gg~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~-  153 (612)
T KOG0603|consen   81 GGDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA-  153 (612)
T ss_pred             cchhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence            999977763   3455777788888999999999999998   999999999999999999999999999876443322 


Q ss_pred             ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCC
Q 013745          246 NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKC  325 (437)
Q Consensus       246 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  325 (437)
                           |||..|||||++.  .....+|.||||++.+||+||-.||.+    +....+.                ..-...
T Consensus       154 -----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il----------------~~~~~~  206 (612)
T KOG0603|consen  154 -----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRIL----------------KAELEM  206 (612)
T ss_pred             -----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHh----------------hhccCC
Confidence                 8999999999998  568899999999999999999999976    1111111                001123


Q ss_pred             CHHHHHHHHHHHHHcCCCCCCCCCCH
Q 013745          326 NRDEAAMCIQLGLLCCQQSVAERPDM  351 (437)
Q Consensus       326 ~~~~~~~l~~l~~~cl~~~p~~RPs~  351 (437)
                      +........+++..+...+|..|.-.
T Consensus       207 p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  207 PRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            44555666677778888888888655

>PRK10345 hypothetical protein; Provisional

Probab=99.85  E-value=6.3e-21  Score=173.42  Aligned_cols=135  Identities=18%  Similarity=0.269  Sum_probs=105.3

Q ss_pred             ccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcC-----CCCcceeeeeeeccCC---ceE-EE
Q 013745           90 DLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-----QHKNLVTLFGCCAEGP---EKM-LV  160 (437)
Q Consensus        90 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~-lv  160 (437)
                      -.+.||+|+||.||. .-.++. .+||++........+.+.+|+.+++.+     .||||+++++++.++.   ..+ +|
T Consensus         6 ~~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          6 EQSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             CcceecCCCceEEEE-CCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            357899999999996 322444 479988765444557789999999999     5799999999998874   333 78


Q ss_pred             Eee--cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHH-HHhhhcCCCceEeeccCCCCEEecC----CCCceeeecc
Q 013745          161 YEY--LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL-LYLHEEAPARIIHRDIKASNILLDE----QLNPKISDFG  233 (437)
Q Consensus       161 ~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L-~~LH~~~~~~iiHrDikp~NIll~~----~~~~kl~DFG  233 (437)
                      +||  +.+++|.+++.+    ..+++.  ..++.+++.++ +|||+++   |+||||||+|||++.    ++.++|+||+
T Consensus        84 ~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             ecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            999  557999999933    235555  35678888788 9999998   999999999999974    3479999954


Q ss_pred             cc
Q 013745          234 LA  235 (437)
Q Consensus       234 la  235 (437)
                      -+
T Consensus       155 G~  156 (210)
T PRK10345        155 GE  156 (210)
T ss_pred             CC
Confidence            33

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.84  E-value=1e-20  Score=188.67  Aligned_cols=215  Identities=25%  Similarity=0.385  Sum_probs=162.8

Q ss_pred             HHcCCCCcceeeeeeeccCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccC
Q 013745          136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIK  215 (437)
Q Consensus       136 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDik  215 (437)
                      |+.+.|.|+.+|+|.+.++...+.|.+||..|+|.+.+..  ....+++-....+++.|+.||+|||... . ..|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP-I-GYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc-c-eeeeeec
Confidence            3568899999999999999999999999999999999954  3467899999999999999999999975 2 2999999


Q ss_pred             CCCEEecCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccC-------cCCcccceehhhHHHHHHHhCCC
Q 013745          216 ASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHG-------YLSVKTDVFSYGVLVLEIVSGRK  288 (437)
Q Consensus       216 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-------~~~~~~DvwSlG~vl~elltg~~  288 (437)
                      +.|+++|..+.+||+|||+.................-..-|.|||.+...       ..+.+.||||||++++|+++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            99999999999999999999876421111111112235679999999764       14677999999999999999999


Q ss_pred             CCCCCCchhh-hhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          289 NHDGRLGKEK-ADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       289 p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ||........ .+++.+...     .....+-|.+.... +....++.++..||..+|.+||+++.|-..++.
T Consensus       157 ~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~  223 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLT  223 (484)
T ss_pred             ccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhh
Confidence            9986433322 223333222     11122223332221 333468899999999999999999999887764

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=2.2e-20  Score=198.50  Aligned_cols=202  Identities=20%  Similarity=0.204  Sum_probs=162.4

Q ss_pred             HHHHHHHhcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCC---CCcceeeeeeeccC
Q 013745           78 LRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ---HKNLVTLFGCCAEG  154 (437)
Q Consensus        78 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  154 (437)
                      ..++++....|.+.+.||+|+||.||+|...+|+.||||+-+......   |.--.+++.||+   -+-|..+..++.-.
T Consensus       690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~  766 (974)
T KOG1166|consen  690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQ  766 (974)
T ss_pred             cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccC
Confidence            344556677899999999999999999997779999999987654431   112234444554   34555566666667


Q ss_pred             CceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEec-------CCCCc
Q 013745          155 PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD-------EQLNP  227 (437)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~-------~~~~~  227 (437)
                      +.-+||+||.+.|+|.+++.   ....++|..+..++.|+++.++.||..+   |||+||||+|+||.       ++..+
T Consensus       767 ~~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l  840 (974)
T KOG1166|consen  767 NASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGL  840 (974)
T ss_pred             CcceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccce
Confidence            77899999999999999984   5677999999999999999999999998   99999999999994       34568


Q ss_pred             eeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCC
Q 013745          228 KISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRK  288 (437)
Q Consensus       228 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~  288 (437)
                      +|+|||.+--+..-.........++|-.+-.+|+..+..++..+|.|.|+.+++.||.|+.
T Consensus       841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            9999999865432222233445788999999999999999999999999999999999973

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.82  E-value=2.8e-21  Score=189.40  Aligned_cols=242  Identities=19%  Similarity=0.200  Sum_probs=163.1

Q ss_pred             ccccceeccCCCeeEEEEEcCCC----cEEEEEEeccCChHHHHHHHHHHHHHHcCC-CCcceeeee-------ee----
Q 013745           88 FSDLNQLGHGGFGPVYRGLMPNG----QEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFG-------CC----  151 (437)
Q Consensus        88 y~~~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~-------~~----  151 (437)
                      +.+.+..+..+++.+...+...+    ..++.+....++........+++-.+.-.. |++.+. .+       .+    
T Consensus       246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~-~d~~~s~~~~~~~~~  324 (516)
T KOG1033|consen  246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSIL-EDLRPSLFESSKRNK  324 (516)
T ss_pred             ccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccc-cCCCCchhhhccccc
Confidence            44556677777777776553222    333444444443222333344544444443 444332 22       11    


Q ss_pred             -ccCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceee
Q 013745          152 -AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKIS  230 (437)
Q Consensus       152 -~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~  230 (437)
                       .....+|+.|++|.-.+|.++|..+......++...+.++.|++.|+.|   ++   .+|||+||.||+...+..+||+
T Consensus       325 v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIg  398 (516)
T KOG1033|consen  325 VGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIG  398 (516)
T ss_pred             cccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhh
Confidence             1123578999999999999999877777788899999999999999999   66   9999999999999999999999


Q ss_pred             ecccccccCCCC----cccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhh
Q 013745          231 DFGLARLFPGED----THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYT  305 (437)
Q Consensus       231 DFGla~~~~~~~----~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~  305 (437)
                      |||+........    .........||..||+||.+.+..|+.++||||||+||+||+. -...|...            
T Consensus       399 DFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~------------  466 (516)
T KOG1033|consen  399 DFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI------------  466 (516)
T ss_pred             hhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH------------
Confidence            999998775544    1222335679999999999999999999999999999999997 33332210            


Q ss_pred             hhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Q 013745          306 WTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSV  354 (437)
Q Consensus       306 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev  354 (437)
                            ....++-|..++.......+.-..++.+++.+.|.+||++.++
T Consensus       467 ------~t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  467 ------ATLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             ------HhhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence                  1111111222221111112223467889999999999955444

>smart00090 RIO RIO-like kinase

Probab=99.82  E-value=1.1e-19  Score=168.96  Aligned_cols=143  Identities=17%  Similarity=0.173  Sum_probs=111.6

Q ss_pred             CccccceeccCCCeeEEEEE--cCCCcEEEEEEeccCChH------------------------HHHHHHHHHHHHHcCC
Q 013745           87 FFSDLNQLGHGGFGPVYRGL--MPNGQEIAVKKLSVDSRQ------------------------GLREFTNEVKLLLKIQ  140 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  140 (437)
                      .|.+.+.||+|+||.||+|.  ..+|+.||||++......                        ....+..|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999998  568999999998743210                        1123568999999997


Q ss_pred             CC--cceeeeeeeccCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCC
Q 013745          141 HK--NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASN  218 (437)
Q Consensus       141 h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~N  218 (437)
                      +.  .+.+++++    ...++||||+++.+|.....   ....+....+..++.|++.+|.+||..+  .|+||||||+|
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~N  179 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYN  179 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhh
Confidence            53  23444443    23589999999988866542   2234566677889999999999999975  49999999999


Q ss_pred             EEecCCCCceeeecccccccC
Q 013745          219 ILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       219 Ill~~~~~~kl~DFGla~~~~  239 (437)
                      |+++ ++.++|+|||++....
T Consensus       180 Ili~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      180 ILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EEEE-CCCEEEEEChhhhccC
Confidence            9999 8899999999997653

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.81  E-value=1.2e-20  Score=197.04  Aligned_cols=210  Identities=20%  Similarity=0.245  Sum_probs=146.8

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      ..+|+.++.|-.|+||.||.++.+ ..+.+|+| +.++.-.    +.+   |+.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li----lRn---ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI----LRN---ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh----hhc---cccccCCccee------------------
Confidence            467999999999999999999854 57788984 4322111    001   33333444444                  


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                         |+-...+   ...+.++...        +.+++|||+.+   |+|||+||+|++|+.-|++|++|||+.+..-....
T Consensus       136 ---gDc~tll---k~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 ---GDCATLL---KNIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ---chhhhhc---ccCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence               3333443   2223444333        78899999998   99999999999999999999999999975311100


Q ss_pred             -------------ccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhc
Q 013745          244 -------------HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQ  310 (437)
Q Consensus       244 -------------~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  310 (437)
                                   ......++||+.|+|||++..+.|+..+|+|++|+|+||.+-|..||.+..+++....+-.....|.
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp  278 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP  278 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc
Confidence                         0112346899999999999999999999999999999999999999999876654432222111111


Q ss_pred             ccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCC
Q 013745          311 GEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPD  350 (437)
Q Consensus       311 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs  350 (437)
                      +             .+.....+..+++.+.++.+|..|--
T Consensus       279 E-------------~dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  279 E-------------EDEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             c-------------cCcCCCHHHHHHHHHHHHhChHhhcc
Confidence            1             12233445667788889999998853

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.80  E-value=3.9e-19  Score=161.26  Aligned_cols=145  Identities=21%  Similarity=0.192  Sum_probs=112.9

Q ss_pred             HHHHHhcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChH----------------------HHHHHHHHHHHHH
Q 013745           80 TLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQ----------------------GLREFTNEVKLLL  137 (437)
Q Consensus        80 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~  137 (437)
                      ++......|.+.+.||+|+||.||++..++|+.||||++......                      ....+..|+.++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            333334458889999999999999999878999999987643210                      1123567899999


Q ss_pred             cCCCCc--ceeeeeeeccCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccC
Q 013745          138 KIQHKN--LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIK  215 (437)
Q Consensus       138 ~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDik  215 (437)
                      .+.+++  +...++.    ...++||||++|++|..+..         ......++.+++.++.++|+.+   |+|||||
T Consensus        89 ~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~  152 (198)
T cd05144          89 ALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLS  152 (198)
T ss_pred             HHHHcCCCCCceeec----CCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence            998774  4444442    34589999999999876541         0234578899999999999988   9999999


Q ss_pred             CCCEEecCCCCceeeecccccccCC
Q 013745          216 ASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       216 p~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |+||++++++.++|+|||++..+..
T Consensus       153 p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         153 EFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             cccEEEcCCCcEEEEECCccccCCC
Confidence            9999999999999999999976644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=3.5e-19  Score=163.06  Aligned_cols=134  Identities=19%  Similarity=0.266  Sum_probs=112.2

Q ss_pred             ceeccCCCeeEEEEEcCCCcEEEEEEeccCCh--------HHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           92 NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR--------QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      +.||+|++|.||+|.. .|..+++|+......        .....+.+|+.++..+.|++|.....++......++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            6799999999999987 678899998653211        1124578899999999999988777777677788999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                      ++|++|.+++...      .+ .+..++.+++.+|.+||+.+   ++|+|++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999887321      12 77889999999999999998   99999999999999 78999999999875

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.78  E-value=1e-18  Score=158.57  Aligned_cols=130  Identities=25%  Similarity=0.337  Sum_probs=105.2

Q ss_pred             eeccCCCeeEEEEEcCCCcEEEEEEeccCC--------hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           93 QLGHGGFGPVYRGLMPNGQEIAVKKLSVDS--------RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        93 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      .||+|+||.||+|.+ ++..|++|+.....        ......+.+|++++..+.++++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999986 67889999865321        112356778999999999887655444455566779999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                      +|++|.+++...   . .      .++.+++.+|.+||+.+   ++|+|++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~---~-~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEG---N-D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhc---H-H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999998877321   1 0      68999999999999998   99999999999999 88999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.77  E-value=1.8e-18  Score=180.15  Aligned_cols=138  Identities=21%  Similarity=0.259  Sum_probs=112.1

Q ss_pred             hcCccccceeccCCCeeEEEEEcCCCcEEEEEEec-cC-------ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCc
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLS-VD-------SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE  156 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~-~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  156 (437)
                      ...|...+.||+|+||.||+|.+.. ..+++|+.. ..       .....+.+.+|++++.+++|++++....++.....
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~  410 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE  410 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence            4456678999999999999998744 344444432 11       11223568899999999999999988777777777


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                      .++||||++|++|.+++.           ....++.+++.+|.+||+.+   ++||||||+|||+ +++.++|+|||+++
T Consensus       411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~  475 (535)
T PRK09605        411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK  475 (535)
T ss_pred             CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence            899999999999988872           45678999999999999998   9999999999999 67899999999997


Q ss_pred             cc
Q 013745          237 LF  238 (437)
Q Consensus       237 ~~  238 (437)
                      ..
T Consensus       476 ~~  477 (535)
T PRK09605        476 YS  477 (535)
T ss_pred             cC
Confidence            53

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.77  E-value=1.2e-18  Score=164.80  Aligned_cols=197  Identities=22%  Similarity=0.273  Sum_probs=137.0

Q ss_pred             CCCcceeeeeeecc---------------------------CCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHH
Q 013745          140 QHKNLVTLFGCCAE---------------------------GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVM  192 (437)
Q Consensus       140 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  192 (437)
                      +|||||+++++|.+                           ...+|+||...+ .+|..++..    ...+.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~----~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT----RHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc----CCCchHHHHHHHH
Confidence            59999999988743                           345688998774 477777733    3345566677899


Q ss_pred             HHHHHHHHhhhcCCCceEeeccCCCCEEe--cCCC--CceeeecccccccCCCCccc----ceeeeecccccCChhhhcc
Q 013745          193 GVARGLLYLHEEAPARIIHRDIKASNILL--DEQL--NPKISDFGLARLFPGEDTHV----NTFRISGTHGYMAPEYALH  264 (437)
Q Consensus       193 qi~~~L~~LH~~~~~~iiHrDikp~NIll--~~~~--~~kl~DFGla~~~~~~~~~~----~~~~~~gt~~Y~aPE~~~~  264 (437)
                      |+++|+.|||.++   |.|||+|.+||||  |+++  .+.|+|||++-.-+......    .....-|...-||||+...
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999998   9999999999999  3443  46889999885433211111    1112347888999998864


Q ss_pred             C------cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHH
Q 013745          265 G------YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGL  338 (437)
Q Consensus       265 ~------~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~  338 (437)
                      .      ..-.|+|.|+.|.+.||+++...||....... .+...     +++.        .++..+...+..+.+++.
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~r~-----Yqe~--------qLPalp~~vpp~~rqlV~  491 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDTRT-----YQES--------QLPALPSRVPPVARQLVF  491 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-echhh-----hhhh--------hCCCCcccCChHHHHHHH
Confidence            3      13458999999999999999999998632211 11101     1111        122233344556778899


Q ss_pred             HcCCCCCCCCCCHHHHHHHh
Q 013745          339 LCCQQSVAERPDMNSVHLML  358 (437)
Q Consensus       339 ~cl~~~p~~RPs~~ev~~~L  358 (437)
                      ..++.||++||+..=....|
T Consensus       492 ~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  492 DLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHhcCCccccCCccHHHhHH
Confidence            99999999999876544443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=6.4e-19  Score=183.48  Aligned_cols=254  Identities=23%  Similarity=0.267  Sum_probs=190.6

Q ss_pred             CccccceeccCCCeeEEEEEcC--CCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCC-CCcceeeeeeeccCCceEEEE
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMP--NGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  161 (437)
                      .|.+.+.||+|+|+.|-.....  ....+|+|.+....  .........|..+-..+. |+|++.+++........++++
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~  100 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL  100 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence            4777888999999999887743  34556777765442  333444556888888887 999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhh-hcCCCceEeeccCCCCEEecCCC-CceeeecccccccC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH-EEAPARIIHRDIKASNILLDEQL-NPKISDFGLARLFP  239 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~~~~iiHrDikp~NIll~~~~-~~kl~DFGla~~~~  239 (437)
                      +|..++++...+... .....+...+-.++.|+..++.|+| ..+   +.||||||+|.+++..+ .++++|||+|..+.
T Consensus       101 ~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen  101 SYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             CcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            999999998877311 1124556677789999999999999 776   99999999999999999 99999999999887


Q ss_pred             C-CCcccceeeeec-ccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccc
Q 013745          240 G-EDTHVNTFRISG-THGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE  316 (437)
Q Consensus       240 ~-~~~~~~~~~~~g-t~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (437)
                      . ..........+| ++.|+|||...+ ....+..|+||.|+++.-+++|..||......... ...|....   ...  
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~~---~~~--  250 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSNK---GRF--  250 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecccc---ccc--
Confidence            6 444444455678 999999999888 46788899999999999999999999765543311 11111110   000  


Q ss_pred             ccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 013745          317 LVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVH  355 (437)
Q Consensus       317 ~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~  355 (437)
                           -............++...++..+|..|.+.+++.
T Consensus       251 -----~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  251 -----TQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             -----ccCccccCChhhhhcccccccCCchhcccccccc
Confidence                 0011112233456677788889999999988764

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.73  E-value=1.8e-17  Score=148.70  Aligned_cols=138  Identities=18%  Similarity=0.199  Sum_probs=99.0

Q ss_pred             cceeccCCCeeEEEEEcCCCcEEEEEEeccCChH--HHHH----------------------HHHHHHHHHcCCCCc--c
Q 013745           91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQ--GLRE----------------------FTNEVKLLLKIQHKN--L  144 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--i  144 (437)
                      .+.||+|+||.||+|...+++.||||++......  ....                      ...|...+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999999878999999998653211  1111                      134566666664332  3


Q ss_pred             eeeeeeeccCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceEeeccCCCCEEecC
Q 013745          145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE-EAPARIIHRDIKASNILLDE  223 (437)
Q Consensus       145 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiHrDikp~NIll~~  223 (437)
                      .+.+++    ...++||||++++.+.........   .. ..+..++.+++.++.++|. .+   |+|+||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence            444433    245899999999654322111100   11 5678899999999999999 77   99999999999999 


Q ss_pred             CCCceeeecccccccCC
Q 013745          224 QLNPKISDFGLARLFPG  240 (437)
Q Consensus       224 ~~~~kl~DFGla~~~~~  240 (437)
                      ++.++|+|||.+.....
T Consensus       150 ~~~~~liDfg~a~~~~~  166 (187)
T cd05119         150 DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             CCcEEEEECcccccccC
Confidence            89999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.72  E-value=6e-17  Score=138.99  Aligned_cols=136  Identities=19%  Similarity=0.171  Sum_probs=114.7

Q ss_pred             ccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCC--CcceeeeeeeccCCceEEEEeecCCC
Q 013745           90 DLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQH--KNLVTLFGCCAEGPEKMLVYEYLPNK  167 (437)
Q Consensus        90 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g  167 (437)
                      +++.||+|.++.||++... +..+++|.......  ...+.+|+.+++.+++  .++++++.++...+..+++|||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            4678999999999999974 47899999865543  4678899999999976  58999999988888899999999988


Q ss_pred             CcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccccc
Q 013745          168 SLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       168 sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                      .+..+          +......++.+++.+|++||.....+++|+|++|+||+++..+.+++.|||.++..
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            77543          45666778999999999999864345999999999999999899999999998743

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.69  E-value=1.6e-16  Score=148.13  Aligned_cols=135  Identities=17%  Similarity=0.198  Sum_probs=104.1

Q ss_pred             ceec-cCCCeeEEEEEcCCCcEEEEEEeccCC-------------hHHHHHHHHHHHHHHcCCCCcc--eeeeeeeccCC
Q 013745           92 NQLG-HGGFGPVYRGLMPNGQEIAVKKLSVDS-------------RQGLREFTNEVKLLLKIQHKNL--VTLFGCCAEGP  155 (437)
Q Consensus        92 ~~lG-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~  155 (437)
                      ..|| .||.|+||.+.. .+..+|||++....             ......+.+|++++.+|+|++|  +..+++.....
T Consensus        37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            5688 899999999887 47789999885321             1223457889999999998875  66666643322


Q ss_pred             c----eEEEEeecCC-CCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceee
Q 013745          156 E----KMLVYEYLPN-KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKIS  230 (437)
Q Consensus       156 ~----~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~  230 (437)
                      .    .++|||+++| .+|.+++..    ..++..    .+.+|+.+|.+||+.|   |+||||||.|||++.++.++|+
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI  184 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI  184 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence            2    2599999997 688877732    234443    3578999999999998   9999999999999998999999


Q ss_pred             eccccccc
Q 013745          231 DFGLARLF  238 (437)
Q Consensus       231 DFGla~~~  238 (437)
                      |||.+...
T Consensus       185 Dfg~~~~~  192 (239)
T PRK01723        185 DFDRGELR  192 (239)
T ss_pred             ECCCcccC
Confidence            99988753

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.58  E-value=1e-14  Score=147.54  Aligned_cols=141  Identities=19%  Similarity=0.232  Sum_probs=99.7

Q ss_pred             ceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHH----------------------------------------HHHHH
Q 013745           92 NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGL----------------------------------------REFTN  131 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~~~  131 (437)
                      +.||.|++|.||+|++++|+.||||+.+.......                                        -.|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            67999999999999998999999999865421110                                        01444


Q ss_pred             HHHHHHcCC----CCcceeeeeeec-cCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHH-HHHHhhhcC
Q 013745          132 EVKLLLKIQ----HKNLVTLFGCCA-EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR-GLLYLHEEA  205 (437)
Q Consensus       132 E~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~-~L~~LH~~~  205 (437)
                      |.+.+.++.    +.+-+.+-..+. .....+|||||++|++|.++......  ..   ....++..++. .+..+|..|
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhCC
Confidence            555555542    333333333332 23456899999999999887632211  12   23456666665 478889887


Q ss_pred             CCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       206 ~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                         ++|+|+||.||+++.++.++|+|||++..++.
T Consensus       278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             ---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence               99999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.53  E-value=9.1e-15  Score=146.40  Aligned_cols=250  Identities=19%  Similarity=0.194  Sum_probs=181.8

Q ss_pred             hcCccccceecc--CCCeeEEEEEc---CCCcEEEEEEecc--CChHHHHHHHHHHHHHHcCC-CCcceeeeeeeccCCc
Q 013745           85 TNFFSDLNQLGH--GGFGPVYRGLM---PNGQEIAVKKLSV--DSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPE  156 (437)
Q Consensus        85 ~~~y~~~~~lG~--G~~g~Vy~~~~---~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  156 (437)
                      ...|-+.+.+|.  |.+|.||.+..   .++..+|+|+-+.  ........=.+|+....+++ |+|.++.+..+...+.
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~  192 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI  192 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence            345777889999  99999999875   3688899997432  22222222345777777775 9999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHH----HHHHhhhcCCCceEeeccCCCCEEecCC-CCceeee
Q 013745          157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR----GLLYLHEEAPARIIHRDIKASNILLDEQ-LNPKISD  231 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~----~L~~LH~~~~~~iiHrDikp~NIll~~~-~~~kl~D  231 (437)
                      .++-+|+| +.+|..+.+.  ....++...++.+..+..+    ||.++|+.+   ++|-|+||.||++..+ ..++++|
T Consensus       193 lfiqtE~~-~~sl~~~~~~--~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~d  266 (524)
T KOG0601|consen  193 LFIQTELC-GESLQSYCHT--PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTD  266 (524)
T ss_pred             ceeeeccc-cchhHHhhhc--ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCC
Confidence            99999999 5677776643  3344777888888888888    999999998   9999999999999999 8899999


Q ss_pred             cccccccCCCCcccce---eeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhh
Q 013745          232 FGLARLFPGEDTHVNT---FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTL  308 (437)
Q Consensus       232 FGla~~~~~~~~~~~~---~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~  308 (437)
                      ||+...+.........   .+..|...|++||...+ -++.+.|+|++|.+..+..+|..+.......        .|..
T Consensus       267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~--------~W~~  337 (524)
T KOG0601|consen  267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS--------SWSQ  337 (524)
T ss_pred             cceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC--------Cccc
Confidence            9999988665432221   22357889999997654 5699999999999999999988766433111        1111


Q ss_pred             hcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          309 FQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       309 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .+...+   -+    ++......++..++..+++.+|..|++...++.
T Consensus       338 ~r~~~i---p~----e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  338 LRQGYI---PL----EFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             cccccC---ch----hhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            111110   00    111112223344788999999999999888754

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.48  E-value=1.4e-13  Score=121.27  Aligned_cols=131  Identities=18%  Similarity=0.129  Sum_probs=97.9

Q ss_pred             cceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcce-eeeeeeccCCceEEEEeecCCCCc
Q 013745           91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV-TLFGCCAEGPEKMLVYEYLPNKSL  169 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gsL  169 (437)
                      ++.|+.|.++.||++.. .++.|++|+...... ....+..|+.+++.+...+++ +++.+..  ...++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            46789999999999987 478899999765432 123457899999998655544 4555443  345899999999888


Q ss_pred             chhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          170 DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA--PARIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       170 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                      ....           .....++.+++++|+.||..+  +..++|+|++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            5420           111235678999999999986  23369999999999999 66899999998863

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.48  E-value=6.6e-14  Score=143.42  Aligned_cols=145  Identities=16%  Similarity=0.170  Sum_probs=91.9

Q ss_pred             cCccccceeccCCCeeEEEEEcCC-CcEEEEEEeccCChHH----------------------------------HHH--
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQG----------------------------------LRE--  128 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~~--  128 (437)
                      ..|+. +.||.|++|.||+|++++ |+.||||+.+..-...                                  .+.  
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            35665 789999999999999876 9999999997542110                                  111  


Q ss_pred             ----HHHHHHHHHcCC----CCcceeeeeeecc-CCceEEEEeecCCCCcchhhhccCCC---CCCCHHHHHHHHHHHHH
Q 013745          129 ----FTNEVKLLLKIQ----HKNLVTLFGCCAE-GPEKMLVYEYLPNKSLDYFIFDKTKS---SSLDWTTRYRIVMGVAR  196 (437)
Q Consensus       129 ----~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~qi~~  196 (437)
                          +.+|+..+.+++    +.+.+.+-..+.+ ....+|||||++|+.+.++..-...+   ..+....+..++.|+  
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--  276 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--  276 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence                233333333332    2233332222222 23457999999999997642111111   112222333333343  


Q ss_pred             HHHHhhhcCCCceEeeccCCCCEEecCCC----CceeeecccccccCCC
Q 013745          197 GLLYLHEEAPARIIHRDIKASNILLDEQL----NPKISDFGLARLFPGE  241 (437)
Q Consensus       197 ~L~~LH~~~~~~iiHrDikp~NIll~~~~----~~kl~DFGla~~~~~~  241 (437)
                           ...|   ++|+|+||.||+++.++    .++++|||++..++..
T Consensus       277 -----f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~  317 (537)
T PRK04750        277 -----FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE  317 (537)
T ss_pred             -----HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence                 3455   99999999999999888    9999999999887543

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.41  E-value=2.8e-13  Score=126.06  Aligned_cols=200  Identities=19%  Similarity=0.261  Sum_probs=136.8

Q ss_pred             HHcCCCCcceeeeeeeccCC-----ceEEEEeecCCCCcchhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCce
Q 013745          136 LLKIQHKNLVTLFGCCAEGP-----EKMLVYEYLPNKSLDYFIFDKT-KSSSLDWTTRYRIVMGVARGLLYLHEEAPARI  209 (437)
Q Consensus       136 l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i  209 (437)
                      |-++.|-|||+++.|+.+.+     ...++.|||..|+|..+|.+.. ....+......+|+-||+.||.|||+.. ++|
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Ppi  199 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Ccc
Confidence            44557999999999986544     4689999999999999986533 3456788888999999999999999987 569


Q ss_pred             EeeccCCCCEEecCCCCceeeecccccccCC--CCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCC
Q 013745          210 IHRDIKASNILLDEQLNPKISDFGLARLFPG--EDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGR  287 (437)
Q Consensus       210 iHrDikp~NIll~~~~~~kl~DFGla~~~~~--~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~  287 (437)
                      +|+++..+-|++..+|-+||+---.......  ......+....+.++|.+||.-.....+-++|||+||...+||.-+.
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE  279 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE  279 (458)
T ss_pred             ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence            9999999999999999888842111100000  00000111234678999999877778888999999999999998876


Q ss_pred             CC-CCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 013745          288 KN-HDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVH  355 (437)
Q Consensus       288 ~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~  355 (437)
                      .- -......+....+..+         .-.+...+          -..++..|++..|+.||+|.+++
T Consensus       280 iq~tnseS~~~~ee~ia~~---------i~~len~l----------qr~~i~kcl~~eP~~rp~ar~ll  329 (458)
T KOG1266|consen  280 IQSTNSESKVEVEENIANV---------IIGLENGL----------QRGSITKCLEGEPNGRPDARLLL  329 (458)
T ss_pred             eccCCCcceeehhhhhhhh---------eeeccCcc----------ccCcCcccccCCCCCCcchhhhh
Confidence            43 2221111111111100         00000000          12356689999999999999874

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.41  E-value=2.5e-12  Score=115.14  Aligned_cols=139  Identities=15%  Similarity=0.097  Sum_probs=100.0

Q ss_pred             cceeccCCCeeEEEEEcCC-------CcEEEEEEeccCC-----h-----------------HHHHHH----HHHHHHHH
Q 013745           91 LNQLGHGGFGPVYRGLMPN-------GQEIAVKKLSVDS-----R-----------------QGLREF----TNEVKLLL  137 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-----~-----------------~~~~~~----~~E~~~l~  137 (437)
                      ...||.|.-+.||.|...+       +..+|||+.+...     .                 .....+    .+|++.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3579999999999998543       4799999886320     0                 011222    38999999


Q ss_pred             cCCC--CcceeeeeeeccCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHh-hhcCCCceEeecc
Q 013745          138 KIQH--KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL-HEEAPARIIHRDI  214 (437)
Q Consensus       138 ~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~~~iiHrDi  214 (437)
                      ++..  -++...+++    ...+|||||+.+..+.....   ....++......+..+++.+|..| |..+   |||+||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL  151 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL  151 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence            9853  455666654    45689999997654422111   122345556677889999999999 7877   999999


Q ss_pred             CCCCEEecCCCCceeeecccccccCC
Q 013745          215 KASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       215 kp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      ++.|||++ ++.++|+|||.+.....
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeCCC
Confidence            99999997 46899999998876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.38  E-value=3e-12  Score=129.75  Aligned_cols=166  Identities=16%  Similarity=0.221  Sum_probs=127.1

Q ss_pred             cCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCCCCcchhhhccCCCCCCCHHH
Q 013745          107 MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTT  186 (437)
Q Consensus       107 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~  186 (437)
                      ..++.+|.|..+............+-++.|+.|+||||++++..+...+..|||+|-+  ..|..++.+.      ....
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l------~~~~  105 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL------GKEE  105 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh------HHHH
Confidence            4478899999887665544566778889999999999999999999999999999987  3555555222      2345


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCc
Q 013745          187 RYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGY  266 (437)
Q Consensus       187 ~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~  266 (437)
                      +..-+.||+.||.|||..+  .++|++|.-+.|+|+..|..||++|.++.....-...  .....--..|..|+.+....
T Consensus       106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cccchhhhcccChhhcCccc
Confidence            5557899999999999766  5999999999999999999999999988755332210  11112233467777554332


Q ss_pred             CCcccceehhhHHHHHHHhC
Q 013745          267 LSVKTDVFSYGVLVLEIVSG  286 (437)
Q Consensus       267 ~~~~~DvwSlG~vl~elltg  286 (437)
                        ...|.|-|||+++|++.|
T Consensus       182 --~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --cchhhhhHHHHHHHHhCc
Confidence              457999999999999999

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.38  E-value=3.1e-13  Score=142.18  Aligned_cols=250  Identities=16%  Similarity=0.174  Sum_probs=177.4

Q ss_pred             HhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      ..+.|.+.+-+-+|+++.++.+.- ..|...++|.....   .....+....+-.++-..++|.+++....+......+|
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            446688888999999999998763 24544444443322   12222333344444444567888877777777788999


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      |++|+.+++|...++.   .+..+.......+..+..+++|||...   ++|||++|.|+|+..++..+++|||......
T Consensus       882 ~~~~~~~~~~~Skl~~---~~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg  955 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHN---SGCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG  955 (1205)
T ss_pred             hhHHhccCCchhhhhc---CCCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence            9999999999888743   235666666777888999999999976   8999999999999999999999998443321


Q ss_pred             CC--------Cc-----------------c----cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCC
Q 013745          240 GE--------DT-----------------H----VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNH  290 (437)
Q Consensus       240 ~~--------~~-----------------~----~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~  290 (437)
                      .-        ..                 .    .......||+.|.+||.+.+......+|+|++|++++|.++|.+||
T Consensus       956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence            00        00                 0    0122356999999999999999999999999999999999999999


Q ss_pred             CCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 013745          291 DGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMN  352 (437)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  352 (437)
                      ...........+...             +...+........+..+++...+..+|.+|-.+.
T Consensus      1036 na~tpq~~f~ni~~~-------------~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNR-------------DIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCcchhhhhhccccC-------------CCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            876655443221111             1111223334445566778888899999998776

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.35  E-value=1e-11  Score=114.13  Aligned_cols=143  Identities=17%  Similarity=0.266  Sum_probs=110.6

Q ss_pred             cceeccCCCeeEEEEEcCCCcEEEEEEeccCCh-HHHHHHHHHHHHHHcCCC--CcceeeeeeeccCC---ceEEEEeec
Q 013745           91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR-QGLREFTNEVKLLLKIQH--KNLVTLFGCCAEGP---EKMLVYEYL  164 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~  164 (437)
                      .+.|+.|.++.||++...+|+.+++|+...... .....+..|+++++.+.+  .++.+++.+.....   ..++||||+
T Consensus         3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            367999999999999876678999999865432 134567899999999975  34567777776543   568999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcC---------------------------------------
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA---------------------------------------  205 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---------------------------------------  205 (437)
                      +|.++...+..    ..++......++.+++++|..||+..                                       
T Consensus        83 ~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          83 DGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            99988765521    34677777888888888888888521                                       


Q ss_pred             --------------CCceEeeccCCCCEEecC--CCCceeeecccccc
Q 013745          206 --------------PARIIHRDIKASNILLDE--QLNPKISDFGLARL  237 (437)
Q Consensus       206 --------------~~~iiHrDikp~NIll~~--~~~~kl~DFGla~~  237 (437)
                                    +..++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          245799999999999998  56689999988764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.35  E-value=7.5e-13  Score=132.77  Aligned_cols=246  Identities=19%  Similarity=0.132  Sum_probs=176.7

Q ss_pred             HhcCccccceeccCCCeeEEEEEc--CCCcEEEEEEeccCCh--HHHHHHHHHHHHHHcCC-CCcceeeeeeeccCCceE
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM--PNGQEIAVKKLSVDSR--QGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKM  158 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  158 (437)
                      ...+|..+..||.|.|+.|+....  .++..|++|-+.....  .....-..|+.+...+. |.++++.+..|......|
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~  342 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY  342 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence            356788999999999999999863  4688899998765422  22222356777777774 999999888888888888


Q ss_pred             EEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCC-CCceeeecccccc
Q 013745          159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ-LNPKISDFGLARL  237 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~-~~~kl~DFGla~~  237 (437)
                      +--|||+++++...+   .....+++..++++..|++.++.++|++.   ++|+|+||+||++..+ +..++.|||+...
T Consensus       343 ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~  416 (524)
T KOG0601|consen  343 IPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR  416 (524)
T ss_pred             CchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence            999999999887665   23345778889999999999999999988   9999999999999875 8889999999875


Q ss_pred             cCCCCcccceeeeecccccC--ChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccc
Q 013745          238 FPGEDTHVNTFRISGTHGYM--APEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKAL  315 (437)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~Y~--aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (437)
                      +......     ..+.-++.  +|+......+..++|+||||.-+.|.+++...-.....        |..       +.
T Consensus       417 ~~~~~~~-----~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------~~~-------i~  476 (524)
T KOG0601|consen  417 LAFSSGV-----FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------SLT-------IR  476 (524)
T ss_pred             cceeccc-----ccccccccccchhhccccccccccccccccccccccccCcccCccccc--------cee-------ee
Confidence            3322111     12233344  45555556789999999999999999998754322111        000       00


Q ss_pred             cccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          316 ELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       316 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                      .-.-+.    .+.....+..+...++..++..||.+.++.....
T Consensus       477 ~~~~p~----~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  477 SGDTPN----LPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             cccccC----CCchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence            000011    1122245667777889999999999988765543

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.22  E-value=9.7e-11  Score=101.77  Aligned_cols=132  Identities=21%  Similarity=0.269  Sum_probs=97.0

Q ss_pred             ceeccCCCeeEEEEEcCCCcEEEEEEeccC--------ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           92 NQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--------SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      ..+++|+-+.+|.+.+ -|..+++|.-...        ..-......+|++++.+++--.|..-+=++.+.+...|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~-~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDF-LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeec-cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            3588999999999976 3445666643221        111234567899999998644443333344556677899999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccccc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                      ++|..|.+.+...          ...++..+-.-+.-||..+   |+|+||.++||++.+.+ +.++||||+...
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccc
Confidence            9999998888332          2457777888889999998   99999999999998664 999999999743

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.18  E-value=2.3e-10  Score=99.00  Aligned_cols=143  Identities=23%  Similarity=0.317  Sum_probs=102.8

Q ss_pred             ccceeccCCCeeEEEEEcCCCcEEEEEEec-cC-------ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           90 DLNQLGHGGFGPVYRGLMPNGQEIAVKKLS-VD-------SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        90 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~-~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      .+..|-||+-+.|+++.+ .|+..+||.-. +.       ..-...+..+|+++|.++.--.|.--.-+|.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            467899999999999988 67777777432 21       1223456788999999986444433333455566678999


Q ss_pred             eecCC-CCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCC---ceeeecccccc
Q 013745          162 EYLPN-KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN---PKISDFGLARL  237 (437)
Q Consensus       162 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~---~kl~DFGla~~  237 (437)
                      ||++| .++.+++.........+ .....++..|-+.+.-||..+   |||+||..+||+|..++.   +.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 46777765443323222 333678899999999999998   999999999999965443   47999999864

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.18  E-value=1.1e-09  Score=105.57  Aligned_cols=259  Identities=14%  Similarity=0.119  Sum_probs=158.0

Q ss_pred             cceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcC-CCCcceeeeee------eccC-CceEEEEe
Q 013745           91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGC------CAEG-PEKMLVYE  162 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~------~~~~-~~~~lv~e  162 (437)
                      .+.||+|+-+.+|-.-  .-...+.|++.........+   -+..|... .||-+-.-+.|      --++ ....++|.
T Consensus        16 gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP   90 (637)
T COG4248          16 GRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP   90 (637)
T ss_pred             CccccCCccceeeecc--hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence            5779999999999542  11223558887654432222   23334443 35543331111      0112 22567888


Q ss_pred             ecCCCCcchhhh----ccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccccc
Q 013745          163 YLPNKSLDYFIF----DKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       163 ~~~~gsL~~~l~----~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                      .+++..=-..++    .+......+|...++.++.++.+.+-||..|   .+-+|+.++|+|+.+++.+.|.|-..-...
T Consensus        91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~  167 (637)
T COG4248          91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQIN  167 (637)
T ss_pred             cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeec
Confidence            877652222222    2334456789999999999999999999998   999999999999999999999885443332


Q ss_pred             CCCCcccceeeeecccccCChhhhc-----cCcCCcccceehhhHHHHHHHhC-CCCCCCCCchh-----hhhhhhhhhh
Q 013745          239 PGEDTHVNTFRISGTHGYMAPEYAL-----HGYLSVKTDVFSYGVLVLEIVSG-RKNHDGRLGKE-----KADLLSYTWT  307 (437)
Q Consensus       239 ~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DvwSlG~vl~elltg-~~p~~~~~~~~-----~~~~~~~~~~  307 (437)
                      ..   .....-.+|...|.+||.-.     +..-+...|.|.||+++++|+.| +.||.+.....     ....+....-
T Consensus       168 ~n---g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f  244 (637)
T COG4248         168 AN---GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF  244 (637)
T ss_pred             cC---CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence            11   11122346889999999664     33557789999999999999987 99997643211     1101111111


Q ss_pred             hhcccccccccCccccCCCHHHHHHHHHHHHHcCCCC--CCCCCCHHHHHHHhcC
Q 013745          308 LFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQS--VAERPDMNSVHLMLSG  360 (437)
Q Consensus       308 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~--p~~RPs~~ev~~~L~~  360 (437)
                      .+......-...+....-....+..+..+..+|+...  +.-||+++..+..|..
T Consensus       245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~a  299 (637)
T COG4248         245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDA  299 (637)
T ss_pred             eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHH
Confidence            1111111111111111112233455666677787654  5689999999887754

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.07  E-value=9.8e-10  Score=98.04  Aligned_cols=126  Identities=24%  Similarity=0.320  Sum_probs=83.4

Q ss_pred             eEEEEEcCCCcEEEEEEeccCC--------------h------------HHHHHHHHHHHHHHcCCCC--cceeeeeeec
Q 013745          101 PVYRGLMPNGQEIAVKKLSVDS--------------R------------QGLREFTNEVKLLLKIQHK--NLVTLFGCCA  152 (437)
Q Consensus       101 ~Vy~~~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~E~~~l~~l~h~--niv~l~~~~~  152 (437)
                      .||.|...+|..+|||+.+...              .            .......+|.+.|.++..-  ++.+.+++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899998889999999886420              0            0112367899999999755  456666553 


Q ss_pred             cCCceEEEEeecC--CCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHH-hhhcCCCceEeeccCCCCEEecCCCCcee
Q 013745          153 EGPEKMLVYEYLP--NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY-LHEEAPARIIHRDIKASNILLDEQLNPKI  229 (437)
Q Consensus       153 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~-LH~~~~~~iiHrDikp~NIll~~~~~~kl  229 (437)
                         ..+|||||++  |..+..+...     .++......++.+++..+.. +|..|   |+|+||.+.|||++++ .+.|
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence               3479999998  6556544311     11134456677788885555 56777   9999999999999987 9999


Q ss_pred             eecccccccC
Q 013745          230 SDFGLARLFP  239 (437)
Q Consensus       230 ~DFGla~~~~  239 (437)
                      +|||.+....
T Consensus       148 IDf~qav~~~  157 (188)
T PF01163_consen  148 IDFGQAVDSS  157 (188)
T ss_dssp             --GTTEEETT
T ss_pred             EecCcceecC
Confidence            9999887653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.05  E-value=3.4e-09  Score=100.09  Aligned_cols=140  Identities=16%  Similarity=0.120  Sum_probs=98.4

Q ss_pred             eeccCCCeeEEEEEcCCCcEEEEEEeccCChH-HH----------HHHHHHHHHHHcCCCCcc--eeeeeeecc-----C
Q 013745           93 QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQ-GL----------REFTNEVKLLLKIQHKNL--VTLFGCCAE-----G  154 (437)
Q Consensus        93 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~E~~~l~~l~h~ni--v~l~~~~~~-----~  154 (437)
                      .+-.-....|++..+ +|+.|.||+....... ..          ..+.+|...+.+|..-+|  +..+++...     .
T Consensus        29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            343334455667666 6789999977433211 11          137789999988853333  334444432     2


Q ss_pred             CceEEEEeecCCC-CcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC-------CCC
Q 013745          155 PEKMLVYEYLPNK-SLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE-------QLN  226 (437)
Q Consensus       155 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~-------~~~  226 (437)
                      ...+||||++++. +|.+++.... ....+......++.+++..+.-||..|   |+|+|++++|||++.       ++.
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence            3468999999886 7888874321 234556677789999999999999998   999999999999975       467


Q ss_pred             ceeeecccccc
Q 013745          227 PKISDFGLARL  237 (437)
Q Consensus       227 ~kl~DFGla~~  237 (437)
                      +.|+||+.++.
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            89999998863

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.02  E-value=3.8e-09  Score=104.47  Aligned_cols=170  Identities=20%  Similarity=0.309  Sum_probs=125.5

Q ss_pred             CCeeEEEEE-cCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeecc----CCceEEEEeecCC-CCcch
Q 013745           98 GFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE----GPEKMLVYEYLPN-KSLDY  171 (437)
Q Consensus        98 ~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~~~-gsL~~  171 (437)
                      .-.+.|++. ..+|..|++|+++............-+++++++.|+|||+|..+|..    +..++|||+|.++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            346778987 45899999999953322222223356888999999999999988863    4567999999986 45655


Q ss_pred             hhhcc------------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          172 FIFDK------------TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       172 ~l~~~------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      +-+..            ..+...++..+|.++.|+..||.++|+.|   +.-+-|.|.+||++.+.+++|...|....+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence            44321            12234678899999999999999999998   8789999999999999999998888776654


Q ss_pred             CCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCC
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKN  289 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p  289 (437)
                      .+..                |.+..   -.+-|.=-||.+++.|.||...
T Consensus       445 ~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            4331                11111   2245777899999999999643

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.91  E-value=1.6e-08  Score=93.11  Aligned_cols=137  Identities=20%  Similarity=0.217  Sum_probs=98.4

Q ss_pred             CccccceeccCCCeeEEEEEcCCCcEEEEEEeccCCh----------------------HHHHHHHHHHHHHHcCCCC--
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR----------------------QGLREFTNEVKLLLKIQHK--  142 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~--  142 (437)
                      -+.+..+||-|.-+.||.|..+.|.++|||.-+....                      -......+|.++|.+|.-.  
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            3667789999999999999999999999996532100                      0123467899999999644  


Q ss_pred             cceeeeeeeccCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEec
Q 013745          143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD  222 (437)
Q Consensus       143 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~  222 (437)
                      .+.+-+++    +...+||||++|-.|...-        ++....-.++..|++-+.-+-..|   |||+|+.+-||+++
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~  236 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVT  236 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEe
Confidence            55555543    4567999999997775432        122333344455555555555666   99999999999999


Q ss_pred             CCCCceeeeccccccc
Q 013745          223 EQLNPKISDFGLARLF  238 (437)
Q Consensus       223 ~~~~~kl~DFGla~~~  238 (437)
                      ++|.+.++||--+...
T Consensus       237 ~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         237 EDGDIVVIDWPQAVPI  252 (304)
T ss_pred             cCCCEEEEeCcccccC
Confidence            9999999999766543

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.75  E-value=4.7e-08  Score=99.95  Aligned_cols=143  Identities=17%  Similarity=0.251  Sum_probs=92.9

Q ss_pred             ceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHH----------------------------------------HHHH
Q 013745           92 NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLR----------------------------------------EFTN  131 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~----------------------------------------~~~~  131 (437)
                      ..|+.++-|.||+|++++|+.||||+.+.+-....+                                        .+.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            578999999999999999999999998765222111                                        1233


Q ss_pred             HHHHHHcCC----CCcceeeeeee-ccCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCC
Q 013745          132 EVKLLLKIQ----HKNLVTLFGCC-AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP  206 (437)
Q Consensus       132 E~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~  206 (437)
                      |..-+.+++    ...-+.+=..| .-.....|+|||++|-.+.++..-+.  ..++.+.+.....++.  +..+=..| 
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~ia~~~~~~f--~~q~~~dg-  285 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKELAELLVRAF--LRQLLRDG-  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHHHHHHHHHHH--HHHHHhcC-
Confidence            333333331    11112222222 22355689999999999988853222  4455444333333322  22222334 


Q ss_pred             CceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       207 ~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                        +.|.|..|.||+++.+|.+.+.|||+...++..
T Consensus       286 --ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         286 --FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             --ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence              999999999999999999999999999877543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.73  E-value=4.8e-08  Score=89.08  Aligned_cols=106  Identities=23%  Similarity=0.263  Sum_probs=81.0

Q ss_pred             HHHHHHHHHHHcCCCC--cceeeeeeeccC----CceEEEEeecCCC-CcchhhhccCCCCCCCHHHHHHHHHHHHHHHH
Q 013745          127 REFTNEVKLLLKIQHK--NLVTLFGCCAEG----PEKMLVYEYLPNK-SLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL  199 (437)
Q Consensus       127 ~~~~~E~~~l~~l~h~--niv~l~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~  199 (437)
                      ..+.+|...+.+|..-  .+...+++....    ...+||+|++++. +|.+++.....   ++......++.+++..++
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA  132 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence            4577888888887533  344455555432    2348999999884 78888743221   556677889999999999


Q ss_pred             HhhhcCCCceEeeccCCCCEEecCCC---Cceeeeccccccc
Q 013745          200 YLHEEAPARIIHRDIKASNILLDEQL---NPKISDFGLARLF  238 (437)
Q Consensus       200 ~LH~~~~~~iiHrDikp~NIll~~~~---~~kl~DFGla~~~  238 (437)
                      -||..|   |+|+|+++.|||++.++   .+.|+||+-++..
T Consensus       133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999998   99999999999998887   8999999987753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.72  E-value=4.7e-09  Score=107.25  Aligned_cols=152  Identities=21%  Similarity=0.297  Sum_probs=105.4

Q ss_pred             HHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccce-e------eeecccccCChhhhc
Q 013745          191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT-F------RISGTHGYMAPEYAL  263 (437)
Q Consensus       191 ~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~-~------~~~gt~~Y~aPE~~~  263 (437)
                      +.+++.||.|+|...  ++||+.|.|++|.++.++..||+.|+.+............ +      -..-...|.|||++.
T Consensus       105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            344559999999874  7999999999999999999999999988765432111110 0      011355799999999


Q ss_pred             cCcCCcccceehhhHHHHHHH-hCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCC
Q 013745          264 HGYLSVKTDVFSYGVLVLEIV-SGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQ  342 (437)
Q Consensus       264 ~~~~~~~~DvwSlG~vl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~  342 (437)
                      +...+.++|+||+||++|-+. .|+.-+.+.........     ..       ...+.....+....+.++.+=+.+++.
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~-----~~-------~~~~~~~~~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF-----SR-------NLLNAGAFGYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhhh-----hh-------cccccccccccccCcHHHHHHHHHHhc
Confidence            998999999999999999999 55555554332221111     00       011112223334556667777788999


Q ss_pred             CCCCCCCCHHHHHH
Q 013745          343 QSVAERPDMNSVHL  356 (437)
Q Consensus       343 ~~p~~RPs~~ev~~  356 (437)
                      .++.-||++.++..
T Consensus       251 ~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  251 GDSAVRPTLDLLLS  264 (700)
T ss_pred             CCcccCcchhhhhc
Confidence            99999998777643

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.67  E-value=3.1e-07  Score=84.90  Aligned_cols=139  Identities=18%  Similarity=0.206  Sum_probs=84.5

Q ss_pred             ceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCc--ceeeeeeeccCCceEEEEeecCCCC-
Q 013745           92 NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN--LVTLFGCCAEGPEKMLVYEYLPNKS-  168 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gs-  168 (437)
                      ..||+|..+.||+.   .+..+++|.......  .....+|.++++.+..-.  +.+.+++....+...+|||+++|.. 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~~--~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGFD--KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCCC--HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            67999999999984   355678898865332  245678999999986433  4667777777777889999998863 


Q ss_pred             cchhhh--------------------ccCCCCCCCHHHHHH-HHHH----------HHH-HHHHhhh-cCCCceEeeccC
Q 013745          169 LDYFIF--------------------DKTKSSSLDWTTRYR-IVMG----------VAR-GLLYLHE-EAPARIIHRDIK  215 (437)
Q Consensus       169 L~~~l~--------------------~~~~~~~l~~~~~~~-i~~q----------i~~-~L~~LH~-~~~~~iiHrDik  215 (437)
                      +...+.                    ............... +..+          +.. ...+|.. .....++|+|+.
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            211110                    000000111111000 0000          000 1112211 112347999999


Q ss_pred             CCCEEecCCCCceeeeccccc
Q 013745          216 ASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       216 p~NIll~~~~~~kl~DFGla~  236 (437)
                      |.||++++++ +.|+||+.+.
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcC
Confidence            9999999888 9999998775

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PRK09902 hypothetical protein; Provisional

Probab=98.66  E-value=3.3e-07  Score=82.55  Aligned_cols=138  Identities=17%  Similarity=0.154  Sum_probs=100.0

Q ss_pred             eccCCCeeEEEEEcCCCcEEEEEEeccC---C---hHHHHHHHHHHHHHHcCCCC--cceeeeeeec-c----CCceEEE
Q 013745           94 LGHGGFGPVYRGLMPNGQEIAVKKLSVD---S---RQGLREFTNEVKLLLKIQHK--NLVTLFGCCA-E----GPEKMLV  160 (437)
Q Consensus        94 lG~G~~g~Vy~~~~~~~~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~-~----~~~~~lv  160 (437)
                      -|+||.+-|++... .|+.+-+|+-...   +   ......|.+|+..|.+|..-  .+.+.. ++. .    .-..+||
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            46699999998766 4557888976521   1   22456789999999998532  244444 222 1    1235799


Q ss_pred             EeecCC-CCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCC--ceeeecccccc
Q 013745          161 YEYLPN-KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN--PKISDFGLARL  237 (437)
Q Consensus       161 ~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~--~kl~DFGla~~  237 (437)
                      +|-++| .+|.+++.+. ...+.+......++.+++..++-||..+   +.|+|+.+.|||++.++.  ++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            997754 4777776332 2235677777889999999999999998   999999999999986677  99999976653

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.64  E-value=4.4e-07  Score=82.06  Aligned_cols=139  Identities=16%  Similarity=0.192  Sum_probs=94.2

Q ss_pred             HHhcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHH---------HHHHHHHHHcCC---CCcceeeeee
Q 013745           83 VATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLRE---------FTNEVKLLLKIQ---HKNLVTLFGC  150 (437)
Q Consensus        83 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~---h~niv~l~~~  150 (437)
                      ...++|.+.+++-......|.+-.. +|+.+++|..+.......+.         ..+++..+.+++   .-.+..++.+
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            4567899999998888888877666 67899999887543332222         223444444443   2222222222


Q ss_pred             -----eccCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCC
Q 013745          151 -----CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL  225 (437)
Q Consensus       151 -----~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~  225 (437)
                           +.-....+|||||++|..|.++.       .++.    .++..+++++.-||..|   ++|+|+.|.|+++++++
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~-------~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~  172 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIE-------DIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG  172 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccch-------hcCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc
Confidence                 22223457899999998886553       1222    24566778899999998   99999999999999654


Q ss_pred             Cceeeecccccc
Q 013745          226 NPKISDFGLARL  237 (437)
Q Consensus       226 ~~kl~DFGla~~  237 (437)
                       +++.||+..+.
T Consensus       173 -i~iID~~~k~~  183 (229)
T PF06176_consen  173 -IRIIDTQGKRM  183 (229)
T ss_pred             -EEEEECccccc
Confidence             99999976653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.59  E-value=7.4e-07  Score=81.51  Aligned_cols=151  Identities=20%  Similarity=0.173  Sum_probs=97.1

Q ss_pred             HHHHHHhcCcccc---ceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHH------------------------HHHHH
Q 013745           79 RTLQVATNFFSDL---NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGL------------------------REFTN  131 (437)
Q Consensus        79 ~~~~~~~~~y~~~---~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------~~~~~  131 (437)
                      ..+.....+..+.   ..|..|.-+.||+|...++..+|||++........                        .-..+
T Consensus        38 ~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~k  117 (268)
T COG1718          38 ETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARK  117 (268)
T ss_pred             HHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHH
Confidence            3333344444333   35678888999999987899999999975421110                        01245


Q ss_pred             HHHHHHcCC--CCcceeeeeeeccCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCce
Q 013745          132 EVKLLLKIQ--HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI  209 (437)
Q Consensus       132 E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i  209 (437)
                      |+.-|.++.  +-.+.+-+.+.    .-.|||||+....+-   .-.....++.......+..++++.+.-|-..+  ++
T Consensus       118 Ef~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~p---AP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a--~L  188 (268)
T COG1718         118 EFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLP---APRLKDVPLELEEAEGLYEDVVEYMRRLYKEA--GL  188 (268)
T ss_pred             HHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCC---CCCcccCCcCchhHHHHHHHHHHHHHHHHHhc--Cc
Confidence            666666653  22333333332    346999999553111   01112223334457778888888888887743  49


Q ss_pred             EeeccCCCCEEecCCCCceeeecccccccC
Q 013745          210 IHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       210 iHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      ||+||..-|||+. ++.+.|+|||-|....
T Consensus       189 VHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         189 VHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             ccccchhhheEEE-CCeEEEEECccccccC
Confidence            9999999999999 8899999999987654

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.54  E-value=8.6e-07  Score=81.73  Aligned_cols=143  Identities=20%  Similarity=0.198  Sum_probs=84.5

Q ss_pred             cceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCC--cceeeeeeec---cCCceEEEEeecC
Q 013745           91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHK--NLVTLFGCCA---EGPEKMLVYEYLP  165 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~---~~~~~~lv~e~~~  165 (437)
                      ++.|+.|..+.||+....+ ..+++|.....  .....+.+|..+++.+...  .+.+++.+..   .....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            4679999999999998756 68999997654  4456777899998888533  3456665432   2334689999999


Q ss_pred             CCCcch----------------hhh---cc-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHhhh
Q 013745          166 NKSLDY----------------FIF---DK-TKSSSLDWTT---------RYRI------------VMGVAR-GLLYLHE  203 (437)
Q Consensus       166 ~gsL~~----------------~l~---~~-~~~~~l~~~~---------~~~i------------~~qi~~-~L~~LH~  203 (437)
                      |..+..                .+.   .. .....+....         ....            ...+.. .+..++.
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            988876                110   11 0111111110         0000            111222 3333332


Q ss_pred             c----CCCceEeeccCCCCEEec-CCCCceeeeccccc
Q 013745          204 E----APARIIHRDIKASNILLD-EQLNPKISDFGLAR  236 (437)
Q Consensus       204 ~----~~~~iiHrDikp~NIll~-~~~~~kl~DFGla~  236 (437)
                      .    .+..++|+|+.|.|||++ +++.+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            1    345599999999999999 66666899998775

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.47  E-value=3.2e-08  Score=100.25  Aligned_cols=189  Identities=17%  Similarity=0.113  Sum_probs=136.9

Q ss_pred             hcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCc-ceeeeeeeccCCceEEEEee
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN-LVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~  163 (437)
                      +.-|...+-+++|++++++|.+--..+....+.+...     ....-++++|.+++||| .+..++-+..+...++++++
T Consensus       241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i  315 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI  315 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence            3446667789999999999987433344445555433     23345899999999999 77777777778888999999


Q ss_pred             cCCC-CcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          164 LPNK-SLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       164 ~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      +.++ +.....  ......+...+...+.+.-+++|++||+.-   =+|+|    ||+..+ +..|..||+....+....
T Consensus       316 ~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~  385 (829)
T KOG0576|consen  316 CSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM  385 (829)
T ss_pred             hcCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc
Confidence            9877 221111  011122344445556677788999999853   38888    777765 679999999988765443


Q ss_pred             cccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCC
Q 013745          243 THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHD  291 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~  291 (437)
                         ......+|+.++|||+.....+..+.|+|++|+-..++.-|-+|-.
T Consensus       386 ---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  386 ---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             ---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence               1224568999999999999999999999999998778877777654

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.45  E-value=1.9e-06  Score=80.65  Aligned_cols=140  Identities=15%  Similarity=0.111  Sum_probs=84.7

Q ss_pred             eeccCCC-eeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCC-CCcceeeeeeeccCCceEEEEeecCCCCcc
Q 013745           93 QLGHGGF-GPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLVYEYLPNKSLD  170 (437)
Q Consensus        93 ~lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  170 (437)
                      .|-.|.. ..||+.... +..++||+.....   ...+.+|+++++.+. +--+.+++++....+..++|||+++|.+|.
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            3444555 888998763 4678888875443   245667999988884 444567787777666789999999998876


Q ss_pred             hhhh------------------ccCC--CCCCCH--HHHHHHHH--------------------HHHHHHHHhhh----c
Q 013745          171 YFIF------------------DKTK--SSSLDW--TTRYRIVM--------------------GVARGLLYLHE----E  204 (437)
Q Consensus       171 ~~l~------------------~~~~--~~~l~~--~~~~~i~~--------------------qi~~~L~~LH~----~  204 (437)
                      ....                  ....  ..++..  ........                    .+...+..|-.    .
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            4320                  0000  001110  00000000                    01111122211    1


Q ss_pred             CCCceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          205 APARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       205 ~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                      .+..++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            12458999999999999998778899998775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.44  E-value=1.3e-06  Score=89.36  Aligned_cols=141  Identities=16%  Similarity=0.230  Sum_probs=90.9

Q ss_pred             ceeccCCCeeEEEEEcCCCcEEEEEEeccCChHH----H---------------------------H------HHHHHHH
Q 013745           92 NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQG----L---------------------------R------EFTNEVK  134 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----~---------------------------~------~~~~E~~  134 (437)
                      +.||.-+.|.||+|+.++|+.||||+-+..-+..    .                           +      +|.+|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            6799999999999999999999999876542111    0                           0      1233333


Q ss_pred             HHHcC----CCCc------ceeeeeeeccCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhc
Q 013745          135 LLLKI----QHKN------LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE  204 (437)
Q Consensus       135 ~l~~l----~h~n------iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~  204 (437)
                      -..++    .|-+      |.+++-.+  .....|+||||+|..+.++..-  ....++...+..-+.++..-+-+-|  
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i--~~~gi~~~~i~~~l~~~~~~qIf~~--  320 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAI--DKRGISPHDILNKLVEAYLEQIFKT--  320 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHH--HHcCCCHHHHHHHHHHHHHHHHHhc--
Confidence            22222    3444      22232222  2356899999999988877432  2234555554444444332222222  


Q ss_pred             CCCceEeeccCCCCEEec----CCCCceeeecccccccCCC
Q 013745          205 APARIIHRDIKASNILLD----EQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       205 ~~~~iiHrDikp~NIll~----~~~~~kl~DFGla~~~~~~  241 (437)
                      |   ++|+|-.|.||+++    .++.+.+.|||+...+...
T Consensus       321 G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  321 G---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             C---CccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            3   99999999999998    3678999999999876543

>PLN02876 acyl-CoA dehydrogenase

Probab=98.33  E-value=7.3e-06  Score=89.96  Aligned_cols=79  Identities=20%  Similarity=0.423  Sum_probs=58.0

Q ss_pred             cceeccCCCeeEEEEEcCCC---cEEEEEEeccCC-hHHHHHHHHHHHHHHcCC-CCcc--eeeeeeeccC---CceEEE
Q 013745           91 LNQLGHGGFGPVYRGLMPNG---QEIAVKKLSVDS-RQGLREFTNEVKLLLKIQ-HKNL--VTLFGCCAEG---PEKMLV  160 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv  160 (437)
                      ++.|+.|.+..+|+....++   ..+++|+..... ......+.+|+++|+.+. |.++  .+++.+|.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            57899999999999876443   467888765432 122346789999999995 6655  7788887664   457899


Q ss_pred             EeecCCCCc
Q 013745          161 YEYLPNKSL  169 (437)
Q Consensus       161 ~e~~~~gsL  169 (437)
                      |||++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999998754

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.31  E-value=3.9e-06  Score=72.81  Aligned_cols=130  Identities=22%  Similarity=0.252  Sum_probs=90.2

Q ss_pred             cccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCCCC
Q 013745           89 SDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKS  168 (437)
Q Consensus        89 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  168 (437)
                      .+.+.||+|.+|.||+|.+ .|..+|+|+-+.++.  ...+..|+++|..+.--++.+=+..+.   ..++.|||+.|-.
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg---~~~i~me~i~G~~   98 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEW-RGGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYG---EDFIRMEYIDGRP   98 (201)
T ss_pred             hhhhhhhcccccEEEEeec-cCceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEec---hhhhhhhhhcCcc
Confidence            3467899999999999998 566899998776554  367889999999998766655333322   2345699999988


Q ss_pred             cchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccC-CCCEEecCCCCceeeecccccc
Q 013745          169 LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIK-ASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       169 L~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDik-p~NIll~~~~~~kl~DFGla~~  237 (437)
                      |.+.-..      .+-.    -...+++.-.-|-..|   |-|..|. |...+|-.++.+.|+||.-|..
T Consensus        99 L~~~~~~------~~rk----~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          99 LGKLEIG------GDRK----HLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhhhhhc------ccHH----HHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            8765411      1222    2344555555566666   9999987 4444444444899999998874

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.29  E-value=9.9e-06  Score=72.96  Aligned_cols=128  Identities=18%  Similarity=0.320  Sum_probs=90.3

Q ss_pred             cceeccCCCeeEEEEEcCCCcEEEEEEeccCC----------------hHHHHHHHHHHHHHHcCC------CCcceeee
Q 013745           91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS----------------RQGLREFTNEVKLLLKIQ------HKNLVTLF  148 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~l~  148 (437)
                      ...||+|+.-.||.  .++....+||+.....                .....+..+|+.....+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            45799999999994  5667778899887654                122455667777666665      78899999


Q ss_pred             eeeccCCceEEEEeecCC--C----CcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEec
Q 013745          149 GCCAEGPEKMLVYEYLPN--K----SLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD  222 (437)
Q Consensus       149 ~~~~~~~~~~lv~e~~~~--g----sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~  222 (437)
                      |+..++....+|+|.+.+  |    +|.+++    ..+.++. ...+.+.   +-..||-+.+   |+.+|++|.||++.
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l----~~~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv~~  152 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYL----KEGGLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIVVQ  152 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHH----HcCCccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEEEE
Confidence            999999999999998643  3    455555    3334555 3333333   4455666665   99999999999995


Q ss_pred             CC--C--Cceeee
Q 013745          223 EQ--L--NPKISD  231 (437)
Q Consensus       223 ~~--~--~~kl~D  231 (437)
                      .+  +  .+.|+|
T Consensus       153 ~~~~~~~~lvlID  165 (199)
T PF10707_consen  153 RRDSGEFRLVLID  165 (199)
T ss_pred             ecCCCceEEEEEe
Confidence            32  2  477777

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.27  E-value=4.7e-06  Score=74.65  Aligned_cols=104  Identities=21%  Similarity=0.230  Sum_probs=82.9

Q ss_pred             HHHHHHHcCCC-CcceeeeeeeccCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCce
Q 013745          131 NEVKLLLKIQH-KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI  209 (437)
Q Consensus       131 ~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i  209 (437)
                      .|.-+++.+.+ +++.+++|+|.    .++|.||...+++...-..-...-..+|..+.+||.++++.+.+|+..-...+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            58888888875 69999999993    46899999877664321000111246899999999999999999998655558


Q ss_pred             EeeccCCCCEEecCCCCceeeeccccccc
Q 013745          210 IHRDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       210 iHrDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                      .-.|++++|+-++++|.+|++|...+...
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcchh
Confidence            99999999999999999999999877654

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.26  E-value=9.5e-06  Score=75.47  Aligned_cols=74  Identities=19%  Similarity=0.329  Sum_probs=47.3

Q ss_pred             cceeccCCCee-EEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCC---cceeeeeeeccC---CceEEEEee
Q 013745           91 LNQLGHGGFGP-VYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHK---NLVTLFGCCAEG---PEKMLVYEY  163 (437)
Q Consensus        91 ~~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e~  163 (437)
                      ++.|+.|+... ||+.    +..+++|......  ....+.+|++++..|...   .+.++++.....   ...+++|++
T Consensus         2 ~~~~~~gG~~n~vy~~----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           2 IEPVDSGGTDNATFRL----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             ceeccCCCcccceEEc----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            35688777774 8975    3457788765422  235688899999887532   233444433322   234889999


Q ss_pred             cCCCCcc
Q 013745          164 LPNKSLD  170 (437)
Q Consensus       164 ~~~gsL~  170 (437)
                      ++|.++.
T Consensus        76 i~G~~l~   82 (235)
T cd05155          76 LEGETAT   82 (235)
T ss_pred             ecCCCCC
Confidence            9998774

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.26  E-value=2.4e-05  Score=70.05  Aligned_cols=125  Identities=26%  Similarity=0.407  Sum_probs=90.1

Q ss_pred             cCccccceeccCCC-eeEEEEEcCCCcEEEEEEecc---CCh------------------HHHHHHHHHHHHHHcCC---
Q 013745           86 NFFSDLNQLGHGGF-GPVYRGLMPNGQEIAVKKLSV---DSR------------------QGLREFTNEVKLLLKIQ---  140 (437)
Q Consensus        86 ~~y~~~~~lG~G~~-g~Vy~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~~l~---  140 (437)
                      ..++.++.||.|.- |.||++.. +|+.||+|.+..   ...                  ....-|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            77999999999999 99999998 788999999321   100                  11234778888888775   


Q ss_pred             CCcc--eeeeeeeccC------------------CceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHH
Q 013745          141 HKNL--VTLFGCCAEG------------------PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY  200 (437)
Q Consensus       141 h~ni--v~l~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~  200 (437)
                      +.++  |+++||..-.                  ....||.||++...            .+.    ..-+.+|.+-|..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence            4566  9999997321                  11256777765432            112    2245677788889


Q ss_pred             hhhcCCCceEeeccCCCCEEecCCCCceeeecccc
Q 013745          201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA  235 (437)
Q Consensus       201 LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  235 (437)
                      +|..+   |+-+|+|+.|..     .-||+|||.+
T Consensus       180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            99988   999999999985     3589999864

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.16  E-value=1.7e-05  Score=73.70  Aligned_cols=75  Identities=12%  Similarity=0.255  Sum_probs=50.4

Q ss_pred             cceeccCCCeeEEEEEcCC--CcEEEEEEeccCChHHHHHHHHHHHHHHcCCC-CcceeeeeeeccCCceEEEEeecCCC
Q 013745           91 LNQLGHGGFGPVYRGLMPN--GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQH-KNLVTLFGCCAEGPEKMLVYEYLPNK  167 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g  167 (437)
                      ++.|..|-...+|+....+  ++.|++|+....... .....+|+.++..+.. .-..++++.+.    ..+||||++|.
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~   77 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR   77 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence            4678888899999988654  678999987543221 1223478888888853 33444554443    24899999997


Q ss_pred             Ccc
Q 013745          168 SLD  170 (437)
Q Consensus       168 sL~  170 (437)
                      ++.
T Consensus        78 ~l~   80 (235)
T cd05157          78 TLE   80 (235)
T ss_pred             cCC
Confidence            763

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10593 hypothetical protein; Provisional

Probab=98.16  E-value=4e-05  Score=73.93  Aligned_cols=77  Identities=13%  Similarity=0.095  Sum_probs=56.3

Q ss_pred             ccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCC---Ccceeeeeeecc---CCceEEEEee
Q 013745           90 DLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQH---KNLVTLFGCCAE---GPEKMLVYEY  163 (437)
Q Consensus        90 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~---~~~~~lv~e~  163 (437)
                      ..+.||.|..+.||+....++ .+++|..+...  ....+..|.+.|+.|.-   -.+.++++++..   .+..+||||+
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~   94 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER   94 (297)
T ss_pred             eeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence            356799999999999876455 46777753311  22567889999998853   367788887754   3568999999


Q ss_pred             cCCCCc
Q 013745          164 LPNKSL  169 (437)
Q Consensus       164 ~~~gsL  169 (437)
                      +++.++
T Consensus        95 i~G~~~  100 (297)
T PRK10593         95 LRGVSV  100 (297)
T ss_pred             cCCEec
Confidence            998765

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.11  E-value=1.9e-05  Score=74.49  Aligned_cols=139  Identities=16%  Similarity=0.114  Sum_probs=79.7

Q ss_pred             eeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcc-eeeeeeeccCCceEEEEeecCCCCcch
Q 013745           93 QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL-VTLFGCCAEGPEKMLVYEYLPNKSLDY  171 (437)
Q Consensus        93 ~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~~  171 (437)
                      .+..|-.+.+|+... +++.+++|..............+|.++++.+....+ .+++..+.    .++||||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            356688889998874 577888987654322211134679999988864333 33444432    369999999877642


Q ss_pred             h-----------------hhccC-CCCCCCHHH-HHHHHHHH---------HHHHHHhhhc-----CCCceEeeccCCCC
Q 013745          172 F-----------------IFDKT-KSSSLDWTT-RYRIVMGV---------ARGLLYLHEE-----APARIIHRDIKASN  218 (437)
Q Consensus       172 ~-----------------l~~~~-~~~~l~~~~-~~~i~~qi---------~~~L~~LH~~-----~~~~iiHrDikp~N  218 (437)
                      .                 ++... ...+++... +..+..++         ...+..+-..     .+..++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 11110 111122211 11111111         1112222111     12348999999999


Q ss_pred             EEecCCCCceeeecccccc
Q 013745          219 ILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       219 Ill~~~~~~kl~DFGla~~  237 (437)
                      |++++++ +.|+||+.|..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999877 89999988763

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.91  E-value=0.00015  Score=69.81  Aligned_cols=142  Identities=15%  Similarity=0.139  Sum_probs=85.2

Q ss_pred             cceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCC--cceeeeeee------ccCCceEEEEe
Q 013745           91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHK--NLVTLFGCC------AEGPEKMLVYE  162 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~------~~~~~~~lv~e  162 (437)
                      ++.|..|....+|+.... +..+++|+....   ....+..|++++..|...  .+.+++...      ...+..++|++
T Consensus        19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTD-SGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeC-CCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            567888888999998764 457889987642   234566788888877532  244444321      22345689999


Q ss_pred             ecCCCCcchh----h----------hccC---CC-----CCCCHHHHH----------HHHHHHHHHHHHhhh----cCC
Q 013745          163 YLPNKSLDYF----I----------FDKT---KS-----SSLDWTTRY----------RIVMGVARGLLYLHE----EAP  206 (437)
Q Consensus       163 ~~~~gsL~~~----l----------~~~~---~~-----~~l~~~~~~----------~i~~qi~~~L~~LH~----~~~  206 (437)
                      |++|..+...    .          +...   ..     ....|....          .....+..++.++-.    ..+
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            9999876431    0          0000   00     011111110          011123334444443    123


Q ss_pred             CceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          207 ARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       207 ~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                      ..++|+|+.|.|||+++++.+.|.||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            459999999999999988777899998775

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.83  E-value=9.9e-05  Score=71.33  Aligned_cols=141  Identities=20%  Similarity=0.318  Sum_probs=84.7

Q ss_pred             cceeccCCCeeEEEEEcCC-------CcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcc-eeeeeeeccCCceEEEEe
Q 013745           91 LNQLGHGGFGPVYRGLMPN-------GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL-VTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e  162 (437)
                      ++.|..|-...||+....+       ++.+++|+...... ......+|++++..+....+ .++++++..    .+|+|
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e   77 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEE   77 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhh
Confidence            4567778888999987654       57899999765432 22345678888888853333 455655542    36899


Q ss_pred             ecCCCCcchhh-----------------hccCCCC------CCC--HHHHHHH--------------------------H
Q 013745          163 YLPNKSLDYFI-----------------FDKTKSS------SLD--WTTRYRI--------------------------V  191 (437)
Q Consensus       163 ~~~~gsL~~~l-----------------~~~~~~~------~l~--~~~~~~i--------------------------~  191 (437)
                      |++|..+....                 +......      ..+  +..+..+                          .
T Consensus        78 ~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (302)
T cd05156          78 FIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFL  157 (302)
T ss_pred             eeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHH
Confidence            99988764311                 1100000      000  1111111                          1


Q ss_pred             HHHHHHHHHhhh------cCCCceEeeccCCCCEEecCC----CCceeeeccccc
Q 013745          192 MGVARGLLYLHE------EAPARIIHRDIKASNILLDEQ----LNPKISDFGLAR  236 (437)
Q Consensus       192 ~qi~~~L~~LH~------~~~~~iiHrDikp~NIll~~~----~~~kl~DFGla~  236 (437)
                      ..+...+.+|-.      ..+..++|+|+.+.|||++++    +.++|+||..|.
T Consensus       158 ~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         158 EDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            122223334432      134568999999999999975    889999998775

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.83  E-value=0.00023  Score=71.02  Aligned_cols=75  Identities=17%  Similarity=0.164  Sum_probs=53.8

Q ss_pred             cceeccCCCeeEEEEEcCCC-cEEEEEEeccC-----C--hHHHHHHHHHHHHHHcCC---CCcceeeeeeeccCCceEE
Q 013745           91 LNQLGHGGFGPVYRGLMPNG-QEIAVKKLSVD-----S--RQGLREFTNEVKLLLKIQ---HKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l  159 (437)
                      .+.||.|.+..||++...+| +.|+||.-...     .  .-..+++..|.+.|+.+.   -.++.+++.+.  ....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence            46799999999999997766 58999985311     1  123456777888888863   24566677663  355789


Q ss_pred             EEeecCCC
Q 013745          160 VYEYLPNK  167 (437)
Q Consensus       160 v~e~~~~g  167 (437)
                      ||||+++.
T Consensus       109 VME~L~~~  116 (401)
T PRK09550        109 VMEDLSDH  116 (401)
T ss_pred             EEecCCCc
Confidence            99999864

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.74  E-value=8.7e-05  Score=80.72  Aligned_cols=197  Identities=20%  Similarity=0.174  Sum_probs=134.9

Q ss_pred             HHHHHHHHHHHcCCCCcceeeeeeeccCCceE----EEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 013745          127 REFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM----LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH  202 (437)
Q Consensus       127 ~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~----lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH  202 (437)
                      ....-|+..+..+.|+|++.++.+-......-    +..++|..-++...+.   .-+.++..+.+.+..++.+||+|+|
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h  303 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLH  303 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHH
Confidence            34456778888889999999998876554332    3457788877777763   3456888999999999999999999


Q ss_pred             hcCCCceEeeccCCC---CEEecCCCCceee--ecccccccCCCCcccceeeeecccccCChhhhccCcCCcc--cceeh
Q 013745          203 EEAPARIIHRDIKAS---NILLDEQLNPKIS--DFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVK--TDVFS  275 (437)
Q Consensus       203 ~~~~~~iiHrDikp~---NIll~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~--~DvwS  275 (437)
                      +..   ..|.-+...   +...+..+.+.++  ||+..+.+........   ..-+..+.+||......+..+  .|+|.
T Consensus       304 ~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~~~~~~~~e~~~~~~~~~~r~~dL~~  377 (1351)
T KOG1035|consen  304 SLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLLAEIRNADEDLKENTAKKSRLTDLWC  377 (1351)
T ss_pred             Hhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcCccccccccccccccchhhhhhHHHH
Confidence            975   555555444   5555667777777  9988887654332221   123556788887776654444  79999


Q ss_pred             hhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 013745          276 YGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVH  355 (437)
Q Consensus       276 lG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~  355 (437)
                      +|..+..+..|..+-.-..                      .+..-+....   ...+.+....|+..++++|+++.+++
T Consensus       378 lgll~~~~~~~~~i~~~~~----------------------~~~~~l~~~~---~~~~~d~~~~~~~~~~~~Rl~~~~ll  432 (1351)
T KOG1035|consen  378 LGLLLLQLSQGEDISEKSA----------------------VPVSLLDVLS---TSELLDALPKCLDEDSEERLSALELL  432 (1351)
T ss_pred             HHHHHhhhhhcCccccccc----------------------chhhhhcccc---chhhhhhhhhhcchhhhhccchhhhh
Confidence            9999999998875532100                      0000011111   11456777899999999999999998


Q ss_pred             HH
Q 013745          356 LM  357 (437)
Q Consensus       356 ~~  357 (437)
                      ..
T Consensus       433 ~~  434 (1351)
T KOG1035|consen  433 TH  434 (1351)
T ss_pred             hc
Confidence            64

>PRK05231 homoserine kinase; Provisional

Probab=97.72  E-value=0.00064  Score=66.18  Aligned_cols=143  Identities=15%  Similarity=0.172  Sum_probs=77.0

Q ss_pred             cceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCc--ceeeeee------eccCCceEEEEe
Q 013745           91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN--LVTLFGC------CAEGPEKMLVYE  162 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~~~~~~lv~e  162 (437)
                      .+.|+.|....+|+....+| .+++|++.....   ..+..|+.++..|...+  +.+.+..      ....+..++++|
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             cchhccccccceEEEEeCCC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            45577788889999876554 688998762222   33334555555553111  2233321      122445789999


Q ss_pred             ecCCCCcchh-----------h---hccCC--------CCCCCH-HHHHH------------HHHH-HHHHHHHhhhc--
Q 013745          163 YLPNKSLDYF-----------I---FDKTK--------SSSLDW-TTRYR------------IVMG-VARGLLYLHEE--  204 (437)
Q Consensus       163 ~~~~gsL~~~-----------l---~~~~~--------~~~l~~-~~~~~------------i~~q-i~~~L~~LH~~--  204 (437)
                      |++|..+...           +   +....        ...+.| .....            .+.+ +...+..+-..  
T Consensus       103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  182 (319)
T PRK05231        103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW  182 (319)
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence            9999765211           0   10000        001111 11111            1111 11122333211  


Q ss_pred             --CCCceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          205 --APARIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       205 --~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                        -+.++||+|+.|.|||++++...-|+||+.+..
T Consensus       183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence              234599999999999999765568999998753

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.68  E-value=0.001  Score=64.54  Aligned_cols=143  Identities=16%  Similarity=0.177  Sum_probs=82.2

Q ss_pred             cceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCC--cceeeeeee------ccCCceEEEEe
Q 013745           91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHK--NLVTLFGCC------AEGPEKMLVYE  162 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~------~~~~~~~lv~e  162 (437)
                      ++.++.|....+|+....+| .+++|+......  ...+..|++++..|...  .+.+++...      ...+..+++++
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            46677887889999876444 688898754321  23445677777776422  234443321      12345689999


Q ss_pred             ecCCCCcchh--------------hhccCCC--C-------CCCHHHHH------------HHHHHHHHHHHHhhh----
Q 013745          163 YLPNKSLDYF--------------IFDKTKS--S-------SLDWTTRY------------RIVMGVARGLLYLHE----  203 (437)
Q Consensus       163 ~~~~gsL~~~--------------l~~~~~~--~-------~l~~~~~~------------~i~~qi~~~L~~LH~----  203 (437)
                      |++|..+...              ++.....  .       .-.|....            .....+...++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            9998665311              1110000  0       00111100            001123334555533    


Q ss_pred             cCCCceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          204 EAPARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       204 ~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                      ..+..++|+|+.+.||++++++.+.|+||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            123569999999999999988777899998775

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.62  E-value=0.00086  Score=64.68  Aligned_cols=138  Identities=20%  Similarity=0.305  Sum_probs=84.8

Q ss_pred             cceeccCCCeeEEEEEcCCCcEEEEEEecc--CChHHHHHHHHHHHHHHcCC--CCcceeeeeeeccCC--ceEEEEeec
Q 013745           91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSV--DSRQGLREFTNEVKLLLKIQ--HKNLVTLFGCCAEGP--EKMLVYEYL  164 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~--~~~lv~e~~  164 (437)
                      ++.+-.|-.-.+|.... +++.++|. ...  ..........+|+.+|+.+.  ---+...+++|.++.  ..|.||+|+
T Consensus        30 v~~~~~G~sn~t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v  107 (321)
T COG3173          30 VEEISGGWSNDTFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV  107 (321)
T ss_pred             eeeccCCcccceEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence            44443344444555444 37888888 321  22233455667888888874  234445677777666  669999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHH-HHHHHHHHHhhh----------------------------------------
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIV-MGVARGLLYLHE----------------------------------------  203 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~-~qi~~~L~~LH~----------------------------------------  203 (437)
                      +|..+...+...    ...    .+++ ..+++.|+-||+                                        
T Consensus       108 eGe~~~~~~~~~----~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~  179 (321)
T COG3173         108 EGEVVWSALPPE----SLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL  179 (321)
T ss_pred             cceeccCcCCcc----cch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence            885443222110    000    1112 244444444543                                        


Q ss_pred             ----------c-----CCCceEeeccCCCCEEecCCCCceeeeccccccc
Q 013745          204 ----------E-----APARIIHRDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       204 ----------~-----~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                                .     ++..++|+|+.+.||+++.++-+=|.||+++..-
T Consensus       180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence                      2     2356999999999999999888999999999754

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.59  E-value=0.00014  Score=69.18  Aligned_cols=148  Identities=18%  Similarity=0.155  Sum_probs=100.5

Q ss_pred             ccHHHHHHHhcC---ccccceeccCCCeeEEEEEcCCCcEEEEEEeccC---------Ch---------HH----HHHHH
Q 013745           76 FDLRTLQVATNF---FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD---------SR---------QG----LREFT  130 (437)
Q Consensus        76 ~~~~~~~~~~~~---y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~---------~~---------~~----~~~~~  130 (437)
                      +++-.+....++   +.+.++||-|.-+-||.+....|++.++|.-+..         ..         .|    .-...
T Consensus        79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~  158 (465)
T KOG2268|consen   79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT  158 (465)
T ss_pred             chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence            455555555543   7888999999999999999989999999854321         00         01    11246


Q ss_pred             HHHHHHHcCC-CCc-ceeeeeeeccCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCc
Q 013745          131 NEVKLLLKIQ-HKN-LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR  208 (437)
Q Consensus       131 ~E~~~l~~l~-h~n-iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~  208 (437)
                      +|+..|+.|. |.. +.+.++    .+..++|||++.|-.|..+-      .-.+..+   +...+..-+.-|-.+|   
T Consensus       159 kEfafmkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~------~v~d~~~---ly~~lm~~Iv~la~~G---  222 (465)
T KOG2268|consen  159 KEFAFMKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVR------HVEDPPT---LYDDLMGLIVRLANHG---  222 (465)
T ss_pred             HHHHHHHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeee------ecCChHH---HHHHHHHHHHHHHHcC---
Confidence            7888888885 322 223333    34568999999998885443      1122233   3333444455566677   


Q ss_pred             eEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          209 IIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       209 iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      +||+|..-=||++++++.++++||--.....
T Consensus       223 lIHgDFNEFNimv~dd~~i~vIDFPQmvS~s  253 (465)
T KOG2268|consen  223 LIHGDFNEFNIMVKDDDKIVVIDFPQMVSTS  253 (465)
T ss_pred             ceecccchheeEEecCCCEEEeechHhhccC
Confidence            9999999999999999999999997665443

>PLN02236 choline kinase

Probab=97.58  E-value=0.00056  Score=67.39  Aligned_cols=142  Identities=17%  Similarity=0.244  Sum_probs=84.1

Q ss_pred             cceeccCCCeeEEEEEcCC-----CcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcc-eeeeeeeccCCceEEEEeec
Q 013745           91 LNQLGHGGFGPVYRGLMPN-----GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL-VTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~  164 (437)
                      +..|-.|-...+|++...+     ++.|++|+......... ...+|..+++.+..-++ .++++.+..+    .|++|+
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi  115 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI  115 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence            4556668889999987432     36889998865432222 23578999888864444 3566666433    589999


Q ss_pred             CCCCcchh-----------------hhccC-C--CCCCCHHHHHHHHHHH-----------------HHHHHHh----hh
Q 013745          165 PNKSLDYF-----------------IFDKT-K--SSSLDWTTRYRIVMGV-----------------ARGLLYL----HE  203 (437)
Q Consensus       165 ~~gsL~~~-----------------l~~~~-~--~~~l~~~~~~~i~~qi-----------------~~~L~~L----H~  203 (437)
                      ++.+|...                 ++... .  .....+..+.++..++                 ...+..|    ..
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            88777421                 11110 0  0111233333333221                 1112222    21


Q ss_pred             -cCCCceEeeccCCCCEEecC-CCCceeeecccccc
Q 013745          204 -EAPARIIHRDIKASNILLDE-QLNPKISDFGLARL  237 (437)
Q Consensus       204 -~~~~~iiHrDikp~NIll~~-~~~~kl~DFGla~~  237 (437)
                       ..+..++|+|+++.|||+++ ++.+.|+||..+..
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence             11345899999999999986 47899999988764

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.46  E-value=0.00082  Score=65.08  Aligned_cols=144  Identities=19%  Similarity=0.185  Sum_probs=99.3

Q ss_pred             cccceeccCCCeeEEEEEcCCCcEEEEEEeccC-----ChH--------------------H-HHHHHHHHHHHHcCCCC
Q 013745           89 SDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD-----SRQ--------------------G-LREFTNEVKLLLKIQHK  142 (437)
Q Consensus        89 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~-----~~~--------------------~-~~~~~~E~~~l~~l~h~  142 (437)
                      ++...|..|.-+.||.|...+|..+|||+++.+     ...                    . .-....|++-|.+|+.-
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            445678899999999999889999999988632     000                    0 01134677777777644


Q ss_pred             cceeeeeeeccCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEec
Q 013745          143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD  222 (437)
Q Consensus       143 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~  222 (437)
                      .|.----+.  -....|||+|+....   +-..+.+...++...+..+-.+++.-+.-|-..+  ++||.||.--|+|+.
T Consensus       227 GIP~PePIl--Lk~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh  299 (520)
T KOG2270|consen  227 GIPCPEPIL--LKNHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH  299 (520)
T ss_pred             CCCCCCcee--eecceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE
Confidence            432111111  123479999995322   2222334556777788889999999999998887  699999999999996


Q ss_pred             CCCCceeeecccccccCC
Q 013745          223 EQLNPKISDFGLARLFPG  240 (437)
Q Consensus       223 ~~~~~kl~DFGla~~~~~  240 (437)
                       +|.+.|+|-+-+...+.
T Consensus       300 -dG~lyiIDVSQSVE~DH  316 (520)
T KOG2270|consen  300 -DGKLYIIDVSQSVEHDH  316 (520)
T ss_pred             -CCEEEEEEccccccCCC
Confidence             45899999887765443

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.41  E-value=0.0019  Score=61.63  Aligned_cols=30  Identities=27%  Similarity=0.549  Sum_probs=25.2

Q ss_pred             ceEeeccCCCCEEecCCCC-ceeeecccccc
Q 013745          208 RIIHRDIKASNILLDEQLN-PKISDFGLARL  237 (437)
Q Consensus       208 ~iiHrDikp~NIll~~~~~-~kl~DFGla~~  237 (437)
                      .++|+|++|.|||+++++. .-|.||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999997555 46999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.29  E-value=4.1e-05  Score=85.00  Aligned_cols=161  Identities=11%  Similarity=-0.037  Sum_probs=118.7

Q ss_pred             HHHHHHHHHcCCCCcceeeeeeecc--CCceEEEEeecCCCCcchhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcC
Q 013745          129 FTNEVKLLLKIQHKNLVTLFGCCAE--GPEKMLVYEYLPNKSLDYFIFDKT-KSSSLDWTTRYRIVMGVARGLLYLHEEA  205 (437)
Q Consensus       129 ~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~  205 (437)
                      ...|..-++...|+++...+.-...  ..+.+.+++|+.+|.+...|.... +.+.++...+.....+.+.+..-+|+..
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            4455566667789998876665533  345689999999999999886543 3344555555544455466666666653


Q ss_pred             --CCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHH
Q 013745          206 --PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEI  283 (437)
Q Consensus       206 --~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~el  283 (437)
                        ..-.+|+++|+-|.+|..+-.+|++++|+.+........  .....+++.|+.|++...-.++.++|+|..|+.+|++
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf--~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSF--FGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCchHhh--hhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHH
Confidence              233799999999999999999999999999843222111  1134578889999999888999999999999999999


Q ss_pred             HhCCCCCC
Q 013745          284 VSGRKNHD  291 (437)
Q Consensus       284 ltg~~p~~  291 (437)
                      .-|..+|.
T Consensus      1434 s~~n~~fi 1441 (2724)
T KOG1826|consen 1434 SDGNAYFI 1441 (2724)
T ss_pred             hcccHHHH
Confidence            99887773

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.06  E-value=0.005  Score=58.93  Aligned_cols=74  Identities=19%  Similarity=0.231  Sum_probs=47.7

Q ss_pred             ccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCC---CCcceeeeeeeccCCceEEEEeecCC
Q 013745           90 DLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ---HKNLVTLFGCCAEGPEKMLVYEYLPN  166 (437)
Q Consensus        90 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~  166 (437)
                      -.+.++.|....+|+.. .+++.+.||+-..   .....|..|.+-|+.|.   --.+.+.+++....+..+|||||++.
T Consensus        21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~   96 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM   96 (288)
T ss_dssp             EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred             eeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence            35678999999999987 4788999998762   22345677888888873   44567788887777777999999987


Q ss_pred             C
Q 013745          167 K  167 (437)
Q Consensus       167 g  167 (437)
                      +
T Consensus        97 ~   97 (288)
T PF03881_consen   97 G   97 (288)
T ss_dssp             -
T ss_pred             C
Confidence            6

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.03  E-value=0.0048  Score=60.49  Aligned_cols=72  Identities=18%  Similarity=0.213  Sum_probs=47.6

Q ss_pred             eeccCCCeeEEEEEcCCC-cEEEEEEecc-------CChHHHHHHHHHHHHHHcCC--CCc-ceeeeeeeccCCceEEEE
Q 013745           93 QLGHGGFGPVYRGLMPNG-QEIAVKKLSV-------DSRQGLREFTNEVKLLLKIQ--HKN-LVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        93 ~lG~G~~g~Vy~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--h~n-iv~l~~~~~~~~~~~lv~  161 (437)
                      .||.|-...||++..++| +.|+||.-..       +..-...+..-|...|+...  .|. +.+++.+  +.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            589999999999997654 6899996531       11223445567888887764  454 4445444  344566999


Q ss_pred             eecCC
Q 013745          162 EYLPN  166 (437)
Q Consensus       162 e~~~~  166 (437)
                      |+++.
T Consensus        80 EdL~~   84 (370)
T TIGR01767        80 EDLSH   84 (370)
T ss_pred             hhCcc
Confidence            99855

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.97  E-value=0.011  Score=58.96  Aligned_cols=73  Identities=12%  Similarity=0.175  Sum_probs=50.9

Q ss_pred             cceeccCCCeeEEEEEcCCCcEEEEEEec-----cCC--hHHHHHHHHHHHHHHcCC---CCcceeeeeeeccCCceEEE
Q 013745           91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLS-----VDS--RQGLREFTNEVKLLLKIQ---HKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~-----~~~--~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv  160 (437)
                      .+.||.|-...||+... .++.++||+-.     ...  .-...+-..|...|+.+.   -.++.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            57899999999999876 45679999765     111  012334445677777664   247778888886  446789


Q ss_pred             EeecCC
Q 013745          161 YEYLPN  166 (437)
Q Consensus       161 ~e~~~~  166 (437)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999977

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.92  E-value=0.0017  Score=59.18  Aligned_cols=123  Identities=18%  Similarity=0.214  Sum_probs=60.9

Q ss_pred             CcEEEEEEeccCChHHHHHHHHHHHHHHcCCC-CcceeeeeeeccCCceEEEEeecCCCCcchhhh--------------
Q 013745          110 GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQH-KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIF--------------  174 (437)
Q Consensus       110 ~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~--------------  174 (437)
                      ++.|+||+...... ..-....|..+++.+.. ..-.++++++.++    +|++|+++..|...-.              
T Consensus         2 ~~~~~~Ri~g~~t~-~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~   76 (211)
T PF01633_consen    2 PEKYLVRIPGEGTE-NFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLA   76 (211)
T ss_dssp             TSEEEEEEEESCGC-SHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCCcc-cccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHH
Confidence            46788888865522 23445678888888864 3445566666443    6779997766532100              


Q ss_pred             ---c--c--CCCCCCCHHHHHHH----------------------HHHHHHHHHHhhh----c-CCCceEeeccCCCCEE
Q 013745          175 ---D--K--TKSSSLDWTTRYRI----------------------VMGVARGLLYLHE----E-APARIIHRDIKASNIL  220 (437)
Q Consensus       175 ---~--~--~~~~~l~~~~~~~i----------------------~~qi~~~L~~LH~----~-~~~~iiHrDikp~NIl  220 (437)
                         .  .  .....--+..+..+                      ...+..-+..+..    . .+.-++|.|+.|.|||
T Consensus        77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil  156 (211)
T PF01633_consen   77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL  156 (211)
T ss_dssp             HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred             HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence               0  0  00111112222222                      1111222222211    1 1234899999999999


Q ss_pred             e-cCCCCceeeecccccc
Q 013745          221 L-DEQLNPKISDFGLARL  237 (437)
Q Consensus       221 l-~~~~~~kl~DFGla~~  237 (437)
                      + +.++.++|+||..|..
T Consensus       157 ~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  157 INNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             ETSSSSCEEE--GTT-EE
T ss_pred             eccCCCeEEEecHHHHhh
Confidence            9 8899999999987753

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.83  E-value=0.013  Score=57.03  Aligned_cols=141  Identities=23%  Similarity=0.330  Sum_probs=83.8

Q ss_pred             ceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcc------eee----eeeeccCCceEEEE
Q 013745           92 NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL------VTL----FGCCAEGPEKMLVY  161 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni------v~l----~~~~~~~~~~~lv~  161 (437)
                      ..|.+ .-..||+....+|+. ++|+....  ....++..|+..|..|.-.+|      ..+    +.........+-|+
T Consensus        32 ~~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf  107 (331)
T COG2334          32 RGLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF  107 (331)
T ss_pred             ccccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence            34555 667899988766665 88988765  223566678888877742222      221    11222223667899


Q ss_pred             eecCCCCcch-hh--------------hc----c-----CCCCCCCHHH-------------HHHHHHHHHHHHHHhhhc
Q 013745          162 EYLPNKSLDY-FI--------------FD----K-----TKSSSLDWTT-------------RYRIVMGVARGLLYLHEE  204 (437)
Q Consensus       162 e~~~~gsL~~-~l--------------~~----~-----~~~~~l~~~~-------------~~~i~~qi~~~L~~LH~~  204 (437)
                      +|++|..+.. ..              +.    .     .......|..             ......++...+..+.+.
T Consensus       108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~  187 (331)
T COG2334         108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR  187 (331)
T ss_pred             EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence            9999988872 11              00    0     0001122320             012233444444444443


Q ss_pred             ----CCCc---eEeeccCCCCEEecCCCC-ceeeeccccc
Q 013745          205 ----APAR---IIHRDIKASNILLDEQLN-PKISDFGLAR  236 (437)
Q Consensus       205 ----~~~~---iiHrDikp~NIll~~~~~-~kl~DFGla~  236 (437)
                          -+..   +||+|+.|.||+++.+.. +.+.||+-+.
T Consensus       188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence                2223   999999999999998875 8999999775

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.78  E-value=0.017  Score=56.07  Aligned_cols=32  Identities=22%  Similarity=0.332  Sum_probs=28.3

Q ss_pred             CCceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          206 PARIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       206 ~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                      +..++|+|+.+.|||+++++.+.|+||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            34599999999999999999999999988764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.74  E-value=0.0075  Score=59.09  Aligned_cols=142  Identities=12%  Similarity=0.266  Sum_probs=81.4

Q ss_pred             cceeccCCCeeEEEEEcCC----CcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcc-eeeeeeeccCCceEEEEeecC
Q 013745           91 LNQLGHGGFGPVYRGLMPN----GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL-VTLFGCCAEGPEKMLVYEYLP  165 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~  165 (437)
                      ++.|-.|-...+|+....+    +..|++|+....... .-.-.+|..+++.+..-++ .++++++..+    +|.+|++
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~   93 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFIN   93 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCCc----Eeehhhc
Confidence            4556668888899886432    237899988654322 1223578888888865444 3566665322    5899998


Q ss_pred             CCCcchh-------h----------hccC-C--CCCCCHHHHHHHHHHH----------------------HHHHHH---
Q 013745          166 NKSLDYF-------I----------FDKT-K--SSSLDWTTRYRIVMGV----------------------ARGLLY---  200 (437)
Q Consensus       166 ~gsL~~~-------l----------~~~~-~--~~~l~~~~~~~i~~qi----------------------~~~L~~---  200 (437)
                      +..|...       +          +... .  ...--+..+.++..++                      ..-+..   
T Consensus        94 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~  173 (330)
T PLN02421         94 ARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE  173 (330)
T ss_pred             CCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence            7766321       1          1110 0  0011233333332221                      111111   


Q ss_pred             hh-h-cCCCceEeeccCCCCEEecC-CCCceeeecccccc
Q 013745          201 LH-E-EAPARIIHRDIKASNILLDE-QLNPKISDFGLARL  237 (437)
Q Consensus       201 LH-~-~~~~~iiHrDikp~NIll~~-~~~~kl~DFGla~~  237 (437)
                      +. . ..+.-.+|.|+.+.|||+++ ++.++++||..|..
T Consensus       174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            11 1 11234799999999999974 57899999988864

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.70  E-value=0.016  Score=55.95  Aligned_cols=29  Identities=28%  Similarity=0.385  Sum_probs=25.2

Q ss_pred             CceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          207 ARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       207 ~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            45899999999999987 678999998664

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.60  E-value=0.04  Score=53.83  Aligned_cols=72  Identities=11%  Similarity=0.100  Sum_probs=44.6

Q ss_pred             CCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCc--ceeee---e--eeccCCceEEEEeecCCCCc
Q 013745           97 GGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN--LVTLF---G--CCAEGPEKMLVYEYLPNKSL  169 (437)
Q Consensus        97 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~---~--~~~~~~~~~lv~e~~~~gsL  169 (437)
                      +.-..||+....+++.+++|+..... ....++..|++.+..|.-..  ++...   |  ....++..+.|+++++|...
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            45578999887778889999886332 23455667888877663211  22211   1  11224557789999988654

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.47  E-value=0.005  Score=62.20  Aligned_cols=47  Identities=19%  Similarity=0.245  Sum_probs=36.9

Q ss_pred             HHHHHHHHHHHcCCCCcceeeeeeeccCC-ceEEEEeecCCCCcchhhh
Q 013745          127 REFTNEVKLLLKIQHKNLVTLFGCCAEGP-EKMLVYEYLPNKSLDYFIF  174 (437)
Q Consensus       127 ~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~  174 (437)
                      .++.-...+++.+.|+|....+++..... ...+|||++ +.+|.+.+.
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~   74 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILK   74 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHH
Confidence            44556778899999999999998876543 357899998 778888874

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.43  E-value=0.015  Score=52.67  Aligned_cols=152  Identities=14%  Similarity=0.100  Sum_probs=90.5

Q ss_pred             CCCeeEEEEEcCCCcEEEEEEeccCChH-HHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCCCCcchhhhc
Q 013745           97 GGFGPVYRGLMPNGQEIAVKKLSVDSRQ-GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD  175 (437)
Q Consensus        97 G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  175 (437)
                      |+-++.-.+..+- .+..+|++....-. ....|..+.+++++++  .|+++..-  +.-.+.++.|+|..-..      
T Consensus        73 ~gNsTl~~~kt~i-G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKI-GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------  141 (308)
T ss_pred             CCceEEEEecccc-chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence            3444444444323 34566776543222 3356788999999885  57777632  33345688998833111      


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccceeeeecccc
Q 013745          176 KTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG  255 (437)
Q Consensus       176 ~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~  255 (437)
                            ..    ..++..=+.+|.-.|+.. ...+|+|..|+||+-|+.|.+||.|=+..-.  .            +..
T Consensus       142 ------~~----~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--~------------~V~  196 (308)
T PF07387_consen  142 ------NF----SNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--N------------QVN  196 (308)
T ss_pred             ------ch----hHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhh--h------------eee
Confidence                  00    011111146788889654 4599999999999999999999999764421  0            111


Q ss_pred             cCChhhhccCcCCcccceehhhHHHHHHHhCC
Q 013745          256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVSGR  287 (437)
Q Consensus       256 Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~  287 (437)
                      |.--   .....+.++.+-+|=.-++++....
T Consensus       197 ~vN~---~Y~~lT~~aE~~~fv~s~l~~v~~~  225 (308)
T PF07387_consen  197 MVNI---EYESLTQEAEVKVFVKSCLKLVEKQ  225 (308)
T ss_pred             EEee---eccccChHHHHHHHHHHHHHHHHHH
Confidence            1111   1123466777777777777776543

The function of this family is unknown.

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.41  E-value=0.011  Score=58.66  Aligned_cols=74  Identities=15%  Similarity=0.214  Sum_probs=49.7

Q ss_pred             cceeccCCCeeEEEEEcCC-CcEEEEEEec----c--CChHHHHHHHHHHHHHHcCC--CCc-ceeeeeeeccCCceEEE
Q 013745           91 LNQLGHGGFGPVYRGLMPN-GQEIAVKKLS----V--DSRQGLREFTNEVKLLLKIQ--HKN-LVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~----~--~~~~~~~~~~~E~~~l~~l~--h~n-iv~l~~~~~~~~~~~lv  160 (437)
                      .+.||.|--.-||++...+ ++.|+||.-.    .  +..-...+..-|.++|+.+.  .|. +.+++.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            5689999999999998743 5689999653    1  11233456667888888764  454 4445544  34456788


Q ss_pred             EeecCC
Q 013745          161 YEYLPN  166 (437)
Q Consensus       161 ~e~~~~  166 (437)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            998854

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.35  E-value=0.013  Score=56.86  Aligned_cols=106  Identities=16%  Similarity=0.153  Sum_probs=73.4

Q ss_pred             CCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecc
Q 013745          154 GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG  233 (437)
Q Consensus       154 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG  233 (437)
                      ....|++|++. |+++...       ....++++..++.+.+..+.-+..+-  +.=|||+.-.||||+ +|++-|+||-
T Consensus       298 ~~y~yl~~kdh-gt~is~i-------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfk  366 (488)
T COG5072         298 TLYLYLHFKDH-GTPISII-------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFK  366 (488)
T ss_pred             ceEEEEEEecC-Cceeeee-------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEee
Confidence            34557888876 6666322       23467889999999998888887764  589999999999999 9999999999


Q ss_pred             cccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhH
Q 013745          234 LARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGV  278 (437)
Q Consensus       234 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~  278 (437)
                      +++.-.....       ......--|-.+. +.-+..-|||-+--
T Consensus       367 lsRl~~~q~~-------isy~rldhp~lF~-G~dd~QFeIYrlMr  403 (488)
T COG5072         367 LSRLSYSQGI-------ISYNRLDHPDLFN-GVDDYQFEIYRLMR  403 (488)
T ss_pred             eeecccCCce-------eeccccCchhhhc-CccceeeeHHHHHH
Confidence            9995332211       1122334455555 33366677775433

>PRK06148 hypothetical protein; Provisional

Probab=95.97  E-value=0.085  Score=59.46  Aligned_cols=142  Identities=20%  Similarity=0.244  Sum_probs=78.3

Q ss_pred             ceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcC-------CCCcceeee-----eeecc-CC--c
Q 013745           92 NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-------QHKNLVTLF-----GCCAE-GP--E  156 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~l~-----~~~~~-~~--~  156 (437)
                      +.|+ |..-.+|+....+|+.+++|+.......  .....|...|..|       ..|.+++..     ..... .+  .
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~--~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~  107 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEPR--VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR  107 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCccch--hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence            5564 4568889988778889999999754322  2333455555433       234444322     11111 22  4


Q ss_pred             eEEEEeecCCCCcchhh-------h----------c----c---CCCCCCCHHH-----------------HHHHHHHHH
Q 013745          157 KMLVYEYLPNKSLDYFI-------F----------D----K---TKSSSLDWTT-----------------RYRIVMGVA  195 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l-------~----------~----~---~~~~~l~~~~-----------------~~~i~~qi~  195 (437)
                      .+-+++|++|..+.+..       .          .    .   .....+.|..                 ...++.+++
T Consensus       108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~  187 (1013)
T PRK06148        108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL  187 (1013)
T ss_pred             EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence            56789999998775410       0          0    0   0001122211                 112222232


Q ss_pred             HHHH-----HhhhcCCCceEeeccCCCCEEecCCC--Cce-eeecccccc
Q 013745          196 RGLL-----YLHEEAPARIIHRDIKASNILLDEQL--NPK-ISDFGLARL  237 (437)
Q Consensus       196 ~~L~-----~LH~~~~~~iiHrDikp~NIll~~~~--~~k-l~DFGla~~  237 (437)
                      ..+.     .|. .-+..+||+|+.+.|||++.++  .+. |+|||.+..
T Consensus       188 ~~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        188 ARFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            2222     121 1234599999999999998775  555 999998864

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.89  E-value=0.47  Score=43.54  Aligned_cols=75  Identities=25%  Similarity=0.300  Sum_probs=52.6

Q ss_pred             ceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCC---CCcceeeeeeeccCCceEEEEeecCCCC
Q 013745           92 NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ---HKNLVTLFGCCAEGPEKMLVYEYLPNKS  168 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~gs  168 (437)
                      +.+--|.--..|.... ...++.||+=.   ......|..|+.-|..|.   --++.+++.+-....+.||||||++-+.
T Consensus        22 ~~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~   97 (286)
T COG3001          22 EEVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP   97 (286)
T ss_pred             cccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence            3444455555565544 56788888743   334456777877777664   3567778888888999999999999887


Q ss_pred             cc
Q 013745          169 LD  170 (437)
Q Consensus       169 L~  170 (437)
                      ++
T Consensus        98 ~d   99 (286)
T COG3001          98 LD   99 (286)
T ss_pred             CC
Confidence            76

>PTZ00384 choline kinase; Provisional

Probab=95.87  E-value=0.056  Score=54.01  Aligned_cols=75  Identities=13%  Similarity=0.306  Sum_probs=46.5

Q ss_pred             cceeccCCCeeEEEEEcCCC--cE-----EEEEEeccCChHHHHHHHHHHHHHHcCCCCcc-eeeeeeeccCCceEEEEe
Q 013745           91 LNQLGHGGFGPVYRGLMPNG--QE-----IAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL-VTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e  162 (437)
                      ++.|..|-...+|++...++  ..     |.++...... ...-.-.+|+.+++.|...++ .++++.+..    ++|+|
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~e  129 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQE  129 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCC-ceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEE
Confidence            45666688899999875432  22     4444332211 111123468999999965444 456666643    59999


Q ss_pred             ecCCCCcc
Q 013745          163 YLPNKSLD  170 (437)
Q Consensus       163 ~~~~gsL~  170 (437)
                      |++|..|.
T Consensus       130 fIeGr~l~  137 (383)
T PTZ00384        130 WVEGNTMG  137 (383)
T ss_pred             EeccccCC
Confidence            99998775

>PTZ00296 choline kinase; Provisional

Probab=95.86  E-value=0.065  Score=54.54  Aligned_cols=76  Identities=12%  Similarity=0.144  Sum_probs=49.5

Q ss_pred             ccceeccCCCeeEEEEEcCC---------CcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcce-eeeeeeccCCceEE
Q 013745           90 DLNQLGHGGFGPVYRGLMPN---------GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV-TLFGCCAEGPEKML  159 (437)
Q Consensus        90 ~~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~l  159 (437)
                      .++.|..|-.-.+|++...+         ++.|++++.......- -.-..|..+++.+...+|- ++++.+.    -+.
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~l-IdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~  183 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDEL-YNPISEFEVYKTMSKYRIAPQLLNTFS----GGR  183 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccce-eCHHHHHHHHHHHHHCCCCCceEEEeC----CCE
Confidence            45677788888999987432         4678888886543322 2334688888877644443 4556553    246


Q ss_pred             EEeecCCCCcc
Q 013745          160 VYEYLPNKSLD  170 (437)
Q Consensus       160 v~e~~~~gsL~  170 (437)
                      |.||++|..|.
T Consensus       184 I~efi~g~~l~  194 (442)
T PTZ00296        184 IEEWLYGDPLR  194 (442)
T ss_pred             EEEeeCCccCC
Confidence            89999987553

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	437
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-57
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-56
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		6e-41
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-40
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-38
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-38
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-38
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-36
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-24
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-24
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		6e-24
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-22
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-22
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-22
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		5e-22
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-22
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-21
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-21
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-21
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-21
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-21
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-21
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-21
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-21
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-21
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-21
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-21
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-21
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-21
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-21
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-21
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-21
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-21
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-21
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-21
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-21
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-21
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-21
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-21
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-21
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-21
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-21
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-21
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-21
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-21
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-21
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		5e-21
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-21
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-21
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		6e-21
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		6e-21
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		7e-21
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		7e-21
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		7e-21
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		8e-21
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		9e-21
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		9e-21
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-20
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-20
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-20
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-20
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-20
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-20
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-20
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-20
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-20
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-20
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-20
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-20
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-20
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-20
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-20
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		5e-20
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		7e-20
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		9e-20
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-19
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-19
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		5e-19
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-19
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		8e-19
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		8e-19
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		9e-19
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-19
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		9e-19
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		9e-19
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		9e-19
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		9e-19
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-19
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		9e-19
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-18
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-18
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-18
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-18
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-18
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-18
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-18
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-18
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-18
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-18
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-18
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-18
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-18
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-18
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-18
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-18
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-18
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-18
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-18
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-18
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-18
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		2e-18
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-18
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-18
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-18
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-18
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-18
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-18
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-18
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-18
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-18
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-18
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-18
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-18
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		6e-18
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		6e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-18
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		6e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-18
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-18
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		6e-18
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		6e-18
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		7e-18
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-18
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		7e-18
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		7e-18
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		7e-18
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		8e-18
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		8e-18
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		8e-18
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-18
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		8e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-18
4h58_A	275	Braf In Complex With Compound 3 Length = 275		9e-18
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-17
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-17
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-17
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-17
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-17
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-17
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-17
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-17
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-17
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-17
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-17
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-17
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-17
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-17
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		4e-17
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-17
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		5e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-17
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-17
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		6e-17
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-17
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		7e-17
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		7e-17
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-17
1fvr_A	327	Tie2 Kinase Domain Length = 327		8e-17
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		9e-17
3a7f_A	303	Human Mst3 Kinase Length = 303		9e-17
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-16
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-16
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-16
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-16
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-16
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-16
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-16
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-16
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-16
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-16
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-16
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-16
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-16
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-16
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-16
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-16
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-16
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-16
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		4e-16
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-16
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-16
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-16
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		5e-16
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-16
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-16
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		5e-16
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-16
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-16
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-16
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		6e-16
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		6e-16
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		6e-16
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-16
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-16
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-16
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-16
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		7e-16
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-16
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-16
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		8e-16
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		9e-16
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-15
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		1e-15
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-15
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-15
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-15
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-15
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-15
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-15
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-15
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-15
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-15
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-15
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-15
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-15
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-15
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-15
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-15
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-15
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-15
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-15
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-15
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-15
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-15
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-15
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-15
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-15
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-15
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-15
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-15
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-15
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-15
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		5e-15
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-15
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		6e-15
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		6e-15
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		6e-15
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		6e-15
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		6e-15
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		6e-15
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-15
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-15
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		7e-15
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-15
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-15
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-15
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		7e-15
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-15
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		7e-15
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		7e-15
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-15
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		7e-15
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		8e-15
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		8e-15
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		8e-15
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-15
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-15
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		9e-15
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		9e-15
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		9e-15
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-14
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-14
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-14
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-14
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-14
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-14
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-14
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-14
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-14
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-14
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-14
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-14
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-14
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-14
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-14
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-14
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-14
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-14
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-14
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		3e-14
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-14
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-14
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-14
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-14
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-14
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-14
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-14
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-14
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-14
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-14
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-14
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-14
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-14
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-14
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-14
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-14
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-14
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-14
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-14
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-14
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-14
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-14
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-14
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-14
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-14
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		6e-14
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-14
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-14
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		7e-14
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		7e-14
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		7e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		7e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		7e-14
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		7e-14
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		7e-14
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		8e-14
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		8e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-14
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		8e-14
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		9e-14
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-14
3b2t_A	311	Structure Of Phosphotransferase Length = 311		9e-14
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		9e-14
4fie_A	423	Full-Length Human Pak4 Length = 423		9e-14
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		9e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		9e-14
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-14
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-13
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-13
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-13
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-13
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-13
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-13
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-13
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-13
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-13
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-13
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-13
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-13
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-13
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-13
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-13
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-13
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-13
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-13
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-13
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-13
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-13
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-13
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-13
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-13
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-13
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-13
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-13
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-13
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-13
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-13
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-13
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-13
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-13
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-13
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-13
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-13
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-13
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-13
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-13
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-13
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-13
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-13
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-13
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-13
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		3e-13
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-13
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-13
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-13
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-13
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-13
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-13
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-13
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-13
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		5e-13
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-13
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		6e-13
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		6e-13
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		6e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-13
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-13
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		6e-13
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		6e-13
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		6e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		7e-13
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		7e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		8e-13
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		8e-13
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		8e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		8e-13
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		9e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-12
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-12
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-12
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-12
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-12
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-12
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-12
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-12
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-12
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-12
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-12
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-12
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-12
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-12
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-12
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-12
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-12
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-12
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-12
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-12
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-12
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-12
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-12
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-12
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-12
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-12
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-12
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-12
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		4e-12
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-12
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		5e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-12
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		5e-12
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-12
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-12
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		5e-12
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		6e-12
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		6e-12
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-12
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-12
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-12
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		6e-12
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-12
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		6e-12
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		6e-12
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-12
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		6e-12
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-12
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		6e-12
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		7e-12
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		7e-12
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-12
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		7e-12
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-12
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-12
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-12
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-12
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		7e-12
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		7e-12
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		7e-12
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		7e-12
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-12
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		7e-12
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-12
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		7e-12
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-12
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-12
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-12
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		7e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		7e-12
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-12
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		7e-12
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		7e-12
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		7e-12
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		7e-12
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		8e-12
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		8e-12
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-12
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		8e-12
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		8e-12
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		8e-12
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		8e-12
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		8e-12
3hec_A	348	P38 In Complex With Imatinib Length = 348		9e-12
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		9e-12
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		9e-12
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		9e-12
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		9e-12
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		9e-12
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		9e-12
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-11
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-11
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-11
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-11
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-11
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-11
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-11
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-11
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-11
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-11
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-11
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-11
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-11
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-11
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-11
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-11
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-11
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-11
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-11
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-11
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-11
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-11
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-11
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-11
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-11
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-11
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-11
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-11
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-11
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-11
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-11
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-11
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-11
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-11
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		4e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		5e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-11
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		5e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		5e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-11
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-11
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		6e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		7e-11
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		7e-11
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		7e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-11
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-11
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		7e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		7e-11
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		7e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		7e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-11
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-11
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		8e-11
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		9e-11
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		9e-11
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		9e-11
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-10
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-10
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-10
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-10
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-10
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-10
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-10
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-10
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-10
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-10
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-10
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-10
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-10
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-10
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-10
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-10
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-10
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-10
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-10
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-10
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-10
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-10
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-10
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		3e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-10
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-10
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		5e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		5e-10
4exu_A	371	Mapk13, Inactive Form Length = 371		5e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		5e-10
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		5e-10
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		5e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-10
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		6e-10
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		6e-10
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		6e-10
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		6e-10
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-10
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-10
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		7e-10
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-10
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		7e-10
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-10
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		7e-10
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-10
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		7e-10
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		7e-10
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		8e-10
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-10
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-10
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		8e-10
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		8e-10
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		8e-10
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		9e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-09
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-09
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-09
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-09
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-09
3soa_A	444	Full-Length Human Camkii Length = 444		2e-09
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-09
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		3e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-09
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-09
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-09
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-09
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-09
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		3e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		3e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		4e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-09
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		4e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		4e-09
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-09
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-09
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		5e-09
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-09
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-09
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		5e-09
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		5e-09
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-09
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		6e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		7e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-09
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		7e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		8e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		8e-09
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		8e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		8e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		9e-09
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		9e-09
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-08
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-08
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-08
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-08
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-08
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-08
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-08
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-08
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-08
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-08
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-08
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-08
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-08
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		3e-08
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-08
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-08
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-08
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-08
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		5e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		6e-08
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		6e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		6e-08
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		7e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-08
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		7e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		7e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		7e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		7e-08
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		7e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		8e-08
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		8e-08
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		8e-08
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		9e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		9e-08
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		9e-08
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		9e-08
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		9e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-07
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-07
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-07
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-07
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-07
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-07
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-07
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-07
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-07
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-07
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-07
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		3e-07
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-07
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-07
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-07
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-07
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		3e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-07
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-07
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		3e-07
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-07
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-07
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-07
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		4e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-07
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		5e-07
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		5e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		6e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		6e-07
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-07
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-07
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		7e-07
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		7e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		7e-07
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		7e-07
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		7e-07
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		8e-07
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		8e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		9e-07
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		1e-06
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-06
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-06
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-06
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-06
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		3e-06
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		3e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-06
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		4e-06
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		4e-06
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-06
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		6e-06
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		6e-06
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		7e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		8e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		8e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		8e-06
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		8e-06
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		9e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		9e-06
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		9e-06
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		9e-06
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-05
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  220 bits (561), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 128/295 (43%), Positives = 178/295 (60%), Gaps = 8/295 (2%)
Query: 76  FDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLR-EFTNEVK 134
           F LR LQVA++ FS+ N LG GGFG VY+G + +G  +AVK+L  +  QG   +F  EV+
Sbjct: 28  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVE 87
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSS-LDWTTRYRIVMG 193
           ++    H+NL+ L G C    E++LVY Y+ N S+   + ++ +S   LDW  R RI +G
Sbjct: 88  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 147
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
            ARGL YLH+    +IIHRD+KA+NILLDE+    + DFGLA+L   +D HV    + GT
Sbjct: 148 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXX-AVRGT 206
Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHD-GRLGKEKADLLSYTWT--LFQ 310
            G++APEY   G  S KTDVF YGV++LE+++G++  D  RL  +  D++   W   L +
Sbjct: 207 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD-DVMLLDWVKGLLK 265
Query: 311 GEKALELVDPSLAKCNRD-EAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFT 364
            +K   LVD  L    +D E    IQ+ LLC Q S  ERP M+ V  ML GD   
Sbjct: 266 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 320

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  217 bits (552), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 126/295 (42%), Positives = 176/295 (59%), Gaps = 8/295 (2%)
Query: 76  FDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLR-EFTNEVK 134
           F LR LQVA++ F + N LG GGFG VY+G + +G  +AVK+L  +  QG   +F  EV+
Sbjct: 20  FSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVE 79
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSS-LDWTTRYRIVMG 193
           ++    H+NL+ L G C    E++LVY Y+ N S+   + ++ +S   LDW  R RI +G
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
            ARGL YLH+    +IIHRD+KA+NILLDE+    + DFGLA+L   +D HV    + G 
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXX-AVRGX 198
Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHD-GRLGKEKADLLSYTWT--LFQ 310
            G++APEY   G  S KTDVF YGV++LE+++G++  D  RL  +  D++   W   L +
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD-DVMLLDWVKGLLK 257
Query: 311 GEKALELVDPSLAKCNRD-EAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFT 364
            +K   LVD  L    +D E    IQ+ LLC Q S  ERP M+ V  ML GD   
Sbjct: 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  164 bits (416), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 104/280 (37%), Positives = 160/280 (57%), Gaps = 7/280 (2%)
Query: 78  LRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLL 137
           L  L+ ATN F     +GHG FG VY+G++ +G ++A+K+ + +S QG+ EF  E++ L 
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIF-DKTKSSSLDWTTRYRIVMGVAR 196
             +H +LV+L G C E  E +L+Y+Y+ N +L   ++     + S+ W  R  I +G AR
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED-THVNTFRISGTHG 255
           GL YLH  A   IIHRD+K+ NILLDE   PKI+DFG+++     D TH+    + GT G
Sbjct: 151 GLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXV-VKGTLG 206
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKAL 315
           Y+ PEY + G L+ K+DV+S+GV++ E++  R      L +E  +L  +        +  
Sbjct: 207 YIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE 266
Query: 316 ELVDPSLAKCNRDEAAMCI-QLGLLCCQQSVAERPDMNSV 354
           ++VDP+LA   R E+        + C   S  +RP M  V
Sbjct: 267 QIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 104/282 (36%), Positives = 161/282 (57%), Gaps = 11/282 (3%)
Query: 78  LRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLL 137
           L  L+ ATN F     +GHG FG VY+G++ +G ++A+K+ + +S QG+ EF  E++ L 
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIF-DKTKSSSLDWTTRYRIVMGVAR 196
             +H +LV+L G C E  E +L+Y+Y+ N +L   ++     + S+ W  R  I +G AR
Sbjct: 91  FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED---THVNTFRISGT 253
           GL YLH  A   IIHRD+K+ NILLDE   PKI+DFG+++   G +   TH+    + GT
Sbjct: 151 GLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISK--KGTELGQTHLXXV-VKGT 204
Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEK 313
            GY+ PEY + G L+ K+DV+S+GV++ E++  R      L +E  +L  +        +
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 314 ALELVDPSLAKCNRDEAAMCI-QLGLLCCQQSVAERPDMNSV 354
             ++VDP+LA   R E+        + C   S  +RP M  V
Sbjct: 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 104/294 (35%), Positives = 154/294 (52%), Gaps = 18/294 (6%)
Query: 76  FDLRTLQVATNFFSDL------NQLGHGGFGPVYRGLMPNGQEIAVKKLS----VDSRQG 125
           F    L+  TN F +       N++G GGFG VY+G + N   +AVKKL+    + + + 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 126 LREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWT 185
            ++F  E+K++ K QH+NLV L G  ++G +  LVY Y+PN SL   +     +  L W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 186 TRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV 245
            R +I  G A G+ +LHE      IHRDIK++NILLDE    KISDFGLAR        V
Sbjct: 134 MRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 246 NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLL-SY 304
              RI GT  YMAPE AL G ++ K+D++S+GV++LEI++G    D    +E   LL   
Sbjct: 191 MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEH--REPQLLLDIK 247
Query: 305 TWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML 358
                + +   + +D  +   +         +   C  +   +RPD+  V  +L
Sbjct: 248 EEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 104/294 (35%), Positives = 154/294 (52%), Gaps = 18/294 (6%)
Query: 76  FDLRTLQVATNFFSDL------NQLGHGGFGPVYRGLMPNGQEIAVKKLS----VDSRQG 125
           F    L+  TN F +       N++G GGFG VY+G + N   +AVKKL+    + + + 
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 67
Query: 126 LREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWT 185
            ++F  E+K++ K QH+NLV L G  ++G +  LVY Y+PN SL   +     +  L W 
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 127
Query: 186 TRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV 245
            R +I  G A G+ +LHE      IHRDIK++NILLDE    KISDFGLAR        V
Sbjct: 128 MRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 184
Query: 246 NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLL-SY 304
              RI GT  YMAPE AL G ++ K+D++S+GV++LEI++G    D    +E   LL   
Sbjct: 185 MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEH--REPQLLLDIK 241
Query: 305 TWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML 358
                + +   + +D  +   +         +   C  +   +RPD+  V  +L
Sbjct: 242 EEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 295

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 104/294 (35%), Positives = 154/294 (52%), Gaps = 18/294 (6%)
Query: 76  FDLRTLQVATNFFSDL------NQLGHGGFGPVYRGLMPNGQEIAVKKLS----VDSRQG 125
           F    L+  TN F +       N++G GGFG VY+G + N   +AVKKL+    + + + 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 73
Query: 126 LREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWT 185
            ++F  E+K++ K QH+NLV L G  ++G +  LVY Y+PN SL   +     +  L W 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 186 TRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV 245
            R +I  G A G+ +LHE      IHRDIK++NILLDE    KISDFGLAR        V
Sbjct: 134 MRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 246 NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLL-SY 304
              RI GT  YMAPE AL G ++ K+D++S+GV++LEI++G    D    +E   LL   
Sbjct: 191 MXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEH--REPQLLLDIK 247
Query: 305 TWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML 358
                + +   + +D  +   +         +   C  +   +RPD+  V  +L
Sbjct: 248 EEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 92/221 (41%), Positives = 127/221 (57%), Gaps = 15/221 (6%)
Query: 76  FDLRTLQVATNFFSDL------NQLGHGGFGPVYRGLMPNGQEIAVKKLS----VDSRQG 125
           F    L+  TN F +       N+ G GGFG VY+G + N   +AVKKL+    + + + 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 64
Query: 126 LREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWT 185
            ++F  E+K+  K QH+NLV L G  ++G +  LVY Y PN SL   +     +  L W 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 186 TRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV 245
            R +I  G A G+ +LHE      IHRDIK++NILLDE    KISDFGLAR        V
Sbjct: 125 XRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 246 NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
              RI GT  Y APE AL G ++ K+D++S+GV++LEI++G
Sbjct: 182 XXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITG 221

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 110/203 (54%), Gaps = 9/203 (4%)
Query: 88  FSDLN---QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLR--EFTNEVKLLLKIQHK 142
           + DLN   ++G G FG V+R    +G ++AVK L        R  EF  EV ++ +++H 
Sbjct: 36  WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
           N+V   G   + P   +V EYL   SL   +        LD   R  +   VA+G+ YLH
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
              P  I+HR++K+ N+L+D++   K+ DFGL+RL     T +++   +GT  +MAPE  
Sbjct: 155 NRNPP-IVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVL 211
Query: 263 LHGYLSVKTDVFSYGVLVLEIVS 285
                + K+DV+S+GV++ E+ +
Sbjct: 212 RDEPSNEKSDVYSFGVILWELAT 234

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 72/207 (34%), Positives = 105/207 (50%), Gaps = 25/207 (12%)
Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSVDS----RQGLREFTNEVKLLLKIQHKNLVTLFG 149
           +G GGFG VYR     G E+AVK    D      Q +     E KL   ++H N++ L G
Sbjct: 15  IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSL--DWTTRYRIVMGVARGLLYLHEEAPA 207
            C + P   LV E+     L+  +  K     +  +W  +      +ARG+ YLH+EA  
Sbjct: 74  VCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQ------IARGMNYLHDEAIV 127
Query: 208 RIIHRDIKASNILLDEQLNP--------KISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
            IIHRD+K+SNIL+ +++          KI+DFGLAR    E         +G + +MAP
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGAYAWMAP 183
Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVSG 286
           E       S  +DV+SYGVL+ E+++G
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTG 210

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 68/203 (33%), Positives = 108/203 (53%), Gaps = 9/203 (4%)
Query: 88  FSDLN---QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLR--EFTNEVKLLLKIQHK 142
           + DLN   ++G G FG V+R    +G ++AVK L        R  EF  EV ++ +++H 
Sbjct: 36  WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
           N+V   G   + P   +V EYL   SL   +        LD   R  +   VA+G+ YLH
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
              P  I+HRD+K+ N+L+D++   K+ DFGL+RL       + +   +GT  +MAPE  
Sbjct: 155 NRNPP-IVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPEVL 211
Query: 263 LHGYLSVKTDVFSYGVLVLEIVS 285
                + K+DV+S+GV++ E+ +
Sbjct: 212 RDEPSNEKSDVYSFGVILWELAT 234

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 92/320 (28%), Positives = 146/320 (45%), Gaps = 44/320 (13%)
Query: 60  SAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLS 119
           S     G   D+W +  +   L+V         +LG G FG V+ G       +A+K L 
Sbjct: 167 SKPQTQGLAKDAWEIPRESLRLEV---------KLGQGCFGEVWMGTWNGTTRVAIKTLK 217
Query: 120 VDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKS 179
             +      F  E +++ K++H+ LV L+   +E P   +V EY+   SL  F+  +T  
Sbjct: 218 PGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGET-G 274
Query: 180 SSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239
             L       +   +A G+ Y+        +HRD++A+NIL+ E L  K++DFGLARL  
Sbjct: 275 KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI- 330
Query: 240 GEDTHVNT-----FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGR 293
            ED          F I  T    APE AL+G  ++K+DV+S+G+L+ E+ + GR  + G 
Sbjct: 331 -EDNEYTARQGAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385
Query: 294 LGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNS 353
           + +E  D         Q E+   +  P   +C      +  Q    C ++   ERP    
Sbjct: 386 VNREVLD---------QVERGYRM--PCPPECPESLHDLMCQ----CWRKEPEERPTFEY 430
Query: 354 VHLMLSGDSFTLPKP-GKPG 372
           +   L  D FT  +P  +PG
Sbjct: 431 LQAFLE-DYFTSTEPQXQPG 449

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 92/320 (28%), Positives = 146/320 (45%), Gaps = 44/320 (13%)
Query: 60  SAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLS 119
           S     G   D+W +  +   L+V         +LG G FG V+ G       +A+K L 
Sbjct: 167 SKPQTQGLAKDAWEIPRESLRLEV---------KLGQGCFGEVWMGTWNGTTRVAIKTLK 217
Query: 120 VDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKS 179
             +      F  E +++ K++H+ LV L+   +E P   +V EY+   SL  F+  +T  
Sbjct: 218 PGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGET-G 274
Query: 180 SSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239
             L       +   +A G+ Y+        +HRD++A+NIL+ E L  K++DFGLARL  
Sbjct: 275 KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI- 330
Query: 240 GEDTHVNT-----FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGR 293
            ED          F I  T    APE AL+G  ++K+DV+S+G+L+ E+ + GR  + G 
Sbjct: 331 -EDNEYTARQGAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385
Query: 294 LGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNS 353
           + +E  D         Q E+   +  P   +C      +  Q    C ++   ERP    
Sbjct: 386 VNREVLD---------QVERGYRM--PCPPECPESLHDLMCQ----CWRKEPEERPTFEY 430
Query: 354 VHLMLSGDSFTLPKPG-KPG 372
           +   L  D FT  +P  +PG
Sbjct: 431 LQAFLE-DYFTSTEPQYQPG 449

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 92/320 (28%), Positives = 146/320 (45%), Gaps = 44/320 (13%)
Query: 60  SAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLS 119
           S     G   D+W +  +   L+V         +LG G FG V+ G       +A+K L 
Sbjct: 250 SKPQTQGLAKDAWEIPRESLRLEV---------KLGQGCFGEVWMGTWNGTTRVAIKTLK 300
Query: 120 VDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKS 179
             +      F  E +++ K++H+ LV L+   +E P   +V EY+   SL  F+  +T  
Sbjct: 301 PGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGET-G 357
Query: 180 SSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239
             L       +   +A G+ Y+        +HRD++A+NIL+ E L  K++DFGLARL  
Sbjct: 358 KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI- 413
Query: 240 GEDTHVNT-----FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGR 293
            ED          F I  T    APE AL+G  ++K+DV+S+G+L+ E+ + GR  + G 
Sbjct: 414 -EDNEYTARQGAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 468
Query: 294 LGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNS 353
           + +E  D         Q E+   +  P   +C      +  Q    C ++   ERP    
Sbjct: 469 VNREVLD---------QVERGYRM--PCPPECPESLHDLMCQ----CWRKEPEERPTFEY 513
Query: 354 VHLMLSGDSFTLPKP-GKPG 372
           +   L  D FT  +P  +PG
Sbjct: 514 LQAFLE-DYFTSTEPQXQPG 532

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 88/289 (30%), Positives = 139/289 (48%), Gaps = 35/289 (12%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           + +LG+G FG V+ G      ++A+K L   +      F  E +++ K++H  LV L+  
Sbjct: 14  IKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGT-MSPESFLEEAQIMKKLKHDKLVQLYAV 72
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
            +E P   +V EY+   SL  F+ D  +  +L       +   VA G+ Y+        I
Sbjct: 73  VSEEP-IYIVTEYMNKGSLLDFLKD-GEGRALKLPNLVDMAAQVAAGMAYIER---MNYI 127
Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT-----FRISGTHGYMAPEYALHG 265
           HRD++++NIL+   L  KI+DFGLARL   ED          F I  T    APE AL+G
Sbjct: 128 HRDLRSANILVGNGLICKIADFGLARLI--EDNEXTARQGAKFPIKWT----APEAALYG 181
Query: 266 YLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK 324
             ++K+DV+S+G+L+ E+V+ GR  + G   +E          L Q E+   +       
Sbjct: 182 RFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---------VLEQVERGYRM------P 226
Query: 325 CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFTLPKPG-KPG 372
           C +D      +L + C ++   ERP    +   L  D FT  +P  +PG
Sbjct: 227 CPQDCPISLHELMIHCWKKDPEERPTFEYLQSFLE-DYFTATEPQYQPG 274

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 92/320 (28%), Positives = 146/320 (45%), Gaps = 44/320 (13%)
Query: 60  SAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLS 119
           S     G   D+W +  +   L+V         +LG G FG V+ G       +A+K L 
Sbjct: 167 SKPQTQGLAKDAWEIPRESLRLEV---------KLGQGCFGEVWMGTWNGTTRVAIKTLK 217
Query: 120 VDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKS 179
             +      F  E +++ K++H+ LV L+   +E P   +V EY+   SL  F+  +T  
Sbjct: 218 PGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVGEYMSKGSLLDFLKGET-G 274
Query: 180 SSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239
             L       +   +A G+ Y+        +HRD++A+NIL+ E L  K++DFGLARL  
Sbjct: 275 KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI- 330
Query: 240 GEDTHVNT-----FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGR 293
            ED          F I  T    APE AL+G  ++K+DV+S+G+L+ E+ + GR  + G 
Sbjct: 331 -EDNEYTARQGAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385
Query: 294 LGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNS 353
           + +E  D         Q E+   +  P   +C      +  Q    C ++   ERP    
Sbjct: 386 VNREVLD---------QVERGYRM--PCPPECPESLHDLMCQ----CWRKEPEERPTFEY 430
Query: 354 VHLMLSGDSFTLPKP-GKPG 372
           +   L  D FT  +P  +PG
Sbjct: 431 LQAFLE-DYFTSTEPQXQPG 449

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 91/317 (28%), Positives = 144/317 (45%), Gaps = 44/317 (13%)
Query: 63  DADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS 122
              G   D+W +  +   L+V         +LG G FG V+ G       +A+K L   +
Sbjct: 4   QTQGLAKDAWEIPRESLRLEV---------KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT 54
Query: 123 RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSL 182
                 F  E +++ KI+H+ LV L+   +E P   +V EY+   SL  F+  +     L
Sbjct: 55  -MSPEAFLQEAQVMKKIRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEM-GKYL 111
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  +   +A G+ Y+        +HRD++A+NIL+ E L  K++DFGLARL   ED
Sbjct: 112 RLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI--ED 166
Query: 243 THVNT-----FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGK 296
                     F I  T    APE AL+G  ++K+DV+S+G+L+ E+ + GR  + G + +
Sbjct: 167 NEYTARQGAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 222
Query: 297 EKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL 356
           E  D         Q E+   +  P   +C      +  Q    C ++   ERP    +  
Sbjct: 223 EVLD---------QVERGYRM--PCPPECPESLHDLMCQ----CWRKDPEERPTFEYLQA 267
Query: 357 MLSGDSFTLPKPG-KPG 372
            L  D FT  +P  +PG
Sbjct: 268 FLE-DYFTSTEPQYQPG 283

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 90/310 (29%), Positives = 144/310 (46%), Gaps = 44/310 (14%)
Query: 70  DSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREF 129
           D+W +  +   L+V         +LG G FG V+ G       +A+K L   +      F
Sbjct: 1   DAWEIPRESLRLEV---------KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAF 50
Query: 130 TNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYR 189
             E +++ K++H+ LV L+   +E P   +V EY+   SL  F+  +T    L       
Sbjct: 51  LQEAQVMKKLRHEKLVQLYAVVSEEP-IXIVTEYMSKGSLLDFLKGET-GKYLRLPQLVD 108
Query: 190 IVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT-- 247
           +   +A G+ Y+        +HRD++A+NIL+ E L  K++DFGLARL   ED       
Sbjct: 109 MAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEXTARQ 163
Query: 248 ---FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLS 303
              F I  T    APE AL+G  ++K+DV+S+G+L+ E+ + GR  + G + +E  D   
Sbjct: 164 GAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD--- 216
Query: 304 YTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSF 363
                 Q E+   +  P   +C      +  Q    C ++   ERP    +   L  D F
Sbjct: 217 ------QVERGYRM--PCPPECPESLHDLMCQ----CWRKEPEERPTFEYLQAFLE-DYF 263
Query: 364 TLPKPG-KPG 372
           T  +P  +PG
Sbjct: 264 TSTEPQYQPG 273

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 89/281 (31%), Positives = 135/281 (48%), Gaps = 36/281 (12%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           + +LG G FG V+ G      ++AVK L   S      F  E  L+ ++QH+ LV L+  
Sbjct: 27  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 85
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMGVARGLLYLHEEAPARI 209
             + P   ++ EY+ N SL  F+  KT S   L       +   +A G+ ++ E      
Sbjct: 86  VTQEP-IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 139
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT-----FRISGTHGYMAPEYALH 264
           IHRD++A+NIL+ + L+ KI+DFGLARL   ED          F I  T    APE   +
Sbjct: 140 IHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWT----APEAINY 193
Query: 265 GYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA 323
           G  ++K+DV+S+G+L+ EIV+ GR  + G    E    L         E+   +V P   
Sbjct: 194 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPD-- 242
Query: 324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFT 364
            C  +      QL  LC ++   +RP  + +  +L  D FT
Sbjct: 243 NCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLE-DFFT 278

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 90/310 (29%), Positives = 144/310 (46%), Gaps = 44/310 (14%)
Query: 70  DSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREF 129
           D+W +  +   L+V         +LG G FG V+ G       +A+K L   +      F
Sbjct: 4   DAWEIPRESLRLEV---------KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAF 53
Query: 130 TNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYR 189
             E +++ K++H+ LV L+   +E P   +V EY+   SL  F+  +T    L       
Sbjct: 54  LQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGET-GKYLRLPQLVD 111
Query: 190 IVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT-- 247
           +   +A G+ Y+        +HRD++A+NIL+ E L  K++DFGLARL   ED       
Sbjct: 112 MAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQ 166
Query: 248 ---FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLS 303
              F I  T    APE AL+G  ++K+DV+S+G+L+ E+ + GR  + G + +E  D   
Sbjct: 167 GAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD--- 219
Query: 304 YTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSF 363
                 Q E+   +  P   +C      +  Q    C ++   ERP    +   L  D F
Sbjct: 220 ------QVERGYRM--PCPPECPESLHDLMCQ----CWRKEPEERPTFEYLQAFLE-DYF 266
Query: 364 TLPKPG-KPG 372
           T  +P  +PG
Sbjct: 267 TSTEPQYQPG 276

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 91/317 (28%), Positives = 145/317 (45%), Gaps = 44/317 (13%)
Query: 63  DADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS 122
              G   D+W +  +   L+V         +LG G FG V+ G       +A+K L   +
Sbjct: 1   QTQGLAKDAWEIPRESLRLEV---------KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT 51
Query: 123 RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSL 182
                 F  E +++ K++H+ LV L+   +E P   +V EY+   SL  F+  +T    L
Sbjct: 52  -MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKGET-GKYL 108
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  +   +A G+ Y+        +HRD++A+NIL+ E L  K++DFGLARL   ED
Sbjct: 109 RLPQLVDMSAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI--ED 163
Query: 243 THVNT-----FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGK 296
                     F I  T    APE AL+G  ++K+DV+S+G+L+ E+ + GR  + G + +
Sbjct: 164 NEYTARQGAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 219
Query: 297 EKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL 356
           E  D         Q E+   +  P   +C      +  Q    C ++   ERP    +  
Sbjct: 220 EVLD---------QVERGYRM--PCPPECPESLHDLMCQ----CWRKEPEERPTFEYLQA 264
Query: 357 MLSGDSFTLPKPG-KPG 372
            L  D FT  +P  +PG
Sbjct: 265 FLE-DYFTSTEPQYQPG 280

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 89/281 (31%), Positives = 135/281 (48%), Gaps = 36/281 (12%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           + +LG G FG V+ G      ++AVK L   S      F  E  L+ ++QH+ LV L+  
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMGVARGLLYLHEEAPARI 209
             + P   ++ EY+ N SL  F+  KT S   L       +   +A G+ ++ E      
Sbjct: 77  VTQEP-IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 130
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT-----FRISGTHGYMAPEYALH 264
           IHRD++A+NIL+ + L+ KI+DFGLARL   ED          F I  T    APE   +
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWT----APEAINY 184
Query: 265 GYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA 323
           G  ++K+DV+S+G+L+ EIV+ GR  + G    E    L         E+   +V P   
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPD-- 233
Query: 324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFT 364
            C  +      QL  LC ++   +RP  + +  +L  D FT
Sbjct: 234 NCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLE-DFFT 269

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 89/281 (31%), Positives = 135/281 (48%), Gaps = 36/281 (12%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           + +LG G FG V+ G      ++AVK L   S      F  E  L+ ++QH+ LV L+  
Sbjct: 26  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 84
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMGVARGLLYLHEEAPARI 209
             + P   ++ EY+ N SL  F+  KT S   L       +   +A G+ ++ E      
Sbjct: 85  VTQEP-IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 138
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT-----FRISGTHGYMAPEYALH 264
           IHRD++A+NIL+ + L+ KI+DFGLARL   ED          F I  T    APE   +
Sbjct: 139 IHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWT----APEAINY 192
Query: 265 GYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA 323
           G  ++K+DV+S+G+L+ EIV+ GR  + G    E    L         E+   +V P   
Sbjct: 193 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPD-- 241
Query: 324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFT 364
            C  +      QL  LC ++   +RP  + +  +L  D FT
Sbjct: 242 NCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLE-DFFT 277

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 91/317 (28%), Positives = 145/317 (45%), Gaps = 44/317 (13%)
Query: 63  DADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS 122
              G   D+W +  +   L+V         +LG G FG V+ G       +A+K L   +
Sbjct: 1   QTQGLAKDAWEIPRESLRLEV---------KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT 51
Query: 123 RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSL 182
                 F  E +++ K++H+ LV L+   +E P   +V EY+   SL  F+  +T    L
Sbjct: 52  -MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMNKGSLLDFLKGET-GKYL 108
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  +   +A G+ Y+        +HRD++A+NIL+ E L  K++DFGLARL   ED
Sbjct: 109 RLPQLVDMSAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI--ED 163
Query: 243 THVNT-----FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGK 296
                     F I  T    APE AL+G  ++K+DV+S+G+L+ E+ + GR  + G + +
Sbjct: 164 NEWTARQGAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 219
Query: 297 EKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL 356
           E  D         Q E+   +  P   +C      +  Q    C ++   ERP    +  
Sbjct: 220 EVLD---------QVERGYRM--PCPPECPESLHDLMCQ----CWRKEPEERPTFEYLQA 264
Query: 357 MLSGDSFTLPKPG-KPG 372
            L  D FT  +P  +PG
Sbjct: 265 FLE-DYFTSTEPQYQPG 280

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 89/281 (31%), Positives = 135/281 (48%), Gaps = 36/281 (12%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           + +LG G FG V+ G      ++AVK L   S      F  E  L+ ++QH+ LV L+  
Sbjct: 20  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 78
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMGVARGLLYLHEEAPARI 209
             + P   ++ EY+ N SL  F+  KT S   L       +   +A G+ ++ E      
Sbjct: 79  VTQEP-IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 132
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT-----FRISGTHGYMAPEYALH 264
           IHRD++A+NIL+ + L+ KI+DFGLARL   ED          F I  T    APE   +
Sbjct: 133 IHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWT----APEAINY 186
Query: 265 GYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA 323
           G  ++K+DV+S+G+L+ EIV+ GR  + G    E    L         E+   +V P   
Sbjct: 187 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPD-- 235
Query: 324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFT 364
            C  +      QL  LC ++   +RP  + +  +L  D FT
Sbjct: 236 NCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLE-DFFT 271

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 89/281 (31%), Positives = 135/281 (48%), Gaps = 36/281 (12%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           + +LG G FG V+ G      ++AVK L   S      F  E  L+ ++QH+ LV L+  
Sbjct: 24  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 82
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMGVARGLLYLHEEAPARI 209
             + P   ++ EY+ N SL  F+  KT S   L       +   +A G+ ++ E      
Sbjct: 83  VTQEP-IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 136
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT-----FRISGTHGYMAPEYALH 264
           IHRD++A+NIL+ + L+ KI+DFGLARL   ED          F I  T    APE   +
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLI--EDNEXTAREGAKFPIKWT----APEAINY 190
Query: 265 GYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA 323
           G  ++K+DV+S+G+L+ EIV+ GR  + G    E    L         E+   +V P   
Sbjct: 191 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPD-- 239
Query: 324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFT 364
            C  +      QL  LC ++   +RP  + +  +L  D FT
Sbjct: 240 NCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLE-DFFT 275

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 89/281 (31%), Positives = 135/281 (48%), Gaps = 36/281 (12%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           + +LG G FG V+ G      ++AVK L   S      F  E  L+ ++QH+ LV L+  
Sbjct: 24  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 82
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMGVARGLLYLHEEAPARI 209
             + P   ++ EY+ N SL  F+  KT S   L       +   +A G+ ++ E      
Sbjct: 83  VTQEP-IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 136
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT-----FRISGTHGYMAPEYALH 264
           IHRD++A+NIL+ + L+ KI+DFGLARL   ED          F I  T    APE   +
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWT----APEAINY 190
Query: 265 GYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA 323
           G  ++K+DV+S+G+L+ EIV+ GR  + G    E    L         E+   +V P   
Sbjct: 191 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPD-- 239
Query: 324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFT 364
            C  +      QL  LC ++   +RP  + +  +L  D FT
Sbjct: 240 NCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLE-DFFT 275

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 89/281 (31%), Positives = 135/281 (48%), Gaps = 36/281 (12%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           + +LG G FG V+ G      ++AVK L   S      F  E  L+ ++QH+ LV L+  
Sbjct: 28  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 86
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMGVARGLLYLHEEAPARI 209
             + P   ++ EY+ N SL  F+  KT S   L       +   +A G+ ++ E      
Sbjct: 87  VTQEP-IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 140
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT-----FRISGTHGYMAPEYALH 264
           IHRD++A+NIL+ + L+ KI+DFGLARL   ED          F I  T    APE   +
Sbjct: 141 IHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWT----APEAINY 194
Query: 265 GYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA 323
           G  ++K+DV+S+G+L+ EIV+ GR  + G    E    L         E+   +V P   
Sbjct: 195 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPD-- 243
Query: 324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFT 364
            C  +      QL  LC ++   +RP  + +  +L  D FT
Sbjct: 244 NCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLE-DFFT 279

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 89/281 (31%), Positives = 135/281 (48%), Gaps = 36/281 (12%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           + +LG G FG V+ G      ++AVK L   S      F  E  L+ ++QH+ LV L+  
Sbjct: 23  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 81
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMGVARGLLYLHEEAPARI 209
             + P   ++ EY+ N SL  F+  KT S   L       +   +A G+ ++ E      
Sbjct: 82  VTQEP-IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 135
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT-----FRISGTHGYMAPEYALH 264
           IHRD++A+NIL+ + L+ KI+DFGLARL   ED          F I  T    APE   +
Sbjct: 136 IHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWT----APEAINY 189
Query: 265 GYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA 323
           G  ++K+DV+S+G+L+ EIV+ GR  + G    E    L         E+   +V P   
Sbjct: 190 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPD-- 238
Query: 324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFT 364
            C  +      QL  LC ++   +RP  + +  +L  D FT
Sbjct: 239 NCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLE-DFFT 274

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 87/279 (31%), Positives = 134/279 (48%), Gaps = 32/279 (11%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           + +LG G FG V+ G      ++AVK L   S      F  E  L+ ++QH+ LV L+  
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMGVARGLLYLHEEAPARI 209
             + P   ++ EY+ N SL  F+  KT S   L       +   +A G+ ++ E      
Sbjct: 77  VTQEP-IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 130
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN---TFRISGTHGYMAPEYALHGY 266
           IHRD++A+NIL+ + L+ KI+DFGLARL    +        F I  T    APE   +G 
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWT----APEAINYGT 186
Query: 267 LSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKC 325
            ++K+DV+S+G+L+ EIV+ GR  + G    E    L         E+   +V P    C
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPD--NC 235
Query: 326 NRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFT 364
             +      QL  LC ++   +RP  + +  +L  D FT
Sbjct: 236 PEE----LYQLMRLCWKERPEDRPTFDYLRSVLE-DFFT 269

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 87/279 (31%), Positives = 134/279 (48%), Gaps = 32/279 (11%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           + +LG G FG V+ G      ++AVK L   S      F  E  L+ ++QH+ LV L+  
Sbjct: 19  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 77
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMGVARGLLYLHEEAPARI 209
             + P   ++ EY+ N SL  F+  KT S   L       +   +A G+ ++ E      
Sbjct: 78  VTQEP-IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 131
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN---TFRISGTHGYMAPEYALHGY 266
           IHRD++A+NIL+ + L+ KI+DFGLARL    +        F I  T    APE   +G 
Sbjct: 132 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWT----APEAINYGT 187
Query: 267 LSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKC 325
            ++K+DV+S+G+L+ EIV+ GR  + G    E    L         E+   +V P    C
Sbjct: 188 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPD--NC 236
Query: 326 NRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFT 364
             +      QL  LC ++   +RP  + +  +L  D FT
Sbjct: 237 PEE----LYQLMRLCWKERPEDRPTFDYLRSVLE-DFFT 270

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 89/281 (31%), Positives = 135/281 (48%), Gaps = 36/281 (12%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           + +LG G FG V+ G      ++AVK L   S      F  E  L+ ++QH+ LV L+  
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMGVARGLLYLHEEAPARI 209
             + P   ++ EY+ N SL  F+  KT S   L       +   +A G+ ++ E      
Sbjct: 77  VTQEP-IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 130
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT-----FRISGTHGYMAPEYALH 264
           IHRD++A+NIL+ + L+ KI+DFGLARL   ED          F I  T    APE   +
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWT----APEAINY 184
Query: 265 GYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA 323
           G  ++K+DV+S+G+L+ EIV+ GR  + G    E    L         E+   +V P   
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPD-- 233
Query: 324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFT 364
            C  +      QL  LC ++   +RP  + +  +L  D FT
Sbjct: 234 NCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLE-DFFT 269

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 90/317 (28%), Positives = 144/317 (45%), Gaps = 44/317 (13%)
Query: 63  DADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS 122
              G   D+W +  +   L+V         +LG G FG V+ G       +A+K L   +
Sbjct: 4   QTQGLAKDAWEIPRESLRLEV---------KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT 54
Query: 123 RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSL 182
                 F  E +++ K++H+ LV L+   +E P   +V EY+   SL  F+  +     L
Sbjct: 55  -MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVIEYMSKGSLLDFLKGEM-GKYL 111
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  +   +A G+ Y+        +HRD++A+NIL+ E L  K++DFGLARL   ED
Sbjct: 112 RLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI--ED 166
Query: 243 THVNT-----FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGK 296
                     F I  T    APE AL+G  ++K+DV+S+G+L+ E+ + GR  + G + +
Sbjct: 167 NEXTARQGAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 222
Query: 297 EKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL 356
           E  D         Q E+   +  P   +C      +  Q    C ++   ERP    +  
Sbjct: 223 EVLD---------QVERGYRM--PCPPECPESLHDLMCQ----CWRKDPEERPTFEYLQA 267
Query: 357 MLSGDSFTLPKPG-KPG 372
            L  D FT  +P  +PG
Sbjct: 268 FLE-DYFTSTEPQYQPG 283

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 90/317 (28%), Positives = 144/317 (45%), Gaps = 44/317 (13%)
Query: 63  DADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS 122
              G   D+W +  +   L+V         +LG G FG V+ G       +A+K L   +
Sbjct: 4   QTQGLAKDAWEIPRESLRLEV---------KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT 54
Query: 123 RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSL 182
                 F  E +++ K++H+ LV L+   +E P   +V EY+   SL  F+  +     L
Sbjct: 55  -MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVIEYMSKGSLLDFLKGEM-GKYL 111
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  +   +A G+ Y+        +HRD++A+NIL+ E L  K++DFGLARL   ED
Sbjct: 112 RLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI--ED 166
Query: 243 THVNT-----FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGK 296
                     F I  T    APE AL+G  ++K+DV+S+G+L+ E+ + GR  + G + +
Sbjct: 167 NEYTARQGAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 222
Query: 297 EKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL 356
           E  D         Q E+   +  P   +C      +  Q    C ++   ERP    +  
Sbjct: 223 EVLD---------QVERGYRM--PCPPECPESLHDLMCQ----CWRKDPEERPTFEYLQA 267
Query: 357 MLSGDSFTLPKPG-KPG 372
            L  D FT  +P  +PG
Sbjct: 268 FLE-DYFTSTEPQYQPG 283

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 89/281 (31%), Positives = 135/281 (48%), Gaps = 36/281 (12%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           + +LG G FG V+ G      ++AVK L   S      F  E  L+ ++QH+ LV L+  
Sbjct: 13  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 71
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMGVARGLLYLHEEAPARI 209
             + P   ++ EY+ N SL  F+  KT S   L       +   +A G+ ++ E      
Sbjct: 72  VTQEP-IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 125
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT-----FRISGTHGYMAPEYALH 264
           IHRD++A+NIL+ + L+ KI+DFGLARL   ED          F I  T    APE   +
Sbjct: 126 IHRDLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWT----APEAINY 179
Query: 265 GYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA 323
           G  ++K+DV+S+G+L+ EIV+ GR  + G    E    L         E+   +V P   
Sbjct: 180 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPD-- 228
Query: 324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFT 364
            C  +      QL  LC ++   +RP  + +  +L  D FT
Sbjct: 229 NCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLE-DFFT 264

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 90/317 (28%), Positives = 144/317 (45%), Gaps = 44/317 (13%)
Query: 63  DADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS 122
              G   D+W +  +   L+V         +LG G FG V+ G       +A+K L   +
Sbjct: 4   QTQGLAKDAWEIPRESLRLEV---------KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT 54
Query: 123 RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSL 182
                 F  E +++ K++H+ LV L+   +E P   +V EY+   SL  F+  +     L
Sbjct: 55  -MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEM-GKYL 111
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  +   +A G+ Y+        +HRD++A+NIL+ E L  K++DFGLARL   ED
Sbjct: 112 RLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI--ED 166
Query: 243 THVNT-----FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGK 296
                     F I  T    APE AL+G  ++K+DV+S+G+L+ E+ + GR  + G + +
Sbjct: 167 NEYTARQGAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 222
Query: 297 EKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL 356
           E  D         Q E+   +  P   +C      +  Q    C ++   ERP    +  
Sbjct: 223 EVLD---------QVERGYRM--PCPPECPESLHDLMCQ----CWRKDPEERPTFEYLQA 267
Query: 357 MLSGDSFTLPKPG-KPG 372
            L  D FT  +P  +PG
Sbjct: 268 FLE-DYFTSTEPQYQPG 283

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 90/317 (28%), Positives = 144/317 (45%), Gaps = 44/317 (13%)
Query: 63  DADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS 122
              G   D+W +  +   L+V         +LG G FG V+ G       +A+K L   +
Sbjct: 4   QTQGLAKDAWEIPRESLRLEV---------KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT 54
Query: 123 RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSL 182
                 F  E +++ K++H+ LV L+   +E P   +V EY+   SL  F+  +     L
Sbjct: 55  -MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVCEYMSKGSLLDFLKGEM-GKYL 111
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  +   +A G+ Y+        +HRD++A+NIL+ E L  K++DFGLARL   ED
Sbjct: 112 RLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI--ED 166
Query: 243 THVNT-----FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGK 296
                     F I  T    APE AL+G  ++K+DV+S+G+L+ E+ + GR  + G + +
Sbjct: 167 NEYTARQGAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 222
Query: 297 EKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL 356
           E  D         Q E+   +  P   +C      +  Q    C ++   ERP    +  
Sbjct: 223 EVLD---------QVERGYRM--PCPPECPESLHDLMCQ----CWRKDPEERPTFEYLQA 267
Query: 357 MLSGDSFTLPKPG-KPG 372
            L  D FT  +P  +PG
Sbjct: 268 FLE-DYFTSTEPQYQPG 283

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 107/221 (48%), Gaps = 17/221 (7%)
Query: 75  FFDLRTLQVATNFFSDLNQLGHGGFGPV----YRGLMPN-GQEIAVKKLSVDSRQGLREF 129
           F D    Q        L QLG G FG V    Y  L  N G+ +AVKKL   + + LR+F
Sbjct: 2   FEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 61
Query: 130 TNEVKLLLKIQHKNLVTLFGCCAEGPEK--MLVYEYLPNKSL-DYFIFDKTKSSSLDWTT 186
             E+++L  +QH N+V   G C     +   L+ EYLP  SL DY    +  +  +D   
Sbjct: 62  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QAHAERIDHIK 118
Query: 187 RYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246
             +    + +G+ YL      R IHRD+   NIL++ +   KI DFGL ++ P +D    
Sbjct: 119 LLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXX 174
Query: 247 TFRISGTHG--YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
             +  G     + APE       SV +DV+S+GV++ E+ +
Sbjct: 175 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 121/239 (50%), Gaps = 8/239 (3%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           + ++G G FG V+ G   N  ++A+K +  +      +F  E ++++K+ H  LV L+G 
Sbjct: 15  VQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 73
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
           C E     LV+E++ +  L  ++  +T+       T   + + V  G+ YL E   A +I
Sbjct: 74  CLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVI 128
Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVK 270
           HRD+ A N L+ E    K+SDFG+ R F  +D + ++        + +PE       S K
Sbjct: 129 HRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 187
Query: 271 TDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRD 328
           +DV+S+GVL+ E+ S G+  ++ R   E  + +S  + L++   A   V   +  C R+
Sbjct: 188 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRE 246

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 76/240 (31%), Positives = 114/240 (47%), Gaps = 31/240 (12%)
Query: 56  AAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPV----YRGLMPN-G 110
           A G + ED D +  +  +L F              L QLG G FG V    Y  L  N G
Sbjct: 25  AMGSAFEDRDPTQFEERHLKF--------------LQQLGKGNFGSVEMCRYDPLQDNTG 70
Query: 111 QEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK--MLVYEYLPNKS 168
           + +AVKKL   + + LR+F  E+++L  +QH N+V   G C     +   L+ EYLP  S
Sbjct: 71  EVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 130
Query: 169 L-DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP 227
           L DY    +     +D     +    + +G+ YL      R IHRD+   NIL++ +   
Sbjct: 131 LRDYL---QKHKERIDHIKLLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRV 184
Query: 228 KISDFGLARLFPGEDTHVNTFRISGTHG--YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           KI DFGL ++ P +D      +  G     + APE       SV +DV+S+GV++ E+ +
Sbjct: 185 KIGDFGLTKVLP-QDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 117/221 (52%), Gaps = 21/221 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQ----EIAVKKLS-VDSRQGLREFTNEVKLLLKIQHKNLVTL 147
           LG G FG VY+G+ +P G+     +A+K L+     +   EF +E  ++  + H +LV L
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSS----LDWTTRYRIVMGVARGLLYLHE 203
            G C   P   LV + +P+  L  ++ +   +      L+W  +      +A+G++YL E
Sbjct: 106 LGVCL-SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 158
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
               R++HRD+ A N+L+    + KI+DFGLARL  G++   N         +MA E   
Sbjct: 159 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 215
Query: 264 HGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLS 303
           +   + ++DV+SYGV + E+++ G K +DG   +E  DLL 
Sbjct: 216 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE 256

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 106/221 (47%), Gaps = 17/221 (7%)
Query: 75  FFDLRTLQVATNFFSDLNQLGHGGFGPV----YRGLMPN-GQEIAVKKLSVDSRQGLREF 129
           F D    Q        L QLG G FG V    Y  L  N G+ +AVKKL   + + LR+F
Sbjct: 6   FEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 65
Query: 130 TNEVKLLLKIQHKNLVTLFGCCAEGPEK--MLVYEYLPNKSL-DYFIFDKTKSSSLDWTT 186
             E+++L  +QH N+V   G C     +   L+ EYLP  SL DY    +     +D   
Sbjct: 66  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIK 122
Query: 187 RYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246
             +    + +G+ YL      R IHRD+   NIL++ +   KI DFGL ++ P +D    
Sbjct: 123 LLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXX 178
Query: 247 TFRISGTHG--YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
             +  G     + APE       SV +DV+S+GV++ E+ +
Sbjct: 179 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 123/242 (50%), Gaps = 14/242 (5%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGL---REFTNEVKLLLKIQHKNLVTL 147
           + ++G G FG V+ G   N  ++A+K +    R+G     +F  E ++++K+ H  LV L
Sbjct: 12  VQEIGSGQFGLVHLGYWLNKDKVAIKTI----REGAMSEEDFIEEAEVMMKLSHPKLVQL 67
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           +G C E     LV+E++ +  L  ++  +T+       T   + + V  G+ YL E   A
Sbjct: 68  YGVCLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEE---A 122
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
            +IHRD+ A N L+ E    K+SDFG+ R F  +D + ++        + +PE       
Sbjct: 123 SVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRY 181
Query: 268 SVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCN 326
           S K+DV+S+GVL+ E+ S G+  ++ R   E  + +S  + L++   A   V   +  C 
Sbjct: 182 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW 241
Query: 327 RD 328
           ++
Sbjct: 242 KE 243

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 106/221 (47%), Gaps = 17/221 (7%)
Query: 75  FFDLRTLQVATNFFSDLNQLGHGGFGPV----YRGLMPN-GQEIAVKKLSVDSRQGLREF 129
           F D    Q        L QLG G FG V    Y  L  N G+ +AVKKL   + + LR+F
Sbjct: 4   FEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 63
Query: 130 TNEVKLLLKIQHKNLVTLFGCCAEGPEK--MLVYEYLPNKSL-DYFIFDKTKSSSLDWTT 186
             E+++L  +QH N+V   G C     +   L+ EYLP  SL DY    +     +D   
Sbjct: 64  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIK 120
Query: 187 RYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246
             +    + +G+ YL      R IHRD+   NIL++ +   KI DFGL ++ P +D    
Sbjct: 121 LLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXX 176
Query: 247 TFRISGTHG--YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
             +  G     + APE       SV +DV+S+GV++ E+ +
Sbjct: 177 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 117/221 (52%), Gaps = 21/221 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQ----EIAVKKLS-VDSRQGLREFTNEVKLLLKIQHKNLVTL 147
           LG G FG VY+G+ +P G+     +A+K L+     +   EF +E  ++  + H +LV L
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSS----LDWTTRYRIVMGVARGLLYLHE 203
            G C   P   LV + +P+  L  ++ +   +      L+W  +      +A+G++YL E
Sbjct: 83  LGVCL-SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 135
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
               R++HRD+ A N+L+    + KI+DFGLARL  G++   N         +MA E   
Sbjct: 136 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 192
Query: 264 HGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLS 303
           +   + ++DV+SYGV + E+++ G K +DG   +E  DLL 
Sbjct: 193 YRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE 233

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 90/320 (28%), Positives = 143/320 (44%), Gaps = 44/320 (13%)
Query: 60  SAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLS 119
           S     G   D+W +  +   L+V         +LG G FG V+ G       +A+K L 
Sbjct: 168 SKPQTQGLAKDAWEIPRESLRLEV---------KLGQGCFGEVWMGTWNGTTRVAIKTLK 218
Query: 120 VDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKS 179
                    F  E +++ K++H+ LV L+   +E P   +V EY+   SL  F+  +   
Sbjct: 219 -PGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEM-G 275
Query: 180 SSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239
             L       +   +A G+ Y+        +HRD++A+NIL+ E L  K++DFGL RL  
Sbjct: 276 KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLGRLI- 331
Query: 240 GEDTHVNT-----FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGR 293
            ED          F I  T    APE AL+G  ++K+DV+S+G+L+ E+ + GR  + G 
Sbjct: 332 -EDNEYTARQGAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 386
Query: 294 LGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNS 353
           + +E  D         Q E+   +  P   +C      +  Q    C ++   ERP    
Sbjct: 387 VNREVLD---------QVERGYRM--PCPPECPESLHDLMCQ----CWRKDPEERPTFEY 431
Query: 354 VHLMLSGDSFTLPKP-GKPG 372
           +   L  D FT  +P  +PG
Sbjct: 432 LQAFLE-DYFTSTEPQXQPG 450

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 90/317 (28%), Positives = 143/317 (45%), Gaps = 44/317 (13%)
Query: 63  DADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS 122
              G   D+W +  +   L+V         +LG G FG V+ G       +A+K L   +
Sbjct: 4   QTQGLAKDAWEIPRESLRLEV---------KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT 54
Query: 123 RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSL 182
                 F  E +++ K++H+ LV L+   +E P   +V EY+   SL  F+  +     L
Sbjct: 55  -MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEM-GKYL 111
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  +   +A G+ Y+        +HRD+ A+NIL+ E L  K++DFGLARL   ED
Sbjct: 112 RLPQLVDMAAQIASGMAYVER---MNYVHRDLAAANILVGENLVCKVADFGLARLI--ED 166
Query: 243 THVNT-----FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGK 296
                     F I  T    APE AL+G  ++K+DV+S+G+L+ E+ + GR  + G + +
Sbjct: 167 NEYTARQGAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 222
Query: 297 EKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL 356
           E  D         Q E+   +  P   +C      +  Q    C ++   ERP    +  
Sbjct: 223 EVLD---------QVERGYRM--PCPPECPESLHDLMCQ----CWRKDPEERPTFEYLQA 267
Query: 357 MLSGDSFTLPKPG-KPG 372
            L  D FT  +P  +PG
Sbjct: 268 FLE-DYFTSTEPQYQPG 283

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 106/221 (47%), Gaps = 17/221 (7%)
Query: 75  FFDLRTLQVATNFFSDLNQLGHGGFGPV----YRGLMPN-GQEIAVKKLSVDSRQGLREF 129
           F D    Q        L QLG G FG V    Y  L  N G+ +AVKKL   + + LR+F
Sbjct: 5   FEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 64
Query: 130 TNEVKLLLKIQHKNLVTLFGCCAEGPEK--MLVYEYLPNKSL-DYFIFDKTKSSSLDWTT 186
             E+++L  +QH N+V   G C     +   L+ EYLP  SL DY    +     +D   
Sbjct: 65  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIK 121
Query: 187 RYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246
             +    + +G+ YL      R IHRD+   NIL++ +   KI DFGL ++ P +D    
Sbjct: 122 LLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXX 177
Query: 247 TFRISGTHG--YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
             +  G     + APE       SV +DV+S+GV++ E+ +
Sbjct: 178 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 135/287 (47%), Gaps = 35/287 (12%)
Query: 93  QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCA 152
           +LG G FG V+ G       +A+K L   +      F  E +++ K++H+ LV L+   +
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 153 EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHR 212
           E P   +V EY+   SL  F+  +     L       +   +A G+ Y+        +HR
Sbjct: 75  EEP-IYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 129
Query: 213 DIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT-----FRISGTHGYMAPEYALHGYL 267
           D++A+NIL+ E L  K++DFGLARL   ED          F I  T    APE AL+G  
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWT----APEAALYGRF 183
Query: 268 SVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCN 326
           ++K+DV+S+G+L+ E+ + GR  + G + +E  D         Q E+   +  P   +C 
Sbjct: 184 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD---------QVERGYRM--PCPPECP 232
Query: 327 RDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFTLPKPG-KPG 372
                +  Q    C ++   ERP    +   L  D FT  +P  +PG
Sbjct: 233 ESLHDLMCQ----CWRKDPEERPTFEYLQAFLE-DYFTSTEPQYQPG 274

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 88/281 (31%), Positives = 135/281 (48%), Gaps = 36/281 (12%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           + +LG G FG V+ G      ++AVK L   S      F  E  L+ ++QH+ LV L+  
Sbjct: 14  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 72
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMGVARGLLYLHEEAPARI 209
             + P   ++ EY+ N SL  F+  KT S   L       +   +A G+ ++ E      
Sbjct: 73  VTQEP-IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 126
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT-----FRISGTHGYMAPEYALH 264
           IHR+++A+NIL+ + L+ KI+DFGLARL   ED          F I  T    APE   +
Sbjct: 127 IHRNLRAANILVSDTLSCKIADFGLARLI--EDNEYTAREGAKFPIKWT----APEAINY 180
Query: 265 GYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA 323
           G  ++K+DV+S+G+L+ EIV+ GR  + G    E    L         E+   +V P   
Sbjct: 181 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPD-- 229
Query: 324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFT 364
            C  +      QL  LC ++   +RP  + +  +L  D FT
Sbjct: 230 NCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLE-DFFT 265

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 89/317 (28%), Positives = 143/317 (45%), Gaps = 44/317 (13%)
Query: 63  DADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS 122
              G   D+W +  +   L+V         +LG G FG V+ G       +A+K L   +
Sbjct: 4   QTQGLAKDAWEIPRESLRLEV---------KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT 54
Query: 123 RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSL 182
                 F  E +++ K++H+ LV L+   +E P   +V EY+    L  F+  +     L
Sbjct: 55  -MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVMEYMSKGCLLDFLKGEM-GKYL 111
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  +   +A G+ Y+        +HRD++A+NIL+ E L  K++DFGLARL   ED
Sbjct: 112 RLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI--ED 166
Query: 243 THVNT-----FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGK 296
                     F I  T    APE AL+G  ++K+DV+S+G+L+ E+ + GR  + G + +
Sbjct: 167 NEYTARQGAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 222
Query: 297 EKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL 356
           E  D         Q E+   +  P   +C      +  Q    C ++   ERP    +  
Sbjct: 223 EVLD---------QVERGYRM--PCPPECPESLHDLMCQ----CWRKDPEERPTFEYLQA 267
Query: 357 MLSGDSFTLPKPG-KPG 372
            L  D FT  +P  +PG
Sbjct: 268 FLE-DYFTSTEPQYQPG 283

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 106/221 (47%), Gaps = 17/221 (7%)
Query: 75  FFDLRTLQVATNFFSDLNQLGHGGFGPV----YRGLMPN-GQEIAVKKLSVDSRQGLREF 129
           F D    Q        L QLG G FG V    Y  L  N G+ +AVKKL   + + LR+F
Sbjct: 3   FEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 62
Query: 130 TNEVKLLLKIQHKNLVTLFGCCAEGPEK--MLVYEYLPNKSL-DYFIFDKTKSSSLDWTT 186
             E+++L  +QH N+V   G C     +   L+ EYLP  SL DY    +     +D   
Sbjct: 63  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIK 119
Query: 187 RYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246
             +    + +G+ YL      R IHRD+   NIL++ +   KI DFGL ++ P +D    
Sbjct: 120 LLQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXX 175
Query: 247 TFRISGTHG--YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
             +  G     + APE       SV +DV+S+GV++ E+ +
Sbjct: 176 KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 135/287 (47%), Gaps = 35/287 (12%)
Query: 93  QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCA 152
           +LG G FG V+ G       +A+K L   +      F  E +++ K++H+ LV L+   +
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 153 EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHR 212
           E P   +V EY+   SL  F+  +     L       +   +A G+ Y+        +HR
Sbjct: 73  EEP-IYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVER---MNYVHR 127
Query: 213 DIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT-----FRISGTHGYMAPEYALHGYL 267
           D++A+NIL+ E L  K++DFGLARL   ED          F I  T    APE AL+G  
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWT----APEAALYGRF 181
Query: 268 SVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCN 326
           ++K+DV+S+G+L+ E+ + GR  + G + +E  D         Q E+   +  P   +C 
Sbjct: 182 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD---------QVERGYRM--PCPPECP 230
Query: 327 RDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFTLPKPG-KPG 372
                +  Q    C ++   ERP    +   L  D FT  +P  +PG
Sbjct: 231 ESLHDLMCQ----CWRKDPEERPTFEYLQAFLE-DYFTSTEPQYQPG 272

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 89/317 (28%), Positives = 143/317 (45%), Gaps = 44/317 (13%)
Query: 63  DADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS 122
              G   D+W +  +   L+V         +LG G FG V+ G       +A+K L   +
Sbjct: 4   QTQGLAKDAWEIPRESLRLEV---------KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT 54
Query: 123 RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSL 182
                 F  E +++ K++H+ LV L+   +E P   +V EY+    L  F+  +     L
Sbjct: 55  -MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGCLLDFLKGEM-GKYL 111
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  +   +A G+ Y+        +HRD++A+NIL+ E L  K++DFGLARL   ED
Sbjct: 112 RLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLI--ED 166
Query: 243 THVNT-----FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGK 296
                     F I  T    APE AL+G  ++K+DV+S+G+L+ E+ + GR  + G + +
Sbjct: 167 NEYTARQGAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 222
Query: 297 EKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL 356
           E  D         Q E+   +  P   +C      +  Q    C ++   ERP    +  
Sbjct: 223 EVLD---------QVERGYRM--PCPPECPESLHDLMCQ----CWRKDPEERPTFEYLQA 267
Query: 357 MLSGDSFTLPKPG-KPG 372
            L  D FT  +P  +PG
Sbjct: 268 FLE-DYFTSTEPQYQPG 283

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 121/239 (50%), Gaps = 8/239 (3%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           + ++G G FG V+ G   N  ++A+K +  +      +F  E ++++K+ H  LV L+G 
Sbjct: 12  VQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
           C E     LV+E++ +  L  ++  +T+       T   + + V  G+ YL E   A +I
Sbjct: 71  CLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVI 125
Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVK 270
           HRD+ A N L+ E    K+SDFG+ R F  +D + ++        + +PE       S K
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 184
Query: 271 TDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRD 328
           +DV+S+GVL+ E+ S G+  ++ R   E  + +S  + L++   A   V   +  C ++
Sbjct: 185 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKE 243

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 121/239 (50%), Gaps = 8/239 (3%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           + ++G G FG V+ G   N  ++A+K +  +      +F  E ++++K+ H  LV L+G 
Sbjct: 10  VQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
           C E     LV+E++ +  L  ++  +T+       T   + + V  G+ YL E   A +I
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVI 123
Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVK 270
           HRD+ A N L+ E    K+SDFG+ R F  +D + ++        + +PE       S K
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182
Query: 271 TDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRD 328
           +DV+S+GVL+ E+ S G+  ++ R   E  + +S  + L++   A   V   +  C ++
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKE 241

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 91  LNQLGHGGFGPV----YRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV 145
           L QLG G FG V    Y  L  N G+ +AVKKL   + + LR+F  E+++L  +QH N+V
Sbjct: 18  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 77
Query: 146 TLFGCCAEGPEK--MLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
              G C     +   L+ EYLP  SL DY    +     +D     +    + +G+ YL 
Sbjct: 78  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL- 133
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG--YMAPE 260
                R IHRD+   NIL++ +   KI DFGL ++ P +D      +  G     + APE
Sbjct: 134 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKEPGESPIFWYAPE 190
Query: 261 YALHGYLSVKTDVFSYGVLVLEIVS 285
                  SV +DV+S+GV++ E+ +
Sbjct: 191 SLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 121/239 (50%), Gaps = 8/239 (3%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           + ++G G FG V+ G   N  ++A+K +  +      +F  E ++++K+ H  LV L+G 
Sbjct: 32  VQEIGSGQFGLVHLGYWLNKDKVAIKTIK-EGSMSEDDFIEEAEVMMKLSHPKLVQLYGV 90
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
           C E     LV+E++ +  L  ++  +T+       T   + + V  G+ YL E   A +I
Sbjct: 91  CLEQAPICLVFEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVI 145
Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVK 270
           HRD+ A N L+ E    K+SDFG+ R F  +D + ++        + +PE       S K
Sbjct: 146 HRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 204
Query: 271 TDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRD 328
           +DV+S+GVL+ E+ S G+  ++ R   E  + +S  + L++   A   V   +  C ++
Sbjct: 205 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKE 263

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 91  LNQLGHGGFGPV----YRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV 145
           L QLG G FG V    Y  L  N G+ +AVKKL   + + LR+F  E+++L  +QH N+V
Sbjct: 13  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 72
Query: 146 TLFGCCAEGPEK--MLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
              G C     +   L+ EYLP  SL DY    +     +D     +    + +G+ YL 
Sbjct: 73  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL- 128
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG--YMAPE 260
                R IHRD+   NIL++ +   KI DFGL ++ P +D      +  G     + APE
Sbjct: 129 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKEPGESPIFWYAPE 185
Query: 261 YALHGYLSVKTDVFSYGVLVLEIVS 285
                  SV +DV+S+GV++ E+ +
Sbjct: 186 SLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 91  LNQLGHGGFGPV----YRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV 145
           L QLG G FG V    Y  L  N G+ +AVKKL   + + LR+F  E+++L  +QH N+V
Sbjct: 14  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 73
Query: 146 TLFGCCAEGPEK--MLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
              G C     +   L+ EYLP  SL DY    +     +D     +    + +G+ YL 
Sbjct: 74  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL- 129
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG--YMAPE 260
                R IHRD+   NIL++ +   KI DFGL ++ P +D      +  G     + APE
Sbjct: 130 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKEPGESPIFWYAPE 186
Query: 261 YALHGYLSVKTDVFSYGVLVLEIVS 285
                  SV +DV+S+GV++ E+ +
Sbjct: 187 SLTESKFSVASDVWSFGVVLYELFT 211

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 91  LNQLGHGGFGPV----YRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV 145
           L QLG G FG V    Y  L  N G+ +AVKKL   + + LR+F  E+++L  +QH N+V
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 146 TLFGCCAEGPEK--MLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
              G C     +   L+ EYLP  SL DY    +     +D     +    + +G+ YL 
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL- 130
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG--YMAPE 260
                R IHRD+   NIL++ +   KI DFGL ++ P +D      +  G     + APE
Sbjct: 131 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKEPGESPIFWYAPE 187
Query: 261 YALHGYLSVKTDVFSYGVLVLEIVS 285
                  SV +DV+S+GV++ E+ +
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 91  LNQLGHGGFGPV----YRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV 145
           L QLG G FG V    Y  L  N G+ +AVKKL   + + LR+F  E+++L  +QH N+V
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 146 TLFGCCAEGPEK--MLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
              G C     +   L+ EYLP  SL DY    +     +D     +    + +G+ YL 
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL- 130
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG--YMAPE 260
                R IHRD+   NIL++ +   KI DFGL ++ P +D      +  G     + APE
Sbjct: 131 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKEPGESPIFWYAPE 187
Query: 261 YALHGYLSVKTDVFSYGVLVLEIVS 285
                  SV +DV+S+GV++ E+ +
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 91  LNQLGHGGFGPV----YRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV 145
           L QLG G FG V    Y  L  N G+ +AVKKL   + + LR+F  E+++L  +QH N+V
Sbjct: 33  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 92
Query: 146 TLFGCCAEGPEK--MLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
              G C     +   L+ EYLP  SL DY    +     +D     +    + +G+ YL 
Sbjct: 93  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL- 148
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG--YMAPE 260
                R IHRD+   NIL++ +   KI DFGL ++ P +D      +  G     + APE
Sbjct: 149 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKEPGESPIFWYAPE 205
Query: 261 YALHGYLSVKTDVFSYGVLVLEIVS 285
                  SV +DV+S+GV++ E+ +
Sbjct: 206 SLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 91  LNQLGHGGFGPV----YRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV 145
           L QLG G FG V    Y  L  N G+ +AVKKL   + + LR+F  E+++L  +QH N+V
Sbjct: 33  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 92
Query: 146 TLFGCCAEGPEK--MLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
              G C     +   L+ EYLP  SL DY    +     +D     +    + +G+ YL 
Sbjct: 93  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL- 148
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG--YMAPE 260
                R IHRD+   NIL++ +   KI DFGL ++ P +D      +  G     + APE
Sbjct: 149 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXKVKEPGESPIFWYAPE 205
Query: 261 YALHGYLSVKTDVFSYGVLVLEIVS 285
                  SV +DV+S+GV++ E+ +
Sbjct: 206 SLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 120/239 (50%), Gaps = 8/239 (3%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           + ++G G FG V+ G   N  ++A+K +  +      +F  E ++++K+ H  LV L+G 
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
           C E     LV E++ +  L  ++  +T+       T   + + V  G+ YL E   A +I
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVI 126
Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVK 270
           HRD+ A N L+ E    K+SDFG+ R F  +D + ++        + +PE       S K
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 271 TDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRD 328
           +DV+S+GVL+ E+ S G+  ++ R   E  + +S  + L++   A   V   +  C R+
Sbjct: 186 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRE 244

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 88/281 (31%), Positives = 134/281 (47%), Gaps = 36/281 (12%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           + +LG G  G V+ G      ++AVK L   S      F  E  L+ ++QH+ LV L+  
Sbjct: 18  VERLGAGQAGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMGVARGLLYLHEEAPARI 209
             + P   ++ EY+ N SL  F+  KT S   L       +   +A G+ ++ E      
Sbjct: 77  VTQEP-IYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 130
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT-----FRISGTHGYMAPEYALH 264
           IHRD++A+NIL+ + L+ KI+DFGLARL   ED          F I  T    APE   +
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLI--EDAEXTAREGAKFPIKWT----APEAINY 184
Query: 265 GYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA 323
           G  ++K+DV+S+G+L+ EIV+ GR  + G    E    L         E+   +V P   
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---------ERGYRMVRPD-- 233
Query: 324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFT 364
            C  +      QL  LC ++   +RP  + +  +L  D FT
Sbjct: 234 NCPEE----LYQLMRLCWKERPEDRPTFDYLRSVLE-DFFT 269

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 106/220 (48%), Gaps = 15/220 (6%)
Query: 75  FFDLRTLQVATNFFSDLNQLGHGGFGPV----YRGLMPN-GQEIAVKKLSVDSRQGLREF 129
           F D    Q        L QLG G FG V    Y  L  N G+ +AVKKL   + + LR+F
Sbjct: 2   FEDRDPTQFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF 61
Query: 130 TNEVKLLLKIQHKNLVTLFGCCAEGPEK--MLVYEYLPNKSLDYFIFDKTKSSSLDWTTR 187
             E+++L  +QH N+V   G C     +   L+ E+LP  SL  ++  +     +D    
Sbjct: 62  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYL--QKHKERIDHIKL 119
Query: 188 YRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
            +    + +G+ YL      R IHRD+   NIL++ +   KI DFGL ++ P +D     
Sbjct: 120 LQYTSQICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEXXK 175
Query: 248 FRISGTHG--YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
            +  G     + APE       SV +DV+S+GV++ E+ +
Sbjct: 176 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 91  LNQLGHGGFGPV----YRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV 145
           L QLG G FG V    Y  L  N G+ +AVKKL   + + LR+F  E+++L  +QH N+V
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 146 TLFGCCAEGPEK--MLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
              G C     +   L+ EYLP  SL DY    +     +D     +    + +G+ YL 
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL- 130
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG--YMAPE 260
                R IHRD+   NIL++ +   KI DFGL ++ P +D      +  G     + APE
Sbjct: 131 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP-QDKEFFKVKEPGESPIFWYAPE 187
Query: 261 YALHGYLSVKTDVFSYGVLVLEIVS 285
                  SV +DV+S+GV++ E+ +
Sbjct: 188 SLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 137/287 (47%), Gaps = 36/287 (12%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           + +LG G FG V+ G   N  ++AVK L   +   ++ F  E  L+  +QH  LV L+  
Sbjct: 18  VKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAV 76
Query: 151 CAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
                   ++ EY+   SL D+   D+     L     +     +A G+ Y+  +     
Sbjct: 77  VTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFS--AQIAEGMAYIERK---NY 131
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT-----FRISGTHGYMAPEYALH 264
           IHRD++A+N+L+ E L  KI+DFGLAR+   ED          F I  T    APE    
Sbjct: 132 IHRDLRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWT----APEAINF 185
Query: 265 GYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA 323
           G  ++K+DV+S+G+L+ EIV+ G+  + GR     AD+++    L QG +      P + 
Sbjct: 186 GCFTIKSDVWSFGILLYEIVTYGKIPYPGRTN---ADVMT---ALSQGYRM-----PRVE 234
Query: 324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFTLPKPGK 370
            C  DE    ++   +C ++   ERP  + +  +L  D F     G+
Sbjct: 235 NCP-DELYDIMK---MCWKEKAEERPTFDYLQSVL--DDFYTATEGQ 275

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 91  LNQLGHGGFGPV----YRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV 145
           L QLG G FG V    Y  L  N G+ +AVKKL   + + LR+F  E+++L  +QH N+V
Sbjct: 16  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 75
Query: 146 TLFGCCAEGPEK--MLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
              G C     +   L+ EYLP  SL DY    +     +D     +    + +G+ YL 
Sbjct: 76  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYL- 131
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG--YMAPE 260
                R IHR++   NIL++ +   KI DFGL ++ P +D      +  G     + APE
Sbjct: 132 --GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLP-QDKEYYKVKEPGESPIFWYAPE 188
Query: 261 YALHGYLSVKTDVFSYGVLVLEIVS 285
                  SV +DV+S+GV++ E+ +
Sbjct: 189 SLTESKFSVASDVWSFGVVLYELFT 213

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 78/242 (32%), Positives = 110/242 (45%), Gaps = 30/242 (12%)
Query: 53  GGRAAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQ 111
           GGRA   S +D D +      LFF           FSDL ++GHG FG VY    + N +
Sbjct: 32  GGRAG--SLKDPDVA-----ELFFK----DDPEKLFSDLREIGHGSFGAVYFARDVRNSE 80
Query: 112 EIAVKKLSVDSRQG---LREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKS 168
            +A+KK+S   +Q     ++   EV+ L K++H N +   GC        LV EY    +
Sbjct: 81  VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSA 140
Query: 169 LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPK 228
            D     K     ++      +  G  +GL YLH      +IHRD+KA NILL E    K
Sbjct: 141 SDLLEVHKKPLQEVEIAA---VTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVK 194
Query: 229 ISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL---HGYLSVKTDVFSYGVLVLEIVS 285
           + DFG A +    +  V      GT  +MAPE  L    G    K DV+S G+  +E+  
Sbjct: 195 LGDFGSASIMAPANXFV------GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 248
Query: 286 GR 287
            +
Sbjct: 249 RK 250

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 133/286 (46%), Gaps = 24/286 (8%)
Query: 73  NLFFD-LRTLQVATNFFSDLNQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFT 130
           NL+F  +   ++     +  ++LG G +G VY G+       +AVK L  D+ + + EF 
Sbjct: 18  NLYFQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFL 76
Query: 131 NEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRI 190
            E  ++ +I+H NLV L G C   P   +V EY+P  +L  ++ +  +         Y +
Sbjct: 77  KEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLY-M 135
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
              ++  + YL ++     IHRD+ A N L+ E    K++DFGL+RL  G DT+      
Sbjct: 136 ATQISSAMEYLEKK---NFIHRDLAARNCLVGENHVVKVADFGLSRLMTG-DTYTAHAGA 191
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLF 309
                + APE   +   S+K+DV+++GVL+ EI + G   + G    +  DLL   + + 
Sbjct: 192 KFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRME 251
Query: 310 QGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVH 355
           Q E       P + +  R            C + S A+RP     H
Sbjct: 252 QPEGC----PPKVYELMR-----------ACWKWSPADRPSFAETH 282

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 84/287 (29%), Positives = 138/287 (48%), Gaps = 36/287 (12%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           + +LG G FG V+ G   N  ++AVK L   +   ++ F  E  L+  +QH  LV L+  
Sbjct: 17  VKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAV 75
Query: 151 CAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
             +     ++ E++   SL D+   D+     L     +     +A G+ Y+  +     
Sbjct: 76  VTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFS--AQIAEGMAYIERK---NY 130
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT-----FRISGTHGYMAPEYALH 264
           IHRD++A+N+L+ E L  KI+DFGLAR+   ED          F I  T    APE    
Sbjct: 131 IHRDLRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWT----APEAINF 184
Query: 265 GYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA 323
           G  ++K++V+S+G+L+ EIV+ G+  + GR     AD++S    L QG +      P + 
Sbjct: 185 GCFTIKSNVWSFGILLYEIVTYGKIPYPGRTN---ADVMS---ALSQGYRM-----PRME 233
Query: 324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFTLPKPGK 370
            C  DE    ++   +C ++   ERP  + +  +L  D F     G+
Sbjct: 234 NCP-DELYDIMK---MCWKEKAEERPTFDYLQSVL--DDFYTATEGQ 274

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 98/209 (46%), Gaps = 19/209 (9%)
Query: 86  NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQG---LREFTNEVKLLLKIQH 141
             FSDL ++GHG FG VY    + N + +A+KK+S   +Q     ++   EV+ L K++H
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
            N +   GC        LV EY    + D     K     ++      +  G  +GL YL
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA---VTHGALQGLAYL 131
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEY 261
           H      +IHRD+KA NILL E    K+ DFG A +    +  V      GT  +MAPE 
Sbjct: 132 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV------GTPYWMAPEV 182
Query: 262 AL---HGYLSVKTDVFSYGVLVLEIVSGR 287
            L    G    K DV+S G+  +E+   +
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERK 211

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 132/291 (45%), Gaps = 49/291 (16%)
Query: 91  LNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKN 143
           + +LG   FG VY+G +         Q +A+K L   +   LRE F +E  L  ++QH N
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIF-------------DKTKSSSLDWTTRYRI 190
           +V L G   +     +++ Y  +  L  F+              D+T  S+L+      +
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
           V  +A G+ YL       ++H+D+   N+L+ ++LN KISD GL R    E    + +++
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAADYYKL 186
Query: 251 SGTH----GYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYT 305
            G       +MAPE  ++G  S+ +D++SYGV++ E+ S G + + G             
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG------------- 233
Query: 306 WTLFQGEKALELV-DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVH 355
              +  +  +E++ +  +  C  D  A    L + C  +  + RP    +H
Sbjct: 234 ---YSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIH 281

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 132/291 (45%), Gaps = 49/291 (16%)
Query: 91  LNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKN 143
           + +LG   FG VY+G +         Q +A+K L   +   LRE F +E  L  ++QH N
Sbjct: 31  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 90
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIF-------------DKTKSSSLDWTTRYRI 190
           +V L G   +     +++ Y  +  L  F+              D+T  S+L+      +
Sbjct: 91  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 150
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
           V  +A G+ YL       ++H+D+   N+L+ ++LN KISD GL R    E    + +++
Sbjct: 151 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAADYYKL 203
Query: 251 SGTH----GYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYT 305
            G       +MAPE  ++G  S+ +D++SYGV++ E+ S G + + G             
Sbjct: 204 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG------------- 250
Query: 306 WTLFQGEKALELV-DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVH 355
              +  +  +E++ +  +  C  D  A    L + C  +  + RP    +H
Sbjct: 251 ---YSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIH 298

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/275 (27%), Positives = 128/275 (46%), Gaps = 32/275 (11%)
Query: 94  LGHGGFGPVYRGLMPNGQ-----EIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLVTL 147
           +G G FG VY+G++          +A+K L     +  R +F  E  ++ +  H N++ L
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
            G  ++    M++ EY+ N +LD F+ +K    S+       ++ G+A G+ YL   A  
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSV--LQLVGMLRGIAAGMKYL---ANM 166
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH---GYMAPEYALH 264
             +HRD+ A NIL++  L  K+SDFGL+R+   ED    T+  SG      + APE   +
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVL--EDDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 265 GYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA 323
              +  +DV+S+G+++ E+++ G + +               W L   E    + D    
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERPY---------------WELSNHEVMKAINDGFRL 269
Query: 324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML 358
               D  +   QL + C QQ  A RP    +  +L
Sbjct: 270 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 304

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 128/289 (44%), Gaps = 45/289 (15%)
Query: 93  QLGHGGFGPVYRG----LMPNGQEI--AVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           +LG G FG V+      L P   +I  AVK L   S    ++F  E +LL  +QH+++V 
Sbjct: 20  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 79
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFI----------FDKTKSSSLDWTTRYRIVMGVAR 196
            +G C EG   ++V+EY+ +  L+ F+           +    + L  +    I   +A 
Sbjct: 80  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAA 139
Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG- 255
           G++YL   A    +HRD+   N L+ E L  KI DFG++R     D +   +   G H  
Sbjct: 140 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR-----DVYSTDYYRVGGHTM 191
Query: 256 ----YMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQG 311
               +M PE  ++   + ++DV+S GV++ EI +         GK+        W     
Sbjct: 192 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT--------YGKQ-------PWYQLSN 236
Query: 312 EKALELVDPS-LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS 359
            + +E +    + +  R       +L L C Q+    R ++  +H +L 
Sbjct: 237 NEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQ 285

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 21/226 (9%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEI----AVKKL-SVDSRQGLREFTNEVKLLLKIQH 141
           F  +  LG G FG VY+GL +P G+++    A+K+L    S +  +E  +E  ++  + +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLP-NKSLDYFIFDKTKSSS---LDWTTRYRIVMGVARG 197
            ++  L G C     + L+ + +P    LDY    K    S   L+W  +      +A+G
Sbjct: 78  PHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IAKG 130
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           + YL +    R++HRD+ A N+L+    + KI+DFGLA+L   E+   +         +M
Sbjct: 131 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 187
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
           A E  LH   + ++DV+SYGV V E+++ G K +DG    E + +L
Sbjct: 188 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 233

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 81/292 (27%), Positives = 129/292 (44%), Gaps = 35/292 (11%)
Query: 93  QLGHGGFGPVY----RGLMPNGQE--IAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           +LG G FG V+      L+P   +  +AVK L   S    ++F  E +LL  +QH+++V 
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIF------------DKTKSSSLDWTTRYRIVMGV 194
            FG C EG   ++V+EY+ +  L+ F+             +      L       +   V
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH 254
           A G++YL   A    +HRD+   N L+ + L  KI DFG++R     D +    R     
Sbjct: 168 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 224
Query: 255 GYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKA 314
            +M PE  L+   + ++DV+S+GV++ EI +         GK+    LS T  +    + 
Sbjct: 225 RWMPPESILYRKFTTESDVWSFGVVLWEIFT--------YGKQPWYQLSNTEAIDCITQG 276
Query: 315 LELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFTLP 366
            EL  P    C  +  A  I  G  C Q+   +R  +  VH  L   +   P
Sbjct: 277 RELERPR--ACPPEVYA--IMRG--CWQREPQQRHSIKDVHARLQALAQAPP 322

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 93  QLGHGGFGPVY----RGLMPNGQE--IAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           +LG G FG V+      L+P   +  +AVK L   S    ++F  E +LL  +QH+++V 
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIF------------DKTKSSSLDWTTRYRIVMGV 194
            FG C EG   ++V+EY+ +  L+ F+             +      L       +   V
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH 254
           A G++YL   A    +HRD+   N L+ + L  KI DFG++R     D +    R     
Sbjct: 139 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 195
Query: 255 GYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
            +M PE  L+   + ++DV+S+GV++ EI +
Sbjct: 196 RWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 21/226 (9%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEI----AVKKL-SVDSRQGLREFTNEVKLLLKIQH 141
           F  +  LG G FG VY+GL +P G+++    A+K+L    S +  +E  +E  ++  + +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARG 197
            ++  L G C     + L+ + +P   L DY    K    S   L+W  +      +A+G
Sbjct: 81  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 133
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           + YL +    R++HRD+ A N+L+    + KI+DFGLA+L   E+   +         +M
Sbjct: 134 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 190
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
           A E  LH   + ++DV+SYGV V E+++ G K +DG    E + +L
Sbjct: 191 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 236

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 125/267 (46%), Gaps = 25/267 (9%)
Query: 92  NQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           ++LG G +G VY G+       +AVK L  D+ + + EF  E  ++ +I+H NLV L G 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 151 CAEGPEKMLVYEYLPNKS-LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
           C   P   ++ E++   + LDY    +     ++      +   ++  + YL ++     
Sbjct: 80  CTREPPFYIITEFMTYGNLLDY--LRECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 134
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           IHRD+ A N L+ E    K++DFGL+RL  G DT+           + APE   +   S+
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAPAGAKFPIKWTAPESLAYNKFSI 193
Query: 270 KTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRD 328
           K+DV+++GVL+ EI + G   + G    +  +LL   + + + E   E V          
Sbjct: 194 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV---------- 243
Query: 329 EAAMCIQLGLLCCQQSVAERPDMNSVH 355
                 +L   C Q + ++RP    +H
Sbjct: 244 -----YELMRACWQWNPSDRPSFAEIH 265

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 125/267 (46%), Gaps = 25/267 (9%)
Query: 92  NQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           ++LG G +G VY G+       +AVK L  D+ + + EF  E  ++ +I+H NLV L G 
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 151 CAEGPEKMLVYEYLPNKS-LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
           C   P   ++ E++   + LDY    +     ++      +   ++  + YL ++     
Sbjct: 79  CTREPPFYIITEFMTYGNLLDY--LRECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 133
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           IHRD+ A N L+ E    K++DFGL+RL  G DT+           + APE   +   S+
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAPAGAKFPIKWTAPESLAYNKFSI 192
Query: 270 KTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRD 328
           K+DV+++GVL+ EI + G   + G    +  +LL   + + + E   E V          
Sbjct: 193 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV---------- 242
Query: 329 EAAMCIQLGLLCCQQSVAERPDMNSVH 355
                 +L   C Q + ++RP    +H
Sbjct: 243 -----YELMRACWQWNPSDRPSFAEIH 264

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 21/226 (9%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEI----AVKKL-SVDSRQGLREFTNEVKLLLKIQH 141
           F  +  LG G FG VY+GL +P G+++    A+K+L    S +  +E  +E  ++  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARG 197
            ++  L G C     + L+ + +P   L DY    K    S   L+W  +      +A+G
Sbjct: 80  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 132
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           + YL +    R++HRD+ A N+L+    + KI+DFGLA+L   E+   +         +M
Sbjct: 133 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
           A E  LH   + ++DV+SYGV V E+++ G K +DG    E + +L
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 235

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 93  QLGHGGFGPVY----RGLMPNGQE--IAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           +LG G FG V+      L+P   +  +AVK L   S    ++F  E +LL  +QH+++V 
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIF------------DKTKSSSLDWTTRYRIVMGV 194
            FG C EG   ++V+EY+ +  L+ F+             +      L       +   V
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH 254
           A G++YL   A    +HRD+   N L+ + L  KI DFG++R     D +    R     
Sbjct: 145 AAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 201
Query: 255 GYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
            +M PE  L+   + ++DV+S+GV++ EI +
Sbjct: 202 RWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 123/267 (46%), Gaps = 25/267 (9%)
Query: 92  NQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           ++LG G FG VY G+       +AVK L  D+ + + EF  E  ++ +I+H NLV L G 
Sbjct: 17  HKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 151 CAEGPEKMLVYEYLPNKS-LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
           C   P   ++ E++   + LDY    +     +       +   ++  + YL ++     
Sbjct: 76  CTREPPFYIITEFMTYGNLLDY--LRECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 130
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           IHRD+ A N L+ E    K++DFGL+RL  G DT            + APE   +   S+
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 270 KTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRD 328
           K+DV+++GVL+ EI + G   + G    +  +LL   + + + E   E V          
Sbjct: 190 KSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKV---------- 239
Query: 329 EAAMCIQLGLLCCQQSVAERPDMNSVH 355
                 +L   C Q + ++RP    +H
Sbjct: 240 -----YELMRACWQWNPSDRPSFAEIH 261

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 21/226 (9%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEI----AVKKL-SVDSRQGLREFTNEVKLLLKIQH 141
           F  +  LG G FG VY+GL +P G+++    A+K+L    S +  +E  +E  ++  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARG 197
            ++  L G C     + L+ + +P   L DY    K    S   L+W  +      +A+G
Sbjct: 77  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 129
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           + YL +    R++HRD+ A N+L+    + KI+DFGLA+L   E+   +         +M
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
           A E  LH   + ++DV+SYGV V E+++ G K +DG    E + +L
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 21/226 (9%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEI----AVKKL-SVDSRQGLREFTNEVKLLLKIQH 141
           F  +  LG G FG VY+GL +P G+++    A+K+L    S +  +E  +E  ++  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARG 197
            ++  L G C     + L+ + +P   L DY    K    S   L+W  +      +A+G
Sbjct: 79  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 131
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           + YL +    R++HRD+ A N+L+    + KI+DFGLA+L   E+   +         +M
Sbjct: 132 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
           A E  LH   + ++DV+SYGV V E+++ G K +DG    E + +L
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 21/226 (9%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEI----AVKKL-SVDSRQGLREFTNEVKLLLKIQH 141
           F  +  LG G FG VY+GL +P G+++    A+K+L    S +  +E  +E  ++  + +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARG 197
            ++  L G C     + L+ + +P   L DY    K    S   L+W  +      +A+G
Sbjct: 83  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 135
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           + YL +    R++HRD+ A N+L+    + KI+DFGLA+L   E+   +         +M
Sbjct: 136 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 192
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
           A E  LH   + ++DV+SYGV V E+++ G K +DG    E + +L
Sbjct: 193 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 238

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 21/226 (9%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEI----AVKKL-SVDSRQGLREFTNEVKLLLKIQH 141
           F  +  LG G FG VY+GL +P G+++    A+K+L    S +  +E  +E  ++  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLP-NKSLDYFIFDKTKSSS---LDWTTRYRIVMGVARG 197
            ++  L G C     + L+ + +P    LDY    K    S   L+W  +      +A+G
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IAKG 129
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           + YL +    R++HRD+ A N+L+    + KI+DFGLA+L   E+   +         +M
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
           A E  LH   + ++DV+SYGV V E+++ G K +DG    E + +L
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 21/226 (9%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEI----AVKKL-SVDSRQGLREFTNEVKLLLKIQH 141
           F  +  LG G FG VY+GL +P G+++    A+K+L    S +  +E  +E  ++  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARG 197
            ++  L G C     + L+ + +P   L DY    K    S   L+W  +      +A+G
Sbjct: 79  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 131
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           + YL +    R++HRD+ A N+L+    + KI+DFGLA+L   E+   +         +M
Sbjct: 132 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
           A E  LH   + ++DV+SYGV V E+++ G K +DG    E + +L
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 21/226 (9%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEI----AVKKL-SVDSRQGLREFTNEVKLLLKIQH 141
           F  +  LG G FG VY+GL +P G+++    A+K+L    S +  +E  +E  ++  + +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARG 197
            ++  L G C     + L+ + +P   L DY    K    S   L+W  +      +A+G
Sbjct: 78  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 130
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           + YL +    R++HRD+ A N+L+    + KI+DFGLA+L   E+   +         +M
Sbjct: 131 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 187
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
           A E  LH   + ++DV+SYGV V E+++ G K +DG    E + +L
Sbjct: 188 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 233

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 21/226 (9%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEI----AVKKL-SVDSRQGLREFTNEVKLLLKIQH 141
           F  +  LG G FG VY+GL +P G+++    A+K+L    S +  +E  +E  ++  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARG 197
            ++  L G C     + L+ + +P   L DY    K    S   L+W  +      +A+G
Sbjct: 80  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 132
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           + YL +    R++HRD+ A N+L+    + KI+DFGLA+L   E+   +         +M
Sbjct: 133 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
           A E  LH   + ++DV+SYGV V E+++ G K +DG    E + +L
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 235

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 21/226 (9%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEI----AVKKL-SVDSRQGLREFTNEVKLLLKIQH 141
           F  +  LG G FG VY+GL +P G+++    A+K+L    S +  +E  +E  ++  + +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARG 197
            ++  L G C     + L+ + +P   L DY    K    S   L+W  +      +A+G
Sbjct: 84  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 136
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           + YL +    R++HRD+ A N+L+    + KI+DFGLA+L   E+   +         +M
Sbjct: 137 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
           A E  LH   + ++DV+SYGV V E+++ G K +DG    E + +L
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 239

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 21/226 (9%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEI----AVKKL-SVDSRQGLREFTNEVKLLLKIQH 141
           F  +  LG G FG VY+GL +P G+++    A+K+L    S +  +E  +E  ++  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARG 197
            ++  L G C     + L+ + +P   L DY    K    S   L+W  +      +A+G
Sbjct: 80  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 132
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           + YL +    R++HRD+ A N+L+    + KI+DFGLA+L   E+   +         +M
Sbjct: 133 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
           A E  LH   + ++DV+SYGV V E+++ G K +DG    E + +L
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 235

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 21/226 (9%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEI----AVKKL-SVDSRQGLREFTNEVKLLLKIQH 141
           F  +  LG G FG VY+GL +P G+++    A+K+L    S +  +E  +E  ++  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARG 197
            ++  L G C     + L+ + +P   L DY    K    S   L+W  +      +A+G
Sbjct: 80  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 132
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           + YL +    R++HRD+ A N+L+    + KI+DFGLA+L   E+   +         +M
Sbjct: 133 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
           A E  LH   + ++DV+SYGV V E+++ G K +DG    E + +L
Sbjct: 190 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 235

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 125/267 (46%), Gaps = 25/267 (9%)
Query: 92  NQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           ++LG G +G VY G+       +AVK L  D+ + + EF  E  ++ +I+H NLV L G 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 151 CAEGPEKMLVYEYLPNKS-LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
           C   P   ++ E++   + LDY    +     ++      +   ++  + YL ++     
Sbjct: 83  CTREPPFYIITEFMTYGNLLDY--LRECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 137
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           IHRD+ A N L+ E    K++DFGL+RL  G DT+           + APE   +   S+
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 270 KTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRD 328
           K+DV+++GVL+ EI + G   + G    +  +LL   + + + E   E V          
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV---------- 246
Query: 329 EAAMCIQLGLLCCQQSVAERPDMNSVH 355
                 +L   C Q + ++RP    +H
Sbjct: 247 -----YELMRACWQWNPSDRPSFAEIH 268

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 21/226 (9%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEI----AVKKL-SVDSRQGLREFTNEVKLLLKIQH 141
           F  +  LG G FG VY+GL +P G+++    A+K+L    S +  +E  +E  ++  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARG 197
            ++  L G C     + L+ + +P   L DY    K    S   L+W  +      +A+G
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 129
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           + YL +    R++HRD+ A N+L+    + KI+DFGLA+L   E+   +         +M
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
           A E  LH   + ++DV+SYGV V E+++ G K +DG    E + +L
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 125/267 (46%), Gaps = 25/267 (9%)
Query: 92  NQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           ++LG G +G VY G+       +AVK L  D+ + + EF  E  ++ +I+H NLV L G 
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 81
Query: 151 CAEGPEKMLVYEYLPNKS-LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
           C   P   ++ E++   + LDY    +     ++      +   ++  + YL ++     
Sbjct: 82  CTREPPFYIITEFMTYGNLLDY--LRECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 136
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           IHRD+ A N L+ E    K++DFGL+RL  G DT+           + APE   +   S+
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 195
Query: 270 KTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRD 328
           K+DV+++GVL+ EI + G   + G    +  +LL   + + + E   E V          
Sbjct: 196 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV---------- 245
Query: 329 EAAMCIQLGLLCCQQSVAERPDMNSVH 355
                 +L   C Q + ++RP    +H
Sbjct: 246 -----YELMRACWQWNPSDRPSFAEIH 267

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 125/267 (46%), Gaps = 25/267 (9%)
Query: 92  NQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           ++LG G +G VY G+       +AVK L  D+ + + EF  E  ++ +I+H NLV L G 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 151 CAEGPEKMLVYEYLPNKS-LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
           C   P   ++ E++   + LDY    +     ++      +   ++  + YL ++     
Sbjct: 80  CTREPPFYIITEFMTYGNLLDY--LRECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 134
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           IHRD+ A N L+ E    K++DFGL+RL  G DT+           + APE   +   S+
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 193
Query: 270 KTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRD 328
           K+DV+++GVL+ EI + G   + G    +  +LL   + + + E   E V          
Sbjct: 194 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV---------- 243
Query: 329 EAAMCIQLGLLCCQQSVAERPDMNSVH 355
                 +L   C Q + ++RP    +H
Sbjct: 244 -----YELMRACWQWNPSDRPSFAEIH 265

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 125/267 (46%), Gaps = 25/267 (9%)
Query: 92  NQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           ++LG G +G VY G+       +AVK L  D+ + + EF  E  ++ +I+H NLV L G 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 151 CAEGPEKMLVYEYLPNKS-LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
           C   P   ++ E++   + LDY    +     ++      +   ++  + YL ++     
Sbjct: 83  CTREPPFYIITEFMTYGNLLDY--LRECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 137
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           IHRD+ A N L+ E    K++DFGL+RL  G DT+           + APE   +   S+
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 270 KTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRD 328
           K+DV+++GVL+ EI + G   + G    +  +LL   + + + E   E V          
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV---------- 246
Query: 329 EAAMCIQLGLLCCQQSVAERPDMNSVH 355
                 +L   C Q + ++RP    +H
Sbjct: 247 -----YELMRACWQWNPSDRPSFAEIH 268

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 125/267 (46%), Gaps = 25/267 (9%)
Query: 92  NQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           ++LG G +G VY G+       +AVK L  D+ + + EF  E  ++ +I+H NLV L G 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 151 CAEGPEKMLVYEYLPNKS-LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
           C   P   ++ E++   + LDY    +     ++      +   ++  + YL ++     
Sbjct: 83  CTREPPFYIIIEFMTYGNLLDY--LRECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 137
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           IHRD+ A N L+ E    K++DFGL+RL  G DT+           + APE   +   S+
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 270 KTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRD 328
           K+DV+++GVL+ EI + G   + G    +  +LL   + + + E   E V          
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV---------- 246
Query: 329 EAAMCIQLGLLCCQQSVAERPDMNSVH 355
                 +L   C Q + ++RP    +H
Sbjct: 247 -----YELMRACWQWNPSDRPSFAEIH 268

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 21/226 (9%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEI----AVKKL-SVDSRQGLREFTNEVKLLLKIQH 141
           F  +  LG G FG VY+GL +P G+++    A+K+L    S +  +E  +E  ++  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARG 197
            ++  L G C     + L+ + +P   L DY    K    S   L+W  +      +A+G
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 129
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           + YL +    R++HRD+ A N+L+    + KI+DFGLA+L   E+   +         +M
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
           A E  LH   + ++DV+SYGV V E+++ G K +DG    E + +L
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 21/226 (9%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEI----AVKKL-SVDSRQGLREFTNEVKLLLKIQH 141
           F  +  LG G FG VY+GL +P G+++    A+K+L    S +  +E  +E  ++  + +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARG 197
            ++  L G C     + L+ + +P   L DY    K    S   L+W  +      +A+G
Sbjct: 87  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 139
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           + YL +    R++HRD+ A N+L+    + KI+DFGLA+L   E+   +         +M
Sbjct: 140 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 196
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
           A E  LH   + ++DV+SYGV V E+++ G K +DG    E + +L
Sbjct: 197 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 242

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 21/226 (9%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEI----AVKKL-SVDSRQGLREFTNEVKLLLKIQH 141
           F  +  LG G FG VY+GL +P G+++    A+K+L    S +  +E  +E  ++  + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARG 197
            ++  L G C     + L+ + +P   L DY    K    S   L+W  +      +A+G
Sbjct: 71  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 123
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           + YL +    R++HRD+ A N+L+    + KI+DFGLA+L   E+   +         +M
Sbjct: 124 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
           A E  LH   + ++DV+SYGV V E+++ G K +DG    E + +L
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 226

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 125/267 (46%), Gaps = 25/267 (9%)
Query: 92  NQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           ++LG G +G VY G+       +AVK L  D+ + + EF  E  ++ +I+H NLV L G 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 79
Query: 151 CAEGPEKMLVYEYLPNKS-LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
           C   P   ++ E++   + LDY    +     ++      +   ++  + YL ++     
Sbjct: 80  CTREPPFYIITEFMTYGNLLDY--LRECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 134
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           IHRD+ A N L+ E    K++DFGL+RL  G DT+           + APE   +   S+
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 193
Query: 270 KTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRD 328
           K+DV+++GVL+ EI + G   + G    +  +LL   + + + E   E V          
Sbjct: 194 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV---------- 243
Query: 329 EAAMCIQLGLLCCQQSVAERPDMNSVH 355
                 +L   C Q + ++RP    +H
Sbjct: 244 -----YELMRACWQWNPSDRPSFAEIH 265

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 125/267 (46%), Gaps = 25/267 (9%)
Query: 92  NQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           ++LG G +G VY G+       +AVK L  D+ + + EF  E  ++ +I+H NLV L G 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 151 CAEGPEKMLVYEYLPNKS-LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
           C   P   ++ E++   + LDY    +     ++      +   ++  + YL ++     
Sbjct: 78  CTREPPFYIITEFMTYGNLLDY--LRECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 132
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           IHRD+ A N L+ E    K++DFGL+RL  G DT+           + APE   +   S+
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 270 KTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRD 328
           K+DV+++GVL+ EI + G   + G    +  +LL   + + + E   E V          
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV---------- 241
Query: 329 EAAMCIQLGLLCCQQSVAERPDMNSVH 355
                 +L   C Q + ++RP    +H
Sbjct: 242 -----YELMRACWQWNPSDRPSFAEIH 263

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 124/267 (46%), Gaps = 25/267 (9%)
Query: 92  NQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           ++LG G +G VY G+       +AVK L  D+ + + EF  E  ++ +I+H NLV L G 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 151 CAEGPEKMLVYEYLPNKS-LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
           C   P   ++ E++   + LDY    +     +       +   ++  + YL ++     
Sbjct: 83  CTREPPFYIITEFMTYGNLLDY--LRECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 137
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           IHRD+ A N L+ E    K++DFGL+RL  G DT+           + APE   +   S+
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 270 KTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRD 328
           K+DV+++GVL+ EI + G   + G    +  +LL   + + + E   E V          
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV---------- 246
Query: 329 EAAMCIQLGLLCCQQSVAERPDMNSVH 355
                 +L   C Q + ++RP    +H
Sbjct: 247 -----YELMRACWQWNPSDRPSFAEIH 268

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 117/226 (51%), Gaps = 21/226 (9%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEI----AVKKL-SVDSRQGLREFTNEVKLLLKIQH 141
           F  +  LG G FG VY+GL +P G+++    A+K+L    S +  +E  +E  ++  + +
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARG 197
            ++  L G C     + L+ + +P   L DY    K    S   L+W  +      +A+G
Sbjct: 102 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 154
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           + YL +    R++HRD+ A N+L+    + KI+DFGLA+L   E+   +         +M
Sbjct: 155 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 211
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
           A E  LH   + ++DV+SYGV V E+++ G K +DG    E + +L
Sbjct: 212 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 257

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 125/267 (46%), Gaps = 25/267 (9%)
Query: 92  NQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           ++LG G +G VY G+       +AVK L  D+ + + EF  E  ++ +I+H NLV L G 
Sbjct: 32  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 90
Query: 151 CAEGPEKMLVYEYLPNKS-LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
           C   P   ++ E++   + LDY    +     ++      +   ++  + YL ++     
Sbjct: 91  CTREPPFYIITEFMTYGNLLDY--LRECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 145
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           IHRD+ A N L+ E    K++DFGL+RL  G DT+           + APE   +   S+
Sbjct: 146 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 204
Query: 270 KTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRD 328
           K+DV+++GVL+ EI + G   + G    +  +LL   + + + E   E V          
Sbjct: 205 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV---------- 254
Query: 329 EAAMCIQLGLLCCQQSVAERPDMNSVH 355
                 +L   C Q + ++RP    +H
Sbjct: 255 -----YELMRACWQWNPSDRPSFAEIH 276

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 125/267 (46%), Gaps = 25/267 (9%)
Query: 92  NQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           ++LG G +G VY G+       +AVK L  D+ + + EF  E  ++ +I+H NLV L G 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 151 CAEGPEKMLVYEYLPNKS-LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
           C   P   ++ E++   + LDY    +     ++      +   ++  + YL ++     
Sbjct: 78  CTREPPFYIITEFMTYGNLLDY--LRECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 132
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           IHRD+ A N L+ E    K++DFGL+RL  G DT+           + APE   +   S+
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 270 KTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRD 328
           K+DV+++GVL+ EI + G   + G    +  +LL   + + + E   E V          
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV---------- 241
Query: 329 EAAMCIQLGLLCCQQSVAERPDMNSVH 355
                 +L   C Q + ++RP    +H
Sbjct: 242 -----YELMRACWQWNPSDRPSFAEIH 263

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 122/264 (46%), Gaps = 21/264 (7%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           L +LG G FG V  G      ++AVK +  +      EF  E + ++K+ H  LV  +G 
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
           C++     +V EY+ N  L  ++  ++    L+ +    +   V  G+ +L      + I
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFI 126
Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVK 270
           HRD+ A N L+D  L  K+SDFG+ R +  +D +V++        + APE   +   S K
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSK 185
Query: 271 TDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEA 330
           +DV+++G+L+ E+ S        LGK   DL + +  + +  +   L  P LA      +
Sbjct: 186 SDVWAFGILMWEVFS--------LGKMPYDLYTNSEVVLKVSQGHRLYRPHLA------S 231
Query: 331 AMCIQLGLLCCQQSVAERPDMNSV 354
               Q+   C  +   +RP    +
Sbjct: 232 DTIYQIMYSCWHELPEKRPTFQQL 255

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 124/267 (46%), Gaps = 25/267 (9%)
Query: 92  NQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           ++LG G +G VY G+       +AVK L  D+ + + EF  E  ++ +I+H NLV L G 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 151 CAEGPEKMLVYEYLPNKS-LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
           C   P   ++ E++   + LDY    +     +       +   ++  + YL ++     
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDY--LRECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 132
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           IHRD+ A N L+ E    K++DFGL+RL  G DT+           + APE   +   S+
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 270 KTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRD 328
           K+DV+++GVL+ EI + G   + G    +  +LL   + + + E   E V          
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV---------- 241
Query: 329 EAAMCIQLGLLCCQQSVAERPDMNSVH 355
                 +L   C Q + ++RP    +H
Sbjct: 242 -----YELMRACWQWNPSDRPSFAEIH 263

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 124/267 (46%), Gaps = 25/267 (9%)
Query: 92  NQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           ++LG G +G VY G+       +AVK L  D+ + + EF  E  ++ +I+H NLV L G 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 151 CAEGPEKMLVYEYLPNKS-LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
           C   P   ++ E++   + LDY    +     +       +   ++  + YL ++     
Sbjct: 78  CTREPPFYIITEFMTYGNLLDY--LRECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 132
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           IHRD+ A N L+ E    K++DFGL+RL  G DT+           + APE   +   S+
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 270 KTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRD 328
           K+DV+++GVL+ EI + G   + G    +  +LL   + + + E   E V          
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV---------- 241
Query: 329 EAAMCIQLGLLCCQQSVAERPDMNSVH 355
                 +L   C Q + ++RP    +H
Sbjct: 242 -----YELMRACWQWNPSDRPSFAEIH 263

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 123/267 (46%), Gaps = 25/267 (9%)
Query: 92  NQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           ++LG G +G VY G+       +AVK L  D+ + + EF  E  ++ +I+H NLV L G 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 151 CAEGPEKMLVYEYLPNKS-LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
           C   P   ++ E++   + LDY    +     +       +   ++  + YL ++     
Sbjct: 76  CTREPPFYIIIEFMTYGNLLDY--LRECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 130
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           IHRD+ A N L+ E    K++DFGL+RL  G DT            + APE   +   S+
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 270 KTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRD 328
           K+DV+++GVL+ EI + G   + G    +  +LL   + + + E   E V          
Sbjct: 190 KSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKV---------- 239
Query: 329 EAAMCIQLGLLCCQQSVAERPDMNSVH 355
                 +L   C Q + ++RP    +H
Sbjct: 240 -----YELMRACWQWNPSDRPSFAEIH 261

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 124/267 (46%), Gaps = 25/267 (9%)
Query: 92  NQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           ++LG G +G VY G+       +AVK L  D+ + + EF  E  ++ +I+H NLV L G 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 151 CAEGPEKMLVYEYLPNKS-LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
           C   P   ++ E++   + LDY    +     +       +   ++  + YL ++     
Sbjct: 78  CTREPPFYIIIEFMTYGNLLDY--LRECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 132
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           IHRD+ A N L+ E    K++DFGL+RL  G DT+           + APE   +   S+
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 270 KTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRD 328
           K+DV+++GVL+ EI + G   + G    +  +LL   + + + E   E V          
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV---------- 241
Query: 329 EAAMCIQLGLLCCQQSVAERPDMNSVH 355
                 +L   C Q + ++RP    +H
Sbjct: 242 -----YELMRACWQWNPSDRPSFAEIH 263

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 13/204 (6%)
Query: 86  NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHK 142
             F+ L+++G G FG VY+G+  + +E+   K+ +D   +   + +   E+ +L +    
Sbjct: 19  ELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKI-IDLEEAEDEIEDIQQEITVLSQCDSP 77
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
            +   FG   +  +  ++ EYL   S      D  K   L+ T    I+  + +GL YLH
Sbjct: 78  YITRYFGSYLKSTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLH 133
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
            E   R IHRDIKA+N+LL EQ + K++DFG+A      DT +      GT  +MAPE  
Sbjct: 134 SE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNXFVGTPFWMAPEVI 188
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
                  K D++S G+  +E+  G
Sbjct: 189 KQSAYDFKADIWSLGITAIELAKG 212

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 124/267 (46%), Gaps = 25/267 (9%)
Query: 92  NQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           ++LG G +G VY G+       +AVK L  D+ + + EF  E  ++ +I+H NLV L G 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 151 CAEGPEKMLVYEYLPNKS-LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
           C   P   ++ E++   + LDY    +     +       +   ++  + YL ++     
Sbjct: 78  CTREPPFYIITEFMTYGNLLDY--LRECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 132
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           IHRD+ A N L+ E    K++DFGL+RL  G DT+           + APE   +   S+
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 270 KTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRD 328
           K+DV+++GVL+ EI + G   + G    +  +LL   + + + E   E V          
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV---------- 241
Query: 329 EAAMCIQLGLLCCQQSVAERPDMNSVH 355
                 +L   C Q + ++RP    +H
Sbjct: 242 -----YELMRACWQWNPSDRPSFAEIH 263

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 126/270 (46%), Gaps = 31/270 (11%)
Query: 92  NQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           ++LG G +G VY G+       +AVK L  D+ + + EF  E  ++ +I+H NLV L G 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 82
Query: 151 CAEGPEKMLVYEYLPNKS-LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
           C   P   ++ E++   + LDY    +     ++      +   ++  + YL ++     
Sbjct: 83  CTREPPFYIITEFMTYGNLLDY--LRECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 137
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT---FRISGTHGYMAPEYALHGY 266
           IHRD+ A N L+ E    K++DFGL+RL  G+    +    F I  T    APE   +  
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWT----APESLAYNK 193
Query: 267 LSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKC 325
            S+K+DV+++GVL+ EI + G   + G    +  +LL   + + + E   E V       
Sbjct: 194 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV------- 246
Query: 326 NRDEAAMCIQLGLLCCQQSVAERPDMNSVH 355
                    +L   C Q + ++RP    +H
Sbjct: 247 --------YELMRACWQWNPSDRPSFAEIH 268

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/226 (30%), Positives = 116/226 (51%), Gaps = 21/226 (9%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEI----AVKKL-SVDSRQGLREFTNEVKLLLKIQH 141
           F  +  LG G FG VY+GL +P G+++    A+K+L    S +  +E  +E  ++  + +
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARG 197
            ++  L G C     + L+ + +P   L DY    K    S   L+W  +      +A G
Sbjct: 74  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAEG 126
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           + YL +    R++HRD+ A N+L+    + KI+DFGLA+L   E+   +         +M
Sbjct: 127 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 183
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
           A E  LH   + ++DV+SYGV V E+++ G K +DG    E + +L
Sbjct: 184 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 229

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 115/227 (50%), Gaps = 21/227 (9%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGL-----REFTNEVKLLLKIQH 141
           F  +  LG G FG VY+GL +P G+++ +    ++ R+       +E  +E  ++  + +
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARG 197
            ++  L G C     + L+ + +P   L DY    K    S   L+W  +      +A+G
Sbjct: 111 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 163
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           + YL +    R++HRD+ A N+L+    + KI+DFGLA+L   E+   +         +M
Sbjct: 164 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 220
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLS 303
           A E  LH   + ++DV+SYGV V E+++ G K +DG    E + +L 
Sbjct: 221 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 267

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 123/267 (46%), Gaps = 25/267 (9%)
Query: 92  NQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           ++LG G +G VY G+       +AVK L  D+ + + EF  E  ++ +I+H NLV L G 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 151 CAEGPEKMLVYEYLPNKS-LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
           C   P   ++ E++   + LDY    +     +       +   ++  + YL ++     
Sbjct: 76  CTREPPFYIITEFMTYGNLLDY--LRECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 130
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           IHRD+ A N L+ E    K++DFGL+RL  G DT            + APE   +   S+
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTFTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 270 KTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRD 328
           K+DV+++GVL+ EI + G   + G    +  +LL   + + + E   E V          
Sbjct: 190 KSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEKV---------- 239
Query: 329 EAAMCIQLGLLCCQQSVAERPDMNSVH 355
                 +L   C Q + ++RP    +H
Sbjct: 240 -----YELMRACWQWNPSDRPSFAEIH 261

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 97/211 (45%), Gaps = 19/211 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCA 152
           LG G FG   +      G+ + +K+L     +  R F  EVK++  ++H N++   G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 153 EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHR 212
           +      + EY+   +L   I  K+  S   W+ R      +A G+ YLH      IIHR
Sbjct: 78  KDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHR 132
Query: 213 DIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR------------ISGTHGYMAPE 260
           D+ + N L+ E  N  ++DFGLARL   E T     R            + G   +MAPE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 261 YALHGYLSVKTDVFSYGVLVLEIVSGRKNHD 291
                    K DVFS+G+++ EI+ GR N D
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEII-GRVNAD 222

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 124/267 (46%), Gaps = 25/267 (9%)
Query: 92  NQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           ++LG G +G VY G+       +AVK L  D+ + + EF  E  ++ +I+H NLV L G 
Sbjct: 20  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 78
Query: 151 CAEGPEKMLVYEYLPNKS-LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
           C   P   ++ E++   + LDY    +     ++      +   ++  + YL ++     
Sbjct: 79  CTREPPFYIIIEFMTYGNLLDY--LRECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 133
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           IHRD+ A N L+ E    K++DFGL+RL  G DT            + APE   +   S+
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTXTAHAGAKFPIKWTAPESLAYNKFSI 192
Query: 270 KTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRD 328
           K+DV+++GVL+ EI + G   + G    +  +LL   + + + E   E V          
Sbjct: 193 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV---------- 242
Query: 329 EAAMCIQLGLLCCQQSVAERPDMNSVH 355
                 +L   C Q + ++RP    +H
Sbjct: 243 -----YELMRACWQWNPSDRPSFAEIH 264

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 107/208 (51%), Gaps = 12/208 (5%)
Query: 84  ATNFFSDLNQLGHGGFGPVYRGLM--PNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLK 138
           ATN   D   +G G FG V  G +  P+ +EI  A+K L V  + +  R+F  E  ++ +
Sbjct: 44  ATNISID-KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 139 IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
             H N++ L G   +    M+V EY+ N SLD F+  +   +         ++ G+A G+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 160
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH-GYM 257
            YL +      +HRD+ A NIL++  L  K+SDFGLAR+   +     T R       + 
Sbjct: 161 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWT 217
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +PE   +   +  +DV+SYG+++ E++S
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/239 (28%), Positives = 122/239 (51%), Gaps = 25/239 (10%)
Query: 68  GADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQG- 125
           GA   + F   R   +A N      Q+G GGFG V++G L+ +   +A+K L +   +G 
Sbjct: 1   GAMGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGE 60
Query: 126 ------LREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKS 179
                  +EF  EV ++  + H N+V L+G     P   +V E++P   L + + D  K+
Sbjct: 61  TEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KA 116
Query: 180 SSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNIL---LDEQ--LNPKISDFGL 234
             + W+ + R+++ +A G+ Y+  + P  I+HRD+++ NI    LDE   +  K++DFGL
Sbjct: 117 HPIKWSVKLRLMLDIALGIEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175
Query: 235 ARLFPGEDTHVNTFRISGTHGYMAPEY--ALHGYLSVKTDVFSYGVLVLEIVSGRKNHD 291
           ++    +  H +   + G   +MAPE   A     + K D +S+ +++  I++G    D
Sbjct: 176 SQ----QSVH-SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 130/268 (48%), Gaps = 33/268 (12%)
Query: 92  NQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFG 149
            ++G G FG VY+G      ++AVK L+V   + Q L+ F NEV +L K +H N++   G
Sbjct: 18  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 75
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
              + P+  +V ++    SL + +      +  +      I    ARG+ YLH ++   I
Sbjct: 76  YSTK-PQLAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGMDYLHAKS---I 129
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL---HGY 266
           IHRD+K++NI L E    KI DFGLA +           ++SG+  +MAPE         
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 189
Query: 267 LSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV-----DPS 321
            S ++DV+++G+++ E+++G+              L Y+  +   ++ +E+V      P 
Sbjct: 190 YSFQSDVYAFGIVLYELMTGQ--------------LPYS-NINNRDQIIEMVGRGSLSPD 234
Query: 322 LAKCNRDEAAMCIQLGLLCCQQSVAERP 349
           L+K   +      +L   C ++   ERP
Sbjct: 235 LSKVRSNCPKRMKRLMAECLKKKRDERP 262

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 125/267 (46%), Gaps = 25/267 (9%)
Query: 92  NQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           ++LG G +G VY G+       +AVK L  D+ + + EF  E  ++ +I+H NLV L G 
Sbjct: 265 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 323
Query: 151 CAEGPEKMLVYEYLPNKS-LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
           C   P   ++ E++   + LDY    +     ++      +   ++  + YL ++     
Sbjct: 324 CTREPPFYIITEFMTYGNLLDY--LRECNRQEVNAVVLLYMATQISSAMEYLEKK---NF 378
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           IHR++ A N L+ E    K++DFGL+RL  G DT+           + APE   +   S+
Sbjct: 379 IHRNLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 437
Query: 270 KTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRD 328
           K+DV+++GVL+ EI + G   + G    +  +LL   + + + E   E V          
Sbjct: 438 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV---------- 487
Query: 329 EAAMCIQLGLLCCQQSVAERPDMNSVH 355
                 +L   C Q + ++RP    +H
Sbjct: 488 -----YELMRACWQWNPSDRPSFAEIH 509

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 107/208 (51%), Gaps = 12/208 (5%)
Query: 84  ATNFFSDLNQLGHGGFGPVYRGLM--PNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLK 138
           ATN   D   +G G FG V  G +  P+ +EI  A+K L V  + +  R+F  E  ++ +
Sbjct: 44  ATNISID-KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 139 IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
             H N++ L G   +    M+V EY+ N SLD F+  +   +         ++ G+A G+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 160
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH-GYM 257
            YL +      +HRD+ A NIL++  L  K+SDFGL+R+   +     T R       + 
Sbjct: 161 KYLSDMG---FVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +PE   +   +  +DV+SYG+++ E++S
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 108/210 (51%), Gaps = 16/210 (7%)
Query: 84  ATNFFSDLNQLGHGGFGPVYRGLM--PNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLK 138
           ATN   D   +G G FG V  G +  P+ +EI  A+K L V  + +  R+F  E  ++ +
Sbjct: 32  ATNISID-KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 90
Query: 139 IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
             H N++ L G   +    M+V EY+ N SLD F+  +   +         ++ G+A G+
Sbjct: 91  FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 148
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH---G 255
            YL +      +HRD+ A NIL++  L  K+SDFGL+R+   ED     +   G      
Sbjct: 149 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKIPIR 203
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           + +PE   +   +  +DV+SYG+++ E++S
Sbjct: 204 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 116/226 (51%), Gaps = 21/226 (9%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEI----AVKKL-SVDSRQGLREFTNEVKLLLKIQH 141
           F  +  L  G FG VY+GL +P G+++    A+K+L    S +  +E  +E  ++  + +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARG 197
            ++  L G C     + L+ + +P   L DY    K    S   L+W  +      +A+G
Sbjct: 84  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 136
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           + YL +    R++HRD+ A N+L+    + KI+DFGLA+L   E+   +         +M
Sbjct: 137 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
           A E  LH   + ++DV+SYGV V E+++ G K +DG    E + +L
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 239

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 116/226 (51%), Gaps = 21/226 (9%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEI----AVKKL-SVDSRQGLREFTNEVKLLLKIQH 141
           F  +  LG G FG VY+GL +P G+++    A+K+L    S +  +E  +E  ++  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARG 197
            ++  L G C     + L+ + +P   L DY    K    S   L+W  +      +A+G
Sbjct: 79  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 131
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           + YL +    R++HRD+ A N+L+    + KI+DFG A+L   E+   +         +M
Sbjct: 132 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
           A E  LH   + ++DV+SYGV V E+++ G K +DG    E + +L
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 124/267 (46%), Gaps = 25/267 (9%)
Query: 92  NQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           ++LG G +G VY G+       +AVK L  D+ + + EF  E  ++ +I+H NLV L G 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 151 CAEGPEKMLVYEYLPNKS-LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
           C   P   ++ E++   + LDY    +     +       +   ++  + YL ++     
Sbjct: 285 CTREPPFYIITEFMTYGNLLDY--LRECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 339
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           IHR++ A N L+ E    K++DFGL+RL  G DT+           + APE   +   S+
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 270 KTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRD 328
           K+DV+++GVL+ EI + G   + G    +  +LL   + + + E   E V          
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV---------- 448
Query: 329 EAAMCIQLGLLCCQQSVAERPDMNSVH 355
                 +L   C Q + ++RP    +H
Sbjct: 449 -----YELMRACWQWNPSDRPSFAEIH 470

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 116/226 (51%), Gaps = 21/226 (9%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEI----AVKKL-SVDSRQGLREFTNEVKLLLKIQH 141
           F  +  L  G FG VY+GL +P G+++    A+K+L    S +  +E  +E  ++  + +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARG 197
            ++  L G C     + L+ + +P   L DY    K    S   L+W  +      +A+G
Sbjct: 84  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 136
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           + YL +    R++HRD+ A N+L+    + KI+DFGLA+L   E+   +         +M
Sbjct: 137 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
           A E  LH   + ++DV+SYGV V E+++ G K +DG    E + +L
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 239

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 107/208 (51%), Gaps = 12/208 (5%)
Query: 84  ATNFFSDLNQLGHGGFGPVYRGLM--PNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLK 138
           ATN   D   +G G FG V  G +  P+ +EI  A+K L V  + +  R+F  E  ++ +
Sbjct: 15  ATNISID-KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 73
Query: 139 IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
             H N++ L G   +    M+V EY+ N SLD F+  +   +         ++ G+A G+
Sbjct: 74  FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 131
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH-GYM 257
            YL +      +HRD+ A NIL++  L  K+SDFGL+R+   +     T R       + 
Sbjct: 132 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 188
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +PE   +   +  +DV+SYG+++ E++S
Sbjct: 189 SPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 116/226 (51%), Gaps = 21/226 (9%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEI----AVKKL-SVDSRQGLREFTNEVKLLLKIQH 141
           F  +  LG G FG VY+GL +P G+++    A+K+L    S +  +E  +E  ++  + +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARG 197
            ++  L G C     + L+ + +P   L DY    K    S   L+W  +      +A+G
Sbjct: 81  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 133
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           + YL +    R++HRD+ A N+L+    + KI+DFG A+L   E+   +         +M
Sbjct: 134 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 190
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
           A E  LH   + ++DV+SYGV V E+++ G K +DG    E + +L
Sbjct: 191 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 236

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 116/226 (51%), Gaps = 21/226 (9%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEI----AVKKL-SVDSRQGLREFTNEVKLLLKIQH 141
           F  +  LG G FG VY+GL +P G+++    A+K+L    S +  +E  +E  ++  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARG 197
            ++  L G C     + L+ + +P   L DY    K    S   L+W  +      +A+G
Sbjct: 79  PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 131
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           + YL +    R++HRD+ A N+L+    + KI+DFG A+L   E+   +         +M
Sbjct: 132 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
           A E  LH   + ++DV+SYGV V E+++ G K +DG    E + +L
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 116/226 (51%), Gaps = 21/226 (9%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEI----AVKKL-SVDSRQGLREFTNEVKLLLKIQH 141
           F  +  LG G FG VY+GL +P G+++    A+K+L    S +  +E  +E  ++  + +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARG 197
            ++  L G C     + L+ + +P   L DY    K    S   L+W  +      +A+G
Sbjct: 84  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 136
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           + YL +    R++HRD+ A N+L+    + KI+DFG A+L   E+   +         +M
Sbjct: 137 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
           A E  LH   + ++DV+SYGV V E+++ G K +DG    E + +L
Sbjct: 194 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 239

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 107/208 (51%), Gaps = 12/208 (5%)
Query: 84  ATNFFSDLNQLGHGGFGPVYRGLM--PNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLK 138
           ATN   D   +G G FG V  G +  P+ +EI  A+K L V  + +  R+F  E  ++ +
Sbjct: 44  ATNISID-KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 139 IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
             H N++ L G   +    M+V EY+ N SLD F+  +   +         ++ G+A G+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 160
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH-GYM 257
            YL +      +HRD+ A NIL++  L  K+SDFGL+R+   +     T R       + 
Sbjct: 161 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +PE   +   +  +DV+SYG+++ E++S
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 116/226 (51%), Gaps = 21/226 (9%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEI----AVKKL-SVDSRQGLREFTNEVKLLLKIQH 141
           F  +  L  G FG VY+GL +P G+++    A+K+L    S +  +E  +E  ++  + +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARG 197
            ++  L G C     + L+ + +P   L DY    K    S   L+W  +      +A+G
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 129
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           + YL +    R++HRD+ A N+L+    + KI+DFGLA+L   E+   +         +M
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
           A E  LH   + ++DV+SYGV V E+++ G K +DG    E + +L
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 107/208 (51%), Gaps = 12/208 (5%)
Query: 84  ATNFFSDLNQLGHGGFGPVYRGLM--PNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLK 138
           ATN   D   +G G FG V  G +  P+ +EI  A+K L V  + +  R+F  E  ++ +
Sbjct: 44  ATNISID-KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 139 IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
             H N++ L G   +    M+V EY+ N SLD F+  +   +         ++ G+A G+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 160
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH-GYM 257
            YL +      +HRD+ A NIL++  L  K+SDFGL+R+   +     T R       + 
Sbjct: 161 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +PE   +   +  +DV+SYG+++ E++S
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 107/208 (51%), Gaps = 12/208 (5%)
Query: 84  ATNFFSDLNQLGHGGFGPVYRGLM--PNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLK 138
           ATN   D   +G G FG V  G +  P+ +EI  A+K L V  + +  R+F  E  ++ +
Sbjct: 44  ATNISID-KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 139 IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
             H N++ L G   +    M+V EY+ N SLD F+  +   +         ++ G+A G+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 160
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH-GYM 257
            YL +      +HRD+ A NIL++  L  K+SDFGL+R+   +     T R       + 
Sbjct: 161 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +PE   +   +  +DV+SYG+++ E++S
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 108/201 (53%), Gaps = 13/201 (6%)
Query: 92  NQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFG 149
            ++G G FG VY+G      ++AVK L+V   + Q L+ F NEV +L K +H N++   G
Sbjct: 42  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
              + P+  +V ++    SL + +      +  +      I    A+G+ YLH ++   I
Sbjct: 100 YSTK-PQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 153
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL---HGY 266
           IHRD+K++NI L E L  KI DFGLA +           ++SG+  +MAPE         
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 213
Query: 267 LSVKTDVFSYGVLVLEIVSGR 287
            S ++DV+++G+++ E+++G+
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQ 234

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 107/208 (51%), Gaps = 12/208 (5%)
Query: 84  ATNFFSDLNQLGHGGFGPVYRGLM--PNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLK 138
           ATN   D   +G G FG V  G +  P+ +EI  A+K L V  + +  R+F  E  ++ +
Sbjct: 42  ATNISID-KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 100
Query: 139 IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
             H N++ L G   +    M+V EY+ N SLD F+  +   +         ++ G+A G+
Sbjct: 101 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 158
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH-GYM 257
            YL +      +HRD+ A NIL++  L  K+SDFGL+R+   +     T R       + 
Sbjct: 159 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 215
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +PE   +   +  +DV+SYG+++ E++S
Sbjct: 216 SPEAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 107/208 (51%), Gaps = 12/208 (5%)
Query: 84  ATNFFSDLNQLGHGGFGPVYRGLM--PNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLK 138
           ATN   D   +G G FG V  G +  P+ +EI  A+K L V  + +  R+F  E  ++ +
Sbjct: 44  ATNISID-KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 139 IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
             H N++ L G   +    M+V EY+ N SLD F+  +   +         ++ G+A G+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 160
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH-GYM 257
            YL +      +HRD+ A NIL++  L  K+SDFGL+R+   +     T R       + 
Sbjct: 161 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +PE   +   +  +DV+SYG+++ E++S
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 116/226 (51%), Gaps = 21/226 (9%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEI----AVKKL-SVDSRQGLREFTNEVKLLLKIQH 141
           F  +  LG G FG VY+GL +P G+++    A+K+L    S +  +E  +E  ++  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARG 197
            ++  L G C     + L+ + +P   L DY    K    S   L+W  +      +A+G
Sbjct: 79  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 131
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           + YL +    R++HRD+ A N+L+    + KI+DFG A+L   E+   +         +M
Sbjct: 132 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
           A E  LH   + ++DV+SYGV V E+++ G K +DG    E + +L
Sbjct: 189 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 109/201 (54%), Gaps = 13/201 (6%)
Query: 92  NQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFG 149
            ++G G FG VY+G      ++AVK L+V   + Q L+ F NEV +L K +H N++ LF 
Sbjct: 14  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFM 70
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
             +  P+  +V ++    SL + +      +  +      I    A+G+ YLH ++   I
Sbjct: 71  GYSTAPQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL---HGY 266
           IHRD+K++NI L E L  KI DFGLA +           ++SG+  +MAPE         
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 267 LSVKTDVFSYGVLVLEIVSGR 287
            S ++DV+++G+++ E+++G+
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQ 206

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 108/201 (53%), Gaps = 13/201 (6%)
Query: 92  NQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFG 149
            ++G G FG VY+G      ++AVK L+V   + Q L+ F NEV +L K +H N++   G
Sbjct: 41  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 98
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
              + P+  +V ++    SL + +      +  +      I    A+G+ YLH ++   I
Sbjct: 99  YSTK-PQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 152
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL---HGY 266
           IHRD+K++NI L E L  KI DFGLA +           ++SG+  +MAPE         
Sbjct: 153 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 212
Query: 267 LSVKTDVFSYGVLVLEIVSGR 287
            S ++DV+++G+++ E+++G+
Sbjct: 213 YSFQSDVYAFGIVLYELMTGQ 233

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 108/201 (53%), Gaps = 13/201 (6%)
Query: 92  NQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFG 149
            ++G G FG VY+G      ++AVK L+V   + Q L+ F NEV +L K +H N++   G
Sbjct: 19  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
              + P+  +V ++    SL + +      +  +      I    A+G+ YLH ++   I
Sbjct: 77  YSTK-PQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 130
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL---HGY 266
           IHRD+K++NI L E L  KI DFGLA +           ++SG+  +MAPE         
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 190
Query: 267 LSVKTDVFSYGVLVLEIVSGR 287
            S ++DV+++G+++ E+++G+
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQ 211

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 116/226 (51%), Gaps = 21/226 (9%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEI----AVKKL-SVDSRQGLREFTNEVKLLLKIQH 141
           F  +  LG G FG VY+GL +P G+++    A+K+L    S +  +E  +E  ++  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARG 197
            ++  L G C     + L+ + +P   L DY    K    S   L+W  +      +A+G
Sbjct: 77  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 129
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           + YL +    R++HRD+ A N+L+    + KI+DFG A+L   E+   +         +M
Sbjct: 130 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
           A E  LH   + ++DV+SYGV V E+++ G K +DG    E + +L
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 108/201 (53%), Gaps = 13/201 (6%)
Query: 92  NQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFG 149
            ++G G FG VY+G      ++AVK L+V   + Q L+ F NEV +L K +H N++   G
Sbjct: 19  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 76
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
              + P+  +V ++    SL + +      +  +      I    A+G+ YLH ++   I
Sbjct: 77  YSTK-PQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 130
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL---HGY 266
           IHRD+K++NI L E L  KI DFGLA +           ++SG+  +MAPE         
Sbjct: 131 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 190
Query: 267 LSVKTDVFSYGVLVLEIVSGR 287
            S ++DV+++G+++ E+++G+
Sbjct: 191 YSFQSDVYAFGIVLYELMTGQ 211

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 108/201 (53%), Gaps = 13/201 (6%)
Query: 92  NQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFG 149
            ++G G FG VY+G      ++AVK L+V   + Q L+ F NEV +L K +H N++   G
Sbjct: 16  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 73
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
              + P+  +V ++    SL + +      +  +      I    A+G+ YLH ++   I
Sbjct: 74  YSTK-PQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 127
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL---HGY 266
           IHRD+K++NI L E L  KI DFGLA +           ++SG+  +MAPE         
Sbjct: 128 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 187
Query: 267 LSVKTDVFSYGVLVLEIVSGR 287
            S ++DV+++G+++ E+++G+
Sbjct: 188 YSFQSDVYAFGIVLYELMTGQ 208

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 107/210 (50%), Gaps = 16/210 (7%)
Query: 84  ATNFFSDLNQLGHGGFGPVYRGLM--PNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLK 138
           ATN   D   +G G FG V  G +  P+ +EI  A+K L V  + +  R+F  E  ++ +
Sbjct: 44  ATNISID-KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 139 IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
             H N++ L G   +    M+V EY+ N SLD F+  +   +         ++ G+A G+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 160
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH---G 255
            YL +      +HRD+ A NIL++  L  K+SDFGL R+   ED     +   G      
Sbjct: 161 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL--EDDPEAAYTTRGGKIPIR 215
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           + +PE   +   +  +DV+SYG+++ E++S
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 130/268 (48%), Gaps = 33/268 (12%)
Query: 92  NQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFG 149
            ++G G FG VY+G      ++AVK L+V   + Q L+ F NEV +L K +H N++ LF 
Sbjct: 30  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL-LFM 86
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
             +  P+  +V ++    SL + +      +  +      I    ARG+ YLH ++   I
Sbjct: 87  GYSTAPQLAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGMDYLHAKS---I 141
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL---HGY 266
           IHRD+K++NI L E    KI DFGLA             ++SG+  +MAPE         
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 267 LSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV-----DPS 321
            S ++DV+++G+++ E+++G+              L Y+  +   ++ +E+V      P 
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQ--------------LPYS-NINNRDQIIEMVGRGSLSPD 246
Query: 322 LAKCNRDEAAMCIQLGLLCCQQSVAERP 349
           L+K   +      +L   C ++   ERP
Sbjct: 247 LSKVRSNCPKRMKRLMAECLKKKRDERP 274

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 125/274 (45%), Gaps = 31/274 (11%)
Query: 94  LGHGGFGPVYRGLM--PNGQE--IAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLF 148
           +G G FG V  G +  P  +E  +A+K L V  + +  R+F  E  ++ +  H N++ L 
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHLE 89
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G   +    M+V EY+ N SLD F+  K             ++ G++ G+ YL +     
Sbjct: 90  GVVTKSKPVMIVTEYMENGSLDTFL--KKNDGQFTVIQLVGMLRGISAGMKYLSDMG--- 144
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH---GYMAPEYALHG 265
            +HRD+ A NIL++  L  K+SDFGL+R+   ED     +   G      + APE     
Sbjct: 145 YVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKIPIRWTAPEAIAFR 202
Query: 266 YLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK 324
             +  +DV+SYG+++ E+VS G + +     ++    +   + L           PS   
Sbjct: 203 KFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEGYRL-----------PSPMD 251
Query: 325 CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML 358
           C     A   QL L C Q+    RP  + +  ML
Sbjct: 252 C----PAALYQLMLDCWQKERNSRPKFDEIVNML 281

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 129/268 (48%), Gaps = 33/268 (12%)
Query: 92  NQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFG 149
            ++G G FG VY+G      ++AVK L+V   + Q L+ F NEV +L K +H N++   G
Sbjct: 30  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
              + P+  +V ++    SL + +      +  +      I    ARG+ YLH ++   I
Sbjct: 88  YSTK-PQLAIVTQWCEGSSLYHHLH--ASETKFEMKKLIDIARQTARGMDYLHAKS---I 141
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL---HGY 266
           IHRD+K++NI L E    KI DFGLA             ++SG+  +MAPE         
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 267 LSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV-----DPS 321
            S ++DV+++G+++ E+++G+              L Y+  +   ++ +E+V      P 
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQ--------------LPYS-NINNRDQIIEMVGRGSLSPD 246
Query: 322 LAKCNRDEAAMCIQLGLLCCQQSVAERP 349
           L+K   +      +L   C ++   ERP
Sbjct: 247 LSKVRSNCPKRMKRLMAECLKKKRDERP 274

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 108/201 (53%), Gaps = 13/201 (6%)
Query: 92  NQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFG 149
            ++G G FG VY+G      ++AVK L+V   + Q L+ F NEV +L K +H N++   G
Sbjct: 14  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
              + P+  +V ++    SL + +      +  +      I    A+G+ YLH ++   I
Sbjct: 72  YSTK-PQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL---HGY 266
           IHRD+K++NI L E L  KI DFGLA +           ++SG+  +MAPE         
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 267 LSVKTDVFSYGVLVLEIVSGR 287
            S ++DV+++G+++ E+++G+
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQ 206

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 121/239 (50%), Gaps = 25/239 (10%)
Query: 68  GADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQG- 125
           GA   + F   R   +A N      Q+G GGFG V++G L+ +   +A+K L +   +G 
Sbjct: 1   GAMGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGE 60
Query: 126 ------LREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKS 179
                  +EF  EV ++  + H N+V L+G     P   +V E++P   L + + D  K+
Sbjct: 61  TEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KA 116
Query: 180 SSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNIL---LDEQ--LNPKISDFGL 234
             + W+ + R+++ +A G+ Y+  + P  I+HRD+++ NI    LDE   +  K++DFG 
Sbjct: 117 HPIKWSVKLRLMLDIALGIEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGT 175
Query: 235 ARLFPGEDTHVNTFRISGTHGYMAPEY--ALHGYLSVKTDVFSYGVLVLEIVSGRKNHD 291
           ++    +  H +   + G   +MAPE   A     + K D +S+ +++  I++G    D
Sbjct: 176 SQ----QSVH-SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 121/239 (50%), Gaps = 25/239 (10%)
Query: 68  GADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQG- 125
           GA   + F   R   +A N      Q+G GGFG V++G L+ +   +A+K L +   +G 
Sbjct: 1   GAMGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGE 60
Query: 126 ------LREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKS 179
                  +EF  EV ++  + H N+V L+G     P   +V E++P   L + + D  K+
Sbjct: 61  TEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLD--KA 116
Query: 180 SSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNIL---LDEQ--LNPKISDFGL 234
             + W+ + R+++ +A G+ Y+  + P  I+HRD+++ NI    LDE   +  K++DF L
Sbjct: 117 HPIKWSVKLRLMLDIALGIEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFSL 175
Query: 235 ARLFPGEDTHVNTFRISGTHGYMAPEY--ALHGYLSVKTDVFSYGVLVLEIVSGRKNHD 291
           ++    +  H +   + G   +MAPE   A     + K D +S+ +++  I++G    D
Sbjct: 176 SQ----QSVH-SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 133/297 (44%), Gaps = 47/297 (15%)
Query: 91  LNQLGHGGFGPVYR----GLMPNG--QEIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKN 143
           +  +G G FG V++    GL+P      +AVK L  ++   ++ +F  E  L+ +  + N
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKS-----SSLDWTTRYR--------- 189
           +V L G CA G    L++EY+    L+ F+   +       S  D +TR R         
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 190 -------IVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  I   VA G+ YL E    + +HRD+   N L+ E +  KI+DFGL+R     D
Sbjct: 172 SCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 243 THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADL 301
            +      +    +M PE   +   + ++DV++YGV++ EI S G + + G   +E   +
Sbjct: 229 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE---V 285
Query: 302 LSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML 358
           + Y            + D ++  C  +       L  LC  +  A+RP   S+H +L
Sbjct: 286 IYY------------VRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 330

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 78/269 (28%), Positives = 125/269 (46%), Gaps = 29/269 (10%)
Query: 94  LGHGGFGPVYRGLM--PNGQEIAV--KKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLF 148
           +G G FG V  G +  P  +++AV  K L V  + +  R+F  E  ++ +  H N+V L 
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHLE 110
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G    G   M+V E++ N +LD F+  +             ++ G+A G+ YL   A   
Sbjct: 111 GVVTRGKPVMIVIEFMENGALDAFL--RKHDGQFTVIQLVGMLRGIAAGMRYL---ADMG 165
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH---GYMAPEYALHG 265
            +HRD+ A NIL++  L  K+SDFGL+R+   ED     +  +G      + APE   + 
Sbjct: 166 YVHRDLAARNILVNSNLVCKVSDFGLSRVI--EDDPEAVYTTTGGKIPVRWTAPEAIQYR 223
Query: 266 YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKC 325
             +  +DV+SYG+++ E++S         G+     +S    +   E+   L  P     
Sbjct: 224 KFTSASDVWSYGIVMWEVMS--------YGERPYWDMSNQDVIKAIEEGYRLPAPM---- 271
Query: 326 NRDEAAMCIQLGLLCCQQSVAERPDMNSV 354
             D  A   QL L C Q+  AERP    +
Sbjct: 272 --DCPAGLHQLMLDCWQKERAERPKFEQI 298

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 107/201 (53%), Gaps = 13/201 (6%)
Query: 92  NQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFG 149
            ++G G FG VY+G      ++AVK L+V   + Q L+ F NEV +L K +H N++   G
Sbjct: 42  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 99
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
              + P+  +V ++    SL + +      +  +      I    A+G+ YLH ++   I
Sbjct: 100 YSTK-PQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 153
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL---HGY 266
           IHRD+K++NI L E L  KI DFGLA             ++SG+  +MAPE         
Sbjct: 154 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 213
Query: 267 LSVKTDVFSYGVLVLEIVSGR 287
            S ++DV+++G+++ E+++G+
Sbjct: 214 YSFQSDVYAFGIVLYELMTGQ 234

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 129/278 (46%), Gaps = 17/278 (6%)
Query: 54  GRAAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEI 113
           G    ++A    G G  SW +  D + L         L +LG G FG V  G      ++
Sbjct: 1   GPLGSKNAPSTAGLGYGSWEI--DPKDLTF-------LKELGTGQFGVVKYGKWRGQYDV 51
Query: 114 AVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFI 173
           A+K +  +      EF  E K+++ + H+ LV L+G C +     ++ EY+ N  L  ++
Sbjct: 52  AIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL 110
Query: 174 FDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG 233
             +             +   V   + YL  +   + +HRD+ A N L+++Q   K+SDFG
Sbjct: 111 --REMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFG 165
Query: 234 LARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDG 292
           L+R +  +D + ++        +  PE  ++   S K+D++++GVL+ EI S G+  ++ 
Sbjct: 166 LSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 224
Query: 293 RLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEA 330
               E A+ ++    L++   A E V   +  C  ++A
Sbjct: 225 FTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKA 262

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 120/248 (48%), Gaps = 14/248 (5%)
Query: 92  NQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDS--RQGL-REFTNEVKLLLKIQHKNLVTL 147
           N LG G F  VYR   +  G E+A+K +   +  + G+ +   NEVK+  +++H +++ L
Sbjct: 17  NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           +    +     LV E   N  ++ ++ ++ K  S +    +  +  +  G+LYLH     
Sbjct: 77  YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF--MHQIITGMLYLHSHG-- 132
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
            I+HRD+  SN+LL   +N KI+DFGLA     +  H   + + GT  Y++PE A     
Sbjct: 133 -ILHRDLTLSNLLLTRNMNIKIADFGLATQL--KMPHEKHYTLCGTPNYISPEIATRSAH 189
Query: 268 SVKTDVFSYGVLVLEIVSGRKNHDGRLGK---EKADLLSYTWTLFQGEKALELVDPSLAK 324
            +++DV+S G +   ++ GR   D    K    K  L  Y    F   +A +L+   L +
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRR 249
Query: 325 CNRDEAAM 332
              D  ++
Sbjct: 250 NPADRLSL 257

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 107/201 (53%), Gaps = 13/201 (6%)
Query: 92  NQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFG 149
            ++G G FG VY+G      ++AVK L+V   + Q L+ F NEV +L K +H N++   G
Sbjct: 34  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 91
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
              + P+  +V ++    SL + +      +  +      I    A+G+ YLH ++   I
Sbjct: 92  YSTK-PQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 145
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL---HGY 266
           IHRD+K++NI L E L  KI DFGLA             ++SG+  +MAPE         
Sbjct: 146 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 205
Query: 267 LSVKTDVFSYGVLVLEIVSGR 287
            S ++DV+++G+++ E+++G+
Sbjct: 206 YSFQSDVYAFGIVLYELMTGQ 226

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 103/218 (47%), Gaps = 32/218 (14%)
Query: 92  NQLGHGGFGPVYRG----LMPNGQE--IAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV 145
            +LG G FG V+      L P   +  +AVK L   +    ++F  E +LL  +QH+++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIF-------------DKTKSSSLDWTTRYRIVM 192
             +G C +G   ++V+EY+ +  L+ F+               +     L  +    I  
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISG 252
            +A G++YL   A    +HRD+   N L+   L  KI DFG++R     D +   +   G
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-----DVYSTDYYRVG 192
Query: 253 THG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
            H      +M PE  ++   + ++DV+S+GV++ EI +
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 107/201 (53%), Gaps = 13/201 (6%)
Query: 92  NQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFG 149
            ++G G FG VY+G      ++AVK L+V   + Q L+ F NEV +L K +H N++   G
Sbjct: 14  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
              + P+  +V ++    SL + +      +  +      I    A+G+ YLH ++   I
Sbjct: 72  YSTK-PQLAIVTQWCEGSSLYHHL--HIIETKFEMIKLIDIARQTAQGMDYLHAKS---I 125
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL---HGY 266
           IHRD+K++NI L E L  KI DFGLA             ++SG+  +MAPE         
Sbjct: 126 IHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP 185
Query: 267 LSVKTDVFSYGVLVLEIVSGR 287
            S ++DV+++G+++ E+++G+
Sbjct: 186 YSFQSDVYAFGIVLYELMTGQ 206

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 128/278 (46%), Gaps = 17/278 (6%)
Query: 54  GRAAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEI 113
           G    ++A    G G  SW +  D + L         L +LG G FG V  G      ++
Sbjct: 1   GPLGSKNAPSTAGLGYGSWEI--DPKDLTF-------LKELGTGQFGVVKYGKWRGQYDV 51
Query: 114 AVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFI 173
           A+K +  +      EF  E K+++ + H+ LV L+G C +     ++ EY+ N  L  ++
Sbjct: 52  AIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL 110
Query: 174 FDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG 233
             +             +   V   + YL  +   + +HRD+ A N L+++Q   K+SDFG
Sbjct: 111 --REMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFG 165
Query: 234 LARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDG 292
           L+R +  +D   ++        +  PE  ++   S K+D++++GVL+ EI S G+  ++ 
Sbjct: 166 LSR-YVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 224
Query: 293 RLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEA 330
               E A+ ++    L++   A E V   +  C  ++A
Sbjct: 225 FTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKA 262

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 102/201 (50%), Gaps = 10/201 (4%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           F  L +LG G +G VY+ +    GQ +A+K++ V+S   L+E   E+ ++ +    ++V 
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVK 88
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
            +G   +  +  +V EY    S+   I  + K+ + D      I+    +GL YLH    
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT--ILQSTLKGLEYLHF--- 143
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGY 266
            R IHRDIKA NILL+ + + K++DFG+A      D       + GT  +MAPE      
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQL--TDXMAKRNXVIGTPFWMAPEVIQEIG 201
Query: 267 LSVKTDVFSYGVLVLEIVSGR 287
            +   D++S G+  +E+  G+
Sbjct: 202 YNCVADIWSLGITAIEMAEGK 222

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 16/210 (7%)
Query: 84  ATNFFSDLNQLGHGGFGPVYRGLM--PNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLK 138
           ATN   D   +G G FG V  G +  P+ +EI  A+K L V  + +  R+F  E  ++ +
Sbjct: 44  ATNISID-KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 139 IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
             H N++ L G   +    M+V E + N SLD F+  +   +         ++ G+A G+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 160
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH---G 255
            YL +      +HRD+ A NIL++  L  K+SDFGL+R+   ED     +   G      
Sbjct: 161 KYLSDMGA---VHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKIPIR 215
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           + +PE   +   +  +DV+SYG+++ E++S
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 117/241 (48%), Gaps = 8/241 (3%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           L +LG G FG V  G      ++A+K +  +      EF  E K+++ + H+ LV L+G 
Sbjct: 20  LKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 78
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
           C +     ++ EY+ N  L  ++  +             +   V   + YL  +   + +
Sbjct: 79  CTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK---QFL 133
Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVK 270
           HRD+ A N L+++Q   K+SDFGL+R +  +D + ++        +  PE  ++   S K
Sbjct: 134 HRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 192
Query: 271 TDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDE 329
           +D++++GVL+ EI S G+  ++     E A+ ++    L++   A E V   +  C  ++
Sbjct: 193 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEK 252
Query: 330 A 330
           A
Sbjct: 253 A 253

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 116/220 (52%), Gaps = 21/220 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQEI----AVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTL 147
           LG G FG VY+G+ +P+G+ +    A+K L  + S +  +E  +E  ++  +    +  L
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 148 FGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSS---LDWTTRYRIVMGVARGLLYLHE 203
            G C     + LV + +P   L D+   ++ +  S   L+W       M +A+G+ YL +
Sbjct: 85  LGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWC------MQIAKGMSYLED 137
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
               R++HRD+ A N+L+    + KI+DFGLARL   ++T  +         +MA E  L
Sbjct: 138 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 194
Query: 264 HGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
               + ++DV+SYGV V E+++ G K +DG   +E  DLL
Sbjct: 195 RRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLL 234

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 117/241 (48%), Gaps = 8/241 (3%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           L +LG G FG V  G      ++A+K +  +      EF  E K+++ + H+ LV L+G 
Sbjct: 13  LKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 71
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
           C +     ++ EY+ N  L  ++  +             +   V   + YL  +   + +
Sbjct: 72  CTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK---QFL 126
Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVK 270
           HRD+ A N L+++Q   K+SDFGL+R +  +D + ++        +  PE  ++   S K
Sbjct: 127 HRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 185
Query: 271 TDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDE 329
           +D++++GVL+ EI S G+  ++     E A+ ++    L++   A E V   +  C  ++
Sbjct: 186 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEK 245
Query: 330 A 330
           A
Sbjct: 246 A 246

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 107/210 (50%), Gaps = 16/210 (7%)
Query: 84  ATNFFSDLNQLGHGGFGPVYRGLM--PNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLK 138
           ATN   D   +G G FG V  G +  P+ +EI  A+K L V  + +  R+F  E  ++ +
Sbjct: 15  ATNISID-KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 73
Query: 139 IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
             H N++ L G   +    M+V E + N SLD F+  +   +         ++ G+A G+
Sbjct: 74  FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 131
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH---G 255
            YL +      +HRD+ A NIL++  L  K+SDFGL+R+   ED     +   G      
Sbjct: 132 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVL--EDDPEAAYTTRGGKIPIR 186
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           + +PE   +   +  +DV+SYG+++ E++S
Sbjct: 187 WTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 117/241 (48%), Gaps = 8/241 (3%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           L +LG G FG V  G      ++A+K +  +      EF  E K+++ + H+ LV L+G 
Sbjct: 14  LKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
           C +     ++ EY+ N  L  ++  +             +   V   + YL  +   + +
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK---QFL 127
Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVK 270
           HRD+ A N L+++Q   K+SDFGL+R +  +D + ++        +  PE  ++   S K
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 186
Query: 271 TDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDE 329
           +D++++GVL+ EI S G+  ++     E A+ ++    L++   A E V   +  C  ++
Sbjct: 187 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEK 246
Query: 330 A 330
           A
Sbjct: 247 A 247

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 117/241 (48%), Gaps = 8/241 (3%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           L +LG G FG V  G      ++A+K +  +      EF  E K+++ + H+ LV L+G 
Sbjct: 9   LKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 67
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
           C +     ++ EY+ N  L  ++  +             +   V   + YL  +   + +
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK---QFL 122
Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVK 270
           HRD+ A N L+++Q   K+SDFGL+R +  +D + ++        +  PE  ++   S K
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181
Query: 271 TDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDE 329
           +D++++GVL+ EI S G+  ++     E A+ ++    L++   A E V   +  C  ++
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEK 241
Query: 330 A 330
           A
Sbjct: 242 A 242

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 87  FFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKN 143
            F+ L ++G G FG V++G+    Q++   K+ +D   +   + +   E+ +L +     
Sbjct: 24  LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKI-IDLEEAEDEIEDIQQEITVLSQCDSSY 82
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           +   +G   +G +  ++ EYL   S      D  ++   D      ++  + +GL YLH 
Sbjct: 83  VTKYYGSYLKGSKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHS 138
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
           E   + IHRDIKA+N+LL EQ + K++DFG+A          NTF   GT  +MAPE   
Sbjct: 139 E---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF--VGTPFWMAPEVIQ 193
Query: 264 HGYLSVKTDVFSYGVLVLEIVSGR 287
                 K D++S G+  +E+  G 
Sbjct: 194 QSAYDSKADIWSLGITAIELAKGE 217

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 12/208 (5%)
Query: 84  ATNFFSDLNQLGHGGFGPVYRGLM--PNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLK 138
           ATN   D   +G G FG V  G +  P+ +EI  A+K L V  + +  R+F  E  ++ +
Sbjct: 44  ATNISID-KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQ 102
Query: 139 IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
             H N++ L G   +    M+V E + N SLD F+  +   +         ++ G+A G+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGM 160
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH-GYM 257
            YL +      +HRD+ A NIL++  L  K+SDFGL+R+   +     T R       + 
Sbjct: 161 KYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 217
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +PE   +   +  +DV+SYG+++ E++S
Sbjct: 218 SPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 108/229 (47%), Gaps = 18/229 (7%)
Query: 67  SGAD--SWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--- 121
           SG D  + NL+F     +     F+ L ++G G FG V++G+    Q++   K+ +D   
Sbjct: 9   SGVDLGTENLYFQSMDPE---ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI-IDLEE 64
Query: 122 SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSS 181
           +   + +   E+ +L +     +   +G   +  +  ++ EYL   S      D  +   
Sbjct: 65  AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGP 120
Query: 182 LDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241
           LD T    I+  + +GL YLH E   + IHRDIKA+N+LL E    K++DFG+A      
Sbjct: 121 LDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 177
Query: 242 DTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNH 290
               NTF   GT  +MAPE         K D++S G+  +E+  G   H
Sbjct: 178 QIKRNTF--VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPH 224

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 74/245 (30%), Positives = 115/245 (46%), Gaps = 33/245 (13%)
Query: 67  SGAD--SWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQ 124
           SG D  + NL+F    LQ+       L     G FG V++  + N + +AVK   +  +Q
Sbjct: 10  SGVDLGTENLYFQSMPLQL-------LEVKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQ 61
Query: 125 GLREFTNEVKLLLKIQHKNLVTLFGCCAEGP----EKMLVYEYLPNKSLDYFIFDKTKSS 180
             +    EV  L  ++H+N++   G    G     +  L+  +    SL  F+    K++
Sbjct: 62  SWQN-EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KAN 116
Query: 181 SLDWTTRYRIVMGVARGLLYLHEEAPA-------RIIHRDIKASNILLDEQLNPKISDFG 233
            + W     I   +ARGL YLHE+ P         I HRDIK+ N+LL   L   I+DFG
Sbjct: 117 VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176
Query: 234 LARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLS------VKTDVFSYGVLVLEIVSGR 287
           LA  F    +  +T    GT  YMAPE  L G ++      ++ D+++ G+++ E+ S  
Sbjct: 177 LALKFEAGKSAGDTHGQVGTRRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235
Query: 288 KNHDG 292
              DG
Sbjct: 236 TAADG 240

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 23/205 (11%)
Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE 153
           +G G FG V +      +++A+K++  +S +  + F  E++ L ++ H N+V L+G C  
Sbjct: 17  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLN 73
Query: 154 GPEKMLVYEYLPNKSLDYFIFDK------TKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
                LV EY    SL   +         T + ++ W       +  ++G+ YLH   P 
Sbjct: 74  --PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWC------LQCSQGVAYLHSMQPK 125
Query: 208 RIIHRDIKASNILLDEQLNP-KISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGY 266
            +IHRD+K  N+LL       KI DFG A      D   +     G+  +MAPE      
Sbjct: 126 ALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSN 180
Query: 267 LSVKTDVFSYGVLVLEIVSGRKNHD 291
            S K DVFS+G+++ E+++ RK  D
Sbjct: 181 YSEKCDVFSWGIILWEVITRRKPFD 205

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 23/205 (11%)
Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE 153
           +G G FG V +      +++A+K++  +S +  + F  E++ L ++ H N+V L+G C  
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 154 GPEKMLVYEYLPNKSLDYFIFDK------TKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
                LV EY    SL   +         T + ++ W       +  ++G+ YLH   P 
Sbjct: 73  --PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWC------LQCSQGVAYLHSMQPK 124
Query: 208 RIIHRDIKASNILLDEQLNP-KISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGY 266
            +IHRD+K  N+LL       KI DFG A      D   +     G+  +MAPE      
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSN 179
Query: 267 LSVKTDVFSYGVLVLEIVSGRKNHD 291
            S K DVFS+G+++ E+++ RK  D
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFD 204

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 117/241 (48%), Gaps = 8/241 (3%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           L +LG G FG V  G      ++A+K +  +      EF  E K+++ + H+ LV L+G 
Sbjct: 14  LKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 72
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
           C +     ++ EY+ N  L  ++  +             +   V   + YL  +   + +
Sbjct: 73  CTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK---QFL 127
Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVK 270
           HRD+ A N L+++Q   K+SDFGL+R +  +D + ++        +  PE  ++   S K
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSK 186
Query: 271 TDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDE 329
           +D++++GVL+ EI S G+  ++     E A+ ++    L++   A E V   +  C  ++
Sbjct: 187 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEK 246
Query: 330 A 330
           A
Sbjct: 247 A 247

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 86  NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHK 142
             F+ L ++G G FG V++G+    Q++   K+ +D   +   + +   E+ +L +    
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI-IDLEEAEDEIEDIQQEITVLSQCDSP 65
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
            +   +G   +  +  ++ EYL   S      D  +   LD T    I+  + +GL YLH
Sbjct: 66  YVTKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLH 121
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
            E   + IHRDIKA+N+LL E    K++DFG+A          NTF   GT  +MAPE  
Sbjct: 122 SE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF--VGTPFWMAPEVI 176
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSGRKNH 290
                  K D++S G+  +E+  G   H
Sbjct: 177 KQSAYDSKADIWSLGITAIELARGEPPH 204

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 106/216 (49%), Gaps = 26/216 (12%)
Query: 88  FSDLNQLGHGGFGPVYRGLMPNG---QEIAVKKL-SVDSRQGLREFTNEVKLLLKI-QHK 142
           F D+  +G G FG V +  +       + A+K++    S+   R+F  E+++L K+  H 
Sbjct: 29  FQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 86
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSL-DY------------FIFDKTKSSSLDWTTRYR 189
           N++ L G C       L  EY P+ +L D+            F    + +S+L       
Sbjct: 87  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 190 IVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR 249
               VARG+ YL ++   + IHRD+ A NIL+ E    KI+DFGL+R   G++ +V    
Sbjct: 147 FAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTM 200
Query: 250 ISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
                 +MA E   +   +  +DV+SYGVL+ EIVS
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 106/216 (49%), Gaps = 26/216 (12%)
Query: 88  FSDLNQLGHGGFGPVYRGLMPNG---QEIAVKKL-SVDSRQGLREFTNEVKLLLKI-QHK 142
           F D+  +G G FG V +  +       + A+K++    S+   R+F  E+++L K+  H 
Sbjct: 19  FQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 76
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSL-DY------------FIFDKTKSSSLDWTTRYR 189
           N++ L G C       L  EY P+ +L D+            F    + +S+L       
Sbjct: 77  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 136
Query: 190 IVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR 249
               VARG+ YL ++   + IHRD+ A NIL+ E    KI+DFGL+R   G++ +V    
Sbjct: 137 FAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTM 190
Query: 250 ISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
                 +MA E   +   +  +DV+SYGVL+ EIVS
Sbjct: 191 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 86  NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHK 142
             F+ L ++G G FG V++G+    Q++   K+ +D   +   + +   E+ +L +    
Sbjct: 22  ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI-IDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
            +   +G   +  +  ++ EYL   S      D  +   LD T    I+  + +GL YLH
Sbjct: 81  YVTKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLH 136
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
            E   + IHRDIKA+N+LL E    K++DFG+A      DT +      GT  +MAPE  
Sbjct: 137 SE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNXFVGTPFWMAPEVI 191
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSGRKNH 290
                  K D++S G+  +E+  G   H
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPPH 219

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 13/208 (6%)
Query: 86  NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHK 142
             F+ L ++G G FG V++G+    Q++   K+ +D   +   + +   E+ +L +    
Sbjct: 7   ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKI-IDLEEAEDEIEDIQQEITVLSQCDSP 65
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
            +   +G   +  +  ++ EYL   S      D  +   LD T    I+  + +GL YLH
Sbjct: 66  YVTKYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLH 121
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
            E   + IHRDIKA+N+LL E    K++DFG+A      DT +      GT  +MAPE  
Sbjct: 122 SE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNXFVGTPFWMAPEVI 176
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSGRKNH 290
                  K D++S G+  +E+  G   H
Sbjct: 177 KQSAYDSKADIWSLGITAIELARGEPPH 204

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 104/205 (50%), Gaps = 17/205 (8%)
Query: 91  LNQLGHGGFGPV----YRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV 145
           ++QLG G FG V    Y  L  N G  +AVK+L        R+F  E+++L K  H + +
Sbjct: 12  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL-KALHSDFI 70
Query: 146 TLFGCCAEGP---EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
             +   + GP   E  LV EYLP+  L  F+  +   + LD +        + +G+ YL 
Sbjct: 71  VKYRGVSYGPGRPELRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLG 128
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG--YMAPE 260
                R +HRD+ A NIL++ + + KI+DFGLA+L P  D      R  G     + APE
Sbjct: 129 SR---RCVHRDLAARNILVESEAHVKIADFGLAKLLP-LDKDXXVVREPGQSPIFWYAPE 184
Query: 261 YALHGYLSVKTDVFSYGVLVLEIVS 285
                  S ++DV+S+GV++ E+ +
Sbjct: 185 SLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 106/202 (52%), Gaps = 17/202 (8%)
Query: 94  LGHGGFGPVYRG--LMPNGQEI--AVKKL-SVDSRQGLREFTNEVKLLLKIQHKNLVTLF 148
           +G G FG V  G   +P  +EI  A+K L S  + +  R+F +E  ++ +  H N++ L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G   +    M++ E++ N SLD F+  +             ++ G+A G+ YL   A   
Sbjct: 101 GVVTKSTPVMIITEFMENGSLDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYL---ADMN 155
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAPEYAL 263
            +HRD+ A NIL++  L  K+SDFGL+R F  +DT   T+  S   G     + APE   
Sbjct: 156 YVHRDLAARNILVNSNLVCKVSDFGLSR-FLEDDTSDPTY-TSALGGKIPIRWTAPEAIQ 213
Query: 264 HGYLSVKTDVFSYGVLVLEIVS 285
           +   +  +DV+SYG+++ E++S
Sbjct: 214 YRKFTSASDVWSYGIVMWEVMS 235

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 19/203 (9%)
Query: 94  LGHGGFGPVYRGLM--PNGQE--IAVKKLS--VDSRQGLREFTNEVKLLLKIQHKNLVTL 147
           +G G FG V RG +  P  +E  +A+K L      RQ  REF +E  ++ + +H N++ L
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ-RREFLSEASIMGQFEHPNIIRL 82
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
            G        M++ E++ N +LD F+  +             ++ G+A G+ YL E +  
Sbjct: 83  EGVVTNSMPVMILTEFMENGALDSFL--RLNDGQFTVIQLVGMLRGIASGMRYLAEMS-- 138
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAPEYA 262
             +HRD+ A NIL++  L  K+SDFGL+R    E+   +    S   G     + APE  
Sbjct: 139 -YVHRDLAARNILVNSNLVCKVSDFGLSRFL--EENSSDPTETSSLGGKIPIRWTAPEAI 195
Query: 263 LHGYLSVKTDVFSYGVLVLEIVS 285
                +  +D +SYG+++ E++S
Sbjct: 196 AFRKFTSASDAWSYGIVMWEVMS 218

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 117/222 (52%), Gaps = 14/222 (6%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFT-NEVKLLLKIQHKNLV 145
           F  L +LG+G +  VY+GL    G  +A+K++ +DS +G       E+ L+ +++H+N+V
Sbjct: 7   FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIV 66
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSS---LDWTTRYRIVMGVARGLLYLH 202
            L+       +  LV+E++ N  L  ++  +T  ++   L+          + +GL + H
Sbjct: 67  RLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH 125
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS-GTHGYMAPEY 261
           E    +I+HRD+K  N+L++++   K+ DFGLAR F      VNTF     T  Y AP+ 
Sbjct: 126 EN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF---GIPVNTFSSEVVTLWYRAPDV 179
Query: 262 ALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLL 302
            +     S   D++S G ++ E+++G+    G   +E+  L+
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI 221

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 98/201 (48%), Gaps = 10/201 (4%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           ++   ++G G  G VY  + +  GQE+A++++++  +       NE+ ++ + ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
                  G E  +V EYL   SL     D    + +D      +     + L +LH    
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 135
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGY 266
            ++IHRDIK+ NILL    + K++DFG       E +  +T  + GT  +MAPE      
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 192
Query: 267 LSVKTDVFSYGVLVLEIVSGR 287
              K D++S G++ +E++ G 
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGE 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 105/204 (51%), Gaps = 15/204 (7%)
Query: 91  LNQLGHGGFGPV----YRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV 145
           ++QLG G FG V    Y  L  N G  +AVK+L        R+F  E+++L K  H + +
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL-KALHSDFI 86
Query: 146 TLFGCCAEGPEKM---LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
             +   + GP +    LV EYLP+  L  F+  +   + LD +        + +G+ YL 
Sbjct: 87  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLG 144
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP-GEDTHVNTFRISGTHGYMAPEY 261
                R +HRD+ A NIL++ + + KI+DFGLA+L P  +D +V          + APE 
Sbjct: 145 SR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201
Query: 262 ALHGYLSVKTDVFSYGVLVLEIVS 285
                 S ++DV+S+GV++ E+ +
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 105/204 (51%), Gaps = 15/204 (7%)
Query: 91  LNQLGHGGFGPV----YRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV 145
           ++QLG G FG V    Y  L  N G  +AVK+L        R+F  E+++L K  H + +
Sbjct: 15  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL-KALHSDFI 73
Query: 146 TLFGCCAEGPEKM---LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
             +   + GP +    LV EYLP+  L  F+  +   + LD +        + +G+ YL 
Sbjct: 74  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLG 131
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP-GEDTHVNTFRISGTHGYMAPEY 261
                R +HRD+ A NIL++ + + KI+DFGLA+L P  +D +V          + APE 
Sbjct: 132 SR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 188
Query: 262 ALHGYLSVKTDVFSYGVLVLEIVS 285
                 S ++DV+S+GV++ E+ +
Sbjct: 189 LSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 105/204 (51%), Gaps = 15/204 (7%)
Query: 91  LNQLGHGGFGPV----YRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV 145
           ++QLG G FG V    Y  L  N G  +AVK+L        R+F  E+++L K  H + +
Sbjct: 16  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL-KALHSDFI 74
Query: 146 TLFGCCAEGPEKM---LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
             +   + GP +    LV EYLP+  L  F+  +   + LD +        + +G+ YL 
Sbjct: 75  VKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLG 132
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP-GEDTHVNTFRISGTHGYMAPEY 261
                R +HRD+ A NIL++ + + KI+DFGLA+L P  +D +V          + APE 
Sbjct: 133 SR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 189
Query: 262 ALHGYLSVKTDVFSYGVLVLEIVS 285
                 S ++DV+S+GV++ E+ +
Sbjct: 190 LSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 118/252 (46%), Gaps = 33/252 (13%)
Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVK---KLSVDS--RQGLREFTNEVKLLLKIQHKNL 144
           L  LG G FG V++G+ +P G+ I +    K+  D   RQ  +  T+ +  +  + H ++
Sbjct: 36  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 95
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG----------V 194
           V L G C  G    LV +YLP  SL            LD   ++R  +G          +
Sbjct: 96  VRLLGLCP-GSSLQLVTQYLPLGSL------------LDHVRQHRGALGPQLLLNWGVQI 142
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH 254
           A+G+ YL E     ++HR++ A N+LL      +++DFG+A L P +D  +         
Sbjct: 143 AKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI 199
Query: 255 GYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEK 313
            +MA E    G  + ++DV+SYGV V E+++ G + + G    E  DLL     L Q + 
Sbjct: 200 KWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQI 259
Query: 314 ALELVDPSLAKC 325
               V   + KC
Sbjct: 260 CTIDVYMVMVKC 271

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 118/252 (46%), Gaps = 33/252 (13%)
Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVK---KLSVDS--RQGLREFTNEVKLLLKIQHKNL 144
           L  LG G FG V++G+ +P G+ I +    K+  D   RQ  +  T+ +  +  + H ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG----------V 194
           V L G C  G    LV +YLP  SL            LD   ++R  +G          +
Sbjct: 78  VRLLGLCP-GSSLQLVTQYLPLGSL------------LDHVRQHRGALGPQLLLNWGVQI 124
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH 254
           A+G+ YL E     ++HR++ A N+LL      +++DFG+A L P +D  +         
Sbjct: 125 AKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI 181
Query: 255 GYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEK 313
            +MA E    G  + ++DV+SYGV V E+++ G + + G    E  DLL     L Q + 
Sbjct: 182 KWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQI 241
Query: 314 ALELVDPSLAKC 325
               V   + KC
Sbjct: 242 CTIDVYMVMVKC 253

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 94  LGHGGFGPV-YRGLMPNGQE---IAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLF 148
           +G G  G V Y  L   GQ    +A+K L    + +  R+F +E  ++ +  H N++ L 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G    G   M+V EY+ N SLD F+  +T            ++ GV  G+ YL +     
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--- 171
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH---GYMAPEYALHG 265
            +HRD+ A N+L+D  L  K+SDFGL+R+   ED     +  +G      + APE     
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVL--EDDPDAAYTTTGGKIPIRWTAPEAIAFR 229
Query: 266 YLSVKTDVFSYGVLVLEIVS 285
             S  +DV+S+GV++ E+++
Sbjct: 230 TFSSASDVWSFGVVMWEVLA 249

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 102/201 (50%), Gaps = 15/201 (7%)
Query: 94  LGHGGFGPVYRGLM--PNGQE--IAVKKLS--VDSRQGLREFTNEVKLLLKIQHKNLVTL 147
           +G G FG V RG +  P  +E  +A+K L      RQ  REF +E  ++ + +H N++ L
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQR-REFLSEASIMGQFEHPNIIRL 80
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
            G        M++ E++ N +LD F+  +             ++ G+A G+ YL E +  
Sbjct: 81  EGVVTNSMPVMILTEFMENGALDSFL--RLNDGQFTVIQLVGMLRGIASGMRYLAEMS-- 136
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLF---PGEDTHVNTFRISGTHGYMAPEYALH 264
             +HRD+ A NIL++  L  K+SDFGL+R       + T+ ++        + APE    
Sbjct: 137 -YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAF 195
Query: 265 GYLSVKTDVFSYGVLVLEIVS 285
              +  +D +SYG+++ E++S
Sbjct: 196 RKFTSASDAWSYGIVMWEVMS 216

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 106/216 (49%), Gaps = 26/216 (12%)
Query: 88  FSDLNQLGHGGFGPVYRGLMPNG---QEIAVKKL-SVDSRQGLREFTNEVKLLLKI-QHK 142
           F D+  +G G FG V +  +       + A+K++    S+   R+F  E+++L K+  H 
Sbjct: 26  FQDV--IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 83
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSL-DY------------FIFDKTKSSSLDWTTRYR 189
           N++ L G C       L  EY P+ +L D+            F    + +S+L       
Sbjct: 84  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 143
Query: 190 IVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR 249
               VARG+ YL ++   + IHR++ A NIL+ E    KI+DFGL+R   G++ +V    
Sbjct: 144 FAADVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSR---GQEVYVKKTM 197
Query: 250 ISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
                 +MA E   +   +  +DV+SYGVL+ EIVS
Sbjct: 198 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 94  LGHGGFGPVYRGL---MPNGQ---EIAVKKLS-VDSRQGLREFTNEVKLLLKIQHKNLVT 146
           LGHG FG VY G    MPN     ++AVK L  V S Q   +F  E  ++ K+ H+N+V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARGLLYLH 202
             G   +   + ++ E +    L  F+ +     ++ SSL       +   +A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 203 EEAPARIIHRDIKASNILLD---EQLNPKISDFGLARLFPGEDTHVNTFRISGTH----G 255
           E      IHRDI A N LL         KI DFG+AR    +    + +R  G       
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 211
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +M PE  + G  + KTD +S+GVL+ EI S
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 116/247 (46%), Gaps = 22/247 (8%)
Query: 92  NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCC 151
            +LG G FG V+        ++AVK +   S   +  F  E  ++  +QH  LV L    
Sbjct: 21  KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVV 79
Query: 152 AEGPEKMLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
            + P   ++ E++   SL D+   D+     L     +     +A G+ ++ +      I
Sbjct: 80  TKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS--AQIAEGMAFIEQR---NYI 133
Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT-----FRISGTHGYMAPEYALHG 265
           HRD++A+NIL+   L  KI+DFGLAR+   ED          F I  T    APE    G
Sbjct: 134 HRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWT----APEAINFG 187
Query: 266 YLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK 324
             ++K+DV+S+G+L++EIV+ GR  + G    E    L   + + + E   E +   + +
Sbjct: 188 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMR 247
Query: 325 C--NRDE 329
           C  NR E
Sbjct: 248 CWKNRPE 254

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 94  LGHGGFGPVYRGL---MPNGQ---EIAVKKLS-VDSRQGLREFTNEVKLLLKIQHKNLVT 146
           LGHG FG VY G    MPN     ++AVK L  V S Q   +F  E  ++ K+ H+N+V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARGLLYLH 202
             G   +   + ++ E +    L  F+ +     ++ SSL       +   +A G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 203 EEAPARIIHRDIKASNILLD---EQLNPKISDFGLARLFPGEDTHVNTFRISGTH----G 255
           E      IHRDI A N LL         KI DFG+AR    +    + +R  G       
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 225
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +M PE  + G  + KTD +S+GVL+ EI S
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/219 (32%), Positives = 107/219 (48%), Gaps = 34/219 (15%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLF-- 148
           L  +G G +G VY+G + + + +AVK  S  +RQ      N  ++ L ++H N+      
Sbjct: 18  LELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEKNIYRVPL-MEHDNIARFIVG 75
Query: 149 --GCCAEGP-EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
                A+G  E +LV EY PN SL  ++   T     DW +  R+   V RGL YLH E 
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRLAHSVTRGLAYLHTEL 131
Query: 206 P------ARIIHRDIKASNILLDEQLNPKISDFGLA------RLF-PGEDTHVNTFRISG 252
           P        I HRD+ + N+L+       ISDFGL+      RL  PGE+ +     + G
Sbjct: 132 PRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV-G 190
Query: 253 THGYMAPEYALHGYLSVK--------TDVFSYGVLVLEI 283
           T  YMAPE  L G ++++         D+++ G++  EI
Sbjct: 191 TIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/247 (29%), Positives = 116/247 (46%), Gaps = 22/247 (8%)
Query: 92  NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCC 151
            +LG G FG V+        ++AVK +   S   +  F  E  ++  +QH  LV L    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 152 AEGPEKMLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
            + P   ++ E++   SL D+   D+     L     +     +A G+ ++ +      I
Sbjct: 253 TKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS--AQIAEGMAFIEQR---NYI 306
Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT-----FRISGTHGYMAPEYALHG 265
           HRD++A+NIL+   L  KI+DFGLAR+   ED          F I  T    APE    G
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWT----APEAINFG 360
Query: 266 YLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK 324
             ++K+DV+S+G+L++EIV+ GR  + G    E    L   + + + E   E +   + +
Sbjct: 361 SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMR 420
Query: 325 C--NRDE 329
           C  NR E
Sbjct: 421 CWKNRPE 427

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 94  LGHGGFGPVYRGL---MPNGQ---EIAVKKLS-VDSRQGLREFTNEVKLLLKIQHKNLVT 146
           LGHG FG VY G    MPN     ++AVK L  V S Q   +F  E  ++ K  H+N+V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARGLLYLH 202
             G   +   + ++ E +    L  F+ +     ++ SSL       +   +A G  YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 203 EEAPARIIHRDIKASNILLD---EQLNPKISDFGLARLFPGEDTHVNTFRISGTH----G 255
           E      IHRDI A N LL         KI DFG+AR    +    + +R  G       
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 210
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +M PE  + G  + KTD +S+GVL+ EI S
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 94  LGHGGFGPVYRGL---MPNGQ---EIAVKKLS-VDSRQGLREFTNEVKLLLKIQHKNLVT 146
           LGHG FG VY G    MPN     ++AVK L  V S Q   +F  E  ++ K  H+N+V 
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARGLLYLH 202
             G   +   + ++ E +    L  F+ +     ++ SSL       +   +A G  YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 203 EEAPARIIHRDIKASNILLD---EQLNPKISDFGLARLFPGEDTHVNTFRISGTH----G 255
           E      IHRDI A N LL         KI DFG+AR    +    + +R  G       
Sbjct: 150 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 202
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +M PE  + G  + KTD +S+GVL+ EI S
Sbjct: 203 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 94  LGHGGFGPVYRGL---MPNGQ---EIAVKKLS-VDSRQGLREFTNEVKLLLKIQHKNLVT 146
           LGHG FG VY G    MPN     ++AVK L  V S Q   +F  E  ++ K  H+N+V 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARGLLYLH 202
             G   +   + ++ E +    L  F+ +     ++ SSL       +   +A G  YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 203 EEAPARIIHRDIKASNILLD---EQLNPKISDFGLARLFPGEDTHVNTFRISGTH----G 255
           E      IHRDI A N LL         KI DFG+AR    +    + +R  G       
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 210
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +M PE  + G  + KTD +S+GVL+ EI S
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 94  LGHGGFGPVYRGLM--PNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLF 148
           +G G FG V  G +  P  +EI  A+K L    + +  R+F +E  ++ +  H N++ L 
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 96
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G   +    M++ EY+ N SLD F+  +             ++ G+  G+ YL + +   
Sbjct: 97  GVVTKCKPVMIITEYMENGSLDAFL--RKNDGRFTVIQLVGMLRGIGSGMKYLSDMSA-- 152
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH---GYMAPEYALHG 265
            +HRD+ A NIL++  L  K+SDFG++R+   ED     +   G      + APE   + 
Sbjct: 153 -VHRDLAARNILVNSNLVCKVSDFGMSRVL--EDDPEAAYTTRGGKIPIRWTAPEAIAYR 209
Query: 266 YLSVKTDVFSYGVLVLEIVS 285
             +  +DV+SYG+++ E++S
Sbjct: 210 KFTSASDVWSYGIVMWEVMS 229

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 94  LGHGGFGPVYRGL---MPNGQ---EIAVKKLS-VDSRQGLREFTNEVKLLLKIQHKNLVT 146
           LGHG FG VY G    MPN     ++AVK L  V S Q   +F  E  ++ K  H+N+V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARGLLYLH 202
             G   +   + ++ E +    L  F+ +     ++ SSL       +   +A G  YL 
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 203 EEAPARIIHRDIKASNILLD---EQLNPKISDFGLARLFPGEDTHVNTFRISGTH----G 255
           E      IHRDI A N LL         KI DFG+AR    +    + +R  G       
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 225
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +M PE  + G  + KTD +S+GVL+ EI S
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 94  LGHGGFGPVYRGL---MPNGQ---EIAVKKLS-VDSRQGLREFTNEVKLLLKIQHKNLVT 146
           LGHG FG VY G    MPN     ++AVK L  V S Q   +F  E  ++ K  H+N+V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARGLLYLH 202
             G   +   + ++ E +    L  F+ +     ++ SSL       +   +A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 203 EEAPARIIHRDIKASNILLD---EQLNPKISDFGLARLFPGEDTHVNTFRISGTH----G 255
           E      IHRDI A N LL         KI DFG+AR    +    + +R  G       
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 211
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +M PE  + G  + KTD +S+GVL+ EI S
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 94  LGHGGFGPVYRGL---MPNGQ---EIAVKKLS-VDSRQGLREFTNEVKLLLKIQHKNLVT 146
           LGHG FG VY G    MPN     ++AVK L  V S Q   +F  E  ++ K  H+N+V 
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARGLLYLH 202
             G   +   + ++ E +    L  F+ +     ++ SSL       +   +A G  YL 
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 174
Query: 203 EEAPARIIHRDIKASNILLD---EQLNPKISDFGLARLFPGEDTHVNTFRISGTH----G 255
           E      IHRDI A N LL         KI DFG+AR    +    + +R  G       
Sbjct: 175 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 227
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +M PE  + G  + KTD +S+GVL+ EI S
Sbjct: 228 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 108/220 (49%), Gaps = 31/220 (14%)
Query: 94  LGHGGFGPVYRGLM------PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVT 146
           LG G FG V +              +AVK L  + S   LR+  +E  +L ++ H +++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTK-------------SSSLDWTTRYRIVMG 193
           L+G C++    +L+ EY    SL  F+ +  K             SSSLD      + MG
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 194 --------VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV 245
                   +++G+ YL E    +++HRD+ A NIL+ E    KISDFGL+R    ED++V
Sbjct: 151 DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 246 NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
              +      +MA E       + ++DV+S+GVL+ EIV+
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 94  LGHGGFGPVYRGL---MPNGQ---EIAVKKLS-VDSRQGLREFTNEVKLLLKIQHKNLVT 146
           LGHG FG VY G    MPN     ++AVK L  V S Q   +F  E  ++ K  H+N+V 
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARGLLYLH 202
             G   +   + ++ E +    L  F+ +     ++ SSL       +   +A G  YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 203 EEAPARIIHRDIKASNILLD---EQLNPKISDFGLARLFPGEDTHVNTFRISGTH----G 255
           E      IHRDI A N LL         KI DFG+AR    +    + +R  G       
Sbjct: 165 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 217
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +M PE  + G  + KTD +S+GVL+ EI S
Sbjct: 218 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 94  LGHGGFGPVYRGL---MPNGQ---EIAVKKL-SVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           LGHG FG VY G    MPN     ++AVK L  V S Q   +F  E  ++ K  H+N+V 
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARGLLYLH 202
             G   +   + ++ E +    L  F+ +     ++ SSL       +   +A G  YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 203 EEAPARIIHRDIKASNILLD---EQLNPKISDFGLARLFPGEDTHVNTFRISGTH----G 255
           E      IHRDI A N LL         KI DFG+AR    +    + +R  G       
Sbjct: 185 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 237
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +M PE  + G  + KTD +S+GVL+ EI S
Sbjct: 238 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           ++   ++G G  G VY  + +  GQE+A++++++  +       NE+ ++ + ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
                  G E  +V EYL   SL     D    + +D      +     + L +LH    
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 135
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGL-ARLFPGEDTHVNTFRISGTHGYMAPEYALHG 265
            ++IHRDIK+ NILL    + K++DFG  A++ P +        + GT  +MAPE     
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR---SEMVGTPYWMAPEVVTRK 191
Query: 266 YLSVKTDVFSYGVLVLEIVSGR 287
               K D++S G++ +E++ G 
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGE 213

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 94  LGHGGFGPVYRGL---MPNGQ---EIAVKKLS-VDSRQGLREFTNEVKLLLKIQHKNLVT 146
           LGHG FG VY G    MPN     ++AVK L  V S Q   +F  E  ++ K  H+N+V 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARGLLYLH 202
             G   +   + ++ E +    L  F+ +     ++ SSL       +   +A G  YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 203 EEAPARIIHRDIKASNILLD---EQLNPKISDFGLARLFPGEDTHVNTFRISGTH----G 255
           E      IHRDI A N LL         KI DFG+AR    +    + +R  G       
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 225
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +M PE  + G  + KTD +S+GVL+ EI S
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 94  LGHGGFGPVYRGLM--PNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLF 148
           +G G FG V  G +  P  +EI  A+K L    + +  R+F +E  ++ +  H N++ L 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G   +    M++ EY+ N SLD F+  +             ++ G+  G+ YL + +   
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFL--RKNDGRFTVIQLVGMLRGIGSGMKYLSDMS--- 130
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH---GYMAPEYALHG 265
            +HRD+ A NIL++  L  K+SDFG++R+   ED     +   G      + APE   + 
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGMSRVL--EDDPEAAYTTRGGKIPIRWTAPEAIAYR 188
Query: 266 YLSVKTDVFSYGVLVLEIVS 285
             +  +DV+SYG+++ E++S
Sbjct: 189 KFTSASDVWSYGIVMWEVMS 208

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 94  LGHGGFGPVYRGLMPN-GQEIAVKKLSV---------DSRQGLREFTNEVKLLLKI-QHK 142
           LG G FG V        G+E AV K++V         D ++ L    +E+K++  + QH+
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL---MSELKIMSHLGQHE 102
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFI-------FDKTKSSSLDWTTRYRIVMGVA 195
           N+V L G C  G   +++ EY     L  F+        DK     L+          VA
Sbjct: 103 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVA 162
Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG 255
           +G+ +L   A    IHRD+ A N+LL      KI DFGLAR    +  ++          
Sbjct: 163 QGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 219
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +MAPE       +V++DV+SYG+L+ EI S
Sbjct: 220 WMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 11/198 (5%)
Query: 94  LGHGGFGPV-YRGLMPNGQE---IAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLF 148
           +G G  G V Y  L   GQ    +A+K L    + +  R+F +E  ++ +  H N++ L 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G    G   M+V EY+ N SLD F+  +T            ++ GV  G+ YL +     
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYLSDLG--- 171
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGE-DTHVNTFRISGTHGYMAPEYALHGYL 267
            +HRD+ A N+L+D  L  K+SDFGL+R+   + D    T        + APE       
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTF 231
Query: 268 SVKTDVFSYGVLVLEIVS 285
           S  +DV+S+GV++ E+++
Sbjct: 232 SSASDVWSFGVVMWEVLA 249

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 102/200 (51%), Gaps = 15/200 (7%)
Query: 94  LGHGGFGPVYRGLM--PNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLF 148
           +G G FG V  G +  P  +EI  A+K L    + +  R+F +E  ++ +  H N++ L 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G   +    M++ EY+ N SLD F+  +             ++ G+  G+ YL + +   
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFL--RKNDGRFTVIQLVGMLRGIGSGMKYLSDMS--- 136
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH---GYMAPEYALHG 265
            +HRD+ A NIL++  L  K+SDFG++R+   ED     +   G      + APE   + 
Sbjct: 137 YVHRDLAARNILVNSNLVCKVSDFGMSRVL--EDDPEAAYTTRGGKIPIRWTAPEAIAYR 194
Query: 266 YLSVKTDVFSYGVLVLEIVS 285
             +  +DV+SYG+++ E++S
Sbjct: 195 KFTSASDVWSYGIVMWEVMS 214

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 94  LGHGGFGPVYRGL---MPNGQ---EIAVKKLS-VDSRQGLREFTNEVKLLLKIQHKNLVT 146
           LGHG FG VY G    MPN     ++AVK L  V S Q   +F  E  ++ K  H+N+V 
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARGLLYLH 202
             G   +   + ++ E +    L  F+ +     ++ SSL       +   +A G  YL 
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 175
Query: 203 EEAPARIIHRDIKASNILLD---EQLNPKISDFGLARLFPGEDTHVNTFRISGTH----G 255
           E      IHRDI A N LL         KI DFG+AR    +      +R  G       
Sbjct: 176 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKGGCAMLPVK 228
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +M PE  + G  + KTD +S+GVL+ EI S
Sbjct: 229 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 98/201 (48%), Gaps = 10/201 (4%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           ++   ++G G  G VY  + +  GQE+A++++++  +       NE+ ++ + ++ N+V 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
                  G E  +V EYL   SL     D    + +D      +     + L +LH    
Sbjct: 83  YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 136
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGY 266
            ++IHR+IK+ NILL    + K++DFG       E +  +T  + GT  +MAPE      
Sbjct: 137 -QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKA 193
Query: 267 LSVKTDVFSYGVLVLEIVSGR 287
              K D++S G++ +E++ G 
Sbjct: 194 YGPKVDIWSLGIMAIEMIEGE 214

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 98/210 (46%), Gaps = 24/210 (11%)
Query: 94  LGHGGFGPVYRGLMPN-GQEIAVKKLSV---------DSRQGLREFTNEVKLLLKI-QHK 142
           LG G FG V        G+E AV K++V         D ++ L    +E+K++  + QH+
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL---MSELKIMSHLGQHE 110
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFI-------FDKTKSSSLDWTTRYRIVMGVA 195
           N+V L G C  G   +++ EY     L  F+        DK     L+          VA
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVA 170
Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG 255
           +G+ +L   A    IHRD+ A N+LL      KI DFGLAR    +  ++          
Sbjct: 171 QGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 227
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +MAPE       +V++DV+SYG+L+ EI S
Sbjct: 228 WMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 69/210 (32%), Positives = 96/210 (45%), Gaps = 25/210 (11%)
Query: 94  LGHGGFGPVYRGL---MPNGQ---EIAVKKLS-VDSRQGLREFTNEVKLLLKIQHKNLVT 146
           LGHG FG VY G    MPN     ++AVK L  V S Q   +F  E  ++ K  H+N+V 
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARGLLYLH 202
             G   +   + ++ E +    L  F+ +     ++ SSL       +   +A G  YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 203 EEAPARIIHRDIKASNILLD---EQLNPKISDFGLARLFPGEDTHVNTFRISGTH----G 255
           E      IHRDI A N LL         KI DFG+AR    +      +R  G       
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKGGCAMLPVK 251
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +M PE  + G  + KTD +S+GVL+ EI S
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 10/201 (4%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           ++   ++G G  G VY  + +  GQE+A++++++  +       NE+ ++ + ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
                  G E  +V EYL   SL     D    + +D      +     + L +LH    
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 135
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGY 266
            ++IHRDIK+ NILL    + K++DFG       E +  +   + GT  +MAPE      
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSX--MVGTPYWMAPEVVTRKA 192
Query: 267 LSVKTDVFSYGVLVLEIVSGR 287
              K D++S G++ +E++ G 
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGE 213

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 10/201 (4%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           ++   ++G G  G VY  + +  GQE+A++++++  +       NE+ ++ + ++ N+V 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
                  G E  +V EYL   SL     D    + +D      +     + L +LH    
Sbjct: 83  YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 136
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGY 266
            ++IHRDIK+ NILL    + K++DFG       E +  +   + GT  +MAPE      
Sbjct: 137 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSX--MVGTPYWMAPEVVTRKA 193
Query: 267 LSVKTDVFSYGVLVLEIVSGR 287
              K D++S G++ +E++ G 
Sbjct: 194 YGPKVDIWSLGIMAIEMIEGE 214

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 105/202 (51%), Gaps = 17/202 (8%)
Query: 94  LGHGGFGPVYRG--LMPNGQEI--AVKKL-SVDSRQGLREFTNEVKLLLKIQHKNLVTLF 148
           +G G FG V  G   +P  +EI  A+K L S  + +  R+F +E  ++ +  H N++ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G   +    M++ E++ N SLD F+  +             ++ G+A G+ YL   A   
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYL---ADMN 129
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAPEYAL 263
            +HR + A NIL++  L  K+SDFGL+R F  +DT   T+  S   G     + APE   
Sbjct: 130 YVHRALAARNILVNSNLVCKVSDFGLSR-FLEDDTSDPTY-TSALGGKIPIRWTAPEAIQ 187
Query: 264 HGYLSVKTDVFSYGVLVLEIVS 285
           +   +  +DV+SYG+++ E++S
Sbjct: 188 YRKFTSASDVWSYGIVMWEVMS 209

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 107/220 (48%), Gaps = 31/220 (14%)
Query: 94  LGHGGFGPVYRGLM------PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVT 146
           LG G FG V +              +AVK L  + S   LR+  +E  +L ++ H +++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTK-------------SSSLDWTTRYRIVMG 193
           L+G C++    +L+ EY    SL  F+ +  K             SSSLD      + MG
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 194 --------VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV 245
                   +++G+ YL E    +++HRD+ A NIL+ E    KISDFGL+R    ED+ V
Sbjct: 151 DLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 246 NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
              +      +MA E       + ++DV+S+GVL+ EIV+
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/245 (28%), Positives = 115/245 (46%), Gaps = 28/245 (11%)
Query: 92  NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCC 151
            +LG G FG V+        ++AVK +   S   +  F  E  ++  +QH  LV L    
Sbjct: 188 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVV 246
Query: 152 AEGPEKMLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
            + P   ++ E++   SL D+   D+     L     +     +A G+ ++ +      I
Sbjct: 247 TKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS--AQIAEGMAFIEQR---NYI 300
Query: 211 HRDIKASNILLDEQLNPKISDFGLARL---FPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
           HRD++A+NIL+   L  KI+DFGLAR+   FP +              + APE    G  
Sbjct: 301 HRDLRAANILVSASLVCKIADFGLARVGAKFPIK--------------WTAPEAINFGSF 346
Query: 268 SVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKC- 325
           ++K+DV+S+G+L++EIV+ GR  + G    E    L   + + + E   E +   + +C 
Sbjct: 347 TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCW 406
Query: 326 -NRDE 329
            NR E
Sbjct: 407 KNRPE 411

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 17/201 (8%)
Query: 92  NQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLVTLFG 149
            Q+G G FG V+ G L  +   +AVK         L+ +F  E ++L +  H N+V L G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
            C +     +V E +  +  D+  F +T+ + L   T  ++V   A G+ YL  +     
Sbjct: 180 VCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISG-----THGYMAPEYALH 264
           IHRD+ A N L+ E+   KISDFG++R     +     +  SG        + APE   +
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSR-----EEADGVYAASGGLRQVPVKWTAPEALNY 289
Query: 265 GYLSVKTDVFSYGVLVLEIVS 285
           G  S ++DV+S+G+L+ E  S
Sbjct: 290 GRYSSESDVWSFGILLWETFS 310

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 94  LGHGGFGPVYRGL---MPNGQ---EIAVKKLS-VDSRQGLREFTNEVKLLLKIQHKNLVT 146
           LGHG FG VY G    MPN     ++AVK L  V S Q   +F  E  ++ K  H+N+V 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARGLLYLH 202
             G   +   + ++ E +    L  F+ +     ++ SSL       +   +A G  YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 203 EEAPARIIHRDIKASNILLD---EQLNPKISDFGLARLFPGEDTHVNTFRISGTH----G 255
           E      IHRDI A N LL         KI DFG+A+    +    + +R  G       
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ----DIYRASYYRKGGCAMLPVK 211
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +M PE  + G  + KTD +S+GVL+ EI S
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 81  LQVATNFFSDLNQ----LGHGGFGPVYRGL-MPNGQEIAVKKLS---VDSRQGLREFTNE 132
           +Q +T  FSD  +    LG G FG V        GQE AVK +S   V  +        E
Sbjct: 40  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 99
Query: 133 VKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVM 192
           V+LL ++ H N++ L+    +     LV E      L   I  + + S +D     RI+ 
Sbjct: 100 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA---RIIR 156
Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQ---LNPKISDFGLARLFPGEDTHVNTFR 249
            V  G+ Y+H+    +I+HRD+K  N+LL+ +    N +I DFGL+  F       +   
Sbjct: 157 QVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI- 212
Query: 250 ISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
             GT  Y+APE  LHG    K DV+S GV++  ++SG
Sbjct: 213 --GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 114/210 (54%), Gaps = 13/210 (6%)
Query: 81  LQVATNFFSDLNQLGHGGFGPVYR-GLMPNGQEIAVKKLSVDSRQGLR-EFTNEVKLLLK 138
           +++  + F  +++LG G  G V++    P+G  +A K + ++ +  +R +   E+++L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 139 IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
                +V  +G      E  +  E++   SLD  +    K+  +      ++ + V +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA-RLFPGEDTHVNTFRISGTHGYM 257
            YL E+   +I+HRD+K SNIL++ +   K+ DFG++ +L    D+  N+F   GT  YM
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSF--VGTRSYM 170
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
           +PE     + SV++D++S G+ ++E+  GR
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 107/220 (48%), Gaps = 31/220 (14%)
Query: 94  LGHGGFGPVYRGLM------PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVT 146
           LG G FG V +              +AVK L  + S   LR+  +E  +L ++ H +++ 
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTK-------------SSSLDWTTRYRIVMG 193
           L+G C++    +L+ EY    SL  F+ +  K             SSSLD      + MG
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 194 --------VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV 245
                   +++G+ YL E +   ++HRD+ A NIL+ E    KISDFGL+R    ED+ V
Sbjct: 151 DLISFAWQISQGMQYLAEMS---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 246 NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
              +      +MA E       + ++DV+S+GVL+ EIV+
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 81  LQVATNFFSDLNQ----LGHGGFGPVYRGL-MPNGQEIAVKKLS---VDSRQGLREFTNE 132
           +Q +T  FSD  +    LG G FG V        GQE AVK +S   V  +        E
Sbjct: 41  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 100
Query: 133 VKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVM 192
           V+LL ++ H N++ L+    +     LV E      L   I  + + S +D     RI+ 
Sbjct: 101 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA---RIIR 157
Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQ---LNPKISDFGLARLFPGEDTHVNTFR 249
            V  G+ Y+H+    +I+HRD+K  N+LL+ +    N +I DFGL+  F       +   
Sbjct: 158 QVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI- 213
Query: 250 ISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
             GT  Y+APE  LHG    K DV+S GV++  ++SG
Sbjct: 214 --GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 101/214 (47%), Gaps = 28/214 (13%)
Query: 94  LGHGGFGPVYRGLMPN-GQEIAVKKLSV---------DSRQGLREFTNEVKLLLKI-QHK 142
           LG G FG V        G+E AV K++V         D ++ L    +E+K++  + QH+
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL---MSELKIMSHLGQHE 110
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTK-----------SSSLDWTTRYRIV 191
           N+V L G C  G   +++ EY     L  F+  K++           +S+L         
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFS 170
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS 251
             VA+G+ +L   A    IHRD+ A N+LL      KI DFGLAR    +  ++      
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 252 GTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
               +MAPE       +V++DV+SYG+L+ EI S
Sbjct: 228 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 92  NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCC 151
            ++G G FG VY+G       + + K+   + +  + F NEV +L K +H N++   G  
Sbjct: 42  TRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM 101
Query: 152 AEGPEKMLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
            +     +V ++    SL  +    +TK           I    A+G+ YLH +    II
Sbjct: 102 TKD-NLAIVTQWCEGSSLYKHLHVQETKFQMFQLID---IARQTAQGMDYLHAK---NII 154
Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL---HGYL 267
           HRD+K++NI L E L  KI DFGLA +           + +G+  +MAPE      +   
Sbjct: 155 HRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPF 214
Query: 268 SVKTDVFSYGVLVLEIVSG 286
           S ++DV+SYG+++ E+++G
Sbjct: 215 SFQSDVYSYGIVLYELMTG 233

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 112/209 (53%), Gaps = 11/209 (5%)
Query: 81  LQVATNFFSDLNQLGHGGFGPVYR-GLMPNGQEIAVKKLSVDSRQGLR-EFTNEVKLLLK 138
           +++  + F  +++LG G  G V++    P+G  +A K + ++ +  +R +   E+++L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 139 IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
                +V  +G      E  +  E++   SLD  +    K+  +      ++ + V +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMA 258
            YL E+   +I+HRD+K SNIL++ +   K+ DFG++      D+  N+F   GT  YM+
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF--VGTRSYMS 171
Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
           PE     + SV++D++S G+ ++E+  GR
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 112/209 (53%), Gaps = 11/209 (5%)
Query: 81  LQVATNFFSDLNQLGHGGFGPVYR-GLMPNGQEIAVKKLSVDSRQGLR-EFTNEVKLLLK 138
           +++  + F  +++LG G  G V++    P+G  +A K + ++ +  +R +   E+++L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 139 IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
                +V  +G      E  +  E++   SLD  +    K+  +      ++ + V +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMA 258
            YL E+   +I+HRD+K SNIL++ +   K+ DFG++      D+  N+F   GT  YM+
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSF--VGTRSYMS 171
Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
           PE     + SV++D++S G+ ++E+  GR
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 112/209 (53%), Gaps = 11/209 (5%)
Query: 81  LQVATNFFSDLNQLGHGGFGPVYR-GLMPNGQEIAVKKLSVDSRQGLR-EFTNEVKLLLK 138
           +++  + F  +++LG G  G V++    P+G  +A K + ++ +  +R +   E+++L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 139 IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
                +V  +G      E  +  E++   SLD  +    K+  +      ++ + V +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMA 258
            YL E+   +I+HRD+K SNIL++ +   K+ DFG++      D+  N+F   GT  YM+
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSF--VGTRSYMS 171
Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
           PE     + SV++D++S G+ ++E+  GR
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 110/203 (54%), Gaps = 13/203 (6%)
Query: 88  FSDLNQLGHGGFGPVYR-GLMPNGQEIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLV 145
           F  +++LG G  G V++    P+G  +A K + ++ +  +R +   E+++L +     +V
Sbjct: 70  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 129
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
             +G      E  +  E++   SLD  +    K+  +      ++ + V +GL YL E+ 
Sbjct: 130 GFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLREKH 186
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLA-RLFPGEDTHVNTFRISGTHGYMAPEYALH 264
             +I+HRD+K SNIL++ +   K+ DFG++ +L    D+  N+F   GT  YM+PE    
Sbjct: 187 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSF--VGTRSYMSPERLQG 239
Query: 265 GYLSVKTDVFSYGVLVLEIVSGR 287
            + SV++D++S G+ ++E+  GR
Sbjct: 240 THYSVQSDIWSMGLSLVEMAVGR 262

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 81  LQVATNFFSDLNQ----LGHGGFGPVYRGL-MPNGQEIAVKKLS---VDSRQGLREFTNE 132
           +Q +T  FSD  +    LG G FG V        GQE AVK +S   V  +        E
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 133 VKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVM 192
           V+LL ++ H N++ L+    +     LV E      L   I  + + S +D     RI+ 
Sbjct: 77  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA---RIIR 133
Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQ---LNPKISDFGLARLFPGEDTHVNTFR 249
            V  G+ Y+H+    +I+HRD+K  N+LL+ +    N +I DFGL+  F       +   
Sbjct: 134 QVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI- 189
Query: 250 ISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
             GT  Y+APE  LHG    K DV+S GV++  ++SG
Sbjct: 190 --GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 108/202 (53%), Gaps = 11/202 (5%)
Query: 88  FSDLNQLGHGGFGPVYR-GLMPNGQEIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLV 145
           F  +++LG G  G V++    P+G  +A K + ++ +  +R +   E+++L +     +V
Sbjct: 27  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 86
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
             +G      E  +  E++   SLD  +    K+  +      ++ + V +GL YL E+ 
Sbjct: 87  GFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLREKH 143
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHG 265
             +I+HRD+K SNIL++ +   K+ DFG++      D+  N+F   GT  YM+PE     
Sbjct: 144 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSMANSF--VGTRSYMSPERLQGT 197
Query: 266 YLSVKTDVFSYGVLVLEIVSGR 287
           + SV++D++S G+ ++E+  GR
Sbjct: 198 HYSVQSDIWSMGLSLVEMAVGR 219

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 114/210 (54%), Gaps = 13/210 (6%)
Query: 81  LQVATNFFSDLNQLGHGGFGPVYR-GLMPNGQEIAVKKLSVDSRQGLR-EFTNEVKLLLK 138
           +++  + F  +++LG G  G V++    P+G  +A K + ++ +  +R +   E+++L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 139 IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
                +V  +G      E  +  E++   SLD  +    K+  +      ++ + V +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA-RLFPGEDTHVNTFRISGTHGYM 257
            YL E+   +I+HRD+K SNIL++ +   K+ DFG++ +L    D+  N+F   GT  YM
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSF--VGTRSYM 170
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
           +PE     + SV++D++S G+ ++E+  GR
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 100/213 (46%), Gaps = 26/213 (12%)
Query: 94  LGHGGFGPVYRGLMPN-GQEIAVKKLSV---------DSRQGLREFTNEVKLLLKI-QHK 142
           LG G FG V        G+E AV K++V         D ++ L    +E+K++  + QH+
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL---MSELKIMSHLGQHE 110
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVA--RGLLY 200
           N+V L G C  G   +++ EY     L  F+  + KS  L+    + I    A  R LL+
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFL--RRKSRVLETDPAFAIANSTASTRDLLH 168
Query: 201 LHEE--------APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISG 252
              +        A    IHRD+ A N+LL      KI DFGLAR    +  ++       
Sbjct: 169 FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 253 THGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
              +MAPE       +V++DV+SYG+L+ EI S
Sbjct: 229 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 127/254 (50%), Gaps = 26/254 (10%)
Query: 94  LGHGGFGPVYRGLM--PNGQEI--AVKKLSVDSRQG-LREFTNEVKLLLKIQHKNLVTLF 148
           +G G FG VY G +   +G++I  AVK L+  +  G + +F  E  ++    H N+++L 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 149 GCC--AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           G C  +EG   ++V  Y+ +  L  FI ++T + ++     +   + VA+G+ YL   A 
Sbjct: 97  GICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKYL---AS 150
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLAR-LFPGEDTHV-NTFRISGTHGYMAPEYALH 264
            + +HRD+ A N +LDE+   K++DFGLAR ++  E   V N         +MA E    
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQT 210
Query: 265 GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE---LVDP- 320
              + K+DV+S+GVL+ E+++      G       +    T  L QG + L+     DP 
Sbjct: 211 QKFTTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 265
Query: 321 --SLAKCNRDEAAM 332
              + KC   +A M
Sbjct: 266 YEVMLKCWHPKAEM 279

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 110/203 (54%), Gaps = 13/203 (6%)
Query: 88  FSDLNQLGHGGFGPVYR-GLMPNGQEIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLV 145
           F  +++LG G  G V++    P+G  +A K + ++ +  +R +   E+++L +     +V
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
             +G      E  +  E++   SLD  +    K+  +      ++ + V +GL YL E+ 
Sbjct: 95  GFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLREKH 151
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLA-RLFPGEDTHVNTFRISGTHGYMAPEYALH 264
             +I+HRD+K SNIL++ +   K+ DFG++ +L    D+  N+F   GT  YM+PE    
Sbjct: 152 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSF--VGTRSYMSPERLQG 204
Query: 265 GYLSVKTDVFSYGVLVLEIVSGR 287
            + SV++D++S G+ ++E+  GR
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGR 227

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 81/275 (29%), Positives = 116/275 (42%), Gaps = 43/275 (15%)
Query: 91  LNQLGHGGFGPVYRGLM--PNGQ--EIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKN 143
           L +LG G FG V RG    P+G+   +AVK L  D     + + +F  EV  +  + H+N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWT--TRYRIVMGVARGLLYL 201
           L+ L+G     P KM V E  P  SL     D+ +     +   T  R  + VA G+ YL
Sbjct: 83  LIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 137
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH-VNTFRISGTHGYMAPE 260
             +   R IHRD+ A N+LL  +   KI DFGL R  P  D H V          + APE
Sbjct: 138 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPE 194
Query: 261 YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD- 319
                  S  +D + +GV + E+ +         G+E        W    G + L  +D 
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFT--------YGQE-------PWIGLNGSQILHKIDK 239
Query: 320 -----PSLAKCNRDEAAMCIQLGLLCCQQSVAERP 349
                P    C +D   + +Q    C      +RP
Sbjct: 240 EGERLPRPEDCPQDIYNVMVQ----CWAHKPEDRP 270

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/190 (32%), Positives = 100/190 (52%), Gaps = 15/190 (7%)
Query: 108 PNGQEIAVKKLSVDSRQ-GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN 166
           P  +++A+K+++++  Q  + E   E++ + +  H N+V+ +       E  LV + L  
Sbjct: 38  PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG 97
Query: 167 KSLDYFIFD-----KTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL 221
            S+   I       + KS  LD +T   I+  V  GL YLH+      IHRD+KA NILL
Sbjct: 98  GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILL 154
Query: 222 DEQLNPKISDFGL-ARLFPGEDTHVNTFRIS--GTHGYMAPEY--ALHGYLSVKTDVFSY 276
            E  + +I+DFG+ A L  G D   N  R +  GT  +MAPE    + GY   K D++S+
Sbjct: 155 GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGY-DFKADIWSF 213
Query: 277 GVLVLEIVSG 286
           G+  +E+ +G
Sbjct: 214 GITAIELATG 223

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/190 (32%), Positives = 100/190 (52%), Gaps = 15/190 (7%)
Query: 108 PNGQEIAVKKLSVDSRQ-GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN 166
           P  +++A+K+++++  Q  + E   E++ + +  H N+V+ +       E  LV + L  
Sbjct: 33  PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG 92
Query: 167 KSLDYFIFD-----KTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL 221
            S+   I       + KS  LD +T   I+  V  GL YLH+      IHRD+KA NILL
Sbjct: 93  GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILL 149
Query: 222 DEQLNPKISDFGL-ARLFPGEDTHVNTFRIS--GTHGYMAPEY--ALHGYLSVKTDVFSY 276
            E  + +I+DFG+ A L  G D   N  R +  GT  +MAPE    + GY   K D++S+
Sbjct: 150 GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGY-DFKADIWSF 208
Query: 277 GVLVLEIVSG 286
           G+  +E+ +G
Sbjct: 209 GITAIELATG 218

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 81/275 (29%), Positives = 116/275 (42%), Gaps = 43/275 (15%)
Query: 91  LNQLGHGGFGPVYRGLM--PNGQ--EIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKN 143
           L +LG G FG V RG    P+G+   +AVK L  D     + + +F  EV  +  + H+N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWT--TRYRIVMGVARGLLYL 201
           L+ L+G     P KM V E  P  SL     D+ +     +   T  R  + VA G+ YL
Sbjct: 83  LIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 137
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH-VNTFRISGTHGYMAPE 260
             +   R IHRD+ A N+LL  +   KI DFGL R  P  D H V          + APE
Sbjct: 138 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194
Query: 261 YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD- 319
                  S  +D + +GV + E+ +         G+E        W    G + L  +D 
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFT--------YGQE-------PWIGLNGSQILHKIDK 239
Query: 320 -----PSLAKCNRDEAAMCIQLGLLCCQQSVAERP 349
                P    C +D   + +Q    C      +RP
Sbjct: 240 EGERLPRPEDCPQDIYNVMVQ----CWAHKPEDRP 270

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 96/196 (48%), Gaps = 7/196 (3%)
Query: 92  NQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLVTLFG 149
            Q+G G FG V+ G L  +   +AVK         L+ +F  E ++L +  H N+V L G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
            C +     +V E +  +  D+  F +T+ + L   T  ++V   A G+ YL  +     
Sbjct: 180 VCTQKQPIYIVMELV--QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           IHRD+ A N L+ E+   KISDFG++R         +         + APE   +G  S 
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 270 KTDVFSYGVLVLEIVS 285
           ++DV+S+G+L+ E  S
Sbjct: 295 ESDVWSFGILLWETFS 310

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 105/217 (48%), Gaps = 21/217 (9%)
Query: 81  LQVATNFFSDLNQ----LGHGGFGPVYRGL-MPNGQEIAVKKLS---VDSRQGLREFTNE 132
           +Q +T  FSD  +    LG G FG V        GQE AVK +S   V  +        E
Sbjct: 23  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 82
Query: 133 VKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVM 192
           V+LL ++ H N++ L+    +     LV E      L   I  + + S +D     RI+ 
Sbjct: 83  VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA---RIIR 139
Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQ---LNPKISDFGLARLFPGEDTHVNTFR 249
            V  G+ Y+H+    +I+HRD+K  N+LL+ +    N +I DFGL+  F       +   
Sbjct: 140 QVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI- 195
Query: 250 ISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
             GT  Y+APE  LHG    K DV+S GV++  ++SG
Sbjct: 196 --GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 81/275 (29%), Positives = 116/275 (42%), Gaps = 43/275 (15%)
Query: 91  LNQLGHGGFGPVYRGLM--PNGQ--EIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKN 143
           L +LG G FG V RG    P+G+   +AVK L  D     + + +F  EV  +  + H+N
Sbjct: 17  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 76
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWT--TRYRIVMGVARGLLYL 201
           L+ L+G     P KM V E  P  SL     D+ +     +   T  R  + VA G+ YL
Sbjct: 77  LIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 131
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH-VNTFRISGTHGYMAPE 260
             +   R IHRD+ A N+LL  +   KI DFGL R  P  D H V          + APE
Sbjct: 132 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 188
Query: 261 YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD- 319
                  S  +D + +GV + E+ +         G+E        W    G + L  +D 
Sbjct: 189 SLKTRTFSHASDTWMFGVTLWEMFT--------YGQEP-------WIGLNGSQILHKIDK 233
Query: 320 -----PSLAKCNRDEAAMCIQLGLLCCQQSVAERP 349
                P    C +D   + +Q    C      +RP
Sbjct: 234 EGERLPRPEDCPQDIYNVMVQ----CWAHKPEDRP 264

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 81/275 (29%), Positives = 116/275 (42%), Gaps = 43/275 (15%)
Query: 91  LNQLGHGGFGPVYRGLM--PNGQ--EIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKN 143
           L +LG G FG V RG    P+G+   +AVK L  D     + + +F  EV  +  + H+N
Sbjct: 13  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWT--TRYRIVMGVARGLLYL 201
           L+ L+G     P KM V E  P  SL     D+ +     +   T  R  + VA G+ YL
Sbjct: 73  LIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH-VNTFRISGTHGYMAPE 260
             +   R IHRD+ A N+LL  +   KI DFGL R  P  D H V          + APE
Sbjct: 128 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 261 YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD- 319
                  S  +D + +GV + E+ +         G+E        W    G + L  +D 
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFT--------YGQE-------PWIGLNGSQILHKIDK 229
Query: 320 -----PSLAKCNRDEAAMCIQLGLLCCQQSVAERP 349
                P    C +D   + +Q    C      +RP
Sbjct: 230 EGERLPRPEDCPQDIYNVMVQ----CWAHKPEDRP 260

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 81/275 (29%), Positives = 116/275 (42%), Gaps = 43/275 (15%)
Query: 91  LNQLGHGGFGPVYRGLM--PNGQ--EIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKN 143
           L +LG G FG V RG    P+G+   +AVK L  D     + + +F  EV  +  + H+N
Sbjct: 17  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 76
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWT--TRYRIVMGVARGLLYL 201
           L+ L+G     P KM V E  P  SL     D+ +     +   T  R  + VA G+ YL
Sbjct: 77  LIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 131
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH-VNTFRISGTHGYMAPE 260
             +   R IHRD+ A N+LL  +   KI DFGL R  P  D H V          + APE
Sbjct: 132 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 188
Query: 261 YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD- 319
                  S  +D + +GV + E+ +         G+E        W    G + L  +D 
Sbjct: 189 SLKTRTFSHASDTWMFGVTLWEMFT--------YGQE-------PWIGLNGSQILHKIDK 233
Query: 320 -----PSLAKCNRDEAAMCIQLGLLCCQQSVAERP 349
                P    C +D   + +Q    C      +RP
Sbjct: 234 EGERLPRPEDCPQDIYNVMVQ----CWAHKPEDRP 264

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 81/275 (29%), Positives = 116/275 (42%), Gaps = 43/275 (15%)
Query: 91  LNQLGHGGFGPVYRGLM--PNGQ--EIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKN 143
           L +LG G FG V RG    P+G+   +AVK L  D     + + +F  EV  +  + H+N
Sbjct: 13  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWT--TRYRIVMGVARGLLYL 201
           L+ L+G     P KM V E  P  SL     D+ +     +   T  R  + VA G+ YL
Sbjct: 73  LIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH-VNTFRISGTHGYMAPE 260
             +   R IHRD+ A N+LL  +   KI DFGL R  P  D H V          + APE
Sbjct: 128 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 261 YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD- 319
                  S  +D + +GV + E+ +         G+E        W    G + L  +D 
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFT--------YGQE-------PWIGLNGSQILHKIDK 229
Query: 320 -----PSLAKCNRDEAAMCIQLGLLCCQQSVAERP 349
                P    C +D   + +Q    C      +RP
Sbjct: 230 EGERLPRPEDCPQDIYNVMVQ----CWAHKPEDRP 260

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/224 (30%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 76  FDLRTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVK 134
            DL  L+     F  +  +G+G +G VY+G  +  GQ  A+K + V   +   E   E+ 
Sbjct: 14  IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEIN 72
Query: 135 LLLKI-QHKNLVTLFGC-CAEGPEKM-----LVYEYLPNKSLDYFIFDKTKSSSLDWTTR 187
           +L K   H+N+ T +G    + P  M     LV E+    S+   I + TK ++L     
Sbjct: 73  MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWI 131
Query: 188 YRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
             I   + RGL +LH+    ++IHRDIK  N+LL E    K+ DFG++          NT
Sbjct: 132 AYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT 188
Query: 248 FRISGTHGYMAPEYAL-----HGYLSVKTDVFSYGVLVLEIVSG 286
           F   GT  +MAPE              K+D++S G+  +E+  G
Sbjct: 189 F--IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 81/275 (29%), Positives = 116/275 (42%), Gaps = 43/275 (15%)
Query: 91  LNQLGHGGFGPVYRGLM--PNGQ--EIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKN 143
           L +LG G FG V RG    P+G+   +AVK L  D     + + +F  EV  +  + H+N
Sbjct: 13  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 72
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWT--TRYRIVMGVARGLLYL 201
           L+ L+G     P KM V E  P  SL     D+ +     +   T  R  + VA G+ YL
Sbjct: 73  LIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH-VNTFRISGTHGYMAPE 260
             +   R IHRD+ A N+LL  +   KI DFGL R  P  D H V          + APE
Sbjct: 128 ESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPE 184
Query: 261 YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD- 319
                  S  +D + +GV + E+ +         G+E        W    G + L  +D 
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFT--------YGQE-------PWIGLNGSQILHKIDK 229
Query: 320 -----PSLAKCNRDEAAMCIQLGLLCCQQSVAERP 349
                P    C +D   + +Q    C      +RP
Sbjct: 230 EGERLPRPEDCPQDIYNVMVQ----CWAHKPEDRP 260

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 107/213 (50%), Gaps = 13/213 (6%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLSVDSRQGLREFT-NEVKLLLKIQHKN 143
           +++L+ +G G +G V   Y  L  N   +A+KK+S    Q   + T  E+K+LL+ +H+N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHEN 86
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           ++ +         + +   Y+    ++  ++   K+  L        +  + RGL Y+H 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF-RISGTHGYMAPEYA 262
              A ++HRD+K SN+LL+   + KI DFGLAR+   +  H         T  Y APE  
Sbjct: 147 ---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 263 LH--GYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           L+  GY +   D++S G ++ E++S R    G+
Sbjct: 204 LNSKGY-TKSIDIWSVGCILAEMLSNRPIFPGK 235

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 108/214 (50%), Gaps = 19/214 (8%)
Query: 91  LNQLGHGGFGPVY--RGLMPNGQEIAVKKLSVDSRQ----GLREFTNEVKLLLKIQHKNL 144
           L  +G G F  V   R ++  G+E+A+K   +D  Q     L++   EV+++  + H N+
Sbjct: 17  LKTIGKGNFAKVKLARHIL-TGREVAIK--IIDKTQLNPTSLQKLFREVRIMKILNHPNI 73
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V LF          L+ EY     +  ++    +    +  +++R ++   +   Y H++
Sbjct: 74  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ---YCHQK 130
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE-YAL 263
              RI+HRD+KA N+LLD  +N KI+DFG +  F      ++TF   G+  Y APE +  
Sbjct: 131 ---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDTF--CGSPPYAAPELFQG 184
Query: 264 HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKE 297
             Y   + DV+S GV++  +VSG    DG+  KE
Sbjct: 185 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 218

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 127/254 (50%), Gaps = 26/254 (10%)
Query: 94  LGHGGFGPVYRGLM--PNGQEI--AVKKLSVDSRQG-LREFTNEVKLLLKIQHKNLVTLF 148
           +G G FG VY G +   +G++I  AVK L+  +  G + +F  E  ++    H N+++L 
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 149 GCC--AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           G C  +EG   ++V  Y+ +  L  FI ++T + ++     +   + VA+G+ YL   A 
Sbjct: 117 GICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKYL---AS 170
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLAR-LFPGEDTHV-NTFRISGTHGYMAPEYALH 264
            + +HRD+ A N +LDE+   K++DFGLAR ++  E   V N         +MA E    
Sbjct: 171 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 230
Query: 265 GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE---LVDP- 320
              + K+DV+S+GVL+ E+++      G       +    T  L QG + L+     DP 
Sbjct: 231 QKFTTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 285
Query: 321 --SLAKCNRDEAAM 332
              + KC   +A M
Sbjct: 286 YEVMLKCWHPKAEM 299

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 127/254 (50%), Gaps = 26/254 (10%)
Query: 94  LGHGGFGPVYRGLM--PNGQEI--AVKKLSVDSRQG-LREFTNEVKLLLKIQHKNLVTLF 148
           +G G FG VY G +   +G++I  AVK L+  +  G + +F  E  ++    H N+++L 
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 149 GCC--AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           G C  +EG   ++V  Y+ +  L  FI ++T + ++     +   + VA+G+ YL   A 
Sbjct: 116 GICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKYL---AS 169
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLAR-LFPGEDTHV-NTFRISGTHGYMAPEYALH 264
            + +HRD+ A N +LDE+   K++DFGLAR ++  E   V N         +MA E    
Sbjct: 170 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 229
Query: 265 GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE---LVDP- 320
              + K+DV+S+GVL+ E+++      G       +    T  L QG + L+     DP 
Sbjct: 230 QKFTTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 284
Query: 321 --SLAKCNRDEAAM 332
              + KC   +A M
Sbjct: 285 YEVMLKCWHPKAEM 298

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 127/254 (50%), Gaps = 26/254 (10%)
Query: 94  LGHGGFGPVYRGLM--PNGQEI--AVKKLSVDSRQG-LREFTNEVKLLLKIQHKNLVTLF 148
           +G G FG VY G +   +G++I  AVK L+  +  G + +F  E  ++    H N+++L 
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 149 GCC--AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           G C  +EG   ++V  Y+ +  L  FI ++T + ++     +   + VA+G+ YL   A 
Sbjct: 96  GICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKYL---AS 149
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLAR-LFPGEDTHV-NTFRISGTHGYMAPEYALH 264
            + +HRD+ A N +LDE+   K++DFGLAR ++  E   V N         +MA E    
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 209
Query: 265 GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE---LVDP- 320
              + K+DV+S+GVL+ E+++      G       +    T  L QG + L+     DP 
Sbjct: 210 QKFTTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 264
Query: 321 --SLAKCNRDEAAM 332
              + KC   +A M
Sbjct: 265 YEVMLKCWHPKAEM 278

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 107/213 (50%), Gaps = 13/213 (6%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLSVDSRQGLREFT-NEVKLLLKIQHKN 143
           +++L+ +G G +G V   Y  L  N   +A+KK+S    Q   + T  E+K+LL+ +H+N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           ++ +         + +   Y+    ++  ++   K+  L        +  + RGL Y+H 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF-RISGTHGYMAPEYA 262
              A ++HRD+K SN+LL+   + KI DFGLAR+   +  H         T  Y APE  
Sbjct: 147 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIM 203
Query: 263 LH--GYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           L+  GY +   D++S G ++ E++S R    G+
Sbjct: 204 LNSKGY-TKSIDIWSVGCILAEMLSNRPIFPGK 235

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 107/213 (50%), Gaps = 13/213 (6%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLSVDSRQGLREFT-NEVKLLLKIQHKN 143
           +++L+ +G G +G V   Y  L  N   +A+KK+S    Q   + T  E+K+LL+ +H+N
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 87
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           ++ +         + +   Y+    ++  ++   K+  L        +  + RGL Y+H 
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 147
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF-RISGTHGYMAPEYA 262
              A ++HRD+K SN+LL+   + KI DFGLAR+   +  H         T  Y APE  
Sbjct: 148 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIM 204
Query: 263 LH--GYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           L+  GY +   D++S G ++ E++S R    G+
Sbjct: 205 LNSKGY-TKSIDIWSVGCILAEMLSNRPIFPGK 236

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 127/254 (50%), Gaps = 26/254 (10%)
Query: 94  LGHGGFGPVYRGLM--PNGQEI--AVKKLSVDSRQG-LREFTNEVKLLLKIQHKNLVTLF 148
           +G G FG VY G +   +G++I  AVK L+  +  G + +F  E  ++    H N+++L 
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 149 GCC--AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           G C  +EG   ++V  Y+ +  L  FI ++T + ++     +   + VA+G+ YL   A 
Sbjct: 90  GICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKYL---AS 143
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLAR-LFPGEDTHV-NTFRISGTHGYMAPEYALH 264
            + +HRD+ A N +LDE+   K++DFGLAR ++  E   V N         +MA E    
Sbjct: 144 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 203
Query: 265 GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE---LVDP- 320
              + K+DV+S+GVL+ E+++      G       +    T  L QG + L+     DP 
Sbjct: 204 QKFTTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 258
Query: 321 --SLAKCNRDEAAM 332
              + KC   +A M
Sbjct: 259 YEVMLKCWHPKAEM 272

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 107/213 (50%), Gaps = 13/213 (6%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLSVDSRQGLREFT-NEVKLLLKIQHKN 143
           +++L+ +G G +G V   Y  L  N   +A+KK+S    Q   + T  E+K+LL+ +H+N
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 80
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           ++ +         + +   Y+    ++  ++   K+  L        +  + RGL Y+H 
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 140
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF-RISGTHGYMAPEYA 262
              A ++HRD+K SN+LL+   + KI DFGLAR+   +  H         T  Y APE  
Sbjct: 141 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 197
Query: 263 LH--GYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           L+  GY +   D++S G ++ E++S R    G+
Sbjct: 198 LNSKGY-TKSIDIWSVGCILAEMLSNRPIFPGK 229

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 107/213 (50%), Gaps = 13/213 (6%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLSVDSRQGLREFT-NEVKLLLKIQHKN 143
           +++L+ +G G +G V   Y  L  N   +A+KK+S    Q   + T  E+K+LL+ +H+N
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 80
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           ++ +         + +   Y+    ++  ++   K+  L        +  + RGL Y+H 
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 140
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF-RISGTHGYMAPEYA 262
              A ++HRD+K SN+LL+   + KI DFGLAR+   +  H         T  Y APE  
Sbjct: 141 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 197
Query: 263 LH--GYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           L+  GY +   D++S G ++ E++S R    G+
Sbjct: 198 LNSKGY-TKSIDIWSVGCILAEMLSNRPIFPGK 229

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 107/213 (50%), Gaps = 13/213 (6%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLSVDSRQGLREFT-NEVKLLLKIQHKN 143
           +++L+ +G G +G V   Y  L  N   +A+KK+S    Q   + T  E+K+LL+ +H+N
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 87
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           ++ +         + +   Y+    ++  ++   K+  L        +  + RGL Y+H 
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 147
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF-RISGTHGYMAPEYA 262
              A ++HRD+K SN+LL+   + KI DFGLAR+   +  H         T  Y APE  
Sbjct: 148 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 204
Query: 263 LH--GYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           L+  GY +   D++S G ++ E++S R    G+
Sbjct: 205 LNSKGY-TKSIDIWSVGCILAEMLSNRPIFPGK 236

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 127/254 (50%), Gaps = 26/254 (10%)
Query: 94  LGHGGFGPVYRGLM--PNGQEI--AVKKLSVDSRQG-LREFTNEVKLLLKIQHKNLVTLF 148
           +G G FG VY G +   +G++I  AVK L+  +  G + +F  E  ++    H N+++L 
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 149 GCC--AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           G C  +EG   ++V  Y+ +  L  FI ++T + ++     +   + VA+G+ YL   A 
Sbjct: 95  GICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKYL---AS 148
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLAR-LFPGEDTHV-NTFRISGTHGYMAPEYALH 264
            + +HRD+ A N +LDE+   K++DFGLAR ++  E   V N         +MA E    
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 208
Query: 265 GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE---LVDP- 320
              + K+DV+S+GVL+ E+++      G       +    T  L QG + L+     DP 
Sbjct: 209 QKFTTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 263
Query: 321 --SLAKCNRDEAAM 332
              + KC   +A M
Sbjct: 264 YEVMLKCWHPKAEM 277

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 107/213 (50%), Gaps = 13/213 (6%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLSVDSRQGLREFT-NEVKLLLKIQHKN 143
           +++L+ +G G +G V   Y  L  N   +A+KK+S    Q   + T  E+K+LL+ +H+N
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 88
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           ++ +         + +   Y+    ++  ++   K+  L        +  + RGL Y+H 
Sbjct: 89  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 148
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF-RISGTHGYMAPEYA 262
              A ++HRD+K SN+LL+   + KI DFGLAR+   +  H         T  Y APE  
Sbjct: 149 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 205
Query: 263 LH--GYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           L+  GY +   D++S G ++ E++S R    G+
Sbjct: 206 LNSKGY-TKSIDIWSVGCILAEMLSNRPIFPGK 237

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 107/213 (50%), Gaps = 13/213 (6%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLSVDSRQGLREFT-NEVKLLLKIQHKN 143
           +++L+ +G G +G V   Y  L  N   +A+KK+S    Q   + T  E+K+LL+ +H+N
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 79
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           ++ +         + +   Y+    ++  ++   K+  L        +  + RGL Y+H 
Sbjct: 80  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 139
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF-RISGTHGYMAPEYA 262
              A ++HRD+K SN+LL+   + KI DFGLAR+   +  H         T  Y APE  
Sbjct: 140 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 196
Query: 263 LH--GYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           L+  GY +   D++S G ++ E++S R    G+
Sbjct: 197 LNSKGY-TKSIDIWSVGCILAEMLSNRPIFPGK 228

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 107/213 (50%), Gaps = 13/213 (6%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLSVDSRQGLREFT-NEVKLLLKIQHKN 143
           +++L+ +G G +G V   Y  L  N   +A+KK+S    Q   + T  E+K+LL+ +H+N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           ++ +         + +   Y+    ++  ++   K+  L        +  + RGL Y+H 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF-RISGTHGYMAPEYA 262
              A ++HRD+K SN+LL+   + KI DFGLAR+   +  H         T  Y APE  
Sbjct: 147 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 263 LH--GYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           L+  GY +   D++S G ++ E++S R    G+
Sbjct: 204 LNSKGY-TKSIDIWSVGCILAEMLSNRPIFPGK 235

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 10/202 (4%)
Query: 86  NFFSDLNQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL 144
            + ++  ++G G  G V      + G+++AVKK+ +  +Q      NEV ++    H N+
Sbjct: 45  EYLANFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNV 104
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V ++     G E  +V E+L   +L     D    + ++      + + V R L YLH +
Sbjct: 105 VDMYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQ 160
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
               +IHRDIK+ +ILL      K+SDFG       E        + GT  +MAPE    
Sbjct: 161 G---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKX--LVGTPYWMAPEVISR 215
Query: 265 GYLSVKTDVFSYGVLVLEIVSG 286
                + D++S G++V+E++ G
Sbjct: 216 LPYGTEVDIWSLGIMVIEMIDG 237

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 103/212 (48%), Gaps = 19/212 (8%)
Query: 83  VATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSV-DSRQGLREFT-NEVKLLLKI 139
           +AT+ +  + ++G G +G VY+   P +G  +A+K + V +  +GL   T  EV LL ++
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 140 Q---HKNLVTLFGCCAEGP-----EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIV 191
           +   H N+V L   CA        +  LV+E++      Y   DK     L   T   ++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYL--DKAPPPGLPAETIKDLM 118
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS 251
               RGL +LH      I+HRD+K  NIL+      K++DFGLAR++      +  F + 
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALFPVV 172
Query: 252 GTHGYMAPEYALHGYLSVKTDVFSYGVLVLEI 283
            T  Y APE  L    +   D++S G +  E+
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 127/254 (50%), Gaps = 26/254 (10%)
Query: 94  LGHGGFGPVYRGLM--PNGQEI--AVKKLSVDSRQG-LREFTNEVKLLLKIQHKNLVTLF 148
           +G G FG VY G +   +G++I  AVK L+  +  G + +F  E  ++    H N+++L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 149 GCC--AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           G C  +EG   ++V  Y+ +  L  FI ++T + ++     +   + VA+G+ YL   A 
Sbjct: 98  GICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKYL---AS 151
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLAR-LFPGEDTHV-NTFRISGTHGYMAPEYALH 264
            + +HRD+ A N +LDE+   K++DFGLAR ++  E   V N         +MA E    
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 265 GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE---LVDP- 320
              + K+DV+S+GVL+ E+++      G       +    T  L QG + L+     DP 
Sbjct: 212 QKFTTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 266
Query: 321 --SLAKCNRDEAAM 332
              + KC   +A M
Sbjct: 267 YEVMLKCWHPKAEM 280

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 127/254 (50%), Gaps = 26/254 (10%)
Query: 94  LGHGGFGPVYRGLM--PNGQEI--AVKKLSVDSRQG-LREFTNEVKLLLKIQHKNLVTLF 148
           +G G FG VY G +   +G++I  AVK L+  +  G + +F  E  ++    H N+++L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 149 GCC--AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           G C  +EG   ++V  Y+ +  L  FI ++T + ++     +   + VA+G+ YL   A 
Sbjct: 98  GICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKYL---AS 151
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLAR-LFPGEDTHV-NTFRISGTHGYMAPEYALH 264
            + +HRD+ A N +LDE+   K++DFGLAR ++  E   V N         +MA E    
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 265 GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE---LVDP- 320
              + K+DV+S+GVL+ E+++      G       +    T  L QG + L+     DP 
Sbjct: 212 QKFTTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 266
Query: 321 --SLAKCNRDEAAM 332
              + KC   +A M
Sbjct: 267 YEVMLKCWHPKAEM 280

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 103/217 (47%), Gaps = 21/217 (9%)
Query: 81  LQVATNFFSDLNQ----LGHGGFGPVYRGLMP-NGQEIAVKKLS---VDSRQGLREFTNE 132
           +Q +T  FSD  +    LG G FG V        GQE AVK +S   V  +        E
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 133 VKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVM 192
           V+LL ++ H N+  L+    +     LV E      L   I  + + S +D     RI+ 
Sbjct: 77  VQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA---RIIR 133
Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQ---LNPKISDFGLARLFPGEDTHVNTFR 249
            V  G+ Y H+    +I+HRD+K  N+LL+ +    N +I DFGL+  F       +   
Sbjct: 134 QVLSGITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKI- 189
Query: 250 ISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
             GT  Y+APE  LHG    K DV+S GV++  ++SG
Sbjct: 190 --GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 127/254 (50%), Gaps = 26/254 (10%)
Query: 94  LGHGGFGPVYRGLM--PNGQEI--AVKKLSVDSRQG-LREFTNEVKLLLKIQHKNLVTLF 148
           +G G FG VY G +   +G++I  AVK L+  +  G + +F  E  ++    H N+++L 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 149 GCC--AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           G C  +EG   ++V  Y+ +  L  FI ++T + ++     +   + VA+G+ YL   A 
Sbjct: 97  GICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKYL---AS 150
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLAR-LFPGEDTHV-NTFRISGTHGYMAPEYALH 264
            + +HRD+ A N +LDE+   K++DFGLAR ++  E   V N         +MA E    
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 210
Query: 265 GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE---LVDP- 320
              + K+DV+S+GVL+ E+++      G       +    T  L QG + L+     DP 
Sbjct: 211 QKFTTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 265
Query: 321 --SLAKCNRDEAAM 332
              + KC   +A M
Sbjct: 266 YEVMLKCWHPKAEM 279

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 75/254 (29%), Positives = 128/254 (50%), Gaps = 26/254 (10%)
Query: 94  LGHGGFGPVYRGLM--PNGQEI--AVKKLSVDSRQG-LREFTNEVKLLLKIQHKNLVTLF 148
           +G G FG VY G +   +G++I  AVK L+  +  G + +F  E  ++    H N+++L 
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 149 GCC--AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           G C  +EG   ++V  Y+ +  L  FI ++T + ++     +   + VA+G+ +L   A 
Sbjct: 103 GICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKFL---AS 156
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLAR-LFPGE-DTHVNTFRISGTHGYMAPEYALH 264
            + +HRD+ A N +LDE+   K++DFGLAR ++  E D+  N         +MA E    
Sbjct: 157 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 216
Query: 265 GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE---LVDP- 320
              + K+DV+S+GVL+ E+++      G       +    T  L QG + L+     DP 
Sbjct: 217 QKFTTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 271
Query: 321 --SLAKCNRDEAAM 332
              + KC   +A M
Sbjct: 272 YEVMLKCWHPKAEM 285

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 76/254 (29%), Positives = 127/254 (50%), Gaps = 26/254 (10%)
Query: 94  LGHGGFGPVYRGLM--PNGQEI--AVKKLSVDSRQG-LREFTNEVKLLLKIQHKNLVTLF 148
           +G G FG VY G +   +G++I  AVK L+  +  G + +F  E  ++    H N+++L 
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 149 GCC--AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           G C  +EG   ++V  Y+ +  L  FI ++T + ++     +   + VA+G+ YL   A 
Sbjct: 93  GICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKYL---AS 146
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLAR-LFPGEDTHV-NTFRISGTHGYMAPEYALH 264
            + +HRD+ A N +LDE+   K++DFGLAR ++  E   V N         +MA E    
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 265 GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE---LVDP- 320
              + K+DV+S+GVL+ E+++      G       +    T  L QG + L+     DP 
Sbjct: 207 QKFTTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 261
Query: 321 --SLAKCNRDEAAM 332
              + KC   +A M
Sbjct: 262 YEVMLKCWHPKAEM 275

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 107/213 (50%), Gaps = 13/213 (6%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLSVDSRQGLREFT-NEVKLLLKIQHKN 143
           +++L+ +G G +G V   Y  L  N   +A+KK+S    Q   + T  E+K+LL+ +H+N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           ++ +         + +   Y+    ++  ++   K+  L        +  + RGL Y+H 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF-RISGTHGYMAPEYA 262
              A ++HRD+K SN+LL+   + KI DFGLAR+   +  H         T  Y APE  
Sbjct: 147 ---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 263 LH--GYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           L+  GY +   D++S G ++ E++S R    G+
Sbjct: 204 LNSKGY-TKSIDIWSVGCILAEMLSNRPIFPGK 235

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 75/254 (29%), Positives = 128/254 (50%), Gaps = 26/254 (10%)
Query: 94  LGHGGFGPVYRGLM--PNGQEI--AVKKLSVDSRQG-LREFTNEVKLLLKIQHKNLVTLF 148
           +G G FG VY G +   +G++I  AVK L+  +  G + +F  E  ++    H N+++L 
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 149 GCC--AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           G C  +EG   ++V  Y+ +  L  FI ++T + ++     +   + VA+G+ +L   A 
Sbjct: 157 GICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKFL---AS 210
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLAR-LFPGE-DTHVNTFRISGTHGYMAPEYALH 264
            + +HRD+ A N +LDE+   K++DFGLAR ++  E D+  N         +MA E    
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 265 GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE---LVDP- 320
              + K+DV+S+GVL+ E+++      G       +    T  L QG + L+     DP 
Sbjct: 271 QKFTTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 325
Query: 321 --SLAKCNRDEAAM 332
              + KC   +A M
Sbjct: 326 YEVMLKCWHPKAEM 339

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 26/215 (12%)
Query: 94  LGHGGFGPVY--------RGLMPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKN 143
           LG G FG V         +        +AVK L  D + + L +  +E++++  I +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFI-------------FDKTKSSSLDWTTRYRI 190
           ++ L G C +     ++ EY    +L  ++              ++     + +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
              +ARG+ YL   A  + IHRD+ A N+L+ E    KI+DFGLAR     D + NT   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
                +MAPE       + ++DV+S+GVL+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 75/254 (29%), Positives = 128/254 (50%), Gaps = 26/254 (10%)
Query: 94  LGHGGFGPVYRGLM--PNGQEI--AVKKLSVDSRQG-LREFTNEVKLLLKIQHKNLVTLF 148
           +G G FG VY G +   +G++I  AVK L+  +  G + +F  E  ++    H N+++L 
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 149 GCC--AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           G C  +EG   ++V  Y+ +  L  FI ++T + ++     +   + VA+G+ +L   A 
Sbjct: 96  GICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKFL---AS 149
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLAR-LFPGE-DTHVNTFRISGTHGYMAPEYALH 264
            + +HRD+ A N +LDE+   K++DFGLAR ++  E D+  N         +MA E    
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 209
Query: 265 GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE---LVDP- 320
              + K+DV+S+GVL+ E+++      G       +    T  L QG + L+     DP 
Sbjct: 210 QKFTTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 264
Query: 321 --SLAKCNRDEAAM 332
              + KC   +A M
Sbjct: 265 YEVMLKCWHPKAEM 278

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 106/202 (52%), Gaps = 11/202 (5%)
Query: 88  FSDLNQLGHGGFGPVYR-GLMPNGQEIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLV 145
           F  +++LG G  G V++    P+G  +A K + ++ +  +R +   E+++L +     +V
Sbjct: 11  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 70
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
             +G      E  +  E++   SLD  +    K+  +      ++ + V +GL YL E+ 
Sbjct: 71  GFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLREKH 127
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHG 265
             +I+HRD+K SNIL++ +   K+ DFG++      D   N F   GT  YM+PE     
Sbjct: 128 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DEMANEF--VGTRSYMSPERLQGT 181
Query: 266 YLSVKTDVFSYGVLVLEIVSGR 287
           + SV++D++S G+ ++E+  GR
Sbjct: 182 HYSVQSDIWSMGLSLVEMAVGR 203

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 75/254 (29%), Positives = 128/254 (50%), Gaps = 26/254 (10%)
Query: 94  LGHGGFGPVYRGLM--PNGQEI--AVKKLSVDSRQG-LREFTNEVKLLLKIQHKNLVTLF 148
           +G G FG VY G +   +G++I  AVK L+  +  G + +F  E  ++    H N+++L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 149 GCC--AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           G C  +EG   ++V  Y+ +  L  FI ++T + ++     +   + VA+G+ +L   A 
Sbjct: 98  GICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKFL---AS 151
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLAR-LFPGE-DTHVNTFRISGTHGYMAPEYALH 264
            + +HRD+ A N +LDE+   K++DFGLAR ++  E D+  N         +MA E    
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 265 GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE---LVDP- 320
              + K+DV+S+GVL+ E+++      G       +    T  L QG + L+     DP 
Sbjct: 212 QKFTTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 266
Query: 321 --SLAKCNRDEAAM 332
              + KC   +A M
Sbjct: 267 YEVMLKCWHPKAEM 280

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 75/254 (29%), Positives = 128/254 (50%), Gaps = 26/254 (10%)
Query: 94  LGHGGFGPVYRGLM--PNGQEI--AVKKLSVDSRQG-LREFTNEVKLLLKIQHKNLVTLF 148
           +G G FG VY G +   +G++I  AVK L+  +  G + +F  E  ++    H N+++L 
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 149 GCC--AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           G C  +EG   ++V  Y+ +  L  FI ++T + ++     +   + VA+G+ +L   A 
Sbjct: 99  GICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKFL---AS 152
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLAR-LFPGE-DTHVNTFRISGTHGYMAPEYALH 264
            + +HRD+ A N +LDE+   K++DFGLAR ++  E D+  N         +MA E    
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 265 GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE---LVDP- 320
              + K+DV+S+GVL+ E+++      G       +    T  L QG + L+     DP 
Sbjct: 213 QKFTTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 267
Query: 321 --SLAKCNRDEAAM 332
              + KC   +A M
Sbjct: 268 YEVMLKCWHPKAEM 281

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/254 (29%), Positives = 128/254 (50%), Gaps = 26/254 (10%)
Query: 94  LGHGGFGPVYRGLM--PNGQEI--AVKKLSVDSRQG-LREFTNEVKLLLKIQHKNLVTLF 148
           +G G FG VY G +   +G++I  AVK L+  +  G + +F  E  ++    H N+++L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 149 GCC--AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           G C  +EG   ++V  Y+ +  L  FI ++T + ++     +   + VA+G+ +L   A 
Sbjct: 98  GICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKFL---AS 151
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLAR-LFPGE-DTHVNTFRISGTHGYMAPEYALH 264
            + +HRD+ A N +LDE+   K++DFGLAR ++  E D+  N         +MA E    
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 265 GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE---LVDP- 320
              + K+DV+S+GVL+ E+++      G       +    T  L QG + L+     DP 
Sbjct: 212 QKFTTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 266
Query: 321 --SLAKCNRDEAAM 332
              + KC   +A M
Sbjct: 267 YEVMLKCWHPKAEM 280

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 13/213 (6%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLSVDSRQGLREFT-NEVKLLLKIQHKN 143
           +++L+ +G G +G V   Y  L  N   +A+KK+S    Q   + T  E+K+LL+ +H+N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           ++ +         + +   Y+    ++  ++   K   L        +  + RGL Y+H 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHS 146
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF-RISGTHGYMAPEYA 262
              A ++HRD+K SN+LL+   + KI DFGLAR+   +  H         T  Y APE  
Sbjct: 147 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 263 LH--GYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           L+  GY +   D++S G ++ E++S R    G+
Sbjct: 204 LNSKGY-TKSIDIWSVGCILAEMLSNRPIFPGK 235

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 26/215 (12%)
Query: 94  LGHGGFGPVY--------RGLMPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKN 143
           LG G FG V         +        +AVK L  D + + L +  +E++++  I +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFI-------------FDKTKSSSLDWTTRYRI 190
           ++TL G C +     ++ EY    +L  ++              ++     + +      
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
              +ARG+ YL   A  + IHRD+ A N+L+ E    KI+DFGLAR     D +  T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
                +MAPE       + ++DV+S+GVL+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 107/213 (50%), Gaps = 13/213 (6%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLSVDSRQGLREFT-NEVKLLLKIQHKN 143
           +++L+ +G G +G V   Y  +  N   +A+KK+S    Q   + T  E+K+LL+ +H+N
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 90
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           ++ +         + +   Y+    ++  ++   K+  L        +  + RGL Y+H 
Sbjct: 91  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 150
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF-RISGTHGYMAPEYA 262
              A ++HRD+K SN+LL+   + KI DFGLAR+   +  H         T  Y APE  
Sbjct: 151 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 207
Query: 263 LH--GYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           L+  GY +   D++S G ++ E++S R    G+
Sbjct: 208 LNSKGY-TKSIDIWSVGCILAEMLSNRPIFPGK 239

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 107/213 (50%), Gaps = 13/213 (6%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLSVDSRQGLREFT-NEVKLLLKIQHKN 143
           +++L+ +G G +G V   Y  +  N   +A+KK+S    Q   + T  E+K+LL+ +H+N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           ++ +         + +   Y+    ++  ++   K+  L        +  + RGL Y+H 
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF-RISGTHGYMAPEYA 262
              A ++HRD+K SN+LL+   + KI DFGLAR+   +  H         T  Y APE  
Sbjct: 143 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 263 LH--GYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           L+  GY +   D++S G ++ E++S R    G+
Sbjct: 200 LNSKGY-TKSIDIWSVGCILAEMLSNRPIFPGK 231

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 126/268 (47%), Gaps = 30/268 (11%)
Query: 76  FDLRTL---QVATNFFSDLNQ---LGHGGFGPVYR-GLMPNGQEIAVKKLSVDSRQGLRE 128
           FD R +   Q A N F  +++   LG G FG V++      G ++A K +     +   E
Sbjct: 73  FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE 132
Query: 129 FTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY 188
             NE+ ++ ++ H NL+ L+       + +LV EY+    L    FD+    S + T   
Sbjct: 133 VKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL----FDRIIDESYNLTELD 188
Query: 189 RIVM--GVARGLLYLHEEAPARIIHRDIKASNILL--DEQLNPKISDFGLARLF-PGEDT 243
            I+    +  G+ ++H+     I+H D+K  NIL    +    KI DFGLAR + P E  
Sbjct: 189 TILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL 245
Query: 244 HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK-ADLL 302
            VN     GT  ++APE   + ++S  TD++S GV+   ++SG     G    E   ++L
Sbjct: 246 KVNF----GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNIL 301
Query: 303 SYTWTL----FQ--GEKALELVDPSLAK 324
           +  W L    FQ   E+A E +   L K
Sbjct: 302 ACRWDLEDEEFQDISEEAKEFISKLLIK 329

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 107/213 (50%), Gaps = 13/213 (6%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLSVDSRQGLREFT-NEVKLLLKIQHKN 143
           +++L+ +G G +G V   Y  L  N   +A++K+S    Q   + T  E+K+LL+ +H+N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNL--NKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHEN 86
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           ++ +         + +   Y+    ++  ++   K+  L        +  + RGL Y+H 
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 146
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF-RISGTHGYMAPEYA 262
              A ++HRD+K SN+LL+   + KI DFGLAR+   +  H         T  Y APE  
Sbjct: 147 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 263 LH--GYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           L+  GY +   D++S G ++ E++S R    G+
Sbjct: 204 LNSKGY-TKSIDIWSVGCILAEMLSNRPIFPGK 235

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 107/213 (50%), Gaps = 13/213 (6%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLSVDSRQGLREFT-NEVKLLLKIQHKN 143
           +++L+ +G G +G V   Y  +  N   +A+KK+S    Q   + T  E+K+LL+ +H+N
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 84
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           ++ +         + +   Y+    ++  ++   K+  L        +  + RGL Y+H 
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF-RISGTHGYMAPEYA 262
              A ++HRD+K SN+LL+   + KI DFGLAR+   +  H         T  Y APE  
Sbjct: 145 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 201
Query: 263 LH--GYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           L+  GY +   D++S G ++ E++S R    G+
Sbjct: 202 LNSKGY-TKSIDIWSVGCILAEMLSNRPIFPGK 233

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 107/213 (50%), Gaps = 13/213 (6%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLSVDSRQGLREFT-NEVKLLLKIQHKN 143
           +++L+ +G G +G V   Y  +  N   +A+KK+S    Q   + T  E+K+LL+ +H+N
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 102
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           ++ +         + +   Y+    ++  ++   K+  L        +  + RGL Y+H 
Sbjct: 103 IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 162
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF-RISGTHGYMAPEYA 262
              A ++HRD+K SN+LL+   + KI DFGLAR+   +  H         T  Y APE  
Sbjct: 163 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 219
Query: 263 LH--GYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           L+  GY +   D++S G ++ E++S R    G+
Sbjct: 220 LNSKGY-TKSIDIWSVGCILAEMLSNRPIFPGK 251

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 13/210 (6%)
Query: 91  LNQLGHGGFGPVY--RGLMPNGQEIAVKKLSVDSRQ---GLREFTNEVKLLLKIQHKNLV 145
           +++LG GG   VY     + N + +A+K + +  R+    L+ F  EV    ++ H+N+V
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIK-VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
           ++     E     LV EY+   +L  +I        L   T       +  G+ + H+  
Sbjct: 75  SMIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAHD-- 129
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHG 265
             RI+HRDIK  NIL+D     KI DFG+A+    E +   T  + GT  Y +PE A   
Sbjct: 130 -MRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 266 YLSVKTDVFSYGVLVLEIVSGRKNHDGRLG 295
                TD++S G+++ E++ G    +G   
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPPFNGETA 217

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 107/213 (50%), Gaps = 13/213 (6%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLSVDSRQGLREFT-NEVKLLLKIQHKN 143
           +++L+ +G G +G V   Y  +  N   +A+KK+S    Q   + T  E+K+LL+ +H+N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           ++ +         + +   Y+    ++  ++   K+  L        +  + RGL Y+H 
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF-RISGTHGYMAPEYA 262
              A ++HRD+K SN+LL+   + KI DFGLAR+   +  H         T  Y APE  
Sbjct: 143 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 263 LH--GYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           L+  GY +   D++S G ++ E++S R    G+
Sbjct: 200 LNSKGY-TKSIDIWSVGCILAEMLSNRPIFPGK 231

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/254 (29%), Positives = 126/254 (49%), Gaps = 26/254 (10%)
Query: 94  LGHGGFGPVYRGLM--PNGQEI--AVKKLSVDSRQG-LREFTNEVKLLLKIQHKNLVTLF 148
           +G G FG VY G +   +G++I  AVK L+  +  G + +F  E  ++    H N+++L 
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 149 GCC--AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           G C  +EG   ++V  Y+ +  L  FI ++T + ++     +   + VA+G+ +L   A 
Sbjct: 99  GICLRSEG-SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG--LQVAKGMKFL---AS 152
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLAR--LFPGEDTHVNTFRISGTHGYMAPEYALH 264
            + +HRD+ A N +LDE+   K++DFGLAR  L    D+  N         +MA E    
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 265 GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE---LVDP- 320
              + K+DV+S+GVL+ E+++      G       +    T  L QG + L+     DP 
Sbjct: 213 QKFTTKSDVWSFGVLLWELMT-----RGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 267
Query: 321 --SLAKCNRDEAAM 332
              + KC   +A M
Sbjct: 268 YEVMLKCWHPKAEM 281

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 107/214 (50%), Gaps = 19/214 (8%)
Query: 91  LNQLGHGGFGPV--YRGLMPNGQEIAVKKLSVDSRQ----GLREFTNEVKLLLKIQHKNL 144
           L  +G G F  V   R ++  G+E+AVK   +D  Q     L++   EV+++  + H N+
Sbjct: 19  LKTIGKGNFAKVKLARHIL-TGKEVAVK--IIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V LF          LV EY     +  ++    +    +   ++R ++   +   Y H++
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQK 132
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE-YAL 263
               I+HRD+KA N+LLD  +N KI+DFG +  F   +  ++TF   G+  Y APE +  
Sbjct: 133 F---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN-KLDTF--CGSPPYAAPELFQG 186
Query: 264 HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKE 297
             Y   + DV+S GV++  +VSG    DG+  KE
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 220

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/223 (29%), Positives = 98/223 (43%), Gaps = 37/223 (16%)
Query: 94  LGHGGFGPVYRGLMPN-GQEIAVKKLSV---------DSRQGLREFTNEVKLLLKI-QHK 142
           LG G FG V        G+E AV K++V         D ++ L    +E+K++  + QH+
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL---MSELKIMSHLGQHE 95
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFI--------------------FDKTKSSSL 182
           N+V L G C  G   +++ EY     L  F+                     DK     L
Sbjct: 96  NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPL 155
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
           +          VA+G+ +L   A    IHRD+ A N+LL      KI DFGLAR    + 
Sbjct: 156 ELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 212
Query: 243 THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
            ++          +MAPE       +V++DV+SYG+L+ EI S
Sbjct: 213 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 107/214 (50%), Gaps = 19/214 (8%)
Query: 91  LNQLGHGGFGPV--YRGLMPNGQEIAVKKLSVDSRQ----GLREFTNEVKLLLKIQHKNL 144
           L  +G G F  V   R ++  G+E+AVK   +D  Q     L++   EV+++  + H N+
Sbjct: 19  LKTIGKGNFAKVKLARHIL-TGKEVAVK--IIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V LF          LV EY     +  ++    +    +   ++R ++   +   Y H++
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQK 132
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE-YAL 263
               I+HRD+KA N+LLD  +N KI+DFG +  F   +  ++TF   G+  Y APE +  
Sbjct: 133 F---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDTF--CGSPPYAAPELFQG 186
Query: 264 HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKE 297
             Y   + DV+S GV++  +VSG    DG+  KE
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 220

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 16/209 (7%)
Query: 87  FFSDLNQLGHGGFGPV----YRGLMPN-GQEIAVKKLSVDSR-QGLREFTNEVKLLLKIQ 140
           F   +  LG G FG V    Y     N G+++AVK L  +S    + +   E+++L  + 
Sbjct: 22  FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 81
Query: 141 HKNLVTLFGCCAE--GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
           H+N+V   G C E  G    L+ E+LP+ SL  ++       +L    +Y +   + +G+
Sbjct: 82  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV--QICKGM 139
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP--GEDTHVNTFRISGTHGY 256
            YL      + +HRD+ A N+L++ +   KI DFGL +      E   V   R S    Y
Sbjct: 140 DYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY 196
Query: 257 MAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
            APE  +     + +DV+S+GV + E+++
Sbjct: 197 -APECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 109/203 (53%), Gaps = 13/203 (6%)
Query: 88  FSDLNQLGHGGFGPVYR-GLMPNGQEIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLV 145
           F  +++LG G  G V +    P+G  +A K + ++ +  +R +   E+++L +     +V
Sbjct: 18  FERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 77
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
             +G      E  +  E++   SLD  +    ++  +      ++ + V RGL YL E+ 
Sbjct: 78  GFYGAFYSDGEISICMEHMDGGSLDQVL---KEAKRIPEEILGKVSIAVLRGLAYLREKH 134
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLA-RLFPGEDTHVNTFRISGTHGYMAPEYALH 264
             +I+HRD+K SNIL++ +   K+ DFG++ +L    D+  N+F   GT  YMAPE    
Sbjct: 135 --QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSF--VGTRSYMAPERLQG 187
Query: 265 GYLSVKTDVFSYGVLVLEIVSGR 287
            + SV++D++S G+ ++E+  GR
Sbjct: 188 THYSVQSDIWSMGLSLVELAVGR 210

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 107/213 (50%), Gaps = 13/213 (6%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLSVDSRQGLREFT-NEVKLLLKIQHKN 143
           +++L+ +G G +G V   Y  +  N   +A+KK+S    Q   + T  E+K+LL+ +H+N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           ++ +         + +   Y+    ++  ++   K+  L        +  + RGL Y+H 
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF-RISGTHGYMAPEYA 262
              A ++HRD+K SN+LL+   + KI DFGLAR+   +  H         T  Y APE  
Sbjct: 143 ---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 263 LH--GYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           L+  GY +   D++S G ++ E++S R    G+
Sbjct: 200 LNSKGY-TKSIDIWSVGCILAEMLSNRPIFPGK 231

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 16/209 (7%)
Query: 87  FFSDLNQLGHGGFGPV----YRGLMPN-GQEIAVKKLSVDSR-QGLREFTNEVKLLLKIQ 140
           F   +  LG G FG V    Y     N G+++AVK L  +S    + +   E+++L  + 
Sbjct: 10  FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 69
Query: 141 HKNLVTLFGCCAE--GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
           H+N+V   G C E  G    L+ E+LP+ SL  ++       +L    +Y +   + +G+
Sbjct: 70  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAV--QICKGM 127
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP--GEDTHVNTFRISGTHGY 256
            YL      + +HRD+ A N+L++ +   KI DFGL +      E   V   R S    Y
Sbjct: 128 DYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY 184
Query: 257 MAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
            APE  +     + +DV+S+GV + E+++
Sbjct: 185 -APECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 11/209 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+L ++ L  F+ D +  + +        +  + +GL + H  
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 129
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL- 263
              R++HRD+K  N+L++ +   K++DFGLAR F G      T  +  T  Y APE  L 
Sbjct: 130 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLG 184
Query: 264 HGYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
             Y S   D++S G +  E+V+ R    G
Sbjct: 185 XKYYSTAVDIWSLGCIFAEMVTRRALFPG 213

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 107/213 (50%), Gaps = 13/213 (6%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLSVDSRQGLREFT-NEVKLLLKIQHKN 143
           +++L+ +G G +G V   Y  +  N   +A+KK+S    Q   + T  E+K+LL+ +H+N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           ++ +         + +   Y+    ++  ++   K+  L        +  + RGL Y+H 
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF-RISGTHGYMAPEYA 262
              A ++HRD+K SN+LL+   + KI DFGLAR+   +  H         T  Y APE  
Sbjct: 143 ---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 263 LH--GYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           L+  GY +   D++S G ++ E++S R    G+
Sbjct: 200 LNSKGY-TKSIDIWSVGCILAEMLSNRPIFPGK 231

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 11/204 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+L ++ L  F+ D +  + +        +  + +GL + H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL- 263
              R++HRD+K  N+L++ +   K++DFGLAR F G      T  +  T  Y APE  L 
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLG 177
Query: 264 HGYLSVKTDVFSYGVLVLEIVSGR 287
             Y S   D++S G +  E+V+ R
Sbjct: 178 XKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 110/215 (51%), Gaps = 17/215 (7%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLSVDSRQGLREFT-NEVKLLLKIQHKN 143
           +++L+ +G G +G V   Y  +  N   +A+KK+S    Q   + T  E+K+LL+ +H+N
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 102
Query: 144 LVTLFGCC-AEGPEKML-VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
           ++ +     A   E+M  VY        D +   KT+  S D    +  +  + RGL Y+
Sbjct: 103 IIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYF--LYQILRGLKYI 160
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF-RISGTHGYMAPE 260
           H    A ++HRD+K SN+LL+   + KI DFGLAR+   +  H         T  Y APE
Sbjct: 161 HS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 217
Query: 261 YALH--GYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
             L+  GY +   D++S G ++ E++S R    G+
Sbjct: 218 IMLNSKGY-TKSIDIWSVGCILAEMLSNRPIFPGK 251

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 107/213 (50%), Gaps = 13/213 (6%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLSVDSRQGLREFT-NEVKLLLKIQHKN 143
           +++L+ +G G +G V   Y  +  N   +A+KK+S    Q   + T  E+K+LL+ +H+N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 82
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           ++ +         + +   Y+    ++  ++   K+  L        +  + RGL Y+H 
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 142
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF-RISGTHGYMAPEYA 262
              A ++HRD+K SN+LL+   + KI DFGLAR+   +  H         T  Y APE  
Sbjct: 143 ---ANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 199
Query: 263 LH--GYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           L+  GY +   D++S G ++ E++S R    G+
Sbjct: 200 LNSKGY-TKSIDIWSVGCILAEMLSNRPIFPGK 231

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 106/214 (49%), Gaps = 19/214 (8%)
Query: 91  LNQLGHGGFGPV--YRGLMPNGQEIAVKKLSVDSRQ----GLREFTNEVKLLLKIQHKNL 144
           L  +G G F  V   R ++  G+E+A+K   +D  Q     L++   EV+++  + H N+
Sbjct: 20  LKTIGKGNFAKVKLARHIL-TGREVAIK--IIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V LF          L+ EY     +  ++    +    +  +++R ++   +   Y H++
Sbjct: 77  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ---YCHQK 133
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE-YAL 263
              RI+HRD+KA N+LLD  +N KI+DFG +  F      ++ F   G   Y APE +  
Sbjct: 134 ---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTV-GGKLDAF--CGAPPYAAPELFQG 187
Query: 264 HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKE 297
             Y   + DV+S GV++  +VSG    DG+  KE
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 221

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 11/209 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+L ++ L  F+ D +  + +        +  + +GL + H  
Sbjct: 72  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 129
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              R++HRD+K  N+L++ +   K++DFGLAR F G      T  +  T  Y APE  L 
Sbjct: 130 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLG 184
Query: 265 -GYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
             Y S   D++S G +  E+V+ R    G
Sbjct: 185 CKYYSTAVDIWSLGCIFAEMVTRRALFPG 213

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 94  LGHGGFGPVYRG------LMPNGQEIAVKKLSVDSRQGL-REFTNEVKLLLKI-QHKNLV 145
           LG G FG V              + +AVK L   +     R   +E+K+L+ I  H N+V
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 146 TLFGCCAE--GPEKMLV--------YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIV---M 192
            L G C +  GP  ++V          YL +K  ++  +   +    D+ T   ++    
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISG 252
            VA+G+ +L   A  + IHRD+ A NILL E+   KI DFGLAR    +   V       
Sbjct: 156 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 253 THGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
              +MAPE       ++++DV+S+GVL+ EI S
Sbjct: 213 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 106/213 (49%), Gaps = 13/213 (6%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLSVDSRQGLREFT-NEVKLLLKIQHKN 143
           +++L+ +G G +G V   Y  +  N   +A+KK+S    Q   + T  E+K+LL  +H+N
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHEN 84
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           ++ +         + +   Y+    ++  ++   K+  L        +  + RGL Y+H 
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF-RISGTHGYMAPEYA 262
              A ++HRD+K SN+LL+   + KI DFGLAR+   +  H         T  Y APE  
Sbjct: 145 ---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 201
Query: 263 LH--GYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           L+  GY +   D++S G ++ E++S R    G+
Sbjct: 202 LNSKGY-TKSIDIWSVGCILAEMLSNRPIFPGK 233

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 11/209 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+L ++ L  F+ D +  + +        +  + +GL + H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              R++HRD+K  N+L++ +   K++DFGLAR F G      T  +  T  Y APE  L 
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLG 177
Query: 265 -GYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
             Y S   D++S G +  E+V+ R    G
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPG 206

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 11/209 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+L ++ L  F+ D +  + +        +  + +GL + H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              R++HRD+K  N+L++ +   K++DFGLAR F G      T  +  T  Y APE  L 
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLG 177
Query: 265 -GYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
             Y S   D++S G +  E+V+ R    G
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPG 206

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 11/209 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+L ++ L  F+ D +  + +        +  + +GL + H  
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              R++HRD+K  N+L++ +   K++DFGLAR F G      T  +  T  Y APE  L 
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLG 176
Query: 265 -GYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
             Y S   D++S G +  E+V+ R    G
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPG 205

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 11/209 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+L ++ L  F+ D +  + +        +  + +GL + H  
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              R++HRD+K  N+L++ +   K++DFGLAR F G      T  +  T  Y APE  L 
Sbjct: 124 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLG 178
Query: 265 -GYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
             Y S   D++S G +  E+V+ R    G
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPG 207

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 11/204 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+L ++ L  F+ D +  + +        +  + +GL + H  
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              R++HRD+K  N+L++ +   K++DFGLAR F G      T  +  T  Y APE  L 
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLG 176
Query: 265 -GYLSVKTDVFSYGVLVLEIVSGR 287
             Y S   D++S G +  E+V+ R
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCA 152
           LG G +G VY G  + N   IA+K++     +  +    E+ L   ++HKN+V   G  +
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 153 EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHR 212
           E     +  E +P  SL   +  K      +  T       +  GL YLH+    +I+HR
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 146
Query: 213 DIKASNILLDEQLNP-KISDFGLARLFPGEDTHVNTFRISGTHGYMAPEY---ALHGYLS 268
           DIK  N+L++      KISDFG ++   G +    TF  +GT  YMAPE       GY  
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF--TGTLQYMAPEIIDKGPRGY-G 203
Query: 269 VKTDVFSYGVLVLEIVSGR 287
              D++S G  ++E+ +G+
Sbjct: 204 KAADIWSLGCTIIEMATGK 222

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 105/204 (51%), Gaps = 11/204 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+L ++ L  F+ D +  + +        +  + +GL + H  
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              R++HRD+K  N+L++ +   K++DFGLAR F G      T  +  T  Y APE  L 
Sbjct: 127 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLG 181
Query: 265 -GYLSVKTDVFSYGVLVLEIVSGR 287
             Y S   D++S G +  E+V+ R
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 21/210 (10%)
Query: 94  LGHGGFGPVYRG------LMPNGQEIAVKKLSVDSRQGL-REFTNEVKLLLKI-QHKNLV 145
           LG G FG V              + +AVK L   +     R   +E+K+L+ I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 146 TLFGCCAE-GPEKMLVYEYLPNKSLDYFI------FDKTKSSSLDWTTRYRIV---MGVA 195
            L G C + G   M++ E+    +L  ++      F   K    D+ T   ++     VA
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG 255
           +G+ +L   A  + IHRD+ A NILL E+   KI DFGLAR    +  +V          
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +MAPE       ++++DV+S+GVL+ EI S
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 19/214 (8%)
Query: 91  LNQLGHGGFGPV--YRGLMPNGQEIAVKKLSVDSRQ----GLREFTNEVKLLLKIQHKNL 144
           L  +G G F  V   R ++  G+E+AV+   +D  Q     L++   EV+++  + H N+
Sbjct: 19  LKTIGKGNFAKVKLARHIL-TGKEVAVR--IIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V LF          LV EY     +  ++    +    +   ++R ++   +   Y H++
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQK 132
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE-YAL 263
               I+HRD+KA N+LLD  +N KI+DFG +  F   +  ++TF   G+  Y APE +  
Sbjct: 133 F---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDTF--CGSPPYAAPELFQG 186
Query: 264 HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKE 297
             Y   + DV+S GV++  +VSG    DG+  KE
Sbjct: 187 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 220

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNLV 145
           +  L ++G G +G VY+     G+  A+KK+ ++   +G+   T  E+ +L +++H N+V
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 146 TLFGCCAEGPEKMLVYEYLPN---KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
            L+         +LV+E+L     K LD           L+  T    ++ +  G+ Y H
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQDLKKLLD------VCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
           +    R++HRD+K  N+L++ +   KI+DFGLAR F G      T  I  T  Y AP+  
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYRAPDVL 172
Query: 263 L-HGYLSVKTDVFSYGVLVLEIVSG 286
           +     S   D++S G +  E+V+G
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 102/211 (48%), Gaps = 9/211 (4%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFT-NEVKLLLKIQHKNLV 145
           ++ L  +G G +G V           +A+KK+S    Q   + T  E+++LL+ +H+N++
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
            +         + +   Y+    ++  ++   KS  L        +  + RGL Y+H   
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHS-- 162
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF-RISGTHGYMAPEYALH 264
            A ++HRD+K SN+L++   + KI DFGLAR+   E  H         T  Y APE  L+
Sbjct: 163 -ANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLN 221
Query: 265 --GYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
             GY +   D++S G ++ E++S R    G+
Sbjct: 222 SKGY-TKSIDIWSVGCILAEMLSNRPIFPGK 251

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 109/230 (47%), Gaps = 28/230 (12%)
Query: 67  SGAD--SWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPN-GQEIAVKKL--SVD 121
           SG D  + NL+F       +   + +L  +G G +G V +    + G+ +A+KK   S D
Sbjct: 10  SGVDLGTENLYFQ------SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD 63
Query: 122 SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSS 181
            +   +    E+KLL +++H+NLV L   C +     LV+E++ +  LD     +   + 
Sbjct: 64  DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDL---ELFPNG 120
Query: 182 LDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF--P 239
           LD+    + +  +  G+ + H      IIHRDIK  NIL+ +    K+ DFG AR    P
Sbjct: 121 LDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177
Query: 240 GE--DTHVNTFRISGTHGYMAPEYALHGYLSVK-TDVFSYGVLVLEIVSG 286
           GE  D  V       T  Y APE  +      K  DV++ G LV E+  G
Sbjct: 178 GEVYDDEV------ATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 94  LGHGGFGPVY--------RGLMPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKN 143
           LG G FG V         +        +AVK L  D + + L +  +E++++  I +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFI-------------FDKTKSSSLDWTTRYRI 190
           ++ L G C +     ++ EY    +L  ++              ++     + +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
              +ARG+ YL   A  + IHRD+ A N+L+ E    KI+DFGLAR     D +  T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
                +MAPE       + ++DV+S+GVL+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 11/199 (5%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCA 152
           LG G +G VY G  + N   IA+K++     +  +    E+ L   ++HKN+V   G  +
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 153 EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHR 212
           E     +  E +P  SL   +  K      +  T       +  GL YLH+    +I+HR
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 132
Query: 213 DIKASNILLDEQLNP-KISDFGLARLFPGEDTHVNTFRISGTHGYMAPEY---ALHGYLS 268
           DIK  N+L++      KISDFG ++   G +    TF  +GT  YMAPE       GY  
Sbjct: 133 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF--TGTLQYMAPEIIDKGPRGY-G 189
Query: 269 VKTDVFSYGVLVLEIVSGR 287
              D++S G  ++E+ +G+
Sbjct: 190 KAADIWSLGCTIIEMATGK 208

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 11/209 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+L ++ L  F+ D +  + +        +  + +GL + H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLSFCHSH 122
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              R++HRD+K  N+L++ +   K++DFGLAR F G      T  +  T  Y APE  L 
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLG 177
Query: 265 -GYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
             Y S   D++S G +  E+V+ R    G
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPG 206

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 21/210 (10%)
Query: 94  LGHGGFGPVYRG------LMPNGQEIAVKKLSVDSRQGL-REFTNEVKLLLKI-QHKNLV 145
           LG G FG V              + +AVK L   +     R   +E+K+L+ I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 146 TLFGCCAE-GPEKMLVYEYLPNKSLDYFI------FDKTKSSSLDWTTRYRIV---MGVA 195
            L G C + G   M++ E+    +L  ++      F   K    D+ T   ++     VA
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG 255
           +G+ +L   A  + IHRD+ A NILL E+   KI DFGLAR    +  +V          
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLK 211
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +MAPE       ++++DV+S+GVL+ EI S
Sbjct: 212 WMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 110/218 (50%), Gaps = 27/218 (12%)
Query: 91  LNQLGHGGFGPV--YRGLMPNGQEIAVKKLSVDSRQ----GLREFTNEVKLLLKIQHKNL 144
           L  +G G F  V   R ++  G+E+AVK   +D  Q     L++   EV+++  + H N+
Sbjct: 12  LKTIGKGNFAKVKLARHIL-TGKEVAVK--IIDKTQLNSSSLQKLFREVRIMKVLNHPNI 68
Query: 145 VTLFGCCAEGPEKMLVYEYLPN-KSLDYFI---FDKTKSSSLDWTTRYRIVMGVARGLLY 200
           V LF          LV EY    +  DY +   + K K +      ++R ++   +   Y
Sbjct: 69  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEAR----AKFRQIVSAVQ---Y 121
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE 260
            H++    I+HRD+KA N+LLD  +N KI+DFG +  F   +  ++TF   G+  Y APE
Sbjct: 122 CHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNK-LDTF--CGSPPYAAPE 175
Query: 261 -YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKE 297
            +    Y   + DV+S GV++  +VSG    DG+  KE
Sbjct: 176 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 213

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 21/215 (9%)
Query: 91  LNQLGHGGFGPV--YRGLMPNGQEIAVKKLSVDSRQ----GLREFTNEVKLLLKIQHKNL 144
           L  +G G F  V   R ++  G+E+AV+   +D  Q     L++   EV+++  + H N+
Sbjct: 19  LKTIGKGNFAKVKLARHIL-TGKEVAVR--IIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V LF          LV EY     +  ++    +    +   ++R ++   +   Y H++
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQK 132
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF-RISGTHGYMAPE-YA 262
               I+HRD+KA N+LLD  +N KI+DFG    F  E T  N      G+  Y APE + 
Sbjct: 133 F---IVHRDLKAENLLLDADMNIKIADFG----FSNEFTFGNKLDEFCGSPPYAAPELFQ 185
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKE 297
              Y   + DV+S GV++  +VSG    DG+  KE
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 220

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 86  NFFSDLNQLGHGGFGPV-YRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL 144
           ++  +  ++G G  G V    +  +G+ +AVKK+ +  +Q      NEV ++   QH+N+
Sbjct: 20  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V ++     G E  +V E+L   +L     D    + ++      + + V + L  LH +
Sbjct: 80  VEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQ 135
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
               +IHRDIK+ +ILL      K+SDFG       E        + GT  +MAPE    
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX--LVGTPYWMAPELISR 190
Query: 265 GYLSVKTDVFSYGVLVLEIVSG 286
                + D++S G++V+E+V G
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDG 212

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 103/215 (47%), Gaps = 21/215 (9%)
Query: 91  LNQLGHGGFGPV--YRGLMPNGQEIAVKKLSVDSRQ----GLREFTNEVKLLLKIQHKNL 144
           L  +G G F  V   R ++  G+E+AVK   +D  Q     L++   EV+++  + H N+
Sbjct: 19  LKTIGKGNFAKVKLARHIL-TGKEVAVK--IIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V LF          LV EY     +  ++    +    +   ++R ++   +   Y H++
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQK 132
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF-RISGTHGYMAPE-YA 262
               I+HRD+KA N+LLD  +N KI+DFG    F  E T  N      G   Y APE + 
Sbjct: 133 F---IVHRDLKAENLLLDADMNIKIADFG----FSNEFTFGNKLDAFCGAPPYAAPELFQ 185
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKE 297
              Y   + DV+S GV++  +VSG    DG+  KE
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 220

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 86  NFFSDLNQLGHGGFGPV-YRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL 144
           ++  +  ++G G  G V    +  +G+ +AVKK+ +  +Q      NEV ++   QH+N+
Sbjct: 24  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 83
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V ++     G E  +V E+L   +L     D    + ++      + + V + L  LH +
Sbjct: 84  VEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQ 139
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
               +IHRDIK+ +ILL      K+SDFG       E        + GT  +MAPE    
Sbjct: 140 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX--LVGTPYWMAPELISR 194
Query: 265 GYLSVKTDVFSYGVLVLEIVSG 286
                + D++S G++V+E+V G
Sbjct: 195 LPYGPEVDIWSLGIMVIEMVDG 216

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 101/216 (46%), Gaps = 28/216 (12%)
Query: 94  LGHGGFGPVY--------RGLMPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKN 143
           LG G FG V         +        +AVK L  D + + L +  +E++++  I +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 144 LVTLFGCCAE-GPEKMLVY--------EYL-----PNKSLDYFIFDKTKSSSLDWTTRYR 189
           ++ L G C + GP  ++V         EYL     P     Y I ++     + +     
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDI-NRVPEEQMTFKDLVS 161
Query: 190 IVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR 249
               +ARG+ YL   A  + IHRD+ A N+L+ E    KI+DFGLAR     D +  T  
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 250 ISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
                 +MAPE       + ++DV+S+GVL+ EI +
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 106/215 (49%), Gaps = 26/215 (12%)
Query: 94  LGHGGFGPVYR----GL---MPNG-QEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKN 143
           LG G FG V      GL    PN   ++AVK L  D + + L +  +E++++  I +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSL-DY----------FIFDKTKSSSLDWTTRYRIVM 192
           ++ L G C +     ++ EY    +L +Y          F F+ + +     +++  +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 193 G--VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
              VARG+ YL   A  + IHRD+ A N+L+ E    KI+DFGLAR     D    T   
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
                +MAPE       + ++DV+S+GVL+ EI +
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 106/213 (49%), Gaps = 13/213 (6%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLSVDSRQGLREFT-NEVKLLLKIQHKN 143
           +++L+ +G G +G V   Y  +  N   +A+KK+S    Q   + T  E+K+LL  +H+N
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHEN 84
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           ++ +         + +   Y+    ++  ++   K+  L        +  + RGL Y+H 
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS 144
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF-RISGTHGYMAPEYA 262
              A ++HRD+K SN+LL+   + KI DFGLAR+   +  H         T  Y APE  
Sbjct: 145 ---ANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 201
Query: 263 LH--GYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           L+  GY +   D++S G ++ E++S R    G+
Sbjct: 202 LNSKGY-TKSIDIWSVGCILAEMLSNRPIFPGK 233

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNLV 145
           +  L ++G G +G VY+     G+  A+KK+ ++   +G+   T  E+ +L +++H N+V
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 146 TLFGCCAEGPEKMLVYEYLPN---KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
            L+         +LV+E+L     K LD           L+  T    ++ +  G+ Y H
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQDLKKLLD------VCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
           +    R++HRD+K  N+L++ +   KI+DFGLAR F G      T  +  T  Y AP+  
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEVV-TLWYRAPDVL 172
Query: 263 L-HGYLSVKTDVFSYGVLVLEIVSG 286
           +     S   D++S G +  E+V+G
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 86  NFFSDLNQLGHGGFGPV-YRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL 144
           ++  +  ++G G  G V    +  +G+ +AVKK+ +  +Q      NEV ++   QH+N+
Sbjct: 29  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 88
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V ++     G E  +V E+L   +L     D    + ++      + + V + L  LH +
Sbjct: 89  VEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQ 144
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
               +IHRDIK+ +ILL      K+SDFG       E        + GT  +MAPE    
Sbjct: 145 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX--LVGTPYWMAPELISR 199
Query: 265 GYLSVKTDVFSYGVLVLEIVSG 286
                + D++S G++V+E+V G
Sbjct: 200 LPYGPEVDIWSLGIMVIEMVDG 221

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNLV 145
           +  L ++G G +G VY+     G+  A+KK+ ++   +G+   T  E+ +L +++H N+V
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 146 TLFGCCAEGPEKMLVYEYLPN---KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
            L+         +LV+E+L     K LD           L+  T    ++ +  G+ Y H
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQDLKKLLD------VCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
           +    R++HRD+K  N+L++ +   KI+DFGLAR F G      T  +  T  Y AP+  
Sbjct: 118 DR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEVV-TLWYRAPDVL 172
Query: 263 L-HGYLSVKTDVFSYGVLVLEIVSG 286
           +     S   D++S G +  E+V+G
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 101/216 (46%), Gaps = 28/216 (12%)
Query: 94  LGHGGFGPVY--------RGLMPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKN 143
           LG G FG V         +        +AVK L  D + + L +  +E++++  I +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 144 LVTLFGCCAE-GPEKMLV--------YEYL-----PNKSLDYFIFDKTKSSSLDWTTRYR 189
           ++ L G C + GP  ++V         EYL     P     Y I ++     + +     
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDI-NRVPEEQMTFKDLVS 161
Query: 190 IVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR 249
               +ARG+ YL   A  + IHRD+ A N+L+ E    KI+DFGLAR     D +  T  
Sbjct: 162 CTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 250 ISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
                 +MAPE       + ++DV+S+GVL+ EI +
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 86  NFFSDLNQLGHGGFGPV-YRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL 144
           ++  +  ++G G  G V    +  +G+ +AVKK+ +  +Q      NEV ++   QH+N+
Sbjct: 31  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 90
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V ++     G E  +V E+L   +L     D    + ++      + + V + L  LH +
Sbjct: 91  VEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQ 146
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
               +IHRDIK+ +ILL      K+SDFG       E        + GT  +MAPE    
Sbjct: 147 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX--LVGTPYWMAPELISR 201
Query: 265 GYLSVKTDVFSYGVLVLEIVSG 286
                + D++S G++V+E+V G
Sbjct: 202 LPYGPEVDIWSLGIMVIEMVDG 223

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 94  LGHGGFGPVYRGLMPN-GQEIAVKKLSV---------DSRQGLREFTNEVKLLLKI-QHK 142
           LG G FG V        G+E AV K++V         D ++ L    +E+K++  + QH+
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL---MSELKIMSHLGQHE 110
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFI-----------FDKTKSSSLDWTTR--YR 189
           N+V L G C  G   +++ EY     L  F+           ++ + +     ++R    
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLH 170
Query: 190 IVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR 249
               VA+G+ +L   A    IHRD+ A N+LL      KI DFGLAR    +  ++    
Sbjct: 171 FSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 227
Query: 250 ISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
                 +MAPE       +V++DV+SYG+L+ EI S
Sbjct: 228 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 83  VATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSV-DSRQGLREFT-NEVKLLLKI 139
           +AT+ +  + ++G G +G VY+   P +G  +A+K + V +  +GL   T  EV LL ++
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 140 Q---HKNLVTLFGCCAEGP-----EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIV 191
           +   H N+V L   CA        +  LV+E++      Y   DK     L   T   ++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYL--DKAPPPGLPAETIKDLM 118
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS 251
               RGL +LH      I+HRD+K  NIL+      K++DFGLAR++      +    + 
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALAPVV 172
Query: 252 GTHGYMAPEYALHGYLSVKTDVFSYGVLVLEI 283
            T  Y APE  L    +   D++S G +  E+
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 26/215 (12%)
Query: 94  LGHGGFGPVY--------RGLMPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKN 143
           LG G FG V         +        +AVK L  D + + L +  +E++++  I +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFI-------------FDKTKSSSLDWTTRYRI 190
           ++ L G C +     ++ EY    +L  ++              ++     + +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
              +ARG+ YL   A  + IHRD+ A N+L+ E    KI+DFGLAR     D    T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
                +MAPE       + ++DV+S+GVL+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 26/215 (12%)
Query: 94  LGHGGFGPVY--------RGLMPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKN 143
           LG G FG V         +        +AVK L  D + + L +  +E++++  I +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFI-------------FDKTKSSSLDWTTRYRI 190
           ++ L G C +     ++ EY    +L  ++              ++     + +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
              +ARG+ YL   A  + IHRD+ A N+L+ E    KI+DFGLAR     D    T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
                +MAPE       + ++DV+S+GVL+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 109/220 (49%), Gaps = 36/220 (16%)
Query: 94  LGHGGFGPVYR----GL---MPNG-QEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKN 143
           LG G FG V      GL    PN   ++AVK L  D + + L +  +E++++  I +HKN
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFI-----------FDKTKSSSLDWTTRYRIVM 192
           ++ L G C +     ++ EY    +L  ++           ++ + +     +++  +  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 193 G--VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
              VARG+ YL   A  + IHRD+ A N+L+ E    KI+DFGLAR     D H   +  
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 192
Query: 251 SGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
             T+G     +MAPE       + ++DV+S+GVL+ EI +
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 109/220 (49%), Gaps = 36/220 (16%)
Query: 94  LGHGGFGPVYR----GL---MPNG-QEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKN 143
           LG G FG V      GL    PN   ++AVK L  D + + L +  +E++++  I +HKN
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFI-----------FDKTKSSSLDWTTRYRIVM 192
           ++ L G C +     ++ EY    +L  ++           ++ + +     +++  +  
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 193 G--VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
              VARG+ YL   A  + IHRD+ A N+L+ E    KI+DFGLAR     D H   +  
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 196
Query: 251 SGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
             T+G     +MAPE       + ++DV+S+GVL+ EI +
Sbjct: 197 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 109/220 (49%), Gaps = 36/220 (16%)
Query: 94  LGHGGFGPVYR----GL---MPNG-QEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKN 143
           LG G FG V      GL    PN   ++AVK L  D + + L +  +E++++  I +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFI-----------FDKTKSSSLDWTTRYRIVM 192
           ++ L G C +     ++ EY    +L  ++           ++ + +     +++  +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 193 G--VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
              VARG+ YL   A  + IHRD+ A N+L+ E    KI+DFGLAR     D H   +  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 207
Query: 251 SGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
             T+G     +MAPE       + ++DV+S+GVL+ EI +
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 109/220 (49%), Gaps = 36/220 (16%)
Query: 94  LGHGGFGPVYR----GL---MPNG-QEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKN 143
           LG G FG V      GL    PN   ++AVK L  D + + L +  +E++++  I +HKN
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFI-----------FDKTKSSSLDWTTRYRIVM 192
           ++ L G C +     ++ EY    +L  ++           ++ + +     +++  +  
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 193 G--VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
              VARG+ YL   A  + IHRD+ A N+L+ E    KI+DFGLAR     D H   +  
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 199
Query: 251 SGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
             T+G     +MAPE       + ++DV+S+GVL+ EI +
Sbjct: 200 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 109/220 (49%), Gaps = 36/220 (16%)
Query: 94  LGHGGFGPVYR----GL---MPNG-QEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKN 143
           LG G FG V      GL    PN   ++AVK L  D + + L +  +E++++  I +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFI-----------FDKTKSSSLDWTTRYRIVM 192
           ++ L G C +     ++ EY    +L  ++           ++ + +     +++  +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 193 G--VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
              VARG+ YL   A  + IHRD+ A N+L+ E    KI+DFGLAR     D H   +  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 207
Query: 251 SGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
             T+G     +MAPE       + ++DV+S+GVL+ EI +
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 102/220 (46%), Gaps = 33/220 (15%)
Query: 95  GHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG 154
             G FG V++  + N   +AVK   +  +Q  +    E+     ++H+NL+        G
Sbjct: 24  ARGRFGCVWKAQLMN-DFVAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKRG 81
Query: 155 P----EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP---- 206
                E  L+  +    SL     D  K + + W     +   ++RGL YLHE+ P    
Sbjct: 82  SNLEVELWLITAFHDKGSLT----DYLKGNIITWNELCHVAETMSRGLSYLHEDVPWCRG 137
Query: 207 ----ARIIHRDIKASNILLDEQLNPKISDFGLA-RLFPGE---DTHVNTFRISGTHGYMA 258
                 I HRD K+ N+LL   L   ++DFGLA R  PG+   DTH       GT  YMA
Sbjct: 138 EGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQV----GTRRYMA 193
Query: 259 PEYALHGYLS------VKTDVFSYGVLVLEIVSGRKNHDG 292
           PE  L G ++      ++ D+++ G+++ E+VS  K  DG
Sbjct: 194 PE-VLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADG 232

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 86  NFFSDLNQLGHGGFGPV-YRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL 144
           ++  +  ++G G  G V    +  +G+ +AVKK+ +  +Q      NEV ++   QH+N+
Sbjct: 74  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 133
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V ++     G E  +V E+L   +L     D    + ++      + + V + L  LH +
Sbjct: 134 VEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQ 189
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
               +IHRDIK+ +ILL      K+SDFG       E        + GT  +MAPE    
Sbjct: 190 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX--LVGTPYWMAPELISR 244
Query: 265 GYLSVKTDVFSYGVLVLEIVSG 286
                + D++S G++V+E+V G
Sbjct: 245 LPYGPEVDIWSLGIMVIEMVDG 266

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 19/211 (9%)
Query: 94  LGHGGFGPVY--RGLMPNGQEIAVKKLSVDSRQ----GLREFTNEVKLLLKIQHKNLVTL 147
           +G G F  V   R ++  G+E+AVK   +D  Q     L++   EV+++  + H N+V L
Sbjct: 23  IGKGNFAKVKLARHVL-TGREVAVK--IIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL 79
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           F          LV EY     +  ++    +    +   ++R ++   +   Y H++   
Sbjct: 80  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQKY-- 134
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE-YALHGY 266
            I+HRD+KA N+LLD  +N KI+DFG +  F   +  ++TF   G+  Y APE +    Y
Sbjct: 135 -IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGN-KLDTF--CGSPPYAAPELFQGKKY 190
Query: 267 LSVKTDVFSYGVLVLEIVSGRKNHDGRLGKE 297
              + DV+S GV++  +VSG    DG+  KE
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 221

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 109/220 (49%), Gaps = 36/220 (16%)
Query: 94  LGHGGFGPVYR----GL---MPNG-QEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKN 143
           LG G FG V      GL    PN   ++AVK L  D + + L +  +E++++  I +HKN
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFI-----------FDKTKSSSLDWTTRYRIVM 192
           ++ L G C +     ++ EY    +L  ++           ++ + +     +++  +  
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 193 G--VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
              VARG+ YL   A  + IHRD+ A N+L+ E    KI+DFGLAR     D H   +  
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 200
Query: 251 SGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
             T+G     +MAPE       + ++DV+S+GVL+ EI +
Sbjct: 201 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 109/220 (49%), Gaps = 36/220 (16%)
Query: 94  LGHGGFGPVYR----GL---MPNG-QEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKN 143
           LG G FG V      GL    PN   ++AVK L  D + + L +  +E++++  I +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFI-----------FDKTKSSSLDWTTRYRIVM 192
           ++ L G C +     ++ EY    +L  ++           ++ + +     +++  +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 193 G--VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
              VARG+ YL   A  + IHRD+ A N+L+ E    KI+DFGLAR     D H   +  
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 207
Query: 251 SGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
             T+G     +MAPE       + ++DV+S+GVL+ EI +
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 103/220 (46%), Gaps = 31/220 (14%)
Query: 94  LGHGGFGPVYR----GLMPNGQ--EIAVKKLSVDSRQGLRE-FTNEVKLLLKI-QHKNLV 145
           LG G FG V      G+   G   ++AVK L   +    RE   +E+K++ ++  H+N+V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSS---LDWTTRYRI------------ 190
            L G C       L++EY     L  ++  K +  S   +++  + R+            
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 191 -----VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV 245
                   VA+G+ +L  ++    +HRD+ A N+L+      KI DFGLAR    +  +V
Sbjct: 173 DLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 229
Query: 246 NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
                     +MAPE    G  ++K+DV+SYG+L+ EI S
Sbjct: 230 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 94  LGHGGFGPVY--------RGLMPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKN 143
           LG G FG V         +        +AVK L  D + + L +  +E++++  I +HKN
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFI-------------FDKTKSSSLDWTTRYRI 190
           ++ L G C +     ++ EY    +L  ++              ++     + +      
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
              +ARG+ YL   A  + IHRD+ A N+L+ E    KI+DFGLAR     D +  T   
Sbjct: 155 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
                +MAPE       + ++DV+S+GVL+ EI +
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 94  LGHGGFGPVY--------RGLMPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKN 143
           LG G FG V         +        +AVK L  D + + L +  +E++++  I +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFI-------------FDKTKSSSLDWTTRYRI 190
           ++ L G C +     ++ EY    +L  ++              ++     + +      
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
              +ARG+ YL   A  + IHRD+ A N+L+ E    KI+DFGLAR     D +  T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
                +MAPE       + ++DV+S+GVL+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 94  LGHGGFGPVY--------RGLMPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKN 143
           LG G FG V         +        +AVK L  D + + L +  +E++++  I +HKN
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFI-------------FDKTKSSSLDWTTRYRI 190
           ++ L G C +     ++ EY    +L  ++              ++     + +      
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
              +ARG+ YL   A  + IHRD+ A N+L+ E    KI+DFGLAR     D +  T   
Sbjct: 150 TYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
                +MAPE       + ++DV+S+GVL+ EI +
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 105/204 (51%), Gaps = 11/204 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E++ ++ L  F+ D +  + +        +  + +GL + H  
Sbjct: 64  VKLLDVIHTENKLYLVFEHV-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              R++HRD+K  N+L++ +   K++DFGLAR F G      T  +  T  Y APE  L 
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLG 176
Query: 265 -GYLSVKTDVFSYGVLVLEIVSGR 287
             Y S   D++S G +  E+V+ R
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 97/202 (48%), Gaps = 10/202 (4%)
Query: 86  NFFSDLNQLGHGGFGPV-YRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL 144
           ++  +  ++G G  G V    +  +G+ +AVKK+ +  +Q      NEV ++   QH+N+
Sbjct: 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 210
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V ++     G E  +V E+L   +L     D    + ++      + + V + L  LH +
Sbjct: 211 VEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQ 266
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
               +IHRDIK+ +ILL      K+SDFG       E        + GT  +MAPE    
Sbjct: 267 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKX--LVGTPYWMAPELISR 321
Query: 265 GYLSVKTDVFSYGVLVLEIVSG 286
                + D++S G++V+E+V G
Sbjct: 322 LPYGPEVDIWSLGIMVIEMVDG 343

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 66/220 (30%), Positives = 109/220 (49%), Gaps = 36/220 (16%)
Query: 94  LGHGGFGPVYR----GL---MPNG-QEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKN 143
           LG G FG V      GL    PN   ++AVK L  D + + L +  +E++++  I +HKN
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFI-----------FDKTKSSSLDWTTRYRIVM 192
           ++ L G C +     ++ EY    +L  ++           ++ + +     +++  +  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 193 G--VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
              VARG+ YL   A  + IHRD+ A N+L+ E    KI+DFGLAR     D H   +  
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 248
Query: 251 SGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
             T+G     +MAPE       + ++DV+S+GVL+ EI +
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 94  LGHGGFGPVY--------RGLMPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKN 143
           LG G FG V         +        +AVK L  D + + L +  +E++++  I +HKN
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFI-------------FDKTKSSSLDWTTRYRI 190
           ++ L G C +     ++ EY    +L  ++              ++     + +      
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
              +ARG+ YL   A  + IHRD+ A N+L+ E    KI+DFGLAR     D +  T   
Sbjct: 152 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
                +MAPE       + ++DV+S+GVL+ EI +
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 94  LGHGGFGPVY--------RGLMPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKN 143
           LG G FG V         +        +AVK L  D + + L +  +E++++  I +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFI-------------FDKTKSSSLDWTTRYRI 190
           ++ L G C +     ++ EY    +L  ++              ++     + +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
              +ARG+ YL   A  + IHRD+ A N+L+ E    +I+DFGLAR     D +  T   
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
                +MAPE       + ++DV+S+GVL+ EI +
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 100/212 (47%), Gaps = 23/212 (10%)
Query: 94  LGHGGFGPVYRG------LMPNGQEIAVKKLSVDSRQGL-REFTNEVKLLLKI-QHKNLV 145
           LG G FG V              + +AVK L   +     R   +E+K+L+ I  H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 146 TLFGCCAE-GPEKMLVYEYLPNKSLDYFI------FDKTKSSSL--DWTTRYRIV---MG 193
            L G C + G   M++ E+    +L  ++      F   K   L  D+ T   ++     
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           VA+G+ +L   A  + IHRD+ A NILL E+   KI DFGLAR    +   V        
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
             +MAPE       ++++DV+S+GVL+ EI S
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 19/212 (8%)
Query: 83  VATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSV-DSRQGLREFT-NEVKLLLKI 139
           +AT+ +  + ++G G +G VY+   P +G  +A+K + V +  +GL   T  EV LL ++
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 140 Q---HKNLVTLFGCCAEGP-----EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIV 191
           +   H N+V L   CA        +  LV+E++      Y   DK     L   T   ++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYL--DKAPPPGLPAETIKDLM 118
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS 251
               RGL +LH      I+HRD+K  NIL+      K++DFGLAR++      +    + 
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALDPVV 172
Query: 252 GTHGYMAPEYALHGYLSVKTDVFSYGVLVLEI 283
            T  Y APE  L    +   D++S G +  E+
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 11/209 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+L ++ L  F+ D +  + +        +  + +GL + H  
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKTFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              R++HRD+K  N+L++ +   K++DFGLAR F G         +  T  Y APE  L 
Sbjct: 126 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPEILLG 180
Query: 265 -GYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
             Y S   D++S G +  E+V+ R    G
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPG 209

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 99/205 (48%), Gaps = 23/205 (11%)
Query: 94  LGHGGFGPVYRG----LMPNGQEIAVKKLS-VDSRQGLREFTNEVKLLLKIQHKNLVTLF 148
           +G G FG VY G       N  + A+K LS +   Q +  F  E  L+  + H N++ L 
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYF----IFDKTKSSSLDWTTRYRIVMG--VARGLLYLH 202
           G        ML  E LP+  L Y     +    +S   + T +  I  G  VARG+ YL 
Sbjct: 89  GI-------MLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLAR-LFPGEDTHVNTFRISGTHGYMAPEY 261
           E+   + +HRD+ A N +LDE    K++DFGLAR +   E   V   R +          
Sbjct: 142 EQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198
Query: 262 ALHGY-LSVKTDVFSYGVLVLEIVS 285
           +L  Y  + K+DV+S+GVL+ E+++
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 11/209 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+L ++ L  F+ D +  + +        +  + +GL + H  
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              R++HRD+K  N+L++ +   K++DFGLAR F G         +  T  Y APE  L 
Sbjct: 125 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPEILLG 179
Query: 265 -GYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
             Y S   D++S G +  E+V+ R    G
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPG 208

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 102/209 (48%), Gaps = 11/209 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+L     D+   D +  + +        +  + +GL + H  
Sbjct: 67  VKLLDVIHTENKLYLVFEFLSMDLKDFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              R++HRD+K  N+L++ +   K++DFGLAR F G         +  T  Y APE  L 
Sbjct: 125 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPEILLG 179
Query: 265 -GYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
             Y S   D++S G +  E+V+ R    G
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPG 208

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 11/204 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+L ++ L  F+ D +  + +        +  + +GL + H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              R++HRD+K  N+L++ +   K++DFGLAR F G         +  T  Y APE  L 
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPEILLG 177
Query: 265 -GYLSVKTDVFSYGVLVLEIVSGR 287
             Y S   D++S G +  E+V+ R
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 11/204 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+L ++ L  F+ D +  + +        +  + +GL + H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              R++HRD+K  N+L++ +   K++DFGLAR F G         +  T  Y APE  L 
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPEILLG 177
Query: 265 -GYLSVKTDVFSYGVLVLEIVSGR 287
             Y S   D++S G +  E+V+ R
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVK-----KLSVDSRQGLREFTNEVKLLLKIQH 141
           +  +  LG G FG V        GQ++A+K      L+    QG  E   E+  L  ++H
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRH 72
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
            +++ L+       E ++V EY  N+  DY +    +   +      R    +   + Y 
Sbjct: 73  PHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEYC 128
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS-GTHGYMAPE 260
           H     +I+HRD+K  N+LLDE LN KI+DFGL+ +     T  N  + S G+  Y APE
Sbjct: 129 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAPE 181
Query: 261 YALHG--YLSVKTDVFSYGVLVLEIVSGRKNHD 291
             + G  Y   + DV+S GV++  ++  R   D
Sbjct: 182 -VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 102/209 (48%), Gaps = 11/209 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+L     D+   D +  + +        +  + +GL + H  
Sbjct: 68  VKLLDVIHTENKLYLVFEFLSMDLKDFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              R++HRD+K  N+L++ +   K++DFGLAR F G         +  T  Y APE  L 
Sbjct: 126 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPEILLG 180
Query: 265 -GYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
             Y S   D++S G +  E+V+ R    G
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPG 209

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 11/209 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+L ++ L  F+ D +  + +        +  + +GL + H  
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              R++HRD+K  N+L++ +   K++DFGLAR F G         +  T  Y APE  L 
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPEILLG 176
Query: 265 -GYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
             Y S   D++S G +  E+V+ R    G
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPG 205

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 11/209 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+L ++ L  F+ D +  + +        +  + +GL + H  
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              R++HRD+K  N+L++ +   K++DFGLAR F G         +  T  Y APE  L 
Sbjct: 124 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPEILLG 178
Query: 265 -GYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
             Y S   D++S G +  E+V+ R    G
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPG 207

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 11/209 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+L ++ L  F+ D +  + +        +  + +GL + H  
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              R++HRD+K  N+L++ +   K++DFGLAR F G         +  T  Y APE  L 
Sbjct: 126 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPEILLG 180
Query: 265 -GYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
             Y S   D++S G +  E+V+ R    G
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPG 209

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 11/209 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+L ++ L  F+ D +  + +        +  + +GL + H  
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              R++HRD+K  N+L++ +   K++DFGLAR F G         +  T  Y APE  L 
Sbjct: 125 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPEILLG 179
Query: 265 -GYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
             Y S   D++S G +  E+V+ R    G
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPG 208

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 11/204 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+L ++ L  F+ D +  + +        +  + +GL + H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              R++HRD+K  N+L++ +   K++DFGLAR F G         +  T  Y APE  L 
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPEILLG 177
Query: 265 -GYLSVKTDVFSYGVLVLEIVSGR 287
             Y S   D++S G +  E+V+ R
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVK-----KLSVDSRQGLREFTNEVKLLLKIQH 141
           +  +  LG G FG V        GQ++A+K      L+    QG  E   E+  L  ++H
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRH 73
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
            +++ L+       E ++V EY  N+  DY +    +   +      R    +   + Y 
Sbjct: 74  PHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEYC 129
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS-GTHGYMAPE 260
           H     +I+HRD+K  N+LLDE LN KI+DFGL+ +     T  N  + S G+  Y APE
Sbjct: 130 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAPE 182
Query: 261 YALHG--YLSVKTDVFSYGVLVLEIVSGRKNHD 291
             + G  Y   + DV+S GV++  ++  R   D
Sbjct: 183 -VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 11/209 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+L ++ L  F+ D +  + +        +  + +GL + H  
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              R++HRD+K  N+L++ +   K++DFGLAR F G         +  T  Y APE  L 
Sbjct: 126 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPEILLG 180
Query: 265 -GYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
             Y S   D++S G +  E+V+ R    G
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPG 209

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 11/209 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+L ++ L  F+ D +  + +        +  + +GL + H  
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 124
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              R++HRD+K  N+L++ +   K++DFGLAR F G         +  T  Y APE  L 
Sbjct: 125 ---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPEILLG 179
Query: 265 -GYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
             Y S   D++S G +  E+V+ R    G
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPG 208

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 11/209 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+L ++ L  F+ D +  + +        +  + +GL + H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              R++HRD+K  N+L++ +   K++DFGLAR F G         +  T  Y APE  L 
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPEILLG 177
Query: 265 -GYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
             Y S   D++S G +  E+V+ R    G
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPG 206

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 11/209 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+L ++ L  F+ D +  + +        +  + +GL + H  
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 126
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              R++HRD+K  N+L++ +   K++DFGLAR F G         +  T  Y APE  L 
Sbjct: 127 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPEILLG 181
Query: 265 -GYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
             Y S   D++S G +  E+V+ R    G
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPG 210

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 11/209 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+L ++ L  F+ D +  + +        +  + +GL + H  
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              R++HRD+K  N+L++ +   K++DFGLAR F G         +  T  Y APE  L 
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPEILLG 176
Query: 265 -GYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
             Y S   D++S G +  E+V+ R    G
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPG 205

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 11/204 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+L ++ L  F+ D +  + +        +  + +GL + H  
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              R++HRD+K  N+L++ +   K++DFGLAR F G         +  T  Y APE  L 
Sbjct: 124 ---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPEILLG 178
Query: 265 -GYLSVKTDVFSYGVLVLEIVSGR 287
             Y S   D++S G +  E+V+ R
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 102/209 (48%), Gaps = 11/209 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+L     D+   D +  + +        +  + +GL + H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKDFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              R++HRD+K  N+L++ +   K++DFGLAR F G         +  T  Y APE  L 
Sbjct: 123 ---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPEILLG 177
Query: 265 -GYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
             Y S   D++S G +  E+V+ R    G
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPG 206

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVK-----KLSVDSRQGLREFTNEVKLLLKIQH 141
           +  +  LG G FG V        GQ++A+K      L+    QG  E   E+  L  ++H
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRH 67
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
            +++ L+       E ++V EY  N+  DY +    +   +      R    +   + Y 
Sbjct: 68  PHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEYC 123
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS-GTHGYMAPE 260
           H     +I+HRD+K  N+LLDE LN KI+DFGL+ +     T  N  + S G+  Y APE
Sbjct: 124 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAPE 176
Query: 261 YALHG--YLSVKTDVFSYGVLVLEIVSGRKNHD 291
             + G  Y   + DV+S GV++  ++  R   D
Sbjct: 177 -VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 11/209 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+ K+ +D+  +G+      E+ LL ++ H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+L ++ L  F+ D +  + +        +  + +GL + H  
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 122
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              R++HRD+K  N+L++ +   K++DFGLAR F G      T  +  T  Y APE  L 
Sbjct: 123 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLG 177
Query: 265 -GYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
             Y S   D++S G +  E+V+ R    G
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPG 206

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 11/209 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+ K+ +D+  +G+      E+ LL ++ H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+L ++ L  F+ D +  + +        +  + +GL + H  
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              R++HRD+K  N+L++ +   K++DFGLAR F G      T  +  T  Y APE  L 
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRAPEILLG 176
Query: 265 -GYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
             Y S   D++S G +  E+V+ R    G
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPG 205

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 110/218 (50%), Gaps = 16/218 (7%)
Query: 73  NLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR-QGLREFT- 130
           NL+F     Q     +  L ++G G +G VY+     G+ +A+K++ +D+  +G+     
Sbjct: 13  NLYF-----QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAI 67
Query: 131 NEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRI 190
            E+ LL ++ H N+V+L           LV+E++  K L   + D+ K+   D   +  +
Sbjct: 68  REISLLKELHHPNIVSLIDVIHSERCLTLVFEFM-EKDLKK-VLDENKTGLQDSQIKIYL 125
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
              + RG+ + H+    RI+HRD+K  N+L++     K++DFGLAR F G      T  +
Sbjct: 126 YQ-LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEV 180
Query: 251 SGTHGYMAPEYAL-HGYLSVKTDVFSYGVLVLEIVSGR 287
             T  Y AP+  +     S   D++S G +  E+++G+
Sbjct: 181 V-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 11/204 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+L ++ L  F+ D +  + +        +  + +GL + H  
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 123
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              R++HRD+K  N+L++ +   K++DFGLAR F G         +  T  Y APE  L 
Sbjct: 124 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPEILLG 178
Query: 265 -GYLSVKTDVFSYGVLVLEIVSGR 287
             Y S   D++S G +  E+V+ R
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 26/215 (12%)
Query: 94  LGHGGFGPVY--------RGLMPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKN 143
           LG G FG V         +        +AVK L  D + + L +  +E++++  I +HKN
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFI-------------FDKTKSSSLDWTTRYRI 190
           ++ L G C +     ++ EY    +L  ++              ++     + +      
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
              +ARG+ YL   A  + IHRD+ A N+L+ E    KI+DFGLAR     D +  T   
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
                +MAPE       + ++DV+S+GVL+ EI +
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 110/218 (50%), Gaps = 16/218 (7%)
Query: 73  NLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR-QGLREFT- 130
           NL+F     Q     +  L ++G G +G VY+     G+ +A+K++ +D+  +G+     
Sbjct: 13  NLYF-----QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAI 67
Query: 131 NEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRI 190
            E+ LL ++ H N+V+L           LV+E++  K L   + D+ K+   D   +  +
Sbjct: 68  REISLLKELHHPNIVSLIDVIHSERCLTLVFEFM-EKDLKK-VLDENKTGLQDSQIKIYL 125
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
              + RG+ + H+    RI+HRD+K  N+L++     K++DFGLAR F G      T  +
Sbjct: 126 YQ-LLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEV 180
Query: 251 SGTHGYMAPEYAL-HGYLSVKTDVFSYGVLVLEIVSGR 287
             T  Y AP+  +     S   D++S G +  E+++G+
Sbjct: 181 V-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVK-----KLSVDSRQGLREFTNEVKLLLKIQH 141
           +  +  LG G FG V        GQ++A+K      L+    QG  E   E+  L  ++H
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRH 63
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
            +++ L+       E ++V EY  N+  DY +    +   +      R    +   + Y 
Sbjct: 64  PHIIKLYDVIKSKDEIIMVIEYAGNELFDYIV----QRDKMSEQEARRFFQQIISAVEYC 119
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS-GTHGYMAPE 260
           H     +I+HRD+K  N+LLDE LN KI+DFGL+ +     T  N  + S G+  Y APE
Sbjct: 120 HRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAPE 172
Query: 261 YALHG--YLSVKTDVFSYGVLVLEIVSGRKNHD 291
             + G  Y   + DV+S GV++  ++  R   D
Sbjct: 173 -VISGKLYAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 20/214 (9%)
Query: 83  VATNFFSD---LNQLGHGGFGPVYRGLMPNGQE-IAVK----KLSVDSRQGLREFTNEVK 134
           +A  F  D   +  LG G +G V   +    +E +AVK    K +VD  + +++   E+ 
Sbjct: 1   MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EIX 57
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMG 193
           +   + H+N+V  +G   EG  + L  EY     L    FD+ +    +      R    
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQ 113
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           +  G++YLH      I HRDIK  N+LLDE+ N KISDFGLA +F   +      ++ GT
Sbjct: 114 LMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGT 170
Query: 254 HGYMAPE-YALHGYLSVKTDVFSYGVLVLEIVSG 286
             Y+APE      + +   DV+S G+++  +++G
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 20/213 (9%)
Query: 84  ATNFFSD---LNQLGHGGFGPVYRGLMPNGQE-IAVK----KLSVDSRQGLREFTNEVKL 135
           A  F  D   +  LG G +G V   +    +E +AVK    K +VD  + +++   E+ +
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EIXI 57
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMGV 194
              + H+N+V  +G   EG  + L  EY     L    FD+ +    +      R    +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQL 113
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH 254
             G++YLH      I HRDIK  N+LLDE+ N KISDFGLA +F   +      ++ GT 
Sbjct: 114 MAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 255 GYMAPE-YALHGYLSVKTDVFSYGVLVLEIVSG 286
            Y+APE      + +   DV+S G+++  +++G
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 20/214 (9%)
Query: 83  VATNFFSD---LNQLGHGGFGPVYRGLMPNGQE-IAVK----KLSVDSRQGLREFTNEVK 134
           +A  F  D   +  LG G +G V   +    +E +AVK    K +VD  + +++   E+ 
Sbjct: 1   MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EIC 57
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMG 193
           +   + H+N+V  +G   EG  + L  EY     L    FD+ +    +      R    
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQ 113
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           +  G++YLH      I HRDIK  N+LLDE+ N KISDFGLA +F   +      ++ GT
Sbjct: 114 LMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 254 HGYMAPE-YALHGYLSVKTDVFSYGVLVLEIVSG 286
             Y+APE      + +   DV+S G+++  +++G
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 20/214 (9%)
Query: 83  VATNFFSD---LNQLGHGGFGPVYRGLMPNGQE-IAVK----KLSVDSRQGLREFTNEVK 134
           +A  F  D   +  LG G +G V   +    +E +AVK    K +VD  + +++   E+ 
Sbjct: 1   MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EIC 57
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMG 193
           +   + H+N+V  +G   EG  + L  EY     L    FD+ +    +      R    
Sbjct: 58  INAMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQ 113
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           +  G++YLH      I HRDIK  N+LLDE+ N KISDFGLA +F   +      ++ GT
Sbjct: 114 LMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 254 HGYMAPE-YALHGYLSVKTDVFSYGVLVLEIVSG 286
             Y+APE      + +   DV+S G+++  +++G
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 20/213 (9%)
Query: 84  ATNFFSD---LNQLGHGGFGPVYRGLMPNGQE-IAVK----KLSVDSRQGLREFTNEVKL 135
           A  F  D   +  LG G +G V   +    +E +AVK    K +VD  + +++   E+ +
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EIXI 57
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMGV 194
              + H+N+V  +G   EG  + L  EY     L    FD+ +    +      R    +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQL 113
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH 254
             G++YLH      I HRDIK  N+LLDE+ N KISDFGLA +F   +      ++ GT 
Sbjct: 114 MAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170
Query: 255 GYMAPE-YALHGYLSVKTDVFSYGVLVLEIVSG 286
            Y+APE      + +   DV+S G+++  +++G
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 13/210 (6%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIF-DKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           V L        +  LV+E+L   S+D   F D +  + +        +  + +GL + H 
Sbjct: 68  VKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
               R++HRD+K  N+L++ +   K++DFGLAR F G         +  T  Y APE  L
Sbjct: 125 H---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPEILL 179
Query: 264 H-GYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
              Y S   D++S G +  E+V+ R    G
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRRALFPG 209

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 104/210 (49%), Gaps = 13/210 (6%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIF-DKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           V L        +  LV+E+L   S+D   F D +  + +        +  + +GL + H 
Sbjct: 66  VKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
               R++HRD+K  N+L++ +   K++DFGLAR F G         +  T  Y APE  L
Sbjct: 123 H---RVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPEILL 177
Query: 264 H-GYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
              Y S   D++S G +  E+V+ R    G
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRRALFPG 207

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 20/214 (9%)
Query: 83  VATNFFSD---LNQLGHGGFGPVYRGLMPNGQE-IAVK----KLSVDSRQGLREFTNEVK 134
           +A  F  D   +  LG G +G V   +    +E +AVK    K +VD  + +++   E+ 
Sbjct: 1   MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EIC 57
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMG 193
           +   + H+N+V  +G   EG  + L  EY     L    FD+ +    +      R    
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQ 113
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           +  G++YLH      I HRDIK  N+LLDE+ N KISDFGLA +F   +      ++ GT
Sbjct: 114 LMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 254 HGYMAPE-YALHGYLSVKTDVFSYGVLVLEIVSG 286
             Y+APE      + +   DV+S G+++  +++G
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 20/214 (9%)
Query: 83  VATNFFSD---LNQLGHGGFGPVYRGLMPNGQE-IAVK----KLSVDSRQGLREFTNEVK 134
           +A  F  D   +  LG G +G V   +    +E +AVK    K +VD  + +++   E+ 
Sbjct: 1   MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EIC 57
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMG 193
           +   + H+N+V  +G   EG  + L  EY     L    FD+ +    +      R    
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQ 113
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           +  G++YLH      I HRDIK  N+LLDE+ N KISDFGLA +F   +      ++ GT
Sbjct: 114 LMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 254 HGYMAPE-YALHGYLSVKTDVFSYGVLVLEIVSG 286
             Y+APE      + +   DV+S G+++  +++G
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 20/214 (9%)
Query: 83  VATNFFSD---LNQLGHGGFGPVYRGLMPNGQE-IAVK----KLSVDSRQGLREFTNEVK 134
           +A  F  D   +  LG G +G V   +    +E +AVK    K +VD  + +++   E+ 
Sbjct: 1   MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EIC 57
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMG 193
           +   + H+N+V  +G   EG  + L  EY     L    FD+ +    +      R    
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQ 113
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           +  G++YLH      I HRDIK  N+LLDE+ N KISDFGLA +F   +      ++ GT
Sbjct: 114 LMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 254 HGYMAPE-YALHGYLSVKTDVFSYGVLVLEIVSG 286
             Y+APE      + +   DV+S G+++  +++G
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 86/178 (48%), Gaps = 9/178 (5%)
Query: 109 NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKS 168
           +G+++AVK + +  +Q      NEV ++   QH N+V ++     G E  ++ E+L   +
Sbjct: 69  SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGA 128
Query: 169 LDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPK 228
           L     D      L+      +   V + L YLH +    +IHRDIK+ +ILL      K
Sbjct: 129 LT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVK 181
Query: 229 ISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
           +SDFG       +        + GT  +MAPE       + + D++S G++V+E+V G
Sbjct: 182 LSDFGFCAQISKDVPKRKX--LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 97/215 (45%), Gaps = 26/215 (12%)
Query: 94  LGHGGFGPVYR----GLMPN--GQEIAVKKLSVDSRQGLRE-FTNEVKLLLKI-QHKNLV 145
           LG G FG V      GL+ +     +AVK L   +    RE   +E+K+L  +  H N+V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 146 TLFGCCAEGPEKMLVYEY--------LPNKSLDYFIFDKTKSSSLDWTTRYRIVMG---- 193
            L G C  G   +++ EY           +  D FI  KT  + ++       +      
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 194 ---VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
              VA+G+ +L   A    IHRD+ A NILL      KI DFGLAR    +  +V     
Sbjct: 167 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 223
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
                +MAPE   +   + ++DV+SYG+ + E+ S
Sbjct: 224 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/199 (34%), Positives = 100/199 (50%), Gaps = 16/199 (8%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFT--NEVKLLLKIQHKNLVTLFGC 150
           LG G FG V +       QE AVK ++  S +     T   EV+LL K+ H N++ LF  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
             +     +V E      L   I  + + S  D     RI+  V  G+ Y+H+     I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA---RIIKQVFSGITYMHKH---NIV 143
Query: 211 HRDIKASNILLDEQ---LNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
           HRD+K  NILL+ +    + KI DFGL+  F  ++T +   RI GT  Y+APE  L G  
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKD-RI-GTAYYIAPE-VLRGTY 199
Query: 268 SVKTDVFSYGVLVLEIVSG 286
             K DV+S GV++  ++SG
Sbjct: 200 DEKCDVWSAGVILYILLSG 218

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 101/214 (47%), Gaps = 25/214 (11%)
Query: 94  LGHGGFGPVYRG------LMPNGQEIAVKKLSVDSRQGL-REFTNEVKLLLKI-QHKNLV 145
           LG G FG V              + +AVK L   +     R   +E+K+L+ I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 146 TLFGCCAE-GPEKMLVYEYLPNKSL--------DYFIFDKTKSSSL--DWTTRYRIV--- 191
            L G C + G   M++ E+    +L        + F+  K     L  D+ T   ++   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS 251
             VA+G+ +L   A  + IHRD+ A NILL E+   KI DFGLAR    +  +V      
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 252 GTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
               +MAPE       ++++DV+S+GVL+ EI S
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/214 (30%), Positives = 101/214 (47%), Gaps = 25/214 (11%)
Query: 94  LGHGGFGPVYRG------LMPNGQEIAVKKLSVDSRQGL-REFTNEVKLLLKI-QHKNLV 145
           LG G FG V              + +AVK L   +     R   +E+K+L+ I  H N+V
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 146 TLFGCCAE--GPEKMLV--------YEYLPNKSLDYFIFDKTKSSSL-DWTTRYRIV--- 191
            L G C +  GP  ++V          YL +K  ++  + +       D+ T   ++   
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS 251
             VA+G+ +L   A  + IHRD+ A NILL E+   KI DFGLAR    +  +V      
Sbjct: 157 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 252 GTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
               +MAPE       ++++DV+S+GVL+ EI S
Sbjct: 214 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 101/214 (47%), Gaps = 25/214 (11%)
Query: 94  LGHGGFGPVYRG------LMPNGQEIAVKKLSVDSRQGL-REFTNEVKLLLKI-QHKNLV 145
           LG G FG V              + +AVK L   +     R   +E+K+L+ I  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 146 TLFGCCAE-GPEKMLVYEYLPNKSL--------DYFIFDKTKSSSL--DWTTRYRIV--- 191
            L G C + G   M++ E+    +L        + F+  K     L  D+ T   ++   
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS 251
             VA+G+ +L   A  + IHRD+ A NILL E+   KI DFGLAR    +  +V      
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 252 GTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
               +MAPE       ++++DV+S+GVL+ EI S
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 97/215 (45%), Gaps = 26/215 (12%)
Query: 94  LGHGGFGPVYR----GLMPN--GQEIAVKKLSVDSRQGLRE-FTNEVKLLLKI-QHKNLV 145
           LG G FG V      GL+ +     +AVK L   +    RE   +E+K+L  +  H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSL--------DYFIFDKTKSSSLDWTTRYRIVMG---- 193
            L G C  G   +++ EY     L        D FI  KT  + ++       +      
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 194 ---VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
              VA+G+ +L   A    IHRD+ A NILL      KI DFGLAR    +  +V     
Sbjct: 151 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
                +MAPE   +   + ++DV+SYG+ + E+ S
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 101/214 (47%), Gaps = 25/214 (11%)
Query: 94  LGHGGFGPVYRG------LMPNGQEIAVKKLSVDSRQGL-REFTNEVKLLLKI-QHKNLV 145
           LG G FG V              + +AVK L   +     R   +E+K+L+ I  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 146 TLFGCCAE-GPEKMLVYEYLPNKSL--------DYFIFDKTKSSSL--DWTTRYRIV--- 191
            L G C + G   M++ E+    +L        + F+  K     L  D+ T   ++   
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS 251
             VA+G+ +L   A  + IHRD+ A NILL E+   KI DFGLAR    +  +V      
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 252 GTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
               +MAPE       ++++DV+S+GVL+ EI S
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 20/213 (9%)
Query: 84  ATNFFSD---LNQLGHGGFGPVYRGLMPNGQE-IAVK----KLSVDSRQGLREFTNEVKL 135
           A  F  D   +  LG G +G V   +    +E +AVK    K +VD  + +++   E+ +
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICI 57
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMGV 194
              + H+N+V  +G   EG  + L  EY     L    FD+ +    +      R    +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQL 113
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH 254
             G++YLH      I HRDIK  N+LLDE+ N KISDFGLA +F   +      ++ GT 
Sbjct: 114 MAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 255 GYMAPE-YALHGYLSVKTDVFSYGVLVLEIVSG 286
            Y+APE      + +   DV+S G+++  +++G
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 92/210 (43%), Gaps = 18/210 (8%)
Query: 86  NFFSDLNQLGHGGFGPVYRGLMP-----NGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKI 139
            +   +  LG G FG V            G+ +AVK L  D     R  +  E+ +L  +
Sbjct: 14  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTL 73
Query: 140 QHKNLVTLFGCCAEGPEK--MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            H++++   GCC +  EK   LV EY+P  SL     D     S+           +  G
Sbjct: 74  YHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEG 129
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-- 255
           + YLH +     IHR++ A N+LLD     KI DFGLA+  P E       R  G     
Sbjct: 130 MAYLHSQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVP-EGHEYYRVREDGDSPVF 185
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           + APE          +DV+S+GV + E+++
Sbjct: 186 WYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 100/214 (46%), Gaps = 25/214 (11%)
Query: 94  LGHGGFGPVYRG------LMPNGQEIAVKKLSVDSRQGL-REFTNEVKLLLKI-QHKNLV 145
           LG G FG V              + +AVK L   +     R   +E+K+L+ I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 146 TLFGCCAE-GPEKMLVYEYLPNKSL--------DYFIFDKTKSSSL--DWTTRYRIV--- 191
            L G C + G   M++ E+    +L        + F+  K     L  D+ T   ++   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS 251
             VA+G+ +L   A  + IHRD+ A NILL E+   KI DFGLAR    +   V      
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 252 GTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
               +MAPE       ++++DV+S+GVL+ EI S
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 20/214 (9%)
Query: 83  VATNFFSD---LNQLGHGGFGPVYRGLMPNGQE-IAVK----KLSVDSRQGLREFTNEVK 134
           +A  F  D   +  LG G +G V   +    +E +AVK    K +VD  + +++   E+ 
Sbjct: 1   MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EIC 57
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMG 193
           +   + H+N+V  +G   EG  + L  EY     L    FD+ +    +      R    
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQ 113
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           +  G++YLH      I HRDIK  N+LLDE+ N KISDFGLA +F   +      ++ GT
Sbjct: 114 LMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 254 HGYMAPE-YALHGYLSVKTDVFSYGVLVLEIVSG 286
             Y+APE      + +   DV+S G+++  +++G
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 92/210 (43%), Gaps = 18/210 (8%)
Query: 86  NFFSDLNQLGHGGFGPVYRGLMP-----NGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKI 139
            +   +  LG G FG V            G+ +AVK L  D     R  +  E+ +L  +
Sbjct: 14  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTL 73
Query: 140 QHKNLVTLFGCCAEGPEK--MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            H++++   GCC +  EK   LV EY+P  SL     D     S+           +  G
Sbjct: 74  YHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEG 129
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-- 255
           + YLH +     IHR++ A N+LLD     KI DFGLA+  P E       R  G     
Sbjct: 130 MAYLHAQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVP-EGHEYYRVREDGDSPVF 185
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           + APE          +DV+S+GV + E+++
Sbjct: 186 WYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 100/214 (46%), Gaps = 25/214 (11%)
Query: 94  LGHGGFGPVYRG------LMPNGQEIAVKKLSVDSRQGL-REFTNEVKLLLKI-QHKNLV 145
           LG G FG V              + +AVK L   +     R   +E+K+L+ I  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 146 TLFGCCAE-GPEKMLVYEYLPNKSL--------DYFIFDKTKSSSL--DWTTRYRIV--- 191
            L G C + G   M++ E+    +L        + F+  K     L  D+ T   ++   
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS 251
             VA+G+ +L   A  + IHRD+ A NILL E+   KI DFGLAR    +   V      
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 252 GTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
               +MAPE       ++++DV+S+GVL+ EI S
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 100/214 (46%), Gaps = 25/214 (11%)
Query: 94  LGHGGFGPVYRG------LMPNGQEIAVKKLSVDSRQGL-REFTNEVKLLLKI-QHKNLV 145
           LG G FG V              + +AVK L   +     R   +E+K+L+ I  H N+V
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 146 TLFGCCAE-GPEKMLVYEYLPNKSL--------DYFIFDKTKSSSL--DWTTRYRIV--- 191
            L G C + G   M++ E+    +L        + F+  K     L  D+ T   ++   
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS 251
             VA+G+ +L   A  + IHRD+ A NILL E+   KI DFGLAR    +   V      
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 252 GTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
               +MAPE       ++++DV+S+GVL+ EI S
Sbjct: 203 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 101/214 (47%), Gaps = 25/214 (11%)
Query: 94  LGHGGFGPVYRG------LMPNGQEIAVKKLSVDSRQGL-REFTNEVKLLLKI-QHKNLV 145
           LG G FG V              + +AVK L   +     R   +E+K+L+ I  H N+V
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 146 TLFGCCAE-GPEKMLVYEYLPNKSL--------DYFIFDKTKSSSL--DWTTRYRIV--- 191
            L G C + G   M++ E+    +L        + F+  K     L  D+ T   ++   
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS 251
             VA+G+ +L   A  + IHRD+ A NILL E+   KI DFGLAR    +  +V      
Sbjct: 192 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248
Query: 252 GTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
               +MAPE       ++++DV+S+GVL+ EI S
Sbjct: 249 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 107/212 (50%), Gaps = 14/212 (6%)
Query: 93  QLGHGGFGPVYRGL--MPNGQ-EIAVKKLSVDSRQG-LREFTNEVKLLLKIQHKNLVTLF 148
           +LG G FG V +G+  M   Q ++A+K L   + +    E   E +++ ++ +  +V L 
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G C +    MLV E      L  F+  K +   +  +    ++  V+ G+ YL E+    
Sbjct: 77  GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPV--SNVAELLHQVSMGMKYLEEK---N 130
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH--GYMAPEYALHGY 266
            +HRD+ A N+LL  +   KISDFGL++    +D++  T R +G     + APE      
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY-TARSAGKWPLKWYAPECINFRK 189
Query: 267 LSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKE 297
            S ++DV+SYGV + E +S G+K +    G E
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 221

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 20/213 (9%)
Query: 84  ATNFFSD---LNQLGHGGFGPVYRGLMPNGQE-IAVK----KLSVDSRQGLREFTNEVKL 135
           A  F  D   +  LG G +G V   +    +E +AVK    K +VD  + +++   E+ +
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICI 57
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMGV 194
              + H+N+V  +G   EG  + L  EY     L    FD+ +    +      R    +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQL 113
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH 254
             G++YLH      I HRDIK  N+LLDE+ N KISDFGLA +F   +      ++ GT 
Sbjct: 114 MAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 255 GYMAPE-YALHGYLSVKTDVFSYGVLVLEIVSG 286
            Y+APE      + +   DV+S G+++  +++G
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 20/214 (9%)
Query: 83  VATNFFSD---LNQLGHGGFGPVYRGLMPNGQE-IAVK----KLSVDSRQGLREFTNEVK 134
           +A  F  D   +  LG G +G V   +    +E +AVK    K +VD  + +++   E+ 
Sbjct: 1   MAVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EIC 57
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMG 193
           +   + H+N+V  +G   EG  + L  EY     L    FD+ +    +      R    
Sbjct: 58  INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQ 113
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           +  G++YLH      I HRDIK  N+LLDE+ N KISDFGLA +F   +      ++ GT
Sbjct: 114 LMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170
Query: 254 HGYMAPE-YALHGYLSVKTDVFSYGVLVLEIVSG 286
             Y+APE      + +   DV+S G+++  +++G
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 101/215 (46%), Gaps = 21/215 (9%)
Query: 91  LNQLGHGGFGPV--YRGLMPNGQEIAVKKLSVDSRQ----GLREFTNEVKLLLKIQHKNL 144
           L  +G G F  V   R ++  G+E+AVK   +D  Q     L++   EV++   + H N+
Sbjct: 19  LKTIGKGNFAKVKLARHIL-TGKEVAVK--IIDKTQLNSSSLQKLFREVRIXKVLNHPNI 75
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V LF          LV EY     +  ++    +    +   ++R ++   +   Y H++
Sbjct: 76  VKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQ---YCHQK 132
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF-RISGTHGYMAPE-YA 262
               I+HRD+KA N+LLD   N KI+DFG    F  E T  N      G   Y APE + 
Sbjct: 133 F---IVHRDLKAENLLLDADXNIKIADFG----FSNEFTFGNKLDAFCGAPPYAAPELFQ 185
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKE 297
              Y   + DV+S GV++  +VSG    DG+  KE
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 220

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 97/215 (45%), Gaps = 26/215 (12%)
Query: 94  LGHGGFGPVYR----GLMPN--GQEIAVKKLSVDSRQGLRE-FTNEVKLLLKI-QHKNLV 145
           LG G FG V      GL+ +     +AVK L   +    RE   +E+K+L  +  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 146 TLFGCCAEGPEKMLVYEY--------LPNKSLDYFIFDKTKSSSLDWTTRYRIVMG---- 193
            L G C  G   +++ EY           +  D FI  KT  + ++       +      
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 194 ---VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
              VA+G+ +L   A    IHRD+ A NILL      KI DFGLAR    +  +V     
Sbjct: 174 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNA 230
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
                +MAPE   +   + ++DV+SYG+ + E+ S
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 97/215 (45%), Gaps = 26/215 (12%)
Query: 94  LGHGGFGPVYR----GLMPN--GQEIAVKKLSVDSRQGLRE-FTNEVKLLLKI-QHKNLV 145
           LG G FG V      GL+ +     +AVK L   +    RE   +E+K+L  +  H N+V
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 146 TLFGCCAEGPEKMLVYEY--------LPNKSLDYFIFDKTKSSSLDWTTRYRIVMG---- 193
            L G C  G   +++ EY           +  D FI  KT  + ++       +      
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 194 ---VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
              VA+G+ +L   A    IHRD+ A NILL      KI DFGLAR    +  +V     
Sbjct: 169 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 225
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
                +MAPE   +   + ++DV+SYG+ + E+ S
Sbjct: 226 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 20/213 (9%)
Query: 84  ATNFFSD---LNQLGHGGFGPVYRGLMPNGQE-IAVK----KLSVDSRQGLREFTNEVKL 135
           A  F  D   +  LG G +G V   +    +E +AVK    K +VD  + +++   E+ +
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICI 57
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMGV 194
              + H+N+V  +G   EG  + L  EY     L    FD+ +    +      R    +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQL 113
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH 254
             G++YLH      I HRDIK  N+LLDE+ N KISDFGLA +F   +      ++ GT 
Sbjct: 114 MAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 255 GYMAPE-YALHGYLSVKTDVFSYGVLVLEIVSG 286
            Y+APE      + +   DV+S G+++  +++G
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 15/204 (7%)
Query: 88  FSDLNQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTN-----EVKLLLKIQH 141
           +  L+ LG G F  VY+    N  Q +A+KK+ +  R   ++  N     E+KLL ++ H
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
            N++ L           LV++++    L+  I D +   +      Y ++    +GL YL
Sbjct: 72  PNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLM--TLQGLEYL 128
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEY 261
           H+     I+HRD+K +N+LLDE    K++DFGLA+ F G        ++  T  Y APE 
Sbjct: 129 HQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYXHQVV-TRWYRAPEL 183
Query: 262 ALHGYL-SVKTDVFSYGVLVLEIV 284
                +  V  D+++ G ++ E++
Sbjct: 184 LFGARMYGVGVDMWAVGCILAELL 207

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 20/213 (9%)
Query: 84  ATNFFSD---LNQLGHGGFGPVYRGLMPNGQE-IAVK----KLSVDSRQGLREFTNEVKL 135
           A  F  D   +  LG G +G V   +    +E +AVK    K +VD  + +++   E+ +
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICI 57
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMGV 194
              + H+N+V  +G   EG  + L  EY     L    FD+ +    +      R    +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQL 113
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH 254
             G++YLH      I HRDIK  N+LLDE+ N KISDFGLA +F   +      ++ GT 
Sbjct: 114 MAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 255 GYMAPE-YALHGYLSVKTDVFSYGVLVLEIVSG 286
            Y+APE      + +   DV+S G+++  +++G
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 20/213 (9%)
Query: 84  ATNFFSD---LNQLGHGGFGPVYRGLMPNGQE-IAVK----KLSVDSRQGLREFTNEVKL 135
           A  F  D   +  LG G +G V   +    +E +AVK    K +VD  + +++   E+ +
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICI 57
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMGV 194
              + H+N+V  +G   EG  + L  EY     L    FD+ +    +      R    +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQL 113
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH 254
             G++YLH      I HRDIK  N+LLDE+ N KISDFGLA +F   +      ++ GT 
Sbjct: 114 MAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170
Query: 255 GYMAPE-YALHGYLSVKTDVFSYGVLVLEIVSG 286
            Y+APE      + +   DV+S G+++  +++G
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 20/213 (9%)
Query: 84  ATNFFSD---LNQLGHGGFGPVYRGLMPNGQE-IAVK----KLSVDSRQGLREFTNEVKL 135
           A  F  D   +  LG G +G V   +    +E +AVK    K +VD  + +++   E+ +
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICI 57
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMGV 194
              + H+N+V  +G   EG  + L  EY     L    FD+ +    +      R    +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQL 113
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH 254
             G++YLH      I HRDIK  N+LLDE+ N KISDFGLA +F   +      ++ GT 
Sbjct: 114 MAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 255 GYMAPE-YALHGYLSVKTDVFSYGVLVLEIVSG 286
            Y+APE      + +   DV+S G+++  +++G
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 20/213 (9%)
Query: 84  ATNFFSD---LNQLGHGGFGPVYRGLMPNGQE-IAVK----KLSVDSRQGLREFTNEVKL 135
           A  F  D   +  LG G +G V   +    +E +AVK    K +VD  + +++   E+ +
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICI 57
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMGV 194
              + H+N+V  +G   EG  + L  EY     L    FD+ +    +      R    +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQL 113
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH 254
             G++YLH      I HRDIK  N+LLDE+ N KISDFGLA +F   +      ++ GT 
Sbjct: 114 MAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 255 GYMAPE-YALHGYLSVKTDVFSYGVLVLEIVSG 286
            Y+APE      + +   DV+S G+++  +++G
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 97/215 (45%), Gaps = 26/215 (12%)
Query: 94  LGHGGFGPVYR----GLMPN--GQEIAVKKLSVDSRQGLRE-FTNEVKLLLKI-QHKNLV 145
           LG G FG V      GL+ +     +AVK L   +    RE   +E+K+L  +  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 146 TLFGCCAEGPEKMLVYEY--------LPNKSLDYFIFDKTKSSSLDWTTRYRIVMG---- 193
            L G C  G   +++ EY           +  D FI  KT  + ++       +      
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 194 ---VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
              VA+G+ +L   A    IHRD+ A NILL      KI DFGLAR    +  +V     
Sbjct: 174 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 230
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
                +MAPE   +   + ++DV+SYG+ + E+ S
Sbjct: 231 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 112/230 (48%), Gaps = 22/230 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFT--NEVKLLLKIQHKNLVTLFGC 150
           LG G FG V +       QE AVK ++  S +     T   EV+LL K+ H N++ LF  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
             +     +V E      L   I  + + S  D     RI+  V  G+ Y+H+     I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA---RIIKQVFSGITYMHKH---NIV 143
Query: 211 HRDIKASNILLDEQ---LNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
           HRD+K  NILL+ +    + KI DFGL+  F  ++T +   RI GT  Y+APE  L G  
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKD-RI-GTAYYIAPE-VLRGTY 199
Query: 268 SVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALEL 317
             K DV+S GV++  ++SG        GK + D+L    T   G+ A +L
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPF---YGKNEYDILKRVET---GKYAFDL 243

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 92/213 (43%), Gaps = 24/213 (11%)
Query: 86  NFFSDLNQLGHGGFG--------PVYRGLMPNGQEIAVKKLSVDSRQGLRE-FTNEVKLL 136
            +   +  LG G FG        P   G    G+ +AVK L  D+    R  +  E+ +L
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDG---TGEMVAVKALKADAGPQHRSGWKQEIDIL 87
Query: 137 LKIQHKNLVTLFGCC--AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGV 194
             + H++++   GCC  A      LV EY+P  SL     D     S+           +
Sbjct: 88  RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQI 143
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH 254
             G+ YLH +     IHRD+ A N+LLD     KI DFGLA+  P E       R  G  
Sbjct: 144 CEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP-EGHEXYRVREDGDS 199
Query: 255 G--YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
              + APE          +DV+S+GV + E+++
Sbjct: 200 PVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 112/230 (48%), Gaps = 22/230 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFT--NEVKLLLKIQHKNLVTLFGC 150
           LG G FG V +       QE AVK ++  S +     T   EV+LL K+ H N++ LF  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
             +     +V E      L   I  + + S  D     RI+  V  G+ Y+H+     I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA---RIIKQVFSGITYMHKH---NIV 143
Query: 211 HRDIKASNILLDEQ---LNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
           HRD+K  NILL+ +    + KI DFGL+  F  ++T +   RI GT  Y+APE  L G  
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKD-RI-GTAYYIAPE-VLRGTY 199
Query: 268 SVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALEL 317
             K DV+S GV++  ++SG        GK + D+L    T   G+ A +L
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPF---YGKNEYDILKRVET---GKYAFDL 243

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 20/213 (9%)
Query: 84  ATNFFSD---LNQLGHGGFGPVYRGLMPNGQE-IAVK----KLSVDSRQGLREFTNEVKL 135
           A  F  D   +  LG G +G V   +    +E +AVK    K +VD  + +++   E+ +
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICI 57
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMGV 194
              + H+N+V  +G   EG  + L  EY     L    FD+ +    +      R    +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQL 113
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH 254
             G++YLH      I HRDIK  N+LLDE+ N KISDFGLA +F   +      ++ GT 
Sbjct: 114 MAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170
Query: 255 GYMAPE-YALHGYLSVKTDVFSYGVLVLEIVSG 286
            Y+APE      + +   DV+S G+++  +++G
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 104/204 (50%), Gaps = 11/204 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D+  +G+      E+ LL ++ H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E++ ++ L  F+ D +  + +        +  + +GL + H  
Sbjct: 68  VKLLDVIHTENKLYLVFEHV-DQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH 125
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
              R++HRD+K  N+L++ +   K++DFGLAR F G         +  T  Y APE  L 
Sbjct: 126 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVV-TLWYRAPEILLG 180
Query: 265 -GYLSVKTDVFSYGVLVLEIVSGR 287
             Y S   D++S G +  E+V+ R
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 20/213 (9%)
Query: 84  ATNFFSD---LNQLGHGGFGPVYRGLMPNGQE-IAVK----KLSVDSRQGLREFTNEVKL 135
           A  F  D   +  LG G +G V   +    +E +AVK    K +VD  + +++   E+ +
Sbjct: 1   AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICI 57
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMGV 194
              + H+N+V  +G   EG  + L  EY     L    FD+ +    +      R    +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQL 113
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH 254
             G++YLH      I HRDIK  N+LLDE+ N KISDFGLA +F   +      ++ GT 
Sbjct: 114 MAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTL 170
Query: 255 GYMAPE-YALHGYLSVKTDVFSYGVLVLEIVSG 286
            Y+APE      + +   DV+S G+++  +++G
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 90  DLNQ-LGHGGFGPVYRGLMPNGQE-IAVK----KLSVDSRQGLREFTNEVKLLLKIQHKN 143
           DL Q LG G +G V   +    +E +AVK    K +VD  + +++   E+ +   + H+N
Sbjct: 8   DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICINKMLNHEN 64
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMGVARGLLYLH 202
           +V  +G   EG  + L  EY     L    FD+ +    +      R    +  G++YLH
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE-Y 261
                 I HRDIK  N+LLDE+ N KISDFGLA +F   +      ++ GT  Y+APE  
Sbjct: 121 GIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 262 ALHGYLSVKTDVFSYGVLVLEIVSG 286
               + +   DV+S G+++  +++G
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAG 202

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/214 (31%), Positives = 100/214 (46%), Gaps = 25/214 (11%)
Query: 94  LGHGGFGPVYRG------LMPNGQEIAVKKLSVDSRQGL-REFTNEVKLLLKI-QHKNLV 145
           LG G FG V              + +AVK L   +     R   +E+K+L+ I  H N+V
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 146 TLFGCCAE-GPEKMLVYEYLPNKSL--------DYFIFDKTKSSSL--DWTTRYRIV--- 191
            L G C + G   M++ E+    +L        + F+  K     L  D+ T   ++   
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS 251
             VA+G+ +L   A  + IHRD+ A NILL E+   KI DFGLAR    +   V      
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 252 GTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
               +MAPE       ++++DV+S+GVL+ EI S
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 17/204 (8%)
Query: 88  FSDLNQLGHGGFGPVY--RGLMPNGQEIAVKKLSVDSRQGLR--EFTNEVKLLLKI-QHK 142
           F  L  LG G FG V+  R    NG+  A+K L  +    L+  E TN+ +L+L I  H 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRH-NGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 66
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
            ++ ++G   +  +  ++ +Y+    L   +    KS              V   L YLH
Sbjct: 67  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLL---RKSQRFPNPVAKFYAAEVCLALEYLH 123
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
            +    II+RD+K  NILLD+  + KI+DFG A+  P       T+ + GT  Y+APE  
Sbjct: 124 SKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYXLCGTPDYIAPEVV 175
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
                +   D +S+G+L+ E+++G
Sbjct: 176 STKPYNKSIDWWSFGILIYEMLAG 199

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 103/222 (46%), Gaps = 28/222 (12%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNGQ-EIAVKKLS---------VDSRQGLREF-- 129
           ++  ++F  + +LG G +G V      NG  E A+K +           D  + + +F  
Sbjct: 33  KIGESYFK-VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHE 91
Query: 130 --TNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTR 187
              NE+ LL  + H N++ LF    +     LV E+     L   I ++ K    D    
Sbjct: 92  EIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAAN- 150
Query: 188 YRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ---LNPKISDFGLARLFPGEDTH 244
             I+  +  G+ YLH+     I+HRDIK  NILL+ +   LN KI DFGL+  F  +   
Sbjct: 151 --IMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL 205
Query: 245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
            +     GT  Y+APE     Y + K DV+S GV++  ++ G
Sbjct: 206 RDRL---GTAYYIAPEVLKKKY-NEKCDVWSCGVIMYILLCG 243

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 120/277 (43%), Gaps = 37/277 (13%)
Query: 93  QLGHGGFGPVYRGLMP-----NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
           +LG G FG V +G            + + K   +      E   E  ++ ++ +  +V +
Sbjct: 376 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 435
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
            G C E    MLV E      L+ ++    ++  +       +V  V+ G+ YL E   +
Sbjct: 436 IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEE---S 488
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAPEYA 262
             +HRD+ A N+LL  Q   KISDFGL++    ++ +      + THG     + APE  
Sbjct: 489 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK----AQTHGKWPVKWYAPECI 544
Query: 263 LHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS 321
            +   S K+DV+S+GVL+ E  S G+K + G  G E   +L         EK   +  P 
Sbjct: 545 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML---------EKGERMGCP- 594
Query: 322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML 358
            A C R+       L  LC    V  RP   +V L L
Sbjct: 595 -AGCPRE----MYDLMNLCWTYDVENRPGFAAVELRL 626

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 120/277 (43%), Gaps = 37/277 (13%)
Query: 93  QLGHGGFGPVYRGLMP-----NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
           +LG G FG V +G            + + K   +      E   E  ++ ++ +  +V +
Sbjct: 377 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 436
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
            G C E    MLV E      L+ ++    ++  +       +V  V+ G+ YL E   +
Sbjct: 437 IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEE---S 489
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAPEYA 262
             +HRD+ A N+LL  Q   KISDFGL++    ++ +      + THG     + APE  
Sbjct: 490 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK----AQTHGKWPVKWYAPECI 545
Query: 263 LHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS 321
            +   S K+DV+S+GVL+ E  S G+K + G  G E   +L         EK   +  P 
Sbjct: 546 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML---------EKGERMGCP- 595
Query: 322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML 358
            A C R+       L  LC    V  RP   +V L L
Sbjct: 596 -AGCPRE----MYDLMNLCWTYDVENRPGFAAVELRL 627

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 93  QLGHGGFGPVY--RGLMPNGQEIAVKKLSVDS-RQGLREFT-NEVKLLLKIQ---HKNLV 145
           ++G G +G V+  R L   G+ +A+K++ V +  +G+   T  EV +L  ++   H N+V
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 146 TLFGCCA-----EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
            LF  C         +  LV+E++      Y   DK     +   T   ++  + RGL +
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL--DKVPEPGVPTETIKDMMFQLLRGLDF 135
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE 260
           LH     R++HRD+K  NIL+      K++DFGLAR++      +    +  T  Y APE
Sbjct: 136 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRAPE 189
Query: 261 YALHGYLSVKTDVFSYGVLVLEI 283
             L    +   D++S G +  E+
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEM 212

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 110/229 (48%), Gaps = 30/229 (13%)
Query: 92  NQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLR------EFTNEVKLLLKIQHKNL 144
           + LG G FG V  G     G ++AVK L+   RQ +R      +   E++ L   +H ++
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILN---RQKIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L+   +   +  +V EY+    L  +I    K+  LD     R+   +  G+ Y H  
Sbjct: 79  IKLYQVISTPSDIFMVMEYVSGGELFDYI---CKNGRLDEKESRRLFQQILSGVDYCHRH 135
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFP-GEDTHVNTFRIS-GTHGYMAPEYA 262
               ++HRD+K  N+LLD  +N KI+DFGL+ +   GE       R S G+  Y APE  
Sbjct: 136 M---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-----FLRXSCGSPNYAAPE-V 186
Query: 263 LHG--YLSVKTDVFSYGVLVLEIVSGR----KNHDGRLGKEKADLLSYT 305
           + G  Y   + D++S GV++  ++ G      +H   L K+  D + YT
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYT 235

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 108/234 (46%), Gaps = 23/234 (9%)
Query: 59  ESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRG-LMPNGQEIAVKK 117
           ES+++ +G G +S N        ++  + F  +  LG G FG V    +   G   AVK 
Sbjct: 4   ESSKEGNGIGVNSSN--------RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKV 55
Query: 118 LSVDS--RQGLREFTNEVKLLLKI--QHKNLVTLFGCCAEGPEKML-VYEYLPNKSLDYF 172
           L  D   +    E T   K +L +   H  L  LF CC + P+++  V E++    L   
Sbjct: 56  LKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDL--- 111
Query: 173 IFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDF 232
           +F   KS   D          +   L++LH++    II+RD+K  N+LLD + + K++DF
Sbjct: 112 MFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADF 168
Query: 233 GLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
           G+ +   G    V T    GT  Y+APE           D ++ GVL+ E++ G
Sbjct: 169 GMCK--EGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 124/288 (43%), Gaps = 37/288 (12%)
Query: 93  QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQG-----LREFTNEVKLLLKIQHKNLVTL 147
           +LG G FG V +G     + +    + +   +        E   E  ++ ++ +  +V +
Sbjct: 12  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 71
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
            G C E    MLV E      L+ ++    ++  +       +V  V+ G+ YL E   +
Sbjct: 72  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEE---S 124
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAPEYA 262
             +HRD+ A N+LL  Q   KISDFGL++    ++ +      + THG     + APE  
Sbjct: 125 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK----AQTHGKWPVKWYAPECI 180
Query: 263 LHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS 321
            +   S K+DV+S+GVL+ E  S G+K + G  G E   +L         EK   +  P 
Sbjct: 181 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML---------EKGERMGCP- 230
Query: 322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFTLPKPG 369
            A C R+       L  LC    V  RP   +V L L    + +   G
Sbjct: 231 -AGCPRE----MYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 273

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 101/223 (45%), Gaps = 27/223 (12%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRG----LMPNGQEIAVKKLSVDSRQGLRE---FTNEVK 134
           +V+    + L +LG G FG VY G    ++    E  V   +V+    LRE   F NE  
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD-----KTKSSSLDWTTRYR 189
           ++      ++V L G  ++G   ++V E + +  L  ++       +        T +  
Sbjct: 73  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 190 IVMG--VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
           I M   +A G+ YL+ +   + +HRD+ A N ++      KI DFG+ R     D +   
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR-----DIYETA 184
Query: 248 FRISGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +   G  G     +MAPE    G  +  +D++S+GV++ EI S
Sbjct: 185 YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/239 (24%), Positives = 106/239 (44%), Gaps = 36/239 (15%)
Query: 66  GSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVY----RGLMPNGQEIAVKKLSVD 121
           GS  D W         +VA    +   +LG G FG VY    +G++ +  E  V   +V+
Sbjct: 1   GSVPDEW---------EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN 51
Query: 122 SRQGLRE---FTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIF---- 174
               +RE   F NE  ++ +    ++V L G  ++G   +++ E +    L  ++     
Sbjct: 52  EAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRP 111
Query: 175 ---DKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISD 231
              +    +    +   ++   +A G+ YL+     + +HRD+ A N ++ E    KI D
Sbjct: 112 EMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 168
Query: 232 FGLARLFPGEDTHVNTFRISGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           FG+ R     D +   +   G  G     +M+PE    G  +  +DV+S+GV++ EI +
Sbjct: 169 FGMTR-----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 71/271 (26%), Positives = 123/271 (45%), Gaps = 28/271 (10%)
Query: 93  QLGHGGFGPVYRG-LMPNGQEIAVKKLSV----DSRQGLREFTNEVKLLLKIQHKNLVTL 147
           ++G G F  VYR   + +G  +A+KK+ +    D++    +   E+ LL ++ H N++  
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAK-ARADCIKEIDLLKQLNHPNVIKY 97
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFI--FDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
           +    E  E  +V E      L   I  F K K    + T  ++  + +   L ++H   
Sbjct: 98  YASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTV-WKYFVQLCSALEHMHSR- 155
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHG 265
             R++HRDIK +N+ +      K+ D GL R F  + T  ++  + GT  YM+PE     
Sbjct: 156 --RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPERIHEN 211
Query: 266 YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD-PSLAK 324
             + K+D++S G L+ E+ + +    G    +K +L S         K +E  D P L  
Sbjct: 212 GYNFKSDIWSLGCLLYEMAALQSPFYG----DKMNLYSLC-------KKIEQCDYPPLPS 260
Query: 325 CNRDEAAMCIQLGLLCCQQSVAERPDMNSVH 355
            +  E     QL  +C      +RPD+  V+
Sbjct: 261 DHYSEELR--QLVNMCINPDPEKRPDVTYVY 289

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 20/212 (9%)
Query: 84  ATNFFSDLNQLGHGGFGPVY--RGLMPNGQEIAVKKLSVDS-RQGLREFT-NEVKLLLKI 139
           A   +  + ++G G +G V+  R L   G+ +A+K++ V +  +G+   T  EV +L  +
Sbjct: 9   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 140 Q---HKNLVTLFGCCA-----EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIV 191
           +   H N+V LF  C         +  LV+E++      Y   DK     +   T   ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL--DKVPEPGVPTETIKDMM 126
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS 251
             + RGL +LH     R++HRD+K  NIL+      K++DFGLAR++      +    + 
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVV 180
Query: 252 GTHGYMAPEYALHGYLSVKTDVFSYGVLVLEI 283
            T  Y APE  L    +   D++S G +  E+
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 101/223 (45%), Gaps = 27/223 (12%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRG----LMPNGQEIAVKKLSVDSRQGLRE---FTNEVK 134
           +V+    + L +LG G FG VY G    ++    E  V   +V+    LRE   F NE  
Sbjct: 12  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 71
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD-----KTKSSSLDWTTRYR 189
           ++      ++V L G  ++G   ++V E + +  L  ++       +        T +  
Sbjct: 72  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 131
Query: 190 IVMG--VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
           I M   +A G+ YL+ +   + +HRD+ A N ++      KI DFG+ R     D +   
Sbjct: 132 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR-----DIYETD 183
Query: 248 FRISGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +   G  G     +MAPE    G  +  +D++S+GV++ EI S
Sbjct: 184 YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 124/288 (43%), Gaps = 37/288 (12%)
Query: 93  QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQG-----LREFTNEVKLLLKIQHKNLVTL 147
           +LG G FG V +G     + +    + +   +        E   E  ++ ++ +  +V +
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
            G C E    MLV E      L+ ++    ++  +       +V  V+ G+ YL E   +
Sbjct: 84  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEE---S 136
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAPEYA 262
             +HRD+ A N+LL  Q   KISDFGL++    ++ +      + THG     + APE  
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK----AQTHGKWPVKWYAPECI 192
Query: 263 LHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS 321
            +   S K+DV+S+GVL+ E  S G+K + G  G E   +L         EK   +  P 
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML---------EKGERMGCP- 242
Query: 322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFTLPKPG 369
            A C R+       L  LC    V  RP   +V L L    + +   G
Sbjct: 243 -AGCPRE----MYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 285

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 99/215 (46%), Gaps = 22/215 (10%)
Query: 83  VATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREF-----TNEVKLL 136
           +AT+ +  + ++G G +G VY+   P +G  +A+K + V +  G           EV LL
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 137 LKIQ---HKNLVTLFGCCAEGP-----EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY 188
            +++   H N+V L   CA        +  LV+E++      Y   DK     L   T  
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYL--DKAPPPGLPAETIK 123
Query: 189 RIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
            ++    RGL +LH      I+HRD+K  NIL+      K++DFGLAR++      +   
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALT 177
Query: 249 RISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEI 283
            +  T  Y APE  L    +   D++S G +  E+
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 100/221 (45%), Gaps = 10/221 (4%)
Query: 78  LRTLQVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQ---GLREFTNEV 133
           L    +  ++F D   LG GGFG V+   M   G+  A KKL+    +   G +    E 
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 134 KLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG 193
           K+L K+  + +V+L        +  LV   +    + Y I++  + +      R      
Sbjct: 237 KILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA 296
Query: 194 -VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISG 252
            +  GL +LH+     II+RD+K  N+LLD+  N +ISD GLA       T    +  +G
Sbjct: 297 QIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY--AG 351
Query: 253 THGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           T G+MAPE  L        D F+ GV + E+++ R     R
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 20/205 (9%)
Query: 91  LNQLGHGGFGPVY--RGLMPNGQEIAVKKLSVDS-RQGLREFT-NEVKLLLKIQ---HKN 143
           + ++G G +G V+  R L   G+ +A+K++ V +  +G+   T  EV +L  ++   H N
Sbjct: 16  VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 75
Query: 144 LVTLFGCCA-----EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
           +V LF  C         +  LV+E++      Y   DK     +   T   ++  + RGL
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL--DKVPEPGVPTETIKDMMFQLLRGL 133
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMA 258
            +LH     R++HRD+K  NIL+      K++DFGLAR++      +    +  T  Y A
Sbjct: 134 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRA 187
Query: 259 PEYALHGYLSVKTDVFSYGVLVLEI 283
           PE  L    +   D++S G +  E+
Sbjct: 188 PEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 100/221 (45%), Gaps = 10/221 (4%)
Query: 78  LRTLQVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQ---GLREFTNEV 133
           L    +  ++F D   LG GGFG V+   M   G+  A KKL+    +   G +    E 
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 134 KLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG 193
           K+L K+  + +V+L        +  LV   +    + Y I++  + +      R      
Sbjct: 237 KILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA 296
Query: 194 -VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISG 252
            +  GL +LH+     II+RD+K  N+LLD+  N +ISD GLA       T    +  +G
Sbjct: 297 QIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY--AG 351
Query: 253 THGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           T G+MAPE  L        D F+ GV + E+++ R     R
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 100/221 (45%), Gaps = 10/221 (4%)
Query: 78  LRTLQVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQ---GLREFTNEV 133
           L    +  ++F D   LG GGFG V+   M   G+  A KKL+    +   G +    E 
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 134 KLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG 193
           K+L K+  + +V+L        +  LV   +    + Y I++  + +      R      
Sbjct: 237 KILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA 296
Query: 194 -VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISG 252
            +  GL +LH+     II+RD+K  N+LLD+  N +ISD GLA       T    +  +G
Sbjct: 297 QIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY--AG 351
Query: 253 THGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           T G+MAPE  L        D F+ GV + E+++ R     R
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 14/199 (7%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-----FTNEVKLLLKIQHKNLVTL 147
           LG G F  V     +   +E A+K L  + R  ++E      T E  ++ ++ H   V L
Sbjct: 45  LGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 102
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           + C  +  +      Y  N  L  +I    K  S D T        +   L YLH +   
Sbjct: 103 YFCFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG-- 157
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
            IIHRD+K  NILL+E ++ +I+DFG A++   E          GT  Y++PE       
Sbjct: 158 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 216
Query: 268 SVKTDVFSYGVLVLEIVSG 286
              +D+++ G ++ ++V+G
Sbjct: 217 CKSSDLWALGCIIYQLVAG 235

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 121/277 (43%), Gaps = 37/277 (13%)
Query: 93  QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQG-----LREFTNEVKLLLKIQHKNLVTL 147
           +LG G FG V +G     + +    + +   +        E   E  ++ ++ +  +V +
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
            G C E    MLV E      L+ ++    ++  +       +V  V+ G+ YL E   +
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEE---S 130
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAPEYA 262
             +HRD+ A N+LL  Q   KISDFGL++    ++ +      + THG     + APE  
Sbjct: 131 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK----AQTHGKWPVKWYAPECI 186
Query: 263 LHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS 321
            +   S K+DV+S+GVL+ E  S G+K + G  G E   +L         EK   +  P 
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML---------EKGERMGCP- 236
Query: 322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML 358
            A C R+       L  LC    V  RP   +V L L
Sbjct: 237 -AGCPRE----MYDLMNLCWTYDVENRPGFAAVELRL 268

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 100/221 (45%), Gaps = 10/221 (4%)
Query: 78  LRTLQVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQ---GLREFTNEV 133
           L    +  ++F D   LG GGFG V+   M   G+  A KKL+    +   G +    E 
Sbjct: 177 LEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEK 236
Query: 134 KLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG 193
           K+L K+  + +V+L        +  LV   +    + Y I++  + +      R      
Sbjct: 237 KILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA 296
Query: 194 -VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISG 252
            +  GL +LH+     II+RD+K  N+LLD+  N +ISD GLA       T    +  +G
Sbjct: 297 QIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY--AG 351
Query: 253 THGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           T G+MAPE  L        D F+ GV + E+++ R     R
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 101/223 (45%), Gaps = 27/223 (12%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRG----LMPNGQEIAVKKLSVDSRQGLRE---FTNEVK 134
           +V+    + L +LG G FG VY G    ++    E  V   +V+    LRE   F NE  
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD-----KTKSSSLDWTTRYR 189
           ++      ++V L G  ++G   ++V E + +  L  ++       +        T +  
Sbjct: 73  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 190 IVMG--VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
           I M   +A G+ YL+ +   + +HRD+ A N ++      KI DFG+ R     D +   
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR-----DIYETD 184
Query: 248 FRISGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +   G  G     +MAPE    G  +  +D++S+GV++ EI S
Sbjct: 185 YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 120/277 (43%), Gaps = 37/277 (13%)
Query: 93  QLGHGGFGPVYRGLMP-----NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
           +LG G FG V +G            + + K   +      E   E  ++ ++ +  +V +
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
            G C E    MLV E      L+ ++    ++  +       +V  V+ G+ YL E   +
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEE---S 146
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAPEYA 262
             +HRD+ A N+LL  Q   KISDFGL++    ++ +      + THG     + APE  
Sbjct: 147 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK----AQTHGKWPVKWYAPECI 202
Query: 263 LHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS 321
            +   S K+DV+S+GVL+ E  S G+K + G  G E   +L         EK   +  P 
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML---------EKGERMGCP- 252
Query: 322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML 358
            A C R+       L  LC    V  RP   +V L L
Sbjct: 253 -AGCPRE----MYDLMNLCWTYDVENRPGFAAVELRL 284

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 120/277 (43%), Gaps = 37/277 (13%)
Query: 93  QLGHGGFGPVYRGLMP-----NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
           +LG G FG V +G            + + K   +      E   E  ++ ++ +  +V +
Sbjct: 34  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 93
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
            G C E    MLV E      L+ ++    ++  +       +V  V+ G+ YL E   +
Sbjct: 94  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEE---S 146
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAPEYA 262
             +HRD+ A N+LL  Q   KISDFGL++    ++ +      + THG     + APE  
Sbjct: 147 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK----AQTHGKWPVKWYAPECI 202
Query: 263 LHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS 321
            +   S K+DV+S+GVL+ E  S G+K + G  G E   +L         EK   +  P 
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML---------EKGERMGCP- 252
Query: 322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML 358
            A C R+       L  LC    V  RP   +V L L
Sbjct: 253 -AGCPRE----MYDLMNLCWTYDVENRPGFAAVELRL 284

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 76/277 (27%), Positives = 121/277 (43%), Gaps = 37/277 (13%)
Query: 93  QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQG-----LREFTNEVKLLLKIQHKNLVTL 147
           +LG G FG V +G     + +    + +   +        E   E  ++ ++ +  +V +
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
            G C E    MLV E      L+ ++    ++  +       +V  V+ G+ YL E   +
Sbjct: 74  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEE---S 126
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAPEYA 262
             +HRD+ A N+LL  Q   KISDFGL++    ++ +      + THG     + APE  
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK----AQTHGKWPVKWYAPECI 182
Query: 263 LHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS 321
            +   S K+DV+S+GVL+ E  S G+K + G  G E   +L         EK   +  P 
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML---------EKGERMGCP- 232
Query: 322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML 358
            A C R+       L  LC    V  RP   +V L L
Sbjct: 233 -AGCPRE----MYDLMNLCWTYDVENRPGFAAVELRL 264

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 20/213 (9%)
Query: 84  ATNFFSD---LNQLGHGGFGPVYRGLMPNGQE-IAVK----KLSVDSRQGLREFTNEVKL 135
           A  F  D   +  LG G  G V   +    +E +AVK    K +VD  + +++   E+ +
Sbjct: 1   AVPFVEDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK---EICI 57
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMGV 194
              + H+N+V  +G   EG  + L  EY     L    FD+ +    +      R    +
Sbjct: 58  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQL 113
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH 254
             G++YLH      I HRDIK  N+LLDE+ N KISDFGLA +F   +      ++ GT 
Sbjct: 114 MAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 170
Query: 255 GYMAPE-YALHGYLSVKTDVFSYGVLVLEIVSG 286
            Y+APE      + +   DV+S G+++  +++G
Sbjct: 171 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 120/277 (43%), Gaps = 37/277 (13%)
Query: 93  QLGHGGFGPVYRGLMP-----NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
           +LG G FG V +G            + + K   +      E   E  ++ ++ +  +V +
Sbjct: 32  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 91
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
            G C E    MLV E      L+ ++    ++  +       +V  V+ G+ YL E   +
Sbjct: 92  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEE---S 144
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAPEYA 262
             +HRD+ A N+LL  Q   KISDFGL++    ++ +      + THG     + APE  
Sbjct: 145 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK----AQTHGKWPVKWYAPECI 200
Query: 263 LHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS 321
            +   S K+DV+S+GVL+ E  S G+K + G  G E   +L         EK   +  P 
Sbjct: 201 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML---------EKGERMGCP- 250
Query: 322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML 358
            A C R+       L  LC    V  RP   +V L L
Sbjct: 251 -AGCPRE----MYDLMNLCWTYDVENRPGFAAVELRL 282

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 103/223 (46%), Gaps = 27/223 (12%)
Query: 82  QVATNFFSDLNQLGHGGFGPVY----RGLMPNGQEIAVKKLSVDSRQGLRE---FTNEVK 134
           +VA    +   +LG G FG VY    +G++ +  E  V   +V+    +RE   F NE  
Sbjct: 11  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 70
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN-------KSLDYFIFDKTKSSSLDWTTR 187
           ++ +    ++V L G  ++G   +++ E +         +SL   + +    +    +  
Sbjct: 71  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 130
Query: 188 YRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
            ++   +A G+ YL+     + +HRD+ A N ++ E    KI DFG+ R     D +   
Sbjct: 131 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETD 182
Query: 248 FRISGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +   G  G     +M+PE    G  +  +DV+S+GV++ EI +
Sbjct: 183 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 107/241 (44%), Gaps = 36/241 (14%)
Query: 64  ADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVY----RGLMPNGQEIAVKKLS 119
           AD    D W         +VA    +   +LG G FG VY    +G++ +  E  V   +
Sbjct: 12  ADVYVPDEW---------EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT 62
Query: 120 VDSRQGLRE---FTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN-------KSL 169
           V+    +RE   F NE  ++ +    ++V L G  ++G   +++ E +         +SL
Sbjct: 63  VNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL 122
Query: 170 DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKI 229
              + +    +    +   ++   +A G+ YL+     + +HRD+ A N ++ E    KI
Sbjct: 123 RPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 179
Query: 230 SDFGLARLFPGEDTHVNTFRISGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIV 284
            DFG+ R     D +   +   G  G     +M+PE    G  +  +DV+S+GV++ EI 
Sbjct: 180 GDFGMTR-----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234
Query: 285 S 285
           +
Sbjct: 235 T 235

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 122/277 (44%), Gaps = 37/277 (13%)
Query: 93  QLGHGGFGPVYRGLMP-----NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
           +LG G FG V +G            + + K   +      E   E  ++ ++ +  +V +
Sbjct: 18  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 77
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
            G C E    MLV E      L+ ++    ++  +       +V  V+ G+ YL E   +
Sbjct: 78  IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEE---S 130
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAPEYA 262
             +HRD+ A N+LL  Q   KISDFGL++    ++   N ++ + THG     + APE  
Sbjct: 131 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE---NXYK-AQTHGKWPVKWYAPECI 186
Query: 263 LHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS 321
            +   S K+DV+S+GVL+ E  S G+K + G  G E   +L         EK   +  P 
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML---------EKGERMGCP- 236
Query: 322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML 358
            A C R+       L  LC    V  RP   +V L L
Sbjct: 237 -AGCPRE----MYDLMNLCWTYDVENRPGFAAVELRL 268

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 94/197 (47%), Gaps = 15/197 (7%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           L  +G G FG V  G    G ++AVK +  D+    + F  E  ++ +++H NLV L G 
Sbjct: 17  LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 73
Query: 151 CAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
             E    + +V EY+   SL  ++  + +S  L      +  + V   + YL        
Sbjct: 74  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---NF 129
Query: 210 IHRDIKASNILLDEQLNPKISDFGLAR-LFPGEDTHVNTFRISGTHGYMAPEYALHGYLS 268
           +HRD+ A N+L+ E    K+SDFGL +     +DT     +      + APE       S
Sbjct: 130 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREAAFS 183
Query: 269 VKTDVFSYGVLVLEIVS 285
            K+DV+S+G+L+ EI S
Sbjct: 184 TKSDVWSFGILLWEIYS 200

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKL--SVDSRQGLREFTNEVKLLLKIQHKNL 144
             DL ++G G +G V + +  P+GQ +AVK++  +VD ++  +   +   ++       +
Sbjct: 24  LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY----RIVMGVARGLLY 200
           V  +G      +  +  E + + S D F   K   S LD         +I +   + L +
Sbjct: 84  VQFYGALFREGDCWICMELM-STSFDKFY--KYVYSVLDDVIPEEILGKITLATVKALNH 140
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE 260
           L E    +IIHRDIK SNILLD   N K+ DFG++      D+   T R +G   YMAPE
Sbjct: 141 LKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKT-RDAGCRPYMAPE 195
Query: 261 -----YALHGYLSVKTDVFSYGVLVLEIVSGR 287
                 +  GY  V++DV+S G+ + E+ +GR
Sbjct: 196 RIDPSASRQGY-DVRSDVWSLGITLYELATGR 226

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 113/251 (45%), Gaps = 18/251 (7%)
Query: 94  LGHGGFGPVYRGLMPNGQ----EIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTL 147
           LG G FG V  G +        ++AVK + +D  S++ + EF +E   +    H N++ L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 148 FGCCAEG-----PEKMLVYEYLPNKSL-DYFIFDK--TKSSSLDWTTRYRIVMGVARGLL 199
            G C E      P+ M++  ++    L  Y ++ +  T    +   T  + ++ +A G+ 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           YL        +HRD+ A N +L + +   ++DFGL++     D +           ++A 
Sbjct: 162 YLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218
Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELV 318
           E       + K+DV+++GV + EI + G   + G    E  D L +   L Q E  L+ +
Sbjct: 219 ESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDEL 278
Query: 319 DPSLAKCNRDE 329
              +  C R +
Sbjct: 279 YEIMYSCWRTD 289

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 107/212 (50%), Gaps = 14/212 (6%)
Query: 93  QLGHGGFGPVYRGL--MPNGQ-EIAVKKLSVDSRQG-LREFTNEVKLLLKIQHKNLVTLF 148
           +LG G FG V +G+  M   Q ++A+K L   + +    E   E +++ ++ +  +V L 
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G C +    MLV E      L  F+  K +   +  +    ++  V+ G+ YL E+    
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPV--SNVAELLHQVSMGMKYLEEK---N 456
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH--GYMAPEYALHGY 266
            +HR++ A N+LL  +   KISDFGL++    +D++  T R +G     + APE      
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY-TARSAGKWPLKWYAPECINFRK 515
Query: 267 LSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKE 297
            S ++DV+SYGV + E +S G+K +    G E
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 106/241 (43%), Gaps = 36/241 (14%)
Query: 64  ADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVY----RGLMPNGQEIAVKKLS 119
           AD    D W         +VA    +   +LG G FG VY    +G++ +  E  V   +
Sbjct: 6   ADVYVPDEW---------EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT 56
Query: 120 VDSRQGLRE---FTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIF-- 174
           V+    +RE   F NE  ++ +    ++V L G  ++G   +++ E +    L  ++   
Sbjct: 57  VNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL 116
Query: 175 -----DKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKI 229
                +    +    +   ++   +A G+ YL+     + +HRD+ A N ++ E    KI
Sbjct: 117 RPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 173
Query: 230 SDFGLARLFPGEDTHVNTFRISGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIV 284
            DFG+ R     D +   +   G  G     +M+PE    G  +  +DV+S+GV++ EI 
Sbjct: 174 GDFGMTR-----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 228
Query: 285 S 285
           +
Sbjct: 229 T 229

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 91/210 (43%), Gaps = 18/210 (8%)
Query: 86  NFFSDLNQLGHGGFGPVYRGLMP-----NGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKI 139
            +   +  LG G FG V            G+ +AVK L       LR  +  E+++L  +
Sbjct: 8   RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTL 67
Query: 140 QHKNLVTLFGCCAEGPEK--MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            H+++V   GCC +  EK   LV EY+P  SL     D      +           +  G
Sbjct: 68  YHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLR----DYLPRHCVGLAQLLLFAQQICEG 123
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-- 255
           + YLH +     IHR + A N+LLD     KI DFGLA+  P E       R  G     
Sbjct: 124 MAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVP-EGHEYYRVREDGDSPVF 179
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           + APE          +DV+S+GV + E+++
Sbjct: 180 WYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 91/210 (43%), Gaps = 18/210 (8%)
Query: 86  NFFSDLNQLGHGGFGPVYRGLMP-----NGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKI 139
            +   +  LG G FG V            G+ +AVK L       LR  +  E+++L  +
Sbjct: 9   RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTL 68
Query: 140 QHKNLVTLFGCCAEGPEK--MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            H+++V   GCC +  EK   LV EY+P  SL     D      +           +  G
Sbjct: 69  YHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLR----DYLPRHCVGLAQLLLFAQQICEG 124
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-- 255
           + YLH +     IHR + A N+LLD     KI DFGLA+  P E       R  G     
Sbjct: 125 MAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVP-EGHEYYRVREDGDSPVF 180
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           + APE          +DV+S+GV + E+++
Sbjct: 181 WYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 106/241 (43%), Gaps = 36/241 (14%)
Query: 64  ADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVY----RGLMPNGQEIAVKKLS 119
           AD    D W         +VA    +   +LG G FG VY    +G++ +  E  V   +
Sbjct: 5   ADVYVPDEW---------EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT 55
Query: 120 VDSRQGLRE---FTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIF-- 174
           V+    +RE   F NE  ++ +    ++V L G  ++G   +++ E +    L  ++   
Sbjct: 56  VNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL 115
Query: 175 -----DKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKI 229
                +    +    +   ++   +A G+ YL+     + +HRD+ A N ++ E    KI
Sbjct: 116 RPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 172
Query: 230 SDFGLARLFPGEDTHVNTFRISGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIV 284
            DFG+ R     D +   +   G  G     +M+PE    G  +  +DV+S+GV++ EI 
Sbjct: 173 GDFGMTR-----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 227
Query: 285 S 285
           +
Sbjct: 228 T 228

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 130/304 (42%), Gaps = 53/304 (17%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K + L
Sbjct: 71  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCAKL 118
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 119 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 175
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADL 301
           T         T  Y APE  L+  + +   D++S G ++ E+++GR       G +  D 
Sbjct: 176 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP---GTDHIDQ 227
Query: 302 LSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD 361
           L     L  G    EL    L K + + A   I        QS+A+ P MN  ++ +  +
Sbjct: 228 LKLILRLV-GTPGAEL----LKKISSESARNYI--------QSLAQMPKMNFANVFIGAN 274
Query: 362 SFTL 365
              +
Sbjct: 275 PLAV 278

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 102/223 (45%), Gaps = 27/223 (12%)
Query: 82  QVATNFFSDLNQLGHGGFGPVY----RGLMPNGQEIAVKKLSVDSRQGLRE---FTNEVK 134
           +VA    +   +LG G FG VY    +G++ +  E  V   +V+    +RE   F NE  
Sbjct: 12  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 71
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIF-------DKTKSSSLDWTTR 187
           ++ +    ++V L G  ++G   +++ E +    L  ++        +    +    +  
Sbjct: 72  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 131
Query: 188 YRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
            ++   +A G+ YL+     + +HRD+ A N ++ E    KI DFG+ R     D +   
Sbjct: 132 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETD 183
Query: 248 FRISGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +   G  G     +M+PE    G  +  +DV+S+GV++ EI +
Sbjct: 184 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 106/241 (43%), Gaps = 36/241 (14%)
Query: 64  ADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVY----RGLMPNGQEIAVKKLS 119
           AD    D W         +VA    +   +LG G FG VY    +G++ +  E  V   +
Sbjct: 5   ADVYVPDEW---------EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT 55
Query: 120 VDSRQGLRE---FTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIF-- 174
           V+    +RE   F NE  ++ +    ++V L G  ++G   +++ E +    L  ++   
Sbjct: 56  VNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL 115
Query: 175 -----DKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKI 229
                +    +    +   ++   +A G+ YL+     + +HRD+ A N ++ E    KI
Sbjct: 116 RPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 172
Query: 230 SDFGLARLFPGEDTHVNTFRISGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIV 284
            DFG+ R     D +   +   G  G     +M+PE    G  +  +DV+S+GV++ EI 
Sbjct: 173 GDFGMTR-----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 227
Query: 285 S 285
           +
Sbjct: 228 T 228

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 106/241 (43%), Gaps = 36/241 (14%)
Query: 64  ADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVY----RGLMPNGQEIAVKKLS 119
           AD    D W         +VA    +   +LG G FG VY    +G++ +  E  V   +
Sbjct: 12  ADVYVPDEW---------EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT 62
Query: 120 VDSRQGLRE---FTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIF-- 174
           V+    +RE   F NE  ++ +    ++V L G  ++G   +++ E +    L  ++   
Sbjct: 63  VNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL 122
Query: 175 -----DKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKI 229
                +    +    +   ++   +A G+ YL+     + +HRD+ A N ++ E    KI
Sbjct: 123 RPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 179
Query: 230 SDFGLARLFPGEDTHVNTFRISGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIV 284
            DFG+ R     D +   +   G  G     +M+PE    G  +  +DV+S+GV++ EI 
Sbjct: 180 GDFGMTR-----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234
Query: 285 S 285
           +
Sbjct: 235 T 235

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 129/304 (42%), Gaps = 53/304 (17%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 93
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 94  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 141
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 142 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 198
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADL 301
           T         T  Y APE  L+  + +   D++S G ++ E+++GR       G +  D 
Sbjct: 199 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP---GTDHIDQ 250
Query: 302 LSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD 361
           L     L  G    EL    L K + + A   I        QS+A+ P MN  ++ +  +
Sbjct: 251 LKLILRLV-GTPGAEL----LKKISSESARNYI--------QSLAQMPKMNFANVFIGAN 297
Query: 362 SFTL 365
              +
Sbjct: 298 PLAV 301

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 129/304 (42%), Gaps = 53/304 (17%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 95  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 142
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 143 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 199
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADL 301
           T         T  Y APE  L+  + +   D++S G ++ E+++GR       G +  D 
Sbjct: 200 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP---GTDHIDQ 251
Query: 302 LSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD 361
           L     L  G    EL    L K + + A   I        QS+A+ P MN  ++ +  +
Sbjct: 252 LKLILRLV-GTPGAEL----LKKISSESARNYI--------QSLAQMPKMNFANVFIGAN 298
Query: 362 SFTL 365
              +
Sbjct: 299 PLAV 302

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 130/304 (42%), Gaps = 53/304 (17%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 71  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR     D
Sbjct: 119 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 172
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADL 301
             +  F    T  Y APE  L+  + +   D++S G ++ E+++GR       G +  D 
Sbjct: 173 DEMAGF--VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP---GTDHIDQ 227
Query: 302 LSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD 361
           L     L  G    EL    L K + + A   I        QS+A+ P MN  ++ +  +
Sbjct: 228 LKLILRLV-GTPGAEL----LKKISSESARNYI--------QSLAQMPKMNFANVFIGAN 274
Query: 362 SFTL 365
              +
Sbjct: 275 PLAV 278

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 93  QLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLVTLFGC 150
           +LG GGFG V R +  + G+++A+K+   +     RE +  E++++ K+ H N+V+    
Sbjct: 22  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 81
Query: 151 CAEGPEKM-------LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
             +G +K+       L  EY     L  ++        L       ++  ++  L YLHE
Sbjct: 82  -PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 140
Query: 204 EAPARIIHRDIKASNILLD---EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE 260
               RIIHRD+K  NI+L    ++L  KI D G A+     D         GT  Y+APE
Sbjct: 141 N---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQYLAPE 194
Query: 261 YALHGYLSVKTDVFSYGVLVLEIVSG 286
                  +V  D +S+G L  E ++G
Sbjct: 195 LLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 93  QLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLVTLFGC 150
           +LG GGFG V R +    G+++A+K+   +     RE +  E++++ K+ H N+V+    
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 151 CAEGPEKM-------LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
             +G +K+       L  EY     L  ++        L       ++  ++  L YLHE
Sbjct: 81  -PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE 139
Query: 204 EAPARIIHRDIKASNILLD---EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE 260
               RIIHRD+K  NI+L    ++L  KI D G A+     D         GT  Y+APE
Sbjct: 140 N---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFVGTLQYLAPE 193
Query: 261 YALHGYLSVKTDVFSYGVLVLEIVSG 286
                  +V  D +S+G L  E ++G
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 18/219 (8%)
Query: 83  VATNFFSDLNQLGHGGFGPVYRGLMPNGQEIA----VKKLSVDSRQGLREFTNEVKLLLK 138
           V  + F  L  +G G FG V      + +++     + K     R  +R    E++++  
Sbjct: 12  VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 139 IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
           ++H  LV L+    +  +  +V + L    L Y +    ++      T    +  +   L
Sbjct: 72  LEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL---QQNVHFKEETVKLFICELVMAL 128
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMA 258
            YL  +   RIIHRD+K  NILLDE  +  I+DF +A + P E T + T  ++GT  YMA
Sbjct: 129 DYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITT--MAGTKPYMA 182
Query: 259 PEYALH----GYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           PE        GY S   D +S GV   E++ GR+ +  R
Sbjct: 183 PEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGRRPYHIR 220

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 94/197 (47%), Gaps = 15/197 (7%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           L  +G G FG V  G    G ++AVK +  D+    + F  E  ++ +++H NLV L G 
Sbjct: 26  LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 82
Query: 151 CAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
             E    + +V EY+   SL  ++  + +S  L      +  + V   + YL        
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---NF 138
Query: 210 IHRDIKASNILLDEQLNPKISDFGLAR-LFPGEDTHVNTFRISGTHGYMAPEYALHGYLS 268
           +HRD+ A N+L+ E    K+SDFGL +     +DT     +      + APE       S
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFS 192
Query: 269 VKTDVFSYGVLVLEIVS 285
            K+DV+S+G+L+ EI S
Sbjct: 193 TKSDVWSFGILLWEIYS 209

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 130/304 (42%), Gaps = 53/304 (17%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR     D
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 176
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADL 301
             +  F    T  Y APE  L+  + +   D++S G ++ E+++GR       G +  D 
Sbjct: 177 DEMAGF--VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP---GTDHIDQ 231
Query: 302 LSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD 361
           L     L  G    EL    L K + + A   I        QS+A+ P MN  ++ +  +
Sbjct: 232 LKLILRLV-GTPGAEL----LKKISSESARNYI--------QSLAQMPKMNFANVFIGAN 278
Query: 362 SFTL 365
              +
Sbjct: 279 PLAV 282

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 106/241 (43%), Gaps = 36/241 (14%)
Query: 64  ADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVY----RGLMPNGQEIAVKKLS 119
           AD    D W         +VA    +   +LG G FG VY    +G++ +  E  V   +
Sbjct: 34  ADVYVPDEW---------EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT 84
Query: 120 VDSRQGLRE---FTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIF-- 174
           V+    +RE   F NE  ++ +    ++V L G  ++G   +++ E +    L  ++   
Sbjct: 85  VNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL 144
Query: 175 -----DKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKI 229
                +    +    +   ++   +A G+ YL+     + +HRD+ A N ++ E    KI
Sbjct: 145 RPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 201
Query: 230 SDFGLARLFPGEDTHVNTFRISGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIV 284
            DFG+ R     D +   +   G  G     +M+PE    G  +  +DV+S+GV++ EI 
Sbjct: 202 GDFGMTR-----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 256
Query: 285 S 285
           +
Sbjct: 257 T 257

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 85/169 (50%), Gaps = 15/169 (8%)
Query: 117 KLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL-----DY 171
           K+S+ S+    +F NE++++  I+++  +T  G      E  ++YEY+ N S+      +
Sbjct: 80  KISIKSKYD--DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYF 137
Query: 172 FIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISD 231
           F+ DK  +  +       I+  V     Y+H E    I HRD+K SNIL+D+    K+SD
Sbjct: 138 FVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSD 195
Query: 232 FGLARLFPGEDTHVNTFRISGTHGYMAPEYALH--GYLSVKTDVFSYGV 278
           FG +      D  +   R  GT+ +M PE+  +   Y   K D++S G+
Sbjct: 196 FGESEYMV--DKKIKGSR--GTYEFMPPEFFSNESSYNGAKVDIWSLGI 240

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 129/304 (42%), Gaps = 53/304 (17%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 71  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 119 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 175
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADL 301
           T         T  Y APE  L+  + +   D++S G ++ E+++GR       G +  D 
Sbjct: 176 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP---GTDHIDQ 227
Query: 302 LSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD 361
           L     L  G    EL    L K + + A   I        QS+A+ P MN  ++ +  +
Sbjct: 228 LKLILRLV-GTPGAEL----LKKISSESARNYI--------QSLAQMPKMNFANVFIGAN 274
Query: 362 SFTL 365
              +
Sbjct: 275 PLAV 278

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 129/304 (42%), Gaps = 53/304 (17%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 179
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADL 301
           T         T  Y APE  L+  + +   D++S G ++ E+++GR       G +  D 
Sbjct: 180 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP---GTDHIDQ 231
Query: 302 LSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD 361
           L     L  G    EL    L K + + A   I        QS+A+ P MN  ++ +  +
Sbjct: 232 LKLILRLV-GTPGAEL----LKKISSESARNYI--------QSLAQMPKMNFANVFIGAN 278
Query: 362 SFTL 365
              +
Sbjct: 279 PLAV 282

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 129/304 (42%), Gaps = 53/304 (17%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 81  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 129 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 185
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADL 301
           T         T  Y APE  L+  + +   D++S G ++ E+++GR       G +  D 
Sbjct: 186 T-----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP---GTDHIDQ 237
Query: 302 LSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD 361
           L     L  G    EL    L K + + A   I        QS+A+ P MN  ++ +  +
Sbjct: 238 LKLILRLV-GTPGAEL----LKKISSESARNYI--------QSLAQMPKMNFANVFIGAN 284
Query: 362 SFTL 365
              +
Sbjct: 285 PLAV 288

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 17/218 (7%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRG----LMPNGQEIAVKKLSVDSRQGLRE---FTNEVK 134
           +V+    + L +LG G FG VY G    ++    E  V   +V+    LRE   F NE  
Sbjct: 10  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 69
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD-----KTKSSSLDWTTRYR 189
           ++      ++V L G  ++G   ++V E + +  L  ++       +        T +  
Sbjct: 70  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 129
Query: 190 IVMG--VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
           I M   +A G+ YL+ +   + +HRD+ A N ++      KI DFG+ R     D     
Sbjct: 130 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKG 186
Query: 248 FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
            +      +MAPE    G  +  +D++S+GV++ EI S
Sbjct: 187 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 17/218 (7%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRG----LMPNGQEIAVKKLSVDSRQGLRE---FTNEVK 134
           +V+    + L +LG G FG VY G    ++    E  V   +V+    LRE   F NE  
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD-----KTKSSSLDWTTRYR 189
           ++      ++V L G  ++G   ++V E + +  L  ++       +        T +  
Sbjct: 73  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 190 IVMG--VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
           I M   +A G+ YL+ +   + +HRD+ A N ++      KI DFG+ R     D     
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKG 189
Query: 248 FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
            +      +MAPE    G  +  +D++S+GV++ EI S
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 17/218 (7%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRG----LMPNGQEIAVKKLSVDSRQGLRE---FTNEVK 134
           +V+    + L +LG G FG VY G    ++    E  V   +V+    LRE   F NE  
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD-----KTKSSSLDWTTRYR 189
           ++      ++V L G  ++G   ++V E + +  L  ++       +        T +  
Sbjct: 73  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 190 IVMG--VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
           I M   +A G+ YL+ +   + +HRD+ A N ++      KI DFG+ R     D     
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKG 189
Query: 248 FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
            +      +MAPE    G  +  +D++S+GV++ EI S
Sbjct: 190 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/258 (27%), Positives = 109/258 (42%), Gaps = 18/258 (6%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNEVKLLL 137
           Q A   F     LG G FG VY       + I   K+   +   + G+  +   EV++  
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            ++H N++ L+G   +     L+ EY P   L     +  K S  D       +  +A  
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L Y H +   R+IHRDIK  N+LL      KI+DFG +   P          +SGT  Y+
Sbjct: 122 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTT----LSGTLDYL 174
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS---YTWTLFQGEKA 314
            PE         K D++S GVL  E + G+   +    +E    +S   +T+  F  E A
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 234
Query: 315 LELVDPSLAKCNRDEAAM 332
            +L+   L K N  +  M
Sbjct: 235 RDLIS-RLLKHNPSQRPM 251

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 27/223 (12%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRG----LMPNGQEIAVKKLSVDSRQGLRE---FTNEVK 134
           +V+    + L +LG G FG VY G    ++    E  V   +V+    LRE   F NE  
Sbjct: 14  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 73
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD-----KTKSSSLDWTTRYR 189
           ++      ++V L G  ++G   ++V E + +  L  ++       +        T +  
Sbjct: 74  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 133
Query: 190 IVMG--VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
           I M   +A G+ YL+ +   + +HR++ A N ++      KI DFG+ R     D +   
Sbjct: 134 IQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR-----DIYETD 185
Query: 248 FRISGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +   G  G     +MAPE    G  +  +D++S+GV++ EI S
Sbjct: 186 YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 79/304 (25%), Positives = 128/304 (42%), Gaps = 53/304 (17%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 95  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 142
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR      
Sbjct: 143 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 194
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADL 301
           T         T  Y APE  L+  + +   D++S G ++ E+++GR       G +  D 
Sbjct: 195 TDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP---GTDHIDQ 251
Query: 302 LSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD 361
           L     L  G    EL    L K + + A   I        QS+A+ P MN  ++ +  +
Sbjct: 252 LKLILRLV-GTPGAEL----LKKISSESARNYI--------QSLAQMPKMNFANVFIGAN 298
Query: 362 SFTL 365
              +
Sbjct: 299 PLAV 302

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 27/223 (12%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRG----LMPNGQEIAVKKLSVDSRQGLRE---FTNEVK 134
           +V+    + L +LG G FG VY G    ++    E  V   +V+    LRE   F NE  
Sbjct: 13  EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 72
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD-----KTKSSSLDWTTRYR 189
           ++      ++V L G  ++G   ++V E + +  L  ++       +        T +  
Sbjct: 73  VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 132
Query: 190 IVMG--VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
           I M   +A G+ YL+ +   + +HR++ A N ++      KI DFG+ R     D +   
Sbjct: 133 IQMAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR-----DIYETD 184
Query: 248 FRISGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +   G  G     +MAPE    G  +  +D++S+GV++ EI S
Sbjct: 185 YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 116/233 (49%), Gaps = 26/233 (11%)
Query: 67  SGAD--SWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLS---- 119
           SG D  + NL+F      +  + +    +LG G F  V +      G+E A K +     
Sbjct: 9   SGVDLGTENLYFQ----SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRL 64
Query: 120 VDSRQGL--REFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKT 177
             SR+G+   E   EV +L +I+H N++TL        + +L+ E +    L  F+ +K 
Sbjct: 65  XSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK- 123
Query: 178 KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNI-LLDEQL-NPKIS--DFG 233
           +S + D  T++  +  +  G+ YLH +   RI H D+K  NI LLD+ + NP+I   DFG
Sbjct: 124 ESLTEDEATQF--LKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFG 178
Query: 234 LARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
           +A      +   N F   GT  ++APE   +  L ++ D++S GV+   ++SG
Sbjct: 179 IAHKIEAGNEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 94/197 (47%), Gaps = 15/197 (7%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           L  +G G FG V  G    G ++AVK +  D+    + F  E  ++ +++H NLV L G 
Sbjct: 11  LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 67
Query: 151 CAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
             E    + +V EY+   SL  ++  + +S  L      +  + V   + YL        
Sbjct: 68  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---NF 123
Query: 210 IHRDIKASNILLDEQLNPKISDFGLAR-LFPGEDTHVNTFRISGTHGYMAPEYALHGYLS 268
           +HRD+ A N+L+ E    K+SDFGL +     +DT     +      + APE       S
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFS 177
Query: 269 VKTDVFSYGVLVLEIVS 285
            K+DV+S+G+L+ EI S
Sbjct: 178 TKSDVWSFGILLWEIYS 194

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 103/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR     D
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTD 176
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
             +  F    T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 177 DEMAGF--VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 115/246 (46%), Gaps = 28/246 (11%)
Query: 54  GRAAGESAEDADGSGADSWNLFFDLRTLQVAT----NFFSDLNQLGHGGFGPVYRGLMPN 109
           G+  G    D D    D W  +   + ++V      +++  L +LG G FG V+R +   
Sbjct: 16  GKYDGPKINDYDKFYEDIWKKYVP-QPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKA 74
Query: 110 GQEIAVKKLSVDSRQGLREFT--NEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNK 167
              + V K  +++   L ++T  NE+ ++ ++ H  L+ L     +  E +L+ E+L   
Sbjct: 75  TGRVFVAKF-INTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGG 133
Query: 168 SLDYFIFDKTKSSSLDWTTRYRIVMGVAR----GLLYLHEEAPARIIHRDIKASNILLDE 223
            L    FD+  +   D+      V+   R    GL ++HE +   I+H DIK  NI+ + 
Sbjct: 134 EL----FDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCET 184
Query: 224 QL--NPKISDFGLA-RLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLV 280
           +   + KI DFGLA +L P E   V T     T  + APE      +   TD+++ GVL 
Sbjct: 185 KKASSVKIIDFGLATKLNPDEIVKVTT----ATAEFAAPEIVDREPVGFYTDMWAIGVLG 240
Query: 281 LEIVSG 286
             ++SG
Sbjct: 241 YVLLSG 246

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 94/197 (47%), Gaps = 15/197 (7%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           L  +G G FG V  G    G ++AVK +  D+    + F  E  ++ +++H NLV L G 
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 254
Query: 151 CAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
             E    + +V EY+   SL  ++  + +S  L      +  + V   + YL        
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---NF 310
Query: 210 IHRDIKASNILLDEQLNPKISDFGLAR-LFPGEDTHVNTFRISGTHGYMAPEYALHGYLS 268
           +HRD+ A N+L+ E    K+SDFGL +     +DT     +      + APE       S
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFS 364
Query: 269 VKTDVFSYGVLVLEIVS 285
            K+DV+S+G+L+ EI S
Sbjct: 365 TKSDVWSFGILLWEIYS 381

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 80/304 (26%), Positives = 128/304 (42%), Gaps = 53/304 (17%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L  +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 25  KTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 84
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 85  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 132
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 133 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 189
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADL 301
           T         T  Y APE  L+  + +   D++S G ++ E+++GR       G +  D 
Sbjct: 190 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFP---GTDHIDQ 241
Query: 302 LSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD 361
           L     L  G    EL    L K + + A   I        QS+A+ P MN  ++ +  +
Sbjct: 242 LKLILRLV-GTPGAEL----LKKISSESARNYI--------QSLAQMPKMNFANVFIGAN 288
Query: 362 SFTL 365
              +
Sbjct: 289 PLAV 292

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 179
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 180 TGY-----VATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 101/223 (45%), Gaps = 27/223 (12%)
Query: 82  QVATNFFSDLNQLGHGGFGPVY----RGLMPNGQEIAVKKLSVDSRQGLRE---FTNEVK 134
           +VA    +   +LG G FG VY    +G++ +  E  V   +V+    +RE   F NE  
Sbjct: 8   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 67
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIF-------DKTKSSSLDWTTR 187
           ++ +    ++V L G  ++G   +++ E +    L  ++        +    +    +  
Sbjct: 68  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 127
Query: 188 YRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
            ++   +A G+ YL+     + +HRD+ A N  + E    KI DFG+ R     D +   
Sbjct: 128 IQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR-----DIYETD 179
Query: 248 FRISGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +   G  G     +M+PE    G  +  +DV+S+GV++ EI +
Sbjct: 180 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 125/260 (48%), Gaps = 45/260 (17%)
Query: 56  AAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPV---YRGLMPNGQE 112
           AA  +A++     A S+++ FD+       + +  +  +G+G +G V    R L   GQ+
Sbjct: 31  AASVAAKNLALLKARSFDVTFDV------GDEYEIIETIGNGAYGVVSSARRRL--TGQQ 82
Query: 113 IAVKKL--SVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLD 170
           +A+KK+  + D     +    E+K+L   +H N++ +         K ++   +P     
Sbjct: 83  VAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAI---------KDILRPTVPYGEFK 133
Query: 171 --YFIFDKTKS-------SSLDWT---TRYRIVMGVARGLLYLHEEAPARIIHRDIKASN 218
             Y + D  +S       SS   T    RY  +  + RGL Y+H    A++IHRD+K SN
Sbjct: 134 SVYVVLDLMESDLHQIIHSSQPLTLEHVRY-FLYQLLRGLKYMHS---AQVIHRDLKPSN 189
Query: 219 ILLDEQLNPKISDFGLAR---LFPGEDTHVNTFRISGTHGYMAPE--YALHGYLSVKTDV 273
           +L++E    KI DFG+AR     P E  +  T  ++ T  Y APE   +LH Y     D+
Sbjct: 190 LLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA-TRWYRAPELMLSLHEYTQA-IDL 247
Query: 274 FSYGVLVLEIVSGRKNHDGR 293
           +S G +  E+++ R+   G+
Sbjct: 248 WSVGCIFGEMLARRQLFPGK 267

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 14/199 (7%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-----FTNEVKLLLKIQHKNLVTL 147
           LG G F  V     +   +E A+K L  + R  ++E      T E  ++ ++ H   V L
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           +    +  +      Y  N  L  +I    K  S D T        +   L YLH +   
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGCLLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG-- 152
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
            IIHRD+K  NILL+E ++ +I+DFG A++   E          GT  Y++PE       
Sbjct: 153 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 211
Query: 268 SVKTDVFSYGVLVLEIVSG 286
           S  +D+++ G ++ ++V+G
Sbjct: 212 SKSSDLWALGCIIYQLVAG 230

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 13/215 (6%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLV 145
           +  L++LG G +  VY+G        +A+K++ ++  +G       EV LL  ++H N+V
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 63
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
           TL           LV+EYL +K L  ++ D     ++     +  +  + RGL Y H + 
Sbjct: 64  TLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLF--LFQLLRGLAYCHRQ- 119
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHG 265
             +++HRD+K  N+L++E+   K++DFGLAR    +     T+       +  P   L G
Sbjct: 120 --KVLHRDLKPQNLLINERGELKLADFGLAR---AKSIPTKTYDNEVVTLWYRPPDILLG 174
Query: 266 Y--LSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK 298
               S + D++  G +  E+ +GR    G   +E+
Sbjct: 175 STDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ 209

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 25/208 (12%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE------FTNEVKLLLKIQHKNLVT 146
           LG G FG V         Q++A+K +S   RQ L++         E+  L  ++H +++ 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFIS---RQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           L+       + ++V EY   +  DY +  + K  + D   R+     +   + Y H    
Sbjct: 74  LYDVITTPTDIVMVIEYAGGELFDYIV--EKKRMTEDEGRRF--FQQIICAIEYCHRH-- 127
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS-GTHGYMAPEYALHG 265
            +I+HRD+K  N+LLD+ LN KI+DFGL+ +     T  N  + S G+  Y APE  ++G
Sbjct: 128 -KIVHRDLKPENLLLDDNLNVKIADFGLSNIM----TDGNFLKTSCGSPNYAAPE-VING 181
Query: 266 --YLSVKTDVFSYGVLVLEIVSGRKNHD 291
             Y   + DV+S G+++  ++ GR   D
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 22/206 (10%)
Query: 93  QLGHGGFGPVYRGLMP-NGQEIAVK-----KLSVDSRQGL--REFTNEVKLLLKIQHKNL 144
           +LG G F  V +      G+E A K     +LS  SR+G+   E   EV +L +I+H N+
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLS-SSRRGVSREEIEREVNILREIRHPNI 70
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           +TL        + +L+ E +    L  F+ +K +S + D  T++  +  +  G+ YLH +
Sbjct: 71  ITLHDIFENKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQF--LKQILDGVHYLHSK 127
Query: 205 APARIIHRDIKASNI-LLDEQL-NPKIS--DFGLARLFPGEDTHVNTFRISGTHGYMAPE 260
              RI H D+K  NI LLD+ + NP+I   DFG+A      +   N F   GT  ++APE
Sbjct: 128 ---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF---GTPEFVAPE 181
Query: 261 YALHGYLSVKTDVFSYGVLVLEIVSG 286
              +  L ++ D++S GV+   ++SG
Sbjct: 182 IVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      +  L+ +G G +G V     + +G +IAVKKLS    S    +    E++L
Sbjct: 44  KTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRL 103
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P  SL+ F             + +  K   L
Sbjct: 104 LKHMKHENVIGLLDV------------FTPATSLEEFNDVYLVTHLMGADLNNIVKCQKL 151
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 152 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 208
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + ++  D++S G ++ E+++GR
Sbjct: 209 TGY-----VATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 82  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 130 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM 186
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 187 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 22/206 (10%)
Query: 93  QLGHGGFGPVYRGLMP-NGQEIAVK-----KLSVDSRQGL--REFTNEVKLLLKIQHKNL 144
           +LG G F  V +      G+E A K     +LS  SR+G+   E   EV +L +I+H N+
Sbjct: 19  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLS-SSRRGVSREEIEREVNILREIRHPNI 77
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           +TL        + +L+ E +    L  F+ +K +S + D  T++  +  +  G+ YLH +
Sbjct: 78  ITLHDIFENKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQF--LKQILDGVHYLHSK 134
Query: 205 APARIIHRDIKASNI-LLDEQL-NPKIS--DFGLARLFPGEDTHVNTFRISGTHGYMAPE 260
              RI H D+K  NI LLD+ + NP+I   DFG+A      +   N F   GT  ++APE
Sbjct: 135 ---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF---GTPEFVAPE 188
Query: 261 YALHGYLSVKTDVFSYGVLVLEIVSG 286
              +  L ++ D++S GV+   ++SG
Sbjct: 189 IVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 82  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 130 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM 186
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 187 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 99/214 (46%), Gaps = 28/214 (13%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           F ++  +G GGFG V++     +G+   +K++  ++ +  RE    VK L K+ H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVH 68
Query: 147 LFGCCA---EGPEK-------------MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRI 190
             GC       PE               +  E+    +L+ +I +K +   LD      +
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALEL 127
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
              + +G+ Y+H +   ++I+RD+K SNI L +    KI DFGL      +       R 
Sbjct: 128 FEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRX---RS 181
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIV 284
            GT  YM+PE         + D+++ G+++ E++
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 108/258 (41%), Gaps = 18/258 (6%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNEVKLLL 137
           Q A   F     LG G FG VY       + I   K+   +   + G+  +   EV++  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            ++H N++ L+G   +     L+ EY P   L     +  K S  D       +  +A  
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L Y H +   R+IHRDIK  N+LL      KI+DFG +   P          + GT  Y+
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTELCGTLDYL 173
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS---YTWTLFQGEKA 314
            PE         K D++S GVL  E + G+   +    +E    +S   +T+  F  E A
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 233
Query: 315 LELVDPSLAKCNRDEAAM 332
            +L+   L K N  +  M
Sbjct: 234 RDLIS-RLLKHNPSQRPM 250

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 20  KTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 80  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 128 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM 184
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 185 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 110/260 (42%), Gaps = 22/260 (8%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNEVKLLL 137
           Q A   F     LG G FG VY       + I   K+   +   + G+  +   EV++  
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            ++H N++ L+G   +     L+ EY P   L     +  K S  D       +  +A  
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG--EDTHVNTFRISGTHG 255
           L Y H +   R+IHRDIK  N+LL      KI+DFG +   P    DT      + GT  
Sbjct: 122 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDT------LCGTLD 172
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS---YTWTLFQGE 312
           Y+ PE         K D++S GVL  E + G+   +    +E    +S   +T+  F  E
Sbjct: 173 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 232
Query: 313 KALELVDPSLAKCNRDEAAM 332
            A +L+   L K N  +  M
Sbjct: 233 GARDLIS-RLLKHNPSQRPM 251

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 82  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 130 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM 186
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 187 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL----DYFIFDKTKSSSLDWTTRYR-- 189
           L  ++H+N++ L               + P +SL    D ++      + L+   + +  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKL 122
Query: 190 -------IVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 179
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 180 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 77  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 125 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 181
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 182 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 99/218 (45%), Gaps = 17/218 (7%)
Query: 82  QVATNFFSDLNQLGHGGFGPVY----RGLMPNGQEIAVKKLSVDSRQGLRE---FTNEVK 134
           +VA    +   +LG G FG VY    +G++ +  E  V   +V+    +RE   F NE  
Sbjct: 6   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 65
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIF-------DKTKSSSLDWTTR 187
           ++ +    ++V L G  ++G   +++ E +    L  ++        +    +    +  
Sbjct: 66  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 125
Query: 188 YRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
            ++   +A G+ YL+     + +HRD+ A N ++ E    KI DFG+ R     D     
Sbjct: 126 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKG 182
Query: 248 FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
            +      +M+PE    G  +  +DV+S+GV++ EI +
Sbjct: 183 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 77  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 125 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 181
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 182 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 179
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 180 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 179
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 180 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 108/258 (41%), Gaps = 18/258 (6%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNEVKLLL 137
           Q A   F     LG G FG VY       + I   K+   +   + G+  +   EV++  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            ++H N++ L+G   +     L+ EY P   L     +  K S  D       +  +A  
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L Y H +   R+IHRDIK  N+LL      KI+DFG +   P          + GT  Y+
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYL 173
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS---YTWTLFQGEKA 314
            PE         K D++S GVL  E + G+   +    +E    +S   +T+  F  E A
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 233
Query: 315 LELVDPSLAKCNRDEAAM 332
            +L+   L K N  +  M
Sbjct: 234 RDLIS-RLLKHNPSQRPM 250

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 108/258 (41%), Gaps = 18/258 (6%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNEVKLLL 137
           Q A   F     LG G FG VY       + I   K+   +   + G+  +   EV++  
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            ++H N++ L+G   +     L+ EY P   L     +  K S  D       +  +A  
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L Y H +   R+IHRDIK  N+LL      KI+DFG +   P          + GT  Y+
Sbjct: 124 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA----LCGTLDYL 176
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS---YTWTLFQGEKA 314
            PE         K D++S GVL  E + G+   +    +E    +S   +T+  F  E A
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 315 LELVDPSLAKCNRDEAAM 332
            +L+   L K N  +  M
Sbjct: 237 RDLIS-RLLKHNPSQRPM 253

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 99/218 (45%), Gaps = 17/218 (7%)
Query: 82  QVATNFFSDLNQLGHGGFGPVY----RGLMPNGQEIAVKKLSVDSRQGLRE---FTNEVK 134
           +VA    +   +LG G FG VY    +G++ +  E  V   +V+    +RE   F NE  
Sbjct: 15  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 74
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIF-------DKTKSSSLDWTTR 187
           ++ +    ++V L G  ++G   +++ E +    L  ++        +    +    +  
Sbjct: 75  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 134
Query: 188 YRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
            ++   +A G+ YL+     + +HRD+ A N ++ E    KI DFG+ R     D     
Sbjct: 135 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKG 191
Query: 248 FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
            +      +M+PE    G  +  +DV+S+GV++ EI +
Sbjct: 192 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 86
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 87  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 134
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 135 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 191
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 192 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 179
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 180 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 77  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 125 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 181
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 182 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 86
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 87  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 134
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 135 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 191
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 192 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 179
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 180 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 85
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 86  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 133
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 134 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 190
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 191 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 179
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 180 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 108/258 (41%), Gaps = 18/258 (6%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNEVKLLL 137
           Q A   F     LG G FG VY       + I   K+   +   + G+  +   EV++  
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            ++H N++ L+G   +     L+ EY P   L     +  K S  D       +  +A  
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANA 122
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L Y H +   R+IHRDIK  N+LL      KI+DFG +   P          + GT  Y+
Sbjct: 123 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRXXLCGTLDYL 175
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS---YTWTLFQGEKA 314
            PE         K D++S GVL  E + G+   +    +E    +S   +T+  F  E A
Sbjct: 176 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 235
Query: 315 LELVDPSLAKCNRDEAAM 332
            +L+   L K N  +  M
Sbjct: 236 RDLIS-RLLKHNPSQRPM 252

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRL 86
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 87  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 134
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 135 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 191
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 192 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 34  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 93
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 94  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 141
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 142 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 198
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 199 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 82  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 130 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 186
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 187 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 108/258 (41%), Gaps = 18/258 (6%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNEVKLLL 137
           Q A   F     LG G FG VY       + I   K+   +   + G+  +   EV++  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            ++H N++ L+G   +     L+ EY P   L     +  K S  D       +  +A  
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L Y H +   R+IHRDIK  N+LL      KI+DFG +   P          + GT  Y+
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRXXLCGTLDYL 173
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS---YTWTLFQGEKA 314
            PE         K D++S GVL  E + G+   +    +E    +S   +T+  F  E A
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 233
Query: 315 LELVDPSLAKCNRDEAAM 332
            +L+   L K N  +  M
Sbjct: 234 RDLIS-RLLKHNPSQRPM 250

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL----DYFIFDKTKSSSLDWTTRYR-- 189
           L  ++H+N++ L               + P +SL    D ++      + L+   + +  
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKL 122
Query: 190 -------IVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM 179
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 180 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 108/258 (41%), Gaps = 18/258 (6%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNEVKLLL 137
           Q A   F     LG G FG VY       + I   K+   +   + G+  +   EV++  
Sbjct: 8   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 67
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            ++H N++ L+G   +     L+ EY P   L     +  K S  D       +  +A  
Sbjct: 68  HLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANA 124
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L Y H +   R+IHRDIK  N+LL      KI+DFG +   P          + GT  Y+
Sbjct: 125 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYL 177
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS---YTWTLFQGEKA 314
            PE         K D++S GVL  E + G+   +    +E    +S   +T+  F  E A
Sbjct: 178 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 237
Query: 315 LELVDPSLAKCNRDEAAM 332
            +L+   L K N  +  M
Sbjct: 238 RDLIS-RLLKHNPSQRPM 254

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 97
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 98  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 145
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 146 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 202
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 203 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 80  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 128 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 184
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 185 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 14  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 73
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 74  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 121
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 122 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 178
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 179 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 179
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 180 TGX-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 99/214 (46%), Gaps = 29/214 (13%)
Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
           + +LG G FG VY+      G   A K +   S + L ++  E+++L    H  +V L G
Sbjct: 24  VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLG 83
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL----YLHEEA 205
                 +  ++ E+ P  ++D  + +      LD       +  V R +L    +LH + 
Sbjct: 84  AYYHDGKLWIMIEFCPGGAVDAIMLE------LDRGLTEPQIQVVCRQMLEALNFLHSK- 136
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLA----RLFPGEDTHVNTFRISGTHGYMAPEY 261
             RIIHRD+KA N+L+  + + +++DFG++    +     D+ +      GT  +MAPE 
Sbjct: 137 --RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAPEV 188
Query: 262 ALHGYLS-----VKTDVFSYGVLVLEIVSGRKNH 290
            +   +       K D++S G+ ++E+      H
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH 222

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 81  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 129 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 185
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 186 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 125/260 (48%), Gaps = 45/260 (17%)
Query: 56  AAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPV---YRGLMPNGQE 112
           AA  +A++     A S+++ FD+       + +  +  +G+G +G V    R L   GQ+
Sbjct: 30  AASVAAKNLALLKARSFDVTFDV------GDEYEIIETIGNGAYGVVSSARRRL--TGQQ 81
Query: 113 IAVKKL--SVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLD 170
           +A+KK+  + D     +    E+K+L   +H N++ +         K ++   +P     
Sbjct: 82  VAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAI---------KDILRPTVPYGEFK 132
Query: 171 --YFIFDKTKS-------SSLDWT---TRYRIVMGVARGLLYLHEEAPARIIHRDIKASN 218
             Y + D  +S       SS   T    RY  +  + RGL Y+H    A++IHRD+K SN
Sbjct: 133 SVYVVLDLMESDLHQIIHSSQPLTLEHVRY-FLYQLLRGLKYMHS---AQVIHRDLKPSN 188
Query: 219 ILLDEQLNPKISDFGLAR---LFPGEDTHVNTFRISGTHGYMAPE--YALHGYLSVKTDV 273
           +L++E    KI DFG+AR     P E  +  T  ++ T  Y APE   +LH Y     D+
Sbjct: 189 LLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA-TRWYRAPELMLSLHEYTQA-IDL 246
Query: 274 FSYGVLVLEIVSGRKNHDGR 293
           +S G +  E+++ R+   G+
Sbjct: 247 WSVGCIFGEMLARRQLFPGK 266

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 99/214 (46%), Gaps = 29/214 (13%)
Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
           + +LG G FG VY+      G   A K +   S + L ++  E+++L    H  +V L G
Sbjct: 16  VGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLG 75
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL----YLHEEA 205
                 +  ++ E+ P  ++D  + +      LD       +  V R +L    +LH + 
Sbjct: 76  AYYHDGKLWIMIEFCPGGAVDAIMLE------LDRGLTEPQIQVVCRQMLEALNFLHSK- 128
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLA----RLFPGEDTHVNTFRISGTHGYMAPEY 261
             RIIHRD+KA N+L+  + + +++DFG++    +     D+ +      GT  +MAPE 
Sbjct: 129 --RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI------GTPYWMAPEV 180
Query: 262 ALHGYLS-----VKTDVFSYGVLVLEIVSGRKNH 290
            +   +       K D++S G+ ++E+      H
Sbjct: 181 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH 214

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 35  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 94
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 95  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 142
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 143 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 199
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 200 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 85
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 86  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 133
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 134 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM 190
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 191 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 108/258 (41%), Gaps = 18/258 (6%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNEVKLLL 137
           Q A   F     LG G FG VY       + I   K+   +   + G+  +   EV++  
Sbjct: 30  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            ++H N++ L+G   +     L+ EY P   L     +  K S  D       +  +A  
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANA 146
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L Y H +   R+IHRDIK  N+LL      KI+DFG +   P          + GT  Y+
Sbjct: 147 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYL 199
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS---YTWTLFQGEKA 314
            PE         K D++S GVL  E + G+   +    +E    +S   +T+  F  E A
Sbjct: 200 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 259
Query: 315 LELVDPSLAKCNRDEAAM 332
            +L+   L K N  +  M
Sbjct: 260 RDLIS-RLLKHNPSQRPM 276

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 80  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 128 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEM 184
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 185 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 179
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 180 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 108/258 (41%), Gaps = 18/258 (6%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNEVKLLL 137
           Q A   F     LG G FG VY       + I   K+   +   + G+  +   EV++  
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            ++H N++ L+G   +     L+ EY P   L     +  K S  D       +  +A  
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L Y H +   R+IHRDIK  N+LL      KI+DFG +   P          + GT  Y+
Sbjct: 124 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYL 176
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS---YTWTLFQGEKA 314
            PE         K D++S GVL  E + G+   +    +E    +S   +T+  F  E A
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 315 LELVDPSLAKCNRDEAAM 332
            +L+   L K N  +  M
Sbjct: 237 RDLIS-RLLKHNPSQRPM 253

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 81  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 129 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 185
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 186 T-----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 110/261 (42%), Gaps = 24/261 (9%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNEVKLLL 137
           Q A   F     LG G FG VY       + I   K+   +   + G+  +   EV++  
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            ++H N++ L+G   +     L+ EY P   L     +  K S  D       +  +A  
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR---ISGTH 254
           L Y H +   R+IHRDIK  N+LL      KI+DFG +        H  + R   + GT 
Sbjct: 124 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDLCGTL 173
Query: 255 GYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS---YTWTLFQG 311
            Y+ PE         K D++S GVL  E + G+   +    +E    +S   +T+  F  
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 233
Query: 312 EKALELVDPSLAKCNRDEAAM 332
           E A +L+   L K N  +  M
Sbjct: 234 EGARDLIS-RLLKHNPSQRPM 253

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 108/258 (41%), Gaps = 18/258 (6%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNEVKLLL 137
           Q A   F     LG G FG VY       + I   K+   +   + G+  +   EV++  
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            ++H N++ L+G   +     L+ EY P   L     +  K S  D       +  +A  
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANA 125
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L Y H +   R+IHRDIK  N+LL      KI+DFG +   P          + GT  Y+
Sbjct: 126 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYL 178
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS---YTWTLFQGEKA 314
            PE         K D++S GVL  E + G+   +    +E    +S   +T+  F  E A
Sbjct: 179 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 238
Query: 315 LELVDPSLAKCNRDEAAM 332
            +L+   L K N  +  M
Sbjct: 239 RDLIS-RLLKHNPSQRPM 255

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 80  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 127
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 128 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 184
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 185 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 179
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 180 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 71  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 118
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 119 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 175
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 176 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 110/261 (42%), Gaps = 24/261 (9%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNEVKLLL 137
           Q A   F     LG G FG VY       + I   K+   +   + G+  +   EV++  
Sbjct: 30  QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 89
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            ++H N++ L+G   +     L+ EY P   L     +  K S  D       +  +A  
Sbjct: 90  HLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANA 146
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR---ISGTH 254
           L Y H +   R+IHRDIK  N+LL      KI+DFG +        H  + R   + GT 
Sbjct: 147 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDLCGTL 196
Query: 255 GYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS---YTWTLFQG 311
            Y+ PE         K D++S GVL  E + G+   +    +E    +S   +T+  F  
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 256
Query: 312 EKALELVDPSLAKCNRDEAAM 332
           E A +L+   L K N  +  M
Sbjct: 257 EGARDLIS-RLLKHNPSQRPM 276

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 13  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 72
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL----DYFIFDKTKSSSLDWTTRYR-- 189
           L  ++H+N++ L               + P +SL    D ++      + L+   + +  
Sbjct: 73  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 120
Query: 190 -------IVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 121 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 177
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 178 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 72  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 119
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 120 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 176
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 177 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 108/258 (41%), Gaps = 18/258 (6%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNEVKLLL 137
           Q A   F     LG G FG VY       + I   K+   +   + G+  +   EV++  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            ++H N++ L+G   +     L+ EY P   L     +  K S  D       +  +A  
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L Y H +   R+IHRDIK  N+LL      KI+DFG +   P          + GT  Y+
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTXLCGTLDYL 173
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS---YTWTLFQGEKA 314
            PE         K D++S GVL  E + G+   +    +E    +S   +T+  F  E A
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 233
Query: 315 LELVDPSLAKCNRDEAAM 332
            +L+   L K N  +  M
Sbjct: 234 RDLIS-RLLKHNPSQRPM 250

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 72  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 119
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 120 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 176
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 177 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 108/258 (41%), Gaps = 18/258 (6%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNEVKLLL 137
           Q A   F     LG G FG VY       + I   K+   +   + G+  +   EV++  
Sbjct: 3   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 62
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            ++H N++ L+G   +     L+ EY P   L     +  K S  D       +  +A  
Sbjct: 63  HLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANA 119
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L Y H +   R+IHRDIK  N+LL      KI+DFG +   P          + GT  Y+
Sbjct: 120 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYL 172
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS---YTWTLFQGEKA 314
            PE         K D++S GVL  E + G+   +    +E    +S   +T+  F  E A
Sbjct: 173 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 232
Query: 315 LELVDPSLAKCNRDEAAM 332
            +L+   L K N  +  M
Sbjct: 233 RDLIS-RLLKHNPSQRPM 249

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 110/261 (42%), Gaps = 24/261 (9%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNEVKLLL 137
           Q A   F     LG G FG VY       + I   K+   +   + G+  +   EV++  
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            ++H N++ L+G   +     L+ EY P   L     +  K S  D       +  +A  
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANA 125
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR---ISGTH 254
           L Y H +   R+IHRDIK  N+LL      KI+DFG +        H  + R   + GT 
Sbjct: 126 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTL 175
Query: 255 GYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS---YTWTLFQG 311
            Y+ PE         K D++S GVL  E + G+   +    +E    +S   +T+  F  
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 235
Query: 312 EKALELVDPSLAKCNRDEAAM 332
           E A +L+   L K N  +  M
Sbjct: 236 EGARDLIS-RLLKHNPSQRPM 255

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 108/258 (41%), Gaps = 18/258 (6%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNEVKLLL 137
           Q A   F     LG G FG VY       + I   K+   +   + G+  +   EV++  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            ++H N++ L+G   +     L+ EY P   L     +  K S  D       +  +A  
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L Y H +   R+IHRDIK  N+LL      KI+DFG +   P          + GT  Y+
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA----LCGTLDYL 173
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS---YTWTLFQGEKA 314
            PE         K D++S GVL  E + G+   +    +E    +S   +T+  F  E A
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 233
Query: 315 LELVDPSLAKCNRDEAAM 332
            +L+   L K N  +  M
Sbjct: 234 RDLIS-RLLKHNPSQRPM 250

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 105/246 (42%), Gaps = 18/246 (7%)
Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNEVKLLLKIQHKNLVTLFG 149
           LG G FG VY       + I   K+   +   + G+  +   EV++   ++H N++ L+G
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
              +     L+ EY P   L     +  K S  D       +  +A  L Y H +   R+
Sbjct: 93  YFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RV 146
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           IHRDIK  N+LL      KI+DFG +   P          + GT  Y+ PE         
Sbjct: 147 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPPEMIEGRMHDE 202
Query: 270 KTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS---YTWTLFQGEKALELVDPSLAKCN 326
           K D++S GVL  E + G+   +    +E    +S   +T+  F  E A +L+   L K N
Sbjct: 203 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS-RLLKHN 261
Query: 327 RDEAAM 332
             +  M
Sbjct: 262 PSQRPM 267

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 110/261 (42%), Gaps = 24/261 (9%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNEVKLLL 137
           Q A   F     LG G FG VY       + I   K+   +   + G+  +   EV++  
Sbjct: 5   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            ++H N++ L+G   +     L+ EY P   L     +  K S  D       +  +A  
Sbjct: 65  HLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR---ISGTH 254
           L Y H +   R+IHRDIK  N+LL      KI+DFG +        H  + R   + GT 
Sbjct: 122 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTL 171
Query: 255 GYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS---YTWTLFQG 311
            Y+ PE         K D++S GVL  E + G+   +    +E    +S   +T+  F  
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 231
Query: 312 EKALELVDPSLAKCNRDEAAM 332
           E A +L+   L K N  +  M
Sbjct: 232 EGARDLIS-RLLKHNPSQRPM 251

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 103/244 (42%), Gaps = 17/244 (6%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNEVKLLL 137
           Q A   F     LG G FG VY       + I   K+   +   + G+  +   EV++  
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            ++H N++ L+G   +     L+ EY P   L     +  K S  D       +  +A  
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANA 125
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L Y H +   R+IHRDIK  N+LL      KI+DFG +   P          + GT  Y+
Sbjct: 126 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYL 178
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS---YTWTLFQGEKA 314
            PE         K D++S GVL  E + G+   +    +E    +S   +T+  F  E A
Sbjct: 179 PPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 238
Query: 315 LELV 318
            +L+
Sbjct: 239 RDLI 242

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 108/258 (41%), Gaps = 18/258 (6%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNEVKLLL 137
           Q A   F     LG G FG VY       + I   K+   +   + G+  +   EV++  
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            ++H N++ L+G   +     L+ EY P   L     +  K S  D       +  +A  
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L Y H +   R+IHRDIK  N+LL      KI+DFG +   P          + GT  Y+
Sbjct: 124 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRXXLCGTLDYL 176
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS---YTWTLFQGEKA 314
            PE         K D++S GVL  E + G+   +    +E    +S   +T+  F  E A
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 315 LELVDPSLAKCNRDEAAM 332
            +L+   L K N  +  M
Sbjct: 237 RDLIS-RLLKHNPSQRPM 253

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 110/261 (42%), Gaps = 24/261 (9%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNEVKLLL 137
           Q A   F     LG G FG VY       + I   K+   +   + G+  +   EV++  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            ++H N++ L+G   +     L+ EY P   L     +  K S  D       +  +A  
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR---ISGTH 254
           L Y H +   R+IHRDIK  N+LL      KI+DFG +        H  + R   + GT 
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTL 170
Query: 255 GYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS---YTWTLFQG 311
            Y+ PE         K D++S GVL  E + G+   +    +E    +S   +T+  F  
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 230
Query: 312 EKALELVDPSLAKCNRDEAAM 332
           E A +L+   L K N  +  M
Sbjct: 231 EGARDLIS-RLLKHNPSQRPM 250

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 93/200 (46%), Gaps = 18/200 (9%)
Query: 94  LGHGGFGPVYRGLMPNGQE-IAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLVTLFGCC 151
           LG G F  V        Q+ +A+K ++ ++ +G      NE+ +L KI+H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 152 AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTR--YRIVMGVARGLLYLHEEAPARI 209
             G    L+ + +    L    FD+       +T R   R++  V   + YLH+     I
Sbjct: 86  ESGGHLYLIMQLVSGGEL----FDRIVEKGF-YTERDASRLIFQVLDAVKYLHDLG---I 137
Query: 210 IHRDIKASNIL---LDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGY 266
           +HRD+K  N+L   LDE     ISDFGL+++   ED         GT GY+APE      
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQKP 194
Query: 267 LSVKTDVFSYGVLVLEIVSG 286
            S   D +S GV+   ++ G
Sbjct: 195 YSKAVDCWSIGVIAYILLCG 214

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 71/258 (27%), Positives = 108/258 (41%), Gaps = 18/258 (6%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNEVKLLL 137
           Q A   F     LG G FG VY       + I   K+   +   + G+  +   EV++  
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            ++H N++ L+G   +     L+ EY P   L     +  K S  D       +  +A  
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L Y H +   R+IHRDIK  N+LL      KI+DFG +   P          + GT  Y+
Sbjct: 124 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYL 176
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS---YTWTLFQGEKA 314
            PE         K D++S GVL  E + G+   +    +E    +S   +T+  F  E A
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 315 LELVDPSLAKCNRDEAAM 332
            +L+   L K N  +  M
Sbjct: 237 RDLIS-RLLKHNPSQRPM 253

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 94  LGHGGFGPVYRGLMPNGQE-IAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLVTLFGCC 151
           LG G F  V        Q+ +A+K ++ ++ +G      NE+ +L KI+H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 152 AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIH 211
             G    L+ + +    L   I +K   +  D +   R++  V   + YLH+     I+H
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS---RLIFQVLDAVKYLHDLG---IVH 139
Query: 212 RDIKASNIL---LDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLS 268
           RD+K  N+L   LDE     ISDFGL+++   ED         GT GY+APE       S
Sbjct: 140 RDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQKPYS 196
Query: 269 VKTDVFSYGVLVLEIVSG 286
              D +S GV+   ++ G
Sbjct: 197 KAVDCWSIGVIAYILLCG 214

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 94  LGHGGFGPVYRGLMPNGQE-IAVKKLSVDSRQGLR-EFTNEVKLLLKIQHKNLVTLFGCC 151
           LG G F  V        Q+ +A+K ++ ++ +G      NE+ +L KI+H N+V L    
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIY 85
Query: 152 AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIH 211
             G    L+ + +    L   I +K   +  D +   R++  V   + YLH+     I+H
Sbjct: 86  ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS---RLIFQVLDAVKYLHDLG---IVH 139
Query: 212 RDIKASNIL---LDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLS 268
           RD+K  N+L   LDE     ISDFGL+++   ED         GT GY+APE       S
Sbjct: 140 RDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQKPYS 196
Query: 269 VKTDVFSYGVLVLEIVSG 286
              D +S GV+   ++ G
Sbjct: 197 KAVDCWSIGVIAYILLCG 214

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 110/261 (42%), Gaps = 24/261 (9%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNEVKLLL 137
           Q A   F     LG G FG VY       + I   K+   +   + G+  +   EV++  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            ++H N++ L+G   +     L+ EY P   L     +  K S  D       +  +A  
Sbjct: 64  HLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR---ISGTH 254
           L Y H +   R+IHRDIK  N+LL      KI+DFG +        H  + R   + GT 
Sbjct: 121 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLCGTL 170
Query: 255 GYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS---YTWTLFQG 311
            Y+ PE         K D++S GVL  E + G+   +    +E    +S   +T+  F  
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVT 230
Query: 312 EKALELVDPSLAKCNRDEAAM 332
           E A +L+   L K N  +  M
Sbjct: 231 EGARDLIS-RLLKHNPSQRPM 250

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 107/260 (41%), Gaps = 22/260 (8%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLR------EFTNEVKL 135
           Q A   F     LG G FG VY  L    Q   +  L V  +  L       +   EV++
Sbjct: 1   QWALEDFEIGRPLGKGKFGNVY--LAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEI 58
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVA 195
              ++H N++ L+G   +     L+ EY P   L     +  K S  D       +  +A
Sbjct: 59  QSHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELA 115
Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG 255
             L Y H +   R+IHRDIK  N+LL      KI+DFG +   P          + GT  
Sbjct: 116 NALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLD 168
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS---YTWTLFQGE 312
           Y+ PE         K D++S GVL  E + G+   +    +E    +S   +T+  F  E
Sbjct: 169 YLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTE 228
Query: 313 KALELVDPSLAKCNRDEAAM 332
            A +L+   L K N  +  M
Sbjct: 229 GARDLIS-RLLKHNPSQRPM 247

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 77  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 124
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 125 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM 181
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 182 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 108/258 (41%), Gaps = 18/258 (6%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNEVKLLL 137
           Q A   F     LG G FG VY       + I   K+   +   + G+  +   EV++  
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            ++H N++ L+G   +     L+ EY P   +     +  K S  D       +  +A  
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEV---YKELQKLSKFDEQRTATYITELANA 125
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L Y H +   R+IHRDIK  N+LL      KI+DFG +   P          + GT  Y+
Sbjct: 126 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRXXLXGTLDYL 178
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS---YTWTLFQGEKA 314
            PE         K D++S GVL  E + G+   +    +E    +S   +T+  F  E A
Sbjct: 179 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 238
Query: 315 LELVDPSLAKCNRDEAAM 332
            +L+   L K N  +  M
Sbjct: 239 RDLIS-RLLKHNPSQRPM 255

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  KS  L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKSQKL 122
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGL R    E 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEM 179
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 180 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 18/200 (9%)
Query: 94  LGHGGFGPVYRGLMPN--GQEI--AVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLVTLF 148
           LG G FG VY G+  N  G++I  AVK    D     +E F +E  ++  + H ++V L 
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G   E P   ++ E  P   L +++  +   +SL   T     + + + + YL       
Sbjct: 80  GIIEEEP-TWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLES---IN 133
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH---GYMAPEYALHG 265
            +HRDI   NIL+      K+ DFGL+R    ED     ++ S T     +M+PE     
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDED----YYKASVTRLPIKWMSPESINFR 189
Query: 266 YLSVKTDVFSYGVLVLEIVS 285
             +  +DV+ + V + EI+S
Sbjct: 190 RFTTASDVWMFAVCMWEILS 209

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 108/258 (41%), Gaps = 18/258 (6%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNEVKLLL 137
           Q A   F     LG G FG VY       + I   K+   +   + G+  +   EV++  
Sbjct: 9   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            ++H N++ L+G   +     L+ EY P   +     +  K S  D       +  +A  
Sbjct: 69  HLRHPNILRLYGYFHDATRVYLILEYAPRGEV---YKELQKLSKFDEQRTATYITELANA 125
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L Y H +   R+IHRDIK  N+LL      KI+DFG +   P          + GT  Y+
Sbjct: 126 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYL 178
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS---YTWTLFQGEKA 314
            PE         K D++S GVL  E + G+   +    +E    +S   +T+  F  E A
Sbjct: 179 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 238
Query: 315 LELVDPSLAKCNRDEAAM 332
            +L+   L K N  +  M
Sbjct: 239 RDLIS-RLLKHNPSQRPM 255

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 95/200 (47%), Gaps = 18/200 (9%)
Query: 94  LGHGGFGPVYRGLMPNGQE-IAVK---KLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
           LG G F  V        Q+ +A+K   K +++ ++G  E  NE+ +L KI+H N+V L  
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSME--NEIAVLHKIKHPNIVALDD 83
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
               G    L+ + +    L   I +K   +  D +   R++  V   + YLH+     I
Sbjct: 84  IYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS---RLIFQVLDAVKYLHDLG---I 137
Query: 210 IHRDIKASNIL---LDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGY 266
           +HRD+K  N+L   LDE     ISDFGL+++   ED         GT GY+APE      
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQKP 194
Query: 267 LSVKTDVFSYGVLVLEIVSG 286
            S   D +S GV+   ++ G
Sbjct: 195 YSKAVDCWSIGVIAYILLCG 214

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 14/199 (7%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-----FTNEVKLLLKIQHKNLVTL 147
           LG G F  V     +   +E A+K L  + R  ++E      T E  ++ ++ H   V L
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           +    +  +      Y  N  L  +I    K  S D T        +   L YLH +   
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG-- 152
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
            IIHRD+K  NILL+E ++ +I+DFG A++   E          GT  Y++PE       
Sbjct: 153 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 268 SVKTDVFSYGVLVLEIVSG 286
              +D+++ G ++ ++V+G
Sbjct: 212 XKSSDLWALGCIIYQLVAG 230

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 14/199 (7%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-----FTNEVKLLLKIQHKNLVTL 147
           LG G F  V     +   +E A+K L  + R  ++E      T E  ++ ++ H   V L
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           +    +  +      Y  N  L  +I    K  S D T        +   L YLH +   
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG-- 152
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
            IIHRD+K  NILL+E ++ +I+DFG A++   E          GT  Y++PE       
Sbjct: 153 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 268 SVKTDVFSYGVLVLEIVSG 286
              +D+++ G ++ ++V+G
Sbjct: 212 CKSSDLWALGCIIYQLVAG 230

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 14/199 (7%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-----FTNEVKLLLKIQHKNLVTL 147
           LG G F  V     +   +E A+K L  + R  ++E      T E  ++ ++ H   V L
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           +    +  +      Y  N  L  +I    K  S D T        +   L YLH +   
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG-- 152
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
            IIHRD+K  NILL+E ++ +I+DFG A++   E          GT  Y++PE       
Sbjct: 153 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 268 SVKTDVFSYGVLVLEIVSG 286
              +D+++ G ++ ++V+G
Sbjct: 212 CKSSDLWALGCIIYQLVAG 230

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 97
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 98  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 145
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR      
Sbjct: 146 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----H 197
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 198 TDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 81  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 128
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E 
Sbjct: 129 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM 185
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 186 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 14/199 (7%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-----FTNEVKLLLKIQHKNLVTL 147
           LG G F  V     +   +E A+K L  + R  ++E      T E  ++ ++ H   V L
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 98
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           +    +  +      Y  N  L  +I    K  S D T        +   L YLH +   
Sbjct: 99  YFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG-- 153
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
            IIHRD+K  NILL+E ++ +I+DFG A++   E          GT  Y++PE       
Sbjct: 154 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 212
Query: 268 SVKTDVFSYGVLVLEIVSG 286
              +D+++ G ++ ++V+G
Sbjct: 213 CKSSDLWALGCIIYQLVAG 231

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 94  LGHGGFGPVYRGLMPNGQ----EIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLVTLF 148
           LG G FG VY G+  N +     +AVK    D     +E F +E  ++  + H ++V L 
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G   E P   ++ E  P   L +++  +   +SL   T     + + + + YL       
Sbjct: 76  GIIEEEP-TWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLES---IN 129
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH---GYMAPEYALHG 265
            +HRDI   NIL+      K+ DFGL+R    ED     ++ S T     +M+PE     
Sbjct: 130 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDED----YYKASVTRLPIKWMSPESINFR 185
Query: 266 YLSVKTDVFSYGVLVLEIVS 285
             +  +DV+ + V + EI+S
Sbjct: 186 RFTTASDVWMFAVCMWEILS 205

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 105/240 (43%), Gaps = 18/240 (7%)
Query: 55  RAAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDL----NQLGHGGFGPVYRGL-MPN 109
           R  G  + + D    D W  ++  + +++  +   D      +LG G FG V+R      
Sbjct: 17  RGKGTVSSNYDNYVFDIWKQYYP-QPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERAT 75
Query: 110 GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL 169
           G   A K +             E++ +  ++H  LV L     +  E +++YE++    L
Sbjct: 76  GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 135
Query: 170 DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP-- 227
              + D+    S D    Y  +  V +GL ++HE      +H D+K  NI+   + +   
Sbjct: 136 FEKVADEHNKMSEDEAVEY--MRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNEL 190
Query: 228 KISDFGL-ARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
           K+ DFGL A L P +   V T    GT  + APE A    +   TD++S GVL   ++SG
Sbjct: 191 KLIDFGLTAHLDPKQSVKVTT----GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 94  LGHGGFGPVYRGLMPNGQ----EIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLVTLF 148
           LG G FG VY G+  N +     +AVK    D     +E F +E  ++  + H ++V L 
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G   E P   ++ E  P   L +++  +   +SL   T     + + + + YL       
Sbjct: 92  GIIEEEP-TWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLES---IN 145
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH---GYMAPEYALHG 265
            +HRDI   NIL+      K+ DFGL+R    ED     ++ S T     +M+PE     
Sbjct: 146 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDED----YYKASVTRLPIKWMSPESINFR 201
Query: 266 YLSVKTDVFSYGVLVLEIVS 285
             +  +DV+ + V + EI+S
Sbjct: 202 RFTTASDVWMFAVCMWEILS 221

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 109/258 (42%), Gaps = 18/258 (6%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNEVKLLL 137
           Q A   F     LG G FG VY     N + I   K+   +   + G+  +   EV++  
Sbjct: 4   QWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            ++H N++ L+G   +     L+ EY P   L     +  K S  D       +  +A  
Sbjct: 64  HLRHPNILRLYGYFHDSTRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L Y H +   ++IHRDIK  N+LL      KI+DFG +   P          + GT  Y+
Sbjct: 121 LSYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAA----LCGTLDYL 173
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS---YTWTLFQGEKA 314
            PE         K D++S GVL  E + G+   +    ++    +S   +T+  F  E A
Sbjct: 174 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTEGA 233
Query: 315 LELVDPSLAKCNRDEAAM 332
            +L+   L K N  +  M
Sbjct: 234 RDLIS-RLLKHNPSQRPM 250

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 105/240 (43%), Gaps = 18/240 (7%)
Query: 55  RAAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDL----NQLGHGGFGPVYRGL-MPN 109
           R  G  + + D    D W  ++  + +++  +   D      +LG G FG V+R      
Sbjct: 123 RGKGTVSSNYDNYVFDIWKQYYP-QPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERAT 181
Query: 110 GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL 169
           G   A K +             E++ +  ++H  LV L     +  E +++YE++    L
Sbjct: 182 GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 241
Query: 170 DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP-- 227
              + D+    S D    Y  +  V +GL ++HE      +H D+K  NI+   + +   
Sbjct: 242 FEKVADEHNKMSEDEAVEY--MRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNEL 296
Query: 228 KISDFGL-ARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
           K+ DFGL A L P +   V T    GT  + APE A    +   TD++S GVL   ++SG
Sbjct: 297 KLIDFGLTAHLDPKQSVKVTT----GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 14/199 (7%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-----FTNEVKLLLKIQHKNLVTL 147
           LG G F  V     +   +E A+K L  + R  ++E      T E  ++ ++ H   V L
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 98
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           +    +  +      Y  N  L  +I    K  S D T        +   L YLH +   
Sbjct: 99  YFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG-- 153
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
            IIHRD+K  NILL+E ++ +I+DFG A++   E          GT  Y++PE       
Sbjct: 154 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 212
Query: 268 SVKTDVFSYGVLVLEIVSG 286
              +D+++ G ++ ++V+G
Sbjct: 213 CKSSDLWALGCIIYQLVAG 231

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 14/199 (7%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-----FTNEVKLLLKIQHKNLVTL 147
           LG G F  V     +   +E A+K L  + R  ++E      T E  ++ ++ H   V L
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           +    +  +      Y  N  L  +I    K  S D T        +   L YLH +   
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG-- 150
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
            IIHRD+K  NILL+E ++ +I+DFG A++   E          GT  Y++PE       
Sbjct: 151 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 268 SVKTDVFSYGVLVLEIVSG 286
              +D+++ G ++ ++V+G
Sbjct: 210 CKSSDLWALGCIIYQLVAG 228

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 14/199 (7%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-----FTNEVKLLLKIQHKNLVTL 147
           LG G F  V     +   +E A+K L  + R  ++E      T E  ++ ++ H   V L
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           +    +  +      Y  N  L  +I    K  S D T        +   L YLH +   
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG-- 150
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
            IIHRD+K  NILL+E ++ +I+DFG A++   E          GT  Y++PE       
Sbjct: 151 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 268 SVKTDVFSYGVLVLEIVSG 286
              +D+++ G ++ ++V+G
Sbjct: 210 CKSSDLWALGCIIYQLVAG 228

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 14/199 (7%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-----FTNEVKLLLKIQHKNLVTL 147
           LG G F  V     +   +E A+K L  + R  ++E      T E  ++ ++ H   V L
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           +    +  +      Y  N  L  +I    K  S D T        +   L YLH +   
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG-- 150
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
            IIHRD+K  NILL+E ++ +I+DFG A++   E          GT  Y++PE       
Sbjct: 151 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSA 209
Query: 268 SVKTDVFSYGVLVLEIVSG 286
              +D+++ G ++ ++V+G
Sbjct: 210 CKSSDLWALGCIIYQLVAG 228

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 14/199 (7%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-----FTNEVKLLLKIQHKNLVTL 147
           LG G F  V     +   +E A+K L  + R  ++E      T E  ++ ++ H   V L
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           +    +  +      Y  N  L  +I    K  S D T        +   L YLH +   
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG-- 152
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
            IIHRD+K  NILL+E ++ +I+DFG A++   E          GT  Y++PE       
Sbjct: 153 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 268 SVKTDVFSYGVLVLEIVSG 286
              +D+++ G ++ ++V+G
Sbjct: 212 CKSSDLWALGCIIYQLVAG 230

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 133/283 (46%), Gaps = 35/283 (12%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKL--SVDSRQGLREFTNEVKL 135
           +  +V  +    + +LG G +G V +   +P+GQ +AVK++  +V+S++  R   +    
Sbjct: 44  QNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS 103
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF---IFDKTKSSSLDWTTRYRIVM 192
           +  +     VT +G      +  +  E + + SLD F   + DK ++   D   +  I +
Sbjct: 104 MRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IAV 160
Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISG 252
            + + L +LH +    +IHRD+K SN+L++     K+ DFG++      D+   T   +G
Sbjct: 161 SIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYL--VDSVAKTID-AG 215
Query: 253 THGYMAPEYA-----LHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTW- 306
              YMAPE         GY SVK+D++S G+ ++E+   R  +D             +W 
Sbjct: 216 CKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYD-------------SWG 261
Query: 307 TLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERP 349
           T FQ  K + + +PS        +A  +     C +++  ERP
Sbjct: 262 TPFQQLKQV-VEEPSPQLPADKFSAEFVDFTSQCLKKNSKERP 303

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 14/199 (7%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-----FTNEVKLLLKIQHKNLVTL 147
           LG G F  V     +   +E A+K L  + R  ++E      T E  ++ ++ H   V L
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           +    +  +      Y  N  L  +I    K  S D T        +   L YLH +   
Sbjct: 98  YFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG-- 152
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
            IIHRD+K  NILL+E ++ +I+DFG A++   E          GT  Y++PE       
Sbjct: 153 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 211
Query: 268 SVKTDVFSYGVLVLEIVSG 286
              +D+++ G ++ ++V+G
Sbjct: 212 CKSSDLWALGCIIYQLVAG 230

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 14/199 (7%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-----FTNEVKLLLKIQHKNLVTL 147
           LG G F  V     +   +E A+K L  + R  ++E      T E  ++ ++ H   V L
Sbjct: 43  LGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 100
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           +    +  +      Y  N  L  +I    K  S D T        +   L YLH +   
Sbjct: 101 YFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG-- 155
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
            IIHRD+K  NILL+E ++ +I+DFG A++   E          GT  Y++PE       
Sbjct: 156 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 214
Query: 268 SVKTDVFSYGVLVLEIVSG 286
              +D+++ G ++ ++V+G
Sbjct: 215 CKSSDLWALGCIIYQLVAG 233

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 14/199 (7%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-----FTNEVKLLLKIQHKNLVTL 147
           LG G F  V     +   +E A+K L  + R  ++E      T E  ++ ++ H   V L
Sbjct: 16  LGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           +    +  +      Y  N  L  +I    K  S D T        +   L YLH +   
Sbjct: 74  YFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG-- 128
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
            IIHRD+K  NILL+E ++ +I+DFG A++   E          GT  Y++PE       
Sbjct: 129 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 187
Query: 268 SVKTDVFSYGVLVLEIVSG 286
              +D+++ G ++ ++V+G
Sbjct: 188 CKSSDLWALGCIIYQLVAG 206

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 14/199 (7%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-----FTNEVKLLLKIQHKNLVTL 147
           LG G F  V     +   +E A+K L  + R  ++E      T E  ++ ++ H   V L
Sbjct: 15  LGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 72
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           +    +  +      Y  N  L  +I    K  S D T        +   L YLH +   
Sbjct: 73  YFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG-- 127
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
            IIHRD+K  NILL+E ++ +I+DFG A++   E          GT  Y++PE       
Sbjct: 128 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 186
Query: 268 SVKTDVFSYGVLVLEIVSG 286
              +D+++ G ++ ++V+G
Sbjct: 187 CKSSDLWALGCIIYQLVAG 205

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI D+GLAR    E 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEM 179
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 180 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 14/199 (7%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-----FTNEVKLLLKIQHKNLVTL 147
           LG G F  V     +   +E A+K L  + R  ++E      T E  ++ ++ H   V L
Sbjct: 22  LGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 79
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           +    +  +      Y  N  L  +I    K  S D T        +   L YLH +   
Sbjct: 80  YFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG-- 134
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
            IIHRD+K  NILL+E ++ +I+DFG A++   E          GT  Y++PE       
Sbjct: 135 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 193
Query: 268 SVKTDVFSYGVLVLEIVSG 286
              +D+++ G ++ ++V+G
Sbjct: 194 CKSSDLWALGCIIYQLVAG 212

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 14/199 (7%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-----FTNEVKLLLKIQHKNLVTL 147
           LG G F  V     +   +E A+K L  + R  ++E      T E  ++ ++ H   V L
Sbjct: 17  LGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 74
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           +    +  +      Y  N  L  +I    K  S D T        +   L YLH +   
Sbjct: 75  YFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG-- 129
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
            IIHRD+K  NILL+E ++ +I+DFG A++   E          GT  Y++PE       
Sbjct: 130 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 188
Query: 268 SVKTDVFSYGVLVLEIVSG 286
              +D+++ G ++ ++V+G
Sbjct: 189 CKSSDLWALGCIIYQLVAG 207

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 14/199 (7%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-----FTNEVKLLLKIQHKNLVTL 147
           LG G F  V     +   +E A+K L  + R  ++E      T E  ++ ++ H   V L
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           +    +  +      Y  N  L  +I    K  S D T        +   L YLH +   
Sbjct: 95  YFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG-- 149
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
            IIHRD+K  NILL+E ++ +I+DFG A++   E          GT  Y++PE       
Sbjct: 150 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 208
Query: 268 SVKTDVFSYGVLVLEIVSG 286
              +D+++ G ++ ++V+G
Sbjct: 209 CKSSDLWALGCIIYQLVAG 227

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 14/199 (7%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-----FTNEVKLLLKIQHKNLVTL 147
           LG G F  V     +   +E A+K L  + R  ++E      T E  ++ ++ H   V L
Sbjct: 18  LGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 75
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           +    +  +      Y  N  L  +I    K  S D T        +   L YLH +   
Sbjct: 76  YFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG-- 130
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
            IIHRD+K  NILL+E ++ +I+DFG A++   E          GT  Y++PE       
Sbjct: 131 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 189
Query: 268 SVKTDVFSYGVLVLEIVSG 286
              +D+++ G ++ ++V+G
Sbjct: 190 CKSSDLWALGCIIYQLVAG 208

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 29/213 (13%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKL-SVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
           + Q+G G +G V+ G    G+++AVK   + +     RE   E+   + ++H+N++    
Sbjct: 42  VKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEASWFRE--TEIYQTVLMRHENILGFIA 98
Query: 150 CCAEGP----EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE- 204
              +G     +  L+ +Y  N SL    +D  KS++LD  +  ++      GL +LH E 
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 205 -----APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN---TFRISGTHGY 256
                 PA I HRD+K+ NIL+ +     I+D GLA  F  +   V+     R+ GT  Y
Sbjct: 155 FSTQGKPA-IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-GTKRY 212
Query: 257 MAPEY------ALHGYLSVKTDVFSYGVLVLEI 283
           M PE         H    +  D++S+G+++ E+
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 14/199 (7%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-----FTNEVKLLLKIQHKNLVTL 147
           LG G F  V     +   +E A+K L  + R  ++E      T E  ++ ++ H   V L
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           +    +  +      Y  N  L  +I    K  S D T        +   L YLH +   
Sbjct: 95  YFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG-- 149
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
            IIHRD+K  NILL+E ++ +I+DFG A++   E          GT  Y++PE       
Sbjct: 150 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 208
Query: 268 SVKTDVFSYGVLVLEIVSG 286
              +D+++ G ++ ++V+G
Sbjct: 209 CKSSDLWALGCIIYQLVAG 227

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 31/214 (14%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSV-DSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
           L  +G G +G V+RG    G+ +AVK  S  D +   RE   E+   + ++H+N++    
Sbjct: 42  LECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIA 98
Query: 150 CCA----EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE- 204
                     +  L+  Y    SL    +D  + ++LD  +  RIV+ +A GL +LH E 
Sbjct: 99  SDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEI 154
Query: 205 -----APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV---NTFRISGTHGY 256
                 PA I HRD+K+ NIL+ +     I+D GLA +       +   N  R+ GT  Y
Sbjct: 155 FGTQGKPA-IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRY 212
Query: 257 MAPEYALHGYLSV-------KTDVFSYGVLVLEI 283
           MAPE  L   + V       + D++++G+++ E+
Sbjct: 213 MAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 31/214 (14%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSV-DSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
           L  +G G +G V+RG    G+ +AVK  S  D +   RE   E+   + ++H+N++    
Sbjct: 13  LECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIA 69
Query: 150 CCA----EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE- 204
                     +  L+  Y    SL    +D  + ++LD  +  RIV+ +A GL +LH E 
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 205 -----APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV---NTFRISGTHGY 256
                 PA I HRD+K+ NIL+ +     I+D GLA +       +   N  R+ GT  Y
Sbjct: 126 FGTQGKPA-IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRY 183
Query: 257 MAPEYALHGYLSV-------KTDVFSYGVLVLEI 283
           MAPE  L   + V       + D++++G+++ E+
Sbjct: 184 MAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 31/214 (14%)
Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSV-DSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
           L  +G G +G V+RG    G+ +AVK  S  D +   RE   E+   + ++H+N++    
Sbjct: 13  LECVGKGRYGEVWRGSW-QGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIA 69
Query: 150 CCA----EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE- 204
                     +  L+  Y    SL    +D  + ++LD  +  RIV+ +A GL +LH E 
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 205 -----APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV---NTFRISGTHGY 256
                 PA I HRD+K+ NIL+ +     I+D GLA +       +   N  R+ GT  Y
Sbjct: 126 FGTQGKPA-IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRY 183
Query: 257 MAPEYALHGYLSV-------KTDVFSYGVLVLEI 283
           MAPE  L   + V       + D++++G+++ E+
Sbjct: 184 MAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 99/227 (43%), Gaps = 41/227 (18%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           F ++  +G GGFG V++     +G+   ++++  ++ +  RE    VK L K+ H N+V 
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAERE----VKALAKLDHVNIVH 69
Query: 147 LFGC-----------------CAEGPEK------------MLVYEYLPNKSLDYFIFDKT 177
             GC                     PE              +  E+    +L+ +I +K 
Sbjct: 70  YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKR 128
Query: 178 KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL 237
           +   LD      +   + +G+ Y+H +   ++IHRD+K SNI L +    KI DFGL   
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 238 FPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIV 284
              +       R  GT  YM+PE         + D+++ G+++ E++
Sbjct: 186 LKNDGKRT---RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 14/199 (7%)
Query: 94  LGHGGFGP-VYRGLMPNGQEIAVKKLSVDSRQGLRE-----FTNEVKLLLKIQHKNLVTL 147
           LG G F   V    +   +E A+K L  + R  ++E      T E  ++ ++ H   V L
Sbjct: 38  LGEGSFSTTVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           +    +  +      Y  N  L  +I    K  S D T        +   L YLH +   
Sbjct: 96  YFTFQDDEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFYTAEIVSALEYLHGKG-- 150
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
            IIHRD+K  NILL+E ++ +I+DFG A++   E          GT  Y++PE       
Sbjct: 151 -IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 209
Query: 268 SVKTDVFSYGVLVLEIVSG 286
              +D+++ G ++ ++V+G
Sbjct: 210 CKSSDLWALGCIIYQLVAG 228

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 108/258 (41%), Gaps = 18/258 (6%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNEVKLLL 137
           Q A   F     LG G FG VY       + I   K+   +   + G+  +   EV++  
Sbjct: 6   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            ++H N++ L+G   +     L+ EY P   L     +  K S  D       +  +A  
Sbjct: 66  HLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANA 122
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L Y H +   R+IHRDIK  N+LL      KI++FG +   P          + GT  Y+
Sbjct: 123 LSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTT----LCGTLDYL 175
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS---YTWTLFQGEKA 314
            PE         K D++S GVL  E + G+   +    +E    +S   +T+  F  E A
Sbjct: 176 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 235
Query: 315 LELVDPSLAKCNRDEAAM 332
            +L+   L K N  +  M
Sbjct: 236 RDLIS-RLLKHNPSQRPM 252

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 86  NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKK-LSVDSRQGLREFTNEVKLLLKIQHKNL 144
           +F+  + +LG G FG VY+        +A  K +   S + L ++  E+ +L    H N+
Sbjct: 37  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 96
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARGLLYLHE 203
           V L           ++ E+    ++D  + +  +  +    ++ ++V       L YLH+
Sbjct: 97  VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNYLHD 153
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS--GTHGYMAPEY 261
               +IIHRD+KA NIL     + K++DFG++     ++T     R S  GT  +MAPE 
Sbjct: 154 N---KIIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRTIQRRDSFIGTPYWMAPEV 206
Query: 262 ALHGY-----LSVKTDVFSYGVLVLEIVSGRKNH 290
            +           K DV+S G+ ++E+      H
Sbjct: 207 VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH 240

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/258 (27%), Positives = 108/258 (41%), Gaps = 18/258 (6%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNEVKLLL 137
           Q A   F     LG G FG VY       + I   K+   +   + G+  +   EV++  
Sbjct: 7   QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            ++H N++ L+G   +     L+ EY P   L     +  K S  D       +  +A  
Sbjct: 67  HLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRTATYITELANA 123
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L Y H +   R+IHRDIK  N+LL      KI++FG +   P          + GT  Y+
Sbjct: 124 LSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTT----LCGTLDYL 176
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS---YTWTLFQGEKA 314
            PE         K D++S GVL  E + G+   +    +E    +S   +T+  F  E A
Sbjct: 177 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 315 LELVDPSLAKCNRDEAAM 332
            +L+   L K N  +  M
Sbjct: 237 RDLIS-RLLKHNPSQRPM 253

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI DF LAR    E 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEM 179
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 180 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 78/162 (48%), Gaps = 7/162 (4%)
Query: 129 FTNEVKLLLKIQHKNLVTLFGCCAEGPEKML--VYEYLPNKSLDYFIFDKTKSSS-LDWT 185
             +EV LL +++H N+V  +    +     L  V EY     L   I   TK    LD  
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 186 TRYRIVMGVARGLLYLHEEAPA--RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243
              R++  +   L   H  +     ++HRD+K +N+ LD + N K+ DFGLAR+   + +
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 171
Query: 244 HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
              TF   GT  YM+PE       + K+D++S G L+ E+ +
Sbjct: 172 FAKTF--VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 21/215 (9%)
Query: 94  LGHGGFGPVYRGLMPNGQE----IAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLVTLF 148
           +G G FG V++G+  + +     +A+K     +   +RE F  E   + +  H ++V L 
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G   E P   ++ E      L  F+  + +  SLD  +       ++  L YL  +   R
Sbjct: 80  GVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 133
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLS 268
            +HRDI A N+L+      K+ DFGL+R +  + T+    +      +MAPE       +
Sbjct: 134 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 192
Query: 269 VKTDVFSYGVLVLEIV-------SGRKNHD--GRL 294
             +DV+ +GV + EI+        G KN+D  GR+
Sbjct: 193 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 227

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 19/210 (9%)
Query: 94  LGHGGFGPVY--RGLMPNGQEIAVKKLSVDSRQG----LREFTNEVKLLLKIQHKNLVTL 147
           LG GG   V+  R L  + +++AVK L  D  +     LR F  E +    + H  +V +
Sbjct: 20  LGFGGMSEVHLARDLR-DHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVAV 77
Query: 148 FGC----CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           +         GP   +V EY+   +L   +  +     +       ++    + L + H+
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQ 134
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV-NTFRISGTHGYMAPEYA 262
                IIHRD+K +NIL+      K+ DFG+AR        V  T  + GT  Y++PE A
Sbjct: 135 NG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQA 191
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
               +  ++DV+S G ++ E+++G     G
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 112/249 (44%), Gaps = 25/249 (10%)
Query: 80  TLQVATNFFSDLNQLGHGGFGPVYRGLMPN-GQEIAVK---KLSVDSRQGLREFTNEVKL 135
            + +  N FS    +G GGFG VY     + G+  A+K   K  +  +QG     NE ++
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RI 241
Query: 136 LLKIQHKNLVTLFGCCAEG---PEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIV 191
           +L +          C +     P+K+  + + +    L Y +      S  D   R+   
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD--MRF-YA 298
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS 251
             +  GL ++H      +++RD+K +NILLDE  + +ISD GLA  F  +  H +     
Sbjct: 299 AEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---- 351
Query: 252 GTHGYMAPEYALHGY-LSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQ 310
           GTHGYMAPE    G       D FS G ++ +++ G         K+K ++   T T+  
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-- 409
Query: 311 GEKALELVD 319
              A+EL D
Sbjct: 410 ---AVELPD 415

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 133/282 (47%), Gaps = 35/282 (12%)
Query: 80  TLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKL--SVDSRQGLREFTNEVKLL 136
           +++V  +    + +LG G +G V +   +P+GQ +AVK++  +V+S++  R   +    +
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 137 LKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF---IFDKTKSSSLDWTTRYRIVMG 193
             +     VT +G      +  +  E + + SLD F   + DK ++   D   +  I + 
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IAVS 117
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           + + L +LH +    +IHRD+K SN+L++     K+ DFG++     +   V     +G 
Sbjct: 118 IVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD---VAKDIDAGC 172
Query: 254 HGYMAPEYA-----LHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTW-T 307
             YMAPE         GY SVK+D++S G+ ++E+   R  +D             +W T
Sbjct: 173 KPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYD-------------SWGT 218
Query: 308 LFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERP 349
            FQ  K + + +PS        +A  +     C +++  ERP
Sbjct: 219 PFQQLKQV-VEEPSPQLPADKFSAEFVDFTSQCLKKNSKERP 259

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 86  NFFSDLNQLGHGGFGPVYR------GLMPNGQEIAVKKLSVDSRQGL--REFTNEVKLLL 137
           +++    +LG G F  V +      GL    + I  K+ +  SR+G+   +   EV +L 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
           +IQH N++TL        + +L+ E +    L  F+ +K    SL        +  +  G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNG 126
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPK----ISDFGLARLFPGEDTHVNTFRISGT 253
           + YLH     +I H D+K  NI+L ++  PK    I DFGLA      +   N F   GT
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GT 180
Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
             ++APE   +  L ++ D++S GV+   ++SG
Sbjct: 181 PAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 112/249 (44%), Gaps = 25/249 (10%)
Query: 80  TLQVATNFFSDLNQLGHGGFGPVYRGLMPN-GQEIAVK---KLSVDSRQGLREFTNEVKL 135
            + +  N FS    +G GGFG VY     + G+  A+K   K  +  +QG     NE ++
Sbjct: 182 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RI 240
Query: 136 LLKIQHKNLVTLFGCCAEG---PEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIV 191
           +L +          C +     P+K+  + + +    L Y +      S  D   R+   
Sbjct: 241 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD--MRF-YA 297
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS 251
             +  GL ++H      +++RD+K +NILLDE  + +ISD GLA  F  +  H +     
Sbjct: 298 AEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---- 350
Query: 252 GTHGYMAPEYALHGY-LSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQ 310
           GTHGYMAPE    G       D FS G ++ +++ G         K+K ++   T T+  
Sbjct: 351 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-- 408
Query: 311 GEKALELVD 319
              A+EL D
Sbjct: 409 ---AVELPD 414

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 21/215 (9%)
Query: 94  LGHGGFGPVYRGLMPNGQE----IAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLVTLF 148
           +G G FG V++G+  + +     +A+K     +   +RE F  E   + +  H ++V L 
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G   E P   ++ E      L  F+  + +  SLD  +       ++  L YL  +   R
Sbjct: 81  GVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 134
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLS 268
            +HRDI A N+L+      K+ DFGL+R +  + T+    +      +MAPE       +
Sbjct: 135 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 193
Query: 269 VKTDVFSYGVLVLEIV-------SGRKNHD--GRL 294
             +DV+ +GV + EI+        G KN+D  GR+
Sbjct: 194 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 228

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 19/214 (8%)
Query: 86  NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKK-LSVDSRQGLREFTNEVKLLLKIQHKNL 144
           +F+  + +LG G FG VY+        +A  K +   S + L ++  E+ +L    H N+
Sbjct: 37  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 96
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARGLLYLHE 203
           V L           ++ E+    ++D  + +  +  +    ++ ++V       L YLH+
Sbjct: 97  VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNYLHD 153
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS--GTHGYMAPEY 261
               +IIHRD+KA NIL     + K++DFG++     ++T     R S  GT  +MAPE 
Sbjct: 154 N---KIIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRXIQRRDSFIGTPYWMAPEV 206
Query: 262 ALHGY-----LSVKTDVFSYGVLVLEIVSGRKNH 290
            +           K DV+S G+ ++E+      H
Sbjct: 207 VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH 240

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 21/215 (9%)
Query: 94  LGHGGFGPVYRGLMPNGQE----IAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLVTLF 148
           +G G FG V++G+  + +     +A+K     +   +RE F  E   + +  H ++V L 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G   E P   ++ E      L  F+  + +  SLD  +       ++  L YL  +   R
Sbjct: 83  GVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 136
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLS 268
            +HRDI A N+L+      K+ DFGL+R +  + T+    +      +MAPE       +
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 195
Query: 269 VKTDVFSYGVLVLEIV-------SGRKNHD--GRL 294
             +DV+ +GV + EI+        G KN+D  GR+
Sbjct: 196 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 230

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 21/215 (9%)
Query: 94  LGHGGFGPVYRGLMPNGQE----IAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLVTLF 148
           +G G FG V++G+  + +     +A+K     +   +RE F  E   + +  H ++V L 
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G   E P   ++ E      L  F+  + +  SLD  +       ++  L YL  +   R
Sbjct: 106 GVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 159
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLS 268
            +HRDI A N+L+      K+ DFGL+R +  + T+    +      +MAPE       +
Sbjct: 160 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 218
Query: 269 VKTDVFSYGVLVLEIV-------SGRKNHD--GRL 294
             +DV+ +GV + EI+        G KN+D  GR+
Sbjct: 219 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 253

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 112/249 (44%), Gaps = 25/249 (10%)
Query: 80  TLQVATNFFSDLNQLGHGGFGPVYRGLMPN-GQEIAVK---KLSVDSRQGLREFTNEVKL 135
            + +  N FS    +G GGFG VY     + G+  A+K   K  +  +QG     NE ++
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RI 241
Query: 136 LLKIQHKNLVTLFGCCAEG---PEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIV 191
           +L +          C +     P+K+  + + +    L Y +      S  D   R+   
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD--MRF-YA 298
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS 251
             +  GL ++H      +++RD+K +NILLDE  + +ISD GLA  F  +  H +     
Sbjct: 299 AEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---- 351
Query: 252 GTHGYMAPEYALHGY-LSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQ 310
           GTHGYMAPE    G       D FS G ++ +++ G         K+K ++   T T+  
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-- 409
Query: 311 GEKALELVD 319
              A+EL D
Sbjct: 410 ---AVELPD 415

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/249 (28%), Positives = 112/249 (44%), Gaps = 25/249 (10%)
Query: 80  TLQVATNFFSDLNQLGHGGFGPVYRGLMPN-GQEIAVK---KLSVDSRQGLREFTNEVKL 135
            + +  N FS    +G GGFG VY     + G+  A+K   K  +  +QG     NE ++
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNE-RI 241
Query: 136 LLKIQHKNLVTLFGCCAEG---PEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIV 191
           +L +          C +     P+K+  + + +    L Y +      S  D   R+   
Sbjct: 242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD--MRF-YA 298
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS 251
             +  GL ++H      +++RD+K +NILLDE  + +ISD GLA  F  +  H +     
Sbjct: 299 AEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---- 351
Query: 252 GTHGYMAPEYALHGY-LSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQ 310
           GTHGYMAPE    G       D FS G ++ +++ G         K+K ++   T T+  
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-- 409
Query: 311 GEKALELVD 319
              A+EL D
Sbjct: 410 ---AVELPD 415

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 101/234 (43%), Gaps = 21/234 (8%)
Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNEVKLLLKIQHKNLVTLFG 149
           LG G FG VY       + I   K+   +   + G+  +   EV++   ++H N++ L+G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
              +     L+ EY P   L     +  K S  D       +  +A  L Y H +   R+
Sbjct: 80  YFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYCHSK---RV 133
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPG--EDTHVNTFRISGTHGYMAPEYALHGYL 267
           IHRDIK  N+LL      KI+DFG +   P    DT      + GT  Y+ PE       
Sbjct: 134 IHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDT------LCGTLDYLPPEMIEGRMH 187
Query: 268 SVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS---YTWTLFQGEKALELV 318
             K D++S GVL  E + G    +    +E    +S   +T+  F  E A +L+
Sbjct: 188 DEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLI 241

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 21/215 (9%)
Query: 94  LGHGGFGPVYRGLMPNGQE----IAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLVTLF 148
           +G G FG V++G+  + +     +A+K     +   +RE F  E   + +  H ++V L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G   E P   ++ E      L  F+  + +  SLD  +       ++  L YL  +   R
Sbjct: 78  GVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLS 268
            +HRDI A N+L+      K+ DFGL+R +  + T+    +      +MAPE       +
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 269 VKTDVFSYGVLVLEIV-------SGRKNHD--GRL 294
             +DV+ +GV + EI+        G KN+D  GR+
Sbjct: 191 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 21/215 (9%)
Query: 94  LGHGGFGPVYRGLMPNGQE----IAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLVTLF 148
           +G G FG V++G+  + +     +A+K     +   +RE F  E   + +  H ++V L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G   E P   ++ E      L  F+  + +  SLD  +       ++  L YL  +   R
Sbjct: 78  GVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 131
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLS 268
            +HRDI A N+L+      K+ DFGL+R +  + T+    +      +MAPE       +
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 269 VKTDVFSYGVLVLEIV-------SGRKNHD--GRL 294
             +DV+ +GV + EI+        G KN+D  GR+
Sbjct: 191 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 21/215 (9%)
Query: 94  LGHGGFGPVYRGLMPNGQE----IAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLVTLF 148
           +G G FG V++G+  + +     +A+K     +   +RE F  E   + +  H ++V L 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G   E P   ++ E      L  F+  + +  SLD  +       ++  L YL  +   R
Sbjct: 75  GVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK---R 128
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLS 268
            +HRDI A N+L+      K+ DFGL+R +  + T+    +      +MAPE       +
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 269 VKTDVFSYGVLVLEIV-------SGRKNHD--GRL 294
             +DV+ +GV + EI+        G KN+D  GR+
Sbjct: 188 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 222

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 101/223 (45%), Gaps = 18/223 (8%)
Query: 88  FSDLNQLGHGGFGPVY---RGLMPNGQEI----AVKKLSVDSRQGLREFTNEVKLLLKIQ 140
           F  L  LG G FG V+   +   P+   +     +KK ++  R  +R    E  +L  + 
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRT-KMERDILADVN 88
Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARGLL 199
           H  +V L        +  L+ ++L    L    F +     +      +  +  +A GL 
Sbjct: 89  HPFVVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALGLD 144
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           +LH      II+RD+K  NILLDE+ + K++DFGL++     D     +   GT  YMAP
Sbjct: 145 HLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK--EAIDHEKKAYSFCGTVEYMAP 199
Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLL 302
           E       S   D +SYGVL+ E+++G     G+  KE   L+
Sbjct: 200 EVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLI 242

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 19/210 (9%)
Query: 94  LGHGGFGPVY--RGLMPNGQEIAVKKLSVDSRQG----LREFTNEVKLLLKIQHKNLVTL 147
           LG GG   V+  R L  + +++AVK L  D  +     LR F  E +    + H  +V +
Sbjct: 20  LGFGGMSEVHLARDLR-DHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVAV 77
Query: 148 FGC----CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           +         GP   +V EY+   +L   +  +     +       ++    + L + H+
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQ 134
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN-TFRISGTHGYMAPEYA 262
                IIHRD+K +NI++      K+ DFG+AR        V  T  + GT  Y++PE A
Sbjct: 135 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
               +  ++DV+S G ++ E+++G     G
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 99/232 (42%), Gaps = 17/232 (7%)
Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNEVKLLLKIQHKNLVTLFG 149
           LG G FG VY       + I   K+   +   + G+  +   EV++   ++H N++ L+G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
              +     L+ EY P   L     +  K S  D       +  +A  L Y H +   R+
Sbjct: 80  YFHDATRVYLILEYAP---LGTVYRELQKLSRFDEQRTATYITELANALSYCHSK---RV 133
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           IHRDIK  N+LL      KI+DFG +   P          + GT  Y+ PE         
Sbjct: 134 IHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTT----LCGTLDYLPPEMIEGRMHDE 189
Query: 270 KTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS---YTWTLFQGEKALELV 318
           K D++S GVL  E + G    +    +E    +S   +T+  F  E A +L+
Sbjct: 190 KVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLI 241

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 21/215 (9%)
Query: 94  LGHGGFGPVYRGLMPNGQE----IAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLVTLF 148
           +G G FG V++G+  + +     +A+K     +   +RE F  E   + +  H ++V L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G   E P   ++ E      L  F+  + +  SLD  +       ++  L YL  +   R
Sbjct: 78  GVITENP-VWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLS 268
            +HRDI A N+L+      K+ DFGL+R +  + T+    +      +MAPE       +
Sbjct: 132 FVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 269 VKTDVFSYGVLVLEIV-------SGRKNHD--GRL 294
             +DV+ +GV + EI+        G KN+D  GR+
Sbjct: 191 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 30/212 (14%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVK--------KLSVDSRQGLREFT-NEVKLLLKIQ-HK 142
           LG G    V R +  P  +E AVK          S +  Q LRE T  EV +L K+  H 
Sbjct: 12  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 71
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
           N++ L           LV++ +    L DY     T+  +L      +I+  +   +  L
Sbjct: 72  NIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVICAL 127
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLA-RLFPGEDTHVNTFRISGTHGYMAPE 260
           H+     I+HRD+K  NILLD+ +N K++DFG + +L PGE        + GT  Y+APE
Sbjct: 128 HK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR----EVCGTPSYLAPE 180
Query: 261 YAL------HGYLSVKTDVFSYGVLVLEIVSG 286
                    H     + D++S GV++  +++G
Sbjct: 181 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 19/210 (9%)
Query: 94  LGHGGFGPVY--RGLMPNGQEIAVKKLSVDSRQG----LREFTNEVKLLLKIQHKNLVTL 147
           LG GG   V+  R L  + +++AVK L  D  +     LR F  E +    + H  +V +
Sbjct: 20  LGFGGMSEVHLARDLR-DHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVAV 77
Query: 148 FGC----CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           +         GP   +V EY+   +L   +  +     +       ++    + L + H+
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQ 134
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN-TFRISGTHGYMAPEYA 262
                IIHRD+K +NI++      K+ DFG+AR        V  T  + GT  Y++PE A
Sbjct: 135 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
               +  ++DV+S G ++ E+++G     G
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI D GLAR    E 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEM 179
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 180 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 95/202 (47%), Gaps = 13/202 (6%)
Query: 91  LNQLGHGGFGPVYRGLMPN-GQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHKNLVTL 147
           L  +G G +G V         Q++AVKKLS    S    R    E++LL  ++H+N++ L
Sbjct: 33  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 148 FGCCAEGPEKMLVYE-YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
                         E YL    +   + +  KS +L       +V  + RGL Y+H    
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHS--- 149
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHG- 265
           A IIHRD+K SN+ ++E    +I DFGLAR    E T         T  Y APE  L+  
Sbjct: 150 AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGY-----VATRWYRAPEIMLNWM 204
Query: 266 YLSVKTDVFSYGVLVLEIVSGR 287
           + +   D++S G ++ E++ G+
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGK 226

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 95/210 (45%), Gaps = 15/210 (7%)
Query: 94  LGHGGFGPVYRG-LMPNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKI--QHKNLVTLF 148
           LG G FG V+        Q  A+K L  D        E T   K +L +  +H  L  +F
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 149 GCCAEGPEKML-VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
            C  +  E +  V EYL    L Y I         D +        +  GL +LH +   
Sbjct: 85  -CTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGLQFLHSKG-- 138
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
            I++RD+K  NILLD+  + KI+DFG+ +     D   N F   GT  Y+APE  L    
Sbjct: 139 -IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXF--CGTPDYIAPEILLGQKY 195
Query: 268 SVKTDVFSYGVLVLEIVSGRKNHDGRLGKE 297
           +   D +S+GVL+ E++ G+    G+  +E
Sbjct: 196 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 225

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI  FGLAR    E 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEM 179
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 180 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 104/227 (45%), Gaps = 16/227 (7%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNG--------QEIAVKKLSVDSRQGLREFTNEV 133
           ++    F  L  LG GG+G V++     G         ++  K + V + +       E 
Sbjct: 13  KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER 72
Query: 134 KLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG 193
            +L +++H  +V L      G +  L+ EYL    L +   ++      D    Y   + 
Sbjct: 73  NILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL-FMQLEREGIFMEDTACFYLAEIS 131
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           +A G  +LH++    II+RD+K  NI+L+ Q + K++DFGL +    + T  +TF   GT
Sbjct: 132 MALG--HLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF--CGT 184
Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKAD 300
             YMAPE  +    +   D +S G L+ ++++G     G   K+  D
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID 231

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 96/216 (44%), Gaps = 23/216 (10%)
Query: 86  NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKK-LSVDSRQGLREFTNEVKLLLKIQHKNL 144
           +F+  + +LG G FG VY+        +A  K +   S + L ++  E+ +L    H N+
Sbjct: 37  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 96
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARGLLYLHE 203
           V L           ++ E+    ++D  + +  +  +    ++ ++V       L YLH+
Sbjct: 97  VKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT---ESQIQVVCKQTLDALNYLHD 153
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLA----RLFPGEDTHVNTFRISGTHGYMAP 259
               +IIHRD+KA NIL     + K++DFG++    R     D  +      GT  +MAP
Sbjct: 154 N---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFI------GTPYWMAP 204
Query: 260 EYALHGY-----LSVKTDVFSYGVLVLEIVSGRKNH 290
           E  +           K DV+S G+ ++E+      H
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH 240

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 30/212 (14%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVK--------KLSVDSRQGLREFT-NEVKLLLKIQ-HK 142
           LG G    V R +  P  +E AVK          S +  Q LRE T  EV +L K+  H 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
           N++ L           LV++ +    L DY     T+  +L      +I+  +   +  L
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVICAL 140
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLA-RLFPGEDTHVNTFRISGTHGYMAPE 260
           H+     I+HRD+K  NILLD+ +N K++DFG + +L PGE        + GT  Y+APE
Sbjct: 141 HK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR----EVCGTPSYLAPE 193
Query: 261 YAL------HGYLSVKTDVFSYGVLVLEIVSG 286
                    H     + D++S GV++  +++G
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 95/210 (45%), Gaps = 15/210 (7%)
Query: 94  LGHGGFGPVYRG-LMPNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKI--QHKNLVTLF 148
           LG G FG V+        Q  A+K L  D        E T   K +L +  +H  L  +F
Sbjct: 26  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 85
Query: 149 GCCAEGPEKML-VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
            C  +  E +  V EYL    L Y I         D +        +  GL +LH +   
Sbjct: 86  -CTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGLQFLHSKG-- 139
Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
            I++RD+K  NILLD+  + KI+DFG+ +     D   N F   GT  Y+APE  L    
Sbjct: 140 -IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEF--CGTPDYIAPEILLGQKY 196
Query: 268 SVKTDVFSYGVLVLEIVSGRKNHDGRLGKE 297
           +   D +S+GVL+ E++ G+    G+  +E
Sbjct: 197 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 226

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 21/215 (9%)
Query: 94  LGHGGFGPVYRGLMPNGQE----IAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLVTLF 148
           +G G FG V++G+  + +     +A+K     +   +RE F  E   + +  H ++V L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G   E P   ++ E      L  F+  + +  SLD  +       ++  L YL  +   R
Sbjct: 458 GVITENP-VWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLS 268
            +HRDI A N+L+      K+ DFGL+R +  + T+    +      +MAPE       +
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 269 VKTDVFSYGVLVLEIV-------SGRKNHD--GRL 294
             +DV+ +GV + EI+        G KN+D  GR+
Sbjct: 571 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI D GLAR    E 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEM 179
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 180 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 86  NFFSDLNQLGHGGFGPVYR------GLMPNGQEIAVKKLSVDSRQGL--REFTNEVKLLL 137
           +++    +LG G F  V +      GL    + I  K+ +  SR+G+   +   EV +L 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
           +IQH N++TL        + +L+ E +    L  F+ +K    SL        +  +  G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNG 126
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNP----KISDFGLARLFPGEDTHVNTFRISGT 253
           + YLH     +I H D+K  NI+L ++  P    KI DFGLA      +   N F   GT
Sbjct: 127 VYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GT 180
Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
             ++APE   +  L ++ D++S GV+   ++SG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 30/212 (14%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVK--------KLSVDSRQGLREFT-NEVKLLLKIQ-HK 142
           LG G    V R +  P  +E AVK          S +  Q LRE T  EV +L K+  H 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
           N++ L           LV++ +    L DY     T+  +L      +I+  +   +  L
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRALLEVICAL 140
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLA-RLFPGEDTHVNTFRISGTHGYMAPE 260
           H+     I+HRD+K  NILLD+ +N K++DFG + +L PGE        + GT  Y+APE
Sbjct: 141 HK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR----SVCGTPSYLAPE 193
Query: 261 YAL------HGYLSVKTDVFSYGVLVLEIVSG 286
                    H     + D++S GV++  +++G
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 86  NFFSDLNQLGHGGFGPVYR------GLMPNGQEIAVKKLSVDSRQGL--REFTNEVKLLL 137
           +++    +LG G F  V +      GL    + I  K+ +  SR+G+   +   EV +L 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
           +IQH N++TL        + +L+ E +    L  F+ +K    SL        +  +  G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNG 126
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNP----KISDFGLARLFPGEDTHVNTFRISGT 253
           + YLH     +I H D+K  NI+L ++  P    KI DFGLA      +   N F   GT
Sbjct: 127 VYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GT 180
Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
             ++APE   +  L ++ D++S GV+   ++SG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 86  NFFSDLNQLGHGGFGPVYR------GLMPNGQEIAVKKLSVDSRQGL--REFTNEVKLLL 137
           +++    +LG G F  V +      GL    + I  K+ +  SR+G+   +   EV +L 
Sbjct: 11  DYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
           +IQH N++TL        + +L+ E +    L  F+ +K    SL        +  +  G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNG 126
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNP----KISDFGLARLFPGEDTHVNTFRISGT 253
           + YLH     +I H D+K  NI+L ++  P    KI DFGLA      +   N F   GT
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GT 180
Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
             ++APE   +  L ++ D++S GV+   ++SG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 86  NFFSDLNQLGHGGFGPVYR------GLMPNGQEIAVKKLSVDSRQGL--REFTNEVKLLL 137
           +++    +LG G F  V +      GL    + I  K+ +  SR+G+   +   EV +L 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
           +IQH N++TL        + +L+ E +    L  F+ +K    SL        +  +  G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNG 126
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNP----KISDFGLARLFPGEDTHVNTFRISGT 253
           + YLH     +I H D+K  NI+L ++  P    KI DFGLA      +   N F   GT
Sbjct: 127 VYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GT 180
Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
             ++APE   +  L ++ D++S GV+   ++SG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 21/215 (9%)
Query: 94  LGHGGFGPVYRGLMPNGQE----IAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLVTLF 148
           +G G FG V++G+  + +     +A+K     +   +RE F  E   + +  H ++V L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G   E P   ++ E      L  F+  + +  SLD  +       ++  L YL  +   R
Sbjct: 78  GVITENP-VWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 131
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLS 268
            +HRDI A N+L+      K+ DFGL+R +  + T     +      +MAPE       +
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTXXKASKGKLPIKWMAPESINFRRFT 190
Query: 269 VKTDVFSYGVLVLEIV-------SGRKNHD--GRL 294
             +DV+ +GV + EI+        G KN+D  GR+
Sbjct: 191 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 225

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 104/234 (44%), Gaps = 38/234 (16%)
Query: 80  TLQVATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLK 138
           +L+ A++F  ++  LG G FG V +     + +  A+KK+   + + L    +EV LL  
Sbjct: 1   SLRYASDF-EEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLAS 58
Query: 139 IQHKNLVTLFGCCAE-------------GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWT 185
           + H+ +V  +    E                  +  EY  N++L   I  +  +   D  
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRD-- 116
Query: 186 TRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR--------- 236
             +R+   +   L Y+H +    IIHRD+K  NI +DE  N KI DFGLA+         
Sbjct: 117 EYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 237 -----LFPGEDTHVNTFRISGTHGYMAPEYAL-HGYLSVKTDVFSYGVLVLEIV 284
                  PG   ++ +    GT  Y+A E     G+ + K D++S G++  E++
Sbjct: 174 KLDSQNLPGSSDNLTS--AIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 86  NFFSDLNQLGHGGFGPVYR------GLMPNGQEIAVKKLSVDSRQGL--REFTNEVKLLL 137
           +++    +LG G F  V +      GL    + I  K+ +  SR+G+   +   EV +L 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 68
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
           +IQH N++TL        + +L+ E +    L  F+ +K    SL        +  +  G
Sbjct: 69  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNG 125
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNP----KISDFGLARLFPGEDTHVNTFRISGT 253
           + YLH     +I H D+K  NI+L ++  P    KI DFGLA      +   N F   GT
Sbjct: 126 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GT 179
Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
             ++APE   +  L ++ D++S GV+   ++SG
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 19/210 (9%)
Query: 94  LGHGGFGPVY--RGLMPNGQEIAVKKLSVDSRQG----LREFTNEVKLLLKIQHKNLVTL 147
           LG GG   V+  R L  + +++AVK L  D  +     LR F  E +    + H  +V +
Sbjct: 20  LGFGGMSEVHLARDLRLH-RDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVAV 77
Query: 148 FGC----CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           +         GP   +V EY+   +L   +  +     +       ++    + L + H+
Sbjct: 78  YATGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQ 134
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN-TFRISGTHGYMAPEYA 262
                IIHRD+K +NI++      K+ DFG+AR        V  T  + GT  Y++PE A
Sbjct: 135 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
               +  ++DV+S G ++ E+++G     G
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 86  NFFSDLNQLGHGGFGPVYR------GLMPNGQEIAVKKLSVDSRQGL--REFTNEVKLLL 137
           +++    +LG G F  V +      GL    + I  K+ +  SR+G+   +   EV +L 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
           +IQH N++TL        + +L+ E +    L  F+ +K    SL        +  +  G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNG 126
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNP----KISDFGLARLFPGEDTHVNTFRISGT 253
           + YLH     +I H D+K  NI+L ++  P    KI DFGLA      +   N F   GT
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GT 180
Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
             ++APE   +  L ++ D++S GV+   ++SG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 21/215 (9%)
Query: 94  LGHGGFGPVYRGLMPNGQE----IAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLVTLF 148
           +G G FG V++G+  + +     +A+K     +   +RE F  E   + +  H ++V L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G   E P   ++ E      L  F+  + +  SLD  +       ++  L YL  +   R
Sbjct: 458 GVITENP-VWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLS 268
            +HRDI A N+L+      K+ DFGL+R +  + T+    +      +MAPE       +
Sbjct: 512 FVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 269 VKTDVFSYGVLVLEIV-------SGRKNHD--GRL 294
             +DV+ +GV + EI+        G KN+D  GR+
Sbjct: 571 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 605

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 86  NFFSDLNQLGHGGFGPVYR------GLMPNGQEIAVKKLSVDSRQGL--REFTNEVKLLL 137
           +++    +LG G F  V +      GL    + I  K+ +  SR+G+   +   EV +L 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 68
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
           +IQH N++TL        + +L+ E +    L  F+ +K    SL        +  +  G
Sbjct: 69  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNG 125
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNP----KISDFGLARLFPGEDTHVNTFRISGT 253
           + YLH     +I H D+K  NI+L ++  P    KI DFGLA      +   N F   GT
Sbjct: 126 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GT 179
Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
             ++APE   +  L ++ D++S GV+   ++SG
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 86  NFFSDLNQLGHGGFGPVYR------GLMPNGQEIAVKKLSVDSRQGL--REFTNEVKLLL 137
           +++    +LG G F  V +      GL    + I  K+ +  SR+G+   +   EV +L 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
           +IQH N++TL        + +L+ E +    L  F+ +K    SL        +  +  G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNG 126
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNP----KISDFGLARLFPGEDTHVNTFRISGT 253
           + YLH     +I H D+K  NI+L ++  P    KI DFGLA      +   N F   GT
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GT 180
Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
             ++APE   +  L ++ D++S GV+   ++SG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 98/201 (48%), Gaps = 15/201 (7%)
Query: 93  QLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQ-GLREFTNEVKLLLKIQHKNLVTLFGC 150
           +LG G FG V+      +G E  +K ++ D  Q  + +   E+++L  + H N++ +F  
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 151 CAEGPEKMLVYEYLPN-KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
             +     +V E     + L+  +  + +  +L       ++  +   L Y H +    +
Sbjct: 89  FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HV 145
Query: 210 IHRDIKASNILLDEQLNP----KISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHG 265
           +H+D+K  NIL  +  +P    KI DFGLA LF  ++   N    +GT  YMAPE     
Sbjct: 146 VHKDLKPENILFQDT-SPHSPIKIIDFGLAELFKSDEHSTNA---AGTALYMAPE-VFKR 200
Query: 266 YLSVKTDVFSYGVLVLEIVSG 286
            ++ K D++S GV++  +++G
Sbjct: 201 DVTFKCDIWSAGVVMYFLLTG 221

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 101/226 (44%), Gaps = 37/226 (16%)
Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKL 135
           +T+      + +L+ +G G +G V        G  +AVKKLS    S    +    E++L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 136 LLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSL 182
           L  ++H+N++ L               + P +SL+ F             + +  K   L
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 122
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                  ++  + RGL Y+H    A IIHRD+K SN+ ++E    KI D GLAR    E 
Sbjct: 123 TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEM 179
Query: 243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           T         T  Y APE  L+  + +   D++S G ++ E+++GR
Sbjct: 180 TGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 86  NFFSDLNQLGHGGFGPVYR------GLMPNGQEIAVKKLSVDSRQGL--REFTNEVKLLL 137
           +++    +LG G F  V +      GL    + I  K+ +  SR+G+   +   EV +L 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
           +IQH N++TL        + +L+ E +    L  F+ +K    SL        +  +  G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNG 126
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNP----KISDFGLARLFPGEDTHVNTFRISGT 253
           + YLH     +I H D+K  NI+L ++  P    KI DFGLA      +   N F   GT
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GT 180
Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
             ++APE   +  L ++ D++S GV+   ++SG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 98/204 (48%), Gaps = 22/204 (10%)
Query: 92  NQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLR------EFTNEVKLLLKIQHKNL 144
           + LG G FG V  G     G ++AVK L+   RQ +R      +   E++ L   +H ++
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILN---RQKIRSLDVVGKIKREIQNLKLFRHPHI 73
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L+   +   +  +V EY+    L  +I    K   ++     R+   +   + Y H  
Sbjct: 74  IKLYQVISTPTDFFMVMEYVSGGELFDYI---CKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
               ++HRD+K  N+LLD  +N KI+DFGL+ +    +   ++    G+  Y APE  + 
Sbjct: 131 M---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS---CGSPNYAAPE-VIS 183
Query: 265 G--YLSVKTDVFSYGVLVLEIVSG 286
           G  Y   + D++S GV++  ++ G
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCG 207

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 24/205 (11%)
Query: 92  NQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLR------EFTNEVKLLLKIQHKNL 144
           + LG G FG V  G     G ++AVK L+   RQ +R      +   E++ L   +H ++
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILN---RQKIRSLDVVGKIKREIQNLKLFRHPHI 73
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L+   +   +  +V EY+    L  +I    K   ++     R+   +   + Y H  
Sbjct: 74  IKLYQVISTPTDFFMVMEYVSGGELFDYI---CKHGRVEEMEARRLFQQILSAVDYCHRH 130
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFP-GEDTHVNTFRISGTHGYMAPEYAL 263
               ++HRD+K  N+LLD  +N KI+DFGL+ +   GE    +     G+  Y APE  +
Sbjct: 131 M---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS----CGSPNYAAPE-VI 182
Query: 264 HG--YLSVKTDVFSYGVLVLEIVSG 286
            G  Y   + D++S GV++  ++ G
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 91  LNQLGHGGFGPVYRGLMPN-GQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHKNLVTL 147
           L  +G G +G V         Q++AVKKLS    S    R    E++LL  ++H+N++ L
Sbjct: 25  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGL 84
Query: 148 FGCCAEGPEKMLVYE-YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
                         E YL    +   + +  K  +L       +V  + RGL Y+H    
Sbjct: 85  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS--- 141
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHG- 265
           A IIHRD+K SN+ ++E    +I DFGLAR    E T         T  Y APE  L+  
Sbjct: 142 AGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGY-----VATRWYRAPEIMLNWM 196
Query: 266 YLSVKTDVFSYGVLVLEIVSGR 287
           + +   D++S G ++ E++ G+
Sbjct: 197 HYNQTVDIWSVGCIMAELLQGK 218

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 7/162 (4%)
Query: 129 FTNEVKLLLKIQHKNLVTLFGCCAEGPEKML--VYEYLPNKSLDYFIFDKTKSSS-LDWT 185
             +EV LL +++H N+V  +    +     L  V EY     L   I   TK    LD  
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 186 TRYRIVMGVARGLLYLHEEAPA--RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243
              R++  +   L   H  +     ++HRD+K +N+ LD + N K+ DFGLAR+   + +
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 171
Query: 244 HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
               F   GT  YM+PE       + K+D++S G L+ E+ +
Sbjct: 172 FAKAF--VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 114/259 (44%), Gaps = 41/259 (15%)
Query: 56  AAGESAEDADGSGADSWNLFF-------DLRTLQVATNFFSDLNQ---LGHGGFGPVYRG 105
           A  +   DA   G +  NL+F       +L     A  F+   +    +G G    V R 
Sbjct: 56  AEAKKLNDAQPKGTE--NLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRC 113
Query: 106 L-MPNGQEIAVK-------KLSVDSRQGLREFTN-EVKLLLKIQ-HKNLVTLFGCCAEGP 155
           +    G E AVK       +LS +  + +RE T  E  +L ++  H +++TL        
Sbjct: 114 VHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173
Query: 156 EKMLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDI 214
              LV++ +    L DY     T+  +L       I+  +   + +LH      I+HRD+
Sbjct: 174 FMFLVFDLMRKGELFDYL----TEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDL 226
Query: 215 KASNILLDEQLNPKISDFGLA-RLFPGEDTHVNTFRISGTHGYMAPEY------ALHGYL 267
           K  NILLD+ +  ++SDFG +  L PGE        + GT GY+APE         H   
Sbjct: 227 KPENILLDDNMQIRLSDFGFSCHLEPGEKLR----ELCGTPGYLAPEILKCSMDETHPGY 282
Query: 268 SVKTDVFSYGVLVLEIVSG 286
             + D+++ GV++  +++G
Sbjct: 283 GKEVDLWACGVILFTLLAG 301

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/92 (43%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           VARG+ +L   +  + IHRD+ A NILL E    KI DFGLAR       +V        
Sbjct: 208 VARGMEFL---SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
             +MAPE       S K+DV+SYGVL+ EI S
Sbjct: 265 LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 86  NFFSDLNQLGHGGFGPVYR------GLMPNGQEIAVKKLSVDSRQGL--REFTNEVKLLL 137
           +++    +LG G F  V +      GL    + I  K+ +  SR+G+   +   EV +L 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
           +IQH N++TL        + +L+ E +    L  F+ +K    SL        +  +  G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNG 126
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNP----KISDFGLARLFPGEDTHVNTFRISGT 253
           + YLH     +I H D+K  NI+L ++  P    KI DFGLA      +   N F   GT
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GT 180
Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
             ++APE   +  L ++ D++S GV+   ++SG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 100/227 (44%), Gaps = 19/227 (8%)
Query: 65  DGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSR 123
           +G  + SW      +  +     F     LG G F  V        G+  AVK +   + 
Sbjct: 6   NGESSSSWK-----KQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKAL 60
Query: 124 QGLRE-FTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSL 182
           +G      NE+ +L KI+H+N+V L           LV + +    L   I +K   +  
Sbjct: 61  KGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEK 120
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL---DEQLNPKISDFGLARLFP 239
           D +T  R V+     + YLH      I+HRD+K  N+L    DE+    ISDFGL+++  
Sbjct: 121 DASTLIRQVLD---AVYYLHRMG---IVHRDLKPENLLYYSQDEESKIMISDFGLSKM-E 173
Query: 240 GEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
           G+   ++T    GT GY+APE       S   D +S GV+   ++ G
Sbjct: 174 GKGDVMST--ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 77/162 (47%), Gaps = 7/162 (4%)
Query: 129 FTNEVKLLLKIQHKNLVTLFGCCAEGPEKML--VYEYLPNKSLDYFIFDKTKSSS-LDWT 185
             +EV LL +++H N+V  +    +     L  V EY     L   I   TK    LD  
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111
Query: 186 TRYRIVMGVARGLLYLHEEAPA--RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243
              R++  +   L   H  +     ++HRD+K +N+ LD + N K+ DFGLAR+   ++ 
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED 171
Query: 244 HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
               F   GT  YM+PE       + K+D++S G L+ E+ +
Sbjct: 172 FAKEF--VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 94/192 (48%), Gaps = 25/192 (13%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFT--NEVKLLLKIQHKNL 144
           +  L ++G G FG V++      GQ++A+KK+ +++ +     T   E+K+L  ++H+N+
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS----------SLDWTTRYRIVMGV 194
           V L   C     +     Y   K+  Y +FD  +                +   R++  +
Sbjct: 80  VNLIEIC-----RTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 134
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP-GEDTHVNTF--RIS 251
             GL Y+H     +I+HRD+KA+N+L+      K++DFGLAR F   +++  N +  R+ 
Sbjct: 135 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 252 GTHGYMAPEYAL 263
            T  Y  PE  L
Sbjct: 192 -TLWYRPPELLL 202

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 86  NFFSDLNQLGHGGFGPVYR------GLMPNGQEIAVKKLSVDSRQGL--REFTNEVKLLL 137
           +++    +LG G F  V +      GL    + I  K+ +  SR+G+   +   EV +L 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
           +IQH N++TL        + +L+ E +    L  F+ +K    SL        +  +  G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNG 126
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNP----KISDFGLARLFPGEDTHVNTFRISGT 253
           + YLH     +I H D+K  NI+L ++  P    KI DFGLA      +   N F   GT
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GT 180
Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
             ++APE   +  L ++ D++S GV+   ++SG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 104/235 (44%), Gaps = 23/235 (9%)
Query: 60  SAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQE---IAVK 116
           +A  A G+ +   + + D       ++FF   ++LG G    VYR      Q+   + V 
Sbjct: 27  TASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVL 86
Query: 117 KLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDK 176
           K +VD +        E+ +LL++ H N++ L        E  LV E +    L   I +K
Sbjct: 87  KKTVDKKI----VRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEK 142
Query: 177 TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL-----DEQLNPKISD 231
              S  D     + ++     + YLHE     I+HRD+K  N+L      D  L  KI+D
Sbjct: 143 GYYSERDAADAVKQIL---EAVAYLHENG---IVHRDLKPENLLYATPAPDAPL--KIAD 194
Query: 232 FGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
           FGL+++    +  V    + GT GY APE         + D++S G++   ++ G
Sbjct: 195 FGLSKIV---EHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 86  NFFSDLNQLGHGGFGPVYR------GLMPNGQEIAVKKLSVDSRQGL--REFTNEVKLLL 137
           +++    +LG G F  V +      GL    + I  K+ +  SR+G+   +   EV +L 
Sbjct: 11  DYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
           +IQH N++TL        + +L+ E +    L  F+ +K    SL        +  +  G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNG 126
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNP----KISDFGLARLFPGEDTHVNTFRISGT 253
           + YLH     +I H D+K  NI+L ++  P    KI DFGLA      +   N F   GT
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GT 180
Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
             ++APE   +  L ++ D++S GV+   ++SG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 107/244 (43%), Gaps = 14/244 (5%)
Query: 64  ADGSGADSWNLFFDLRTLQ---VATNFFSDLNQLGHGGFGPVYR-GLMPNGQEIAVKKLS 119
           AD   +  +N F   + L+   V  N F     LG GGFG V    +   G+  A KKL 
Sbjct: 159 ADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLE 218
Query: 120 VDSRQ---GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDK 176
               +   G     NE ++L K+  + +V+L           LV   +    L + I+  
Sbjct: 219 KKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM 278
Query: 177 TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
            ++   +    +     +  GL  LH E   RI++RD+K  NILLD+  + +ISD GLA 
Sbjct: 279 GQAGFPEARAVF-YAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAV 334
Query: 237 LFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGK 296
             P   T        GT GYMAPE   +   +   D ++ G L+ E+++G+     R  K
Sbjct: 335 HVPEGQTIKGRV---GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 391
Query: 297 EKAD 300
            K +
Sbjct: 392 IKRE 395

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 19/210 (9%)
Query: 94  LGHGGFGPVY--RGLMPNGQEIAVKKLSVDSRQG----LREFTNEVKLLLKIQHKNLVTL 147
           LG GG   V+  R L  + +++AVK L  D  +     LR F  E +    + H  +V +
Sbjct: 20  LGFGGMSEVHLARDLRLH-RDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVAV 77
Query: 148 FGC----CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           +         GP   +V EY+   +L   +  +     +       ++    + L + H+
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQ 134
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN-TFRISGTHGYMAPEYA 262
                IIHRD+K +NI++      K+ DFG+AR        V  T  + GT  Y++PE A
Sbjct: 135 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
               +  ++DV+S G ++ E+++G     G
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 107/244 (43%), Gaps = 14/244 (5%)
Query: 64  ADGSGADSWNLFFDLRTLQ---VATNFFSDLNQLGHGGFGPVYR-GLMPNGQEIAVKKLS 119
           AD   +  +N F   + L+   V  N F     LG GGFG V    +   G+  A KKL 
Sbjct: 159 ADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLE 218
Query: 120 VDSRQ---GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDK 176
               +   G     NE ++L K+  + +V+L           LV   +    L + I+  
Sbjct: 219 KKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM 278
Query: 177 TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
            ++   +    +     +  GL  LH E   RI++RD+K  NILLD+  + +ISD GLA 
Sbjct: 279 GQAGFPEARAVF-YAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAV 334
Query: 237 LFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGK 296
             P   T        GT GYMAPE   +   +   D ++ G L+ E+++G+     R  K
Sbjct: 335 HVPEGQTIKGRV---GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 391
Query: 297 EKAD 300
            K +
Sbjct: 392 IKRE 395

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 91  LNQLGHGGFGPVYRGLMPN-GQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHKNLVTL 147
           L  +G G +G V         Q++AVKKLS    S    R    E++LL  ++H+N++ L
Sbjct: 33  LRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGL 92
Query: 148 FGCCAEGPEKMLVYE-YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
                         E YL    +   + +  K  +L       +V  + RGL Y+H    
Sbjct: 93  LDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHS--- 149
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHG- 265
           A IIHRD+K SN+ ++E    +I DFGLAR    E T         T  Y APE  L+  
Sbjct: 150 AGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGY-----VATRWYRAPEIMLNWM 204
Query: 266 YLSVKTDVFSYGVLVLEIVSGR 287
           + +   D++S G ++ E++ G+
Sbjct: 205 HYNQTVDIWSVGCIMAELLQGK 226

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 86  NFFSDLNQLGHGGFGPVYR------GLMPNGQEIAVKKLSVDSRQGL--REFTNEVKLLL 137
           +++    +LG G F  V +      GL    + I  K+ +  SR+G+   +   EV +L 
Sbjct: 11  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIK-KRRTKSSRRGVSREDIEREVSILK 69
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
           +IQH N++TL        + +L+ E +    L  F+ +K    SL        +  +  G
Sbjct: 70  EIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEK---ESLTEEEATEFLKQILNG 126
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPK----ISDFGLARLFPGEDTHVNTFRISGT 253
           + YLH     +I H D+K  NI+L ++  PK    I DFGLA      +   N F   GT
Sbjct: 127 VYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GT 180
Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
             ++APE   +  L ++ D++S GV+   ++SG
Sbjct: 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 81/164 (49%), Gaps = 21/164 (12%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFT--NEVKLLLKIQHKNL 144
           +  L ++G G FG V++      GQ++A+KK+ +++ +     T   E+K+L  ++H+N+
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS----------SLDWTTRYRIVMGV 194
           V L   C     +     Y   K   Y +FD  +                +   R++  +
Sbjct: 80  VNLIEIC-----RTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 134
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238
             GL Y+H     +I+HRD+KA+N+L+      K++DFGLAR F
Sbjct: 135 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF 175

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 19/210 (9%)
Query: 94  LGHGGFGPVY--RGLMPNGQEIAVKKLSVDSRQG----LREFTNEVKLLLKIQHKNLVTL 147
           LG GG   V+  R L  + +++AVK L  D  +     LR F  E +    + H  +V +
Sbjct: 37  LGFGGMSEVHLARDLRLH-RDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVAV 94
Query: 148 FGC----CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           +         GP   +V EY+   +L   +  +     +       ++    + L + H+
Sbjct: 95  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQ 151
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN-TFRISGTHGYMAPEYA 262
                IIHRD+K +NI++      K+ DFG+AR        V  T  + GT  Y++PE A
Sbjct: 152 NG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 208
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
               +  ++DV+S G ++ E+++G     G
Sbjct: 209 RGDSVDARSDVYSLGCVLYEVLTGEPPFTG 238

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 96/213 (45%), Gaps = 17/213 (7%)
Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLSVD---SRQGLREFTNEVKLLLKIQHKN 143
           F+ L  LG G FG V        +E+ A+K L  D       +     E ++L  +    
Sbjct: 21  FNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPP 80
Query: 144 LVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
            +T    C +  +++  V EY+    L Y I    +               ++ GL +LH
Sbjct: 81  FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI---QQVGKFKEPQAVFYAAEISIGLFFLH 137
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLAR--LFPGEDTHVNTFRISGTHGYMAPE 260
           +     II+RD+K  N++LD + + KI+DFG+ +  +  G    V T    GT  Y+APE
Sbjct: 138 KRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDG----VTTREFCGTPDYIAPE 190
Query: 261 YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
              +       D ++YGVL+ E+++G+   DG 
Sbjct: 191 IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE 223

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 93/192 (48%), Gaps = 25/192 (13%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFT--NEVKLLLKIQHKNL 144
           +  L ++G G FG V++      GQ++A+KK+ +++ +     T   E+K+L  ++H+N+
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS----------SLDWTTRYRIVMGV 194
           V L   C     +     Y   K   Y +FD  +                +   R++  +
Sbjct: 80  VNLIEIC-----RTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 134
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP-GEDTHVNTF--RIS 251
             GL Y+H     +I+HRD+KA+N+L+      K++DFGLAR F   +++  N +  R+ 
Sbjct: 135 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 252 GTHGYMAPEYAL 263
            T  Y  PE  L
Sbjct: 192 -TLWYRPPELLL 202

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 37/217 (17%)
Query: 88  FSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKL--SVDSRQGLREFTNEVKLLLKIQHKNL 144
           + DL  +G G +G V   +    G ++A+KKL     S    +    E++LL  ++H+N+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFI-------FDKT------KSSSLDWTTRYRIV 191
           + L               + P+++LD F        F  T      K   L       +V
Sbjct: 87  IGLLDV------------FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLV 134
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS 251
             + +GL Y+H    A IIHRD+K  N+ ++E    KI DFGLAR     D+ +    + 
Sbjct: 135 YQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMXGXVV- 187
Query: 252 GTHGYMAPEYALHGYLSVKT-DVFSYGVLVLEIVSGR 287
            T  Y APE  L+     +T D++S G ++ E+++G+
Sbjct: 188 -TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 81/164 (49%), Gaps = 21/164 (12%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFT--NEVKLLLKIQHKNL 144
           +  L ++G G FG V++      GQ++A+KK+ +++ +     T   E+K+L  ++H+N+
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 78
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS----------SLDWTTRYRIVMGV 194
           V L   C     +     Y   K   Y +FD  +                +   R++  +
Sbjct: 79  VNLIEIC-----RTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 133
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238
             GL Y+H     +I+HRD+KA+N+L+      K++DFGLAR F
Sbjct: 134 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF 174

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 16/222 (7%)
Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEI-------AVKKLSVDSRQGLREFTNEVKLLLKIQ 140
           F  L  LG G FG V+     +G +         +KK ++  R  +R    E  +L+++ 
Sbjct: 27  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVN 85
Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
           H  +V L        +  L+ ++L  +  D F    T+ S     T   +   +A   L 
Sbjct: 86  HPFIVKLHYAFQTEGKLYLILDFL--RGGDLF----TRLSKEVMFTEEDVKFYLAELALA 139
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE 260
           L       II+RD+K  NILLDE+ + K++DFGL++     D     +   GT  YMAPE
Sbjct: 140 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPE 197
Query: 261 YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLL 302
                  +   D +S+GVL+ E+++G     G+  KE   ++
Sbjct: 198 VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 239

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 16/222 (7%)
Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEI-------AVKKLSVDSRQGLREFTNEVKLLLKIQ 140
           F  L  LG G FG V+     +G +         +KK ++  R  +R    E  +L+++ 
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVN 84
Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
           H  +V L        +  L+ ++L  +  D F    T+ S     T   +   +A   L 
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFL--RGGDLF----TRLSKEVMFTEEDVKFYLAELALA 138
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE 260
           L       II+RD+K  NILLDE+ + K++DFGL++     D     +   GT  YMAPE
Sbjct: 139 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPE 196
Query: 261 YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLL 302
                  +   D +S+GVL+ E+++G     G+  KE   ++
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 238

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVK----KLSVDSRQGL--REFTNEVK 134
           Q   +F+    +LG G F  V +      G E A K    + S  SR+G+   E   EV 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGV 194
           +L ++ H N++TL        + +L+ E +    L  F+  K   S  + T+    +  +
Sbjct: 68  ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS---FIKQI 124
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNP----KISDFGLARLFPGEDTHVNTFRI 250
             G+ YLH     +I H D+K  NI+L ++  P    K+ DFGLA          N F  
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-- 179
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
            GT  ++APE   +  L ++ D++S GV+   ++SG
Sbjct: 180 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 16/222 (7%)
Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEI-------AVKKLSVDSRQGLREFTNEVKLLLKIQ 140
           F  L  LG G FG V+     +G +         +KK ++  R  +R    E  +L+++ 
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT-KMERDILVEVN 84
Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
           H  +V L        +  L+ ++L  +  D F    T+ S     T   +   +A   L 
Sbjct: 85  HPFIVKLHYAFQTEGKLYLILDFL--RGGDLF----TRLSKEVMFTEEDVKFYLAELALA 138
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE 260
           L       II+RD+K  NILLDE+ + K++DFGL++     D     +   GT  YMAPE
Sbjct: 139 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPE 196
Query: 261 YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLL 302
                  +   D +S+GVL+ E+++G     G+  KE   ++
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 238

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 103/227 (45%), Gaps = 16/227 (7%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNG--------QEIAVKKLSVDSRQGLREFTNEV 133
           ++    F  L  LG GG+G V++     G         ++  K + V + +       E 
Sbjct: 13  KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAER 72
Query: 134 KLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG 193
            +L +++H  +V L      G +  L+ EYL    L +   ++      D    Y   + 
Sbjct: 73  NILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL-FMQLEREGIFMEDTACFYLAEIS 131
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           +A G  +LH++    II+RD+K  NI+L+ Q + K++DFGL +    + T  + F   GT
Sbjct: 132 MALG--HLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXF--CGT 184
Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKAD 300
             YMAPE  +    +   D +S G L+ ++++G     G   K+  D
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID 231

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 24/233 (10%)
Query: 67  SGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYR-GLMPNGQEIAVKKLSVDSRQG 125
           SG  +  L    +  Q   N   +L ++G G  G V++      G  IAVK++    R G
Sbjct: 6   SGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR---RSG 62
Query: 126 LREFTNEVKLLLKIQHKN-----LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS 180
            +E    + + L +  K+     +V  FG      +  +  E +   +       K    
Sbjct: 63  NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEK---LKKRMQG 119
Query: 181 SLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA-RLFP 239
            +      ++ + + + L YL E+    +IHRD+K SNILLDE+   K+ DFG++ RL  
Sbjct: 120 PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLV- 176
Query: 240 GEDTHVNTFRISGTHGYMAPEY-----ALHGYLSVKTDVFSYGVLVLEIVSGR 287
            +D   +  R +G   YMAPE             ++ DV+S G+ ++E+ +G+
Sbjct: 177 -DDKAKD--RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 103/234 (44%), Gaps = 38/234 (16%)
Query: 80  TLQVATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLK 138
           +L+ A++F  ++  LG G FG V +     + +  A+KK+   + + L    +EV LL  
Sbjct: 1   SLRYASDF-EEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLAS 58
Query: 139 IQHKNLVTLFGCCAE-------------GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWT 185
           + H+ +V  +    E                  +  EY  N +L   I  +  +   D  
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD-- 116
Query: 186 TRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR--------- 236
             +R+   +   L Y+H +    IIHRD+K  NI +DE  N KI DFGLA+         
Sbjct: 117 EYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 237 -----LFPGEDTHVNTFRISGTHGYMAPEYAL-HGYLSVKTDVFSYGVLVLEIV 284
                  PG   ++ +    GT  Y+A E     G+ + K D++S G++  E++
Sbjct: 174 KLDSQNLPGSSDNLTS--AIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 103/231 (44%), Gaps = 30/231 (12%)
Query: 67  SGAD--SWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIA-----VKKL 118
           SG D  + NL+F         + +    +LG G F  V R + +  GQE A      KKL
Sbjct: 9   SGVDLGTENLYFQ--------SMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKL 60
Query: 119 SVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTK 178
           S    Q L     E ++   ++H N+V L    +E     L+++ +    L   I  +  
Sbjct: 61  SARDHQKLE---REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY 117
Query: 179 SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN---PKISDFGLA 235
            S  D +     +  +   +L+ H+     ++HRD+K  N+LL  +L     K++DFGLA
Sbjct: 118 YSEADAS---HCIQQILEAVLHCHQMG---VVHRDLKPENLLLASKLKGAAVKLADFGLA 171
Query: 236 RLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
               GE      F  +GT GY++PE           D+++ GV++  ++ G
Sbjct: 172 IEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVK----KLSVDSRQGL--REFTNEVK 134
           Q   +F+    +LG G F  V +      G E A K    + S  SR+G+   E   EV 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGV 194
           +L ++ H N++TL        + +L+ E +    L  F+  K   S  + T+    +  +
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS---FIKQI 124
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNP----KISDFGLARLFPGEDTHVNTFRI 250
             G+ YLH     +I H D+K  NI+L ++  P    K+ DFGLA          N F  
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-- 179
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
            GT  ++APE   +  L ++ D++S GV+   ++SG
Sbjct: 180 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 99/226 (43%), Gaps = 20/226 (8%)
Query: 94  LGHGGFGPVYRGLMPNGQ----EIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTL 147
           LG G FG V    +        ++AVK L  D  +   + EF  E   + +  H ++  L
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 148 FGCC----AEG--PEKMLVYEYLPNKSLDYFIFDK---TKSSSLDWTTRYRIVMGVARGL 198
            G      A+G  P  M++  ++ +  L  F+          +L   T  R ++ +A G+
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMA 258
            YL        IHRD+ A N +L E +   ++DFGL+R     D +           ++A
Sbjct: 151 EYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLA 207
Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSY 304
            E       +V +DV+++GV + EI++  +      G E A++ +Y
Sbjct: 208 LESLADNLYTVHSDVWAFGVTMWEIMT--RGQTPYAGIENAEIYNY 251

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 18/209 (8%)
Query: 92  NQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHKNLVTLF 148
             +G G +G V   +   +G+++A+KKLS    S    +    E+ LL  +QH+N++ L 
Sbjct: 48  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 107
Query: 149 GCCAEGPEKMLVYEY---LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
                       Y++   +P    D     K             +V  + +GL Y+H   
Sbjct: 108 DVFTPASSLRNFYDFYLVMPFMQTD---LQKIMGMEFSEEKIQYLVYQMLKGLKYIHS-- 162
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHG 265
            A ++HRD+K  N+ ++E    KI DFGLAR     D  +  + +  T  Y APE  L  
Sbjct: 163 -AGVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVV--TRWYRAPEVILSW 216
Query: 266 -YLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
            + +   D++S G ++ E+++G+    G+
Sbjct: 217 MHYNQTVDIWSVGCIMAEMLTGKTLFKGK 245

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 98/222 (44%), Gaps = 29/222 (13%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLV 145
           F  +  LG GGFG V+      +    A+K++ + +R+  RE    EVK L K++H  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 146 TLFGCCAEG-------PEKMLVYEYLP-----NKSLDYFIFDKTKSSSLDWTTRYRIVMG 193
             F    E        P    VY Y+       ++L  ++  +      + +    I + 
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR-----------LFPGED 242
           +A  + +LH +    ++HRD+K SNI        K+ DFGL             L P   
Sbjct: 127 IAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 243 THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIV 284
              +T ++ GT  YM+PE       S K D+FS G+++ E++
Sbjct: 184 YARHTGQV-GTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVK----KLSVDSRQGL--REFTNEVK 134
           Q   +F+    +LG G F  V +      G E A K    + S  SR+G+   E   EV 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGV 194
           +L ++ H N++TL        + +L+ E +    L  F+  K   S  + T+    +  +
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS---FIKQI 124
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNP----KISDFGLARLFPGEDTHVNTFRI 250
             G+ YLH     +I H D+K  NI+L ++  P    K+ DFGLA          N F  
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-- 179
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
            GT  ++APE   +  L ++ D++S GV+   ++SG
Sbjct: 180 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 107/227 (47%), Gaps = 42/227 (18%)
Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVKKL------SVDSRQGLREFTNEVKLLLKIQ-HK 142
           + +LG G +G V++ +    G+ +AVKK+      S D+++  RE    + +L ++  H+
Sbjct: 14  VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFRE----IMILTELSGHE 69
Query: 143 NLVTLFGCCAEGPEK--MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
           N+V L        ++   LV++Y+        +    +++ L+   +  +V  + + + Y
Sbjct: 70  NIVNLLNVLRADNDRDVYLVFDYMETD-----LHAVIRANILEPVHKQYVVYQLIKVIKY 124
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS--------- 251
           LH      ++HRD+K SNILL+ + + K++DFGL+R F       N   +S         
Sbjct: 125 LHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 252 ----------GTHGYMAPEYALHGYLSVK-TDVFSYGVLVLEIVSGR 287
                      T  Y APE  L      K  D++S G ++ EI+ G+
Sbjct: 182 DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 103/234 (44%), Gaps = 38/234 (16%)
Query: 80  TLQVATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLK 138
           +L+ A++F  ++  LG G FG V +     + +  A+KK+   + + L    +EV LL  
Sbjct: 1   SLRYASDF-EEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVXLLAS 58
Query: 139 IQHKNLVTLFGCCAE-----GPEK--------MLVYEYLPNKSLDYFIFDKTKSSSLDWT 185
           + H+ +V  +    E      P           +  EY  N++L   I  +  +   D  
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRD-- 116
Query: 186 TRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR--------- 236
             +R+   +   L Y+H +    IIHR++K  NI +DE  N KI DFGLA+         
Sbjct: 117 EYWRLFRQILEALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 237 -----LFPGEDTHVNTFRISGTHGYMAPEYAL-HGYLSVKTDVFSYGVLVLEIV 284
                  PG   ++ +    GT  Y+A E     G+ + K D +S G++  E +
Sbjct: 174 KLDSQNLPGSSDNLTS--AIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 104/231 (45%), Gaps = 27/231 (11%)
Query: 82  QVATNFFSDL---NQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQ--GLREFTNEVKL 135
           ++  N  SD    + LG G +G V      P G+ +A+KK+    +    LR    E+K+
Sbjct: 4   RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKI 62
Query: 136 LLKIQHKNLVTLFGC----CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIV 191
           L   +H+N++T+F        E   ++ + + L    L   I   T+  S D    +  +
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI--STQMLSDDHIQYF--I 118
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF--PGEDTHVNTFR 249
               R +  LH    + +IHRD+K SN+L++   + K+ DFGLAR+      D    T +
Sbjct: 119 YQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 250 ISG------THGYMAPEYAL-HGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
            SG      T  Y APE  L     S   DV+S G ++ E+   R    GR
Sbjct: 176 QSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR 226

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 92  NQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHKNLVTLF 148
             +G G +G V   +   +G+++A+KKLS    S    +    E+ LL  +QH+N++ L 
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTR--YRIVMGVARGLLYLHEEAP 206
                       Y++     + +   D  K   L ++      +V  + +GL Y+H    
Sbjct: 90  DVFTPASSLRNFYDFY--LVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHS--- 144
Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHG- 265
           A ++HRD+K  N+ ++E    KI DFGLAR     D  +  + +  T  Y APE  L   
Sbjct: 145 AGVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVV--TRWYRAPEVILSWM 199
Query: 266 YLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           + +   D++S G ++ E+++G+    G+
Sbjct: 200 HYNQTVDIWSVGCIMAEMLTGKTLFKGK 227

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVK----KLSVDSRQGL--REFTNEVK 134
           Q   +F+    +LG G F  V +      G E A K    + S  SR+G+   E   EV 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGV 194
           +L ++ H N++TL        + +L+ E +    L  F+  K   S  + T+    +  +
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS---FIKQI 124
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNP----KISDFGLARLFPGEDTHVNTFRI 250
             G+ YLH     +I H D+K  NI+L ++  P    K+ DFGLA          N F  
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-- 179
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
            GT  ++APE   +  L ++ D++S GV+   ++SG
Sbjct: 180 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 104/231 (45%), Gaps = 27/231 (11%)
Query: 82  QVATNFFSDL---NQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQ--GLREFTNEVKL 135
           ++  N  SD    + LG G +G V      P G+ +A+KK+    +    LR    E+K+
Sbjct: 4   RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKI 62
Query: 136 LLKIQHKNLVTLFGC----CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIV 191
           L   +H+N++T+F        E   ++ + + L    L   I   T+  S D    +  +
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI--STQMLSDDHIQYF--I 118
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF--PGEDTHVNTFR 249
               R +  LH    + +IHRD+K SN+L++   + K+ DFGLAR+      D    T +
Sbjct: 119 YQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 250 ISG------THGYMAPEYAL-HGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
            SG      T  Y APE  L     S   DV+S G ++ E+   R    GR
Sbjct: 176 QSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR 226

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 104/231 (45%), Gaps = 27/231 (11%)
Query: 82  QVATNFFSDL---NQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQ--GLREFTNEVKL 135
           ++  N  SD    + LG G +G V      P G+ +A+KK+    +    LR    E+K+
Sbjct: 4   RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKI 62
Query: 136 LLKIQHKNLVTLFGC----CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIV 191
           L   +H+N++T+F        E   ++ + + L    L   I   T+  S D    +  +
Sbjct: 63  LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI--STQMLSDDHIQYF--I 118
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF--PGEDTHVNTFR 249
               R +  LH    + +IHRD+K SN+L++   + K+ DFGLAR+      D    T +
Sbjct: 119 YQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 250 ISG------THGYMAPEYAL-HGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
            SG      T  Y APE  L     S   DV+S G ++ E+   R    GR
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGR 226

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVK----KLSVDSRQGL--REFTNEVK 134
           Q   +F+    +LG G F  V +      G E A K    + S  SR+G+   E   EV 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGV 194
           +L ++ H N++TL        + +L+ E +    L  F+  K   S  + T+    +  +
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS---FIKQI 124
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNP----KISDFGLARLFPGEDTHVNTFRI 250
             G+ YLH     +I H D+K  NI+L ++  P    K+ DFGLA          N F  
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-- 179
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
            GT  ++APE   +  L ++ D++S GV+   ++SG
Sbjct: 180 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 100/216 (46%), Gaps = 20/216 (9%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVK----KLSVDSRQGL--REFTNEVK 134
           Q   +F+    +LG G F  V +      G E A K    + S  SR+G+   E   EV 
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGV 194
           +L ++ H N++TL        + +L+ E +    L  F+  K   S  + T+    +  +
Sbjct: 68  ILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS---FIKQI 124
Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNP----KISDFGLARLFPGEDTHVNTFRI 250
             G+ YLH     +I H D+K  NI+L ++  P    K+ DFGLA          N F  
Sbjct: 125 LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF-- 179
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
            GT  ++APE   +  L ++ D++S GV+   ++SG
Sbjct: 180 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 35/213 (16%)
Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSV-DSRQGLREFTNEVKLLLKIQHKNLVTLFGC-- 150
           +G G FG V+RG    G+E+AVK  S  + R   RE   E+   + ++H+N++       
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADN 68
Query: 151 --CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE---- 204
                  +  LV +Y  + SL    FD     ++      ++ +  A GL +LH E    
Sbjct: 69  KDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 124
Query: 205 --APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS-----GTHGYM 257
              PA I HRD+K+ NIL+ +     I+D GLA      D+  +T  I+     GT  YM
Sbjct: 125 QGKPA-IAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYM 180
Query: 258 APEYALHGYLSVK-------TDVFSYGVLVLEI 283
           APE  L   +++K        D+++ G++  EI
Sbjct: 181 APE-VLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 30/222 (13%)
Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTN-EVKLLLKIQHKNLVT 146
           +++   +G+G FG V++  +    E+A+KK+  D R     F N E++++  ++H N+V 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVD 96
Query: 147 LFGCCAEGPEKM------LVYEYLPNK----SLDYFIFDKTKSSSLDWTTRYRIVMGVAR 196
           L        +K       LV EY+P      S  Y    +T    L     Y+++    R
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLL----R 152
Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNP-KISDFGLARLFPGEDTHVNTFRISGTHG 255
            L Y+H      I HRDIK  N+LLD      K+ DFG A++    + +V+      +  
Sbjct: 153 SLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXI---CSRY 206
Query: 256 YMAPE--YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLG 295
           Y APE  +    Y +   D++S G ++ E++ G+    G  G
Sbjct: 207 YRAPELIFGATNY-TTNIDIWSTGCVMAELMQGQPLFPGESG 247

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 111/249 (44%), Gaps = 26/249 (10%)
Query: 88  FSDLNQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           + DL  LG GG G V+  +  +  + +A+KK+ +   Q ++    E+K++ ++ H N+V 
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 147 LF--------------GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVM 192
           +F              G   E     +V EY+     +       +   L+   R   + 
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVL----EQGPLLEEHARL-FMY 127
Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRIS 251
            + RGL Y+H    A ++HRD+K +N+ ++ E L  KI DFGLAR+     +H       
Sbjct: 128 QLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184
Query: 252 -GTHGYMAPEYALHGYLSVKT-DVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLF 309
             T  Y +P   L      K  D+++ G +  E+++G+    G    E+  L+  +  + 
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244
Query: 310 QGEKALELV 318
             E   EL+
Sbjct: 245 HEEDRQELL 253

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 35/213 (16%)
Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSV-DSRQGLREFTNEVKLLLKIQHKNLVTLFGC-- 150
           +G G FG V+RG    G+E+AVK  S  + R   RE   E+   + ++H+N++       
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADN 73
Query: 151 --CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE---- 204
                  +  LV +Y  + SL    FD     ++      ++ +  A GL +LH E    
Sbjct: 74  KDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 129
Query: 205 --APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS-----GTHGYM 257
              PA I HRD+K+ NIL+ +     I+D GLA      D+  +T  I+     GT  YM
Sbjct: 130 QGKPA-IAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYM 185
Query: 258 APEYALHGYLSVK-------TDVFSYGVLVLEI 283
           APE  L   +++K        D+++ G++  EI
Sbjct: 186 APE-VLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           VA+G+ +L   A  + IHRD+ A NILL E+   KI DFGLAR    +  +V        
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
             +MAPE       ++++DV+S+GVL+ EI S
Sbjct: 266 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           VA+G+ +L   A  + IHRD+ A NILL E+   KI DFGLAR    +  +V        
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
             +MAPE       ++++DV+S+GVL+ EI S
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 16/210 (7%)
Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLRE-FTNEVKLLLKIQHKNLVTLFG 149
           LG GGF   +     + +E+   K+   S   +   RE  + E+ +   + H+++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
              +     +V E    +SL      K + +  +   RY +   +  G  YLH     R+
Sbjct: 107 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARYYL-RQIVLGCQYLHRN---RV 160
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARL--FPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
           IHRD+K  N+ L+E L  KI DFGLA    + GE   V    + GT  Y+APE       
Sbjct: 161 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV----LCGTPNYIAPEVLSKKGH 216
Query: 268 SVKTDVFSYGVLVLEIVSGRKNHDGRLGKE 297
           S + DV+S G ++  ++ G+   +    KE
Sbjct: 217 SFEVDVWSIGCIMYTLLVGKPPFETSCLKE 246

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           VA+G+ +L   A  + IHRD+ A NILL E+   KI DFGLAR    +  +V        
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
             +MAPE       ++++DV+S+GVL+ EI S
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 16/210 (7%)
Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLRE-FTNEVKLLLKIQHKNLVTLFG 149
           LG GGF   +     + +E+   K+   S   +   RE  + E+ +   + H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
              +     +V E    +SL      K + +  +   RY +   +  G  YLH     R+
Sbjct: 83  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARYYL-RQIVLGCQYLHRN---RV 136
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARL--FPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
           IHRD+K  N+ L+E L  KI DFGLA    + GE   V    + GT  Y+APE       
Sbjct: 137 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV----LCGTPNYIAPEVLSKKGH 192
Query: 268 SVKTDVFSYGVLVLEIVSGRKNHDGRLGKE 297
           S + DV+S G ++  ++ G+   +    KE
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPPFETSCLKE 222

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 16/210 (7%)
Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLRE-FTNEVKLLLKIQHKNLVTLFG 149
           LG GGF   +     + +E+   K+   S   +   RE  + E+ +   + H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
              +     +V E    +SL      K + +  +   RY +   +  G  YLH     R+
Sbjct: 109 FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARYYL-RQIVLGCQYLHRN---RV 162
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARL--FPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
           IHRD+K  N+ L+E L  KI DFGLA    + GE   V    + GT  Y+APE       
Sbjct: 163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV----LCGTPNYIAPEVLSKKGH 218
Query: 268 SVKTDVFSYGVLVLEIVSGRKNHDGRLGKE 297
           S + DV+S G ++  ++ G+   +    KE
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPPFETSCLKE 248

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 35/213 (16%)
Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSV-DSRQGLREFTNEVKLLLKIQHKNLVTLFGC-- 150
           +G G FG V+RG    G+E+AVK  S  + R   RE   E+   + ++H+N++       
Sbjct: 37  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADN 93
Query: 151 --CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE---- 204
                  +  LV +Y  + SL    FD     ++      ++ +  A GL +LH E    
Sbjct: 94  KDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 149
Query: 205 --APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS-----GTHGYM 257
              PA I HRD+K+ NIL+ +     I+D GLA      D+  +T  I+     GT  YM
Sbjct: 150 QGKPA-IAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYM 205
Query: 258 APEYALHGYLSVK-------TDVFSYGVLVLEI 283
           APE  L   +++K        D+++ G++  EI
Sbjct: 206 APE-VLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 37/92 (40%), Positives = 53/92 (57%), Gaps = 3/92 (3%)
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           VA+G+ +L   A  + IHRD+ A NILL E+   KI DFGLAR    +  +V        
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
             +MAPE       ++++DV+S+GVL+ EI S
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 35/213 (16%)
Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSV-DSRQGLREFTNEVKLLLKIQHKNLVTLFGC-- 150
           +G G FG V+RG    G+E+AVK  S  + R   RE   E+   + ++H+N++       
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADN 70
Query: 151 --CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE---- 204
                  +  LV +Y  + SL    FD     ++      ++ +  A GL +LH E    
Sbjct: 71  KDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 126
Query: 205 --APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS-----GTHGYM 257
              PA I HRD+K+ NIL+ +     I+D GLA      D+  +T  I+     GT  YM
Sbjct: 127 QGKPA-IAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYM 182
Query: 258 APEYALHGYLSVK-------TDVFSYGVLVLEI 283
           APE  L   +++K        D+++ G++  EI
Sbjct: 183 APE-VLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 92/203 (45%), Gaps = 24/203 (11%)
Query: 93  QLGHGGFGPVYRGLMPNGQ---EIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
           +LG G FG V+R  M + Q   + AVKK+ ++  +       E+     +    +V L+G
Sbjct: 81  RLGRGSFGEVHR--MEDKQTGFQCAVKKVRLEVFR-----AEELMACAGLTSPRIVPLYG 133
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVA-RGLLYLHEEAPAR 208
              EGP   +  E L   SL   +    K        R    +G A  GL YLH     R
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLV----KEQGCLPEDRALYYLGQALEGLEYLHSR---R 186
Query: 209 IIHRDIKASNILLD-EQLNPKISDFGLARLFP----GEDTHVNTFRISGTHGYMAPEYAL 263
           I+H D+KA N+LL  +  +  + DFG A        G+D     + I GT  +MAPE  L
Sbjct: 187 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDY-IPGTETHMAPEVVL 245
Query: 264 HGYLSVKTDVFSYGVLVLEIVSG 286
                 K DV+S   ++L +++G
Sbjct: 246 GRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 35/213 (16%)
Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSV-DSRQGLREFTNEVKLLLKIQHKNLVTLFGC-- 150
           +G G FG V+RG    G+E+AVK  S  + R   RE   E+   + ++H+N++       
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADN 67
Query: 151 --CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE---- 204
                  +  LV +Y  + SL    FD     ++      ++ +  A GL +LH E    
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 205 --APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS-----GTHGYM 257
              PA I HRD+K+ NIL+ +     I+D GLA      D+  +T  I+     GT  YM
Sbjct: 124 QGKPA-IAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYM 179
Query: 258 APEYALHGYLSVK-------TDVFSYGVLVLEI 283
           APE  L   +++K        D+++ G++  EI
Sbjct: 180 APE-VLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 35/213 (16%)
Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSV-DSRQGLREFTNEVKLLLKIQHKNLVTLFGC-- 150
           +G G FG V+RG    G+E+AVK  S  + R   RE   E+   + ++H+N++       
Sbjct: 50  IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIAADN 106
Query: 151 --CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE---- 204
                  +  LV +Y  + SL    FD     ++      ++ +  A GL +LH E    
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 205 --APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS-----GTHGYM 257
              PA I HRD+K+ NIL+ +     I+D GLA      D+  +T  I+     GT  YM
Sbjct: 163 QGKPA-IAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYM 218
Query: 258 APEYALHGYLSVK-------TDVFSYGVLVLEI 283
           APE  L   +++K        D+++ G++  EI
Sbjct: 219 APE-VLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 87/204 (42%), Gaps = 17/204 (8%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V     M  G   A+K L       L+E     NE ++L  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF 102
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARGLLYLH 202
           LV L     +     +V EY P   +    F   +          R     +     YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
                 +I+RD+K  N+++D+Q   K++DFGLA+   G      T+ + GT  Y+APE  
Sbjct: 159 S---LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKG-----RTWXLCGTPEYLAPEII 210
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
           L    +   D ++ GVL+ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 29/210 (13%)
Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSV-DSRQGLREFTNEVKLLLKIQHKNLVTLFGCCA 152
           +G G +G V+RGL  +G+ +AVK  S  D +   RE   E+   + ++H N++       
Sbjct: 16  VGKGRYGEVWRGLW-HGESVAVKIFSSRDEQSWFRE--TEIYNTVLLRHDNILGFIASDM 72
Query: 153 ----EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE---- 204
                  +  L+  Y  + SL    +D  +  +L+     R+ +  A GL +LH E    
Sbjct: 73  TSRNSSTQLWLITHYHEHGSL----YDFLQRQTLEPHLALRLAVSAACGLAHLHVEIFGT 128
Query: 205 --APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV---NTFRISGTHGYMAP 259
              PA I HRD K+ N+L+   L   I+D GLA +      ++   N  R+ GT  YMAP
Sbjct: 129 QGKPA-IAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV-GTKRYMAP 186
Query: 260 EY-----ALHGYLSVK-TDVFSYGVLVLEI 283
           E          + S K TD++++G+++ EI
Sbjct: 187 EVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 130/291 (44%), Gaps = 37/291 (12%)
Query: 73  NLFFD--LRTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKL--SVDSRQGLR 127
           NL+F       +V  +    + +LG G +G V +   +P+GQ  AVK++  +V+S++  R
Sbjct: 19  NLYFQGAXENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKR 78
Query: 128 EFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF---IFDKTKSSSLDW 184
              +       +     VT +G      +  +  E L + SLD F   + DK ++   D 
Sbjct: 79  LLXDLDISXRTVDCPFTVTFYGALFREGDVWICXE-LXDTSLDKFYKQVIDKGQTIPEDI 137
Query: 185 TTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244
             +  I + + + L +LH +    +IHRD+K SN+L++     K  DFG++     +   
Sbjct: 138 LGK--IAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKXCDFGISGYLVDD--- 190
Query: 245 VNTFRISGTHGYMA-----PEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKA 299
           V     +G   Y A     PE    GY SVK+D++S G+  +E+   R  +D        
Sbjct: 191 VAKDIDAGCKPYXAPERINPELNQKGY-SVKSDIWSLGITXIELAILRFPYD-------- 241
Query: 300 DLLSYTW-TLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERP 349
                +W T FQ  K + + +PS        +A  +     C +++  ERP
Sbjct: 242 -----SWGTPFQQLKQV-VEEPSPQLPADKFSAEFVDFTSQCLKKNSKERP 286

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 18/206 (8%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFT--NEVKLLLKIQHKNL 144
           +  + +LG G +G VY+ +     + +A+K++ ++  +     T   EV LL ++QH+N+
Sbjct: 36  YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNI 95
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L           L++EY  N    Y   +   S  +  +  Y+++ GV     + H  
Sbjct: 96  IELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVN----FCHSR 151
Query: 205 APARIIHRDIKASNILL---DEQLNP--KISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
              R +HRD+K  N+LL   D    P  KI DFGLAR F G      T  I  T  Y  P
Sbjct: 152 ---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEII-TLWYRPP 206
Query: 260 EYALHG-YLSVKTDVFSYGVLVLEIV 284
           E  L   + S   D++S   +  E++
Sbjct: 207 EILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 100/220 (45%), Gaps = 18/220 (8%)
Query: 85  TNFFSDLNQLGHGGFGPVY--RGLMPNGQEIA--VKKLSVDSRQGLREFTNEVKLLLKIQ 140
           +  +  + +LG G +G V   R  + + +     ++K SV +    +    EV +L  + 
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK-LLEEVAVLKLLD 94
Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
           H N++ L+    +     LV E      L   I  + K + +D      I+  V  G+ Y
Sbjct: 95  HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV---IIKQVLSGVTY 151
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNP---KISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           LH+     I+HRD+K  N+LL+ +      KI DFGL+ +F  +          GT  Y+
Sbjct: 152 LHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL---GTAYYI 205
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKE 297
           APE     Y   K DV+S GV++  +++G     G+  +E
Sbjct: 206 APEVLRKKY-DEKCDVWSIGVILFILLAGYPPFGGQTDQE 244

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 12/208 (5%)
Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLRE-FTNEVKLLLKIQHKNLVTLFG 149
           LG GGF   +     + +E+   K+   S   +   RE  + E+ +   + H+++V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
              +     +V E    +SL      K + +  +   RY +   +  G  YLH     R+
Sbjct: 89  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARYYL-RQIVLGCQYLHRN---RV 142
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           IHRD+K  N+ L+E L  KI DFGLA     +     T  + GT  Y+APE       S 
Sbjct: 143 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 200
Query: 270 KTDVFSYGVLVLEIVSGRKNHDGRLGKE 297
           + DV+S G ++  ++ G+   +    KE
Sbjct: 201 EVDVWSIGCIMYTLLVGKPPFETSCLKE 228

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 106/255 (41%), Gaps = 43/255 (16%)
Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE 153
           +G G FG VY G       I +  +  D+   L+ F  EV    + +H+N+V   G C  
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 154 GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRD 213
            P   ++      ++L   + D      LD     +I   + +G+ YLH +    I+H+D
Sbjct: 101 PPHLAIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155
Query: 214 IKASNILLDEQLNPK--ISDFGLARL--FPGEDTHVNTFRI-SGTHGYMAPEYALHGY-- 266
           +K+ N+  D   N K  I+DFGL  +          +  RI +G   ++APE        
Sbjct: 156 LKSKNVFYD---NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPD 212
Query: 267 -------LSVKTDVFSYGV-------------------LVLEIVSGRKNHDGR--LGKEK 298
                   S  +DVF+ G                    ++ ++ +G K +  +  +GKE 
Sbjct: 213 TEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEI 272
Query: 299 ADLLSYTWTLFQGEK 313
           +D+L + W   Q E+
Sbjct: 273 SDILLFCWAFEQEER 287

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 18/199 (9%)
Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE 153
           LG G FG V+R +  + ++  + K              E+ +L   +H+N++ L      
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 154 GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRI--VMGVARGLLYLHEEAPARIIH 211
             E ++++E++    LD  IF++  +S+ +   R  +  V  V   L +LH      I H
Sbjct: 73  MEELVMIFEFISG--LD--IFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGH 125
Query: 212 RDIKASNILLDEQLNP--KISDFGLAR-LFPGEDTHVNTFRISGTH-GYMAPEYALHGYL 267
            DI+  NI+   + +   KI +FG AR L PG++     FR+  T   Y APE   H  +
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-----FRLLFTAPEYYAPEVHQHDVV 180
Query: 268 SVKTDVFSYGVLVLEIVSG 286
           S  TD++S G LV  ++SG
Sbjct: 181 STATDMWSLGTLVYVLLSG 199

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 12/208 (5%)
Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLRE-FTNEVKLLLKIQHKNLVTLFG 149
           LG GGF   +     + +E+   K+   S   +   RE  + E+ +   + H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
              +     +V E    +SL      K + +  +   RY +   +  G  YLH     R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARYYL-RQIVLGCQYLHRN---RV 138
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           IHRD+K  N+ L+E L  KI DFGLA     +     T  + GT  Y+APE       S 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 270 KTDVFSYGVLVLEIVSGRKNHDGRLGKE 297
           + DV+S G ++  ++ G+   +    KE
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPFETSCLKE 224

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 12/208 (5%)
Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLRE-FTNEVKLLLKIQHKNLVTLFG 149
           LG GGF   +     + +E+   K+   S   +   RE  + E+ +   + H+++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
              +     +V E    +SL      K + +  +   RY +   +  G  YLH     R+
Sbjct: 85  FFEDNDFVFVVLELCRRRSL--LELHKRRKALTEPEARYYL-RQIVLGCQYLHRN---RV 138
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           IHRD+K  N+ L+E L  KI DFGLA     +     T  + GT  Y+APE       S 
Sbjct: 139 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSKKGHSF 196
Query: 270 KTDVFSYGVLVLEIVSGRKNHDGRLGKE 297
           + DV+S G ++  ++ G+   +    KE
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPFETSCLKE 224

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  +G G FG V     M  G   A+K L       L++     NE ++L  +    
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           LV L     +     +V EY+P    D F   +      +   R+     +     YLH 
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGG--DMFSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS 159
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
                +I+RD+K  N+L+D+Q   K++DFG A+   G      T+ + GT  Y+APE  L
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 211
Query: 264 HGYLSVKTDVFSYGVLVLEIVSG 286
               +   D ++ GVL+ E+ +G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  +G G FG V     M  G   A+K L       L++     NE ++L  +    
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           LV L     +     +V EY+P    D F   +      +   R+     +     YLH 
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGG--DMFSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS 159
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
                +I+RD+K  N+L+D+Q   K++DFG A+   G      T+ + GT  Y+APE  L
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 211
Query: 264 HGYLSVKTDVFSYGVLVLEIVSG 286
               +   D ++ GVL+ E+ +G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 96/205 (46%), Gaps = 12/205 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           +  L ++G G +G V++       EI A+K++ +D   +G+      E+ LL +++HKN+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+       YF    + +  LD       +  + +GL + H  
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQDLKKYF---DSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
               ++HRD+K  N+L++     K++DFGLAR F G      +  +  T  Y  P+    
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLADFGLARAF-GIPVRCYSAEVV-TLWYRPPDVLFG 175
Query: 265 GYL-SVKTDVFSYGVLVLEIVSGRK 288
             L S   D++S G +  E+ +  +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAAR 200

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 85  TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIA-----VKKLSVDSRQGLREFTNEVKLLLK 138
           T  +    +LG G F  V R + +  GQE A      KKLS    Q L     E ++   
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE---REARICRL 66
Query: 139 IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
           ++H N+V L    +E     L+++ +    L   I  +   S  D +     +  +   +
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS---HCIQQILEAV 123
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLN---PKISDFGLARLFPGEDTHVNTFRISGTHG 255
           L+ H+     ++HR++K  N+LL  +L     K++DFGLA    GE      F  +GT G
Sbjct: 124 LHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFAGTPG 178
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
           Y++PE           D+++ GV++  ++ G
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 102/235 (43%), Gaps = 27/235 (11%)
Query: 66  GSGAD--SWNLFFDLRTLQVATNFFSD---LNQLGHGGFGPVYRGLMPNGQE------IA 114
            SG D  + NL+F  + +   T F  D     +LG G F  V R +     +      I 
Sbjct: 8   SSGVDLGTENLYF--QXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIIN 65
Query: 115 VKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIF 174
            KKLS    Q L     E ++   ++H N+V L    +E     LV++ +    L   I 
Sbjct: 66  TKKLSARDHQKLE---REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIV 122
Query: 175 DKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN---PKISD 231
            +   S  D +     +  +   + ++H+     I+HRD+K  N+LL  +      K++D
Sbjct: 123 AREYYSEADAS---HCIHQILESVNHIHQH---DIVHRDLKPENLLLASKCKGAAVKLAD 176
Query: 232 FGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
           FGLA    GE      F  +GT GY++PE           D+++ GV++  ++ G
Sbjct: 177 FGLAIEVQGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 87/204 (42%), Gaps = 17/204 (8%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V     M  G   A+K L       L+E     NE ++L  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF 102
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARGLLYLH 202
           LV L     +     +V EY P   +    F   +          R     +     YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
                 +I+RD+K  N+++D+Q   +++DFGLA+   G      T+ + GT  Y+APE  
Sbjct: 159 S---LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKG-----RTWXLCGTPEYLAPEII 210
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
           L    +   D ++ GVL+ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 25/223 (11%)
Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTN-EVKLLLKIQHKNLV 145
           ++D   +G+G FG VY+  L  +G+ +A+KK+  D R     F N E++++ K+ H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 110
Query: 146 TL---FGCCAEGPEKM---LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL 199
            L   F    E  +++   LV +Y+P               +L        +  + R L 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNP-KISDFGLAR-LFPGEDTHVNTFRISGTHGYM 257
           Y+H      I HRDIK  N+LLD      K+ DFG A+ L  GE    N   I   + Y 
Sbjct: 171 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY-YR 223
Query: 258 APE--YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK 298
           APE  +    Y S   DV+S G ++ E++ G+    G  G ++
Sbjct: 224 APELIFGATDYTS-SIDVWSAGCVLAELLLGQPIFPGDSGVDQ 265

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 20/217 (9%)
Query: 77  DLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNE 132
           D+ T     + F     LG G FG VY         I   K+   S   ++G+  +   E
Sbjct: 14  DILTRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRRE 73
Query: 133 VKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVM 192
           +++   + H N++ L+    +     L+ EY P   L     +  KS + D      I+ 
Sbjct: 74  IEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGEL---YKELQKSCTFDEQRTATIME 130
Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR--- 249
            +A  L+Y H +   ++IHRDIK  N+LL  +   KI+DFG +        H  + R   
Sbjct: 131 ELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWS-------VHAPSLRRKT 180
Query: 250 ISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
           + GT  Y+ PE       + K D++  GVL  E++ G
Sbjct: 181 MCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 106/223 (47%), Gaps = 25/223 (11%)
Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTN-EVKLLLKIQHKNLV 145
           ++D   +G+G FG VY+  L  +G+ +A+KK+  D R     F N E++++ K+ H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 76
Query: 146 TL-FGCCAEGPEKMLVY-----EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL 199
            L +   + G +K +VY     +Y+P               +L        +  + R L 
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNP-KISDFGLAR-LFPGEDTHVNTFRISGTHGYM 257
           Y+H      I HRDIK  N+LLD      K+ DFG A+ L  GE    N   I   + Y 
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY-YR 189
Query: 258 APE--YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK 298
           APE  +    Y S   DV+S G ++ E++ G+    G  G ++
Sbjct: 190 APELIFGATDYTS-SIDVWSAGCVLAELLLGQPIFPGDSGVDQ 231

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 25/223 (11%)
Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTN-EVKLLLKIQHKNLV 145
           ++D   +G+G FG VY+  L  +G+ +A+KK+  D R     F N E++++ K+ H N+V
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 114
Query: 146 TL---FGCCAEGPEKM---LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL 199
            L   F    E  +++   LV +Y+P               +L        +  + R L 
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 174
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNP-KISDFGLAR-LFPGEDTHVNTFRISGTHGYM 257
           Y+H      I HRDIK  N+LLD      K+ DFG A+ L  GE    N   I   + Y 
Sbjct: 175 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY-YR 227
Query: 258 APE--YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK 298
           APE  +    Y S   DV+S G ++ E++ G+    G  G ++
Sbjct: 228 APELIFGATDYTS-SIDVWSAGCVLAELLLGQPIFPGDSGVDQ 269

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 25/223 (11%)
Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTN-EVKLLLKIQHKNLV 145
           ++D   +G+G FG VY+  L  +G+ +A+KK+  D R     F N E++++ K+ H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 110
Query: 146 TL---FGCCAEGPEKM---LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL 199
            L   F    E  +++   LV +Y+P               +L        +  + R L 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNP-KISDFGLAR-LFPGEDTHVNTFRISGTHGYM 257
           Y+H      I HRDIK  N+LLD      K+ DFG A+ L  GE    N   I   + Y 
Sbjct: 171 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY-YR 223
Query: 258 APE--YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK 298
           APE  +    Y S   DV+S G ++ E++ G+    G  G ++
Sbjct: 224 APELIFGATDYTS-SIDVWSAGCVLAELLLGQPIFPGDSGVDQ 265

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 25/223 (11%)
Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTN-EVKLLLKIQHKNLV 145
           ++D   +G+G FG VY+  L  +G+ +A+KK+  D R     F N E++++ K+ H N+V
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 104
Query: 146 TL---FGCCAEGPEKM---LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL 199
            L   F    E  +++   LV +Y+P               +L        +  + R L 
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 164
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNP-KISDFGLAR-LFPGEDTHVNTFRISGTHGYM 257
           Y+H      I HRDIK  N+LLD      K+ DFG A+ L  GE    N   I   + Y 
Sbjct: 165 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY-YR 217
Query: 258 APE--YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK 298
           APE  +    Y S   DV+S G ++ E++ G+    G  G ++
Sbjct: 218 APELIFGATDYTS-SIDVWSAGCVLAELLLGQPIFPGDSGVDQ 259

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 25/223 (11%)
Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTN-EVKLLLKIQHKNLV 145
           ++D   +G+G FG VY+  L  +G+ +A+KK+  D R     F N E++++ K+ H N+V
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 95
Query: 146 TL---FGCCAEGPEKM---LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL 199
            L   F    E  +++   LV +Y+P               +L        +  + R L 
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 155
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNP-KISDFGLAR-LFPGEDTHVNTFRISGTHGYM 257
           Y+H      I HRDIK  N+LLD      K+ DFG A+ L  GE    N   I   + Y 
Sbjct: 156 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY-YR 208
Query: 258 APE--YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK 298
           APE  +    Y S   DV+S G ++ E++ G+    G  G ++
Sbjct: 209 APELIFGATDYTS-SIDVWSAGCVLAELLLGQPIFPGDSGVDQ 250

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 25/223 (11%)
Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTN-EVKLLLKIQHKNLV 145
           ++D   +G+G FG VY+  L  +G+ +A+KK+  D R     F N E++++ K+ H N+V
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 88
Query: 146 TL---FGCCAEGPEKM---LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL 199
            L   F    E  +++   LV +Y+P               +L        +  + R L 
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNP-KISDFGLAR-LFPGEDTHVNTFRISGTHGYM 257
           Y+H      I HRDIK  N+LLD      K+ DFG A+ L  GE    N   I   + Y 
Sbjct: 149 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY-YR 201
Query: 258 APE--YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK 298
           APE  +    Y S   DV+S G ++ E++ G+    G  G ++
Sbjct: 202 APELIFGATDYTS-SIDVWSAGCVLAELLLGQPIFPGDSGVDQ 243

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 25/223 (11%)
Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTN-EVKLLLKIQHKNLV 145
           ++D   +G+G FG VY+  L  +G+ +A+KK+  D R     F N E++++ K+ H N+V
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 112
Query: 146 TL---FGCCAEGPEKM---LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL 199
            L   F    E  +++   LV +Y+P               +L        +  + R L 
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 172
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNP-KISDFGLAR-LFPGEDTHVNTFRISGTHGYM 257
           Y+H      I HRDIK  N+LLD      K+ DFG A+ L  GE    N   I   + Y 
Sbjct: 173 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY-YR 225
Query: 258 APE--YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK 298
           APE  +    Y S   DV+S G ++ E++ G+    G  G ++
Sbjct: 226 APELIFGATDYTS-SIDVWSAGCVLAELLLGQPIFPGDSGVDQ 267

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 25/223 (11%)
Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTN-EVKLLLKIQHKNLV 145
           ++D   +G+G FG VY+  L  +G+ +A+KK+  D R     F N E++++ K+ H N+V
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 81
Query: 146 TL---FGCCAEGPEKM---LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL 199
            L   F    E  +++   LV +Y+P               +L        +  + R L 
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 141
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNP-KISDFGLAR-LFPGEDTHVNTFRISGTHGYM 257
           Y+H      I HRDIK  N+LLD      K+ DFG A+ L  GE    N   I   + Y 
Sbjct: 142 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY-YR 194
Query: 258 APE--YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK 298
           APE  +    Y S   DV+S G ++ E++ G+    G  G ++
Sbjct: 195 APELIFGATDYTS-SIDVWSAGCVLAELLLGQPIFPGDSGVDQ 236

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V     M  G   A+K L       L++     NE ++L  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           LV L     +     +V EY+P   +  F   +      +   R+     +     YLH 
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHS 159
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
                +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+APE  L
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIIL 211
Query: 264 HGYLSVKTDVFSYGVLVLEIVSG 286
               +   D ++ GVL+ E+ +G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 25/223 (11%)
Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTN-EVKLLLKIQHKNLV 145
           ++D   +G+G FG VY+  L  +G+ +A+KK+  D R     F N E++++ K+ H N+V
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 84
Query: 146 TL---FGCCAEGPEKM---LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL 199
            L   F    E  +++   LV +Y+P               +L        +  + R L 
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 144
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNP-KISDFGLAR-LFPGEDTHVNTFRISGTHGYM 257
           Y+H      I HRDIK  N+LLD      K+ DFG A+ L  GE    N   I   + Y 
Sbjct: 145 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY-YR 197
Query: 258 APE--YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK 298
           APE  +    Y S   DV+S G ++ E++ G+    G  G ++
Sbjct: 198 APELIFGATDYTS-SIDVWSAGCVLAELLLGQPIFPGDSGVDQ 239

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V     M  G   A+K L       L++     NE ++L  +    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           LV L     +     +V EY+P   +  F   +      +   R+     +     YLH 
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHS 160
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
                +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+APE  L
Sbjct: 161 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIIL 212
Query: 264 HGYLSVKTDVFSYGVLVLEIVSG 286
               +   D ++ GVL+ E+ +G
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 15/203 (7%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V     M  G   A+K L       L++     NE ++L  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           LV L     +     +V EY+P   +  F   +      +   R+     +     YLH 
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHS 159
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
                +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+APE  L
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIIL 211
Query: 264 HGYLSVKTDVFSYGVLVLEIVSG 286
               +   D ++ GVL+ E+ +G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 25/223 (11%)
Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTN-EVKLLLKIQHKNLV 145
           ++D   +G+G FG VY+  L  +G+ +A+KK+  D R     F N E++++ K+ H N+V
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 88
Query: 146 TL---FGCCAEGPEKM---LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL 199
            L   F    E  +++   LV +Y+P               +L        +  + R L 
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNP-KISDFGLAR-LFPGEDTHVNTFRISGTHGYM 257
           Y+H      I HRDIK  N+LLD      K+ DFG A+ L  GE    N   I   + Y 
Sbjct: 149 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY-YR 201
Query: 258 APE--YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK 298
           APE  +    Y S   DV+S G ++ E++ G+    G  G ++
Sbjct: 202 APELIFGATDYTS-SIDVWSAGCVLAELLLGQPIFPGDSGVDQ 243

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 25/223 (11%)
Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTN-EVKLLLKIQHKNLV 145
           ++D   +G+G FG VY+  L  +G+ +A+KK+  D R     F N E++++ K+ H N+V
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 155
Query: 146 TL---FGCCAEGPEKM---LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL 199
            L   F    E  +++   LV +Y+P               +L        +  + R L 
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 215
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNP-KISDFGLAR-LFPGEDTHVNTFRISGTHGYM 257
           Y+H      I HRDIK  N+LLD      K+ DFG A+ L  GE    N   I   + Y 
Sbjct: 216 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY-YR 268
Query: 258 APE--YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK 298
           APE  +    Y S   DV+S G ++ E++ G+    G  G ++
Sbjct: 269 APELIFGATDYTS-SIDVWSAGCVLAELLLGQPIFPGDSGVDQ 310

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 25/223 (11%)
Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTN-EVKLLLKIQHKNLV 145
           ++D   +G+G FG VY+  L  +G+ +A+KK+  D R     F N E++++ K+ H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 76
Query: 146 TL---FGCCAEGPEKM---LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL 199
            L   F    E  +++   LV +Y+P               +L        +  + R L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNP-KISDFGLAR-LFPGEDTHVNTFRISGTHGYM 257
           Y+H      I HRDIK  N+LLD      K+ DFG A+ L  GE    N   I   + Y 
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY-YR 189
Query: 258 APE--YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK 298
           APE  +    Y S   DV+S G ++ E++ G+    G  G ++
Sbjct: 190 APELIFGATDYTS-SIDVWSAGCVLAELLLGQPIFPGDSGVDQ 231

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 25/223 (11%)
Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTN-EVKLLLKIQHKNLV 145
           ++D   +G+G FG VY+  L  +G+ +A+KK+  D R     F N E++++ K+ H N+V
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 80
Query: 146 TL---FGCCAEGPEKM---LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL 199
            L   F    E  +++   LV +Y+P               +L        +  + R L 
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 140
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNP-KISDFGLAR-LFPGEDTHVNTFRISGTHGYM 257
           Y+H      I HRDIK  N+LLD      K+ DFG A+ L  GE    N   I   + Y 
Sbjct: 141 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY-YR 193
Query: 258 APE--YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK 298
           APE  +    Y S   DV+S G ++ E++ G+    G  G ++
Sbjct: 194 APELIFGATDYTS-SIDVWSAGCVLAELLLGQPIFPGDSGVDQ 235

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 93/185 (50%), Gaps = 27/185 (14%)
Query: 112 EIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYEYLP----- 165
           E AVK +     +  R+ T E+++LL+  QH N++TL     +G    +V E +      
Sbjct: 49  EFAVKIID----KSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELL 104
Query: 166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNIL-LDEQ 224
           +K L    F + ++S++ +T        + + + YLH +    ++HRD+K SNIL +DE 
Sbjct: 105 DKILRQKFFSEREASAVLFT--------ITKTVEYLHAQG---VVHRDLKPSNILYVDES 153
Query: 225 LNP---KISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVL 281
            NP   +I DFG A+    E+  + T     T  ++APE           D++S GVL+ 
Sbjct: 154 GNPESIRICDFGFAKQLRAENGLLMT--PCYTANFVAPEVLERQGYDAACDIWSLGVLLY 211
Query: 282 EIVSG 286
            +++G
Sbjct: 212 TMLTG 216

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 20/211 (9%)
Query: 85  TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIA-----VKKLSVDSRQGLREFTNEVKLLLK 138
           T+ +    +LG G F  V R + +P GQE A      KKLS    Q L     E ++   
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLE---REARICRL 59
Query: 139 IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
           ++H N+V L    +E     LV++ +    L   I  +   S  D +     +  +   +
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCIQQILESV 116
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLN---PKISDFGLARLFPGEDTHVNTFRISGTHG 255
            + H      I+HRD+K  N+LL  +      K++DFGLA    G+      F  +GT G
Sbjct: 117 NHCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQ--AWFGFAGTPG 171
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
           Y++PE           D+++ GV++  ++ G
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 25/223 (11%)
Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTN-EVKLLLKIQHKNLV 145
           ++D   +G+G FG VY+  L  +G+ +A+KK+  D R     F N E++++ K+ H N+V
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 77
Query: 146 TL---FGCCAEGPEKM---LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL 199
            L   F    E  +++   LV +Y+P               +L        +  + R L 
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 137
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNP-KISDFGLAR-LFPGEDTHVNTFRISGTHGYM 257
           Y+H      I HRDIK  N+LLD      K+ DFG A+ L  GE    N   I   + Y 
Sbjct: 138 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY-YR 190
Query: 258 APE--YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK 298
           APE  +    Y S   DV+S G ++ E++ G+    G  G ++
Sbjct: 191 APELIFGATDYTS-SIDVWSAGCVLAELLLGQPIFPGDSGVDQ 232

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 90/202 (44%), Gaps = 22/202 (10%)
Query: 93  QLGHGGFGPVYRGLMPNGQ---EIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
           +LG G FG V+R  M + Q   + AVKK+ ++  +       E+     +    +V L+G
Sbjct: 100 RLGRGSFGEVHR--MEDKQTGFQCAVKKVRLEVFR-----AEELMACAGLTSPRIVPLYG 152
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVA-RGLLYLHEEAPAR 208
              EGP   +  E L   SL   +    K        R    +G A  GL YLH     R
Sbjct: 153 AVREGPWVNIFMELLEGGSLGQLV----KEQGCLPEDRALYYLGQALEGLEYLHSR---R 205
Query: 209 IIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFR---ISGTHGYMAPEYALH 264
           I+H D+KA N+LL  +  +  + DFG A     +    +      I GT  +MAPE  L 
Sbjct: 206 ILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLG 265
Query: 265 GYLSVKTDVFSYGVLVLEIVSG 286
                K DV+S   ++L +++G
Sbjct: 266 RSCDAKVDVWSSCCMMLHMLNG 287

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 25/223 (11%)
Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTN-EVKLLLKIQHKNLV 145
           ++D   +G+G FG VY+  L  +G+ +A+KK+  D R     F N E++++ K+ H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 76
Query: 146 TL---FGCCAEGPEKM---LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL 199
            L   F    E  +++   LV +Y+P               +L        +  + R L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNP-KISDFGLAR-LFPGEDTHVNTFRISGTHGYM 257
           Y+H      I HRDIK  N+LLD      K+ DFG A+ L  GE    N   I   + Y 
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY-YR 189
Query: 258 APE--YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK 298
           APE  +    Y S   DV+S G ++ E++ G+    G  G ++
Sbjct: 190 APELIFGATDYTS-SIDVWSAGCVLAELLLGQPIFPGDSGVDQ 231

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 25/223 (11%)
Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTN-EVKLLLKIQHKNLV 145
           ++D   +G+G FG VY+  L  +G+ +A+KK+  D R     F N E++++ K+ H N+V
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 89
Query: 146 TL---FGCCAEGPEKM---LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL 199
            L   F    E  +++   LV +Y+P               +L        +  + R L 
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 149
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNP-KISDFGLAR-LFPGEDTHVNTFRISGTHGYM 257
           Y+H      I HRDIK  N+LLD      K+ DFG A+ L  GE    N   I   + Y 
Sbjct: 150 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY-YR 202
Query: 258 APE--YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK 298
           APE  +    Y S   DV+S G ++ E++ G+    G  G ++
Sbjct: 203 APELIFGATDYTS-SIDVWSAGCVLAELLLGQPIFPGDSGVDQ 244

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 17/204 (8%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  +G G FG V     M  G   A+K L       L++     NE ++L  +    
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARGLLYLH 202
           LV L     +     +V EY+P   +    F   +          R     +     YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
                 +I+RD+K  N+L+D+Q   K++DFG A+   G      T+ + GT  Y+APE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAPEII 210
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
           L    +   D ++ GVL+ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 20/211 (9%)
Query: 85  TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIA-----VKKLSVDSRQGLREFTNEVKLLLK 138
           T+ +    +LG G F  V R + +P GQE A      KKLS    Q L     E ++   
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLE---REARICRL 59
Query: 139 IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
           ++H N+V L    +E     LV++ +    L   I  +   S  D +     +  +   +
Sbjct: 60  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCIQQILESV 116
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQ---LNPKISDFGLARLFPGEDTHVNTFRISGTHG 255
            + H      I+HRD+K  N+LL  +      K++DFGLA    G+      F  +GT G
Sbjct: 117 NHCHLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQ--AWFGFAGTPG 171
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
           Y++PE           D+++ GV++  ++ G
Sbjct: 172 YLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 25/223 (11%)
Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTN-EVKLLLKIQHKNLV 145
           ++D   +G+G FG VY+  L  +G+ +A+KK+  D R     F N E++++ K+ H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIV 76
Query: 146 TL---FGCCAEGPEKM---LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL 199
            L   F    E  +++   LV +Y+P               +L        +  + R L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNP-KISDFGLAR-LFPGEDTHVNTFRISGTHGYM 257
           Y+H      I HRDIK  N+LLD      K+ DFG A+ L  GE    N   I   + Y 
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY-YR 189
Query: 258 APE--YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK 298
           APE  +    Y S   DV+S G ++ E++ G+    G  G ++
Sbjct: 190 APELIFGATDYTS-SIDVWSAGCVLAELLLGQPIFPGDSGVDQ 231

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 16/204 (7%)
Query: 94  LGHGGFGPVYRGLMPN----GQ----EIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV 145
           LG G F  +++G+       GQ    E+ +K L    R     F     ++ K+ HK+LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
             +G C  G E +LV E++   SLD ++       ++ W  +  +   +A  + +L E  
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLEENT 133
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLF-PGEDTHVNTFRISGTHGYMAPEYALH 264
              +IH ++ A NILL  + + K  +    +L  PG    V    I        P   + 
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIE 190
Query: 265 G--YLSVKTDVFSYGVLVLEIVSG 286
               L++ TD +S+G  + EI SG
Sbjct: 191 NPKNLNLATDKWSFGTTLWEICSG 214

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 88/203 (43%), Gaps = 15/203 (7%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V     M  G   A+K L       L++     NE ++L  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           LV L     +     +V EY P   +  F   +      +   R+     +     YLH 
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHS 159
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
                +I+RD+K  N+++D+Q   K++DFG A+   G      T+ + GT  Y+APE  L
Sbjct: 160 ---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIIL 211
Query: 264 HGYLSVKTDVFSYGVLVLEIVSG 286
               +   D ++ GVL+ E+ +G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 17/204 (8%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V     M  G   A+K L       L++     NE ++L  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARGLLYLH 202
           LV L     +     +V EY+P   +    F   +          R     +     YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
                 +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+APE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEII 210
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
           L    +   D ++ GVL+ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 17/204 (8%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V     M  G   A+K L       L++     NE ++L  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARGLLYLH 202
           LV L     +     +V EY+P   +    F   +          R     +     YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
                 +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+APE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEII 210
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
           L    +   D ++ GVL+ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 17/204 (8%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V     M  G   A+K L       L++     NE ++L  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARGLLYLH 202
           LV L     +     +V EY+P   +    F   +          R     +     YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
                 +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+APE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEII 210
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
           L    +   D ++ GVL+ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 17/204 (8%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V     M  G   A+K L       L++     NE ++L  +    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARGLLYLH 202
           LV L     +     +V EY+P   +    F   +          R     +     YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
                 +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+APE  
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEII 211
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
           L    +   D ++ GVL+ E+ +G
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 72/153 (47%), Gaps = 12/153 (7%)
Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
           H  LV L  C         V EY+    L   +F   +   L           ++  L Y
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 168
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR--LFPGEDTHVNTFRISGTHGYMA 258
           LHE     II+RD+K  N+LLD + + K++D+G+ +  L PG+ T  +TF   GT  Y+A
Sbjct: 169 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT--STF--CGTPNYIA 221
Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHD 291
           PE           D ++ GVL+ E+++GR   D
Sbjct: 222 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 77/273 (28%), Positives = 115/273 (42%), Gaps = 31/273 (11%)
Query: 73  NLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVK---KLSVDSRQGLRE 128
           NL+F     Q  ++ +  + +LG G +G V        G E A+K   K SV +      
Sbjct: 13  NLYF-----QGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGA 67
Query: 129 FTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY 188
             +EV +L ++ H N++ L+    +     LV E      L   I  + K S +D     
Sbjct: 68  LLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV-- 125
Query: 189 RIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP---KISDFGLARLFPGEDTHV 245
            I+  V  G  YLH+     I+HRD+K  N+LL+ +      KI DFGL+  F       
Sbjct: 126 -IMKQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMK 181
Query: 246 NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYT 305
                 GT  Y+APE     Y   K DV+S GV++  ++ G     G+  +E        
Sbjct: 182 ERL---GTAYYIAPEVLRKKY-DEKCDVWSCGVILYILLCGYPPFGGQTDQE-------- 229
Query: 306 WTLFQGEKALELVDPSLAKCNRDEAAMCIQLGL 338
             L + EK     DP       DEA   ++L L
Sbjct: 230 -ILKRVEKGKFSFDPPDWTQVSDEAKQLVKLML 261

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 17/204 (8%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V     M  G   A+K L       L++     NE ++L  +    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARGLLYLH 202
           LV L     +     +V EY+P   +    F   +          R     +     YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
                 +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+APE  
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEYLAPEII 211
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
           L    +   D ++ GVL+ E+ +G
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/185 (29%), Positives = 92/185 (49%), Gaps = 27/185 (14%)
Query: 112 EIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYEY-----LP 165
           E AVK +     +  R+ T E+++LL+  QH N++TL     +G    +V E      L 
Sbjct: 49  EFAVKIID----KSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELL 104
Query: 166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNIL-LDEQ 224
           +K L    F + ++S++ +T        + + + YLH +    ++HRD+K SNIL +DE 
Sbjct: 105 DKILRQKFFSEREASAVLFT--------ITKTVEYLHAQG---VVHRDLKPSNILYVDES 153
Query: 225 LNP---KISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVL 281
            NP   +I DFG A+    E+  + T     T  ++APE           D++S GVL+ 
Sbjct: 154 GNPESIRICDFGFAKQLRAENGLLXT--PCYTANFVAPEVLERQGYDAACDIWSLGVLLY 211
Query: 282 EIVSG 286
             ++G
Sbjct: 212 TXLTG 216

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 39/217 (17%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHKNL 144
           +  L  +G G  G V        G  +AVKKLS    ++   +    E+ LL  + HKN+
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 85
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLD-----YFIFDKTKSS-------SLDWTTRYRIVM 192
           ++L               + P K+L+     Y + +   ++        LD      ++ 
Sbjct: 86  ISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLY 133
Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISG 252
            +  G+ +LH    A IIHRD+K SNI++      KI DFGLAR      T    F ++ 
Sbjct: 134 QMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR------TACTNFMMTP 184
Query: 253 ---THGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
              T  Y APE  L    +   D++S G ++ E+V G
Sbjct: 185 YVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 107/230 (46%), Gaps = 29/230 (12%)
Query: 67  SGAD--SWNLFFDLRTLQVATNFFSDLNQLGHGGFG-PVYRGLMPNGQEIAVKKLSVD-- 121
           SG D  + NL+F       +   +  L ++G G FG  +      +G++  +K++++   
Sbjct: 9   SGVDLGTENLYFQ------SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM 62
Query: 122 SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKT---- 177
           S +   E   EV +L  ++H N+V       E     +V +Y     L   I  +     
Sbjct: 63  SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLF 122
Query: 178 -KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
            +   LDW  +      +   L ++H+    +I+HRDIK+ NI L +    ++ DFG+AR
Sbjct: 123 QEDQILDWFVQ------ICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIAR 173
Query: 237 LFPGEDTHVNTFRIS-GTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +    ++ V   R   GT  Y++PE   +   + K+D+++ G ++ E+ +
Sbjct: 174 VL---NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCT 220

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 17/204 (8%)
Query: 88  FSDLNQLGHGGFGPVYR-GLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V     M  G   A+K L       L++     NE ++L  +    
Sbjct: 29  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 88
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARGLLYLH 202
           LV L     +     +V EY+P   +    F   +          R     +     YLH
Sbjct: 89  LVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 144
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
                 +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+APE  
Sbjct: 145 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEYLAPEII 196
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
           L    +   D ++ GVL+ E+ +G
Sbjct: 197 LSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 22/210 (10%)
Query: 85  TNFFSDLNQLGHGGFGPVYRGLMPNGQ---EIAVKKLSVDSRQGLREFTNEVKLLLKIQH 141
            ++ +   +LG G FG V+R  M + Q   + AVKK+ ++  +       E+     +  
Sbjct: 71  VHWMTHQPRLGRGSFGEVHR--MKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSS 123
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVA-RGLLY 200
             +V L+G   EGP   +  E L   SL   I    K        R    +G A  GL Y
Sbjct: 124 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEY 179
Query: 201 LHEEAPARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFR---ISGTHGY 256
           LH     RI+H D+KA N+LL  +     + DFG A     +    +      I GT  +
Sbjct: 180 LHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 236
Query: 257 MAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
           MAPE  +      K D++S   ++L +++G
Sbjct: 237 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 86/204 (42%), Gaps = 17/204 (8%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V     M  G   A+K L       L++     NE ++L  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARGLLYLH 202
           LV L     +     +V EY P   +    F   +          R     +     YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
                 +I+RD+K  N+++D+Q   K++DFG A+   G      T+ + GT  Y+APE  
Sbjct: 159 S---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEII 210
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
           L    +   D ++ GVL+ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           F  +  LG G F  V+       G+  A+K +            NE+ +L KI+H+N+VT
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           L           LV + +    L   I ++   +  D +    ++  V   + YLHE   
Sbjct: 71  LEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL---VIQQVLSAVKYLHENG- 126
Query: 207 ARIIHRDIKASNIL-LDEQLNPK--ISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
             I+HRD+K  N+L L  + N K  I+DFGL+++   E   + +    GT GY+APE   
Sbjct: 127 --IVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMS-TACGTPGYVAPEVLA 180
Query: 264 HGYLSVKTDVFSYGVLVLEIVSG 286
               S   D +S GV+   ++ G
Sbjct: 181 QKPYSKAVDCWSIGVITYILLCG 203

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 102/241 (42%), Gaps = 15/241 (6%)
Query: 55  RAAGE----SAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVY-RGLMPN 109
           +AA E    S   +D SGA+   +       +V  N F  L  LG G FG V        
Sbjct: 113 QAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKAT 172
Query: 110 GQEIAVKKLS---VDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN 166
           G+  A+K L    + ++  +     E ++L   +H  L  L            V EY   
Sbjct: 173 GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 232
Query: 167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN 226
             L +F   + +  S D    Y     +   L YLH E    +++RD+K  N++LD+  +
Sbjct: 233 GEL-FFHLSRERVFSEDRARFYG--AEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGH 287
Query: 227 PKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
            KI+DFGL +    +   + TF   GT  Y+APE           D +  GV++ E++ G
Sbjct: 288 IKITDFGLCKEGIKDGATMKTF--CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG 345
Query: 287 R 287
           R
Sbjct: 346 R 346

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 16/210 (7%)
Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSVDSR----QGLREFTNEVKLLLKIQHKNLVTLFG 149
           LG GGF   Y     + +E+   K+   S         + + E+ +   + + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
              +     +V E    +SL      K + +  +   RY +   + +G+ YLH     R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 163
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARL--FPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
           IHRD+K  N+ L++ ++ KI DFGLA    F GE        + GT  Y+APE       
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT----LCGTPNYIAPEVLCKKGH 219
Query: 268 SVKTDVFSYGVLVLEIVSGRKNHDGRLGKE 297
           S + D++S G ++  ++ G+   +    KE
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPPFETSCLKE 249

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 90/204 (44%), Gaps = 16/204 (7%)
Query: 94  LGHGGFGPVYRGLMPN----GQ----EIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV 145
           LG G F  +++G+       GQ    E+ +K L    R     F     ++ K+ HK+LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
             +G C  G E +LV E++   SLD ++       ++ W  +  +   +A  + +L E  
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFLEENT 133
Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLF-PGEDTHVNTFRISGTHGYMAPEYALH 264
              +IH ++ A NILL  + + K  +    +L  PG    V    I        P   + 
Sbjct: 134 ---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIE 190
Query: 265 G--YLSVKTDVFSYGVLVLEIVSG 286
               L++ TD +S+G  + EI SG
Sbjct: 191 NPKNLNLATDKWSFGTTLWEICSG 214

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 95/203 (46%), Gaps = 12/203 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLSVDSR-QGLREFT-NEVKLLLKIQHKNL 144
           +  L ++G G +G V++       EI A+K++ +D   +G+      E+ LL +++HKN+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+       YF    + +  LD       +  + +GL + H  
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQDLKKYF---DSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
               ++HRD+K  N+L++     K+++FGLAR F G      +  +  T  Y  P+    
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWYRPPDVLFG 175
Query: 265 GYL-SVKTDVFSYGVLVLEIVSG 286
             L S   D++S G +  E+ + 
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANA 198

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 70/152 (46%), Gaps = 29/152 (19%)
Query: 120 VDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD---- 175
           +  R  + +   E+ +L K+ H N+V L     +           PN+   Y +F+    
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDD-----------PNEDHLYMVFELVNQ 122
Query: 176 -------KTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPK 228
                    K  S D    Y     + +G+ YLH +   +IIHRDIK SN+L+ E  + K
Sbjct: 123 GPVMEVPTLKPLSEDQARFY--FQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIK 177
Query: 229 ISDFGLARLFPGEDTHVNTFRISGTHGYMAPE 260
           I+DFG++  F G D  ++     GT  +MAPE
Sbjct: 178 IADFGVSNEFKGSDALLSN--TVGTPAFMAPE 207

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 69/153 (45%), Gaps = 12/153 (7%)
Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
           H  LV L  C         V EY+    L   +F   +   L           ++  L Y
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 136
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR--LFPGEDTHVNTFRISGTHGYMA 258
           LHE     II+RD+K  N+LLD + + K++D+G+ +  L PG+ T        GT  Y+A
Sbjct: 137 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSX----FCGTPNYIA 189
Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHD 291
           PE           D ++ GVL+ E+++GR   D
Sbjct: 190 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 98/232 (42%), Gaps = 11/232 (4%)
Query: 60  SAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKL 118
           S   +D SGA+   +       +V  N F  L  LG G FG V        G+  A+K L
Sbjct: 125 SGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKIL 184
Query: 119 S---VDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD 175
               + ++  +     E ++L   +H  L  L            V EY     L +F   
Sbjct: 185 KKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL-FFHLS 243
Query: 176 KTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235
           + +  S D    Y     +   L YLH E    +++RD+K  N++LD+  + KI+DFGL 
Sbjct: 244 RERVFSEDRARFYG--AEIVSALDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLC 299
Query: 236 RLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
           +    +   + TF   GT  Y+APE           D +  GV++ E++ GR
Sbjct: 300 KEGIKDGATMKTF--CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 16/210 (7%)
Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSVDSR----QGLREFTNEVKLLLKIQHKNLVTLFG 149
           LG GGF   Y     + +E+   K+   S         + + E+ +   + + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
              +     +V E    +SL      K + +  +   RY +   + +G+ YLH     R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 163
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARL--FPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
           IHRD+K  N+ L++ ++ KI DFGLA    F GE        + GT  Y+APE       
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKX----LCGTPNYIAPEVLCKKGH 219
Query: 268 SVKTDVFSYGVLVLEIVSGRKNHDGRLGKE 297
           S + D++S G ++  ++ G+   +    KE
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPPFETSCLKE 249

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 69/153 (45%), Gaps = 12/153 (7%)
Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
           H  LV L  C         V EY+    L   +F   +   L           ++  L Y
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 125
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR--LFPGEDTHVNTFRISGTHGYMA 258
           LHE     II+RD+K  N+LLD + + K++D+G+ +  L PG+ T        GT  Y+A
Sbjct: 126 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSX----FCGTPNYIA 178
Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHD 291
           PE           D ++ GVL+ E+++GR   D
Sbjct: 179 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 69/153 (45%), Gaps = 12/153 (7%)
Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
           H  LV L  C         V EY+    L   +F   +   L           ++  L Y
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 121
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR--LFPGEDTHVNTFRISGTHGYMA 258
           LHE     II+RD+K  N+LLD + + K++D+G+ +  L PG+ T        GT  Y+A
Sbjct: 122 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSX----FCGTPNYIA 174
Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHD 291
           PE           D ++ GVL+ E+++GR   D
Sbjct: 175 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 94/217 (43%), Gaps = 27/217 (12%)
Query: 84  ATNFFSD----LNQLGHGGFGPVYR------GLMPNGQEIAVKKLSVDSRQGLREFTNEV 133
           A+  FSD      +LG G F  V R      GL    + I  KKLS    Q L     E 
Sbjct: 23  ASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EA 79
Query: 134 KLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG 193
           ++  K+QH N+V L     E     LV++ +    L   I  +   S  D +     +  
Sbjct: 80  RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQ 136
Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLN---PKISDFGLA-RLFPGEDTHVNTFR 249
           +   + Y H      I+HR++K  N+LL  +      K++DFGLA  +   E  H     
Sbjct: 137 ILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH----G 189
Query: 250 ISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
            +GT GY++PE       S   D+++ GV++  ++ G
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 16/210 (7%)
Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSVDSR----QGLREFTNEVKLLLKIQHKNLVTLFG 149
           LG GGF   Y     + +E+   K+   S         + + E+ +   + + ++V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
              +     +V E    +SL      K + +  +   RY  +    +G+ YLH     R+
Sbjct: 94  FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARY-FMRQTIQGVQYLHNN---RV 147
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARL--FPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
           IHRD+K  N+ L++ ++ KI DFGLA    F GE        + GT  Y+APE       
Sbjct: 148 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKK----DLCGTPNYIAPEVLCKKGH 203
Query: 268 SVKTDVFSYGVLVLEIVSGRKNHDGRLGKE 297
           S + D++S G ++  ++ G+   +    KE
Sbjct: 204 SFEVDIWSLGCILYTLLVGKPPFETSCLKE 233

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 67/151 (44%), Gaps = 10/151 (6%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCC 151
           L  GGF  VY    + +G+E A+K+L  +  +  R    EV  + K+  H N+V      
Sbjct: 36  LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 152 AEGPEK-------MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + G E+        L+   L    L  F+        L   T  +I     R + ++H +
Sbjct: 96  SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ 155
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLA 235
            P  IIHRD+K  N+LL  Q   K+ DFG A
Sbjct: 156 KPP-IIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 22/210 (10%)
Query: 85  TNFFSDLNQLGHGGFGPVYRGLMPNGQ---EIAVKKLSVDSRQGLREFTNEVKLLLKIQH 141
            ++ +   ++G G FG V+R  M + Q   + AVKK+ ++  +       E+     +  
Sbjct: 57  VHWMTHQPRVGRGSFGEVHR--MKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSS 109
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVA-RGLLY 200
             +V L+G   EGP   +  E L   SL   I    K        R    +G A  GL Y
Sbjct: 110 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEY 165
Query: 201 LHEEAPARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFR---ISGTHGY 256
           LH     RI+H D+KA N+LL  +     + DFG A     +    +      I GT  +
Sbjct: 166 LHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 222
Query: 257 MAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
           MAPE  +      K D++S   ++L +++G
Sbjct: 223 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 30/211 (14%)
Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNEVKLLLKIQHKN 143
           F  +  LG G FG VY       + I   K+   S   ++G+  +   E+++   ++H N
Sbjct: 16  FDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSL-----DYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
           ++ ++    +     L+ E+ P   L      +  FD+ +S++         +  +A  L
Sbjct: 76  ILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF--------MEELADAL 127
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR---ISGTHG 255
            Y HE    ++IHRDIK  N+L+  +   KI+DFG +        H  + R   + GT  
Sbjct: 128 HYCHER---KVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRXMCGTLD 177
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
           Y+ PE         K D++  GVL  E + G
Sbjct: 178 YLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 12/203 (5%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKL--SVDSRQGLREFTNEVKLLLKIQHKNL 144
           +  + ++G G +G V++      GQ +A+KK   S D     +    E+++L +++H NL
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L           LV+EY  +  L     D+ +    +   +  I     + + + H+ 
Sbjct: 65  VNLLEVFRRKRRLHLVFEYCDHTVLHEL--DRYQRGVPEHLVK-SITWQTLQAVNFCHKH 121
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL- 263
                IHRD+K  NIL+ +    K+ DFG ARL  G   + +      T  Y +PE  + 
Sbjct: 122 ---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE--VATRWYRSPELLVG 176
Query: 264 HGYLSVKTDVFSYGVLVLEIVSG 286
                   DV++ G +  E++SG
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 16/210 (7%)
Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSVDSR----QGLREFTNEVKLLLKIQHKNLVTLFG 149
           LG GGF   Y     + +E+   K+   S         + + E+ +   + + ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
              +     +V E    +SL      K + +  +   RY +   + +G+ YLH     R+
Sbjct: 110 FFEDDDFVYVVLEICRRRSL--LELHKRRKAVTEPEARYFMRQTI-QGVQYLHNN---RV 163
Query: 210 IHRDIKASNILLDEQLNPKISDFGLARL--FPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
           IHRD+K  N+ L++ ++ KI DFGLA    F GE        + GT  Y+APE       
Sbjct: 164 IHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKK----DLCGTPNYIAPEVLCKKGH 219
Query: 268 SVKTDVFSYGVLVLEIVSGRKNHDGRLGKE 297
           S + D++S G ++  ++ G+   +    KE
Sbjct: 220 SFEVDIWSLGCILYTLLVGKPPFETSCLKE 249

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 37/216 (17%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
           + +L  +G G  G V   Y  ++   + +A+KKLS    ++   +    E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYF--------IFDKTKSS----SLDWTTRYRI 190
           N++ L               + P KSL+ F        + D   S      LD      +
Sbjct: 84  NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
           +  +  G+ +LH    A IIHRD+K SNI++      KI DFGLAR   G    +  + +
Sbjct: 132 LYQMLVGIKHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLART-AGTSFMMTPYVV 187
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
             T  Y APE  L        D++S GV++ E++ G
Sbjct: 188 --TRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 87/203 (42%), Gaps = 15/203 (7%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V     M  G   A+K L       L++     NE ++L  +    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           L  L     +     +V EY P   +  F   +      +   R+     +     YLH 
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEM--FSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHS 160
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
                +I+RD+K  N+++D+Q   K++DFG A+   G      T+ + GT  Y+APE  L
Sbjct: 161 ---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIIL 212
Query: 264 HGYLSVKTDVFSYGVLVLEIVSG 286
               +   D ++ GVL+ E+ +G
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 37/216 (17%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
           + +L  +G G  G V   Y  ++   + +A+KKLS    ++   +    E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVVAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYF--------IFDKTKSS----SLDWTTRYRI 190
           N++ L               + P KSL+ F        + D   S      LD      +
Sbjct: 84  NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
           +  +  G+ +LH    A IIHRD+K SNI++      KI DFGLAR   G    +  + +
Sbjct: 132 LYQMLVGIKHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLART-AGTSFMMTPYVV 187
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
             T  Y APE  L        D++S GV++ E++ G
Sbjct: 188 --TRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 93/211 (44%), Gaps = 20/211 (9%)
Query: 85  TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIA-----VKKLSVDSRQGLREFTNEVKLLLK 138
           T+ +     +G G F  V R + +  G E A      KKLS    Q L     E ++   
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLE---REARICRL 59
Query: 139 IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
           ++H N+V L    +E     LV++ +    L   I  +   S  D +     +  +   +
Sbjct: 60  LKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS---HCIQQILEAV 116
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLN---PKISDFGLARLFPGEDTHVNTFRISGTHG 255
           L+ H+     ++HRD+K  N+LL  +      K++DFGLA    G+      F  +GT G
Sbjct: 117 LHCHQMG---VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQ--AWFGFAGTPG 171
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
           Y++PE           D+++ GV++  ++ G
Sbjct: 172 YLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 92/210 (43%), Gaps = 22/210 (10%)
Query: 85  TNFFSDLNQLGHGGFGPVYRGLMPNGQ---EIAVKKLSVDSRQGLREFTNEVKLLLKIQH 141
            ++ +   ++G G FG V+R  M + Q   + AVKK+ ++  +       E+     +  
Sbjct: 73  VHWMTHQPRVGRGSFGEVHR--MKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSS 125
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVA-RGLLY 200
             +V L+G   EGP   +  E L   SL   I    K        R    +G A  GL Y
Sbjct: 126 PRIVPLYGAVREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEY 181
Query: 201 LHEEAPARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFR---ISGTHGY 256
           LH     RI+H D+KA N+LL  +     + DFG A     +    +      I GT  +
Sbjct: 182 LHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 238
Query: 257 MAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
           MAPE  +      K D++S   ++L +++G
Sbjct: 239 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 17/204 (8%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V     M  G   A+K L       L++     NE ++L  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARGLLYLH 202
           LV L     +     +V EY P   +    F   +          R     +     YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
                 +I+RD+K  N+++D+Q   +++DFG A+   G      T+ + GT  Y+APE  
Sbjct: 159 S---LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEII 210
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
           L    +   D ++ GVL+ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 17/212 (8%)
Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLSVDS--RQGLREFTNEVKLLLKIQHKN- 143
           F+ L  LG G FG V         E+ AVK L  D   +    E T   K +L +  K  
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402
Query: 144 -LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
            L  L  C         V EY+    L Y I    +               +A GL +L 
Sbjct: 403 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI---QQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLAR--LFPGEDTHVNTFRISGTHGYMAPE 260
            +    II+RD+K  N++LD + + KI+DFG+ +  ++ G    V T    GT  Y+APE
Sbjct: 460 SKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG----VTTKXFCGTPDYIAPE 512
Query: 261 YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
              +       D +++GVL+ E+++G+   +G
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 544

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 21/219 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCC 151
           LG G +  V   + + NG+E AVK +   +         EV+ L + Q +KN++ L    
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFF 80
Query: 152 AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIH 211
            +     LV+E L   S+   I    K    +     R+V  VA  L +LH +    I H
Sbjct: 81  EDDTRFYLVFEKLQGGSILAHI---QKQKHFNEREASRVVRDVAAALDFLHTKG---IAH 134
Query: 212 RDIKASNILLD--EQLNP-KISDFGLAR--LFPGEDTHVNTFRIS---GTHGYMAPEYA- 262
           RD+K  NIL +  E+++P KI DF L          T + T  ++   G+  YMAPE   
Sbjct: 135 RDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVE 194
Query: 263 ----LHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKE 297
                  +   + D++S GV++  ++SG     G  G +
Sbjct: 195 VFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGAD 233

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 104/245 (42%), Gaps = 50/245 (20%)
Query: 66  GSGADSWNLFFDLRTLQVATNFFS------DLNQLGHGGFGPVYRGL-MPNGQEIAVKKL 118
           GS  DS        ++QVA + F+       L  +G G  G V        G  +AVKKL
Sbjct: 1   GSHMDS-----QFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL 55
Query: 119 S--VDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLD-----Y 171
           S    ++   +    E+ LL  + HKN+++L               + P K+L+     Y
Sbjct: 56  SRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV------------FTPQKTLEEFQDVY 103
Query: 172 FIFDKTKSS-------SLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ 224
            + +   ++        LD      ++  +  G+ +LH    A IIHRD+K SNI++   
Sbjct: 104 LVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSD 160
Query: 225 LNPKISDFGLARLFPGEDTHVNTFRISG---THGYMAPEYALHGYLSVKTDVFSYGVLVL 281
              KI DFGLAR      T    F ++    T  Y APE  L        D++S G ++ 
Sbjct: 161 CTLKILDFGLAR------TASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 214
Query: 282 EIVSG 286
           E+V G
Sbjct: 215 ELVKG 219

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 85/204 (41%), Gaps = 17/204 (8%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V     M  G   A+K L       L++     NE ++L  +    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARGLLYLH 202
           L  L     +     +V EY P   +    F   +          R     +     YLH
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
                 +I+RD+K  N+++D+Q   K++DFG A+   G      T+ + GT  Y+APE  
Sbjct: 160 S---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEII 211
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
           L    +   D ++ GVL+ E+ +G
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 85/204 (41%), Gaps = 17/204 (8%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V     M  G   A+K L       L++     NE ++L  +    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARGLLYLH 202
           L  L     +     +V EY P   +    F   +          R     +     YLH
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
                 +I+RD+K  N+++D+Q   K++DFG A+   G      T+ + GT  Y+APE  
Sbjct: 160 S---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEII 211
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
           L    +   D ++ GVL+ E+ +G
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 89/204 (43%), Gaps = 23/204 (11%)
Query: 93  QLGHGGFGPVYR------GLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           +LG G F  V R      GL    + I  KKLS    Q L     E ++  K+QH N+V 
Sbjct: 12  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRKLQHPNIVR 68
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           L     E     LV++ +    L   I  +   S  D +     +  +   + Y H    
Sbjct: 69  LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQILESIAYCHSNG- 124
Query: 207 ARIIHRDIKASNILLDEQLN---PKISDFGLA-RLFPGEDTHVNTFRISGTHGYMAPEYA 262
             I+HR++K  N+LL  +      K++DFGLA  +   E  H      +GT GY++PE  
Sbjct: 125 --IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH----GFAGTPGYLSPEVL 178
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
                S   D+++ GV++  ++ G
Sbjct: 179 KKDPYSKPVDIWACGVILYILLVG 202

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 89/204 (43%), Gaps = 23/204 (11%)
Query: 93  QLGHGGFGPVYR------GLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           +LG G F  V R      GL    + I  KKLS    Q L     E ++  K+QH N+V 
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRKLQHPNIVR 69
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           L     E     LV++ +    L   I  +   S  D +     +  +   + Y H    
Sbjct: 70  LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQILESIAYCHSNG- 125
Query: 207 ARIIHRDIKASNILLDEQLN---PKISDFGLA-RLFPGEDTHVNTFRISGTHGYMAPEYA 262
             I+HR++K  N+LL  +      K++DFGLA  +   E  H      +GT GY++PE  
Sbjct: 126 --IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH----GFAGTPGYLSPEVL 179
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
                S   D+++ GV++  ++ G
Sbjct: 180 KKDPYSKPVDIWACGVILYILLVG 203

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/261 (27%), Positives = 110/261 (42%), Gaps = 26/261 (9%)
Query: 85  TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQ 140
           ++ +  + +LG G +G V        G E A+K   K SV +        +EV +L ++ 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
           H N++ L+    +     LV E      L   I  + K S +D      I+  V  G  Y
Sbjct: 63  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAV---IMKQVLSGTTY 119
Query: 201 LHEEAPARIIHRDIKASNILLDEQLNP---KISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           LH+     I+HRD+K  N+LL+ +      KI DFGL+  F             GT  Y+
Sbjct: 120 LHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERL---GTAYYI 173
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALEL 317
           APE     Y   K DV+S GV++  ++ G     G+  +E          L + EK    
Sbjct: 174 APEVLRKKY-DEKCDVWSCGVILYILLCGYPPFGGQTDQE---------ILKRVEKGKFS 223
Query: 318 VDPSLAKCNRDEAAMCIQLGL 338
            DP       DEA   ++L L
Sbjct: 224 FDPPDWTQVSDEAKQLVKLML 244

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 17/204 (8%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V        G   A+K L       L++     NE ++L  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARGLLYLH 202
           LV L     +     +V EY+P   +    F   +          R     +     YLH
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
                 +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+APE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEII 210
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
           L    +   D ++ GVL+ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 101/232 (43%), Gaps = 46/232 (19%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLS-------VDSRQGLREFTNEVKLLLKIQHKNLV 145
           LG G    V+RG     G   A+K  +       VD +  +REF    ++L K+ HKN+V
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ--MREF----EVLKKLNHKNIV 70
Query: 146 TLFGCCAEGP--EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
            LF    E     K+L+ E+ P  SL   + + + +  L  +    ++  V  G+ +L E
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 204 EAPARIIHRDIKASNILL----DEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
                I+HR+IK  NI+     D Q   K++DFG AR    ++  V+ +   GT  Y+ P
Sbjct: 131 NG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY---GTEEYLHP 184
Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQG 311
                       D++   VL       RK+H  + G    DL S   T +  
Sbjct: 185 ------------DMYERAVL-------RKDHQKKYGA-TVDLWSIGVTFYHA 216

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 17/204 (8%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V        G   A+K L       L++     NE ++L  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARGLLYLH 202
           LV L     +     +V EY+P   +    F   +          R     +     YLH
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
                 +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+APE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEII 210
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
           L    +   D ++ GVL+ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 88/203 (43%), Gaps = 15/203 (7%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V        G   A+K L       L++     NE ++L  +    
Sbjct: 36  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 95
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           LV L     +     +V EY+P   +  F   +      +   R+     +     YLH 
Sbjct: 96  LVKLEFSFKDNSNLYMVMEYVPGGEM--FSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS 152
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
                +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+APE  L
Sbjct: 153 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEIIL 204
Query: 264 HGYLSVKTDVFSYGVLVLEIVSG 286
               +   D ++ GVL+ E+ +G
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAG 227

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 30/205 (14%)
Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSVDS---RQGLR-EFTNEVKLLLKIQHKNLVTLFG 149
           LG G FG VY       + I   K+   S   ++G+  +   E+++   ++H N++ ++ 
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 150 CCAEGPEKMLVYEYLPNKSL-----DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
              +     L+ E+ P   L      +  FD+ +S++         +  +A  L Y HE 
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF--------MEELADALHYCHER 134
Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR---ISGTHGYMAPEY 261
              ++IHRDIK  N+L+  +   KI+DFG +        H  + R   + GT  Y+ PE 
Sbjct: 135 ---KVIHRDIKPENLLMGYKGELKIADFGWS-------VHAPSLRRRXMCGTLDYLPPEM 184
Query: 262 ALHGYLSVKTDVFSYGVLVLEIVSG 286
                   K D++  GVL  E + G
Sbjct: 185 IEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 17/204 (8%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V        G   A+K L       L++     NE ++L  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARGLLYLH 202
           LV L     +     +V EY+P   +    F   +          R     +     YLH
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
                 +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+APE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEII 210
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
           L    +   D ++ GVL+ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 89/204 (43%), Gaps = 23/204 (11%)
Query: 93  QLGHGGFGPVYR------GLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           +LG G F  V R      GL    + I  KKLS    Q L     E ++  K+QH N+V 
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRKLQHPNIVR 69
Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           L     E     LV++ +    L   I  +   S  D +     +  +   + Y H    
Sbjct: 70  LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS---HCIQQILESIAYCHSNG- 125
Query: 207 ARIIHRDIKASNILLDEQLN---PKISDFGLA-RLFPGEDTHVNTFRISGTHGYMAPEYA 262
             I+HR++K  N+LL  +      K++DFGLA  +   E  H      +GT GY++PE  
Sbjct: 126 --IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH----GFAGTPGYLSPEVL 179
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
                S   D+++ GV++  ++ G
Sbjct: 180 KKDPYSKPVDIWACGVILYILLVG 203

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 93/213 (43%), Gaps = 17/213 (7%)
Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLSVDS--RQGLREFTNEVKLLLKIQHKN- 143
           F+ L  LG G FG V         E+ AVK L  D   +    E T   K +L +  K  
Sbjct: 22  FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 144 -LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
            L  L  C         V EY+    L Y I    +               +A GL +L 
Sbjct: 82  FLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI---QQVGRFKEPHAVFYAAEIAIGLFFLQ 138
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLAR--LFPGEDTHVNTFRISGTHGYMAPE 260
            +    II+RD+K  N++LD + + KI+DFG+ +  ++ G    V T    GT  Y+APE
Sbjct: 139 SKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG----VTTKXFCGTPDYIAPE 191
Query: 261 YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
              +       D +++GVL+ E+++G+   +G 
Sbjct: 192 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE 224

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 106/223 (47%), Gaps = 25/223 (11%)
Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTN-EVKLLLKIQHKNLV 145
           ++D   +G+G FG VY+  L  +G+ +A+KK+     QG + F N E++++ K+ H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQG-KAFKNRELQIMRKLDHCNIV 76
Query: 146 TL---FGCCAEGPEKM---LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL 199
            L   F    E  +++   LV +Y+P               +L        +  + R L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNP-KISDFGLAR-LFPGEDTHVNTFRISGTHGYM 257
           Y+H      I HRDIK  N+LLD      K+ DFG A+ L  GE    N   I   + Y 
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY-YR 189
Query: 258 APE--YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK 298
           APE  +    Y S   DV+S G ++ E++ G+    G  G ++
Sbjct: 190 APELIFGATDYTS-SIDVWSAGCVLAELLLGQPIFPGDSGVDQ 231

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 106/223 (47%), Gaps = 25/223 (11%)
Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTN-EVKLLLKIQHKNLV 145
           ++D   +G+G FG VY+  L  +G+ +A+KK+     QG + F N E++++ K+ H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQG-KAFKNRELQIMRKLDHCNIV 76
Query: 146 TL---FGCCAEGPEKM---LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL 199
            L   F    E  +++   LV +Y+P               +L        +  + R L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNP-KISDFGLAR-LFPGEDTHVNTFRISGTHGYM 257
           Y+H      I HRDIK  N+LLD      K+ DFG A+ L  GE    N   I   + Y 
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSXICSRY-YR 189
Query: 258 APE--YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK 298
           APE  +    Y S   DV+S G ++ E++ G+    G  G ++
Sbjct: 190 APELIFGATDYTS-SIDVWSAGCVLAELLLGQPIFPGDSGVDQ 231

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 17/204 (8%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V        G   A+K L       L++     NE ++L  +    
Sbjct: 64  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARGLLYLH 202
           LV L     +     +V EY+P   +    F   +          R     +     YLH
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 179
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
                 +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+APE  
Sbjct: 180 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEII 231
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
           L    +   D ++ GVL+ E+ +G
Sbjct: 232 LSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 106/245 (43%), Gaps = 26/245 (10%)
Query: 60  SAEDADGSGADSWNLFFDLRTL-------QVATNFFSDLNQLGHGGFGPVYRGLMPNGQE 112
           SA+  DG G     +  +LRT        +V    F  L  LG G +G V+     +G +
Sbjct: 22  SADGGDG-GEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHD 80
Query: 113 I-------AVKKLSVDSRQGLREFTNEVKLLLK--IQHKNLVTLFGCCAEGPEKMLVYEY 163
                    +KK ++  +    E T   + +L+   Q   LVTL        +  L+ +Y
Sbjct: 81  TGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDY 140
Query: 164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE 223
           +    L       T  S  +  T + + + V   +L L       II+RDIK  NILLD 
Sbjct: 141 INGGEL------FTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDS 194
Query: 224 QLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL--SVKTDVFSYGVLVL 281
             +  ++DFGL++ F  ++T    +   GT  YMAP+    G        D +S GVL+ 
Sbjct: 195 NGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMY 253
Query: 282 EIVSG 286
           E+++G
Sbjct: 254 ELLTG 258

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 106/223 (47%), Gaps = 25/223 (11%)
Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTN-EVKLLLKIQHKNLV 145
           ++D   +G+G FG VY+  L  +G+ +A+KK+     QG + F N E++++ K+ H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQG-KAFKNRELQIMRKLDHCNIV 76
Query: 146 TL---FGCCAEGPEKM---LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL 199
            L   F    E  +++   LV +Y+P               +L        +  + R L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNP-KISDFGLAR-LFPGEDTHVNTFRISGTHGYM 257
           Y+H      I HRDIK  N+LLD      K+ DFG A+ L  GE    N   I   + Y 
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYICSRY-YR 189
Query: 258 APE--YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK 298
           APE  +    Y S   DV+S G ++ E++ G+    G  G ++
Sbjct: 190 APELIFGATDYTS-SIDVWSAGCVLAELLLGQPIFPGDSGVDQ 231

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 17/204 (8%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V        G   A+K L       L++     NE ++L  +    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARGLLYLH 202
           LV L     +     +V EY+P   +    F   +          R     +     YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
                 +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+APE  
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEII 211
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
           L    +   D ++ GVL+ E+ +G
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 26/210 (12%)
Query: 86  NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKN 143
           NF + LN+  H G   +++G    G +I VK L V   S +  R+F  E   L    H N
Sbjct: 13  NFLTKLNE-NHSG--ELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 144 LVTLFGCC--AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
           ++ + G C     P   L+  ++P  SL Y +  +  +  +D +   +  + +ARG+ +L
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSL-YNVLHEGTNFVVDQSQAVKFALDMARGMAFL 127
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKIS--DFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           H   P  I    + + ++++DE +  +IS  D   +   PG        R+     ++AP
Sbjct: 128 HTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSFQSPG--------RMYAP-AWVAP 177
Query: 260 EYALHGYLS----VKTDVFSYGVLVLEIVS 285
           E AL            D++S+ VL+ E+V+
Sbjct: 178 E-ALQKKPEDTNRRSADMWSFAVLLWELVT 206

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 17/204 (8%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V        G   A+K L       L++     NE ++L  +    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARGLLYLH 202
           LV L     +     +V EY+P   +    F   +          R     +     YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
                 +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+APE  
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEII 211
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
           L    +   D ++ GVL+ E+ +G
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 17/204 (8%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V        G   A+K L       L++     NE ++L  +    
Sbjct: 36  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 95
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARGLLYLH 202
           LV L     +     +V EY+P   +    F   +          R     +     YLH
Sbjct: 96  LVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 151
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
                 +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+APE  
Sbjct: 152 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAPEII 203
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
           L    +   D ++ GVL+ E+ +G
Sbjct: 204 LSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 19/214 (8%)
Query: 87  FFSDLNQL----GHGGFGPVYRGL-MPNGQEIAVKKLSV---DSRQGL--REFTNEVKLL 136
            F D+ +L    G G F  V R +    GQ+ AVK + V    S  GL   +   E  + 
Sbjct: 21  LFEDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 80
Query: 137 LKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSL-DWTTRYRIVMGVA 195
             ++H ++V L    +      +V+E++    L + I  +  +  +         +  + 
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNP---KISDFGLARLFPGEDTHVNTFRISG 252
             L Y H+     IIHRD+K  N+LL  + N    K+ DFG+A    GE   V   R+ G
Sbjct: 141 EALRYCHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL-GESGLVAGGRV-G 195
Query: 253 THGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
           T  +MAPE           DV+  GV++  ++SG
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 17/204 (8%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V        G   A+K L       L++     NE ++L  +    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARGLLYLH 202
           LV L     +     +V EY+P   +    F   +          R     +     YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
                 +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+APE  
Sbjct: 160 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEII 211
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
           L    +   D ++ GVL+ E+ +G
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 100/232 (43%), Gaps = 46/232 (19%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLS-------VDSRQGLREFTNEVKLLLKIQHKNLV 145
           LG G    V+RG     G   A+K  +       VD +  +REF    ++L K+ HKN+V
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ--MREF----EVLKKLNHKNIV 70
Query: 146 TLFGCCAEGP--EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
            LF    E     K+L+ E+ P  SL   + + + +  L  +    ++  V  G+ +L E
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE 130
Query: 204 EAPARIIHRDIKASNILL----DEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
                I+HR+IK  NI+     D Q   K++DFG AR    ++  V  +   GT  Y+ P
Sbjct: 131 NG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLY---GTEEYLHP 184
Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQG 311
                       D++   VL       RK+H  + G    DL S   T +  
Sbjct: 185 ------------DMYERAVL-------RKDHQKKYGA-TVDLWSIGVTFYHA 216

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 18/220 (8%)
Query: 73  NLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEI--AVKKLSVDSRQGLREFT 130
           NL+F   T      +++  N +G G +G V +  +  G  I  A KK+     + +  F 
Sbjct: 13  NLYFQGSTKGDINQYYTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFK 71
Query: 131 NEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRI 190
            E++++  + H N++ L+    +  +  LV E      L   +  K      D     RI
Sbjct: 72  QEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA---RI 128
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILL--DEQLNP-KISDFGL-ARLFPGEDTHVN 246
           +  V   + Y H+     + HRD+K  N L   D   +P K+ DFGL AR  PG+     
Sbjct: 129 MKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK 185
Query: 247 TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
                GT  Y++P+  L G    + D +S GV++  ++ G
Sbjct: 186 V----GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 21/215 (9%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
           + +L  +G G  G V   Y  ++   + +A+KKLS    ++   +    E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARGL 198
           N+++L       P+K L  E   +  L   + D    +     LD      ++  +  G+
Sbjct: 84  NIISLLNVFT--PQKTL--EEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGI 139
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMA 258
            +LH    A IIHRD+K SNI++      KI DFGLAR   G    +  + +  T  Y A
Sbjct: 140 KHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLART-AGTSFMMTPYVV--TRYYRA 193
Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           PE  L        D++S G ++ E+V  +    GR
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 228

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 85/204 (41%), Gaps = 17/204 (8%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V        G   A+K L       L++     NE ++L  +    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARGLLYLH 202
           LV L     +     +V EY P   +    F   +          R     +     YLH
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 159
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
                 +I+RD+K  N+++D+Q   K++DFG A+   G      T+ + GT  Y+APE  
Sbjct: 160 S---LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEII 211
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
           L    +   D ++ GVL+ E+ +G
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 17/204 (8%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V     M  G   A+K L       L++     NE ++L  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VARGLLYLH 202
           LV L     +     +V EY+    +    F   +          R     +     YLH
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
                 +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+APE  
Sbjct: 159 S---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEII 210
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
           L    +   D ++ GVL+ E+ +G
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 37/216 (17%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
           + +L  +G G  G V   Y  ++   + +A+KKLS    ++   +    E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYF--------IFDKTKSS----SLDWTTRYRI 190
           N++ L               + P KSL+ F        + D   S      LD      +
Sbjct: 84  NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
           +  +  G+ +LH    A IIHRD+K SNI++      KI DFGLAR   G    +  + +
Sbjct: 132 LYQMLVGIKHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLART-AGTSFMMTPYVV 187
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
             T  Y APE  L        D++S G ++ E++ G
Sbjct: 188 --TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 37/216 (17%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
           + +L  +G G  G V   Y  ++   + +A+KKLS    ++   +    E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYF--------IFDKTKSS----SLDWTTRYRI 190
           N++ L               + P KSL+ F        + D   S      LD      +
Sbjct: 84  NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
           +  +  G+ +LH    A IIHRD+K SNI++      KI DFGLAR   G    +  + +
Sbjct: 132 LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVV 187
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
             T  Y APE  L        D++S G ++ E++ G
Sbjct: 188 --TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 109/233 (46%), Gaps = 33/233 (14%)
Query: 67  SGAD--SWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSR 123
           SG D  + NL+F      V ++ +     +G G +    R +      E AVK +     
Sbjct: 9   SGVDLGTENLYFQS---MVFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVID---- 61
Query: 124 QGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYEY-----LPNKSLDYFIFDKT 177
           +  R+ + E+++LL+  QH N++TL     +G    LV E      L +K L    F + 
Sbjct: 62  KSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSER 121
Query: 178 KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNIL-LDEQLNP---KISDFG 233
           ++S         ++  + + + YLH +    ++HRD+K SNIL +DE  NP   +I DFG
Sbjct: 122 EASF--------VLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFG 170
Query: 234 LARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
            A+    E+  + T     T  ++APE           D++S G+L+  +++G
Sbjct: 171 FAKQLRAENGLLMT--PCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 85/170 (50%), Gaps = 23/170 (13%)
Query: 127 REFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYEY-----LPNKSLDYFIFDKTKSS 180
           R+ + E+++LL+  QH N++TL     +G    LV E      L +K L    F + ++S
Sbjct: 65  RDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREAS 124
Query: 181 SLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNIL-LDEQLNP---KISDFGLAR 236
                    ++  + + + YLH +    ++HRD+K SNIL +DE  NP   +I DFG A+
Sbjct: 125 F--------VLHTIGKTVEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAK 173
Query: 237 LFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
               E+  + T     T  ++APE           D++S G+L+  +++G
Sbjct: 174 QLRAENGLLMT--PCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 37/216 (17%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
           + +L  +G G  G V   Y  ++   + +A+KKLS    ++   +    E+ L+  + HK
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 85
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLD-----YFIFD-------KTKSSSLDWTTRYRI 190
           N++ L               + P KSL+     Y + +       +     LD      +
Sbjct: 86  NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 133
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
           +  +  G+ +LH    A IIHRD+K SNI++      KI DFGLAR   G    +  F +
Sbjct: 134 LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMVPFVV 189
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
             T  Y APE  L        D++S G ++ E++ G
Sbjct: 190 --TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 21/215 (9%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
           + +L  +G G  G V   Y  ++   + +A+KKLS    ++   +    E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARGL 198
           N+++L       P+K L  E   +  L   + D    +     LD      ++  +  G+
Sbjct: 84  NIISLLNVFT--PQKTL--EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMA 258
            +LH    A IIHRD+K SNI++      KI DFGLAR   G    +  + +  T  Y A
Sbjct: 140 KHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLART-AGTSFMMTPYVV--TRYYRA 193
Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           PE  L        D++S G ++ E+V  +    GR
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 228

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 37/216 (17%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
           + +L  +G G  G V   Y  ++   + +A+KKLS    ++   +    E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYF--------IFDKTKSS----SLDWTTRYRI 190
           N++ L               + P KSL+ F        + D   S      LD      +
Sbjct: 84  NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
           +  +  G+ +LH    A IIHRD+K SNI++      KI DFGLAR   G    +  + +
Sbjct: 132 LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLART-AGTSFMMTPYVV 187
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
             T  Y APE  L        D++S G ++ E++ G
Sbjct: 188 --TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 21/215 (9%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
           + +L  +G G  G V   Y  ++   + +A+KKLS    ++   +    E+ L+  + HK
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARGL 198
           N+++L       P+K L  E   +  L   + D    +     LD      ++  +  G+
Sbjct: 122 NIISLLNVFT--PQKTL--EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 177
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMA 258
            +LH    A IIHRD+K SNI++      KI DFGLAR   G    +  + +  T  Y A
Sbjct: 178 KHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVV--TRYYRA 231
Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           PE  L        D++S G ++ E+V  +    GR
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 266

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 106/230 (46%), Gaps = 26/230 (11%)
Query: 88  FSDLNQL-----GHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ- 140
           F D+ QL     G G    V   + +   QE AVK +             EV++L + Q 
Sbjct: 10  FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQG 69
Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
           H+N++ L     E     LV+E +   S+   I  +   + L+ +    +V  VA  L +
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDF 126
Query: 201 LHEEAPARIIHRDIKASNILLDE--QLNP-KISDFGLAR--LFPGEDTHVNTFRI---SG 252
           LH +    I HRD+K  NIL +   Q++P KI DFGL       G+ + ++T  +    G
Sbjct: 127 LHNKG---IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCG 183
Query: 253 THGYMAPEY--ALHGYLSV---KTDVFSYGVLVLEIVSGRKNHDGRLGKE 297
           +  YMAPE   A     S+   + D++S GV++  ++SG     GR G +
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD 233

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 21/215 (9%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
           + +L  +G G  G V   Y  ++   + +A+KKLS    ++   +    E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARGL 198
           N+++L       P+K L  E   +  L   + D    +     LD      ++  +  G+
Sbjct: 84  NIISLLNVFT--PQKTL--EEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGI 139
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMA 258
            +LH    A IIHRD+K SNI++      KI DFGLAR   G    +  + +  T  Y A
Sbjct: 140 KHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLART-AGTSFMMTPYVV--TRYYRA 193
Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           PE  L        D++S G ++ E+V  +    GR
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 228

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 95/216 (43%), Gaps = 37/216 (17%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
           + +L  +G G  G V   Y  ++   + +A+KKLS    ++   +    E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYF--------IFDKTKSS----SLDWTTRYRI 190
           N++ L               + P KSL+ F        + D   S      LD      +
Sbjct: 84  NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL 131
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
           +  +  G+ +LH    A IIHRD+K SNI++      KI DFGLAR   G    +  + +
Sbjct: 132 LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDATLKILDFGLART-AGTSFMMTPYVV 187
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
             T  Y APE  L        D++S G ++ E++ G
Sbjct: 188 --TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 21/215 (9%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
           + +L  +G G  G V   Y  ++   + +A+KKLS    ++   +    E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHK 83
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARGL 198
           N+++L       P+K L  E   +  L   + D    +     LD      ++  +  G+
Sbjct: 84  NIISLLNVFT--PQKTL--EEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGI 139
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMA 258
            +LH    A IIHRD+K SNI++      KI DFGLAR   G    +  + +  T  Y A
Sbjct: 140 KHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLART-AGTSFMMTPYVV--TRYYRA 193
Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           PE  L        D++S G ++ E+V  +    GR
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 228

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 37/216 (17%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
           + +L  +G G  G V   Y  ++   + +A+KKLS    ++   +    E+ L+  + HK
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLD-----YFIFD-------KTKSSSLDWTTRYRI 190
           N++ L               + P KSL+     Y + +       +     LD      +
Sbjct: 85  NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 132
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
           +  +  G+ +LH    A IIHRD+K SNI++      KI DFGLAR   G    +  + +
Sbjct: 133 LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVV 188
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
             T  Y APE  L        D++S G ++ E++ G
Sbjct: 189 --TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 21/215 (9%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
           + +L  +G G  G V   Y  ++   + +A+KKLS    ++   +    E+ L+  + HK
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARGL 198
           N+++L       P+K L  E   +  L   + D    +     LD      ++  +  G+
Sbjct: 77  NIISLLNVFT--PQKTL--EEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGI 132
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMA 258
            +LH    A IIHRD+K SNI++      KI DFGLAR   G    +  + +  T  Y A
Sbjct: 133 KHLHS---AGIIHRDLKPSNIVVKSDXTLKILDFGLART-AGTSFMMTPYVV--TRYYRA 186
Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           PE  L        D++S G ++ E+V  +    GR
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 90/208 (43%), Gaps = 29/208 (13%)
Query: 93  QLGHGGFGPVYRGLMPNGQ------EIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           ++G G F  VY+GL           E+  +KL+   RQ  +E   E + L  +QH N+V 
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKE---EAEXLKGLQHPNIVR 89
Query: 147 LFGC---CAEGPEKM-LVYEYLPNKSLDYFI--FDKTKSSSL-DWTTRYRIVMGVARGLL 199
            +       +G + + LV E   + +L  ++  F   K   L  W  +      + +GL 
Sbjct: 90  FYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQ------ILKGLQ 143
Query: 200 YLHEEAPARIIHRDIKASNILLDEQL-NPKISDFGLARLFPGEDTHVNTFRISGTHGYMA 258
           +LH   P  IIHRD+K  NI +     + KI D GLA L            + GT  + A
Sbjct: 144 FLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFXA 198
Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVSG 286
           PE     Y     DV+++G   LE  + 
Sbjct: 199 PEXYEEKY-DESVDVYAFGXCXLEXATS 225

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/269 (23%), Positives = 99/269 (36%), Gaps = 78/269 (28%)
Query: 88  FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLV 145
           F  +  +G GGFG V+      +    A+K++ + +R+  RE    EVK L K++H  +V
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 146 TLFGCCAEGPEKMLVYE----YLPNKSLDYFIFDKT------------------------ 177
             F    E P +    E    +L ++S D+ +   +                        
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 178 -----------------KSSSLDWTTR------------YRIVMGVARGLLYLHEEAPAR 208
                            K +  DW  R              I + +A  + +LH +    
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG--- 184
Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLF-------------PGEDTHVNTFRISGTHG 255
           ++HRD+K SNI        K+ DFGL                 P   TH       GT  
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQV---GTKL 241
Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIV 284
           YM+PE       S K D+FS G+++ E++
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 37/216 (17%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
           + +L  +G G  G V   Y  ++   + +A+KKLS    ++   +    E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLD-----YFIFD-------KTKSSSLDWTTRYRI 190
           N++ L               + P KSL+     Y + +       +     LD      +
Sbjct: 84  NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
           +  +  G+ +LH    A IIHRD+K SNI++      KI DFGLAR   G    +  + +
Sbjct: 132 LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVV 187
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
             T  Y APE  L        D++S G ++ E++ G
Sbjct: 188 --TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 96/219 (43%), Gaps = 43/219 (19%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
           + +L  +G G  G V   Y  ++   + +A+KKLS    ++   +    E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLD-----YFIFD-------KTKSSSLDWTTRYRI 190
           N++ L               + P KSL+     Y + +       +     LD      +
Sbjct: 84  NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
           +  +  G+ +LH    A IIHRD+K SNI++      KI DFGLAR      T   +F +
Sbjct: 132 LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFMM 182
Query: 251 SG---THGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
           +    T  Y APE  L        D++S G ++ E++ G
Sbjct: 183 TPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 21/215 (9%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
           + +L  +G G  G V   Y  ++   + +A+KKLS    ++   +    E+ L+  + HK
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARGL 198
           N+++L       P+K L  E   +  L   + D    +     LD      ++  +  G+
Sbjct: 122 NIISLLNVFT--PQKTL--EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 177
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMA 258
            +LH    A IIHRD+K SNI++      KI DFGLAR   G    +  + +  T  Y A
Sbjct: 178 KHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVV--TRYYRA 231
Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           PE  L        D++S G ++ E+V  +    GR
Sbjct: 232 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 266

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 21/215 (9%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
           + +L  +G G  G V   Y  ++   + +A+KKLS    ++   +    E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARGL 198
           N+++L       P+K L  E   +  L   + D    +     LD      ++  +  G+
Sbjct: 84  NIISLLNVFT--PQKTL--EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMA 258
            +LH    A IIHRD+K SNI++      KI DFGLAR   G    +  + +  T  Y A
Sbjct: 140 KHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVV--TRYYRA 193
Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           PE  L        D++S G ++ E+V  +    GR
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 228

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 37/216 (17%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
           + +L  +G G  G V   Y  ++   + +A+KKLS    ++   +    E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLD-----YFIFD-------KTKSSSLDWTTRYRI 190
           N++ L               + P KSL+     Y + +       +     LD      +
Sbjct: 84  NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
           +  +  G+ +LH    A IIHRD+K SNI++      KI DFGLAR   G    +  + +
Sbjct: 132 LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVV 187
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
             T  Y APE  L        D++S G ++ E++ G
Sbjct: 188 --TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 21/215 (9%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
           + +L  +G G  G V   Y  ++   + +A+KKLS    ++   +    E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARGL 198
           N+++L       P+K L  E   +  L   + D    +     LD      ++  +  G+
Sbjct: 84  NIISLLNVFT--PQKTL--EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMA 258
            +LH    A IIHRD+K SNI++      KI DFGLAR   G    +  + +  T  Y A
Sbjct: 140 KHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVV--TRYYRA 193
Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           PE  L        D++S G ++ E+V  +    GR
Sbjct: 194 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 228

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 21/215 (9%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
           + +L  +G G  G V   Y  ++   + +A+KKLS    ++   +    E+ L+  + HK
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARGL 198
           N+++L       P+K L  E   +  L   + D    +     LD      ++  +  G+
Sbjct: 78  NIISLLNVFT--PQKTL--EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 133
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMA 258
            +LH    A IIHRD+K SNI++      KI DFGLAR   G    +  + +  T  Y A
Sbjct: 134 KHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVV--TRYYRA 187
Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           PE  L        D++S G ++ E+V  +    GR
Sbjct: 188 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 222

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 21/215 (9%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
           + +L  +G G  G V   Y  ++   + +A+KKLS    ++   +    E+ L+  + HK
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARGL 198
           N+++L       P+K L  E   +  L   + D    +     LD      ++  +  G+
Sbjct: 78  NIISLLNVFT--PQKTL--EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 133
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMA 258
            +LH    A IIHRD+K SNI++      KI DFGLAR   G    +  + +  T  Y A
Sbjct: 134 KHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVV--TRYYRA 187
Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           PE  L        D++S G ++ E+V  +    GR
Sbjct: 188 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 222

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 21/215 (9%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
           + +L  +G G  G V   Y  ++   + +A+KKLS    ++   +    E+ L+  + HK
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARGL 198
           N+++L       P+K L  E   +  L   + D    +     LD      ++  +  G+
Sbjct: 85  NIISLLNVFT--PQKTL--EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 140
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMA 258
            +LH    A IIHRD+K SNI++      KI DFGLAR   G    +  + +  T  Y A
Sbjct: 141 KHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVV--TRYYRA 194
Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           PE  L        D++S G ++ E+V  +    GR
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 229

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 21/215 (9%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
           + +L  +G G  G V   Y  ++   + +A+KKLS    ++   +    E+ L+  + HK
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARGL 198
           N+++L       P+K L  E   +  L   + D    +     LD      ++  +  G+
Sbjct: 85  NIISLLNVFT--PQKTL--EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 140
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMA 258
            +LH    A IIHRD+K SNI++      KI DFGLAR   G    +  + +  T  Y A
Sbjct: 141 KHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVV--TRYYRA 194
Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           PE  L        D++S G ++ E+V  +    GR
Sbjct: 195 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 229

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 21/215 (9%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
           + +L  +G G  G V   Y  ++   + +A+KKLS    ++   +    E+ L+  + HK
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARGL 198
           N+++L       P+K L  E   +  L   + D    +     LD      ++  +  G+
Sbjct: 77  NIISLLNVFT--PQKTL--EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 132
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMA 258
            +LH    A IIHRD+K SNI++      KI DFGLAR   G    +  + +  T  Y A
Sbjct: 133 KHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVV--TRYYRA 186
Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           PE  L        D++S G ++ E+V  +    GR
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 21/215 (9%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
           + +L  +G G  G V   Y  ++   + +A+KKLS    ++   +    E+ L+  + HK
Sbjct: 25  YQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 82
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARGL 198
           N+++L       P+K L  E   +  L   + D    +     LD      ++  +  G+
Sbjct: 83  NIISLLNVFT--PQKTL--EEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 138
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMA 258
            +LH    A IIHRD+K SNI++      KI DFGLAR   G    +  + +  T  Y A
Sbjct: 139 KHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVV--TRYYRA 192
Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           PE  L        D++S G ++ E+V  +    GR
Sbjct: 193 PEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 227

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           YLH      +I+RD+K  N+L+D+Q   K++DFG A+   G      T+ + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAP 208
Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVSG 286
           E  L    +   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/226 (27%), Positives = 104/226 (46%), Gaps = 23/226 (10%)
Query: 66  GSGAD--SWNLFFDLRTLQVATNFFS-DLNQLGHGGFGPVYRGLMPN-GQEIAVKKLSVD 121
            SG D  + NL+F  ++++   NF+     +LG G F  V + +  + GQE A K L   
Sbjct: 8   SSGVDLGTENLYF--QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKR 65
Query: 122 SR-QGLR-EFTNEVKLL-LKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTK 178
            R Q  R E  +E+ +L L      ++ L        E +L+ EY     +      +  
Sbjct: 66  RRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL- 124
Query: 179 SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP----KISDFGL 234
           +  +      R++  +  G+ YLH+     I+H D+K  NILL   + P    KI DFG+
Sbjct: 125 AEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLS-SIYPLGDIKIVDFGM 180
Query: 235 ARLFPGEDTHVNTFR-ISGTHGYMAPEYALHGYLSVKTDVFSYGVL 279
           +R       H    R I GT  Y+APE   +  ++  TD+++ G++
Sbjct: 181 SRKI----GHACELREIMGTPEYLAPEILNYDPITTATDMWNIGII 222

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           YLH      +I+RD+K  N+L+DEQ   +++DFG A+   G      T+ + GT  Y+AP
Sbjct: 143 YLHS---LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 194
Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVSG 286
           E  L    +   D ++ GVL+ E+ +G
Sbjct: 195 EIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 23/227 (10%)
Query: 88  FSDLNQLGHGGFGP-VYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLV 145
           F   + LGHG  G  VYRG+  N +++AVK++  +          EV+LL +  +H N++
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDN-RDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81
Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMGVARGLLYLHEE 204
             F C  +  +   +   L   +L  ++  K  +   L+  T   ++     GL +LH  
Sbjct: 82  RYF-CTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPIT---LLQQTTSGLAHLHS- 136
Query: 205 APARIIHRDIKASNILLDE-----QLNPKISDFGLA-RLFPGEDTHVNTFRISGTHGYMA 258
               I+HRD+K  NIL+       ++   ISDFGL  +L  G  +      + GT G++A
Sbjct: 137 --LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 259 PEYALHGYLSVKT---DVFSYGVLVLEIVSGRKNHDGRLGKEKADLL 302
           PE          T   D+FS G +   ++S   +  G+  + +A++L
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL 241

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 50/87 (57%), Gaps = 8/87 (9%)
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           YLH      +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ ++GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLAGTPEYLAP 207
Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVSG 286
           E  L    +   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 43/226 (19%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
           + +L  +G G  G V   Y  ++   + +A+KKLS    ++   +    E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLD-----YFIFD-------KTKSSSLDWTTRYRI 190
           N++ L               + P KSL+     Y + +       +     LD      +
Sbjct: 84  NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
           +  +  G+ +LH    A IIHRD+K SNI++      KI DFGLAR      T   +F +
Sbjct: 132 LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFMM 182
Query: 251 SG---THGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
                T  Y APE  L        D++S G ++ E+V  +    GR
Sbjct: 183 EPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGR 228

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 37/223 (16%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
           + +L  +G G  G V   Y  ++   + +A+KKLS    ++   +    E+ L+  + HK
Sbjct: 31  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 88
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLD-----YFIFD-------KTKSSSLDWTTRYRI 190
           N++ L               + P KSL+     Y + +       +     LD      +
Sbjct: 89  NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 136
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
           +  +  G+ +LH    A IIHRD+K SNI++      KI DFGLAR   G    +  + +
Sbjct: 137 LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVV 192
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
             T  Y APE  L        D++S G ++ E+V  +    GR
Sbjct: 193 --TRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGR 233

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 15/203 (7%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V       +G   A+K L       L++     NE ++L  +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           LV L     +     +V EY+    +  F   +      +   R+     +     YLH 
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHS 159
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
                +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+APE  L
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIIL 211
Query: 264 HGYLSVKTDVFSYGVLVLEIVSG 286
               +   D ++ GVL+ E+ +G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 15/203 (7%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V       +G   A+K L       L++     NE ++L  +    
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           LV L     +     +V EY+    +  F   +      +   R+     +     YLH 
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHS 180
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
                +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+APE  L
Sbjct: 181 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIIL 232
Query: 264 HGYLSVKTDVFSYGVLVLEIVSG 286
               +   D ++ GVL+ E+ +G
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 37/223 (16%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
           + +L  +G G  G V   Y  ++   + +A+KKLS    ++   +    E+ L+  + HK
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 77
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLD-----YFIFD-------KTKSSSLDWTTRYRI 190
           N++ L               + P KSL+     Y + +       +     LD      +
Sbjct: 78  NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 125
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
           +  +  G+ +LH    A IIHRD+K SNI++      KI DFGLAR   G    +  + +
Sbjct: 126 LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMMTPYVV 181
Query: 251 SGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
             T  Y APE  L        D++S G ++ E+V  +    GR
Sbjct: 182 --TRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGR 222

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN------EVKLLLKIQH--KNL 144
           LG GGFG VY G+ + +   +A+K +  D      E  N      EV LL K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L     E P+  ++    P    D F F  T+  +L           V   + + H  
Sbjct: 92  IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 148
Query: 205 APARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA- 262
               ++HRDIK  NIL+D  +   K+ DFG   L   +DT    F   GT  Y  PE+  
Sbjct: 149 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDF--DGTRVYSPPEWIR 202
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
            H Y      V+S G+L+ ++V G
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN------EVKLLLKIQH--KNL 144
           LG GGFG VY G+ + +   +A+K +  D      E  N      EV LL K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L     E P+  ++    P    D F F  T+  +L           V   + + H  
Sbjct: 92  IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 148
Query: 205 APARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA- 262
               ++HRDIK  NIL+D  +   K+ DFG   L   +DT    F   GT  Y  PE+  
Sbjct: 149 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDF--DGTRVYSPPEWIR 202
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
            H Y      V+S G+L+ ++V G
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN------EVKLLLKIQH--KNL 144
           LG GGFG VY G+ + +   +A+K +  D      E  N      EV LL K+      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L     E P+  ++    P    D F F  T+  +L           V   + + H  
Sbjct: 91  IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 147
Query: 205 APARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA- 262
               ++HRDIK  NIL+D  +   K+ DFG   L   +DT    F   GT  Y  PE+  
Sbjct: 148 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDF--DGTRVYSPPEWIR 201
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
            H Y      V+S G+L+ ++V G
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN------EVKLLLKIQH--KNL 144
           LG GGFG VY G+ + +   +A+K +  D      E  N      EV LL K+      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L     E P+  ++    P    D F F  T+  +L           V   + + H  
Sbjct: 91  IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 147
Query: 205 APARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA- 262
               ++HRDIK  NIL+D  +   K+ DFG   L   +DT    F   GT  Y  PE+  
Sbjct: 148 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDF--DGTRVYSPPEWIR 201
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
            H Y      V+S G+L+ ++V G
Sbjct: 202 YHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN------EVKLLLKIQH--KNL 144
           LG GGFG VY G+ + +   +A+K +  D      E  N      EV LL K+      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L     E P+  ++    P    D F F  T+  +L           V   + + H  
Sbjct: 92  IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 148
Query: 205 APARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA- 262
               ++HRDIK  NIL+D  +   K+ DFG   L   +DT    F   GT  Y  PE+  
Sbjct: 149 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDF--DGTRVYSPPEWIR 202
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
            H Y      V+S G+L+ ++V G
Sbjct: 203 YHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN------EVKLLLKIQH--KNL 144
           LG GGFG VY G+ + +   +A+K +  D      E  N      EV LL K+      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L     E P+  ++    P    D F F  T+  +L           V   + + H  
Sbjct: 111 IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 167
Query: 205 APARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA- 262
               ++HRDIK  NIL+D  +   K+ DFG   L   +DT    F   GT  Y  PE+  
Sbjct: 168 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDF--DGTRVYSPPEWIR 221
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
            H Y      V+S G+L+ ++V G
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCG 245

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 15/203 (7%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V       +G   A+K L       L++     NE ++L  +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           LV L     +     +V EY+    +  F   +      +   R+     +     YLH 
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHS 159
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
                +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+APE  L
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIIL 211
Query: 264 HGYLSVKTDVFSYGVLVLEIVSG 286
               +   D ++ GVL+ E+ +G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 15/203 (7%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V       +G   A+K L       L++     NE ++L  +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           LV L     +     +V EY+    +  F   +      +   R+     +     YLH 
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFXEPHARFYAAQ-IVLTFEYLHS 159
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
                +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+APE  L
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIIL 211
Query: 264 HGYLSVKTDVFSYGVLVLEIVSG 286
               +   D ++ GVL+ E+ +G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 15/203 (7%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V       +G   A+K L       L++     NE ++L  +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           LV L     +     +V EY+    +  F   +      +   R+     +     YLH 
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFAEPHARFYAAQ-IVLTFEYLHS 159
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
                +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+APE  L
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIIL 211
Query: 264 HGYLSVKTDVFSYGVLVLEIVSG 286
               +   D ++ GVL+ E+ +G
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN------EVKLLLKIQ--HKNL 144
           LG GGFG VY G+ + +   +A+K +  D      E  N      EV LL K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L     E P+  ++    P    D F F  T+  +L           V   + + H  
Sbjct: 72  IRLLDWF-ERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHNX 129
Query: 205 APARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA- 262
               ++HRDIK  NIL+D  +   K+ DFG   L   +DT    F   GT  Y  PE+  
Sbjct: 130 G---VLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDF--DGTRVYSPPEWIR 182
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
            H Y      V+S G+L+ ++V G
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN------EVKLLLKIQH--KNL 144
           LG GGFG VY G+ + +   +A+K +  D      E  N      EV LL K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L     E P+  ++    P    D F F  T+  +L           V   + + H  
Sbjct: 105 IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 161
Query: 205 APARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA- 262
               ++HRDIK  NIL+D  +   K+ DFG   L   +DT    F   GT  Y  PE+  
Sbjct: 162 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDF--DGTRVYSPPEWIR 215
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
            H Y      V+S G+L+ ++V G
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN------EVKLLLKIQH--KNL 144
           LG GGFG VY G+ + +   +A+K +  D      E  N      EV LL K+      +
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L     E P+  ++    P    D F F  T+  +L           V   + + H  
Sbjct: 124 IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 180
Query: 205 APARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA- 262
               ++HRDIK  NIL+D  +   K+ DFG   L   +DT    F   GT  Y  PE+  
Sbjct: 181 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDF--DGTRVYSPPEWIR 234
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
            H Y      V+S G+L+ ++V G
Sbjct: 235 YHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 15/203 (7%)
Query: 88  FSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLSVDSRQGLREFT---NEVKLLLKIQHKN 143
           F  +  LG G FG V       +G   A+K L       L++     NE ++L  +    
Sbjct: 38  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 97
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           LV L     +     +V EY+    +  F   +      +   R+     +     YLH 
Sbjct: 98  LVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFXEPHARF-YAAQIVLTFEYLHS 154
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
                +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+APE  L
Sbjct: 155 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIIL 206
Query: 264 HGYLSVKTDVFSYGVLVLEIVSG 286
               +   D ++ GVL+ E+ +G
Sbjct: 207 SKGYNKAVDWWALGVLIYEMAAG 229

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN------EVKLLLKIQH--KNL 144
           LG GGFG VY G+ + +   +A+K +  D      E  N      EV LL K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L     E P+  ++    P    D F F  T+  +L           V   + + H  
Sbjct: 105 IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 161
Query: 205 APARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA- 262
               ++HRDIK  NIL+D  +   K+ DFG   L   +DT    F   GT  Y  PE+  
Sbjct: 162 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDF--DGTRVYSPPEWIR 215
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
            H Y      V+S G+L+ ++V G
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN------EVKLLLKIQH--KNL 144
           LG GGFG VY G+ + +   +A+K +  D      E  N      EV LL K+      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L     E P+  ++    P    D F F  T+  +L           V   + + H  
Sbjct: 119 IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 175
Query: 205 APARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA- 262
               ++HRDIK  NIL+D  +   K+ DFG   L   +DT    F   GT  Y  PE+  
Sbjct: 176 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDF--DGTRVYSPPEWIR 229
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
            H Y      V+S G+L+ ++V G
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN------EVKLLLKIQH--KNL 144
           LG GGFG VY G+ + +   +A+K +  D      E  N      EV LL K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L     E P+  ++    P    D F F  T+  +L           V   + + H  
Sbjct: 105 IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 161
Query: 205 APARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA- 262
               ++HRDIK  NIL+D  +   K+ DFG   L   +DT    F   GT  Y  PE+  
Sbjct: 162 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDF--DGTRVYSPPEWIR 215
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
            H Y      V+S G+L+ ++V G
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN------EVKLLLKIQH--KNL 144
           LG GGFG VY G+ + +   +A+K +  D      E  N      EV LL K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L     E P+  ++    P    D F F  T+  +L           V   + + H  
Sbjct: 104 IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 160
Query: 205 APARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA- 262
               ++HRDIK  NIL+D  +   K+ DFG   L   +DT    F   GT  Y  PE+  
Sbjct: 161 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDF--DGTRVYSPPEWIR 214
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
            H Y      V+S G+L+ ++V G
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN------EVKLLLKIQH--KNL 144
           LG GGFG VY G+ + +   +A+K +  D      E  N      EV LL K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L     E P+  ++    P    D F F  T+  +L           V   + + H  
Sbjct: 104 IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 160
Query: 205 APARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA- 262
               ++HRDIK  NIL+D  +   K+ DFG   L   +DT    F   GT  Y  PE+  
Sbjct: 161 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDF--DGTRVYSPPEWIR 214
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
            H Y      V+S G+L+ ++V G
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN------EVKLLLKIQH--KNL 144
           LG GGFG VY G+ + +   +A+K +  D      E  N      EV LL K+      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L     E P+  ++    P    D F F  T+  +L           V   + + H  
Sbjct: 119 IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 175
Query: 205 APARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA- 262
               ++HRDIK  NIL+D  +   K+ DFG   L   +DT    F   GT  Y  PE+  
Sbjct: 176 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDF--DGTRVYSPPEWIR 229
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
            H Y      V+S G+L+ ++V G
Sbjct: 230 YHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN------EVKLLLKIQH--KNL 144
           LG GGFG VY G+ + +   +A+K +  D      E  N      EV LL K+      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L     E P+  ++    P    D F F  T+  +L           V   + + H  
Sbjct: 105 IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 161
Query: 205 APARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA- 262
               ++HRDIK  NIL+D  +   K+ DFG   L   +DT    F   GT  Y  PE+  
Sbjct: 162 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDF--DGTRVYSPPEWIR 215
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
            H Y      V+S G+L+ ++V G
Sbjct: 216 YHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           YLH      +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLXGTPEYLAP 207
Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVSG 286
           E  L    +   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN------EVKLLLKIQH--KNL 144
           LG GGFG VY G+ + +   +A+K +  D      E  N      EV LL K+      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L     E P+  ++    P    D F F  T+  +L           V   + + H  
Sbjct: 76  IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 132
Query: 205 APARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA- 262
               ++HRDIK  NIL+D  +   K+ DFG   L   +DT    F   GT  Y  PE+  
Sbjct: 133 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDF--DGTRVYSPPEWIR 186
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
            H Y      V+S G+L+ ++V G
Sbjct: 187 YHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN------EVKLLLKIQH--KNL 144
           LG GGFG VY G+ + +   +A+K +  D      E  N      EV LL K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L     E P+  ++    P    D F F  T+  +L           V   + + H  
Sbjct: 77  IRLLDWF-ERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 133
Query: 205 APARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA- 262
               ++HRDIK  NIL+D  +   K+ DFG   L   +DT    F   GT  Y  PE+  
Sbjct: 134 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDF--DGTRVYSPPEWIR 187
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
            H Y      V+S G+L+ ++V G
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN------EVKLLLKIQH--KNL 144
           LG GGFG VY G+ + +   +A+K +  D      E  N      EV LL K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L     E P+  ++    P    D F F  T+  +L           V   + + H  
Sbjct: 104 IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 160
Query: 205 APARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA- 262
               ++HRDIK  NIL+D  +   K+ DFG   L   +DT    F   GT  Y  PE+  
Sbjct: 161 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDF--DGTRVYSPPEWIR 214
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
            H Y      V+S G+L+ ++V G
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           YLH      +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+AP
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 208
Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVSG 286
           E  L    +   D ++ GVL+ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           YLH      +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVSG 286
           E  L    +   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN------EVKLLLKIQH--KNL 144
           LG GGFG VY G+ + +   +A+K +  D      E  N      EV LL K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L     E P+  ++    P    D F F  T+  +L           V   + + H  
Sbjct: 77  IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 133
Query: 205 APARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA- 262
               ++HRDIK  NIL+D  +   K+ DFG   L   +DT    F   GT  Y  PE+  
Sbjct: 134 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDF--DGTRVYSPPEWIR 187
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
            H Y      V+S G+L+ ++V G
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           YLH      +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVSG 286
           E  L    +   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           YLH      +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVSG 286
           E  L    +   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           YLH      +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVSG 286
           E  L    +   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN------EVKLLLKIQH--KNL 144
           LG GGFG VY G+ + +   +A+K +  D      E  N      EV LL K+      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L     E P+  ++    P    D F F  T+  +L           V   + + H  
Sbjct: 104 IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 160
Query: 205 APARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA- 262
               ++HRDIK  NIL+D  +   K+ DFG   L   +DT    F   GT  Y  PE+  
Sbjct: 161 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDF--DGTRVYSPPEWIR 214
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
            H Y      V+S G+L+ ++V G
Sbjct: 215 YHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           YLH      +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVSG 286
           E  L    +   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN------EVKLLLKIQH--KNL 144
           LG GGFG VY G+ + +   +A+K +  D      E  N      EV LL K+      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L     E P+  ++    P    D F F  T+  +L           V   + + H  
Sbjct: 77  IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 133
Query: 205 APARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA- 262
               ++HRDIK  NIL+D  +   K+ DFG   L   +DT    F   GT  Y  PE+  
Sbjct: 134 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDF--DGTRVYSPPEWIR 187
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
            H Y      V+S G+L+ ++V G
Sbjct: 188 YHRYHGRSAAVWSLGILLYDMVCG 211

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 43/226 (19%)
Query: 88  FSDLNQLGHGGFGPV---YRGLMPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHK 142
           + +L  +G G  G V   Y  ++   + +A+KKLS    ++   +    E+ L+  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLD-----YFIFD-------KTKSSSLDWTTRYRI 190
           N++ L               + P KSL+     Y + +       +     LD      +
Sbjct: 84  NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
           +  +  G+ +LH    A IIHRD+K SNI++      KI DFGLAR      T   +F +
Sbjct: 132 LYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFMM 182
Query: 251 SG---THGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
                T  Y APE  L        D++S G ++ E+V  +    GR
Sbjct: 183 EPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGR 228

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN------EVKLLLKIQ--HKNL 144
           LG GGFG VY G+ + +   +A+K +  D      E  N      EV LL K+      +
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L     E P+  ++    P    D F F  T+  +L           V   + + H  
Sbjct: 75  IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 131
Query: 205 APARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA- 262
               ++HRDIK  NIL+D  +   K+ DFG   L   +DT    F   GT  Y  PE+  
Sbjct: 132 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDF--DGTRVYSPPEWIR 185
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
            H Y      V+S G+L+ ++V G
Sbjct: 186 YHRYHGRSAAVWSLGILLYDMVCG 209

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN------EVKLLLKIQ--HKNL 144
           LG GGFG VY G+ + +   +A+K +  D      E  N      EV LL K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L     E P+  ++    P    D F F  T+  +L           V   + + H  
Sbjct: 72  IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 128
Query: 205 APARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA- 262
               ++HRDIK  NIL+D  +   K+ DFG   L   +DT    F   GT  Y  PE+  
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDF--DGTRVYSPPEWIR 182
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
            H Y      V+S G+L+ ++V G
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 16/201 (7%)
Query: 66  GSGAD--SWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS- 122
            SG D  + NL+F  +++ V    +S L Q+G GG   V++ L    Q  A+K ++++  
Sbjct: 8   SSGVDLGTENLYF--QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA 65
Query: 123 -RQGLREFTNEVKLLLKIQHKN--LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKS 179
             Q L  + NE+  L K+Q  +  ++ L+          +V E   N  L+ ++    K 
Sbjct: 66  DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL---KKK 121
Query: 180 SSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239
            S+D   R      +   +  +H+     I+H D+K +N L+ + +  K+ DFG+A    
Sbjct: 122 KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQ 177
Query: 240 GEDTHVNTFRISGTHGYMAPE 260
            + T V      GT  YM PE
Sbjct: 178 PDTTSVVKDSQVGTVNYMPPE 198

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 91/222 (40%), Gaps = 26/222 (11%)
Query: 78  LRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKL----SVDSRQGLREFTNEV 133
           +R LQ+    +  +  +G G FG V        Q++   KL     +  R     F  E 
Sbjct: 67  IRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEER 126
Query: 134 KLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL-----DYFIFDKTKSSSLDWTTRY 188
            ++       +V LF    +     +V EY+P   L     +Y + +K       W   Y
Sbjct: 127 DIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK-------WAKFY 179
Query: 189 RIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
                 A  +L L       +IHRD+K  N+LLD+  + K++DFG   +   E   V+  
Sbjct: 180 -----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC-MKMDETGMVHCD 233
Query: 249 RISGTHGYMAPEYAL----HGYLSVKTDVFSYGVLVLEIVSG 286
              GT  Y++PE        GY   + D +S GV + E++ G
Sbjct: 234 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           YLH      +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+AP
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGA-----TWTLCGTPEYLAP 228
Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVSG 286
           E  L    +   D ++ GVL+ E+ +G
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN------EVKLLLKIQ--HKNL 144
           LG GGFG VY G+ + +   +A+K +  D      E  N      EV LL K+      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L     E P+  ++    P    D F F  T+  +L           V   + + H  
Sbjct: 72  IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 128
Query: 205 APARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA- 262
               ++HRDIK  NIL+D  +   K+ DFG   L   +DT    F   GT  Y  PE+  
Sbjct: 129 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDF--DGTRVYSPPEWIR 182
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
            H Y      V+S G+L+ ++V G
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 20/204 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN------EVKLLLKIQ--HKNL 144
           LG GGFG VY G+ + +   +A+K +  D      E  N      EV LL K+      +
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 98
Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L     E P+  ++    P    D F F  T+  +L           V   + + H  
Sbjct: 99  IRLLDW-FERPDSFVLILERPEPVQDLFDF-ITERGALQEELARSFFWQVLEAVRHCHN- 155
Query: 205 APARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA- 262
               ++HRDIK  NIL+D  +   K+ DFG   L   +DT    F   GT  Y  PE+  
Sbjct: 156 --CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDF--DGTRVYSPPEWIR 209
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSG 286
            H Y      V+S G+L+ ++V G
Sbjct: 210 YHRYHGRSAAVWSLGILLYDMVCG 233

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 18/207 (8%)
Query: 86  NFFSDLNQLGHGGFGPVYRGLMPNGQEI--AVKKLSVDSRQGLREFTNEVKLLLKIQHKN 143
            +++  N +G G +G V +  +  G  I  A KK+     + +  F  E++++  + H N
Sbjct: 9   QYYTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           ++ L+    +  +  LV E      L   +  K      D     RI+  V   + Y H+
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA---RIMKDVLSAVAYCHK 124
Query: 204 EAPARIIHRDIKASNILL--DEQLNP-KISDFGL-ARLFPGEDTHVNTFRISGTHGYMAP 259
                + HRD+K  N L   D   +P K+ DFGL AR  PG+          GT  Y++P
Sbjct: 125 ---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV----GTPYYVSP 177
Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVSG 286
           +  L G    + D +S GV++  ++ G
Sbjct: 178 Q-VLEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 99/239 (41%), Gaps = 27/239 (11%)
Query: 73  NLFFDLRTLQVATNFFSDLNQLGHGGFGPV--YRGLMPNGQEIAVKKLSVDSRQGLREFT 130
           NL+F    + +    +  + +LG GGF  V    GL  +G   A+K++    +Q   E  
Sbjct: 16  NLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLH-DGHFYALKRILCHEQQDREEAQ 74
Query: 131 NEVKLLLKIQHKNLVTLFGCC----AEGPEKMLVYEYLPNKSLDYFIFD-KTKSSSLDWT 185
            E  +     H N++ L   C        E  L+  +    +L   I   K K + L   
Sbjct: 75  READMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTED 134
Query: 186 TRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV 245
               +++G+ RGL  +H +  A   HRD+K +NILL ++  P + D G          HV
Sbjct: 135 QILWLLLGICRGLEAIHAKGYA---HRDLKPTNILLGDEGQPVLMDLGSMN---QACIHV 188
Query: 246 NTFRIS----------GTHGYMAPE---YALHGYLSVKTDVFSYGVLVLEIVSGRKNHD 291
              R +           T  Y APE      H  +  +TDV+S G ++  ++ G   +D
Sbjct: 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 22/206 (10%)
Query: 94  LGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTN------EVKLLLKIQ----HK 142
           LG GGFG V+ G  + +  ++A+K +  +   G    ++      EV LL K+     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
            ++ L          MLV E  P  + D F +   K    +  +R      VA  + + H
Sbjct: 99  GVIRLLDWFETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSRCFFGQVVA-AIQHCH 156
Query: 203 EEAPARIIHRDIKASNILLDEQLN-PKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEY 261
                 ++HRDIK  NIL+D +    K+ DFG   L    D     F   GT  Y  PE+
Sbjct: 157 SRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALL--HDEPYTDF--DGTRVYSPPEW 209
Query: 262 -ALHGYLSVKTDVFSYGVLVLEIVSG 286
            + H Y ++   V+S G+L+ ++V G
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCG 235

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 66/230 (28%), Positives = 105/230 (45%), Gaps = 26/230 (11%)
Query: 88  FSDLNQL-----GHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ- 140
           F D+ QL     G G    V   + +   QE AVK +             EV++L + Q 
Sbjct: 10  FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQG 69
Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
           H+N++ L     E     LV+E +   S+   I  +   + L+ +    +V  VA  L +
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDF 126
Query: 201 LHEEAPARIIHRDIKASNILLDE--QLNP-KISDFGLAR--LFPGEDTHVNTFRI---SG 252
           LH +    I HRD+K  NIL +   Q++P KI DF L       G+ + ++T  +    G
Sbjct: 127 LHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183
Query: 253 THGYMAPEY--ALHGYLSV---KTDVFSYGVLVLEIVSGRKNHDGRLGKE 297
           +  YMAPE   A     S+   + D++S GV++  ++SG     GR G +
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD 233

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 111/246 (45%), Gaps = 46/246 (18%)
Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTN----EVKLLLKIQ-HKNLVTLF 148
           LG+G  G V       G+ +AVK++ +D       F +    E+KLL +   H N++  +
Sbjct: 41  LGYGSSGTVVFQGSFQGRPVAVKRMLID-------FCDIALMEIKLLTESDDHPNVIRYY 93
Query: 149 GCCAEGPEKML-VYEYLPNKSLDYFIFDKTKS-SSLDWTTRYR---IVMGVARGLLYLHE 203
             C+E  ++ L +   L N +L   +  K  S  +L     Y    ++  +A G+ +LH 
Sbjct: 94  --CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 151
Query: 204 EAPARIIHRDIKASNILLD-------------EQLNPKISDFGLARLFPGEDTHVNTFRI 250
               +IIHRD+K  NIL+              E L   ISDFGL +     D+    FR 
Sbjct: 152 ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL---DSGQXXFRX 205
Query: 251 -----SGTHGYMAPEY---ALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLL 302
                SGT G+ APE    +    L+   D+FS G +   I+S  K+  G     +++++
Sbjct: 206 NLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 265
Query: 303 SYTWTL 308
              ++L
Sbjct: 266 RGIFSL 271

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 68/246 (27%), Positives = 111/246 (45%), Gaps = 46/246 (18%)
Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTN----EVKLLLKIQ-HKNLVTLF 148
           LG+G  G V       G+ +AVK++ +D       F +    E+KLL +   H N++  +
Sbjct: 41  LGYGSSGTVVFQGSFQGRPVAVKRMLID-------FCDIALMEIKLLTESDDHPNVIRYY 93
Query: 149 GCCAEGPEKML-VYEYLPNKSLDYFIFDKTKS-SSLDWTTRYR---IVMGVARGLLYLHE 203
             C+E  ++ L +   L N +L   +  K  S  +L     Y    ++  +A G+ +LH 
Sbjct: 94  --CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 151
Query: 204 EAPARIIHRDIKASNILLD-------------EQLNPKISDFGLARLFPGEDTHVNTFRI 250
               +IIHRD+K  NIL+              E L   ISDFGL +     D+    FR 
Sbjct: 152 ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL---DSGQXXFRX 205
Query: 251 -----SGTHGYMAPEY---ALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLL 302
                SGT G+ APE    +    L+   D+FS G +   I+S  K+  G     +++++
Sbjct: 206 NLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNII 265
Query: 303 SYTWTL 308
              ++L
Sbjct: 266 RGIFSL 271

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           YLH      +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVSG 286
           E  L    +   D ++ GVL+ ++ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEI--AVK---KLSVDSRQGLREFTNEVKLLLK-IQH 141
           F  L  +G G FG V        +E+  AVK   K ++  ++  +   +E  +LLK ++H
Sbjct: 40  FHFLKVIGKGSFGKVLLARH-KAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 98
Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
             LV L        +   V +Y+    L Y +  + +   L+   R+     +A  L YL
Sbjct: 99  PFLVGLHFSFQTADKLYFVLDYINGGELFYHL--QRERCFLEPRARF-YAAEIASALGYL 155
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEY 261
           H      I++RD+K  NILLD Q +  ++DFGL +     ++  +TF   GT  Y+APE 
Sbjct: 156 HS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTF--CGTPEYLAPEV 210
Query: 262 ALHGYLSVKTDVFSYGVLVLEIVSG 286
                     D +  G ++ E++ G
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 12/210 (5%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS---VDSRQGLREFTNEVKLLL 137
           +V  N F  L  LG G FG V        G+  A+K L    + ++  +     E ++L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
             +H  L  L            V EY     L +F   + +  + +    Y     +   
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEERARFYG--AEIVSA 117
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L YLH      +++RDIK  N++LD+  + KI+DFGL +    +   + TF   GT  Y+
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF--CGTPEYL 172
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
           APE           D +  GV++ E++ GR
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 12/210 (5%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS---VDSRQGLREFTNEVKLLL 137
           +V  N F  L  LG G FG V        G+  A+K L    + ++  +     E ++L 
Sbjct: 4   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 63
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
             +H  L  L            V EY     L +F   + +  + +    Y     +   
Sbjct: 64  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEERARFYG--AEIVSA 120
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L YLH      +++RDIK  N++LD+  + KI+DFGL +    +   + TF   GT  Y+
Sbjct: 121 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF--CGTPEYL 175
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
           APE           D +  GV++ E++ GR
Sbjct: 176 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 11/210 (5%)
Query: 82  QVATNFFSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLS---VDSRQGLREFTNEVKLLL 137
           +V  N F  L  LG G FG V        G+  A+K L    + ++  +     E ++L 
Sbjct: 5   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 64
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
             +H  L  L            V EY     L +F   + +  S D    Y     +   
Sbjct: 65  NSRHPFLTALKYSFQTHDRLCFVMEYANGGEL-FFHLSRERVFSEDRARFYGA--EIVSA 121
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L YLH E    +++RD+K  N++LD+  + KI+DFGL +    +   +  F   GT  Y+
Sbjct: 122 LDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF--CGTPEYL 177
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
           APE           D +  GV++ E++ GR
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 11/210 (5%)
Query: 82  QVATNFFSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLS---VDSRQGLREFTNEVKLLL 137
           +V  N F  L  LG G FG V        G+  A+K L    + ++  +     E ++L 
Sbjct: 6   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 65
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
             +H  L  L            V EY     L +F   + +  S D    Y     +   
Sbjct: 66  NSRHPFLTALKYSFQTHDRLCFVMEYANGGEL-FFHLSRERVFSEDRARFYGA--EIVSA 122
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L YLH E    +++RD+K  N++LD+  + KI+DFGL +    +   +  F   GT  Y+
Sbjct: 123 LDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF--CGTPEYL 178
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
           APE           D +  GV++ E++ GR
Sbjct: 179 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 77/175 (44%), Gaps = 15/175 (8%)
Query: 125 GLREFTNEVKLLLKIQHKNLVTLFGCC-AEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSL 182
           G      E++LL +++HKN++ L      E  +KM +V EY      +  + D       
Sbjct: 49  GEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRF 106
Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL---FP 239
                +     +  GL YLH +    I+H+DIK  N+LL      KIS  G+A     F 
Sbjct: 107 PVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163
Query: 240 GEDTHVNTFRISGTHGYMAPEYA--LHGYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
            +DT   +    G+  +  PE A  L  +   K D++S GV +  I +G    +G
Sbjct: 164 ADDTCRTS---QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG 215

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 89/205 (43%), Gaps = 22/205 (10%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN------EVKLLLKIQH--KNL 144
           LG GGFG VY G+ + +   +A+K +  D      E  N      EV LL K+      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 145 VTLFGCCAEGPEKMLVYEYL-PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           + L          +L+ E + P + L  FI   T+  +L           V   + + H 
Sbjct: 76  IRLLDWFERPDSFVLILERMEPVQDLFDFI---TERGALQEELARSFFWQVLEAVRHCHN 132
Query: 204 EAPARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
                ++HRDIK  NIL+D  +   K+ DFG   L   +DT    F   GT  Y  PE+ 
Sbjct: 133 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDF--DGTRVYSPPEWI 185
Query: 263 -LHGYLSVKTDVFSYGVLVLEIVSG 286
             H Y      V+S G+L+ ++V G
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCG 210

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 11/210 (5%)
Query: 82  QVATNFFSDLNQLGHGGFGPVY-RGLMPNGQEIAVKKLS---VDSRQGLREFTNEVKLLL 137
           +V  N F  L  LG G FG V        G+  A+K L    + ++  +     E ++L 
Sbjct: 4   RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 63
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
             +H  L  L            V EY     L +F   + +  S D    Y     +   
Sbjct: 64  NSRHPFLTALKYSFQTHDRLCFVMEYANGGEL-FFHLSRERVFSEDRARFYGA--EIVSA 120
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L YLH E    +++RD+K  N++LD+  + KI+DFGL +    +   +  F   GT  Y+
Sbjct: 121 LDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXF--CGTPEYL 176
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
           APE           D +  GV++ E++ GR
Sbjct: 177 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 12/210 (5%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS---VDSRQGLREFTNEVKLLL 137
           +V  N F  L  LG G FG V        G+  A+K L    + ++  +     E ++L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
             +H  L  L            V EY     L +F   + +  + +    Y     +   
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEERARFYG--AEIVSA 117
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L YLH      +++RDIK  N++LD+  + KI+DFGL +    +   + TF   GT  Y+
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF--CGTPEYL 172
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
           APE           D +  GV++ E++ GR
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 112/250 (44%), Gaps = 50/250 (20%)
Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTN----EVKLLLKIQ-HKNLVTLF 148
           LG+G  G V       G+ +AVK++ +D       F +    E+KLL +   H N++  +
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRMLID-------FCDIALMEIKLLTESDDHPNVIRYY 75
Query: 149 GCCAEGPEKML-VYEYLPNKSLDYFIFDKTKS-SSLDWTTRYR---IVMGVARGLLYLHE 203
             C+E  ++ L +   L N +L   +  K  S  +L     Y    ++  +A G+ +LH 
Sbjct: 76  --CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 204 EAPARIIHRDIKASNILLD-------------EQLNPKISDFGLARLFPGEDTHVNTFRI 250
               +IIHRD+K  NIL+              E L   ISDFGL +     D+  ++FR 
Sbjct: 134 ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL---DSGQSSFRT 187
Query: 251 -----SGTHGYMAPE-------YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK 298
                SGT G+ APE             L+   D+FS G +   I+S  K+  G     +
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247
Query: 299 ADLLSYTWTL 308
           ++++   ++L
Sbjct: 248 SNIIRGIFSL 257

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 49/87 (56%), Gaps = 8/87 (9%)
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           YLH      +I+RD+K  N+++D+Q   +++DFG A+   G      T+ + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAP 207
Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVSG 286
           E  +    +   D ++ GVL+ E+ +G
Sbjct: 208 EIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/256 (25%), Positives = 119/256 (46%), Gaps = 54/256 (21%)
Query: 73  NLFFD-LRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQE-IAVKKLS------VDSRQ 124
           NL+F  ++ + V  N+    + +G G +G VY     N ++ +A+KK++      +D ++
Sbjct: 13  NLYFQGIKNVHVPDNYIIK-HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKR 71
Query: 125 GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKS----- 179
            LRE T    +L +++   ++ L+      P+ +L ++ L      Y + +   S     
Sbjct: 72  ILREIT----ILNRLKSDYIIRLYDLII--PDDLLKFDEL------YIVLEIADSDLKKL 119
Query: 180 --SSLDWTTRY--RIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235
             + +  T  +   I+  +  G  ++HE     IIHRD+K +N LL++  + K+ DFGLA
Sbjct: 120 FKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176
Query: 236 RLFPGE-DTH-VNTFRIS---GTHG---------------YMAPEYALHGYLSVKT-DVF 274
           R    E DT+ VN    +   G H                Y APE  L      K+ D++
Sbjct: 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIW 236
Query: 275 SYGVLVLEIVSGRKNH 290
           S G +  E+++  ++H
Sbjct: 237 STGCIFAELLNMLQSH 252

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/262 (24%), Positives = 116/262 (44%), Gaps = 61/262 (23%)
Query: 73  NLFFD---LRTLQVATNFFSDLNQL-GHGGFGPVYRGLMPNG-QEIAVKKLS------VD 121
           NL+F    ++ ++V  N+  ++  L G G +G VY     N  + +A+KK++      +D
Sbjct: 13  NLYFQGAIIKNVKVPDNY--EIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLID 70
Query: 122 SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKS-- 179
            ++ LRE T    +L +++   ++ L       PE +L ++ L      Y + +   S  
Sbjct: 71  CKRILREIT----ILNRLKSDYIIRLHDLII--PEDLLKFDEL------YIVLEIADSDL 118
Query: 180 -----SSLDWTTRY--RIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDF 232
                + +  T ++   I+  +  G  ++HE     IIHRD+K +N LL++  + KI DF
Sbjct: 119 KKLFKTPIFLTEQHVKTILYNLLLGEKFIHESG---IIHRDLKPANCLLNQDCSVKICDF 175
Query: 233 GLARLFPGE-DTHV-------NTFRISGTHG---------------YMAPEYA-LHGYLS 268
           GLAR    + D H+             G H                Y APE   L    +
Sbjct: 176 GLARTINSDKDIHIVNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYT 235
Query: 269 VKTDVFSYGVLVLEIVSGRKNH 290
              D++S G +  E+++  K+H
Sbjct: 236 NSIDIWSTGCIFAELLNMMKSH 257

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 66  GSGAD--SWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS- 122
            SG D  + NL+F  +++ V    +S L Q+G GG   V++ L    Q  A+K ++++  
Sbjct: 8   SSGVDLGTENLYF--QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA 65
Query: 123 -RQGLREFTNEVKLLLKIQHKN--LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKS 179
             Q L  + NE+  L K+Q  +  ++ L+          +V E   N  L+ ++    K 
Sbjct: 66  DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL---KKK 121
Query: 180 SSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239
            S+D   R      +   +  +H+     I+H D+K +N L+ + +  K+ DFG+A    
Sbjct: 122 KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQ 177
Query: 240 GEDTHVNTFRISGTHGYMAPE 260
            +   V      GT  YM PE
Sbjct: 178 PDXXXVVKDSQVGTVNYMPPE 198

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 97/231 (41%), Gaps = 24/231 (10%)
Query: 66  GSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSV---D 121
           GS AD   LF D+  L            +G G F  V R +    GQ+ AVK + V    
Sbjct: 15  GSMADDDVLFEDVYEL---------CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFT 65
Query: 122 SRQGL--REFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKS 179
           S  GL   +   E  +   ++H ++V L    +      +V+E++    L + I  +  +
Sbjct: 66  SSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADA 125
Query: 180 SSL-DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP---KISDFGLA 235
             +         +  +   L Y H+     IIHRD+K   +LL  + N    K+  FG+A
Sbjct: 126 GFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA 182
Query: 236 RLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
               GE   V   R+ GT  +MAPE           DV+  GV++  ++SG
Sbjct: 183 IQL-GESGLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           YLH      +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT  Y+AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWXLCGTPEYLAP 207
Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVSG 286
              L    +   D ++ GVL+ E+ +G
Sbjct: 208 AIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 89/210 (42%), Gaps = 26/210 (12%)
Query: 86  NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKN 143
           NF + LN+  H G   +++G    G +I VK L V   S +  R+F  E   L    H N
Sbjct: 13  NFLTKLNE-NHSG--ELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 144 LVTLFGCC--AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
           ++ + G C     P   L+  + P  SL Y +  +  +  +D +   +  +  ARG  +L
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWXPYGSL-YNVLHEGTNFVVDQSQAVKFALDXARGXAFL 127
Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKIS--DFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           H   P  I    + + ++ +DE    +IS  D   +   PG               ++AP
Sbjct: 128 HTLEPL-IPRHALNSRSVXIDEDXTARISXADVKFSFQSPGRXY---------APAWVAP 177
Query: 260 EYALHGYLS----VKTDVFSYGVLVLEIVS 285
           E AL            D +S+ VL+ E+V+
Sbjct: 178 E-ALQKKPEDTNRRSADXWSFAVLLWELVT 206

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 19/209 (9%)
Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCA 152
           LG G F    + +   + Q  AVK +S       ++    +KL     H N+V L     
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG--HPNIVKLHEVFH 76
Query: 153 EGPEKMLVYEYLPNKSLDYFIFDKTKSSS-LDWTTRYRIVMGVARGLLYLHEEAPARIIH 211
           +     LV E L    L    F++ K       T    I+  +   + ++H+     ++H
Sbjct: 77  DQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMHD---VGVVH 129
Query: 212 RDIKASNILL---DEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLS 268
           RD+K  N+L    ++ L  KI DFG ARL P ++  + T     T  Y APE        
Sbjct: 130 RDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPELLNQNGYD 187
Query: 269 VKTDVFSYGVLVLEIVSGR---KNHDGRL 294
              D++S GV++  ++SG+   ++HD  L
Sbjct: 188 ESCDLWSLGVILYTMLSGQVPFQSHDRSL 216

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 12/210 (5%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS---VDSRQGLREFTNEVKLLL 137
           +V  N F  L  LG G FG V        G+  A+K L    + ++  +     E ++L 
Sbjct: 6   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 65
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
             +H  L  L            V EY     L +F   + +  + +    Y     +   
Sbjct: 66  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEERARFYG--AEIVSA 122
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L YLH      +++RDIK  N++LD+  + KI+DFGL +    +   +  F   GT  Y+
Sbjct: 123 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXF--CGTPEYL 177
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
           APE           D +  GV++ E++ GR
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 110/250 (44%), Gaps = 50/250 (20%)
Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTN----EVKLLLKIQ-HKNLVTLF 148
           LG+G  G V       G+ +AVK++ +D       F +    E+KLL +   H N++  +
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRMLID-------FCDIALMEIKLLTESDDHPNVIRYY 75
Query: 149 GCCAEGPEKML-VYEYLPNKSLDYFIFDKTKS-SSLDWTTRYR---IVMGVARGLLYLHE 203
             C+E  ++ L +   L N +L   +  K  S  +L     Y    ++  +A G+ +LH 
Sbjct: 76  --CSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS 133
Query: 204 EAPARIIHRDIKASNILLD-------------EQLNPKISDFGLARLFPGEDTHVNTFRI 250
               +IIHRD+K  NIL+              E L   ISDFGL +     D+    FR 
Sbjct: 134 ---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL---DSGQXXFRX 187
Query: 251 -----SGTHGYMAPE-------YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK 298
                SGT G+ APE             L+   D+FS G +   I+S  K+  G     +
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247
Query: 299 ADLLSYTWTL 308
           ++++   ++L
Sbjct: 248 SNIIRGIFSL 257

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 12/210 (5%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS---VDSRQGLREFTNEVKLLL 137
           +V  N F  L  LG G FG V        G+  A+K L    + ++  +     E ++L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
             +H  L  L            V EY     L +F   + +  + +    Y     +   
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEERARFYG--AEIVSA 117
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L YLH      +++RDIK  N++LD+  + KI+DFGL +    +   +  F   GT  Y+
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXF--CGTPEYL 172
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
           APE           D +  GV++ E++ GR
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 48/87 (55%), Gaps = 8/87 (9%)
Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           YLH      +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT   +AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEALAP 207
Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVSG 286
           E  L    +   D ++ GVL+ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 12/210 (5%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS---VDSRQGLREFTNEVKLLL 137
           +V  N F  L  LG G FG V        G+  A+K L    + ++  +     E ++L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
             +H  L  L            V EY     L +F   + +  + +    Y     +   
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEERARFYG--AEIVSA 117
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L YLH      +++RDIK  N++LD+  + KI+DFGL +    +   +  F   GT  Y+
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXF--CGTPEYL 172
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
           APE           D +  GV++ E++ GR
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 70/156 (44%), Gaps = 24/156 (15%)
Query: 85  TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKL------SVDSRQGLREFTNEVKLLL 137
           T  F +L ++G G FG V++ +   +G   A+K+       SVD +  LRE      L  
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG- 66
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL------DYFIFDKTKSSSLDWTTRYRIV 191
             QH ++V  F   AE    ++  EY    SL      +Y I    K + L       ++
Sbjct: 67  --QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK-----DLL 119
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP 227
           + V RGL Y+H  +   ++H DIK SNI +     P
Sbjct: 120 LQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIP 152

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 70/156 (44%), Gaps = 24/156 (15%)
Query: 85  TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKL------SVDSRQGLREFTNEVKLLL 137
           T  F +L ++G G FG V++ +   +G   A+K+       SVD +  LRE      L  
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG- 68
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL------DYFIFDKTKSSSLDWTTRYRIV 191
             QH ++V  F   AE    ++  EY    SL      +Y I    K + L       ++
Sbjct: 69  --QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK-----DLL 121
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP 227
           + V RGL Y+H  +   ++H DIK SNI +     P
Sbjct: 122 LQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIP 154

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 88/210 (41%), Gaps = 12/210 (5%)
Query: 82  QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS---VDSRQGLREFTNEVKLLL 137
           +V  N F  L  LG G FG V        G+  A+K L    + ++  +     E ++L 
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
             +H  L  L            V EY     L +F   + +  + +    Y     +   
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGEL-FFHLSRERVFTEERARFYG--AEIVSA 117
Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L YLH      +++RDIK  N++LD+  + KI+DFGL +    +   +  F   GT  Y+
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXF--CGTPEYL 172
Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
           APE           D +  GV++ E++ GR
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 70/156 (44%), Gaps = 24/156 (15%)
Query: 85  TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKL------SVDSRQGLREFTNEVKLLL 137
           T  F +L ++G G FG V++ +   +G   A+K+       SVD +  LRE      L  
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG- 66
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL------DYFIFDKTKSSSLDWTTRYRIV 191
             QH ++V  F   AE    ++  EY    SL      +Y I    K + L       ++
Sbjct: 67  --QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK-----DLL 119
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP 227
           + V RGL Y+H  +   ++H DIK SNI +     P
Sbjct: 120 LQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIP 152

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 70/156 (44%), Gaps = 24/156 (15%)
Query: 85  TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKL------SVDSRQGLREFTNEVKLLL 137
           T  F +L ++G G FG V++ +   +G   A+K+       SVD +  LRE      L  
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLG- 64
Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL------DYFIFDKTKSSSLDWTTRYRIV 191
             QH ++V  F   AE    ++  EY    SL      +Y I    K + L       ++
Sbjct: 65  --QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELK-----DLL 117
Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP 227
           + V RGL Y+H  +   ++H DIK SNI +     P
Sbjct: 118 LQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIP 150

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 19/214 (8%)
Query: 87  FFSDLNQL----GHGGFGPVYRGL-MPNGQEIAVKKLSV---DSRQGL--REFTNEVKLL 136
            F D+ +L    G G F  V R +    GQ+ AVK + V    S  GL   +   E  + 
Sbjct: 21  LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 80
Query: 137 LKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSL-DWTTRYRIVMGVA 195
             ++H ++V L    +      +V+E++    L + I  +  +  +         +  + 
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNP---KISDFGLARLFPGEDTHVNTFRISG 252
             L Y H+     IIHRD+K   +LL  + N    K+  FG+A    GE   V   R+ G
Sbjct: 141 EALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL-GESGLVAGGRV-G 195
Query: 253 THGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG 286
           T  +MAPE           DV+  GV++  ++SG
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 17/202 (8%)
Query: 63  DADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS 122
           D D   + S N       + V    +S L Q+G GG   V++ L    Q  A+K ++++ 
Sbjct: 38  DDDDKASSSAN-----ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE 92
Query: 123 --RQGLREFTNEVKLLLKIQHKN--LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTK 178
              Q L  + NE+  L K+Q  +  ++ L+          +V E   N  L+ ++    K
Sbjct: 93  ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL---KK 148
Query: 179 SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238
             S+D   R      +   +  +H+     I+H D+K +N L+ + +  K+ DFG+A   
Sbjct: 149 KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQM 204
Query: 239 PGEDTHVNTFRISGTHGYMAPE 260
             + T V      GT  YM PE
Sbjct: 205 QPDTTSVVKDSQVGTVNYMPPE 226

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 17/202 (8%)
Query: 63  DADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS 122
           D D   + S N       + V    +S L Q+G GG   V++ L    Q  A+K ++++ 
Sbjct: 38  DDDDKASSSAN-----ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE 92
Query: 123 --RQGLREFTNEVKLLLKIQHKN--LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTK 178
              Q L  + NE+  L K+Q  +  ++ L+          +V E   N  L+ ++    K
Sbjct: 93  ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL---KK 148
Query: 179 SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238
             S+D   R      +   +  +H+     I+H D+K +N L+ + +  K+ DFG+A   
Sbjct: 149 KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQM 204
Query: 239 PGEDTHVNTFRISGTHGYMAPE 260
             + T V      GT  YM PE
Sbjct: 205 QPDTTSVVKDSQVGTVNYMPPE 226

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 119/278 (42%), Gaps = 37/278 (13%)
Query: 94  LGHGGFGPVYRGL--MPNGQEIAVKKL--SVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
           + HGG G +Y  L    NG+ + +K L  S D+           + L ++ H ++V +F 
Sbjct: 88  IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAER-QFLAEVVHPSIVQIFN 146
Query: 150 CCAE-----GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
                     P   +V EY+  +SL      ++K   L        ++ +   L YLH  
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLK-----RSKGQKLPVAEAIAYLLEILPALSYLHSI 201
Query: 205 APARIIHRDIKASNILL-DEQLNPKISDFGLARLFPGEDTHVNTF-RISGTHGYMAPEYA 262
               +++ D+K  NI+L +EQL  K+ D G         + +N+F  + GT G+ APE  
Sbjct: 202 G---LVYNDLKPENIMLTEEQL--KLIDLGAV-------SRINSFGYLYGTPGFQAPEIV 249
Query: 263 LHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRL--GKEKADLLSYTWTLFQGEKALELVDP 320
             G  +V TD+++ G  +  +       +GR   G  + D +  T+  + G      +DP
Sbjct: 250 RTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSY-GRLLRRAIDP 307
Query: 321 SLAKCNRDEAAMCIQL-GLL---CCQQSVAERPDMNSV 354
              +       M  QL G+L     Q +   RP ++++
Sbjct: 308 DPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLSTI 345

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 73/147 (49%), Gaps = 28/147 (19%)
Query: 188 YRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP---KISDFGLARLFPGEDTH 244
           Y++++ V     YLHE     IIHRD+K  N+LL  Q      KI+DFG +++  GE + 
Sbjct: 121 YQMLLAVQ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSL 172
Query: 245 VNTFRISGTHGYMAPEYALH----GYLSVKTDVFSYGVLVLEIVSG---------RKNHD 291
           + T  + GT  Y+APE  +     GY +   D +S GV++   +SG         + +  
Sbjct: 173 MRT--LCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 229
Query: 292 GRLGKEKADLLSYTWTLFQGEKALELV 318
            ++   K + +   W     EKAL+LV
Sbjct: 230 DQITSGKYNFIPEVWAEV-SEKALDLV 255

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 73/147 (49%), Gaps = 28/147 (19%)
Query: 188 YRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP---KISDFGLARLFPGEDTH 244
           Y++++ V     YLHE     IIHRD+K  N+LL  Q      KI+DFG +++  GE + 
Sbjct: 121 YQMLLAVQ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSL 172
Query: 245 VNTFRISGTHGYMAPEYALH----GYLSVKTDVFSYGVLVLEIVSG---------RKNHD 291
           + T  + GT  Y+APE  +     GY +   D +S GV++   +SG         + +  
Sbjct: 173 MRT--LCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 229
Query: 292 GRLGKEKADLLSYTWTLFQGEKALELV 318
            ++   K + +   W     EKAL+LV
Sbjct: 230 DQITSGKYNFIPEVWAEV-SEKALDLV 255

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 73/147 (49%), Gaps = 28/147 (19%)
Query: 188 YRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP---KISDFGLARLFPGEDTH 244
           Y++++ V     YLHE     IIHRD+K  N+LL  Q      KI+DFG +++  GE + 
Sbjct: 120 YQMLLAVQ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSL 171
Query: 245 VNTFRISGTHGYMAPEYALH----GYLSVKTDVFSYGVLVLEIVSG---------RKNHD 291
           + T  + GT  Y+APE  +     GY +   D +S GV++   +SG         + +  
Sbjct: 172 MRT--LCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 228
Query: 292 GRLGKEKADLLSYTWTLFQGEKALELV 318
            ++   K + +   W     EKAL+LV
Sbjct: 229 DQITSGKYNFIPEVWAEV-SEKALDLV 254

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 73/147 (49%), Gaps = 28/147 (19%)
Query: 188 YRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP---KISDFGLARLFPGEDTH 244
           Y++++ V     YLHE     IIHRD+K  N+LL  Q      KI+DFG +++  GE + 
Sbjct: 121 YQMLLAVQ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSL 172
Query: 245 VNTFRISGTHGYMAPEYALH----GYLSVKTDVFSYGVLVLEIVSG---------RKNHD 291
           + T  + GT  Y+APE  +     GY +   D +S GV++   +SG         + +  
Sbjct: 173 MRT--LCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 229
Query: 292 GRLGKEKADLLSYTWTLFQGEKALELV 318
            ++   K + +   W     EKAL+LV
Sbjct: 230 DQITSGKYNFIPEVWAEV-SEKALDLV 255

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 73/147 (49%), Gaps = 28/147 (19%)
Query: 188 YRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP---KISDFGLARLFPGEDTH 244
           Y++++ V     YLHE     IIHRD+K  N+LL  Q      KI+DFG +++  GE + 
Sbjct: 127 YQMLLAVQ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSL 178
Query: 245 VNTFRISGTHGYMAPEYALH----GYLSVKTDVFSYGVLVLEIVSG---------RKNHD 291
           + T  + GT  Y+APE  +     GY +   D +S GV++   +SG         + +  
Sbjct: 179 MRT--LCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 235
Query: 292 GRLGKEKADLLSYTWTLFQGEKALELV 318
            ++   K + +   W     EKAL+LV
Sbjct: 236 DQITSGKYNFIPEVWAEV-SEKALDLV 261

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 83/184 (45%), Gaps = 12/184 (6%)
Query: 81  LQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS--RQGLREFTNEVKLLLK 138
           + V    +S L Q+G GG   V++ L    Q  A+K ++++    Q L  + NE+  L K
Sbjct: 4   ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 63
Query: 139 IQHKN--LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR 196
           +Q  +  ++ L+          +V E   N  L+ ++    K  S+D   R      +  
Sbjct: 64  LQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL---KKKKSIDPWERKSYWKNMLE 119
Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGY 256
            +  +H+     I+H D+K +N L+ + +  K+ DFG+A     + T V      GT  Y
Sbjct: 120 AVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNY 175
Query: 257 MAPE 260
           M PE
Sbjct: 176 MPPE 179

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 83/184 (45%), Gaps = 12/184 (6%)
Query: 81  LQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS--RQGLREFTNEVKLLLK 138
           + V    +S L Q+G GG   V++ L    Q  A+K ++++    Q L  + NE+  L K
Sbjct: 3   ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 62
Query: 139 IQHKN--LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR 196
           +Q  +  ++ L+          +V E   N  L+ ++    K  S+D   R      +  
Sbjct: 63  LQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL---KKKKSIDPWERKSYWKNMLE 118
Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGY 256
            +  +H+     I+H D+K +N L+ + +  K+ DFG+A     + T V      GT  Y
Sbjct: 119 AVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNY 174
Query: 257 MAPE 260
           M PE
Sbjct: 175 MPPE 178

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 30/213 (14%)
Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--------SRQGLREFTNEVKLLLK 138
           +S ++ LG G FG V+  +     +E+ VK +  +            L + T E+ +L +
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 139 IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
           ++H N++ +           LV E      LD F F   +   LD      I   +   +
Sbjct: 86  VEHANIIKVLDIFENQGFFQLVMEK-HGSGLDLFAF-IDRHPRLDEPLASYIFRQLVSAV 143
Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA------RLFPGEDTHVNTFRISG 252
            YL  +    IIHRDIK  NI++ E    K+ DFG A      +LF         +   G
Sbjct: 144 GYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF---------YTFCG 191
Query: 253 THGYMAPEYAL-HGYLSVKTDVFSYGVLVLEIV 284
           T  Y APE  + + Y   + +++S GV +  +V
Sbjct: 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 73/147 (49%), Gaps = 28/147 (19%)
Query: 188 YRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP---KISDFGLARLFPGEDTH 244
           Y++++ V     YLHE     IIHRD+K  N+LL  Q      KI+DFG +++  GE + 
Sbjct: 260 YQMLLAVQ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSL 311
Query: 245 VNTFRISGTHGYMAPEYALH----GYLSVKTDVFSYGVLVLEIVSG---------RKNHD 291
           + T  + GT  Y+APE  +     GY +   D +S GV++   +SG         + +  
Sbjct: 312 MRT--LCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK 368
Query: 292 GRLGKEKADLLSYTWTLFQGEKALELV 318
            ++   K + +   W     EKAL+LV
Sbjct: 369 DQITSGKYNFIPEVWAEV-SEKALDLV 394

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 18/106 (16%)
Query: 188 YRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP---KISDFGLARLFPGEDTH 244
           Y++++ V     YLHE     IIHRD+K  N+LL  Q      KI+DFG +++  GE + 
Sbjct: 246 YQMLLAVQ----YLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSL 297
Query: 245 VNTFRISGTHGYMAPEYALH----GYLSVKTDVFSYGVLVLEIVSG 286
           + T  + GT  Y+APE  +     GY +   D +S GV++   +SG
Sbjct: 298 MRT--LCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSG 340

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 83/184 (45%), Gaps = 12/184 (6%)
Query: 81  LQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS--RQGLREFTNEVKLLLK 138
           + V    +S L Q+G GG   V++ L    Q  A+K ++++    Q L  + NE+  L K
Sbjct: 7   ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 66
Query: 139 IQHKN--LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR 196
           +Q  +  ++ L+          +V E   N  L+ ++    K  S+D   R      +  
Sbjct: 67  LQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWL---KKKKSIDPWERKSYWKNMLE 122
Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGY 256
            +  +H+     I+H D+K +N L+ + +  K+ DFG+A     + T V      GT  Y
Sbjct: 123 AVHTIHQHG---IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNY 178
Query: 257 MAPE 260
           M PE
Sbjct: 179 MPPE 182

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 84/202 (41%), Gaps = 16/202 (7%)
Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTN---EVKLLLKI-QHKN 143
           F  L++LGHG +G V++        +   K S+   +G ++      EV    K+ QH  
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118
Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
            V L     EG    L  E L   SL      +   +SL     +  +      L +LH 
Sbjct: 119 CVRLEQAWEEGGILYLQTE-LCGPSLQQHC--EAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFG-LARLFPGEDTHVNTFRISGTHGYMAPEYA 262
           +    ++H D+K +NI L  +   K+ DFG L  L       V      G   YMAPE  
Sbjct: 176 QG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ----EGDPRYMAPEL- 227
Query: 263 LHGYLSVKTDVFSYGVLVLEIV 284
           L G      DVFS G+ +LE+ 
Sbjct: 228 LQGSYGTAADVFSLGLTILEVA 249

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 66/268 (24%), Positives = 109/268 (40%), Gaps = 62/268 (23%)
Query: 73  NLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFT-- 130
           NL+F   +L      +     +G G +G V   +    Q  A++ + + ++  +R+    
Sbjct: 13  NLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAI--ENQTRAIRAIKIMNKNKIRQINPK 70
Query: 131 ------NEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE-----YLPNKSLDYFIFDKTKS 179
                  EV+L+ K+ H N+  L+    +     LV E     +L +K L+ FI D T  
Sbjct: 71  DVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDK-LNVFIDDSTGK 129
Query: 180 -----------------------------SSLDWTTRYRIVMGVAR----GLLYLHEEAP 206
                                         SLD+  R +++  + R     L YLH +  
Sbjct: 130 CAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG- 188
Query: 207 ARIIHRDIKASNILL--DEQLNPKISDFGLARLF----PGEDTHVNTFRISGTHGYMAPE 260
             I HRDIK  N L   ++    K+ DFGL++ F     GE   + T   +GT  ++APE
Sbjct: 189 --ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT--KAGTPYFVAPE 244
Query: 261 Y--ALHGYLSVKTDVFSYGVLVLEIVSG 286
                +     K D +S GVL+  ++ G
Sbjct: 245 VLNTTNESYGPKCDAWSAGVLLHLLLMG 272
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	437
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-149
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-144
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-131
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-87
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	6e-68
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-62
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-60
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-60
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-58
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-58
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-58
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-56
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-55
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-51
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-51
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	4e-51
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-50
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	9e-50
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	9e-45
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-43
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	6e-43
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-42
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-42
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-41
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-41
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-41
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-41
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	8e-41
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	9e-41
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-40
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-40
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-40
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-40
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-40
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-40
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-40
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	7e-40
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-39
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-39
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-39
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-39
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-39
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-39
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-39
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-39
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-39
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	7e-39
3pls_A	298	Macrophage-stimulating protein receptor; protein k	8e-39
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-38
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-38
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-38
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-38
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-38
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-38
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	3e-38
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	8e-38
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-37
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-37
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-37
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-37
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-37
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-37
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-37
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-37
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-37
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	7e-37
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	8e-37
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-36
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-36
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-36
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-35
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-35
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-35
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-34
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-34
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	8e-34
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-33
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-33
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-33
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-33
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-33
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-33
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-32
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-32
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-32
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-32
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-32
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-32
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-32
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-32
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-31
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-31
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-31
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-31
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-31
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-31
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-30
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-30
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-30
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-30
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-30
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	9e-30
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-29
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-29
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	5e-29
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-29
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-28
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-28
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-27
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-27
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-27
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-26
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-26
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-26
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-26
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-26
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	5e-26
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	7e-26
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	7e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-25
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-25
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-25
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-25
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-25
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	5e-25
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-25
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	9e-25
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-24
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-24
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-24
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-24
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-24
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-24
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-24
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-24
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-24
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-24
3o0g_A	292	Cell division protein kinase 5; kinase activator c	4e-24
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-24
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-24
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-24
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-23
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-23
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-23
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-23
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-23
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-23
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-23
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-23
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-23
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	7e-23
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-23
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	7e-23
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	8e-23
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-22
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-22
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-22
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-22
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-22
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-22
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-22
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-22
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-22
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-22
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	7e-22
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	8e-22
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	9e-22
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-21
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-21
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-21
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-21
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-21
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-21
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-21
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	6e-21
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	7e-21
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	7e-21
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-20
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-20
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-20
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-20
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-20
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-20
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-20
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-20
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	6e-20
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	9e-20
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-19
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-19
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-19
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-19
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-19
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-19
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-19
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-19
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	6e-19
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	8e-19
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-18
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-07
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-17
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-17
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-16
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-16
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	7e-16
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-15
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-15
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-15
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	6e-15
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	8e-15
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-14
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-14
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-14
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-14
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	7e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	7e-14
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	8e-14
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	8e-14
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	9e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-13
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	8e-13
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	9e-13
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	4e-12
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-11
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-10
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-09
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-09
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-08
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-08
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	7e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	6e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-04
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	6e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  426 bits (1098), Expect = e-149
 Identities = 127/293 (43%), Positives = 176/293 (60%), Gaps = 6/293 (2%)

Query: 76  FDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGL-REFTNEVK 134
           F LR LQVA++ FS+ N LG GGFG VY+G + +G  +AVK+L  +  QG   +F  EV+
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79

Query: 135 LLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSS-LDWTTRYRIVMG 193
           ++    H+NL+ L G C    E++LVY Y+ N S+   + ++ +S   LDW  R RI +G
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139

Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
            ARGL YLH+    +IIHRD+KA+NILLDE+    + DFGLA+L   +DTHV T  + GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198

Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGR--LGKEKADLLSYTWTLFQG 311
            G++APEY   G  S KTDVF YGV++LE+++G++  D       +   LL +   L + 
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258

Query: 312 EKALELVDPSL-AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSF 363
           +K   LVD  L      +E    IQ+ LLC Q S  ERP M+ V  ML GD  
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  412 bits (1061), Expect = e-144
 Identities = 107/315 (33%), Positives = 163/315 (51%), Gaps = 20/315 (6%)

Query: 62  EDADGSGADSWNLFFDLRTLQVATNFFSD------LNQLGHGGFGPVYRGLMPNGQEIAV 115
           E+     +D+    F    L+  TN F +       N++G GGFG VY+G + N   +AV
Sbjct: 1   ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59

Query: 116 KKLS----VDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDY 171
           KKL+    + + +  ++F  E+K++ K QH+NLV L G  ++G +  LVY Y+PN SL  
Sbjct: 60  KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119

Query: 172 FIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISD 231
            +     +  L W  R +I  G A G+ +LHE      IHRDIK++NILLDE    KISD
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176

Query: 232 FGLARLFP-GEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNH 290
           FGLAR       T + + RI GT  YMAPE  L G ++ K+D++S+GV++LEI++G    
Sbjct: 177 FGLARASEKFAQTVMTS-RIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAV 234

Query: 291 DGRLGKEKADLLSYTWTLFQGEKALE-LVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERP 349
           D     +   LL     +   EK +E  +D  +   +         +   C  +   +RP
Sbjct: 235 DEHREPQL--LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRP 292

Query: 350 DMNSVHLMLSGDSFT 364
           D+  V  +L   + +
Sbjct: 293 DIKKVQQLLQEMTAS 307

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  379 bits (976), Expect = e-131
 Identities = 106/315 (33%), Positives = 166/315 (52%), Gaps = 7/315 (2%)

Query: 50  SLRGGRAAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPN 109
           S         +   +        +    L  L+ ATN F     +GHG FG VY+G++ +
Sbjct: 3   SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62

Query: 110 GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL 169
           G ++A+K+ + +S QG+ EF  E++ L   +H +LV+L G C E  E +L+Y+Y+ N +L
Sbjct: 63  GAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNL 122

Query: 170 DYFIFDKTK-SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPK 228
              ++     + S+ W  R  I +G ARGL YLH  A   IIHRD+K+ NILLDE   PK
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPK 179

Query: 229 ISDFGLARLFPGED-THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
           I+DFG+++     D TH++T  + GT GY+ PEY + G L+ K+DV+S+GV++ E++  R
Sbjct: 180 ITDFGISKKGTELDQTHLST-VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCAR 238

Query: 288 KNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA-KCNRDEAAMCIQLGLLCCQQSVA 346
                 L +E  +L  +        +  ++VDP+LA K   +         + C   S  
Sbjct: 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSE 298

Query: 347 ERPDMNSVHLMLSGD 361
           +RP M  V   L   
Sbjct: 299 DRPSMGDVLWKLEYA 313

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  267 bits (685), Expect = 4e-87
 Identities = 77/323 (23%), Positives = 120/323 (37%), Gaps = 34/323 (10%)

Query: 60  SAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLS 119
                  SG D          L   +     L     G FG V++      + +AVK   
Sbjct: 3   HHHHHHSSGVD-----LGTENLYFQSMPLQLLEVKARGRFGCVWKA-QLLNEYVAVKIFP 56

Query: 120 VDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP----EKMLVYEYLPNKSLDYFIFD 175
           +  +Q   +   EV  L  ++H+N++   G    G     +  L+  +    SL  F+  
Sbjct: 57  IQDKQSW-QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-- 113

Query: 176 KTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA-------RIIHRDIKASNILLDEQLNPK 228
             K++ + W     I   +ARGL YLHE+ P         I HRDIK+ N+LL   L   
Sbjct: 114 --KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171

Query: 229 ISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL-----SVKTDVFSYGVLVLEI 283
           I+DFGLA  F    +  +T    GT  YMAPE             ++ D+++ G+++ E+
Sbjct: 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

Query: 284 VSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV-----DPSLAKCNRDEAAMC--IQL 336
            S     DG + +               E   E+V      P L    +  A M    + 
Sbjct: 232 ASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCET 291

Query: 337 GLLCCQQSVAERPDMNSVHLMLS 359
              C       R     V   ++
Sbjct: 292 IEECWDHDAEARLSAGCVGERIT 314

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  218 bits (558), Expect = 6e-68
 Identities = 69/334 (20%), Positives = 117/334 (35%), Gaps = 44/334 (13%)

Query: 74  LFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEV 133
           +        +  +    L  +G G +G VY+G + + + +AVK  S  +RQ        +
Sbjct: 1   MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK-NI 58

Query: 134 KLLLKIQHKNLVTLFGCCAEGP-----EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY 188
             +  ++H N+                E +LV EY PN SL  ++   T     DW +  
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSC 114

Query: 189 RIVMGVARGLLYLHEEAPAR------IIHRDIKASNILLDEQLNPKISDFGLARLFPG-- 240
           R+   V RGL YLH E P        I HRD+ + N+L+       ISDFGL+    G  
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 241 ----EDTHVNTFRISGTHGYMAPEYALHGYLSV--------KTDVFSYGVLVLEIVSGRK 288
                +         GT  YMAPE  L G +++        + D+++ G++  EI   R 
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFM-RC 232

Query: 289 NHDGRLGKEKADLLSYTWTLFQGEKALELVD--------PSL-AKCNRDEAAMCIQLGLL 339
                        +++   +       ++          P        +  A+      +
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292

Query: 340 --CCQQSVAERPDMNSVHLMLSGDSFTLPKPGKP 371
             C  Q    R         ++       +    
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELMMIWERNKSV 326

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  203 bits (519), Expect = 2e-62
 Identities = 66/205 (32%), Positives = 111/205 (54%), Gaps = 9/205 (4%)

Query: 88  FSDL---NQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHK 142
           + DL    ++G G FG V+R    +G ++AVK L       + + EF  EV ++ +++H 
Sbjct: 36  WCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHP 94

Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
           N+V   G   + P   +V EYL   SL   +        LD   R  +   VA+G+ YLH
Sbjct: 95  NIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH 154

Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
              P  I+HR++K+ N+L+D++   K+ DFGL+RL     T +++   +GT  +MAPE  
Sbjct: 155 NRNPP-IVHRNLKSPNLLVDKKYTVKVCDFGLSRLK--ASTFLSSKSAAGTPEWMAPEVL 211

Query: 263 LHGYLSVKTDVFSYGVLVLEIVSGR 287
                + K+DV+S+GV++ E+ + +
Sbjct: 212 RDEPSNEKSDVYSFGVILWELATLQ 236

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  198 bits (506), Expect = 1e-60
 Identities = 71/291 (24%), Positives = 118/291 (40%), Gaps = 27/291 (9%)

Query: 88  FSDL---NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL 144
           + ++     +G G FG V +      +++A+K++  +S    + F  E++ L ++ H N+
Sbjct: 7   YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE--RKAFIVELRQLSRVNHPNI 63

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L+G C       LV EY    SL   +                  +  ++G+ YLH  
Sbjct: 64  VKLYGACLNPV--CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 205 APARIIHRDIKASNILLDEQLN-PKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
            P  +IHRD+K  N+LL       KI DFG A       T        G+  +MAPE   
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT-----NNKGSAAWMAPEVFE 176

Query: 264 HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA 323
               S K DVFS+G+++ E+++ RK  D   G          W +  G +      P L 
Sbjct: 177 GSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR----IMWAVHNGTR------PPLI 226

Query: 324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFTLPKPGKPGIQ 374
           K         +     C  +  ++RP M  +  +++      P   +P   
Sbjct: 227 KNLPKPIESLMT---RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQY 274

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  197 bits (502), Expect = 2e-60
 Identities = 73/215 (33%), Positives = 108/215 (50%), Gaps = 24/215 (11%)

Query: 88  FSDL---NQLGHGGFGPVYRGLMPNGQEIAVKKL----SVDSRQGLREFTNEVKLLLKIQ 140
           F++L     +G GGFG VYR     G E+AVK        D  Q +     E KL   ++
Sbjct: 6   FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64

Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
           H N++ L G C + P   LV E+     L+  +  K     +         + +ARG+ Y
Sbjct: 65  HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNY 120

Query: 201 LHEEAPARIIHRDIKASNILLDEQLNP--------KISDFGLARLFPGEDTHVNTFRISG 252
           LH+EA   IIHRD+K+SNIL+ +++          KI+DFGLAR +    T   +    G
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSAA--G 176

Query: 253 THGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
            + +MAPE       S  +DV+SYGVL+ E+++G 
Sbjct: 177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  192 bits (490), Expect = 1e-58
 Identities = 58/219 (26%), Positives = 111/219 (50%), Gaps = 28/219 (12%)

Query: 88  FSDL---NQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQG-------LREFTNEVKLL 136
            +++    Q+G GGFG V++G L+ +   +A+K L +   +G        +EF  EV ++
Sbjct: 18  DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIM 77

Query: 137 LKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR 196
             + H N+V L+G     P   +V E++P   L + + DK     + W+ + R+++ +A 
Sbjct: 78  SNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIAL 133

Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQ-----LNPKISDFGLARLFPGEDTHVNTFRIS 251
           G+ Y+  + P  I+HRD+++ NI L        +  K++DFGL++      + +      
Sbjct: 134 GIEYMQNQNPP-IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGL-----L 187

Query: 252 GTHGYMAPE--YALHGYLSVKTDVFSYGVLVLEIVSGRK 288
           G   +MAPE   A     + K D +S+ +++  I++G  
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  192 bits (490), Expect = 3e-58
 Identities = 74/287 (25%), Positives = 112/287 (39%), Gaps = 34/287 (11%)

Query: 88  FSDL---NQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN 143
            SDL     LG G FG   +      G+ + +K+L     +  R F  EVK++  ++H N
Sbjct: 9   PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPN 68

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           ++   G   +      + EY+   +L   I  K+  S   W+ R      +A G+ YLH 
Sbjct: 69  VLKFIGVLYKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHS 126

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS------------ 251
                IIHRD+ + N L+ E  N  ++DFGLARL   E T     R              
Sbjct: 127 M---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVV 183

Query: 252 GTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQG 311
           G   +MAPE         K DVFS+G+++ EI+         L +     L+        
Sbjct: 184 GNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV------- 236

Query: 312 EKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML 358
              L+   P    C          + + CC     +RP    +   L
Sbjct: 237 RGFLDRYCPP--NCPPSFF----PITVRCCDLDPEKRPSFVKLEHWL 277

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  187 bits (476), Expect = 1e-56
 Identities = 49/211 (23%), Positives = 90/211 (42%), Gaps = 22/211 (10%)

Query: 88  FSDL---NQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHK 142
           F  L    +L     G +++G    G +I VK L V   S +  R+F  E   L    H 
Sbjct: 9   FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHP 67

Query: 143 NLVTLFGCCAEGPEK--MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
           N++ + G C   P     L+  ++P  SL   + +   +  +D +   +  + +ARG+ +
Sbjct: 68  NVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAF 126

Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE 260
           LH   P  I    + + ++++DE +  +IS   +   F  +              ++APE
Sbjct: 127 LHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF--QSPGR-----MYAPAWVAPE 178

Query: 261 YALHG----YLSVKTDVFSYGVLVLEIVSGR 287
            AL            D++S+ VL+ E+V+  
Sbjct: 179 -ALQKKPEDTNRRSADMWSFAVLLWELVTRE 208

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  183 bits (466), Expect = 7e-55
 Identities = 73/279 (26%), Positives = 130/279 (46%), Gaps = 26/279 (9%)

Query: 88  FSDL---NQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHK 142
              +    ++G G FG VY+G   +G ++AVK L+V   + Q L+ F NEV +L K +H 
Sbjct: 23  DGQITVGQRIGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 80

Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
           N++   G     P+  +V ++    SL + +      +  +      I    ARG+ YLH
Sbjct: 81  NILLFMGYSTA-PQLAIVTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLH 137

Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE-- 260
            +    IIHRD+K++NI L E    KI DFGLA             ++SG+  +MAPE  
Sbjct: 138 AK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

Query: 261 -YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD 319
                   S ++DV+++G+++ E+++G+  +     +++         + +G  +     
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-----IEMVGRGSLS----- 244

Query: 320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML 358
           P L+K   +      +L   C ++   ERP    +   +
Sbjct: 245 PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  175 bits (445), Expect = 1e-51
 Identities = 54/215 (25%), Positives = 96/215 (44%), Gaps = 27/215 (12%)

Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKL--LLKIQHKNLVTLF 148
           L  +G G +G V+RG    G+ +AVK  S    +  + +  E +L   + ++H+N++   
Sbjct: 13  LECVGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFI 68

Query: 149 GCCAEGPEK----MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
                         L+  Y    SL  ++    + ++LD  +  RIV+ +A GL +LH E
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIE 124

Query: 205 APAR-----IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS--GTHGYM 257
                    I HRD+K+ NIL+ +     I+D GLA +       ++       GT  YM
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184

Query: 258 APE------YALHGYLSVKTDVFSYGVLVLEIVSG 286
           APE               + D++++G+++ E+   
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  174 bits (444), Expect = 3e-51
 Identities = 64/288 (22%), Positives = 113/288 (39%), Gaps = 39/288 (13%)

Query: 88  FSDL---NQLGHGGFGPVYRGLMPNGQEIAVKKLSV--DSRQGLREFTNEVKLLLKIQHK 142
           F  L     +G G FG VY G   +G E+A++ + +  D+   L+ F  EV    + +H+
Sbjct: 32  FEQLEIGELIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHE 89

Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
           N+V   G C   P   ++      ++L   +  +     LD     +I   + +G+ YLH
Sbjct: 90  NVVLFMGACMSPPHLAIITSLCKGRTLYSVV--RDAKIVLDVNKTRQIAQEIVKGMGYLH 147

Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS---GTHGYMAP 259
            +    I+H+D+K+ N+  D      I+DFGL  +           ++    G   ++AP
Sbjct: 148 AKG---ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP 203

Query: 260 E---------YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQ 310
           E                S  +DVF+ G +  E+ +       +         +  W +  
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ------PAEAIIWQMGT 257

Query: 311 GEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML 358
           G K      P+L++    +      + L C      ERP    +  ML
Sbjct: 258 GMK------PNLSQIGMGKE--ISDILLFCWAFEQEERPTFTKLMDML 297

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  174 bits (443), Expect = 4e-51
 Identities = 75/329 (22%), Positives = 131/329 (39%), Gaps = 46/329 (13%)

Query: 59  ESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKL 118
           +S     GSG          + +Q+       + Q+G G +G V+ G    G+++AVK  
Sbjct: 17  QSQSSGSGSGLPLLVQRTIAKQIQM-------VKQIGKGRYGEVWMGKW-RGEKVAVKVF 68

Query: 119 SVDSRQGLREFTNEVK--LLLKIQHKNLVTLFGCCAEG----PEKMLVYEYLPNKSLDYF 172
                     +  E +    + ++H+N++       +G     +  L+ +Y  N SL  +
Sbjct: 69  F---TTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDY 125

Query: 173 IFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR-----IIHRDIKASNILLDEQLNP 227
           +    KS++LD  +  ++      GL +LH E  +      I HRD+K+ NIL+ +    
Sbjct: 126 L----KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC 181

Query: 228 KISDFGLARLFPGEDTHVNTFRIS--GTHGYMAPEYALHGYLSV-------KTDVFSYGV 278
            I+D GLA  F  +   V+    +  GT  YM PE  L   L+          D++S+G 
Sbjct: 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFG- 239

Query: 279 LVL-EIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD-----PSLAKCNRDEAAM 332
           L+L E+   R    G + + +        +    E   E+V      PS       +  +
Sbjct: 240 LILWEVAR-RCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECL 298

Query: 333 CIQLGLL--CCQQSVAERPDMNSVHLMLS 359
                L+  C   + A R     V   L+
Sbjct: 299 RQMGKLMTECWAHNPASRLTALRVKKTLA 327

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  171 bits (435), Expect = 9e-50
 Identities = 60/262 (22%), Positives = 106/262 (40%), Gaps = 38/262 (14%)

Query: 48  KTSLRGGRAAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDL---NQLGHGGFGPVYR 104
           +  +  G    +   D   SG+ S       RT+         +     +G G FG V+R
Sbjct: 7   RPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTI------ARTIVLQESIGKGRFGEVWR 60

Query: 105 GLMPNGQEIAVKKLSVDSRQGLREFTNE--VKLLLKIQHKNLVTLFGCC----AEGPEKM 158
           G    G+E+AVK  S    +  R +  E  +   + ++H+N++              +  
Sbjct: 61  GKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116

Query: 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR-----IIHRD 213
           LV +Y  + SL  ++       ++      ++ +  A GL +LH E         I HRD
Sbjct: 117 LVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 172

Query: 214 IKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS--GTHGYMAPEYALHGYLSV-- 269
           +K+ NIL+ +     I+D GLA         ++       GT  YMAPE  L   +++  
Sbjct: 173 LKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE-VLDDSINMKH 231

Query: 270 -----KTDVFSYGVLVLEIVSG 286
                + D+++ G++  EI   
Sbjct: 232 FESFKRADIYAMGLVFWEIARR 253

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  158 bits (403), Expect = 9e-45
 Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 22/214 (10%)

Query: 91  LNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLF 148
             Q+G G FG V+ G +  +   +AVK            +F  E ++L +  H N+V L 
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178

Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G C +     +V E +       F+  +T+ + L   T  ++V   A G+ YL  +    
Sbjct: 179 GVCTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLESK---C 233

Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGY----MAPEYALH 264
            IHRD+ A N L+ E+   KISDFG++R               G         APE   +
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV----YAASGGLRQVPVKWTAPEALNY 289

Query: 265 GYLSVKTDVFSYGVLVLEIVS-------GRKNHD 291
           G  S ++DV+S+G+L+ E  S          N  
Sbjct: 290 GRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  153 bits (390), Expect = 2e-43
 Identities = 62/224 (27%), Positives = 113/224 (50%), Gaps = 23/224 (10%)

Query: 91  LNQLGHGGFGPVYRG-LMPNGQE----IAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNL 144
           +  LG G FG VY+G  +P G++    +A+K+L    S +  +E  +E  ++  + + ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
             L G C       L+ + +P   L  ++  +    ++         + +A+G+ YL + 
Sbjct: 80  CRLLGICLTST-VQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLEDR 136

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAP 259
              R++HRD+ A N+L+    + KI+DFGLA+L   E+   +        G     +MA 
Sbjct: 137 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-----EGGKVPIKWMAL 188

Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
           E  LH   + ++DV+SYGV V E+++ G K +DG    E + +L
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  152 bits (387), Expect = 6e-43
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 21/207 (10%)

Query: 91  LNQLGHGGFGPVYRGLMP-----NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV 145
           ++QLG G FG V            G  +AVK+L        R+F  E+++L  +    +V
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87

Query: 146 TLFGCCAEGPEK--MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
              G       +   LV EYLP+  L  F+  +   + LD +        + +G+ YL  
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS 145

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMA 258
               R +HRD+ A NIL++ + + KI+DFGLA+L P +    + +      G     + A
Sbjct: 146 R---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK---DYYV-VREPGQSPIFWYA 198

Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVS 285
           PE       S ++DV+S+GV++ E+ +
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFT 225

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  151 bits (383), Expect = 1e-42
 Identities = 68/231 (29%), Positives = 108/231 (46%), Gaps = 32/231 (13%)

Query: 68  GADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMP-----NGQEIAVKKLSVDS 122
           G+D     F+ R L+        L QLG G FG V            G+ +AVKKL   +
Sbjct: 1   GSDPTQ--FEERHLKF-------LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST 51

Query: 123 RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK--MLVYEYLPNKSLDYFIFDKTKSS 180
            + LR+F  E+++L  +QH N+V   G C     +   L+ EYLP  SL  ++  +    
Sbjct: 52  EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKE 109

Query: 181 SLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP- 239
            +D     +    + +G+ YL  +   R IHRD+   NIL++ +   KI DFGL ++ P 
Sbjct: 110 RIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166

Query: 240 GEDTHVNTFRISGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
            ++            G     + APE       SV +DV+S+GV++ E+ +
Sbjct: 167 DKEFFK-----VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  150 bits (382), Expect = 3e-42
 Identities = 65/242 (26%), Positives = 109/242 (45%), Gaps = 23/242 (9%)

Query: 91  LNQLGHGGFGPVYRGLMP-----NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV 145
           L QLG G FG V            G+ +AVKKL   + + LR+F  E+++L  +QH N+V
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 146 TLFGCCAEGPEK--MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
              G C     +   L+ EYLP  SL  ++  +     +D     +    + +G+ YL  
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT 163

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP-GEDTHVNTFRISGTHG-----YM 257
           +   R IHRD+   NIL++ +   KI DFGL ++ P  ++ +          G     + 
Sbjct: 164 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYK-----VKEPGESPIFWY 215

Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALEL 317
           APE       SV +DV+S+GV++ E+ +  +       +    + +           +EL
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275

Query: 318 VD 319
           + 
Sbjct: 276 LK 277

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  148 bits (375), Expect = 2e-41
 Identities = 50/229 (21%), Positives = 101/229 (44%), Gaps = 25/229 (10%)

Query: 91  LNQLGHGGFGPVYRGLMP-----NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNL 144
           +  LG G FG V            G+++AVK L  +     + +   E+++L  + H+N+
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 145 VTLFGCCAEGPEK--MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
           V   G C E       L+ E+LP+ SL  ++      + ++   + +  + + +G+ YL 
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLG 143

Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP-GEDTHVNTFRISGTHG-----Y 256
                + +HRD+ A N+L++ +   KI DFGL +     ++ +                +
Sbjct: 144 SR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT-----VKDDRDSPVFW 195

Query: 257 MAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSY 304
            APE  +     + +DV+S+GV + E+++    +        K    ++
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH 244

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  147 bits (372), Expect = 4e-41
 Identities = 64/218 (29%), Positives = 93/218 (42%), Gaps = 29/218 (13%)

Query: 93  QLGHGGFGPVYRGL--MPNGQEI--AVKKL---SVDSRQGLREFTNEVKLLLKIQHKNLV 145
           +LG G FG V RG    P+G+ +  AVK L    +   + + +F  EV  +  + H+NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
            L+G     P   +V E  P  SL   +  +         T  R  + VA G+ YL  + 
Sbjct: 85  RLYGVVLTPP-MKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEGMGYLESK- 140

Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAPE 260
             R IHRD+ A N+LL  +   KI DFGL R  P  D H         H      + APE
Sbjct: 141 --RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV----MQEHRKVPFAWCAPE 194

Query: 261 YALHGYLSVKTDVFSYGVLVLEIVS-------GRKNHD 291
                  S  +D + +GV + E+ +       G     
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ 232

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  147 bits (373), Expect = 7e-41
 Identities = 61/224 (27%), Positives = 113/224 (50%), Gaps = 23/224 (10%)

Query: 91  LNQLGHGGFGPVYRG-LMPNGQEI----AVKKLSVDS-RQGLREFTNEVKLLLKIQHKNL 144
           +  LG G FG VY+G  +P G+++    A+K+L   +  +  +E  +E  ++  + + ++
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
             L G C       L+ + +P   L  ++  +    ++         + +A+G+ YL + 
Sbjct: 80  CRLLGICLTST-VQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLEDR 136

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAP 259
              R++HRD+ A N+L+    + KI+DFGLA+L   E+   +        G     +MA 
Sbjct: 137 ---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA-----EGGKVPIKWMAL 188

Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
           E  LH   + ++DV+SYGV V E+++ G K +DG    E + +L
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  147 bits (373), Expect = 7e-41
 Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 23/223 (10%)

Query: 92  NQLGHGGFGPVYRG-LMPNGQEI----AVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLV 145
             LG G FG V++G  +P G+ I     +K +   S RQ  +  T+ +  +  + H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
            L G C       LV +YLP  SL   +  +    +L         + +A+G+ YL E  
Sbjct: 79  RLLGLCPGSS-LQLVTQYLPLGSLLDHV--RQHRGALGPQLLLNWGVQIAKGMYYLEEH- 134

Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAPE 260
              ++HR++ A N+LL      +++DFG+A L P +D  +       +       +MA E
Sbjct: 135 --GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY-----SEAKTPIKWMALE 187

Query: 261 YALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLL 302
               G  + ++DV+SYGV V E+++ G + + G    E  DLL
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL 230

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  146 bits (371), Expect = 8e-41
 Identities = 59/229 (25%), Positives = 95/229 (41%), Gaps = 27/229 (11%)

Query: 91  LNQLGHGGFGPVYRGLMPN-----GQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNL 144
           +  LG G FG V            G+ +AVK L  D   Q    +  E+ +L  + H+++
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 145 VTLFGCCAEGPEK--MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
           +   GCC +       LV EY+P  SL  ++       S+           +  G+ YLH
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 151

Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP-GEDTHVNTFRISGTHG-----Y 256
            +     IHRD+ A N+LLD     KI DFGLA+  P G + +          G     +
Sbjct: 152 AQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR-----VREDGDSPVFW 203

Query: 257 MAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSY 304
            APE          +DV+S+GV + E+++    +        +   ++ 
Sbjct: 204 YAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ 252

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  149 bits (379), Expect = 9e-41
 Identities = 57/202 (28%), Positives = 91/202 (45%), Gaps = 25/202 (12%)

Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           L  +G G FG V  G    G ++AVK +  D+    + F  E  ++ +++H NLV L G 
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 254

Query: 151 C-AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
              E     +V EY+   SL  ++  + +S  L      +  + V   + YL        
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---NF 310

Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG------YMAPEYAL 263
           +HRD+ A N+L+ E    K+SDFGL +         ++              + APE   
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASS----TQDTGKLPVKWTAPEALR 359

Query: 264 HGYLSVKTDVFSYGVLVLEIVS 285
               S K+DV+S+G+L+ EI S
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYS 381

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  145 bits (367), Expect = 2e-40
 Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 26/215 (12%)

Query: 93  QLGHGGFGPVYRG-LMPNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLF 148
           +LG G FG V +G      ++I  A+K L     +    E   E +++ ++ +  +V L 
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G C      MLV E      L  F+    K   +  +    ++  V+ G+ YL E+    
Sbjct: 77  GVCQAEA-LMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEK---N 130

Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAPEYAL 263
            +HRD+ A N+LL  +   KISDFGL++    +D++      + + G     + APE   
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT----ARSAGKWPLKWYAPECIN 186

Query: 264 HGYLSVKTDVFSYGVLVLEIVS-------GRKNHD 291
               S ++DV+SYGV + E +S         K  +
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 221

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  144 bits (365), Expect = 3e-40
 Identities = 56/218 (25%), Positives = 92/218 (42%), Gaps = 29/218 (13%)

Query: 91  LNQLGHGGFGPVYRGL--MPNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLV 145
              LG G FG VY G+     G++I  AVK    D +     +F +E  ++  + H ++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
            L G   E P   ++ E  P   L +++  +   +SL   T     + + + + YL    
Sbjct: 77  KLIGIIEEEP-TWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLESI- 132

Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAPE 260
               +HRDI   NIL+      K+ DFGL+R    ED          +       +M+PE
Sbjct: 133 --NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY------YKASVTRLPIKWMSPE 184

Query: 261 YALHGYLSVKTDVFSYGVLVLEIVS-------GRKNHD 291
                  +  +DV+ + V + EI+S         +N D
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  143 bits (364), Expect = 3e-40
 Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 20/211 (9%)

Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           + ++G G FG V+ G   N  ++A+K +   +     +F  E ++++K+ H  LV L+G 
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
           C E     LV E++ +  L  ++  +T+       T   + + V  G+ YL E     +I
Sbjct: 72  CLEQAPICLVTEFMEHGCLSDYL--RTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVI 126

Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGED--THVNT-FRISGTHGYMAPEYALHGYL 267
           HRD+ A N L+ E    K+SDFG+ R    +   +   T F +     + +PE       
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK----WASPEVFSFSRY 182

Query: 268 SVKTDVFSYGVLVLEIVS-------GRKNHD 291
           S K+DV+S+GVL+ E+ S        R N +
Sbjct: 183 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  143 bits (364), Expect = 4e-40
 Identities = 64/213 (30%), Positives = 104/213 (48%), Gaps = 24/213 (11%)

Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           + +LG G FG V+ G      ++AVK L   S      F  E  L+ ++QH+ LV L+  
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV 76

Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
             + P   ++ EY+ N SL  F+        L       +   +A G+ ++ E      I
Sbjct: 77  VTQEP-IYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYI 131

Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAPEYALHG 265
           HRD++A+NIL+ + L+ KI+DFGLARL    +        +         + APE   +G
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEY------TAREGAKFPIKWTAPEAINYG 185

Query: 266 YLSVKTDVFSYGVLVLEIVS-------GRKNHD 291
             ++K+DV+S+G+L+ EIV+       G  N +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  143 bits (364), Expect = 6e-40
 Identities = 58/219 (26%), Positives = 101/219 (46%), Gaps = 32/219 (14%)

Query: 91  LNQLGHGGFGPVYRG----LMPNGQEI--AVKKLSVDSRQGLREFTNEVKLLLKIQHKNL 144
             +LG G FG V+      L P   ++  AVK L   +    ++F  E +LL  +QH+++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSLDWTTRYRIV 191
           V  +G C +G   ++V+EY+ +  L+ F                +     L  +    I 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS 251
             +A G++YL  +     +HRD+   N L+   L  KI DFG++R     D +       
Sbjct: 140 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYR-----V 191

Query: 252 GTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           G H      +M PE  ++   + ++DV+S+GV++ EI +
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  143 bits (363), Expect = 6e-40
 Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 26/206 (12%)

Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           L  +G G FG V  G    G ++AVK +  D+    + F  E  ++ +++H NLV L G 
Sbjct: 26  LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGV 82

Query: 151 C-AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
              E     +V EY+   SL  ++  + +S  L      +  + V   + YL        
Sbjct: 83  IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEGN---NF 138

Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG------YMAPEYAL 263
           +HRD+ A N+L+ E    K+SDFGL +     +        S          + APE   
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK-----EAS------STQDTGKLPVKWTAPEALR 187

Query: 264 HGYLSVKTDVFSYGVLVLEIVS-GRK 288
               S K+DV+S+G+L+ EI S GR 
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRV 213

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  143 bits (363), Expect = 6e-40
 Identities = 56/218 (25%), Positives = 90/218 (41%), Gaps = 29/218 (13%)

Query: 91  LNQLGHGGFGPVYRGL--MPNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLV 145
              +G G FG V++G+   P    +  A+K      S     +F  E   + +  H ++V
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
            L G   E P   ++ E      L  F+  + +  SLD  +       ++  L YL  + 
Sbjct: 80  KLIGVITENP-VWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESK- 135

Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAPE 260
             R +HRDI A N+L+      K+ DFGL+R                + G     +MAPE
Sbjct: 136 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY------YKASKGKLPIKWMAPE 187

Query: 261 YALHGYLSVKTDVFSYGVLVLEIVS-------GRKNHD 291
                  +  +DV+ +GV + EI+        G KN+D
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 225

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  143 bits (362), Expect = 7e-40
 Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 14/202 (6%)

Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           L +LG G FG V  G      ++AVK +   S     EF  E + ++K+ H  LV  +G 
Sbjct: 13  LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGV 71

Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
           C++     +V EY+ N  L  ++  ++    L+ +    +   V  G+ +L      + I
Sbjct: 72  CSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFI 126

Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH---GYMAPEYALHGYL 267
           HRD+ A N L+D  L  K+SDFG+ R    +          GT     + APE   +   
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ----YVSSVGTKFPVKWSAPEVFHYFKY 182

Query: 268 SVKTDVFSYGVLVLEIVS-GRK 288
           S K+DV+++G+L+ E+ S G+ 
Sbjct: 183 SSKSDVWAFGILMWEVFSLGKM 204

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  143 bits (363), Expect = 1e-39
 Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 28/220 (12%)

Query: 91  LNQLGHGGFGPVYRGLM--PNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLV 145
              +G G FG VY G +   +G++I  AVK L+       + +F  E  ++    H N++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 146 TLFGCCAEG-PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           +L G C       ++V  Y+ +  L  FI  + ++ +          + VA+G+ YL  +
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYLASK 147

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG------YMA 258
              + +HRD+ A N +LDE+   K++DFGLAR    ++     + +    G      +MA
Sbjct: 148 ---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE----YYSVHNKTGAKLPVKWMA 200

Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVS-------GRKNHD 291
            E       + K+DV+S+GVL+ E+++            D
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  142 bits (361), Expect = 1e-39
 Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 20/211 (9%)

Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           L +LG G FG V  G      ++A+K +   S     EF  E K+++ + H+ LV L+G 
Sbjct: 29  LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
           C +     ++ EY+ N  L  ++  +             +   V   + YL  +   + +
Sbjct: 88  CTKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESK---QFL 142

Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGED--THVNT-FRISGTHGYMAPEYALHGYL 267
           HRD+ A N L+++Q   K+SDFGL+R    ++  + V + F +     +  PE  ++   
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR----WSPPEVLMYSKF 198

Query: 268 SVKTDVFSYGVLVLEIVS-------GRKNHD 291
           S K+D++++GVL+ EI S          N +
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 229

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  146 bits (371), Expect = 1e-39
 Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 20/211 (9%)

Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
             +LG G FG V+        ++AVK +   S   +  F  E  ++  +QH  LV L   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
             + P   ++ E++   SL  F+    + S             +A G+ ++ +      I
Sbjct: 252 VTKEP-IYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYI 306

Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG---YMAPEYALHGYL 267
           HRD++A+NIL+   L  KI+DFGLAR+    +         G      + APE    G  
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNE----YTAREGAKFPIKWTAPEAINFGSF 362

Query: 268 SVKTDVFSYGVLVLEIVS-------GRKNHD 291
           ++K+DV+S+G+L++EIV+       G  N +
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIPYPGMSNPE 393

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  143 bits (363), Expect = 1e-39
 Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 31/218 (14%)

Query: 91  LNQLGHGGFGPVYRG----LMPNGQEI--AVKKLSVDSRQGLREFTNEVKLLLKIQHKNL 144
             +LG G FG V+      L+P   ++  AVK L   S    ++F  E +LL  +QH+++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYF------------IFDKTKSSSLDWTTRYRIVM 192
           V  FG C EG   ++V+EY+ +  L+ F              +      L       +  
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISG 252
            VA G++YL        +HRD+   N L+ + L  KI DFG++R     D +       G
Sbjct: 166 QVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR-----VG 217

Query: 253 THG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
                   +M PE  L+   + ++DV+S+GV++ EI +
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  142 bits (359), Expect = 3e-39
 Identities = 52/225 (23%), Positives = 95/225 (42%), Gaps = 35/225 (15%)

Query: 91  LNQLGHGGFGPVYRGL--------MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHK 142
              LG G F  +++G+          +  E+ +K L    R     F     ++ K+ HK
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
           +LV  +G C  G E +LV E++   SLD ++  K   + ++   +  +   +A  + +L 
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYL--KKNKNCINILWKLEVAKQLAAAMHFLE 130

Query: 203 EEAPARIIHRDIKASNILLDEQLNP--------KISDFGLARLFPGEDTHVNTFRISGTH 254
           E     +IH ++ A NILL  + +         K+SD G++         +   RI    
Sbjct: 131 EN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV--LPKDILQERIP--- 182

Query: 255 GYMAPEYALHG-YLSVKTDVFSYGVLVLEIVS-------GRKNHD 291
            ++ PE   +   L++ TD +S+G  + EI S          +  
Sbjct: 183 -WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  146 bits (371), Expect = 3e-39
 Identities = 56/196 (28%), Positives = 99/196 (50%), Gaps = 7/196 (3%)

Query: 91  LNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
            ++LG G +G VY G        +AVK L  D+ + + EF  E  ++ +I+H NLV L G
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 283

Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
            C   P   ++ E++   +L  ++ +  +   +       +   ++  + YL ++     
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLEKK---NF 339

Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           IHR++ A N L+ E    K++DFGL+RL    DT+           + APE   +   S+
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSI 398

Query: 270 KTDVFSYGVLVLEIVS 285
           K+DV+++GVL+ EI +
Sbjct: 399 KSDVWAFGVLLWEIAT 414

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  142 bits (361), Expect = 3e-39
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 22/210 (10%)

Query: 91  LNQLGHGGFGPVYRGL--MPNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLV 145
              +G G  G V  G   +P  +++  A+K L    + +  R+F +E  ++ +  H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
            L G    G   M+V EY+ N SLD F+  +T            ++ GV  G+ YL +  
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYLSDL- 170

Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG------YMAP 259
               +HRD+ A N+L+D  L  K+SDFGL+R+   +     T     T G      + AP
Sbjct: 171 --GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYT-----TTGGKIPIRWTAP 223

Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVS-GRK 288
           E       S  +DV+S+GV++ E+++ G +
Sbjct: 224 EAIAFRTFSSASDVWSFGVVMWEVLAYGER 253

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  141 bits (358), Expect = 5e-39
 Identities = 55/227 (24%), Positives = 102/227 (44%), Gaps = 34/227 (14%)

Query: 91  LNQLGHGGFGPVYRGLM--PNGQEI--AVKKLSVD--SRQGLREFTNEVKLLLKIQHKNL 144
              LG G FG V  G +   +G  +  AVK + +D  S++ + EF +E   +    H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 145 VTLFGCCAEG-----PEKMLVYEYLPNKSLDYFI---FDKTKSSSLDWTTRYRIVMGVAR 196
           + L G C E      P+ M++  ++    L  ++     +T    +   T  + ++ +A 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG- 255
           G+ YL        +HRD+ A N +L + +   ++DFGL++     D +       G    
Sbjct: 159 GMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR-----QGRIAK 210

Query: 256 ----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS-------GRKNHD 291
               ++A E       + K+DV+++GV + EI +       G +NH+
Sbjct: 211 MPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  141 bits (357), Expect = 6e-39
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 22/207 (10%)

Query: 93  QLGHGGFGPVYRGLMPNG---QEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTL 147
           +LG G FG V +G        + +AVK L  +        E   E  ++ ++ +  +V +
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
            G C      MLV E      L+ ++    ++  +       +V  V+ G+ YL E    
Sbjct: 84  IGICEAES-WMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYLEES--- 136

Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAPEYA 262
             +HRD+ A N+LL  Q   KISDFGL++    ++ +      + THG     + APE  
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK----AQTHGKWPVKWYAPECI 192

Query: 263 LHGYLSVKTDVFSYGVLVLEIVS-GRK 288
            +   S K+DV+S+GVL+ E  S G+K
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQK 219

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  140 bits (356), Expect = 7e-39
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 33/220 (15%)

Query: 91  LNQLGHGGFGPVYRG----LMPNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKIQHKN 143
           + +LG   FG VY+G      P  Q    A+K L          EF +E  L  ++QH N
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSLDWTTRYRI 190
           +V L G   +     +++ Y  +  L  F               D+T  S+L+      +
Sbjct: 74  VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
           V  +A G+ YL       ++H+D+   N+L+ ++LN KISD GL R     D +      
Sbjct: 134 VAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK----- 185

Query: 251 SGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
              +      +MAPE  ++G  S+ +D++SYGV++ E+ S
Sbjct: 186 LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  140 bits (356), Expect = 8e-39
 Identities = 58/216 (26%), Positives = 94/216 (43%), Gaps = 26/216 (12%)

Query: 94  LGHGGFGPVYRGLMPNGQE----IAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLF 148
           +G G FG VY G   +  +     A+K LS     Q +  F  E  L+  + H N++ L 
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88

Query: 149 GCCAEG-PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           G          ++  Y+ +  L  FI  ++   +          + VARG+ YL E+   
Sbjct: 89  GIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEYLAEQ--- 143

Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAPEYA 262
           + +HRD+ A N +LDE    K++DFGLAR     D    + +    H      + A E  
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDI--LDREYYSVQ-QHRHARLPVKWTALESL 200

Query: 263 LHGYLSVKTDVFSYGVLVLEIVS-------GRKNHD 291
                + K+DV+S+GVL+ E+++            D
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  142 bits (360), Expect = 1e-38
 Identities = 62/207 (29%), Positives = 105/207 (50%), Gaps = 16/207 (7%)

Query: 91  LNQLGHGGFGPVYRGL--MPNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLV 145
              +G G FG V  G   +P+ +EI  A+K L V  + +  R+F  E  ++ +  H N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
            L G   +    M+V EY+ N SLD F+  +   +         ++ G+A G+ YL +  
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTVIQLVGMLRGIASGMKYLSDM- 166

Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH---GYMAPEYA 262
               +HRD+ A NIL++  L  K+SDFGL R+   ED     +   G      + +PE  
Sbjct: 167 --GYVHRDLAARNILINSNLVCKVSDFGLGRVL--EDDPEAAYTTRGGKIPIRWTSPEAI 222

Query: 263 LHGYLSVKTDVFSYGVLVLEIVS-GRK 288
            +   +  +DV+SYG+++ E++S G +
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGER 249

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  140 bits (356), Expect = 1e-38
 Identities = 52/214 (24%), Positives = 97/214 (45%), Gaps = 27/214 (12%)

Query: 91  LNQLGHGGFGPVYRG----LMPNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKIQHKN 143
             +LG G FG VY G    ++ +  E   A+K ++   S +   EF NE  ++ +    +
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------IFDKTKSSSLDWTTRYRIVMGVAR 196
           +V L G  ++G   +++ E +    L  +       + +    +    +   ++   +A 
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGY 256
           G+ YL+     + +HRD+ A N ++ E    KI DFG+ R     D +   +   G  G 
Sbjct: 150 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDYYRKGGKGL 201

Query: 257 -----MAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
                M+PE    G  +  +DV+S+GV++ EI +
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  141 bits (357), Expect = 1e-38
 Identities = 59/208 (28%), Positives = 108/208 (51%), Gaps = 17/208 (8%)

Query: 91  LNQLGHGGFGPVYRGL--MPNGQE---IAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNL 144
              +G G FG VY+G+    +G++   +A+K L    + +   +F  E  ++ +  H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L G  ++    M++ EY+ N +LD F+  + K           ++ G+A G+ YL   
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYLANM 166

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH---GYMAPEY 261
                +HRD+ A NIL++  L  K+SDFGL+R+   ED    T+  SG      + APE 
Sbjct: 167 ---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL--EDDPEATYTTSGGKIPIRWTAPEA 221

Query: 262 ALHGYLSVKTDVFSYGVLVLEIVS-GRK 288
             +   +  +DV+S+G+++ E+++ G +
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGER 249

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  143 bits (363), Expect = 2e-38
 Identities = 61/198 (30%), Positives = 99/198 (50%), Gaps = 13/198 (6%)

Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
             +LG G FG V+ G       +A+K L   +      F  E +++ K++H+ LV L+  
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
            +E P   +V EY+   SL  F         L       +   +A G+ Y+        +
Sbjct: 248 VSEEP-IYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 302

Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGED---THVNTFRISGTHGYMAPEYALHGYL 267
           HRD++A+NIL+ E L  K++DFGLARL    +        F I     + APE AL+G  
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK----WTAPEAALYGRF 358

Query: 268 SVKTDVFSYGVLVLEIVS 285
           ++K+DV+S+G+L+ E+ +
Sbjct: 359 TIKSDVWSFGILLTELTT 376

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  140 bits (355), Expect = 3e-38
 Identities = 65/214 (30%), Positives = 93/214 (43%), Gaps = 27/214 (12%)

Query: 91  LNQLGHGGFGPVYRGLMPNG------QEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKN 143
           +  LGHG FG VY G +          ++AVK L    S Q   +F  E  ++ K  H+N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFI----FDKTKSSSLDWTTRYRIVMGVARGLL 199
           +V   G   +   + ++ E +    L  F+       ++ SSL       +   +A G  
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 200 YLHEEAPARIIHRDIKASNILLD---EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGY 256
           YL E      IHRDI A N LL         KI DFG+AR     D +  ++   G    
Sbjct: 155 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRASYYRKGGCAM 206

Query: 257 -----MAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
                M PE  + G  + KTD +S+GVL+ EI S
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  139 bits (352), Expect = 3e-38
 Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 26/215 (12%)

Query: 91  LNQLGHGGFGPVYRGLMPNGQEI--AVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLF 148
            ++LG G +G VY G+      +  AVK L  D+ + + EF  E  ++ +I+H NLV L 
Sbjct: 18  KHKLGGGQYGEVYEGVW-KKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLL 75

Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G C   P   ++ E++   +L  ++  +     +       +   ++  + YL ++    
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEKK---N 131

Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAPEYAL 263
            IHRD+ A N L+ E    K++DFGL+RL    DT+      +         + APE   
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTY-----TAHAGAKFPIKWTAPESLA 185

Query: 264 HGYLSVKTDVFSYGVLVLEIVS-------GRKNHD 291
           +   S+K+DV+++GVL+ EI +       G     
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 220

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  140 bits (354), Expect = 3e-38
 Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 28/215 (13%)

Query: 91  LNQLGHGGFGPVYRGLMPNG----QEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNL 144
              LG G FG V    +        ++AVK L  D  +   + EF  E   + +  H ++
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 145 VTLFGCCAEG------PEKMLVYEYLPNKSLDYFIFD---KTKSSSLDWTTRYRIVMGVA 195
             L G           P  M++  ++ +  L  F+          +L   T  R ++ +A
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147

Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG 255
            G+ YL        IHRD+ A N +L E +   ++DFGL+R     D +       G   
Sbjct: 148 CGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR-----QGCAS 199

Query: 256 -----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
                ++A E       +V +DV+++GV + EI++
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  143 bits (361), Expect = 8e-38
 Identities = 61/198 (30%), Positives = 99/198 (50%), Gaps = 13/198 (6%)

Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
             +LG G FG V+ G       +A+K L   +      F  E +++ K++H+ LV L+  
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
            +E P   +V EY+   SL  F         L       +   +A G+ Y+        +
Sbjct: 331 VSEEP-IYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYV 385

Query: 211 HRDIKASNILLDEQLNPKISDFGLARLFPGED---THVNTFRISGTHGYMAPEYALHGYL 267
           HRD++A+NIL+ E L  K++DFGLARL    +        F I     + APE AL+G  
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK----WTAPEAALYGRF 441

Query: 268 SVKTDVFSYGVLVLEIVS 285
           ++K+DV+S+G+L+ E+ +
Sbjct: 442 TIKSDVWSFGILLTELTT 459

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  139 bits (352), Expect = 1e-37
 Identities = 65/214 (30%), Positives = 92/214 (42%), Gaps = 27/214 (12%)

Query: 91  LNQLGHGGFGPVYRGLMPNG------QEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKN 143
           +  LGHG FG VY G +          ++AVK L    S Q   +F  E  ++ K  H+N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFI----FDKTKSSSLDWTTRYRIVMGVARGLL 199
           +V   G   +   + ++ E +    L  F+       ++ SSL       +   +A G  
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 200 YLHEEAPARIIHRDIKASNILLD---EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGY 256
           YL E      IHRDI A N LL         KI DFG+AR     D +   +   G    
Sbjct: 196 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-----DIYRAGYYRKGGCAM 247

Query: 257 -----MAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
                M PE  + G  + KTD +S+GVL+ EI S
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  139 bits (352), Expect = 1e-37
 Identities = 59/220 (26%), Positives = 105/220 (47%), Gaps = 28/220 (12%)

Query: 91  LNQLGHGGFGPVYRGLM--PNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLV 145
              +G G FG VY G +   +G++I  AVK L+       + +F  E  ++    H N++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 146 TLFGCC--AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           +L G C  +EG   ++V  Y+ +  L  FI  + ++ +          + VA+G+ +L  
Sbjct: 154 SLLGICLRSEGS-PLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFLAS 210

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMA 258
           +   + +HRD+ A N +LDE+   K++DFGLAR    ++        + T       +MA
Sbjct: 211 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH---NKTGAKLPVKWMA 264

Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVS-------GRKNHD 291
            E       + K+DV+S+GVL+ E+++            D
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  137 bits (347), Expect = 2e-37
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 17/203 (8%)

Query: 93  QLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFG 149
           ++G G F  VY+GL      E+A  +L     ++   + F  E ++L  +QH N+V  + 
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 150 CCAEGPEKM----LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
                 +      LV E + + +L  ++    +   +           + +GL +LH   
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 149

Query: 206 PARIIHRDIKASNILLDEQL-NPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
           P  IIHRD+K  NI +     + KI D GLA L     +        GT  +MAPE    
Sbjct: 150 PP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAVI--GTPEFMAPEMYEE 204

Query: 265 GYLSVKTDVFSYGVLVLEIVSGR 287
            Y     DV+++G+ +LE+ +  
Sbjct: 205 KY-DESVDVYAFGMCMLEMATSE 226

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  143 bits (362), Expect = 2e-37
 Identities = 56/215 (26%), Positives = 90/215 (41%), Gaps = 29/215 (13%)

Query: 94  LGHGGFGPVYRGL--MPNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLF 148
           +G G FG V++G+   P    +  A+K      S     +F  E   + +  H ++V L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457

Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G   E P   ++ E      L  F+  + +  SLD  +       ++  L YL  +   R
Sbjct: 458 GVITENP-VWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESK---R 511

Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAPEYAL 263
            +HRDI A N+L+      K+ DFGL+R                + G     +MAPE   
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY------YKASKGKLPIKWMAPESIN 565

Query: 264 HGYLSVKTDVFSYGVLVLEIVS-------GRKNHD 291
               +  +DV+ +GV + EI+        G KN+D
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 600

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  137 bits (348), Expect = 2e-37
 Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 34/217 (15%)

Query: 92  NQLGHGGFGPVYRG-LMPNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVT 146
           + +G G FG V +  +  +G  +  A+K++    S+   R+F  E+++L K+  H N++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSLDWTTRYRIVMG 193
           L G C       L  EY P+ +L  F                 + +S+L           
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           VARG+ YL ++   + IHRD+ A NIL+ E    KI+DFGL+R   G++ +V       T
Sbjct: 151 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV-----KKT 199

Query: 254 HG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
            G     +MA E   +   +  +DV+SYGVL+ EIVS
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  137 bits (348), Expect = 2e-37
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 41/228 (17%)

Query: 91  LNQLGHGGFGPVYRGLMPNG------QEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKN 143
              LG G FG V +    +         +AVK L  + S   LR+  +E  +L ++ H +
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSL-DY--------------------FIFDKTKSSSL 182
           ++ L+G C++    +L+ EY    SL  +                       D     +L
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                      +++G+ YL   A  +++HRD+ A NIL+ E    KISDFGL+R    ED
Sbjct: 148 TMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204

Query: 243 THVNTFRISGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           ++V       + G     +MA E       + ++DV+S+GVL+ EIV+
Sbjct: 205 SYV-----KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  142 bits (360), Expect = 2e-37
 Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 20/206 (9%)

Query: 93  QLGHGGFGPVYRGL--MPNGQ-EIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLF 148
           +LG G FG V +G+  M   Q ++A+K L     +    E   E +++ ++ +  +V L 
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
           G C      MLV E      L  F+    K   +  +    ++  V+ G+ YL E+    
Sbjct: 403 GVCQAEA-LMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYLEEK---N 456

Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAPEYAL 263
            +HR++ A N+LL  +   KISDFGL++    +D++      + + G     + APE   
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY----TARSAGKWPLKWYAPECIN 512

Query: 264 HGYLSVKTDVFSYGVLVLEIVS-GRK 288
               S ++DV+SYGV + E +S G+K
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQK 538

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  137 bits (347), Expect = 3e-37
 Identities = 65/222 (29%), Positives = 96/222 (43%), Gaps = 35/222 (15%)

Query: 91  LNQLGHGGFGPVYRGLMPN------GQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHK 142
              LG G FG V              + +AVK L    +    R   +E+K+L+ I  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91

Query: 143 NLVTLFGCC-AEGPEKMLVYEYLPNKSL-DY----------FIFDKTKSSSLDWTTRYRI 190
           N+V L G C   G   M++ E+    +L  Y          +            T  + I
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 191 VMG--VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
                VA+G+ +L   A  + IHRD+ A NILL E+   KI DFGLAR     D + +  
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDPD 203

Query: 249 RISGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
            +          +MAPE       ++++DV+S+GVL+ EI S
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  137 bits (348), Expect = 3e-37
 Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 36/223 (16%)

Query: 91  LNQLGHGGFGPVYRGL--------MPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-Q 140
              LG G FG V                  +AVK L  D + + L +  +E++++  I +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSL-DY------------FIFDKTKSSSLDWTTR 187
           HKN++ L G C +     ++ EY    +L +Y            +  ++     + +   
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 188 YRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
                 +ARG+ YL   A  + IHRD+ A N+L+ E    KI+DFGLAR     D +   
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNID 211

Query: 248 FRISGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +    T+G     +MAPE       + ++DV+S+GVL+ EI +
Sbjct: 212 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  137 bits (347), Expect = 7e-37
 Identities = 60/223 (26%), Positives = 101/223 (45%), Gaps = 36/223 (16%)

Query: 91  LNQLGHGGFGPVYRGL--------MPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-Q 140
              LG G FG V                  +AVK L  D + + L +  +E++++  I +
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSL-DY------------FIFDKTKSSSLDWTTR 187
           HKN++ L G C +     ++ EY    +L +Y            +  ++     + +   
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 188 YRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
                 +ARG+ YL  +   + IHRD+ A N+L+ E    KI+DFGLAR     D +   
Sbjct: 206 VSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR-----DINNID 257

Query: 248 FRISGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +    T+G     +MAPE       + ++DV+S+GVL+ EI +
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  135 bits (343), Expect = 8e-37
 Identities = 60/223 (26%), Positives = 90/223 (40%), Gaps = 36/223 (16%)

Query: 91  LNQLGHGGFGPVYRG----LMPNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKI-QHK 142
              LG G FG V       L+ +   +  AVK L             +E+K+L  +  H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSLDWTTRYR 189
           N+V L G C  G   +++ EY     L  F                  +   L       
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 190 IVMG--VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
           +     VA+G+ +L   A    IHRD+ A NILL      KI DFGLAR     D   ++
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLAR-----DIKNDS 199

Query: 248 FRISGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
             +   +      +MAPE   +   + ++DV+SYG+ + E+ S
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  135 bits (343), Expect = 1e-36
 Identities = 59/219 (26%), Positives = 90/219 (41%), Gaps = 32/219 (14%)

Query: 91  LNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHK 142
              LG G FG V               ++AVK L             +E+K++  + QH+
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSL-----------DYFIFDKTKSSSLDWTTRYRIV 191
           N+V L G C  G   +++ EY     L           +        +S+          
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS 251
             VA+G+ +L   A    IHRD+ A N+LL      KI DFGLAR    +  ++      
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI-----V 222

Query: 252 GTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
             +      +MAPE       +V++DV+SYG+L+ EI S
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  134 bits (339), Expect = 2e-36
 Identities = 61/199 (30%), Positives = 94/199 (47%), Gaps = 11/199 (5%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCA 152
           LG G +G VY G  + N   IA+K++     +  +    E+ L   ++HKN+V   G  +
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 153 EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHR 212
           E     +  E +P  SL   +  K      +  T       +  GL YLH+    +I+HR
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 146

Query: 213 DIKASNILLDEQL-NPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE---YALHGYLS 268
           DIK  N+L++      KISDFG ++   G +    TF   GT  YMAPE       GY  
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT--GTLQYMAPEIIDKGPRGY-G 203

Query: 269 VKTDVFSYGVLVLEIVSGR 287
              D++S G  ++E+ +G+
Sbjct: 204 KAADIWSLGCTIIEMATGK 222

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  135 bits (342), Expect = 2e-36
 Identities = 60/228 (26%), Positives = 95/228 (41%), Gaps = 41/228 (17%)

Query: 91  LNQLGHGGFGPVYRG----LMPNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKIQHKN 143
           +  +G G FG V++     L+P       AVK L  + S     +F  E  L+ +  + N
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYF---------------------IFDKTKSSSL 182
           +V L G CA G    L++EY+    L+ F                              L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
               +  I   VA G+ YL E    + +HRD+   N L+ E +  KI+DFGL+R     D
Sbjct: 172 SCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

Query: 243 THVNTFRISGTHGY-----MAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
            +      +  +       M PE   +   + ++DV++YGV++ EI S
Sbjct: 229 YYK-----ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  132 bits (335), Expect = 2e-35
 Identities = 59/228 (25%), Positives = 92/228 (40%), Gaps = 41/228 (17%)

Query: 91  LNQLGHGGFGPVYRG----LMPNGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKI-QHK 142
              LG G FG V       +   G  I  AVK L             +E+K++ ++  H+
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSL------------------DYFIFDKTKSSSLDW 184
           N+V L G C       L++EY     L                  +     + +      
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 185 TTRYRIVMG--VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
           T    +     VA+G+ +L        +HRD+ A N+L+      KI DFGLAR     D
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLAR-----D 221

Query: 243 THVNTFRISGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
              ++  +   +      +MAPE    G  ++K+DV+SYG+L+ EI S
Sbjct: 222 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  132 bits (335), Expect = 4e-35
 Identities = 63/223 (28%), Positives = 106/223 (47%), Gaps = 36/223 (16%)

Query: 91  LNQLGHGGFGPVYRGLMPN--------GQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-Q 140
              LG G FG V                 ++AVK L  D + + L +  +E++++  I +
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSL-DY----------FIFDKTKSSSLDWTTRYR 189
           HKN++ L G C +     ++ EY    +L +Y          + ++ + +     +++  
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 190 IVMG--VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
           +     VARG+ YL   A  + IHRD+ A N+L+ E    KI+DFGLAR     D H   
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHID 245

Query: 248 FRISGTHG-----YMAPEYALHGYLSVKTDVFSYGVLVLEIVS 285
           +    T+G     +MAPE       + ++DV+S+GVL+ EI +
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  131 bits (331), Expect = 5e-35
 Identities = 58/243 (23%), Positives = 103/243 (42%), Gaps = 25/243 (10%)

Query: 60  SAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLS 119
               + G    + NL+F  +++ V    +S L Q+G GG   V++ L    Q  A+K ++
Sbjct: 4   HHHHSSGVDLGTENLYF--QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN 61

Query: 120 VDSR--QGLREFTNEVKLLLKIQHKNL--VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFD 175
           ++    Q L  + NE+  L K+Q  +   + L+          +V E   N  L+ ++  
Sbjct: 62  LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK 120

Query: 176 KTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA 235
           K     +D   R      +   +  +H+     I+H D+K +N L+ +    K+ DFG+A
Sbjct: 121 KKS---IDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIA 173

Query: 236 RLFPGEDTHVNTFRISGTHGYMAPE-----------YALHGYLSVKTDVFSYGVLVLEIV 284
                + T V      GT  YM PE                 +S K+DV+S G ++  + 
Sbjct: 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 233

Query: 285 SGR 287
            G+
Sbjct: 234 YGK 236

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  129 bits (327), Expect = 1e-34
 Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 29/221 (13%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLV 145
           F  +  LG GGFG V+      +    A+K++ + +R+  RE    EVK L K++H  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 146 TLFGCCAEGPEKM------------LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG 193
             F    E                 +  +    ++L  ++  +      + +    I + 
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126

Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS-- 251
           +A  + +LH +    ++HRD+K SNI        K+ DFGL      ++           
Sbjct: 127 IAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 252 --------GTHGYMAPE-YALHGYLSVKTDVFSYGVLVLEI 283
                   GT  YM+PE    + Y S K D+FS G+++ E+
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFEL 223

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  130 bits (328), Expect = 2e-34
 Identities = 54/224 (24%), Positives = 94/224 (41%), Gaps = 23/224 (10%)

Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR--QGLREFTNEVKLL 136
             + V    +S L Q+G GG   V++ L    Q  A+K ++++    Q L  + NE+  L
Sbjct: 2   ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 61

Query: 137 LKIQHKNL--VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGV 194
            K+Q  +   + L+          +V E   N  L+ ++  K     +D   R      +
Sbjct: 62  NKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNM 117

Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH 254
              +  +H+     I+H D+K +N L+ +    K+ DFG+A     + T V      GT 
Sbjct: 118 LEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTV 173

Query: 255 GYMAPE-----------YALHGYLSVKTDVFSYGVLVLEIVSGR 287
            YM PE                 +S K+DV+S G ++  +  G+
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  127 bits (321), Expect = 8e-34
 Identities = 54/203 (26%), Positives = 97/203 (47%), Gaps = 10/203 (4%)

Query: 85  TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN 143
              ++   ++G G  G VY  + +  GQE+A++++++  +       NE+ ++ + ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           +V        G E  +V EYL   SL     D    + +D      +     + L +LH 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS 134

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
               ++IHRDIK+ NILL    + K++DFG       E +  +T    GT  +MAPE   
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM--VGTPYWMAPEVVT 189

Query: 264 HGYLSVKTDVFSYGVLVLEIVSG 286
                 K D++S G++ +E++ G
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEG 212

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  129 bits (325), Expect = 1e-33
 Identities = 53/224 (23%), Positives = 93/224 (41%), Gaps = 23/224 (10%)

Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR--QGLREFTNEVKLL 136
             + V    +S L Q+G GG   V++ L    Q  A+K ++++    Q L  + NE+  L
Sbjct: 49  ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYL 108

Query: 137 LKIQHKNL--VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGV 194
            K+Q  +   + L+          +V E   N  L+ ++  K     +D   R      +
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKS---IDPWERKSYWKNM 164

Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH 254
              +  +H+     I+H D+K +N L+ +    K+ DFG+A     + T V      G  
Sbjct: 165 LEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAV 220

Query: 255 GYMAPE-----------YALHGYLSVKTDVFSYGVLVLEIVSGR 287
            YM PE                 +S K+DV+S G ++  +  G+
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  128 bits (323), Expect = 1e-33
 Identities = 47/201 (23%), Positives = 90/201 (44%), Gaps = 11/201 (5%)

Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTL 147
           L ++G G FG         +G++  +K++++   S +   E   EV +L  ++H N+V  
Sbjct: 29  LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQY 88

Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
                E     +V +Y     L   I +  K             + +   L ++H+    
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVHDR--- 144

Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE-YALHGY 266
           +I+HRDIK+ NI L +    ++ DFG+AR+              GT  Y++PE      Y
Sbjct: 145 KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC--IGTPYYLSPEICENKPY 202

Query: 267 LSVKTDVFSYGVLVLEIVSGR 287
            + K+D+++ G ++ E+ + +
Sbjct: 203 -NNKSDIWALGCVLYELCTLK 222

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  127 bits (321), Expect = 3e-33
 Identities = 57/216 (26%), Positives = 111/216 (51%), Gaps = 11/216 (5%)

Query: 74  LFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQG-LREFTN 131
           L    +  ++  + F  +++LG G  G V++    P+G  +A K + ++ +     +   
Sbjct: 21  LTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR 80

Query: 132 EVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIV 191
           E+++L +     +V  +G      E  +  E++   SLD  +    K+  +      ++ 
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVS 137

Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS 251
           + V +GL YL E+   +I+HRD+K SNIL++ +   K+ DFG++      D+  N+F   
Sbjct: 138 IAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF--V 191

Query: 252 GTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
           GT  YM+PE     + SV++D++S G+ ++E+  GR
Sbjct: 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  125 bits (316), Expect = 4e-33
 Identities = 53/219 (24%), Positives = 102/219 (46%), Gaps = 30/219 (13%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           F ++  +G GGFG V++     +G+   +K++  ++ +  RE    VK L K+ H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVH 68

Query: 147 LFGC-------------CAEGPEKMLVY---EYLPNKSLDYFIFDKTKSSSLDWTTRYRI 190
             GC              +   +   ++   E+    +L+ +I +K +   LD      +
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALEL 127

Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
              + +G+ Y+H +   ++I+RD+K SNI L +    KI DFGL      +       + 
Sbjct: 128 FEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR-TRSK- 182

Query: 251 SGTHGYMAPE-YALHGYLSVKTDVFSYGVLVLEIVSGRK 288
            GT  YM+PE  +   Y   + D+++ G+++ E++    
Sbjct: 183 -GTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCD 219

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  125 bits (317), Expect = 4e-33
 Identities = 66/271 (24%), Positives = 103/271 (38%), Gaps = 23/271 (8%)

Query: 22  HHNHNHNLSVDEMNLKHFISNLFPCLKTSLRGGRAAGESAEDADGSGADSWNLFFDLRTL 81
           HH+H+H+  VD      +  ++       +     A E+ +      +   + F      
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQS--- 58

Query: 82  QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSR--QGLREFTNEVKLLLK 138
                 F  L++LGHG +G V++     +G+  AVK+     R  +       EV    K
Sbjct: 59  ------FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEK 112

Query: 139 I-QHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
           + QH   V L     EG    L  E     SL      +   +SL     +  +      
Sbjct: 113 VGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC--EAWGASLPEAQVWGYLRDTLLA 169

Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L +LH +    ++H D+K +NI L  +   K+ DFGL     G           G   YM
Sbjct: 170 LAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEVQE--GDPRYM 223

Query: 258 APEYALHGYLSVKTDVFSYGVLVLEIVSGRK 288
           APE     Y     DVFS G+ +LE+    +
Sbjct: 224 APELLQGSY-GTAADVFSLGLTILEVACNME 253

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  125 bits (316), Expect = 5e-33
 Identities = 53/203 (26%), Positives = 97/203 (47%), Gaps = 12/203 (5%)

Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVT 146
             ++G G F  VYR   + +G  +A+KK+ +      +   +   E+ LL ++ H N++ 
Sbjct: 37  EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 96

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFI-FDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
            +    E  E  +V E      L   I   K +   +   T ++  + +   L ++H   
Sbjct: 97  YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR- 155

Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE-YALH 264
             R++HRDIK +N+ +      K+ D GL R F  + T  ++    GT  YM+PE    +
Sbjct: 156 --RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMSPERIHEN 211

Query: 265 GYLSVKTDVFSYGVLVLEIVSGR 287
           GY + K+D++S G L+ E+ + +
Sbjct: 212 GY-NFKSDIWSLGCLLYEMAALQ 233

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  125 bits (315), Expect = 1e-32
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 10/203 (4%)

Query: 85  TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN 143
                   ++G G  G V       +G+++AVK + +  +Q      NEV ++   QH N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           +V ++     G E  ++ E+L   +L     D      L+      +   V + L YLH 
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA 159

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
           +    +IHRDIK+ +ILL      K+SDFG       +     +    GT  +MAPE   
Sbjct: 160 Q---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL--VGTPYWMAPEVIS 214

Query: 264 HGYLSVKTDVFSYGVLVLEIVSG 286
               + + D++S G++V+E+V G
Sbjct: 215 RSLYATEVDIWSLGIMVIEMVDG 237

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  124 bits (313), Expect = 1e-32
 Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 33/226 (14%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           F ++  LG G FG V +     + +  A+KK+     + L    +EV LL  + H+ +V 
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVR 66

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFI---------FD--KTKSSSLDWTTRYRIVMGVA 195
            +    E    +     +  KS  +           +D   +++ +      +R+   + 
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126

Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF--------------PGE 241
             L Y+H +    IIHRD+K  NI +DE  N KI DFGLA+                PG 
Sbjct: 127 EALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183

Query: 242 DTHVNTFRISGTHGYMAPE-YALHGYLSVKTDVFSYGVLVLEIVSG 286
             ++ +    GT  Y+A E     G+ + K D++S G++  E++  
Sbjct: 184 SDNLTSAI--GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  124 bits (313), Expect = 1e-32
 Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 11/201 (5%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQG-LREFTNEVKLLLKIQHKNLV 145
           F+ L ++G G FG V++G+     + +A+K + ++  +  + +   E+ +L +     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
             +G   +  +  ++ EYL   S      D  +   LD T    I+  + +GL YLH E 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLHSE- 138

Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHG 265
             + IHRDIKA+N+LL E    K++DFG+A          NTF   GT  +MAPE     
Sbjct: 139 --KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF--VGTPFWMAPEVIKQS 194

Query: 266 YLSVKTDVFSYGVLVLEIVSG 286
               K D++S G+  +E+  G
Sbjct: 195 AYDSKADIWSLGITAIELARG 215

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  124 bits (313), Expect = 2e-32
 Identities = 59/220 (26%), Positives = 101/220 (45%), Gaps = 19/220 (8%)

Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-RQGLREFTNEVKLL 136
           +          DL ++G G +G V + +  P+GQ +AVK++      +  ++   ++ ++
Sbjct: 15  QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74

Query: 137 LK-IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY--RIVMG 193
           ++      +V  +G      +  +  E + + S D F                  +I + 
Sbjct: 75  MRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLA 133

Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL-ARLFPGEDTHVNTFRISG 252
             + L +L E    +IIHRDIK SNILLD   N K+ DFG+  +L    D+   T    G
Sbjct: 134 TVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL---VDSIAKTRDA-G 187

Query: 253 THGYMAPE-----YALHGYLSVKTDVFSYGVLVLEIVSGR 287
              YMAPE      +  GY  V++DV+S G+ + E+ +GR
Sbjct: 188 CRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGR 226

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  123 bits (311), Expect = 3e-32
 Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 10/203 (4%)

Query: 85  TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN 143
              F  L +LG G +G VY+ +    GQ +A+K++ V+S   L+E   E+ ++ +    +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPH 85

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           +V  +G   +  +  +V EY    S+   I  + ++ +L       I+    +GL YLH 
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHF 143

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
               R IHRDIKA NILL+ + + K++DFG+A          NT    GT  +MAPE   
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV--IGTPFWMAPEVIQ 198

Query: 264 HGYLSVKTDVFSYGVLVLEIVSG 286
               +   D++S G+  +E+  G
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEG 221

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  123 bits (311), Expect = 3e-32
 Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 22/222 (9%)

Query: 82  QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKI 139
             + + +   + LG G    V+RG     G   A+K  +  S     +    E ++L K+
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 140 QHKNLVTLFGCCAEGPEKM--LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            HKN+V LF    E   +   L+ E+ P  SL   + + + +  L  +    ++  V  G
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 198 LLYLHEEAPARIIHRDIKASNILL----DEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           + +L E     I+HR+IK  NI+     D Q   K++DFG AR    +D    +    GT
Sbjct: 125 MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVSLY--GT 178

Query: 254 HGYMAPE--------YALHGYLSVKTDVFSYGVLVLEIVSGR 287
             Y+ P+                   D++S GV      +G 
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  125 bits (315), Expect = 6e-32
 Identities = 51/205 (24%), Positives = 86/205 (41%), Gaps = 21/205 (10%)

Query: 93  QLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCC 151
            LGHG  G +    M + +++AVK++  +          EV+LL +  +H N++  F C 
Sbjct: 31  VLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD---REVQLLRESDEHPNVIRYF-CT 86

Query: 152 AEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
            +  +   +  E       +Y          L+      ++     GL +LH      I+
Sbjct: 87  EKDRQFQYIAIELCAATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLHS---LNIV 140

Query: 211 HRDIKASNILLDEQ-----LNPKISDFGLAR-LFPGEDTHVNTFRISGTHGYMAPEY--- 261
           HRD+K  NIL+        +   ISDFGL + L  G  +      + GT G++APE    
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200

Query: 262 ALHGYLSVKTDVFSYGVLVLEIVSG 286
                 +   D+FS G +   ++S 
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVISE 225

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  123 bits (310), Expect = 6e-32
 Identities = 55/209 (26%), Positives = 87/209 (41%), Gaps = 18/209 (8%)

Query: 85  TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN 143
            ++ +   ++G G FG V+R      G + AVKK+ ++  +       E+     +    
Sbjct: 57  VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPR 111

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           +V L+G   EGP   +  E L   SL   I    +   L        +     GL YLH 
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLI---KQMGCLPEDRALYYLGQALEGLEYLHT 168

Query: 204 EAPARIIHRDIKASNILLDEQLNP-KISDFGLA-RLFPGEDTHVNTFRIS--GTHGYMAP 259
               RI+H D+KA N+LL    +   + DFG A  L P              GT  +MAP
Sbjct: 169 R---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225

Query: 260 EYALH-GYLSVKTDVFSYGVLVLEIVSGR 287
           E  +       K D++S   ++L +++G 
Sbjct: 226 EVVMGKPC-DAKVDIWSSCCMMLHMLNGC 253

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  122 bits (307), Expect = 1e-31
 Identities = 52/231 (22%), Positives = 90/231 (38%), Gaps = 19/231 (8%)

Query: 73  NLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN 131
           NL+F    + +    +  + +LG GGF  V     + +G   A+K++    +Q   E   
Sbjct: 16  NLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQR 75

Query: 132 EVKLLLKIQHKNLVTLFGCCAEGPEKM----LVYEYLPNKSL-DYFIFDKTKSSSLDWTT 186
           E  +     H N++ L   C           L+  +    +L +     K K + L    
Sbjct: 76  EADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQ 135

Query: 187 RYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246
              +++G+ RGL  +H +      HRD+K +NILL ++  P + D G             
Sbjct: 136 ILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSR 192

Query: 247 TFRI-------SGTHGYMAPE---YALHGYLSVKTDVFSYGVLVLEIVSGR 287
                        T  Y APE      H  +  +TDV+S G ++  ++ G 
Sbjct: 193 QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  120 bits (304), Expect = 2e-31
 Identities = 57/220 (25%), Positives = 108/220 (49%), Gaps = 22/220 (10%)

Query: 80  TLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-RQGLREFTNEVKLLL 137
           +++V  +    + +LG G +G V +   +P+GQ +AVK++      Q  +    ++ + +
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60

Query: 138 K-IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYF---IFDKTKSSSLDWTTRYRIVMG 193
           + +     VT +G      +  +  E + + SLD F   + DK ++   D   +  I + 
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGK--IAVS 117

Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV-NTFRISG 252
           + + L +LH +    +IHRD+K SN+L++     K+ DFG++      D    +    +G
Sbjct: 118 IVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDID--AG 171

Query: 253 THGYMAPE-----YALHGYLSVKTDVFSYGVLVLEIVSGR 287
              YMAPE         GY SVK+D++S G+ ++E+   R
Sbjct: 172 CKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILR 210

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  121 bits (305), Expect = 2e-31
 Identities = 51/209 (24%), Positives = 94/209 (44%), Gaps = 15/209 (7%)

Query: 85  TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN 143
              +  + +LG G FG VY+      G   A K +   S + L ++  E+++L    H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           +V L G      +  ++ E+ P  ++D  +        L       +   +   L +LH 
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALNFLHS 135

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
           +   RIIHRD+KA N+L+  + + +++DFG++          ++F   GT  +MAPE  +
Sbjct: 136 K---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF--IGTPYWMAPEVVM 190

Query: 264 H------GYLSVKTDVFSYGVLVLEIVSG 286
                   Y   K D++S G+ ++E+   
Sbjct: 191 CETMKDTPY-DYKADIWSLGITLIEMAQI 218

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  122 bits (308), Expect = 3e-31
 Identities = 55/222 (24%), Positives = 91/222 (40%), Gaps = 22/222 (9%)

Query: 82  QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKI 139
             + + +   + LG G    V+RG     G   A+K  +  S     +    E ++L K+
Sbjct: 5   STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 140 QHKNLVTLFGCCAEGPEKM--LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
            HKN+V LF    E   +   L+ E+ P  SL   + + + +  L  +    ++  V  G
Sbjct: 65  NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124

Query: 198 LLYLHEEAPARIIHRDIKASNILL----DEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           + +L E     I+HR+IK  NI+     D Q   K++DFG AR    +D    +    GT
Sbjct: 125 MNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL-EDDEQFVSL--YGT 178

Query: 254 HGYMAPE--------YALHGYLSVKTDVFSYGVLVLEIVSGR 287
             Y+ P+                   D++S GV      +G 
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  120 bits (304), Expect = 5e-31
 Identities = 69/207 (33%), Positives = 96/207 (46%), Gaps = 21/207 (10%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQG---LREFTNEVKLLLKIQHKN 143
           FSDL ++GHG FG VY    + N + +A+KK+S   +Q     ++   EV+ L K++H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
            +   GC        LV EY    + D     +     L       +  G  +GL YLH 
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASD---LLEVHKKPLQEVEIAAVTHGALQGLAYLHS 172

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
                +IHRD+KA NILL E    K+ DFG A          N+F   GT  +MAPE  L
Sbjct: 173 H---NMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANSF--VGTPYWMAPEVIL 223

Query: 264 H----GYLSVKTDVFSYGVLVLEIVSG 286
                 Y   K DV+S G+  +E+   
Sbjct: 224 AMDEGQY-DGKVDVWSLGITCIELAER 249

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  124 bits (311), Expect = 1e-30
 Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 21/207 (10%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLVTLFGCC 151
           LG GGFG V R +    G+++A+K+   +     RE +  E++++ K+ H N+V+     
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR-EV 80

Query: 152 AEGPEKM-------LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
            +G +K+       L  EY     L  ++        L       ++  ++  L YLHE 
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN 140

Query: 205 APARIIHRDIKASNILLD---EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE- 260
              RIIHRD+K  NI+L    ++L  KI D G A+    +      F   GT  Y+APE 
Sbjct: 141 ---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEF--VGTLQYLAPEL 194

Query: 261 YALHGYLSVKTDVFSYGVLVLEIVSGR 287
                Y +V  D +S+G L  E ++G 
Sbjct: 195 LEQKKY-TVTVDYWSFGTLAFECITGF 220

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  118 bits (298), Expect = 1e-30
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 10/205 (4%)

Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTL 147
           L  +G G +G   +     +G+ +  K+L     +    +   +EV LL +++H N+V  
Sbjct: 11  LYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRY 70

Query: 148 FGCCAEGPEKML--VYEYLPNKSLDYFI-FDKTKSSSLDWTTRYRIVMGVARGLLYLHE- 203
           +    +     L  V EY     L   I     +   LD     R++  +   L   H  
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130

Query: 204 -EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
            +    ++HRD+K +N+ LD + N K+ DFGLAR+   + +   TF   GT  YM+PE  
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF--VGTPYYMSPEQM 188

Query: 263 LHGYLSVKTDVFSYGVLVLEIVSGR 287
                + K+D++S G L+ E+ +  
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELCALM 213

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  118 bits (299), Expect = 1e-30
 Identities = 64/212 (30%), Positives = 104/212 (49%), Gaps = 16/212 (7%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQ-GLREFTNEVKLLLKIQHKNLV 145
           +     +G G    V      P  +++A+K+++++  Q  + E   E++ + +  H N+V
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76

Query: 146 TLFGCCAEGPEKMLVYEYLPNKSL-----DYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
           + +       E  LV + L   S+           + KS  LD +T   I+  V  GL Y
Sbjct: 77  SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136

Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGL-ARLFPGEDTHVNTFRIS--GTHGYM 257
           LH+      IHRD+KA NILL E  + +I+DFG+ A L  G D   N  R +  GT  +M
Sbjct: 137 LHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193

Query: 258 APE--YALHGYLSVKTDVFSYGVLVLEIVSGR 287
           APE    + GY   K D++S+G+  +E+ +G 
Sbjct: 194 APEVMEQVRGY-DFKADIWSFGITAIELATGA 224

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  119 bits (301), Expect = 1e-30
 Identities = 55/231 (23%), Positives = 93/231 (40%), Gaps = 23/231 (9%)

Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLL 137
           +T+++          L  GGF  VY    + +G+E A+K+L  +  +  R    EV  + 
Sbjct: 21  QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMK 80

Query: 138 KIQ-HKNLVTLFGCCAEGPEKM-------LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYR 189
           K+  H N+V      + G E+        L+   L    L  F+        L   T  +
Sbjct: 81  KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140

Query: 190 IVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR-LFPGEDTHVNTF 248
           I     R + ++H + P  IIHRD+K  N+LL  Q   K+ DFG A  +    D   +  
Sbjct: 141 IFYQTCRAVQHMHRQKPP-IIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQ 199

Query: 249 RIS---------GTHGYMAPE---YALHGYLSVKTDVFSYGVLVLEIVSGR 287
           R +          T  Y  PE      +  +  K D+++ G ++  +   +
Sbjct: 200 RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  118 bits (297), Expect = 3e-30
 Identities = 58/235 (24%), Positives = 103/235 (43%), Gaps = 22/235 (9%)

Query: 64  ADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS 122
           +  SG  +  L    +  Q   N   +L ++G G  G V++      G  IAVK++    
Sbjct: 3   SGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG 62

Query: 123 -RQGLREFTNEVKLLLK-IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS 180
            ++  +    ++ ++LK      +V  FG      +  +  E +     +     K    
Sbjct: 63  NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAE--KLKKRMQG 119

Query: 181 SLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL-ARLFP 239
            +      ++ + + + L YL E+    +IHRD+K SNILLDE+   K+ DFG+  RL  
Sbjct: 120 PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGRLV- 176

Query: 240 GEDTHV-NTFRISGTHGYMAPE------YALHGYLSVKTDVFSYGVLVLEIVSGR 287
             D    +    +G   YMAPE           Y  ++ DV+S G+ ++E+ +G+
Sbjct: 177 --DDKAKDRS--AGCAAYMAPERIDPPDPTKPDY-DIRADVWSLGISLVELATGQ 226

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  118 bits (297), Expect = 9e-30
 Identities = 41/225 (18%), Positives = 81/225 (36%), Gaps = 20/225 (8%)

Query: 77  DLRTLQVATNFFSDLNQLGHG--GFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTN 131
            + +       +  L  +G G      V      P G+ + V++++++  S + +     
Sbjct: 16  GMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQG 75

Query: 132 EVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRI 190
           E+ +     H N+V          E  +V  ++   S  D  +        ++      I
Sbjct: 76  ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD--LICTHFMDGMNELAIAYI 133

Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
           + GV + L Y+H       +HR +KAS+IL+       +S                    
Sbjct: 134 LQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHD 190

Query: 251 S-----GTHGYMAPE---YALHGYLSVKTDVFSYGVLVLEIVSGR 287
                     +++PE     L GY   K+D++S G+   E+ +G 
Sbjct: 191 FPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGH 234

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  115 bits (290), Expect = 2e-29
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 11/206 (5%)

Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVKKLS---VDSRQGLREFTNEVKLLLKIQHKNLVT 146
           +++LG GG   VY         ++A+K +     +  + L+ F  EV    ++ H+N+V+
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           +     E     LV EY+   +L  +I        L   T       +  G+ + H+   
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAHD--- 129

Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGY 266
            RI+HRDIK  NIL+D     KI DFG+A+    E +   T  + GT  Y +PE A    
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGTVQYFSPEQAKGEA 188

Query: 267 LSVKTDVFSYGVLVLEIVSGRKNHDG 292
               TD++S G+++ E++ G    +G
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPPFNG 214

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  115 bits (289), Expect = 5e-29
 Identities = 53/201 (26%), Positives = 86/201 (42%), Gaps = 18/201 (8%)

Query: 94  LGHGGFGPVYRG-LMPNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
           LG GGF   +        +  A K   K  +       + + E+ +   + H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 150 CCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSS--LDWTTRYRIVMGVARGLLYLHEEAP 206
              E  + + +V E    +SL     +  K      +   RY  +  +  G  YLH    
Sbjct: 109 F-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARY-YLRQIVLGCQYLHRN-- 160

Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGY 266
            R+IHRD+K  N+ L+E L  KI DFGLA     +        + GT  Y+APE      
Sbjct: 161 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKG 217

Query: 267 LSVKTDVFSYGVLVLEIVSGR 287
            S + DV+S G ++  ++ G+
Sbjct: 218 HSFEVDVWSIGCIMYTLLVGK 238

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  113 bits (286), Expect = 5e-29
 Identities = 49/226 (21%), Positives = 84/226 (37%), Gaps = 36/226 (15%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKK--LSVDSRQGLREFTNEVKLLLKI-QHKN 143
           F +L ++G G FG V++ +   +G   A+K+    +      +    EV     + QH +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKS-SSLDWTTRYRIVMGVARGLLYLH 202
           +V  F   AE    ++  EY    SL   I +  +  S         +++ V RGL Y+H
Sbjct: 73  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132

Query: 203 EEAPARIIHRDIKASNILLDE-------------------QLNPKISDFGLARLFPGEDT 243
                 ++H DIK SNI +                     ++  KI D G          
Sbjct: 133 SM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQV 189

Query: 244 HVNTFRISGTHGYMAPE--YALHGYLSVKTDVFSYGVLVLEIVSGR 287
                   G   ++A E     + +L  K D+F+  + V+      
Sbjct: 190 EE------GDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAE 228

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  114 bits (288), Expect = 6e-29
 Identities = 67/226 (29%), Positives = 103/226 (45%), Gaps = 24/226 (10%)

Query: 76  FDLRTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVK 134
            DL  L+     F  +  +G+G +G VY+G  +  GQ  A+K + V       E   E+ 
Sbjct: 14  IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEIN 72

Query: 135 LLLKI-QHKNLVTLFGC------CAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSSLDWTT 186
           +L K   H+N+ T +G            +  LV E+    S+ D  +   TK ++L    
Sbjct: 73  MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKNTKGNTLKEEW 130

Query: 187 RYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN 246
              I   + RGL +LH+    ++IHRDIK  N+LL E    K+ DFG++          N
Sbjct: 131 IAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN 187

Query: 247 TFRISGTHGYMAPE------YALHGYLSVKTDVFSYGVLVLEIVSG 286
           TF   GT  +MAPE           Y   K+D++S G+  +E+  G
Sbjct: 188 TF--IGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEG 230

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  113 bits (284), Expect = 1e-28
 Identities = 53/201 (26%), Positives = 86/201 (42%), Gaps = 18/201 (8%)

Query: 94  LGHGGFGPVYRG-LMPNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
           LG GGF   +        +  A K   K  +       + + E+ +   + H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 150 CCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSS--LDWTTRYRIVMGVARGLLYLHEEAP 206
              E  + + +V E    +SL     +  K      +   RY  +  +  G  YLH    
Sbjct: 83  F-FEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARY-YLRQIVLGCQYLHRN-- 134

Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGY 266
            R+IHRD+K  N+ L+E L  KI DFGLA     +        + GT  Y+APE      
Sbjct: 135 -RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKG 191

Query: 267 LSVKTDVFSYGVLVLEIVSGR 287
            S + DV+S G ++  ++ G+
Sbjct: 192 HSFEVDVWSIGCIMYTLLVGK 212

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  111 bits (280), Expect = 3e-28
 Identities = 59/198 (29%), Positives = 100/198 (50%), Gaps = 11/198 (5%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
           LG G F  VYR   +  G E+A+K   K ++     ++   NEVK+  +++H +++ L+ 
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
              +     LV E   N  ++ ++ ++ K  S +   R   +  +  G+LYLH      I
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS-ENEAR-HFMHQIITGMLYLHSH---GI 133

Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
           +HRD+  SN+LL   +N KI+DFGLA           T  + GT  Y++PE A      +
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRSAHGL 191

Query: 270 KTDVFSYGVLVLEIVSGR 287
           ++DV+S G +   ++ GR
Sbjct: 192 ESDVWSLGCMFYTLLIGR 209

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  113 bits (284), Expect = 1e-27
 Identities = 59/229 (25%), Positives = 90/229 (39%), Gaps = 36/229 (15%)

Query: 86  NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNL 144
           N       LG+G  G V       G+ +AVK++ +D          E+KLL +   H N+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIAL---MEIKLLTESDDHPNV 71

Query: 145 VTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTR----YRIVMGVARGLL 199
           +  + C       + +  E   N +L   +  K  S       +      ++  +A G+ 
Sbjct: 72  IRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 200 YLHEEAPARIIHRDIKASNILLD-------------EQLNPKISDFGLARLFPGEDTHVN 246
           +LH     +IIHRD+K  NIL+              E L   ISDFGL +      +   
Sbjct: 130 HLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186

Query: 247 TFR--ISGTHGYMAPE-------YALHGYLSVKTDVFSYGVLVLEIVSG 286
           T     SGT G+ APE             L+   D+FS G +   I+S 
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  114 bits (288), Expect = 1e-27
 Identities = 47/208 (22%), Positives = 82/208 (39%), Gaps = 24/208 (11%)

Query: 94  LGHGGFGPVYRG--LMPNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLVTL--F 148
           + HGG G +Y       NG+ + +K L        +     E + L ++ H ++V +  F
Sbjct: 88  IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147

Query: 149 GCCAEGPEKMLVY---EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
               +     + Y   EY+  +SL      K     L        ++ +   L YLH   
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLHS-- 200

Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHG 265
              +++ D+K  NI+L E+   K+ D G                + GT G+ APE    G
Sbjct: 201 -IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI----NSFGY--LYGTPGFQAPEIVRTG 252

Query: 266 YLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
             +V TD+++ G  +  +       +GR
Sbjct: 253 -PTVATDIYTVGRTLAALTLDLPTRNGR 279

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  109 bits (275), Expect = 2e-27
 Identities = 56/199 (28%), Positives = 87/199 (43%), Gaps = 16/199 (8%)

Query: 94  LGHGGFGPVYRG-LMPNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
           LG G FG VY      +   +A+K   K  ++      +   EV++   ++H N++ L+G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76

Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
              +     L+ EY P  ++    + +  K S  D       +  +A  L Y H +   R
Sbjct: 77  YFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYCHSK---R 129

Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLS 268
           +IHRDIK  N+LL      KI+DFG +   P            GT  Y+ PE        
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--DL--CGTLDYLPPEMIEGRMHD 185

Query: 269 VKTDVFSYGVLVLEIVSGR 287
            K D++S GVL  E + G+
Sbjct: 186 EKVDLWSLGVLCYEFLVGK 204

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  109 bits (273), Expect = 1e-26
 Identities = 41/231 (17%), Positives = 70/231 (30%), Gaps = 28/231 (12%)

Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRG------LMPNGQEIAVKKLSVDSRQGLREFTNE 132
              Q+ +      + LG G F  VY           N Q+  +K     +       T  
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117

Query: 133 VKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFI--FDKTKSSSLDWTTRYRI 190
           ++ L        +  +         +LV E     +L   I  +  T    +        
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP-----------KISDFGLA---R 236
            M +   +  +H+     IIH DIK  N +L                  + D G +   +
Sbjct: 178 AMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234

Query: 237 LFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
           LFP + T         T G+   E   +   + + D F     V  ++ G 
Sbjct: 235 LFP-KGTIFTAKC--ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  107 bits (270), Expect = 1e-26
 Identities = 53/209 (25%), Positives = 95/209 (45%), Gaps = 17/209 (8%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLF- 148
           LG GG   V+    + + +++AVK L  D          F  E +    + H  +V ++ 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79

Query: 149 -GCCAEGPEKMLVY---EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
            G  AE P   L Y   EY+   +L   +  +     +       ++    + L + H+ 
Sbjct: 80  TGE-AETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQ- 134

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLAR-LFPGEDTHVNTFRISGTHGYMAPEYAL 263
               IIHRD+K +NI++      K+ DFG+AR +    ++   T  + GT  Y++PE A 
Sbjct: 135 --NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192

Query: 264 HGYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
              +  ++DV+S G ++ E+++G     G
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  109 bits (274), Expect = 2e-26
 Identities = 61/223 (27%), Positives = 104/223 (46%), Gaps = 30/223 (13%)

Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLK 138
           +T +     +++   +G+G FG V++  +    E+A+KK+  D R   R    E++++  
Sbjct: 33  KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRI 88

Query: 139 IQHKNLVTLFGCCAEGPEKM------LVYEYLP---NKSLDYFIFDKTKSSSLDWTTRYR 189
           ++H N+V L        +K       LV EY+P    ++  ++   K     L    +  
Sbjct: 89  VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPML--LIKLY 146

Query: 190 IVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP-KISDFGLAR-LFPGEDTHVNT 247
           +   + R L Y+H      I HRDIK  N+LLD      K+ DFG A+ L  GE    N 
Sbjct: 147 MYQ-LLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NV 199

Query: 248 FRISGTHGYMAPEYALHG---YLSVKTDVFSYGVLVLEIVSGR 287
             I  +  Y APE  + G   Y +   D++S G ++ E++ G+
Sbjct: 200 SYIC-SRYYRAPE-LIFGATNY-TTNIDIWSTGCVMAELMQGQ 239

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  110 bits (276), Expect = 2e-26
 Identities = 67/209 (32%), Positives = 94/209 (44%), Gaps = 29/209 (13%)

Query: 92  NQLGHGGFGPVYRGLM-PNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
             LG G FG V        GQE AVK   K  V  +        EV+LL ++ H N++ L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91

Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY------RIVMGVARGLLYL 201
           +    +     LV E      L    FD+  S       R+      RI+  V  G+ Y+
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGEL----FDEIISRK-----RFSEVDAARIIRQVLSGITYM 142

Query: 202 HEEAPARIIHRDIKASNILL---DEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMA 258
           H+    +I+HRD+K  N+LL    +  N +I DFGL+  F             GT  Y+A
Sbjct: 143 HK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK---DKIGTAYYIA 196

Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
           PE  LHG    K DV+S GV++  ++SG 
Sbjct: 197 PE-VLHGTYDEKCDVWSTGVILYILLSGC 224

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  105 bits (265), Expect = 5e-26
 Identities = 52/200 (26%), Positives = 85/200 (42%), Gaps = 18/200 (9%)

Query: 94  LGHGGFGPVYRG-LMPNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
           LG G FG VY      N   +A+K   K  ++      +   E+++   ++H N++ ++ 
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDK-TKSSSLD-WTTRYRIVMGVARGLLYLHEEAPA 207
              +     L+ E+ P   L    + +  K    D   +    +  +A  L Y HE    
Sbjct: 82  YFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSA-TFMEELADALHYCHER--- 133

Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
           ++IHRDIK  N+L+  +   KI+DFG +   P       T    GT  Y+ PE       
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--TM--CGTLDYLPPEMIEGKTH 189

Query: 268 SVKTDVFSYGVLVLEIVSGR 287
             K D++  GVL  E + G 
Sbjct: 190 DEKVDLWCAGVLCYEFLVGM 209

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  107 bits (268), Expect = 5e-26
 Identities = 51/222 (22%), Positives = 88/222 (39%), Gaps = 39/222 (17%)

Query: 94  LGHGGFGPVYRGLMPNGQEIAVKKLS-----------------VDSRQGLREFTNEVKLL 136
           L  G F  +      + +  A+KK                   +  +    +F NE++++
Sbjct: 39  LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 137 LKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVA 195
             I+++  +T  G      E  ++YEY+ N S+             LD      I + V 
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSI----LKFDEYFFVLDKNYTCFIPIQVI 153

Query: 196 R--------GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
           +           Y+H E    I HRD+K SNIL+D+    K+SDFG +     +      
Sbjct: 154 KCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK--G 209

Query: 248 FRISGTHGYMAPEYALH--GYLSVKTDVFSYGVLVLEIVSGR 287
            R  GT+ +M PE+  +   Y   K D++S G+ +  +    
Sbjct: 210 SR--GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  107 bits (270), Expect = 7e-26
 Identities = 63/214 (29%), Positives = 99/214 (46%), Gaps = 29/214 (13%)

Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           ++D   +G+G FG VY+  L  +G+ +A+KK+  D R   RE    ++++ K+ H N+V 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVR 111

Query: 147 LFGCCAEGPEKM------LVYEYLP---NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
           L        EK       LV +Y+P    +   ++   K          +  +   + R 
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP--VIYVKLYMYQ-LFRS 168

Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNP-KISDFGLAR-LFPGEDTHVNTFRISGTHG 255
           L Y+H      I HRDIK  N+LLD      K+ DFG A+ L  GE    N   I  +  
Sbjct: 169 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSYIC-SRY 221

Query: 256 YMAPEYAL--HGYLSVKTDVFSYGVLVLEIVSGR 287
           Y APE       Y +   DV+S G ++ E++ G+
Sbjct: 222 YRAPELIFGATDY-TSSIDVWSAGCVLAELLLGQ 254

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  107 bits (268), Expect = 7e-26
 Identities = 68/287 (23%), Positives = 119/287 (41%), Gaps = 37/287 (12%)

Query: 18  NHQHHHNHNHNLSVDEMNLKHFISNLFPCLKTSLRGGRAAGESAEDADGSGADSWNLF-- 75
           +H HHH+   +L  + +  +   ++     ++     +    +A+  +     S      
Sbjct: 3   HHHHHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSAL 62

Query: 76  ----------FDLRTLQVATNFFSDL------NQLGHGGFGPVYRGLM-PNGQEIAVKKL 118
                     FD R +       +          LG G FG V++      G ++A K +
Sbjct: 63  AVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKII 122

Query: 119 SVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKT 177
                +   E  NE+ ++ ++ H NL+ L+    E    + LV EY+    L    FD+ 
Sbjct: 123 KTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF-ESKNDIVLVMEYVDGGEL----FDRI 177

Query: 178 KSSSLDWTTRY--RIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP--KISDFG 233
              S + T       +  +  G+ ++H+     I+H D+K  NIL   +     KI DFG
Sbjct: 178 IDESYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFG 234

Query: 234 LARLF-PGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVL 279
           LAR + P E   VN     GT  ++APE   + ++S  TD++S GV+
Sbjct: 235 LARRYKPREKLKVNF----GTPEFLAPEVVNYDFVSFPTDMWSVGVI 277

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  106 bits (265), Expect = 1e-25
 Identities = 56/264 (21%), Positives = 86/264 (32%), Gaps = 72/264 (27%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLV 145
           F  +  +G GGFG V+      +    A+K++ + +R+  RE    EVK L K++H  +V
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67

Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYR---------------- 189
             F    E P +    E       D        S S       +                
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127

Query: 190 ----------IVMG-------------------------------VARGLLYLHEEAPAR 208
                     I M                                +A  + +LH +    
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---G 184

Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS----------GTHGYMA 258
           ++HRD+K SNI        K+ DFGL      ++                   GT  YM+
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244

Query: 259 PEYALHGYLSVKTDVFSYGVLVLE 282
           PE       S K D+FS G+++ E
Sbjct: 245 PEQIHGNNYSHKVDIFSLGLILFE 268

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  104 bits (261), Expect = 3e-25
 Identities = 43/203 (21%), Positives = 77/203 (37%), Gaps = 11/203 (5%)

Query: 94  LGHGGFGPVYRGLMPN-GQEIAVKKLSVD--SRQGLRE-FTNEVKLLLKIQHKNLVTLFG 149
           +G GG G VY        + +A+K +S    S    R     E +   ++Q  ++V +  
Sbjct: 42  VGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD 101

Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
                 +  +    +    L   +    +   L       IV  +   L   H    A  
Sbjct: 102 FGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAHA---AGA 155

Query: 210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSV 269
            HRD+K  NIL+       + DFG+A     ++         GT  YMAPE     + + 
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASAT-TDEKLTQLGNTVGTLYYMAPERFSESHATY 214

Query: 270 KTDVFSYGVLVLEIVSGRKNHDG 292
           + D+++   ++ E ++G   + G
Sbjct: 215 RADIYALTCVLYECLTGSPPYQG 237

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  106 bits (267), Expect = 3e-25
 Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 34/218 (15%)

Query: 85  TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVK-----KLSVDSRQGLREFTNEVKLLLK 138
           +  +  + +LG G +G V          E A+K      +S  S   L     EV +L  
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLL---EEVAVLKL 92

Query: 139 IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY------RIVM 192
           + H N++ L+    +     LV E      L    FD+          ++       I+ 
Sbjct: 93  LDHPNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRM-----KFNEVDAAVIIK 143

Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILL---DEQLNPKISDFGLARLFPGEDTHVNTFR 249
            V  G+ YLH+     I+HRD+K  N+LL   ++    KI DFGL+ +F  +        
Sbjct: 144 QVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK---E 197

Query: 250 ISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
             GT  Y+APE  L      K DV+S GV++  +++G 
Sbjct: 198 RLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  106 bits (267), Expect = 4e-25
 Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 18/215 (8%)

Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLS---VDSRQGLREFTNEVKLLL 137
            +  ++F D   LG GGFG V+   M    ++ A KKL+   +  R+G +    E K+L 
Sbjct: 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240

Query: 138 KIQHKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG-VA 195
           K+  + +V+L     E    + LV   +    + Y I++  + +      R       + 
Sbjct: 241 KVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIV 299

Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG 255
            GL +LH+     II+RD+K  N+LLD+  N +ISD GLA       T    +  +GT G
Sbjct: 300 SGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY--AGTPG 354

Query: 256 YMAPE---YALHGYLSVKTDVFSYGVLVLEIVSGR 287
           +MAPE      + + SV  D F+ GV + E+++ R
Sbjct: 355 FMAPELLLGEEYDF-SV--DYFALGVTLYEMIAAR 386

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  104 bits (260), Expect = 5e-25
 Identities = 59/268 (22%), Positives = 95/268 (35%), Gaps = 60/268 (22%)

Query: 73  NLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVK-----KLSVDSRQGL 126
           NL+F   +L      +     +G G +G V   +        A+K     K+   + + +
Sbjct: 13  NLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDV 72

Query: 127 REFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWT 185
                EV+L+ K+ H N+  L+    E  + + LV E      L   +      S+    
Sbjct: 73  ERIKTEVRLMKKLHHPNIARLYEVY-EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCA 131

Query: 186 TRY-------------------------------------RIVMGVARGLLYLHEEAPAR 208
                                                    I+  +   L YLH +    
Sbjct: 132 MDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---G 188

Query: 209 IIHRDIKASNILL--DEQLNPKISDFGLARLF----PGEDTHVNTFRISGTHGYMAPE-- 260
           I HRDIK  N L   ++    K+ DFGL++ F     GE   + T   +GT  ++APE  
Sbjct: 189 ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTT--KAGTPYFVAPEVL 246

Query: 261 -YALHGYLSVKTDVFSYGVLVLEIVSGR 287
                 Y   K D +S GVL+  ++ G 
Sbjct: 247 NTTNESY-GPKCDAWSAGVLLHLLLMGA 273

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score =  103 bits (259), Expect = 5e-25
 Identities = 50/182 (27%), Positives = 86/182 (47%), Gaps = 22/182 (12%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQ------GLREFTNEVKLLLKIQ 140
           F  + ++G G +G VY+      G+ +A+KK+ +D+         +RE    + LL ++ 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIRE----ISLLKELN 60

Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPN--KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
           H N+V L        +  LV+E+L    K       D +  + +        +  + +GL
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKKF----MDASALTGIPLPLIKSYLFQLLQGL 116

Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMA 258
            + H     R++HRD+K  N+L++ +   K++DFGLAR F G      T  +  T  Y A
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVV-TLWYRA 171

Query: 259 PE 260
           PE
Sbjct: 172 PE 173

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  103 bits (259), Expect = 5e-25
 Identities = 52/181 (28%), Positives = 92/181 (50%), Gaps = 17/181 (9%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQG-----LREFTNEVKLLLKIQH 141
           F  L +LG+G +  VY+GL    G  +A+K++ +DS +G     +RE    + L+ +++H
Sbjct: 7   FKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISLMKELKH 62

Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPN--KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL 199
           +N+V L+       +  LV+E++ N  K              L+          + +GL 
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122

Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           + HE    +I+HRD+K  N+L++++   K+ DFGLAR F G   +  +  +  T  Y AP
Sbjct: 123 FCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVV-TLWYRAP 177

Query: 260 E 260
           +
Sbjct: 178 D 178

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  102 bits (256), Expect = 9e-25
 Identities = 55/198 (27%), Positives = 85/198 (42%), Gaps = 25/198 (12%)

Query: 93  QLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLVTLFGC 150
           +LG G FG V+      +G E  +K ++ D  Q   E    E+++L  + H N++ +F  
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88

Query: 151 CAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRY------RIVMGVARGLLYLHE 203
             E    M +V E      L     ++  S+               ++  +   L Y H 
Sbjct: 89  F-EDYHNMYIVMETCEGGEL----LERIVSAQAR-GKALSEGYVAELMKQMMNALAYFHS 142

Query: 204 EAPARIIHRDIKASNILL---DEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE 260
           +    ++H+D+K  NIL          KI DFGLA LF   D H      +GT  YMAPE
Sbjct: 143 Q---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF-KSDEHSTN--AAGTALYMAPE 196

Query: 261 YALHGYLSVKTDVFSYGV 278
                 ++ K D++S GV
Sbjct: 197 -VFKRDVTFKCDIWSAGV 213

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  102 bits (257), Expect = 1e-24
 Identities = 49/179 (27%), Positives = 87/179 (48%), Gaps = 18/179 (10%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQ------GLREFTNEVKLLLKIQH 141
           +  L ++G G +G VY+     G+ +A+K++ +D+         +RE    + LL ++ H
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIRE----ISLLKELHH 78

Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
            N+V+L           LV+E++  K L   +      + L  +     +  + RG+ + 
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFME-KDLKKVL--DENKTGLQDSQIKIYLYQLLRGVAHC 135

Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE 260
           H+    RI+HRD+K  N+L++     K++DFGLAR F G      T  +  T  Y AP+
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVV-TLWYRAPD 189

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  102 bits (256), Expect = 1e-24
 Identities = 56/209 (26%), Positives = 84/209 (40%), Gaps = 26/209 (12%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLS----VDSRQGLREFTNEVKLLLKIQHKNLVTLF 148
           LG G +G V   L        AVK L          G      E++LL +++HKN++ L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 149 G-CCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLD-WTTRY---RIVMGVARGLLYLH 202
                E  +KM +V EY      +  + D                 +++ G+     YLH
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE----YLH 126

Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP--GEDTHVNTFRISGTHGYMAPE 260
            +    I+H+DIK  N+LL      KIS  G+A        D    T    G+  +  PE
Sbjct: 127 SQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS--QGSPAFQPPE 181

Query: 261 YA--LHGYLSVKTDVFSYGVLVLEIVSGR 287
            A  L  +   K D++S GV +  I +G 
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  104 bits (262), Expect = 2e-24
 Identities = 56/243 (23%), Positives = 98/243 (40%), Gaps = 22/243 (9%)

Query: 48  KTSLRGGRAAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDL----NQLGHGGFGPVY 103
               +  R  G  + + D    D W  ++  + +++  +   D      +LG G FG V+
Sbjct: 116 DEQGKIVRGKGTVSSNYDNYVFDIWKQYYP-QPVEIKHDHVLDHYDIHEELGTGAFGVVH 174

Query: 104 RGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE 162
           R      G   A K +             E++ +  ++H  LV L     +  E +++YE
Sbjct: 175 RVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234

Query: 163 YLPNKSLDYFIFDKTKSSSLDWTTRY--RIVMGVARGLLYLHEEAPARIIHRDIKASNIL 220
           ++    L    F+K        +       +  V +GL ++HE      +H D+K  NI+
Sbjct: 235 FMSGGEL----FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIM 287

Query: 221 LDEQLNP--KISDFGLARLF-PGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYG 277
              + +   K+ DFGL     P +   V     +GT  + APE A    +   TD++S G
Sbjct: 288 FTTKRSNELKLIDFGLTAHLDPKQSVKV----TTGTAEFAAPEVAEGKPVGYYTDMWSVG 343

Query: 278 VLV 280
           VL 
Sbjct: 344 VLS 346

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  101 bits (253), Expect = 2e-24
 Identities = 45/190 (23%), Positives = 75/190 (39%), Gaps = 14/190 (7%)

Query: 93  QLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCC 151
            +G G +G V   +        A KK+     + +  F  E++++  + H N++ L+   
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75

Query: 152 AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIH 211
            +  +  LV E      L   +  K      D     + V+     + Y H+     + H
Sbjct: 76  EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA---VAYCHKL---NVAH 129

Query: 212 RDIKASNILL---DEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLS 268
           RD+K  N L          K+ DFGLA  F      + T    GT  Y++P+  L G   
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARF-KPGKMMRT--KVGTPYYVSPQ-VLEGLYG 185

Query: 269 VKTDVFSYGV 278
            + D +S GV
Sbjct: 186 PECDEWSAGV 195

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  101 bits (255), Expect = 2e-24
 Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 21/208 (10%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQG-----LREFTNEVKLLLKIQH 141
           +  L++LG G +  VY+G        +A+K++ ++  +G     +RE    V LL  ++H
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIRE----VSLLKDLKH 59

Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
            N+VTL           LV+EYL +K L  ++      + ++       +  + RGL Y 
Sbjct: 60  ANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYL--DDCGNIINMHNVKLFLFQLLRGLAYC 116

Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEY 261
           H     +++HRD+K  N+L++E+   K++DFGLAR      T      +  T  Y  P+ 
Sbjct: 117 HR---QKVLHRDLKPQNLLINERGELKLADFGLARAK-SIPTKTYDNEVV-TLWYRPPDI 171

Query: 262 ALHG--YLSVKTDVFSYGVLVLEIVSGR 287
            L    Y S + D++  G +  E+ +GR
Sbjct: 172 LLGSTDY-STQIDMWGVGCIFYEMATGR 198

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  102 bits (256), Expect = 2e-24
 Identities = 57/217 (26%), Positives = 88/217 (40%), Gaps = 29/217 (13%)

Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           F      G G FG V  G     G  +A+KK+  D R   RE    ++ L  + H N+V 
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPNIVQ 83

Query: 147 LFGC-CAEGPEKM------LVYEYLP---NKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR 196
           L       G          +V EY+P   ++    +   +          +  +   + R
Sbjct: 84  LQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPP--PILIKVFLFQ-LIR 140

Query: 197 GLLYLHEEAPARIIHRDIKASNILLDE---QLNPKISDFGLAR-LFPGEDTHVNTFRISG 252
            +  LH  +   + HRDIK  N+L++E    L  K+ DFG A+ L P E    N   I  
Sbjct: 141 SIGCLHLPS-VNVCHRDIKPHNVLVNEADGTL--KLCDFGSAKKLSPSEP---NVAYIC- 193

Query: 253 THGYMAPEYAL--HGYLSVKTDVFSYGVLVLEIVSGR 287
           +  Y APE       Y +   D++S G +  E++ G 
Sbjct: 194 SRYYRAPELIFGNQHY-TTAVDIWSVGCIFAEMMLGE 229

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  102 bits (255), Expect = 3e-24
 Identities = 20/229 (8%), Positives = 48/229 (20%), Gaps = 43/229 (18%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFG 149
           L  G    V+    +   ++ A+K  ++    SR  L           ++  ++      
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 150 CC--------------------------AEGPEKMLVYEYLP---NKSLDYFIFDKTKSS 180
                                             +L+                F      
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189

Query: 181 SLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG 240
                  + +   + R    L       ++H      N+ +       + D        G
Sbjct: 190 DEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWK-VG 245

Query: 241 EDTHVNTFRISGTHGYMAPEYALHGYLSV--KTDVFSYGVLVLEIVSGR 287
                     S    Y   E+      +     + +  G+ +  +    
Sbjct: 246 TRGPA----SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  103 bits (259), Expect = 3e-24
 Identities = 64/212 (30%), Positives = 90/212 (42%), Gaps = 36/212 (16%)

Query: 92  NQLGHGGFGPVYRGLM-PNGQEIAVK-----KLSVDSRQGLREFTNEVKLLLKIQHKNLV 145
             LG G FG V +       QE AVK              +     EV+LL K+ H N++
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL---REVELLKKLDHPNIM 84

Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY------RIVMGVARGLL 199
            LF    +     +V E      L    FD+          R+      RI+  V  G+ 
Sbjct: 85  KLFEILEDSSSFYIVGELYTGGEL----FDEIIKRK-----RFSEHDAARIIKQVFSGIT 135

Query: 200 YLHEEAPARIIHRDIKASNILL---DEQLNPKISDFGLARLF-PGEDTHVNTFRISGTHG 255
           Y+H+     I+HRD+K  NILL   ++  + KI DFGL+  F              GT  
Sbjct: 136 YMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK----DRIGTAY 188

Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
           Y+APE  L G    K DV+S GV++  ++SG 
Sbjct: 189 YIAPE-VLRGTYDEKCDVWSAGVILYILLSGT 219

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  100 bits (252), Expect = 3e-24
 Identities = 60/195 (30%), Positives = 85/195 (43%), Gaps = 22/195 (11%)

Query: 93  QLGHGGFGPVYRGLM-PNGQEIAVK-----KLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
            LG G FG V +       QE AVK              +     EV+LL K+ H N++ 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL---REVELLKKLDHPNIMK 85

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           LF    +     +V E      L   I  + + S  D     + V      + Y+H+   
Sbjct: 86  LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG---ITYMHKH-- 140

Query: 207 ARIIHRDIKASNILL---DEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
             I+HRD+K  NILL   ++  + KI DFGL+  F  ++T +      GT  Y+APE  L
Sbjct: 141 -NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF-QQNTKMKD--RIGTAYYIAPE-VL 195

Query: 264 HGYLSVKTDVFSYGV 278
            G    K DV+S GV
Sbjct: 196 RGTYDEKCDVWSAGV 210

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  102 bits (256), Expect = 4e-24
 Identities = 58/244 (23%), Positives = 96/244 (39%), Gaps = 20/244 (8%)

Query: 45  PCLKTSLRGGRAAGESAEDADGSGADSWNLFFDLRTLQVATNFFSDL----NQLGHGGFG 100
                S   G+  G    D D    D W   +  + ++V      D      +LG G FG
Sbjct: 7   HHHHGSKVRGKYDGPKINDYDKFYEDIWK-KYVPQPVEVKQGSVYDYYDILEELGSGAFG 65

Query: 101 PVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML 159
            V+R +    G+    K ++           NE+ ++ ++ H  L+ L     +  E +L
Sbjct: 66  VVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVL 125

Query: 160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRY--RIVMGVARGLLYLHEEAPARIIHRDIKAS 217
           + E+L    L    FD+  +     +       +     GL ++HE     I+H DIK  
Sbjct: 126 ILEFLSGGEL----FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPE 178

Query: 218 NILLDEQLNP--KISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFS 275
           NI+ + +     KI DFGLA     ++    T     T  + APE      +   TD+++
Sbjct: 179 NIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREPVGFYTDMWA 235

Query: 276 YGVL 279
            GVL
Sbjct: 236 IGVL 239

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  100 bits (252), Expect = 4e-24
 Identities = 52/211 (24%), Positives = 98/211 (46%), Gaps = 24/211 (11%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQ------GLREFTNEVKLLLKIQ 140
           +  L ++G G +G V++       + +A+K++ +D          LRE    + LL +++
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALRE----ICLLKELK 59

Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
           HKN+V L        +  LV+E+   + L  +    + +  LD       +  + +GL +
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYF--DSCNGDLDPEIVKSFLFQLLKGLGF 116

Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE 260
            H      ++HRD+K  N+L++     K+++FGLAR F G      +  +  T  Y  P+
Sbjct: 117 CHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVV-TLWYRPPD 171

Query: 261 YALHG---YLSVKTDVFSYGVLVLEIVSGRK 288
             L G   Y S   D++S G +  E+ +  +
Sbjct: 172 -VLFGAKLY-STSIDMWSAGCIFAELANAGR 200

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  100 bits (251), Expect = 5e-24
 Identities = 50/179 (27%), Positives = 88/179 (49%), Gaps = 18/179 (10%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQ------GLREFTNEVKLLLKIQH 141
           +  L ++G G +G VY+     G+  A+KK+ ++          +RE    + +L +++H
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIRE----ISILKELKH 59

Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
            N+V L+         +LV+E+L  + L   +        L+  T    ++ +  G+ Y 
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLL--DVCEGGLESVTAKSFLLQLLNGIAYC 116

Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE 260
           H+    R++HRD+K  N+L++ +   KI+DFGLAR F G      T  I  T  Y AP+
Sbjct: 117 HDR---RVLHRDLKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIV-TLWYRAPD 170

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  101 bits (254), Expect = 5e-24
 Identities = 49/157 (31%), Positives = 80/157 (50%), Gaps = 12/157 (7%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE---FTN--EVKLLLKIQH 141
           +  L+ LG G F  VY+       Q +A+KK+ +  R   ++    T   E+KLL ++ H
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71

Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
            N++ L           LV++++    L+  I  K  S  L  +     ++   +GL YL
Sbjct: 72  PNIIGLLDAFGHKSNISLVFDFME-TDLEVII--KDNSLVLTPSHIKAYMLMTLQGLEYL 128

Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF 238
           H+     I+HRD+K +N+LLDE    K++DFGLA+ F
Sbjct: 129 HQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSF 162

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  100 bits (251), Expect = 6e-24
 Identities = 49/210 (23%), Positives = 86/210 (40%), Gaps = 24/210 (11%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN--EVKLLLKIQHKNL 144
           +  + ++G G +G V++      GQ +A+KK        + +     E+++L +++H NL
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNL 64

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L           LV+EY  +  L            +       I     + + + H+ 
Sbjct: 65  VNLLEVFRRKRRLHLVFEYCDHTVLHEL---DRYQRGVPEHLVKSITWQTLQAVNFCHK- 120

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAP 259
                IHRD+K  NIL+ +    K+ DFG ARL  G     + +            Y +P
Sbjct: 121 --HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGP---SDYY----DDEVATRWYRSP 171

Query: 260 EYALHG--YLSVKTDVFSYGVLVLEIVSGR 287
           E  +    Y     DV++ G +  E++SG 
Sbjct: 172 ELLVGDTQY-GPPVDVWAIGCVFAELLSGV 200

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  102 bits (257), Expect = 1e-23
 Identities = 65/215 (30%), Positives = 100/215 (46%), Gaps = 21/215 (9%)

Query: 82  QVATNFFSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLS---VDSRQGLREFTNEVKLLL 137
            V  N F     LG GGFG V    +    ++ A KKL    +  R+G     NE ++L 
Sbjct: 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE 239

Query: 138 KIQHKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMGVA 195
           K+  + +V+L     E  + + LV   +    L + I+   ++         Y     + 
Sbjct: 240 KVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY--AAEIC 296

Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG 255
            GL  LH E   RI++RD+K  NILLD+  + +ISD GLA   P   T +      GT G
Sbjct: 297 CGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGR--VGTVG 350

Query: 256 YMAPE---YALHGYLSVKTDVFSYGVLVLEIVSGR 287
           YMAPE      + + S   D ++ G L+ E+++G+
Sbjct: 351 YMAPEVVKNERYTF-SP--DWWALGCLLYEMIAGQ 382

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  100 bits (251), Expect = 1e-23
 Identities = 45/201 (22%), Positives = 74/201 (36%), Gaps = 25/201 (12%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVK-----KLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
           +G G F  V R +    GQ+ AVK     K +        +   E  +   ++H ++V L
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY------RIVMGVARGLLYL 201
               +      +V+E++    L + I  +  +        Y        +  +   L Y 
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAG-----FVYSEAVASHYMRQILEALRYC 146

Query: 202 HEEAPARIIHRDIKASNILL---DEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMA 258
           H+     IIHRD+K   +LL   +     K+  FG+A                GT  +MA
Sbjct: 147 HDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTPHFMA 201

Query: 259 PEYALHGYLSVKTDVFSYGVL 279
           PE           DV+  GV+
Sbjct: 202 PEVVKREPYGKPVDVWGCGVI 222

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 98.8 bits (247), Expect = 1e-23
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 22/207 (10%)

Query: 85  TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVK-----KLSVDSRQGLRE-FTNEVKLLL 137
            + +    +LG G F  V +      G+E A K     +LS   R   RE    EV +L 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
           +I+H N++TL        + +L+ E +    L  F+ +K   +  + T   + ++    G
Sbjct: 64  EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD---G 120

Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNP----KISDFGLARLF-PGEDTHVNTFRISG 252
           + YLH +   RI H D+K  NI+L ++  P    K+ DFG+A     G +       I G
Sbjct: 121 VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN----IFG 173

Query: 253 THGYMAPEYALHGYLSVKTDVFSYGVL 279
           T  ++APE   +  L ++ D++S GV+
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVI 200

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  101 bits (254), Expect = 2e-23
 Identities = 61/228 (26%), Positives = 94/228 (41%), Gaps = 43/228 (18%)

Query: 85  TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLS-------------VDSRQGLREFT 130
              +  + +LG G +G V          E A+K +               +  +   E  
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 131 NEVKLLLKIQHKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRY- 188
           NE+ LL  + H N++ LF    E  +   LV E+     L    F++  +       ++ 
Sbjct: 95  NEISLLKSLDHPNIIKLFDVF-EDKKYFYLVTEFYEGGEL----FEQIINRH-----KFD 144

Query: 189 -----RIVMGVARGLLYLHEEAPARIIHRDIKASNILL---DEQLNPKISDFGLARLF-P 239
                 I+  +  G+ YLH+     I+HRDIK  NILL   +  LN KI DFGL+  F  
Sbjct: 145 ECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK 201

Query: 240 GEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
                       GT  Y+APE  L    + K DV+S GV++  ++ G 
Sbjct: 202 DYKLR----DRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  100 bits (251), Expect = 2e-23
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 29/205 (14%)

Query: 93  QLGHGGFGPVYRGL-MPNGQEIAVK-----KLSVDSRQGLRE---FTNEVKLLLKIQHKN 143
            LG G  G V         +++A++     K ++ S +          E+++L K+ H  
Sbjct: 142 TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 201

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLH 202
           ++ +     +  +  +V E +    L    FDK   +  L   T       +   + YLH
Sbjct: 202 IIKIKNFF-DAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLH 256

Query: 203 EEAPARIIHRDIKASNILL---DEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           E     IIHRD+K  N+LL   +E    KI+DFG +++  GE + + T    GT  Y+AP
Sbjct: 257 EN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTL--CGTPTYLAP 310

Query: 260 E----YALHGYLSVKTDVFSYGVLV 280
           E        GY +   D +S GV++
Sbjct: 311 EVLVSVGTAGY-NRAVDCWSLGVIL 334

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 98.5 bits (246), Expect = 2e-23
 Identities = 60/205 (29%), Positives = 90/205 (43%), Gaps = 30/205 (14%)

Query: 93  QLGHGGFGPVYRGL-MPNGQEIAVK--------KLSVDSRQGLRE-FTNEVKLLLKI-QH 141
            LG G    V R +  P  +E AVK          S +  Q LRE    EV +L K+  H
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83

Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
            N++ L           LV++ +    L DY + +K   S  +     R ++ V   +  
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFDY-LTEKVTLSEKETRKIMRALLEV---ICA 139

Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE 260
           LH+     I+HRD+K  NILLD+ +N K++DFG +         +    + GT  Y+APE
Sbjct: 140 LHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQL-DPGEKLRE--VCGTPSYLAPE 193

Query: 261 -------YALHGYLSVKTDVFSYGV 278
                      GY   + D++S GV
Sbjct: 194 IIECSMNDNHPGY-GKEVDMWSTGV 217

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 98.0 bits (245), Expect = 3e-23
 Identities = 54/195 (27%), Positives = 84/195 (43%), Gaps = 21/195 (10%)

Query: 93  QLGHGGFGPVYRGL-MPNGQEIAVK-----KLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           +LG G F  V R +    G E A K     KLS    Q L     E ++  K+QH N+V 
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRKLQHPNIVR 69

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           L     E     LV++ +    L   I  +   S  D +   + ++     + Y H    
Sbjct: 70  LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES---IAYCHSN-- 124

Query: 207 ARIIHRDIKASNILL---DEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
             I+HR++K  N+LL    +    K++DFGLA     +    +    +GT GY++PE   
Sbjct: 125 -GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV-NDSEAWHG--FAGTPGYLSPEVLK 180

Query: 264 HGYLSVKTDVFSYGV 278
               S   D+++ GV
Sbjct: 181 KDPYSKPVDIWACGV 195

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 98.5 bits (246), Expect = 3e-23
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 24/208 (11%)

Query: 85  TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVK-----KLSVDSRQGLRE-FTNEVKLLL 137
            +F+    +LG G F  V +      G E A K     +     R   RE    EV +L 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70

Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYR-IVMGVAR 196
           ++ H N++TL        + +L+ E +    L  F+  K   S  + T+  + I+ GV  
Sbjct: 71  QVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN- 129

Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNP----KISDFGLARLF-PGEDTHVNTFRIS 251
              YLH +   +I H D+K  NI+L ++  P    K+ DFGLA     G +       I 
Sbjct: 130 ---YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN----IF 179

Query: 252 GTHGYMAPEYALHGYLSVKTDVFSYGVL 279
           GT  ++APE   +  L ++ D++S GV+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 97.7 bits (244), Expect = 7e-23
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 22/209 (10%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN--EVKLLLKIQHKNL 144
           + +L  +G G +G V +      G+ +A+KK        + +     E+KLL +++H+NL
Sbjct: 27  YENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENL 86

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L   C +     LV+E++ +  LD     +   + LD+    + +  +  G+ + H  
Sbjct: 87  VNLLEVCKKKKRWYLVFEFVDHTILDDL---ELFPNGLDYQVVQKYLFQIINGIGFCHS- 142

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAP 259
               IIHRDIK  NIL+ +    K+ DFG AR           +            Y AP
Sbjct: 143 --HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP---GEVY----DDEVATRWYRAP 193

Query: 260 EYALHG-YLSVKTDVFSYGVLVLEIVSGR 287
           E  +         DV++ G LV E+  G 
Sbjct: 194 ELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 97.3 bits (243), Expect = 7e-23
 Identities = 56/231 (24%), Positives = 91/231 (39%), Gaps = 51/231 (22%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLS----VDSRQGLREFTN----------------- 131
           +G G +G V       +    A+K LS    +      R                     
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 132 -----EVKLLLKIQHKNLVTLFGCCAEGPEK---MLVYEYLPNKSLDYFIFDKTKSSSLD 183
                E+ +L K+ H N+V L     + P +    +V+E +    +     +      L 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----MEVPTLKPLS 135

Query: 184 WTT--RY--RIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239
                 Y   ++ G+     YLH +   +IIHRDIK SN+L+ E  + KI+DFG++  F 
Sbjct: 136 EDQARFYFQDLIKGIE----YLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188

Query: 240 GEDTHVNTFRISGTHGYMAPE---YALHGYLSVKTDVFSYGVLVLEIVSGR 287
           G D  ++     GT  +MAPE        +     DV++ GV +   V G+
Sbjct: 189 GSDALLSNT--VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 97.4 bits (243), Expect = 7e-23
 Identities = 60/206 (29%), Positives = 87/206 (42%), Gaps = 22/206 (10%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVK---KLSVDSRQGLREFTN---EVKLLLKIQHK--NL 144
           LG GGFG VY G+ + +   +A+K   K  +     L   T    EV LL K+      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHE 203
           + L          +L+ E  P    D  +FD  T+  +L           V   + + H 
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELARSFFWQVLEAVRHCHN 167

Query: 204 EAPARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEY- 261
                ++HRDIK  NIL+D  +   K+ DFG   L    DT    F   GT  Y  PE+ 
Sbjct: 168 C---GVLHRDIKDENILIDLNRGELKLIDFGSGALLK--DTVYTDF--DGTRVYSPPEWI 220

Query: 262 ALHGYLSVKTDVFSYGVLVLEIVSGR 287
             H Y      V+S G+L+ ++V G 
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGD 246

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 98.2 bits (245), Expect = 7e-23
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 24/208 (11%)

Query: 85  TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVK-----KLSVDSRQGLRE-FTNEVKLLL 137
            +F+    +LG G F  V +      G E A K     +     R   RE    EV +L 
Sbjct: 11  EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70

Query: 138 KIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYR-IVMGVAR 196
           ++ H N++TL        + +L+ E +    L  F+  K   S  + T+  + I+ GV  
Sbjct: 71  QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVN- 129

Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNP----KISDFGLARLF-PGEDTHVNTFRIS 251
              YLH +   +I H D+K  NI+L ++  P    K+ DFGLA     G +       I 
Sbjct: 130 ---YLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN----IF 179

Query: 252 GTHGYMAPEYALHGYLSVKTDVFSYGVL 279
           GT  ++APE   +  L ++ D++S GV+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 98.2 bits (245), Expect = 8e-23
 Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 29/204 (14%)

Query: 93  QLGHGGFGPVYRGL-MPNGQEIAVK-------KLSVDSRQGLRE-FTNEVKLLLKI-QHK 142
            +G G    V R +    G E AVK       +LS +  + +RE    E  +L ++  H 
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160

Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
           +++TL           LV++ +    L DY + +K   S  +  TR  I+  +   + +L
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDY-LTEKVALSEKE--TR-SIMRSLLEAVSFL 216

Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE- 260
           H      I+HRD+K  NILLD+ +  ++SDFG +         +    + GT GY+APE 
Sbjct: 217 HAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHL-EPGEKLRE--LCGTPGYLAPEI 270

Query: 261 ------YALHGYLSVKTDVFSYGV 278
                     GY   + D+++ GV
Sbjct: 271 LKCSMDETHPGY-GKEVDLWACGV 293

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 98.6 bits (245), Expect = 1e-22
 Identities = 27/233 (11%), Positives = 66/233 (28%), Gaps = 43/233 (18%)

Query: 94  LGHGGFGPVYRGLMPN-GQEIAVK------KLSVDSRQGLREFTNEVKLLLKIQH----- 141
           LG               G+   V       +   ++ + ++E    ++LL  I++     
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 142 --------------KNLVTLFGCCAEGPEKMLVYEYLPNKS--------LDYFIFDKTKS 179
                              +     +  +  ++  +              +  +   +  
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 180 SSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239
            SL    R ++ + V R L  LH      ++H  ++  +I+LD++    ++ F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR-D 261

Query: 240 GEDTHVNTFRISGTHGYMAPEYAL-----HGYLSVKTDVFSYGVLVLEIVSGR 287
           G        R        A             ++   D ++ G+ +  I    
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 98.1 bits (245), Expect = 2e-22
 Identities = 51/195 (26%), Positives = 86/195 (44%), Gaps = 20/195 (10%)

Query: 93  QLGHGGFGPVYRGL-MPNGQEIAVK-----KLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           +LG G F  V R + +  GQE A       KLS    Q L     E ++   ++H N+V 
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE---REARICRLLKHPNIVR 74

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           L    +E     L+++ +    L   I  +   S  D +   + ++     +L+ H+   
Sbjct: 75  LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEA---VLHCHQM-- 129

Query: 207 ARIIHRDIKASNILL---DEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
             ++HR++K  N+LL    +    K++DFGLA    GE         +GT GY++PE   
Sbjct: 130 -GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAGTPGYLSPEVLR 186

Query: 264 HGYLSVKTDVFSYGV 278
                   D+++ GV
Sbjct: 187 KDPYGKPVDLWACGV 201

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 97.4 bits (242), Expect = 2e-22
 Identities = 32/239 (13%), Positives = 69/239 (28%), Gaps = 54/239 (22%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQG------LREFTNEVKLLLKIQ------ 140
           LG               G+   V       R        ++E    ++LL  I+      
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 141 ----------------HKNLVTLFGCCAEGPEKMLVYEYLPNKS-----LDYFIFDKTKS 179
                            K ++ +     +       + Y   +S      +  +   +  
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 180 SSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP 239
            SL    R ++ + V R L  LH      ++H  ++  +I+LD++    ++ F       
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--- 254

Query: 240 GEDTHVNTFRISGTHGYMAPEYALH-----------GYLSVKTDVFSYGVLVLEIVSGR 287
             D          + G+  PE                 ++   D ++ G+++  I    
Sbjct: 255 -RDGARVVSS--VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 54/195 (27%), Positives = 83/195 (42%), Gaps = 21/195 (10%)

Query: 93  QLGHGGFGPVYRGL-MPNGQEIAVK-----KLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           +LG G F  V R +    G E A K     KLS    Q L     E ++  K+QH N+V 
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE---REARICRKLQHPNIVR 92

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           L     E     LV++ +    L   I  +   S  D +   + ++     + Y H    
Sbjct: 93  LHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES---IAYCHSN-- 147

Query: 207 ARIIHRDIKASNILL---DEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
             I+HR++K  N+LL    +    K++DFGLA      +        +GT GY++PE   
Sbjct: 148 -GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLK 203

Query: 264 HGYLSVKTDVFSYGV 278
               S   D+++ GV
Sbjct: 204 KDPYSKPVDIWACGV 218

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 95.8 bits (239), Expect = 2e-22
 Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 24/208 (11%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVK---KLSVDSRQGLREFTN---EVKLLLKI----QHK 142
           LG GGFG V+ G  + +  ++A+K   +  V     L +      EV LL K+     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYL 201
            ++ L          MLV E  P  + D  +FD  T+   L           V   + + 
Sbjct: 99  GVIRLLDWFETQEGFMLVLER-PLPAQD--LFDYITEKGPLGEGPSRCFFGQVVAAIQHC 155

Query: 202 HEEAPARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE 260
           H      ++HRDIK  NIL+D  +   K+ DFG   L    D     F   GT  Y  PE
Sbjct: 156 HS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH--DEPYTDF--DGTRVYSPPE 208

Query: 261 Y-ALHGYLSVKTDVFSYGVLVLEIVSGR 287
           + + H Y ++   V+S G+L+ ++V G 
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGD 236

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 95.8 bits (239), Expect = 3e-22
 Identities = 55/203 (27%), Positives = 89/203 (43%), Gaps = 29/203 (14%)

Query: 93  QLGHGGFGPVYRGL-MPNGQEIAVK-----KLSVDSRQGLRE---FTNEVKLLLKIQHKN 143
            LG G  G V         +++A+K     K ++ S +          E+++L K+ H  
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLH 202
           ++ +     +  +  +V E +    L    FDK   +  L   T       +   + YLH
Sbjct: 77  IIKIKNFF-DAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQMLLAVQYLH 131

Query: 203 EEAPARIIHRDIKASNILL---DEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           E     IIHRD+K  N+LL   +E    KI+DFG +++  GE + + T  + GT  Y+AP
Sbjct: 132 EN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRT--LCGTPTYLAP 185

Query: 260 E----YALHGYLSVKTDVFSYGV 278
           E        GY +   D +S GV
Sbjct: 186 EVLVSVGTAGY-NRAVDCWSLGV 207

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 96.2 bits (240), Expect = 3e-22
 Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 34/217 (15%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQ------GLREFTNEVKLLLKIQ 140
           +  + +LG G +G VY+ +     + +A+K++ ++  +       +RE    V LL ++Q
Sbjct: 36  YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIRE----VSLLKELQ 91

Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPN---KSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
           H+N++ L           L++EY  N   K +D       K+  +        +  +  G
Sbjct: 92  HRNIIELKSVIHHNHRLHLIFEYAENDLKKYMD-------KNPDVSMRVIKSFLYQLING 144

Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNP-----KISDFGLARLFPGEDTHVNTFRISG 252
           + + H     R +HRD+K  N+LL           KI DFGLAR F G      T  I  
Sbjct: 145 VNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIRQFTHEII- 199

Query: 253 THGYMAPEYAL--HGYLSVKTDVFSYGVLVLEIVSGR 287
           T  Y  PE  L    Y S   D++S   +  E++   
Sbjct: 200 TLWYRPPEILLGSRHY-STSVDIWSIACIWAEMLMKT 235

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 95.4 bits (238), Expect = 4e-22
 Identities = 50/195 (25%), Positives = 90/195 (46%), Gaps = 24/195 (12%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVK--KLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
           LG G FG V+R +   + +    K  K+    +  ++    E+ +L   +H+N++ L   
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHRNILHLHES 69

Query: 151 CAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTR--YRIVMGVARGLLYLHEEAPA 207
             E  E++ +++E++    +    F++  +S+ +   R     V  V   L +LH     
Sbjct: 70  F-ESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQFLHSH--- 121

Query: 208 RIIHRDIKASNILLDEQLNP--KISDFGLARLF-PGEDTHVNTFRISGTHGYMAPEYALH 264
            I H DI+  NI+   + +   KI +FG AR   PG++  +    +     Y APE   H
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL----LFTAPEYYAPEVHQH 177

Query: 265 GYLSVKTDVFSYGVL 279
             +S  TD++S G L
Sbjct: 178 DVVSTATDMWSLGTL 192

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 94.9 bits (237), Expect = 4e-22
 Identities = 60/218 (27%), Positives = 98/218 (44%), Gaps = 30/218 (13%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTN-----EVKLLLKIQ- 140
           +  + ++G G +G VY+     +G  +A+K + V +  G           EV LL +++ 
Sbjct: 11  YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70

Query: 141 --HKNLVTLFGCCAEGPEK-----MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG 193
             H N+V L   CA           LV+E++ ++ L  ++ DK     L   T   ++  
Sbjct: 71  FEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKDLMRQ 128

Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF--PGEDTH--VNTFR 249
             RGL +LH      I+HRD+K  NIL+      K++DFGLAR++      T   V    
Sbjct: 129 FLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVV---- 181

Query: 250 ISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
              T  Y APE  L    +   D++S G +  E+   +
Sbjct: 182 ---TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 95.1 bits (237), Expect = 7e-22
 Identities = 66/261 (25%), Positives = 105/261 (40%), Gaps = 28/261 (10%)

Query: 22  HHNHNHNLSVDEMNLKHFISNLFPCLKTSLRGGRAAGESAEDADGSGADSWNLFFDLRTL 81
           HH+H+H+  VD      +  ++      S   G A+       DGS  D+ + FF++   
Sbjct: 2   HHHHHHSSGVDLGTENLYFQSMSSV-TASAAPGTASLVPDYWIDGSNRDALSDFFEVE-- 58

Query: 82  QVATNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ 140
                     ++LG G    VYR       +  A+K   +      +    E+ +LL++ 
Sbjct: 59  ----------SELGRGATSIVYRCKQKGTQKPYALK--VLKKTVDKKIVRTEIGVLLRLS 106

Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
           H N++ L        E  LV E +    L   I +K   S  D       V  +   + Y
Sbjct: 107 HPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAA---DAVKQILEAVAY 163

Query: 201 LHEEAPARIIHRDIKASNILL---DEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           LHE     I+HRD+K  N+L          KI+DFGL+++   +          GT GY 
Sbjct: 164 LHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC---GTPGYC 217

Query: 258 APEYALHGYLSVKTDVFSYGV 278
           APE         + D++S G+
Sbjct: 218 APEILRGCAYGPEVDMWSVGI 238

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 95.0 bits (237), Expect = 7e-22
 Identities = 58/208 (27%), Positives = 94/208 (45%), Gaps = 24/208 (11%)

Query: 85  TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVK-----KLSVDSRQGLRE-FTNEVKLLL 137
            +++    +LG G F  V +      G + A K     +     R   RE    EV +L 
Sbjct: 10  DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69

Query: 138 KIQHKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR 196
           +IQH N++TL     E    + L+ E +    L  F+ +K   +  + T   + ++    
Sbjct: 70  EIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN--- 125

Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNP----KISDFGLARLF-PGEDTHVNTFRIS 251
           G+ YLH     +I H D+K  NI+L ++  P    KI DFGLA     G +       I 
Sbjct: 126 GVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN----IF 178

Query: 252 GTHGYMAPEYALHGYLSVKTDVFSYGVL 279
           GT  ++APE   +  L ++ D++S GV+
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 94.6 bits (236), Expect = 8e-22
 Identities = 59/220 (26%), Positives = 104/220 (47%), Gaps = 36/220 (16%)

Query: 88  FSDLNQLGHGGFGPVYRG--LMPNGQEIAVKKLSVDS-RQG-----LREFTNEVKLLLKI 139
           +  + ++G G +G V++   L   G+ +A+K++ V +  +G     +RE    V +L  +
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE----VAVLRHL 68

Query: 140 Q---HKNLVTLFGCCAEGPEK-----MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIV 191
           +   H N+V LF  C            LV+E++ ++ L  ++ DK     +   T   ++
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMM 126

Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF--PGEDTH--VNT 247
             + RGL +LH     R++HRD+K  NIL+      K++DFGLAR++      T   V  
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV-- 181

Query: 248 FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
                T  Y APE  L    +   D++S G +  E+   +
Sbjct: 182 -----TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 97.3 bits (242), Expect = 9e-22
 Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 24/211 (11%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLS---VDSRQGLREFTNEVKLLLKIQHKN 143
           FS    +G GGFG VY     +  ++ A+K L    +  +QG     NE  +L  +   +
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250

Query: 144 ---LVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL 199
              +V +       P+K+  + + +    L Y +  +    S      Y     +  GL 
Sbjct: 251 CPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFY--AAEIILGLE 306

Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           ++H      +++RD+K +NILLDE  + +ISD GLA  F  +  H       GTHGYMAP
Sbjct: 307 HMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--AS--VGTHGYMAP 359

Query: 260 EYAL--HGY-LSVKTDVFSYGVLVLEIVSGR 287
           E       Y  S   D FS G ++ +++ G 
Sbjct: 360 EVLQKGVAYDSSA--DWFSLGCMLFKLLRGH 388

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 55/222 (24%), Positives = 100/222 (45%), Gaps = 36/222 (16%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS-RQGLREFTN--EVKLLLKIQHKN 143
           +  L ++G G FG V++      GQ++A+KK+ +++ ++G    T   E+K+L  ++H+N
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP-ITALREIKILQLLKHEN 77

Query: 144 LVTLFGCCAEGPEKM--------LVYEYLPN---KSLDYFIFDKTKSSSLDWTTRYRIVM 192
           +V L   C               LV+++  +     L               +   R++ 
Sbjct: 78  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS------NVLVKFTLSEIKRVMQ 131

Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISG 252
            +  GL Y+H     +I+HRD+KA+N+L+      K++DFGLAR F       N+     
Sbjct: 132 MLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAF---SLAKNSQPNRY 185

Query: 253 THG-----YMAPEYALHG--YLSVKTDVFSYGVLVLEIVSGR 287
           T+      Y  PE  L    Y     D++  G ++ E+ +  
Sbjct: 186 TNRVVTLWYRPPELLLGERDY-GPPIDLWGAGCIMAEMWTRS 226

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 93.0 bits (232), Expect = 1e-21
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 23/204 (11%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLVTLFGCC 151
           LG G +G V   +     + +AVK + +       E    E+ +   + H+N+V  +G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 152 AEGPEKMLVYEYLPNKSLDYFIFDKTKSS---SLDWTTRY--RIVMGVARGLLYLHEEAP 206
            EG  + L  EY     L    FD+ +           R+  +++ GV     YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHGI-- 124

Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFP--GEDTHVNTFRISGTHGYMAPE-YAL 263
             I HRDIK  N+LLDE+ N KISDFGLA +F     +  +N     GT  Y+APE    
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPELLKR 181

Query: 264 HGYLSVKTDVFSYGVLVLEIVSGR 287
             + +   DV+S G+++  +++G 
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGE 205

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 93.4 bits (233), Expect = 1e-21
 Identities = 54/191 (28%), Positives = 82/191 (42%), Gaps = 16/191 (8%)

Query: 93  QLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCC 151
            LG G F  V+       G+  A+K +            NE+ +L KI+H+N+VTL    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 152 AEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARII 210
            E      LV + +    L   I ++   +  D +    ++  V   + YLHE     I+
Sbjct: 76  -ESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS---LVIQQVLSAVKYLHEN---GIV 128

Query: 211 HRDIKASNILL---DEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
           HRD+K  N+L    +E     I+DFGL+++              GT GY+APE       
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPY 184

Query: 268 SVKTDVFSYGV 278
           S   D +S GV
Sbjct: 185 SKAVDCWSIGV 195

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 55/201 (27%), Positives = 86/201 (42%), Gaps = 32/201 (15%)

Query: 92  NQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLK-IQHKNLVTLFG 149
             +G G +    R +      E AVK +    R    E    +++LL+  QH N++TL  
Sbjct: 28  EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE----IEILLRYGQHPNIITLKD 83

Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY------RIVMGVARGLLYLHE 203
              +G    +V E +    L     DK           +       ++  + + + YLH 
Sbjct: 84  VYDDGKYVYVVTELMKGGEL----LDKILRQ-----KFFSEREASAVLFTITKTVEYLHA 134

Query: 204 EAPARIIHRDIKASNILL-DEQLNP---KISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           +    ++HRD+K SNIL  DE  NP   +I DFG A+    E+  + T     T  ++AP
Sbjct: 135 Q---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYTANFVAP 189

Query: 260 E-YALHGYLSVKTDVFSYGVL 279
           E     GY     D++S GVL
Sbjct: 190 EVLERQGY-DAACDIWSLGVL 209

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 52/199 (26%), Positives = 83/199 (41%), Gaps = 30/199 (15%)

Query: 93  QLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGC 150
            LG G F    + +   + Q  AVK +S       +    E+  L   + H N+V L   
Sbjct: 18  PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQ---KEITALKLCEGHPNIVKLHEV 74

Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY------RIVMGVARGLLYLHEE 204
             +     LV E L    L    F++ K         +       I+  +   + ++H+ 
Sbjct: 75  FHDQLHTFLVMELLNGGEL----FERIKKKK-----HFSETEASYIMRKLVSAVSHMHDV 125

Query: 205 APARIIHRDIKASNILL---DEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE- 260
               ++HRD+K  N+L    ++ L  KI DFG ARL P ++  + T     T  Y APE 
Sbjct: 126 ---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPEL 180

Query: 261 YALHGYLSVKTDVFSYGVL 279
              +GY     D++S GV+
Sbjct: 181 LNQNGY-DESCDLWSLGVI 198

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 93.5 bits (233), Expect = 2e-21
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 37/210 (17%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVK-----KLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
           +G G F  V     +  G+E+A+K     +L+  S Q L     EV+++  + H N+V L
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF---REVRIMKILNHPNIVKL 79

Query: 148 FGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR--------GL 198
           F    E  + + L+ EY     +    FD             R+    AR         +
Sbjct: 80  FEVI-ETEKTLYLIMEYASGGEV----FDY-------LVAHGRMKEKEARSKFRQIVSAV 127

Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMA 258
            Y H++   RI+HRD+KA N+LLD  +N KI+DFG +  F      ++ F   G   Y A
Sbjct: 128 QYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT-VGGKLDAF--CGAPPYAA 181

Query: 259 PE-YALHGYLSVKTDVFSYGVLVLEIVSGR 287
           PE +    Y   + DV+S GV++  +VSG 
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGS 211

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 93.6 bits (233), Expect = 2e-21
 Identities = 52/215 (24%), Positives = 83/215 (38%), Gaps = 40/215 (18%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVK-----KLSVDS---RQGLREFTNEVKLLLKIQHKNL 144
           LG G FG V+  +     +E+ VK     K+  D       L + T E+ +L +++H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFI----------FDK-TKSSSLDWTTRYRIVMG 193
           + +              +   N+     +          F    +   LD      I   
Sbjct: 92  IKV-------------LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138

Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           +   + YL  +    IIHRDIK  NI++ E    K+ DFG A           TF   GT
Sbjct: 139 LVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE-RGKLFYTF--CGT 192

Query: 254 HGYMAPE-YALHGYLSVKTDVFSYGVLVLEIVSGR 287
             Y APE    + Y   + +++S GV +  +V   
Sbjct: 193 IEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 91.9 bits (229), Expect = 6e-21
 Identities = 51/202 (25%), Positives = 88/202 (43%), Gaps = 30/202 (14%)

Query: 93  QLGHGGFGPVYRGL-MPNGQEIAVK-----KLSVDSRQGLREFTNEVKLLLKIQH-KNLV 145
           +LG G F  V + +    GQE A K     +   D R  +    +E+ +L   +    ++
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEIL---HEIAVLELAKSCPRVI 92

Query: 146 TLFGCCAEGPEKM-LVYEYLPNKSL-DYFIFDKTKSSSLDWTTRY--RIVMGVARGLLYL 201
            L     E   ++ L+ EY     +    + +  +  S +   R   +I+ GV     YL
Sbjct: 93  NLHEVY-ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVY----YL 147

Query: 202 HEEAPARIIHRDIKASNILL---DEQLNPKISDFGLARLF-PGEDTHVNTFRISGTHGYM 257
           H+     I+H D+K  NILL       + KI DFG++R      +       I GT  Y+
Sbjct: 148 HQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE----IMGTPEYL 200

Query: 258 APEYALHGYLSVKTDVFSYGVL 279
           APE   +  ++  TD+++ G++
Sbjct: 201 APEILNYDPITTATDMWNIGII 222

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 92.9 bits (231), Expect = 7e-21
 Identities = 56/250 (22%), Positives = 95/250 (38%), Gaps = 55/250 (22%)

Query: 81  LQVATNFFSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI 139
           L+ ++  +S    LG G FG V     + +G+  A+KK+  D R   RE    + ++  +
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVL 57

Query: 140 QHKNLVTL---FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDW------------ 184
            H N++ L   F    +   K        NK             S+              
Sbjct: 58  DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117

Query: 185 ----TTRYRIVMGVA-------------------RGLLYLHEEAPARIIHRDIKASNILL 221
                T ++++                       R + ++H      I HRDIK  N+L+
Sbjct: 118 EYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLV 174

Query: 222 DEQLNP-KISDFGLAR-LFPGEDTHVNTFRISGTHGYMAPEYAL--HGYLSVKTDVFSYG 277
           + + N  K+ DFG A+ L P E    +   I  +  Y APE  L    Y +   D++S G
Sbjct: 175 NSKDNTLKLCDFGSAKKLIPSEP---SVAYIC-SRFYRAPELMLGATEY-TPSIDLWSIG 229

Query: 278 VLVLEIVSGR 287
            +  E++ G+
Sbjct: 230 CVFGELILGK 239

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 91.1 bits (227), Expect = 7e-21
 Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 32/208 (15%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
           LG G FG V  G     G ++AVK   +  + S   + +   E++ L   +H +++ L+ 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 150 CCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR--------GLLY 200
                P    +V EY+    L    FD             R+    AR         + Y
Sbjct: 79  V-ISTPTDFFMVMEYVSGGEL----FDYICK-------HGRVEEMEARRLFQQILSAVDY 126

Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE 260
            H      ++HRD+K  N+LLD  +N KI+DFGL+ +   +   + T    G+  Y APE
Sbjct: 127 CHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTS--CGSPNYAAPE 180

Query: 261 -YALHGYLSVKTDVFSYGVLVLEIVSGR 287
             +   Y   + D++S GV++  ++ G 
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGT 208

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 60/207 (28%), Positives = 94/207 (45%), Gaps = 29/207 (14%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLVTLFGCC 151
           LG G +G V   +     + +AVK + +       E    E+ +   + H+N+V  +G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 152 AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR--------GLLYLHE 203
            EG  + L  EY     L    FD+ +           +    A+        G++YLH 
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEP-------DIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP--GEDTHVNTFRISGTHGYMAPE- 260
                I HRDIK  N+LLDE+ N KISDFGLA +F     +  +N     GT  Y+APE 
Sbjct: 124 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM--CGTLPYVAPEL 178

Query: 261 YALHGYLSVKTDVFSYGVLVLEIVSGR 287
                + +   DV+S G+++  +++G 
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGE 205

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 59/236 (25%), Positives = 100/236 (42%), Gaps = 64/236 (27%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSV-----DSRQGLREFTNEVKLLLKIQH 141
           F   + LG G +G V      P G+ +A+KK+        + + LRE    +K+L   +H
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLRE----IKILKHFKH 68

Query: 142 KNLVTLFGC-CAEGPEKM----LVYEYLP--------NKSLD-----YFIFDKTKSSSLD 183
           +N++T+F     +  E      ++ E +          + L      YFI          
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFI---------- 118

Query: 184 WTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243
               Y+ +    R +  LH    + +IHRD+K SN+L++   + K+ DFGLAR+   +++
Sbjct: 119 ----YQTL----RAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARII--DES 165

Query: 244 HVNTFRISGTHGYM----------APEYAL--HGYLSVKTDVFSYGVLVLEIVSGR 287
             +    +G    M          APE  L    Y S   DV+S G ++ E+   R
Sbjct: 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKY-SRAMDVWSCGCILAELFLRR 220

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 66/229 (28%), Positives = 111/229 (48%), Gaps = 57/229 (24%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS-----VDSRQGLREFTNEVKLLLKIQH 141
           +++L+ +G G +G V       N   +A+KK+S        ++ LRE    +K+LL+ +H
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLRE----IKILLRFRH 84

Query: 142 KNLVTLFGC-CAEGPEKM----LVYEY-------------LPNKSLDYFIFDKTKSSSLD 183
           +N++ +     A   E+M    +V +              L N  + YF+          
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFL---------- 134

Query: 184 WTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT 243
               Y+I+    RGL Y+H    A ++HRD+K SN+LL+   + KI DFGLAR+   +  
Sbjct: 135 ----YQIL----RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVA--DPD 181

Query: 244 HVNTFRISG---THGYMAPEYAL--HGYLSVKTDVFSYGVLVLEIVSGR 287
           H +T  ++    T  Y APE  L   GY +   D++S G ++ E++S R
Sbjct: 182 HDHTGFLTEYVATRWYRAPEIMLNSKGY-TKSIDIWSVGCILAEMLSNR 229

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 91.8 bits (228), Expect = 2e-20
 Identities = 37/162 (22%), Positives = 74/162 (45%), Gaps = 23/162 (14%)

Query: 93  QLGHGGFGPVYRG---LMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTL 147
           ++G G +G VY+       + ++ A+K++     S    RE    + LL +++H N+++L
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPNVISL 83

Query: 148 FGCCAEGPEK--MLVYEYLPN---KSLDYFIFDKTKSSSLDWTTRYR--IVMGVARGLLY 200
                   ++   L+++Y  +     + +    K     +         ++  +  G+ Y
Sbjct: 84  QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143

Query: 201 LHEEAPARIIHRDIKASNILLDEQLNP----KISDFGLARLF 238
           LH      ++HRD+K +NIL+  +       KI+D G ARLF
Sbjct: 144 LHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 90.4 bits (225), Expect = 3e-20
 Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 36/216 (16%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQ 140
           +     +G G +G V   +   +G+++A+KKLS      + +++  RE    + LL  +Q
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRE----LLLLKHMQ 81

Query: 141 HKNLVTLF------GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGV 194
           H+N++ L              +  LV  ++    L   +         +   +Y +V  +
Sbjct: 82  HENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM----GLKFSEEKIQY-LVYQM 135

Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH-VNTFRISGT 253
            +GL Y+H    A ++HRD+K  N+ ++E    KI DFGLAR    E T  V       T
Sbjct: 136 LKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYV------VT 186

Query: 254 HGYMAPEYAL--HGYLSVKTDVFSYGVLVLEIVSGR 287
             Y APE  L    Y +   D++S G ++ E+++G+
Sbjct: 187 RWYRAPEVILSWMHY-NQTVDIWSVGCIMAEMLTGK 221

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 89.6 bits (223), Expect = 3e-20
 Identities = 51/208 (24%), Positives = 75/208 (36%), Gaps = 35/208 (16%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCC 151
           LG G    V   + +   QE AVK +             EV++L + Q H+N++ L    
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80

Query: 152 AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY------RIVMGVARGLLYLHEEA 205
            E     LV+E +   S+                  +       +V  VA  L +LH + 
Sbjct: 81  EEEDRFYLVFEKMRGGSI----LSHIHKRR-----HFNELEASVVVQDVASALDFLHNK- 130

Query: 206 PARIIHRDIKASNILL---DEQLNPKISDFGLARLFPGEDTHVNTFRIS-----GTHGYM 257
              I HRD+K  NIL    ++    KI DF L                      G+  YM
Sbjct: 131 --GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188

Query: 258 APE------YALHGYLSVKTDVFSYGVL 279
           APE           Y   + D++S GV+
Sbjct: 189 APEVVEAFSEEASIY-DKRCDLWSLGVI 215

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 91.0 bits (226), Expect = 5e-20
 Identities = 55/285 (19%), Positives = 100/285 (35%), Gaps = 82/285 (28%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQ 140
           +   + +G G +G VY        + +A+KK++      +D ++ LRE    + +L +++
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILRE----ITILNRLK 83

Query: 141 HKNLVTLFG-CCAEGPEKM----LVYEYLP---------NKSLD-----YFIFDKTKSSS 181
              ++ L+     +   K     +V E               L        +        
Sbjct: 84  SDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTIL-------- 135

Query: 182 LDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241
                 Y ++     G  ++HE   + IIHRD+K +N LL++  + K+ DFGLAR    E
Sbjct: 136 ------YNLL----LGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182

Query: 242 DTHVNTFRISGTHG--------------------YMAPEYAL--HGYLSVKTDVFSYGVL 279
                   +                         Y APE  L    Y +   D++S G +
Sbjct: 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENY-TKSIDIWSTGCI 241

Query: 280 VLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK 324
             E+++  ++H                 LF G     L     +K
Sbjct: 242 FAELLNMLQSHINDPTNRFP--------LFPGSSCFPLSPDRNSK 278

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 89.3 bits (222), Expect = 6e-20
 Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 30/220 (13%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS----VDSRQGLREFTNEVKLLLKIQHK 142
           + DL  LG GG G V+  +     + +A+KK+        +  LRE    +K++ ++ H 
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALRE----IKIIRRLDHD 68

Query: 143 NLVTLFGC-CAEGPEKMLVYEYLPNKSLDYFIFD--KT------KSSSL-DWTTRYRIVM 192
           N+V +F      G +       L   +  Y + +  +T      +   L +   R   + 
Sbjct: 69  NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL-FMY 127

Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVN--TFR 249
            + RGL Y+H    A ++HRD+K +N+ ++ E L  KI DFGLAR+     +H    +  
Sbjct: 128 QLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184

Query: 250 ISGTHGYMAPEYAL--HGYLSVKTDVFSYGVLVLEIVSGR 287
           +  T  Y +P   L  + Y +   D+++ G +  E+++G+
Sbjct: 185 LV-TKWYRSPRLLLSPNNY-TKAIDMWAAGCIFAEMLTGK 222

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 89.3 bits (222), Expect = 9e-20
 Identities = 62/223 (27%), Positives = 103/223 (46%), Gaps = 49/223 (21%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQ 140
           + DL  +G G +G V   +    G ++A+KKL       + +++  RE    ++LL  ++
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRE----LRLLKHMR 82

Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLD-----YFIFDK--------TKSSSLDWTTR 187
           H+N++ L               + P+++LD     Y +            K   L     
Sbjct: 83  HENVIGLLDV------------FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 130

Query: 188 YRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT-HVN 246
             +V  + +GL Y+H    A IIHRD+K  N+ ++E    KI DFGLAR    E T +V 
Sbjct: 131 QFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV 187

Query: 247 TFRISGTHGYMAPEYAL--HGYLSVKTDVFSYGVLVLEIVSGR 287
           T R      Y APE  L    Y +   D++S G ++ E+++G+
Sbjct: 188 T-RW-----YRAPEVILNWMRY-TQTVDIWSVGCIMAEMITGK 223

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 51/222 (22%), Positives = 91/222 (40%), Gaps = 36/222 (16%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLS--VDSRQGLREFTN---------EVKLL 136
           ++    +  G +G V  G+   G  +A+K++   V   + +   ++         E++LL
Sbjct: 24  YTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLL 83

Query: 137 LKIQHKNLVTLFGC-CAEGPEKM----LVYEYLPNKSLDYFIFDKTKSSSL-DWTTRYRI 190
               H N++ L           M    LV E +    L   I    +   +     +Y  
Sbjct: 84  NHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI--HDQRIVISPQHIQY-F 139

Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT---HVNT 247
           +  +  GL  LHE   A ++HRD+   NILL +  +  I DF LAR    +     +V  
Sbjct: 140 MYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTH 196

Query: 248 FRISGTHGYMAPEYAL--HGYLSVKTDVFSYGVLVLEIVSGR 287
            R      Y APE  +   G+ +   D++S G ++ E+ + +
Sbjct: 197 -RW-----YRAPELVMQFKGF-TKLVDMWSAGCVMAEMFNRK 231

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 49/236 (20%), Positives = 80/236 (33%), Gaps = 51/236 (21%)

Query: 70  DSWNLFFDLRTLQVATNFFSDL-----NQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSR 123
            S  L    +  +      +D        LG G  G V        GQ+ A+K   +   
Sbjct: 8   HSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK--LLYDS 65

Query: 124 QGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFI--------- 173
              R+   EV    +     ++V +            VYE + +      I         
Sbjct: 66  PKARQ---EVDHHWQASGGPHIVCILD----------VYENMHHGKRCLLIIMECMEGGE 112

Query: 174 -FDK-TKSSSLDWTTRY--RIVMGVARGLLYLHEEAPARIIHRDIKASNILL---DEQLN 226
            F +  +     +T R    I+  +   + +LH      I HRD+K  N+L    ++   
Sbjct: 113 LFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAV 169

Query: 227 PKISDFGLARLFPGED--THVNTFRISGTHGYMAPE-YALHGYLSVKTDVFSYGVL 279
            K++DFG A+        T         T  Y+APE      Y     D++S GV+
Sbjct: 170 LKLTDFGFAKETTQNALQTPC------YTPYYVAPEVLGPEKY-DKSCDMWSLGVI 218

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 89.8 bits (223), Expect = 1e-19
 Identities = 54/207 (26%), Positives = 93/207 (44%), Gaps = 30/207 (14%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
           LG G FG V  G     G ++AVK   +  + S   + +   E++ L   +H +++ L+ 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR--------GLLYL 201
             +   +  +V EY+    L    FD             R+    +R        G+ Y 
Sbjct: 84  VISTPSDIFMVMEYVSGGEL----FDYI-------CKNGRLDEKESRRLFQQILSGVDYC 132

Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE- 260
           H      ++HRD+K  N+LLD  +N KI+DFGL+ +   +   + T    G+  Y APE 
Sbjct: 133 HRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRTS--CGSPNYAAPEV 186

Query: 261 YALHGYLSVKTDVFSYGVLVLEIVSGR 287
            +   Y   + D++S GV++  ++ G 
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGT 213

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 56/213 (26%), Positives = 92/213 (43%), Gaps = 29/213 (13%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQ 140
           + +L  +G G  G V         + +A+KKLS        +++  RE    + L+  + 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRE----LVLMKCVN 82

Query: 141 HKNLVTLF------GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGV 194
           HKN++ L           E  +  +V E +   +L   I    +         Y ++  +
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI----QMELDHERMSY-LLYQM 136

Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH 254
             G+ +LH    A IIHRD+K SNI++      KI DFGLAR      + + T  +  T 
Sbjct: 137 LCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVV-TR 190

Query: 255 GYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
            Y APE  L        D++S G ++ E++ G 
Sbjct: 191 YYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 87.7 bits (218), Expect = 2e-19
 Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 17/200 (8%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
           LG G FG V         Q++A+K   +  +           E+  L  ++H +++ L+ 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYR-IVMGVARGLLYLHEEAPAR 208
                 + ++V EY   +  DY I +K + +  +    ++ I+  +     Y H     +
Sbjct: 77  VITTPTDIVMVIEYAGGELFDY-IVEKKRMTEDEGRRFFQQIICAIE----YCHRH---K 128

Query: 209 IIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE-YALHGYL 267
           I+HRD+K  N+LLD+ LN KI+DFGL+ +   +   + T    G+  Y APE      Y 
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMT-DGNFLKTS--CGSPNYAAPEVINGKLYA 185

Query: 268 SVKTDVFSYGVLVLEIVSGR 287
             + DV+S G+++  ++ GR
Sbjct: 186 GPEVDVWSCGIVLYVMLVGR 205

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 87.3 bits (217), Expect = 3e-19
 Identities = 43/209 (20%), Positives = 93/209 (44%), Gaps = 25/209 (11%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS-VDSRQGLREFTNEVKLLLKIQ-HKNL 144
           +  + +LG G +  V+  + + N +++ VK L  V  ++  RE    +K+L  ++   N+
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKRE----IKILENLRGGPNI 93

Query: 145 VTLFGCCAEGPEKMLVY--EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
           +TL     +   +      E++ N          T     D+  R+  +  + + L Y H
Sbjct: 94  ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT-----DYDIRF-YMYEILKALDYCH 147

Query: 203 EEAPARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEY 261
                 I+HRD+K  N+++D E    ++ D+GLA  +     +    R++ +  +  PE 
Sbjct: 148 S---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVA-SRYFKGPEL 201

Query: 262 AL--HGYLSVKTDVFSYGVLVLEIVSGRK 288
            +    Y     D++S G ++  ++  ++
Sbjct: 202 LVDYQMY-DYSLDMWSLGCMLASMIFRKE 229

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 88.4 bits (219), Expect = 3e-19
 Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 35/216 (16%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQ 140
           + +L  +G G  G V         + +A+KKLS        +++  RE    + L+  + 
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRE----LVLMKCVN 119

Query: 141 HKNLVTLFG--CCAEGPEKM----LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGV 194
           HKN+++L       +  E+     LV E +    L   I    +         Y ++  +
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI----QMELDHERMSY-LLYQM 173

Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT---HVNTFRIS 251
             G+ +LH    A IIHRD+K SNI++      KI DFGLAR          +V      
Sbjct: 174 LCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV------ 224

Query: 252 GTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
            T  Y APE  L        D++S G ++ E+V  +
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 88.3 bits (219), Expect = 4e-19
 Identities = 42/203 (20%), Positives = 77/203 (37%), Gaps = 51/203 (25%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQ 140
           +   + +G G +G V         + +A+KK+       +D ++ LRE    + +L ++ 
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILRE----IAILNRLN 110

Query: 141 HKNLVTLFG-CCAEGPEKM----LVYEYLP---------NKSLD-----YFIFDKTKSSS 181
           H ++V +      +  EK     +V E               L        +        
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLL-------- 162

Query: 182 LDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241
                 Y ++     G+ Y+H    A I+HRD+K +N L+++  + K+ DFGLAR     
Sbjct: 163 ------YNLL----VGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP 209

Query: 242 DTHVNTFRISGTHGYMAPEYALH 264
           +   +   IS     M      H
Sbjct: 210 ENGNSQLPISPREDDMNLVTFPH 232

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 87.0 bits (216), Expect = 6e-19
 Identities = 66/217 (30%), Positives = 106/217 (48%), Gaps = 37/217 (17%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQ 140
           + +L+ +G G +G V        G  +AVKKLS      + +++  RE    ++LL  ++
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRE----LRLLKHMK 86

Query: 141 HKNLVTLFGCC--AEGPEKM----LVYEYLPNKSLDYFIFDKTKSSSL-DWTTRYRIVMG 193
           H+N++ L      A   E+     LV   +    L+  +    K   L D   ++ ++  
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIV----KCQKLTDDHVQF-LIYQ 140

Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT-HVNTFRISG 252
           + RGL Y+H    A IIHRD+K SN+ ++E    KI DFGLAR    E T +V       
Sbjct: 141 ILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV------A 191

Query: 253 THGYMAPEYAL--HGYLSVKTDVFSYGVLVLEIVSGR 287
           T  Y APE  L    Y +   D++S G ++ E+++GR
Sbjct: 192 TRWYRAPEIMLNWMHY-NQTVDIWSVGCIMAELLTGR 227

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 86.6 bits (215), Expect = 8e-19
 Identities = 63/212 (29%), Positives = 93/212 (43%), Gaps = 26/212 (12%)

Query: 88  FSDLNQLGHGGFGPVY----RGLMPNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQ 140
           F  L  +G G FG V            +  A+K   K     R  +R    E++++  ++
Sbjct: 17  FEILRAIGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE 73

Query: 141 HKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL 199
           H  LV L+    +  E M +V + L    L Y +  +      +    +  +  +   L 
Sbjct: 74  HPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL-QQNVHFKEETVKLF--ICELVMALD 129

Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           YL  +   RIIHRD+K  NILLDE  +  I+DF +A + P E     T   +GT  YMAP
Sbjct: 130 YLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI-TTM--AGTKPYMAP 183

Query: 260 E----YALHGYLSVKTDVFSYGVLVLEIVSGR 287
           E        GY S   D +S GV   E++ GR
Sbjct: 184 EMFSSRKGAGY-SFAVDWWSLGVTAYELLRGR 214

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 84.8 bits (210), Expect = 4e-18
 Identities = 46/200 (23%), Positives = 72/200 (36%), Gaps = 31/200 (15%)

Query: 94  LGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCC 151
           LG G  G V +       ++ A+K   +      R    EV+L  +     ++V +    
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALK--MLQDCPKARR---EVELHWRASQCPHIVRIVDVY 124

Query: 152 AEGPEKM----LVYEYLPNKSLDYFIFDK-TKSSSLDWTTRY--RIVMGVARGLLYLHEE 204
                      +V E L    L    F +        +T R    I+  +   + YLH  
Sbjct: 125 ENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI 180

Query: 205 APARIIHRDIKASNILL---DEQLNPKISDFGLARLFPGEDTHVNTFR-ISGTHGYMAPE 260
               I HRD+K  N+L          K++DFG A+         N+      T  Y+APE
Sbjct: 181 ---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH----NSLTTPCYTPYYVAPE 233

Query: 261 -YALHGYLSVKTDVFSYGVL 279
                 Y     D++S GV+
Sbjct: 234 VLGPEKY-DKSCDMWSLGVI 252

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 84.2 bits (208), Expect = 4e-18
 Identities = 46/192 (23%), Positives = 80/192 (41%), Gaps = 17/192 (8%)

Query: 99  FGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM 158
           FG +   L     E    K      +  +++   + + LK +  ++ +     + G  + 
Sbjct: 111 FGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170

Query: 159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASN 218
                +  +     ++       L           VA+G+ +L   A  + IHRD+ A N
Sbjct: 171 KSLSDVEEEEAPEDLYKDF----LTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARN 223

Query: 219 ILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHG-----YMAPEYALHGYLSVKTDV 273
           ILL E+   KI DFGLAR     D + +   +          +MAPE       ++++DV
Sbjct: 224 ILLSEKNVVKICDFGLAR-----DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 278

Query: 274 FSYGVLVLEIVS 285
           +S+GVL+ EI S
Sbjct: 279 WSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 33/154 (21%), Positives = 55/154 (35%), Gaps = 19/154 (12%)

Query: 92  NQLGHGGFGPVYRGL------MPNGQEIAVKKLSVDSRQG-LREFTNEVKLLLKI-QHKN 143
             LG G FG V              + +AVK L   +     R   +E+K+L+ I  H N
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 144 LVTLFGCC-AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
           +V L G C   G   M++ E+    +L  ++           + R   V    +G  +  
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFRQ 137

Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLAR 236
            +     I  D+K     +    +   S F   +
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 57/246 (23%), Positives = 104/246 (42%), Gaps = 74/246 (30%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS------VDSRQGLREFTNEVKLLLKIQ 140
           +  + +LG G +G V++ +    G+ +AVKK+        D+++  RE    + +L ++ 
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFRE----IMILTELS 66

Query: 141 -HKNLVTLFGCCAEGPEKM----LVYEYLP--------NKSLD-----YFIFDKTKSSSL 182
            H+N+V L        +      LV++Y+            L+     Y +         
Sbjct: 67  GHENIVNLLNVLR--ADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVV--------- 115

Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
                Y+++    + + YLH      ++HRD+K SNILL+ + + K++DFGL+R F    
Sbjct: 116 -----YQLI----KVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR 163

Query: 243 THVNTFRISGTHG-------------------YMAPEYAL--HGYLSVKTDVFSYGVLVL 281
              N   +S                       Y APE  L    Y +   D++S G ++ 
Sbjct: 164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKY-TKGIDMWSLGCILG 222

Query: 282 EIVSGR 287
           EI+ G+
Sbjct: 223 EILCGK 228

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 81.1 bits (201), Expect = 3e-17
 Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 22/210 (10%)

Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQHKN 143
           F     LG G F  V     +   +E A+K   K  +     +   T E  ++ ++ H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91

Query: 144 LVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRY---RIVMGVARGLL 199
            V L+    +  EK+     Y  N  L      K  S      TR+    IV      L 
Sbjct: 92  FVKLYFTF-QDDEKLYFGLSYAKNGEL-LKYIRKIGSFDET-CTRFYTAEIVSA----LE 144

Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           YLH +    IIHRD+K  NILL+E ++ +I+DFG A++   E          GT  Y++P
Sbjct: 145 YLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201

Query: 260 EYAL-HGY-LSVKTDVFSYGVLVLEIVSGR 287
           E         S   D+++ G ++ ++V+G 
Sbjct: 202 ELLTEKSACKSS--DLWALGCIIYQLVAGL 229

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 49/209 (23%), Positives = 76/209 (36%), Gaps = 36/209 (17%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
           +G G FG           + +AVK   + +       RE    +     ++H N+V    
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQRE----IINHRSLRHPNIVRFKE 83

Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR--------GLLYL 201
                    ++ EY     L    +++  +         R     AR        G+ Y 
Sbjct: 84  VILTPTHLAIIMEYASGGEL----YERICN-------AGRFSEDEARFFFQQLLSGVSYC 132

Query: 202 HEEAPARIIHRDIKASNILLDEQLNP--KISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           H     +I HRD+K  N LLD    P  KI DFG ++      +   +    GT  Y+AP
Sbjct: 133 HSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKST--VGTPAYIAP 186

Query: 260 E-YALHGYLSVKTDVFSYGVLVLEIVSGR 287
           E      Y     DV+S GV +  ++ G 
Sbjct: 187 EVLLRQEYDGKIADVWSCGVTLYVMLVGA 215

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 77.5 bits (191), Expect = 4e-16
 Identities = 25/204 (12%), Positives = 53/204 (25%), Gaps = 47/204 (23%)

Query: 91  LNQLGHGGFGPVYRG----LMPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKN 143
           L   G       ++     L    +++A+  +          L+E  +    L +I    
Sbjct: 36  LIFHGGVPPLQFWQALDTAL---DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           +  +          ++V E++   SL          +S       R +  +A      H 
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAHR 147

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
              A +       S +         +S  G   L                   M      
Sbjct: 148 ---AGVALSIDHPSRVR--------VSIDGDVVL--------------AYPATMPDA--- 179

Query: 264 HGYLSVKTDVFSYGVLVLEIVSGR 287
               + + D+   G  +  ++  R
Sbjct: 180 ----NPQDDIRGIGASLYALLVNR 199

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 78.2 bits (193), Expect = 7e-16
 Identities = 50/229 (21%), Positives = 88/229 (38%), Gaps = 25/229 (10%)

Query: 74  LFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLS---VDSRQGLREF 129
           +   L+ +++  + F  L  +G G F  V    M    ++ A+K ++   +  R  +  F
Sbjct: 49  IVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCF 108

Query: 130 TNEVKLLLKIQHKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRY 188
             E  +L+    + +  L     +    + LV EY     L   +    +    +    Y
Sbjct: 109 REERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFY 167

Query: 189 --RIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA-RLFPGEDTHV 245
              IVM     +  +H       +HRDIK  NILLD   + +++DFG   +L        
Sbjct: 168 LAEIVMA----IDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS 220

Query: 246 NTFRISGTHGYMAPE-------YALHGYLSVKTDVFSYGVLVLEIVSGR 287
                 GT  Y++PE           G    + D ++ GV   E+  G+
Sbjct: 221 LVA--VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 76.4 bits (189), Expect = 1e-15
 Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 26/212 (12%)

Query: 88  FSDLNQLGHGGFGPVY----RGLMPNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQ 140
           F  L  LG G FG V+           Q  A+K   K ++  R  +R    E  +L+++ 
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVEVN 84

Query: 141 HKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYR--IVMGVARG 197
           H  +V L     +   K+ L+ ++L    L +    K    + +    Y   + +     
Sbjct: 85  HPFIVKLH-YAFQTEGKLYLILDFLRGGDL-FTRLSKEVMFTEEDVKFYLAELAL----A 138

Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L +LH      II+RD+K  NILLDE+ + K++DFGL++     +    +F   GT  YM
Sbjct: 139 LDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF--CGTVEYM 193

Query: 258 APEYAL-HGY-LSVKTDVFSYGVLVLEIVSGR 287
           APE     G+  S   D +S+GVL+ E+++G 
Sbjct: 194 APEVVNRRGHTQSA--DWWSFGVLMFEMLTGT 223

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 76.0 bits (188), Expect = 2e-15
 Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 26/213 (12%)

Query: 88  FSDLNQLGHGGFGPVY---RGLMPNGQEI-AVK---KLSVDSRQGLREFT-NEVKLLLKI 139
           F  L  LG GG+G V+   +    N  +I A+K   K  +         T  E  +L ++
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78

Query: 140 QHKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYR--IVMGVAR 196
           +H  +V L     +   K+ L+ EYL    L   + ++      D    Y   I M    
Sbjct: 79  KHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQL-EREGIFMEDTACFYLAEISMA--- 133

Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGY 256
            L +LH++    II+RD+K  NI+L+ Q + K++DFGL +    + T  +TF   GT  Y
Sbjct: 134 -LGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF--CGTIEY 187

Query: 257 MAPEYAL-HGY-LSVKTDVFSYGVLVLEIVSGR 287
           MAPE  +  G+  +V  D +S G L+ ++++G 
Sbjct: 188 MAPEILMRSGHNRAV--DWWSLGALMYDMLTGA 218

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 65/238 (27%), Positives = 104/238 (43%), Gaps = 21/238 (8%)

Query: 59  ESAEDADGSGADSWNLFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEI----A 114
            S   +D SGA+   +       +V  N F  L  LG G FG V                
Sbjct: 121 RSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKI 180

Query: 115 VKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFI 173
           +KK  + ++  +     E ++L   +H  L  L     +  +++  V EY     L +F 
Sbjct: 181 LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGEL-FFH 238

Query: 174 FDKTKSSSLDWTTRY--RIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISD 231
             + +  S D    Y   IV      L YLH E    +++RD+K  N++LD+  + KI+D
Sbjct: 239 LSRERVFSEDRARFYGAEIVS----ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITD 292

Query: 232 FGLARLFPGEDTHVNTFRISGTHGYMAPEYAL-HGY-LSVKTDVFSYGVLVLEIVSGR 287
           FGL +    +   + TF   GT  Y+APE    + Y  +V  D +  GV++ E++ GR
Sbjct: 293 FGLCKEGIKDGATMKTF--CGTPEYLAPEVLEDNDYGRAV--DWWGLGVVMYEMMCGR 346

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 74.6 bits (184), Expect = 6e-15
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 27/210 (12%)

Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLS----VDSRQGLREFT-NEVKLLLKIQH 141
           F  +  LG G FG V       +G   A+K L     V  +Q   E T NE ++L  +  
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ--IEHTLNEKRILQAVNF 100

Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY--RIVMGVARGLL 199
             LV L     +     +V EY+    + +    +    S      Y  +IV+       
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM-FSHLRRIGRFSEPHARFYAAQIVLT----FE 155

Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           YLH      +I+RD+K  N+L+D+Q   +++DFG A+   G      T+ + GT   +AP
Sbjct: 156 YLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEALAP 207

Query: 260 EYALH-GY-LSVKTDVFSYGVLVLEIVSGR 287
           E  L  GY  +V  D ++ GVL+ E+ +G 
Sbjct: 208 EIILSKGYNKAV--DWWALGVLIYEMAAGY 235

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 75.4 bits (185), Expect = 8e-15
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 35/216 (16%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEI----AVKKLSVDSRQGLREFTNEVK--------L 135
           F+ L  LG G FG V         E+     +KK  V          ++V+        L
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD-------DDVECTMVEKRVL 395

Query: 136 LLKIQHKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGV 194
            L  +   L  L   C +  +++  V EY+    L Y I  +           Y     +
Sbjct: 396 ALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFY--AAEI 451

Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTH 254
           A GL +L  +    II+RD+K  N++LD + + KI+DFG+ +    +     TF   GT 
Sbjct: 452 AIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF--CGTP 506

Query: 255 GYMAPE---YALHGYLSVKTDVFSYGVLVLEIVSGR 287
            Y+APE   Y  +G  SV  D +++GVL+ E+++G+
Sbjct: 507 DYIAPEIIAYQPYGK-SV--DWWAFGVLLYEMLAGQ 539

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 48/224 (21%), Positives = 89/224 (39%), Gaps = 25/224 (11%)

Query: 78  LRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLSVDS--RQGLREFTN-EV 133
           ++ +++    F  L  +G G FG V    + N  ++ A+K L+     ++        E 
Sbjct: 66  VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREER 125

Query: 134 KLLLKIQHKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRY--RI 190
            +L+    K + TL     +    + LV +Y     L   +         +    Y   +
Sbjct: 126 DVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEM 184

Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA-RLFPGEDTHVNTFR 249
           V+     +  +H+      +HRDIK  NIL+D   + +++DFG   +L        +   
Sbjct: 185 VIA----IDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVA- 236

Query: 250 ISGTHGYMAPE------YALHGYLSVKTDVFSYGVLVLEIVSGR 287
             GT  Y++PE           Y   + D +S GV + E++ G 
Sbjct: 237 -VGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGE 278

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 53/231 (22%), Positives = 93/231 (40%), Gaps = 42/231 (18%)

Query: 78  LRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLS---VDSRQGLREFTNEV 133
           +R L++    +  +  +G G FG V      + +++ A+K LS   +  R     F  E 
Sbjct: 61  IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 120

Query: 134 KLLLKIQHKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVM 192
            ++       +V LF    +    + +V EY+P   L            ++  + Y +  
Sbjct: 121 DIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDL------------VNLMSNYDVPE 167

Query: 193 GVAR--------GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA-RLFPGEDT 243
             AR         L  +H       IHRD+K  N+LLD+  + K++DFG   ++      
Sbjct: 168 KWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 224

Query: 244 HVNTFRISGTHGYMAPE-------YALHGYLSVKTDVFSYGVLVLEIVSGR 287
             +T    GT  Y++PE          +G      D +S GV + E++ G 
Sbjct: 225 RCDTA--VGTPDYISPEVLKSQGGDGYYG-REC--DWWSVGVFLYEMLVGD 270

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 72.6 bits (179), Expect = 3e-14
 Identities = 54/210 (25%), Positives = 92/210 (43%), Gaps = 24/210 (11%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEI----AVKKLSVDSRQGLREFTNEVKLLLKIQHKN 143
           F  L  LG G FG V                ++K  + ++  +     E ++L   +H  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 144 LVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYR--IVMGVARGLLY 200
           L  L     +  +++  V EY     L + +  + +  + +    Y   IV      L Y
Sbjct: 67  LTALK-YAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSA----LEY 120

Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE 260
           LH      +++RDIK  N++LD+  + KI+DFGL +    +   + TF   GT  Y+APE
Sbjct: 121 LHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF--CGTPEYLAPE 175

Query: 261 ---YALHGYLSVKTDVFSYGVLVLEIVSGR 287
                 +G  +V  D +  GV++ E++ GR
Sbjct: 176 VLEDNDYGR-AV--DWWGLGVVMYEMMCGR 202

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 71.5 bits (176), Expect = 6e-14
 Identities = 60/218 (27%), Positives = 96/218 (44%), Gaps = 39/218 (17%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEI----AVKKLSVDSRQGLREFTNEVK--------L 135
           F+ L  LG G FG V         E+     +KK  V          ++V+        L
Sbjct: 22  FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD-------DDVECTMVEKRVL 74

Query: 136 LLKIQHKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYR--IVM 192
            L  +   L  L   C +  +++  V EY+    L Y I  +           Y   I +
Sbjct: 75  ALPGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFYAAEIAI 132

Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISG 252
           G    L +L  +    II+RD+K  N++LD + + KI+DFG+ +    +     TF   G
Sbjct: 133 G----LFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF--CG 183

Query: 253 THGYMAPE---YALHGYLSVKTDVFSYGVLVLEIVSGR 287
           T  Y+APE   Y  +G  SV  D +++GVL+ E+++G+
Sbjct: 184 TPDYIAPEIIAYQPYGK-SV--DWWAFGVLLYEMLAGQ 218

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 71.2 bits (175), Expect = 7e-14
 Identities = 37/160 (23%), Positives = 56/160 (35%), Gaps = 36/160 (22%)

Query: 94  LGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCC 151
           LG G  G V +       ++ A+K   +      R    EV+L  +  Q  ++V +    
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALK--MLQDCPKARR---EVELHWRASQCPHIVRIVD-- 78

Query: 152 AEGPEKMLVYEYLPNKSLDYFI----------FDK-TKSSSLDWTTRY--RIVMGVARGL 198
                   VYE L        I          F +        +T R    I+  +   +
Sbjct: 79  --------VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 130

Query: 199 LYLHEEAPARIIHRDIKASNILL---DEQLNPKISDFGLA 235
            YLH      I HRD+K  N+L          K++DFG A
Sbjct: 131 QYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 71.5 bits (176), Expect = 7e-14
 Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 39/218 (17%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEI----AVKKLSVDSRQGLREFTNEVK--------L 135
           F  +  LG G FG V    +    ++     +KK  +          ++V+        L
Sbjct: 25  FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQD-------DDVECTMTEKRIL 77

Query: 136 LLKIQHKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRY--RIVM 192
            L   H  L  LF CC + P+++  V E++    L + I  K++         Y   I+ 
Sbjct: 78  SLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHI-QKSRRFDEARARFYAAEIIS 135

Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISG 252
                L++LH++    II+RD+K  N+LLD + + K++DFG+ +          TF   G
Sbjct: 136 A----LMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF--CG 186

Query: 253 THGYMAPE---YALHGYLSVKTDVFSYGVLVLEIVSGR 287
           T  Y+APE     L+G  +V  D ++ GVL+ E++ G 
Sbjct: 187 TPDYIAPEILQEMLYGP-AV--DWWAMGVLLYEMLCGH 221

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 71.1 bits (175), Expect = 8e-14
 Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 25/211 (11%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEI----AVKKLSVDSRQGLREFTNEVKLLLKI-QHK 142
           F  L  +G G +  V    +     I     VKK  V+  + +     E  +  +   H 
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70

Query: 143 NLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYR--IVMGVARGLL 199
            LV L   C +   ++  V EY+    L + +  + +    +    Y   I +     L 
Sbjct: 71  FLVGLH-SCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPEEHARFYSAEISLA----LN 124

Query: 200 YLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           YLHE     II+RD+K  N+LLD + + K++D+G+ +         +TF   GT  Y+AP
Sbjct: 125 YLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF--CGTPNYIAP 179

Query: 260 E---YALHGYLSVKTDVFSYGVLVLEIVSGR 287
           E      +G+ SV  D ++ GVL+ E+++GR
Sbjct: 180 EILRGEDYGF-SV--DWWALGVLMFEMMAGR 207

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 71.6 bits (176), Expect = 8e-14
 Identities = 66/280 (23%), Positives = 117/280 (41%), Gaps = 44/280 (15%)

Query: 19  HQHHHNHNHNLSVDEMNLKHFISNLFPCLKTSLRGGRAAGESAEDADGSGADSWNLFFDL 78
           + HHH+H++++   E             + + +   + A  + E    S +       D 
Sbjct: 4   YHHHHHHDYDIPTTENLYFQ------GAMGSGIEEEKEAMNTRESGKASSSLGLQ---DF 54

Query: 79  RTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEI----AVKKLSVDSRQGLREFTNEVK 134
             L+V          +G G +  V    +     I     VKK  V+  + +     E  
Sbjct: 55  DLLRV----------IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKH 104

Query: 135 LLLKI-QHKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYR--I 190
           +  +   H  LV L   C +   ++  V EY+    L + +  + +    +    Y   I
Sbjct: 105 VFEQASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLPEEHARFYSAEI 162

Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRI 250
            +     L YLHE     II+RD+K  N+LLD + + K++D+G+ +         +TF  
Sbjct: 163 SLA----LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF-- 213

Query: 251 SGTHGYMAPE---YALHGYLSVKTDVFSYGVLVLEIVSGR 287
            GT  Y+APE      +G+ SV  D ++ GVL+ E+++GR
Sbjct: 214 CGTPNYIAPEILRGEDYGF-SV--DWWALGVLMFEMMAGR 250

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 71.2 bits (175), Expect = 9e-14
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 30/217 (13%)

Query: 88  FSDLNQLGHGGFGPVY---RGLMPNGQEI-AVK---KLSVDSRQGLREFT-NEVKLLLKI 139
           F  L  LG G +G V+   +    +  ++ A+K   K ++  +    E T  E ++L  I
Sbjct: 56  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115

Query: 140 QHKN-LVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRY--RIVMGVA 195
           +    LVTL     +   K+ L+ +Y+    L +    + +  +      Y   IV+   
Sbjct: 116 RQSPFLVTLH-YAFQTETKLHLILDYINGGEL-FTHLSQRERFTEHEVQIYVGEIVLA-- 171

Query: 196 RGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF-PGEDTHVNTFRISGTH 254
             L +LH+     II+RDIK  NILLD   +  ++DFGL++ F   E      F   GT 
Sbjct: 172 --LEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF--CGTI 224

Query: 255 GYMAPE---YALHGYL-SVKTDVFSYGVLVLEIVSGR 287
            YMAP+       G+  +V  D +S GVL+ E+++G 
Sbjct: 225 EYMAPDIVRGGDSGHDKAV--DWWSLGVLMYELLTGA 259

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 69.2 bits (170), Expect = 4e-13
 Identities = 67/218 (30%), Positives = 98/218 (44%), Gaps = 39/218 (17%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEI----AVKKLSVDSRQGLREFTNEVK--------L 135
           F     LG G FG V+        +     A+KK  V          ++V+        L
Sbjct: 19  FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMD-------DDVECTMVEKRVL 71

Query: 136 LLKIQHKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRY--RIVM 192
            L  +H  L  +F C  +  E +  V EYL    L Y I        L   T Y   I++
Sbjct: 72  SLAWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHI-QSCHKFDLSRATFYAAEIIL 129

Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISG 252
           G    L +LH +    I++RD+K  NILLD+  + KI+DFG+ +     D   NTF   G
Sbjct: 130 G----LQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF--CG 180

Query: 253 THGYMAPE---YALHGYLSVKTDVFSYGVLVLEIVSGR 287
           T  Y+APE      + + SV  D +S+GVL+ E++ G+
Sbjct: 181 TPDYIAPEILLGQKYNH-SV--DWWSFGVLLYEMLIGQ 215

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 67.9 bits (167), Expect = 8e-13
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 33/213 (15%)

Query: 88  FSDLNQLGHGGFGPVY--RGLMPNGQEIAVKKLS----VDSRQGLREFT-NEVKLLLKIQ 140
           F  L  LG G FG V+  R    NG+  A+K L     V  +Q   E T +E  +L  + 
Sbjct: 8   FQILRTLGTGSFGRVHLIR-SRHNGRYYAMKVLKKEIVVRLKQ--VEHTNDERLMLSIVT 64

Query: 141 HKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRY---RIVMGVAR 196
           H  ++ ++G   +  +++ ++ +Y+    L + +  K++        ++    + +    
Sbjct: 65  HPFIIRMWGTFQD-AQQIFMIMDYIEGGEL-FSLLRKSQRFPNP-VAKFYAAEVCLA--- 118

Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGY 256
            L YLH +    II+RD+K  NILLD+  + KI+DFG A+          T    GT  Y
Sbjct: 119 -LEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKY---VPDVTYTL--CGTPDY 169

Query: 257 MAPEYAL-HGY-LSVKTDVFSYGVLVLEIVSGR 287
           +APE      Y  S+  D +S+G+L+ E+++G 
Sbjct: 170 IAPEVVSTKPYNKSI--DWWSFGILIYEMLAGY 200

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 68.4 bits (168), Expect = 9e-13
 Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 27/212 (12%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEI-AVKKLS----VDSRQGLREFTNEVK--LLLKIQ 140
           F  L  +G G FG V        +   AVK L     +  ++   +     +  LL  ++
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKE--EKHIMSERNVLLKNVK 97

Query: 141 HKNLVTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRY--RIVMGVARG 197
           H  LV L     +  +K+  V +Y+    L Y +  + +         Y   I       
Sbjct: 98  HPFLVGLH-FSFQTADKLYFVLDYINGGELFYHL-QRERCFLEPRARFYAAEIASA---- 151

Query: 198 LLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYM 257
           L YLH      I++RD+K  NILLD Q +  ++DFGL +     ++  +TF   GT  Y+
Sbjct: 152 LGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTF--CGTPEYL 206

Query: 258 APEYAL-HGY-LSVKTDVFSYGVLVLEIVSGR 287
           APE      Y  +V  D +  G ++ E++ G 
Sbjct: 207 APEVLHKQPYDRTV--DWWCLGAVLYEMLYGL 236

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 66.1 bits (160), Expect = 4e-12
 Identities = 26/227 (11%), Positives = 66/227 (29%), Gaps = 50/227 (22%)

Query: 83  VATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS--------RQGLREFTNEVK 134
           + T       ++G G FG V++ +  +   +A+K ++++         ++   E   E+ 
Sbjct: 17  LPTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 135 LLLKIQ---------HKNLVTLFGCC-------------------AEGPEKMLVYEYLPN 166
           +  ++           +  + L                        +G        +  +
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135

Query: 167 KSLDYFIF-------DKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNI 219
           +      F       ++ ++      T   I+  +   L         R  HRD+   N+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNV 193

Query: 220 LLDEQLNPKISDFGLARLFP----GEDTHVNTFRISGTHGYMAPEYA 262
           LL +    K+      +       G    +  + +S         + 
Sbjct: 194 LLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFC 240

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 62.0 bits (151), Expect = 6e-11
 Identities = 45/159 (28%), Positives = 71/159 (44%), Gaps = 15/159 (9%)

Query: 93  QLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSR-QGLREFTNEVKLLLKIQHKNLV-TLFG 149
           ++G G FG +Y G  +  G+E+A+K   V ++   L     E K+   +Q    + T+  
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLH---IESKIYKMMQGGVGIPTIRW 72

Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
           C AEG   ++V E L   SL+      ++  SL   T   +   +   + Y+H       
Sbjct: 73  CGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSL--KTVLLLADQMISRIEYIHS---KNF 126

Query: 210 IHRDIKASNILLDEQLNPK---ISDFGLARLFPGEDTHV 245
           IHRD+K  N L+          I DFGLA+ +    TH 
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 165

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 59.7 bits (145), Expect = 5e-10
 Identities = 37/164 (22%), Positives = 66/164 (40%), Gaps = 25/164 (15%)

Query: 93  QLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQH-KNLVTLFGC 150
           ++G G FG +  G  +   + +A+K   + SR    +   E +   ++     +  ++  
Sbjct: 16  KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDGIPQVYYF 73

Query: 151 CAEGPEKMLVYEYLPNKSL-DYFIFDKTKSSSLDWTTRYRIVMGVARGLL----YLHEEA 205
              G    +V E L   SL D F       S        + V+ +A  L+    Y+H + 
Sbjct: 74  GPCGKYNAMVLELL-GPSLEDLFDLCDRTFS-------LKTVLMIAIQLISRMEYVHSKN 125

Query: 206 PARIIHRDIKASNILLDEQLNPK-----ISDFGLARLFPGEDTH 244
              +I+RD+K  N L+    N       I DF LA+ +   +T 
Sbjct: 126 ---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 58.5 bits (142), Expect = 8e-10
 Identities = 34/163 (20%), Positives = 68/163 (41%), Gaps = 23/163 (14%)

Query: 93  QLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV-TLFGC 150
           ++G G FG ++ G  + N Q++A+K     S     +  +E +    +     +  ++  
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 74

Query: 151 CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL----YLHEEAP 206
             EG   +LV + L   SL+  +    +  S+      + V   A+ +L     +HE   
Sbjct: 75  GQEGLHNVLVIDLLG-PSLEDLLDLCGRKFSV------KTVAMAAKQMLARVQSIHE--- 124

Query: 207 ARIIHRDIKASNILLDEQLNPK-----ISDFGLARLFPGEDTH 244
             +++RDIK  N L+    +       + DFG+ + +    T 
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 40/159 (25%), Positives = 70/159 (44%), Gaps = 15/159 (9%)

Query: 93  QLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSR-QGLREFTNEVKLLLKIQHKNLV-TLFG 149
           ++G G FG +Y G  +   +E+A+K  +V ++   L     E K+   +Q    +  +  
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLL---YESKIYRILQGGTGIPNVRW 70

Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
              EG   +LV + L   SL+      ++  SL   T   +   +   + ++H ++    
Sbjct: 71  FGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSL--KTVLMLADQMINRVEFVHSKS---F 124

Query: 210 IHRDIKASNILLDEQLNPK---ISDFGLARLFPGEDTHV 245
           +HRDIK  N L+          I DFGLA+ +    TH 
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ 163

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 35/179 (19%), Positives = 69/179 (38%), Gaps = 38/179 (21%)

Query: 93  QLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLV------ 145
           ++G GGFG +Y        ++ A   + V+ ++    F +E+K   ++  K+ +      
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF-SELKFYQRVAKKDCIKKWIER 102

Query: 146 ---------TLFGC----CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVM 192
                      +G           + +V E L    L   I  +  +           V+
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQK-ISGQNGTFKK------STVL 154

Query: 193 GVARGLL----YLHEEAPARIIHRDIKASNILLDEQLNPKI--SDFGLARLFPGEDTHV 245
            +   +L    Y+HE      +H DIKA+N+LL  +   ++  +D+GL+  +     H 
Sbjct: 155 QLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 31/176 (17%), Positives = 59/176 (33%), Gaps = 27/176 (15%)

Query: 92  NQLGHGGFGPVYRGL---------MPNGQEIAVK----------KLSVDSRQGLREFTNE 132
           +       G +Y             P  Q+ ++K          + +   R       N+
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107

Query: 133 VKLLLKIQHKNLVTLFGC-CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIV 191
            K L       + T  G    +   + LV   L  +SL     D +    L   +  ++ 
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSPKHVLSERSVLQVA 165

Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKI--SDFGLARLFPGEDTHV 245
             +   L +LHE      +H ++ A NI +D +   ++  + +G A  +     HV
Sbjct: 166 CRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 56.6 bits (137), Expect = 5e-09
 Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 40/223 (17%)

Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQ------ 140
           + +LG G F  V+    M N   +A+K      V +         E+KLL ++       
Sbjct: 24  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED----EIKLLQRVNDADNTK 79

Query: 141 -----HKNLVTLFGC-CAEGPEKM---LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIV 191
                  +++ L      +GP  +   +V+E L  ++L   +  K +   +      +I 
Sbjct: 80  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENL-LALIKKYEHRGIPLIYVKQIS 137

Query: 192 MGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP------KISDFGLARLFPGEDTHV 245
             +  GL Y+H      IIH DIK  N+L++   +P      KI+D G A      D H 
Sbjct: 138 KQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW---YDEHY 192

Query: 246 NTFRISGTHGYMAPEYAL-HGYLSVKTDVFSYGVLVLEIVSGR 287
               I     Y +PE  L   +     D++S   L+ E+++G 
Sbjct: 193 TNS-IQTRE-YRSPEVLLGAPW-GCGADIWSTACLIFELITGD 232

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 57.0 bits (138), Expect = 5e-09
 Identities = 54/217 (24%), Positives = 89/217 (41%), Gaps = 42/217 (19%)

Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVK---KLSVDSRQGLREFTNEVKLLLKIQHK---- 142
           L  +G G FG V +       Q +A+K         RQ       E+++L  ++ +    
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAA----EEIRILEHLRKQDKDN 157

Query: 143 --NLVTLFGC-------CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG 193
             N++ +          C       + +E L + +L Y +  K K          +    
Sbjct: 158 TMNVIHMLENFTFRNHIC-------MTFELL-SMNL-YELIKKNKFQGFSLPLVRKFAHS 208

Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNP--KISDFGLARLFPGEDTHVNTFRIS 251
           + + L  LH+    RIIH D+K  NILL +Q     K+ DFG +     E   V T+ I 
Sbjct: 209 ILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY---EHQRVYTY-IQ 261

Query: 252 GTHGYMAPEYAL-HGYLSVKTDVFSYGVLVLEIVSGR 287
               Y APE  L   Y  +  D++S G ++ E+++G 
Sbjct: 262 SRF-YRAPEVILGARY-GMPIDMWSLGCILAELLTGY 296

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 35/183 (19%), Positives = 63/183 (34%), Gaps = 43/183 (23%)

Query: 93  QLGHGGFGPVYRGLMPNGQEIAVK-----KLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
            +G GGFG +Y   M + + +        K+       L     E+K   +      +  
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLF---TELKFYQRAAKPEQIQK 98

Query: 148 -----------------FGCCAEGPEK--MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY 188
                             G   +  +    ++ +      L        K  S       
Sbjct: 99  WIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSR------ 151

Query: 189 RIVMGVARGLL----YLHEEAPARIIHRDIKASNILLDEQLNPKI--SDFGLARLFPGED 242
           + V+ ++  +L    Y+HE      +H DIKASN+LL+ +   ++   D+GLA  +  E 
Sbjct: 152 KTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208

Query: 243 THV 245
            H 
Sbjct: 209 VHK 211

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 53.9 bits (130), Expect = 4e-08
 Identities = 50/220 (22%), Positives = 84/220 (38%), Gaps = 40/220 (18%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKL-SVDS--RQGLREFTNEVKLLLKIQH-- 141
           +   + +G G FG V +       + +A+K + +  +   Q       EV+LL  +    
Sbjct: 56  YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQ----IEVRLLELMNKHD 111

Query: 142 ----KNLVTLFGC-------CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRI 190
                 +V L          C       LV+E L + +L Y +   T    +      + 
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLC-------LVFEML-SYNL-YDLLRNTNFRGVSLNLTRKF 162

Query: 191 VMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP--KISDFGLARLFPGEDTHVNTF 248
              +   LL+L       IIH D+K  NILL        KI DFG +         +  +
Sbjct: 163 AQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ---LGQRIYQY 218

Query: 249 RISGTHGYMAPEYAL-HGYLSVKTDVFSYGVLVLEIVSGR 287
            I     Y +PE  L   Y  +  D++S G +++E+ +G 
Sbjct: 219 -IQSRF-YRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGE 255

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 53.4 bits (128), Expect = 7e-08
 Identities = 56/277 (20%), Positives = 91/277 (32%), Gaps = 75/277 (27%)

Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ--------H 141
           + +LG G F  V+    +   + +A+K +            +E++LL  ++         
Sbjct: 42  IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT-ETALDEIRLLKSVRNSDPNDPNR 100

Query: 142 KNLVTLFGC-CAEGPEKM---LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG 197
           + +V L       G       +V+E L    L  +I  K+    L      +I+  V +G
Sbjct: 101 EMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWI-IKSNYQGLPLPCVKKIIQQVLQG 158

Query: 198 LLYLHEEAPARIIHRDIKASNILL------------------------------------ 221
           L YLH +   RIIH DIK  NILL                                    
Sbjct: 159 LDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPAT 216

Query: 222 -------------DEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLS 268
                         E+L  KI+D G A       T         T  Y + E  +    +
Sbjct: 217 AGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ-----TRQYRSLEVLIGSGYN 271

Query: 269 VKTDVFSYGVLVLEIVSGR---KNHDGRLGKEKADLL 302
              D++S   +  E+ +G    + H G       D +
Sbjct: 272 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHI 308

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.4 bits (122), Expect = 4e-07
 Identities = 66/422 (15%), Positives = 120/422 (28%), Gaps = 131/422 (31%)

Query: 10  RHPILDDQNHQHHHN--HNHNLSVDEMN---------LKHFISNLFP-----------CL 47
           R P +  + +    +  +N N    + N         L+  +  L P             
Sbjct: 103 RQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG 162

Query: 48  KTSLRGGRAAGESAEDADGSGADSWNLF-FDLRTLQVATNFFSDLNQLGHGGFGPVYRGL 106
           KT +     A +            + +F  +L+           L +L           +
Sbjct: 163 KTWV-----ALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKL--------LYQI 209

Query: 107 MPNGQEIAVKKLSVDSRQGLREFTNEVK-----LLLKIQHKN-LVTL------------- 147
            PN    +      D    ++   + ++     LL    ++N L+ L             
Sbjct: 210 DPNWTSRS------DHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFN 263

Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH---EE 204
             C      K+L+                        TTR++ V          H   + 
Sbjct: 264 LSC------KILL------------------------TTRFKQVTDFLSAATTTHISLDH 293

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
               +   ++K+   LL + L+ +  D       P E    N  R+S        +    
Sbjct: 294 HSMTLTPDEVKS---LLLKYLDCRPQDL------PREVLTTNPRRLSII-AESIRDGLAT 343

Query: 265 --GYLSVKTD----VFSYGVLVLEIVSGRKNHDGRLG------KEKADLLSYTWTLFQGE 312
              +  V  D    +    + VLE    RK  D RL            LLS  W      
Sbjct: 344 WDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFD-RLSVFPPSAHIPTILLSLIWFDVIKS 402

Query: 313 KAL----ELVDPSLAKCNRDEAAMCI---QLGLLCCQQSVAERPDMNSVHLMLSGDSFTL 365
             +    +L   SL +    E+ + I    L L        +  +  ++H  +  D + +
Sbjct: 403 DVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKV------KLENEYALHRSIV-DHYNI 455

Query: 366 PK 367
           PK
Sbjct: 456 PK 457

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 50.2 bits (119), Expect = 1e-06
 Identities = 61/400 (15%), Positives = 127/400 (31%), Gaps = 121/400 (30%)

Query: 21  HHHNHNHNLSVDEMNLKH----------FISNLFPC------LKTSLRGGRAAGESAEDA 64
           HHH+H+ +    E   ++          F+ N F C       K+ L        S E+ 
Sbjct: 1   HHHHHHMDFETGEHQYQYKDILSVFEDAFVDN-FDCKDVQDMPKSIL--------SKEEI 51

Query: 65  D---GSGAD---SWNLFFDLRTLQ--VATNFFSDLNQLGHGGF----------GPV---- 102
           D    S      +  LF+ L + Q  +   F  ++ ++ +  F           P     
Sbjct: 52  DHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINY-KFLMSPIKTEQRQPSMMTR 110

Query: 103 ----YRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG--------- 149
                R  + N  ++   K +V SR  L+ +    + LL+++    V + G         
Sbjct: 111 MYIEQRDRLYNDNQV-FAKYNV-SR--LQPYLKLRQALLELRPAKNVLIDGVLGSGKTWV 166

Query: 150 ----CCAEGPEKML---VYEYL-------PNKSLD-----YFIFDKTKSSSLDWTTRYRI 190
               C +   +  +   ++ +L       P   L+      +  D   +S  D ++  ++
Sbjct: 167 ALDVCLSYKVQCKMDFKIF-WLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKL 225

Query: 191 VMGVARGLLYLHEEAPARII-HRDIKASNILLDEQLNPKISD-FGL-AR-LFPGEDTHVN 246
            +   +  L        R++  +  +   ++L    N K  + F L  + L       V 
Sbjct: 226 RIHSIQAEL-------RRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVT 278

Query: 247 TFRISGTHGYMAPEYALHG------------YLSVKTD-----VFSYGVLVLEIVSGRKN 289
            F  + T  +++ ++                YL  +       V +     L I+     
Sbjct: 279 DFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSII----- 333

Query: 290 HDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDE 329
                 ++        W     +K   +++ SL      E
Sbjct: 334 --AESIRDGLATWDN-WKHVNCDKLTTIIESSLNVLEPAE 370

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 50.2 bits (119), Expect = 1e-06
 Identities = 52/382 (13%), Positives = 112/382 (29%), Gaps = 111/382 (29%)

Query: 90  DLNQLGHGGFGPVYRGLMPNGQEIAVKKLSV-DSRQGLRE-FTN-EVKLLLKIQHKNLVT 146
           +  +  +      Y+ ++   ++  V      D +   +   +  E+  ++  +     T
Sbjct: 10  ETGEHQYQ-----YKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGT 64

Query: 147 --LFGCCAEGPEKMLVYEYLPNKSL--DY-FIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
             LF       E+M V +++  + L  +Y F+            T  R            
Sbjct: 65  LRLFWTLLSKQEEM-VQKFV-EEVLRINYKFLMSP-------IKTEQR------------ 103

Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEY 261
               P+ +    I+  + L ++  N   + + ++RL P         R            
Sbjct: 104 ---QPSMMTRMYIEQRDRLYND--NQVFAKYNVSRLQP-----YLKLRQ----------- 142

Query: 262 ALHGYLSVKTDVFSYG-------VLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKA 314
           AL   L    +V   G        + L++         ++ + K D   + W        
Sbjct: 143 ALLE-LRPAKNVLIDGVLGSGKTWVALDVCL-----SYKV-QCKMDFKIF-WL------- 187

Query: 315 LELVDPSLAKCNRDEAAMCIQLGLLCCQ--QSVAERPDMNSVHLMLSGDSFTLPKPGKPG 372
                 +L  CN  E  +   L  L  Q   +   R D +S ++ L   S       +  
Sbjct: 188 ------NLKNCNSPETVL-EMLQKLLYQIDPNWTSRSD-HSSNIKLRIHSIQAEL--RRL 237

Query: 373 IQGRGGR---------WTTSTISAFTN------TNTNTTNTNTNASSSTNTGVTKISGGN 417
           ++ +                  +AF        T      T+   S++T T ++      
Sbjct: 238 LKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDF-LSAATTTHISLDHHSM 296

Query: 418 SFVEEYSRN------SISYSSL 433
           +   +  ++            L
Sbjct: 297 TLTPDEVKSLLLKYLDCRPQDL 318

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 43.9 bits (104), Expect = 6e-05
 Identities = 52/264 (19%), Positives = 86/264 (32%), Gaps = 79/264 (29%)

Query: 91  LNQLGHGGFGPVYRG--LMPNGQEIAVKKL-SVDS--RQGLREFTNEVKLLLKIQHK--- 142
           +  LG G FG V           ++A+K + +V         E    + +L KI+ K   
Sbjct: 24  VGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE----INVLKKIKEKDKE 79

Query: 143 ---NLVTLFGC-------CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVM 192
                V +          C       + +E L  K+  +    +             +  
Sbjct: 80  NKFLCVLMSDWFNFHGHMC-------IAFELL-GKNT-FEFLKENNFQPYPLPHVRHMAY 130

Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP-------------------KISDFG 233
            +   L +LHE    ++ H D+K  NIL                          +++DFG
Sbjct: 131 QLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187

Query: 234 LARLFPGEDTHVNTFRISGTHGYMAPEYAL-HGYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
            A     +  H  T  ++  H Y  PE  L  G+ +   DV+S G ++ E   G      
Sbjct: 188 SATF---DHEHHTTI-VATRH-YRPPEVILELGW-AQPCDVWSIGCILFEYYRG------ 235

Query: 293 RLGKEKADLLSYTWTLFQGEKALE 316
                        +TLFQ  +  E
Sbjct: 236 -------------FTLFQTHENRE 246

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 55/265 (20%), Positives = 91/265 (34%), Gaps = 79/265 (29%)

Query: 91  LNQLGHGGFGPVYRG--LMPNGQEIAVKKL-SVDS--RQGLREFTNEVKLLLKIQHK--- 142
           ++ LG G FG V         G+ +AVK + +VD        E    +++L  +      
Sbjct: 19  VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE----IQVLEHLNTTDPN 74

Query: 143 ---NLVTLFGC-------CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVM 192
                V +          C       +V+E L   S  Y    +            ++  
Sbjct: 75  STFRCVQMLEWFEHHGHIC-------IVFELL-GLST-YDFIKENGFLPFRLDHIRKMAY 125

Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP-------------------KISDFG 233
            + + + +LH     ++ H D+K  NIL  +                       K+ DFG
Sbjct: 126 QICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182

Query: 234 LARLFPGEDTHVNTFRISGTHGYMAPEYAL-HGYLSVKTDVFSYGVLVLEIVSGRKNHDG 292
            A     +D H +T  +S  H Y APE  L  G+ S   DV+S G +++E   G      
Sbjct: 183 SATY---DDEHHSTL-VSTRH-YRAPEVILALGW-SQPCDVWSIGCILIEYYLG------ 230

Query: 293 RLGKEKADLLSYTWTLFQGEKALEL 317
                        +T+F    + E 
Sbjct: 231 -------------FTVFPTHDSKEH 242

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 40.8 bits (96), Expect = 6e-04
 Identities = 58/268 (21%), Positives = 97/268 (36%), Gaps = 83/268 (30%)

Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVKKL-SVDS--RQGLREFTNEVKLLLKIQH----- 141
           + ++G G FG V     + N +  AVK + ++    R    E      +L KIQ+     
Sbjct: 40  IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE----ADILKKIQNDDINN 95

Query: 142 KNLVTLFGC-------CAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGV 194
            N+V   G        C       L++E L   SL Y I  +   +           + +
Sbjct: 96  NNIVKYHGKFMYYDHMC-------LIFEPL-GPSL-YEIITRNNYNGFHIEDIKLYCIEI 146

Query: 195 ARGLLYLHEEAPARIIHRDIKASNILLDEQLNP-------------------------KI 229
            + L YL +     + H D+K  NILLD+                             K+
Sbjct: 147 LKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203

Query: 230 SDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL-HGYLSVKTDVFSYGVLVLEIVSGRK 288
            DFG A     +  +  +  I+    Y APE  L  G+  V +D++S+G ++ E+ +G  
Sbjct: 204 IDFGCATF---KSDYHGSI-INTRQ-YRAPEVILNLGW-DVSSDMWSFGCVLAELYTG-- 255

Query: 289 NHDGRLGKEKADLLSYTWTLFQGEKALE 316
                              LF+  + +E
Sbjct: 256 -----------------SLLFRTHEHME 266

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	437
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.78
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.49
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.35
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.29
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.18
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	99.11
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.87
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.73
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.73
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.63
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.59
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.57
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.38
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.31
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.13
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.02
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.89
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.85
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.71
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.68
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.67
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.64
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.63
3mes_A	424	Choline kinase; malaria, structural genomics, stru	97.55
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.55
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.44
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.29
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.88
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.73
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	87.7
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	87.13
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	85.12

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.8e-60  Score=455.22  Aligned_cols=257  Identities=26%  Similarity=0.427  Sum_probs=215.1

Q ss_pred             cCccccceeccCCCeeEEEEEcC------CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      ++|.+.++||+|+||+||+|++.      ++..||||++........++|.+|+++|++|+|||||+++++|.+++..+|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            56889999999999999999853      478899999987777777889999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhcc----------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCcee
Q 013745          160 VYEYLPNKSLDYFIFDK----------TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKI  229 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~----------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl  229 (437)
                      |||||++|+|.++|...          .....++|..++.|+.||+.||+|||+++   ||||||||+||||++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            99999999999999643          23357999999999999999999999998   999999999999999999999


Q ss_pred             eecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhh
Q 013745          230 SDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTL  308 (437)
Q Consensus       230 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  308 (437)
                      +|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |+.||.+....+....+..    
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~----  245 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ----  245 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHH----
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc----
Confidence            99999987654443333334679999999999999999999999999999999998 8999987655433222111    


Q ss_pred             hcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          309 FQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       309 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                         +..        ...+...+.++.+|+.+||+.||++||||.+|+++|+.
T Consensus       246 ---~~~--------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~  286 (299)
T 4asz_A          246 ---GRV--------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQN  286 (299)
T ss_dssp             ---TCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCC--------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence               110        11122344568899999999999999999999999985

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.6e-59  Score=456.86  Aligned_cols=257  Identities=27%  Similarity=0.407  Sum_probs=208.0

Q ss_pred             cCccccceeccCCCeeEEEEEcC------CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      ++|.+.++||+|+||+||+|++.      +++.||||++........+.|.+|+++|++|+|||||+++++|.+.+..+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            56888899999999999999853      478899999987777777889999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccC------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCc
Q 013745          160 VYEYLPNKSLDYFIFDKT------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP  227 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~  227 (437)
                      |||||++|+|.+++....            ...+++|..++.|+.||+.||+|||+++   ||||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            999999999999986532            2356999999999999999999999988   9999999999999999999


Q ss_pred             eeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhh
Q 013745          228 KISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTW  306 (437)
Q Consensus       228 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~  306 (437)
                      ||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+....+....+..  
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~--  275 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ--  275 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH--
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc--
Confidence            9999999997755444433445679999999999999999999999999999999999 8999987655443222211  


Q ss_pred             hhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          307 TLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       307 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                           +..     +.   .+...+.++.+|+.+||+.||++||||.||++.|+.
T Consensus       276 -----g~~-----~~---~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~  316 (329)
T 4aoj_A          276 -----GRE-----LE---RPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA  316 (329)
T ss_dssp             -----TCC-----CC---CCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHH
T ss_pred             -----CCC-----CC---CcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence                 110     11   122334568899999999999999999999999985

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.2e-59  Score=453.53  Aligned_cols=257  Identities=27%  Similarity=0.444  Sum_probs=212.4

Q ss_pred             cCccccceeccCCCeeEEEEEc------CCCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM  158 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  158 (437)
                      .++++.++||+|+||+||+|.+      .+++.||||++... .....++|.+|+.+|++++|||||+++|+|.+.+..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            3467789999999999999985      25688999999754 2334578999999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCC
Q 013745          159 LVYEYLPNKSLDYFIFDKTK-------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL  225 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~  225 (437)
                      ||||||++|+|.++|..+..             ...++|..++.|+.|||.||+|||+++   ||||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence            99999999999999964321             246899999999999999999999998   99999999999999999


Q ss_pred             CceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhh
Q 013745          226 NPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSY  304 (437)
Q Consensus       226 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~  304 (437)
                      .+||+|||+|+.....+........+||+.|||||++.++.|+.++|||||||+||||+| |+.||.+....+....+. 
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~-  261 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR-  261 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH-
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-
Confidence            999999999987654433333335679999999999999999999999999999999998 899998766544322221 


Q ss_pred             hhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          305 TWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       305 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                           . +..        ...+...+..+.+|+.+||+.||++||||.||++.|+.
T Consensus       262 -----~-~~~--------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a  303 (308)
T 4gt4_A          262 -----N-RQV--------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRA  303 (308)
T ss_dssp             -----T-TCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             -----c-CCC--------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence                 1 111        11122345568899999999999999999999999984

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=6.8e-59  Score=447.01  Aligned_cols=258  Identities=27%  Similarity=0.406  Sum_probs=205.1

Q ss_pred             hcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      .++|.+.++||+|+||+||+|+++  ..||||+++..  .....+.|.+|+.+|++++|||||++++++.+ +.++||||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            356888999999999999999874  36999998743  34556789999999999999999999999865 56899999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      ||+||+|.++|...  ...+++..++.|+.|||.||+|||+++   ||||||||+||||++++.+||+|||+|+......
T Consensus       112 y~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          112 WCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             CCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             cCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            99999999998533  356999999999999999999999988   9999999999999999999999999998765443


Q ss_pred             cccceeeeecccccCChhhhcc---CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          243 THVNTFRISGTHGYMAPEYALH---GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                      ........+||+.|||||++.+   +.|+.++|||||||+||||+||+.||.+..........      ...    ....
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~------~~~----~~~~  256 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM------VGR----GYAS  256 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH------HHT----TCCC
T ss_pred             cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHH------Hhc----CCCC
Confidence            3333445689999999999974   35899999999999999999999999875543221110      000    1112


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      |.+...+...+..+.+|+.+||+.+|++||||.||++.|+.
T Consensus       257 p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~  297 (307)
T 3omv_A          257 PDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL  297 (307)
T ss_dssp             CCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred             CCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            22333334455678899999999999999999999988764

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.1e-59  Score=455.96  Aligned_cols=254  Identities=21%  Similarity=0.307  Sum_probs=206.0

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      ++|++++.||+|+||+||+|+. .+|+.||||++...  .....+.+.+|+++|++|+|||||+++++|.+++.+|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            5799999999999999999984 47999999999754  34456789999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      ||+||+|.++|... ....+++..++.|+.||+.||+|||+++   ||||||||+||||+.+|.+||+|||+|+.+....
T Consensus       104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            99999999998543 3456899999999999999999999998   9999999999999999999999999998764321


Q ss_pred             cccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccc
Q 013745          243 THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL  322 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  322 (437)
                        ......+||+.|||||++.+..|+.++|||||||+||||+||+.||.+....+....+      ....         .
T Consensus       180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i------~~~~---------~  242 (350)
T 4b9d_A          180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI------ISGS---------F  242 (350)
T ss_dssp             --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH------HHTC---------C
T ss_pred             --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH------HcCC---------C
Confidence              1122467999999999999999999999999999999999999999876543322211      1110         0


Q ss_pred             cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          323 AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       323 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                      ...+...+.++.+|+.+||+.||++|||+.|+++  ++..
T Consensus       243 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          243 PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence            1112233456889999999999999999999985  4543

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.4e-58  Score=449.00  Aligned_cols=249  Identities=24%  Similarity=0.344  Sum_probs=209.2

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      ..|+++++||+|+||+||+|+. .+|+.||||++........+.+.+|+.+|++++|||||+++++|.+++.+|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            4699999999999999999985 479999999997654444466889999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      +||+|.+++..    ..+++..+..|+.||+.||+|||+++   ||||||||+||||+.+|.+||+|||+|+.+......
T Consensus       154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  226 (346)
T 4fih_A          154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  226 (346)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred             CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence            99999998843    45999999999999999999999998   999999999999999999999999999987544332


Q ss_pred             cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccC
Q 013745          245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK  324 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  324 (437)
                        ....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+....+....+..            ...+.+ .
T Consensus       227 --~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~------------~~~~~~-~  291 (346)
T 4fih_A          227 --RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD------------NLPPRL-K  291 (346)
T ss_dssp             --BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH------------SSCCCC-S
T ss_pred             --ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc------------CCCCCC-C
Confidence              2346899999999999999999999999999999999999999987554333222111            001111 1


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          325 CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       325 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .....+.++.+|+.+||+.||++|||+.|+++
T Consensus       292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11233456788999999999999999999875

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=3.8e-58  Score=441.21  Aligned_cols=248  Identities=22%  Similarity=0.277  Sum_probs=209.7

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ++|++++.||+|+||+||+|+. .+|+.||||++.+.   .....+.+.+|+++|++|+|||||+++++|.+++.+||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5799999999999999999984 57999999999753   2233567899999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      |||+||+|.+++...   +.+++..+..|+.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.+...
T Consensus       112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            999999999998543   56999999999999999999999998   999999999999999999999999999987654


Q ss_pred             CcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                      .........+||+.|||||++.+..|+.++|||||||+||||++|+.||.+....+....+.      ...       ..
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~------~~~-------~~  252 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII------KLE-------YD  252 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HTC-------CC
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------cCC-------CC
Confidence            44444446789999999999999999999999999999999999999998765433322111      100       01


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVH  355 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~  355 (437)
                         .+...+.++.+|+.+||+.||++|||+.|++
T Consensus       253 ---~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          253 ---FPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             ---CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             ---CCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence               1112344578899999999999999999863

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.3e-57  Score=450.68  Aligned_cols=249  Identities=24%  Similarity=0.344  Sum_probs=209.6

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      +.|+++++||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++|+|||||+++++|.+.+.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            5699999999999999999985 479999999997655444567889999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      +||+|.+++..    ..+++..+..|+.||+.||+|||+++   ||||||||+||||+.+|.+||+|||+|+.+......
T Consensus       231 ~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~  303 (423)
T 4fie_A          231 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR  303 (423)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred             CCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence            99999998843    35899999999999999999999998   999999999999999999999999999987544332


Q ss_pred             cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccC
Q 013745          245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK  324 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  324 (437)
                        ....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+....+....+..            ...+.+ .
T Consensus       304 --~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~------------~~~~~~-~  368 (423)
T 4fie_A          304 --RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD------------NLPPRL-K  368 (423)
T ss_dssp             --BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH------------SCCCCC-S
T ss_pred             --ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc------------CCCCCC-c
Confidence              2357899999999999999999999999999999999999999987554333222211            011111 1


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          325 CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       325 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .....+..+.+|+.+||+.||++|||+.|+++
T Consensus       369 ~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          369 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11223456788999999999999999999875

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.6e-57  Score=438.58  Aligned_cols=250  Identities=23%  Similarity=0.289  Sum_probs=204.7

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      +.|++.++||+|+||+||+|+. .+|+.||||++.....     ..+|+.+|++|+|||||+++++|.+++.+|||||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            5688899999999999999985 4799999999975432     236999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCC-CceeeecccccccCCCCc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL-NPKISDFGLARLFPGEDT  243 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~-~~kl~DFGla~~~~~~~~  243 (437)
                      +||+|.+++...   +.+++..++.|+.||+.||+|||+++   ||||||||+||||+.+| .+||+|||+|+.+.....
T Consensus       133 ~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          133 EGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             TTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             CCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            999999999543   46999999999999999999999998   99999999999999987 599999999998754322


Q ss_pred             cc---ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          244 HV---NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       244 ~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                      ..   ....++||+.|||||++.+..|+.++|||||||+||||+||+.||.+....+....+.      ...       +
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~------~~~-------~  273 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA------SEP-------P  273 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH------HSC-------C
T ss_pred             ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH------cCC-------C
Confidence            11   1224679999999999999999999999999999999999999998755433222111      111       1


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                      .+...++..+..+.+++.+||+.||++|||+.||++.|.
T Consensus       274 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~  312 (336)
T 4g3f_A          274 PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG  312 (336)
T ss_dssp             GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence            111223344566888999999999999999999988764

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.3e-56  Score=421.78  Aligned_cols=249  Identities=22%  Similarity=0.315  Sum_probs=193.2

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++....   ......+.+|+++|++++|||||++++++.+.+..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            6799999999999999999985 479999999997542   233567899999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      ||| +|+|.+++..   .+.+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.....
T Consensus        93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 6788888854   356999999999999999999999998   999999999999999999999999999876433


Q ss_pred             CcccceeeeecccccCChhhhccCcC-CcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYL-SVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                      ..   ....+||+.|||||++.+..+ +.++|||||||+||||+||+.||.+....+....+.      . ..      .
T Consensus       166 ~~---~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~------~-~~------~  229 (275)
T 3hyh_A          166 NF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNIS------N-GV------Y  229 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------H-TC------C
T ss_pred             Cc---cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH------c-CC------C
Confidence            22   224689999999999998765 689999999999999999999998754332221111      1 00      0


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                      .   .+...+.++.+++.+||+.||++|||+.|+++  +++.
T Consensus       230 ~---~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          230 T---LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             C---CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             C---CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence            1   11123456788999999999999999999986  5653

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.3e-56  Score=438.23  Aligned_cols=268  Identities=27%  Similarity=0.359  Sum_probs=217.3

Q ss_pred             ccHHHHHHHhcCccccceeccCCCeeEEEEEcC------CCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCC-Ccceee
Q 013745           76 FDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQH-KNLVTL  147 (437)
Q Consensus        76 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv~l  147 (437)
                      ++..+.+...++|++.+.||+|+||+||+|.+.      .++.||||++.... ....+.|.+|+++|.+++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            455566666788999999999999999999843      24689999997543 4446779999999999965 999999


Q ss_pred             eeeeccC-CceEEEEeecCCCCcchhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeec
Q 013745          148 FGCCAEG-PEKMLVYEYLPNKSLDYFIFDKT-------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRD  213 (437)
Q Consensus       148 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrD  213 (437)
                      +++|.+. ..++||||||++|+|.++|....             ....+++..++.|+.|||+||+|||+++   |||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence            9998664 56899999999999999996432             1345899999999999999999999998   99999


Q ss_pred             cCCCCEEecCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCC
Q 013745          214 IKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDG  292 (437)
Q Consensus       214 ikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~  292 (437)
                      |||+||||++++.+||+|||+|+.+............+||+.|||||++.++.|+.++|||||||+||||+| |+.||.+
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999998765554444445789999999999999999999999999999999998 9999987


Q ss_pred             CCchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          293 RLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ....+..  .    .....+..     +.   .+...+.++.+++.+||+.||++|||+.||++.|+.
T Consensus       291 ~~~~~~~--~----~~i~~g~~-----~~---~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~  344 (353)
T 4ase_A          291 VKIDEEF--C----RRLKEGTR-----MR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  344 (353)
T ss_dssp             CCCSHHH--H----HHHHHTCC-----CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCHHHHH--H----HHHHcCCC-----CC---CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence            5432211  1    11111111     11   112334568899999999999999999999998763

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4e-56  Score=424.65  Aligned_cols=247  Identities=23%  Similarity=0.325  Sum_probs=197.9

Q ss_pred             ccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeecc----CCceEEE
Q 013745           88 FSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE----GPEKMLV  160 (437)
Q Consensus        88 y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv  160 (437)
                      |++.++||+|+||+||+|.. .++..||||++...  .....+.|.+|+++|++|+|||||+++++|.+    +..+|||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            46778899999999999985 47899999999643  34456779999999999999999999999864    3567999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC-CCCceeeecccccccC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE-QLNPKISDFGLARLFP  239 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~-~~~~kl~DFGla~~~~  239 (437)
                      ||||+||+|.+++...   ..+++..++.|+.||+.||+|||+++ .+||||||||+||||+. +|.+||+|||+|+...
T Consensus       108 mEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            9999999999999543   56899999999999999999999986 35999999999999984 7999999999998653


Q ss_pred             CCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                      ..    .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||.+.......  ..    ....+..    .
T Consensus       184 ~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~--~~----~i~~~~~----~  248 (290)
T 3fpq_A          184 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YR----RVTSGVK----P  248 (290)
T ss_dssp             TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HH----HHTTTCC----C
T ss_pred             CC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHH--HH----HHHcCCC----C
Confidence            32    1235689999999998865 6999999999999999999999999764432211  11    1111100    0


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      +....   ..+.++.+|+.+||+.||++|||+.|+++
T Consensus       249 ~~~~~---~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          249 ASFDK---VAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             GGGGG---CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCc---cCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11111   12235788999999999999999999976

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.5e-55  Score=425.14  Aligned_cols=265  Identities=22%  Similarity=0.279  Sum_probs=200.5

Q ss_pred             cCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC----ceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP----EKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  161 (437)
                      ++|.+.++||+|+||+||+|++ +|+.||||++...... ...+..|+..+.+++|||||+++++|.+.+    .+||||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            4688889999999999999998 6899999999754332 123345666667889999999999997654    579999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA-----PARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----~~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                      |||++|+|.+++..    ..++|..+++++.|++.||+|||+++     ..+||||||||+||||+.++.+||+|||+|+
T Consensus        81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            99999999999943    35899999999999999999999872     2349999999999999999999999999998


Q ss_pred             ccCCCCccc--ceeeeecccccCChhhhccC------cCCcccceehhhHHHHHHHhCCCCCCCCCchhhh--h------
Q 013745          237 LFPGEDTHV--NTFRISGTHGYMAPEYALHG------YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKA--D------  300 (437)
Q Consensus       237 ~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~------~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~--~------  300 (437)
                      .........  .....+||+.|||||++.+.      .++.++|||||||+||||+||.+||.........  .      
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            775443221  22246799999999999764      4788999999999999999998887543221110  0      


Q ss_pred             hhhhhhhhhcccccccccCccccC--CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          301 LLSYTWTLFQGEKALELVDPSLAK--CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      .........    ....++|.++.  ...+....+.+|+.+||+.||++||||.||++.|+.
T Consensus       237 ~~~~~~~~~----~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  294 (303)
T 3hmm_A          237 SVEEMRKVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             CHHHHHHHH----TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             hHHHHHHHH----hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            001111111    11122333321  123566778999999999999999999999999874

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.7e-56  Score=429.49  Aligned_cols=247  Identities=24%  Similarity=0.298  Sum_probs=197.3

Q ss_pred             cCccccceeccCCCeeEEEEEc----CCCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM----PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      ++|++++.||+|+||+||+|+.    .+++.||||++....  ......+.+|+++|++++|||||+++++|.+.+.+||
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            5699999999999999999974    257899999996532  2223467889999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      |||||+||+|.+++...   +.+++..+..++.||+.||+|||+++   |+||||||+|||++.+|.+||+|||+|+...
T Consensus       104 vmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            99999999999998543   46999999999999999999999998   9999999999999999999999999998754


Q ss_pred             CCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                      .....  ....+||+.|||||++.+..|+.++|||||||+||||+||+.||.+....+....+.      ...       
T Consensus       178 ~~~~~--~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~------~~~-------  242 (304)
T 3ubd_A          178 DHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL------KAK-------  242 (304)
T ss_dssp             ---CC--CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCC-------
T ss_pred             CCCcc--ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHH------cCC-------
Confidence            33322  224689999999999999999999999999999999999999998765443322211      100       


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHH
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDM-----NSVHL  356 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~ev~~  356 (437)
                      .   ..+...+.++.+|+.+||+.||++|||+     +|+++
T Consensus       243 ~---~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          243 L---GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             C---CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             C---CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            0   1112234567889999999999999984     56653

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=4.2e-55  Score=420.59  Aligned_cols=255  Identities=22%  Similarity=0.338  Sum_probs=193.0

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC--------
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP--------  155 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  155 (437)
                      ++|++++.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|++|+|||||+++++|.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            4599999999999999999985 47999999999754 3444567899999999999999999999986544        


Q ss_pred             ----ceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeee
Q 013745          156 ----EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISD  231 (437)
Q Consensus       156 ----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~D  231 (437)
                          .+|+|||||++|+|.+++..+......++..++.|+.||+.||+|||+++   ||||||||+||||+.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence                36899999999999999965544445667778999999999999999998   99999999999999999999999


Q ss_pred             cccccccCCCCccc----------ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhh
Q 013745          232 FGLARLFPGEDTHV----------NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADL  301 (437)
Q Consensus       232 FGla~~~~~~~~~~----------~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~  301 (437)
                      ||+|+.+.......          .....+||+.|||||++.+..|+.++|||||||+||||++   ||....  +....
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~~  236 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ERVRT  236 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHHH
Confidence            99999875432211          1123579999999999999999999999999999999996   775321  11111


Q ss_pred             hhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          302 LSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       302 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                      +.   ... ..        ..+.........+.+++.+||+.||++|||+.|+++  ++++
T Consensus       237 ~~---~~~-~~--------~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~  285 (299)
T 4g31_A          237 LT---DVR-NL--------KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED  285 (299)
T ss_dssp             HH---HHH-TT--------CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred             HH---HHh-cC--------CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence            11   110 00        011111233445678999999999999999999986  5654

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-52  Score=418.63  Aligned_cols=268  Identities=21%  Similarity=0.285  Sum_probs=206.4

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeecc------CC
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE------GP  155 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~  155 (437)
                      .++|++++.||+|+||+||+|+. .+|+.||||++...  .....+.+.+|+++|++|+|||||++++++..      .+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            36799999999999999999985 47999999999754  34445678899999999999999999998753      46


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccc
Q 013745          156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA  235 (437)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  235 (437)
                      .+|||||||+ |+|.+++.   ..+.+++..+..|+.||+.||.|||+++   ||||||||+|||++.+|.+||+|||+|
T Consensus       133 ~~~ivmE~~~-g~L~~~i~---~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla  205 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIH---SSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA  205 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHT---SSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEEeCCC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence            7899999995 67888883   3467999999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCc--ccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccc
Q 013745          236 RLFPGEDT--HVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGE  312 (437)
Q Consensus       236 ~~~~~~~~--~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  312 (437)
                      +.+.....  .......+||+.|||||++.+. .++.++||||+|||+|||++|++||.+....+....+..........
T Consensus       206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~  285 (398)
T 4b99_A          206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA  285 (398)
T ss_dssp             BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence            87643221  1222356899999999998875 67999999999999999999999999876555443332221111100


Q ss_pred             ccc-----------cccCcc----ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--Hhc
Q 013745          313 KAL-----------ELVDPS----LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLS  359 (437)
Q Consensus       313 ~~~-----------~~~d~~----l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~  359 (437)
                      ...           ..+.+.    +....+....++.+|+.+||+.||++|||+.|+++  ++.
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~  349 (398)
T 4b99_A          286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLA  349 (398)
T ss_dssp             GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGT
T ss_pred             HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhC
Confidence            000           000000    00011123456789999999999999999999875  454

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.8e-51  Score=404.20  Aligned_cols=200  Identities=25%  Similarity=0.377  Sum_probs=171.7

Q ss_pred             HhcCccccceeccCCCeeEEEEEc----CCCcEEEEEEeccCChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCceE
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM----PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKM  158 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  158 (437)
                      ..++|++.++||+|+||+||+|+.    .+++.||||++.....  ...+.+|+++|+.+ +|||||+++++|.+.+..|
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            467899999999999999999974    2578899999865433  35678999999998 6999999999999999999


Q ss_pred             EEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCC-CCceeeecccccc
Q 013745          159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ-LNPKISDFGLARL  237 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~-~~~kl~DFGla~~  237 (437)
                      ||||||++|+|.+++      ..+++..+..++.||+.||+|||+++   |+||||||+|||++.+ +.+||+|||+|+.
T Consensus        97 lvmE~~~g~~L~~~~------~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           97 IAMPYLEHESFLDIL------NSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             EEEECCCCCCHHHHH------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEeCCCcccHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            999999999999988      24899999999999999999999998   9999999999999876 7999999999986


Q ss_pred             cCCCCccc--------------------------ceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCC
Q 013745          238 FPGEDTHV--------------------------NTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNH  290 (437)
Q Consensus       238 ~~~~~~~~--------------------------~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~  290 (437)
                      ........                          .....+||+.|+|||++.+. .|+.++||||+|||+|||++|+.||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            54322110                          11235799999999999876 5899999999999999999999999


Q ss_pred             CCCC
Q 013745          291 DGRL  294 (437)
Q Consensus       291 ~~~~  294 (437)
                      ....
T Consensus       248 ~~~~  251 (361)
T 4f9c_A          248 YKAS  251 (361)
T ss_dssp             SCCS
T ss_pred             CCCC
Confidence            6543

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.5e-50  Score=393.17  Aligned_cols=278  Identities=36%  Similarity=0.628  Sum_probs=238.1

Q ss_pred             HHHHHhcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           80 TLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        80 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      ++...+++|++.+.||+|+||.||+|+..+++.||||++........+.+.+|+.++++++||||+++++++.+.+..++
T Consensus        33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  112 (321)
T 2qkw_B           33 DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL  112 (321)
T ss_dssp             CCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred             HHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            34446789999999999999999999987899999999987666667889999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccccc
Q 013745          160 VYEYLPNKSLDYFIFDKT-KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                      ||||+++|+|.+++.... ....+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  189 (321)
T 2qkw_B          113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKG  189 (321)
T ss_dssp             EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEEC
T ss_pred             EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccccccc
Confidence            999999999999985432 2236899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          239 PGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       239 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      .............||+.|+|||++.+..++.++|||||||++|||++|+.||......+......|.............+
T Consensus       190 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (321)
T 2qkw_B          190 TELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV  269 (321)
T ss_dssp             SSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSS
T ss_pred             ccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhc
Confidence            43333222334568999999999999999999999999999999999999998776666555566655555555555666


Q ss_pred             Cccc-cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          319 DPSL-AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       319 d~~l-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ++.+ .......+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  312 (321)
T 2qkw_B          270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY  312 (321)
T ss_dssp             SSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            6655 35567888999999999999999999999999999874

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=8.3e-51  Score=423.89  Aligned_cols=256  Identities=21%  Similarity=0.296  Sum_probs=213.6

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++........+.+.+|+.+|+.|+|||||+++++|.+...+||||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            36899999999999999999985 47999999999877666677899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCC--CCceeeecccccccCCC
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ--LNPKISDFGLARLFPGE  241 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~--~~~kl~DFGla~~~~~~  241 (437)
                      |+||+|.+++..  ....+++..+..++.||+.||.|||+++   |+||||||+|||++.+  +.+||+|||+|+.+...
T Consensus       236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            999999988843  3356999999999999999999999998   9999999999999854  89999999999987543


Q ss_pred             CcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                      ..   ....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+....+....+...      .  ....++.
T Consensus       311 ~~---~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~------~--~~~~~~~  379 (573)
T 3uto_A          311 QS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC------D--WNMDDSA  379 (573)
T ss_dssp             SE---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT------C--CCCCSGG
T ss_pred             Cc---eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhC------C--CCCCccc
Confidence            32   23568999999999999999999999999999999999999999876654433222110      0  0011111


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                      ..    ..+..+.+|+.+||+.||++||++.|+++  +|..
T Consensus       380 ~~----~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~  416 (573)
T 3uto_A          380 FS----GISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTP  416 (573)
T ss_dssp             GT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSC
T ss_pred             cc----CCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCC
Confidence            11    22345778999999999999999999987  5543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.6e-50  Score=421.15  Aligned_cols=253  Identities=24%  Similarity=0.268  Sum_probs=202.8

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC------hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCce
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS------RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK  157 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  157 (437)
                      -++|+++++||+|+||+||+|+. .+|+.||||++.+..      .........++.+++.++|||||+++++|.+.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            36799999999999999999984 479999999996431      11122233446777788999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                      |||||||+||+|..+|...   +.+++..+..|+.||+.||+|||+++   ||||||||+||||+.+|.+||+|||+|+.
T Consensus       268 ylVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence            9999999999999998543   56999999999999999999999998   99999999999999999999999999998


Q ss_pred             cCCCCcccceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccc
Q 013745          238 FPGEDTHVNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE  316 (437)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (437)
                      +.....    ...+||+.|||||++.. ..|+.++|||||||+||||++|++||.+....+...+......   .     
T Consensus       342 ~~~~~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~---~-----  409 (689)
T 3v5w_A          342 FSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT---M-----  409 (689)
T ss_dssp             CSSCCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH---C-----
T ss_pred             cCCCCC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC---C-----
Confidence            754332    24689999999999975 5799999999999999999999999976443332221111111   0     


Q ss_pred             ccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH--HhcC
Q 013745          317 LVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPD-----MNSVHL--MLSG  360 (437)
Q Consensus       317 ~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~--~L~~  360 (437)
                        ..   ..+...+.++.+|+.+||+.||.+|++     +.||++  ++++
T Consensus       410 --~~---~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~  455 (689)
T 3v5w_A          410 --AV---ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  455 (689)
T ss_dssp             --CC---CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred             --CC---CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence              00   112234456789999999999999998     688764  4444

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=8e-51  Score=393.55  Aligned_cols=260  Identities=26%  Similarity=0.414  Sum_probs=204.9

Q ss_pred             HhcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ..++|++.+.||+|+||.||+|.. +|+.||||++...  .....+.+.+|++++++++||||+++++++.+....++||
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            356799999999999999999987 6889999999754  3445577899999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      ||+++++|.+++........+++..++.++.||+.||+|||+++ .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~  192 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST  192 (309)
T ss_dssp             ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred             ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence            99999999999854332334899999999999999999999976 34999999999999999999999999999865432


Q ss_pred             CcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                      ..  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+..     .. .        
T Consensus       193 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~-----~~-~--------  256 (309)
T 3p86_A          193 FL--SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF-----KC-K--------  256 (309)
T ss_dssp             -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHH-----SC-C--------
T ss_pred             cc--ccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-----cC-C--------
Confidence            21  12245799999999999999999999999999999999999999987554332221110     00 0        


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCC
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD  361 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~  361 (437)
                      ....+...+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus       257 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~  296 (309)
T 3p86_A          257 RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL  296 (309)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            0111223345688999999999999999999999998854

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=8.3e-50  Score=388.51  Aligned_cols=289  Identities=43%  Similarity=0.718  Sum_probs=239.3

Q ss_pred             ccccHHHHHHHhcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCCh-HHHHHHHHHHHHHHcCCCCcceeeeeeec
Q 013745           74 LFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR-QGLREFTNEVKLLLKIQHKNLVTLFGCCA  152 (437)
Q Consensus        74 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~  152 (437)
                      ..|+..++....++|++.+.||+|+||.||+|...+++.||||++..... .....+.+|+.++++++||||+++++++.
T Consensus        18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   97 (326)
T 3uim_A           18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM   97 (326)
T ss_dssp             EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred             ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence            46788999999999999999999999999999987899999999975432 22236889999999999999999999999


Q ss_pred             cCCceEEEEeecCCCCcchhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeee
Q 013745          153 EGPEKMLVYEYLPNKSLDYFIFDKT-KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISD  231 (437)
Q Consensus       153 ~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~D  231 (437)
                      .....++||||+++|+|.+++.... ....+++..++.++.|++.||.|||++...+|+||||||+|||++.++.+||+|
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D  177 (326)
T 3uim_A           98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD  177 (326)
T ss_dssp             CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred             cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence            9999999999999999999986543 334599999999999999999999999222399999999999999999999999


Q ss_pred             cccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCC--chhhhhhhhhhhhhh
Q 013745          232 FGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRL--GKEKADLLSYTWTLF  309 (437)
Q Consensus       232 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~--~~~~~~~~~~~~~~~  309 (437)
                      ||+++......... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....  .........|.....
T Consensus       178 fg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  256 (326)
T 3uim_A          178 FGLAKLMDYKDTHV-TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL  256 (326)
T ss_dssp             CSSCEECCSSSSCE-ECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred             CccccccCcccccc-cccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence            99998775443322 224569999999999999999999999999999999999999996321  112223344555555


Q ss_pred             cccccccccCccc-cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCCCC
Q 013745          310 QGEKALELVDPSL-AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSF  363 (437)
Q Consensus       310 ~~~~~~~~~d~~l-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~  363 (437)
                      .........+..+ ..........+.+++.+||+.+|.+|||+.+|++.|++...
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  311 (326)
T 3uim_A          257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL  311 (326)
T ss_dssp             SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred             hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence            5555555555554 35677888999999999999999999999999999997654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=9.5e-49  Score=388.48  Aligned_cols=258  Identities=26%  Similarity=0.374  Sum_probs=212.1

Q ss_pred             hcCccccceeccCCCeeEEEEEc--------CCCcEEEEEEeccC-ChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccC
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM--------PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEG  154 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  154 (437)
                      .++|++.+.||+|+||.||+|..        .++..||||++... .....+.+.+|+.+++++ +||||++++++|.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            46799999999999999999974        24567999999755 344567899999999999 899999999999999


Q ss_pred             CceEEEEeecCCCCcchhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEe
Q 013745          155 PEKMLVYEYLPNKSLDYFIFDKTK-------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL  221 (437)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll  221 (437)
                      +..|+||||+++|+|.+++.....             ...+++..++.++.||+.||+|||+++   |+||||||+||||
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            999999999999999999865431             245899999999999999999999998   9999999999999


Q ss_pred             cCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhh
Q 013745          222 DEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKAD  300 (437)
Q Consensus       222 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~  300 (437)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+...
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~  316 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK  316 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            9999999999999987654433333333457889999999999999999999999999999999 999998754433221


Q ss_pred             hhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          301 LLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      .+.       ....        ...+...+..+.+++.+||+.+|++||++.||++.|+.
T Consensus       317 ~~~-------~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~  361 (370)
T 2psq_A          317 LLK-------EGHR--------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  361 (370)
T ss_dssp             HHH-------TTCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHh-------cCCC--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            111       0100        01122334568899999999999999999999999874

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.9e-49  Score=385.98  Aligned_cols=267  Identities=26%  Similarity=0.356  Sum_probs=207.6

Q ss_pred             hcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC----ceEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP----EKMLV  160 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv  160 (437)
                      .++|++.+.||+|+||.||+|+. .++.||||++...... ...+.+|+.++++++||||+++++++....    ..++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            46799999999999999999987 4799999999755433 345667999999999999999999998754    36999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhc----------CCCceEeeccCCCCEEecCCCCceee
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE----------APARIIHRDIKASNILLDEQLNPKIS  230 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----------~~~~iiHrDikp~NIll~~~~~~kl~  230 (437)
                      |||+++|+|.+++..    ..+++..++.++.|++.||+|||+.          +   |+||||||+|||++.++.+||+
T Consensus       101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A          101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred             EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence            999999999999843    3489999999999999999999998          6   9999999999999999999999


Q ss_pred             ecccccccCCCCcccceeeeecccccCChhhhcc-----CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhh
Q 013745          231 DFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH-----GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYT  305 (437)
Q Consensus       231 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~  305 (437)
                      |||+++.+.............||+.|+|||++.+     ..++.++|||||||++|||++|+.||.+.............
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            9999987765443333334679999999999987     35677899999999999999999999865432221111100


Q ss_pred             hhhhccc-----ccccccCccccC--CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          306 WTLFQGE-----KALELVDPSLAK--CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       306 ~~~~~~~-----~~~~~~d~~l~~--~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      .......     .......+.+..  .....+..+.+++.+||+.||++|||+.+|++.|+.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  315 (322)
T 3soc_A          254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ  315 (322)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            0000000     000111111111  122456779999999999999999999999999874

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.4e-47  Score=366.79  Aligned_cols=280  Identities=35%  Similarity=0.562  Sum_probs=232.0

Q ss_pred             ccccHHHHHHHhcCcccc------ceeccCCCeeEEEEEcCCCcEEEEEEeccC----ChHHHHHHHHHHHHHHcCCCCc
Q 013745           74 LFFDLRTLQVATNFFSDL------NQLGHGGFGPVYRGLMPNGQEIAVKKLSVD----SRQGLREFTNEVKLLLKIQHKN  143 (437)
Q Consensus        74 ~~~~~~~~~~~~~~y~~~------~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~n  143 (437)
                      ..|++.++..++++|...      +.||+|+||.||+|.. +++.||||++...    .....+.+.+|+.++++++|||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            457888999999988877      8999999999999987 6889999998643    2334577899999999999999


Q ss_pred             ceeeeeeeccCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC
Q 013745          144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE  223 (437)
Q Consensus       144 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~  223 (437)
                      |+++++++.+.+..++||||+++++|.+++........+++..++.++.||+.||.|||+++   |+||||||+|||++.
T Consensus        92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~  168 (307)
T 2nru_A           92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDE  168 (307)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECT
T ss_pred             eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcC
Confidence            99999999999999999999999999999865555567999999999999999999999998   999999999999999


Q ss_pred             CCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhh
Q 013745          224 QLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS  303 (437)
Q Consensus       224 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~  303 (437)
                      ++.+||+|||+++...............||+.|+|||++.+ .++.++|||||||++|+|++|+.||..........  .
T Consensus       169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~  245 (307)
T 2nru_A          169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL--D  245 (307)
T ss_dssp             TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT--H
T ss_pred             CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH--H
Confidence            99999999999987654433333334578999999998865 57999999999999999999999998654332211  1


Q ss_pred             hhhhhhc-ccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          304 YTWTLFQ-GEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       304 ~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      +...... .....+.+++.+.......+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~  303 (307)
T 2nru_A          246 IKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE  303 (307)
T ss_dssp             HHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             HHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            1111111 12233445555666777888999999999999999999999999999975

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=9.8e-48  Score=371.40  Aligned_cols=259  Identities=26%  Similarity=0.427  Sum_probs=211.7

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      .++|.+.+.||+|+||.||+|.. .+++.||+|++........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            46799999999999999999985 47899999999777777778899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +++++|.+++...  ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            9999999998542  356999999999999999999999998   99999999999999999999999999987654332


Q ss_pred             ccc------------eeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcc
Q 013745          244 HVN------------TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQG  311 (437)
Q Consensus       244 ~~~------------~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  311 (437)
                      ...            .....||+.|+|||++.+..++.++|||||||++|||++|..||...............      
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~------  237 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR------  237 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHH------
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhh------
Confidence            211            11356999999999999999999999999999999999999998754332211100000      


Q ss_pred             cccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCC
Q 013745          312 EKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD  361 (437)
Q Consensus       312 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~  361 (437)
                          ...+.   ..+...+..+.+++.+||+.+|++||++.+|+++|+..
T Consensus       238 ----~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l  280 (310)
T 3s95_A          238 ----GFLDR---YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL  280 (310)
T ss_dssp             ----HHHHH---TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----ccccc---cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                00000   11122334578899999999999999999999999853

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5.7e-48  Score=371.35  Aligned_cols=250  Identities=24%  Similarity=0.384  Sum_probs=207.7

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      .++|++.+.||+|+||.||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            45799999999999999999984 57999999999765444457788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +++++|.+++..    ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++........
T Consensus        99 ~~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            999999999843    35899999999999999999999998   99999999999999999999999999987654433


Q ss_pred             ccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcccc
Q 013745          244 HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA  323 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  323 (437)
                      .  .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.      .... ...      
T Consensus       172 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~------~~~~-~~~------  236 (297)
T 3fxz_A          172 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA------TNGT-PEL------  236 (297)
T ss_dssp             C--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH------HHCS-CCC------
T ss_pred             c--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hCCC-CCC------
Confidence            2  224579999999999999999999999999999999999999997654432221111      0000 000      


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       324 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ..+...+..+.+++.+||+.||++||++.|+++
T Consensus       237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            111233455788999999999999999999975

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-48  Score=386.68  Aligned_cols=260  Identities=27%  Similarity=0.356  Sum_probs=213.6

Q ss_pred             HhcCccccceeccCCCeeEEEEEc--------CCCcEEEEEEeccC-ChHHHHHHHHHHHHHHcC-CCCcceeeeeeecc
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM--------PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAE  153 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  153 (437)
                      ..++|.+.+.||+|+||.||+|..        ..+..||||++... .......+.+|+++++++ +||||+++++++.+
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            356899999999999999999984        23467999999754 345567899999999999 89999999999999


Q ss_pred             CCceEEEEeecCCCCcchhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEE
Q 013745          154 GPEKMLVYEYLPNKSLDYFIFDKTK-------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNIL  220 (437)
Q Consensus       154 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIl  220 (437)
                      .+..++||||+++|+|.+++.....             ...+++..++.++.||+.||+|||+++   |+||||||+|||
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl  223 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL  223 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence            9999999999999999999865431             245899999999999999999999998   999999999999


Q ss_pred             ecCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhh
Q 013745          221 LDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKA  299 (437)
Q Consensus       221 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~  299 (437)
                      |+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....+..
T Consensus       224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~  303 (382)
T 3tt0_A          224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF  303 (382)
T ss_dssp             ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred             EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999999987755443333334567899999999999999999999999999999999 99999865543322


Q ss_pred             hhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCC
Q 013745          300 DLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD  361 (437)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~  361 (437)
                      ..+..       ...     .   ..+...+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus       304 ~~~~~-------~~~-----~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  350 (382)
T 3tt0_A          304 KLLKE-------GHR-----M---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  350 (382)
T ss_dssp             HHHHT-------TCC-----C---CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHc-------CCC-----C---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            21111       100     0   01112345688899999999999999999999999853

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.9e-47  Score=372.47  Aligned_cols=256  Identities=25%  Similarity=0.396  Sum_probs=208.7

Q ss_pred             hcCccccceeccCCCeeEEEEEcC----CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP----NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      .++|++.+.||+|+||.||+|.+.    .+..||||++... .....+.+.+|+.++++++||||+++++++.+....++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            467999999999999999999863    3456999999764 44556789999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      ||||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       128 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          128 VTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            9999999999999843  3356999999999999999999999998   9999999999999999999999999998875


Q ss_pred             CCCccc-ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccc
Q 013745          240 GEDTHV-NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALEL  317 (437)
Q Consensus       240 ~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (437)
                      ...... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+....           
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-----------  271 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY-----------  271 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTC-----------
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC-----------
Confidence            432221 1222346778999999999999999999999999999999 999998765443322211100           


Q ss_pred             cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          318 VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       318 ~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                       .   ...+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       272 -~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~  310 (325)
T 3kul_A          272 -R---LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDA  310 (325)
T ss_dssp             -C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -C---CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence             0   01112334568899999999999999999999999985

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=4e-47  Score=369.88  Aligned_cols=253  Identities=24%  Similarity=0.318  Sum_probs=202.7

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      .++|++.+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            367999999999999999999854 78999999996543 2234568899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |+++++|.+++.   ....+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+....
T Consensus        86 ~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCCcHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            999999999883   3456999999999999999999999998   9999999999999999999999999998764333


Q ss_pred             cccceeeeecccccCChhhhccCcC-CcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          243 THVNTFRISGTHGYMAPEYALHGYL-SVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                      .........||+.|+|||++.+..+ +.++|||||||++|||++|+.||......... ...+...    ..    ..+.
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~----~~----~~~~  230 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEK----KT----YLNP  230 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHHTT----CT----TSTT
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHhcc----cc----cCCc
Confidence            3322334679999999999987765 78999999999999999999999765432211 1111000    00    0000


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                          .......+.+++.+||+.||++|||+.|+++
T Consensus       231 ----~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          231 ----WKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             ----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----cccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence                1123345778999999999999999999864

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2e-47  Score=372.75  Aligned_cols=247  Identities=24%  Similarity=0.360  Sum_probs=206.7

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++...  .....+.+.+|+++++.++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            46799999999999999999985 58999999999654  4455677899999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      ||+++++|.+++...   +.+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        94 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           94 EYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             CCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             ECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            999999999998543   45899999999999999999999998   999999999999999999999999999876543


Q ss_pred             CcccceeeeecccccCChhhhccCcCC-cccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYLS-VKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                      ..   ....+||+.|+|||++.+..+. .++|||||||++|||++|+.||.+....+....+.      ...       .
T Consensus       168 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~------~~~-------~  231 (328)
T 3fe3_A          168 GK---LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL------RGK-------Y  231 (328)
T ss_dssp             CG---GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCC-------C
T ss_pred             Cc---cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH------hCC-------C
Confidence            32   2245799999999999988764 89999999999999999999998765433222111      100       0


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                         ..+...+..+.+++.+||+.||.+|||+.|+++
T Consensus       232 ---~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          232 ---RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             ---CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             ---CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence               111123455788999999999999999999975

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=9.3e-48  Score=378.37  Aligned_cols=252  Identities=22%  Similarity=0.290  Sum_probs=190.7

Q ss_pred             HHhcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           83 VATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        83 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ...++|++.+.||+|+||.||+|+.. +++.||||++....  ..+.+.+|+.++++++||||+++++++.+....++||
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  127 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL  127 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence            34678999999999999999999964 68899999997543  2356789999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC---CCCceeeeccccccc
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE---QLNPKISDFGLARLF  238 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~---~~~~kl~DFGla~~~  238 (437)
                      ||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||+++..
T Consensus       128 e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~  201 (349)
T 2w4o_A          128 ELVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV  201 (349)
T ss_dssp             CCCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred             EeCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence            99999999998843   356899999999999999999999998   999999999999975   889999999999876


Q ss_pred             CCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          239 PGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       239 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      .....   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ..   ......  ....
T Consensus       202 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~---~i~~~~--~~~~  271 (349)
T 2w4o_A          202 EHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM--FR---RILNCE--YYFI  271 (349)
T ss_dssp             --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH--HH---HHHTTC--CCCC
T ss_pred             Ccccc---cccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH--HH---HHHhCC--CccC
Confidence            43321   22457899999999999999999999999999999999999999765433211  11   111100  0011


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .    ......+..+.+++.+||+.||++||++.++++
T Consensus       272 ~----~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          272 S----PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             T----TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C----chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1    111233456789999999999999999999976

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.5e-47  Score=378.61  Aligned_cols=250  Identities=25%  Similarity=0.325  Sum_probs=200.6

Q ss_pred             cceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCCCCc
Q 013745           91 LNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSL  169 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  169 (437)
                      .+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++.+.+..+|||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            56899999999999984 47899999999877666678899999999999999999999999999999999999999999


Q ss_pred             chhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEe--cCCCCceeeecccccccCCCCcccce
Q 013745          170 DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL--DEQLNPKISDFGLARLFPGEDTHVNT  247 (437)
Q Consensus       170 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll--~~~~~~kl~DFGla~~~~~~~~~~~~  247 (437)
                      .+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||+  +.++.+||+|||+++.+......   
T Consensus       174 ~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~---  245 (373)
T 2x4f_A          174 FDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL---  245 (373)
T ss_dssp             HHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC---
T ss_pred             HHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc---
Confidence            8887532  346899999999999999999999998   9999999999999  56788999999999987543322   


Q ss_pred             eeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCH
Q 013745          248 FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNR  327 (437)
Q Consensus       248 ~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  327 (437)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+.      ...  .........    
T Consensus       246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~------~~~--~~~~~~~~~----  313 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNIL------ACR--WDLEDEEFQ----  313 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------HTC--CCSCSGGGT----
T ss_pred             ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hcc--CCCChhhhc----
Confidence            23469999999999999999999999999999999999999998765433222111      000  000111111    


Q ss_pred             HHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          328 DEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       328 ~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                      ..+..+.+++.+||+.+|.+||++.|+++  ++..
T Consensus       314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~  348 (373)
T 2x4f_A          314 DISEEAKEFISKLLIKEKSWRISASEALKHPWLSD  348 (373)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred             cCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence            23456788999999999999999999987  5553

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.7e-47  Score=368.96  Aligned_cols=247  Identities=23%  Similarity=0.267  Sum_probs=194.8

Q ss_pred             HHhcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCceE
Q 013745           83 VATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKM  158 (437)
Q Consensus        83 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  158 (437)
                      ...++|++.++||+|+||+||+|+.. +|+.||||++...  .......+..|+..+.++ +||||++++++|.+++..+
T Consensus        54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~  133 (311)
T 3p1a_A           54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY  133 (311)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence            34578999999999999999999865 7999999998643  333344556666666555 8999999999999999999


Q ss_pred             EEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccccc
Q 013745          159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                      +||||+ +++|.+++...  ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus       134 lv~e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~  207 (311)
T 3p1a_A          134 LQTELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVEL  207 (311)
T ss_dssp             EEEECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred             EEEecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeec
Confidence            999999 67888887543  346999999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          239 PGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       239 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      .....   .....||+.|+|||++.+ .++.++|||||||++|||++|..|+......          .......    .
T Consensus       208 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~----------~~~~~~~----~  269 (311)
T 3p1a_A          208 GTAGA---GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW----------QQLRQGY----L  269 (311)
T ss_dssp             C---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH----------HHHTTTC----C
T ss_pred             ccCCC---CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH----------HHHhccC----C
Confidence            54322   223568999999998876 7899999999999999999998776542111          0011000    0


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .+.+.   ...+..+.+++.+||+.+|++|||+.|+++
T Consensus       270 ~~~~~---~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          270 PPEFT---AGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             CHHHH---TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             Ccccc---cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            11111   123456889999999999999999999986

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.1e-47  Score=381.79  Aligned_cols=256  Identities=25%  Similarity=0.343  Sum_probs=209.8

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      .++|++.+.||+|+||.||+|.+. +++.||||++... .......+.+|+++|++++||||+++++++...+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            467999999999999999999965 7899999998754 33444678899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |+++|+|.+++...  ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus       193 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          193 LVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             CCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred             cCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence            99999999998543  245899999999999999999999998   9999999999999999999999999998654322


Q ss_pred             cccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          243 THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                      .........+++.|+|||++.++.++.++|||||||++|||++ |..||.+....+....+..       +..     . 
T Consensus       268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~-------~~~-----~-  334 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK-------GGR-----L-  334 (377)
T ss_dssp             EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHT-------TCC-----C-
T ss_pred             eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------CCC-----C-
Confidence            2111112345788999999999999999999999999999998 9999987654433222111       000     0 


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                        ..+...+..+.+++.+||+.+|++|||+.+|++.|+.
T Consensus       335 --~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  371 (377)
T 3cbl_A          335 --PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS  371 (377)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence              1111234567889999999999999999999999874

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.5e-47  Score=372.71  Aligned_cols=258  Identities=26%  Similarity=0.376  Sum_probs=210.3

Q ss_pred             hcCccccceeccCCCeeEEEEEc--------CCCcEEEEEEeccC-ChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccC
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM--------PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEG  154 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~--------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  154 (437)
                      .++|++.+.||+|+||.||+|..        .++..||||++... .......+.+|+.+++++ +||||+++++++.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            46799999999999999999984        25678999999754 344567789999999999 899999999999999


Q ss_pred             CceEEEEeecCCCCcchhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEe
Q 013745          155 PEKMLVYEYLPNKSLDYFIFDKTK-------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL  221 (437)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll  221 (437)
                      +..++||||+++++|.+++.....             ...+++..++.++.||+.||.|||+++   |+||||||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence            999999999999999999865432             234899999999999999999999998   9999999999999


Q ss_pred             cCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhh
Q 013745          222 DEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKAD  300 (437)
Q Consensus       222 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~  300 (437)
                      +.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+...
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~  270 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK  270 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH
Confidence            9999999999999987765443333334457889999999999999999999999999999999 999998654433221


Q ss_pred             hhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          301 LLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      .+.   .    ...     .   ..+...+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       271 ~~~---~----~~~-----~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  315 (334)
T 2pvf_A          271 LLK---E----GHR-----M---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  315 (334)
T ss_dssp             HHH---H----TCC-----C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHh---c----CCC-----C---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            111   1    000     0   1112234568889999999999999999999999875

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3e-47  Score=360.43  Aligned_cols=254  Identities=26%  Similarity=0.423  Sum_probs=209.8

Q ss_pred             hcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      .++|++.+.||+|+||.||+|...+++.||||++...... .+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            4679999999999999999999878899999999765432 367889999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      ++++|.+++..  ....+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++........
T Consensus        88 ~~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  162 (269)
T 4hcu_A           88 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  162 (269)
T ss_dssp             TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             CCCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence            99999999843  3356899999999999999999999998   999999999999999999999999999876432211


Q ss_pred             cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCcccc
Q 013745          245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA  323 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  323 (437)
                       ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+...            ...   
T Consensus       163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~------------~~~---  226 (269)
T 4hcu_A          163 -SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG------------FRL---  226 (269)
T ss_dssp             -STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT------------CCC---
T ss_pred             -cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC------------ccC---
Confidence             1123446788999999999999999999999999999999 99999875543322211110            000   


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       324 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ..+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~  263 (269)
T 4hcu_A          227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE  263 (269)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHH
Confidence            0111224557889999999999999999999999874

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.1e-47  Score=375.16  Aligned_cols=268  Identities=27%  Similarity=0.373  Sum_probs=215.4

Q ss_pred             ccHHHHHHHhcCccccceeccCCCeeEEEEEc------CCCcEEEEEEeccC-ChHHHHHHHHHHHHHHcC-CCCcceee
Q 013745           76 FDLRTLQVATNFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTL  147 (437)
Q Consensus        76 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l  147 (437)
                      ++....+...++|++.+.||+|+||.||+|.+      .+++.||||++... .....+.+.+|++++.++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            45666667788999999999999999999972      35689999999764 344457799999999999 79999999


Q ss_pred             eeeeccCCc-eEEEEeecCCCCcchhhhccCC------------------------------------------------
Q 013745          148 FGCCAEGPE-KMLVYEYLPNKSLDYFIFDKTK------------------------------------------------  178 (437)
Q Consensus       148 ~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------  178 (437)
                      ++++.+.+. .++||||+++|+|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            999987654 8999999999999999865432                                                


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          179 ---------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       179 ---------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                                     ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                           122899999999999999999999998   99999999999999999999999999987654443


Q ss_pred             ccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCccc
Q 013745          244 HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL  322 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  322 (437)
                      ........||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+...  .    ......     ..  
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~--~----~~~~~~-----~~--  315 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC--R----RLKEGT-----RM--  315 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH--H----HHHHTC-----CC--
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH--H----HHHcCC-----CC--
Confidence            333345678999999999999999999999999999999998 999997654332111  0    000000     00  


Q ss_pred             cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          323 AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       323 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                       ..+...+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       316 -~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  352 (359)
T 3vhe_A          316 -RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  352 (359)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence             1111233568889999999999999999999999874

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.2e-46  Score=364.57  Aligned_cols=268  Identities=20%  Similarity=0.282  Sum_probs=205.8

Q ss_pred             hcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      .++|++++.||+|+||.||+|+..+|+.||||++....  ......+.+|++++++++||||+++++++.+....++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            46799999999999999999998789999999997542  2234678899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |+++ +|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus       100 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A          100 FMEK-DLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             CCSE-EHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             CCCC-CHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            9975 77776643  3356899999999999999999999998   9999999999999999999999999998765332


Q ss_pred             cccceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccc-------
Q 013745          243 THVNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKA-------  314 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------  314 (437)
                      ..  .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+............       
T Consensus       174 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          174 RS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP  251 (311)
T ss_dssp             C-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred             cc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence            22  223468999999999876 56899999999999999999999999876654433222111100000000       


Q ss_pred             ------ccccCc-cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          315 ------LELVDP-SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       315 ------~~~~d~-~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                            ...... ......+....++.+++.+||+.||++|||+.|+++  ++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  306 (311)
T 3niz_A          252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD  306 (311)
T ss_dssp             HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred             hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence                  000000 000111123456789999999999999999999986  5553

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.3e-46  Score=365.92  Aligned_cols=259  Identities=24%  Similarity=0.328  Sum_probs=211.8

Q ss_pred             ccHHHHHHHhc----------CccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcc
Q 013745           76 FDLRTLQVATN----------FFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL  144 (437)
Q Consensus        76 ~~~~~~~~~~~----------~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni  144 (437)
                      |+..++..+++          .|+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||||
T Consensus        25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni  104 (321)
T 2c30_A           25 VTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNV  104 (321)
T ss_dssp             CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTB
T ss_pred             CcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCc
Confidence            45555555554          2778889999999999999865 799999999976655556778999999999999999


Q ss_pred             eeeeeeeccCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCC
Q 013745          145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ  224 (437)
Q Consensus       145 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~  224 (437)
                      +++++++...+..++||||+++++|.+++.    ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.+
T Consensus       105 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~  177 (321)
T 2c30_A          105 VEMYKSYLVGEELWVLMEFLQGGALTDIVS----QVRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLD  177 (321)
T ss_dssp             CCEEEEEEETTEEEEEECCCCSCBHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTT
T ss_pred             ceEEEEEEECCEEEEEEecCCCCCHHHHHH----hcCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCC
Confidence            999999999999999999999999999883    346899999999999999999999998   9999999999999999


Q ss_pred             CCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhh
Q 013745          225 LNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSY  304 (437)
Q Consensus       225 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~  304 (437)
                      +.+||+|||++.........  .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+  
T Consensus       178 ~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~--  253 (321)
T 2c30_A          178 GRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--  253 (321)
T ss_dssp             CCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH--
T ss_pred             CcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--
Confidence            99999999999876543222  22457999999999999999999999999999999999999999765433221111  


Q ss_pred             hhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          305 TWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       305 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                       ..         ...+.+ ......+..+.+++.+||+.||++||++.+|++
T Consensus       254 -~~---------~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          254 -RD---------SPPPKL-KNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             -HH---------SSCCCC-TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -hc---------CCCCCc-CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             10         001111 011123445788999999999999999999986

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5.9e-47  Score=357.99  Aligned_cols=255  Identities=26%  Similarity=0.380  Sum_probs=211.3

Q ss_pred             hcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      .++|++.+.||+|+||.||+|...++..||||++...... ...+.+|+.++.+++||||+++++++.+....++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC-HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            5679999999999999999999888889999999765432 367889999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      ++++|.+++...  ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.........
T Consensus        86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            999999998543  245899999999999999999999998   999999999999999999999999999876544322


Q ss_pred             cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCcccc
Q 013745          245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA  323 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  323 (437)
                      . .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||...........+..      ..   ....    
T Consensus       161 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~------~~---~~~~----  226 (268)
T 3sxs_A          161 S-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ------GH---RLYR----  226 (268)
T ss_dssp             E-CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT------TC---CCCC----
T ss_pred             c-ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHc------CC---CCCC----
Confidence            2 223456778999999999999999999999999999999 9999986554332211111      00   0000    


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCC
Q 013745          324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD  361 (437)
Q Consensus       324 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~  361 (437)
                        +...+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus       227 --~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (268)
T 3sxs_A          227 --PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL  262 (268)
T ss_dssp             --CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGG
T ss_pred             --CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence              111234578899999999999999999999999854

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.7e-47  Score=380.50  Aligned_cols=250  Identities=22%  Similarity=0.307  Sum_probs=198.5

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC---ChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCceEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD---SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  159 (437)
                      .++|+++++||+|+||.||+|+.+ +++.||||++...   .......+.+|..++.++ +|||||+++++|.+....++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            467999999999999999999854 6889999999754   223335578899999887 89999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      ||||+++|+|..++...   ..+++..++.++.||+.||+|||+++   |+||||||+||||+.+|.+||+|||+++...
T Consensus       131 V~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            99999999999888543   46899999999999999999999998   9999999999999999999999999998643


Q ss_pred             CCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhh--hhhhhhhhhcccccccc
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKAD--LLSYTWTLFQGEKALEL  317 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  317 (437)
                      ....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+...  .............    
T Consensus       205 ~~~~--~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----  278 (396)
T 4dc2_A          205 RPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----  278 (396)
T ss_dssp             CTTC--CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC----
T ss_pred             cCCC--ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc----
Confidence            2222  2234689999999999999999999999999999999999999997543221110  0111111111000    


Q ss_pred             cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 013745          318 VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDM  351 (437)
Q Consensus       318 ~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  351 (437)
                           ...+...+..+.+++.+||+.||++||++
T Consensus       279 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          279 -----IRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             -----cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence                 11122344567899999999999999996

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=9.7e-47  Score=362.16  Aligned_cols=260  Identities=25%  Similarity=0.351  Sum_probs=207.9

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++...   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            56799999999999999999984 47899999998543   344567789999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||+++++|.+++...   ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            9999999999998543   46899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                      .... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.......      ......     ....
T Consensus       164 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~~~~~-----~~~~  231 (294)
T 4eqm_A          164 TSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA------IKHIQD-----SVPN  231 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH------HHHHSS-----CCCC
T ss_pred             cccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhhc-----cCCC
Confidence            3222 222457999999999999999999999999999999999999999875433211      111110     0000


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHhcCCC
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERP-DMNSVHLMLSGDS  362 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~ev~~~L~~~~  362 (437)
                      .........+..+.+++.+||+.+|++|| ++.++.+.|+...
T Consensus       232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence            01112223445688899999999999999 9999999998643

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3e-47  Score=377.28  Aligned_cols=258  Identities=27%  Similarity=0.393  Sum_probs=209.3

Q ss_pred             hcCccccceeccCCCeeEEEEEcC------CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCce
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK  157 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  157 (437)
                      .++|++.+.||+|+||.||+|.+.      +++.||||++... .......+.+|+.++++++||||+++++++.+....
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            467999999999999999999842      4678999999654 445556789999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccC----CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCC---Cceee
Q 013745          158 MLVYEYLPNKSLDYFIFDKT----KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL---NPKIS  230 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~---~~kl~  230 (437)
                      ++||||+++|+|.+++....    ....+++..++.++.||+.||+|||+++   |+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999986543    2246899999999999999999999998   99999999999999555   59999


Q ss_pred             ecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhh
Q 013745          231 DFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLF  309 (437)
Q Consensus       231 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  309 (437)
                      |||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||......+....+..     
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~-----  301 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS-----  301 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT-----
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-----
Confidence            9999986532222222223567899999999999999999999999999999998 9999987654332221111     


Q ss_pred             cccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          310 QGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       310 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                       ...         ...+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       302 -~~~---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~  342 (367)
T 3l9p_A          302 -GGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  342 (367)
T ss_dssp             -TCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CCC---------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence             000         01112234457889999999999999999999999874

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.6e-46  Score=361.29  Aligned_cols=272  Identities=22%  Similarity=0.273  Sum_probs=214.7

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC--ceEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP--EKMLV  160 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv  160 (437)
                      .++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            467999999999999999999854 68999999997542 233567889999999999999999999987655  77999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEe----cCCCCceeeeccccc
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL----DEQLNPKISDFGLAR  236 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll----~~~~~~kl~DFGla~  236 (437)
                      |||+++++|.+++........+++..++.++.||+.||.|||+++   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999976555556999999999999999999999998   9999999999999    788889999999998


Q ss_pred             ccCCCCcccceeeeecccccCChhhhc--------cCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhh-hhhhhhhh
Q 013745          237 LFPGEDTHVNTFRISGTHGYMAPEYAL--------HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKA-DLLSYTWT  307 (437)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~--------~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~-~~~~~~~~  307 (437)
                      ........   ....||+.|+|||++.        +..++.++|||||||++|||++|+.||......... ..+.....
T Consensus       165 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          165 ELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             ECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             ecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            77544322   2356899999999986        468899999999999999999999999754432221 11111111


Q ss_pred             hhcccccc----------cc--cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCCC
Q 013745          308 LFQGEKAL----------EL--VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDS  362 (437)
Q Consensus       308 ~~~~~~~~----------~~--~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~  362 (437)
                      ........          ..  ..+............+.+++.+||+.||++||++.|+++-...+.
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            10000000          00  001112445678888999999999999999999999999877543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=9.8e-47  Score=369.19  Aligned_cols=248  Identities=23%  Similarity=0.270  Sum_probs=205.6

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      .++|++++.||+|+||.||+|+.. +|+.||||++...   .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            367999999999999999999854 7999999999753   223356788999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||+++|+|..++...   ..+++..++.++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||+++....
T Consensus        84 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           84 MEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            9999999999888543   46899999999999999999999998   99999999999999999999999999986433


Q ss_pred             CCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                      ....  ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+.      ...       .
T Consensus       158 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~------~~~-------~  222 (337)
T 1o6l_A          158 DGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL------MEE-------I  222 (337)
T ss_dssp             TTCC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCC-------C
T ss_pred             CCCc--ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHH------cCC-------C
Confidence            2222  234689999999999999999999999999999999999999998654332221111      000       0


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERP-----DMNSVHL  356 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~  356 (437)
                         ..+...+..+.+++.+||+.+|++||     ++.+|++
T Consensus       223 ---~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          223 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence               11122345678899999999999999     8999875

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=9.2e-48  Score=374.53  Aligned_cols=271  Identities=25%  Similarity=0.334  Sum_probs=211.3

Q ss_pred             cCccccceeccCCCeeEEEEEc-----CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeec--cCCceE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-----PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCA--EGPEKM  158 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~  158 (437)
                      ++|++.+.||+|+||.||+|.+     .+++.||||++........+.+.+|++++++++||||+++++++.  +....+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5699999999999999999983     368899999998777777788999999999999999999999886  456689


Q ss_pred             EEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccccc
Q 013745          159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                      +||||+++++|.+++...  ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence            999999999999998543  235899999999999999999999998   999999999999999999999999999977


Q ss_pred             CCCCccc-ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccc
Q 013745          239 PGEDTHV-NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALEL  317 (437)
Q Consensus       239 ~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (437)
                      ....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........... .............+.
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM-GCERDVPALSRLLEL  256 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC-C----CCHHHHHHHH
T ss_pred             ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc-ccccccccHHHHHHH
Confidence            5433221 12234578889999999999999999999999999999999999865332111000 000000000000000


Q ss_pred             cCc-cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCCC
Q 013745          318 VDP-SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDS  362 (437)
Q Consensus       318 ~d~-~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~  362 (437)
                      +.. .....+...+..+.+++.+||+.+|++||++.+|++.|+...
T Consensus       257 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  302 (327)
T 3lxl_A          257 LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW  302 (327)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred             hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            000 011122344566889999999999999999999999998654

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=5.7e-47  Score=367.74  Aligned_cols=265  Identities=25%  Similarity=0.373  Sum_probs=205.0

Q ss_pred             ccccceeccCCCeeEEEEEc-----CCCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeecc--CCceEE
Q 013745           88 FSDLNQLGHGGFGPVYRGLM-----PNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAE--GPEKML  159 (437)
Q Consensus        88 y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l  159 (437)
                      |++++.||+|+||.||++.+     .+++.||||++.... ....+.+.+|++++++++||||+++++++.+  ....++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            49999999999999998863     268899999997653 4456779999999999999999999999987  457899


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      ||||+++++|.+++..    ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus       113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            9999999999999843    34899999999999999999999998   9999999999999999999999999999875


Q ss_pred             CCCcc-cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          240 GEDTH-VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       240 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      ..... .......||..|+|||++.+..++.++|||||||++|||++|+.||........ ....+...........+.+
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  264 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTVLRLTELL  264 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHHHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhHHHHHHHH
Confidence            44322 112234578889999999999999999999999999999999999865322110 0000000000000001111


Q ss_pred             Ccc-ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          319 DPS-LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       319 d~~-l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ... ....+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  307 (318)
T 3lxp_A          265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT  307 (318)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence            110 111222345678899999999999999999999999875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=7.4e-47  Score=375.26  Aligned_cols=256  Identities=27%  Similarity=0.404  Sum_probs=198.6

Q ss_pred             hcCccccceeccCCCeeEEEEEcC----CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP----NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      .++|++.+.||+|+||.||+|+..    ++..||||++... .....+.+.+|+.++++++||||+++++++.+....++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            457999999999999999999854    5778999999754 34456789999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      ||||+++++|.+++..  ....+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       124 v~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          124 VTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            9999999999999843  3356999999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCccc-ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccc
Q 013745          240 GEDTHV-NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALEL  317 (437)
Q Consensus       240 ~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (437)
                      ...... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+....+..       ..  . 
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~-------~~--~-  268 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE-------GY--R-  268 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHT-------TE--E-
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------CC--C-
Confidence            432211 1112345778999999999999999999999999999998 9999976554332221110       00  0 


Q ss_pred             cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          318 VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       318 ~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                           ...+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       269 -----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~  306 (373)
T 2qol_A          269 -----LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDK  306 (373)
T ss_dssp             -----CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -----CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHH
Confidence                 01112344568899999999999999999999999875

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-46  Score=366.08  Aligned_cols=255  Identities=21%  Similarity=0.247  Sum_probs=209.2

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      .++|++.+.||+|+||.||+|... +++.||+|++..... ....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc-cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            467999999999999999999854 688999999975543 346788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC--CCCceeeecccccccCCC
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE--QLNPKISDFGLARLFPGE  241 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~--~~~~kl~DFGla~~~~~~  241 (437)
                      +++++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.  ++.+||+|||+++.+...
T Consensus        83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            999999998833  2346899999999999999999999998   999999999999987  789999999999887543


Q ss_pred             CcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                      ..   .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+..      ...  . .+..
T Consensus       158 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~------~~~--~-~~~~  225 (321)
T 1tki_A          158 DN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN------AEY--T-FDEE  225 (321)
T ss_dssp             CE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH------TCC--C-CCHH
T ss_pred             Cc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHc------CCC--C-CChh
Confidence            32   2346799999999999999899999999999999999999999987654332221111      000  0 0000


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                      .   ....+..+.+++.+||+.||++|||+.|+++  ++..
T Consensus       226 ~---~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~  263 (321)
T 1tki_A          226 A---FKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             H---HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             h---hccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhcc
Confidence            0   0122456789999999999999999999986  5554

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-46  Score=368.79  Aligned_cols=264  Identities=28%  Similarity=0.437  Sum_probs=214.6

Q ss_pred             HHHHhcCccccceeccCCCeeEEEEEcC------CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeecc
Q 013745           81 LQVATNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE  153 (437)
Q Consensus        81 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  153 (437)
                      +....++|++.+.||+|+||.||+|...      +++.||||++... .....+.+.+|+.++++++||||+++++++.+
T Consensus        42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  121 (343)
T 1luf_A           42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV  121 (343)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence            3445688999999999999999999853      3488999999754 34446779999999999999999999999999


Q ss_pred             CCceEEEEeecCCCCcchhhhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEee
Q 013745          154 GPEKMLVYEYLPNKSLDYFIFDKTK---------------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHR  212 (437)
Q Consensus       154 ~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHr  212 (437)
                      .+..++||||+++++|.+++.....                     ...+++..++.++.||+.||.|||+++   |+||
T Consensus       122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~  198 (343)
T 1luf_A          122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR  198 (343)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence            9999999999999999999865321                     256899999999999999999999998   9999


Q ss_pred             ccCCCCEEecCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCC
Q 013745          213 DIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHD  291 (437)
Q Consensus       213 Dikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~  291 (437)
                      ||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||.
T Consensus       199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  278 (343)
T 1luf_A          199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  278 (343)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence            9999999999999999999999987643332222234568899999999999999999999999999999999 999998


Q ss_pred             CCCchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCCC
Q 013745          292 GRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDS  362 (437)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~  362 (437)
                      +....+....+      .. +.        ....+...+..+.+++.+||+.+|++||++.+|++.|+...
T Consensus       279 ~~~~~~~~~~~------~~-~~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~  334 (343)
T 1luf_A          279 GMAHEEVIYYV------RD-GN--------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  334 (343)
T ss_dssp             TSCHHHHHHHH------HT-TC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCChHHHHHHH------hC-CC--------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence            65443322111      11 11        01112233456889999999999999999999999998644

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.4e-46  Score=371.55  Aligned_cols=251  Identities=23%  Similarity=0.316  Sum_probs=206.2

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChH------HHHHHHHHHHHHHcCCCCcceeeeeeeccCCce
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQ------GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK  157 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  157 (437)
                      .++|++.+.||+|+||.||+|... +|+.||||++......      ..+.+.+|+.+|++++||||++++++|.+....
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            567999999999999999999854 7899999999754321      246788999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCC----Cceeeecc
Q 013745          158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL----NPKISDFG  233 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~----~~kl~DFG  233 (437)
                      ++||||+++|+|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           91 VLILELVSGGELFDFLA---QKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEECCCSCBHHHHHT---TCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEcCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            99999999999999984   3456999999999999999999999998   99999999999998777    79999999


Q ss_pred             cccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccc
Q 013745          234 LARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEK  313 (437)
Q Consensus       234 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (437)
                      +++.......   ....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+...      . 
T Consensus       165 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~------~-  234 (361)
T 2yab_A          165 LAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV------S-  234 (361)
T ss_dssp             SCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT------C-
T ss_pred             CceEcCCCCc---cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc------C-
Confidence            9987754322   22457999999999999999999999999999999999999999876543322211110      0 


Q ss_pred             cccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          314 ALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       314 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                       .. .++..   ....+..+.+++.+||+.||++|||+.|+++
T Consensus       235 -~~-~~~~~---~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          235 -YD-FDEEF---FSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             -CC-CCHHH---HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -CC-CCchh---ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             00 01000   0122345788999999999999999999875

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.9e-46  Score=379.00  Aligned_cols=267  Identities=19%  Similarity=0.206  Sum_probs=213.1

Q ss_pred             cHHHHHHHhcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCCh---HHHHHHHHHHHHHHcCCCCcceeeeeeec
Q 013745           77 DLRTLQVATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR---QGLREFTNEVKLLLKIQHKNLVTLFGCCA  152 (437)
Q Consensus        77 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~  152 (437)
                      ..+++....++|++.++||+|+||+||+|+.+ +++.||||++.....   .....+.+|+.++..++||||++++++|.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            34555566789999999999999999999954 588999999964321   11234789999999999999999999999


Q ss_pred             cCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeec
Q 013745          153 EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDF  232 (437)
Q Consensus       153 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DF  232 (437)
                      +....|||||||++|+|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+||
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF  219 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF  219 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence            99999999999999999999853  2356999999999999999999999998   999999999999999999999999


Q ss_pred             ccccccCCCCcccceeeeecccccCChhhhc-----cCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhh
Q 013745          233 GLARLFPGEDTHVNTFRISGTHGYMAPEYAL-----HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWT  307 (437)
Q Consensus       233 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~  307 (437)
                      |+++......... ....+||+.|+|||++.     ...++.++|||||||++|||++|+.||.+....+....+.....
T Consensus       220 Gla~~~~~~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~  298 (437)
T 4aw2_A          220 GSCLKLMEDGTVQ-SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE  298 (437)
T ss_dssp             TTCEECCTTSCEE-CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH
T ss_pred             hhhhhcccCCCcc-cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc
Confidence            9998765443322 22467999999999997     45789999999999999999999999987654443322211110


Q ss_pred             hhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHH--HhcC
Q 013745          308 LFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAE--RPDMNSVHL--MLSG  360 (437)
Q Consensus       308 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~--~L~~  360 (437)
                      .        ..   .+......+..+.+++.+|++.+|++  ||+++||++  ++.+
T Consensus       299 ~--------~~---~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~  344 (437)
T 4aw2_A          299 R--------FQ---FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG  344 (437)
T ss_dssp             H--------CC---CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred             c--------cc---CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence            0        00   11111123445788999999988888  999999986  5665

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.4e-46  Score=363.21  Aligned_cols=259  Identities=28%  Similarity=0.405  Sum_probs=213.4

Q ss_pred             HhcCccccceeccCCCeeEEEEEc------CCCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCc
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE  156 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  156 (437)
                      ..++|.+.+.||+|+||.||+|..      .+++.||||++... .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            356799999999999999999974      24578999999754 34556789999999999999999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccC
Q 013745          157 KMLVYEYLPNKSLDYFIFDKTK---------------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIK  215 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDik  215 (437)
                      .++||||+++++|.+++.....                     ...+++..++.++.||+.||.|||+++   |+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence            9999999999999999865432                     234899999999999999999999998   9999999


Q ss_pred             CCCEEecCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCC
Q 013745          216 ASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRL  294 (437)
Q Consensus       216 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~  294 (437)
                      |+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+..
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987755443333334567889999999999999999999999999999999 999998755


Q ss_pred             chhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          295 GKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      .......+..       ...        ...+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       258 ~~~~~~~~~~-------~~~--------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~  308 (314)
T 2ivs_A          258 PERLFNLLKT-------GHR--------MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK  308 (314)
T ss_dssp             GGGHHHHHHT-------TCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHhhc-------CCc--------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            4332221111       100        01112334568899999999999999999999999874

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.4e-47  Score=365.91  Aligned_cols=271  Identities=25%  Similarity=0.379  Sum_probs=205.0

Q ss_pred             hcCccccceeccCCCeeEEEEEc-----CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeecc--CCce
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-----PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE--GPEK  157 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  157 (437)
                      .++|++++.||+|+||.||+|++     .+++.||||++........+.+.+|+.++++++||||+++++++..  ....
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            46799999999999999999973     3688999999987777777889999999999999999999999854  3568


Q ss_pred             EEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                      ++||||+++++|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        89 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            9999999999999998543  245899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcc-cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccc
Q 013745          238 FPGEDTH-VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE  316 (437)
Q Consensus       238 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (437)
                      ....... .......++..|+|||++.+..++.++|||||||++|||++|..||.........................+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  243 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence            6543221 111223467789999999999999999999999999999999999864321100000000000000000000


Q ss_pred             cc-CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          317 LV-DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       317 ~~-d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      .+ .......+...+..+.+++.+||+.+|++|||+.+|++.|+.
T Consensus       244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~  288 (295)
T 3ugc_A          244 LLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ  288 (295)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             HHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence            00 000111122345668899999999999999999999999874

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=5.5e-47  Score=373.85  Aligned_cols=271  Identities=23%  Similarity=0.255  Sum_probs=210.2

Q ss_pred             cccHHHHHHHhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCC-----CCcceeee
Q 013745           75 FFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-----HKNLVTLF  148 (437)
Q Consensus        75 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~  148 (437)
                      .|+++......++|+++++||+|+||.||+|+. .+++.||||++... ......+..|+.+++.+.     ||||++++
T Consensus        24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~  102 (360)
T 3llt_A           24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYH  102 (360)
T ss_dssp             SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred             eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence            344555556678999999999999999999985 47899999999743 334466788999999996     99999999


Q ss_pred             eeeccCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC-----
Q 013745          149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE-----  223 (437)
Q Consensus       149 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~-----  223 (437)
                      +++...+..++||||+ +++|.+++... ....+++..++.++.||+.||+|||+++   |+||||||+|||++.     
T Consensus       103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~  177 (360)
T 3llt_A          103 GKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEK  177 (360)
T ss_dssp             EEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCE
T ss_pred             ceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccc
Confidence            9999999999999999 99999998544 3346899999999999999999999998   999999999999975     


Q ss_pred             --------------------CCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHH
Q 013745          224 --------------------QLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEI  283 (437)
Q Consensus       224 --------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~el  283 (437)
                                          ++.+||+|||+++......     ....||+.|+|||++.+..++.++|||||||++|||
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el  252 (360)
T 3llt_A          178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL  252 (360)
T ss_dssp             EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred             cccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence                                8899999999998754322     135689999999999999999999999999999999


Q ss_pred             HhCCCCCCCCCchhhhhhhhhhhhhhccc--------cccccc--------CccccC--------------CCHHHHHHH
Q 013745          284 VSGRKNHDGRLGKEKADLLSYTWTLFQGE--------KALELV--------DPSLAK--------------CNRDEAAMC  333 (437)
Q Consensus       284 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~--------d~~l~~--------------~~~~~~~~l  333 (437)
                      ++|+.||......+....+..........        .....+        .+....              ........+
T Consensus       253 l~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (360)
T 3llt_A          253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF  332 (360)
T ss_dssp             HHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred             HHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence            99999998765443332221111000000        000000        000000              000112567


Q ss_pred             HHHHHHcCCCCCCCCCCHHHHHH
Q 013745          334 IQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       334 ~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .+++.+||+.||++|||+.|+++
T Consensus       333 ~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          333 CDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHhcCChhhCCCHHHHhc
Confidence            79999999999999999999874

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=8e-47  Score=368.23  Aligned_cols=255  Identities=25%  Similarity=0.428  Sum_probs=201.1

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcE----EEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQE----IAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM  158 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  158 (437)
                      .++|++.+.||+|+||.||+|++. +++.    ||+|.+... .......+.+|+.++++++||||++++++|.+.. .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            457999999999999999999843 4544    588887543 2344577999999999999999999999998754 78


Q ss_pred             EEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccccc
Q 013745          159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                      +|+||+++|+|.+++...  ...+++..++.|+.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            999999999999998543  356999999999999999999999998   999999999999999999999999999987


Q ss_pred             CCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccc
Q 013745          239 PGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALEL  317 (437)
Q Consensus       239 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (437)
                      .............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+....      .    
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~------~----  237 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE------R----  237 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC------C----
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCC------C----
Confidence            65444333334557889999999999999999999999999999999 999998755443322211100      0    


Q ss_pred             cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          318 VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       318 ~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                           ...+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       238 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~  275 (327)
T 3poz_A          238 -----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK  275 (327)
T ss_dssp             -----CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHH
T ss_pred             -----CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence                 01122334568899999999999999999999998874

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.7e-46  Score=374.34  Aligned_cols=266  Identities=20%  Similarity=0.224  Sum_probs=211.4

Q ss_pred             cHHHHHHHhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeec
Q 013745           77 DLRTLQVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCA  152 (437)
Q Consensus        77 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  152 (437)
                      ..++.....++|++++.||+|+||.||+|+. .+|+.||||++.+..   ......+.+|+.++..++||||++++++|.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            3455556678999999999999999999985 479999999996532   222345789999999999999999999999


Q ss_pred             cCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeec
Q 013745          153 EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDF  232 (437)
Q Consensus       153 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DF  232 (437)
                      +.+..||||||+++|+|.+++...  ...+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+||
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF  206 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF  206 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence            999999999999999999998543  246899999999999999999999998   999999999999999999999999


Q ss_pred             ccccccCCCCcccceeeeecccccCChhhhc-------cCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhh
Q 013745          233 GLARLFPGEDTHVNTFRISGTHGYMAPEYAL-------HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYT  305 (437)
Q Consensus       233 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-------~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~  305 (437)
                      |+++........ .....+||+.|+|||++.       ...++.++|||||||++|||++|+.||.+....+....+...
T Consensus       207 Gla~~~~~~~~~-~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~  285 (412)
T 2vd5_A          207 GSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY  285 (412)
T ss_dssp             TTCEECCTTSCE-ECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred             hhheeccCCCcc-ccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence            999877543322 122467999999999997       357899999999999999999999999876544332222111


Q ss_pred             hhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCC---CCHHHHHH--HhcC
Q 013745          306 WTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAER---PDMNSVHL--MLSG  360 (437)
Q Consensus       306 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~R---Ps~~ev~~--~L~~  360 (437)
                      ....        ..+   ......+.++.+++.+||+ +|.+|   |++.||++  ++.+
T Consensus       286 ~~~~--------~~p---~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~  333 (412)
T 2vd5_A          286 KEHL--------SLP---LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG  333 (412)
T ss_dssp             HHHC--------CCC-------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred             ccCc--------CCC---ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence            1000        001   1112234567889999999 99988   68999875  5555

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.4e-46  Score=365.23  Aligned_cols=259  Identities=24%  Similarity=0.390  Sum_probs=194.4

Q ss_pred             HhcCccccceeccCCCeeEEEEEcCC-Cc---EEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCce
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMPN-GQ---EIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK  157 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  157 (437)
                      ..++|++.+.||+|+||.||+|.... ++   .||||++...  .....+.+.+|+.++++++||||+++++++......
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            35679999999999999999998643 32   7999999754  344567899999999999999999999999877655


Q ss_pred             ------EEEEeecCCCCcchhhhccC---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCce
Q 013745          158 ------MLVYEYLPNKSLDYFIFDKT---KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPK  228 (437)
Q Consensus       158 ------~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~k  228 (437)
                            ++||||+++++|.+++....   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEE
Confidence                  99999999999999886432   2236899999999999999999999998   99999999999999999999


Q ss_pred             eeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhh
Q 013745          229 ISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWT  307 (437)
Q Consensus       229 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~  307 (437)
                      |+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+.    
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~----  253 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI----  253 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH----
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh----
Confidence            999999987654443333334457889999999999999999999999999999999 999998755433222111    


Q ss_pred             hhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          308 LFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       308 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                        ...         ....+...+..+.+++.+||+.||++||++.+|++.|+.
T Consensus       254 --~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~  295 (323)
T 3qup_A          254 --GGN---------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELEN  295 (323)
T ss_dssp             --TTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             --cCC---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence              000         011122334568899999999999999999999999885

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.4e-46  Score=358.32  Aligned_cols=254  Identities=24%  Similarity=0.393  Sum_probs=206.8

Q ss_pred             hcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      .++|++++.||+|+||.||+|.+.++..||||++...... .+.+.+|++++.+++||||+++++++.+....++||||+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  101 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM  101 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEecc
Confidence            5679999999999999999999888889999999765332 367889999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      ++++|.+++...  ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++........
T Consensus       102 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  176 (283)
T 3gen_A          102 ANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  176 (283)
T ss_dssp             TTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred             CCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence            999999998542  346899999999999999999999998   999999999999999999999999999876432211


Q ss_pred             cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCcccc
Q 013745          245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA  323 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  323 (437)
                       ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+...            ..... 
T Consensus       177 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~------------~~~~~-  242 (283)
T 3gen_A          177 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG------------LRLYR-  242 (283)
T ss_dssp             -STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT------------CCCCC-
T ss_pred             -cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc------------cCCCC-
Confidence             1112346788999999999999999999999999999998 99999875543332221110            00001 


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       324 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                        +...+..+.+++.+||+.+|++||++.+|++.|..
T Consensus       243 --~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~  277 (283)
T 3gen_A          243 --PHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  277 (283)
T ss_dssp             --CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence              11223467889999999999999999999998864

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=6.8e-47  Score=372.66  Aligned_cols=254  Identities=22%  Similarity=0.310  Sum_probs=203.6

Q ss_pred             HHhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCce
Q 013745           83 VATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEK  157 (437)
Q Consensus        83 ~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  157 (437)
                      ...++|++++.||+|+||.||+|+. .+|+.||||++...   .......+.+|+.++..+ +||||+++++++.+.+..
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            3457899999999999999999985 46899999999754   233456688999999998 699999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                      |+||||+++|+|..++...   ..+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.
T Consensus       100 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE  173 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceee
Confidence            9999999999999988543   45899999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccc
Q 013745          238 FPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALEL  317 (437)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (437)
                      ......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+.      ...    .
T Consensus       174 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~------~~~----~  241 (353)
T 3txo_A          174 GICNGV--TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL------NDE----V  241 (353)
T ss_dssp             SCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCC----C
T ss_pred             cccCCc--cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH------cCC----C
Confidence            433222  2234689999999999999999999999999999999999999998765443322211      100    0


Q ss_pred             cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHH--HhcC
Q 013745          318 VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDM------NSVHL--MLSG  360 (437)
Q Consensus       318 ~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~------~ev~~--~L~~  360 (437)
                            ..+......+.+++.+||+.+|++||++      .+|++  ++++
T Consensus       242 ------~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~  286 (353)
T 3txo_A          242 ------VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE  286 (353)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred             ------CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence                  1111234457889999999999999998      77765  4544

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.5e-46  Score=366.51  Aligned_cols=259  Identities=19%  Similarity=0.223  Sum_probs=208.3

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCceEEEEe
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      .++|++.+.||+|+||.||+|.. .+++.||||++.....  ...+.+|+.+++++ +||||+++++++......++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            46799999999999999999984 5799999999875432  24577899999999 89999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCC-----ceeeecccccc
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN-----PKISDFGLARL  237 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~-----~kl~DFGla~~  237 (437)
                      |+ +++|.+++...  ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.     +||+|||+++.
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            99 99999998543  357999999999999999999999998   999999999999998887     99999999997


Q ss_pred             cCCCCccc-----ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccc
Q 013745          238 FPGEDTHV-----NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGE  312 (437)
Q Consensus       238 ~~~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  312 (437)
                      +.......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+..........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~  239 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT  239 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence            65433221     1234679999999999999999999999999999999999999998754433322222111110000


Q ss_pred             ccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          313 KALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       313 ~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                           ....+...   .+ .+.+++..||+.+|.+||++.+|++.|+.
T Consensus       240 -----~~~~~~~~---~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~  278 (330)
T 2izr_A          240 -----PIEVLCEN---FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTD  278 (330)
T ss_dssp             -----CHHHHTTT---CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             -----CHHHHhcc---Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence                 00001111   22 78899999999999999999999999874

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-46  Score=370.87  Aligned_cols=252  Identities=22%  Similarity=0.290  Sum_probs=208.1

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      .++|++.+.||+|+||.||+|... +|+.||+|++..........+.+|+.+|++++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            467999999999999999999854 7899999999876665667889999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC--CCCceeeecccccccCCC
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE--QLNPKISDFGLARLFPGE  241 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~--~~~~kl~DFGla~~~~~~  241 (437)
                      +++|+|.+++..  ....+++..++.++.||+.||+|||+++   |+||||||+|||++.  ++.+||+|||+++.....
T Consensus       130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            999999988843  2346899999999999999999999998   999999999999974  577999999999887543


Q ss_pred             CcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                      ..   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+.   .   ...  . .++ 
T Consensus       205 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~---~---~~~--~-~~~-  271 (387)
T 1kob_A          205 EI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK---R---CDW--E-FDE-  271 (387)
T ss_dssp             SC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH---H---CCC--C-CCS-
T ss_pred             cc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHH---h---CCC--C-CCc-
Confidence            32   224579999999999999999999999999999999999999998754432221111   0   000  0 011 


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                        ......+..+.+++.+||+.||++||++.++++
T Consensus       272 --~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          272 --DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             --STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             --cccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence              111223456789999999999999999999976

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.4e-46  Score=364.78  Aligned_cols=257  Identities=21%  Similarity=0.300  Sum_probs=204.8

Q ss_pred             HHHHhcCcccc-ceeccCCCeeEEEEEcC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCC-CCcceeeeeeeccCC
Q 013745           81 LQVATNFFSDL-NQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGP  155 (437)
Q Consensus        81 ~~~~~~~y~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  155 (437)
                      .+...++|.+. +.||+|+||.||+|... +++.||||++...  .......+.+|+.++.++. ||||+++++++.+..
T Consensus        23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~  102 (327)
T 3lm5_A           23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS  102 (327)
T ss_dssp             HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence            34556778888 89999999999999854 7999999998753  2233567889999999995 699999999999999


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC---CCCceeeec
Q 013745          156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE---QLNPKISDF  232 (437)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~---~~~~kl~DF  232 (437)
                      ..++||||+++|+|.+++... ....+++..++.++.||+.||+|||+++   |+||||||+|||++.   ++.+||+||
T Consensus       103 ~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Df  178 (327)
T 3lm5_A          103 EIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDF  178 (327)
T ss_dssp             EEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred             eEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeC
Confidence            999999999999999988432 3357999999999999999999999998   999999999999987   789999999


Q ss_pred             ccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccc
Q 013745          233 GLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGE  312 (437)
Q Consensus       233 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  312 (437)
                      |+++.......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+....      
T Consensus       179 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~------  249 (327)
T 3lm5_A          179 GMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVN------  249 (327)
T ss_dssp             GGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------
T ss_pred             ccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcc------
Confidence            99987653322   123579999999999999999999999999999999999999998765433322111100      


Q ss_pred             ccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          313 KALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       313 ~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                        ....    .......+..+.+++.+||+.+|++||++.++++
T Consensus       250 --~~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          250 --VDYS----EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             --CCCC----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             --cccC----chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence              0000    1111233455788999999999999999999975

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.3e-46  Score=363.79  Aligned_cols=251  Identities=24%  Similarity=0.320  Sum_probs=205.7

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCCh------HHHHHHHHHHHHHHcCCCCcceeeeeeeccCCce
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR------QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK  157 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  157 (437)
                      .++|++.+.||+|+||.||+|... +|+.||||++.....      ...+.+.+|+.++++++||||+++++++.+....
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            467999999999999999999854 789999999975421      1356788999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCC----Cceeeecc
Q 013745          158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL----NPKISDFG  233 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~----~~kl~DFG  233 (437)
                      ++||||+++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++    .+||+|||
T Consensus        90 ~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           90 ILILELVAGGELFDFLA---EKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEEECCCSCBHHHHHT---TSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCCCHHHHHH---hcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            99999999999999984   3356999999999999999999999998   99999999999998887    79999999


Q ss_pred             cccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccc
Q 013745          234 LARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEK  313 (437)
Q Consensus       234 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (437)
                      +++.......   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+....+....       
T Consensus       164 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-------  233 (326)
T 2y0a_A          164 LAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN-------  233 (326)
T ss_dssp             TCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTC-------
T ss_pred             CCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcC-------
Confidence            9987753322   123569999999999999999999999999999999999999998755433222111000       


Q ss_pred             cccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          314 ALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       314 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                       ....+....    ..+..+.+++.+||+.||++|||+.++++
T Consensus       234 -~~~~~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          234 -YEFEDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             -CCCCHHHHT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -CCcCccccc----cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             000000001    22345788999999999999999999976

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.6e-46  Score=378.10  Aligned_cols=253  Identities=20%  Similarity=0.280  Sum_probs=206.2

Q ss_pred             HhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      ..++|++.+.||+|+||.||+|.. .+|+.||+|++....  ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            467899999999999999999984 478999999997543  33456789999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEec---CCCCceeeecccccc
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD---EQLNPKISDFGLARL  237 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~---~~~~~kl~DFGla~~  237 (437)
                      |||+++|+|.+.+...   ..+++..+..++.||+.||.|||+++   |+||||||+|||++   .++.+||+|||++..
T Consensus        89 ~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           89 FDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             ECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            9999999998888543   46899999999999999999999998   99999999999998   467899999999987


Q ss_pred             cCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccc
Q 013745          238 FPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALEL  317 (437)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (437)
                      .......  .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+....+...       . ...
T Consensus       163 ~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~-------~-~~~  232 (444)
T 3soa_A          163 VEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAG-------A-YDF  232 (444)
T ss_dssp             CCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-------C-CCC
T ss_pred             ecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhC-------C-CCC
Confidence            6543322  22457999999999999999999999999999999999999999875543322211110       0 011


Q ss_pred             cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          318 VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       318 ~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ..+.    ....+..+.+++.+||+.||++|||+.|+++
T Consensus       233 ~~~~----~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          233 PSPE----WDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             CTTT----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             Cccc----cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            1111    1123456788999999999999999999976

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.1e-46  Score=368.46  Aligned_cols=252  Identities=21%  Similarity=0.290  Sum_probs=206.2

Q ss_pred             HhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      ..++|++.+.||+|+||.||+|.. .+|+.||||++...  .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            457899999999999999999985 47899999999754  344557789999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCC---CCceeeecccccc
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ---LNPKISDFGLARL  237 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~---~~~kl~DFGla~~  237 (437)
                      |||+++|+|.+.+..   ...+++..++.++.||+.||.|||+++   |+||||||+|||++.+   +.+||+|||++..
T Consensus       107 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          107 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             ECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            999999999888843   356899999999999999999999998   9999999999999765   4599999999987


Q ss_pred             cCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccc
Q 013745          238 FPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALEL  317 (437)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (437)
                      ......   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+..       +. ...
T Consensus       181 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~-------~~-~~~  249 (362)
T 2bdw_A          181 VNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA-------GA-YDY  249 (362)
T ss_dssp             CTTCCS---CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------TC-CCC
T ss_pred             ecCCcc---cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh-------CC-CCC
Confidence            654322   1245799999999999999999999999999999999999999986544322211110       00 000


Q ss_pred             cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          318 VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       318 ~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ..+..    ...+..+.+++.+||+.||++||++.++++
T Consensus       250 ~~~~~----~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          250 PSPEW----DTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             CTTGG----GGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             Ccccc----cCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            11111    123456788999999999999999999975

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=5.3e-47  Score=378.54  Aligned_cols=251  Identities=22%  Similarity=0.313  Sum_probs=197.5

Q ss_pred             hcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCC--CCcceeeeeeeccCCceEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQ--HKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv  160 (437)
                      .++|++.+.||+|+||.||+|...+++.||||++...  .....+.+.+|+.+|.+++  ||||+++++++...+..++|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            3569999999999999999999878999999999654  3455678999999999996  59999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      || +.+++|.+++...   ..+++..++.++.||+.||.|||+++   |+||||||+|||++ ++.+||+|||+++.+..
T Consensus       135 ~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             Ee-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            99 5688999988543   46889999999999999999999998   99999999999995 58999999999987754


Q ss_pred             CCcccceeeeecccccCChhhhcc-----------CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhh
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALH-----------GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLF  309 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~  309 (437)
                      ..........+||+.|+|||++.+           ..++.++|||||||+||||++|+.||........     ......
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-----~~~~~~  281 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-----KLHAII  281 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-----HHHHHH
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH-----HHHHHh
Confidence            433322334679999999999875           4689999999999999999999999975432211     111111


Q ss_pred             cccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          310 QGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       310 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ....     ......   .....+.+++.+||+.||++||++.+|++
T Consensus       282 ~~~~-----~~~~~~---~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          282 DPNH-----EIEFPD---IPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             CTTS-----CCCCCC---CSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             Cccc-----cCCCCc---cchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            1110     001111   11346788999999999999999999985

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.7e-46  Score=357.59  Aligned_cols=249  Identities=25%  Similarity=0.291  Sum_probs=196.8

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCCh--------------------------HHHHHHHHHHHHHH
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSR--------------------------QGLREFTNEVKLLL  137 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~  137 (437)
                      .++|++.+.||+|+||.||+|+. .+++.||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            46799999999999999999985 4789999999965421                          11356889999999


Q ss_pred             cCCCCcceeeeeeecc--CCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccC
Q 013745          138 KIQHKNLVTLFGCCAE--GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIK  215 (437)
Q Consensus       138 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDik  215 (437)
                      +++||||+++++++.+  ....++||||+++++|.+++    ....+++..++.++.||+.||.|||+++   |+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence            9999999999999986  56789999999999998765    3357999999999999999999999998   9999999


Q ss_pred             CCCEEecCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCc---CCcccceehhhHHHHHHHhCCCCCCC
Q 013745          216 ASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGY---LSVKTDVFSYGVLVLEIVSGRKNHDG  292 (437)
Q Consensus       216 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~~~~~DvwSlG~vl~elltg~~p~~~  292 (437)
                      |+|||++.++.+||+|||+++.+......  .....||+.|+|||++.+..   ++.++|||||||++|||++|+.||..
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSCE--ECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             HHHEEECCCCCEEEecCCCcccccccccc--ccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            99999999999999999999877543322  22357999999999998764   47889999999999999999999976


Q ss_pred             CCchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          293 RLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .........      .... . ..  .+...    ..+..+.+++.+||+.||++||++.||++
T Consensus       243 ~~~~~~~~~------~~~~-~-~~--~~~~~----~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          243 ERIMCLHSK------IKSQ-A-LE--FPDQP----DIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SSHHHHHHH------HHHC-C-CC--CCSSS----CCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccHHHHHHH------Hhcc-c-CC--CCCcc----ccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            443221111      1000 0 00  01111    23345788999999999999999999864

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=4.9e-47  Score=373.07  Aligned_cols=246  Identities=30%  Similarity=0.453  Sum_probs=199.8

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      .+.|++++.||+|+||.||+|+. .+++.||||++....   ....+.+.+|++++++++||||+++++++.+....++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            35599999999999999999984 579999999997542   33446789999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||+. |+|.+++...  ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       133 ~e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  206 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  206 (348)
T ss_dssp             EECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             EecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence            99997 5777766432  356899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCcccceeeeecccccCChhhhc---cCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccc
Q 013745          241 EDTHVNTFRISGTHGYMAPEYAL---HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALEL  317 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (437)
                      ..      ...||+.|+|||++.   .+.++.++|||||||++|||++|+.||.........      .......     
T Consensus       207 ~~------~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------~~~~~~~-----  269 (348)
T 1u5q_A          207 AN------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQNE-----  269 (348)
T ss_dssp             BC------CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHSC-----
T ss_pred             CC------cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHhcC-----
Confidence            21      356899999999985   467899999999999999999999999765432221      1111111     


Q ss_pred             cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          318 VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       318 ~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                       .+.+.  ....+..+.+++.+||+.+|++||++.++++
T Consensus       270 -~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          270 -SPALQ--SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             -CCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -CCCCC--CCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence             01110  1122345778999999999999999999975

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=7.1e-46  Score=355.34  Aligned_cols=263  Identities=21%  Similarity=0.265  Sum_probs=200.5

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      ++|++++.||+|+||+||+|... +++.||||++...  .......+.+|+.++++++||||+++++++.++...++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57999999999999999999854 7899999999754  33345678899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |+++ +|...+..  ....+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            9976 44444422  2356999999999999999999999998   9999999999999999999999999998765332


Q ss_pred             cccceeeeecccccCChhhhccCc-CCcccceehhhHHHHHHHhCCCCCC-CCCchhhhhhhhhhhhhhccccc---ccc
Q 013745          243 THVNTFRISGTHGYMAPEYALHGY-LSVKTDVFSYGVLVLEIVSGRKNHD-GRLGKEKADLLSYTWTLFQGEKA---LEL  317 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DvwSlG~vl~elltg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~---~~~  317 (437)
                      ..  .....||+.|+|||++.+.. ++.++|||||||++|||++|..||. +....+....+............   .+.
T Consensus       156 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  233 (292)
T 3o0g_A          156 RC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             SC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             cc--ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence            22  22356899999999998765 8999999999999999999888854 33222211111110000000000   000


Q ss_pred             ----------cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          318 ----------VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       318 ----------~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                                ....+....+.....+.+++.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                      000111222334566789999999999999999999976

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.7e-46  Score=355.99  Aligned_cols=263  Identities=22%  Similarity=0.325  Sum_probs=201.6

Q ss_pred             cCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCCh--HHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR--QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      ++|++++.||+|+||.||+|...+|+.||||++.....  .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            57999999999999999999987899999999975432  2236688999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +++ +|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence            975 88887743  2356899999999999999999999998   99999999999999999999999999987643222


Q ss_pred             ccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhh-----hcccccccc
Q 013745          244 HVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTL-----FQGEKALEL  317 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~  317 (437)
                      .  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+....+......     +........
T Consensus       156 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T 1ob3_A          156 K--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             c--cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccc
Confidence            1  1234689999999999764 6899999999999999999999999876543322211110000     000000000


Q ss_pred             cCccc--------cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          318 VDPSL--------AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       318 ~d~~l--------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .++..        .......+..+.+++.+||+.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            11110        1111233456789999999999999999999975

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.1e-46  Score=381.59  Aligned_cols=258  Identities=25%  Similarity=0.394  Sum_probs=211.4

Q ss_pred             HHhcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           83 VATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        83 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      ...++|++.+.||+|+||.||+|.+.++..||||++..... ..+.|.+|+.+|++++|||||++++++. ....++|||
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e  262 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM-SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE  262 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred             echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc-cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence            34577999999999999999999987889999999976543 3578999999999999999999999987 567899999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |+++|+|.+++.... ...+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++......
T Consensus       263 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~  338 (454)
T 1qcf_A          263 FMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE  338 (454)
T ss_dssp             CCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred             ecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence            999999999985331 235788999999999999999999998   9999999999999999999999999998764321


Q ss_pred             cccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          243 THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                      .. ......+++.|+|||++....++.++|||||||+||||++ |+.||.+....+....+...   .   .      . 
T Consensus       339 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~---~---~------~-  404 (454)
T 1qcf_A          339 YT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG---Y---R------M-  404 (454)
T ss_dssp             HH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT---C---C------C-
T ss_pred             ee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC---C---C------C-
Confidence            11 1112346788999999999999999999999999999999 99999876544332221110   0   0      0 


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCCC
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDS  362 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~  362 (437)
                        ..+...+..+.+++.+||+.+|++|||+.+|++.|+...
T Consensus       405 --~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~  443 (454)
T 1qcf_A          405 --PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY  443 (454)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             --CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence              011233456889999999999999999999999999654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.6e-46  Score=370.24  Aligned_cols=250  Identities=25%  Similarity=0.355  Sum_probs=205.3

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      .++|++++.||+|+||.||+|.. .+++.||||++....   ......+.+|+.+|+.++|||||+++++|.+....|+|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            36799999999999999999985 468899999986432   23346788999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||+++|+|..++..   ...+++..++.++.||+.||.|||+++   |+||||||+||||+.+|.+||+|||+++.+..
T Consensus        94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            999999999998843   356999999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCcccceeeeecccccCChhhhcc---CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccc
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALH---GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALEL  317 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (437)
                      ...   ....+||+.|+|||++..   ..++.++|||||||++|||++|+.||...........+.....          
T Consensus       168 ~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~----------  234 (384)
T 4fr4_A          168 ETQ---ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET----------  234 (384)
T ss_dssp             TCC---BCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH----------
T ss_pred             CCc---eeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh----------
Confidence            322   224679999999999974   4589999999999999999999999986544333222221111          


Q ss_pred             cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHH
Q 013745          318 VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPD-MNSVHL  356 (437)
Q Consensus       318 ~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~ev~~  356 (437)
                         .....+...+..+.+++.+||+.+|.+||+ +.+|++
T Consensus       235 ---~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          235 ---TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ---CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ---cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence               011122233456889999999999999998 777764

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.3e-46  Score=364.21  Aligned_cols=252  Identities=21%  Similarity=0.338  Sum_probs=200.3

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC-------
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP-------  155 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------  155 (437)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||++++++|.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            467999999999999999999965 79999999997543 334577999999999999999999999985543       


Q ss_pred             --------------------------------------------------ceEEEEeecCCCCcchhhhccCCCCCCCHH
Q 013745          156 --------------------------------------------------EKMLVYEYLPNKSLDYFIFDKTKSSSLDWT  185 (437)
Q Consensus       156 --------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~  185 (437)
                                                                        ..++|||||++++|.+++.........++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              379999999999999999766555567777


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc----------cceeeeecccc
Q 013745          186 TRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH----------VNTFRISGTHG  255 (437)
Q Consensus       186 ~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~  255 (437)
                      .++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            89999999999999999998   999999999999999999999999999987654221          11123569999


Q ss_pred             cCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHH
Q 013745          256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQ  335 (437)
Q Consensus       256 Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~  335 (437)
                      |+|||++.+..++.++|||||||++|||++|..|+..     .........            ..............+.+
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~------------~~~~~~~~~~~~~~~~~  304 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVR------------NLKFPLLFTQKYPQEHM  304 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHH------------TTCCCHHHHHHCHHHHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhh------------ccCCCcccccCChhHHH
Confidence            9999999999999999999999999999998776421     111111000            00111112234456788


Q ss_pred             HHHHcCCCCCCCCCCHHHHHH
Q 013745          336 LGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       336 l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ++.+||+.||++||++.++++
T Consensus       305 li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          305 MVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCCCCcCCCHHHHhh
Confidence            999999999999999999986

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=5.2e-46  Score=351.91  Aligned_cols=253  Identities=30%  Similarity=0.441  Sum_probs=197.6

Q ss_pred             hcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCCh----HHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR----QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      .++|++.+.||+|+||.||+|.. .++.||||++.....    ...+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            36799999999999999999997 588999999875422    2346788999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC--------CCCceeeec
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE--------QLNPKISDF  232 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~--------~~~~kl~DF  232 (437)
                      |||+++++|.+++.    ...+++..++.++.|++.||.|||+++..+|+||||||+|||++.        ++.+||+||
T Consensus        85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999998882    356899999999999999999999987555899999999999986        778999999


Q ss_pred             ccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccc
Q 013745          233 GLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGE  312 (437)
Q Consensus       233 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  312 (437)
                      |+++.......    ....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.........      .....
T Consensus       161 g~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~------~~~~~  230 (271)
T 3dtc_A          161 GLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYG------VAMNK  230 (271)
T ss_dssp             CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH------HHTSC
T ss_pred             Ccccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHh------hhcCC
Confidence            99986643322    134689999999999999999999999999999999999999986543322111      10000


Q ss_pred             ccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          313 KALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       313 ~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                           ...   ..+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       231 -----~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          231 -----LAL---PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             -----CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             -----CCC---CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence                 000   1112334568899999999999999999999999974

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.5e-46  Score=365.59  Aligned_cols=265  Identities=18%  Similarity=0.220  Sum_probs=199.4

Q ss_pred             hcCccccceeccCCCeeEEEEEcC----CCcEEEEEEeccCChHH-----------HHHHHHHHHHHHcCCCCcceeeee
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP----NGQEIAVKKLSVDSRQG-----------LREFTNEVKLLLKIQHKNLVTLFG  149 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~~  149 (437)
                      .++|++.+.||+|+||.||+|...    ++..||||++.......           ...+.+|+.++..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            467999999999999999999864    57889999987553211           123667889999999999999999


Q ss_pred             eecc----CCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCC
Q 013745          150 CCAE----GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL  225 (437)
Q Consensus       150 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~  225 (437)
                      ++..    ....++||||+ +++|.+++...   ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN---GTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGG---GBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence            9887    77889999999 99999998433   37999999999999999999999998   99999999999998877


Q ss_pred             --CceeeecccccccCCCCcc-----cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhh
Q 013745          226 --NPKISDFGLARLFPGEDTH-----VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK  298 (437)
Q Consensus       226 --~~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~  298 (437)
                        .+||+|||+++.+......     .......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence              9999999999876432111     111245799999999999999999999999999999999999999964322211


Q ss_pred             hhhhhhhhhhhcccccccccCccccC--CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCCCC
Q 013745          299 ADLLSYTWTLFQGEKALELVDPSLAK--CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSF  363 (437)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~~  363 (437)
                      ..  ........     ..+...+..  .....+..+.+++.+||+.+|++||++.+|++.|+...+
T Consensus       269 ~~--~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          269 AV--QTAKTNLL-----DELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HH--HHHHHHHH-----HTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HH--HHHHHhhc-----ccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            11  11110000     000110000  001234468899999999999999999999999997654

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-46  Score=364.60  Aligned_cols=262  Identities=25%  Similarity=0.350  Sum_probs=210.3

Q ss_pred             HhcCccccceeccCCCeeEEEEEc------CCCcEEEEEEeccC-ChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCC
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGP  155 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  155 (437)
                      ..++|++.+.||+|+||.||+|..      .++..||||++... .....+.+.+|+.++.++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            457899999999999999999984      24668999999754 233446789999999999 8999999999999999


Q ss_pred             ceEEEEeecCCCCcchhhhccCCC--------------------CCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccC
Q 013745          156 EKMLVYEYLPNKSLDYFIFDKTKS--------------------SSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIK  215 (437)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDik  215 (437)
                      ..++||||+++|+|.+++......                    ..+++..++.++.||+.||.|||+++   |+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence            999999999999999998654321                    34899999999999999999999998   9999999


Q ss_pred             CCCEEecCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCC
Q 013745          216 ASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRL  294 (437)
Q Consensus       216 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~  294 (437)
                      |+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999999999987654443333334568899999999999999999999999999999998 999998654


Q ss_pred             chhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCCC
Q 013745          295 GKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDS  362 (437)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~  362 (437)
                      ......      .......     .+   ..+...+..+.+++.+||+.+|.+||++.+|++.|+...
T Consensus       280 ~~~~~~------~~~~~~~-----~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~  333 (344)
T 1rjb_A          280 VDANFY------KLIQNGF-----KM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL  333 (344)
T ss_dssp             CSHHHH------HHHHTTC-----CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             cHHHHH------HHHhcCC-----CC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            322211      1111110     01   111123456888999999999999999999999998643

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.4e-46  Score=373.55  Aligned_cols=263  Identities=21%  Similarity=0.222  Sum_probs=210.4

Q ss_pred             HHHHHHhcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccC
Q 013745           79 RTLQVATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG  154 (437)
Q Consensus        79 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  154 (437)
                      +.+....++|++++.||+|+||.||+|+.+ +++.||+|++....   ......+.+|+.+++.++|||||+++++|.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            344455688999999999999999999854 68999999986431   11223477899999999999999999999999


Q ss_pred             CceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccc
Q 013745          155 PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL  234 (437)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl  234 (437)
                      ...|+||||++||+|.+++..    ..+++..++.++.||+.||+|||+++   |+||||||+||||+.+|.+||+|||+
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~  214 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT  214 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence            999999999999999998843    35899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcccceeeeecccccCChhhhccCc----CCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhc
Q 013745          235 ARLFPGEDTHVNTFRISGTHGYMAPEYALHGY----LSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQ  310 (437)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  310 (437)
                      ++........ .....+||+.|+|||++.+..    ++.++|||||||++|||++|+.||.+....+....+......  
T Consensus       215 a~~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--  291 (410)
T 3v8s_A          215 CMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS--  291 (410)
T ss_dssp             CEECCTTSEE-ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH--
T ss_pred             eEeeccCCcc-cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccc--
Confidence            9876543322 222467999999999998765    889999999999999999999999876544332222111100  


Q ss_pred             ccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCC--CCCHHHHHH--HhcCC
Q 013745          311 GEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAE--RPDMNSVHL--MLSGD  361 (437)
Q Consensus       311 ~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~--RPs~~ev~~--~L~~~  361 (437)
                            ...+...    ..+..+.+|+.+||+.+|.+  ||++.||++  ++++.
T Consensus       292 ------~~~p~~~----~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          292 ------LTFPDDN----DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             ------CCCCTTC----CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             ------ccCCCcc----cccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence                  0011111    23345778999999999988  999999985  56653

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=9.6e-46  Score=355.25  Aligned_cols=259  Identities=23%  Similarity=0.344  Sum_probs=201.3

Q ss_pred             hcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHc--CCCCcceeeeeeecc----CCceE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLK--IQHKNLVTLFGCCAE----GPEKM  158 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~~~~  158 (437)
                      .++|++.+.||+|+||.||+|.. +++.||||++....   ...+..|.+++..  ++||||+++++++..    ....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            57899999999999999999987 78999999986543   3445567777766  789999999998644    34579


Q ss_pred             EEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhh--------hcCCCceEeeccCCCCEEecCCCCceee
Q 013745          159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH--------EEAPARIIHRDIKASNILLDEQLNPKIS  230 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~~~iiHrDikp~NIll~~~~~~kl~  230 (437)
                      +||||+++|+|.+++    ....+++..++.++.||+.||+|||        +.+   |+||||||+|||++.++.+||+
T Consensus        83 lv~e~~~~g~L~~~l----~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           83 LITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EEECCCTTCBHHHHH----TTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred             EehhhccCCCHHHHH----hhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence            999999999999998    2346999999999999999999999        766   9999999999999999999999


Q ss_pred             ecccccccCCCCcccc--eeeeecccccCChhhhccC------cCCcccceehhhHHHHHHHhC----------CCCCCC
Q 013745          231 DFGLARLFPGEDTHVN--TFRISGTHGYMAPEYALHG------YLSVKTDVFSYGVLVLEIVSG----------RKNHDG  292 (437)
Q Consensus       231 DFGla~~~~~~~~~~~--~~~~~gt~~Y~aPE~~~~~------~~~~~~DvwSlG~vl~elltg----------~~p~~~  292 (437)
                      |||+++..........  .....||+.|+|||++.+.      .++.++|||||||++|||++|          +.||..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            9999987644332211  1234799999999999877      556799999999999999999          888865


Q ss_pred             CCchhhhhhhhhhhhhhcccccccccCcccc--CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          293 RLGKEKADLLSYTWTLFQGEKALELVDPSLA--KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ........  ..........    ...+.+.  ......+..+.+++.+||+.||++|||+.+|++.|+.
T Consensus       236 ~~~~~~~~--~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          236 VVPNDPSF--EDMRKVVCVD----QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             TSCSSCCH--HHHHHHHTTS----CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             cCCCCcch--hhhhHHHhcc----CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence            43322111  0111111100    0111111  1223567889999999999999999999999999873

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=9.3e-46  Score=357.51  Aligned_cols=254  Identities=27%  Similarity=0.431  Sum_probs=198.8

Q ss_pred             cCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecC
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLP  165 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  165 (437)
                      ++|++.+.||+|+||.||+|.. .++.||||++....  ..+.+.+|+.++++++||||+++++++.+  ..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence            5699999999999999999987 57899999996443  34678999999999999999999999874  4799999999


Q ss_pred             CCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCC-ceeeecccccccCCCCcc
Q 013745          166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN-PKISDFGLARLFPGEDTH  244 (437)
Q Consensus       166 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~-~kl~DFGla~~~~~~~~~  244 (437)
                      +++|.+++........+++..++.++.|++.||.|||+.++.+|+||||||+|||++.++. +||+|||++.......  
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~--  160 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM--  160 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc--
Confidence            9999999965544446789999999999999999999943234999999999999998887 7999999998654321  


Q ss_pred             cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccC
Q 013745          245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK  324 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  324 (437)
                         ....||+.|+|||++.+..++.++|||||||++|||++|+.||.........    ..+......      .+.+  
T Consensus       161 ---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~~~~~~~~------~~~~--  225 (307)
T 2eva_A          161 ---TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR----IMWAVHNGT------RPPL--  225 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH----HHHHHHTTC------CCCC--
T ss_pred             ---ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH----HHHHHhcCC------CCCc--
Confidence               1346899999999999999999999999999999999999999754332211    111111110      0111  


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCCC
Q 013745          325 CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDS  362 (437)
Q Consensus       325 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~  362 (437)
                       ....+..+.+++.+||+.+|++||++.+|++.|+...
T Consensus       226 -~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  262 (307)
T 2eva_A          226 -IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM  262 (307)
T ss_dssp             -BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred             -ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence             1123345788999999999999999999999998644

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3.1e-46  Score=367.79  Aligned_cols=257  Identities=22%  Similarity=0.300  Sum_probs=205.3

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC-----hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS-----RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM  158 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  158 (437)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++....     ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            46799999999999999999985 478999999986431     113567899999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCC---ceeeeccc
Q 013745          159 LVYEYLPNKSLDYFIFDKT-KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN---PKISDFGL  234 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~---~kl~DFGl  234 (437)
                      +|||||++++|.+.+.... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999987775432 3346899999999999999999999998   999999999999986655   99999999


Q ss_pred             ccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccc
Q 013745          235 ARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKA  314 (437)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  314 (437)
                      ++........  ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....    +...   ...... 
T Consensus       180 a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~---i~~~~~-  249 (351)
T 3c0i_A          180 AIQLGESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER----LFEG---IIKGKY-  249 (351)
T ss_dssp             CEECCTTSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH----HHHH---HHHTCC-
T ss_pred             eeEecCCCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH----HHHH---HHcCCC-
Confidence            9877543322  22457999999999999999999999999999999999999999864211    1111   000000 


Q ss_pred             ccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--Hhc
Q 013745          315 LELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLS  359 (437)
Q Consensus       315 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~  359 (437)
                        ...+..   ....+..+.+++.+||+.||++||++.++++  ++.
T Consensus       250 --~~~~~~---~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~  291 (351)
T 3c0i_A          250 --KMNPRQ---WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK  291 (351)
T ss_dssp             --CCCHHH---HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             --CCCccc---cccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhc
Confidence              000000   0122356788999999999999999999985  454

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.1e-46  Score=366.56  Aligned_cols=250  Identities=22%  Similarity=0.307  Sum_probs=203.8

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      .++|.+.+.||+|+||.||+|.. .+++.||||++....   ......+.+|+.+++.++||||+++++++.+....++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            36799999999999999999984 578999999986431   11235688999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||+ +|+|.+++...   ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus        88 ~E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~  160 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD  160 (336)
T ss_dssp             ECCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred             EECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence            9999 77888877543   46899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCcccceeeeecccccCChhhhccCcC-CcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGYL-SVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                      ...   ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...........                +.
T Consensus       161 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~----------------i~  221 (336)
T 3h4j_B          161 GNF---LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----------------VN  221 (336)
T ss_dssp             SBT---TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC----------------CC
T ss_pred             Ccc---cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH----------------HH
Confidence            322   124579999999999988765 7899999999999999999999976433221111                11


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                      ......+...+..+.+++.+||+.||.+|||+.|+++  ++..
T Consensus       222 ~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          222 SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence            1111112223456788999999999999999999975  5554

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=4.1e-46  Score=383.34  Aligned_cols=257  Identities=25%  Similarity=0.403  Sum_probs=212.5

Q ss_pred             HhcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      ...+|++.+.||+|+||.||+|.+. ++..||||++..... ..+.|.+|+.+|++++|||||+++++|.+....++|||
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            3467999999999999999999965 488999999975533 35779999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |+++|+|.+++... ....+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++......
T Consensus       297 ~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  372 (495)
T 1opk_A          297 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT  372 (495)
T ss_dssp             CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred             ccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence            99999999998543 3356899999999999999999999998   9999999999999999999999999998765432


Q ss_pred             cccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          243 THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                      .. ......+++.|+|||++.+..++.++|||||||+||||++ |+.||.+....+....+..       ..     .. 
T Consensus       373 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~-------~~-----~~-  438 (495)
T 1opk_A          373 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK-------DY-----RM-  438 (495)
T ss_dssp             EE-CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT-------TC-----CC-
T ss_pred             ee-ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------CC-----CC-
Confidence            21 1223446788999999999999999999999999999999 9999987654332221111       00     00 


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCC
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD  361 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~  361 (437)
                        ..+...+..+.+|+.+||+.+|++||++.+|++.|+..
T Consensus       439 --~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~  476 (495)
T 1opk_A          439 --ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  476 (495)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             --CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence              11223345688899999999999999999999999864

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.7e-46  Score=379.50  Aligned_cols=257  Identities=27%  Similarity=0.439  Sum_probs=206.2

Q ss_pred             HhcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      ..++|++.+.||+|+||.||+|.+.++..||||++..... ..+.|.+|+.+|++++||||+++++++.+ +..++||||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            3567999999999999999999987778899999975432 24678999999999999999999999976 678999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +++|+|.+++... ....+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus       260 ~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  335 (452)
T 1fmk_A          260 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  335 (452)
T ss_dssp             CTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred             hcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence            9999999998532 2245899999999999999999999998   99999999999999999999999999987653322


Q ss_pred             ccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCccc
Q 013745          244 HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL  322 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  322 (437)
                      . ......++..|+|||++.+..++.++|||||||+||||++ |+.||.+....+....+...      ..         
T Consensus       336 ~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~------~~---------  399 (452)
T 1fmk_A          336 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG------YR---------  399 (452)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT------CC---------
T ss_pred             e-cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC------CC---------
Confidence            1 1223456789999999999999999999999999999999 99999876544332221110      00         


Q ss_pred             cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCCC
Q 013745          323 AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDS  362 (437)
Q Consensus       323 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~  362 (437)
                      ...+...+..+.+++.+||+.+|++|||+.+|+++|+...
T Consensus       400 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            0112234456889999999999999999999999999754

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=5.5e-46  Score=354.10  Aligned_cols=254  Identities=23%  Similarity=0.312  Sum_probs=196.3

Q ss_pred             hcCccccceeccCCCeeEEEEEcC----CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP----NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      .++|++.+.||+|+||.||+|...    .+..||+|++... .....+.+.+|+.++++++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            567999999999999999999853    2457999998754 3445677899999999999999999999985 457899


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      ||||+++++|.+++...  ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        93 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  167 (281)
T ss_dssp             EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence            99999999999998533  346899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      ...... .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+.      ....     
T Consensus       168 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~------~~~~-----  235 (281)
T 1mp8_A          168 DSTYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE------NGER-----  235 (281)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH------TTCC-----
T ss_pred             cccccc-cccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH------cCCC-----
Confidence            432221 223456789999999999999999999999999999996 999998755433221111      1000     


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                          ...+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       236 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~  273 (281)
T 1mp8_A          236 ----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  273 (281)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                01122334568889999999999999999999999874

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.7e-46  Score=365.42  Aligned_cols=256  Identities=27%  Similarity=0.400  Sum_probs=203.4

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcE----EEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQE----IAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM  158 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  158 (437)
                      .++|++.+.||+|+||.||+|.+. +++.    ||+|++.... ......+.+|+.++++++||||+++++++. ....+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            356999999999999999999853 4554    7788775332 222345678999999999999999999986 45689


Q ss_pred             EEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccccc
Q 013745          159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                      +||||+++|+|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        91 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             EEEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             EEEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence            999999999999988532  357899999999999999999999998   999999999999999999999999999987


Q ss_pred             CCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccc
Q 013745          239 PGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALEL  317 (437)
Q Consensus       239 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (437)
                      .............||..|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+.....         .
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---------~  236 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER---------L  236 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB---------C
T ss_pred             CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC---------C
Confidence            65544433345668889999999999999999999999999999999 9999987554433222211100         0


Q ss_pred             cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCC
Q 013745          318 VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD  361 (437)
Q Consensus       318 ~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~  361 (437)
                            ..+...+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus       237 ------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~  274 (325)
T 3kex_A          237 ------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM  274 (325)
T ss_dssp             ------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred             ------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                  00111223467899999999999999999999999753

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=9.5e-46  Score=357.28  Aligned_cols=260  Identities=27%  Similarity=0.363  Sum_probs=212.5

Q ss_pred             HhcCccccceeccCCCeeEEEEEc------CCCcEEEEEEeccCC-hHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCC
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGP  155 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  155 (437)
                      ..++|++.+.||+|+||.||+|..      .+++.||||++.... ....+.+.+|+.+++++ +||||+++++++.+.+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            356799999999999999999973      357889999997553 34457789999999999 8999999999999999


Q ss_pred             ceEEEEeecCCCCcchhhhccCC---------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEE
Q 013745          156 EKMLVYEYLPNKSLDYFIFDKTK---------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNIL  220 (437)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIl  220 (437)
                      ..++||||+++|+|.+++.....               ...+++..++.++.||+.||.|||+++   |+||||||+|||
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil  177 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL  177 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence            99999999999999999865432               125899999999999999999999998   999999999999


Q ss_pred             ecCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhh
Q 013745          221 LDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKA  299 (437)
Q Consensus       221 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~  299 (437)
                      ++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.......
T Consensus       178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~  257 (313)
T 1t46_A          178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF  257 (313)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred             EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH
Confidence            99999999999999988765544333334567889999999999999999999999999999999 99999765432211


Q ss_pred             hhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          300 DLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      .  .....    .     ....   .+...+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       258 ~--~~~~~----~-----~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  304 (313)
T 1t46_A          258 Y--KMIKE----G-----FRML---SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (313)
T ss_dssp             H--HHHHH----T-----CCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             H--HHhcc----C-----CCCC---CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence            1  11000    0     0000   111234568889999999999999999999999874

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.9e-46  Score=361.47  Aligned_cols=256  Identities=26%  Similarity=0.430  Sum_probs=201.5

Q ss_pred             hcCccccceeccCCCeeEEEEEcCC-----CcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPN-----GQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM  158 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  158 (437)
                      ..+|.+.+.||+|+||.||+|....     +..||||++... .......+.+|+.++++++||||+++++++.+.+..+
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            3568889999999999999998532     235999999754 3444567899999999999999999999999999999


Q ss_pred             EEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccccc
Q 013745          159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                      +||||+++++|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus       123 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          123 IITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            999999999999998542  356899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCccc-ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhccccccc
Q 013745          239 PGEDTHV-NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALE  316 (437)
Q Consensus       239 ~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (437)
                      ....... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+.      ....   
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~------~~~~---  268 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN------DGFR---  268 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH------TTCC---
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH------CCCc---
Confidence            5432211 1112346788999999999999999999999999999999 999997654433221111      0000   


Q ss_pred             ccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          317 LVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       317 ~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                         .   ..+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       269 ---~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  306 (333)
T 1mqb_A          269 ---L---PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK  306 (333)
T ss_dssp             ---C---CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             ---C---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence               0   1112334568899999999999999999999999875

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-46  Score=359.98  Aligned_cols=245  Identities=24%  Similarity=0.336  Sum_probs=204.7

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      .++|++++.||+|+||.||+|+.. +|+.||+|++....   ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            367999999999999999999854 79999999997532   12346688999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||+++|+|.+++..   ...+++..++.++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||+++....
T Consensus        85 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD  158 (318)
T ss_dssp             ECCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             EeCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence            999999999999853   346899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                      .     ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........      +....       .
T Consensus       159 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~------i~~~~-------~  220 (318)
T 1fot_A          159 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK------ILNAE-------L  220 (318)
T ss_dssp             C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------HHHCC-------C
T ss_pred             c-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH------HHhCC-------C
Confidence            2     2246799999999999999999999999999999999999999986543322211      11110       0


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERP-----DMNSVHL  356 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~  356 (437)
                         ..+......+.+++.+|++.+|++||     ++.+|++
T Consensus       221 ---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          221 ---RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence               11112345678899999999999999     8899874

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=7.8e-46  Score=354.64  Aligned_cols=259  Identities=27%  Similarity=0.436  Sum_probs=196.6

Q ss_pred             hcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      .++|++.+.||+|+||.||+|...  ..||||++...  .....+.+.+|+.++++++||||+++++++ .....++|||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e   99 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ   99 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence            567999999999999999999863  36999999754  345567899999999999999999999966 4556899999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |+++++|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus       100 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A          100 WCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             CCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             ecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence            9999999998843  3456899999999999999999999998   9999999999999999999999999998665433


Q ss_pred             cccceeeeecccccCChhhhc---cCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          243 THVNTFRISGTHGYMAPEYAL---HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                      .........||+.|+|||++.   +..++.++|||||||++|||++|+.||......+..  ......    ..    ..
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~~~----~~----~~  244 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--IEMVGR----GS----LS  244 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH--HHHHHH----TS----CC
T ss_pred             ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH--HHHhcc----cc----cC
Confidence            333333467999999999987   567889999999999999999999999765443221  111111    11    11


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCC
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD  361 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~  361 (437)
                      +.+.......+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus       245 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l  286 (289)
T 3og7_A          245 PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL  286 (289)
T ss_dssp             CCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             cchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            112222234456788999999999999999999999999853

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.6e-46  Score=355.64  Aligned_cols=252  Identities=25%  Similarity=0.357  Sum_probs=199.0

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      .++|.+.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            45699999999999999999985 478999999987542 3345778899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEe---cCCCCceeeeccccccc
Q 013745          163 YLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL---DEQLNPKISDFGLARLF  238 (437)
Q Consensus       163 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll---~~~~~~kl~DFGla~~~  238 (437)
                      |+++++|.+.+... .....+++..++.++.||+.||+|||+++   |+||||||+|||+   +.++.+||+|||++..+
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999887543 23356999999999999999999999998   9999999999999   45688999999999876


Q ss_pred             CCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          239 PGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       239 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      .....   .....||+.|+|||++. +.++.++|||||||++|||++|+.||.+....+.........            
T Consensus       178 ~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~------------  241 (285)
T 3is5_A          178 KSDEH---STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE------------  241 (285)
T ss_dssp             ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------------
T ss_pred             CCccc---CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCC------------
Confidence            44322   22456899999999886 568999999999999999999999998755433221111100            


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                       +.........+..+.+++.+||+.||++||++.||++
T Consensus       242 -~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          242 -PNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             -CCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             -cccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             0000000012345778999999999999999999975

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.1e-45  Score=362.94  Aligned_cols=250  Identities=22%  Similarity=0.305  Sum_probs=200.4

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC---ChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCceEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD---SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  159 (437)
                      .++|++++.||+|+||.||+|+.+ +++.||||++...   .....+.+.+|+.++.++ +||||+++++++.+....|+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            357999999999999999999854 6899999999754   344556788999999988 89999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      ||||+++|+|..++...   ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        88 v~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~  161 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  161 (345)
T ss_dssp             EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred             EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence            99999999999988543   46899999999999999999999998   9999999999999999999999999998643


Q ss_pred             CCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhh--hhhhhhhhhhcccccccc
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKA--DLLSYTWTLFQGEKALEL  317 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  317 (437)
                      ....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ..............    
T Consensus       162 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~----  235 (345)
T 3a8x_A          162 RPGD--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----  235 (345)
T ss_dssp             CTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC----
T ss_pred             CCCC--cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC----
Confidence            2222  123467999999999999999999999999999999999999999753221110  00011111111000    


Q ss_pred             cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCH
Q 013745          318 VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDM  351 (437)
Q Consensus       318 ~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~  351 (437)
                           ...+...+..+.+++.+||+.||++||++
T Consensus       236 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          236 -----IRIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             -----CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence                 01122334567889999999999999996

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.9e-46  Score=368.27  Aligned_cols=250  Identities=26%  Similarity=0.343  Sum_probs=204.5

Q ss_pred             HHHhcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC---hHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCc
Q 013745           82 QVATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS---RQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPE  156 (437)
Q Consensus        82 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  156 (437)
                      ....++|++.+.||+|+||.||+|+.+ +|+.||||++....   ......+..|..++..+ +||||+++++++.+...
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            345678999999999999999999854 78999999997532   22345678899999877 89999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                      .|+||||+++|+|..++...   ..+++..++.++.||+.||+|||+++   |+||||||+|||++.+|.+||+|||+++
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~  166 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK  166 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence            99999999999999998543   46899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccc
Q 013745          237 LFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE  316 (437)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (437)
                      ........  ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+..      .     
T Consensus       167 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~------~-----  233 (345)
T 1xjd_A          167 ENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM------D-----  233 (345)
T ss_dssp             CCCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------C-----
T ss_pred             hcccCCCc--ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh------C-----
Confidence            65332222  2346899999999999999999999999999999999999999987554332221110      0     


Q ss_pred             ccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHH-HHH
Q 013745          317 LVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMN-SVH  355 (437)
Q Consensus       317 ~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-ev~  355 (437)
                        .+.   .+...+..+.+++.+||+.+|++||++. +|+
T Consensus       234 --~~~---~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          234 --NPF---YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             --CCC---CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             --CCC---CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence              011   1112345678899999999999999997 664

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-46  Score=365.65  Aligned_cols=263  Identities=25%  Similarity=0.402  Sum_probs=207.3

Q ss_pred             hcCccccceeccCCCeeEEEEEc-----CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC--ce
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-----PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP--EK  157 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~  157 (437)
                      .++|++++.||+|+||.||+|..     .+++.||||++........+.+.+|+.++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            46699999999999999999983     368999999998766666788999999999999999999999987654  78


Q ss_pred             EEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                      ++||||+++++|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            9999999999999998543  346899999999999999999999998   99999999999999999999999999988


Q ss_pred             cCCCCcccc-eeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhh---------hhhhhhhh
Q 013745          238 FPGEDTHVN-TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKA---------DLLSYTWT  307 (437)
Q Consensus       238 ~~~~~~~~~-~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~---------~~~~~~~~  307 (437)
                      ......... .....++..|+|||++.+..++.++|||||||++|||++|..||.........         ........
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  274 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence            754432211 12234678899999999999999999999999999999999998642110000         00000000


Q ss_pred             hhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          308 LFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       308 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ......        ....+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       275 ~~~~~~--------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~  319 (326)
T 2w1i_A          275 LLKNNG--------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ  319 (326)
T ss_dssp             HHHTTC--------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             HhhcCC--------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            000000        001122344568899999999999999999999999874

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.9e-46  Score=362.76  Aligned_cols=263  Identities=22%  Similarity=0.371  Sum_probs=213.7

Q ss_pred             HHHHhcCccccceeccCCCeeEEEEEcC------CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeecc
Q 013745           81 LQVATNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE  153 (437)
Q Consensus        81 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  153 (437)
                      .++..++|++.+.||+|+||.||+|+..      +++.||||++... .......+.+|+.++++++||||+++++++.+
T Consensus        20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   99 (322)
T 1p4o_A           20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   99 (322)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence            3455678999999999999999999753      4778999999754 33445678999999999999999999999999


Q ss_pred             CCceEEEEeecCCCCcchhhhccC-------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCC
Q 013745          154 GPEKMLVYEYLPNKSLDYFIFDKT-------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN  226 (437)
Q Consensus       154 ~~~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~  226 (437)
                      ....++||||+++++|.+++....       ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.
T Consensus       100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~  176 (322)
T 1p4o_A          100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT  176 (322)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCC
T ss_pred             CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCe
Confidence            999999999999999999985422       1246789999999999999999999998   999999999999999999


Q ss_pred             ceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhh
Q 013745          227 PKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYT  305 (437)
Q Consensus       227 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~  305 (437)
                      +||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+.  
T Consensus       177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~--  254 (322)
T 1p4o_A          177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM--  254 (322)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH--
T ss_pred             EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHH--
Confidence            99999999986644332222223457889999999999999999999999999999999 899997654433221111  


Q ss_pred             hhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCC
Q 013745          306 WTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD  361 (437)
Q Consensus       306 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~  361 (437)
                          . ..        ........+..+.+++.+||+.+|.+||++.+|++.|+..
T Consensus       255 ----~-~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~  297 (322)
T 1p4o_A          255 ----E-GG--------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  297 (322)
T ss_dssp             ----T-TC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             ----c-CC--------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence                0 00        0111223345678899999999999999999999999864

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.2e-45  Score=354.07  Aligned_cols=262  Identities=18%  Similarity=0.219  Sum_probs=209.8

Q ss_pred             HhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCceEEEE
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++.....  ...+.+|+.+++++ +|+|++++++++.+....++||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            356799999999999999999984 5799999999865432  24577899999999 7999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCC-----ceeeeccccc
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN-----PKISDFGLAR  236 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~-----~kl~DFGla~  236 (437)
                      ||+ +++|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.     +||+|||+++
T Consensus        86 e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           86 DLL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             ECC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             Eec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            999 99999998543  346999999999999999999999998   999999999999987776     9999999998


Q ss_pred             ccCCCCcc-----cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcc
Q 013745          237 LFPGEDTH-----VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQG  311 (437)
Q Consensus       237 ~~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  311 (437)
                      ........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+.........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  239 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence            77544322     1123457999999999999999999999999999999999999999875433322222211111000


Q ss_pred             cccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCC
Q 013745          312 EKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD  361 (437)
Q Consensus       312 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~  361 (437)
                              ..........+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus       240 --------~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~  281 (298)
T 1csn_A          240 --------TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  281 (298)
T ss_dssp             --------SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             --------ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence                    000011112345688999999999999999999999998853

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.5e-45  Score=351.95  Aligned_cols=256  Identities=26%  Similarity=0.410  Sum_probs=212.8

Q ss_pred             HhcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      ..++|++.+.||+|+||.||+|... ++..||||++..... ..+.+.+|+.++++++||||+++++++.+....++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST-HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH-HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            4677999999999999999999854 588999999975543 35778999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |+++++|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+||+++.++.+||+|||++.......
T Consensus        90 ~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  165 (288)
T 3kfa_A           90 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  165 (288)
T ss_dssp             CCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred             cCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence            99999999998543 3456999999999999999999999998   9999999999999999999999999998775433


Q ss_pred             cccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          243 THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                      .. ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+...            ... 
T Consensus       166 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~------------~~~-  231 (288)
T 3kfa_A          166 YT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD------------YRM-  231 (288)
T ss_dssp             SE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT------------CCC-
T ss_pred             cc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcc------------CCC-
Confidence            22 2224567889999999999999999999999999999999 99999865443322211110            000 


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                        ..+...+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       232 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~  268 (288)
T 3kfa_A          232 --ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET  268 (288)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence              1112234568899999999999999999999999874

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=9.6e-46  Score=364.08  Aligned_cols=245  Identities=22%  Similarity=0.286  Sum_probs=205.3

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      .++|++++.||+|+||.||+|+.. +|+.||||++....   ....+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            367999999999999999999854 79999999996432   22346788999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||+++|+|.+++...   ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       120 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence            9999999999998543   45899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                      .     ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+.      .. .      .
T Consensus       194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~------~~-~------~  255 (350)
T 1rdq_E          194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV------SG-K------V  255 (350)
T ss_dssp             C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HC-C------C
T ss_pred             C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHH------cC-C------C
Confidence            2     224679999999999999999999999999999999999999998754433221111      10 0      0


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERPD-----MNSVHL  356 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~  356 (437)
                         ..+...+..+.+++.+||+.||.+||+     +.+|++
T Consensus       256 ---~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          256 ---RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             ---CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence               111123456788999999999999998     888864

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.6e-45  Score=374.59  Aligned_cols=250  Identities=26%  Similarity=0.356  Sum_probs=205.8

Q ss_pred             HhcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC-ceEEEEe
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP-EKMLVYE  162 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e  162 (437)
                      ..++|++.+.||+|+||.||+|.+ .|+.||||++....  ..+.|.+|+.+|++++||||+++++++.+.. ..++|||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            346799999999999999999987 47899999997654  3467899999999999999999999987655 7899999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |+++|+|.+++... ....+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus       268 ~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  343 (450)
T 1k9a_A          268 YMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  343 (450)
T ss_dssp             CCTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             ecCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence            99999999998654 2345789999999999999999999998   9999999999999999999999999998653221


Q ss_pred             cccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          243 THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                           ....+++.|+|||++.+..++.++|||||||+||||++ |+.||......+....+..       +..     . 
T Consensus       344 -----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-------~~~-----~-  405 (450)
T 1k9a_A          344 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-------GYK-----M-  405 (450)
T ss_dssp             --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHT-------TCC-----C-
T ss_pred             -----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------CCC-----C-
Confidence                 12356889999999999999999999999999999998 9999987654433221111       100     0 


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                        ..+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       406 --~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~  442 (450)
T 1k9a_A          406 --DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH  442 (450)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence              1122344568899999999999999999999998874

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.9e-45  Score=365.64  Aligned_cols=268  Identities=17%  Similarity=0.188  Sum_probs=205.0

Q ss_pred             hcCccccceeccC--CCeeEEEEEcC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           85 TNFFSDLNQLGHG--GFGPVYRGLMP-NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        85 ~~~y~~~~~lG~G--~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      .++|++.+.||+|  +||.||+|+.. +|+.||||++...  .....+.+.+|+.++++++|||||++++++.+.+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4679999999999  99999999954 7999999999754  34455778899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      ||||+++++|.+++... ....+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||++....
T Consensus       104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            99999999999998543 2356999999999999999999999998   9999999999999999999999999987543


Q ss_pred             CCCcc-----cceeeeecccccCChhhhcc--CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhh-hhhhhhc-
Q 013745          240 GEDTH-----VNTFRISGTHGYMAPEYALH--GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLS-YTWTLFQ-  310 (437)
Q Consensus       240 ~~~~~-----~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~-~~~~~~~-  310 (437)
                      .....     .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||.+........... ....... 
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  259 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence            22111     11112468999999999987  579999999999999999999999998654432221100 0000000 


Q ss_pred             -----cc-------------ccccc----------cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          311 -----GE-------------KALEL----------VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       311 -----~~-------------~~~~~----------~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                           ..             ...+.          .+.............+.+|+.+||+.||++|||+.|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence                 00             00000          000000122334566889999999999999999999974

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.9e-46  Score=350.08  Aligned_cols=254  Identities=26%  Similarity=0.422  Sum_probs=209.0

Q ss_pred             hcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      .++|++.+.||+|+||.||+|...+++.||+|++...... .+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            3579999999999999999999878889999999765432 367889999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      ++++|.+++...  ...+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++.........
T Consensus        86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  160 (267)
T 3t9t_A           86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  160 (267)
T ss_dssp             TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccc
Confidence            999999998543  356899999999999999999999998   999999999999999999999999999876432111


Q ss_pred             cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCcccc
Q 013745          245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA  323 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  323 (437)
                       ......++..|+|||++.+..++.++||||||+++|||++ |+.||......+....+.      ...      ...  
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~------~~~------~~~--  225 (267)
T 3t9t_A          161 -SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS------TGF------RLY--  225 (267)
T ss_dssp             -STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH------TTC------CCC--
T ss_pred             -ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHh------cCC------cCC--
Confidence             1112356788999999999999999999999999999999 899998654433221111      100      000  


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       324 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                       .+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       226 -~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~  261 (267)
T 3t9t_A          226 -KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAE  261 (267)
T ss_dssp             -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence             111234567889999999999999999999999874

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.7e-45  Score=357.19  Aligned_cols=266  Identities=23%  Similarity=0.362  Sum_probs=191.2

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      .++|++++.||+|+||.||+|... +|+.||||++.... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            457999999999999999999854 68999999997543 2234668899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccC---CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          163 YLPNKSLDYFIFDKT---KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      |++ ++|.+++....   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            997 58888875432   2245899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccc-----c
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGE-----K  313 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----~  313 (437)
                      .....  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+....+..........     .
T Consensus       160 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          160 IPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             SCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             CCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            33221  1234689999999999864 68999999999999999999999998766543332221110000000     0


Q ss_pred             cccccCccc-------------cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          314 ALELVDPSL-------------AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       314 ~~~~~d~~l-------------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ......+.+             ..........+.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            000000000             0001123456889999999999999999999875

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4e-46  Score=358.28  Aligned_cols=270  Identities=21%  Similarity=0.366  Sum_probs=204.9

Q ss_pred             hcCccccceeccCCCeeEEEEE-----cCCCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccC--Cc
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGL-----MPNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG--PE  156 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~  156 (437)
                      .++|++.+.||+|+||.||+|+     ..+++.||||++.... ....+.+.+|+.++++++||||+++++++...  ..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            3459999999999999999998     2368999999997542 33457789999999999999999999999876  66


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                      .++||||+++++|.+++...  ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++.
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEEeCCCCcHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence            89999999999999998543  346899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcc-cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccc
Q 013745          237 LFPGEDTH-VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKAL  315 (437)
Q Consensus       237 ~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (437)
                      ........ .......||..|+|||++.+..++.++|||||||++|||++|..|+.............. ..........
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~  253 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT-HGQMTVTRLV  253 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSC-CGGGHHHHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCc-ccccCHHHHH
Confidence            87544322 112234578889999999999999999999999999999999998643211000000000 0000000000


Q ss_pred             ccc-CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          316 ELV-DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       316 ~~~-d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ..+ .......+...+..+.+++.+||+.+|.+|||+.+|++.|+.
T Consensus       254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  299 (302)
T 4e5w_A          254 NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA  299 (302)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            000 000111223345668899999999999999999999999873

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.9e-46  Score=369.65  Aligned_cols=266  Identities=23%  Similarity=0.327  Sum_probs=194.8

Q ss_pred             HHhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCC-CCcceeeeeeeccCC--c
Q 013745           83 VATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGP--E  156 (437)
Q Consensus        83 ~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~  156 (437)
                      ...++|++++.||+|+||.||+|.. .+|+.||||++...  .......+.+|+.++.++. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            4567899999999999999999984 47999999998643  4455677889999999997 999999999997543  6


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                      .|+|||||+ ++|..++..    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            899999997 588888743    46899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCc-------------------ccceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCch
Q 013745          237 LFPGEDT-------------------HVNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGK  296 (437)
Q Consensus       237 ~~~~~~~-------------------~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~  296 (437)
                      .+.....                   .......+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            7643111                   111223579999999999987 57999999999999999999999999876654


Q ss_pred             hhhhhhhhhhhhhccccccccc------------------CccccCC-------------CHHHHHHHHHHHHHcCCCCC
Q 013745          297 EKADLLSYTWTLFQGEKALELV------------------DPSLAKC-------------NRDEAAMCIQLGLLCCQQSV  345 (437)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~------------------d~~l~~~-------------~~~~~~~l~~l~~~cl~~~p  345 (437)
                      +....+................                  .......             .......+.+|+.+||+.||
T Consensus       238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP  317 (388)
T 3oz6_A          238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP  317 (388)
T ss_dssp             HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence            4332221111000000000000                  0000000             00224568899999999999


Q ss_pred             CCCCCHHHHHH
Q 013745          346 AERPDMNSVHL  356 (437)
Q Consensus       346 ~~RPs~~ev~~  356 (437)
                      ++|||+.|+++
T Consensus       318 ~~R~t~~e~l~  328 (388)
T 3oz6_A          318 NKRISANDALK  328 (388)
T ss_dssp             GGSCCHHHHTT
T ss_pred             ccCCCHHHHhC
Confidence            99999999865

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.6e-45  Score=356.14  Aligned_cols=268  Identities=27%  Similarity=0.375  Sum_probs=214.6

Q ss_pred             ccHHHHHHHhcCccccceeccCCCeeEEEEEc------CCCcEEEEEEeccC-ChHHHHHHHHHHHHHHcC-CCCcceee
Q 013745           76 FDLRTLQVATNFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTL  147 (437)
Q Consensus        76 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l  147 (437)
                      ++........++|++.+.||+|+||.||+|..      .+++.||||++... .....+.+.+|+.++.++ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            44555566678999999999999999999973      35689999999754 344456789999999999 69999999


Q ss_pred             eeeeccCC-ceEEEEeecCCCCcchhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeec
Q 013745          148 FGCCAEGP-EKMLVYEYLPNKSLDYFIFDKTK-------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRD  213 (437)
Q Consensus       148 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrD  213 (437)
                      ++++...+ ..++||||+++++|.+++.....             ...+++..++.++.||+.||.|||+++   |+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence            99987654 48999999999999999864332             123889999999999999999999998   99999


Q ss_pred             cCCCCEEecCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCC
Q 013745          214 IKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDG  292 (437)
Q Consensus       214 ikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~  292 (437)
                      |||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||.+
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999999999999987755443333334668999999999999999999999999999999998 9999976


Q ss_pred             CCchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          293 RLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      .......  ...    ......     .   ..+...+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       254 ~~~~~~~--~~~----~~~~~~-----~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  307 (316)
T 2xir_A          254 VKIDEEF--CRR----LKEGTR-----M---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  307 (316)
T ss_dssp             CCCSHHH--HHH----HHHTCC-----C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cchhHHH--HHH----hccCcc-----C---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            5432211  110    000000     0   1111234567889999999999999999999999874

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.9e-46  Score=362.40  Aligned_cols=264  Identities=21%  Similarity=0.233  Sum_probs=204.8

Q ss_pred             HHHhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC-----ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC
Q 013745           82 QVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD-----SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP  155 (437)
Q Consensus        82 ~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  155 (437)
                      ....++|++.+.||+|+||.||+|.. .+++.||+|++...     .....+.+.+|+.++++++||||+++++++.+.+
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            45578899999999999999999985 47889999998643     2344577899999999999999999999999999


Q ss_pred             ceEEEEeecCCCCcchhhhccC-------------------------------------CCCCCCHHHHHHHHHHHHHHH
Q 013745          156 EKMLVYEYLPNKSLDYFIFDKT-------------------------------------KSSSLDWTTRYRIVMGVARGL  198 (437)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~qi~~~L  198 (437)
                      ..++||||+++|+|.+++....                                     ....+++..++.++.||+.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence            9999999999999998874210                                     012246778889999999999


Q ss_pred             HHhhhcCCCceEeeccCCCCEEecCCC--CceeeecccccccCCCCcc--cceeeeecccccCChhhhcc--CcCCcccc
Q 013745          199 LYLHEEAPARIIHRDIKASNILLDEQL--NPKISDFGLARLFPGEDTH--VNTFRISGTHGYMAPEYALH--GYLSVKTD  272 (437)
Q Consensus       199 ~~LH~~~~~~iiHrDikp~NIll~~~~--~~kl~DFGla~~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~--~~~~~~~D  272 (437)
                      +|||+++   |+||||||+|||++.++  .+||+|||+++.+......  .......||+.|+|||++.+  ..++.++|
T Consensus       182 ~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          182 HYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            9999998   99999999999998776  8999999999876432211  11224569999999999975  67899999


Q ss_pred             eehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 013745          273 VFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMN  352 (437)
Q Consensus       273 vwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  352 (437)
                      ||||||++|||++|+.||.+....+....+.      ....  ....+...    ..+..+.+++.+||+.+|++||++.
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~------~~~~--~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~  326 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVL------NKKL--CFENPNYN----VLSPLARDLLSNLLNRNVDERFDAM  326 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCCC--CTTSGGGG----GSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChHHHHHHHH------hccc--ccCCcccc----cCCHHHHHHHHHHcCCChhHCCCHH
Confidence            9999999999999999998765443222111      1100  01111111    2335678899999999999999999


Q ss_pred             HHHH--HhcC
Q 013745          353 SVHL--MLSG  360 (437)
Q Consensus       353 ev~~--~L~~  360 (437)
                      ++++  ++++
T Consensus       327 ~~l~hp~~~~  336 (345)
T 3hko_A          327 RALQHPWISQ  336 (345)
T ss_dssp             HHHHSHHHHT
T ss_pred             HHhcChhhcc
Confidence            9986  5654

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.6e-46  Score=363.30  Aligned_cols=251  Identities=22%  Similarity=0.307  Sum_probs=196.6

Q ss_pred             hcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCC--CcceeeeeeeccCCceEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQH--KNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv  160 (437)
                      .++|++++.||+|+||.||+|...+++.||||++...  .....+.+.+|+.+|.+++|  |||+++++++.+....++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            4679999999999999999999888999999998754  34456778999999999986  9999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      || +.+++|.+++..   ...+++..++.++.||+.||.|||+++   |+||||||+|||++ ++.+||+|||+++.+..
T Consensus        88 ~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             Ee-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            99 568899999854   356899999999999999999999998   99999999999997 57899999999987754


Q ss_pred             CCcccceeeeecccccCChhhhcc-----------CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhh
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALH-----------GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLF  309 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~  309 (437)
                      ...........||+.|+|||++.+           ..++.++|||||||++|||++|+.||........     ......
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~~~~  234 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-----KLHAII  234 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-----HHHHHH
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH-----HHHHHh
Confidence            443333335679999999999875           6789999999999999999999999975432211     111111


Q ss_pred             cccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          310 QGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       310 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .....        ...+......+.+++.+||+.||++|||+.++++
T Consensus       235 ~~~~~--------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          235 DPNHE--------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             CTTSC--------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cCCcc--------cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence            10000        0111122345788999999999999999999985

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.6e-45  Score=359.12  Aligned_cols=248  Identities=25%  Similarity=0.319  Sum_probs=194.9

Q ss_pred             hcCccccceeccCCCeeEEEEEc----CCCcEEEEEEeccCC----hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCc
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM----PNGQEIAVKKLSVDS----RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE  156 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  156 (437)
                      .++|++.+.||+|+||.||+|+.    .+++.||||++....    ......+.+|+.++++++||||+++++++...+.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46799999999999999999985    478999999997542    2334567889999999999999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                      .++||||+++++|.+++...   ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            99999999999999988543   45889999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccc
Q 013745          237 LFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE  316 (437)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (437)
                      ........  ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+.      ...    
T Consensus       170 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~------~~~----  237 (327)
T 3a62_A          170 ESIHDGTV--THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKIL------KCK----  237 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH------HTC----
T ss_pred             ccccCCcc--ccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHH------hCC----
Confidence            64332221  223579999999999999999999999999999999999999998755433221111      100    


Q ss_pred             ccCccccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 013745          317 LVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERP-----DMNSVHL  356 (437)
Q Consensus       317 ~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~  356 (437)
                         .   ..+...+..+.+++.+||+.+|++||     ++.++++
T Consensus       238 ---~---~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          238 ---L---NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ---C---CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ---C---CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence               0   11122345678899999999999999     6777765

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.8e-45  Score=352.89  Aligned_cols=266  Identities=24%  Similarity=0.303  Sum_probs=200.5

Q ss_pred             HHhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC-----hHHHHHHHHHHHHHHcCC---CCcceeeeeeecc
Q 013745           83 VATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS-----RQGLREFTNEVKLLLKIQ---HKNLVTLFGCCAE  153 (437)
Q Consensus        83 ~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~  153 (437)
                      ...++|++.+.||+|+||.||+|+. .+++.||||++....     ......+.+|+.++++++   ||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            4567899999999999999999995 478999999986432     111245567777777664   9999999999977


Q ss_pred             CC-----ceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCce
Q 013745          154 GP-----EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPK  228 (437)
Q Consensus       154 ~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~k  228 (437)
                      ..     ..++||||+. ++|.+++... ....+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+|
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k  160 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK  160 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence            55     4799999996 5998888543 2345999999999999999999999998   99999999999999999999


Q ss_pred             eeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhh
Q 013745          229 ISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTL  308 (437)
Q Consensus       229 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~  308 (437)
                      |+|||+++........   ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+......
T Consensus       161 l~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  237 (308)
T 3g33_A          161 LADFGLARIYSYQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL  237 (308)
T ss_dssp             ECSCSCTTTSTTCCCS---GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             EeeCccccccCCCccc---CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            9999999876543322   2357899999999999999999999999999999999999999876654433222111111


Q ss_pred             hcccccccc-------cC----ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          309 FQGEKALEL-------VD----PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       309 ~~~~~~~~~-------~d----~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .........       ..    ..+....+.....+.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            111000000       00    0000111233456789999999999999999999875

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.2e-45  Score=363.62  Aligned_cols=249  Identities=23%  Similarity=0.291  Sum_probs=204.0

Q ss_pred             HhcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC---hHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCceE
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS---RQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKM  158 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  158 (437)
                      ..++|++++.||+|+||.||+|+.+ +++.||||++....   ....+.+..|..++..+ +||||+++++++.+.+..|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            4578999999999999999999864 58899999997542   23346688999999988 7999999999999999999


Q ss_pred             EEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccccc
Q 013745          159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                      +||||++||+|..++...   ..+++..++.++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||+++..
T Consensus        98 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            999999999999998543   45899999999999999999999998   999999999999999999999999999864


Q ss_pred             CCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          239 PGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       239 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      .....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+.      ...      
T Consensus       172 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~------~~~------  237 (353)
T 2i0e_A          172 IWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM------EHN------  237 (353)
T ss_dssp             CCTTC--CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCC------
T ss_pred             ccCCc--ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHH------hCC------
Confidence            32222  2234679999999999999999999999999999999999999998755433221111      100      


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPD-----MNSVHL  356 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~  356 (437)
                       .   ..+...+..+.+++.+||+.+|.+||+     +.+|++
T Consensus       238 -~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          238 -V---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             -C---CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             -C---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence             0   111233456788999999999999995     466653

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4.3e-45  Score=372.22  Aligned_cols=270  Identities=20%  Similarity=0.255  Sum_probs=189.6

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeecc-----CCc
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE-----GPE  156 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~  156 (437)
                      .++|++.+.||+|+||+||+|+.. +++.||||++...  .....+.+.+|+.+|++++|||||++++++..     ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            468999999999999999999854 7899999999653  44556788999999999999999999999843     356


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                      .|+||||+ +++|..++.   ....+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       132 ~~lv~e~~-~~~L~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFR---TPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCC-SEEHHHHHH---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEecc-ccchhhhcc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence            89999998 578888873   3356999999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcc-------------------------cceeeeecccccCChhhh-ccCcCCcccceehhhHHHHHHHh-----
Q 013745          237 LFPGEDTH-------------------------VNTFRISGTHGYMAPEYA-LHGYLSVKTDVFSYGVLVLEIVS-----  285 (437)
Q Consensus       237 ~~~~~~~~-------------------------~~~~~~~gt~~Y~aPE~~-~~~~~~~~~DvwSlG~vl~ellt-----  285 (437)
                      ........                         ......+||+.|+|||++ ....++.++||||||||||||++     
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~  284 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN  284 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccc
Confidence            76432211                         112245789999999986 45679999999999999999999     


Q ss_pred             ------CCCCCCCCCchh-----------------hhhhhhhhhhhhcccc--------------cccc----cCccccC
Q 013745          286 ------GRKNHDGRLGKE-----------------KADLLSYTWTLFQGEK--------------ALEL----VDPSLAK  324 (437)
Q Consensus       286 ------g~~p~~~~~~~~-----------------~~~~~~~~~~~~~~~~--------------~~~~----~d~~l~~  324 (437)
                            |+++|.+.....                 ..+.+...........              ....    ....+..
T Consensus       285 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  364 (458)
T 3rp9_A          285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAE  364 (458)
T ss_dssp             CSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGG
T ss_pred             ccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHH
Confidence                  666776543100                 0000000000000000              0000    0001111


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcCC
Q 013745          325 CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSGD  361 (437)
Q Consensus       325 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~~  361 (437)
                      ..+.....+.+|+.+||+.||++|||+.|+++  ++++.
T Consensus       365 ~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~  403 (458)
T 3rp9_A          365 RFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV  403 (458)
T ss_dssp             GSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence            12233566889999999999999999999987  56653

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=7.8e-45  Score=370.92  Aligned_cols=252  Identities=24%  Similarity=0.365  Sum_probs=207.7

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      .++|.+.+.||+|+||.||+|+.. +|+.||||++....   ......+.+|+.+++.++||||+++++++.+....++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            367999999999999999999854 79999999996532   12346788999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||+++|+|.+++.   ....+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        95 ~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~  168 (476)
T 2y94_A           95 MEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  168 (476)
T ss_dssp             EECCSSEEHHHHTT---SSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred             EeCCCCCcHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence            99999999999984   3456999999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCcccceeeeecccccCChhhhccCcC-CcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGYL-SVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                      ...   ....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||...........      +... .      
T Consensus       169 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~------i~~~-~------  232 (476)
T 2y94_A          169 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK------ICDG-I------  232 (476)
T ss_dssp             TCC---BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHH------HHTT-C------
T ss_pred             ccc---ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHH------HhcC-C------
Confidence            322   224579999999999988755 7899999999999999999999986543322111      1110 0      


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcCC
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSGD  361 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~~  361 (437)
                         ...+......+.+++.+||+.||++|||+.+|++  ++...
T Consensus       233 ---~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          233 ---FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             ---cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence               0011122345788999999999999999999986  66653

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.5e-45  Score=347.93  Aligned_cols=254  Identities=25%  Similarity=0.449  Sum_probs=202.5

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChH---H----HHHHHHHHHHHHcCCCCcceeeeeeeccCCc
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQ---G----LREFTNEVKLLLKIQHKNLVTLFGCCAEGPE  156 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  156 (437)
                      .++|++.+.||+|+||.||+|+. .+++.||||++......   .    .+.+.+|+.++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            46799999999999999999985 47899999998643211   1    167889999999999999999999997665 


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCC-----ceeee
Q 013745          157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN-----PKISD  231 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~-----~kl~D  231 (437)
                       ++||||+++++|.+.+..  ....+++..++.++.|++.||+|||+++ .+|+||||||+|||++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             799999999999888744  3457999999999999999999999975 34999999999999988776     99999


Q ss_pred             cccccccCCCCcccceeeeecccccCChhhhc--cCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhh
Q 013745          232 FGLARLFPGEDTHVNTFRISGTHGYMAPEYAL--HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLF  309 (437)
Q Consensus       232 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~--~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~  309 (437)
                      ||+++.....     .....||+.|+|||++.  ...++.++|||||||++|||++|+.||........... .....  
T Consensus       173 fg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~--  244 (287)
T 4f0f_A          173 FGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI-NMIRE--  244 (287)
T ss_dssp             CTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH-HHHHH--
T ss_pred             CCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH-HHHhc--
Confidence            9999854332     22457899999999984  45688999999999999999999999976543322111 11000  


Q ss_pred             cccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          310 QGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       310 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                       .     ...+   ..+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       245 -~-----~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          245 -E-----GLRP---TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             -S-----CCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             -c-----CCCC---CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence             0     0111   1122334568899999999999999999999999974

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.3e-45  Score=351.13  Aligned_cols=264  Identities=23%  Similarity=0.317  Sum_probs=202.2

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      .++|++++.||+|+||.||+|... +|+.||||++....  ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            367999999999999999999854 68999999986543  333567889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      ||+++++|..++..   ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        82 e~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  155 (311)
T 4agu_A           82 EYCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP  155 (311)
T ss_dssp             ECCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EeCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence            99999999888732   356899999999999999999999998   999999999999999999999999999876533


Q ss_pred             CcccceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhh--------hhhccc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTW--------TLFQGE  312 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~--------~~~~~~  312 (437)
                      ...  .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+....        ..+...
T Consensus       156 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (311)
T 4agu_A          156 SDY--YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN  233 (311)
T ss_dssp             ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred             ccc--cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence            222  123568999999999976 578999999999999999999999998766544332221110        001100


Q ss_pred             ccc---cccCcc----ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          313 KAL---ELVDPS----LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       313 ~~~---~~~d~~----l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ...   ...++.    +....+..+..+.+++.+||+.||++|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000   000000    00001233456889999999999999999999975

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-45  Score=348.47  Aligned_cols=257  Identities=26%  Similarity=0.402  Sum_probs=208.9

Q ss_pred             hcCccccc-eeccCCCeeEEEEEcC---CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           85 TNFFSDLN-QLGHGGFGPVYRGLMP---NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        85 ~~~y~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      .++|.+.+ .||+|+||.||+|...   ++..||||++... .....+.+.+|++++++++||||+++++++ ..+..++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            35577776 9999999999999743   6788999999764 345567899999999999999999999999 4567899


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      ||||+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        87 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~  161 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG  161 (287)
T ss_dssp             EEECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EEEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence            9999999999998843  3456999999999999999999999998   9999999999999999999999999998775


Q ss_pred             CCCccc-ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccc
Q 013745          240 GEDTHV-NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALEL  317 (437)
Q Consensus       240 ~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (437)
                      ...... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+..       ..    
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~-------~~----  230 (287)
T 1u59_A          162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-------GK----  230 (287)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT-------TC----
T ss_pred             cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc-------CC----
Confidence            433221 1222346889999999998899999999999999999998 9999987554332221111       00    


Q ss_pred             cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCCC
Q 013745          318 VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDS  362 (437)
Q Consensus       318 ~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~  362 (437)
                          ....+...+..+.+++.+||+.+|++||++.+|++.|+...
T Consensus       231 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  271 (287)
T 1u59_A          231 ----RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  271 (287)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                01112234456889999999999999999999999998643

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=3.7e-45  Score=373.09  Aligned_cols=260  Identities=25%  Similarity=0.269  Sum_probs=196.9

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccC------C
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG------P  155 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  155 (437)
                      .++|++++.||+|+||.||+|.. .+++.||||++...  .......+.+|+.+|+.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            57899999999999999999984 47899999999754  445567789999999999999999999999654      3


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccc
Q 013745          156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA  235 (437)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  235 (437)
                      ..|+||||++++ |...+.     ..+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||++
T Consensus       141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence            569999999765 545541     24889999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhh---------
Q 013745          236 RLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTW---------  306 (437)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~---------  306 (437)
                      +.......   ....+||+.|+|||++.+..++.++|||||||+||||++|+.||.+....+....+....         
T Consensus       212 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          212 RTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  288 (464)
T ss_dssp             -----CCC---C----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred             eecCCCcc---cCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            87644322   224679999999999999999999999999999999999999998765433322211100         


Q ss_pred             -------hhhccc------ccccccCccc----cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          307 -------TLFQGE------KALELVDPSL----AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       307 -------~~~~~~------~~~~~~d~~l----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                             ......      .....+...+    ..........+.+|+.+||+.||++|||+.|+++
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                   000000      0000000000    0011123567899999999999999999999875

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=359.71  Aligned_cols=255  Identities=25%  Similarity=0.424  Sum_probs=198.8

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcE----EEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQE----IAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM  158 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  158 (437)
                      .++|++++.||+|+||.||+|... +++.    ||+|.+... .......+.+|+.++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            467999999999999999999843 5554    477777533 3344577899999999999999999999998764 88


Q ss_pred             EEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccccc
Q 013745          159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                      +|+||+++|+|.+++...  ...+++..++.|+.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            999999999999998543  356899999999999999999999998   999999999999999999999999999877


Q ss_pred             CCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccc
Q 013745          239 PGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALEL  317 (437)
Q Consensus       239 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (437)
                      .............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+...       .    
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-------~----  236 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-------E----  236 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT-------C----
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-------C----
Confidence            54433333334457889999999999999999999999999999999 99999876544332221110       0    


Q ss_pred             cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          318 VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       318 ~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                          ....+...+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       237 ----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  275 (327)
T 3lzb_A          237 ----RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSK  275 (327)
T ss_dssp             ----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                001112234468889999999999999999999999885

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.4e-46  Score=361.04  Aligned_cols=254  Identities=21%  Similarity=0.329  Sum_probs=195.7

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCc----
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE----  156 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  156 (437)
                      .++|++.+.||+|+||.||+|+. .+++.||||++...   .......+.+|+.++++++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46799999999999999999984 57899999999754   33445678999999999999999999999876544    


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                      .|+||||+++++|.+++...   ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            39999999999999998543   46899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcc-cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccc
Q 013745          237 LFPGEDTH-VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKAL  315 (437)
Q Consensus       237 ~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (437)
                      .+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+........      .......  
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~------~~~~~~~--  236 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY------QHVREDP--  236 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHHHCCC--
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHhcCCC--
Confidence            76543221 22224568999999999999999999999999999999999999998755432211      1111100  


Q ss_pred             cccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          316 ELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       316 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                        ..+.  ......+..+.+++.+||+.||++||++.+++.
T Consensus       237 --~~~~--~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~  273 (311)
T 3ork_A          237 --IPPS--ARHEGLSADLDAVVLKALAKNPENRYQTAAEMR  273 (311)
T ss_dssp             --CCHH--HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             --CCcc--cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence              0000  001123456788999999999999997776653

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.1e-45  Score=358.47  Aligned_cols=262  Identities=27%  Similarity=0.376  Sum_probs=210.9

Q ss_pred             HHHhcCccccceeccCCCeeEEEEEcC-CC-----cEEEEEEeccC-ChHHHHHHHHHHHHHHcC-CCCcceeeeeeecc
Q 013745           82 QVATNFFSDLNQLGHGGFGPVYRGLMP-NG-----QEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAE  153 (437)
Q Consensus        82 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  153 (437)
                      +...++|++.+.||+|+||.||+|... ++     ..||+|++... .....+.+.+|+.+++++ +||||+++++++.+
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            344678999999999999999999853 23     47999999754 344557789999999999 89999999999999


Q ss_pred             CCceEEEEeecCCCCcchhhhccC-----------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEec
Q 013745          154 GPEKMLVYEYLPNKSLDYFIFDKT-----------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD  222 (437)
Q Consensus       154 ~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~  222 (437)
                      .+..++||||+++|+|.+++....           ....+++..++.++.||+.||.|||+++   |+||||||+|||++
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLT  198 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEE
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEEC
Confidence            999999999999999999986432           1346899999999999999999999998   99999999999999


Q ss_pred             CCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhh
Q 013745          223 EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADL  301 (437)
Q Consensus       223 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~  301 (437)
                      .++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.+........ 
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~-  277 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY-  277 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH-
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH-
Confidence            999999999999987654433333334567889999999999999999999999999999998 999997654322211 


Q ss_pred             hhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          302 LSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       302 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                       .    ......     ....   +...+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       278 -~----~~~~~~-----~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  323 (333)
T 2i1m_A          278 -K----LVKDGY-----QMAQ---PAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE  323 (333)
T ss_dssp             -H----HHHHTC-----CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -H----HHhcCC-----CCCC---CCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence             1    111000     0001   11224567889999999999999999999999874

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=5.1e-46  Score=377.87  Aligned_cols=253  Identities=23%  Similarity=0.277  Sum_probs=198.7

Q ss_pred             HhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      ..++|++++.||+|+||.||+|.. .+|+.||||++...   .......+.+|+.+++.++||||++++++|.+.+..++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            457899999999999999999984 47899999999743   33344667889999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceEeeccCCCCEEecCCCCceeeeccccccc
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE-EAPARIIHRDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                      ||||+++|+|..++...   ..+++..++.++.||+.||+|||+ .+   |+||||||+||||+.++.+||+|||+++..
T Consensus       226 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~  299 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG  299 (446)
T ss_dssp             EECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred             EEeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence            99999999999888543   468999999999999999999998 77   999999999999999999999999999864


Q ss_pred             CCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          239 PGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       239 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      ......  ....+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.........+..      ..      
T Consensus       300 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~------~~------  365 (446)
T 4ejn_A          300 IKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM------EE------  365 (446)
T ss_dssp             CC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CC------
T ss_pred             cCCCcc--cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHh------CC------
Confidence            332222  2246799999999999999999999999999999999999999987554332222110      00      


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH--HhcC
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERP-----DMNSVHL--MLSG  360 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~--~L~~  360 (437)
                          ...+...+..+.+++.+||+.||++||     ++.++++  ++.+
T Consensus       366 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~  410 (446)
T 4ejn_A          366 ----IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG  410 (446)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             ----CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence                011122345678899999999999999     9999975  4554

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=7.1e-46  Score=354.29  Aligned_cols=250  Identities=24%  Similarity=0.353  Sum_probs=203.0

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CC-------cEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCc
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NG-------QEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE  156 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  156 (437)
                      .++|.+.+.||+|+||.||+|... ++       ..||+|++........+.+.+|+.++++++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            467999999999999999999854 33       4799999977666667889999999999999999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCC--------ce
Q 013745          157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN--------PK  228 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~--------~k  228 (437)
                      .++||||+++++|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.        +|
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence            99999999999999998543  234899999999999999999999998   999999999999998887        99


Q ss_pred             eeecccccccCCCCcccceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCC-CCCCCchhhhhhhhhhh
Q 013745          229 ISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKN-HDGRLGKEKADLLSYTW  306 (437)
Q Consensus       229 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p-~~~~~~~~~~~~~~~~~  306 (437)
                      |+|||++......      ....||+.|+|||++.+ ..++.++|||||||++|||++|..| |.............   
T Consensus       162 l~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~---  232 (289)
T 4fvq_A          162 LSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE---  232 (289)
T ss_dssp             ECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH---
T ss_pred             eccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh---
Confidence            9999999755322      13458999999999987 6799999999999999999996554 44332221111100   


Q ss_pred             hhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCCC
Q 013745          307 TLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDS  362 (437)
Q Consensus       307 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~  362 (437)
                         ...        .+   +...+..+.+++.+||+.+|++||++.+|++.|+...
T Consensus       233 ---~~~--------~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~  274 (289)
T 4fvq_A          233 ---DRH--------QL---PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF  274 (289)
T ss_dssp             ---TTC--------CC---CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred             ---ccC--------CC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence               000        00   0011234678999999999999999999999999654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=4.2e-45  Score=369.61  Aligned_cols=199  Identities=24%  Similarity=0.363  Sum_probs=166.6

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccC-----Cc
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG-----PE  156 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  156 (437)
                      .++|++.+.||+|+||.||+|+. .+++.||||++...  .......+.+|+.+|++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            46799999999999999999985 47889999999753  444567889999999999999999999999766     56


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                      .|+||||++ ++|..++..   ...+++..++.++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            899999985 599888842   356999999999999999999999998   9999999999999999999999999999


Q ss_pred             ccCCCCcc--------------------cceeeeecccccCChhhh-ccCcCCcccceehhhHHHHHHHhCCCCC
Q 013745          237 LFPGEDTH--------------------VNTFRISGTHGYMAPEYA-LHGYLSVKTDVFSYGVLVLEIVSGRKNH  290 (437)
Q Consensus       237 ~~~~~~~~--------------------~~~~~~~gt~~Y~aPE~~-~~~~~~~~~DvwSlG~vl~elltg~~p~  290 (437)
                      ........                    ......+||+.|+|||++ ....++.++|||||||++|||++|..||
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            87543221                    112346799999999986 4567999999999999999999855444

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5.1e-45  Score=352.69  Aligned_cols=259  Identities=24%  Similarity=0.410  Sum_probs=197.8

Q ss_pred             HhcCccccceeccCCCeeEEEEEcC----CCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCc-
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMP----NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE-  156 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-  156 (437)
                      ..++|.+.+.||+|+||.||+|...    +++.||||++...  .....+.+.+|+.++++++||||+++++++.+... 
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            3567999999999999999999743    3458999999754  34456779999999999999999999999977553 


Q ss_pred             ----eEEEEeecCCCCcchhhhcc---CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCcee
Q 013745          157 ----KMLVYEYLPNKSLDYFIFDK---TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKI  229 (437)
Q Consensus       157 ----~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl  229 (437)
                          .++||||+++++|.+++...   .....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEE
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEE
Confidence                49999999999999988532   23457999999999999999999999998   999999999999999999999


Q ss_pred             eecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhh
Q 013745          230 SDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTL  308 (437)
Q Consensus       230 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  308 (437)
                      +|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||...........+.     
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-----  263 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL-----  263 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-----
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH-----
Confidence            99999987654433222333457889999999999999999999999999999999 899997655433221111     


Q ss_pred             hcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          309 FQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       309 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                       ....         ...+...+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       264 -~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  305 (313)
T 3brb_A          264 -HGHR---------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEK  305 (313)
T ss_dssp             -TTCC---------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             -cCCC---------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence             1000         01112233568899999999999999999999999875

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.4e-45  Score=361.73  Aligned_cols=252  Identities=20%  Similarity=0.226  Sum_probs=192.2

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      .++|++++.||+|+||.||+|+.. +++.||||++...... .+.+.+|+.++++++||||+++++++.+....++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            467999999999999999999854 7899999999754332 35678999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCC--ceeeecccccccCCC
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN--PKISDFGLARLFPGE  241 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~--~kl~DFGla~~~~~~  241 (437)
                      +++|+|.+++...   ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.  +||+|||+++.....
T Consensus        98 ~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           98 ASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             CCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            9999999988543   45899999999999999999999998   999999999999987765  999999999854322


Q ss_pred             CcccceeeeecccccCChhhhccCcCCcc-cceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYLSVK-TDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                      ..   .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.........  ..........       
T Consensus       172 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~--~~~~~~~~~~-------  239 (361)
T 3uc3_A          172 SQ---PKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRK--TIQRILSVKY-------  239 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHH--HHHHHHTTCC-------
T ss_pred             CC---CCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHH--HHHHHhcCCC-------
Confidence            21   223569999999999988877655 8999999999999999999986443222111  1111111000       


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .+.. ....+..+.+++.+||+.+|++|||+.|+++
T Consensus       240 ~~~~-~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          240 SIPD-DIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             CCCT-TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CCCC-cCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence            0000 0012345788999999999999999999985

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=2.2e-45  Score=363.33  Aligned_cols=265  Identities=18%  Similarity=0.213  Sum_probs=202.5

Q ss_pred             hcCccccceeccCCCeeEEEEEcCC------CcEEEEEEeccCChHHH-----------HHHHHHHHHHHcCCCCcceee
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPN------GQEIAVKKLSVDSRQGL-----------REFTNEVKLLLKIQHKNLVTL  147 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l  147 (437)
                      .++|++.+.||+|+||.||+|.+..      ++.||||++........           ..+..|+..+..++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            4689999999999999999998643      47899999876542211           123456667788899999999


Q ss_pred             eeeeccC----CceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEec-
Q 013745          148 FGCCAEG----PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD-  222 (437)
Q Consensus       148 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~-  222 (437)
                      ++++...    ...+|||||+ +++|.+++..  ....+++..++.|+.||+.||+|||+++   |+||||||+||||+ 
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~  187 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY  187 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence            9998764    4579999999 9999999854  3356999999999999999999999998   99999999999999 


Q ss_pred             -CCCCceeeecccccccCCCCccc-----ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCch
Q 013745          223 -EQLNPKISDFGLARLFPGEDTHV-----NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGK  296 (437)
Q Consensus       223 -~~~~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~  296 (437)
                       .++.+||+|||+++.+.......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence             88999999999998764322111     112345999999999999999999999999999999999999999854322


Q ss_pred             hhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          297 EKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ...  +......+. ....+.+++.+.  ....+..+.+++..||+.+|.+||++.+|+++|+.
T Consensus       268 ~~~--~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~  326 (364)
T 3op5_A          268 PKY--VRDSKIRYR-ENIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQ  326 (364)
T ss_dssp             HHH--HHHHHHHHH-HCHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             HHH--HHHHHHHhh-hhHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHH
Confidence            211  111111111 111222222221  01224567889999999999999999999999875

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3.8e-45  Score=347.62  Aligned_cols=254  Identities=29%  Similarity=0.453  Sum_probs=207.3

Q ss_pred             hcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      .++|++.+.||+|+||.||+|...+++.||||++..... ..+.+.+|++++++++||||+++++++.+ +..++||||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~   89 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence            467999999999999999999987888999999975432 24678899999999999999999999874 4689999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      ++++|.+++.... ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.........
T Consensus        90 ~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  165 (279)
T 1qpc_A           90 ENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (279)
T ss_dssp             TTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence            9999999984321 125899999999999999999999998   999999999999999999999999999877543322


Q ss_pred             cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCcccc
Q 013745          245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA  323 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  323 (437)
                      . .....++..|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+.   .   . .     ...  
T Consensus       166 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~---~---~-~-----~~~--  230 (279)
T 1qpc_A          166 A-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE---R---G-Y-----RMV--  230 (279)
T ss_dssp             C-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---T---T-C-----CCC--
T ss_pred             c-ccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHh---c---c-c-----CCC--
Confidence            1 123456789999999999999999999999999999999 999998655433221111   0   0 0     000  


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       324 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                       .+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       231 -~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~  266 (279)
T 1qpc_A          231 -RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (279)
T ss_dssp             -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence             111234568899999999999999999999999885

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.6e-45  Score=344.18  Aligned_cols=252  Identities=21%  Similarity=0.348  Sum_probs=204.9

Q ss_pred             hcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccC--CceEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG--PEKMLV  160 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  160 (437)
                      .++|++.+.||+|+||.||+|+. +++.||||++...  .....+.+.+|+.++++++||||+++++++.+.  ...++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            35799999999999999999998 5889999999754  344557799999999999999999999999877  778999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||+++|+|.+++... ....+++..++.++.||+.||.|||+++ ..|+||||||+|||++.++.++|+|||++.....
T Consensus        88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~  165 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS  165 (271)
T ss_dssp             EECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred             ecccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence            9999999999998543 2346899999999999999999999975 3499999999999999999999999988765322


Q ss_pred             CCcccceeeeecccccCChhhhccCcCCc---ccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccc
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGYLSV---KTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALEL  317 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~---~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (437)
                      .       ...||+.|+|||++.+..++.   ++|||||||++|||++|+.||...........      .....     
T Consensus       166 ~-------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~------~~~~~-----  227 (271)
T 3kmu_A          166 P-------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK------VALEG-----  227 (271)
T ss_dssp             T-------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHH------HHHSC-----
T ss_pred             c-------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHH------HHhcC-----
Confidence            2       245799999999998765444   79999999999999999999986544332111      11000     


Q ss_pred             cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          318 VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       318 ~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ..+.   .+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       228 ~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~  267 (271)
T 3kmu_A          228 LRPT---IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEK  267 (271)
T ss_dssp             CCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            0111   122334568899999999999999999999999874

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=7.5e-45  Score=346.28  Aligned_cols=255  Identities=21%  Similarity=0.305  Sum_probs=207.9

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++...  .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            57899999999999999999985 46899999999654  3445577889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCC---ceeeeccccccc
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN---PKISDFGLARLF  238 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~---~kl~DFGla~~~  238 (437)
                      ||+++++|.+.+...   ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.   +||+|||++...
T Consensus        85 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           85 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            999999998887543   45899999999999999999999998   999999999999986655   999999999876


Q ss_pred             CCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          239 PGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       239 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      ......   ....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+...        .....
T Consensus       159 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--------~~~~~  227 (284)
T 3kk8_A          159 NDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG--------AYDYP  227 (284)
T ss_dssp             CSSCBC---CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--------CCCCC
T ss_pred             ccCccc---cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhc--------cccCC
Confidence            543322   2356899999999999999999999999999999999999999765543322211110        00011


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                      .+..    ...+..+.+++.+||+.+|++||++.++++  ++.+
T Consensus       228 ~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  267 (284)
T 3kk8_A          228 SPEW----DTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN  267 (284)
T ss_dssp             TTTT----TTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHS
T ss_pred             chhh----cccCHHHHHHHHHHcccChhhCCCHHHHhcCccccC
Confidence            1111    123345788999999999999999999986  5553

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.6e-45  Score=364.10  Aligned_cols=270  Identities=22%  Similarity=0.285  Sum_probs=211.8

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC--ceEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP--EKMLV  160 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv  160 (437)
                      .++|.+.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|++++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            467999999999999999999854 68999999997542 233567789999999999999999999987655  67999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEe----cCCCCceeeeccccc
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL----DEQLNPKISDFGLAR  236 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll----~~~~~~kl~DFGla~  236 (437)
                      |||+++|+|.+++........+++..++.++.||+.||+|||+++   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999865544455999999999999999999999998   9999999999999    778889999999998


Q ss_pred             ccCCCCcccceeeeecccccCChhhhcc--------CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhh-hhhhhhhh
Q 013745          237 LFPGEDTHVNTFRISGTHGYMAPEYALH--------GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKA-DLLSYTWT  307 (437)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~-~~~~~~~~  307 (437)
                      .......   .....||+.|+|||++.+        ..++.++|||||||++|||++|+.||......... ..+.....
T Consensus       165 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          165 ELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             ECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             EccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            7654322   223568999999999875        57889999999999999999999999754332211 11111111


Q ss_pred             hhccccc----------ccc--cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          308 LFQGEKA----------LEL--VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       308 ~~~~~~~----------~~~--~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      .......          .+.  ..+............+.+++.+||+.||++||++.++++.+..
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~  306 (396)
T 4eut_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (396)
T ss_dssp             SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHH
Confidence            0000000          000  0011123457788889999999999999999999999887754

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.6e-45  Score=346.70  Aligned_cols=250  Identities=20%  Similarity=0.256  Sum_probs=204.3

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      .++|++.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+....++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            567999999999999999999854 6789999999765444567889999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEe---cCCCCceeeecccccccCC
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL---DEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll---~~~~~~kl~DFGla~~~~~  240 (437)
                      +++++|.+++...   ..+++..++.++.|++.||.|||+++   |+||||||+|||+   +.++.+||+|||++.....
T Consensus        88 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           88 CTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             CCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            9999998888543   45899999999999999999999998   9999999999999   7889999999999987654


Q ss_pred             CCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                      ....   ....||+.|+|||++.+. ++.++|||||||++|||++|+.||......+....+..      ...  .....
T Consensus       162 ~~~~---~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~------~~~--~~~~~  229 (277)
T 3f3z_A          162 GKMM---RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE------GTF--TFPEK  229 (277)
T ss_dssp             TSCB---CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CCC--CCCHH
T ss_pred             ccch---hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh------CCC--CCCch
Confidence            3322   235689999999988765 89999999999999999999999987554332211110      000  00000


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ...    ..+..+.+++.+||+.+|++||++.++++
T Consensus       230 ~~~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          230 DWL----NVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             HHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             hhh----cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000    22456788999999999999999999974

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.5e-45  Score=382.50  Aligned_cols=257  Identities=27%  Similarity=0.434  Sum_probs=210.2

Q ss_pred             HhcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      ..++|++.+.||+|+||.||+|.+..+..||||++..... ..+.|.+|+++|++++||||+++++++.+ ...+|||||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            3567999999999999999999987778899999976432 24678999999999999999999999976 678999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +++|+|.+++... ....+++..++.|+.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.......
T Consensus       343 ~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  418 (535)
T 2h8h_A          343 MSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  418 (535)
T ss_dssp             CTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred             hcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence            9999999998532 2245899999999999999999999998   99999999999999999999999999987643211


Q ss_pred             ccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCccc
Q 013745          244 HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL  322 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  322 (437)
                       .......++..|+|||++....++.++|||||||+||||++ |+.||.+....+....+..       +..     .  
T Consensus       419 -~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~-------~~~-----~--  483 (535)
T 2h8h_A          419 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-------GYR-----M--  483 (535)
T ss_dssp             -HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHT-------TCC-----C--
T ss_pred             -ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-------CCC-----C--
Confidence             11112346788999999999999999999999999999999 9999987654433222111       000     0  


Q ss_pred             cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCCC
Q 013745          323 AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDS  362 (437)
Q Consensus       323 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~  362 (437)
                       ..+...+..+.+|+.+||+.+|++||++.+|+++|+...
T Consensus       484 -~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          484 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             -CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence             111233456889999999999999999999999999644

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6.1e-45  Score=353.80  Aligned_cols=251  Identities=23%  Similarity=0.301  Sum_probs=205.8

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCCh------HHHHHHHHHHHHHHcCCCCcceeeeeeeccCCce
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR------QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK  157 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  157 (437)
                      .++|++.+.||+|+||.||+|... +|+.||||++.....      ...+.+.+|+.++++++||||+++++++.+....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            567999999999999999999854 789999999975421      1356789999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCC----Cceeeecc
Q 013745          158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL----NPKISDFG  233 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~----~~kl~DFG  233 (437)
                      ++||||+++++|.+++..   ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            999999999999999843   356899999999999999999999998   99999999999999888    79999999


Q ss_pred             cccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccc
Q 013745          234 LARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEK  313 (437)
Q Consensus       234 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (437)
                      ++.........   ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+....+..      .. 
T Consensus       165 ~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~------~~-  234 (321)
T 2a2a_A          165 LAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITS------VS-  234 (321)
T ss_dssp             TCEECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT------TC-
T ss_pred             cceecCccccc---cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh------cc-
Confidence            99876543221   235689999999999999999999999999999999999999987554332211110      00 


Q ss_pred             cccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          314 ALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       314 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                        ...++...   ...+..+.+++.+||+.||++||++.++++
T Consensus       235 --~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          235 --YDFDEEFF---SHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             --CCCCHHHH---TTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             --cccChhhh---cccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence              00011110   122345788999999999999999999976

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.1e-45  Score=357.70  Aligned_cols=267  Identities=24%  Similarity=0.336  Sum_probs=199.0

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHH-HHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQG-LREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      ++|++++.||+|+||.||+|... +++.||||++....... ...+.+|+.++++++||||+++++++.+....++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57999999999999999999854 78999999997543221 12456799999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      ++ ++|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  155 (324)
T 3mtl_A           82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  155 (324)
T ss_dssp             CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence            97 5887777433  346899999999999999999999998   99999999999999999999999999986543322


Q ss_pred             ccceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccC---
Q 013745          244 HVNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD---  319 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d---  319 (437)
                      .  .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+.................   
T Consensus       156 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (324)
T 3mtl_A          156 T--YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEE  233 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred             c--cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchh
Confidence            1  223468999999999877 5789999999999999999999999987665443332221111100000000000   


Q ss_pred             ------c-----cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          320 ------P-----SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       320 ------~-----~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                            +     .+....+.....+.+++.+||+.||++|||+.|+++  ++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  287 (324)
T 3mtl_A          234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLS  287 (324)
T ss_dssp             HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGG
T ss_pred             hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhh
Confidence                  0     000011123456789999999999999999999986  5554

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=5.1e-45  Score=355.16  Aligned_cols=258  Identities=28%  Similarity=0.404  Sum_probs=204.3

Q ss_pred             hcCccccceeccCCCeeEEEEEc------CCCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCce
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK  157 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  157 (437)
                      .++|++.+.||+|+||.||+|.+      .+++.||||++... .......+.+|+.++++++||||+++++++.+....
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            46799999999999999999983      25778999999744 445567789999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccCC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC---CCCceee
Q 013745          158 MLVYEYLPNKSLDYFIFDKTK----SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE---QLNPKIS  230 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~---~~~~kl~  230 (437)
                      ++||||+++++|.+++.....    ...+++..++.++.||+.||.|||+++   |+||||||+|||++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence            999999999999999865432    245899999999999999999999998   999999999999984   4569999


Q ss_pred             ecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhh
Q 013745          231 DFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLF  309 (437)
Q Consensus       231 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  309 (437)
                      |||+++...............||+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+.      
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~------  259 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT------  259 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH------
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh------
Confidence            9999986543332222223457899999999999999999999999999999998 999997654432221111      


Q ss_pred             cccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          310 QGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       310 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ....         .......+..+.+++.+||+.+|.+||++.+|++.|+.
T Consensus       260 ~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  301 (327)
T 2yfx_A          260 SGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  301 (327)
T ss_dssp             TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cCCC---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            0000         01112234567889999999999999999999998874

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=6.4e-45  Score=346.58  Aligned_cols=254  Identities=24%  Similarity=0.329  Sum_probs=203.2

Q ss_pred             hcCccccceeccCCCeeEEEEEcCC----CcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPN----GQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      .++|++.+.||+|+||.||+|++..    +..||||++... .....+.+.+|+.++++++||||+++++++.++ ..++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~   89 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence            4679999999999999999998432    346999999765 344567899999999999999999999998754 5689


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      ||||+++++|.+++...  ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus        90 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  164 (281)
T 3cc6_A           90 IMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE  164 (281)
T ss_dssp             EEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred             EEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence            99999999999998543  346899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      ...... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||......+....+...      ..     
T Consensus       165 ~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~------~~-----  232 (281)
T 3cc6_A          165 DEDYYK-ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG------DR-----  232 (281)
T ss_dssp             ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT------CC-----
T ss_pred             cccccc-cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC------CC-----
Confidence            433221 123457889999999999999999999999999999998 99999765443322211110      00     


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                       .   ..+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       233 -~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~  270 (281)
T 3cc6_A          233 -L---PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD  270 (281)
T ss_dssp             -C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -C---CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence             0   0111233558889999999999999999999999874

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=5.1e-45  Score=346.90  Aligned_cols=246  Identities=25%  Similarity=0.318  Sum_probs=201.6

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      .++|++.+.||+|+||.||+|.. .+++.||||++....   ......+.+|+.++++++||||+++++++.+....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            56799999999999999999985 467899999986432   22246688999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||+++++|.+++...   ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        88 ~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            9999999999988543   45899999999999999999999988   99999999999999999999999999976543


Q ss_pred             CCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                      ..    .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+...             ..
T Consensus       162 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------~~  224 (279)
T 3fdn_A          162 SR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-------------EF  224 (279)
T ss_dssp             ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-------------CC
T ss_pred             cc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC-------------CC
Confidence            22    12456899999999999999999999999999999999999999865543322211110             00


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                         ..+...+..+.+++.+||+.+|++||++.||++
T Consensus       225 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          225 ---TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             ---CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ---CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence               111123345778999999999999999999986

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-44  Score=358.88  Aligned_cols=263  Identities=24%  Similarity=0.342  Sum_probs=201.0

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC------
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP------  155 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  155 (437)
                      .++|++++.||+|+||.||+|.. .+|+.||||++...  .......+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46799999999999999999985 47999999999643  3444577899999999999999999999997653      


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccc
Q 013745          156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA  235 (437)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  235 (437)
                      ..|+||||+ +++|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            459999999 8899988843    45899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcccceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhh------
Q 013745          236 RLFPGEDTHVNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTL------  308 (437)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~------  308 (437)
                      +......     ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+......      
T Consensus       176 ~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~  250 (367)
T 1cm8_A          176 RQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  250 (367)
T ss_dssp             EECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccccccc-----CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            8764321     23568999999999887 68999999999999999999999999876544332221111000      


Q ss_pred             --hccc-------ccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          309 --FQGE-------KALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       309 --~~~~-------~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                        ....       .........+..........+.+|+.+||+.||++|||+.++++  +++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~  313 (367)
T 1cm8_A          251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES  313 (367)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred             HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHh
Confidence              0000       00000011112222334566889999999999999999999987  5654

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=8.5e-45  Score=345.03  Aligned_cols=248  Identities=26%  Similarity=0.398  Sum_probs=183.1

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCCh---HHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSR---QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ++|++.+.||+|+||.||+|.. .+|+.||||++.....   ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            5699999999999999999985 5799999999964321   22467889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      ||+++++|.+++..  ....+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        91 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           91 EMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             ECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             ecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            99999999998843  3356899999999999999999999998   999999999999999999999999999876533


Q ss_pred             CcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                      ...  .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+      ..       .+..
T Consensus       166 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~-------~~~~  230 (278)
T 3cok_A          166 HEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV------VL-------ADYE  230 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C------CS-------SCCC
T ss_pred             CCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH------hh-------cccC
Confidence            221  22356899999999999989999999999999999999999999764432211100      00       0001


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                         .+...+..+.+++.+||+.||++||++.+|++
T Consensus       231 ---~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          231 ---MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             ---CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ---CccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence               11123456788999999999999999999875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.6e-45  Score=382.38  Aligned_cols=254  Identities=26%  Similarity=0.402  Sum_probs=202.2

Q ss_pred             Cccccc-eeccCCCeeEEEEEcC---CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           87 FFSDLN-QLGHGGFGPVYRGLMP---NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        87 ~y~~~~-~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ++.+.+ .||+|+||.||+|.+.   ++..||||++... .....+.+.+|+++|++++|||||++++++.. +..++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            344444 7999999999999753   5667999999754 23346789999999999999999999999976 5689999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      ||+++|+|.+++..  ....+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.+...
T Consensus       415 E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~  489 (613)
T 2ozo_A          415 EMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD  489 (613)
T ss_dssp             ECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred             EeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence            99999999999843  3456999999999999999999999998   999999999999999999999999999876533


Q ss_pred             Cccc-ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          242 DTHV-NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       242 ~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                      .... ......+++.|+|||++.+..++.++|||||||+||||++ |+.||.+....+....+..       +..     
T Consensus       490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~-------~~~-----  557 (613)
T 2ozo_A          490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-------GKR-----  557 (613)
T ss_dssp             ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHT-------TCC-----
T ss_pred             CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-------CCC-----
Confidence            2211 1112345689999999999999999999999999999998 9999987665443322211       110     


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCC
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD  361 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~  361 (437)
                         ...+...+..+.+|+.+||+.+|++||++.+|++.|+..
T Consensus       558 ---~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          558 ---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             ---CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ---CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence               011223446688999999999999999999999999863

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=3.9e-45  Score=353.83  Aligned_cols=261  Identities=24%  Similarity=0.288  Sum_probs=198.0

Q ss_pred             hcCcccc-ceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCceEEEE
Q 013745           85 TNFFSDL-NQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        85 ~~~y~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      .+.|++. +.||+|+||.||+|.. .+++.||||++..........+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            3568885 7899999999999984 47899999999766555567789999999985 7999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCC---ceeeeccccccc
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN---PKISDFGLARLF  238 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~---~kl~DFGla~~~  238 (437)
                      ||+++++|.+++...   ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.   +||+|||++...
T Consensus        91 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~  164 (316)
T 2ac3_A           91 EKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI  164 (316)
T ss_dssp             ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred             EcCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence            999999999998543   46899999999999999999999998   999999999999988776   999999999865


Q ss_pred             CCCCc-----ccceeeeecccccCChhhhcc-----CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhh------
Q 013745          239 PGEDT-----HVNTFRISGTHGYMAPEYALH-----GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLL------  302 (437)
Q Consensus       239 ~~~~~-----~~~~~~~~gt~~Y~aPE~~~~-----~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~------  302 (437)
                      .....     ........||+.|+|||++.+     ..++.++|||||||++|||++|+.||.+....+.....      
T Consensus       165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  244 (316)
T 2ac3_A          165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA  244 (316)
T ss_dssp             -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred             ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence            42211     111123468999999999975     56899999999999999999999999875432210000      


Q ss_pred             --hhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          303 --SYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       303 --~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                        ........... .........    ..+..+.+++.+||+.||++||++.|+++
T Consensus       245 ~~~~~~~~i~~~~-~~~~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          245 CQNMLFESIQEGK-YEFPDKDWA----HISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHHHCC-CCCCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHhccC-cccCchhcc----cCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence              00000000000 000000001    13456889999999999999999999986

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.5e-44  Score=346.80  Aligned_cols=255  Identities=25%  Similarity=0.363  Sum_probs=201.0

Q ss_pred             cCccccceeccCCCeeEEEEEcCC----CcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeee-ccCCceEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMPN----GQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCC-AEGPEKML  159 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~l  159 (437)
                      .+|++.+.||+|+||.||+|...+    ...||+|++... .....+.+.+|+.++++++||||+++++++ ..+...++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            468999999999999999998432    235899998754 445567899999999999999999999985 45567899


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      ||||+++++|.+++..  ....+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       105 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             EEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             EEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence            9999999999999843  3456899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcc--cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhccccccc
Q 013745          240 GEDTH--VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALE  316 (437)
Q Consensus       240 ~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (437)
                      .....  .......||+.|+|||.+.+..++.++|||||||++|||++ |.+||......+....+      .....   
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~------~~~~~---  250 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL------LQGRR---  250 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH------HTTCC---
T ss_pred             ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH------hcCCC---
Confidence            33211  11223457889999999999999999999999999999999 55666554332221111      11000   


Q ss_pred             ccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          317 LVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       317 ~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                         ..   .+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       251 ---~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~  288 (298)
T 3f66_A          251 ---LL---QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA  288 (298)
T ss_dssp             ---CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CC---CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence               00   011223458889999999999999999999999875

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=5.2e-45  Score=376.05  Aligned_cols=254  Identities=25%  Similarity=0.319  Sum_probs=202.8

Q ss_pred             HhcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCCh-------------HHHHHHHHHHHHHHcCCCCcceeeee
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-------------QGLREFTNEVKLLLKIQHKNLVTLFG  149 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~  149 (437)
                      ..++|.++++||+|+||.||+|... +++.||||++.....             ...+.+.+|+.++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3578999999999999999999854 688999999975421             23467889999999999999999999


Q ss_pred             eeccCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCC---C
Q 013745          150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL---N  226 (437)
Q Consensus       150 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~---~  226 (437)
                      ++.+....++|||||++|+|.+.+...   ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++   .
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence            999999999999999999998888543   45899999999999999999999998   99999999999998776   6


Q ss_pred             ceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhh
Q 013745          227 PKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTW  306 (437)
Q Consensus       227 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~  306 (437)
                      +||+|||+++.+.....   .....||+.|+|||++. +.++.++|||||||++|+|++|..||.+....+....+... 
T Consensus       188 ~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-  262 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG-  262 (504)
T ss_dssp             EEECCCTTCEECCTTSC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-
T ss_pred             EEEEECCCCEEcCCCCc---cccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-
Confidence            99999999987754322   22456999999999987 46899999999999999999999999876544332222110 


Q ss_pred             hhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--Hhc
Q 013745          307 TLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLS  359 (437)
Q Consensus       307 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~  359 (437)
                            .. ....+...    ..+..+.+++.+||+.+|.+|||+.|+++  ++.
T Consensus       263 ------~~-~~~~~~~~----~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~  306 (504)
T 3q5i_A          263 ------KY-YFDFNDWK----NISDEAKELIKLMLTYDYNKRCTAEEALNSRWIK  306 (504)
T ss_dssp             ------CC-CCCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             ------CC-CCCccccC----CCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhh
Confidence                  00 00000001    22356788999999999999999999975  454

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-45  Score=362.53  Aligned_cols=261  Identities=16%  Similarity=0.179  Sum_probs=200.6

Q ss_pred             hcCccccceeccCCCeeEEEEEcC---------CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCccee---------
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP---------NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT---------  146 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~---------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------  146 (437)
                      .++|++.+.||+|+||.||+|...         +++.||||++...     ..+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            357999999999999999999865         3789999999754     35678999999999999998         


Q ss_pred             ------eeeeecc-CCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCE
Q 013745          147 ------LFGCCAE-GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNI  219 (437)
Q Consensus       147 ------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NI  219 (437)
                            +++++.. ....++||||+ +++|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence                  5566654 67889999999 99999998543 2356999999999999999999999998   99999999999


Q ss_pred             EecCCC--CceeeecccccccCCCCccc-----ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCC
Q 013745          220 LLDEQL--NPKISDFGLARLFPGEDTHV-----NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDG  292 (437)
Q Consensus       220 ll~~~~--~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~  292 (437)
                      |++.++  .+||+|||+++.+.......     ......||+.|+|||++.+..++.++|||||||+||||++|+.||..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  89999999998764322111     11234689999999999999999999999999999999999999986


Q ss_pred             CCchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          293 RLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ...... ...........  ......+....  ....+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       271 ~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  333 (352)
T 2jii_A          271 CLPNTE-DIMKQKQKFVD--KPGPFVGPCGH--WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA  333 (352)
T ss_dssp             GTTCHH-HHHHHHHHHHH--SCCCEECTTSC--EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             CCcCHH-HHHHHHHhccC--Chhhhhhhccc--cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence            542211 11111111100  01111111100  01123568889999999999999999999999875

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.4e-45  Score=364.08  Aligned_cols=245  Identities=23%  Similarity=0.259  Sum_probs=192.6

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC---hHHHHHHHHHHHH-HHcCCCCcceeeeeeeccCCceEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS---RQGLREFTNEVKL-LLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      .++|++++.||+|+||.||+|+.+ +++.||||++....   ......+.+|..+ ++.++||||++++++|.+.+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            467999999999999999999854 68899999997542   2334556777776 567899999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      ||||++||+|..++...   ..+++..++.++.||+.||+|||+++   |+||||||+|||++.+|.+||+|||+++...
T Consensus       117 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            99999999999988543   45889999999999999999999998   9999999999999999999999999998643


Q ss_pred             CCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                      ....  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+.      ...       
T Consensus       191 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~------~~~-------  255 (373)
T 2r5t_A          191 EHNS--TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL------NKP-------  255 (373)
T ss_dssp             CCCC--CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHH------HSC-------
T ss_pred             cCCC--ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH------hcc-------
Confidence            3222  1234679999999999999999999999999999999999999998754433221111      100       


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNS  353 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  353 (437)
                      .   ..+......+.+++.+||+.||.+||++.+
T Consensus       256 ~---~~~~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          256 L---QLKPNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             C---CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             c---CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence            0   011123345788999999999999999853

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=5.6e-45  Score=355.78  Aligned_cols=264  Identities=27%  Similarity=0.359  Sum_probs=195.2

Q ss_pred             hcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHH--HHcCCCCcceeeeeee-----ccCCce
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKL--LLKIQHKNLVTLFGCC-----AEGPEK  157 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~-----~~~~~~  157 (437)
                      .++|++.+.||+|+||.||+|+. +++.||||++.....   ..+..|.++  +..++||||+++++.+     ......
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            46799999999999999999987 789999999975433   333444444  4558999999999754     233467


Q ss_pred             EEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhc---------CCCceEeeccCCCCEEecCCCCce
Q 013745          158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE---------APARIIHRDIKASNILLDEQLNPK  228 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---------~~~~iiHrDikp~NIll~~~~~~k  228 (437)
                      ++||||+++|+|.+++..    ..+++..++.++.||+.||.|||+.         +   |+||||||+||||+.++.+|
T Consensus        88 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred             EEEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence            899999999999999843    2358899999999999999999998         6   99999999999999999999


Q ss_pred             eeecccccccCCCCcc------cceeeeecccccCChhhhcc-------CcCCcccceehhhHHHHHHHhCCCCCCCCCc
Q 013745          229 ISDFGLARLFPGEDTH------VNTFRISGTHGYMAPEYALH-------GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLG  295 (437)
Q Consensus       229 l~DFGla~~~~~~~~~------~~~~~~~gt~~Y~aPE~~~~-------~~~~~~~DvwSlG~vl~elltg~~p~~~~~~  295 (437)
                      |+|||+++.+......      .......||+.|+|||++.+       ..++.++|||||||++|||++|..||.....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            9999999876533211      11123468999999999987       4677899999999999999999777643322


Q ss_pred             hhhhhhh-h----------hhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          296 KEKADLL-S----------YTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       296 ~~~~~~~-~----------~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ....... .          ..............+. .........+..+.+++.+||+.||++|||+.||++.|+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~  315 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFP-EAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE  315 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCC-TTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCC-cccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence            1111000 0          0000000000000011 1112233567789999999999999999999999999885

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.7e-44  Score=342.14  Aligned_cols=253  Identities=24%  Similarity=0.338  Sum_probs=204.4

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      .++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            467999999999999999999854 7899999998643 23345778999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |+++++|.+++.   ....+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++..+....
T Consensus        86 ~~~~~~L~~~l~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           86 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ecCCCcHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            999999999883   3356899999999999999999999998   9999999999999999999999999998764333


Q ss_pred             cccceeeeecccccCChhhhccCcC-CcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          243 THVNTFRISGTHGYMAPEYALHGYL-SVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                      .........||+.|+|||++.+..+ +.++|||||||++|||++|+.||......... ...+.     ....  .. +.
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~-----~~~~--~~-~~  230 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWK-----EKKT--YL-NP  230 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHHHH-----TTCT--TS-TT
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHhh-----hccc--cc-Cc
Confidence            2222234578999999999987664 78999999999999999999999865432211 11110     0000  00 01


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                          ....+..+.+++.+||+.+|++||++.+|++
T Consensus       231 ----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          231 ----WKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             ----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                1123345778999999999999999999865

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.2e-44  Score=370.16  Aligned_cols=260  Identities=21%  Similarity=0.277  Sum_probs=205.3

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCC-CcceeeeeeeccCCceEEEEe
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQH-KNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  162 (437)
                      .++|++.++||+|+||.||+|+. .+++.||||++......  ..+.+|+++++.|+| ++|..+..++......+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46899999999999999999984 57999999988654332  357789999999986 555566666677888899999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEe---cCCCCceeeecccccccC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL---DEQLNPKISDFGLARLFP  239 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll---~~~~~~kl~DFGla~~~~  239 (437)
                      |+ +++|.+++...  ...+++..++.|+.||+.||+|||+++   |+||||||+||||   +.++.+||+|||+++.+.
T Consensus        84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 99999998532  356999999999999999999999998   9999999999999   689999999999998875


Q ss_pred             CCCccc-----ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccc
Q 013745          240 GEDTHV-----NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKA  314 (437)
Q Consensus       240 ~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  314 (437)
                      ......     ......||+.|+|||++.+..++.++||||||||||||++|+.||.+.........+........    
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~----  233 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV----  233 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH----
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc----
Confidence            443221     12246799999999999999999999999999999999999999987554333222222111100    


Q ss_pred             ccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          315 LELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       315 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ...+.....    ..+.++.+++..||+.+|++||++.+|+++|+.
T Consensus       234 ~~~~~~l~~----~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~  275 (483)
T 3sv0_A          234 ATSIEALCR----GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRD  275 (483)
T ss_dssp             HSCHHHHHT----TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             cccHHHHhc----CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            000000001    224568899999999999999999999998764

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.4e-45  Score=357.68  Aligned_cols=253  Identities=21%  Similarity=0.233  Sum_probs=180.0

Q ss_pred             Ccccc---ceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCC-CCcceeeeeeeccCCceEEEE
Q 013745           87 FFSDL---NQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        87 ~y~~~---~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  161 (437)
                      +|++.   +.||+|+||.||+|... +++.||||++...   ....+.+|+.+++++. ||||+++++++.+....++||
T Consensus         9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~   85 (325)
T 3kn6_A            9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM   85 (325)
T ss_dssp             HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence            45554   78999999999999854 7899999999654   2356778999999997 999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCC---Cceeeeccccccc
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL---NPKISDFGLARLF  238 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~---~~kl~DFGla~~~  238 (437)
                      ||+++|+|.+++...   ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++   .+||+|||+++..
T Consensus        86 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~  159 (325)
T 3kn6_A           86 ELLNGGELFERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLK  159 (325)
T ss_dssp             CCCCSCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred             EccCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence            999999999998543   56999999999999999999999998   99999999999997665   7999999999876


Q ss_pred             CCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          239 PGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       239 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      ......  ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.....................+.. ...
T Consensus       160 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~-~~~  236 (325)
T 3kn6_A          160 PPDNQP--LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF-SFE  236 (325)
T ss_dssp             CC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC-CCC
T ss_pred             CCCCCc--ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC-CCC
Confidence            543222  22456899999999999999999999999999999999999999865432111111111111111100 000


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVH  355 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~  355 (437)
                      .    ......+..+.+++.+||+.||++||++.+++
T Consensus       237 ~----~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell  269 (325)
T 3kn6_A          237 G----EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR  269 (325)
T ss_dssp             S----HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred             c----ccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence            0    00112345688999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.1e-44  Score=346.75  Aligned_cols=261  Identities=22%  Similarity=0.292  Sum_probs=201.7

Q ss_pred             HhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeee-ccCCceEEEE
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCC-AEGPEKMLVY  161 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~  161 (437)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++......  ..+.+|+.++++++|++++..+..+ ......++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            357899999999999999999984 57899999987644322  3577899999999988877766665 6677789999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEe---cCCCCceeeeccccccc
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL---DEQLNPKISDFGLARLF  238 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll---~~~~~~kl~DFGla~~~  238 (437)
                      ||+ +++|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||+++..
T Consensus        85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            999 99999988532  346999999999999999999999998   9999999999999   78999999999999877


Q ss_pred             CCCCccc-----ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccc
Q 013745          239 PGEDTHV-----NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEK  313 (437)
Q Consensus       239 ~~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (437)
                      .......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+.........  
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--  236 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS--  236 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH--
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc--
Confidence            5443211     122457899999999999999999999999999999999999999865443322222111110000  


Q ss_pred             cccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          314 ALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       314 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                            ..........+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       237 ------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (296)
T 4hgt_A          237 ------TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN  277 (296)
T ss_dssp             ------SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred             ------chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence                  00000001223568899999999999999999999999875

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2e-44  Score=352.47  Aligned_cols=253  Identities=23%  Similarity=0.310  Sum_probs=208.8

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      .++|.+.+.||+|+||.||++... +++.||+|++...   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            467999999999999999999854 6889999998643   344567789999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||+++++|.+++...   ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       120 ~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          120 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             ECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            9999999999987443   46899999999999999999999998   99999999999999999999999999987653


Q ss_pred             CCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                      ....  .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.      ...       .
T Consensus       194 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~------~~~-------~  258 (335)
T 2owb_A          194 DGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK------KNE-------Y  258 (335)
T ss_dssp             TTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------HTC-------C
T ss_pred             Cccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHh------cCC-------C
Confidence            3222  223568999999999999999999999999999999999999998654332211111      000       0


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcCC
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSGD  361 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~~  361 (437)
                      .+   +......+.+++.+||+.||++||++.++++  ++...
T Consensus       259 ~~---~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~  298 (335)
T 2owb_A          259 SI---PKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG  298 (335)
T ss_dssp             CC---CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             CC---CccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence            01   1122345778999999999999999999986  56543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=7.4e-45  Score=356.69  Aligned_cols=251  Identities=22%  Similarity=0.301  Sum_probs=200.0

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCceEEEEe
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      .++|++.+.||+|+||.||+|..+ +|+.||||++......    ..+|++++.++ +||||+++++++.+....|+|||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            567999999999999999999854 7899999999755322    34688888888 79999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCC----CCceeeeccccccc
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ----LNPKISDFGLARLF  238 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~----~~~kl~DFGla~~~  238 (437)
                      |+++|+|.+++..   ...+++..++.++.||+.||.|||+++   |+||||||+|||+.++    +.+||+|||+++..
T Consensus        97 ~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           97 LMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             CCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            9999999998843   356899999999999999999999998   9999999999998433    34999999999876


Q ss_pred             CCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          239 PGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       239 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      ......  ....+||+.|+|||++.+..++.++|||||||++|||++|+.||..........+......    +.. ...
T Consensus       171 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~----~~~-~~~  243 (342)
T 2qr7_A          171 RAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGS----GKF-SLS  243 (342)
T ss_dssp             BCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHH----CCC-CCC
T ss_pred             cCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHcc----CCc-ccC
Confidence            543322  2245789999999999988899999999999999999999999986433222222111110    100 000


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                          .......+..+.+++.+||+.||++||++.++++
T Consensus       244 ----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          244 ----GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             ----STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ----ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                1112234456788999999999999999999975

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=7.9e-45  Score=354.50  Aligned_cols=264  Identities=25%  Similarity=0.378  Sum_probs=201.9

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++...  .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            357999999999999999999854 6899999998644  3334566889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      ||+++++|..++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       104 e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          104 EFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             ECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            9999999988763   2346899999999999999999999998   999999999999999999999999999876433


Q ss_pred             CcccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhh--------hhhhccc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYT--------WTLFQGE  312 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~~~  312 (437)
                      ...  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+....+...        ...+...
T Consensus       178 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          178 GEV--YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             ccc--cCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence            221  1235689999999999876 7899999999999999999999999876544332211110        0001100


Q ss_pred             ccc-cccCccc------cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          313 KAL-ELVDPSL------AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       313 ~~~-~~~d~~l------~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ... ....+.+      ....+..+..+.+++.+||+.||++|||+.|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            000 0000111      0111233566889999999999999999999875

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=5.1e-45  Score=356.84  Aligned_cols=242  Identities=23%  Similarity=0.275  Sum_probs=200.3

Q ss_pred             HhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCCh--------HHHHHHHHHHHHHHcCCCCcceeeeeeeccC
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSR--------QGLREFTNEVKLLLKIQHKNLVTLFGCCAEG  154 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  154 (437)
                      ..++|++.+.||+|+||.||+|+. .+++.||||++.....        .....+.+|+.++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            356899999999999999999984 5789999999975421        1234567899999999999999999999999


Q ss_pred             CceEEEEeecCCC-CcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecc
Q 013745          155 PEKMLVYEYLPNK-SLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG  233 (437)
Q Consensus       155 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG  233 (437)
                      +..++||||+.+| +|..++..   ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999999776 88888743   346999999999999999999999998   9999999999999999999999999


Q ss_pred             cccccCCCCcccceeeeecccccCChhhhccCcC-CcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccc
Q 013745          234 LARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL-SVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGE  312 (437)
Q Consensus       234 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  312 (437)
                      +++.......   .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||........              
T Consensus       176 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--------------  238 (335)
T 3dls_A          176 SAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE--------------  238 (335)
T ss_dssp             TCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT--------------
T ss_pred             cceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh--------------
Confidence            9987754332   224579999999999988776 8899999999999999999999964211000              


Q ss_pred             ccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          313 KALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       313 ~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                         ....     .+...+..+.+++.+||+.+|++||++.+|++
T Consensus       239 ---~~~~-----~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  274 (335)
T 3dls_A          239 ---AAIH-----PPYLVSKELMSLVSGLLQPVPERRTTLEKLVT  274 (335)
T ss_dssp             ---TCCC-----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---hccC-----CCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               0000     01112345788999999999999999999976

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.7e-44  Score=359.41  Aligned_cols=267  Identities=20%  Similarity=0.216  Sum_probs=203.9

Q ss_pred             HHHHhcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCC-CC-----cceeeeeeecc
Q 013745           81 LQVATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HK-----NLVTLFGCCAE  153 (437)
Q Consensus        81 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~  153 (437)
                      .....++|++.+.||+|+||.||+|... +++.||||++... ......+..|+.+++.++ |+     +|+++++++..
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~  127 (382)
T 2vx3_A           49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF  127 (382)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred             CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence            3445678999999999999999999854 7889999999744 334567788999998885 55     49999999999


Q ss_pred             CCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEec--CCCCceeee
Q 013745          154 GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD--EQLNPKISD  231 (437)
Q Consensus       154 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~--~~~~~kl~D  231 (437)
                      .+..++||||++ ++|.+++... ....+++..++.++.||+.||.|||++. .+|+||||||+||||+  .++.+||+|
T Consensus       128 ~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          128 RNHLCLVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             TTEEEEEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEECC
T ss_pred             CCceEEEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEEEe
Confidence            999999999995 5898888543 2346899999999999999999999531 2399999999999994  578899999


Q ss_pred             cccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcc
Q 013745          232 FGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQG  311 (437)
Q Consensus       232 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  311 (437)
                      ||+++......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+.........
T Consensus       205 FG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  279 (382)
T 2vx3_A          205 FGSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA  279 (382)
T ss_dssp             CTTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred             ccCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            99998764332     2356899999999999999999999999999999999999999876554332222111000000


Q ss_pred             ------cc---ccc-cc-----------------Cc---------------------cccCCCHHHHHHHHHHHHHcCCC
Q 013745          312 ------EK---ALE-LV-----------------DP---------------------SLAKCNRDEAAMCIQLGLLCCQQ  343 (437)
Q Consensus       312 ------~~---~~~-~~-----------------d~---------------------~l~~~~~~~~~~l~~l~~~cl~~  343 (437)
                            ..   ..+ ..                 .+                     ........+...+.+|+.+||+.
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~  359 (382)
T 2vx3_A          280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY  359 (382)
T ss_dssp             HHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred             HHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence                  00   000 00                 00                     00011234456789999999999


Q ss_pred             CCCCCCCHHHHHH
Q 013745          344 SVAERPDMNSVHL  356 (437)
Q Consensus       344 ~p~~RPs~~ev~~  356 (437)
                      ||++|||+.|+++
T Consensus       360 dP~~Rpta~e~L~  372 (382)
T 2vx3_A          360 DPKTRIQPYYALQ  372 (382)
T ss_dssp             CTTTSCCHHHHTT
T ss_pred             ChhhCCCHHHHhc
Confidence            9999999999975

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-45  Score=361.06  Aligned_cols=255  Identities=25%  Similarity=0.386  Sum_probs=193.6

Q ss_pred             CccccceeccCCCeeEEEEEcC--CC--cEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeecc-CCceEEE
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMP--NG--QEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE-GPEKMLV  160 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv  160 (437)
                      .|.+.+.||+|+||.||+|.+.  ++  ..||||.+... .....+.+.+|+.++++++||||+++++++.. .+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4778899999999999999853  22  36899998643 34456789999999999999999999998654 5678999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||+++|+|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence            999999999999843  3356889999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCccc--ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccc
Q 013745          241 EDTHV--NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALEL  317 (437)
Q Consensus       241 ~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (437)
                      .....  ......+|+.|+|||++.+..++.++|||||||++|||++ |.+||......+....+      .....   .
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~------~~~~~---~  315 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL------LQGRR---L  315 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH------HTTCC---C
T ss_pred             cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH------HcCCC---C
Confidence            32111  1123457889999999999999999999999999999999 67788765433222111      11110   0


Q ss_pred             cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCC
Q 013745          318 VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD  361 (437)
Q Consensus       318 ~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~  361 (437)
                      .      .+...+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus       316 ~------~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i  353 (373)
T 3c1x_A          316 L------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  353 (373)
T ss_dssp             C------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            0      1112334688899999999999999999999999853

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-44  Score=349.35  Aligned_cols=269  Identities=22%  Similarity=0.334  Sum_probs=201.9

Q ss_pred             HHHHHHHhcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcC--CCCcceeeeeeeccC-
Q 013745           78 LRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI--QHKNLVTLFGCCAEG-  154 (437)
Q Consensus        78 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~-  154 (437)
                      ........++|++.+.||+|+||.||+|+. .++.||||++.....   ..+..|.+++..+  +||||+++++++... 
T Consensus        29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~  104 (337)
T 3mdy_A           29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKGT  104 (337)
T ss_dssp             HHHHTTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred             cccccccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence            334445567899999999999999999987 489999999864432   3445566666655  899999999999877 


Q ss_pred             ---CceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCceEeeccCCCCEEecCCCC
Q 013745          155 ---PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA-----PARIIHRDIKASNILLDEQLN  226 (437)
Q Consensus       155 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----~~~iiHrDikp~NIll~~~~~  226 (437)
                         ...++||||+++|+|.+++..    ..+++..++.++.|++.||.|||+++     ..+|+||||||+|||++.++.
T Consensus       105 ~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~  180 (337)
T 3mdy_A          105 GSWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT  180 (337)
T ss_dssp             GGGCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC
T ss_pred             CCCCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC
Confidence               678999999999999999843    35899999999999999999999981     112999999999999999999


Q ss_pred             ceeeecccccccCCCCcccc--eeeeecccccCChhhhccCcCCcc------cceehhhHHHHHHHhC----------CC
Q 013745          227 PKISDFGLARLFPGEDTHVN--TFRISGTHGYMAPEYALHGYLSVK------TDVFSYGVLVLEIVSG----------RK  288 (437)
Q Consensus       227 ~kl~DFGla~~~~~~~~~~~--~~~~~gt~~Y~aPE~~~~~~~~~~------~DvwSlG~vl~elltg----------~~  288 (437)
                      +||+|||+++.+........  .....||+.|+|||++.+..++.+      +|||||||++|||++|          +.
T Consensus       181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~  260 (337)
T 3mdy_A          181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL  260 (337)
T ss_dssp             EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred             EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence            99999999987644332211  113469999999999988766665      9999999999999999          66


Q ss_pred             CCCCCCchhhhhhhhhhhhhhcccccccccCcccc--CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          289 NHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA--KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       289 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~--~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ||..........  .........    ....+.+.  ......+..+.+++.+||+.||++||++.+|++.|+.
T Consensus       261 p~~~~~~~~~~~--~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  328 (337)
T 3mdy_A          261 PYHDLVPSDPSY--EDMREIVCI----KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK  328 (337)
T ss_dssp             TTTTTSCSSCCH--HHHHHHHTT----SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             cHhhhcCCCCch--hhhHHHHhh----hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence            665432221110  000111100    11111111  1122677889999999999999999999999999874

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1e-44  Score=347.08  Aligned_cols=254  Identities=28%  Similarity=0.413  Sum_probs=204.5

Q ss_pred             hcCccccc-eeccCCCeeEEEEEc---CCCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceE
Q 013745           85 TNFFSDLN-QLGHGGFGPVYRGLM---PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM  158 (437)
Q Consensus        85 ~~~y~~~~-~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  158 (437)
                      .++|.+.+ .||+|+||.||+|.+   .+++.||||++....  ....+.+.+|+.++++++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            45688888 999999999999953   357889999997542  33357799999999999999999999999 566789


Q ss_pred             EEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccccc
Q 013745          159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                      +||||+++++|.+++..   ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus        94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            99999999999999854   245899999999999999999999998   999999999999999999999999999877


Q ss_pred             CCCCccc-ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhccccccc
Q 013745          239 PGEDTHV-NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALE  316 (437)
Q Consensus       239 ~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (437)
                      ....... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+....+..       ..   
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-------~~---  237 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-------GE---  237 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-------TC---
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-------CC---
Confidence            5443221 1122346788999999999899999999999999999999 9999987554332221110       00   


Q ss_pred             ccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          317 LVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       317 ~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                           ....+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       238 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  276 (291)
T 1xbb_A          238 -----RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  276 (291)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             -----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                 011122344568899999999999999999999999985

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8.1e-45  Score=351.14  Aligned_cols=258  Identities=17%  Similarity=0.172  Sum_probs=199.6

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      .++|++.+.||+|+||.||+|... +++.||||++...   .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            467999999999999999999854 7899999999754   233457789999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||+++++|.+++...   ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus       113 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            9999999999998543   46899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                      ..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..........      ......       +
T Consensus       187 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~~~~-------~  252 (309)
T 2h34_A          187 EKLTQ-LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGA------HINQAI-------P  252 (309)
T ss_dssp             -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHH------HHHSCC-------C
T ss_pred             ccccc-ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHH------HhccCC-------C
Confidence            32221 224568999999999999999999999999999999999999997643221110      000000       0


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHhcCCC
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERP-DMNSVHLMLSGDS  362 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~ev~~~L~~~~  362 (437)
                      .........+..+.+++.+||+.+|++|| ++.++++.|+...
T Consensus       253 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l  295 (309)
T 2h34_A          253 RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL  295 (309)
T ss_dssp             CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred             CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence            01111223344678899999999999999 9999999998643

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.4e-44  Score=374.74  Aligned_cols=254  Identities=27%  Similarity=0.338  Sum_probs=207.1

Q ss_pred             HhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      ..++|++.+.||+|+||.||+|+. .+|+.||||++....   ......+.+|+.+|++++|||||++++++.+....|+
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            346799999999999999999985 479999999996431   2234668899999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      ||||++||+|..++.... ...+++..++.++.||+.||.|||+++   |+||||||+||||+.+|.+||+|||+++...
T Consensus       262 VmEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             EECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence            999999999999885432 345999999999999999999999998   9999999999999999999999999998775


Q ss_pred             CCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                      ....   ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........+......   .      .
T Consensus       338 ~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~---~------~  405 (576)
T 2acx_A          338 EGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE---V------P  405 (576)
T ss_dssp             TTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH---C------C
T ss_pred             cCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc---c------c
Confidence            4332   22357999999999999999999999999999999999999999875432211111110000   0      0


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERP-----DMNSVHL  356 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~  356 (437)
                         ...+...+..+.+|+.+||+.||.+||     ++.||++
T Consensus       406 ---~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          406 ---EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ---ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence               011223345688899999999999999     7788864

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=5.6e-45  Score=355.46  Aligned_cols=268  Identities=20%  Similarity=0.255  Sum_probs=197.4

Q ss_pred             HhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCCh--HHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSR--QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      ..++|++.+.||+|+||.||+|+. .+++.||||++.....  .....+.+|+.++++++||||+++++++.+....++|
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  111 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI  111 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence            357899999999999999999984 4789999999975432  2345678999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEec-----CCCCceeeecccc
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD-----EQLNPKISDFGLA  235 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~-----~~~~~kl~DFGla  235 (437)
                      |||++ ++|.+++...   ..+++..++.++.||+.||.|||+++   |+||||||+|||++     .++.+||+|||++
T Consensus       112 ~e~~~-~~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          112 FEYAE-NDLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EECCS-EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EecCC-CCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            99997 4888887433   45899999999999999999999998   99999999999994     4555999999999


Q ss_pred             cccCCCCcccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccc
Q 013745          236 RLFPGEDTHVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKA  314 (437)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  314 (437)
                      +.+......  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+....+............
T Consensus       185 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  262 (329)
T 3gbz_A          185 RAFGIPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTW  262 (329)
T ss_dssp             HHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cccCCcccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhh
Confidence            876533222  2235689999999999875 5899999999999999999999999876544332221111100000000


Q ss_pred             c--------cccCccccCC------CHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          315 L--------ELVDPSLAKC------NRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       315 ~--------~~~d~~l~~~------~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                      .        ....+.....      .......+.+++.+||+.||++|||+.|+++  ++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  324 (329)
T 3gbz_A          263 PGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSH  324 (329)
T ss_dssp             TTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred             hhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCC
Confidence            0        0000000000      0013356789999999999999999999986  5554

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.3e-44  Score=346.55  Aligned_cols=260  Identities=24%  Similarity=0.349  Sum_probs=198.0

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++...   .......+.+|+.++++++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            45799999999999999999984 57999999999752   345567789999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          161 YEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      |||+++++|.+++... .....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            9999999999988542 23456899999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                      .....  .....|++.|+|||++.+..++.++|||||||++|||++|+.||.+...... .+   ...... ...     
T Consensus       188 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~---~~~~~~-~~~-----  255 (310)
T 2wqm_A          188 SKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SL---CKKIEQ-CDY-----  255 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-HH---HHHHHT-TCS-----
T ss_pred             CCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-HH---HHHhhc-ccC-----
Confidence            43221  1235689999999999999999999999999999999999999975432111 11   111110 000     


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCC
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD  361 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~  361 (437)
                      +.+.  ....+..+.+++.+||+.||++||++.+|++.|+..
T Consensus       256 ~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l  295 (310)
T 2wqm_A          256 PPLP--SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM  295 (310)
T ss_dssp             CCCC--TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCc--ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            0110  112345688899999999999999999999998753

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.5e-44  Score=343.38  Aligned_cols=252  Identities=27%  Similarity=0.374  Sum_probs=200.4

Q ss_pred             CccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecC
Q 013745           87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLP  165 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  165 (437)
                      +|.....||+|+||.||+|.. .+++.||||++........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            345556899999999999984 4788999999987655556789999999999999999999999999999999999999


Q ss_pred             CCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC-CCCceeeecccccccCCCCcc
Q 013745          166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE-QLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       166 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~-~~~~kl~DFGla~~~~~~~~~  244 (437)
                      +++|.+++........+++..++.++.||+.||.|||+++   |+||||||+|||++. ++.+||+|||++.........
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~  179 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC  179 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence            9999999866544456788999999999999999999998   999999999999987 899999999999876543221


Q ss_pred             cceeeeecccccCChhhhccCc--CCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccc
Q 013745          245 VNTFRISGTHGYMAPEYALHGY--LSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL  322 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~~--~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  322 (437)
                        .....||+.|+|||++.+..  ++.++|||||||++|||++|+.||..........   ......       ...+. 
T Consensus       180 --~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~-------~~~~~-  246 (295)
T 2clq_A          180 --TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM---FKVGMF-------KVHPE-  246 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH---HHHHHH-------CCCCC-
T ss_pred             --ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH---Hhhccc-------ccccc-
Confidence              22356899999999997753  8999999999999999999999996533222110   000000       01111 


Q ss_pred             cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          323 AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       323 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                        .+...+..+.+++.+||+.+|++||++.++++
T Consensus       247 --~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          247 --IPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             --CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             --ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              12233456788999999999999999999974

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=4.1e-44  Score=343.23  Aligned_cols=252  Identities=22%  Similarity=0.308  Sum_probs=208.0

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      .++|.+.+.||+|+||.||+|... +++.||+|++...   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            467999999999999999999854 6889999998643   344567789999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||+++++|.+++...   ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus        94 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           94 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            9999999999987433   46899999999999999999999998   99999999999999999999999999987653


Q ss_pred             CCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                      ....  .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+.      .. .      .
T Consensus       168 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------~~-~------~  232 (294)
T 2rku_A          168 DGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIK------KN-E------Y  232 (294)
T ss_dssp             TTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------TT-C------C
T ss_pred             Cccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh------hc-c------C
Confidence            3222  223568999999999999899999999999999999999999998654433211110      00 0      0


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                      .+   +......+.+++.+||+.+|++||++.++++  ++..
T Consensus       233 ~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~  271 (294)
T 2rku_A          233 SI---PKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTS  271 (294)
T ss_dssp             CC---CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred             CC---ccccCHHHHHHHHHHcccChhhCcCHHHHhhChheec
Confidence            11   1123345788999999999999999999986  5554

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.4e-44  Score=371.86  Aligned_cols=255  Identities=26%  Similarity=0.383  Sum_probs=206.5

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      .++|++.+.||+|+||.||+|+.. +|+.||||++....   ......+.+|+.++++++||||++++++|.+....|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            367999999999999999999854 79999999996432   22346788999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          161 YEYLPNKSLDYFIFDKT-KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      |||++||+|..++.... ....+++..++.++.||+.||.|||+++   |+||||||+||||+.+|.+||+|||+++.+.
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            99999999999886432 2457999999999999999999999998   9999999999999999999999999998775


Q ss_pred             CCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                      .....  ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........  ........        
T Consensus       341 ~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~--~~~~i~~~--------  408 (543)
T 3c4z_A          341 AGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKE--LKQRVLEQ--------  408 (543)
T ss_dssp             TTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHH--HHHHHHHC--------
T ss_pred             CCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHH--HHHHHhhc--------
Confidence            43322  2245799999999999999999999999999999999999999986543211111  11111110        


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHH
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDM-----NSVHL  356 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~ev~~  356 (437)
                        ....+...+..+.+++.+||+.+|++||++     .+|++
T Consensus       409 --~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          409 --AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             --ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence              011122344567889999999999999975     66653

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.3e-45  Score=353.71  Aligned_cols=262  Identities=23%  Similarity=0.273  Sum_probs=205.1

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeec----cCCceEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCA----EGPEKML  159 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~l  159 (437)
                      .++|++.+.||+|+||.||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++.    .....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            56799999999999999999985 579999999997776667788999999999999999999999986    3457899


Q ss_pred             EEeecCCCCcchhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccccc
Q 013745          160 VYEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                      ||||+++++|.+++... .....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            99999999999988642 23467999999999999999999999998   999999999999999999999999998765


Q ss_pred             CCCCccc-------ceeeeecccccCChhhhccC---cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhh
Q 013745          239 PGEDTHV-------NTFRISGTHGYMAPEYALHG---YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTL  308 (437)
Q Consensus       239 ~~~~~~~-------~~~~~~gt~~Y~aPE~~~~~---~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~  308 (437)
                      .......       ......||+.|+|||++.+.   .++.++|||||||++|||++|+.||.........  +...  .
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~--~  260 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS--VALA--V  260 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC--HHHH--H
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch--hhHH--h
Confidence            3211100       00123479999999998755   3789999999999999999999999532111000  0000  0


Q ss_pred             hcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCCC
Q 013745          309 FQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDS  362 (437)
Q Consensus       309 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~  362 (437)
                       ...    ...+.    ....+..+.+++.+||+.+|.+||++.+|++.|+...
T Consensus       261 -~~~----~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          261 -QNQ----LSIPQ----SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             -HCC------CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             -hcc----CCCCc----cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence             000    00011    1123456889999999999999999999999998643

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.2e-44  Score=359.52  Aligned_cols=256  Identities=20%  Similarity=0.202  Sum_probs=192.8

Q ss_pred             hcCcccc-ceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHH-cCCCCcceeeeeeecc----CCce
Q 013745           85 TNFFSDL-NQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLL-KIQHKNLVTLFGCCAE----GPEK  157 (437)
Q Consensus        85 ~~~y~~~-~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~----~~~~  157 (437)
                      .++|.+. +.||+|+||+||+|... +++.||||++...     ..+.+|+.++. .++||||++++++|..    ....
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            3567766 78999999999999854 7899999999643     34567888874 4589999999998865    5678


Q ss_pred             EEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC---CCCceeeeccc
Q 013745          158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE---QLNPKISDFGL  234 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~---~~~~kl~DFGl  234 (437)
                      |||||||++|+|.+++... ....+++..++.|+.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||+
T Consensus       135 ~lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence            9999999999999998543 2346999999999999999999999998   999999999999987   78999999999


Q ss_pred             ccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccc
Q 013745          235 ARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKA  314 (437)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  314 (437)
                      ++.......   ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.............  ..... +. 
T Consensus       211 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~--~~i~~-~~-  283 (400)
T 1nxk_A          211 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--TRIRM-GQ-  283 (400)
T ss_dssp             CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHH--HHHHH-TC-
T ss_pred             ccccCCCCc---cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHH--HHHHc-Cc-
Confidence            987643322   224678999999999999999999999999999999999999997654322110000  00000 00 


Q ss_pred             ccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          315 LELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       315 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                      .....+.    ....+..+.+|+.+||+.||++|||+.+|++  ++.+
T Consensus       284 ~~~~~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  327 (400)
T 1nxk_A          284 YEFPNPE----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  327 (400)
T ss_dssp             CCCCTTT----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             ccCCCcc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence            0011111    1123456789999999999999999999986  4543

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.5e-44  Score=344.54  Aligned_cols=260  Identities=22%  Similarity=0.293  Sum_probs=204.6

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeee-ccCCceEEEEe
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCC-AEGPEKMLVYE  162 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e  162 (437)
                      .++|++.+.||+|+||.||+|+. .+++.||||++......  ..+.+|+.++++++|++++..+.++ ......++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            56799999999999999999984 58999999998754332  4578999999999988877666655 56677899999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEe---cCCCCceeeecccccccC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL---DEQLNPKISDFGLARLFP  239 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll---~~~~~~kl~DFGla~~~~  239 (437)
                      |+ +++|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||+++...
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            99 99999998432  356999999999999999999999998   9999999999999   588999999999998775


Q ss_pred             CCCccc-----ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccc
Q 013745          240 GEDTHV-----NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKA  314 (437)
Q Consensus       240 ~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  314 (437)
                      ......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+........    
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----  235 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM----  235 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH----
T ss_pred             ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc----
Confidence            443211     12245799999999999999999999999999999999999999986543322221111111000    


Q ss_pred             ccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          315 LELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       315 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                          ...........+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       236 ----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~  277 (296)
T 3uzp_A          236 ----STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN  277 (296)
T ss_dssp             ----HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred             ----CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence                000000011233568899999999999999999999999885

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-44  Score=343.73  Aligned_cols=254  Identities=24%  Similarity=0.281  Sum_probs=200.9

Q ss_pred             CccccceeccCCCeeEEEEEcC-C---CcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCce-EEE
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMP-N---GQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK-MLV  160 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~-~---~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv  160 (437)
                      .|...+.||+|+||.||+|.+. +   +..||+|++... .....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            4667799999999999999842 2   237999999754 445567899999999999999999999999876665 999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||+.+++|.+++..  ....+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            999999999999843  3456899999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCcc--cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCC-CCCCCchhhhhhhhhhhhhhcccccccc
Q 013745          241 EDTH--VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKN-HDGRLGKEKADLLSYTWTLFQGEKALEL  317 (437)
Q Consensus       241 ~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (437)
                      ....  .......+|+.|+|||.+.+..++.++|||||||++|+|++|..| |......+....+..       ..    
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~-------~~----  245 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ-------GR----  245 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHT-------TC----
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhc-------CC----
Confidence            2211  112234578999999999999999999999999999999996555 443332221111110       00    


Q ss_pred             cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          318 VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       318 ~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                       ..   ..+...+..+.+++.+||+.+|.+|||+.+|++.|+.
T Consensus       246 -~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~  284 (298)
T 3pls_A          246 -RL---PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQ  284 (298)
T ss_dssp             -CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CC---CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence             00   1111233568899999999999999999999999875

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.1e-44  Score=355.15  Aligned_cols=253  Identities=17%  Similarity=0.145  Sum_probs=202.9

Q ss_pred             HHHhcCccccceeccCCCeeEEEEE------cCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCC---CCcceeeeeeec
Q 013745           82 QVATNFFSDLNQLGHGGFGPVYRGL------MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ---HKNLVTLFGCCA  152 (437)
Q Consensus        82 ~~~~~~y~~~~~lG~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~  152 (437)
                      +...++|.+.+.||+|+||.||+|.      ..+++.||||++.....   ..+..|+.++.+++   |+||+++++++.
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~  137 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHL  137 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence            3446789999999999999999994      44789999999976543   45678888888887   999999999999


Q ss_pred             cCCceEEEEeecCCCCcchhhhccC--CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC-------
Q 013745          153 EGPEKMLVYEYLPNKSLDYFIFDKT--KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE-------  223 (437)
Q Consensus       153 ~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~-------  223 (437)
                      ..+..++||||+++|+|.+++....  ....+++..++.|+.||+.||+|||+++   |+||||||+||||+.       
T Consensus       138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~  214 (365)
T 3e7e_A          138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDD  214 (365)
T ss_dssp             CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC--
T ss_pred             cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccc
Confidence            9999999999999999999986422  3467999999999999999999999998   999999999999998       


Q ss_pred             ----CCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhh
Q 013745          224 ----QLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKA  299 (437)
Q Consensus       224 ----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~  299 (437)
                          ++.+||+|||+++.+............+||+.|+|||++.+..++.++|||||||++|||++|+.||........ 
T Consensus       215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-  293 (365)
T 3e7e_A          215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-  293 (365)
T ss_dssp             ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-
T ss_pred             cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-
Confidence                899999999999765433323333356799999999999999999999999999999999999999954322100 


Q ss_pred             hhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCC-CCHHHHHHHhcC
Q 013745          300 DLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAER-PDMNSVHLMLSG  360 (437)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~R-Ps~~ev~~~L~~  360 (437)
                                       .+...+....  ....+.+++..|++.+|.+| |++.++.+.|+.
T Consensus       294 -----------------~~~~~~~~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~  336 (365)
T 3e7e_A          294 -----------------KPEGLFRRLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK  336 (365)
T ss_dssp             -----------------EECSCCTTCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred             -----------------eechhccccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence                             0011111111  13345677889999999988 578888777763

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.8e-44  Score=345.86  Aligned_cols=248  Identities=25%  Similarity=0.426  Sum_probs=205.8

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      .+.|++++.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            35699999999999999999984 478999999997542 3345778999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |+++++|.+++.    ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.......
T Consensus       101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            999999999883    356899999999999999999999998   9999999999999999999999999998765432


Q ss_pred             cccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccc
Q 013745          243 THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL  322 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  322 (437)
                      ..  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.   .    ..     .+.+
T Consensus       174 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~----~~-----~~~~  239 (303)
T 3a7i_A          174 IK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP---K----NN-----PPTL  239 (303)
T ss_dssp             CC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---H----SC-----CCCC
T ss_pred             cc--cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhh---c----CC-----CCCC
Confidence            22  223568999999999999999999999999999999999999997654332211110   0    00     0111


Q ss_pred             cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          323 AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       323 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                         ....+..+.+++.+||+.+|++||++.+|++
T Consensus       240 ---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          240 ---EGNYSKPLKEFVEACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             ---CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ---ccccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence               1123345788999999999999999999976

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.4e-44  Score=358.00  Aligned_cols=263  Identities=25%  Similarity=0.344  Sum_probs=188.5

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccC------C
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG------P  155 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  155 (437)
                      .++|++++.||+|+||.||+|.. .+|+.||||++...  .......+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            46799999999999999999984 57899999999653  344567788999999999999999999998654      5


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccc
Q 013745          156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA  235 (437)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  235 (437)
                      ..++|||++ +++|..++.    ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence            679999999 789988873    256999999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcccceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhh-----
Q 013745          236 RLFPGEDTHVNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLF-----  309 (437)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~-----  309 (437)
                      +.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+.......     
T Consensus       180 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~  254 (367)
T 2fst_X          180 RHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL  254 (367)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             cccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            875432     123578999999999887 689999999999999999999999998766543332221110000     


Q ss_pred             ---ccccc---cccc----CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          310 ---QGEKA---LELV----DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       310 ---~~~~~---~~~~----d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                         .....   ...+    ...+..........+.+|+.+||+.||++|||+.++++  ++..
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~  317 (367)
T 2fst_X          255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  317 (367)
T ss_dssp             TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhh
Confidence               00000   0000    00000111123456789999999999999999999975  4543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.4e-43  Score=340.91  Aligned_cols=256  Identities=22%  Similarity=0.248  Sum_probs=201.8

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC----hHHHHHHHHHHHHHHcCCCCcceeeeeee--ccCCce
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS----RQGLREFTNEVKLLLKIQHKNLVTLFGCC--AEGPEK  157 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~--~~~~~~  157 (437)
                      .++|++.+.||+|+||.||+|.. .+++.||||++....    ......+.+|+.++++++||||+++++++  .+....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            47899999999999999999985 478999999997542    23457789999999999999999999998  455678


Q ss_pred             EEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                      ++||||++++ |.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999877 65665433 3467999999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcccceeeeecccccCChhhhccC--cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccc
Q 013745          238 FPGEDTHVNTFRISGTHGYMAPEYALHG--YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKAL  315 (437)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (437)
                      ..............||+.|+|||++.+.  .++.++|||||||++|||++|+.||.+.........+.      . ..  
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~------~-~~--  229 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG------K-GS--  229 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH------H-CC--
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHh------c-CC--
Confidence            6543333333345689999999999764  34789999999999999999999998654332211111      0 00  


Q ss_pred             cccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcCC
Q 013745          316 ELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSGD  361 (437)
Q Consensus       316 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~~  361 (437)
                          .   ..+......+.+++.+||+.||++||++.++++  ++...
T Consensus       230 ----~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  270 (305)
T 2wtk_C          230 ----Y---AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK  270 (305)
T ss_dssp             ----C---CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred             ----C---CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence                0   111123446788999999999999999999985  56543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.3e-44  Score=343.67  Aligned_cols=258  Identities=22%  Similarity=0.295  Sum_probs=204.9

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeec--cCCceEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCA--EGPEKML  159 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l  159 (437)
                      .++|++.+.||+|+||.||+|... +++.||+|++...  .....+.+.+|+.++++++||||+++++++.  .....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            467999999999999999999854 7899999999754  3445677899999999999999999999874  4678899


Q ss_pred             EEeecCCCCcchhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcC--CCceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          160 VYEYLPNKSLDYFIFDKT-KSSSLDWTTRYRIVMGVARGLLYLHEEA--PARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                      ||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+  ..+|+||||||+|||++.++.+||+|||+++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999986432 3345899999999999999999999976  1239999999999999999999999999998


Q ss_pred             ccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccc
Q 013745          237 LFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE  316 (437)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (437)
                      ........  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+.      . +..  
T Consensus       165 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~------~-~~~--  233 (279)
T 2w5a_A          165 ILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR------E-GKF--  233 (279)
T ss_dssp             HC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------H-TCC--
T ss_pred             eecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHh------h-ccc--
Confidence            76543221  113468999999999999999999999999999999999999998754332211111      0 110  


Q ss_pred             ccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          317 LVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       317 ~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                            ...+...+..+.+++.+||+.+|++||++.+|++.+.
T Consensus       234 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          234 ------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             ------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence                  0111233456888999999999999999999988765

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-44  Score=352.90  Aligned_cols=265  Identities=25%  Similarity=0.311  Sum_probs=198.6

Q ss_pred             HhcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChH-----HHHHHHHHHHHHHcCCCCcceeeeeeeccCCce
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQ-----GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK  157 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  157 (437)
                      ..++|++.+.||+|+||.||+|... +|+.||||++......     ..+.+.+|+.++++++||||+++++++.+....
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI   87 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence            3567999999999999999999964 6899999999753211     124678999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                      ++||||+++ +|..++..  ....+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        88 ~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             EEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             EEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            999999976 78777733  3356889999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccc-
Q 013745          238 FPGEDTHVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKAL-  315 (437)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-  315 (437)
                      +......  .....||+.|+|||++.+. .++.++|||||||++|||++|.+||.+....+....+............. 
T Consensus       162 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  239 (346)
T 1ua2_A          162 FGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD  239 (346)
T ss_dssp             TTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred             ccCCccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence            6543222  2235689999999999764 58999999999999999999999998765443322211110000000000 


Q ss_pred             -----cccC-ccccC-----CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          316 -----ELVD-PSLAK-----CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       316 -----~~~d-~~l~~-----~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                           +.+. .....     .....+..+.+++.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence                 0000 00000     01223466889999999999999999999986

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.7e-44  Score=351.53  Aligned_cols=254  Identities=29%  Similarity=0.402  Sum_probs=202.7

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEE--EEEEeccC-ChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCceEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEI--AVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  160 (437)
                      ++|++.+.||+|+||.||+|+.. ++..+  |||++... .....+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            57999999999999999999854 56654  99988643 333456788999999999 899999999999999999999


Q ss_pred             EeecCCCCcchhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCc
Q 013745          161 YEYLPNKSLDYFIFDKT-------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP  227 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~  227 (437)
                      |||+++++|.+++....             ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999985432             2357899999999999999999999998   9999999999999999999


Q ss_pred             eeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhh
Q 013745          228 KISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTW  306 (437)
Q Consensus       228 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~  306 (437)
                      ||+|||+++......   ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+..  
T Consensus       182 kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~--  256 (327)
T 1fvr_A          182 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ--  256 (327)
T ss_dssp             EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG--
T ss_pred             EEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhc--
Confidence            999999997542211   1123456889999999999999999999999999999998 9999987554332211110  


Q ss_pred             hhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          307 TLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       307 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                           ..     ..   ..+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       257 -----~~-----~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  297 (327)
T 1fvr_A          257 -----GY-----RL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  297 (327)
T ss_dssp             -----TC-----CC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -----CC-----CC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                 00     00   1111234568899999999999999999999998874

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.8e-44  Score=353.31  Aligned_cols=266  Identities=23%  Similarity=0.326  Sum_probs=201.2

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeecc--------
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAE--------  153 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------  153 (437)
                      .++|++++.||+|+||.||+|+. .+|+.||||++....  ......+.+|+.++++++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            36799999999999999999985 578999999986442  2223567899999999999999999999876        


Q ss_pred             CCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecc
Q 013745          154 GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG  233 (437)
Q Consensus       154 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG  233 (437)
                      .+..++||||+++ +|...+..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCC-CHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence            4468999999975 66666533  3356999999999999999999999998   9999999999999999999999999


Q ss_pred             cccccCCCCcc--cceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhc
Q 013745          234 LARLFPGEDTH--VNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQ  310 (437)
Q Consensus       234 la~~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  310 (437)
                      +++.+......  .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+........
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            99876532211  11224568999999999876 4689999999999999999999999987665443333222111111


Q ss_pred             ccc--------cccccCccc--cCCCHH------HHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          311 GEK--------ALELVDPSL--AKCNRD------EAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       311 ~~~--------~~~~~d~~l--~~~~~~------~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ...        ..+.+....  ......      ....+.+|+.+||+.||++|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            000        000000000  000001      1345789999999999999999999975

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.7e-44  Score=353.14  Aligned_cols=275  Identities=18%  Similarity=0.235  Sum_probs=203.0

Q ss_pred             cHHHHHHHhcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccC-----------ChHHHHHHHHHHHHHHcCCCCcce
Q 013745           77 DLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD-----------SRQGLREFTNEVKLLLKIQHKNLV  145 (437)
Q Consensus        77 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~-----------~~~~~~~~~~E~~~l~~l~h~niv  145 (437)
                      ...++....++|++.+.||+|+||.||+|...+|+.||||++...           .....+.+.+|+.++++++||||+
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv   92 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL   92 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence            456777888999999999999999999999878999999998542           122347789999999999999999


Q ss_pred             eeeeeec-----cCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEE
Q 013745          146 TLFGCCA-----EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNIL  220 (437)
Q Consensus       146 ~l~~~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIl  220 (437)
                      ++++++.     .....++||||++ |+|.+.+..  ....+++..++.++.||+.||.|||+++   |+||||||+|||
T Consensus        93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl  166 (362)
T 3pg1_A           93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNIL  166 (362)
T ss_dssp             CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEE
T ss_pred             ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEE
Confidence            9999984     3446799999997 577777643  3457999999999999999999999998   999999999999


Q ss_pred             ecCCCCceeeecccccccCCCCcccceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhh
Q 013745          221 LDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKA  299 (437)
Q Consensus       221 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~  299 (437)
                      ++.++.+||+|||+++.......   .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+..
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  243 (362)
T 3pg1_A          167 LADNNDITICDFNLAREDTADAN---KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL  243 (362)
T ss_dssp             ECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             EcCCCCEEEEecCcccccccccc---cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999999999985533222   224568999999999887 67999999999999999999999999876543322


Q ss_pred             hhhhhhhhh--------hcc--------cccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          300 DLLSYTWTL--------FQG--------EKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       300 ~~~~~~~~~--------~~~--------~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                      ..+......        +..        ...............+.....+.+++.+||+.||++|||+.++++  ++++
T Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~  322 (362)
T 3pg1_A          244 NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFES  322 (362)
T ss_dssp             HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTT
T ss_pred             HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhh
Confidence            211100000        000        000000000001111223456889999999999999999999985  4544

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.1e-44  Score=343.10  Aligned_cols=251  Identities=24%  Similarity=0.309  Sum_probs=202.5

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCCh------HHHHHHHHHHHHHHcCCCCcceeeeeeeccCCce
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR------QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK  157 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  157 (437)
                      .++|++.+.||+|+||.||+|... +++.||||++.....      ...+.+.+|+.++++++||||+++++++.+....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            467999999999999999999864 789999999865421      1357789999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCC----Cceeeecc
Q 013745          158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL----NPKISDFG  233 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~----~~kl~DFG  233 (437)
                      ++||||+++++|.+++...   ..+++..++.++.||+.||.|||+++   |+||||||+||+++.++    .+||+|||
T Consensus        84 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            9999999999999998543   46899999999999999999999998   99999999999998877    89999999


Q ss_pred             cccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccc
Q 013745          234 LARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEK  313 (437)
Q Consensus       234 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (437)
                      ++........   .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+...       .
T Consensus       158 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------~  227 (283)
T 3bhy_A          158 IAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV-------N  227 (283)
T ss_dssp             TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-------C
T ss_pred             cceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhc-------c
Confidence            9987644322   12346899999999999999999999999999999999999999875543322111100       0


Q ss_pred             cccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          314 ALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       314 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                        ...+...   ....+..+.+++.+||+.+|++||++.++++
T Consensus       228 --~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          228 --YDFDEEY---FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             --CCCCHHH---HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --cCCcchh---cccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence              0000000   0122345788999999999999999999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.5e-44  Score=341.99  Aligned_cols=250  Identities=23%  Similarity=0.276  Sum_probs=206.4

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      .++|++.+.||+|+||.||+|... +++.||||++....   ......+.+|+.++++++||||+++++++.+.+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            367999999999999999999854 68899999986432   12246788999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||+++++|.+++...   ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus        93 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  166 (284)
T 2vgo_A           93 LEFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS  166 (284)
T ss_dssp             ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred             EEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence            9999999999988543   35899999999999999999999998   99999999999999999999999999976543


Q ss_pred             CCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                      ...    ....|++.|+|||++.+..++.++||||||+++|+|++|+.||......+....+      ...       +.
T Consensus       167 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~------~~~-------~~  229 (284)
T 2vgo_A          167 LRR----RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI------VNV-------DL  229 (284)
T ss_dssp             SCB----CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HTT-------CC
T ss_pred             ccc----ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHH------hcc-------cc
Confidence            221    2356899999999999999999999999999999999999999865443321111      100       01


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                      .   .+...+..+.+++.+||+.+|.+||++.++++  ++..
T Consensus       230 ~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~  268 (284)
T 2vgo_A          230 K---FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKA  268 (284)
T ss_dssp             C---CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHH
T ss_pred             C---CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHh
Confidence            1   11223456788999999999999999999985  5554

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.7e-45  Score=364.50  Aligned_cols=242  Identities=14%  Similarity=0.132  Sum_probs=189.0

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHH---HHHcCCCCcceeee-------ee
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVK---LLLKIQHKNLVTLF-------GC  150 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~---~l~~l~h~niv~l~-------~~  150 (437)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++...   .....+.+.+|+.   ++++++|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46799999999999999999995 47999999999733   3345678899994   55555799999998       55


Q ss_pred             eccCC-----------------ceEEEEeecCCCCcchhhhccCC----CCCCCHHHHHHHHHHHHHHHHHhhhcCCCce
Q 013745          151 CAEGP-----------------EKMLVYEYLPNKSLDYFIFDKTK----SSSLDWTTRYRIVMGVARGLLYLHEEAPARI  209 (437)
Q Consensus       151 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i  209 (437)
                      +.+.+                 ..|+||||+ +|+|.+++.....    ...+++..++.|+.||+.||+|||+++   |
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            54443                 278999999 6899999864321    123445888899999999999999998   9


Q ss_pred             EeeccCCCCEEecCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccC-----------cCCcccceehhhH
Q 013745          210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHG-----------YLSVKTDVFSYGV  278 (437)
Q Consensus       210 iHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----------~~~~~~DvwSlG~  278 (437)
                      +||||||+||||+.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++|||||||
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999986432     1224567 999999999887           8999999999999


Q ss_pred             HHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          279 LVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       279 vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      +||||++|+.||.+.........+                ......    .+..+.+++.+||+.||++||++.++++
T Consensus       302 il~elltg~~Pf~~~~~~~~~~~~----------------~~~~~~----~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGGSEWI----------------FRSCKN----IPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHSSCCC------CCSGGG----------------GSSCCC----CCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHCCCCCcccccccchhhh----------------hhhccC----CCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            999999999999764432221111                001112    2345788999999999999999999985

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.3e-44  Score=344.02  Aligned_cols=249  Identities=26%  Similarity=0.364  Sum_probs=197.5

Q ss_pred             hcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccC-CceEEEEee
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG-PEKMLVYEY  163 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~  163 (437)
                      .++|++.+.||+|+||.||+|.. +|+.||||++....  ..+.+.+|+.++++++||||+++++++.+. +..++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            46799999999999999999987 58899999997543  346788999999999999999999997554 478999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +++++|.+++.... ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++........
T Consensus        97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  172 (278)
T 1byg_A           97 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD  172 (278)
T ss_dssp             CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccccc
Confidence            99999999985432 234788999999999999999999998   99999999999999999999999999986543221


Q ss_pred             ccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCccc
Q 013745          244 HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL  322 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  322 (437)
                           ...+++.|+|||++.+..++.++||||||+++|||++ |+.||......+....+.       ...     ..  
T Consensus       173 -----~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-------~~~-----~~--  233 (278)
T 1byg_A          173 -----TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGY-----KM--  233 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-------TTC-----CC--
T ss_pred             -----CCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-------cCC-----CC--
Confidence                 2357889999999999999999999999999999998 999997654332221111       000     01  


Q ss_pred             cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          323 AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       323 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                       ..+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       234 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  270 (278)
T 1byg_A          234 -DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH  270 (278)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence             1112334568889999999999999999999999874

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.8e-44  Score=359.58  Aligned_cols=263  Identities=22%  Similarity=0.280  Sum_probs=203.7

Q ss_pred             HHhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCC--------CCcceeeeeeec-
Q 013745           83 VATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ--------HKNLVTLFGCCA-  152 (437)
Q Consensus        83 ~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~-  152 (437)
                      ...++|++.+.||+|+||.||+|+. .+++.||||++... ....+.+.+|+.++++++        |+||+++++++. 
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~  112 (397)
T 1wak_A           34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI  112 (397)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred             hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence            3457899999999999999999984 47899999999754 344577889999999985        788999999987 


Q ss_pred             ---cCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCceEeeccCCCCEEecCCC---
Q 013745          153 ---EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE-APARIIHRDIKASNILLDEQL---  225 (437)
Q Consensus       153 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~iiHrDikp~NIll~~~~---  225 (437)
                         .....++||||+ +++|.+.+... ....+++..++.++.||+.||.|||++ +   |+||||||+||||+.++   
T Consensus       113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~  187 (397)
T 1wak_A          113 SGVNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYI  187 (397)
T ss_dssp             EETTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHH
T ss_pred             cCCCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhh
Confidence               566889999999 55555555433 335699999999999999999999998 7   99999999999998775   


Q ss_pred             ----------------------------------------------CceeeecccccccCCCCcccceeeeecccccCCh
Q 013745          226 ----------------------------------------------NPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP  259 (437)
Q Consensus       226 ----------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aP  259 (437)
                                                                    .+||+|||+++......     ....||+.|+||
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~gt~~y~aP  262 (397)
T 1wak_A          188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQYRSL  262 (397)
T ss_dssp             HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCSCGGGCCH
T ss_pred             hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccCCCCCcccCC
Confidence                                                          89999999998764321     234689999999


Q ss_pred             hhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhh---hhhhhhhh------------------hccccccccc
Q 013745          260 EYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKAD---LLSYTWTL------------------FQGEKALELV  318 (437)
Q Consensus       260 E~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~---~~~~~~~~------------------~~~~~~~~~~  318 (437)
                      |++.+..++.++|||||||+||||++|+.||......+...   .+......                  +........+
T Consensus       263 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  342 (397)
T 1wak_A          263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI  342 (397)
T ss_dssp             HHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred             hhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence            99999999999999999999999999999998655332111   11111000                  0000000000


Q ss_pred             Cc-----------cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          319 DP-----------SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       319 d~-----------~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ..           ............+.+|+.+||+.||++|||+.||++
T Consensus       343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            00           001345677888999999999999999999999975

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.7e-44  Score=347.70  Aligned_cols=254  Identities=23%  Similarity=0.290  Sum_probs=205.1

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      .++|.+.+.||+|+||.||+|... +|+.||||++..........+.+|+.++++++||||+++++++.+....++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            567999999999999999999854 7999999999866544456788999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEe---cCCCCceeeecccccccCC
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL---DEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll---~~~~~~kl~DFGla~~~~~  240 (437)
                      +++++|.+++...   ..+++..++.++.|++.||.|||+.+   |+||||||+|||+   +.++.+||+|||++.....
T Consensus        88 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           88 VSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             CCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             CCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            9999999888543   45899999999999999999999998   9999999999999   7889999999999976533


Q ss_pred             CCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                      ..    .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..       .. ..... 
T Consensus       162 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~-------~~-~~~~~-  228 (304)
T 2jam_A          162 GI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE-------GY-YEFES-  228 (304)
T ss_dssp             BT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-------CC-CCCCT-
T ss_pred             Cc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc-------CC-CCCCc-
Confidence            21    1134689999999999999999999999999999999999999986544322211110       00 00001 


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                         ......+..+.+++.+||+.||++||++.++++  ++.+
T Consensus       229 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  267 (304)
T 2jam_A          229 ---PFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG  267 (304)
T ss_dssp             ---TTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHS
T ss_pred             ---cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccC
Confidence               111233456889999999999999999999986  5654

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.7e-44  Score=363.74  Aligned_cols=254  Identities=20%  Similarity=0.270  Sum_probs=192.1

Q ss_pred             HHHhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC--------hHHHHHHHHHHHHHHcCCCCcceeeeeeec
Q 013745           82 QVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS--------RQGLREFTNEVKLLLKIQHKNLVTLFGCCA  152 (437)
Q Consensus        82 ~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  152 (437)
                      ....++|.+.+.||+|+||.||+|.. .+++.||||++....        ......+.+|+.+|++++||||+++++++.
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            34568899999999999999999984 478999999986431        112234789999999999999999999985


Q ss_pred             cCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCC---Ccee
Q 013745          153 EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL---NPKI  229 (437)
Q Consensus       153 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~---~~kl  229 (437)
                      . +..++||||+++|+|.+++.   ....+++..++.++.||+.||+|||+++   |+||||||+|||++.++   .+||
T Consensus       211 ~-~~~~lv~e~~~~g~L~~~l~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          211 A-EDYYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             S-SEEEEEEECCTTCBGGGGTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             c-CceEEEEEcCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEE
Confidence            4 45899999999999988873   3456999999999999999999999998   99999999999997544   5999


Q ss_pred             eecccccccCCCCcccceeeeecccccCChhhhcc---CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhh
Q 013745          230 SDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH---GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTW  306 (437)
Q Consensus       230 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~  306 (437)
                      +|||+++.......   ....+||+.|+|||++.+   ..++.++|||||||++|||++|+.||.........  ...  
T Consensus       284 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~--~~~--  356 (419)
T 3i6u_A          284 TDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQ--  356 (419)
T ss_dssp             CCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH--HHH--
T ss_pred             eecccceecCCCcc---ccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH--HHH--
Confidence            99999987653321   224679999999999864   57889999999999999999999999764332111  000  


Q ss_pred             hhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          307 TLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       307 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                        ..... .... +..   ....+..+.+++.+||+.+|++||++.++++
T Consensus       357 --i~~~~-~~~~-~~~---~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          357 --ITSGK-YNFI-PEV---WAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             --HHTTC-CCCC-HHH---HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --HhcCC-CCCC-chh---hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence              00000 0000 000   0123456789999999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=6.1e-45  Score=354.85  Aligned_cols=258  Identities=22%  Similarity=0.260  Sum_probs=190.3

Q ss_pred             HhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCC-CCcceeeeeee--------cc
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCC--------AE  153 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~--------~~  153 (437)
                      ...+|++.+.||+|+||.||+|+. .+++.||||++........+.+.+|+.++.++. ||||+++++++        ..
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            456899999999999999999985 478999999997777666778999999999996 99999999998        34


Q ss_pred             CCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecc
Q 013745          154 GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG  233 (437)
Q Consensus       154 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG  233 (437)
                      ....++||||+. |+|.+++........+++..++.++.||+.||.|||+++ .+|+||||||+|||++.++.+||+|||
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg  183 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG  183 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred             CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence            445799999995 788888765445567999999999999999999999975 349999999999999999999999999


Q ss_pred             cccccCCCCccc----------ceeeeecccccCChhhh---ccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhh
Q 013745          234 LARLFPGEDTHV----------NTFRISGTHGYMAPEYA---LHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKAD  300 (437)
Q Consensus       234 la~~~~~~~~~~----------~~~~~~gt~~Y~aPE~~---~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~  300 (437)
                      +++.........          ......||+.|+|||++   .+..++.++|||||||++|||++|+.||........  
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--  261 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI--  261 (337)
T ss_dssp             TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh--
Confidence            998765432211          11134589999999998   566789999999999999999999999975332111  


Q ss_pred             hhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCC
Q 013745          301 LLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD  361 (437)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~  361 (437)
                       ...   ..      .  .+...    .....+.+++.+||+.+|++||++.+|++.|+..
T Consensus       262 -~~~---~~------~--~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~  306 (337)
T 3ll6_A          262 -VNG---KY------S--IPPHD----TQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI  306 (337)
T ss_dssp             --------C------C--CCTTC----CSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             -hcC---cc------c--CCccc----ccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             000   00      0  00001    1123367899999999999999999999998753

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=8e-44  Score=352.43  Aligned_cols=259  Identities=21%  Similarity=0.320  Sum_probs=207.8

Q ss_pred             cHHHHHHHhcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC--------hHHHHHHHHHHHHHHcC-CCCccee
Q 013745           77 DLRTLQVATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS--------RQGLREFTNEVKLLLKI-QHKNLVT  146 (437)
Q Consensus        77 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~  146 (437)
                      .........++|++.+.||+|+||.||+|+.. +|+.||||++....        ....+.+.+|+.+++++ +||||++
T Consensus        85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~  164 (365)
T 2y7j_A           85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT  164 (365)
T ss_dssp             HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred             cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            34445556688999999999999999999964 79999999986542        11245678999999999 7999999


Q ss_pred             eeeeeccCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCC
Q 013745          147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN  226 (437)
Q Consensus       147 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~  226 (437)
                      +++++......++||||+++++|.+++...   ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.
T Consensus       165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~  238 (365)
T 2y7j_A          165 LIDSYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQ  238 (365)
T ss_dssp             EEEEEEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCC
T ss_pred             EEEEEeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCC
Confidence            999999999999999999999999998543   46899999999999999999999998   999999999999999999


Q ss_pred             ceeeecccccccCCCCcccceeeeecccccCChhhhccC------cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhh
Q 013745          227 PKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHG------YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKAD  300 (437)
Q Consensus       227 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~------~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~  300 (437)
                      +||+|||++..+.....   .....||+.|+|||++.+.      .++.++|||||||++|||++|+.||..........
T Consensus       239 ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  315 (365)
T 2y7j_A          239 IRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLR  315 (365)
T ss_dssp             EEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             EEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            99999999987754332   2245799999999998643      58899999999999999999999997654332211


Q ss_pred             hhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          301 LLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .+..       .. .....+....    .+..+.+++.+||+.+|++||++.++++
T Consensus       316 ~i~~-------~~-~~~~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          316 MIME-------GQ-YQFSSPEWDD----RSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHHH-------TC-CCCCHHHHSS----SCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHh-------CC-CCCCCccccc----CCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1110       00 0000011111    2345788999999999999999999986

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.4e-43  Score=346.50  Aligned_cols=267  Identities=22%  Similarity=0.305  Sum_probs=208.9

Q ss_pred             cHHHHHHHhcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHc--CCCCcceeeeeeeccC
Q 013745           77 DLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLK--IQHKNLVTLFGCCAEG  154 (437)
Q Consensus        77 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~  154 (437)
                      .........++|++.+.||+|+||.||+|+. +++.||||++....   ...+.+|++++..  ++||||+++++++...
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            3444556678899999999999999999987 68999999996442   3567789999887  7899999999999877


Q ss_pred             C----ceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhh--------hcCCCceEeeccCCCCEEec
Q 013745          155 P----EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH--------EEAPARIIHRDIKASNILLD  222 (437)
Q Consensus       155 ~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--------~~~~~~iiHrDikp~NIll~  222 (437)
                      .    ..++||||+++|+|.+++..    ..+++..++.++.|++.||.|||        +.+   |+||||||+|||++
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~  181 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVK  181 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEEC
T ss_pred             CCccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEEC
Confidence            6    78999999999999999843    35899999999999999999999        666   99999999999999


Q ss_pred             CCCCceeeecccccccCCCCccc--ceeeeecccccCChhhhccC------cCCcccceehhhHHHHHHHhC--------
Q 013745          223 EQLNPKISDFGLARLFPGEDTHV--NTFRISGTHGYMAPEYALHG------YLSVKTDVFSYGVLVLEIVSG--------  286 (437)
Q Consensus       223 ~~~~~kl~DFGla~~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~------~~~~~~DvwSlG~vl~elltg--------  286 (437)
                      .++.+||+|||+++.........  ......||+.|+|||++.+.      .++.++|||||||++|||++|        
T Consensus       182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~  261 (342)
T 1b6c_B          182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE  261 (342)
T ss_dssp             TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred             CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence            99999999999998765443221  12235689999999999876      344789999999999999999        


Q ss_pred             --CCCCCCCCchhhhhhhhhhhhhhcccccccccCccccC--CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          287 --RKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK--CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       287 --~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                        +.||..........  .........    ....+.+..  ........+.+++.+||+.+|++||++.+|++.|+.
T Consensus       262 ~~~~p~~~~~~~~~~~--~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~  333 (342)
T 1b6c_B          262 DYQLPYYDLVPSDPSV--EEMRKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  333 (342)
T ss_dssp             CCCCTTTTTSCSSCCH--HHHHHHHTT----SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             ccccCccccCcCcccH--HHHHHHHHH----HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHH
Confidence              77876543221110  011111111    111121111  123667789999999999999999999999999874

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.3e-44  Score=342.73  Aligned_cols=245  Identities=22%  Similarity=0.276  Sum_probs=198.7

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCceEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  160 (437)
                      .++|++.+.||+|+||.||+|... +++.||||++...  .......+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            567999999999999999999864 7999999999753  334456788999999999 899999999999999999999


Q ss_pred             EeecCCCCcchhhhccC-CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCC---------------
Q 013745          161 YEYLPNKSLDYFIFDKT-KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ---------------  224 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~---------------  224 (437)
                      |||+++++|.+++.... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.+               
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            99999999999986432 1256899999999999999999999998   9999999999999844               


Q ss_pred             ----CCceeeecccccccCCCCcccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhh
Q 013745          225 ----LNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKA  299 (437)
Q Consensus       225 ----~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~  299 (437)
                          ..+||+|||++.......      ...||+.|+|||++.+. .++.++|||||||++|||++|.+++......   
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---  237 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---  237 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---
T ss_pred             cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---
Confidence                479999999998765432      23589999999999876 6778999999999999999999876432110   


Q ss_pred             hhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          300 DLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                             ........     +.   .+...+..+.+++.+||+.||++||++.++++
T Consensus       238 -------~~~~~~~~-----~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          238 -------HEIRQGRL-----PR---IPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             -------HHHHTTCC-----CC---CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------HHHHcCCC-----CC---CCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                   00000110     11   11123456788999999999999999999865

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.8e-44  Score=347.60  Aligned_cols=269  Identities=23%  Similarity=0.354  Sum_probs=199.1

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeec-----------
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCA-----------  152 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-----------  152 (437)
                      .++|++.+.||+|+||.||+|... +++.||||++........+.+.+|+.++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            467999999999999999999864 58999999998777777788999999999999999999998873           


Q ss_pred             ---cCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEec-CCCCce
Q 013745          153 ---EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD-EQLNPK  228 (437)
Q Consensus       153 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~-~~~~~k  228 (437)
                         +....++||||++ |+|.+++.    ...+++..++.++.||+.||+|||+++   |+||||||+|||++ +++.+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence               4467899999997 68988873    356899999999999999999999998   99999999999997 567999


Q ss_pred             eeecccccccCCCCcc-cceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhh
Q 013745          229 ISDFGLARLFPGEDTH-VNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTW  306 (437)
Q Consensus       229 l~DFGla~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~  306 (437)
                      |+|||+++........ .......+|..|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+....
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  241 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI  241 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            9999999876432111 11123457899999998876 678999999999999999999999998765433222111110


Q ss_pred             hhhccccccc------------ccCc--cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcCC
Q 013745          307 TLFQGEKALE------------LVDP--SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSGD  361 (437)
Q Consensus       307 ~~~~~~~~~~------------~~d~--~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~~  361 (437)
                      .........+            ...+  .+.......+..+.+++.+||+.||++||++.++++  ++...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (320)
T 2i6l_A          242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY  312 (320)
T ss_dssp             CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence            0000000000            0000  000111223456889999999999999999999976  66643

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.4e-45  Score=358.48  Aligned_cols=254  Identities=25%  Similarity=0.303  Sum_probs=201.8

Q ss_pred             hcCccccceeccCCCeeEEEEEc----CCCcEEEEEEeccCC----hHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCC
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM----PNGQEIAVKKLSVDS----RQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGP  155 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  155 (437)
                      .++|++.+.||+|+||.||+|+.    .+++.||||++....    ....+.+.+|+.++.++ +||||+++++++....
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            46799999999999999999985    378999999986431    12234567899999999 6999999999999999


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccc
Q 013745          156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA  235 (437)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  235 (437)
                      ..++||||+++++|.+++...   ..+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            999999999999999998543   35899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcccceeeeecccccCChhhhccC--cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccc
Q 013745          236 RLFPGEDTHVNTFRISGTHGYMAPEYALHG--YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEK  313 (437)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (437)
                      +.+....... ....+||+.|+|||++.+.  .++.++|||||||+||||++|+.||...........+.  ......  
T Consensus       207 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~--~~~~~~--  281 (355)
T 1vzo_A          207 KEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--RRILKS--  281 (355)
T ss_dssp             EECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH--HHHHHC--
T ss_pred             eecccCCCCc-ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHH--HHHhcc--
Confidence            8764332222 2245799999999999863  57899999999999999999999997543322211111  111100  


Q ss_pred             cccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHHH
Q 013745          314 ALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERP-----DMNSVHLM  357 (437)
Q Consensus       314 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~~  357 (437)
                              ....+...+..+.+++.+||+.||++||     ++.++++.
T Consensus       282 --------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          282 --------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             --------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             --------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence                    0112223345678899999999999999     89998763

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.6e-44  Score=368.91  Aligned_cols=250  Identities=24%  Similarity=0.321  Sum_probs=199.1

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      .++|++++.||+|+||.||+|+.. ++..||||++....  ......+.+|+.++++++||||++++++|.+....++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            456999999999999999999854 78999999997542  223467889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC---CCCceeeeccccccc
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE---QLNPKISDFGLARLF  238 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~---~~~~kl~DFGla~~~  238 (437)
                      |||++|+|.+.+...   ..+++..++.++.||+.||.|||+++   |+||||||+|||++.   ++.+||+|||+++.+
T Consensus       116 e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          116 ECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            999999998887543   45899999999999999999999998   999999999999976   455999999999877


Q ss_pred             CCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          239 PGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       239 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      .....   ....+||+.|+|||++. +.++.++|||||||++|+|++|+.||.+....+....+....        ....
T Consensus       190 ~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--------~~~~  257 (494)
T 3lij_A          190 ENQKK---MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGK--------YTFD  257 (494)
T ss_dssp             BTTBC---BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--------CCCC
T ss_pred             CCCcc---ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--------CCCC
Confidence            54322   22457999999999886 468999999999999999999999998765543322211110        0011


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .+...    ..+..+.+++.+||+.+|.+|||+.++++
T Consensus       258 ~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          258 SPEWK----NVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             SGGGT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             chhcc----cCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            11111    23345788999999999999999999974

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.3e-44  Score=368.43  Aligned_cols=253  Identities=25%  Similarity=0.307  Sum_probs=203.7

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      .++|++++.||+|+||+||+|... +++.||||++...  .......+.+|+.++++++||||+++++++.+....++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            467999999999999999999854 7899999998643  1223567889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEec---CCCCceeeeccccccc
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD---EQLNPKISDFGLARLF  238 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~---~~~~~kl~DFGla~~~  238 (437)
                      |||++++|.+.+...   ..+++..++.++.||+.||.|||+++   |+||||||+|||++   .++.+||+|||+++.+
T Consensus       101 e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A          101 ELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            999999998888543   46899999999999999999999998   99999999999995   4567999999999876


Q ss_pred             CCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          239 PGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       239 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      .....   .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+....+...      ..  ...
T Consensus       175 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~------~~--~~~  242 (486)
T 3mwu_A          175 QQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETG------KY--AFD  242 (486)
T ss_dssp             CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------CC--CSC
T ss_pred             CCCCc---cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CC--CCC
Confidence            54322   223569999999999876 5899999999999999999999999876543322211110      00  000


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--Hhc
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLS  359 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~  359 (437)
                      .+...    ..+..+.+++.+||+.+|++|||+.++++  +++
T Consensus       243 ~~~~~----~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~  281 (486)
T 3mwu_A          243 LPQWR----TISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ  281 (486)
T ss_dssp             SGGGG----GSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHH
T ss_pred             CcccC----CCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhc
Confidence            11111    23345789999999999999999999986  454

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.6e-44  Score=354.83  Aligned_cols=262  Identities=23%  Similarity=0.313  Sum_probs=204.9

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      .++|++.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            467999999999999999999854 7899999999765 34456778999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE-APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      |+++++|.+++...   ..+++..++.++.|++.||.|||++ +   |+||||||+|||++.++.+||+|||++......
T Consensus       112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            99999999998543   3589999999999999999999996 7   999999999999999999999999999765322


Q ss_pred             CcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhh-------------
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTL-------------  308 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~-------------  308 (437)
                      .    .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+...........             
T Consensus       186 ~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          186 M----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             C--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             c----ccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence            1    12357899999999999999999999999999999999999999865543322111100000             


Q ss_pred             ----------hcccccccccC----cccc-CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          309 ----------FQGEKALELVD----PSLA-KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       309 ----------~~~~~~~~~~d----~~l~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                                .......+.++    .... ......+..+.+++.+||+.||++|||+.++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                      00000000000    0000 001123456889999999999999999999975

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.7e-44  Score=379.72  Aligned_cols=247  Identities=29%  Similarity=0.418  Sum_probs=198.6

Q ss_pred             ceeccCCCeeEEEEEc---CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCC
Q 013745           92 NQLGHGGFGPVYRGLM---PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN  166 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  166 (437)
                      +.||+|+||.||+|.+   ..++.||||++...  .....+.+.+|+.+|++++|||||++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999964   35688999999754  23346789999999999999999999999965 468999999999


Q ss_pred             CCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc-c
Q 013745          167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH-V  245 (437)
Q Consensus       167 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~-~  245 (437)
                      |+|.+++..   ...+++..++.|+.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.+...... .
T Consensus       454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            999999843   356899999999999999999999998   999999999999999999999999999977543321 1


Q ss_pred             ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccC
Q 013745          246 NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK  324 (437)
Q Consensus       246 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  324 (437)
                      ......+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+....+....+...       ..        ..
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~-------~~--------~~  592 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-------ER--------MG  592 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-------CC--------CC
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-------CC--------CC
Confidence            1223456789999999999999999999999999999998 99999876654432222111       00        11


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          325 CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       325 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      .+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       593 ~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  628 (635)
T 4fl3_A          593 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  628 (635)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            122344668899999999999999999999999874

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=4.8e-44  Score=380.28  Aligned_cols=250  Identities=23%  Similarity=0.297  Sum_probs=206.0

Q ss_pred             HHhcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC---ChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCce
Q 013745           83 VATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD---SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEK  157 (437)
Q Consensus        83 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  157 (437)
                      ...++|++++.||+|+||.||+|+.. +++.||||++...   .....+.+..|..++..+ +||||+++++++.+.+.+
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            34578999999999999999999854 6889999999743   223346678899999988 699999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                      ||||||+++|+|..++...   ..+++..++.|+.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.
T Consensus       418 ~lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~  491 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE  491 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred             EEEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeec
Confidence            9999999999999998543   46899999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccc
Q 013745          238 FPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALEL  317 (437)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (437)
                      .......  ....+||+.|+|||++.+..++.++|||||||+||||++|+.||.+....+....+.      ...     
T Consensus       492 ~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~------~~~-----  558 (674)
T 3pfq_A          492 NIWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM------EHN-----  558 (674)
T ss_dssp             CCCTTCC--BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------SSC-----
T ss_pred             cccCCcc--cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH------hCC-----
Confidence            5333222  235689999999999999999999999999999999999999998765433222111      110     


Q ss_pred             cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHH
Q 013745          318 VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDM-----NSVHL  356 (437)
Q Consensus       318 ~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~-----~ev~~  356 (437)
                           ...+...+.++.+|+.+||+.||++||++     .+|++
T Consensus       559 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          559 -----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             -----CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                 01122344568899999999999999998     77764

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.5e-44  Score=369.11  Aligned_cols=254  Identities=26%  Similarity=0.315  Sum_probs=206.8

Q ss_pred             HhcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      ..++|++.+.||+|+||.||+|+.. +|+.||||++...   .......+.+|+.++++++||||+++++++.+....++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3567999999999999999999854 7999999998643   23345778999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEe---cCCCCceeeeccccc
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL---DEQLNPKISDFGLAR  236 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll---~~~~~~kl~DFGla~  236 (437)
                      ||||+.+++|.+.+..   ...+++..++.++.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||+++
T Consensus       104 v~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          104 VGEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             EECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             EEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            9999999999888843   356899999999999999999999998   9999999999999   567899999999998


Q ss_pred             ccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccc
Q 013745          237 LFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE  316 (437)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (437)
                      .+......   ....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+....+..      ...  .
T Consensus       178 ~~~~~~~~---~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~------~~~--~  245 (484)
T 3nyv_A          178 HFEASKKM---KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------GKY--T  245 (484)
T ss_dssp             HBCCCCSH---HHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CCC--C
T ss_pred             Eccccccc---ccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc------CCC--C
Confidence            77544322   23569999999999876 689999999999999999999999987654332221111      000  0


Q ss_pred             ccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--Hhc
Q 013745          317 LVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLS  359 (437)
Q Consensus       317 ~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~  359 (437)
                      ...+...    ..+..+.+++.+||+.+|++|||+.++++  +++
T Consensus       246 ~~~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~  286 (484)
T 3nyv_A          246 FELPQWK----KVSESAKDLIRKMLTYVPSMRISARDALDHEWIQ  286 (484)
T ss_dssp             CCSGGGG----GSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred             CCCcccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhc
Confidence            0011111    23455788999999999999999999985  444

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.6e-43  Score=357.72  Aligned_cols=203  Identities=23%  Similarity=0.322  Sum_probs=175.3

Q ss_pred             HhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcC------CCCcceeeeeeeccCCc
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI------QHKNLVTLFGCCAEGPE  156 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~  156 (437)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++... ......+.+|+.+++.+      +|+||+++++++.....
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            356799999999999999999985 46899999999754 33446778899888887      57799999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCC--ceeeeccc
Q 013745          157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN--PKISDFGL  234 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~--~kl~DFGl  234 (437)
                      .++||||+. ++|.+++... ....+++..++.++.||+.||+|||+++   |+||||||+||||+.++.  +||+|||+
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             EEEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence            999999995 6888887543 3356999999999999999999999998   999999999999999887  99999999


Q ss_pred             ccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchh
Q 013745          235 ARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKE  297 (437)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~  297 (437)
                      ++......     ....||+.|+|||++.+..++.++|||||||+||||++|++||.+....+
T Consensus       249 a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~  306 (429)
T 3kvw_A          249 SCYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD  306 (429)
T ss_dssp             CEETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             ceecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence            98654322     13578999999999999999999999999999999999999998766543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.6e-43  Score=356.68  Aligned_cols=260  Identities=23%  Similarity=0.293  Sum_probs=195.3

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeecc------CCce
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE------GPEK  157 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~  157 (437)
                      ..+|++.+.||+|+||.||+|+.. +|+.||||++.....    .+.+|+++|++++|||||+++++|..      ....
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            346999999999999999999964 699999999865432    23469999999999999999999843      2236


Q ss_pred             EEEEeecCCCCcchhhhc-cCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCC-CCceeeecccc
Q 013745          158 MLVYEYLPNKSLDYFIFD-KTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ-LNPKISDFGLA  235 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~-~~~kl~DFGla  235 (437)
                      ++||||+++ +|..++.. ......+++..++.++.||+.||+|||+++   |+||||||+||||+.+ +.+||+|||++
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence            799999976 55554432 223467999999999999999999999998   9999999999999955 56899999999


Q ss_pred             cccCCCCcccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhh--------h
Q 013745          236 RLFPGEDTHVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYT--------W  306 (437)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~--------~  306 (437)
                      +.+......   ....||+.|+|||++.+. .++.++|||||||+||||++|+.||.+....+....+...        +
T Consensus       205 ~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          205 KQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI  281 (420)
T ss_dssp             EECCTTCCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             hhcccCCCc---eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            876543322   235689999999999765 7999999999999999999999999876544332211110        0


Q ss_pred             hhhcccccccccCccccC------CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          307 TLFQGEKALELVDPSLAK------CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       307 ~~~~~~~~~~~~d~~l~~------~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .... ....+...+.+..      .....+..+.+|+.+||+.||++||++.|+++
T Consensus       282 ~~~~-~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          282 REMN-PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHC-SCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhhC-hhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            0000 0001111111111      11223467889999999999999999999985

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.1e-43  Score=345.62  Aligned_cols=255  Identities=16%  Similarity=0.261  Sum_probs=198.5

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCC-CCcceeeeeeecc--CCceEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAE--GPEKMLV  160 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv  160 (437)
                      .++|++.+.||+|+||.||+|+. .+++.||||++.....   ..+.+|+.++++++ ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCH---HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccch---HHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            36799999999999999999984 5789999999975433   56789999999997 9999999999987  6678999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCC-CceeeecccccccC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL-NPKISDFGLARLFP  239 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~-~~kl~DFGla~~~~  239 (437)
                      |||+++++|..++.      .+++..++.++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+++...
T Consensus       112 ~e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~  182 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH  182 (330)
T ss_dssp             EECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EeccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence            99999999988872      3888999999999999999999998   99999999999999776 89999999998765


Q ss_pred             CCCcccceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccc-
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALEL-  317 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  317 (437)
                      .....   ....||..|+|||++.+ ..++.++|||||||++|||++|+.||......... + .............+. 
T Consensus       183 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l-~~~~~~~~~~~~~~~~  257 (330)
T 3nsz_A          183 PGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-L-VRIAKVLGTEDLYDYI  257 (330)
T ss_dssp             TTCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-H-HHHHHHHCHHHHHHHH
T ss_pred             CCCcc---ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-H-HHHHHhcCCchhhhHH
Confidence            43322   23468999999999987 67999999999999999999999999543322110 0 000000000000000 


Q ss_pred             ------cC----------------ccc-cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          318 ------VD----------------PSL-AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       318 ------~d----------------~~l-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                            .+                ... .......+..+.+++.+||+.||++|||+.|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                  00                000 0111123566889999999999999999999986

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=4.4e-44  Score=341.99  Aligned_cols=250  Identities=26%  Similarity=0.313  Sum_probs=201.7

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      .++|++.+.||+|+||.||+|... +++.||||++...  .......+.+|+.++++++||||+++++++.+....++||
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            467999999999999999999854 7899999998643  2234577889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCC---CCceeeeccccccc
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ---LNPKISDFGLARLF  238 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~---~~~kl~DFGla~~~  238 (437)
                      ||+++++|.+.+...   ..+++..++.++.||+.||.|||+++   |+||||||+|||++.+   +.+||+|||++...
T Consensus       101 e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~  174 (287)
T 2wei_A          101 ELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (287)
T ss_dssp             CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred             EccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence            999999998887543   35899999999999999999999998   9999999999999754   46999999999876


Q ss_pred             CCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          239 PGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       239 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      ......   ....||+.|+|||++.+. ++.++||||||+++|+|++|+.||.+....+....+.      . +.. ...
T Consensus       175 ~~~~~~---~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------~-~~~-~~~  242 (287)
T 2wei_A          175 QQNTKM---KDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE------T-GKY-AFD  242 (287)
T ss_dssp             CCCSSC---SCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------H-CCC-CCC
T ss_pred             cCCCcc---ccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH------c-CCC-CCC
Confidence            543221   134589999999988764 8999999999999999999999998754432211111      0 000 000


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .+...    ..+..+.+++.+||+.+|++||++.++++
T Consensus       243 ~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          243 LPQWR----TISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             SGGGT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             chhhh----hcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            01111    22345788999999999999999999986

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4.6e-44  Score=353.83  Aligned_cols=268  Identities=22%  Similarity=0.312  Sum_probs=204.2

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccC-----Cce
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG-----PEK  157 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  157 (437)
                      .++|++++.||+|+||.||+|.. .+++.||||++... .......+.+|++++.+++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            45799999999999999999984 47889999999754 344457789999999999999999999998654     468


Q ss_pred             EEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                      ++||||++ ++|.+++..    ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            99999996 588888732    35899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCccc-ceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccc-
Q 013745          238 FPGEDTHV-NTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKA-  314 (437)
Q Consensus       238 ~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-  314 (437)
                      ........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+....+............ 
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  257 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN  257 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHH
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            65332211 11245799999999987654 5899999999999999999999999876554433222111000000000 


Q ss_pred             -----------ccccCc---cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          315 -----------LELVDP---SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       315 -----------~~~~d~---~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                                 .....+   ......+.....+.+++.+||+.||++|||+.++++  +++.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  319 (364)
T 3qyz_A          258 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ  319 (364)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred             HhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhh
Confidence                       000000   000111223456889999999999999999999986  4543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.1e-44  Score=344.88  Aligned_cols=265  Identities=24%  Similarity=0.334  Sum_probs=187.9

Q ss_pred             HHhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           83 VATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        83 ~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      ...++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence            3457899999999999999999985 478999999986542 33456788999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhcc-----CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccc
Q 013745          161 YEYLPNKSLDYFIFDK-----TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA  235 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  235 (437)
                      |||+++++|.+++...     .....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~  168 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS  168 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence            9999999999988531     13456899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcc---cceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcc
Q 013745          236 RLFPGEDTH---VNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQG  311 (437)
Q Consensus       236 ~~~~~~~~~---~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  311 (437)
                      .........   .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........   .......
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~  245 (303)
T 2vwi_A          169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML---TLQNDPP  245 (303)
T ss_dssp             HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH---HHTSSCC
T ss_pred             heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH---HhccCCC
Confidence            876433211   11223568999999999876 5689999999999999999999999986543322111   0000000


Q ss_pred             cccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          312 EKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       312 ~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .......++..   ....+..+.+++.+||+.||.+||++.+|++
T Consensus       246 ~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          246 SLETGVQDKEM---LKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             CTTC-----CC---CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccccccccchh---hhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            00000011111   1123346788999999999999999999975

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.5e-43  Score=351.28  Aligned_cols=263  Identities=23%  Similarity=0.263  Sum_probs=195.4

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC------
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP------  155 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  155 (437)
                      .++|++++.||+|+||.||+|.. .+++.||||++...  .......+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            46799999999999999999984 47899999999753  3445577889999999999999999999997654      


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccc
Q 013745          156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA  235 (437)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  235 (437)
                      ..++||||+++ +|.+.+.     ..+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCCC-CHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence            67999999975 6767662     34889999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhh----------
Q 013745          236 RLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYT----------  305 (437)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~----------  305 (437)
                      +.......   .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+...          
T Consensus       175 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  251 (371)
T 2xrw_A          175 RTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK  251 (371)
T ss_dssp             ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHT
T ss_pred             cccccccc---cCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            87643221   22357899999999999999999999999999999999999999876543322111000          


Q ss_pred             ------hhhhccc------ccccccCccc----cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--Hhc
Q 013745          306 ------WTLFQGE------KALELVDPSL----AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLS  359 (437)
Q Consensus       306 ------~~~~~~~------~~~~~~d~~l----~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~  359 (437)
                            .......      ...+......    ..........+.+|+.+||+.||++|||+.|+++  ++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~  323 (371)
T 2xrw_A          252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYIN  323 (371)
T ss_dssp             TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred             HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchh
Confidence                  0000000      0000000000    0111234667899999999999999999999986  555

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=7.5e-44  Score=337.97  Aligned_cols=251  Identities=22%  Similarity=0.337  Sum_probs=198.1

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      .++|.+.+.||+|+||.||+|... +|+.||||++....   ......+.+|+.+++.++||||+++++++......++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            467999999999999999999864 79999999986432   22346788999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||+++++|.+++...   ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            9999999999998543   45899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCcccceeeeecccccCChhhhccCcC-CcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGYL-SVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                      ...   .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...........+.       ...      
T Consensus       164 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-------~~~------  227 (276)
T 2h6d_A          164 GEF---LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIR-------GGV------  227 (276)
T ss_dssp             ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------HCC------
T ss_pred             Ccc---eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh-------cCc------
Confidence            322   123468999999999988765 689999999999999999999997654322211110       000      


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                         ...+......+.+++.+||+.+|++||++.+|++  ++..
T Consensus       228 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~  267 (276)
T 2h6d_A          228 ---FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQ  267 (276)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred             ---ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhcc
Confidence               0011123355788999999999999999999986  4553

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.7e-44  Score=359.38  Aligned_cols=265  Identities=21%  Similarity=0.287  Sum_probs=199.8

Q ss_pred             hcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC------ceE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP------EKM  158 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~  158 (437)
                      ..+|++.+.||+|+||.||+|+...+..||+|++......    ..+|+.+++.++||||++++++|....      ..+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            4569999999999999999999777777999988654322    236999999999999999999985433      378


Q ss_pred             EEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEec-CCCCceeeecccccc
Q 013745          159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD-EQLNPKISDFGLARL  237 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~-~~~~~kl~DFGla~~  237 (437)
                      +||||++++.+............+++..++.++.||+.||+|||+++   |+||||||+||||+ .++.+||+|||+++.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            99999987655444332334567999999999999999999999998   99999999999999 799999999999987


Q ss_pred             cCCCCcccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhh--------hh
Q 013745          238 FPGEDTHVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTW--------TL  308 (437)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~--------~~  308 (437)
                      +......   ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+....+....        ..
T Consensus       192 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  268 (394)
T 4e7w_A          192 LIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT  268 (394)
T ss_dssp             CCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             ccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            6443322   235689999999998765 69999999999999999999999998766443322211110        00


Q ss_pred             hcccccccccCcccc------CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          309 FQGEKALELVDPSLA------KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       309 ~~~~~~~~~~d~~l~------~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                      ... ...+...+...      ......+..+.+|+.+||+.||++|||+.|+++  ++++
T Consensus       269 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  327 (394)
T 4e7w_A          269 MNP-NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDE  327 (394)
T ss_dssp             HCG-GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGST
T ss_pred             hCh-hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhh
Confidence            000 00000001110      111224457889999999999999999999986  4554

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.9e-44  Score=344.38  Aligned_cols=252  Identities=21%  Similarity=0.319  Sum_probs=198.6

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      .++|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.++++++||||+++++++...+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            467999999999999999999964 6899999999766555567899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +++++|..++...  ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....... 
T Consensus        98 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  171 (302)
T 2j7t_A           98 CPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-  171 (302)
T ss_dssp             CTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred             CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence            9999999887543  345899999999999999999999998   9999999999999999999999999986432111 


Q ss_pred             ccceeeeecccccCChhhhc-----cCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          244 HVNTFRISGTHGYMAPEYAL-----HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                       .......||+.|+|||++.     ...++.++|||||||++|+|++|+.||..........      ....... ... 
T Consensus       172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~~~-~~~-  242 (302)
T 2j7t_A          172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL------KIAKSDP-PTL-  242 (302)
T ss_dssp             -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHSCC-CCC-
T ss_pred             -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH------HHhccCC-ccc-
Confidence             1112346899999999984     5678999999999999999999999998654332211      1111000 000 


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                           ..+...+..+.+++.+||+.+|++||++.+|++
T Consensus       243 -----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          243 -----LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             -----SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             -----CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                 011123456788999999999999999999865

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.6e-44  Score=342.60  Aligned_cols=257  Identities=27%  Similarity=0.382  Sum_probs=198.1

Q ss_pred             hcCccccceeccCCCeeEEEEEcC--CCc--EEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCce
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP--NGQ--EIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK  157 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  157 (437)
                      .++|++.+.||+|+||.||+|.+.  +++  .||||++...   .....+.+.+|+.++++++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            467999999999999999999842  333  6899998754   2344678899999999999999999999998765 8


Q ss_pred             EEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                      ++||||+++++|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus        96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence            9999999999999988543  246899999999999999999999998   99999999999999999999999999988


Q ss_pred             cCCCCccc-ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccc
Q 013745          238 FPGEDTHV-NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKAL  315 (437)
Q Consensus       238 ~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (437)
                      ........ ......+|..|+|||++.+..++.++||||||+++|||++ |+.||......+....+      ...... 
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~------~~~~~~-  243 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI------DKEGER-  243 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH------HTSCCC-
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHH------HccCCC-
Confidence            75433221 1223457889999999999999999999999999999999 99999865443221111      110000 


Q ss_pred             cccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCC
Q 013745          316 ELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD  361 (437)
Q Consensus       316 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~  361 (437)
                         .    ......+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus       244 ---~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  282 (291)
T 1u46_A          244 ---L----PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  282 (291)
T ss_dssp             ---C----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---C----CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence               0    11123345688999999999999999999999999853

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1e-43  Score=338.06  Aligned_cols=246  Identities=23%  Similarity=0.382  Sum_probs=202.0

Q ss_pred             HhcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeecc---------
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE---------  153 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------  153 (437)
                      ..++|++.+.||+|+||.||+|... +++.||||++.....    .+.+|++++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG----GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH----HHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4567999999999999999999864 799999999976542    45689999999999999999998854         


Q ss_pred             -------CCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCC
Q 013745          154 -------GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN  226 (437)
Q Consensus       154 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~  226 (437)
                             ....++||||+++++|.+++.... ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence                   445799999999999999985432 356899999999999999999999998   999999999999999999


Q ss_pred             ceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhh
Q 013745          227 PKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTW  306 (437)
Q Consensus       227 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~  306 (437)
                      +||+|||++.........   ....||+.|+|||++.+..++.++|||||||++|||++|..|+...     ...    +
T Consensus       161 ~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~----~  228 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----SKF----F  228 (284)
T ss_dssp             EEECCCTTCEESSCCSCC---CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HHH----H
T ss_pred             EEECcchhheeccccccc---cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----HHH----H
Confidence            999999999877543321   2346899999999999999999999999999999999999887421     110    0


Q ss_pred             hhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          307 TLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       307 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ......        .+.   ...+..+.+++.+||+.+|.+||++.++++.|..
T Consensus       229 ~~~~~~--------~~~---~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~  271 (284)
T 2a19_B          229 TDLRDG--------IIS---DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV  271 (284)
T ss_dssp             HHHHTT--------CCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHhhcc--------ccc---ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            111111        011   1223457789999999999999999999999875

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.4e-43  Score=342.64  Aligned_cols=255  Identities=24%  Similarity=0.376  Sum_probs=201.9

Q ss_pred             HhcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      ..++|++.+.||+|+||.||+|... +|+.||||++.....  ...+.+|+.++++++||||+++++++......++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC--CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH--HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            4567999999999999999999854 689999999975432  3668899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |+++++|.+++..  ....+++..++.++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||++.......
T Consensus       105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred             cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence            9999999998843  2356899999999999999999999998   9999999999999999999999999998765432


Q ss_pred             cccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccc
Q 013745          243 THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL  322 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  322 (437)
                      ..  .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........      ... ..     .+..
T Consensus       180 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------~~~-~~-----~~~~  245 (314)
T 3com_A          180 AK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM------IPT-NP-----PPTF  245 (314)
T ss_dssp             SC--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH------HHH-SC-----CCCC
T ss_pred             cc--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH------Hhc-CC-----Cccc
Confidence            21  2235689999999999999999999999999999999999999976543222111      000 00     0000


Q ss_pred             cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          323 AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       323 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                       ......+..+.+++.+||+.+|.+||++.++++  ++.+
T Consensus       246 -~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~  284 (314)
T 3com_A          246 -RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS  284 (314)
T ss_dssp             -SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHT
T ss_pred             -CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhc
Confidence             011122356788999999999999999999975  4543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.6e-43  Score=338.47  Aligned_cols=249  Identities=23%  Similarity=0.332  Sum_probs=198.5

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeecc----CCceE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE----GPEKM  158 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  158 (437)
                      ..|.+.+.||+|+||.||+|.. .++..||+|++...  .....+.+.+|+.++++++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            3488899999999999999985 47889999998643  34556778999999999999999999998864    45689


Q ss_pred             EEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEec-CCCCceeeecccccc
Q 013745          159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD-EQLNPKISDFGLARL  237 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~-~~~~~kl~DFGla~~  237 (437)
                      +||||+++++|.+++...   ..+++..++.++.||+.||.|||+.+ .+|+||||||+|||++ .++.+||+|||++..
T Consensus       106 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            999999999999998543   45899999999999999999999975 3499999999999997 789999999999976


Q ss_pred             cCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccc
Q 013745          238 FPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALEL  317 (437)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (437)
                      .....    .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||.........  ...    ......   
T Consensus       182 ~~~~~----~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~----~~~~~~---  247 (290)
T 1t4h_A          182 KRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YRR----VTSGVK---  247 (290)
T ss_dssp             CCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HHH----HTTTCC---
T ss_pred             ccccc----cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH--HHH----HhccCC---
Confidence            54332    224568999999998764 5899999999999999999999999764432211  111    110100   


Q ss_pred             cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          318 VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       318 ~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                       ......   ..+..+.+++.+||+.+|++||++.+|++
T Consensus       248 -~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          248 -PASFDK---VAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -CGGGGG---CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -ccccCC---CCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence             001111   12245788999999999999999999986

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=9e-44  Score=339.66  Aligned_cols=253  Identities=24%  Similarity=0.339  Sum_probs=187.3

Q ss_pred             HhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC-h-HHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS-R-QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      ..++|++.+.||+|+||.||+|.. .+|+.||||++.... . ...+.+.++...++.++||||+++++++.+.+..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            357899999999999999999985 578999999997542 2 2233445555568888999999999999999999999


Q ss_pred             EeecCCCCcchhhhc-cCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCceEeeccCCCCEEecCCCCceeeeccccccc
Q 013745          161 YEYLPNKSLDYFIFD-KTKSSSLDWTTRYRIVMGVARGLLYLHEE-APARIIHRDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                      |||+++ +|.+++.. ......+++..++.++.|++.||.|||++ +   |+||||||+|||++.++.+||+|||+++..
T Consensus        85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999974 77776643 22346799999999999999999999998 7   999999999999999999999999999876


Q ss_pred             CCCCcccceeeeecccccCChhhh----ccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccc
Q 013745          239 PGEDTHVNTFRISGTHGYMAPEYA----LHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKA  314 (437)
Q Consensus       239 ~~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  314 (437)
                      ......   ....||+.|+|||++    .+..++.++|||||||++|||++|+.||.........  +.   ......  
T Consensus       161 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~---~~~~~~--  230 (290)
T 3fme_A          161 VDDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ--LK---QVVEEP--  230 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH--HH---HHHHSC--
T ss_pred             cccccc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH--HH---HHhccC--
Confidence            443221   234689999999996    4567899999999999999999999999753322111  01   011100  


Q ss_pred             ccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          315 LELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       315 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                          .+..  .....+..+.+++.+||+.+|++|||+.++++
T Consensus       231 ----~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          231 ----SPQL--PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             ----CCCC--CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ----CCCc--ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                0011  01123456789999999999999999999976

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.6e-43  Score=346.31  Aligned_cols=268  Identities=24%  Similarity=0.279  Sum_probs=202.7

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccC-----Cce
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG-----PEK  157 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  157 (437)
                      .++|.+.+.||+|+||.||+|... +|+.||||++... .......+.+|+.++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            567999999999999999999854 7899999999744 344456788999999999999999999987654     678


Q ss_pred             EEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                      ++||||+. ++|.+++..    ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            99999996 588888743    46899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCccc--------ceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhh
Q 013745          238 FPGEDTHV--------NTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTL  308 (437)
Q Consensus       238 ~~~~~~~~--------~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~  308 (437)
                      ........        ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  241 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT  241 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence            65332111        1123468999999998765 67899999999999999999999999876543322211110000


Q ss_pred             hcccccc---------cc-------cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          309 FQGEKAL---------EL-------VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       309 ~~~~~~~---------~~-------~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                      .......         +.       ....+....+..+..+.+++.+||+.||++|||+.++++  +++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  311 (353)
T 2b9h_A          242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT  311 (353)
T ss_dssp             CCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             CchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence            0000000         00       000001111233456789999999999999999999986  5543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.7e-44  Score=356.92  Aligned_cols=270  Identities=21%  Similarity=0.306  Sum_probs=183.9

Q ss_pred             hcCccc-cceeccCCCeeEEEEEcC---CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeee--ccCCceE
Q 013745           85 TNFFSD-LNQLGHGGFGPVYRGLMP---NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCC--AEGPEKM  158 (437)
Q Consensus        85 ~~~y~~-~~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~--~~~~~~~  158 (437)
                      .+.|++ .++||+|+||.||+|+..   +++.||||++......  ..+.+|+.+|++++||||+++++++  ......+
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKVFLSHADRKVW   96 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC--HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC--HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence            345776 457999999999999854   5789999999754322  4677999999999999999999999  4577889


Q ss_pred             EEEeecCCCCcchhhhcc------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEe----cCCCCce
Q 013745          159 LVYEYLPNKSLDYFIFDK------TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL----DEQLNPK  228 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll----~~~~~~k  228 (437)
                      +||||+.+ +|.+++...      .....+++..++.|+.||+.||.|||+++   |+||||||+||||    +.++.+|
T Consensus        97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEE
Confidence            99999965 676665421      12235899999999999999999999998   9999999999999    7789999


Q ss_pred             eeecccccccCCCCcc-cceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhh------h
Q 013745          229 ISDFGLARLFPGEDTH-VNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKA------D  300 (437)
Q Consensus       229 l~DFGla~~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~------~  300 (437)
                      |+|||+++.+...... ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.......      .
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  252 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD  252 (405)
T ss_dssp             ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred             EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence            9999999876533211 122346789999999999874 5999999999999999999999999765432100      0


Q ss_pred             hhhhhhhhhccc--ccccc-------------c-CccccCCC---------HHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 013745          301 LLSYTWTLFQGE--KALEL-------------V-DPSLAKCN---------RDEAAMCIQLGLLCCQQSVAERPDMNSVH  355 (437)
Q Consensus       301 ~~~~~~~~~~~~--~~~~~-------------~-d~~l~~~~---------~~~~~~l~~l~~~cl~~~p~~RPs~~ev~  355 (437)
                      .+..........  .....             + ......+.         ......+.+|+.+||+.||.+|||+.|++
T Consensus       253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L  332 (405)
T 3rgf_A          253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM  332 (405)
T ss_dssp             HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            000000000000  00000             0 00000000         01134678999999999999999999998


Q ss_pred             H--HhcC
Q 013745          356 L--MLSG  360 (437)
Q Consensus       356 ~--~L~~  360 (437)
                      +  ++.+
T Consensus       333 ~hp~f~~  339 (405)
T 3rgf_A          333 QDPYFLE  339 (405)
T ss_dssp             TSGGGTS
T ss_pred             cChhhcc
Confidence            6  4543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=8.5e-44  Score=345.76  Aligned_cols=252  Identities=21%  Similarity=0.251  Sum_probs=195.9

Q ss_pred             HhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC--------hHHHHHHHHHHHHHHcCCCCcceeeeeeeccC
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS--------RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG  154 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  154 (437)
                      ..++|++.+.||+|+||.||+|.. .+++.||||++....        ......+.+|+.++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            457899999999999999999985 468999999986432        11234578999999999999999999998765


Q ss_pred             CceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCC---ceeee
Q 013745          155 PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN---PKISD  231 (437)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~---~kl~D  231 (437)
                      . .++||||+++++|.+++.   ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.   +||+|
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVV---GNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHS---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             c-eEEEEecCCCCcHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence            5 899999999999998883   3457899999999999999999999998   999999999999987654   99999


Q ss_pred             cccccccCCCCcccceeeeecccccCChhhhc---cCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhh
Q 013745          232 FGLARLFPGEDTHVNTFRISGTHGYMAPEYAL---HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTL  308 (437)
Q Consensus       232 FGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~  308 (437)
                      ||+++.......   .....||+.|+|||++.   ...++.++|||||||++|+|++|+.||.........  ...... 
T Consensus       161 fg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~-  234 (322)
T 2ycf_A          161 FGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQITS-  234 (322)
T ss_dssp             CTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--HHHHHH-
T ss_pred             Cccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--HHHHHh-
Confidence            999987643321   12356899999999974   457899999999999999999999999754332111  010000 


Q ss_pred             hcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          309 FQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       309 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                         ... . ..+..   ....+..+.+++.+||+.||++||++.++++
T Consensus       235 ---~~~-~-~~~~~---~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          235 ---GKY-N-FIPEV---WAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             ---TCC-C-CCHHH---HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ---Ccc-c-cCchh---hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence               000 0 00000   0123456789999999999999999999975

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6.9e-44  Score=351.36  Aligned_cols=271  Identities=20%  Similarity=0.224  Sum_probs=192.1

Q ss_pred             HHHHHHhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCc-
Q 013745           79 RTLQVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE-  156 (437)
Q Consensus        79 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-  156 (437)
                      .......++|++.+.||+|+||.||+|+. .+|+.||||++...... ...+.+|++.+..++||||++++++|..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF-RNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC-CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc-cHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            34455678999999999999999999985 47899999998654322 2455678888899999999999999865333 


Q ss_pred             ------eEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhh--hcCCCceEeeccCCCCEEecC-CCCc
Q 013745          157 ------KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH--EEAPARIIHRDIKASNILLDE-QLNP  227 (437)
Q Consensus       157 ------~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH--~~~~~~iiHrDikp~NIll~~-~~~~  227 (437)
                            .++||||++++.+..+.........+++..++.++.|++.||.|||  +.+   |+||||||+|||++. ++.+
T Consensus        95 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~  171 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL  171 (360)
T ss_dssp             CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred             cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence                  7899999987433333222234567899999999999999999999  877   999999999999996 8999


Q ss_pred             eeeecccccccCCCCcccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhh
Q 013745          228 KISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTW  306 (437)
Q Consensus       228 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~  306 (437)
                      ||+|||+++........   ....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+....
T Consensus       172 kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~  248 (360)
T 3e3p_A          172 KLCDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL  248 (360)
T ss_dssp             EECCCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred             EEeeCCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence            99999999876543322   234689999999998765 58999999999999999999999998765443322221110


Q ss_pred             h--------hhc-ccccccccC-------ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          307 T--------LFQ-GEKALELVD-------PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       307 ~--------~~~-~~~~~~~~d-------~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .        ... ........+       ..+.......+..+.+|+.+||+.||++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            0        000 000000000       0011122234667899999999999999999999975

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.3e-43  Score=338.43  Aligned_cols=251  Identities=23%  Similarity=0.307  Sum_probs=203.9

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC---------hHHHHHHHHHHHHHHcCC-CCcceeeeeeecc
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS---------RQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAE  153 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  153 (437)
                      .++|++.+.||+|+||.||+|... +|+.||||++....         ....+.+.+|+.+++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            567999999999999999999854 78999999996542         123456889999999996 9999999999999


Q ss_pred             CCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecc
Q 013745          154 GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFG  233 (437)
Q Consensus       154 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFG  233 (437)
                      ....++||||+++++|.+++...   ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred             CCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEeccc
Confidence            99999999999999999998543   46899999999999999999999998   9999999999999999999999999


Q ss_pred             cccccCCCCcccceeeeecccccCChhhhc------cCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhh
Q 013745          234 LARLFPGEDTHVNTFRISGTHGYMAPEYAL------HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWT  307 (437)
Q Consensus       234 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~------~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~  307 (437)
                      ++........   .....||+.|+|||++.      ...++.++|||||||++|||++|+.||...........+.    
T Consensus       170 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----  242 (298)
T 1phk_A          170 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM----  242 (298)
T ss_dssp             TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----
T ss_pred             chhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHh----
Confidence            9987654332   22356899999999985      4468899999999999999999999997654332211111    


Q ss_pred             hhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          308 LFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       308 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                        ...  .....+.    ....+..+.+++.+||+.+|++||++.++++
T Consensus       243 --~~~--~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          243 --SGN--YQFGSPE----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             --HTC--CCCCTTT----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             --cCC--cccCccc----ccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence              000  0001111    1133456889999999999999999999975

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.5e-43  Score=342.46  Aligned_cols=262  Identities=20%  Similarity=0.245  Sum_probs=205.9

Q ss_pred             HhcCccccceeccCCCeeEEEEEc--CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCC------cceeeeeeeccCC
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM--PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHK------NLVTLFGCCAEGP  155 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~  155 (437)
                      ..++|++.+.||+|+||.||+|..  .+++.||||++... ....+.+.+|+.+++.++|+      +|+++++++...+
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~   90 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG   90 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence            356899999999999999999985  36889999999754 33456788999999998765      4999999999999


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC------------
Q 013745          156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE------------  223 (437)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~------------  223 (437)
                      ..++||||+ +++|.+++... ....+++..++.++.||+.||+|||+++   |+||||||+|||++.            
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred             cEEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence            999999999 88998888543 2346899999999999999999999998   999999999999987            


Q ss_pred             -------CCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCch
Q 013745          224 -------QLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGK  296 (437)
Q Consensus       224 -------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~  296 (437)
                             ++.+||+|||+++......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             cccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence                   6789999999998754322     1356899999999999999999999999999999999999999876554


Q ss_pred             hhhhhhhhhhhhhcc--------ccc------------------ccccCc--cccCCCHHHHHHHHHHHHHcCCCCCCCC
Q 013745          297 EKADLLSYTWTLFQG--------EKA------------------LELVDP--SLAKCNRDEAAMCIQLGLLCCQQSVAER  348 (437)
Q Consensus       297 ~~~~~~~~~~~~~~~--------~~~------------------~~~~d~--~l~~~~~~~~~~l~~l~~~cl~~~p~~R  348 (437)
                      +....+.........        ...                  .....+  ............+.+++.+||+.||++|
T Consensus       241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  320 (339)
T 1z57_A          241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR  320 (339)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence            433222111100000        000                  000000  0011233567789999999999999999


Q ss_pred             CCHHHHHH
Q 013745          349 PDMNSVHL  356 (437)
Q Consensus       349 Ps~~ev~~  356 (437)
                      ||+.||++
T Consensus       321 pt~~ell~  328 (339)
T 1z57_A          321 ITLREALK  328 (339)
T ss_dssp             CCHHHHTT
T ss_pred             cCHHHHhc
Confidence            99999974

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.2e-43  Score=348.08  Aligned_cols=263  Identities=22%  Similarity=0.275  Sum_probs=204.3

Q ss_pred             hcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChH-----------------HHHHHHHHHHHHHcCCCCcceee
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQ-----------------GLREFTNEVKLLLKIQHKNLVTL  147 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~~l~~l~h~niv~l  147 (437)
                      .++|++.+.||+|+||.||+|.. +++.||||++......                 ....+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46799999999999999999998 8999999998643211                 11778899999999999999999


Q ss_pred             eeeeccCCceEEEEeecCCCCcchh------hhccCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceEeeccCCCCEE
Q 013745          148 FGCCAEGPEKMLVYEYLPNKSLDYF------IFDKTKSSSLDWTTRYRIVMGVARGLLYLHE-EAPARIIHRDIKASNIL  220 (437)
Q Consensus       148 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiHrDikp~NIl  220 (437)
                      ++++.+.+..++||||+++++|.++      +.. .....+++..++.++.||+.||.|||+ .+   |+||||||+|||
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence            9999999999999999999999998      422 224679999999999999999999999 87   999999999999


Q ss_pred             ecCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccC-cCCc-ccceehhhHHHHHHHhCCCCCCCCCc-hh
Q 013745          221 LDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHG-YLSV-KTDVFSYGVLVLEIVSGRKNHDGRLG-KE  297 (437)
Q Consensus       221 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~-~~DvwSlG~vl~elltg~~p~~~~~~-~~  297 (437)
                      ++.++.+||+|||++......    ......||+.|+|||++.+. .++. ++|||||||++|||++|+.||..... .+
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  260 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE  260 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred             EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            999999999999999876443    12245689999999999887 6666 99999999999999999999986554 22


Q ss_pred             hhhhhhhhhhhhcccc--cc-cccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          298 KADLLSYTWTLFQGEK--AL-ELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       298 ~~~~~~~~~~~~~~~~--~~-~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ....+......+....  .. ..............+..+.+++.+||+.+|.+||++.++++
T Consensus       261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1111110000000000  00 00000000111234566889999999999999999999986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.6e-44  Score=354.03  Aligned_cols=264  Identities=20%  Similarity=0.262  Sum_probs=197.7

Q ss_pred             HHHhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeecc-------
Q 013745           82 QVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE-------  153 (437)
Q Consensus        82 ~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------  153 (437)
                      +...++|++.+.||+|+||.||+|.. .+|+.||||++......    ..+|+.+++.++||||++++++|..       
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            44567899999999999999999984 57999999998654322    2379999999999999999999843       


Q ss_pred             -------------------------------CCceEEEEeecCCCCcchhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHh
Q 013745          154 -------------------------------GPEKMLVYEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYL  201 (437)
Q Consensus       154 -------------------------------~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~L  201 (437)
                                                     ....++||||++ ++|.+.+... .....+++..++.++.||+.||.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           334789999997 5777666432 2346799999999999999999999


Q ss_pred             hhcCCCceEeeccCCCCEEec-CCCCceeeecccccccCCCCcccceeeeecccccCChhhhccC-cCCcccceehhhHH
Q 013745          202 HEEAPARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVL  279 (437)
Q Consensus       202 H~~~~~~iiHrDikp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~v  279 (437)
                      |+++   |+||||||+|||++ .++.+||+|||+++.+......   ....||+.|+|||++.+. .++.++|||||||+
T Consensus       158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9998   99999999999998 6889999999999876443322   234689999999998875 58999999999999


Q ss_pred             HHHHHhCCCCCCCCCchhhhhhhhhhhhhhc-------ccccccccCcccc------CCCHHHHHHHHHHHHHcCCCCCC
Q 013745          280 VLEIVSGRKNHDGRLGKEKADLLSYTWTLFQ-------GEKALELVDPSLA------KCNRDEAAMCIQLGLLCCQQSVA  346 (437)
Q Consensus       280 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~d~~l~------~~~~~~~~~l~~l~~~cl~~~p~  346 (437)
                      +|||++|+.||.+....+....+........       .....+...+.+.      ..+...+..+.+|+.+||+.+|+
T Consensus       232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  311 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD  311 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence            9999999999987655443222111000000       0000000001100      11222445688999999999999


Q ss_pred             CCCCHHHHHH
Q 013745          347 ERPDMNSVHL  356 (437)
Q Consensus       347 ~RPs~~ev~~  356 (437)
                      +|||+.|+++
T Consensus       312 ~R~t~~e~l~  321 (383)
T 3eb0_A          312 LRINPYEAMA  321 (383)
T ss_dssp             GSCCHHHHHT
T ss_pred             hCCCHHHHhc
Confidence            9999999974

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.4e-43  Score=349.77  Aligned_cols=258  Identities=22%  Similarity=0.312  Sum_probs=197.7

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCce----
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK----  157 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  157 (437)
                      .++|.+.+.||+|+||.||+|.. .+|+.||||++...  .......+.+|+.+++.++||||+++++++......    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            46799999999999999999984 47899999999754  344467788999999999999999999999877655    


Q ss_pred             --EEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccc
Q 013745          158 --MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA  235 (437)
Q Consensus       158 --~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  235 (437)
                        ++||||+. ++|..++     ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIM-----GMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence              99999996 5777666     234899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcccceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccc--
Q 013745          236 RLFPGEDTHVNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGE--  312 (437)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--  312 (437)
                      +......     ....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+..........  
T Consensus       192 ~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  266 (371)
T 4exu_A          192 RHADAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  266 (371)
T ss_dssp             -------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cccccCc-----CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence            8654322     23468999999999987 689999999999999999999999998765433222211100000000  


Q ss_pred             ------c---ccccc----CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          313 ------K---ALELV----DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       313 ------~---~~~~~----d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                            .   ....+    ........+.....+.+|+.+||+.||++|||+.++++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence                  0   00000    00001111223566889999999999999999999975

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.1e-44  Score=346.07  Aligned_cols=256  Identities=25%  Similarity=0.379  Sum_probs=198.3

Q ss_pred             HHhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcC-CCCcceeeeeeecc------C
Q 013745           83 VATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAE------G  154 (437)
Q Consensus        83 ~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------~  154 (437)
                      ...++|++.+.||+|+||.||+|.. .+++.||||++..... ....+.+|+.+++++ +||||+++++++..      .
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   99 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   99 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCC
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcccc
Confidence            3467899999999999999999985 4789999999975433 236788999999999 79999999999976      4


Q ss_pred             CceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccc
Q 013745          155 PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL  234 (437)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl  234 (437)
                      ...++||||+++++|.+++... ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~  175 (326)
T 2x7f_A          100 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV  175 (326)
T ss_dssp             CEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred             ceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcC
Confidence            6789999999999999998543 2356899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcccceeeeecccccCChhhhc-----cCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhh
Q 013745          235 ARLFPGEDTHVNTFRISGTHGYMAPEYAL-----HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLF  309 (437)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~  309 (437)
                      +.........  .....||+.|+|||++.     +..++.++|||||||++|+|++|+.||...........      ..
T Consensus       176 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------~~  247 (326)
T 2x7f_A          176 SAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL------IP  247 (326)
T ss_dssp             TC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH------HH
T ss_pred             ceecCcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH------hh
Confidence            9876432221  22356899999999987     56789999999999999999999999976543322111      10


Q ss_pred             cccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--Hhc
Q 013745          310 QGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLS  359 (437)
Q Consensus       310 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~  359 (437)
                      . ..     .+.+  .....+..+.+++.+||+.+|.+||++.++++  ++.
T Consensus       248 ~-~~-----~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~  291 (326)
T 2x7f_A          248 R-NP-----APRL--KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIR  291 (326)
T ss_dssp             H-SC-----CCCC--SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHH
T ss_pred             c-Cc-----cccC--CccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHh
Confidence            0 00     0111  01122346788999999999999999999986  554

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.1e-43  Score=341.83  Aligned_cols=264  Identities=23%  Similarity=0.342  Sum_probs=201.4

Q ss_pred             hcCccccceeccCCCeeEEEEEc--CCCcEEEEEEeccCC--hHHHHHHHHHHHHHHcC---CCCcceeeeeeec-----
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM--PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKI---QHKNLVTLFGCCA-----  152 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----  152 (437)
                      .++|++.+.||+|+||.||+|..  .+|+.||||++....  ......+.+|+.+++.+   +||||+++++++.     
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            57899999999999999999986  468899999986432  11123456777777766   8999999999987     


Q ss_pred             cCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeec
Q 013745          153 EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDF  232 (437)
Q Consensus       153 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DF  232 (437)
                      .....++||||++ |+|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+||
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           90 RETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             SEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecC
Confidence            5567899999997 6998888543 2345899999999999999999999998   999999999999999999999999


Q ss_pred             ccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccc
Q 013745          233 GLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGE  312 (437)
Q Consensus       233 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  312 (437)
                      |+++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+..........
T Consensus       165 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (326)
T 1blx_A          165 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  241 (326)
T ss_dssp             CSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             cccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence            9998764322   1224568999999999999999999999999999999999999998765443322111110000000


Q ss_pred             c-----------cccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          313 K-----------ALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       313 ~-----------~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .           ........+.......+..+.+++.+||+.+|++||++.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0           0000011111222334556789999999999999999999984

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=8.3e-43  Score=343.25  Aligned_cols=258  Identities=22%  Similarity=0.305  Sum_probs=198.5

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCc-----
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE-----  156 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  156 (437)
                      .++|.+.+.||+|+||.||+|.. .+|+.||||++...  .......+.+|+.++++++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            46799999999999999999985 47999999999653  34445778999999999999999999999987654     


Q ss_pred             -eEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccc
Q 013745          157 -KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA  235 (437)
Q Consensus       157 -~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  235 (437)
                       .++||||+. ++|.+++.     ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999996 58877662     34899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcccceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhh------
Q 013745          236 RLFPGEDTHVNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTL------  308 (437)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~------  308 (437)
                      +.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+....+......      
T Consensus       174 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  248 (353)
T 3coi_A          174 RHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  248 (353)
T ss_dssp             TC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHH
T ss_pred             cCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            865432     123568999999999887 67899999999999999999999999876543322111110000      


Q ss_pred             --hccc-------ccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          309 --FQGE-------KALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       309 --~~~~-------~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                        ....       .......+.+.......+..+.+++.+||+.||++||++.++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          249 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             TTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence              0000       00000011111222344567889999999999999999999975

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.3e-43  Score=341.20  Aligned_cols=256  Identities=22%  Similarity=0.304  Sum_probs=197.9

Q ss_pred             HhcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCC--CCcceeeeeeeccCCceEE
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQ--HKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~l  159 (437)
                      ..++|++.+.||+|+||.||+|...+++.||||++...  .......+.+|+.++.+++  ||||+++++++......++
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l  105 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM  105 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence            35679999999999999999999888999999999644  3455678899999999997  5999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      ||| +.+++|.+++...   ..+++..++.++.||+.||.|||+++   |+||||||+|||+++ +.+||+|||+++...
T Consensus       106 v~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~  177 (313)
T 3cek_A          106 VME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQ  177 (313)
T ss_dssp             EEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred             EEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccccccc
Confidence            999 5688999998543   46899999999999999999999998   999999999999964 899999999998765


Q ss_pred             CCCcccceeeeecccccCChhhhcc-----------CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhh
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALH-----------GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTL  308 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~-----------~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~  308 (437)
                      ............||+.|+|||++.+           ..++.++|||||||++|||++|+.||........     .....
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-----~~~~~  252 (313)
T 3cek_A          178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-----KLHAI  252 (313)
T ss_dssp             ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-----HHHHH
T ss_pred             CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH-----HHHHH
Confidence            4433322334568999999999875           4788999999999999999999999975433211     11111


Q ss_pred             hcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          309 FQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       309 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                      ......     .....   ..+..+.+++.+||+.+|++||++.+|++  +++.
T Consensus       253 ~~~~~~-----~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~  298 (313)
T 3cek_A          253 IDPNHE-----IEFPD---IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  298 (313)
T ss_dssp             HCTTSC-----CCCCC---CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred             Hhcccc-----cCCcc---cchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence            111100     01111   12346788999999999999999999985  4543

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2e-43  Score=350.09  Aligned_cols=253  Identities=9%  Similarity=-0.015  Sum_probs=180.3

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC---hHHHHHHHHHHHHHHcC--CCCcceeeee-------eec
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKI--QHKNLVTLFG-------CCA  152 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l--~h~niv~l~~-------~~~  152 (437)
                      ..|.+.+.||+|+||.||+|.. .+|+.||||++....   ....+.+.+|+.+++.|  +||||++++.       ++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            4589999999999999999995 478999999998653   23455677885544444  6999888553       332


Q ss_pred             cC-----------------CceEEEEeecCCCCcchhhhccCCCCCCCHHHH------HHHHHHHHHHHHHhhhcCCCce
Q 013745          153 EG-----------------PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTR------YRIVMGVARGLLYLHEEAPARI  209 (437)
Q Consensus       153 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qi~~~L~~LH~~~~~~i  209 (437)
                      ..                 ...+|||||++ ++|.+++....  ..+++..+      +.++.||+.||+|||+++   |
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---i  215 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD--FVYVFRGDEGILALHILTAQLIRLAANLQSKG---L  215 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH--HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc--cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---C
Confidence            22                 33799999998 89999986532  23455556      678899999999999998   9


Q ss_pred             EeeccCCCCEEecCCCCceeeecccccccCCCCcccceeeeecccccCChhhhcc--CcCCcccceehhhHHHHHHHhCC
Q 013745          210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH--GYLSVKTDVFSYGVLVLEIVSGR  287 (437)
Q Consensus       210 iHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DvwSlG~vl~elltg~  287 (437)
                      +||||||+||||+.++.+||+|||+++......     ....+|+.|+|||++.+  ..++.++|||||||+||||++|+
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~  290 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF  290 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence            999999999999999999999999998764321     12356799999999987  68999999999999999999999


Q ss_pred             CCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          288 KNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       288 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .||.............   .............+.    ....+..+.+++.+||+.||++||++.++++
T Consensus       291 ~Pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          291 LPFGLVTPGIKGSWKR---PSLRVPGTDSLAFGS----CTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             CSTTBCCTTCTTCCCB---CCTTSCCCCSCCCTT----SSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCcCcccccchhh---hhhhhccccccchhh----ccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            9998654322111000   000000000111111    1133456888999999999999999999964

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4.8e-43  Score=371.48  Aligned_cols=259  Identities=23%  Similarity=0.315  Sum_probs=206.0

Q ss_pred             HHHHHhcCccccceeccCCCeeEEEEEcC----CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccC
Q 013745           80 TLQVATNFFSDLNQLGHGGFGPVYRGLMP----NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG  154 (437)
Q Consensus        80 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  154 (437)
                      ......++|++.+.||+|+||.||+|.+.    .+..||||++... .....+.+.+|+.++++++||||+++++++.+ 
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-  462 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-  462 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-
Confidence            33444578999999999999999999853    2467999998754 34445779999999999999999999999854 


Q ss_pred             CceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccc
Q 013745          155 PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL  234 (437)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl  234 (437)
                      +..++||||+++|+|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       463 ~~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~  537 (656)
T 2j0j_A          463 NPVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGL  537 (656)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred             CceEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCC
Confidence            5689999999999999998533  346899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccc
Q 013745          235 ARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEK  313 (437)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (437)
                      ++......... .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+..      ...
T Consensus       538 a~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~------~~~  610 (656)
T 2j0j_A          538 SRYMEDSTYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN------GER  610 (656)
T ss_dssp             CCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH------TCC
T ss_pred             CeecCCCccee-ccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc------CCC
Confidence            98765433222 223457789999999999999999999999999999997 9999987554332221111      000


Q ss_pred             cccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          314 ALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       314 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                               ...+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       611 ---------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~  648 (656)
T 2j0j_A          611 ---------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  648 (656)
T ss_dssp             ---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                     01122334568899999999999999999999998874

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.6e-44  Score=349.35  Aligned_cols=245  Identities=23%  Similarity=0.354  Sum_probs=198.0

Q ss_pred             HHHHHhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCCh------HHHHHHHHHHHHHHcCC--CCcceeeeee
Q 013745           80 TLQVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSR------QGLREFTNEVKLLLKIQ--HKNLVTLFGC  150 (437)
Q Consensus        80 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~  150 (437)
                      +.+...++|++.+.||+|+||.||+|+. .+++.||||++.....      .....+.+|+.++++++  |+||++++++
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~  116 (320)
T 3a99_A           37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW  116 (320)
T ss_dssp             ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred             ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence            3344567899999999999999999984 5789999999965421      11244668999999996  5999999999


Q ss_pred             eccCCceEEEEeecCC-CCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEec-CCCCce
Q 013745          151 CAEGPEKMLVYEYLPN-KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD-EQLNPK  228 (437)
Q Consensus       151 ~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~-~~~~~k  228 (437)
                      +...+..++|||++.+ ++|.+++...   ..+++..++.++.||+.||+|||+++   |+||||||+|||++ +++.+|
T Consensus       117 ~~~~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~k  190 (320)
T 3a99_A          117 FERPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELK  190 (320)
T ss_dssp             EECSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEE
T ss_pred             EecCCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEE
Confidence            9999999999999976 8999888543   46899999999999999999999998   99999999999999 789999


Q ss_pred             eeecccccccCCCCcccceeeeecccccCChhhhccCcC-CcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhh
Q 013745          229 ISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL-SVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWT  307 (437)
Q Consensus       229 l~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~  307 (437)
                      |+|||+++.......    ....||+.|+|||++.+..+ +.++|||||||++|||++|+.||......     .     
T Consensus       191 L~Dfg~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~-----  256 (320)
T 3a99_A          191 LIDFGSGALLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-----I-----  256 (320)
T ss_dssp             ECCCTTCEECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH-----H-----
T ss_pred             EeeCccccccccccc----cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh-----h-----
Confidence            999999987654322    23568999999999987765 78899999999999999999999642110     0     


Q ss_pred             hhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          308 LFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       308 ~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                        ....   .       .....+..+.+++.+||+.+|++||++.+|++
T Consensus       257 --~~~~---~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          257 --RGQV---F-------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             --HCCC---C-------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --cccc---c-------ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence              0000   0       01122345788999999999999999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=7.3e-44  Score=345.17  Aligned_cols=258  Identities=23%  Similarity=0.349  Sum_probs=199.3

Q ss_pred             HHhcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           83 VATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        83 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      ...++|++.+.||+|+||.||+|....  .||+|++....  ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  107 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII  107 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence            345789999999999999999998743  59999987532  22235577899999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||+++++|.+++..  ....+++..++.++.||+.||+|||+++   |+||||||+|||++ ++.+||+|||+++....
T Consensus       108 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~  181 (319)
T 2y4i_B          108 TSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGV  181 (319)
T ss_dssp             CBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred             eecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence            999999999999843  2346899999999999999999999998   99999999999998 67999999999876532


Q ss_pred             CCc---ccceeeeecccccCChhhhcc---------CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhh
Q 013745          241 EDT---HVNTFRISGTHGYMAPEYALH---------GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTL  308 (437)
Q Consensus       241 ~~~---~~~~~~~~gt~~Y~aPE~~~~---------~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~  308 (437)
                      ...   ........||+.|+|||++.+         ..++.++|||||||++|||++|+.||...........      .
T Consensus       182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~------~  255 (319)
T 2y4i_B          182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ------M  255 (319)
T ss_dssp             ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH------H
T ss_pred             ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------h
Confidence            111   111223458999999999875         3578999999999999999999999986543322111      1


Q ss_pred             hcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCCC
Q 013745          309 FQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDS  362 (437)
Q Consensus       309 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~  362 (437)
                      ... .     .+.+..  ...+..+.+++.+||+.+|++||++.+|+++|+...
T Consensus       256 ~~~-~-----~~~~~~--~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~  301 (319)
T 2y4i_B          256 GTG-M-----KPNLSQ--IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP  301 (319)
T ss_dssp             HTT-C-----CCCCCC--SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred             ccC-C-----CCCCCc--CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            110 0     111100  012234788999999999999999999999999754

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.9e-42  Score=342.56  Aligned_cols=265  Identities=22%  Similarity=0.300  Sum_probs=202.0

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCC-----------CCcceeeeeeec
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-----------HKNLVTLFGCCA  152 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~  152 (437)
                      .++|++.+.||+|+||.||+|+. .+++.||||++... ......+.+|+.++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            46799999999999999999984 57899999999754 334567889999999886           899999999987


Q ss_pred             cCC----ceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCceEeeccCCCCEEec-----
Q 013745          153 EGP----EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE-APARIIHRDIKASNILLD-----  222 (437)
Q Consensus       153 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~iiHrDikp~NIll~-----  222 (437)
                      ...    ..++||||+ +++|.+++... ....+++..++.++.||+.||+|||++ +   |+||||||+||||+     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence            654    789999999 89999988543 234589999999999999999999998 7   99999999999994     


Q ss_pred             -CCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhh--
Q 013745          223 -EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKA--  299 (437)
Q Consensus       223 -~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~--  299 (437)
                       ..+.+||+|||+++......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||.........  
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             cCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence             34479999999998764322     1346899999999999999999999999999999999999999865422110  


Q ss_pred             -hhhhhhhh------------------hhcccccccccC-----------ccccCCCHHHHHHHHHHHHHcCCCCCCCCC
Q 013745          300 -DLLSYTWT------------------LFQGEKALELVD-----------PSLAKCNRDEAAMCIQLGLLCCQQSVAERP  349 (437)
Q Consensus       300 -~~~~~~~~------------------~~~~~~~~~~~d-----------~~l~~~~~~~~~~l~~l~~~cl~~~p~~RP  349 (437)
                       ..+.....                  .+........+.           ......+......+.+|+.+||+.||++||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence             00000000                  001000000000           001134567788999999999999999999


Q ss_pred             CHHHHHH--HhcC
Q 013745          350 DMNSVHL--MLSG  360 (437)
Q Consensus       350 s~~ev~~--~L~~  360 (437)
                      |+.||++  ++.+
T Consensus       327 t~~ell~hp~f~~  339 (373)
T 1q8y_A          327 DAGGLVNHPWLKD  339 (373)
T ss_dssp             CHHHHHTCGGGTT
T ss_pred             CHHHHhhChhhhc
Confidence            9999986  5543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.1e-42  Score=339.34  Aligned_cols=262  Identities=21%  Similarity=0.248  Sum_probs=202.2

Q ss_pred             HhcCccccceeccCCCeeEEEEEcC-CC-cEEEEEEeccCChHHHHHHHHHHHHHHcCCCCc------ceeeeeeeccCC
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMP-NG-QEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN------LVTLFGCCAEGP  155 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~  155 (437)
                      ..++|++.+.||+|+||.||+|... ++ +.||||++... ....+.+.+|+.++++++|++      ++.+++++...+
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~   95 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG   95 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence            3578999999999999999999853 44 68999999754 334567889999999997665      899999999999


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEe--------------
Q 013745          156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL--------------  221 (437)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll--------------  221 (437)
                      ..++||||+ +++|.+.+... ....+++..++.++.||+.||.|||+++   |+||||||+|||+              
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             eEEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence            999999999 55666665433 3356899999999999999999999998   9999999999999              


Q ss_pred             -----cCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCch
Q 013745          222 -----DEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGK  296 (437)
Q Consensus       222 -----~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~  296 (437)
                           +.++.+||+|||+++......     ....||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                 678899999999998754322     1356899999999999999999999999999999999999999876554


Q ss_pred             hhhhhhhhhhhhhcc--------ccc------------------ccccCc--cccCCCHHHHHHHHHHHHHcCCCCCCCC
Q 013745          297 EKADLLSYTWTLFQG--------EKA------------------LELVDP--SLAKCNRDEAAMCIQLGLLCCQQSVAER  348 (437)
Q Consensus       297 ~~~~~~~~~~~~~~~--------~~~------------------~~~~d~--~l~~~~~~~~~~l~~l~~~cl~~~p~~R  348 (437)
                      +....+.........        ...                  .+...+  ............+.+|+.+||+.||++|
T Consensus       246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            332222111100000        000                  000000  0011223456688999999999999999


Q ss_pred             CCHHHHHH
Q 013745          349 PDMNSVHL  356 (437)
Q Consensus       349 Ps~~ev~~  356 (437)
                      ||+.++++
T Consensus       326 pt~~e~l~  333 (355)
T 2eu9_A          326 ITLAEALL  333 (355)
T ss_dssp             CCHHHHTT
T ss_pred             cCHHHHhc
Confidence            99999974

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.2e-42  Score=333.39  Aligned_cols=252  Identities=25%  Similarity=0.363  Sum_probs=192.6

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeecc----------
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE----------  153 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----------  153 (437)
                      .++|++.+.||+|+||.||+|+. .+++.||||++... ....+.+.+|+.++++++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            46799999999999999999985 47899999999643 3445778999999999999999999998754          


Q ss_pred             ---CCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceee
Q 013745          154 ---GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKIS  230 (437)
Q Consensus       154 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~  230 (437)
                         ....++||||+++++|.+++...  ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence               35679999999999999998542  346788999999999999999999998   9999999999999999999999


Q ss_pred             ecccccccCCCCc------------ccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchh
Q 013745          231 DFGLARLFPGEDT------------HVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKE  297 (437)
Q Consensus       231 DFGla~~~~~~~~------------~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~  297 (437)
                      |||++........            ........||+.|+|||++.+. .++.++|||||||++|||++   ||....  .
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--~  233 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--E  233 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--H
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--h
Confidence            9999987643210            1112235689999999999865 78999999999999999998   553211  1


Q ss_pred             hhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          298 KADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .......   .....   ..+.   .......+..+.+++.+||+.||++||++.++++
T Consensus       234 ~~~~~~~---~~~~~---~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          234 RVNILKK---LRSVS---IEFP---PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHHHHH---HHSTT---CCCC---TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHh---ccccc---cccC---ccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            1111111   10000   0011   1223344456788999999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.3e-42  Score=336.28  Aligned_cols=254  Identities=25%  Similarity=0.367  Sum_probs=178.8

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC-ChHHHHHHHHHHH-HHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD-SRQGLREFTNEVK-LLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++... .......+..|+. +++.++||||+++++++.+.+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            46799999999999999999985 47899999999754 3334455666666 677789999999999999999999999


Q ss_pred             eecCCCCcchhhhc--cCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCceEeeccCCCCEEecCCCCceeeeccccccc
Q 013745          162 EYLPNKSLDYFIFD--KTKSSSLDWTTRYRIVMGVARGLLYLHEE-APARIIHRDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       162 e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                      ||+++ +|.+++..  ......+++..++.++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+++..
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99975 77666642  12246789999999999999999999998 8   999999999999999999999999999876


Q ss_pred             CCCCcccceeeeecccccCChhhh----ccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccc
Q 013745          239 PGEDTHVNTFRISGTHGYMAPEYA----LHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKA  314 (437)
Q Consensus       239 ~~~~~~~~~~~~~gt~~Y~aPE~~----~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  314 (437)
                      .....   .....||+.|+|||++    .+..++.++|||||||++|||++|+.||........     .......    
T Consensus       177 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~~----  244 (327)
T 3aln_A          177 VDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLTQVVK----  244 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCCC----
T ss_pred             ccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHHHHhc----
Confidence            43322   1234689999999998    456789999999999999999999999975332110     0000000    


Q ss_pred             ccccCcccc-CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          315 LELVDPSLA-KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       315 ~~~~d~~l~-~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                        ...+.+. ......+..+.+++.+||+.||++||++.+|++
T Consensus       245 --~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          245 --GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             --SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence              0001111 111123456889999999999999999999965

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=336.21  Aligned_cols=245  Identities=26%  Similarity=0.379  Sum_probs=190.8

Q ss_pred             HHHHHhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCCh------HHHHHHHHHHHHHHcC----CCCcceeee
Q 013745           80 TLQVATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSR------QGLREFTNEVKLLLKI----QHKNLVTLF  148 (437)
Q Consensus        80 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~  148 (437)
                      ..+...++|++.+.||+|+||.||+|+. .+++.||||++.....      .....+.+|+.++.++    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            4455678899999999999999999985 4789999999975432      1223456799999998    899999999


Q ss_pred             eeeccCCceEEEEee-cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEec-CCCC
Q 013745          149 GCCAEGPEKMLVYEY-LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD-EQLN  226 (437)
Q Consensus       149 ~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~-~~~~  226 (437)
                      +++...+..++|||+ +.+++|.+++...   ..+++..++.++.||+.||.|||+++   |+||||||+|||++ .++.
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~  178 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGC  178 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTE
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCe
Confidence            999999999999999 7899999998543   45899999999999999999999998   99999999999999 8899


Q ss_pred             ceeeecccccccCCCCcccceeeeecccccCChhhhccCcC-CcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhh
Q 013745          227 PKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL-SVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYT  305 (437)
Q Consensus       227 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~  305 (437)
                      +||+|||+++.......    ....||..|+|||++.+..+ +.++|||||||++|||++|+.||.....     ...  
T Consensus       179 ~kl~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~--  247 (312)
T 2iwi_A          179 AKLIDFGSGALLHDEPY----TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----ILE--  247 (312)
T ss_dssp             EEECCCSSCEECCSSCB----CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----HHH--
T ss_pred             EEEEEcchhhhcccCcc----cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----Hhh--
Confidence            99999999987754322    23568999999999987765 4589999999999999999999964211     000  


Q ss_pred             hhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          306 WTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       306 ~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                           ..          ..........+.+++.+||+.+|++||++.++++
T Consensus       248 -----~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          248 -----AE----------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             -----TC----------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----hc----------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 00          0011123456788999999999999999999987

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=7e-42  Score=346.18  Aligned_cols=253  Identities=26%  Similarity=0.333  Sum_probs=188.7

Q ss_pred             cCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCceEEEEeec
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      +.|.+.+.||+|+||+||.+...+|+.||||++....   .+.+.+|+.++.++ +|||||++++++.+....++|||||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            4566778999999999987666689999999986542   34577899999876 8999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCC----CCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCC-------------CCc
Q 013745          165 PNKSLDYFIFDKTKSS----SLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQ-------------LNP  227 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~-------------~~~  227 (437)
                      . |+|.+++.......    ...+..++.++.||+.||+|||+++   |+||||||+|||++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence            5 69999985432211    1133456789999999999999998   9999999999999754             479


Q ss_pred             eeeecccccccCCCCccc--ceeeeecccccCChhhhcc-------CcCCcccceehhhHHHHHHHh-CCCCCCCCCchh
Q 013745          228 KISDFGLARLFPGEDTHV--NTFRISGTHGYMAPEYALH-------GYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKE  297 (437)
Q Consensus       228 kl~DFGla~~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~-------~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~  297 (437)
                      ||+|||+++.........  ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            999999999875433221  1224579999999999976       578999999999999999999 999997543322


Q ss_pred             hhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          298 KADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      . ..+.   ....    .   ...........+..+.+++.+||+.||++||++.+|++
T Consensus       248 ~-~i~~---~~~~----~---~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 S-NIIR---GIFS----L---DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             H-HHHH---TCCC----C---CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H-HHhc---CCCC----c---ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            1 1111   0000    0   00011123466778999999999999999999999975

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.6e-42  Score=336.73  Aligned_cols=256  Identities=18%  Similarity=0.199  Sum_probs=175.1

Q ss_pred             hcCccccc-eeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeecc----CCceE
Q 013745           85 TNFFSDLN-QLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE----GPEKM  158 (437)
Q Consensus        85 ~~~y~~~~-~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  158 (437)
                      .++|.+++ .||+|+||.||+|... +|+.||||++..... ...   +....++.+.||||+++++++..    ....+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-ARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-HHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-HHH---HHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            56799865 5999999999999854 799999999965322 112   23334566799999999999876    45589


Q ss_pred             EEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC---CCCceeeecccc
Q 013745          159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE---QLNPKISDFGLA  235 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~---~~~~kl~DFGla  235 (437)
                      +||||+++|+|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.   ++.+||+|||++
T Consensus       103 lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            999999999999998543 2356999999999999999999999998   999999999999976   455999999999


Q ss_pred             cccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccc
Q 013745          236 RLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKAL  315 (437)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (437)
                      +.......    ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.............   ..... ...
T Consensus       179 ~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~-~~~  250 (336)
T 3fhr_A          179 KETTQNAL----QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK---RRIRL-GQY  250 (336)
T ss_dssp             EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred             eecccccc----ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH---Hhhhc-ccc
Confidence            87643221    23568999999999998899999999999999999999999997654332111000   00000 000


Q ss_pred             cccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          316 ELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       316 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                      ....+    .....+..+.+++.+||+.+|++|||+.++++  ++.+
T Consensus       251 ~~~~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  293 (336)
T 3fhr_A          251 GFPNP----EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ  293 (336)
T ss_dssp             CCCTT----TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             ccCch----hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence            00111    11233456789999999999999999999997  6654

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=329.52  Aligned_cols=251  Identities=24%  Similarity=0.368  Sum_probs=179.7

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC-h-HHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS-R-QGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      .++|++++.||+|+||.||+|... +|+.||||++.... . ...+.+.++..+++.++||||+++++++.+.+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            467999999999999999999864 78999999997543 2 22334455556788889999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE-APARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      ||+ ++.+..+...  ....+++..++.++.||+.||.|||++ +   |+||||||+|||++.++.+||+|||++.....
T Consensus       104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            999 5555554422  235689999999999999999999995 7   99999999999999999999999999987644


Q ss_pred             CCcccceeeeecccccCChhhhc-----cCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccc
Q 013745          241 EDTHVNTFRISGTHGYMAPEYAL-----HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKAL  315 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (437)
                      ...   .....||+.|+|||++.     ...++.++|||||||++|||++|+.||........  .+.   ......   
T Consensus       178 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~---~~~~~~---  246 (318)
T 2dyl_A          178 DKA---KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE--VLT---KVLQEE---  246 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--HHH---HHHHSC---
T ss_pred             Ccc---ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH--HHH---HHhccC---
Confidence            322   12356899999999994     45789999999999999999999999975332211  111   111110   


Q ss_pred             cccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          316 ELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       316 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                         .+.+.. ....+..+.+++.+||+.||.+||++.+|++
T Consensus       247 ---~~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          247 ---PPLLPG-HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             ---CCCCCS-SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ---CCCCCc-cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence               011110 1123345788999999999999999999975

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6.4e-42  Score=358.65  Aligned_cols=258  Identities=22%  Similarity=0.297  Sum_probs=201.2

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeecc------CCc
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE------GPE  156 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  156 (437)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            36799999999999999999985 47899999998754 44556779999999999999999999999765      677


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCC---ceeeecc
Q 013745          157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLN---PKISDFG  233 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~---~kl~DFG  233 (437)
                      .++||||+++|+|.+++........+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence            8999999999999999976555557999999999999999999999998   999999999999997765   8999999


Q ss_pred             cccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccc-
Q 013745          234 LARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGE-  312 (437)
Q Consensus       234 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-  312 (437)
                      ++.........   ....||+.|+|||++.+..++.++|||||||++|||++|+.||........     |........ 
T Consensus       170 ~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~-----~~~~i~~~~~  241 (676)
T 3qa8_A          170 YAKELDQGELC---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ-----WHGKVREKSN  241 (676)
T ss_dssp             CCCBTTSCCCC---CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHH-----SSTTCC----
T ss_pred             ccccccccccc---ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhh-----hhhhhhcccc
Confidence            99877543322   245789999999999999999999999999999999999999976432211     110000000 


Q ss_pred             ------------ccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHH
Q 013745          313 ------------KALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNS  353 (437)
Q Consensus       313 ------------~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~e  353 (437)
                                  .......+.........+..+.+++.+||+.||++|||+.+
T Consensus       242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence                        00000011112344557788999999999999999999965

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=343.43  Aligned_cols=250  Identities=24%  Similarity=0.334  Sum_probs=187.0

Q ss_pred             hcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCceEEEEee
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      ..+|.+.+.||+|+||+||.....+++.||||++.....   ..+.+|+.+|+++ +|||||++++++.+....++||||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~   99 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL   99 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence            456999999999999997655455899999999965432   2245799999999 799999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC-----CCCceeeeccccccc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE-----QLNPKISDFGLARLF  238 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~-----~~~~kl~DFGla~~~  238 (437)
                      |. |+|.+++....  ..+.+..++.++.||+.||.|||+++   |+||||||+||||+.     ...+||+|||+++..
T Consensus       100 ~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~  173 (432)
T 3p23_A          100 CA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL  173 (432)
T ss_dssp             CS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred             CC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence            96 58988885432  34555667889999999999999998   999999999999943     335789999999876


Q ss_pred             CCCCc-ccceeeeecccccCChhhhc---cCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccc
Q 013745          239 PGEDT-HVNTFRISGTHGYMAPEYAL---HGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEK  313 (437)
Q Consensus       239 ~~~~~-~~~~~~~~gt~~Y~aPE~~~---~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (437)
                      ..... ........||+.|+|||++.   ...++.++|||||||++|||++ |..||...........       . ...
T Consensus       174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~-------~-~~~  245 (432)
T 3p23_A          174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL-------L-GAC  245 (432)
T ss_dssp             ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH-------T-TCC
T ss_pred             cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH-------h-ccC
Confidence            53321 11223467999999999997   4567889999999999999999 9999964332221110       0 000


Q ss_pred             cccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          314 ALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       314 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .....     .........+.+++.+||+.||++||++.+|++
T Consensus       246 ~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          246 SLDCL-----HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CCTTS-----CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             Ccccc-----CccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            00111     112244556789999999999999999999974

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.9e-40  Score=353.84  Aligned_cols=238  Identities=21%  Similarity=0.284  Sum_probs=192.9

Q ss_pred             HhcCccccceeccCCCeeEEEEEcC--CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCc----
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMP--NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPE----  156 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  156 (437)
                      ..++|++.+.||+|+||.||+|.+.  +|+.||||++... .......+.+|+.++.+++||||+++++++...+.    
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            4578999999999999999999864  6899999998654 34455678999999999999999999999987665    


Q ss_pred             -eEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccc
Q 013745          157 -KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA  235 (437)
Q Consensus       157 -~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  235 (437)
                       .||||||++|++|.+++.     ..+++..++.|+.||+.||.|||+++   |+||||||+|||++.+ .+||+|||++
T Consensus       158 ~~~lv~E~~~g~~L~~~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a  228 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKG-----QKLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAV  228 (681)
T ss_dssp             EEEEEEECCCCEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred             eeEEEEEeCCCCcHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccc
Confidence             699999999999988762     26899999999999999999999998   9999999999999985 8999999999


Q ss_pred             cccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccc
Q 013745          236 RLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKAL  315 (437)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (437)
                      +.....      ....||+.|+|||++.++. +.++|||||||+||+|++|..||.+......                 
T Consensus       229 ~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-----------------  284 (681)
T 2pzi_A          229 SRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL-----------------  284 (681)
T ss_dssp             EETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----------------
T ss_pred             hhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccccc-----------------
Confidence            876543      2356899999999987765 8999999999999999999988864211100                 


Q ss_pred             cccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCC-HHHHHHHhc
Q 013745          316 ELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPD-MNSVHLMLS  359 (437)
Q Consensus       316 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs-~~ev~~~L~  359 (437)
                         ...  .........+.+++.+||+.||++||+ ++++...|.
T Consensus       285 ---~~~--~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          285 ---PED--DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             ---CTT--CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             ---ccc--ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence               000  001123356789999999999999995 555555554

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.2e-40  Score=315.72  Aligned_cols=230  Identities=12%  Similarity=0.033  Sum_probs=183.7

Q ss_pred             HhcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      ..++|++.+.||+|+||.||+|... +++.||||++....   ....+.+.+|+.++.+++||||+++++++.+.+..|+
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            3567999999999999999999864 58999999997542   3445778999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      ||||++|++|.+++..    + .....+..|+.||+.||.|||+++   |+||||||+|||++.++.+||+++       
T Consensus       109 v~e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~-------  173 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYP-------  173 (286)
T ss_dssp             EEECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSC-------
T ss_pred             EEEecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEec-------
Confidence            9999999999999832    2 355678899999999999999998   999999999999999999999744       


Q ss_pred             CCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                                     .|++|       ++.++|||||||++|||++|+.||.+.........   ........    .  
T Consensus       174 ---------------~~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~---~~~~~~~~----~--  222 (286)
T 3uqc_A          174 ---------------ATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP---AERDTAGQ----P--  222 (286)
T ss_dssp             ---------------CCCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE---CCBCTTSC----B--
T ss_pred             ---------------cccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH---HHHHhccC----C--
Confidence                           34443       68999999999999999999999987554321100   00000000    0  


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      +.........+..+.+++.+||+.||++| |+.|+++.|+.
T Consensus       223 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~  262 (286)
T 3uqc_A          223 IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQ  262 (286)
T ss_dssp             CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHH
T ss_pred             CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHH
Confidence            00001112334568899999999999999 99999999985

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-40  Score=334.77  Aligned_cols=241  Identities=15%  Similarity=0.142  Sum_probs=180.6

Q ss_pred             hcCccccceeccCCCeeEEEEE-cCCCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCC-Ccceeee-----------
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQH-KNLVTLF-----------  148 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l~-----------  148 (437)
                      ...|...+.||+|+||+||+|. ..+|+.||||++....   ....+.+.+|+.+++.++| +|...+.           
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            3458888999999999999999 4579999999987432   2225678999999999987 3221111           


Q ss_pred             ----------eeecc-----CCceEEEEeecCCCCcchhhhc----cCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCce
Q 013745          149 ----------GCCAE-----GPEKMLVYEYLPNKSLDYFIFD----KTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI  209 (437)
Q Consensus       149 ----------~~~~~-----~~~~~lv~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i  209 (437)
                                .++..     ....+++|+++ +++|.+++..    ......+++..++.++.||+.||+|||+++   |
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence                      11111     22456777766 6899888731    123456788899999999999999999998   9


Q ss_pred             EeeccCCCCEEecCCCCceeeecccccccCCCCcccceeeeecccccCChhhh----------ccCcCCcccceehhhHH
Q 013745          210 IHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA----------LHGYLSVKTDVFSYGVL  279 (437)
Q Consensus       210 iHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~----------~~~~~~~~~DvwSlG~v  279 (437)
                      +||||||+||||+.++.+||+|||+++.....     ....+| +.|+|||++          ....++.++|||||||+
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            99999999999999999999999999865432     224567 999999999          55568899999999999


Q ss_pred             HHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 013745          280 VLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVH  355 (437)
Q Consensus       280 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~  355 (437)
                      +|||++|+.||...........      .+.          ....    .+..+.+|+.+||+.+|++||++.+++
T Consensus       307 l~elltg~~Pf~~~~~~~~~~~------~~~----------~~~~----~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGGSEW------IFR----------SCKN----IPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSCSGG------GGS----------SCCC----CCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHHCCCCCCCcchhhhHHH------HHh----------hccc----CCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            9999999999976443221111      000          0011    235688999999999999999977764

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.6e-39  Score=310.95  Aligned_cols=231  Identities=19%  Similarity=0.193  Sum_probs=179.7

Q ss_pred             hcCcccc-ceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHH-HcCCCCcceeeeeeecc----CCce
Q 013745           85 TNFFSDL-NQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLL-LKIQHKNLVTLFGCCAE----GPEK  157 (437)
Q Consensus        85 ~~~y~~~-~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~  157 (437)
                      .++|.+. +.||+|+||.||+|.. .+++.||||++...     ..+.+|+.++ +.++||||+++++++..    ....
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            3567777 7899999999999985 47899999999643     3456788888 56689999999999876    6778


Q ss_pred             EEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC---CCCceeeeccc
Q 013745          158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE---QLNPKISDFGL  234 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~---~~~~kl~DFGl  234 (437)
                      ++||||+++++|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.   ++.+||+|||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            9999999999999998653 3356999999999999999999999998   999999999999998   78999999999


Q ss_pred             ccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccc
Q 013745          235 ARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKA  314 (437)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  314 (437)
                      +....                        +..++.++|||||||++|||++|+.||.............           
T Consensus       167 a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~-----------  211 (299)
T 3m2w_A          167 AKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-----------  211 (299)
T ss_dssp             CEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC-----------
T ss_pred             ccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH-----------
Confidence            86532                        2346889999999999999999999997644322110000           


Q ss_pred             ccccCccccCCC----HHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          315 LELVDPSLAKCN----RDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       315 ~~~~d~~l~~~~----~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                       ..+.......+    ...+..+.+++.+||+.||++||++.++++  ++.+
T Consensus       212 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~  262 (299)
T 3m2w_A          212 -TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  262 (299)
T ss_dssp             -CSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             -HHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcc
Confidence             00000000011    123456889999999999999999999986  5553

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.1e-40  Score=323.85  Aligned_cols=242  Identities=13%  Similarity=0.114  Sum_probs=183.1

Q ss_pred             hcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCC--------hHHHHHHHHHHHHHHcCC---------C------
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS--------RQGLREFTNEVKLLLKIQ---------H------  141 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h------  141 (437)
                      .++|++.+.||+|+||.||+|+. +|+.||||++....        ....+.+.+|+.++++++         |      
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46799999999999999999988 78999999997542        222467889999998886         5      


Q ss_pred             -----------Ccceeeeeeecc-------------CCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHH
Q 013745          142 -----------KNLVTLFGCCAE-------------GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARG  197 (437)
Q Consensus       142 -----------~niv~l~~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~  197 (437)
                                 |||++++++|.+             ....||||||+++|++.+.+.    ...+++..++.++.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~----~~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR----TKLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT----TTCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH----hcCCCHHHHHHHHHHHHHH
Confidence                       455555555543             678999999999997766652    2568999999999999999


Q ss_pred             HHHhh-hcCCCceEeeccCCCCEEecCCC--------------------CceeeecccccccCCCCcccceeeeeccccc
Q 013745          198 LLYLH-EEAPARIIHRDIKASNILLDEQL--------------------NPKISDFGLARLFPGEDTHVNTFRISGTHGY  256 (437)
Q Consensus       198 L~~LH-~~~~~~iiHrDikp~NIll~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y  256 (437)
                      |.||| +++   |+||||||+||||+.++                    .+||+|||+|+.....       ..+||+.|
T Consensus       174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y  243 (336)
T 2vuw_A          174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS  243 (336)
T ss_dssp             HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred             HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence            99999 888   99999999999999887                    8999999999876432       34799999


Q ss_pred             CChhhhccCcCCcccceehhhHH-HHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHH
Q 013745          257 MAPEYALHGYLSVKTDVFSYGVL-VLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQ  335 (437)
Q Consensus       257 ~aPE~~~~~~~~~~~DvwSlG~v-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~  335 (437)
                      +|||++.+.. +.++||||||++ .+++++|..||......  .....   .......   .............+.++.+
T Consensus       244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~--~~~~~---~~~~~~~---~~~~~~~~~~~~~s~~~~d  314 (336)
T 2vuw_A          244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL--HYLTD---KMLKQMT---FKTKCNTPAMKQIKRKIQE  314 (336)
T ss_dssp             TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH--HHHHH---HHHHTCC---CSSCCCSHHHHHHHHHHHH
T ss_pred             cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh--hHHHH---hhhhhhc---cCcccchhhhhhcCHHHHH
Confidence            9999998776 899999998777 78889999998421000  00000   0100000   0000111223457788999


Q ss_pred             HHHHcCCCCCCCCCCHHHHH
Q 013745          336 LGLLCCQQSVAERPDMNSVH  355 (437)
Q Consensus       336 l~~~cl~~~p~~RPs~~ev~  355 (437)
                      |+.+||+.+     |+.|++
T Consensus       315 li~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          315 FHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHGGGSS-----SHHHHH
T ss_pred             HHHHHhccC-----CHHHHH
Confidence            999999976     888887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=3.6e-34  Score=298.37  Aligned_cols=186  Identities=19%  Similarity=0.186  Sum_probs=131.4

Q ss_pred             eeccCCCeeEEEEE-cCCCcEEEEEEeccC----------ChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCceEEE
Q 013745           93 QLGHGGFGPVYRGL-MPNGQEIAVKKLSVD----------SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        93 ~lG~G~~g~Vy~~~-~~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  160 (437)
                      .++.|++|.+..++ .-.|+.||||++...          .....++|.+|+++|+++ .|+||++++++++++...|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            35677777766654 225889999999653          123456799999999999 699999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||++|++|.++|..   .++++..   +|+.||+.||+|||++|   ||||||||+||||+.+|.+||+|||+|+....
T Consensus       321 MEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          321 MEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             EecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            999999999999943   3456654   48899999999999998   99999999999999999999999999997754


Q ss_pred             CCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCC
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNH  290 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~  290 (437)
                      .....  ...+||+.|||||++.+. +..++|+||+|+++++|.++..++
T Consensus       392 ~~~~~--~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          392 DCSWP--TNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             --CCS--HHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             CCccc--cCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence            43322  246799999999998764 577899999999999887765443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=1e-29  Score=263.35  Aligned_cols=186  Identities=17%  Similarity=0.167  Sum_probs=146.0

Q ss_pred             cccceeccCCCeeEEEEEcCCCcEEEEEEeccCC--------hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           89 SDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS--------RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        89 ~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      ...+.||+|+||.||+|.. .++.+++|+.....        ....+.+.+|++++++++||||+++..++......+||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4467899999999999965 67889999864321        11234589999999999999999666666677778999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||+++++|.+++..           ++.++.|++.||.|||+++   |+||||||+|||++.  .+||+|||+++....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999998832           5679999999999999998   999999999999998  999999999998754


Q ss_pred             CCccc-----ceeeeecccccCChhhhcc--CcCCcccceehhhHHHHHHHhCCCCCC
Q 013745          241 EDTHV-----NTFRISGTHGYMAPEYALH--GYLSVKTDVFSYGVLVLEIVSGRKNHD  291 (437)
Q Consensus       241 ~~~~~-----~~~~~~gt~~Y~aPE~~~~--~~~~~~~DvwSlG~vl~elltg~~p~~  291 (437)
                      .....     ......||+.|||||++..  ..|+..+|+|+..+-..+-+.++.+|.
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            32211     1124679999999999987  568889999999999999888877663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=1.6e-26  Score=220.01  Aligned_cols=164  Identities=18%  Similarity=0.117  Sum_probs=129.5

Q ss_pred             HHHHHHhcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCCh------------------HHHHHHHHHHHHHHcCC
Q 013745           79 RTLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR------------------QGLREFTNEVKLLLKIQ  140 (437)
Q Consensus        79 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~  140 (437)
                      ..+......|.+.+.||+|+||.||+|...+|+.||||++.....                  .....+.+|+.++++++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            344444566888899999999999999987799999999964321                  13456889999999999


Q ss_pred             CCcceeeeeeeccCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEE
Q 013745          141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNIL  220 (437)
Q Consensus       141 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIl  220 (437)
                        | +++.+++.. +..++||||++|++|.+ +.         ......++.|++.||.|||+.+   |+||||||+|||
T Consensus       163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~---------~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NIL  225 (282)
T 1zar_A          163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR---------VENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVL  225 (282)
T ss_dssp             --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC---------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEE
T ss_pred             --C-CCcCeEEec-cceEEEEEecCCCcHHH-cc---------hhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEE
Confidence              5 666665543 56799999999999987 41         1234579999999999999998   999999999999


Q ss_pred             ecCCCCceeeecccccccCCCCcccceeeeecccccCChhhhcc----------CcCCcccceeh
Q 013745          221 LDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH----------GYLSVKTDVFS  275 (437)
Q Consensus       221 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~----------~~~~~~~DvwS  275 (437)
                      ++ ++.+||+|||+++.               +..|+|||++..          ..++..+|+|.
T Consensus       226 l~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          226 VS-EEGIWIIDFPQSVE---------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             EE-TTEEEECCCTTCEE---------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             EE-CCcEEEEECCCCeE---------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            99 99999999999963               455789998864          34555666654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=7.6e-22  Score=185.30  Aligned_cols=137  Identities=17%  Similarity=0.179  Sum_probs=106.7

Q ss_pred             CccccceeccCCCeeEEEEEc-CCCcE--EEEEEeccCChH------------------------HHHHHHHHHHHHHcC
Q 013745           87 FFSDLNQLGHGGFGPVYRGLM-PNGQE--IAVKKLSVDSRQ------------------------GLREFTNEVKLLLKI  139 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l  139 (437)
                      -|++.+.||+|+||.||+|.. .+|+.  ||||++......                        ....+.+|+.+|.++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            377889999999999999987 68889  999987543111                        123578999999999


Q ss_pred             CCCcc--eeeeeeeccCCceEEEEeecCC-C----CcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhh-hcCCCceEe
Q 013745          140 QHKNL--VTLFGCCAEGPEKMLVYEYLPN-K----SLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH-EEAPARIIH  211 (437)
Q Consensus       140 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~~~~iiH  211 (437)
                      .|+++  ..++.+    ...+|||||+.+ |    +|.++...      .++..+..++.|++.+|.||| +.+   |+|
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH  194 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVH  194 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence            88754  334432    356899999942 4    45444311      234567889999999999999 887   999


Q ss_pred             eccCCCCEEecCCCCceeeeccccccc
Q 013745          212 RDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       212 rDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                      |||||+|||++.  .++|+|||+|...
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999998  9999999999765

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.78  E-value=1.3e-19  Score=177.67  Aligned_cols=146  Identities=14%  Similarity=0.164  Sum_probs=103.4

Q ss_pred             cHHHHHHHhcC---ccccceeccCCCeeEEEEEcCCCcEEEEEEeccCC--------------hHHHHH--------HHH
Q 013745           77 DLRTLQVATNF---FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS--------------RQGLRE--------FTN  131 (437)
Q Consensus        77 ~~~~~~~~~~~---y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--------------~~~~~~--------~~~  131 (437)
                      ++-.+....++   |++.+.||+|+||.||+|...+|+.||||+++...              ......        ..+
T Consensus        83 D~LAL~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~k  162 (397)
T 4gyi_A           83 DYLALHTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIK  162 (397)
T ss_dssp             HHHHHHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHH
Confidence            44444444433   99999999999999999998899999999875320              000111        234


Q ss_pred             HHHHHHcCCCCcce--eeeeeeccCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCce
Q 013745          132 EVKLLLKIQHKNLV--TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI  209 (437)
Q Consensus       132 E~~~l~~l~h~niv--~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~i  209 (437)
                      |...|.++.+.++.  ..+++    ...+|||||++|++|..+..         ......++.||+.+|.|||+.|   |
T Consensus       163 E~~nL~rL~~~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~---------~~~~~~l~~qll~~l~~lH~~g---I  226 (397)
T 4gyi_A          163 EFAFMKALYEEGFPVPEPIAQ----SRHTIVMSLVDALPMRQVSS---------VPDPASLYADLIALILRLAKHG---L  226 (397)
T ss_dssp             HHHHHHHHHHTTCSCCCEEEE----ETTEEEEECCSCEEGGGCCC---------CSCHHHHHHHHHHHHHHHHHTT---E
T ss_pred             HHHHHHHHHhcCCCCCeeeec----cCceEEEEecCCccHhhhcc---------cHHHHHHHHHHHHHHHHHHHCC---C
Confidence            56666666433332  11221    12379999999988865431         1234568899999999999988   9


Q ss_pred             EeeccCCCCEEecCCCC----------ceeeeccccccc
Q 013745          210 IHRDIKASNILLDEQLN----------PKISDFGLARLF  238 (437)
Q Consensus       210 iHrDikp~NIll~~~~~----------~kl~DFGla~~~  238 (437)
                      |||||||.||||++++.          +.|+||+-+...
T Consensus       227 VHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          227 IHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             ECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             cCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence            99999999999988773          889999987654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.49  E-value=7e-14  Score=130.80  Aligned_cols=144  Identities=12%  Similarity=0.061  Sum_probs=112.8

Q ss_pred             HhcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCC-CCcceeeeeeeccCCceEEEEe
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      ..+.|++...++.|+++.||++.. .++.+++|+...........+.+|+.+++.+. +.++.++++++...+..|+|||
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e   90 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS   90 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             HhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence            345798899999999999999876 46899999986432122245778999999885 6778889999988888999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhc--------------------------------------
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE--------------------------------------  204 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~--------------------------------------  204 (437)
                      |++|.+|...+.        +......++.+++++|+.||+.                                      
T Consensus        91 ~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T 3tm0_A           91 EADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             CCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred             ecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence            999999876531        1123346888999999999981                                      


Q ss_pred             ------------------CCCceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          205 ------------------APARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       205 ------------------~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                                        .+..++|+|++|.|||+++++.+.|+||+.+.
T Consensus       163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                              11348999999999999876666799998775

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.35  E-value=1.1e-12  Score=121.95  Aligned_cols=137  Identities=18%  Similarity=0.114  Sum_probs=100.7

Q ss_pred             CccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCc--ceeeeeeeccCCceEEEEeec
Q 013745           87 FFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN--LVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~  164 (437)
                      .|.+....+.|..+.||++...+|+.++||+.....   ...+.+|+.+++.+.+.+  +.++++++...+..++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            344433334566699999987678889999976541   245678999999886444  456888888777889999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcC---------------------------------------
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA---------------------------------------  205 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---------------------------------------  205 (437)
                      +|.+|.  ..   .   .+   ...++.++++.|..||+..                                       
T Consensus        98 ~G~~l~--~~---~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (264)
T 1nd4_A           98 PGQDLL--SS---H---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA  166 (264)
T ss_dssp             SSEETT--TS---C---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred             CCcccC--cC---c---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence            998884  21   1   11   2356778888888888743                                       


Q ss_pred             ----------------CCceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          206 ----------------PARIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       206 ----------------~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                                      +..++|+|++|.|||+++++.+.|+|||.+..
T Consensus       167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                            12399999999999998776677999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.29  E-value=1.5e-11  Score=120.49  Aligned_cols=142  Identities=15%  Similarity=0.279  Sum_probs=107.7

Q ss_pred             ccceeccCCCeeEEEEEcCCCcEEEEEEec--cCC-hHHHHHHHHHHHHHHcCC--CCcceeeeeeeccC---CceEEEE
Q 013745           90 DLNQLGHGGFGPVYRGLMPNGQEIAVKKLS--VDS-RQGLREFTNEVKLLLKIQ--HKNLVTLFGCCAEG---PEKMLVY  161 (437)
Q Consensus        90 ~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~  161 (437)
                      .++.|+.|.++.||+.... +..+++|+..  ... ......+.+|+.+++.|.  +..+.+++.++.+.   +..|+||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            4678999999999998874 4688899876  332 122346788999999997  45678888888776   4479999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcC------------------------------------
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA------------------------------------  205 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~------------------------------------  205 (437)
                      ||++|..+.+..     ...++...+..++.++++.|+.||+..                                    
T Consensus       121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999998885422     134677888899999999999999831                                    


Q ss_pred             -------------------CCceEeeccCCCCEEecCCCC--ceeeecccccc
Q 013745          206 -------------------PARIIHRDIKASNILLDEQLN--PKISDFGLARL  237 (437)
Q Consensus       206 -------------------~~~iiHrDikp~NIll~~~~~--~kl~DFGla~~  237 (437)
                                         +..++|+|++|.|||++.++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               246999999999999987753  68999998874

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.18  E-value=2.8e-11  Score=115.68  Aligned_cols=183  Identities=17%  Similarity=0.188  Sum_probs=123.1

Q ss_pred             cceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCC-CCc--ceeeeeeeccCC---ceEEEEeec
Q 013745           91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKN--LVTLFGCCAEGP---EKMLVYEYL  164 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e~~  164 (437)
                      ++.++.|....||++.    ..+++|+....  .....+.+|+++|+.+. +..  +.+++.......   ..|+||+++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4669999999999863    56889986532  34567889999998884 322  344555443333   348999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhc----------------------------------------
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE----------------------------------------  204 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----------------------------------------  204 (437)
                      +|.+|.....     ..++...+..++.+++..|+.||+.                                        
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9998875432     2366777788888888888888861                                        


Q ss_pred             ---------------CCCceEeeccCCCCEEecC--CCCceeeecccccccCCCCcccceeeeeccccc---CChhhhcc
Q 013745          205 ---------------APARIIHRDIKASNILLDE--QLNPKISDFGLARLFPGEDTHVNTFRISGTHGY---MAPEYALH  264 (437)
Q Consensus       205 ---------------~~~~iiHrDikp~NIll~~--~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y---~aPE~~~~  264 (437)
                                     .+..++|+|++|.||++++  ...+.|+||+.+..-+....      +.....+   ..|+....
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D------l~~~~~~~~~~~~~~~~~  247 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND------FISLMEDDEEYGMEFVSK  247 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH------HHTTCCTTTSCCHHHHHH
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH------HHHHHhhccccCHHHHHH
Confidence                           1235899999999999998  55678999998875322100      0001111   23332211


Q ss_pred             ---C--c---------CCcccceehhhHHHHHHHhCCCCC
Q 013745          265 ---G--Y---------LSVKTDVFSYGVLVLEIVSGRKNH  290 (437)
Q Consensus       265 ---~--~---------~~~~~DvwSlG~vl~elltg~~p~  290 (437)
                         .  .         .....+.|+++.++|.+.+|..+|
T Consensus       248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence               0  0         122358999999999999998775

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.73  E-value=7.1e-08  Score=92.11  Aligned_cols=136  Identities=21%  Similarity=0.190  Sum_probs=95.6

Q ss_pred             cceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCC---cceeeeeeec-cCCceEEEEeecCC
Q 013745           91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHK---NLVTLFGCCA-EGPEKMLVYEYLPN  166 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~  166 (437)
                      ++.++.|....||+.    |..++||+..  .......+.+|+++|+.|.+.   .+.+.+.+.. ..+..++|||+++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            466889999999987    5678889853  233456788999999999742   3455666653 44567899999999


Q ss_pred             CCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhc------------------------------------------
Q 013745          167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE------------------------------------------  204 (437)
Q Consensus       167 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~------------------------------------------  204 (437)
                      ..+.....     ..++......++.+++..|+.||+.                                          
T Consensus        98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            88866321     1234445555566666666666542                                          


Q ss_pred             ---------------CCCceEeeccCCCCEEecC---CCCc-eeeecccccc
Q 013745          205 ---------------APARIIHRDIKASNILLDE---QLNP-KISDFGLARL  237 (437)
Q Consensus       205 ---------------~~~~iiHrDikp~NIll~~---~~~~-kl~DFGla~~  237 (437)
                                     .+..++|+|++|.|||++.   ++.+ .|+||+.+..
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                           2234799999999999987   4554 8999998864

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.63  E-value=1.9e-07  Score=87.08  Aligned_cols=135  Identities=21%  Similarity=0.154  Sum_probs=96.9

Q ss_pred             eeccCCCe-eEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCC-CCcceeeeeeeccCCceEEEEeecCCCCc
Q 013745           93 QLGHGGFG-PVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLVYEYLPNKSL  169 (437)
Q Consensus        93 ~lG~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL  169 (437)
                      .+..|..+ .||+.... ++..++||+-...   ....+.+|..+|+.|. +--+.++++++.+.+..++|||+++|.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            44555555 68987754 5678899986532   2456778999998885 33466788888888899999999999887


Q ss_pred             chhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhc---------------------------------------------
Q 013745          170 DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE---------------------------------------------  204 (437)
Q Consensus       170 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---------------------------------------------  204 (437)
                      .+....       .......++.+++..|..||..                                             
T Consensus       108 ~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          108 FQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            665421       1123345667777777777751                                             


Q ss_pred             ----------CCCceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          205 ----------APARIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       205 ----------~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                                .+..++|+|+.+.|||+++++.+-|+||+.+..
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                      112379999999999999877777999987753

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.59  E-value=7.2e-08  Score=93.91  Aligned_cols=81  Identities=5%  Similarity=-0.033  Sum_probs=56.5

Q ss_pred             ccee-ccCCCeeEEEEEcC-------CCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCC-C--CcceeeeeeeccC--
Q 013745           91 LNQL-GHGGFGPVYRGLMP-------NGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQ-H--KNLVTLFGCCAEG--  154 (437)
Q Consensus        91 ~~~l-G~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~--  154 (437)
                      .+.| +.|....+|+....       +++.+++|+.....   ......+.+|+.+++.|. +  -.+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4667 88999999998753       26788999865322   001134668888888874 2  3567788777655  


Q ss_pred             -CceEEEEeecCCCCcch
Q 013745          155 -PEKMLVYEYLPNKSLDY  171 (437)
Q Consensus       155 -~~~~lv~e~~~~gsL~~  171 (437)
                       +..++||||++|..+.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             35689999999987754

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.57  E-value=3.8e-07  Score=87.21  Aligned_cols=138  Identities=14%  Similarity=0.124  Sum_probs=91.7

Q ss_pred             cceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCC---CCcceeeeeeeccCCceEEEEeecCCC
Q 013745           91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ---HKNLVTLFGCCAEGPEKMLVYEYLPNK  167 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g  167 (437)
                      .+.|+.|....+|+... +++.++||+....   ....+..|+..|+.|.   ...+.+++.+....+..++||||+++.
T Consensus        41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            56799999999999876 5678899987543   2456788999998884   356788888887778899999999998


Q ss_pred             Ccch-----------hhhccCCCC-------------------CCCHHHHH---HHH----------------HHHHHHH
Q 013745          168 SLDY-----------FIFDKTKSS-------------------SLDWTTRY---RIV----------------MGVARGL  198 (437)
Q Consensus       168 sL~~-----------~l~~~~~~~-------------------~l~~~~~~---~i~----------------~qi~~~L  198 (437)
                      .+..           .|+......                   .-+|...+   ++.                ..++..+
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            7632           112211100                   11344322   111                1111111


Q ss_pred             -HHhhh-cCCCceEeeccCCCCEEecCCCCceeeecc
Q 013745          199 -LYLHE-EAPARIIHRDIKASNILLDEQLNPKISDFG  233 (437)
Q Consensus       199 -~~LH~-~~~~~iiHrDikp~NIll~~~~~~kl~DFG  233 (437)
                       ..|.. ..++.++|+|+.+.||+++.++ +.|.||.
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             23321 1245699999999999999887 8889973

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.38  E-value=1.8e-06  Score=83.12  Aligned_cols=141  Identities=12%  Similarity=0.174  Sum_probs=79.8

Q ss_pred             cceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCC--CCcceeeeee------eccCCceEEEEe
Q 013745           91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ--HKNLVTLFGC------CAEGPEKMLVYE  162 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~------~~~~~~~~lv~e  162 (437)
                      ++.|+.|..+.||+....+| .+++|+.... .   ..+..|+.+++.|.  .-.+.+++..      ....+..++||+
T Consensus        37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EEECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            34566678899999886444 5899998752 2   23334555555553  1123333331      123556789999


Q ss_pred             ecCCCCcch--------------hhhccCC-C----------CCCCHHHH------------------------------
Q 013745          163 YLPNKSLDY--------------FIFDKTK-S----------SSLDWTTR------------------------------  187 (437)
Q Consensus       163 ~~~~gsL~~--------------~l~~~~~-~----------~~l~~~~~------------------------------  187 (437)
                      |++|..+..              .++.... .          ....|...                              
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            999876531              0111100 0          00122211                              


Q ss_pred             -HHHHHHHHHHHHHhhh----------cCCCceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          188 -YRIVMGVARGLLYLHE----------EAPARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       188 -~~i~~qi~~~L~~LH~----------~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                       ..+..++..++.+|+.          ..+..++|+|+++.|||++.++.+.|+||+.+.
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence             0111223445666763          123459999999999999888899999998775

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.31  E-value=1.4e-06  Score=86.10  Aligned_cols=75  Identities=13%  Similarity=0.168  Sum_probs=49.5

Q ss_pred             cceeccCCCeeEEEEEcC-CCcEEEEEEeccCCh-------HHHHHHHHHHHHHHcCCC--Cc-ceeeeeeeccCCceEE
Q 013745           91 LNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSR-------QGLREFTNEVKLLLKIQH--KN-LVTLFGCCAEGPEKML  159 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~l  159 (437)
                      .+.||.|.++.||++... +++.++||.......       .....+..|.++|+.+..  +. +.+++.+.  ....++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence            578999999999999754 568899998653211       112446778898887742  44 34555443  445689


Q ss_pred             EEeecCCC
Q 013745          160 VYEYLPNK  167 (437)
Q Consensus       160 v~e~~~~g  167 (437)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.13  E-value=7.5e-06  Score=77.09  Aligned_cols=82  Identities=18%  Similarity=0.180  Sum_probs=59.6

Q ss_pred             hcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCC---CcceeeeeeeccCCceEEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQH---KNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~~lv~  161 (437)
                      .....-++.+|.|..+.||+....+|+.|+||+...........|..|+..|+.|.-   -.+.+++++.    ..++||
T Consensus        14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~   89 (288)
T 3f7w_A           14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM   89 (288)
T ss_dssp             CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred             CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence            345666788999999999999988999999998764433323457789999988842   2344555542    347999


Q ss_pred             eecCCCCcc
Q 013745          162 EYLPNKSLD  170 (437)
Q Consensus       162 e~~~~gsL~  170 (437)
                      ||++++...
T Consensus        90 e~l~~~~~~   98 (288)
T 3f7w_A           90 EWVDERPPT   98 (288)
T ss_dssp             ECCCCCCCC
T ss_pred             EeecccCCC
Confidence            999877653

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.02  E-value=1.9e-05  Score=78.59  Aligned_cols=76  Identities=9%  Similarity=0.069  Sum_probs=45.6

Q ss_pred             CceEeeccCCCCEEecCCCCceeeecccccccCCCCcccceeeee--cccccCChhhhccC---cCCcccceehhhHHHH
Q 013745          207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS--GTHGYMAPEYALHG---YLSVKTDVFSYGVLVL  281 (437)
Q Consensus       207 ~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~--gt~~Y~aPE~~~~~---~~~~~~DvwSlG~vl~  281 (437)
                      ..++|+|++|.|||++.++ ++|+||+.+..-+..- ...  ...  -...|++|+.....   ......++..+...+|
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dla--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DIG--AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HHH--HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HHH--HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            4599999999999998876 9999999887532110 000  000  01345666554311   1112344557777778


Q ss_pred             HHHhC
Q 013745          282 EIVSG  286 (437)
Q Consensus       282 elltg  286 (437)
                      +.+.+
T Consensus       308 ~~y~~  312 (420)
T 2pyw_A          308 NLFNK  312 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            77764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.89  E-value=3.7e-05  Score=73.31  Aligned_cols=143  Identities=13%  Similarity=0.136  Sum_probs=79.0

Q ss_pred             cceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCc--ceeeeeee------ccCCceEEEEe
Q 013745           91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN--LVTLFGCC------AEGPEKMLVYE  162 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~------~~~~~~~lv~e  162 (437)
                      ++.|+.|....+|+....+| .+++|+.....  ....+..|+.++..|...+  +.+++...      ...+..+++|+
T Consensus        27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~  103 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS  103 (322)
T ss_dssp             EEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             eeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence            45677888899999886555 68899886521  1134456777777664212  23333211      12345689999


Q ss_pred             ecCCCCcchh--------------hhccCCC---C---CC---CHHHHHH------------HHHHHHHHHHHhhhc---
Q 013745          163 YLPNKSLDYF--------------IFDKTKS---S---SL---DWTTRYR------------IVMGVARGLLYLHEE---  204 (437)
Q Consensus       163 ~~~~gsL~~~--------------l~~~~~~---~---~l---~~~~~~~------------i~~qi~~~L~~LH~~---  204 (437)
                      |++|..+...              ++.....   .   ..   .|...+.            +...+...+.++...   
T Consensus       104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~  183 (322)
T 2ppq_A          104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK  183 (322)
T ss_dssp             CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred             eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence            9998765321              1111000   0   01   1221100            001134445555432   


Q ss_pred             -CCCceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          205 -APARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       205 -~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                       .+..++|+|+.+.|||+++++.+.|+||+.+.
T Consensus       184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence             23459999999999999987666899998775

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.85  E-value=2.8e-05  Score=77.64  Aligned_cols=75  Identities=12%  Similarity=0.251  Sum_probs=52.1

Q ss_pred             ccceeccCCCeeEEEEEcCC--------CcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcc-eeeeeeeccCCceEEE
Q 013745           90 DLNQLGHGGFGPVYRGLMPN--------GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL-VTLFGCCAEGPEKMLV  160 (437)
Q Consensus        90 ~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv  160 (437)
                      .++.|+.|....||++...+        ++.+++|+......  ...+.+|+.+++.|...++ .++++.+.+    .+|
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v  150 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  150 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence            35678889999999998642        57899999853211  1445579999888853333 567776653    389


Q ss_pred             EeecCCCCcc
Q 013745          161 YEYLPNKSLD  170 (437)
Q Consensus       161 ~e~~~~gsL~  170 (437)
                      +||++|.+|.
T Consensus       151 ~e~l~G~~l~  160 (429)
T 1nw1_A          151 EEYIPSRPLS  160 (429)
T ss_dssp             ECCCCEEECC
T ss_pred             EEEeCCcccC
Confidence            9999875553

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.71  E-value=0.00026  Score=67.54  Aligned_cols=143  Identities=13%  Similarity=0.147  Sum_probs=81.5

Q ss_pred             cceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCC--cceeeeee-----eccCCceEEEEee
Q 013745           91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHK--NLVTLFGC-----CAEGPEKMLVYEY  163 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~e~  163 (437)
                      +..|+ |....||+....+|+.+++|+...... ....+..|..+++.|...  .+++++..     ....+..++||++
T Consensus        31 ~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           31 LTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             CEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             EEeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence            34577 888999998776777899999863311 234566788888777422  23444443     1123456789999


Q ss_pred             cCCCCcch----h----------hhcc---C---CCCCCCHHHH----HHH---------------HHHHHHHHHHhhhc
Q 013745          164 LPNKSLDY----F----------IFDK---T---KSSSLDWTTR----YRI---------------VMGVARGLLYLHEE  204 (437)
Q Consensus       164 ~~~gsL~~----~----------l~~~---~---~~~~l~~~~~----~~i---------------~~qi~~~L~~LH~~  204 (437)
                      ++|..+..    .          ++..   .   ....+++...    ..+               ...+...+..+...
T Consensus       109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~  188 (328)
T 1zyl_A          109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH  188 (328)
T ss_dssp             CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence            98865431    0          1110   0   0111222111    000               11111222222221


Q ss_pred             ----CCCceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          205 ----APARIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       205 ----~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                          .+..++|+|+++.|||++ + .+.|+||+.+..
T Consensus       189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                234589999999999999 4 899999987754

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.68  E-value=0.00013  Score=71.52  Aligned_cols=142  Identities=18%  Similarity=0.251  Sum_probs=85.1

Q ss_pred             cceeccCCCeeEEEEEcC--------CCcEEEEEEeccCChHHHHHHHHHHHHHHcCC-CCcceeeeeeeccCCceEEEE
Q 013745           91 LNQLGHGGFGPVYRGLMP--------NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ++.|..|-...+|++...        +++.+++|+.... ......+.+|..+++.|. +.-..++++++.+    .+||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            467878889999998864        2478999986432 122355668999998885 3333567777654    2999


Q ss_pred             eecCCCCcchhh-----------------hcc--CCCCCCC--HHHHHHHHHHHHH-------------------HHHHh
Q 013745          162 EYLPNKSLDYFI-----------------FDK--TKSSSLD--WTTRYRIVMGVAR-------------------GLLYL  201 (437)
Q Consensus       162 e~~~~gsL~~~l-----------------~~~--~~~~~l~--~~~~~~i~~qi~~-------------------~L~~L  201 (437)
                      ||++|..|..--                 +..  .......  +..+.+|..++..                   .+..|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            999987664210                 110  0011122  3455555544422                   12333


Q ss_pred             h----hc-CCCceEeeccCCCCEEecCC----CCceeeecccccc
Q 013745          202 H----EE-APARIIHRDIKASNILLDEQ----LNPKISDFGLARL  237 (437)
Q Consensus       202 H----~~-~~~~iiHrDikp~NIll~~~----~~~kl~DFGla~~  237 (437)
                      .    .. .+..++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            2    21 23459999999999999876    7899999987753

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.67  E-value=5.7e-05  Score=71.45  Aligned_cols=72  Identities=10%  Similarity=0.120  Sum_probs=46.3

Q ss_pred             cceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcc-eeeeeeeccCCceEEEEeec-CCCC
Q 013745           91 LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL-VTLFGCCAEGPEKMLVYEYL-PNKS  168 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~gs  168 (437)
                      ++.|+.|....+|+.     +.+++|+....... .....+|+.+++.+...++ .++++++.  +.-++|+||+ +|.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCcc
Confidence            678999999999998     56888988643211 1123468877777742222 45665543  3457899999 7666


Q ss_pred             cc
Q 013745          169 LD  170 (437)
Q Consensus       169 L~  170 (437)
                      +.
T Consensus        95 l~   96 (301)
T 3dxq_A           95 MS   96 (301)
T ss_dssp             CC
T ss_pred             CC
Confidence            64

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.64  E-value=0.00012  Score=73.48  Aligned_cols=75  Identities=9%  Similarity=0.072  Sum_probs=49.3

Q ss_pred             cceeccCCCeeEEEEEcCC-CcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcc-eeeeeeeccCCceEEEEeecCCCC
Q 013745           91 LNQLGHGGFGPVYRGLMPN-GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL-VTLFGCCAEGPEKMLVYEYLPNKS  168 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gs  168 (437)
                      ++.|+.|-...+|++...+ +..+++|+........ -...+|..+++.|...++ .++++++..    .+||||++|..
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence            4678889999999998654 4788999875322111 112479999998875445 567777732    35999999866


Q ss_pred             cc
Q 013745          169 LD  170 (437)
Q Consensus       169 L~  170 (437)
                      |.
T Consensus       188 l~  189 (458)
T 2qg7_A          188 LS  189 (458)
T ss_dssp             CC
T ss_pred             CC
Confidence            53

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.63  E-value=0.00017  Score=69.14  Aligned_cols=142  Identities=18%  Similarity=0.149  Sum_probs=72.4

Q ss_pred             cceeccCCCee-EEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCC--CcceeeeeeeccCCceEEEEeecCCC
Q 013745           91 LNQLGHGGFGP-VYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQH--KNLVTLFGCCAEGPEKMLVYEYLPNK  167 (437)
Q Consensus        91 ~~~lG~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g  167 (437)
                      ++.|+.|+... +|+....+++.+++|.......   ..+..|+.+++.|..  -.+.+++.+..+.+  ++|||++.+.
T Consensus        23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~   97 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA   97 (333)
T ss_dssp             ECC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred             eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence            34566665554 6677654467888886543321   223456777766642  23455666544333  7899999775


Q ss_pred             Ccchhhhc--------------------cC---CCCCCCHHHHH-------HHH-------------HHHHHHHHHhhh-
Q 013745          168 SLDYFIFD--------------------KT---KSSSLDWTTRY-------RIV-------------MGVARGLLYLHE-  203 (437)
Q Consensus       168 sL~~~l~~--------------------~~---~~~~l~~~~~~-------~i~-------------~qi~~~L~~LH~-  203 (437)
                      .+...+..                    ..   ....++.....       .+.             ..+...+..|-. 
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            55432211                    00   01112211100       000             011122222211 


Q ss_pred             --cCCCceEeeccCCCCEEecCC----CCceeeecccccc
Q 013745          204 --EAPARIIHRDIKASNILLDEQ----LNPKISDFGLARL  237 (437)
Q Consensus       204 --~~~~~iiHrDikp~NIll~~~----~~~kl~DFGla~~  237 (437)
                        ..+..++|+|+.+.|||++.+    +.+.|+||+.+..
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence              123459999999999999874    6789999998864

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=97.55  E-value=0.0004  Score=68.98  Aligned_cols=142  Identities=11%  Similarity=0.136  Sum_probs=86.0

Q ss_pred             ccceeccCCCeeEEEEEcCC--------CcEEEEEEeccCChHHHHHHHHHHHHHHcCC-CCcceeeeeeeccCCceEEE
Q 013745           90 DLNQLGHGGFGPVYRGLMPN--------GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        90 ~~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  160 (437)
                      .++.|..|-...+|+....+        ++.+++|+....... .-...+|..+++.|. +.-..++++.+.    -++|
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I  148 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRI  148 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEE
Confidence            35678888889999988642        578999987543211 112347888888875 322445665443    3789


Q ss_pred             EeecCCCCcchh-h----------------hc--c-----C---CCCCCCHHHHHHHHHHHH------------------
Q 013745          161 YEYLPNKSLDYF-I----------------FD--K-----T---KSSSLDWTTRYRIVMGVA------------------  195 (437)
Q Consensus       161 ~e~~~~gsL~~~-l----------------~~--~-----~---~~~~l~~~~~~~i~~qi~------------------  195 (437)
                      |||++|..|..- +                +.  .     .   ...+.-+..+.+|..++-                  
T Consensus       149 ~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l  228 (424)
T 3mes_A          149 EEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKI  228 (424)
T ss_dssp             EECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHH
T ss_pred             EEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHH
Confidence            999999765321 0                00  0     0   111112444444443321                  


Q ss_pred             -HHHHHhh---------------------hcCCCceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          196 -RGLLYLH---------------------EEAPARIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       196 -~~L~~LH---------------------~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                       ..+.+|.                     ...+..++|+|+.+.||+ +.++.+.|+||..+..
T Consensus       229 ~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          229 LEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence             2223332                     112345899999999999 7888999999988863

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.55  E-value=0.00011  Score=71.59  Aligned_cols=74  Identities=11%  Similarity=0.115  Sum_probs=45.4

Q ss_pred             cceeccCCCeeEEEEEcCC---------CcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCc-ceeeeeeeccCCceEEE
Q 013745           91 LNQLGHGGFGPVYRGLMPN---------GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN-LVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv  160 (437)
                      ++.|+.|....+|+....+         ++.+++|+....... ......|..+++.|...+ +.++++.+.    -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~~----~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTFN----GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEecC----CcEE
Confidence            4678888889999987543         268888987543221 112357888888775333 346665542    3689


Q ss_pred             EeecCCCCc
Q 013745          161 YEYLPNKSL  169 (437)
Q Consensus       161 ~e~~~~gsL  169 (437)
                      |||++|..+
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999988654

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.44  E-value=0.00067  Score=65.31  Aligned_cols=68  Identities=9%  Similarity=0.039  Sum_probs=43.3

Q ss_pred             ccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCC---CCcceeeeee------eccCCceEEEEeecC
Q 013745           95 GHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ---HKNLVTLFGC------CAEGPEKMLVYEYLP  165 (437)
Q Consensus        95 G~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~------~~~~~~~~lv~e~~~  165 (437)
                      |.|....||+....+| .+++|+......      ..|+.+++.|.   -|++++.+..      ....+..++||+|++
T Consensus        32 G~g~~N~vy~v~~~~g-~~vLK~~~~~~~------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~  104 (339)
T 3i1a_A           32 GADTNAFAYQADSESK-SYFIKLKYGYHD------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIH  104 (339)
T ss_dssp             TSCSSCEEEEEECSSC-EEEEEEEECSSC------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCC
T ss_pred             cCccccceEEEEeCCC-CEEEEEecCccc------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccC
Confidence            3344689999987666 899998765432      24555555552   2334444432      123466789999999


Q ss_pred             CCCc
Q 013745          166 NKSL  169 (437)
Q Consensus       166 ~gsL  169 (437)
                      |..+
T Consensus       105 G~~~  108 (339)
T 3i1a_A          105 APNG  108 (339)
T ss_dssp             CCBT
T ss_pred             CCcC
Confidence            8766

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.88  E-value=0.001  Score=59.12  Aligned_cols=103  Identities=11%  Similarity=0.045  Sum_probs=65.7

Q ss_pred             CCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcccc
Q 013745          167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN  246 (437)
Q Consensus       167 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  246 (437)
                      -+|.++|..  ...++++.++|.++.|.+.+|.-+-.+..  -..+=+-|..|+|..+|.|.+.+ +.+.          
T Consensus        33 vSL~eIL~~--~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           33 LSLEEILRL--YNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             ccHHHHHHH--cCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc----------
Confidence            367788743  45789999999999999999877622110  11223457899999999888764 1110          


Q ss_pred             eeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCC
Q 013745          247 TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKN  289 (437)
Q Consensus       247 ~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p  289 (437)
                          .....+.+||... ...+.+.=|||||++||.-+--..|
T Consensus        98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence                1133467888763 3456788899999999999864443

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.73  E-value=0.034  Score=54.52  Aligned_cols=30  Identities=30%  Similarity=0.439  Sum_probs=25.0

Q ss_pred             ceEeeccCCCCEEe------cCCCCceeeecccccc
Q 013745          208 RIIHRDIKASNILL------DEQLNPKISDFGLARL  237 (437)
Q Consensus       208 ~iiHrDikp~NIll------~~~~~~kl~DFGla~~  237 (437)
                      .++|+|+.+.|||+      +++..++++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36899999999999      4567799999988753

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=87.70  E-value=0.88  Score=40.18  Aligned_cols=116  Identities=10%  Similarity=0.065  Sum_probs=78.0

Q ss_pred             CCCcceeeeeeeccCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCE
Q 013745          140 QHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNI  219 (437)
Q Consensus       140 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NI  219 (437)
                      .+|+++.. .+-.+.+.+.+.++.-+  ....+-    .-..++...+++++.+|+....+++.     -+|--|.|+||
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL  110 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFD----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL  110 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGG----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCc--ccCCHH----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence            58888876 45555666666666443  222221    12346788999999999988866654     57889999999


Q ss_pred             EecCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCC
Q 013745          220 LLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHD  291 (437)
Q Consensus       220 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~  291 (437)
                      +++.++.+++.=.|+-..+...              =+.+|-+.          -.+=|++..+++++..|.
T Consensus       111 ~f~~~~~p~i~~RGik~~l~P~--------------~~~ee~fL----------~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          111 FFTRDGLPIAKTRGLQNVVDPL--------------PVSEAEFL----------TRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EECTTSCEEESCCEETTTBSCC--------------CCCHHHHH----------HHHHHHHHHHHCTTCCHH
T ss_pred             EEcCCCCEEEEEccCccCCCCC--------------CCCHHHHH----------HHHHHHHHHHHcCCCCHH
Confidence            9999999999887765433211              11233222          245588899999988874

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=87.13  E-value=0.07  Score=53.40  Aligned_cols=59  Identities=12%  Similarity=0.090  Sum_probs=17.1

Q ss_pred             ccceeccCCCeeEEEEEcCC-CcEEEE------EEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeee
Q 013745           90 DLNQLGHGGFGPVYRGLMPN-GQEIAV------KKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCC  151 (437)
Q Consensus        90 ~~~~lG~G~~g~Vy~~~~~~-~~~vav------K~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  151 (437)
                      +.+.||   ||.||+|.+.. ..+|||      |.....  .......+.+|..++..++|||+++.+++.
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence            456776   99999998743 467888      665432  223345688899999999999999987764

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=85.12  E-value=1.8  Score=38.23  Aligned_cols=115  Identities=14%  Similarity=0.097  Sum_probs=75.2

Q ss_pred             CCCcceeeeeeeccCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHH-HhhhcCCCceEeeccCCCC
Q 013745          140 QHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLL-YLHEEAPARIIHRDIKASN  218 (437)
Q Consensus       140 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~-~LH~~~~~~iiHrDikp~N  218 (437)
                      .||.+ . ..+-.+++.+.+.++.-+++.=...+      ..++...+++++.+|+.... +++.     -+|--|.|+|
T Consensus        48 ~~~~f-~-~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N  114 (219)
T 4ano_A           48 VDPCI-V-RDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN  114 (219)
T ss_dssp             SCSSS-E-EEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred             cCCCC-C-eEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence            57877 2 23335666666666654333222222      24678899999999888777 6655     5788899999


Q ss_pred             EEecCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCC
Q 013745          219 ILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHD  291 (437)
Q Consensus       219 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~  291 (437)
                      |+++.++.++|.=.|+-..++..              =+.+|-+..          .+=|++..++.++..|+
T Consensus       115 L~f~~~~~p~i~hRGi~~~lpP~--------------e~~ee~fl~----------qyKali~all~~K~~Fe  163 (219)
T 4ano_A          115 LMFNRALEPFFLHVGVKESLPPD--------------EWDDERLLR----------EVKATVLALTEGEYRFD  163 (219)
T ss_dssp             EEECTTCCEEESCCEETTTBSSC--------------SCCHHHHHH----------HHHHHHHHHTTCSSCHH
T ss_pred             EEEeCCCcEEEEEcCCcccCCCC--------------CCCHHHHHH----------HHHHHHHHHHcCCCCHH
Confidence            99999999999887765433111              123333322          35578888888887764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	437
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-70
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-65
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-63
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-63
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-62
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-61
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-61
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-59
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-58
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-58
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-58
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-58
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-57
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-57
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-57
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-56
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	6e-56
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	8e-56
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	9e-56
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-55
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-54
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-54
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-54
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	7e-54
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-53
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-53
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	4e-53
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-52
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-50
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-49
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-49
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-48
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-48
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-47
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-46
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-44
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-43
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	7e-43
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-42
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-42
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-42
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	6e-42
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	9e-42
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-41
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	4e-41
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-41
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-40
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-40
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-38
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-37
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-37
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-36
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	8e-36
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-35
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	8e-35
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-34
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-30
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-29
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-28
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-21

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (566), Expect = 1e-70
 Identities = 69/283 (24%), Positives = 129/283 (45%), Gaps = 19/283 (6%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
            +   ++G G FG VY+G       + +  ++  + Q L+ F NEV +L K +H N++  
Sbjct: 10  ITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69

Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
            G     P+  +V ++    SL + +      +  +      I    A+G+ YLH +   
Sbjct: 70  MGYS-TAPQLAIVTQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAK--- 123

Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH--- 264
            IIHRD+K++NI L E L  KI DFGLA +           ++SG+  +MAPE       
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183

Query: 265 GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK 324
              S ++DV+++G+++ E+++G+  +     +++   +               + P L+K
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM----------VGRGYLSPDLSK 233

Query: 325 CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFTLPK 367
              +      +L   C ++   ERP    +   +   + +LPK
Sbjct: 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 2e-65
 Identities = 76/277 (27%), Positives = 127/277 (45%), Gaps = 22/277 (7%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
              + +LG G FG V+ G      ++AVK L   S      F  E  L+ ++QH+ LV L
Sbjct: 15  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRL 73

Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           +    + P   ++ EY+ N SL  F+        L       +   +A G+ ++ E    
Sbjct: 74  YAVVTQEP-IYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEER--- 128

Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
             IHRD++A+NIL+ + L+ KI+DFGLARL    +             + APE   +G  
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPEAINYGTF 187

Query: 268 SVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNR 327
           ++K+DV+S+G+L+ EIV+  +             ++    +   E+   +V P    C  
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPG--------MTNPEVIQNLERGYRMVRPD--NCPE 237

Query: 328 DEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFT 364
           +      QL  LC ++   +RP  + +  +L  D FT
Sbjct: 238 E----LYQLMRLCWKERPEDRPTFDYLRSVLE-DFFT 269

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 2e-63
 Identities = 66/272 (24%), Positives = 119/272 (43%), Gaps = 21/272 (7%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
            + + ++G G FG V+ G   N  ++A+K +  +      +F  E ++++K+ H  LV L
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQL 65

Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           +G C E     LV+E++ +  L  ++  +         T   + + V  G+ YL E    
Sbjct: 66  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF--AAETLLGMCLDVCEGMAYLEEA--- 120

Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
            +IHRD+ A N L+ E    K+SDFG+ R    +    ++        + +PE       
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRY 179

Query: 268 SVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNR 327
           S K+DV+S+GVL+ E+ S         GK   +  S +  +        L  P      R
Sbjct: 180 SSKSDVWSFGVLMWEVFSE--------GKIPYENRSNSEVVEDISTGFRLYKP------R 225

Query: 328 DEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS 359
             +    Q+   C ++   +RP  + +   L+
Sbjct: 226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (521), Expect = 3e-63
 Identities = 55/219 (25%), Positives = 108/219 (49%), Gaps = 11/219 (5%)

Query: 81  LQVATNFFSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLK 138
           +++  + F  +++LG G  G V++    P+G  +A K + ++ +  +R     E+++L +
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 139 IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
                +V  +G      E  +  E++   SLD  +    +   +      ++ + V +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGL 117

Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMA 258
            YL E+   +I+HRD+K SNIL++ +   K+ DFG++        +       GT  YM+
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMS 171

Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKE 297
           PE     + SV++D++S G+ ++E+  GR        KE
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 210

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  200 bits (510), Expect = 6e-62
 Identities = 74/310 (23%), Positives = 126/310 (40%), Gaps = 45/310 (14%)

Query: 77  DLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPN------GQEIAVKKLSVDSRQGLR-EF 129
            L +L+   N    +  +G G FG V++   P          +AVK L  ++   ++ +F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 130 TNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSS-------- 181
             E  L+ +  + N+V L G CA G    L++EY+    L+ F+   +  +         
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 182 -------------LDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPK 228
                        L    +  I   VA G+ YL E    + +HRD+   N L+ E +  K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180

Query: 229 ISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRK 288
           I+DFGL+R     D +      +    +M PE   +   + ++DV++YGV++ EI S   
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240

Query: 289 NHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAER 348
                +  E              E    + D ++  C  +       L  LC  +  A+R
Sbjct: 241 QPYYGMAHE--------------EVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADR 286

Query: 349 PDMNSVHLML 358
           P   S+H +L
Sbjct: 287 PSFCSIHRIL 296

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 1e-61
 Identities = 66/272 (24%), Positives = 118/272 (43%), Gaps = 23/272 (8%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
            + L +LG G FG V  G      ++A+K +   S     EF  E K+++ + H+ LV L
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQL 64

Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           +G C +     ++ EY+ N  L  ++ +              +   V   + YL      
Sbjct: 65  YGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLE---SK 119

Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
           + +HRD+ A N L+++Q   K+SDFGL+R    ++   +         +  PE  ++   
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPEVLMYSKF 178

Query: 268 SVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNR 327
           S K+D++++GVL+ EI S        LGK   +  + + T     + L L  P LA    
Sbjct: 179 SSKSDIWAFGVLMWEIYS--------LGKMPYERFTNSETAEHIAQGLRLYRPHLA---- 226

Query: 328 DEAAMCIQLGLLCCQQSVAERPDMNSV--HLM 357
             +     +   C  +   ERP    +  +++
Sbjct: 227 --SEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 6e-61
 Identities = 74/281 (26%), Positives = 122/281 (43%), Gaps = 22/281 (7%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
                +LG G FG V+ G       +A+K L          F  E +++ K++H+ LV L
Sbjct: 19  LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQL 77

Query: 148 FGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
           +   +E P   +V EY+   SL  F+  +T            +   +A G+ Y+      
Sbjct: 78  YAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYL-RLPQLVDMAAQIASGMAYVE---RM 132

Query: 208 RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
             +HRD++A+NIL+ E L  K++DFGLARL    +             + APE AL+G  
Sbjct: 133 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPEAALYGRF 191

Query: 268 SVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNR 327
           ++K+DV+S+G+L+ E+ +         G+     +     L Q E+   +  P       
Sbjct: 192 TIKSDVWSFGILLTELTTK--------GRVPYPGMVNREVLDQVERGYRMPCPP------ 237

Query: 328 DEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFTLPKP 368
           +       L   C ++   ERP    +   L  D FT  +P
Sbjct: 238 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLE-DYFTSTEP 277

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  194 bits (493), Expect = 3e-59
 Identities = 76/277 (27%), Positives = 111/277 (40%), Gaps = 33/277 (11%)

Query: 85  TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQG---LREFTNEVKLLLKIQ 140
              FSDL ++GHG FG VY    + N + +A+KK+S   +Q     ++   EV+ L K++
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
           H N +   GC        LV EY    + D     K     L       +  G  +GL Y
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAY 130

Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE 260
           LH      +IHRD+KA NILL E    K+ DFG A +    ++ V      GT  +MAPE
Sbjct: 131 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV------GTPYWMAPE 181

Query: 261 YAL---HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALEL 317
             L    G    K DV+S G+  +E+   +                            + 
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------------YHIAQN 229

Query: 318 VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSV 354
             P+L   +  E          C Q+   +RP    +
Sbjct: 230 ESPALQSGHWSEYF--RNFVDSCLQKIPQDRPTSEVL 264

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  191 bits (486), Expect = 2e-58
 Identities = 64/273 (23%), Positives = 119/273 (43%), Gaps = 23/273 (8%)

Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
            +  ++LG G +G VY G        +AVK L  D+ + + EF  E  ++ +I+H NLV 
Sbjct: 19  ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQ 77

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           L G C   P   ++ E++   +L  ++ +  +   +       +   ++  + YL ++  
Sbjct: 78  LLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKK-- 134

Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGY 266
              IHRD+ A N L+ E    K++DFGL+RL  G+    +         + APE   +  
Sbjct: 135 -NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAYNK 192

Query: 267 LSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA-KC 325
            S+K+DV+++GVL+ EI +   +    +                  +  EL++     + 
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGI---------------DLSQVYELLEKDYRMER 237

Query: 326 NRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML 358
                    +L   C Q + ++RP    +H   
Sbjct: 238 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  191 bits (486), Expect = 2e-58
 Identities = 68/301 (22%), Positives = 122/301 (40%), Gaps = 38/301 (12%)

Query: 76  FDLRTLQVATNFFSD---------LNQLGHGGFGPVYRGLMP----NGQEIAVKKLSVD- 121
           F       A   F+             +G G FG V  G +         +A+K L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 122 SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSS 181
           + +  R+F +E  ++ +  H N++ L G   +    M++ E++ N SLD F+       +
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 182 LDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE 241
                   ++ G+A G+ YL        +HRD+ A NIL++  L  K+SDFGL+R    +
Sbjct: 127 --VIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 242 ---DTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKE 297
               T+ +         + APE   +   +  +DV+SYG+++ E++S G + +     ++
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241

Query: 298 KADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLM 357
             + +   + L                   D  +   QL L C Q+    RP    +   
Sbjct: 242 VINAIEQDYRL---------------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

Query: 358 L 358
           L
Sbjct: 287 L 287

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 4e-58
 Identities = 62/292 (21%), Positives = 115/292 (39%), Gaps = 29/292 (9%)

Query: 91  LNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGC 150
              +G G FG V+RG    G+E+AVK  S    +       E+   + ++H+N++     
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAA 65

Query: 151 CAEG----PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
             +      +  LV +Y  + SL  ++       ++      ++ +  A GL +LH E  
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIV 121

Query: 207 A-----RIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF--RISGTHGYMAP 259
                  I HRD+K+ NIL+ +     I+D GLA         ++       GT  YMAP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 260 EYAL------HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEK--ADLLSYTWTLFQG 311
           E         H     + D+++ G++  EI             +    DL+    ++ + 
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 312 EKAL--ELVDPSLAKCNRDEAAM--CIQLGLLCCQQSVAERPDMNSVHLMLS 359
            K +  + + P++    +   A+    ++   C   + A R     +   LS
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 9e-58
 Identities = 78/292 (26%), Positives = 124/292 (42%), Gaps = 35/292 (11%)

Query: 74  LFFDLRTLQVATNFFSDLNQLGHGGFGPVYRGLMPN---GQEIAVKKLSVDSRQG--LRE 128
           ++ D + L +      +  +LG G FG V +G        + +AVK L  ++       E
Sbjct: 1   VYLDRKLLTL------EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE 54

Query: 129 FTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRY 188
              E  ++ ++ +  +V + G C E    MLV E      L+ ++        +      
Sbjct: 55  LLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNII 110

Query: 189 RIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT- 247
            +V  V+ G+ YL E      +HRD+ A N+LL  Q   KISDFGL++    ++ +    
Sbjct: 111 ELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167

Query: 248 FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTW 306
                   + APE   +   S K+DV+S+GVL+ E  S G+K + G  G E   +L    
Sbjct: 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML---- 223

Query: 307 TLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML 358
                EK   +  P+   C R+       L  LC    V  RP   +V L L
Sbjct: 224 -----EKGERMGCPA--GCPRE----MYDLMNLCWTYDVENRPGFAAVELRL 264

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (477), Expect = 2e-57
 Identities = 67/272 (24%), Positives = 108/272 (39%), Gaps = 27/272 (9%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTL 147
              L  +G G FG V  G    G ++AVK +  D+    + F  E  ++ +++H NLV L
Sbjct: 9   LKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQL 65

Query: 148 FGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
            G   E    + +V EY+   SL  ++  +   S L      +  + V   + YL     
Sbjct: 66  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN-- 122

Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGY 266
              +HRD+ A N+L+ E    K+SDFGL +                   + APE      
Sbjct: 123 -NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGK-----LPVKWTAPEALREKK 176

Query: 267 LSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCN 326
            S K+DV+S+G+L+ EI S  +    R        +     + + EK  ++  P    C 
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPYPR--------IPLKDVVPRVEKGYKMDAPD--GCP 226

Query: 327 RDEAAMCIQLGLLCCQQSVAERPDMNSVHLML 358
                   ++   C     A RP    +   L
Sbjct: 227 PA----VYEVMKNCWHLDAAMRPSFLQLREQL 254

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (477), Expect = 3e-57
 Identities = 61/286 (21%), Positives = 113/286 (39%), Gaps = 28/286 (9%)

Query: 85  TNFFSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKN 143
            +F+  + +LG G FG VY+          A K +   S + L ++  E+ +L    H N
Sbjct: 11  EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           +V L           ++ E+    ++D  + +  +   L  +    +       L YLH+
Sbjct: 71  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHD 128

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
               +IIHRD+KA NIL     + K++DFG++          ++F   GT  +MAPE  +
Sbjct: 129 ---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEVVM 183

Query: 264 -----HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV 318
                      K DV+S G+ ++E+      H                 L +  K+    
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---------VLLKIAKSEPPT 234

Query: 319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSV--HLMLSGDS 362
               ++ + +           C +++V  R   + +  H  ++ DS
Sbjct: 235 LAQPSRWSSN----FKDFLKKCLEKNVDARWTTSQLLQHPFVTVDS 276

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 5e-57
 Identities = 66/289 (22%), Positives = 125/289 (43%), Gaps = 28/289 (9%)

Query: 80  TLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQE-----IAVKKLSVDSRQGLR-EFTNEV 133
           T ++  +  +    +G G FG VY+G++          +A+K L     +  R +F  E 
Sbjct: 1   TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60

Query: 134 KLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMG 193
            ++ +  H N++ L G  ++    M++ EY+ N +LD F+ +K             ++ G
Sbjct: 61  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE--FSVLQLVGMLRG 118

Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF-RISG 252
           +A G+ YL        +HRD+ A NIL++  L  K+SDFGL+R+   +     T      
Sbjct: 119 IAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175

Query: 253 THGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGE 312
              + APE   +   +  +DV+S+G+++ E+++  +     L                  
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL---------------SNH 220

Query: 313 KALELVDPSLA-KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG 360
           + ++ ++         D  +   QL + C QQ  A RP    +  +L  
Sbjct: 221 EVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 4e-56
 Identities = 68/292 (23%), Positives = 118/292 (40%), Gaps = 33/292 (11%)

Query: 86  NFFSDLNQLGHGGFGPVYRGLM---PNGQEIAVKKLSVDSRQG-LREFTNEVKLLLKIQH 141
           N      +LG G FG V +G+        ++A+K L   + +    E   E +++ ++ +
Sbjct: 9   NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 68

Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
             +V L G C +    MLV E      L  F+  K +   +  +    ++  V+ G+ YL
Sbjct: 69  PYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE--IPVSNVAELLHQVSMGMKYL 125

Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVN-TFRISGTHGYMAPE 260
            E+     +HRD+ A N+LL  +   KISDFGL++    +D++            + APE
Sbjct: 126 EEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 182

Query: 261 YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD- 319
                  S ++DV+SYGV + E                   LSY    ++  K  E++  
Sbjct: 183 CINFRKFSSRSDVWSYGVTMWE------------------ALSYGQKPYKKMKGPEVMAF 224

Query: 320 ---PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDSFTLPKP 368
                  +C  +       L   C      +RPD  +V   +    ++L   
Sbjct: 225 IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 6e-56
 Identities = 64/270 (23%), Positives = 108/270 (40%), Gaps = 22/270 (8%)

Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLV 145
           +  +  LG G +G V         + +AVK + +       E    E+ +   + H+N+V
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
             +G   EG  + L  EY     L   I        +      R    +  G++YLH   
Sbjct: 67  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG-- 121

Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHG 265
              I HRDIK  N+LLDE+ N KISDFGLA +F   +      ++ GT  Y+APE     
Sbjct: 122 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180

Query: 266 -YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK 324
            + +   DV+S G+++  +++G    D           S +   +   K  +       K
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQP---------SDSCQEYSDWKEKKTYLNPWKK 231

Query: 325 CNRDEAAMCIQLGLLCCQQSVAERPDMNSV 354
            +       + L      ++ + R  +  +
Sbjct: 232 IDSA----PLALLHKILVENPSARITIPDI 257

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 8e-56
 Identities = 60/275 (21%), Positives = 107/275 (38%), Gaps = 25/275 (9%)

Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNL 144
           +  L  +G G +G   +     +G+ +  K+L   S      +   +EV LL +++H N+
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 145 VTLFGCCAEGPEKML--VYEYLPNKSLDYFIFDKTKSS-SLDWTTRYRIVMGVARGLLYL 201
           V  +    +     L  V EY     L   I   TK    LD     R++  +   L   
Sbjct: 66  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125

Query: 202 HE--EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           H   +    ++HRD+K +N+ LD + N K+ DFGLAR+   + +    F    T  YM+P
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG--TPYYMSP 183

Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD 319
           E       + K+D++S G L+ E+ +          KE A                ++ +
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG---------------KIRE 228

Query: 320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSV 354
               +     +    ++           RP +  +
Sbjct: 229 GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 263

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (469), Expect = 9e-56
 Identities = 69/298 (23%), Positives = 107/298 (35%), Gaps = 41/298 (13%)

Query: 88  FSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKI- 139
            S    LG G FG V                +AVK L   +    RE   +E+K+L  + 
Sbjct: 25  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84

Query: 140 QHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSS---------------SLDW 184
            H N+V L G C  G   +++ EY     L  F+  K  S                +LD 
Sbjct: 85  NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144

Query: 185 TTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH 244
                    VA+G+ +L  +     IHRD+ A NILL      KI DFGLAR    +  +
Sbjct: 145 EDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201

Query: 245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSY 304
           V          +MAPE   +   + ++DV+SYG+ + E+ S   +               
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY------------- 248

Query: 305 TWTLFQGEKALELVDPSLA-KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD 361
              +    K  +++             A    +   C      +RP    +  ++   
Sbjct: 249 -PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 2e-55
 Identities = 70/279 (25%), Positives = 123/279 (44%), Gaps = 28/279 (10%)

Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQE----IAVKKLS-VDSRQGLREFTNEVKLLLKIQH 141
           F  +  LG G FG VY+G  +P G++    +A+K+L    S +  +E  +E  ++  + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
            ++  L G C       L+ + +P   L  ++ +   +            + +A+G+ YL
Sbjct: 71  PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIG--SQYLLNWCVQIAKGMNYL 127

Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEY 261
                 R++HRD+ A N+L+    + KI+DFGLA+L   E+   +         +MA E 
Sbjct: 128 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 262 ALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP 320
            LH   + ++DV+SYGV V E+++ G K +DG    E + +L         EK   L  P
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---------EKGERLPQP 235

Query: 321 SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS 359
                          + + C       RP    + +  S
Sbjct: 236 P------ICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 1e-54
 Identities = 68/296 (22%), Positives = 111/296 (37%), Gaps = 44/296 (14%)

Query: 91  LNQLGHGGFGPVYRGLMPN------GQEIAVKKLSVDSRQGLRE-FTNEVKLLLKI-QHK 142
              LG G FG V               ++AVK L   +    RE   +E+K++ ++  H+
Sbjct: 42  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 101

Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSS--------------------L 182
           N+V L G C       L++EY     L  ++  K +  S                    L
Sbjct: 102 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 161

Query: 183 DWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED 242
            +         VA+G+ +L  +     +HRD+ A N+L+      KI DFGLAR    + 
Sbjct: 162 TFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 218

Query: 243 THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLL 302
            +V          +MAPE    G  ++K+DV+SYG+L+ EI S      G        + 
Sbjct: 219 NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL-----GVNPYPGIPVD 273

Query: 303 SYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML 358
           +  + L Q    ++                   +   C      +RP   ++   L
Sbjct: 274 ANFYKLIQNGFKMD--------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (456), Expect = 3e-54
 Identities = 72/284 (25%), Positives = 108/284 (38%), Gaps = 37/284 (13%)

Query: 88  FSDLNQLGHGGFGPVYRGLMP----NGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQ 140
              L +LG G FG V RG           +AVK L  D     + + +F  EV  +  + 
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69

Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
           H+NL+ L+G     P KM V E  P  SL   +            T  R  + VA G+ Y
Sbjct: 70  HRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGH--FLLGTLSRYAVQVAEGMGY 126

Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP-GEDTHVNTFRISGTHGYMAP 259
           L  +   R IHRD+ A N+LL  +   KI DFGL R  P  +D +V          + AP
Sbjct: 127 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD 319
           E       S  +D + +GV + E                  + +Y    + G    +++ 
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWE------------------MFTYGQEPWIGLNGSQILH 225

Query: 320 PSLAKCNR-----DEAAMCIQLGLLCCQQSVAERPDMNSVHLML 358
               +  R     D       + + C      +RP   ++   L
Sbjct: 226 KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 4e-54
 Identities = 61/276 (22%), Positives = 113/276 (40%), Gaps = 27/276 (9%)

Query: 92  NQLGHGGFGPVYRGLMPN----GQEIAVKKLSVDSRQG-LREFTNEVKLLLKIQHKNLVT 146
             +G G FG VY G + +        AVK L+  +  G + +F  E  ++    H N+++
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92

Query: 147 LFGCCAEGPEK-MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
           L G C       ++V  Y+ +  L  FI ++T + ++     + + +        +   A
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKG-----MKFLA 147

Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS--GTHGYMAPEYAL 263
             + +HRD+ A N +LDE+   K++DFGLAR    ++      +        +MA E   
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207

Query: 264 HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA 323
               + K+DV+S+GVL+ E+++              D+  Y        +   L+ P   
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAPPYP--DVNTFDITVYLL------QGRRLLQPEYC 259

Query: 324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS 359
                      ++ L C       RP  + +   +S
Sbjct: 260 ------PDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 7e-54
 Identities = 66/281 (23%), Positives = 109/281 (38%), Gaps = 32/281 (11%)

Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLS---VDSRQGLREFTNEVKLLLKIQHKN 143
           F     LG G FG VY      +   +A+K L    ++      +   EV++   ++H N
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           ++ L+G   +     L+ EY P  ++   +    K S  D       +  +A  L Y H 
Sbjct: 68  ILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYCHS 124

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
               R+IHRDIK  N+LL      KI+DFG +   P          + GT  Y+ PE   
Sbjct: 125 ---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEMIE 177

Query: 264 HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA 323
                 K D++S GVL  E + G+   +    +E           ++    +E   P   
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE----------TYKRISRVEFTFPDFV 227

Query: 324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSV--HLMLSGDS 362
                       L     + + ++RP +  V  H  ++ +S
Sbjct: 228 ------TEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 262

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 3e-53
 Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 10/207 (4%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           ++   ++G G  G VY  + +  GQE+A++++++  +       NE+ ++ + ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
                  G E  +V EYL   SL   + +       D      +     + L +LH    
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALEFLHSN-- 135

Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGY 266
            ++IHRDIK+ NILL    + K++DFG       E +  +T    GT  +MAPE      
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--GTPYWMAPEVVTRKA 192

Query: 267 LSVKTDVFSYGVLVLEIVSGRKNHDGR 293
              K D++S G++ +E++ G   +   
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNE 219

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 3e-53
 Identities = 58/271 (21%), Positives = 109/271 (40%), Gaps = 30/271 (11%)

Query: 92  NQLGHGGFGPVYRG-LMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLF 148
            ++G G F  VY+G       E+A  +L     ++   + F  E ++L  +QH N+V  +
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 149 GCCAEGPEK----MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
                  +     +LV E + + +L  ++    +   +           + +GL +LH  
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTR 131

Query: 205 APARIIHRDIKASNILL-DEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
            P  IIHRD+K  NI +     + KI D GLA L            + GT  +MAPE   
Sbjct: 132 TP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFMAPEMYE 186

Query: 264 HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA 323
             Y     DV+++G+ +LE+ +    +                 +++  +    V P+  
Sbjct: 187 EKY-DESVDVYAFGMCMLEMATSEYPYSEC---------QNAAQIYR--RVTSGVKPA-- 232

Query: 324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSV 354
             ++       ++   C +Q+  ER  +  +
Sbjct: 233 SFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 4e-53
 Identities = 72/290 (24%), Positives = 120/290 (41%), Gaps = 38/290 (13%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNG---QEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHK 142
               + +G G FG V +  +       + A+K++    S+   R+F  E+++L K+  H 
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71

Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFI-------------FDKTKSSSLDWTTRYR 189
           N++ L G C       L  EY P+ +L  F+                + +S+L       
Sbjct: 72  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131

Query: 190 IVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFR 249
               VARG+ YL ++   + IHRD+ A NIL+ E    KI+DFGL+R     + +V    
Sbjct: 132 FAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKKTM 185

Query: 250 ISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLF 309
                 +MA E   +   +  +DV+SYGVL+ EIVS         G      ++      
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSL--------GGTPYCGMTCAELYE 237

Query: 310 QGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS 359
           +  +   L  P       +       L   C ++   ERP    + + L+
Sbjct: 238 KLPQGYRLEKPL------NCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (446), Expect = 2e-52
 Identities = 59/289 (20%), Positives = 116/289 (40%), Gaps = 33/289 (11%)

Query: 88  FSDLNQLGHGGFGPVYRGL------MPNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQ 140
            +   +LG G FG VY G+            +A+K ++   S +   EF NE  ++ +  
Sbjct: 22  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81

Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIF-------DKTKSSSLDWTTRYRIVMG 193
             ++V L G  ++G   +++ E +    L  ++        +    +    +   ++   
Sbjct: 82  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141

Query: 194 VARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGT 253
           +A G+ YL+     + +HRD+ A N ++ E    KI DFG+ R     D +    +    
Sbjct: 142 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198

Query: 254 HGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEK 313
             +M+PE    G  +  +DV+S+GV++ EI +  +                 +     E+
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE---------------QPYQGLSNEQ 243

Query: 314 ALELV-DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD 361
            L  V +  L     +   M  +L  +C Q +   RP    +   +  +
Sbjct: 244 VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 2e-50
 Identities = 62/274 (22%), Positives = 104/274 (37%), Gaps = 26/274 (9%)

Query: 91  LNQLGHGGFGPVYRGLMPN----GQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHKNLV 145
              +G G FG V++G+  +       +A+K     +   +RE F  E   + +  H ++V
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71

Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
            L G   E P   ++ E      L  F+  +  S  LD  +       ++  L YL  + 
Sbjct: 72  KLIGVITENP-VWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAYLESK- 127

Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHG 265
             R +HRDI A N+L+      K+ DFGL+R       +  + +      +MAPE     
Sbjct: 128 --RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS-KGKLPIKWMAPESINFR 184

Query: 266 YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKC 325
             +  +DV+ +GV + EI+          G +    +     + + E    L  P    C
Sbjct: 185 RFTSASDVWMFGVCMWEILMH--------GVKPFQGVKNNDVIGRIENGERLPMPP--NC 234

Query: 326 NRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS 359
                     L   C     + RP    +   LS
Sbjct: 235 PPT----LYSLMTKCWAYDPSRRPRFTELKAQLS 264

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 3e-49
 Identities = 53/210 (25%), Positives = 87/210 (41%), Gaps = 10/210 (4%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS---VDSRQGLREFTNEVKLLLKIQHKN 143
           F     LG G F  V     +   +E A+K L    +     +   T E  ++ ++ H  
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
            V L+    +  +      Y  N  L  +I    K  S D T        +   L YLH 
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHG 126

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
           +    IIHRD+K  NILL+E ++ +I+DFG A++   E          GT  Y++PE   
Sbjct: 127 K---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183

Query: 264 HGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
                  +D+++ G ++ ++V+G       
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPPFRAG 213

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  168 bits (427), Expect = 4e-49
 Identities = 50/200 (25%), Positives = 85/200 (42%), Gaps = 11/200 (5%)

Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
             +LG G FG V+R      G   A K +             E++ +  ++H  LV L  
Sbjct: 31  HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD 90

Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
              +  E +++YE++    L   + D+     +        +  V +GL ++HE      
Sbjct: 91  AFEDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHE---NNY 145

Query: 210 IHRDIKASNILLDEQLNP--KISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
           +H D+K  NI+   + +   K+ DFGL      + +   T    GT  + APE A    +
Sbjct: 146 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPV 202

Query: 268 SVKTDVFSYGVLVLEIVSGR 287
              TD++S GVL   ++SG 
Sbjct: 203 GYYTDMWSVGVLSYILLSGL 222

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 1e-48
 Identities = 70/291 (24%), Positives = 111/291 (38%), Gaps = 38/291 (13%)

Query: 91  LNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVDSRQG-LREFTNEVKLLLKIQH-K 142
              LG G FG V              + +AVK L   +     R   +E+K+L+ I H  
Sbjct: 18  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 77

Query: 143 NLVTLFGCCAE-GPEKMLVYEYLPNKSLDYFIFDK-------------TKSSSLDWTTRY 188
           N+V L G C + G   M++ E+    +L  ++  K                  L      
Sbjct: 78  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 137

Query: 189 RIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTF 248
                VA+G+ +L      + IHRD+ A NILL E+   KI DFGLAR    +  +V   
Sbjct: 138 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 194

Query: 249 RISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTL 308
                  +MAPE       ++++DV+S+GVL+ EI S   +           +       
Sbjct: 195 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRR 249

Query: 309 FQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS 359
            +    +   D +  +          Q  L C     ++RP  + +   L 
Sbjct: 250 LKEGTRMRAPDYTTPE--------MYQTMLDCWHGEPSQRPTFSELVEHLG 292

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (417), Expect = 3e-48
 Identities = 67/292 (22%), Positives = 112/292 (38%), Gaps = 40/292 (13%)

Query: 91  LNQLGHGGFGPVYRGLMP--------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-Q 140
              LG G FG V                 ++AVK L  D + + L +  +E++++  I +
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77

Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDK-------------TKSSSLDWTTR 187
           HKN++ L G C +     ++ EY    +L  ++  +                  L     
Sbjct: 78  HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 137

Query: 188 YRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNT 247
                 VARG+ YL  +   + IHRD+ A N+L+ E    KI+DFGLAR     D +  T
Sbjct: 138 VSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 194

Query: 248 FRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWT 307
                   +MAPE       + ++DV+S+GVL+ EI +         G      +     
Sbjct: 195 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTL--------GGSPYPGVPVEEL 246

Query: 308 LFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS 359
               ++   +  PS      +       +   C     ++RP    +   L 
Sbjct: 247 FKLLKEGHRMDKPS------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  164 bits (415), Expect = 2e-47
 Identities = 61/288 (21%), Positives = 109/288 (37%), Gaps = 25/288 (8%)

Query: 86  NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL 144
           +++  L +LG G FG V+R +    G+    K ++           NE+ ++ ++ H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L     +  E +L+ E+L    L   I    +   +        +     GL ++HE 
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMHE- 145

Query: 205 APARIIHRDIKASNILLDEQLNP--KISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
               I+H DIK  NI+ + +     KI DFGLA     ++    T   + T  + APE  
Sbjct: 146 --HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT---TATAEFAAPEIV 200

Query: 263 LHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL 322
               +   TD+++ GVL   ++SG     G    E    +             E  + + 
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK--------RCDWEFDEDAF 252

Query: 323 AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSV--HLMLSGDSFTLPKP 368
           +  + +             Q+   +R  ++    H  L GD   L   
Sbjct: 253 SSVSPE----AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 296

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 2e-46
 Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 7/207 (3%)

Query: 85  TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHK 142
              +++L+ +G G +G V       N   +A+KK+S    Q   +    E+K+LL+ +H+
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
           N++ +         + +   YL    +   ++   K+  L        +  + RGL Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF-PGEDTHVNTFRISGTHGYMAPEY 261
                 ++HRD+K SN+LL+   + KI DFGLAR+  P  D          T  Y APE 
Sbjct: 127 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 262 ALHG-YLSVKTDVFSYGVLVLEIVSGR 287
            L+    +   D++S G ++ E++S R
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNR 210

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  156 bits (395), Expect = 2e-44
 Identities = 60/228 (26%), Positives = 92/228 (40%), Gaps = 18/228 (7%)

Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLS---VDSRQGLREFTNEV---KLLLKIQ 140
           FS    +G GGFG VY       G+  A+K L    +  +QG     NE     L+    
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 141 HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
              +V +        +   + + +    L Y +                    +  GL +
Sbjct: 66  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF---SEADMRFYAAEIILGLEH 122

Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE 260
           +H      +++RD+K +NILLDE  + +ISD GLA  F  +  H       GTHGYMAPE
Sbjct: 123 MHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGTHGYMAPE 175

Query: 261 YALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWT 307
               G       D FS G ++ +++ G         K+K ++   T T
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT 223

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 1e-43
 Identities = 52/210 (24%), Positives = 85/210 (40%), Gaps = 12/210 (5%)

Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
              LG G FG V+R +   + +    K + V           E+ +L   +H+N++ L  
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHE 68

Query: 150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARI 209
                 E ++++E++    +   I   T +  L+       V  V   L +LH      I
Sbjct: 69  SFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS---HNI 123

Query: 210 IHRDIKASNILLDEQLNP--KISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYL 267
            H DI+  NI+   + +   KI +FG AR     D     F       Y APE   H  +
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPEYYAPEVHQHDVV 180

Query: 268 SVKTDVFSYGVLVLEIVSGRKNHDGRLGKE 297
           S  TD++S G LV  ++SG         ++
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQ 210

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  151 bits (381), Expect = 7e-43
 Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 15/207 (7%)

Query: 91  LNQLGHGGFGPVYRG-LMPNGQEIAVKKLS---VDSRQGLREFTNEVKLLLKIQHKNLVT 146
           L  LG G FG V+      NG+  A+K L    V   + +    +E  +L  + H  ++ 
Sbjct: 9   LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 68

Query: 147 LFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAP 206
           ++G   +  +  ++ +Y+    L   +    +               V   L YLH    
Sbjct: 69  MWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---PNPVAKFYAAEVCLALEYLHS--- 122

Query: 207 ARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGY 266
             II+RD+K  NILLD+  + KI+DFG A+  P          + GT  Y+APE      
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAPEVVSTKP 177

Query: 267 LSVKTDVFSYGVLVLEIVSGRKNHDGR 293
            +   D +S+G+L+ E+++G       
Sbjct: 178 YNKSIDWWSFGILIYEMLAGYTPFYDS 204

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (378), Expect = 2e-42
 Identities = 64/211 (30%), Positives = 92/211 (43%), Gaps = 13/211 (6%)

Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVD---SRQGLREFTNEVKLL-LKIQHK 142
           F     LG G FG V+        Q  A+K L  D       +     E ++L L  +H 
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
            L  +F           V EYL    L Y I    K    D +        +  GL +LH
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLH 120

Query: 203 EEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYA 262
            +    I++RD+K  NILLD+  + KI+DFG+ +     D   NTF   GT  Y+APE  
Sbjct: 121 SK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC--GTPDYIAPEIL 175

Query: 263 LHGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           L    +   D +S+GVL+ E++ G+    G+
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 206

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  148 bits (375), Expect = 3e-42
 Identities = 63/278 (22%), Positives = 102/278 (36%), Gaps = 26/278 (9%)

Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
             ++G G FG +Y G  +  G+E+A+K   V ++    +   E K+   +Q    +    
Sbjct: 12  GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIR 69

Query: 150 -CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
            C AEG   ++V E L     D F F   K       T   +   +   + Y+H      
Sbjct: 70  WCGAEGDYNVMVMELLGPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYIHS---KN 123

Query: 209 IIHRDIKASNIL---LDEQLNPKISDFGLARLFPGEDTHVNTF-----RISGTHGYMAPE 260
            IHRD+K  N L     +     I DFGLA+ +    TH +        ++GT  Y +  
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183

Query: 261 YALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP 320
             L    S + D+ S G +++    G     G     K             EK +     
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS-----EKKMSTPIE 238

Query: 321 SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLML 358
            L K    E A  +     C      ++PD + +  + 
Sbjct: 239 VLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLF 273

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  147 bits (373), Expect = 4e-42
 Identities = 50/218 (22%), Positives = 95/218 (43%), Gaps = 15/218 (6%)

Query: 85  TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQ 140
           ++ +     LG GG   V+    +   +++AVK L  D          F  E +    + 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 141 HKNLVTLFGCCAE----GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR 196
           H  +V ++         GP   +V EY+   +L   +  +     +       ++    +
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122

Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR-LFPGEDTHVNTFRISGTHG 255
            L + H+     IIHRD+K +NI++      K+ DFG+AR +    ++   T  + GT  
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           Y++PE A    +  ++DV+S G ++ E+++G     G 
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD 217

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  148 bits (375), Expect = 6e-42
 Identities = 63/285 (22%), Positives = 107/285 (37%), Gaps = 28/285 (9%)

Query: 85  TNFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE-FTNEVKLLLKIQHK 142
            + +   + LG G F  V         + +A+K ++  + +G      NE+ +L KI+H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 143 NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLH 202
           N+V L      G    L+ + +    L   I +K            R++  V   + YLH
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLH 124

Query: 203 EEAPARIIHRDIKASNILL---DEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           +     I+HRD+K  N+L    DE     ISDFGL+++   ED         GT GY+AP
Sbjct: 125 DL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAP 178

Query: 260 EYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD 319
           E       S   D +S GV+   ++ G          +  + +         +   E   
Sbjct: 179 EVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL--------KAEYEFDS 230

Query: 320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSV--HLMLSGDS 362
           P     +               ++   +R        H  ++GD+
Sbjct: 231 PYWDDISDS----AKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT 271

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  147 bits (371), Expect = 9e-42
 Identities = 62/288 (21%), Positives = 106/288 (36%), Gaps = 41/288 (14%)

Query: 87  FFSD---LNQLGHGGFGPVYRGL-MPNGQEIAVKKL--------SVDSRQGLRE-FTNEV 133
           F+ +      LG G    V R +  P  +E AVK +        S +  Q LRE    EV
Sbjct: 1   FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60

Query: 134 KLLLKIQ-HKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVM 192
            +L K+  H N++ L           LV++ +    L  ++ +K     L      +I+ 
Sbjct: 61  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMR 117

Query: 193 GVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISG 252
            +   +  LH+     I+HRD+K  NILLD+ +N K++DFG +      +       + G
Sbjct: 118 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCG 171

Query: 253 THGYMAPEYAL------HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTW 306
           T  Y+APE         H     + D++S GV++  +++G      R       ++    
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM--- 228

Query: 307 TLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSV 354
                    +   P     +         L          +R      
Sbjct: 229 -----SGNYQFGSPEWDDYSDT----VKDLVSRFLVVQPQKRYTAEEA 267

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 2e-41
 Identities = 64/284 (22%), Positives = 113/284 (39%), Gaps = 24/284 (8%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNL 144
           F  + ++G G +G VY+      G+ +A+KK+ +D  +         E+ LL ++ H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+L      +   D +  + +        +  + +GL + H  
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCHSH 121

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE-YAL 263
              R++HRD+K  N+L++ +   K++DFGLAR F              T  Y APE    
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE--VVTLWYRAPEILLG 176

Query: 264 HGYLSVKTDVFSYGVLVLEIVSGRKNHDGR-----LGKEKADLLSYTWTLFQGEKALELV 318
             Y S   D++S G +  E+V+ R    G      L +    L +    ++ G  ++   
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 319 DPSLAKCNRDE--------AAMCIQLGLLCCQQSVAERPDMNSV 354
            PS  K  R +              L          +R    + 
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  145 bits (367), Expect = 4e-41
 Identities = 53/209 (25%), Positives = 96/209 (45%), Gaps = 11/209 (5%)

Query: 88  FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLV 145
           +  L ++G G +G VY+     G+  A+KK+ ++            E+ +L +++H N+V
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63

Query: 146 TLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA 205
            L+         +LV+E+L           +     L+  T    ++ +  G+ Y H+  
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG---LESVTAKSFLLQLLNGIAYCHD-- 118

Query: 206 PARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL-H 264
             R++HRD+K  N+L++ +   KI+DFGLAR F           +  T  Y AP+  +  
Sbjct: 119 -RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPDVLMGS 175

Query: 265 GYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
              S   D++S G +  E+V+G     G 
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 4e-41
 Identities = 67/304 (22%), Positives = 109/304 (35%), Gaps = 34/304 (11%)

Query: 91  LNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQG-----LREFTNEVKLLLKIQHKNL 144
           L+ LG G F  VY+       Q +A+KK+ +  R        R    E+KLL ++ H N+
Sbjct: 3   LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI 62

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           + L           LV++++          +      L  +     ++   +GL YLH+ 
Sbjct: 63  IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV---LTPSHIKAYMLMTLQGLEYLHQH 119

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL- 263
               I+HRD+K +N+LLDE    K++DFGLA+ F G      T ++  T  Y APE    
Sbjct: 120 ---WILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYTHQV-VTRWYRAPELLFG 174

Query: 264 HGYLSVKTDVFSYGVLVLEIVSGRKNHDGR------------LGKEKADLLSYTWTLFQG 311
                V  D+++ G ++ E++       G             LG    +      +L   
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234

Query: 312 EKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSV--HLMLSGD-----SFT 364
                     L           + L       +   R            S          
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQ 294

Query: 365 LPKP 368
           LP+P
Sbjct: 295 LPRP 298

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 3e-40
 Identities = 58/215 (26%), Positives = 94/215 (43%), Gaps = 19/215 (8%)

Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT 146
           ++D   +G+G FG VY+  L  +G+ +A+KK+  D R        E++++ K+ H N+V 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVR 77

Query: 147 LFGCCAEGPEKM------LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
           L        EK       LV +Y+P               +L        +  + R L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 201 LHEEAPARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAP 259
           +H      I HRDIK  N+LLD +    K+ DFG A+     + +V+         Y AP
Sbjct: 138 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS---RYYRAP 191

Query: 260 EYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
           E        +   DV+S G ++ E++ G+    G 
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  143 bits (361), Expect = 4e-40
 Identities = 46/282 (16%), Positives = 91/282 (32%), Gaps = 30/282 (10%)

Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQH-KNLVTLF 148
             ++G G FG ++ G  + N Q++A+K      R    +  +E +    +     +  ++
Sbjct: 10  GRRIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTGIPNVY 67

Query: 149 GCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPAR 208
               EG   +LV + L                     T       +   +  +HE     
Sbjct: 68  YFGQEGLHNVLVIDLLGP---SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KS 121

Query: 209 IIHRDIKASNILLDEQLNP-----KISDFGLARLFPGEDTHVNTFR-----ISGTHGYMA 258
           +++RDIK  N L+    +       + DFG+ + +    T  +        +SGT  YM+
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181

Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV 318
               L    S + D+ + G + +  + G     G                   E+  E  
Sbjct: 182 INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY---------ERIGEKK 232

Query: 319 DP-SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS 359
               L +          +        +    PD + +  + S
Sbjct: 233 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 2e-39
 Identities = 66/285 (23%), Positives = 115/285 (40%), Gaps = 27/285 (9%)

Query: 91  LNQLGHGGFGPVYRG--LMPNGQEIAVKKLSVDSRQG--LREFTNEVKLLLKI---QHKN 143
           + ++G G +G V++   L   G+ +A+K++ V + +         EV +L  +   +H N
Sbjct: 12  VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 71

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLD---YFIFDKTKSSSLDWTTRYRIVMGVARGLLY 200
           +V LF  C            L  + +D       DK     +   T   ++  + RGL +
Sbjct: 72  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF 131

Query: 201 LHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE 260
           LH     R++HRD+K  NIL+      K++DFGLAR++  +        +  T  Y APE
Sbjct: 132 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWYRAPE 185

Query: 261 YALHGYLSVKTDVFSYGVLVLEIVSGR-----KNHDGRLGKEKADLLSYTWTLFQGEKAL 315
             L    +   D++S G +  E+   +      +   +LGK    +       +  + AL
Sbjct: 186 VLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245

Query: 316 ELVD------PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSV 354
                       + K   D   +   L L C   + A+R    S 
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 2e-38
 Identities = 62/280 (22%), Positives = 107/280 (38%), Gaps = 32/280 (11%)

Query: 86  NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQG------LREFTNEVKLLLK 138
           +++    +LG G F  V +      G + A K +     +         +   EV +L +
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 139 IQHKNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
           IQH N++TL        + +L+ E +    L  F+ +K     L        +  +  G+
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---LTEEEATEFLKQILNGV 126

Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNP----KISDFGLARLFPGEDTHVNTFRISGTH 254
            YLH     +I H D+K  NI+L ++  P    KI DFGLA      +   N F   GT 
Sbjct: 127 YYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF---GTP 180

Query: 255 GYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKA 314
            ++APE   +  L ++ D++S GV+   ++SG     G   +E    +S           
Sbjct: 181 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--------AVN 232

Query: 315 LELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSV 354
            E  D   +  +                +   +R  +   
Sbjct: 233 YEFEDEYFSNTSAL----AKDFIRRLLVKDPKKRMTIQDS 268

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 2e-37
 Identities = 53/270 (19%), Positives = 96/270 (35%), Gaps = 29/270 (10%)

Query: 94  LGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCC 151
           LG G  G V +       ++ A+K L     Q   +   EV+L  +  Q  ++V +    
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVY 74

Query: 152 ----AEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPA 207
               A     ++V E L    L   I D+    +        I+  +   + YLH     
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSI--- 130

Query: 208 RIIHRDIKASNILLDEQLNP---KISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
            I HRD+K  N+L   +      K++DFG A+     ++         T  Y+APE    
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGP 187

Query: 265 GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK 324
                  D++S GV++  ++ G        G   +  +     + Q     E  +P  ++
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ----YEFPNPEWSE 243

Query: 325 CNRDEAAMCIQLGLLCCQQSVAERPDMNSV 354
            + +       L     +    +R  +   
Sbjct: 244 VSEE----VKMLIRNLLKTEPTQRMTITEF 269

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 5e-37
 Identities = 52/220 (23%), Positives = 95/220 (43%), Gaps = 20/220 (9%)

Query: 88  FSDLNQLGHGGFGPVYRG-LMPNGQEIAVKKLSVDSRQG--LREFTNEVKLLLKIQHKNL 144
           +  L ++G G FG V++      GQ++A+KK+ +++ +         E+K+L  ++H+N+
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 145 VTLFGCCAEGPEKM--------LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVAR 196
           V L   C               LV+++  +           K      +   R++  +  
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLN 128

Query: 197 GLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRIS--GTH 254
           GL Y+H     +I+HRD+KA+N+L+      K++DFGLAR F            +   T 
Sbjct: 129 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185

Query: 255 GYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
            Y  PE  L         D++  G ++ E+ +      G 
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 225

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (335), Expect = 1e-36
 Identities = 54/208 (25%), Positives = 82/208 (39%), Gaps = 20/208 (9%)

Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLRE------FTNEVKLLLKIQ--H 141
              LG GGFG VY G+ + +   +A+K +  D      E         EV LL K+    
Sbjct: 9   GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68

Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
             ++ L          +L+ E        +    +    +L           V   + + 
Sbjct: 69  SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHC 126

Query: 202 HEEAPARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPE 260
           H      ++HRDIK  NIL+D  +   K+ DFG   L   +DT    F   GT  Y  PE
Sbjct: 127 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFD--GTRVYSPPE 179

Query: 261 YAL-HGYLSVKTDVFSYGVLVLEIVSGR 287
           +   H Y      V+S G+L+ ++V G 
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGD 207

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 8e-36
 Identities = 44/204 (21%), Positives = 85/204 (41%), Gaps = 10/204 (4%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNL 144
           +  L ++G G +G V++       + +A+K++ +D            E+ LL +++HKN+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 145 VTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE 204
           V L        +  LV+E+       YF          D       +  + +GL + H  
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL---DPEIVKSFLFQLLKGLGFCHSR 120

Query: 205 APARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALH 264
               ++HRD+K  N+L++     K+++FGLAR F G      +  +              
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLFGA 176

Query: 265 GYLSVKTDVFSYGVLVLEIVSGRK 288
              S   D++S G +  E+ +  +
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGR 200

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 2e-35
 Identities = 50/210 (23%), Positives = 81/210 (38%), Gaps = 12/210 (5%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS---VDSRQGLREFTNEVKLLLKIQHKN 143
           F  L  LG G FG V        G+  A+K L    + ++  +     E ++L   +H  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           L  L            V EY     L + +   ++               +   L YLH 
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHS 123

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
                +++RDIK  N++LD+  + KI+DFGL +    +          GT  Y+APE   
Sbjct: 124 ---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLE 178

Query: 264 HGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
                   D +  GV++ E++ GR     +
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  130 bits (327), Expect = 8e-35
 Identities = 49/210 (23%), Positives = 82/210 (39%), Gaps = 15/210 (7%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS---VDSRQGLREFTNEVKLLLKIQHKN 143
           F  +  LG G FG V       +G   A+K L    V   + +    NE ++L  +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 144 LVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           LV L     +     +V EY+    +   +    +               +     YLH 
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHS 159

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
                +I+RD+K  N+L+D+Q   +++DFG A+   G    +      GT   +APE  L
Sbjct: 160 ---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC-----GTPEALAPEIIL 211

Query: 264 HGYLSVKTDVFSYGVLVLEIVSGRKNHDGR 293
               +   D ++ GVL+ E+ +G       
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 4e-34
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 13/207 (6%)

Query: 86  NFFSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKL--SVDSRQGLREFTNEVKLLLKIQHK 142
             + DL  +G G +G V   +    G ++A+KKL     S    +    E++LL  ++H+
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 143 NLVTLFGCCAEGPEKMLVYE-YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
           N++ L              + YL    +   +    K   L       +V  + +GL Y+
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137

Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEY 261
           H    A IIHRD+K  N+ ++E    KI DFGLAR    E T     R      Y APE 
Sbjct: 138 HA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTR-----WYRAPEV 189

Query: 262 AL-HGYLSVKTDVFSYGVLVLEIVSGR 287
            L     +   D++S G ++ E+++G+
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGK 216

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 5e-31
 Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 18/208 (8%)

Query: 91  LNQLGHGGFGPVYRG----LMPNGQEIAVKKLS----VDSRQGLREFTNEVKLLLKIQHK 142
           L  LG G +G V+          G+  A+K L     V   +       E ++L  I+  
Sbjct: 29  LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 88

Query: 143 -NLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
             LVTL        +  L+ +Y+    L   +  + +            V  +   L +L
Sbjct: 89  PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVLALEHL 145

Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEY 261
           H+     II+RDIK  NILLD   +  ++DFGL++ F  ++T    +   GT  YMAP+ 
Sbjct: 146 HK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDI 201

Query: 262 ALHG--YLSVKTDVFSYGVLVLEIVSGR 287
              G        D +S GVL+ E+++G 
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGA 229

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  116 bits (291), Expect = 6e-30
 Identities = 42/222 (18%), Positives = 93/222 (41%), Gaps = 24/222 (10%)

Query: 75  FFDLRTLQVATNFFSD---LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFT 130
           ++D  +  V      D   + +LG G +  V+  + + N +++ VK L    ++   +  
Sbjct: 21  YWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIK 77

Query: 131 NEVKLLLKIQ-HKNLVTLFGCCAEGPEKM--LVYEYLPNKSLDYFIFDKTKSSSLDWTTR 187
            E+K+L  ++   N++TL     +   +   LV+E++ N              +L     
Sbjct: 78  REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDI 131

Query: 188 YRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVN 246
              +  + + L Y H      I+HRD+K  N+++D E    ++ D+GLA  +     +  
Sbjct: 132 RFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-- 186

Query: 247 TFRISGTHGYMAPEYAL-HGYLSVKTDVFSYGVLVLEIVSGR 287
                 +  +  PE  + +       D++S G ++  ++  +
Sbjct: 187 -NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK 227

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (290), Expect = 1e-29
 Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 13/205 (6%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLS--VDSRQGLREFTNEVKLLLKIQHKNL 144
           + +L+ +G G +G V        G  +AVKKLS    S    +    E++LL  ++H+N+
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79

Query: 145 VTLFGCCAEGPEKM-LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE 203
           + L                YL    +   + +  K   L       ++  + RGL Y+H 
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS 139

Query: 204 EAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYAL 263
                IIHRD+K SN+ ++E    KI DFGLAR    E T     R      Y APE  L
Sbjct: 140 A---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW-----YRAPEIML 191

Query: 264 -HGYLSVKTDVFSYGVLVLEIVSGR 287
              + +   D++S G ++ E+++GR
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGR 216

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 4e-29
 Identities = 53/209 (25%), Positives = 85/209 (40%), Gaps = 21/209 (10%)

Query: 88  FSDLNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNL 144
           + +L  +G G  G V         + +A+KKLS    ++   +    E+ L+  + HKN+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 145 VTLFGCCA------EGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGL 198
           ++L           E  +  LV E +          +       D      ++  +  G+
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLCGI 132

Query: 199 LYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMA 258
            +LH      IIHRD+K SNI++      KI DFGLAR      T         T  Y A
Sbjct: 133 KHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRA 186

Query: 259 PEYALHGYLSVKTDVFSYGVLVLEIVSGR 287
           PE  L        D++S G ++ E+V  +
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  113 bits (283), Expect = 1e-28
 Identities = 44/222 (19%), Positives = 80/222 (36%), Gaps = 18/222 (8%)

Query: 91  LNQLGHGGFGPVYRGL-MPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFG 149
           + +LG G F  V+    M N   +A+K +  D +       +E+KLL ++   +      
Sbjct: 18  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDS 76

Query: 150 CCAEGPEKMLVYEYLPNKSLDYF-------------IFDKTKSSSLDWTTRYRIVMGVAR 196
             A    K+L +      +  +              +  K +   +      +I   +  
Sbjct: 77  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136

Query: 197 GLLYLHEEAPARIIHRDIKASNILLD-EQLNPKISDFGLARLFPGEDTHVNTFRISGTHG 255
           GL Y+H      IIH DIK  N+L++       +    +A L        +      T  
Sbjct: 137 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 256 YMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKE 297
           Y +PE  L        D++S   L+ E+++G    +   G  
Sbjct: 195 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 236

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 89.8 bits (222), Expect = 1e-21
 Identities = 34/201 (16%), Positives = 56/201 (27%), Gaps = 25/201 (12%)

Query: 92  NQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR----------QGLREFTNEVKLLLKIQH 141
             +G G    V+        E  VK   V              G   F+       + + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 142 KNLVTLFGCCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYL 201
           + L  L G          VY +  N  L   I  K             ++  +   +   
Sbjct: 66  RALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119

Query: 202 HEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEY 261
           +      I+H D+   N+L+ E+    I DF  +     E        I          Y
Sbjct: 120 YHR---GIVHGDLSQYNVLVSEE-GIWIIDFPQSV----EVGEEGWREILERDVRNIITY 171

Query: 262 ALHGYLSVKTDVFSYGVLVLE 282
               Y   + D+ S    +L+
Sbjct: 172 FSRTY-RTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	437
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.84
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.35
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.85
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.53
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.48
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.01

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-57  Score=424.24  Aligned_cols=253  Identities=24%  Similarity=0.313  Sum_probs=204.3

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      .++|++++.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..|||||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            35799999999999999999985 479999999997543 2334568899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      ||++|+|.+++.   ....+++..++.++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+|+.+....
T Consensus        84 y~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~  157 (271)
T d1nvra_          84 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  157 (271)
T ss_dssp             CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ccCCCcHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence            999999999983   3457999999999999999999999998   9999999999999999999999999999875444


Q ss_pred             cccceeeeecccccCChhhhccCcC-CcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          243 THVNTFRISGTHGYMAPEYALHGYL-SVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                      ........+||+.|||||++.+..+ +.++|||||||+||||++|+.||...........      .......   ..+ 
T Consensus       158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~------~~~~~~~---~~~-  227 (271)
T d1nvra_         158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS------DWKEKKT---YLN-  227 (271)
T ss_dssp             EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH------HHHTTCT---TST-
T ss_pred             ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH------HHhcCCC---CCC-
Confidence            3333345789999999999988765 6789999999999999999999976543221110      0000000   000 


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                         .....+.++.+|+.+||+.||++|||++||++
T Consensus       228 ---~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         228 ---PWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             ---TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               01122355778999999999999999999854

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-56  Score=424.33  Aligned_cols=258  Identities=28%  Similarity=0.433  Sum_probs=204.5

Q ss_pred             hcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      .++|++.+.||+|+||+||+|+++  ..||||++...  .....+.|.+|+.+|++++|||||++++++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            467999999999999999999863  36999998643  34556789999999999999999999998765 56899999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      ||++|+|.+++..  ....+++..++.++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+|+......
T Consensus        84 y~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          84 WCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             cCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            9999999999853  3356999999999999999999999998   9999999999999999999999999998775444


Q ss_pred             cccceeeeecccccCChhhhccC---cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          243 THVNTFRISGTHGYMAPEYALHG---YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~---~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                      .........||+.|||||++.+.   .++.++|||||||+||||+||+.||.+..........  ...        ....
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~--~~~--------~~~~  228 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM--VGR--------GYLS  228 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH--HHH--------TSCC
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHH--Hhc--------CCCC
Confidence            33334456799999999999753   5899999999999999999999999875543322111  111        0111


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      +.+.......+..+.+|+.+||+.+|++||||.+|++.|+.
T Consensus       229 p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~  269 (276)
T d1uwha_         229 PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL  269 (276)
T ss_dssp             CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            22222333445678899999999999999999999999874

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-56  Score=421.12  Aligned_cols=253  Identities=26%  Similarity=0.422  Sum_probs=199.3

Q ss_pred             cCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecC
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLP  165 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  165 (437)
                      ++|++.+.||+|+||+||+|++.+++.||||++...... .++|.+|++++++++|||||+++++|...+..++|||||+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~-~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC-HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc-HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            569999999999999999999888889999999765433 4679999999999999999999999999999999999999


Q ss_pred             CCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCccc
Q 013745          166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV  245 (437)
Q Consensus       166 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  245 (437)
                      +|+|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.........
T Consensus        84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence            9999998743  3456899999999999999999999998   9999999999999999999999999998775443322


Q ss_pred             ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhC-CCCCCCCCchhhhhhhhhhhhhhcccccccccCccccC
Q 013745          246 NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSG-RKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK  324 (437)
Q Consensus       246 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  324 (437)
                       .....||+.|+|||++.+..++.++|||||||++|||+|+ ++||......+....+...      .   ....     
T Consensus       159 -~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~------~---~~~~-----  223 (263)
T d1sm2a_         159 -STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG------F---RLYK-----  223 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT------C---CCCC-----
T ss_pred             -ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc------C---CCCC-----
Confidence             2245789999999999999999999999999999999995 5555544332222211110      0   0111     


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          325 CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       325 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                       +...+.++.+++.+||+.||++||||++|++.|+.
T Consensus       224 -p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~  258 (263)
T d1sm2a_         224 -PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE  258 (263)
T ss_dssp             -CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence             11234568899999999999999999999999874

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-56  Score=423.06  Aligned_cols=249  Identities=24%  Similarity=0.389  Sum_probs=207.9

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      ++|++++.||+|+||+||+|+. .+|+.||||++........+.+.+|+.+|++++|||||+++++|.+.+..|+|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            4699999999999999999984 479999999997654444577899999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      +||+|.+++..    ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+.+......
T Consensus       100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~  172 (293)
T d1yhwa1         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK  172 (293)
T ss_dssp             TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence            99999988743    35899999999999999999999998   999999999999999999999999999987543322


Q ss_pred             cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccC
Q 013745          245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK  324 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  324 (437)
                        ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+      .....      +.+ .
T Consensus       173 --~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~------~~~~~------~~~-~  237 (293)
T d1yhwa1         173 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------ATNGT------PEL-Q  237 (293)
T ss_dssp             --BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------HHHCS------CCC-S
T ss_pred             --ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHH------HhCCC------CCC-C
Confidence              22467999999999999999999999999999999999999999865543322111      11100      000 1


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          325 CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       325 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .+...+..+.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11233456788999999999999999999864

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-56  Score=417.88  Aligned_cols=248  Identities=25%  Similarity=0.328  Sum_probs=208.1

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ++|++.+.||+|+||+||+|+. .+++.||||++....   ......+.+|+.++++++|||||++++++.+++..|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            5799999999999999999985 478999999986432   223567889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      |||++|+|.+++...   ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+.....
T Consensus        86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            999999999998543   46899999999999999999999998   999999999999999999999999999876543


Q ss_pred             CcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                      .    .....||+.|+|||++.+..++.++|||||||+||||++|+.||.+....+....+.      ..       ...
T Consensus       160 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~------~~-------~~~  222 (263)
T d2j4za1         160 R----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------RV-------EFT  222 (263)
T ss_dssp             C----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------TT-------CCC
T ss_pred             c----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH------cC-------CCC
Confidence            2    224579999999999999999999999999999999999999998765433222111      10       011


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--Hhc
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLS  359 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~  359 (437)
                      +   +...+.++.+++.+||+.||++|||+.||++  +|.
T Consensus       223 ~---p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~  259 (263)
T d2j4za1         223 F---PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT  259 (263)
T ss_dssp             C---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHH
T ss_pred             C---CccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcC
Confidence            1   1123456788999999999999999999986  544

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-56  Score=418.05  Aligned_cols=254  Identities=22%  Similarity=0.310  Sum_probs=196.7

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeecc--CCceEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE--GPEKMLV  160 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  160 (437)
                      ++|++++.||+|+||+||+|+. .+|+.||||++...  .....+.+.+|+++|++++|||||++++++.+  ...+|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            5799999999999999999985 47899999999754  34456778999999999999999999999865  4568999


Q ss_pred             EeecCCCCcchhhhcc-CCCCCCCHHHHHHHHHHHHHHHHHhhhcCC--CceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          161 YEYLPNKSLDYFIFDK-TKSSSLDWTTRYRIVMGVARGLLYLHEEAP--ARIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~--~~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                      ||||++|+|.+++... .....+++..++.++.||+.||.|||+++.  .+|+||||||+||||+.++.+||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999988543 234679999999999999999999999752  3499999999999999999999999999998


Q ss_pred             cCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccc
Q 013745          238 FPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALEL  317 (437)
Q Consensus       238 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (437)
                      +......  ....+||+.|+|||++.+..++.++|||||||++|||+||+.||.+....+....+.      . ...   
T Consensus       164 ~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~------~-~~~---  231 (269)
T d2java1         164 LNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR------E-GKF---  231 (269)
T ss_dssp             C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH------H-TCC---
T ss_pred             cccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHH------c-CCC---
Confidence            7543322  224679999999999999999999999999999999999999998755433222111      0 110   


Q ss_pred             cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          318 VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       318 ~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                           ...+...+.++.+|+.+||+.||++|||+.||++
T Consensus       232 -----~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         232 -----RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                 1111223456888999999999999999999864

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.1e-55  Score=421.03  Aligned_cols=255  Identities=25%  Similarity=0.409  Sum_probs=198.3

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCc---EEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQ---EIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      ++|++.++||+|+||+||+|.++ +++   .||||++... .....+.|.+|+++|++++|||||+++++|.+.+..++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            56888999999999999999854 332   5889988654 455567899999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      ||||++|+|.+++..  ..+.+++..++.|+.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+.+..
T Consensus       106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence            999999999998743  3456999999999999999999999998   99999999999999999999999999997754


Q ss_pred             CCcccc---eeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhccccccc
Q 013745          241 EDTHVN---TFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALE  316 (437)
Q Consensus       241 ~~~~~~---~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (437)
                      ......   .....||+.|||||++.++.++.++|||||||+||||+| |+.||.+....+....+..      ..+   
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~------~~~---  251 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ------DYR---  251 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT------TCC---
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHc------CCC---
Confidence            332211   122457999999999999999999999999999999998 8999987654433222111      100   


Q ss_pred             ccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          317 LVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       317 ~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                            ...+...+..+.+|+.+||+.+|++||||.+|++.|+.
T Consensus       252 ------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~  289 (299)
T d1jpaa_         252 ------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK  289 (299)
T ss_dssp             ------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             ------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                  01122345568899999999999999999999998863

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=417.42  Aligned_cols=253  Identities=28%  Similarity=0.436  Sum_probs=205.4

Q ss_pred             hcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      .++|++.+.||+|+||.||+|.+++++.||||++..... ..+.|.+|+++|++++|||||++++++.+ +..++|||||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            357999999999999999999988888999999975543 34679999999999999999999998865 5679999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      ++|+|.+++.... ...+++..++.|+.||++||.|||+++   |+||||||+||||++++.+||+|||+|+........
T Consensus        90 ~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~  165 (272)
T d1qpca_          90 ENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (272)
T ss_dssp             TTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             CCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCccc
Confidence            9999998774332 245899999999999999999999998   999999999999999999999999999987544332


Q ss_pred             cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCC-CCCCchhhhhhhhhhhhhhcccccccccCcccc
Q 013745          245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNH-DGRLGKEKADLLSYTWTLFQGEKALELVDPSLA  323 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  323 (437)
                      . .....||+.|+|||++.++.++.++|||||||+||||+||..|+ ......+....+.      . +     ..+.. 
T Consensus       166 ~-~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~------~-~-----~~~~~-  231 (272)
T d1qpca_         166 A-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE------R-G-----YRMVR-  231 (272)
T ss_dssp             C-CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH------T-T-----CCCCC-
T ss_pred             c-ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHH------h-c-----CCCCC-
Confidence            2 22456899999999999999999999999999999999965554 4433222211111      0 0     01111 


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       324 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                        +...+..+.+|+.+||+.+|++||||.+|+++|+
T Consensus       232 --p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~  265 (272)
T d1qpca_         232 --PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE  265 (272)
T ss_dssp             --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             --cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence              1223456889999999999999999999999887

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.5e-55  Score=418.10  Aligned_cols=255  Identities=25%  Similarity=0.410  Sum_probs=210.3

Q ss_pred             hcCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      .++|++.+.||+|+||+||+|++. +++.||||++..+.. ..++|.+|+++|++++|||||+++++|.+++..++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            467999999999999999999854 688999999975543 346799999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      |++|+|..++... ....+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+.......
T Consensus        95 ~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~  170 (287)
T d1opja_          95 MTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  170 (287)
T ss_dssp             CTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred             ccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence            9999999998543 3467999999999999999999999998   99999999999999999999999999997754433


Q ss_pred             ccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCc-hhhhhhhhhhhhhhcccccccccCccc
Q 013745          244 HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLG-KEKADLLSYTWTLFQGEKALELVDPSL  322 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~d~~l  322 (437)
                      .. .....||+.|+|||++.++.++.++|||||||++|||++|..||..... ......+       ..+.     .+  
T Consensus       171 ~~-~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i-------~~~~-----~~--  235 (287)
T d1opja_         171 TA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------EKDY-----RM--  235 (287)
T ss_dssp             EE-ETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-------HTTC-----CC--
T ss_pred             ee-eccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH-------hcCC-----CC--
Confidence            22 2245689999999999999999999999999999999997766643322 2211111       1110     01  


Q ss_pred             cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          323 AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       323 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                       ..+...+..+.+|+.+||+.||++|||+.+|+++|+.
T Consensus       236 -~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~  272 (287)
T d1opja_         236 -ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET  272 (287)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence             1122334568899999999999999999999999874

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-55  Score=409.93  Aligned_cols=252  Identities=25%  Similarity=0.413  Sum_probs=212.5

Q ss_pred             cCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecC
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLP  165 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  165 (437)
                      ++|++.++||+|+||+||+|++++++.||||+++..... .++|.+|+.++++++|||||+++++|.+.+..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~-~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC-HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC-HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            579999999999999999999888889999999865433 4679999999999999999999999999999999999999


Q ss_pred             CCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCccc
Q 013745          166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV  245 (437)
Q Consensus       166 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  245 (437)
                      +|+|..++...  ...+++..+++++.|+++||+|||+++   |+||||||+|||++.++.+||+|||+++.........
T Consensus        83 ~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          83 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             TEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred             CCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence            99999887433  356889999999999999999999998   9999999999999999999999999998765443322


Q ss_pred             ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccC
Q 013745          246 NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK  324 (437)
Q Consensus       246 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  324 (437)
                       .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....+....+..      ..+   ...     
T Consensus       158 -~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~------~~~---~~~-----  222 (258)
T d1k2pa_         158 -SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ------GLR---LYR-----  222 (258)
T ss_dssp             -CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHT------TCC---CCC-----
T ss_pred             -ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHh------CCC---CCC-----
Confidence             224568999999999999999999999999999999998 8999987765443322211      100   111     


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          325 CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       325 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                       +...+..+.+++.+||+.+|++|||+.+|++.|.
T Consensus       223 -p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  256 (258)
T d1k2pa_         223 -PHLASEKVYTIMYSCWHEKADERPTFKILLSNIL  256 (258)
T ss_dssp             -CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             -cccccHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence             1123356889999999999999999999999885

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=419.87  Aligned_cols=251  Identities=23%  Similarity=0.331  Sum_probs=206.9

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      +.|++++.||+|+||+||+|+. .+|+.||||++........+.+.+|+++|++++|||||++++++.+.+..+||||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            4699999999999999999985 478999999998766666678899999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      ++|+|..++.+.  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+....... 
T Consensus        92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~-  165 (288)
T d2jfla1          92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-  165 (288)
T ss_dssp             TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH-
T ss_pred             CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCcc-
Confidence            999999987543  346999999999999999999999998   99999999999999999999999999976532211 


Q ss_pred             cceeeeecccccCChhhhc-----cCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          245 VNTFRISGTHGYMAPEYAL-----HGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~-----~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                       .....+||+.|+|||++.     ...|+.++|||||||+||||++|+.||.+....+....      ......      
T Consensus       166 -~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~------i~~~~~------  232 (288)
T d2jfla1         166 -RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK------IAKSEP------  232 (288)
T ss_dssp             -HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH------HHHSCC------
T ss_pred             -cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHH------HHcCCC------
Confidence             122467999999999984     45689999999999999999999999987554332211      111100      


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      +.+ ..+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       233 ~~~-~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         233 PTL-AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             CCC-SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCC-CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            001 111233456788999999999999999999976

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-55  Score=413.56  Aligned_cols=254  Identities=26%  Similarity=0.405  Sum_probs=207.9

Q ss_pred             cCccccce-eccCCCeeEEEEEcC---CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           86 NFFSDLNQ-LGHGGFGPVYRGLMP---NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        86 ~~y~~~~~-lG~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      ++|.+.+. ||+|+||+||+|.++   ++..||||++... .....+.|.+|+++|++++|||||++++++.+ +..|||
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            45777774 999999999999753   4557999999754 34556789999999999999999999999865 468999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      ||||++|+|.+++.  .....+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.+..
T Consensus        87 mE~~~~g~L~~~l~--~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          87 MEMAGGGPLHKFLV--GKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EECCTTEEHHHHHT--TCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCcHHHHhh--ccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence            99999999999873  23457999999999999999999999998   99999999999999999999999999998765


Q ss_pred             CCccc-ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          241 EDTHV-NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       241 ~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      ..... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||.+....+....+.       .+..    
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~-------~~~~----  230 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-------QGKR----  230 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH-------TTCC----
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-------cCCC----
Confidence            43222 2223568999999999999999999999999999999998 999998765443322211       1111    


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                       +   ..+...+.++.+|+.+||+.+|++||||.+|++.|+.
T Consensus       231 -~---~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         231 -M---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             -C---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             -C---CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence             1   1122344568899999999999999999999999875

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-55  Score=426.32  Aligned_cols=264  Identities=24%  Similarity=0.338  Sum_probs=207.3

Q ss_pred             HhcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           84 ATNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        84 ~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ..++|++++.||+|+||+||+|+. .+|+.||+|++... .......+.+|+.+|++++|||||+++++|.+....|+||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            367899999999999999999995 47899999999754 3344567899999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhc-CCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE-APARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~-~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      |||+||+|.+++.+.   ..+++..++.++.||+.||.|||++ +   |+||||||+||||+.+|.+||+|||+|+.+..
T Consensus        84 Ey~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             ECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             EcCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            999999999998543   4589999999999999999999975 6   99999999999999999999999999987643


Q ss_pred             CCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhh-hhhhc---------
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYT-WTLFQ---------  310 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~-~~~~~---------  310 (437)
                      ..    ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+....+........ .....         
T Consensus       158 ~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (322)
T d1s9ja_         158 SM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  233 (322)
T ss_dssp             HT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred             Cc----cccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence            21    22468999999999999999999999999999999999999999875433221110000 00000         


Q ss_pred             -------------ccccccc-------cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--Hhc
Q 013745          311 -------------GEKALEL-------VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLS  359 (437)
Q Consensus       311 -------------~~~~~~~-------~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~  359 (437)
                                   .....+.       ..+.+.  ....+.++.+++.+||+.||++|||++|+++  +++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~  302 (322)
T d1s9ja_         234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLP--SGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK  302 (322)
T ss_dssp             ------------CCCCHHHHHHHHHTSCCCCCC--BTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             cccccccccccccchhHHHHHhhhhccCCccCc--cccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhC
Confidence                         0000000       000000  0112356788999999999999999999976  454

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-55  Score=418.88  Aligned_cols=248  Identities=22%  Similarity=0.281  Sum_probs=203.7

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++...   .....+.+.+|+++|++++|||||+++++|.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5699999999999999999985 47999999998643   2233467899999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      |||+||+|.+++...   +.+++..++.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+|+.+...
T Consensus        88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            999999999887543   46999999999999999999999998   999999999999999999999999999987654


Q ss_pred             CcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                      .........+||+.|+|||++.+..++.++|||||||+||||++|+.||.+....+....+      ....       ..
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i------~~~~-------~~  228 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI------IKLE-------YD  228 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HTTC-------CC
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHH------HcCC-------CC
Confidence            4333344567999999999999999999999999999999999999999875543322111      1110       01


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVH  355 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~  355 (437)
                         .+...+.++.+|+.+||+.||++|||++|++
T Consensus       229 ---~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         229 ---FPEKFFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             ---CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             ---CCccCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence               1112345678899999999999999999864

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-54  Score=419.57  Aligned_cols=258  Identities=26%  Similarity=0.358  Sum_probs=207.7

Q ss_pred             hcCccccceeccCCCeeEEEEEcCC-C-----cEEEEEEeccC-ChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCc
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPN-G-----QEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPE  156 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  156 (437)
                      .++|++.++||+|+||+||+|++.. +     ..||+|++... .......+.+|+.+|.++ +|||||+++++|.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            3679999999999999999998532 2     36899998654 333446788999999998 89999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCC--------------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCC
Q 013745          157 KMLVYEYLPNKSLDYFIFDKTK--------------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKA  216 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp  216 (437)
                      .++|||||++|+|.+++.....                    ...+++..++.++.||+.||+|||+++   ||||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence            9999999999999999865321                    245899999999999999999999998   99999999


Q ss_pred             CCEEecCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCc
Q 013745          217 SNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLG  295 (437)
Q Consensus       217 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~  295 (437)
                      +|||++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||+||||+| |+.||.+...
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987765544433445678999999999999999999999999999999998 8999986544


Q ss_pred             hhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          296 KEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                      .....      .....+.     .+   ..+...+.++.+|+.+||+.+|++|||++||++.|.
T Consensus       273 ~~~~~------~~~~~~~-----~~---~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 DANFY------KLIQNGF-----KM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SHHHH------HHHHTTC-----CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHH------HHHhcCC-----CC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            32211      1111111     01   112233456889999999999999999999999985

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=6.4e-54  Score=419.00  Aligned_cols=252  Identities=21%  Similarity=0.292  Sum_probs=210.6

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      .++|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++|||||+++++|.+++..||||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            35799999999999999999985 47999999999877766678899999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEec--CCCCceeeecccccccCCC
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD--EQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~--~~~~~kl~DFGla~~~~~~  241 (437)
                      |+||+|.+++..  ....+++..++.|+.||+.||.|||+++   ||||||||+|||++  .++.+||+|||+|+.+...
T Consensus       105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            999999988843  3356999999999999999999999998   99999999999995  4688999999999987544


Q ss_pred             CcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                      ..   .....||+.|||||++.+..++.++|||||||++|||++|+.||.+....+....+...      ..  ......
T Consensus       180 ~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~------~~--~~~~~~  248 (350)
T d1koaa2         180 QS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC------DW--NMDDSA  248 (350)
T ss_dssp             SC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT------CC--CSCCGG
T ss_pred             cc---cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhC------CC--CCCccc
Confidence            32   23467999999999999999999999999999999999999999876544332221110      00  000111


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ..    ..+..+.+|+.+||+.||++|||+.|+++
T Consensus       249 ~~----~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         249 FS----GISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             GG----GCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             cc----CCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11    23345788999999999999999999987

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-54  Score=411.34  Aligned_cols=255  Identities=27%  Similarity=0.418  Sum_probs=202.3

Q ss_pred             cCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecC
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLP  165 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  165 (437)
                      ++|++.+.||+|+||.||+|++++++.||||++..... ..+.|.+|+.++++++|||||+++++|.+ +..++|||||+
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~   94 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS   94 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecC
Confidence            57999999999999999999988888999999975533 34679999999999999999999999965 56899999999


Q ss_pred             CCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCccc
Q 013745          166 NKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV  245 (437)
Q Consensus       166 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~  245 (437)
                      +|+|..++.... ...+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.........
T Consensus        95 ~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~  170 (285)
T d1fmka3          95 KGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  170 (285)
T ss_dssp             TCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence            999998875432 346999999999999999999999998   9999999999999999999999999998765433222


Q ss_pred             ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCC-CCchhhhhhhhhhhhhhcccccccccCccccC
Q 013745          246 NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDG-RLGKEKADLLSYTWTLFQGEKALELVDPSLAK  324 (437)
Q Consensus       246 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  324 (437)
                       .....||+.|+|||++..+.++.++|||||||+||||++|..|+.. ....+....+.   .    +.     .+   .
T Consensus       171 -~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~---~----~~-----~~---~  234 (285)
T d1fmka3         171 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE---R----GY-----RM---P  234 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---T----TC-----CC---C
T ss_pred             -eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH---h----cC-----CC---C
Confidence             2245689999999999999999999999999999999997666543 33222221111   1    00     01   1


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCCC
Q 013745          325 CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGDS  362 (437)
Q Consensus       325 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~~  362 (437)
                      .+...+.++.+++.+||+.||++||+|++|+++|+...
T Consensus       235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence            12233456889999999999999999999999998644

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=7.9e-54  Score=418.67  Aligned_cols=256  Identities=23%  Similarity=0.316  Sum_probs=212.7

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeec
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYL  164 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  164 (437)
                      ++|++++.||+|+||+||+|+. .+|+.||||++..........+.+|+.+|++|+|||||+++++|.+++..|||||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            5699999999999999999985 479999999998776666678899999999999999999999999999999999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEec--CCCCceeeecccccccCCCC
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD--EQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~--~~~~~kl~DFGla~~~~~~~  242 (437)
                      +||+|.+.+.  .....+++..++.|+.||+.||.|||+++   |+||||||+||||+  .++.+||+|||+|+.+....
T Consensus       109 ~gg~L~~~~~--~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~  183 (352)
T d1koba_         109 SGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  183 (352)
T ss_dssp             CCCBHHHHTT--CTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CCChHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence            9999988763  23456999999999999999999999998   99999999999997  67899999999999875443


Q ss_pred             cccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccc
Q 013745          243 THVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL  322 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  322 (437)
                      .   .....||+.|+|||++.+..++.++|||||||+||||+||+.||.+....+....+.      ....  .. .   
T Consensus       184 ~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~------~~~~--~~-~---  248 (352)
T d1koba_         184 I---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK------RCDW--EF-D---  248 (352)
T ss_dssp             C---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH------HCCC--CC-C---
T ss_pred             c---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hCCC--CC-C---
Confidence            2   234679999999999999999999999999999999999999998765443322111      1000  00 0   


Q ss_pred             cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcCC
Q 013745          323 AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSGD  361 (437)
Q Consensus       323 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~~  361 (437)
                      .......+.++.+|+.+||+.||.+|||+.|+++  ++++.
T Consensus       249 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         249 EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            1112234456789999999999999999999976  46543

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-54  Score=409.96  Aligned_cols=247  Identities=29%  Similarity=0.418  Sum_probs=199.6

Q ss_pred             ceeccCCCeeEEEEEcC---CCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEeecCC
Q 013745           92 NQLGHGGFGPVYRGLMP---NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEYLPN  166 (437)
Q Consensus        92 ~~lG~G~~g~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  166 (437)
                      ++||+|+||+||+|.++   .++.||||++...  .....+.|.+|+++|++++|||||+++++|.+ +..+||||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            57999999999999753   3568999999643  23345679999999999999999999999965 467899999999


Q ss_pred             CCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCccc-
Q 013745          167 KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTHV-  245 (437)
Q Consensus       167 gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~-  245 (437)
                      |+|.+++..   ...+++..++.|+.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.+....... 
T Consensus        92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            999998853   356999999999999999999999998   9999999999999999999999999999875443322 


Q ss_pred             ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCccccC
Q 013745          246 NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLAK  324 (437)
Q Consensus       246 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  324 (437)
                      ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.+....+....+..       +..     +   .
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~-------~~~-----~---~  230 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-------GER-----M---G  230 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-------TCC-----C---C
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHc-------CCC-----C---C
Confidence            2234568999999999999999999999999999999998 8999987654433222211       110     1   1


Q ss_pred             CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          325 CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       325 ~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      .+...+.++.+|+.+||+.||++|||+.+|+++|+.
T Consensus       231 ~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            122334568899999999999999999999988863

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-54  Score=407.74  Aligned_cols=255  Identities=25%  Similarity=0.403  Sum_probs=198.5

Q ss_pred             cCccccceeccCCCeeEEEEEcCCC-----cEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMPNG-----QEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      ..|+..++||+|+||.||+|.++..     ..||||++... .......|.+|+.+|++++|||||++++++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4588899999999999999985432     36999999754 34445679999999999999999999999999999999


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      |||||.++++.+++..  ....+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus        87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence            9999999999887743  3357999999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCccc-ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCC-CCchhhhhhhhhhhhhhcccccccc
Q 013745          240 GEDTHV-NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDG-RLGKEKADLLSYTWTLFQGEKALEL  317 (437)
Q Consensus       240 ~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  317 (437)
                      ...... ......||+.|+|||++.++.++.++|||||||+||||++|..|+.. ....+....+       ..+.    
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i-------~~~~----  230 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI-------NDGF----  230 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-------HTTC----
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHH-------hccC----
Confidence            432221 22235689999999999999999999999999999999997665543 3222211111       1110    


Q ss_pred             cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          318 VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       318 ~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                       .+   ..+...+..+.+|+.+||+.+|++||+|.||+++|+.
T Consensus       231 -~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~  269 (283)
T d1mqba_         231 -RL---PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK  269 (283)
T ss_dssp             -CC---CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             -CC---CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence             11   1122344568899999999999999999999999874

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.2e-54  Score=414.02  Aligned_cols=255  Identities=22%  Similarity=0.285  Sum_probs=193.7

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC-hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS-RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      .+.|++.+.||+|+||+||+|+. .+|+.||||++.... ......+.+|+.+|++++|||||++++++.+++..|||||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            46799999999999999999985 478999999997543 2234568899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEec---CCCCceeeecccccccC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD---EQLNPKISDFGLARLFP  239 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~---~~~~~kl~DFGla~~~~  239 (437)
                      ||+||+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||+.   +++.+||+|||+|+...
T Consensus        88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            9999999999843   356999999999999999999999998   99999999999994   57899999999998764


Q ss_pred             CCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                      ....   ....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+....+....+.      ....  ....
T Consensus       162 ~~~~---~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~------~~~~--~~~~  230 (307)
T d1a06a_         162 PGSV---LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL------KAEY--EFDS  230 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH------TTCC--CCCT
T ss_pred             CCCe---eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHh------ccCC--CCCC
Confidence            3322   224679999999999999999999999999999999999999998755433222111      1100  0001


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                          ......+..+.+++.+||+.||++|||+.|+++  ++.+
T Consensus       231 ----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         231 ----PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             ----TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             ----ccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence                111233456889999999999999999999987  4543

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-53  Score=401.02  Aligned_cols=247  Identities=23%  Similarity=0.325  Sum_probs=197.2

Q ss_pred             ccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeecc----CCceEEE
Q 013745           88 FSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE----GPEKMLV  160 (437)
Q Consensus        88 y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv  160 (437)
                      |++.++||+|+||+||+|+.. +++.||+|++...  .....+.+.+|+++|++++|||||+++++|.+    ...+++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            466778999999999999854 7889999998643  34456779999999999999999999999864    4567999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEec-CCCCceeeecccccccC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD-EQLNPKISDFGLARLFP  239 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~-~~~~~kl~DFGla~~~~  239 (437)
                      ||||++|+|.+++...   ..+++..++.|+.||+.||+|||+++ .+|+||||||+||||+ +++.+||+|||+|+...
T Consensus        91 mE~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            9999999999998543   46899999999999999999999976 4499999999999996 57899999999998653


Q ss_pred             CCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccC
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVD  319 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  319 (437)
                      ...    ....+||+.|||||++.+ .++.++|||||||+||||++|+.||.+.......  ..    ....+..    .
T Consensus       167 ~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~--~~----~i~~~~~----~  231 (270)
T d1t4ha_         167 ASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YR----RVTSGVK----P  231 (270)
T ss_dssp             TTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HH----HHTTTCC----C
T ss_pred             CCc----cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHH--HH----HHHcCCC----C
Confidence            322    224679999999998865 5899999999999999999999999754432211  11    1111100    0


Q ss_pred             ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          320 PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       320 ~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      +.+..   ....++.+|+.+||+.||++|||+.|+++
T Consensus       232 ~~~~~---~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         232 ASFDK---VAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             GGGGG---CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccCc---cCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            11111   12335778999999999999999999976

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.5e-54  Score=413.97  Aligned_cols=248  Identities=30%  Similarity=0.444  Sum_probs=203.5

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ..|+.++.||+|+||+||+|+. .+|+.||||++....   ....+.+.+|+.+|++++|||||++++++.+.+..|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            3499999999999999999984 578999999997542   334567899999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      |||++|+|..++..   ...+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+|+.....
T Consensus        95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (309)
T d1u5ra_          95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (309)
T ss_dssp             ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence            99999999766633   356999999999999999999999998   999999999999999999999999999865432


Q ss_pred             CcccceeeeecccccCChhhhcc---CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALH---GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~---~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                            ....||+.|||||++.+   +.|+.++|||||||++|||++|+.||.+....+...      ......      
T Consensus       169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~------~i~~~~------  230 (309)
T d1u5ra_         169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQNE------  230 (309)
T ss_dssp             ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHSC------
T ss_pred             ------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHH------HHHhCC------
Confidence                  23579999999999864   468999999999999999999999998654332211      111110      


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--Hhc
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLS  359 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~  359 (437)
                      .+.+.  ....+..+.+++.+||+.||++|||+.|+++  ++.
T Consensus       231 ~~~~~--~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~  271 (309)
T d1u5ra_         231 SPALQ--SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL  271 (309)
T ss_dssp             CCCCS--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred             CCCCC--CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhc
Confidence            01111  1123456888999999999999999999976  454

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.4e-54  Score=410.61  Aligned_cols=263  Identities=28%  Similarity=0.430  Sum_probs=213.2

Q ss_pred             HHHHHhcCccccceeccCCCeeEEEEEcC------CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeec
Q 013745           80 TLQVATNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCA  152 (437)
Q Consensus        80 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  152 (437)
                      +++...++|++.+.||+|+||+||+|+++      +++.||||++... .....++|.+|+.+|++++||||++++++|.
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            34445678999999999999999999853      4578999999754 3444577999999999999999999999999


Q ss_pred             cCCceEEEEeecCCCCcchhhhccC---------------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEe
Q 013745          153 EGPEKMLVYEYLPNKSLDYFIFDKT---------------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIH  211 (437)
Q Consensus       153 ~~~~~~lv~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiH  211 (437)
                      +....++||||+++|+|.+++....                     ....+++..++.++.|++.||+|||+++   |||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH  163 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH  163 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence            9999999999999999999985432                     1235899999999999999999999998   999


Q ss_pred             eccCCCCEEecCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCC-CCC
Q 013745          212 RDIKASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGR-KNH  290 (437)
Q Consensus       212 rDikp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~-~p~  290 (437)
                      |||||+||||+.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|. +||
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence            9999999999999999999999998765444333344567899999999999999999999999999999999985 577


Q ss_pred             CCCCchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          291 DGRLGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      .+....+....+.       .+..        ...+...+.++.+|+.+||+.+|++||||.||+++|+.
T Consensus       244 ~~~~~~e~~~~v~-------~~~~--------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~  298 (301)
T d1lufa_         244 YGMAHEEVIYYVR-------DGNI--------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR  298 (301)
T ss_dssp             TTSCHHHHHHHHH-------TTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHH-------cCCC--------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            7654443322111       1111        11122334568899999999999999999999999974

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-53  Score=405.60  Aligned_cols=251  Identities=24%  Similarity=0.322  Sum_probs=206.7

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC------hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCce
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS------RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK  157 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  157 (437)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++....      ....+.+.+|+.+|++++|||||+++++|.+.+..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            46799999999999999999985 479999999986431      12357789999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCC----Cceeeecc
Q 013745          158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL----NPKISDFG  233 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~----~~kl~DFG  233 (437)
                      |||||||++|+|.+++...   ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++    .+||+|||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence            9999999999999998543   46999999999999999999999998   99999999999998776    49999999


Q ss_pred             cccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccc
Q 013745          234 LARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEK  313 (437)
Q Consensus       234 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  313 (437)
                      +|+........   ....||+.|+|||++.+..++.++|||||||+||||++|+.||.+....+....+..      ...
T Consensus       163 ~a~~~~~~~~~---~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~------~~~  233 (293)
T d1jksa_         163 LAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA------VNY  233 (293)
T ss_dssp             TCEECTTSCBC---SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT------TCC
T ss_pred             hhhhcCCCccc---cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHh------cCC
Confidence            99887543322   245789999999999999999999999999999999999999987654433221111      000


Q ss_pred             cccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          314 ALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       314 ~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                        .. .+..   ....+..+.+|+.+||+.||++|||++|+++
T Consensus       234 --~~-~~~~---~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         234 --EF-EDEY---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             --CC-CHHH---HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --CC-Cchh---cCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              00 0000   0123345788999999999999999999976

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-53  Score=409.95  Aligned_cols=248  Identities=23%  Similarity=0.267  Sum_probs=207.6

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      -++|++++.||+|+||.||+|+. .+|+.||||++.+.   .....+.+.+|+.+|++++|||||+++++|.+.+.+|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            36799999999999999999985 57999999999753   223357788999999999999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      ||||+||+|..++...   ..+++..++.++.||+.||+|||+++   |+||||||+|||++.+|.+||+|||+|+....
T Consensus        84 ~ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          84 MEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eeccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            9999999999988543   46899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                      ....  ....+||+.|+|||++.+..|+.++|||||||+||||++|++||.+....+....+.      . ..      .
T Consensus       158 ~~~~--~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~------~-~~------~  222 (337)
T d1o6la_         158 DGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL------M-EE------I  222 (337)
T ss_dssp             TTCC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------H-CC------C
T ss_pred             CCcc--cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHh------c-CC------C
Confidence            3322  234689999999999999999999999999999999999999998765433222111      0 00      0


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERPD-----MNSVHL  356 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~  356 (437)
                         ..+...+.++.+|+.+||+.||.+||+     +.++++
T Consensus       223 ---~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         223 ---RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence               112233456788999999999999995     778765

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-53  Score=408.09  Aligned_cols=254  Identities=26%  Similarity=0.438  Sum_probs=202.2

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCc----EEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQ----EIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      .+|+++++||+|+||+||+|.+. +|+    .||+|++... .....++|.+|++++++++|||||+++++|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            45999999999999999999853 454    5889988643 334467899999999999999999999999875 5678


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      ++||+.+|+|.+.+..  ....+++..++.|+.||+.||+|||+++   |+||||||+||||+.++.+||+|||+|+...
T Consensus        88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            8999999999888754  3457999999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      ............||+.|+|||++.++.++.++|||||||+||||+| |.+||.+....+....+...      .+     
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~------~~-----  231 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG------ER-----  231 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHT------CC-----
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC------CC-----
Confidence            5554444445678999999999999999999999999999999998 78999876544332222111      00     


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                          ...+...+..+.+|+.+||+.+|++|||+.+|++.|+.
T Consensus       232 ----~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~  269 (317)
T d1xkka_         232 ----LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK  269 (317)
T ss_dssp             ----CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence                01122344568899999999999999999999988763

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-53  Score=398.04  Aligned_cols=253  Identities=23%  Similarity=0.322  Sum_probs=196.3

Q ss_pred             hcCccccceeccCCCeeEEEEEcCC----CcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMPN----GQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  159 (437)
                      .++|++.+.||+|+||.||+|++..    +..||||++... .....+.|.+|+.+|++++|||||++++++.+ +..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEE
Confidence            3679999999999999999998532    346889988644 44446779999999999999999999999964 67899


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccC
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFP  239 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~  239 (437)
                      ||||+++|+|..++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+|+.+.
T Consensus        85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence            9999999999988743  3457899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhccccccccc
Q 013745          240 GEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELV  318 (437)
Q Consensus       240 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (437)
                      ...... .....||+.|+|||++.+..++.++|||||||++|||++ |.+||.+....+....+.      ....     
T Consensus       160 ~~~~~~-~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~------~~~~-----  227 (273)
T d1mp8a_         160 DSTYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE------NGER-----  227 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH------TTCC-----
T ss_pred             CCccee-ccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH------cCCC-----
Confidence            433322 224568999999999999999999999999999999998 899998765443322111      1110     


Q ss_pred             CccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhc
Q 013745          319 DPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLS  359 (437)
Q Consensus       319 d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~  359 (437)
                       +   ..+...+..+.+|+.+||+.||++|||+.||++.|+
T Consensus       228 -~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~  264 (273)
T d1mp8a_         228 -L---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLS  264 (273)
T ss_dssp             -C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -C---CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence             0   112233456889999999999999999999998876

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-52  Score=404.47  Aligned_cols=248  Identities=23%  Similarity=0.327  Sum_probs=206.9

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ++|++++.||+|+||+||+|+. .+|+.||||++...   .....+.+.+|+.+|++++|||||++++++.+.+..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5799999999999999999995 47999999999643   2233567889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      |||+||+|..++..   ...+++..++.++.||+.||+|||+++   |+||||||+||||+.+|.+||+|||+|+.....
T Consensus        84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            99999999888743   345788999999999999999999998   999999999999999999999999999986533


Q ss_pred             CcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                      .     ...+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+....+....+.      ...       . 
T Consensus       158 ~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~------~~~-------~-  218 (316)
T d1fota_         158 T-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL------NAE-------L-  218 (316)
T ss_dssp             B-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------HCC-------C-
T ss_pred             c-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHH------cCC-------C-
Confidence            2     24689999999999999999999999999999999999999998755433222111      110       0 


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCC-----CHHHHHH--HhcC
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAERP-----DMNSVHL--MLSG  360 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~RP-----s~~ev~~--~L~~  360 (437)
                        ..+...+..+.+++.+||+.||.+||     +++++++  ++++
T Consensus       219 --~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~  262 (316)
T d1fota_         219 --RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE  262 (316)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             --CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccccc
Confidence              11122335578899999999999996     8999975  4544

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-53  Score=396.68  Aligned_cols=248  Identities=26%  Similarity=0.361  Sum_probs=198.2

Q ss_pred             cCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeecc-CCceEEEEeec
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE-GPEKMLVYEYL  164 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  164 (437)
                      ++|++.+.||+|+||.||+|++ .|+.||||+++.+..  .+.|.+|++++++++|||||+++++|.+ .+.+++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHHH--HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            5689999999999999999998 578999999975433  4678999999999999999999999865 45689999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      ++|+|.+++.... ...+++..++.|+.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......  
T Consensus        84 ~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--  157 (262)
T d1byga_          84 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  157 (262)
T ss_dssp             TTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred             CCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCC--
Confidence            9999999986432 235899999999999999999999988   9999999999999999999999999998654322  


Q ss_pred             cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhcccccccccCcccc
Q 013745          245 VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSLA  323 (437)
Q Consensus       245 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  323 (437)
                         ....+|..|+|||++.++.++.++|||||||++|||+| |++||......+....+.       .+.     .+.  
T Consensus       158 ---~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~-------~~~-----~~~--  220 (262)
T d1byga_         158 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGY-----KMD--  220 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHT-------TTC-----CCC--
T ss_pred             ---ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------cCC-----CCC--
Confidence               23467999999999999999999999999999999998 788887654443322221       111     111  


Q ss_pred             CCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          324 KCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       324 ~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                       .+...+.++.+|+.+||+.||++||||.+|+++|+.
T Consensus       221 -~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~  256 (262)
T d1byga_         221 -APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH  256 (262)
T ss_dssp             -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence             122334567899999999999999999999999874

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-52  Score=399.45  Aligned_cols=263  Identities=24%  Similarity=0.280  Sum_probs=201.0

Q ss_pred             ccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChH-----HHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           90 DLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQ-----GLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        90 ~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      .+++||+|+||+||+|+. .+|+.||||++......     ..+.+.+|+.+|++++|||||++++++.+++..|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            468899999999999995 47999999999654221     124688999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +.++++..+.   .....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|+.......
T Consensus        82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             hcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            9988776655   33466899999999999999999999998   99999999999999999999999999987654432


Q ss_pred             ccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccc-------
Q 013745          244 HVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKAL-------  315 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------  315 (437)
                      ..  ...+||+.|+|||++... .++.++|||||||++|||++|+.||.+....+....+.............       
T Consensus       156 ~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~  233 (299)
T d1ua2a_         156 AY--THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD  233 (299)
T ss_dssp             CC--CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             cc--cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence            22  235799999999998755 68999999999999999999999998766544332221111000000000       


Q ss_pred             -----cccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          316 -----ELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       316 -----~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                           ......+..........+.+|+.+||+.||++|||++|+++  +|+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~  285 (299)
T d1ua2a_         234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN  285 (299)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred             hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence                 00000000111123456889999999999999999999986  5654

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-52  Score=403.65  Aligned_cols=255  Identities=21%  Similarity=0.253  Sum_probs=208.5

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++...... ...+.+|+++|++++|||||+++++|.+.+.+||||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            46799999999999999999985 47899999999866543 35688999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC--CCCceeeecccccccCCC
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE--QLNPKISDFGLARLFPGE  241 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~--~~~~kl~DFGla~~~~~~  241 (437)
                      |+||+|.+++..  ....+++..++.|+.||+.||+|||+++   |+||||||+|||++.  .+.+||+|||+++.....
T Consensus        83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            999999998843  3346999999999999999999999998   999999999999984  457999999999876443


Q ss_pred             CcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                      ..   .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.+....+....+.      ....  ......
T Consensus       158 ~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~------~~~~--~~~~~~  226 (321)
T d1tkia_         158 DN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM------NAEY--TFDEEA  226 (321)
T ss_dssp             CE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------HTCC--CCCHHH
T ss_pred             Cc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hCCC--CCChhh
Confidence            22   234678999999999999999999999999999999999999998765443322111      1000  000000


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                      ..    ..+.++.+++.+||+.||++|||+.|+++  ++..
T Consensus       227 ~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         227 FK----EISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             HT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             cc----CCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence            01    12345788999999999999999999987  5553

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-52  Score=400.32  Aligned_cols=267  Identities=27%  Similarity=0.341  Sum_probs=202.1

Q ss_pred             cHHHHHHHhcCccccceeccCCCeeEEEEEcC------CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcC-CCCcceeee
Q 013745           77 DLRTLQVATNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLF  148 (437)
Q Consensus        77 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~  148 (437)
                      +....++..++|++.++||+|+||.||+|.+.      +++.||||++... .....+.+.+|..++.++ +|+|||.++
T Consensus         4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence            33444444578999999999999999999842      3568999999754 344456788888888877 689999999


Q ss_pred             eeeccC-CceEEEEeecCCCCcchhhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeecc
Q 013745          149 GCCAEG-PEKMLVYEYLPNKSLDYFIFDKT-------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDI  214 (437)
Q Consensus       149 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDi  214 (437)
                      +++... ...++|||||++|+|.+++....             ....+++..++.++.||+.||.|||+++   ||||||
T Consensus        84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDl  160 (299)
T d1ywna1          84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL  160 (299)
T ss_dssp             EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcC
Confidence            987654 56899999999999999986432             1345899999999999999999999998   999999


Q ss_pred             CCCCEEecCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCC-CCCCCC
Q 013745          215 KASNILLDEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGR-KNHDGR  293 (437)
Q Consensus       215 kp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~-~p~~~~  293 (437)
                      ||+||||+.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+||. +||.+.
T Consensus       161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~  240 (299)
T d1ywna1         161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  240 (299)
T ss_dssp             CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999998765544443444567999999999999999999999999999999999874 577654


Q ss_pred             CchhhhhhhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          294 LGKEKADLLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ...+...      .....+..     +.   .+...+.++.+++.+||+.||++|||+.||++.|+.
T Consensus       241 ~~~~~~~------~~~~~~~~-----~~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~  293 (299)
T d1ywna1         241 KIDEEFC------RRLKEGTR-----MR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  293 (299)
T ss_dssp             CCSHHHH------HHHHHTCC-----CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CHHHHHH------HHHhcCCC-----CC---CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            3322111      11111111     11   112234568899999999999999999999998863

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.5e-52  Score=394.59  Aligned_cols=257  Identities=21%  Similarity=0.314  Sum_probs=200.7

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC----c
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP----E  156 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~  156 (437)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++...   .......+.+|++++++++|||||++++++....    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            56799999999999999999984 57999999999754   3444567999999999999999999999987644    3


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                      .|||||||+|++|..++...   +.+++..++.++.||+.||+|||+++   |+||||||+|||++.++.++|+|||.+.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence            78999999999999887443   46999999999999999999999998   9999999999999999999999999997


Q ss_pred             ccCCCCc-ccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccc
Q 013745          237 LFPGEDT-HVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKAL  315 (437)
Q Consensus       237 ~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (437)
                      ....... .......+||+.|+|||++.+..++.++|||||||++|||+||+.||.+....+...      ........ 
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~------~~~~~~~~-  232 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY------QHVREDPI-  232 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHHHCCCC-
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHH------HHHhcCCC-
Confidence            6543322 222334679999999999999999999999999999999999999998755433211      11111110 


Q ss_pred             cccCccccCCCHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHhc
Q 013745          316 ELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERP-DMNSVHLMLS  359 (437)
Q Consensus       316 ~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RP-s~~ev~~~L~  359 (437)
                         .+.  ......+..+.+++.+||+.||++|| +++++++-|.
T Consensus       233 ---~~~--~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         233 ---PPS--ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             ---CGG--GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             ---CCc--hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence               000  11112345678899999999999999 8999887664

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-52  Score=397.79  Aligned_cols=258  Identities=27%  Similarity=0.365  Sum_probs=207.9

Q ss_pred             hcCccccceeccCCCeeEEEEEcC--------CCcEEEEEEeccCC-hHHHHHHHHHHHHHHcC-CCCcceeeeeeeccC
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP--------NGQEIAVKKLSVDS-RQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEG  154 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  154 (437)
                      .++|++.+.||+|+||.||+|+..        ++..||||++.... .....++.+|+..+.++ +|||||+++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            367999999999999999999742        23479999997653 44567888999999888 799999999999999


Q ss_pred             CceEEEEeecCCCCcchhhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEe
Q 013745          155 PEKMLVYEYLPNKSLDYFIFDKTK-------------SSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL  221 (437)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll  221 (437)
                      +..++|||||++|+|.+++..+..             ...+++..++.++.||+.||+|||+++   ||||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence            999999999999999999965431             246899999999999999999999998   9999999999999


Q ss_pred             cCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhh
Q 013745          222 DEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKAD  300 (437)
Q Consensus       222 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~  300 (437)
                      +.++.+||+|||+++...............||+.|+|||++.++.|+.++|||||||++|||++ |.+||.+....+...
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~  248 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK  248 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH
Confidence            9999999999999998765554444445679999999999999999999999999999999998 788887655433221


Q ss_pred             hhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          301 LLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      .+       ..+..     +   ..+...+..+.+|+.+||+.+|++|||+.||++.|+.
T Consensus       249 ~i-------~~~~~-----~---~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~  293 (299)
T d1fgka_         249 LL-------KEGHR-----M---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  293 (299)
T ss_dssp             HH-------HTTCC-----C---CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HH-------HcCCC-----C---CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence            11       11111     1   1112234568899999999999999999999999974

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.8e-52  Score=405.26  Aligned_cols=248  Identities=21%  Similarity=0.283  Sum_probs=207.3

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC---hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ++|++++.||+|+||.||+|+. .+|+.||||++....   ....+.+.+|+++|+.++|||||++++++.+....++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            5799999999999999999985 479999999986432   233467889999999999999999999999999999999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGE  241 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~  241 (437)
                      ||+.+|+|..++...   ..+++..++.++.||+.||.|||+++   ||||||||+||||+.+|.+||+|||+|+.+...
T Consensus       121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            999999999988543   46899999999999999999999998   999999999999999999999999999987532


Q ss_pred             CcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCcc
Q 013745          242 DTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPS  321 (437)
Q Consensus       242 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  321 (437)
                      .     ....||+.|||||++.+..++.++|||||||+||||+||+.||.+.........+.      ...       . 
T Consensus       195 ~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~------~~~-------~-  255 (350)
T d1rdqe_         195 T-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV------SGK-------V-  255 (350)
T ss_dssp             B-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCC-------C-
T ss_pred             c-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHh------cCC-------C-
Confidence            2     24679999999999999999999999999999999999999998754333221111      100       0 


Q ss_pred             ccCCCHHHHHHHHHHHHHcCCCCCCCC-----CCHHHHHH--HhcC
Q 013745          322 LAKCNRDEAAMCIQLGLLCCQQSVAER-----PDMNSVHL--MLSG  360 (437)
Q Consensus       322 l~~~~~~~~~~l~~l~~~cl~~~p~~R-----Ps~~ev~~--~L~~  360 (437)
                        ..+...+.++.+++.+||+.||.+|     |++++|++  ++.+
T Consensus       256 --~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~  299 (350)
T d1rdqe_         256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             --CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             --CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccC
Confidence              1112234567889999999999999     48999976  5554

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-52  Score=394.90  Aligned_cols=255  Identities=27%  Similarity=0.385  Sum_probs=197.9

Q ss_pred             cCccccceeccCCCeeEEEEEcC--CC--cEEEEEEeccC---ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP--NG--QEIAVKKLSVD---SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKM  158 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  158 (437)
                      ++|++++.||+|+||.||+|+..  ++  ..||||++...   .....+.|.+|+.+|++++|||||+++++|.+ ...+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            56999999999999999999842  23  36899998653   33445789999999999999999999999976 4678


Q ss_pred             EEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccccc
Q 013745          159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                      +|||||++|+|.+.+...  ...+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.+
T Consensus        87 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence            999999999998887543  346999999999999999999999998   999999999999999999999999999987


Q ss_pred             CCCCccc-ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhhhhhhhhhhhccccccc
Q 013745          239 PGEDTHV-NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKADLLSYTWTLFQGEKALE  316 (437)
Q Consensus       239 ~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (437)
                      ....... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||.+....+....      ....+..  
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~------i~~~~~~--  233 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK------IDKEGER--  233 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH------HHTSCCC--
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHH------HHhCCCC--
Confidence            5543322 2223567889999999999999999999999999999998 8999987654433221      1111111  


Q ss_pred             ccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          317 LVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       317 ~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                         +   ..+...+..+.+|+.+||+.||++||||.+|+++|+.
T Consensus       234 ---~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         234 ---L---PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             ---C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---C---CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence               0   1112233568899999999999999999999999863

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1e-51  Score=390.82  Aligned_cols=250  Identities=23%  Similarity=0.309  Sum_probs=205.2

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC---------hHHHHHHHHHHHHHHcCC-CCcceeeeeeeccC
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---------RQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEG  154 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  154 (437)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++....         ....+.+.+|+.++++++ |||||++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            6799999999999999999985 579999999986542         112346889999999997 99999999999999


Q ss_pred             CceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccc
Q 013745          155 PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL  234 (437)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl  234 (437)
                      +..|||||||++|+|.+++...   +.+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence            9999999999999999999543   46999999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcccceeeeecccccCChhhhcc------CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhh
Q 013745          235 ARLFPGEDTHVNTFRISGTHGYMAPEYALH------GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTL  308 (437)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~------~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~  308 (437)
                      ++.+......   ....||+.|+|||++.+      ..++.++||||+||+||||++|+.||.+....+....+.     
T Consensus       157 a~~~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~-----  228 (277)
T d1phka_         157 SCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM-----  228 (277)
T ss_dssp             CEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----
T ss_pred             eeEccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHH-----
Confidence            9987543322   24679999999999864      357889999999999999999999998765433222111     


Q ss_pred             hcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          309 FQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       309 ~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                       ....  ....+.    ....+.++.+++.+||+.+|++||++.||++
T Consensus       229 -~~~~--~~~~~~----~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         229 -SGNY--QFGSPE----WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             -HTCC--CCCTTT----GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -hCCC--CCCCcc----cccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence             1100  111111    1133456889999999999999999999865

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.2e-51  Score=405.17  Aligned_cols=248  Identities=24%  Similarity=0.284  Sum_probs=199.5

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC---hHHHHHH---HHHHHHHHcCCCCcceeeeeeeccCCceE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREF---TNEVKLLLKIQHKNLVTLFGCCAEGPEKM  158 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~  158 (437)
                      ++|++.+.||+|+||.||+|+. .+|+.||||++....   ......+   .+|+.+++.++|||||+++++|.+.+..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            6799999999999999999985 479999999986431   1112233   34577778889999999999999999999


Q ss_pred             EEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccccc
Q 013745          159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                      +|||||+||+|.+++...   ..+++..++.++.||+.||.|||+++   ||||||||+||||+.+|.+||+|||+|+.+
T Consensus        84 ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            999999999999998543   46889999999999999999999998   999999999999999999999999999977


Q ss_pred             CCCCcccceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccc
Q 013745          239 PGEDTHVNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALEL  317 (437)
Q Consensus       239 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (437)
                      .....    ...+||+.|+|||++.. ..|+.++|||||||+||||+||+.||.+....+...+...   ....      
T Consensus       158 ~~~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~---~~~~------  224 (364)
T d1omwa3         158 SKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM---TLTM------  224 (364)
T ss_dssp             SSSCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH---SSSC------
T ss_pred             CCCcc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---cccC------
Confidence            54332    24579999999999975 4689999999999999999999999987554332221111   0000      


Q ss_pred             cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH
Q 013745          318 VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPD-----MNSVHL  356 (437)
Q Consensus       318 ~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~  356 (437)
                       ..   ..+...+.++.+|+.+||+.||++|||     ++|+++
T Consensus       225 -~~---~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         225 -AV---ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             -CC---CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             -CC---CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence             01   111123456788999999999999999     688864

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-51  Score=396.16  Aligned_cols=259  Identities=22%  Similarity=0.361  Sum_probs=213.4

Q ss_pred             hcCccccceeccCCCeeEEEEEcC------CCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCce
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLMP------NGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEK  157 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  157 (437)
                      .++|++.+.||+|+||.||+|.+.      +++.||||++... .......|.+|+.++++++|||||+++++|......
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            367999999999999999999752      3578999999754 444456789999999999999999999999999999


Q ss_pred             EEEEeecCCCCcchhhhcc-------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceee
Q 013745          158 MLVYEYLPNKSLDYFIFDK-------TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKIS  230 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~  230 (437)
                      ++|||||++|+|.+++...       .....+++..+.+++.|+++||.|||+++   |+||||||+||||++++.+||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence            9999999999999987532       22345789999999999999999999988   9999999999999999999999


Q ss_pred             ecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCC-CCCCCCCchhhhhhhhhhhhhh
Q 013745          231 DFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGR-KNHDGRLGKEKADLLSYTWTLF  309 (437)
Q Consensus       231 DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~-~p~~~~~~~~~~~~~~~~~~~~  309 (437)
                      |||+|+...............||+.|+|||.+.++.++.++|||||||+||||+||. +||.+....+....+.      
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~------  249 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM------  249 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH------
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH------
Confidence            999998775544444444567899999999999999999999999999999999985 6776654433322211      


Q ss_pred             cccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCC
Q 013745          310 QGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD  361 (437)
Q Consensus       310 ~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~  361 (437)
                      . +.        ....+...+..+.+++.+||+.+|++||||.+|++.|+..
T Consensus       250 ~-~~--------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         250 E-GG--------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             T-TC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             h-CC--------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            1 11        1111223345688999999999999999999999999864

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-51  Score=394.55  Aligned_cols=259  Identities=27%  Similarity=0.369  Sum_probs=211.4

Q ss_pred             hcCccccceeccCCCeeEEEEEc------CCCcEEEEEEeccC-ChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCc
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM------PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPE  156 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  156 (437)
                      .++|++.++||+|+||.||+|++      .+++.||||++... .......+.+|+.+++++ +|||||+++++|.+...
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            46799999999999999999974      35678999999754 344556789999999999 69999999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccC---------------CCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEe
Q 013745          157 KMLVYEYLPNKSLDYFIFDKT---------------KSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILL  221 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll  221 (437)
                      .++|||||++|+|.+++....               ....+++..++.++.||+.||+|||+++   |+||||||+|||+
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence            999999999999999986532               2236899999999999999999999998   9999999999999


Q ss_pred             cCCCCceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHh-CCCCCCCCCchhhhh
Q 013745          222 DEQLNPKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVS-GRKNHDGRLGKEKAD  300 (437)
Q Consensus       222 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~ellt-g~~p~~~~~~~~~~~  300 (437)
                      +.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+| |.+||......+...
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~  258 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY  258 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            9999999999999998765554444445789999999999999999999999999999999999 555565543322211


Q ss_pred             hhhhhhhhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          301 LLSYTWTLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                            .....+.     .+.   .+...+..+.+|+.+||+.||++||||.+|+++|+.
T Consensus       259 ------~~i~~~~-----~~~---~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~  304 (311)
T d1t46a_         259 ------KMIKEGF-----RML---SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (311)
T ss_dssp             ------HHHHHTC-----CCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------HHHhcCC-----CCC---CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                  1111110     011   112234568899999999999999999999999974

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-51  Score=392.46  Aligned_cols=269  Identities=22%  Similarity=0.291  Sum_probs=204.3

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      ++|+++++||+|+||+||+|+. .+|+.||||++....  ......+.+|+++|++++|||||+++++|.+....|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5799999999999999999985 579999999996543  2235678899999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      |+.++.+.... . .....+++..++.++.||+.||.|||+++   ||||||||+|||++.++.+||+|||+|+......
T Consensus        82 ~~~~~~~~~~~-~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQDLKKFMD-A-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEEHHHHHH-H-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCchhhhhh-h-hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence            99765444332 2 33467999999999999999999999998   9999999999999999999999999998775433


Q ss_pred             cccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccc-----c-
Q 013745          243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKA-----L-  315 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----~-  315 (437)
                      ...  ....||+.|+|||++... .++.++|||||||++|+|++|+.||.+....+....+............     . 
T Consensus       157 ~~~--~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (298)
T d1gz8a_         157 RTY--THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP  234 (298)
T ss_dssp             BCT--TCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             ccc--eeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccc
Confidence            222  235799999999988766 4689999999999999999999999876543322211110000000000     0 


Q ss_pred             ---c----ccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcCC
Q 013745          316 ---E----LVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSGD  361 (437)
Q Consensus       316 ---~----~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~~  361 (437)
                         .    ................+.+++.+||+.||++|||+.|+++  +|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~  289 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV  289 (298)
T ss_dssp             TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccC
Confidence               0    0000000111123456788999999999999999999986  56543

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-52  Score=399.85  Aligned_cols=247  Identities=26%  Similarity=0.348  Sum_probs=203.7

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCC---hHHHHHHHHHHHHHH-cCCCCcceeeeeeeccCCceEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDS---RQGLREFTNEVKLLL-KIQHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv  160 (437)
                      ++|++.+.||+|+||+||+|+. .+|+.||||++.+..   ....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            5799999999999999999985 479999999997432   223456677777765 68999999999999999999999


Q ss_pred             EeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCC
Q 013745          161 YEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPG  240 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~  240 (437)
                      ||||++|+|..++...   ..+++..++.++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            9999999999998543   45889999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCc
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDP  320 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  320 (437)
                      ....  .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+....+..       .      .+
T Consensus       156 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~-------~------~~  220 (320)
T d1xjda_         156 GDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-------D------NP  220 (320)
T ss_dssp             TTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-------C------CC
T ss_pred             cccc--ccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc-------C------CC
Confidence            3322  2246799999999999999999999999999999999999999987655433222111       0      11


Q ss_pred             cccCCCHHHHHHHHHHHHHcCCCCCCCCCCHH-HHHH
Q 013745          321 SLAKCNRDEAAMCIQLGLLCCQQSVAERPDMN-SVHL  356 (437)
Q Consensus       321 ~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~-ev~~  356 (437)
                      ..   +...+.++.+|+.+||+.||++||++. +|++
T Consensus       221 ~~---p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         221 FY---PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CC---CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CC---CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            11   122345678999999999999999995 6753

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-51  Score=395.15  Aligned_cols=254  Identities=30%  Similarity=0.403  Sum_probs=202.9

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCc--EEEEEEeccC-ChHHHHHHHHHHHHHHcC-CCCcceeeeeeeccCCceEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQ--EIAVKKLSVD-SRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAEGPEKMLV  160 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  160 (437)
                      ++|++.++||+|+||.||+|+++ +|.  .||||++... .....+.|.+|+++|.++ +|||||+++++|.+++..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            67999999999999999999864 444  4678887543 334456799999999999 799999999999999999999


Q ss_pred             EeecCCCCcchhhhcc-------------CCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCc
Q 013745          161 YEYLPNKSLDYFIFDK-------------TKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNP  227 (437)
Q Consensus       161 ~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~  227 (437)
                      |||+++|+|.+++...             .....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999998643             23467999999999999999999999998   9999999999999999999


Q ss_pred             eeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCC-CCCCCCCchhhhhhhhhhh
Q 013745          228 KISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGR-KNHDGRLGKEKADLLSYTW  306 (437)
Q Consensus       228 kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~-~p~~~~~~~~~~~~~~~~~  306 (437)
                      ||+|||+++.......   .....||..|+|||.+.++.++.++|||||||++|||++|. +||.+....+....+.   
T Consensus       167 kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~---  240 (309)
T d1fvra_         167 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP---  240 (309)
T ss_dssp             EECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG---
T ss_pred             EEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH---
Confidence            9999999986543222   22346899999999999999999999999999999999976 5676554333222111   


Q ss_pred             hhhcccccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          307 TLFQGEKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       307 ~~~~~~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                         ...      .+   ..+...+.++.+|+.+||+.||++||||.||++.|+.
T Consensus       241 ---~~~------~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~  282 (309)
T d1fvra_         241 ---QGY------RL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  282 (309)
T ss_dssp             ---GTC------CC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---hcC------CC---CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence               100      11   1122334568899999999999999999999998874

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-51  Score=396.98  Aligned_cols=252  Identities=20%  Similarity=0.202  Sum_probs=198.3

Q ss_pred             hcCccccc-eeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcC-CCCcceeeeeeecc----CCce
Q 013745           85 TNFFSDLN-QLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKI-QHKNLVTLFGCCAE----GPEK  157 (437)
Q Consensus        85 ~~~y~~~~-~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~~  157 (437)
                      .++|+++. .||+|+||+||+|+. .+++.||||++...     ..+.+|+.++.++ +|||||+++++|.+    ...+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            46798875 599999999999984 57999999998643     3466899987654 89999999999865    4668


Q ss_pred             EEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC---CCCceeeeccc
Q 013745          158 MLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE---QLNPKISDFGL  234 (437)
Q Consensus       158 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~---~~~~kl~DFGl  234 (437)
                      |+|||||+||+|.+++..+ ....+++..++.|+.||+.||+|||+++   |+||||||+|||++.   ++.+||+|||+
T Consensus        85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence            9999999999999998543 2356999999999999999999999998   999999999999975   56799999999


Q ss_pred             ccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccc
Q 013745          235 ARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKA  314 (437)
Q Consensus       235 a~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  314 (437)
                      |+........   ...+||+.|+|||++.+..|+.++|||||||+||||+||+.||.+.........+.   ....... 
T Consensus       161 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~---~~i~~~~-  233 (335)
T d2ozaa1         161 AKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---TRIRMGQ-  233 (335)
T ss_dssp             CEECCCCCCC---CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCS-
T ss_pred             eeeccCCCcc---ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH---HHHhcCC-
Confidence            9877544332   24579999999999999999999999999999999999999997654332211110   0000000 


Q ss_pred             ccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          315 LELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       315 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      .....    ......+.++.+|+.+||+.||++|||+.|+++
T Consensus       234 ~~~~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         234 YEFPN----PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             SSCCT----THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCC----cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            00000    111234567889999999999999999999987

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.3e-50  Score=385.61  Aligned_cols=263  Identities=22%  Similarity=0.299  Sum_probs=203.3

Q ss_pred             cCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCC--hHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEee
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDS--RQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYEY  163 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  163 (437)
                      ++|+++++||+|+||+||+|+.++|+.||||++....  ......+.+|+.+|++++|||||+++++|...+..+++|||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5899999999999999999998889999999997543  22356789999999999999999999999999999999999


Q ss_pred             cCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCc
Q 013745          164 LPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDT  243 (437)
Q Consensus       164 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~  243 (437)
                      +.++.+..+.   .....+++..++.++.||+.||+|||+++   ||||||||+|||++.++.+||+|||++........
T Consensus        82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            9887776665   33467999999999999999999999998   99999999999999999999999999988654332


Q ss_pred             ccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcc---------cc
Q 013745          244 HVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQG---------EK  313 (437)
Q Consensus       244 ~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------~~  313 (437)
                      .  .....|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+....+....+.........         ..
T Consensus       156 ~--~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (286)
T d1ob3a_         156 K--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             c--cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence            2  2234689999999998764 6799999999999999999999999876544332221111000000         00


Q ss_pred             ccc---ccCcc-ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          314 ALE---LVDPS-LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       314 ~~~---~~d~~-l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ...   ...+. ...........+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000   00000 01112223456789999999999999999999973

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-50  Score=387.74  Aligned_cols=252  Identities=26%  Similarity=0.412  Sum_probs=199.6

Q ss_pred             cceeccCCCeeEEEEEcCCC----cEEEEEEecc-CChHHHHHHHHHHHHHHcCCCCcceeeeeeecc-CCceEEEEeec
Q 013745           91 LNQLGHGGFGPVYRGLMPNG----QEIAVKKLSV-DSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE-GPEKMLVYEYL  164 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~  164 (437)
                      .++||+|+||+||+|++.++    ..||||++.. ......++|.+|+++|++++|||||++++++.+ +...++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46899999999999985432    2589999974 355566889999999999999999999999865 46789999999


Q ss_pred             CCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCCcc
Q 013745          165 PNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGEDTH  244 (437)
Q Consensus       165 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~~~  244 (437)
                      ++|+|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+||||++++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999998843  3456788899999999999999999998   999999999999999999999999999876543322


Q ss_pred             c--ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcccccccccCccc
Q 013745          245 V--NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALELVDPSL  322 (437)
Q Consensus       245 ~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  322 (437)
                      .  ......||+.|+|||++..+.++.++|||||||++|||+||..||.......  ....+   .....+   ...   
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~---i~~g~~---~~~---  255 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVY---LLQGRR---LLQ---  255 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH---HHTTCC---CCC---
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHH---HHcCCC---CCC---
Confidence            1  1223568999999999999999999999999999999999888876433211  11111   111111   011   


Q ss_pred             cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcCC
Q 013745          323 AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSGD  361 (437)
Q Consensus       323 ~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~~  361 (437)
                         +...+..+.+|+.+||+.||++||+|.||++.|+..
T Consensus       256 ---p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i  291 (311)
T d1r0pa_         256 ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  291 (311)
T ss_dssp             ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence               112335688999999999999999999999998753

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-50  Score=386.80  Aligned_cols=265  Identities=22%  Similarity=0.266  Sum_probs=198.3

Q ss_pred             cCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC----ceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP----EKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  161 (437)
                      ..|.+.+.||+|+||.||+|++ +|+.||||++...... ......|+..+.+++|||||++++++.+.+    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            4678889999999999999987 7899999999654332 122334555556789999999999997654    578999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcC-----CCceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEA-----PARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~-----~~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                      |||++|+|.+++..    ..++|..++.++.|++.||.|||+.+     ..+|+||||||+||||+.++.+||+|||+++
T Consensus        81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            99999999999953    35899999999999999999999741     1349999999999999999999999999998


Q ss_pred             ccCCCCccc--ceeeeecccccCChhhhccC------cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhh--------
Q 013745          237 LFPGEDTHV--NTFRISGTHGYMAPEYALHG------YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKAD--------  300 (437)
Q Consensus       237 ~~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~------~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~--------  300 (437)
                      .........  ......||+.|+|||++.+.      .++.++|||||||+||||+||..||..........        
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence            775433221  22346799999999998764      36789999999999999999998875433221110        


Q ss_pred             hhhhhhhhhcccccccccCccccC--CCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          301 LLSYTWTLFQGEKALELVDPSLAK--CNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~d~~l~~--~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      ..........    .....|.++.  ........+.+|+.+||+.||++|||+.||++.|+.
T Consensus       237 ~~~~~~~~~~----~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~  294 (303)
T d1vjya_         237 SVEEMRKVVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             CHHHHHHHHT----TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             hHHHHHHHHh----ccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            0011111111    1112222211  122456678999999999999999999999998863

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-50  Score=386.59  Aligned_cols=264  Identities=24%  Similarity=0.343  Sum_probs=199.6

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CC-CcEEEEEEeccCC--hHHHHHHHHHHHHHHcC---CCCcceeeeeeecc----
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PN-GQEIAVKKLSVDS--RQGLREFTNEVKLLLKI---QHKNLVTLFGCCAE----  153 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----  153 (437)
                      .++|+++++||+|+||+||+|+. ++ ++.||||++....  ......+.+|+.+|+.|   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999985 34 6679999986432  22223456777777665   79999999999853    


Q ss_pred             -CCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeec
Q 013745          154 -GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDF  232 (437)
Q Consensus       154 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DF  232 (437)
                       ....+++|||++++.+....  ......+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~--~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLD--KVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHH--HSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhh--hccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence             34679999999888775443  234567899999999999999999999998   999999999999999999999999


Q ss_pred             ccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccc
Q 013745          233 GLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGE  312 (437)
Q Consensus       233 Gla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  312 (437)
                      |+++......   ......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+....+....+..........
T Consensus       161 g~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  237 (305)
T d1blxa_         161 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  237 (305)
T ss_dssp             CSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             hhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchh
Confidence            9998653322   2235679999999999999999999999999999999999999998766544332221111000000


Q ss_pred             -----------ccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          313 -----------KALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       313 -----------~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                                 .........+..........+.+|+.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                       00000011111222233456788999999999999999999975

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-51  Score=384.35  Aligned_cols=244  Identities=23%  Similarity=0.357  Sum_probs=196.1

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCCh------HHHHHHHHHHHHHHcCC--CCcceeeeeeeccCC
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSR------QGLREFTNEVKLLLKIQ--HKNLVTLFGCCAEGP  155 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~  155 (437)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++.....      .....+.+|+.+|++++  |||||++++++.+.+
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            46799999999999999999985 5799999999864311      11233668999999997  899999999999999


Q ss_pred             ceEEEEeecCC-CCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC-CCCceeeecc
Q 013745          156 EKMLVYEYLPN-KSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE-QLNPKISDFG  233 (437)
Q Consensus       156 ~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~-~~~~kl~DFG  233 (437)
                      ..++||||+.+ +++.+++..   ...+++..++.++.||+.||+|||+++   |+||||||+|||++. ++.+||+|||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG  156 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG  156 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             eEEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence            99999999976 566666633   346899999999999999999999998   999999999999985 4789999999


Q ss_pred             cccccCCCCcccceeeeecccccCChhhhccCc-CCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccc
Q 013745          234 LARLFPGEDTHVNTFRISGTHGYMAPEYALHGY-LSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGE  312 (437)
Q Consensus       234 la~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  312 (437)
                      +|+......    .....||+.|+|||++.+.. ++.++|||||||+||||++|+.||.....     .       ....
T Consensus       157 ~a~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----i-------~~~~  220 (273)
T d1xwsa_         157 SGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I-------IRGQ  220 (273)
T ss_dssp             TCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H-------HHCC
T ss_pred             cceeccccc----ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----H-------hhcc
Confidence            998764332    22467999999999998775 46789999999999999999999975211     0       0000


Q ss_pred             ccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          313 KALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       313 ~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                      .   .+       +...+.++.+++.+||+.||++|||++|+++  ++++
T Consensus       221 ~---~~-------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  260 (273)
T d1xwsa_         221 V---FF-------RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQD  260 (273)
T ss_dssp             C---CC-------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred             c---CC-------CCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence            0   01       1122346788999999999999999999986  5553

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=381.64  Aligned_cols=263  Identities=24%  Similarity=0.345  Sum_probs=199.1

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC------
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP------  155 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  155 (437)
                      .++|+++++||+|+||+||+|+. .+|+.||||++...  .....+.+.+|+++|++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            46799999999999999999985 47999999999753  3445677899999999999999999999997654      


Q ss_pred             ceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccc
Q 013745          156 EKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLA  235 (437)
Q Consensus       156 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla  235 (437)
                      .+|+||||+ +.+|..++.    ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+|
T Consensus        97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence            469999999 667766652    246999999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhh------
Q 013745          236 RLFPGEDTHVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTL------  308 (437)
Q Consensus       236 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~------  308 (437)
                      +.......     ...||+.|+|||++.+. .++.++|||||||++|||++|+.||.+................      
T Consensus       169 ~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         169 RQADSEMT-----GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV  243 (346)
T ss_dssp             EECCSSCC-----SSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             eccCCccc-----cccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence            87654322     35689999999998764 6799999999999999999999999876543332221111000      


Q ss_pred             --hcc-------cccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          309 --FQG-------EKALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       309 --~~~-------~~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                        ...       ....+.....+..........+.+|+.+||+.||++|||+.|+++  +|++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~  306 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES  306 (346)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred             hhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence              000       000000111111222233456788999999999999999999987  5654

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=376.80  Aligned_cols=265  Identities=22%  Similarity=0.305  Sum_probs=199.3

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeecc--------C
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE--------G  154 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~  154 (437)
                      ++|+++++||+|+||+||+|+. .+|+.||||++...  .......+.+|+.+|++++||||+++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            6799999999999999999995 58999999998644  23334678899999999999999999998854        3


Q ss_pred             CceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccc
Q 013745          155 PEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGL  234 (437)
Q Consensus       155 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGl  234 (437)
                      ...++||||+.++.+....   .....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        90 ~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence            4679999999887766544   34457899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCcc--cceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhcc
Q 013745          235 ARLFPGEDTH--VNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQG  311 (437)
Q Consensus       235 a~~~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  311 (437)
                      ++.+......  ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.........+.........
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            9876543221  112235799999999998765 6899999999999999999999999876654443333222211111


Q ss_pred             cccccc--------cCcc--ccCCCH------HHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          312 EKALEL--------VDPS--LAKCNR------DEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       312 ~~~~~~--------~d~~--l~~~~~------~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ......        +...  ......      .....+++|+.+||+.||++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            110000        0000  000000      11345678999999999999999999975

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-49  Score=383.13  Aligned_cols=260  Identities=23%  Similarity=0.280  Sum_probs=197.2

Q ss_pred             CccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcceeeeeeecc------CCceEE
Q 013745           87 FFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE------GPEKML  159 (437)
Q Consensus        87 ~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~~l  159 (437)
                      +|..+++||+|+||+||+|+. .+|+.||||++......    +.+|+++|++++|||||+++++|..      ..+++|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            588899999999999999995 47999999999755322    2379999999999999999999843      335789


Q ss_pred             EEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCC-Cceeeeccccccc
Q 013745          160 VYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL-NPKISDFGLARLF  238 (437)
Q Consensus       160 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~-~~kl~DFGla~~~  238 (437)
                      |||||+++.+..+.........+++..++.|+.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+++.+
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987655554433345567999999999999999999999998   99999999999999775 8999999999877


Q ss_pred             CCCCcccceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhh--------hhhh
Q 013745          239 PGEDTHVNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYT--------WTLF  309 (437)
Q Consensus       239 ~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~--------~~~~  309 (437)
                      ......   ....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+...        +...
T Consensus       174 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  250 (350)
T d1q5ka_         174 VRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  250 (350)
T ss_dssp             CTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             cCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence            543322   23578999999998875 47899999999999999999999999876644332221110        0000


Q ss_pred             ccc----ccccccCcc-ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          310 QGE----KALELVDPS-LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       310 ~~~----~~~~~~d~~-l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ...    ......... ...........+.+|+.+||+.||++|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000    000000000 01112234456889999999999999999999985

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-48  Score=380.20  Aligned_cols=265  Identities=22%  Similarity=0.290  Sum_probs=198.2

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC-ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCC----ceE
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD-SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGP----EKM  158 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~  158 (437)
                      +.+|++++.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+.+|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            45799999999999999999984 58999999999754 3445677899999999999999999999986543    234


Q ss_pred             EEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccccc
Q 013745          159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLF  238 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~  238 (437)
                      ++++|+.+|+|.+++..    ..+++..++.++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+++..
T Consensus        87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            55566779999999843    35899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcc-cceeeeecccccCChhhhcc-CcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccccc
Q 013745          239 PGEDTH-VNTFRISGTHGYMAPEYALH-GYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKALE  316 (437)
Q Consensus       239 ~~~~~~-~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (437)
                      ...... ......+||+.|+|||++.. ..++.++||||+||++|||++|+.||.+....+...................
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  239 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence            433221 11234679999999999855 4679999999999999999999999987654333222111111000000000


Q ss_pred             ----------ccCcc-----ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          317 ----------LVDPS-----LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       317 ----------~~d~~-----l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                                ...+.     .....+....++.+++.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                      00000     00111122346789999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.2e-48  Score=370.44  Aligned_cols=260  Identities=22%  Similarity=0.287  Sum_probs=197.5

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCccee-eeeeeccCCceEEEEe
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNLVT-LFGCCAEGPEKMLVYE  162 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e  162 (437)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++......  .++..|++++++++|+|++. +..++.+....++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            35799999999999999999985 57899999998754332  45778999999998776554 5566677788899999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEec---CCCCceeeecccccccC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLD---EQLNPKISDFGLARLFP  239 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~---~~~~~kl~DFGla~~~~  239 (437)
                      |+ +++|...+..  ....+++..++.++.|++.||+|||+++   |+||||||+|||++   .+..+||+|||+|+.+.
T Consensus        84 ~~-~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~  157 (299)
T d1ckia_          84 LL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  157 (299)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred             Ec-CCchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence            99 5566555532  3456999999999999999999999998   99999999999985   45679999999999875


Q ss_pred             CCCccc-----ceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccc
Q 013745          240 GEDTHV-----NTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKA  314 (437)
Q Consensus       240 ~~~~~~-----~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  314 (437)
                      ......     ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.........   
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~---  234 (299)
T d1ckia_         158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS---  234 (299)
T ss_dssp             CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH---
T ss_pred             ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC---
Confidence            443221     223457999999999999999999999999999999999999999875544333222111111000   


Q ss_pred             ccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          315 LELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       315 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                           ..........+.++.+++..||+.+|++||++.++.+.|+.
T Consensus       235 -----~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  275 (299)
T d1ckia_         235 -----TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN  275 (299)
T ss_dssp             -----SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred             -----CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence                 00001111234567889999999999999999999888874

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=9.6e-48  Score=366.81  Aligned_cols=260  Identities=18%  Similarity=0.220  Sum_probs=205.1

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCC-CcceeeeeeeccCCceEEEEe
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQH-KNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  162 (437)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++.....  ...+.+|+++++.|.| +|++.+++++..+...++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            56899999999999999999995 4789999999865432  2446789999999975 899999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecC-----CCCceeeecccccc
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDE-----QLNPKISDFGLARL  237 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~-----~~~~kl~DFGla~~  237 (437)
                      |+ +++|.+++..  ....+++..+..++.|++.||+|||+++   |+||||||+|||++.     ++.+||+|||+|+.
T Consensus        82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            99 7899888743  3356899999999999999999999998   999999999999964     57899999999998


Q ss_pred             cCCCCcc-----cceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccc
Q 013745          238 FPGEDTH-----VNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGE  312 (437)
Q Consensus       238 ~~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  312 (437)
                      +......     ......+||+.|||||++.+..++.++|||||||++|||++|+.||.+....................
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  235 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence            7543221     12234679999999999999999999999999999999999999998655443322222111110000


Q ss_pred             ccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHhcC
Q 013745          313 KALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHLMLSG  360 (437)
Q Consensus       313 ~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~~L~~  360 (437)
                      .        ........+.++.+++..|++.+|++||+++.+.+.|+.
T Consensus       236 ~--------~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~  275 (293)
T d1csna_         236 P--------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK  275 (293)
T ss_dssp             C--------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             C--------hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence            0        001111223567888999999999999999999887764

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=364.97  Aligned_cols=266  Identities=20%  Similarity=0.268  Sum_probs=206.6

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccCCceEEEEe
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEGPEKMLVYE  162 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  162 (437)
                      ++|+++++||+|+||+||+|+. .+++.||||+++..  .......+.+|+.+|+.++||||++++++|.+....++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5799999999999999999995 57899999998644  33456788999999999999999999999999999999999


Q ss_pred             ecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeecccccccCCCC
Q 013745          163 YLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLARLFPGED  242 (437)
Q Consensus       163 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~~~~~~~  242 (437)
                      ++.+++|..++.   ....+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.++......
T Consensus        82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            999998887763   3456889999999999999999999998   9999999999999999999999999999875443


Q ss_pred             cccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCc-hhhhhhhhhhhhhhcccc-------
Q 013745          243 THVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLG-KEKADLLSYTWTLFQGEK-------  313 (437)
Q Consensus       243 ~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~-------  313 (437)
                      ...  ....+++.|+|||++... .++.++|||||||++|||++|+.||....+ .+....+...........       
T Consensus       156 ~~~--~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (292)
T d1unla_         156 RCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             SCC--CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             ccc--eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence            322  234578899999998766 479999999999999999999999754332 222221111111000000       


Q ss_pred             ----cccc--cCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--Hhc
Q 013745          314 ----ALEL--VDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLS  359 (437)
Q Consensus       314 ----~~~~--~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~  359 (437)
                          ....  ...............+.+|+.+||+.||++|||++||++  +|+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~  287 (292)
T d1unla_         234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS  287 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGS
T ss_pred             ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhc
Confidence                0000  001111222334456788999999999999999999976  554

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5.3e-47  Score=367.53  Aligned_cols=256  Identities=16%  Similarity=0.250  Sum_probs=196.4

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCC-CCcceeeeeeecc--CCceEEEE
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAE--GPEKMLVY  161 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~  161 (437)
                      ++|+++++||+|+||+||+|+. .+|+.||||++....   .+.+.+|+.+|+++. ||||++++++|..  ....++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            5799999999999999999985 579999999997544   356789999999995 9999999999874  45689999


Q ss_pred             eecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCC-CceeeecccccccCC
Q 013745          162 EYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQL-NPKISDFGLARLFPG  240 (437)
Q Consensus       162 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~-~~kl~DFGla~~~~~  240 (437)
                      |||.+++|..+.      ..+++..++.++.||+.||.|||+++   |+||||||+||||+.++ .+||+|||+|+....
T Consensus       112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence            999999997654      35899999999999999999999998   99999999999998655 589999999987754


Q ss_pred             CCcccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhh-hhhhh--------hh-hhh
Q 013745          241 EDTHVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKA-DLLSY--------TW-TLF  309 (437)
Q Consensus       241 ~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~-~~~~~--------~~-~~~  309 (437)
                      ....   ....||+.|+|||.+.+. .++.++||||+||++|||++|+.||......... ..+..        .+ ...
T Consensus       183 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~  259 (328)
T d3bqca1         183 GQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  259 (328)
T ss_dssp             TCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             CCcc---cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhc
Confidence            3322   245789999999998765 5799999999999999999999999764432111 00000        00 000


Q ss_pred             ccc---ccccccC--------ccc-cCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          310 QGE---KALELVD--------PSL-AKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       310 ~~~---~~~~~~d--------~~l-~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                      ...   .......        ... .........++.+|+.+||+.||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000   0000000        000 0111223456789999999999999999999976

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-47  Score=373.00  Aligned_cols=264  Identities=24%  Similarity=0.320  Sum_probs=200.2

Q ss_pred             hcCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeeccC-----Cc
Q 013745           85 TNFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAEG-----PE  156 (437)
Q Consensus        85 ~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  156 (437)
                      .++|+++++||+|+||+||+|+. .+|+.||||++...  .....+.+.+|+.+|++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            56799999999999999999984 57999999999754  344556789999999999999999999998633     34


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                      .+++|+|+.+|+|.+++.    ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhcc----cccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence            467778888999999883    346999999999999999999999998   9999999999999999999999999997


Q ss_pred             ccCCCCcccceeeeecccccCChhhhccC-cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccc---
Q 013745          237 LFPGEDTHVNTFRISGTHGYMAPEYALHG-YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGE---  312 (437)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---  312 (437)
                      .....     .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+..........   
T Consensus       170 ~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         170 HTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred             ccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            65322     2245789999999987765 57899999999999999999999998766443333221111100000   


Q ss_pred             ------------ccccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH--HhcC
Q 013745          313 ------------KALELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL--MLSG  360 (437)
Q Consensus       313 ------------~~~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~--~L~~  360 (437)
                                  .........+..........+.+|+.+||+.||++|||+.|+++  ++..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~  306 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  306 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence                        00000000000111123456789999999999999999999986  6654

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-47  Score=371.59  Aligned_cols=259  Identities=24%  Similarity=0.252  Sum_probs=192.6

Q ss_pred             cCccccceeccCCCeeEEEEEcC-CCcEEEEEEeccC--ChHHHHHHHHHHHHHHcCCCCcceeeeeeecc------CCc
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD--SRQGLREFTNEVKLLLKIQHKNLVTLFGCCAE------GPE  156 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  156 (437)
                      ++|+++++||+|+||+||+|+.. +|+.||||++...  .......+.+|+.+|++++|||||+++++|..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            67999999999999999999954 7999999999754  34455678999999999999999999999953      467


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                      .|+|||||.++.+..+.      ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchHHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence            89999999776554332      35899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhh----------
Q 013745          237 LFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTW----------  306 (437)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~----------  306 (437)
                      .......   ....+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.........+....          
T Consensus       168 ~~~~~~~---~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         168 TAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             ccccccc---cccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence            7654332   224578999999999999999999999999999999999999998765433221111000          


Q ss_pred             ------hhhccc------ccccccCcc----ccCCCHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Q 013745          307 ------TLFQGE------KALELVDPS----LAKCNRDEAAMCIQLGLLCCQQSVAERPDMNSVHL  356 (437)
Q Consensus       307 ------~~~~~~------~~~~~~d~~----l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~ev~~  356 (437)
                            ......      .....+...    ...........+.+|+.+||+.||++|||++||++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                  000000      000011111    11112345677899999999999999999999974

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-48  Score=372.08  Aligned_cols=256  Identities=24%  Similarity=0.286  Sum_probs=203.5

Q ss_pred             cCccccceeccCCCeeEEEEEc----CCCcEEEEEEeccC----ChHHHHHHHHHHHHHHcCCC-CcceeeeeeeccCCc
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM----PNGQEIAVKKLSVD----SRQGLREFTNEVKLLLKIQH-KNLVTLFGCCAEGPE  156 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  156 (437)
                      ++|++++.||+|+||+||+|+.    .+|+.||||++...    .....+.+.+|+++|++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            6699999999999999999973    25889999998643    12224567889999999976 899999999999999


Q ss_pred             eEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          157 KMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       157 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                      .++||||+.+|+|..++...   ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHhc---ccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            99999999999999998544   35678899999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcccceeeeecccccCChhhhccC--cCCcccceehhhHHHHHHHhCCCCCCCCCchhhhhhhhhhhhhhccccc
Q 013745          237 LFPGEDTHVNTFRISGTHGYMAPEYALHG--YLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKADLLSYTWTLFQGEKA  314 (437)
Q Consensus       237 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~--~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  314 (437)
                      .+....... .....|++.|+|||.+.+.  .++.++|||||||+||||++|+.||.+....+....+........    
T Consensus       178 ~~~~~~~~~-~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~----  252 (322)
T d1vzoa_         178 EFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE----  252 (322)
T ss_dssp             ECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC----
T ss_pred             hhccccccc-ccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCC----
Confidence            765433322 2245799999999999764  578899999999999999999999987654433322221111100    


Q ss_pred             ccccCccccCCCHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHH--HhcC
Q 013745          315 LELVDPSLAKCNRDEAAMCIQLGLLCCQQSVAERPD-----MNSVHL--MLSG  360 (437)
Q Consensus       315 ~~~~d~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs-----~~ev~~--~L~~  360 (437)
                              ...+...+.++.+++.+||+.||++||+     ++|+++  ++++
T Consensus       253 --------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         253 --------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  297 (322)
T ss_dssp             --------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             --------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence                    1112234567888999999999999994     788875  4543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.2e-42  Score=335.43  Aligned_cols=265  Identities=21%  Similarity=0.237  Sum_probs=195.8

Q ss_pred             cCccccceeccCCCeeEEEEEc-CCCcEEEEEEeccCChHHHHHHHHHHHHHHcCC-----------CCcceeeeeeecc
Q 013745           86 NFFSDLNQLGHGGFGPVYRGLM-PNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-----------HKNLVTLFGCCAE  153 (437)
Q Consensus        86 ~~y~~~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~  153 (437)
                      ++|+++++||+|+||+||+|+. .+|+.||||++..... ..+.+.+|+.++++++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            4599999999999999999985 5799999999975533 3466788999998875           5789999988754


Q ss_pred             --CCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhh-cCCCceEeeccCCCCEEecCCCC----
Q 013745          154 --GPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE-EAPARIIHRDIKASNILLDEQLN----  226 (437)
Q Consensus       154 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~iiHrDikp~NIll~~~~~----  226 (437)
                        ....+++|+++..+..............+++..+..++.||+.||.|||+ .+   |+||||||+||||+.++.    
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence              34567777777666554444444556778999999999999999999998 66   999999999999986654    


Q ss_pred             --ceeeecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHHHHHHhCCCCCCCCCchhhhh----
Q 013745          227 --PKISDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLVLEIVSGRKNHDGRLGKEKAD----  300 (437)
Q Consensus       227 --~kl~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl~elltg~~p~~~~~~~~~~~----  300 (437)
                        +||+|||.+.......     ...+||+.|+|||++....++.++||||+||+++||++|+.||..........    
T Consensus       169 ~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         169 IQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             EEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             ceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence              8999999998654322     24578999999999999999999999999999999999999997543321111    


Q ss_pred             hhhhhhh-----------------hhcccccccccC-----------ccccCCCHHHHHHHHHHHHHcCCCCCCCCCCHH
Q 013745          301 LLSYTWT-----------------LFQGEKALELVD-----------PSLAKCNRDEAAMCIQLGLLCCQQSVAERPDMN  352 (437)
Q Consensus       301 ~~~~~~~-----------------~~~~~~~~~~~d-----------~~l~~~~~~~~~~l~~l~~~cl~~~p~~RPs~~  352 (437)
                      +....+.                 .+........+.           +............+.+|+.+|++.||.+|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            0000000                 000000000000           011234567788999999999999999999999


Q ss_pred             HHHH--Hhc
Q 013745          353 SVHL--MLS  359 (437)
Q Consensus       353 ev~~--~L~  359 (437)
                      |+++  +++
T Consensus       324 e~L~Hp~f~  332 (362)
T d1q8ya_         324 GLVNHPWLK  332 (362)
T ss_dssp             HHHTCGGGT
T ss_pred             HHhcCcccC
Confidence            9976  454

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=3.6e-26  Score=202.84  Aligned_cols=170  Identities=17%  Similarity=0.112  Sum_probs=122.7

Q ss_pred             ccccceeccCCCeeEEEEEcCCCcEEEEEEeccCCh------------------HHHHHHHHHHHHHHcCCCCcceeeee
Q 013745           88 FSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSR------------------QGLREFTNEVKLLLKIQHKNLVTLFG  149 (437)
Q Consensus        88 y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~  149 (437)
                      +.+.++||+|+||+||+|...+|+.||||+++....                  .....+.+|...+.++.|.+++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            346789999999999999988899999998753210                  11233567899999999999998887


Q ss_pred             eeccCCceEEEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhcCCCceEeeccCCCCEEecCCCCcee
Q 013745          150 CCAEGPEKMLVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEEAPARIIHRDIKASNILLDEQLNPKI  229 (437)
Q Consensus       150 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iiHrDikp~NIll~~~~~~kl  229 (437)
                      +..    .+++|||+++..+..          ++...+..++.|++.+|+|||+++   |+||||||+|||+++++ ++|
T Consensus        82 ~~~----~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~l  143 (191)
T d1zara2          82 WEG----NAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWI  143 (191)
T ss_dssp             EET----TEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEE
T ss_pred             ecC----CEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEE
Confidence            642    379999998765532          333556779999999999999998   99999999999999664 899


Q ss_pred             eecccccccCCCCcccceeeeecccccCChhhhccCcCCcccceehhhHHH
Q 013745          230 SDFGLARLFPGEDTHVNTFRISGTHGYMAPEYALHGYLSVKTDVFSYGVLV  280 (437)
Q Consensus       230 ~DFGla~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DvwSlG~vl  280 (437)
                      +|||+|+....+......   ...... -.+.+ ...|+.++|+||+.--+
T Consensus       144 iDFG~a~~~~~~~~~~~l---~rd~~~-~~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         144 IDFPQSVEVGEEGWREIL---ERDVRN-IITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCCTTCEETTSTTHHHHH---HHHHHH-HHHHH-HHHHCCCCCHHHHHHHH
T ss_pred             EECCCcccCCCCCcHHHH---HHHHHH-HHHHH-cCCCCCcccHHHHHHHH
Confidence            999999876433221100   000000 01112 35678999999976443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.84  E-value=4.7e-09  Score=95.40  Aligned_cols=148  Identities=12%  Similarity=0.067  Sum_probs=102.2

Q ss_pred             HHHHHhcCccccceeccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCC-CCcceeeeeeeccCCceE
Q 013745           80 TLQVATNFFSDLNQLGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKM  158 (437)
Q Consensus        80 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  158 (437)
                      ++......|++++..+-++.+.||+... +++.++||+...........+.+|..++..|. +--+.+++.++..++..+
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~   86 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence            3444556777777666566678998865 56778889886544333345678888888774 333567788888888899


Q ss_pred             EEEeecCCCCcchhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhhc----------------------------------
Q 013745          159 LVYEYLPNKSLDYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHEE----------------------------------  204 (437)
Q Consensus       159 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~----------------------------------  204 (437)
                      +||++++|.++......        ......++.++++.|+.||+.                                  
T Consensus        87 lv~~~l~G~~~~~~~~~--------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T d1j7la_          87 LLMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEECCSSEEHHHHTTT--------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred             EEEEecccccccccccc--------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence            99999999887554311        112233455666666666641                                  


Q ss_pred             ----------------------CCCceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          205 ----------------------APARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       205 ----------------------~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                                            .+..++|+|+.|.|||+++++.+-|+||+.+.
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                  01237999999999999987666799998775

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.35  E-value=9e-07  Score=79.36  Aligned_cols=130  Identities=18%  Similarity=0.123  Sum_probs=86.4

Q ss_pred             eeccCCC-eeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCC--CcceeeeeeeccCCceEEEEeecCCCCc
Q 013745           93 QLGHGGF-GPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQH--KNLVTLFGCCAEGPEKMLVYEYLPNKSL  169 (437)
Q Consensus        93 ~lG~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL  169 (437)
                      .+..|.. +.||+...+++..+++|.......   ..+..|+..++.|..  -.+.+++.+..+.+..++||++++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4455553 678999887788889998754432   235578888777642  3356678888888888999999998766


Q ss_pred             chhhhccCCCCCCCHHHHHHHHHHHHHHHHHhhh----------------------------------------------
Q 013745          170 DYFIFDKTKSSSLDWTTRYRIVMGVARGLLYLHE----------------------------------------------  203 (437)
Q Consensus       170 ~~~l~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~----------------------------------------------  203 (437)
                      ....        ...   ..++.+++..|+-||+                                              
T Consensus        94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            4321        111   1122333444444442                                              


Q ss_pred             -----c----CCCceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          204 -----E----APARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       204 -----~----~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                           .    .+..++|+|+.|.|||++++..+-|+||+.+.
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                 1    12337999999999999987667899998765

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.85  E-value=1.7e-05  Score=75.82  Aligned_cols=77  Identities=13%  Similarity=0.134  Sum_probs=49.0

Q ss_pred             cceeccCCCeeEEEEEcC-CCcEEEEEEeccC----C---hHHHHHHHHHHHHHHcCC--C-CcceeeeeeeccCCceEE
Q 013745           91 LNQLGHGGFGPVYRGLMP-NGQEIAVKKLSVD----S---RQGLREFTNEVKLLLKIQ--H-KNLVTLFGCCAEGPEKML  159 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~----~---~~~~~~~~~E~~~l~~l~--h-~niv~l~~~~~~~~~~~l  159 (437)
                      .+.||.|....||++... +++.|+||.-...    .   .....+...|++.|+.+.  . ..+.+++.+.  ....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence            467999999999999864 4678999965321    1   112234556888887663  2 3455566553  445689


Q ss_pred             EEeecCCCCc
Q 013745          160 VYEYLPNKSL  169 (437)
Q Consensus       160 v~e~~~~gsL  169 (437)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999977543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.53  E-value=0.00012  Score=67.78  Aligned_cols=137  Identities=12%  Similarity=0.125  Sum_probs=78.5

Q ss_pred             CCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCCCcc--eeeee-----eeccCCceEEEEeecCCCCcc
Q 013745           98 GFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQHKNL--VTLFG-----CCAEGPEKMLVYEYLPNKSLD  170 (437)
Q Consensus        98 ~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~gsL~  170 (437)
                      .--.||++..++|+.|++|+.+... ...+++..|...+..|...+|  +..+.     .+......+.++++++|..+.
T Consensus        34 ~EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~  112 (325)
T d1zyla1          34 YENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE  112 (325)
T ss_dssp             SSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred             ccceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence            3468999998899999999986542 234667788888887742222  11111     123345678899999875442


Q ss_pred             hh----h----------hc----c--CCCCCCCH-------------------HHHHHHHHHHHHHHHHhhh----cCCC
Q 013745          171 YF----I----------FD----K--TKSSSLDW-------------------TTRYRIVMGVARGLLYLHE----EAPA  207 (437)
Q Consensus       171 ~~----l----------~~----~--~~~~~l~~-------------------~~~~~i~~qi~~~L~~LH~----~~~~  207 (437)
                      ..    +          +.    .  .....+++                   .....+...+...+..+..    ..+.
T Consensus       113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~  192 (325)
T d1zyla1         113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV  192 (325)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred             CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence            11    0          00    0  00111111                   1111122222233333322    2345


Q ss_pred             ceEeeccCCCCEEecCCCCceeeecccccc
Q 013745          208 RIIHRDIKASNILLDEQLNPKISDFGLARL  237 (437)
Q Consensus       208 ~iiHrDikp~NIll~~~~~~kl~DFGla~~  237 (437)
                      .+||+|+.+.|||++++  ..++||+-++.
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhccc
Confidence            68999999999999744  45899987763

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.48  E-value=0.00016  Score=68.82  Aligned_cols=74  Identities=11%  Similarity=0.192  Sum_probs=51.2

Q ss_pred             cceeccCCCeeEEEEEcCC--------CcEEEEEEeccCChHHHHHHHHHHHHHHcCC-CCcceeeeeeeccCCceEEEE
Q 013745           91 LNQLGHGGFGPVYRGLMPN--------GQEIAVKKLSVDSRQGLREFTNEVKLLLKIQ-HKNLVTLFGCCAEGPEKMLVY  161 (437)
Q Consensus        91 ~~~lG~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  161 (437)
                      ++.|+.|-.-.+|++..++        .+.|++++..... . .....+|..+++.+. +.-..++++++.+    .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-h-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            4689989999999987543        3567777765322 2 234567999998885 4334578887754    6899


Q ss_pred             eecCCCCcc
Q 013745          162 EYLPNKSLD  170 (437)
Q Consensus       162 e~~~~gsL~  170 (437)
                      ||++|..|.
T Consensus       121 efi~g~~l~  129 (395)
T d1nw1a_         121 EYIPSRPLS  129 (395)
T ss_dssp             CCCCEEECC
T ss_pred             EEeccccCC
Confidence            999886553

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.01  E-value=0.00085  Score=61.35  Aligned_cols=157  Identities=10%  Similarity=-0.036  Sum_probs=80.3

Q ss_pred             cHHHHHHHhcCccccce-----eccCCCeeEEEEEcCCCcEEEEEEeccCChHHHHHHHHHHHHHHcCCC-----Cccee
Q 013745           77 DLRTLQVATNFFSDLNQ-----LGHGGFGPVYRGLMPNGQEIAVKKLSVDSRQGLREFTNEVKLLLKIQH-----KNLVT  146 (437)
Q Consensus        77 ~~~~~~~~~~~y~~~~~-----lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-----~niv~  146 (437)
                      +..+++....+|.+.+.     |..|---+.|+....+| .+++|++.....  ..++..|++++..|..     |..+.
T Consensus         4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi~   80 (316)
T d2ppqa1           4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPLP   80 (316)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred             CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccce
Confidence            34566666667766433     44666688899887555 589999864321  2344456777766642     22222


Q ss_pred             eee---eeccCCceEEEEeecCCCCcchhhh--------------cc--C-C---CCC------------------CCHH
Q 013745          147 LFG---CCAEGPEKMLVYEYLPNKSLDYFIF--------------DK--T-K---SSS------------------LDWT  185 (437)
Q Consensus       147 l~~---~~~~~~~~~lv~e~~~~gsL~~~l~--------------~~--~-~---~~~------------------l~~~  185 (437)
                      ..+   +..-......++.++.+........              ..  . .   ...                  ....
T Consensus        81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (316)
T d2ppqa1          81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK  160 (316)
T ss_dssp             BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred             ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence            110   0111334456677666644321100              00  0 0   000                  0011


Q ss_pred             HHHHHHHHHHHHHHHhhhc-CCCceEeeccCCCCEEecCCCCceeeeccccc
Q 013745          186 TRYRIVMGVARGLLYLHEE-APARIIHRDIKASNILLDEQLNPKISDFGLAR  236 (437)
Q Consensus       186 ~~~~i~~qi~~~L~~LH~~-~~~~iiHrDikp~NIll~~~~~~kl~DFGla~  236 (437)
                      .....+..+...+.-.... -+.++||+|+.++||+++++...-|.||+.+.
T Consensus       161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            1112222222222222221 24559999999999999988777899999875